PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tokuyama, Y; Horn, HF; Kawamura, K; Tarapore, P; Fukasawa, K				Tokuyama, Y; Horn, HF; Kawamura, K; Tarapore, P; Fukasawa, K			Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CELL-CYCLE; MAJOR NUCLEOLAR PROTEINS; PHASE-TRANSITION; ANIMAL-CELLS; S-PHASE; B23; INSTABILITY; TUMORS; CDC2; P53	The kinase activity of cyclin-dependent kinase 2 (CDK2)-cyclin E is required for centrosomes to initiate duplication. We have recently found that nucleophosmin (NPM/B23), a phosphoprotein primarily found in nucleolus, associates with unduplicated centrosomes and is a direct substrate of CDK2-cyclin E in centrosome duplication. Upon phosphorylation by CDK2-cyclin E, NPM/B23 dissociates from centrosomes, which is a prerequisite step for centrosomes to initiate duplication. Here, we identified that threonine 199 (Thr(199)) of NPM/B23 is the major phosphorylation target site of CDK2-cyclin E in vitro, and the same site is phosphorylated in vivo. NPM/T199A, a nonphosphorylatable NPM/B23 substitution mutant (Thr(199) --> Ala) acts as dominant negative when expressed in cells, resulting in specific inhibition of centrosome duplication. As expected, NPM/T199A remains associated with the centrosomes. These observations provide direct evidence that the CDK2 cyclin E-mediated phosphorylation on Thr(199) determines association and dissociation of NPM/B23 to the centrosomes, which is a critical control for the centrosome to initiate duplication.	Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Vontz Ctr Mol Studies, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Fukasawa, K (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Vontz Ctr Mol Studies, POB 670521, Cincinnati, OH 45267 USA.	Fukasawa.Kenji@uc.edu	Tarapore, Pheruza/A-8876-2013	Tarapore, Pheruza/0000-0003-0911-3661; Horn, Henning/0000-0002-5885-8996				BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Bornens Michel, 1992, P1; BRINKLEY BR, 1985, ANNU REV CELL BIOL, V1, P145, DOI 10.1146/annurev.cellbio.1.1.145; CARBONAROHALL D, 1993, ONCOGENE, V8, P1649; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; CHAN PK, 1990, BIOCHEM J, V270, P549, DOI 10.1042/bj2700549; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FUKASAWA K, 1994, CELL GROWTH DIFFER, V5, P1093; Fukasawa K, 1997, ONCOGENE, V15, P1295, DOI 10.1038/sj.onc.1201482; Higuchi R., 1989, PCR TECHNOLOGY, P61; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Jiang PS, 2000, CANCER LETT, V153, P151, DOI 10.1016/S0304-3835(00)00362-1; JOSHI HC, 1994, CURR OPIN CELL BIOL, V6, P55, DOI 10.1016/0955-0674(94)90116-3; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Lange BMH, 1996, TRENDS CELL BIOL, V6, P348, DOI 10.1016/0962-8924(96)10033-7; LEWIN B, 1990, CELL, V61, P743, DOI 10.1016/0092-8674(90)90181-D; Lingle WL, 1999, AM J PATHOL, V155, P1941, DOI 10.1016/S0002-9440(10)65513-7; MARRACCINO RL, 1992, MOL BIOL CELL, V3, P389, DOI 10.1091/mbc.3.4.389; MAZIA D, 1987, INT REV CYTOL, V100, P49; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Mussman JG, 2000, ONCOGENE, V19, P1635, DOI 10.1038/sj.onc.1203460; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Nigg E A, 1988, Int Rev Cytol, V110, P27; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; Pihan GA, 1998, CANCER RES, V58, P3974; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; PRESTAYKO AW, 1974, BIOCHEMISTRY-US, V13, P1945, DOI 10.1021/bi00706a026; RAPPAPORT R, 1986, INT REV CYTOL, V105, P245, DOI 10.1016/S0074-7696(08)61065-7; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; SPECTOR DL, 1984, CHROMOSOMA, V90, P139, DOI 10.1007/BF00292451; Szebeni A, 1999, PROTEIN SCI, V8, P905; Takemura M, 1999, J BIOCHEM-TOKYO, V125, P904, DOI 10.1093/oxfordjournals.jbchem.a022367; Tournier Frederic, 1994, V13, P303; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vandre D.D., 1989, MITOSIS MOL MECHANIS, P39; Weber RG, 1998, CYTOGENET CELL GENET, V83, P266, DOI 10.1159/000015168; YUNG BYM, 1985, BIOCHIM BIOPHYS ACTA, V826, P167, DOI 10.1016/0167-4781(85)90002-8; Zatsepina OV, 1999, J CELL SCI, V112, P455	47	176	186	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21529	21537		10.1074/jbc.M100014200	http://dx.doi.org/10.1074/jbc.M100014200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11278991	hybrid			2022-12-27	WOS:000169297900098
J	Sixt, M; Hallmann, R; Wendler, O; Scharffetter-Kochanek, K; Sorokin, LM				Sixt, M; Hallmann, R; Wendler, O; Scharffetter-Kochanek, K; Sorokin, LM			Cell adhesion and migration properties of beta(2)-integrin negative polymorphonuclear granulocytes on defined extracellular matrix molecules - Relevance for leukocyte extravasation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-NEUTROPHILS; INTEGRIN ALPHA-6; SKELETAL-MUSCLE; LAMININ ALPHA-1; EXPRESSION; BINDING; MOUSE; CHAINS; COLLAGEN; IDENTIFICATION	Regulated adhesion of leukocytes to the extracellular matrix is essential for transmigration of blood vessels and subsequent migration into the stroma of inflamed tissues. Although beta (2)-integrins play an indisputable role in adhesion of polymorphonuclear granulocytes (PMN) to endothelium, we show here that beta (1)- and beta (3)-integrins but not beta (2)-integrin are essential for the adhesion to and migration on extracellular matrix molecules of the endothelial cell basement membrane and subjacent interstitial matrix. Mouse wild type and beta (2)-integrin null PMN and the progranulocytic cell line 32DC13 were employed in in vitro adhesion and migration assays using extracellular matrix molecules expressed at sites of extravasation in vivo, in particular the endothelial cell laminins 8 and 10, Wild type and beta (2)-integrin null PMN showed the same pattern of ECM binding, indicating that beta (2)-integrins do not mediate specific adhesion of PMN to the extracellular matrix molecules tested; binding was observed to the interstitial matrix molecules, fibronectin and vitronectin, via integrins alpha (5)beta (1) and alpha (v)beta (3), respectively; to laminin 10 via alpha (6)beta (1); but not to laminins 1, 2, and 8, collagen type I and IV, perlecan, or tenascin-C, PMN binding to laminins 1, 2, and 8 could not be induced despite surface expression of functionally active integrin alpha (6)beta (1), a major laminin receptor, demonstrating that expression of alpha (6)beta (1) alone is insufficient for ligand binding and suggesting the involvement of accessory factors. Nevertheless, laminins 1, 8, and 10 supported PMN migration, indicating that differential cellular signaling via laminins is independent of the extent of adhesion. The data demonstrate that adhesive and nonadhesive interactions with components of the endothelial cell basement membrane and subjacent interstitium play decisive roles in controlling PMN movement into sites of inflammation and illustrate that beta (2)-integrins are not essential for such interactions.	Univ Erlangen Nurnberg, Interdisciplinary Ctr Clin Res, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Inst Expt Med, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany; Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Cologne	Sorokin, LM (corresponding author), Univ Erlangen Nurnberg, Interdisciplinary Ctr Clin Res, Nikolaus Fiebiger Ctr, Gluckstr 6, D-91054 Erlangen, Germany.		Sixt, Michael/F-3925-2010	Sixt, Michael/0000-0002-6620-9179; Sorokin, Lydia/0000-0001-7704-7921; Wendler, Olaf/0000-0002-5443-4889				ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; AUMAILLEY M, 1987, J BIOL CHEM, V262, P11532; Aumailley M, 1998, J ANAT, V193, P1, DOI 10.1046/j.1469-7580.1998.19310001.x; AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D; AUMAILLEY M, 1990, EXP CELL RES, V188, P55, DOI 10.1016/0014-4827(90)90277-H; Bazzoni G, 1999, CURR OPIN CELL BIOL, V11, P573, DOI 10.1016/S0955-0674(99)00023-X; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Canfield SM, 1999, J IMMUNOL, V163, P3430; DELWEL GO, 1996, ADHESION RECEPTORS T, P9; DURR J, 1993, EXP CELL RES, V207, P235, DOI 10.1006/excr.1993.1189; EBLE JA, 1997, INTEGRIN LIGAND INTE, P123; EBLE JA, 1997, INTEGRIN LIGAND INTE, P1; EKBLOM PKG, 1991, DEV VASCULAR SYSTEM, V14, P81; Frieser M, 1996, EUR J IMMUNOL, V26, P3127, DOI 10.1002/eji.1830261245; Frieser M, 1997, EUR J BIOCHEM, V246, P727, DOI 10.1111/j.1432-1033.1997.t01-1-00727.x; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GALLIANO MF, 1995, J BIOL CHEM, V270, P21820, DOI 10.1074/jbc.270.37.21820; GU Y, 1999, BLOOD, V93, P1; GULLBERG D, 1992, EMBO J, V11, P3865, DOI 10.1002/j.1460-2075.1992.tb05479.x; Hangan D, 1997, CANCER RES, V57, P3812; HANSELL P, 1994, J LEUKOCYTE BIOL, V56, P464, DOI 10.1002/jlb.56.4.464; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; JOHANSSON S, 1984, J CELL BIOL, V98, P810, DOI 10.1083/jcb.98.3.810; Kaji T, 2000, J BIOL CHEM, V275, P1463, DOI 10.1074/jbc.275.2.1463; Kikkawa Y, 2000, J CELL SCI, V113, P869; KLEIN G, 1995, MATRIX BIOL, V14, P457, DOI 10.1016/0945-053X(95)90003-9; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853; KRAMER MD, 1993, INT CONGR SER, V1042, P295; KUBES P, 1995, FASEB J, V9, P1103; Lefebvre O, 1999, DEV BIOL, V210, P135, DOI 10.1006/dbio.1999.9270; LEIVO I, 1988, P NATL ACAD SCI USA, V85, P1544, DOI 10.1073/pnas.85.5.1544; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; MONBOISSE JC, 1991, J LEUKOCYTE BIOL, V50, P373, DOI 10.1002/jlb.50.4.373; Nelimarkka L, 1997, J BIOL CHEM, V272, P12730, DOI 10.1074/jbc.272.19.12730; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; PAULSSON M, 1989, J BIOL CHEM, V264, P18726; PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x; Pedraza C, 2000, J IMMUNOL, V165, P5831, DOI 10.4049/jimmunol.165.10.5831; PFAFF M, 1994, J BIOL CHEM, V269, P20233; Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244; Rosenblatt S, 1997, BIOCHEM J, V324, P311, DOI 10.1042/bj3240311; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; SCHULER F, 1995, J CELL SCI, V108, P3795; Skubitz KM, 1996, J IMMUNOL, V157, P3617; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SOROKIN L, 1994, EUR J BIOCHEM, V223, P603, DOI 10.1111/j.1432-1033.1994.tb19031.x; Sorokin LM, 2000, EXP CELL RES, V256, P500, DOI 10.1006/excr.2000.4842; Sorokin LM, 1997, DEV DYNAM, V210, P446, DOI 10.1002/(SICI)1097-0177(199712)210:4<446::AID-AJA8>3.0.CO;2-G; SOROKIN LM, 1992, EXP CELL RES, V201, P137, DOI 10.1016/0014-4827(92)90357-E; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STEWART M, 1995, CURR OPIN CELL BIOL, V7, P690, DOI 10.1016/0955-0674(95)80111-1; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9; TOKIDA Y, 1990, J BIOL CHEM, V265, P18123; Vaday GG, 2000, J LEUKOCYTE BIOL, V67, P149, DOI 10.1002/jlb.67.2.149; VALTIERI M, 1987, J IMMUNOL, V138, P3829; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331; WALZOG B, 1995, EXP CELL RES, V218, P28, DOI 10.1006/excr.1995.1127; WARNER NL, 1969, J NATL CANCER I, V43, P963; Weismann M, 1997, J IMMUNOL, V158, P1618; Werb Z, 1998, ANN NY ACAD SCI, V857, P110, DOI 10.1111/j.1749-6632.1998.tb10111.x; Werr J, 1998, J EXP MED, V187, P2091, DOI 10.1084/jem.187.12.2091; Werr J, 2000, BLOOD, V95, P1804, DOI 10.1182/blood.V95.5.1804.005k11_1804_1809	70	98	100	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18878	18887		10.1074/jbc.M010898200	http://dx.doi.org/10.1074/jbc.M010898200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278780	hybrid			2022-12-27	WOS:000169091000032
J	Le Naour, F; Hohenkirk, L; Grolleau, A; Misek, DE; Lescure, P; Geiger, JD; Hanash, S; Beretta, L				Le Naour, F; Hohenkirk, L; Grolleau, A; Misek, DE; Lescure, P; Geiger, JD; Hanash, S; Beretta, L			Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; CALCIUM-BINDING PROTEINS; CANCER-IMMUNOTHERAPY; ARACHIDONIC-ACID; TUMOR-GROWTH; IN-VITRO; CALRETICULIN; IMMUNITY; METABOLISM; GENERATION	Dendritic cells (DCs) are antigen-presenting cells that play major role in initiating primary immune responses. We have utilized two independent approaches, DNA microarrays and proteomics, to analyze the expression profile of human CD14(+) blood monocytes and their derived DCs. Analysis of gene expression changes at the RNA level using oligonucleotide microarrays complementary to 6300 human genes showed that similar to 40% of the genes were expressed in DCs, A total of 255 genes (4%) were found to be regulated during DC differentiation or maturation. Most of these genes were not previously associated with DCs and included genes encoding secreted proteins as well as genes involved in cell adhesion, signaling, and lipid metabolism. Protein analysis of the same cell populations was done using two-dimensional gel electrophoresis. A total of 900 distinct protein spots were included, and 4% of them exhibited quantitative changes during DC differentiation and maturation. Differentially expressed proteins were identified by mass spectrometry and found to represent proteins with Ca2+ binding, fatty acid binding, or chaperone activities as well as proteins involved in cell motility, In addition, proteomic analysis provided an assessment of post-translational modifications. The chaperone protein, calreticulin, was found to undergo cleavage, yielding a novel form. The combined oligonucleotide microarray and proteomic approaches have uncovered novel genes associated with DC differentiation and maturation and has allowed analysis of post-translational modifications of specific proteins as part of these processes.	Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Beretta, L (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	berettal@umich.edu	Julius, Annabelle/A-7276-2010	Laura, Beretta/0000-0002-2054-684X				Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Avigan D, 1999, BLOOD REV, V13, P51, DOI 10.1016/S0268-960X(99)90023-1; BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Basu S, 1999, J EXP MED, V189, P797, DOI 10.1084/jem.189.5.797; Borkakoti N, 1998, PROG BIOPHYS MOL BIO, V70, P73, DOI 10.1016/S0079-6107(98)00003-0; Chen BG, 1998, BLOOD, V91, P4652, DOI 10.1182/blood.V91.12.4652.412a03_4652_4661; Clarkson MR, 1998, NEPHROL DIAL TRANSPL, V13, P3043, DOI 10.1093/ndt/13.12.3043; Colaco CALS, 1998, CELL MOL BIOL, V44, P883; DWORNICZAK B, 1987, NUCLEIC ACIDS RES, V15, P5181, DOI 10.1093/nar/15.13.5181; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fearnley DB, 1997, BLOOD, V89, P3708, DOI 10.1182/blood.V89.10.3708.3708_3708_3716; Geiger J, 2000, LANCET, V356, P1163, DOI 10.1016/S0140-6736(00)02762-8; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Glatz JFC, 1996, PROG LIPID RES, V35, P243, DOI 10.1016/S0163-7827(96)00006-9; Gluckman JC, 1997, CYTOKINES CELL MOL T, V3, P187; Hanash S, 1998, GEL ELECTROPHORESIS, P189; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Hashimoto S, 1999, BLOOD, V94, P845, DOI 10.1182/blood.V94.3.845.415k09_845_852; JAATTELA M, 1993, J EXP MED, V177, P231, DOI 10.1084/jem.177.1.231; Kerkhoff C, 1999, J BIOL CHEM, V274, P32672, DOI 10.1074/jbc.274.46.32672; Klempt M, 1997, FEBS LETT, V408, P81, DOI 10.1016/S0014-5793(97)00394-3; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; KUHN H, 1995, J LIPID MEDIAT CELL, V12, P157, DOI 10.1016/0929-7855(95)00016-J; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Liang XL, 1996, ANAL CHEM, V68, P1012, DOI 10.1021/ac950685z; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; MANARA GC, 1993, BLOOD, V82, P2865; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; MING Z, 1993, J BIOL CHEM, V268, P35; Nair S, 1999, J IMMUNOL, V162, P6426; O'Donovan N, 1999, CYTOGENET CELL GENET, V84, P39, DOI 10.1159/000015209; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Pike SE, 1999, BLOOD, V94, P2461, DOI 10.1182/blood.V94.7.2461.419a26_2461_2468; Pike SE, 1998, J EXP MED, V188, P2349, DOI 10.1084/jem.188.12.2349; PRIETO J, 1989, SCAND J IMMUNOL, V29, P391, DOI 10.1111/j.1365-3083.1989.tb01138.x; Samali A, 1996, EXP CELL RES, V223, P163, DOI 10.1006/excr.1996.0070; Siegenthaler G, 1997, J BIOL CHEM, V272, P9371; Sigal E, 1994, Adv Prostaglandin Thromboxane Leukot Res, V22, P309; STAHLER JR, 1989, PROTEIN STRUCTURE PR, P65; STRAHLER JR, 1991, BIOCHEM BIOPH RES CO, V175, P134, DOI 10.1016/S0006-291X(05)81211-2; SUN HQ, 1995, J CELL BIOL, V129, P147, DOI 10.1083/jcb.129.1.147; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Timmerman JM, 1999, ANNU REV MED, V50, P507; Todryk S, 1999, J IMMUNOL, V163, P1398; Trahey M, 1999, P NATL ACAD SCI USA, V96, P3006, DOI 10.1073/pnas.96.6.3006; ULLRICH A, 1994, J BIOL CHEM, V269, P18401; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; Young J W, 1999, Curr Opin Hematol, V6, P135, DOI 10.1097/00062752-199905000-00003; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	53	193	207	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17920	17931		10.1074/jbc.M100156200	http://dx.doi.org/10.1074/jbc.M100156200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279020	hybrid			2022-12-27	WOS:000168866500043
J	Monje-Casas, F; Jurado, J; Prieto-Alamo, MJ; Holmgren, A; Pueyo, C				Monje-Casas, F; Jurado, J; Prieto-Alamo, MJ; Holmgren, A; Pueyo, C			Expression analysis of the nrdHIEF operon from Escherichia coli - Conditions that trigger the transcript level in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOTIDE REDUCTASE; SALMONELLA-TYPHIMURIUM; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; THIOREDOXIN; GLUTAREDOXIN; MUTAGENESIS; PCR; K-12-MUTANTS; GLUTATHIONE	Escherichia coli has two aerobic ribonucleotide reductases encoded by the nrdAB and nrdHIEF operons, While NrdAB is active during aerobiosis, NrdEF is considered a cryptic enzyme with no obvious function. Here, we present evidence that nrdHIEF expression might be important under certain circumstances. Basal transcript levels were dramatically enhanced (25-75-fold), depending on the growth-phase and the growth-medium composition. Likewise, a large increase of > 100-fold in nrdHIEF mRNA was observed in bacteria lacking Trx1 and Grx1, the two main NrdAB reductants. Moreover, nrdHIEF expression was triggered in response to oxidative stress, particularly in mutants missing hydroperoxidase I and alkyl-hydroperoxide reductase activities (69.7-fold) and in cells treated with oxidants (up to 23.4-fold over the enhanced transcript level possessed by cells grown on minimal medium). The mechanism(s) that triggers nrdHIEF expression remains unknown, but our findings exclude putative global regulators like RpoS, Fis, cAMP, OxyR, SoxR/S, or Reck What we have learned about nrdHIEF expression indicates strong differences between its regulation and that of the nrdAB operon and of genes coding for components of both thioredoxin/glutaredoxin pathways. We propose that E. coli might optimize the responses to different stimuli by co-evolving the expression levels for its multiple reductases and electron donors.	Univ Cordoba, Dept Bioquim & Biol Mol, E-14071 Cordoba, Spain; Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, S-17177 Stockholm, Sweden	Universidad de Cordoba; Karolinska Institutet	Pueyo, C (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Campus Rabanales,Edificio C-6,Planta 2A,Carretera, E-14071 Cordoba, Spain.		Monje-Casas, Fernando/M-3062-2014; Carpio, Juan Jurado/K-7808-2014; Prieto-Alamo, Maria Jose/K-6141-2014; Pueyo, Carmen/B-4509-2016	Monje-Casas, Fernando/0000-0002-3587-2373; Carpio, Juan Jurado/0000-0003-1701-8496; Prieto-Alamo, Maria Jose/0000-0002-8164-032X; Pueyo, Carmen/0000-0002-2624-2011				ABRIL N, 1992, ENVIRON MOL MUTAGEN, V19, P288, DOI 10.1002/em.2850190405; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; AUGUSTIN LB, 1994, J BACTERIOL, V176, P378, DOI 10.1128/JB.176.2.378-387.1994; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; Das KC, 2000, BIOCHEM BIOPH RES CO, V277, P443, DOI 10.1006/bbrc.2000.3689; EPE B, 1995, REV PHYSL BIOCH PHAR, V127, P223; EPSTEIN W, 1975, P NATL ACAD SCI USA, V72, P2300, DOI 10.1073/pnas.72.6.2300; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Friedberg E. C., 1995, DNA REPAIR MUTAGENES, P1; Gallardo-Madueno R, 1998, J BIOL CHEM, V273, P18382, DOI 10.1074/jbc.273.29.18382; GREENBERG JT, 1989, J BACTERIOL, V171, P3933, DOI 10.1128/jb.171.7.3933-3939.1989; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Jacobs PW, 1998, J MOL CATAL A-CHEM, V131, P5, DOI 10.1016/S1381-1169(97)00252-5; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Jordan A, 1996, MOL MICROBIOL, V19, P777, DOI 10.1046/j.1365-2958.1996.424950.x; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; LIN E, 1995, REGULATION GENE EXPR; MCCULLOCH RK, 1995, PCR METH APPL, V4, P219; MEIR E, 1985, CURR MICROBIOL, V12, P315, DOI 10.1007/BF01567889; Michan C, 1999, J BACTERIOL, V181, P2759; Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841; MirandaVizuete A, 1996, J BIOL CHEM, V271, P19099, DOI 10.1074/jbc.271.32.19099; MIRANDAVIZUETE A, 1994, J BIOL CHEM, V269, P16631; Prieto-Alamo MJ, 2000, J BIOL CHEM, V275, P13398, DOI 10.1074/jbc.275.18.13398; PRIETOALAMO MJ, 1993, CARCINOGENESIS, V14, P237, DOI 10.1093/carcin/14.2.237; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; PUEYO C, 2001, IN PRESS METHODS ENZ; RAEYMAEKERS L, 1993, ANAL BIOCHEM, V214, P582, DOI 10.1006/abio.1993.1542; ROSNER JL, 1994, ANTIMICROB AGENTS CH, V38, P1829, DOI 10.1128/AAC.38.8.1829; Ruiz-Laguna J, 2000, ENVIRON MOL MUTAGEN, V35, P22, DOI 10.1002/(SICI)1098-2280(2000)35:1<22::AID-EM4>3.0.CO;2-X; SPECTOR A, 1988, J BIOL CHEM, V263, P4984; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Takemoto T, 1998, FREE RADICAL BIO MED, V24, P556, DOI 10.1016/S0891-5849(97)00287-6; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; TSANEVA IR, 1990, J BACTERIOL, V172, P4197, DOI 10.1128/jb.172.8.4197-4205.1990	42	78	81	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18031	18037		10.1074/jbc.M011728200	http://dx.doi.org/10.1074/jbc.M011728200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278973	hybrid			2022-12-27	WOS:000168866500056
J	Ito, A; Levery, SB; Saito, S; Satoh, M; Hakomori, S				Ito, A; Levery, SB; Saito, S; Satoh, M; Hakomori, S			A novel ganglioside isolated from renal cell carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; NUCLEAR MAGNETIC-RESONANCE; GLOBE-SERIES GANGLIOSIDES; STRUCTURE ELUCIDATION; CLINICAL-SIGNIFICANCE; SPECTROSCOPY; RESOLUTION; GLYCOLIPIDS; GLYCOSPHINGOLIPIDS; H-1-NMR	In renal cell carcinoma (RCC), the level of higher gangliosides is correlated with degree of metastatic potential, and cell lines derived from metastatic deposits of RCC are characterized by high expression of disialogangliosides (Saito, S,, Orikasa, S., Ohyama, C., Satoh, M,, and Fukushi, Y. (1991) Int. J. Cancer 49, 329-334 and Saito, S., Orikasa, S., Satoh, M., Ohyama, C., Ito, A., and Takahashi, T, (1997) Jpn. J. Cancer Res. (Gann) 88, 652-659). We now report two disialogangliosides, G1 and G2, found in the RCC cell line TOS-1, G1 from TOS-1 cells was characterized as having a novel hybrid structure between ganglio-series (region I as in Structure I; same as the terminal structure of ganglioside GM2), and the lacto-series type 1 (region II). The characterization was based on reactivity with various monoclonal antibodies (mAbs) with defined epitope specificity, as well as monosaccharide and fatty acid component analysis, H-1 NMR spectroscopy, and electrospray ionization mass spectrometry of the intact compound. G1 showed strong reactivity with mAb RM2, raised originally against TOS-1 cells, and weak cross-reactivity with anti-GM2 mAb MK-1-8. The antigen is hereby termed GalNAc disialosyl Lc(4)Cer (IV(4)GalNAcIV(3)NeuAcIII(6)NeuAcLc(4); abbreviated GalNAcDSLc(4)). [GRAPHICS] G2 was identified by H-1 NMR and mass spectrometry as having a structure similar to Structure I but without the GalNAc beta1 -->4 substitution and showed strong reactivity with mAb FH9 reported previously to be specific for disialosyl lacto-series type 1 (disialosyl Lc(4)) having vicinal alpha2 -->3 and alpha2 -->6 sialosyl residues, an antigen associated with human colonic cancer. Clinicopathological studies indicate that expression of these disialoganglioside antigems in RCC tissue is correlated with the metastatic potential of RCC.	Univ Washington, Pacific NW Res Inst, Div Biomembrane Res, Seattle, WA 98122 USA; Univ Washington, Dept Pathobiol, Seattle, WA 98122 USA; Univ Washington, Dept Microbiol, Seattle, WA 98122 USA; Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Tohoku Univ, Sch Med, Dept Urol, Aoba Ku, Sendai, Miyagi 9808574, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University System of Georgia; University of Georgia; Tohoku University	Hakomori, S (corresponding author), Univ Washington, Pacific NW Res Inst, Div Biomembrane Res, Seattle, WA 98122 USA.			Saito, Seiichi/0000-0001-8734-4591; Ito, Akihiro/0000-0001-7224-1100	NATIONAL CANCER INSTITUTE [R01CA082167] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NCI NIH HHS [CA82167, CA80054] Funding Source: Medline; NCRR NIH HHS [P41 RR005351] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ADAMS J, 1993, MASS SPECTROM REV, V12, P51, DOI 10.1002/mas.1280120103; Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; ANDO S, 1989, J BIOL CHEM, V264, P3478; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BRODT P, 1996, CELL ADHESION INVASI, P167; Bush CA, 1988, B MAGN RESON, V10, P73; COSTELLO CE, 1990, METHOD ENZYMOL, V193, P738, DOI 10.1016/0076-6879(90)93448-T; DABROWSKI J, 1980, BIOCHEMISTRY-US, V19, P5652, DOI 10.1021/bi00565a030; DABROWSKI J, 1981, ARCH BIOCHEM BIOPHYS, V210, P405, DOI 10.1016/0003-9861(81)90203-4; DEGASPERI R, 1987, J BIOL CHEM, V262, P17149; DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUKUSHI Y, 1986, J UROLOGY, V135, P1048, DOI 10.1016/S0022-5347(17)45973-8; FUKUSHI Y, 1989, J NATL CANCER I, V81, P352, DOI 10.1093/jnci/81.5.352; FUKUSHI Y, 1986, BIOCHEMISTRY-US, V25, P2859, DOI 10.1021/bi00358a018; Hakomori S, 1996, CANCER RES, V56, P5309; HOLMES EH, 1989, ARCH BIOCHEM BIOPHYS, V274, P14, DOI 10.1016/0003-9861(89)90410-4; Hsu FF, 2001, J AM SOC MASS SPECTR, V12, P61, DOI 10.1016/S1044-0305(00)00194-X; KANNAGI R, 1984, J BIOL CHEM, V259, P8444; Kannagi R, 1997, GLYCOCONJUGATE J, V14, P577, DOI 10.1023/A:1018532409041; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2687, DOI 10.1021/bi00280a015; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; Levery SB, 1998, BIOCHEMISTRY-US, V37, P8764, DOI 10.1021/bi9730083; Levery SB, 2000, RAPID COMMUN MASS SP, V14, P551, DOI 10.1002/(SICI)1097-0231(20000415)14:7<551::AID-RCM909>3.3.CO;2-C; LEVERY SB, 1994, ARCH BIOCHEM BIOPHYS, V312, P125, DOI 10.1006/abbi.1994.1290; LEVERY SB, 1991, GLYCOCONJUGATE J, V8, P484, DOI 10.1007/BF00769848; LEVERY SB, 1988, CARBOHYD RES, V178, P121, DOI 10.1016/0008-6215(88)80106-X; MAGNANI JL, 1980, ANAL BIOCHEM, V109, P399, DOI 10.1016/0003-2697(80)90667-3; NAKAO T, 1993, J BIOL CHEM, V268, P21028; OSTRANDER GK, 1988, J BIOL CHEM, V263, P18716; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; SAITO S, 1994, J BIOL CHEM, V269, P5644; SAITO S, 1991, INT J CANCER, V49, P329; Saito S, 1997, JPN J CANCER RES, V88, P652, DOI 10.1111/j.1349-7006.1997.tb00433.x; Satoh M, 1996, CANCER RES, V56, P1932; Satoh M, 1999, TOHOKU J EXP MED, V189, P95, DOI 10.1620/tjem.189.95; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Stroud MR, 1996, BIOCHEMISTRY-US, V35, P758, DOI 10.1021/bi951600r	40	50	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16695	16703		10.1074/jbc.M011791200	http://dx.doi.org/10.1074/jbc.M011791200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278988	Green Published, hybrid			2022-12-27	WOS:000168730400016
J	Ito, K; Olsen, SL; Qiu, W; Deeley, RG; Cole, SPC				Ito, K; Olsen, SL; Qiu, W; Deeley, RG; Cole, SPC			Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT TRANSPORT; P-GLYCOPROTEIN; PHARMACOLOGICAL CHARACTERIZATION; SUBSTRATE-SPECIFICITY; TRANSMEMBRANE DOMAIN; MEMBRANE TOPOLOGY; LEUKOTRIENE C-4; MRP; GLUTATHIONE; BINDING	Multidrug resistance protein 1 (MRP1/ABCC1) belongs to the ATP-binding cassette transporter superfamily and is capable of conferring resistance to a broad range of chemotherapeutic agents and transporting structurally diverse conjugated organic anions. In this study, we found that substitution of a highly conserved tryptophan at position 1246 with cysteine (W1246C-MRP1) in the putative last transmembrane segment (TM17) of MRP1 eliminated 17 beta -estradiol 17-(beta -D-glucuronide) (E(2)17 betaG) transport by membrane vesicles prepared from transiently transfected human embryonic kidney cells while leaving the capacity for leukotriene C-4- and verapamil-stimulated glutathione transport intact. In addition, in contrast to wild-type MRP1, leukotriene C-4 transport by the W1246C-MRP1 protein was no longer inhibitable by E(2)17 betaG, indicating that the mutant protein had lost the ability to bind the glucuronide. A similar phenotype was observed when Trp(1246) was replaced with Ale, Phe, and Tyr. Confocal microscopy of cells expressing Trp(1246) mutant MRP1 molecules fused at the C terminus with green fluorescent protein showed that they were correctly routed to the plasma membrane. In addition to the loss of E(2)17 betaG transport, HeLa cells stably transfected with W1246C-MRP1 cDNA were not resistant to the Vinca alkaloid vincristine and accumulated levels of [H-3]vincristine comparable to those in vector control-transfected cells. Cells expressing W1246C-MRP1 were also not resistant to cationic anthracyclines (doxorubicin, daunorubicin) or the electroneutral epipodophyllotoxin VP-16. In contrast, resistance to sodium arsenite was only partially diminished, and resistance to potassium antimony tartrate remained comparable to that of cells expressing wild-type MRP1. This suggests that the structural determinants required for transport of heavy metal oxyanions differ from those for chemotherapeutic agents. Our results provide the first example of a tryptophan residue being so critically important for substrate specificity in a eukaryotic ATP-binding cassette transporter.	Queens Univ, Canc Res Labs, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Cole, SPC (corresponding author), Queens Univ, Canc Res Labs, Botterell Hall,Rm 328, Kingston, ON K7L 3N6, Canada.	coles@post.queensu.ca	Cole, Susan P.C./I-6389-2017; Deeley, Roger/J-4828-2012	Cole, Susan P.C./0000-0001-6571-6884; 				Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Bakos E, 2000, MOL PHARMACOL, V57, P760, DOI 10.1124/mol.57.4.760; Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1991, CANCER RES, V51, P3345; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; COLE SPC, 1990, CANCER CHEMOTH PHARM, V26, P250, DOI 10.1007/BF02897225; Cui YH, 1999, MOL PHARMACOL, V55, P929; Gao M, 1998, J BIOL CHEM, V273, P10733, DOI 10.1074/jbc.273.17.10733; Gottesman MM, 1996, CURR OPIN GENET DEV, V6, P610, DOI 10.1016/S0959-437X(96)80091-8; GRANT CE, 1994, CANCER RES, V54, P357; Hafkemeyer P, 1998, BIOCHEMISTRY-US, V37, P16400, DOI 10.1021/bi980871+; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1999, J BIOL CHEM, V274, P15420, DOI 10.1074/jbc.274.22.15420; Hipfner DR, 1996, CANCER RES, V56, P3307; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; Hirohashi T, 1999, J BIOL CHEM, V274, P15181, DOI 10.1074/jbc.274.21.15181; Hooijberg JH, 1997, FEBS LETT, V413, P344, DOI 10.1016/S0014-5793(97)00940-X; ITO K, 2000, P AM ASSOC CANC RES, V41, P4297; ITO K, 2000, P AM ASSOC CANC RES, V41, P674; JEDLITSCHKY G, 1994, CANCER RES, V54, P4833; Keppler D, 1997, BIOL CHEM, V378, P787; Konig J, 1999, BBA-BIOMEMBRANES, V1461, P377, DOI 10.1016/S0005-2736(99)00169-8; Kool M, 1999, P NATL ACAD SCI USA, V96, P6914, DOI 10.1073/pnas.96.12.6914; Loe DW, 2000, BIOCHEM BIOPH RES CO, V275, P795, DOI 10.1006/bbrc.2000.3384; Loe DW, 2000, J PHARMACOL EXP THER, V293, P530; Loe DW, 1997, MOL PHARMACOL, V51, P1034, DOI 10.1124/mol.51.6.1034; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Loe DW, 1998, CANCER RES, V58, P5130; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; LOO TW, 1993, J BIOL CHEM, V268, P19965; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; Renes J, 1999, BRIT J PHARMACOL, V126, P681, DOI 10.1038/sj.bjp.0702360; Ryu S, 2000, J BIOL CHEM, V275, P39617, DOI 10.1074/jbc.M005149200; Stride BD, 1997, MOL PHARMACOL, V52, P344, DOI 10.1124/mol.52.3.344; Suzuki H, 1998, SEMIN LIVER DIS, V18, P359, DOI 10.1055/s-2007-1007170; Taniguchi K, 1996, CANCER RES, V56, P4124; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; Zhang DW, 2001, J BIOL CHEM, V276, P13231, DOI 10.1074/jbc.M010008200; ZHANG XP, 1995, J BIOL CHEM, V270, P5441, DOI 10.1074/jbc.270.10.5441; Zheleznova EE, 2000, TRENDS BIOCHEM SCI, V25, P39, DOI 10.1016/S0968-0004(99)01514-5	41	135	137	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15616	15624		10.1074/jbc.M011246200	http://dx.doi.org/10.1074/jbc.M011246200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278867	hybrid			2022-12-27	WOS:000168623100009
J	Martin, AG; San-Antonio, B; Fresno, M				Martin, AG; San-Antonio, B; Fresno, M			Regulation of nuclear factor kappa B transactivation - Implication of phosphatidylinositol 3-kinase and protein kinase C xi IN c-Rel activation by tumor necrosis factor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; TRANSCRIPTION FACTOR-IIB; SIGNAL-TRANSDUCTION; V-REL; PHOSPHORYLATION; ZETA; DOMAIN; P65; ONCOPROTEIN; CELLS	Transactivation by c-Rel (nuclear factor kappaB) was dependent on phosphorylation of several serines in the transactivation domain, indicating that it is a phosphorylation-dependent Ser-rich domain. By Ser --> Ala mutational and deletion analysis, we have identified two regions in this domain: 1) a C-terminal region (amino acids 540-588), which is required for basal activity; and 2) the 422-540 region, which responds to external stimuli as tumor necrosis factor (TNF) alpha or phorbol myristate acetate plus ionomycin. Ser from 454 to 473 were shown to be required for TNF alpha -induced activation, whereas Ser between 492 and 519 were required for phorbol myristate acetate plus ionomycin activation. Phosphatidylinositol S-kinase (PI3K) and protein kinase C (PKC) zeta were identified as downstream signaling molecules of TNF alpha -activation of c-Rel transactivating activity. Interestingly, dominant negative forms of PI3K inhibited PKC zeta activation and dominant negative PKC zeta inhibited PI3K-mediated activation of c-Rel transactivating activity, indicating a cross-talk between both enzymes. We have identified the critical role of different Ser for PKC zeta- and PI3K-mediated responses. Interestingly, those c-Rel mutants not only did not respond to TNF alpha but also acted as dominant negative forms of nuclear factor kappaB activation.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Fresno, M (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Cantoblanco, Madrid 28049, Spain.			Fresno Escudero, Manuel/0000-0002-9223-5477				Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BULL P, 1990, MOL CELL BIOL, V10, P5473, DOI 10.1128/MCB.10.10.5473; Chen CL, 1999, MOL CELL BIOL, V19, P307; Chen E, 1998, J BIOL CHEM, V273, P35201, DOI 10.1074/jbc.273.52.35201; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; DOMINGUEZ I, 1993, MOL CELL BIOL, V13, P1290, DOI 10.1128/MCB.13.2.1290; Folgueira L, 1996, J VIROL, V70, P223, DOI 10.1128/JVI.70.1.223-231.1996; Gerondakis S, 1996, P NATL ACAD SCI USA, V93, P3405, DOI 10.1073/pnas.93.8.3405; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GREENBLATT J, 1992, NATURE, V360, P16, DOI 10.1038/360016a0; HAHN S, 1993, CELL, V72, P481, DOI 10.1016/0092-8674(93)90064-W; Hiramoto M, 1998, J IMMUNOL, V160, P810; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; ISHIKAWA H, 1993, ONCOGENE, V8, P2889; Kaliman P, 1999, J BIOL CHEM, V274, P17437, DOI 10.1074/jbc.274.25.17437; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; KERR LD, 1993, NATURE, V365, P412, DOI 10.1038/365412a0; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Martin AG, 2000, J BIOL CHEM, V275, P24383, DOI 10.1074/jbc.M909396199; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Norris JL, 1999, J BIOL CHEM, V274, P13841, DOI 10.1074/jbc.274.20.13841; Ozes ON, 1999, NATURE, V401, P82; PIMENTELMUINOS FX, 1995, EUR J IMMUNOL, V25, P179, DOI 10.1002/eji.1830250130; Reddy SAG, 2000, J IMMUNOL, V164, P1355, DOI 10.4049/jimmunol.164.3.1355; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; SCHMITZ ML, 1995, IMMUNOBIOLOGY, V193, P116, DOI 10.1016/S0171-2985(11)80534-6; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; SCHMITZ ML, 1995, J BIOL CHEM, V270, P15576, DOI 10.1074/jbc.270.26.15576; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; XU X, 1993, MOL CELL BIOL, V13, P6733, DOI 10.1128/MCB.13.11.6733; YANO O, 1987, EMBO J, V6, P3317, DOI 10.1002/j.1460-2075.1987.tb02652.x; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	47	86	88	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15840	15849		10.1074/jbc.M011313200	http://dx.doi.org/10.1074/jbc.M011313200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278885	hybrid			2022-12-27	WOS:000168623100037
J	Moor, AN; Gan, XHT; Karmazyn, M; Fliegel, L				Moor, AN; Gan, XHT; Karmazyn, M; Fliegel, L			Activation of Na+/H+ exchanger-directed protein kinases in the ischemic and ischemic-reperfused rat myocardium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASES; SODIUM-HYDROGEN EXCHANGE; RIBOSOMAL S6 KINASE; SMOOTH-MUSCLE CELLS; CARDIAC MYOCYTES; H+ EXCHANGER; INTRACELLULAR PH; STIMULATION; STRESS; HEARTS	The activity of the Na+/H+ exchanger has been implicated as an important contributing factor in damage to the myocardium that occurs during ischemia and reperfusion. We examined regulation of the protein in ischemic and reperfused isolated hearts and isolated ventricular myocytes. In isolated myocytes, extracellular signal-regulated kinases were important in regulating activity of the exchanger after recovery from ischemia. Ischemia followed by reperfusion caused a strong inhibitory effect on NHE1 activity that abated with continued reperfusion. Four major protein kinases of size 90, 55, 44, and 40 kDa phosphorylated the Na+/H+ exchanger. The Na+/H+ exchanger-directed kinases demonstrated dramatic increases in activity of 2-10-fold that was induced by 3 different models of ischemia and reperfusion in intact hearts and isolated myocytes, p90(rsk) was identified as the 90-kDa protein kinase activated by ischemia and reperfusion while ERK1/2 was identified as accounting for some of the 44-kDa protein kinase phosphorylating the Na+/H+ exchanger. The results demonstrate that MAPK-dependent pathways including p90(rsk) and ERK1/2 and are important in regulating the Na+/H+ exchanger and show their dramatic increase in activity toward the Na+/H+ exchanger during ischemia and reperfusion of the myocardium. They also show that ischemia followed by reperfusion have important inhibitory effects on Na+/H+ exchanger activity.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Western Ontario, Dept Pharmacol & Toxicol, London, ON N6A 5C1, Canada	University of Alberta; Western University (University of Western Ontario)	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.							Abe JI, 2000, J BIOL CHEM, V275, P1739, DOI 10.1074/jbc.275.3.1739; Aharonovitz O, 1996, J BIOL CHEM, V271, P16494, DOI 10.1074/jbc.271.28.16494; Avkiran M, 1999, AM J CARDIOL, V83, p10G; Bianchini L, 1997, J BIOL CHEM, V272, P271; Bogoyevitch MA, 1996, CIRC RES, V79, P162, DOI 10.1161/01.RES.79.2.162; BOND JM, 1993, AM J PHYSIOL, V265, pC129, DOI 10.1152/ajpcell.1993.265.1.C129; Clerk A, 1998, J BIOL CHEM, V273, P7228, DOI 10.1074/jbc.273.13.7228; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; FLIEGEL L, 1991, FEBS LETT, V279, P25, DOI 10.1016/0014-5793(91)80241-T; FLIEGEL L, 1992, BIOCHEM J, V282, P139, DOI 10.1042/bj2820139; Fliegel L, 1997, J MOL CELL CARDIOL, V29, P1991, DOI 10.1006/jmcc.1997.0479; Fliegel L, 1996, NAPLUS HPLUS EXCHANG, P1; Gan XHT, 1999, AM J PHYSIOL-HEART C, V277, pH993, DOI 10.1152/ajpheart.1999.277.3.H993; Haworth RS, 1999, AM J PHYSIOL-CELL PH, V277, pC1202, DOI 10.1152/ajpcell.1999.277.6.C1202; IWAKURA K, 1990, EUR J PHARMACOL, V186, P29; Karmazyn M, 1999, CIRC RES, V85, P777, DOI 10.1161/01.RES.85.9.777; Karmazyn M., 1996, NAPLUS HPLUS EXCHANG, P189; KHANDOUDI N, 1994, CIRC RES, V75, P369, DOI 10.1161/01.RES.75.2.369; Knight RJ, 1996, BIOCHEM BIOPH RES CO, V218, P83, DOI 10.1006/bbrc.1996.0016; KRAMER BK, 1991, CIRC RES, V68, P269, DOI 10.1161/01.RES.68.1.269; Kusuhara M, 1998, CIRC RES, V83, P824, DOI 10.1161/01.RES.83.8.824; Meyer M, 1996, BASIC RES CARDIOL, V91, P86; Moor AN, 1999, J BIOL CHEM, V274, P22985, DOI 10.1074/jbc.274.33.22985; NOEL J, 1995, AM J PHYSIOL-CELL PH, V268, pC283, DOI 10.1152/ajpcell.1995.268.2.C283; Omura T, 1999, J MOL CELL CARDIOL, V31, P1269, DOI 10.1006/jmcc.1999.0959; Phan VN, 1997, HYPERTENSION, V29, P1265, DOI 10.1161/01.HYP.29.6.1265; Sabri A, 1998, CIRC RES, V82, P1053, DOI 10.1161/01.RES.82.10.1053; SARDET C, 1991, J BIOL CHEM, V266, P19166; Seko Y, 1996, CIRC RES, V78, P82, DOI 10.1161/01.RES.78.1.82; Shimizu N, 1998, CARDIOVASC RES, V38, P116, DOI 10.1016/S0008-6363(97)00327-1; Silva NLCL, 1997, PFLUG ARCH EUR J PHY, V433, P792, DOI 10.1007/s004240050347; Snabaitis AK, 2000, CIRC RES, V86, P214, DOI 10.1161/01.RES.86.2.214; Sugden PH, 1998, CIRC RES, V83, P345, DOI 10.1161/01.RES.83.4.345; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Takahashi E., 1997, HYPERTENSION, V29, P1265; TAKAICHI K, 1993, AM J PHYSIOL, V264, pC944, DOI 10.1152/ajpcell.1993.264.4.C944; Takeishi Y, 1999, CIRC RES, V85, P1164; TERZIC A, 1992, J PHYSIOL-LONDON, V447, P275, DOI 10.1113/jphysiol.1992.sp019002; WALLERT MA, 1992, AM J PHYSIOL, V263, pC1096, DOI 10.1152/ajpcell.1992.263.5.C1096; Wang H, 1997, BIOCHEMISTRY-US, V36, P9151, DOI 10.1021/bi970802f; Wang HY, 1997, J BIOL CHEM, V272, P26545, DOI 10.1074/jbc.272.42.26545; YASUTAKE M, 1995, CARDIOVASC RES, V29, P222, DOI 10.1016/S0008-6363(96)88574-9; Yin TG, 1997, J BIOL CHEM, V272, P19943, DOI 10.1074/jbc.272.32.19943	44	82	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16113	16122		10.1074/jbc.M100519200	http://dx.doi.org/10.1074/jbc.M100519200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279085	hybrid			2022-12-27	WOS:000168623100075
J	Loo, TW; Clarke, DM				Loo, TW; Clarke, DM			Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED ATPASE ACTIVITY; PREDICTED TRANSMEMBRANE DOMAIN; CYSTEINE-SCANNING MUTAGENESIS; HIV-1 PROTEASE INHIBITORS; DISULFIDE CROSS-LINKING; BLOOD-BRAIN-BARRIER; FUNCTIONAL CONSEQUENCES; SUBSTRATE-SPECIFICITY; LABELING SITES; TRANSPORTER	Defining the residues involved in the binding of a substrate provides insight into how the human multidrug resistance P-glycoprotein (P-gp) can transport a wide range of structurally diverse compounds out of the cell. Because verapamil is the most potent stimulator of P-gp ATPase activity, we synthesized a thiol-reactive analog of verapamil (MTS-verapamil) and used it with cysteine-scanning mutagenesis to identify the reactive residues within the drug-binding domain of P-gp. MTS-verapamil stimulated the ATPase activity of Cys-less P-gp and had a K-m value (25 muM) that was similar to that of verapamil, 252 P-gp mutants containing a single cysteine within the predicted transmembrane (TM) segments were expressed in HEK 293 cells and purified by nickel-chelate chromatography and assayed for inhibition by MTS-verapamil. The activities of 15 mutants, Y118C (TM2), V125C (TM2), S222C (TM4), L339C (TM6), A342C (TM6), A729C (TM7), A841C (TM9), N842C (TM9), I868C (TM10), A871C (TM10), F942C (TM11), T945C (TM11), V982C (TM12), G984C (TM12), and A985C (TM12), were inhibited by MTS-verapamil. Four mutants, S222C (TM4), L339C (TM6), A342C (TM6), and G984C (TM12), were significantly protected from inhibition by MTS-verapamil by pretreatment with verapamil, Less protection was observed in mutants I868C (TM10), F942C (TM11) and T945C (TM11). These results indicate that residues in TMs 4, 6, 10, 11, and 12 must contribute to the binding of verapamil.	Univ Toronto, Dept Med, Canadian Inst Hlth, Res Grp Membrane Biol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, Canadian Inst Hlth, Res Grp Membrane Biol, Rm 7342,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.		Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	NATIONAL CANCER INSTITUTE [R01CA080900] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA80900] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; BRUGGEMANN EP, 1992, J BIOL CHEM, V267, P21020; Bruice T.W., 1982, J PROTEIN CHEM, V1, P47, DOI DOI 10.1007/BF01025550; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Chen G, 1997, J BIOL CHEM, V272, P5974, DOI 10.1074/jbc.272.9.5974; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Degtiar VE, 1997, BIOPHYS J, V73, P157, DOI 10.1016/S0006-3495(97)78056-1; DEVINE SE, 1992, P NATL ACAD SCI USA, V89, P4564, DOI 10.1073/pnas.89.10.4564; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; DOIGE CA, 1993, BIOCHIM BIOPHYS ACTA, V1146, P65, DOI 10.1016/0005-2736(93)90339-2; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; GREENBERGER LM, 1993, J BIOL CHEM, V268, P11417; GROS P, 1991, P NATL ACAD SCI USA, V88, P7289, DOI 10.1073/pnas.88.16.7289; Hargreaves AC, 1996, MOL PHARMACOL, V50, P1284; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hockerman GH, 1997, J BIOL CHEM, V272, P18759, DOI 10.1074/jbc.272.30.18759; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Hrycyna CA, 1998, J BIOL CHEM, V273, P16631, DOI 10.1074/jbc.273.27.16631; KAJIJI S, 1993, BIOCHEMISTRY-US, V32, P4185, DOI 10.1021/bi00067a005; Kast C, 1996, J BIOL CHEM, V271, P9240, DOI 10.1074/jbc.271.16.9240; Kenyon G L, 1977, Methods Enzymol, V47, P407; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2000, J BIOL CHEM, V275, P19435, DOI 10.1074/jbc.C000222200; Loo TW, 1999, BBA-BIOMEMBRANES, V1461, P315, DOI 10.1016/S0005-2736(99)00165-0; Loo TW, 1999, J BIOL CHEM, V274, P35388, DOI 10.1074/jbc.274.50.35388; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; LOO TW, 1993, J BIOL CHEM, V268, P3143; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; Loo TW, 2000, J BIOL CHEM, V275, P5253, DOI 10.1074/jbc.275.8.5253; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Loo TW, 1998, J BIOL CHEM, V273, P32373, DOI 10.1074/jbc.273.49.32373; LOO TW, 1994, BIOCHEMISTRY-US, V33, P14049, DOI 10.1021/bi00251a013; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1994, J BIOL CHEM, V269, P7750; Loo TW, 2000, J BIOL CHEM, V275, P39272, DOI 10.1074/jbc.M007741200; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; LOO TW, 1993, J BIOL CHEM, V268, P19965; Martin C, 2000, MOL PHARMACOL, V58, P624, DOI 10.1124/mol.58.3.624; MORRIS DI, 1994, MOL PHARMACOL, V46, P329; Pascaud C, 1998, BIOCHEM J, V333, P351, DOI 10.1042/bj3330351; Rauer H, 1999, BRIT J PHARMACOL, V127, P1065, DOI 10.1038/sj.bjp.0702599; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; Robert J, 1999, EUR J CLIN INVEST, V29, P536, DOI 10.1046/j.1365-2362.1999.00495.x; Sahin-Toth M, 2000, P NATL ACAD SCI USA, V97, P10729, DOI 10.1073/pnas.200351797; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Shapiro AB, 1999, EUR J BIOCHEM, V259, P841, DOI 10.1046/j.1432-1327.1999.00098.x; Sharom FJ, 1997, J MEMBRANE BIOL, V160, P161, DOI 10.1007/s002329900305; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; ZHANG XP, 1995, J BIOL CHEM, V270, P5441, DOI 10.1074/jbc.270.10.5441; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6; Zhou Y, 1999, MOL CELL BIOL, V19, P1450	64	171	174	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14972	14979		10.1074/jbc.M100407200	http://dx.doi.org/10.1074/jbc.M100407200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279063	hybrid			2022-12-27	WOS:000168528800061
J	Kurokawa, Y; Yanagi, H; Yura, T				Kurokawa, Y; Yanagi, H; Yura, T			Overproduction of bacterial protein disulfide isomerase (DsbC) and its modulator (DsbD) markedly enhances periplasmic production of human nerve growth factor in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLO-BETA-LACTAMASE; HIGH-LEVEL EXPRESSION; IN-VIVO; BOND FORMATION; BACTEROIDES-FRAGILIS; ALKALINE-PHOSPHATASE; CYSTEINE RESIDUES; FOLDING CATALYSTS; ELECTRONS; CELL	Production of eukaryotic proteins with multiple disulfide bonds in the Escherichia coli periplasm often encounters difficulty in obtaining soluble products with native structure. Human nerve growth factor beta (NGF) contains three disulfide bonds between nonconsecutive cysteine residues and forms insoluble aggregates when expressed in E. coli. We now report that overexpression of Dsb proteins known to catalyze formation and isomerization of disulfide bonds can substantially enhance periplasmic production of NGF. A set of pACYC184-based plasmids that permit dsb expression under the araB promoter were introduced into cells carrying a compatible plasmid that expresses NGF. The efficiency of periplasmic production of NGF fused to the OmpT signal peptide was strikingly improved by coexpression of DsbCD or DsbABCD proteins (up to 80% of total NGF produced). Coexpression of DsbAB was hardly effective, whereas that of DsbAC increased the total yield but not the periplasmic expression. These results suggest synergistic roles of DsbC and DsbD in disulfide isomerization that appear to become limiting upon NGF production. Furthermore, recombinant NGF produced with excess DsbCD (or DsbABCD) was biologically active judged by the neurite outgrowth assay using rat PC12 cells.	HSP Res Inst, Kyoto 6008813, Japan		Yura, T (corresponding author), 12 Hazamacho,Sakyo Ku, Kyoto 6068071, Japan.							AKIYAMA Y, 1992, J BIOL CHEM, V267, P22440; ALKSNE LE, 1995, J BACTERIOL, V177, P462, DOI 10.1128/jb.177.2.462-464.1995; Alksne LE, 1996, J BACTERIOL, V178, P4306; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1994, MOL MICROBIOL, V14, P199, DOI 10.1111/j.1365-2958.1994.tb01281.x; BECK R, 1994, PROTEIN EXPRES PURIF, V5, P192, DOI 10.1006/prep.1994.1030; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Chung J, 2000, MOL MICROBIOL, V35, P1099, DOI 10.1046/j.1365-2958.2000.01778.x; FUJIMORI K, 1992, BIOSCI BIOTECH BIOCH, V56, P1985, DOI 10.1271/bbb.56.1985; Georgiou G, 1996, CURR OPIN BIOTECH, V7, P190, DOI 10.1016/S0958-1669(96)80012-7; HOCKNEY RC, 1994, TRENDS BIOTECHNOL, V12, P456, DOI 10.1016/0167-7799(94)90021-3; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Joly JC, 1998, P NATL ACAD SCI USA, V95, P2773, DOI 10.1073/pnas.95.6.2773; JOLY JC, 1994, BIOCHEMISTRY-US, V33, P4231, DOI 10.1021/bi00180a017; Kishigami S, 1996, GENES CELLS, V1, P201, DOI 10.1046/j.1365-2443.1996.d01-233.x; Kurokawa Y, 2000, APPL ENVIRON MICROB, V66, P3960, DOI 10.1128/AEM.66.9.3960-3965.2000; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Missiakas D, 1997, J BACTERIOL, V179, P2465, DOI 10.1128/jb.179.8.2465-2471.1997; MISSIAKAS D, 1994, EMBO J, V13, P2013, DOI 10.1002/j.1460-2075.1994.tb06471.x; MISSIAKAS D, 1995, EMBO J, V14, P3415, DOI 10.1002/j.1460-2075.1995.tb07347.x; Ostermeier M, 1996, J BIOL CHEM, V271, P10616, DOI 10.1074/jbc.271.18.10616; OSTERMEIER M, 1994, J BIOL CHEM, V269, P21072; PEREZPEREZ J, 1994, BIO-TECHNOL, V12, P178, DOI 10.1038/nbt0294-178; PEREZPEREZ J, 1995, GENE, V158, P141, DOI 10.1016/0378-1119(95)00127-R; PerezPerez J, 1996, J BIOTECHNOL, V49, P245, DOI 10.1016/0168-1656(96)83990-3; Qiu J, 1998, APPL ENVIRON MICROB, V64, P4891; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; SHEVCHIK VE, 1995, MOL MICROBIOL, V16, P745, DOI 10.1111/j.1365-2958.1995.tb02435.x; Sone M, 1997, J BIOL CHEM, V272, P10349; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Thomas JG, 1997, APPL BIOCHEM BIOTECH, V66, P197, DOI 10.1007/BF02785589; TOBE T, 1984, MOL GEN GENET, V195, P10, DOI 10.1007/BF00332716; WALKER KW, 1994, J BIOL CHEM, V269, P28487; WULFING C, 1994, J MOL BIOL, V242, P655, DOI 10.1006/jmbi.1994.1615; WUNDERLICH M, 1993, J BIOL CHEM, V268, P24547; YAMAMORI T, 1982, P NATL ACAD SCI-BIOL, V79, P860, DOI 10.1073/pnas.79.3.860; YANO R, 1990, J BACTERIOL, V172, P2124, DOI 10.1128/jb.172.4.2124-2130.1990; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019	41	61	73	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14393	14399		10.1074/jbc.M100132200	http://dx.doi.org/10.1074/jbc.M100132200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11279016	hybrid			2022-12-27	WOS:000168356600116
J	Malnasi-Csizmadia, A; Kovacs, M; Woolley, RJ; Botchway, SW; Bagshaw, CR				Malnasi-Csizmadia, A; Kovacs, M; Woolley, RJ; Botchway, SW; Bagshaw, CR			The dynamics of the relay loop tryptophan residue in the Dictyostelium myosin motor domain and the origin of spectroscopic signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; TIME-RESOLVED FLUORESCENCE; X-RAY STRUCTURES; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; MOLECULAR MOTOR; ATP HYDROLYSIS; LIGHT-CHAIN; DISCOIDEUM; PROTEINS	Steady-state and time-resolved fluorescence measurements were performed on a Dictyostelium discoideum myosin II motor domain construct retaining a single tryptophan residue at position 501, located on the relay loop. Other tryptophan residues were mutated to phe nylalanine, The Trp-501 residue showed a large enhancement in fluorescence in the presence of ATP and a small quench in the presence of ADP as a result of perturbing both the ground and excited state processes. Fluorescence lifetime and quantum yield measurements indicated that at least three microstates of Trp-801 were present in all nucleotide states examined, and these could not be assigned to a particular gross conformation of the motor domain. Enhancement in emission intensity was associated with a reduction of the contribution from a statically quenched component and an increase in a component with a 5-ns lifetime, with little change in the contribution from a 1-ns lifetime component, Anisotropy measurements indicated that the Trp-501 side chain was relatively immobile in all nucleotide states, and the fluorescence was effectively depolarized by rotation of the whole motor domain with a correlation time on 50-70 ns. Overall these data suggest that the backbone of the relay loop remains structured throughout the myosin ATPase cycle but that the Trp-801 side chain experiences a different weighting in local environments provided by surrounding residues as the adjacent converter domain rolls around the relay loop.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Rutherford Appleton Lab, Cent Laser Facil, Didcot OX11 0QX, Oxon, England; Eotvos Lorand Univ, Dept Biochem, H-1088 Budapest, Hungary	University of Leicester; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Eotvos Lorand University	Bagshaw, CR (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	crb5@le.ac.uk	Kovacs, Mihaly/A-6841-2011; Bagshaw, Clive R./L-5484-2019; Csizmadia, András Málnási/K-7632-2018	Bagshaw, Clive R./0000-0002-5396-153X; Csizmadia, András Málnási/0000-0002-2430-8398; Kovacs, Mihaly/0000-0002-1200-4741				BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; BAGSHAW CR, 1972, COLD SPRING HARB SYM, V37, P127; Baker JE, 1998, P NATL ACAD SCI USA, V95, P2944, DOI 10.1073/pnas.95.6.2944; Batra R, 1999, BIOL CHEM, V380, P1017, DOI 10.1515/BC.1999.126; Bauer CB, 1997, J MOL BIOL, V274, P394, DOI 10.1006/jmbi.1997.1325; BEECHEM JM, 1985, ANNU REV BIOCHEM, V54, P43, DOI 10.1146/annurev.biochem.54.1.43; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Dahms TES, 1997, METHOD ENZYMOL, V278, P202; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Gastmans M, 1999, PROTEINS, V35, P464, DOI 10.1002/(SICI)1097-0134(19990601)35:4<464::AID-PROT10>3.3.CO;2-Z; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Gulick AM, 2000, J BIOL CHEM, V275, P398, DOI 10.1074/jbc.275.1.398; Highsmith S, 2000, BIOCHEMISTRY-US, V39, P12330, DOI 10.1021/bi001146d; HIRATSUKA T, 1992, J BIOL CHEM, V267, P14949; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; JOHNSON KA, 1978, BIOCHEMISTRY-US, V17, P3432, DOI 10.1021/bi00610a002; LAKOWICZ JR, 1992, BIOPHYS CHEM, V45, P1, DOI 10.1016/0301-4622(92)87017-D; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; MORITA F, 1966, BIOCHEM BIOPH RES CO, V22, P297, DOI 10.1016/0006-291X(66)90481-5; Onishi H, 2000, P NATL ACAD SCI USA, V97, P11203, DOI 10.1073/pnas.200362897; Park S, 1997, BIOCHEMISTRY-US, V36, P3368, DOI 10.1021/bi9624999; Park S, 2000, BIOCHEMISTRY-US, V39, P11732, DOI 10.1021/bi000945t; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; ROSENFELD SS, 1994, J BIOL CHEM, V269, P30187; Shih WM, 2000, CELL, V102, P683, DOI 10.1016/S0092-8674(00)00090-8; Shih WM, 2001, J BIOL CHEM, V276, P19491, DOI 10.1074/jbc.M010887200; Sillen A, 2000, PROTEIN SCI, V9, P158; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; TORGERSON PM, 1984, BIOCHEMISTRY-US, V23, P3002, DOI 10.1021/bi00308a024; WERBER MM, 1972, BIOCHEMISTRY-US, V11, P2872, DOI 10.1021/bi00765a021; Yengo CM, 2000, J BIOL CHEM, V275, P25481, DOI 10.1074/jbc.M002910200	34	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19483	19490		10.1074/jbc.M010886200	http://dx.doi.org/10.1074/jbc.M010886200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278775	hybrid			2022-12-27	WOS:000169091000110
J	Okano, J; Rustgi, AK				Okano, J; Rustgi, AK			Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE; INDUCED APOPTOSIS; TAXOL; MICROTUBULES; BINDING; INVOLVEMENT; EXPRESSION; INHIBITOR	Paclitaxel is a widely used chemotherapeutic agent and is known to induce programmed cell death (apoptosis) in a variety of cell types, but the precise underlying mechanisms are poorly understood. To elucidate these mechanisms, we challenged human esophageal squamous cancer cell lines with paclitaxel and investigated its effects upon signal transduction pathways. Physiologically relevant concentrations of paclitaxel (1-1,000 nM) induced apoptosis, All three mitogen-activated protein kinase (MAPK) family members, c-Jun N-terminal kinase (JNK), p38 MAPK, and extracellular signal-regulated kinase (ERK) were activated upon paclitaxel treatment. Interestingly, JNK activation and p38 MAPK activation were delayed and peaked at 48 h, whereas ERK activity was sustained over 72 h, In addition, Ras activation and MAPK/ERK kinase (MEK) phosphorylation were observed in concordance with ERK activation. While ERK activation was completely ablated by MEK inhibitors, immunoprecipitation and Western blot analysis revealed that neither MEK-1 nor MEK-2 was involved, but instead another member of the MEK family may potentially participate. Although pretreatment with a general caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone rescued the cell death, it did not prevent Res or ERK activation. Furthermore, inhibition of JNK, p38 MAPK, or MEK did not alter PARP cleavage and the cell death induced by paclitaxel, These results in aggregate suggest that the delayed activation of JNK, p38 MAPK, and ERK was not linked to activation of the cell death machinery.	Univ Penn, Div Gastroenterol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Rustgi, AK (corresponding author), Univ Penn, Div Gastroenterol, 600A CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.	anil2@mail.med.upenn.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK57735, P30 DK 50306] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Andre N, 2000, CANCER RES, V60, P5349; Best A, 1996, J BIOL CHEM, V271, P3756; Bhat N, 1999, J IMMUNOL, V162, P7335; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Blagosklonny MV, 2000, LEUKEMIA, V14, P1502, DOI 10.1038/sj.leu.2401864; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Crown J, 2000, LANCET, V355, P1176, DOI 10.1016/S0140-6736(00)02074-2; CURSIO R, 2000, HEPATOLOGY, V32, P1029; Diaz JF, 2000, J BIOL CHEM, V275, P26265, DOI 10.1074/jbc.M003120200; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Fang M, 2000, ANTICANCER RES, V20, P103; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Foey AD, 1998, J IMMUNOL, V160, P920; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; GERERSCH E, 2000, J CELL SCI, V113, P4319; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Huang Y, 2000, CANCER RES, V60, P4426; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kalechman Y, 2000, INT J CANCER, V86, P281, DOI 10.1002/(SICI)1097-0215(20000415)86:2<281::AID-IJC20>3.0.CO;2-X; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Kuboki Y, 2000, J BIOL CHEM, V275, P39815, DOI 10.1074/jbc.C000403200; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kurokawa H, 2000, CANCER RES, V60, P5887; Lieu CH, 1998, CELL GROWTH DIFFER, V9, P767; Lou PJ, 2000, J CELL BIOCHEM, V79, P542, DOI 10.1002/1097-4644(20001215)79:4<542::AID-JCB30>3.0.CO;2-Q; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCawley LJ, 1999, J BIOL CHEM, V274, P4347, DOI 10.1074/jbc.274.7.4347; Ming XF, 1998, EMBO J, V17, P6039, DOI 10.1093/emboj/17.20.6039; Mitsuuchi Y, 2000, CANCER RES, V60, P5390; Mohr S, 1998, P NATL ACAD SCI USA, V95, P5045, DOI 10.1073/pnas.95.9.5045; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Page C, 2000, ANTICANCER RES, V20, P407; Paumelle R, 2000, MOL BIOL CELL, V11, P3751, DOI 10.1091/mbc.11.11.3751; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Punn A, 2000, BIOCHEM J, V350, P891, DOI 10.1042/0264-6021:3500891; Remacle-Bonnet MM, 2000, CANCER RES, V60, P2007; Rodi DJ, 1999, J MOL BIOL, V285, P197, DOI 10.1006/jmbi.1998.2303; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Shen SC, 1998, CELL GROWTH DIFFER, V9, P23; Shtil AA, 1999, ONCOGENE, V18, P377, DOI 10.1038/sj.onc.1202305; Subbaramaiah K, 2000, J BIOL CHEM, V275, P14838, DOI 10.1074/jbc.275.20.14838; Thissen JA, 1997, J BIOL CHEM, V272, P30362, DOI 10.1074/jbc.272.48.30362; Torocsik B, 2000, BIOCHEM BIOPH RES CO, V278, P550, DOI 10.1006/bbrc.2000.3836; Townsend KJ, 1998, ONCOGENE, V17, P1223, DOI 10.1038/sj.onc.1202035; Weiner LM, 1999, SEMIN ONCOL, V26, P106; Wu-Wong JR, 2000, J PHARMACOL EXP THER, V293, P514; Yang CPH, 2000, CANCER RES, V60, P5171; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhang ZQ, 2000, CANCER RES, V60, P901; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343; Zhu XY, 2000, ONCOGENE, V19, P4354, DOI 10.1038/sj.onc.1203781	57	101	105	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19555	19564		10.1074/jbc.M011164200	http://dx.doi.org/10.1074/jbc.M011164200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278851	hybrid			2022-12-27	WOS:000169091000119
J	Costas, AMG; White, AK; Metcalf, WW				Costas, AMG; White, AK; Metcalf, WW			Purification and characterization of a novel phosphorus-oxidizing enzyme from Pseudomonas stutzeri WM88	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-LACTATE DEHYDROGENASE; DELBRUECKII SUBSP BULGARICUS; BOND-CLEAVING ENZYME; ESCHERICHIA-COLI; CARBOXYPHOSPHONOENOLPYRUVATE PHOSPHONOMUTASE; D-2-HYDROXY-4-METHYLVALERATE DEHYDROGENASE; LACTOBACILLUS-PLANTARUM; CARBON; GENE; EXPRESSION	The ptxD gene from Pseudomonas stutzeri WM88 encoding the novel phosphorus oxidizing enzyme NAD:phosphite oxidoreductase (trivial name phosphite dehydrogenase, PtxD) was cloned into an expression vector and overproduced in Escherichia coli, The heterologously produced enzyme is indistinguishable from the native enzyme based on mass spectrometry, amino-terminal sequencing, and specific activity analyses. Recombinant PtxD was purified to homogeneity via a two-step affinity protocol and characterized. The enzyme stoichiometrically produces NADH and phosphate from NAD and phosphite, The reverse reaction was not observed. Gel filtration analysis of the purified protein is consistent with PtxD acting as a homodimer, PtxD has a high affinity for its substrates with K-m values of 53.1 +/- 6.1 muM and 54.6 +/- 6.7 muM, for phosphite and NAD, respectively. V-max and k(cat) were determined to be 12.2 +/- 0.3 mu mol min(-1) mg(-1) and 440 min(-1). NADP can substitute poorly for NAD; however, none of the numerous compounds examined were able to substitute for phosphite. Initial rate studies in the absence or presence of products and in the presence of the dead end inhibitor sulfite are most consistent with a sequential ordered mechanism for the PtxD reaction, with NAD binding first and NADH being released last. Amino acid sequence comparisons place PtxD as a new member of the D-2-hydroxyacid NAD-dependent dehydrogenases, the only one to have an inorganic substrate. To our knowledge, this is the first detailed biochemical study on an enzyme capable of direct oxidation of a reduced phosphorus compound.	Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Metcalf, WW (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin, Urbana, IL 61801 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR011966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059334] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 11966] Funding Source: Medline; NIGMS NIH HHS [GM07283-26, GM59334] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS F, 1953, SOIL SCI, V75, P361, DOI 10.1097/00010694-195305000-00004; Alvarez JA, 1997, EUR J BIOCHEM, V244, P203, DOI 10.1111/j.1432-1033.1997.00203.x; AUSEBEL FM, 1992, CURRENT PROTOCOLS MO; Baker AS, 1998, BIOCHEMISTRY-US, V37, P9305, DOI 10.1021/bi972677d; BARD AJ, 1985, STANDARD POTENTIALS, P153; Bernard N, 1997, EUR J BIOCHEM, V244, P213, DOI 10.1111/j.1432-1033.1997.00213.x; CASIDA LE, 1960, J BACTERIOL, V80, P237, DOI 10.1128/JB.80.2.237-241.1960; CHEN CM, 1990, J BIOL CHEM, V265, P4461; CHENAULT HK, 1987, APPL BIOCHEM BIOTECH, V14, P147, DOI 10.1007/BF02798431; Cleland W W, 1979, Methods Enzymol, V63, P103; Cleland W. W, 1970, ENZYMES, V2, P1; CUTTING JA, 1984, METHOD ENZYMOL, V104, P451; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; FOSTER TL, 1978, APPL ENVIRON MICROB, V35, P937, DOI 10.1128/AEM.35.5.937-944.1978; GOLDBERG JD, 1994, J MOL BIOL, V236, P1123, DOI 10.1016/0022-2836(94)90016-7; GRANT GA, 1989, BIOCHEM BIOPH RES CO, V165, P1371, DOI 10.1016/0006-291X(89)92755-1; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; HEEB MJ, 1984, METHOD ENZYMOL, V104, P416; HEINEN W, 1974, ARCH MICROBIOL, V95, P267, DOI 10.1007/BF02451767; HIDAKA T, 1992, MOL GEN GENET, V233, P476, DOI 10.1007/BF00265446; HIDAKA T, 1990, J BACTERIOL, V172, P3066, DOI 10.1128/jb.172.6.3066-3072.1990; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; Horiguchi M., 1984, BIOCH NATURAL C P CO, P24; KENNEDY KE, 1970, SCIENCE, V168, P989, DOI 10.1126/science.168.3934.989; KOCHHAR S, 1992, BIOCHEM BIOPH RES CO, V184, P60, DOI 10.1016/0006-291X(92)91157-L; Kulakova AN, 1997, GENE, V195, P49, DOI 10.1016/S0378-1119(97)00151-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANAUZE JM, 1970, BIOCHIM BIOPHYS ACTA, V212, P332, DOI 10.1016/0005-2744(70)90214-7; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LEE KS, 1992, J BACTERIOL, V174, P2501, DOI 10.1128/jb.174.8.2501-2510.1992; MALACINS.GM, 1967, J BACTERIOL, V93, P1906, DOI 10.1128/JB.93.6.1906-1910.1967; MALACINSKI G, 1966, J BACTERIOL, V91, P578, DOI 10.1128/JB.91.2.578-582.1966; MCMULLAN G, 1992, APPL ENVIRON MICROB, V58, P1364, DOI 10.1128/AEM.58.4.1364-1366.1992; METCALF WW, 1991, J BACTERIOL, V173, P587, DOI 10.1128/jb.173.2.587-600.1991; Metcalf WW, 1998, J BACTERIOL, V180, P5547, DOI 10.1128/JB.180.21.5547-5558.1998; PEACOCK D, 1970, Biochemical Journal, V120, P763; ROBERTSON JG, 1991, INTELLIKINETICS VERS; Schink B, 2000, NATURE, V406, P37, DOI 10.1038/35017644; Segal H.I, 1993, ENZYME KINETICS; SEIDEL HM, 1988, NATURE, V335, P457, DOI 10.1038/335457a0; Stoll VS, 1996, STRUCTURE, V4, P437, DOI 10.1016/S0969-2126(96)00049-4; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SZMELCMAN S, 1976, EUR J BIOCHEM, V65, P13, DOI 10.1111/j.1432-1033.1976.tb10383.x; TAGUCHI H, 1993, J BIOL CHEM, V268, P18030; TAGUCHI H, 1991, J BIOL CHEM, V266, P12588; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson R, 1999, J YOUTH ADOLESCENCE, V28, P197, DOI 10.1023/A:1021601431296; Tishkov VI, 1996, FEBS LETT, V390, P104, DOI 10.1016/0014-5793(96)00641-2; Vrtis JM, 2001, J AM CHEM SOC, V123, P2672, DOI 10.1021/ja004301k; WACKETT LP, 1987, J BACTERIOL, V169, P710, DOI 10.1128/jb.169.2.710-717.1987; WANNER BL, 1986, J MOL BIOL, V191, P39, DOI 10.1016/0022-2836(86)90421-3; Wise DJ, 1997, ARCH BIOCHEM BIOPHYS, V344, P176, DOI 10.1006/abbi.1997.0186	53	118	132	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17429	17436		10.1074/jbc.M011764200	http://dx.doi.org/10.1074/jbc.M011764200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278981	hybrid			2022-12-27	WOS:000168730400111
J	Zhou, H; Kartsogiannis, V; Hu, YS; Elliott, J; Quinn, JMW; McKinstry, WJ; Gillespie, MT; Ng, KW				Zhou, H; Kartsogiannis, V; Hu, YS; Elliott, J; Quinn, JMW; McKinstry, WJ; Gillespie, MT; Ng, KW			A novel osteoblast-derived C-type lectin that inhibits osteoclast formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; HORMONE-RELATED PROTEIN; BONE MORPHOGENETIC PROTEIN-2; COLONY-STIMULATING FACTOR; MESSENGER-RNA LEVELS; OSTEOPROTEGERIN-LIGAND; DIFFERENTIATION FACTOR; PARATHYROID-HORMONE; ANIMAL LECTINS; RETINOIC ACID	We have cloned and expressed murine osteoclast inhibitory lectin (mOCIL), a 207-amino acid type II transmembrane C-type lectin. In osteoclast formation assays of primary murine calvarial osteoblasts with bone marrow cells, antisense oligonucleotides for mOCIL increased tartrate-resistant acid phosphatase-positive mononucleate cell formation by 3-5-fold, whereas control oligonucleotides had no effect. The extracellular domain of mOCIL, expressed as a recombinant protein in Escherichia coli, dose-dependently inhibited multinucleate osteoclast formation in murine osteoblast and spleen cell co-cultures as well as in spleen cell cultures treated with RANKL and macrophage colony-stimulating factor. Furthermore, mOCIL acted directly on macrophage/monocyte cells as evidenced by its inhibitory action on adherent spleen cell cultures, which were depleted of stromal and lymphocytic cells. mOCIL completely inhibited osteoclast formation during the proliferative phase of osteoclast formation and resulted in 70% inhibition during the differentiation phase. Osteoblast OCIL mRNA expression was enhanced by parathyroid hormone, calcitriol, interleukin-1 alpha and -11, and retinoic acid. In rodent tissues, Northern blotting, in situ hybridization, and immunohistochemistry demonstrated OCIL expression in osteoblasts and chondrocytes as well as in a variety of extraskeletal tissues. The overlapping tissue distribution of OCIL mRNA and protein with that of RANKL strongly suggests an interaction between these molecules in the skeleton and in extraskeletal tissues.	Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia	St Vincent's Hospital Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research	Ng, KW (corresponding author), Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia.	k.ng@medicine.unimelb.edu.au	McKinstry, William J/D-2612-2013	McKinstry, William J/0000-0001-9668-9364; Zhou, Hong/0000-0001-5899-9660; Gillespie, Matthew/0000-0001-6543-8909				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; BISKOBING DM, 1995, J BONE MINER RES, V10, P1025; Brandstrom H, 1998, BIOCHEM BIOPH RES CO, V247, P338, DOI 10.1006/bbrc.1998.8783; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Choi SJ, 1998, J CLIN INVEST, V102, P1360, DOI 10.1172/JCI2667; Choi SJ, 1999, J BIOL CHEM, V274, P27747, DOI 10.1074/jbc.274.39.27747; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CUMMINGS RD, 1992, BIOESSAYS, V14, P849, DOI 10.1002/bies.950141210; DANKS JA, 1989, J BONE MINER RES, V4, P273; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; DRICKAMER K, 1993, CURR OPIN STRUC BIOL, V3, P393, DOI 10.1016/S0959-440X(05)80112-5; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Gabius HJ, 1997, EUR J BIOCHEM, V243, P543, DOI 10.1111/j.1432-1033.1997.t01-1-00543.x; Hakeda Y, 1998, BIOCHEM BIOPH RES CO, V251, P796, DOI 10.1006/bbrc.1998.9523; Hofbauer LC, 2000, J BONE MINER RES, V15, P2, DOI 10.1359/jbmr.2000.15.1.2; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4382, DOI 10.1210/en.140.10.4382; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Hofbauer LC, 1998, BIOCHEM BIOPH RES CO, V250, P776, DOI 10.1006/bbrc.1998.9394; Horwood NJ, 1998, J CLIN INVEST, V101, P595, DOI 10.1172/JCI1333; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hu YS, 1998, MOL ENDOCRINOL, V12, P1721, DOI 10.1210/me.12.11.1721; IKEGAME M, 1995, J BONE MINER RES, V10, P59; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; Kartsogiannis V, 1997, BONE, V21, P385, DOI 10.1016/S8756-3282(97)00180-4; Kartsogiannis V, 1998, BONE, V22, P189, DOI 10.1016/S8756-3282(97)00278-0; Kieda C, 1998, ADV EXP MED BIOL, V435, P75; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kwon BS, 1998, FASEB J, V12, P845, DOI 10.1096/fasebj.12.10.845; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Lauzurica P, 2000, BLOOD, V95, P2312, DOI 10.1182/blood.V95.7.2312.007k16_2312_2320; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; Martin TJ, 1998, CRIT REV EUKAR GENE, V8, P107, DOI 10.1615/CritRevEukarGeneExpr.v8.i2.10; MARTIN TJ, 1989, ENDOCRIN METAB CLIN, V18, P833, DOI 10.1016/S0889-8529(18)30346-3; Marzio R, 1997, J LEUKOCYTE BIOL, V62, P349, DOI 10.1002/jlb.62.3.349; Miura R, 1999, J BIOL CHEM, V274, P11431, DOI 10.1074/jbc.274.16.11431; NG KW, 1988, J BONE MINER RES, V3, P53; Quinn JMW, 1999, BONE, V25, P1, DOI 10.1016/S8756-3282(99)00094-0; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Romas E, 1996, J EXP MED, V183, P2581, DOI 10.1084/jem.183.6.2581; Sharon N, 1995, ESSAYS BIOCHEM, V30, P59; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; SUDA T, 1995, ENDOCRINE REV MONOGR, V4, P266; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252; Tan KB, 1997, GENE, V204, P35, DOI 10.1016/S0378-1119(97)00509-X; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TRAIANEDES K, 1995, J BIOL CHEM, V270, P20891, DOI 10.1074/jbc.270.36.20891; Tsukii K, 1998, BIOCHEM BIOPH RES CO, V246, P337, DOI 10.1006/bbrc.1998.8610; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; ZHOU H, 1991, J BONE MINER RES, V6, P767; ZHOU H, 1994, J BIOL CHEM, V269, P22433	62	62	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14916	14923		10.1074/jbc.M011554200	http://dx.doi.org/10.1074/jbc.M011554200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278931	hybrid			2022-12-27	WOS:000168528800054
J	Zitzer, A; Bittman, R; Verbicky, CA; Erukulla, RK; Bhakdi, S; Weis, S; Valeva, A; Palmer, M				Zitzer, A; Bittman, R; Verbicky, CA; Erukulla, RK; Bhakdi, S; Weis, S; Valeva, A; Palmer, M			Coupling of cholesterol and cone-shaped lipids in bilayers augments membrane permeabilization by the cholesterol-specific toxins streptolysin O and Vibrio cholerae cytolysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEMLIKI-FOREST-VIRUS; STRUCTURAL REQUIREMENTS; CONTAINING LIPOSOMES; MAXIMUM SOLUBILITY; FUSION; BINDING; PORE; SPHINGOLIPIDS; INDUCTION; DAMAGE	Vibrio cholerae cytolysin (VCC) forms oligomeric pores in lipid bilayers containing cholesterol, Membrane permeabilization is inefficient if the sterol is embedded within bilayers prepared from phosphatidylcholine only but is greatly enhanced if the target membrane also contains ceramide, Although the enhancement of VCC action is stereospecific with respect to cholesterol, we show here that no such specificity applies to the two stereocenters in ceramide; all four stereoisomers of ceramide enhanced VCC activity in cholesterol-containing bilayers, A wide variety of ceramide analogs were as effective as D-erythro-ceramide, as was diacylglycerol, suggesting that the effect of ceramide exemplifies a general trend of lipids with a small headgroup to augment the activity of VCC, Incorporation of these cone-shaped lipids into cholesterol-containing bilayers also gave similar effects with streptolysin O, another cholesterol-specific but structurally unrelated cytolysin, In contrast, the activity of staphylococcal alpha -hemolysin, which does not share with the other toxins the requirement for cholesterol, was far less affected by the presence of lipids with a conical shape. The collective data indicate that sphingolipids and glycerolipids do not interact with the cytolysins specifically, Instead, lipids that have a conical molecular shape appear to effect a change in the energetic state of membrane cholesterol that in turn augments the interaction of the sterol with the cholesterol-specific cytolysins.	Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, D-55101 Mainz, Germany; CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	Johannes Gutenberg University of Mainz; City University of New York (CUNY) System; Queens College NY (CUNY)	Palmer, M (corresponding author), Texas A&M Univ, Dept Med Biochem & Genet, 440 Reynolds Med Bldg, College Stn, TX 77843 USA.	mpalmer@medicine.tamu.edu						Alonso A, 2000, BIOCHEMISTRY-US, V39, P14019, DOI 10.1021/bi001739o; Alouf JE, 1991, SOURCEBOOK BACTERIAL, P147; Berger A, 1996, MOL PHARMACOL, V50, P451; BHAKDI S, 1985, INFECT IMMUN, V47, P52; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Chun J, 2000, J ORG CHEM, V65, P7634, DOI 10.1021/jo001227f; CLEJAN S, 1984, J BIOL CHEM, V259, P823; Corbin J, 1998, BBA-BIOMEMBRANES, V1414, P65, DOI 10.1016/S0005-2736(98)00153-9; CORVER J, 1995, J VIROL, V69, P3220, DOI 10.1128/JVI.69.5.3220-3223.1995; DORFLER HD, 1990, ADV COLLOID INTERFAC, V31, P1, DOI 10.1016/0001-8686(90)80003-I; FERNANDEZBALLESTER G, 1994, BIOCHEMISTRY-US, V33, P4065, DOI 10.1021/bi00179a035; FUGLER L, 1985, J BIOL CHEM, V260, P4098; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; He LL, 1999, J AM CHEM SOC, V121, P3897, DOI 10.1021/ja981493z; Holopainen JM, 1998, BIOCHEMISTRY-US, V37, P17562, DOI 10.1021/bi980915e; Holopainen JM, 1997, CHEM PHYS LIPIDS, V88, P1, DOI 10.1016/S0009-3084(97)00040-6; Hong-wei S, 1975, Biochemistry, V14, P847; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Huang JY, 1999, BBA-BIOMEMBRANES, V1417, P89, DOI 10.1016/S0005-2736(98)00260-0; Ikigai H, 1996, INFECT IMMUN, V64, P2968, DOI 10.1128/IAI.64.8.2968-2973.1996; Jarvis WD, 1996, J BIOL CHEM, V271, P8275, DOI 10.1074/jbc.271.14.8275; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; Karasavvas N, 1996, CELL DEATH DIFFER, V3, P149; Karasavvas N, 1996, EUR J BIOCHEM, V236, P729, DOI 10.1111/j.1432-1033.1996.00729.x; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; LEE YC, 1993, BIOPHYS J, V65, P1429, DOI 10.1016/S0006-3495(93)81206-2; MOESBY L, 1995, BIOCHEMISTRY-US, V34, P10319, DOI 10.1021/bi00033a001; NIEVA JL, 1994, EMBO J, V13, P2797, DOI 10.1002/j.1460-2075.1994.tb06573.x; OHNOIWASHITA Y, 1992, BIOCHIM BIOPHYS ACTA, V1109, P81, DOI 10.1016/0005-2736(92)90190-W; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; PALMER M, 1993, J BIOL CHEM, V268, P11963; PRIGENT D, 1976, BIOCHIM BIOPHYS ACTA, V443, P288, DOI 10.1016/0005-2736(76)90511-3; RODRIGUEZA WV, 1995, BIOCHEMISTRY-US, V34, P6208, DOI 10.1021/bi00018a025; SILVIUS JR, 1992, BIOCHEMISTRY-US, V31, P3398, DOI 10.1021/bi00128a014; WATSON KC, 1974, BIOCHEM J, V140, P95, DOI 10.1042/bj1400095; Weller U, 1996, EUR J BIOCHEM, V236, P34, DOI 10.1111/j.1432-1033.1996.00034.x; WILSCHUT J, 1995, MOL MEMBR BIOL, V12, P143, DOI 10.3109/09687689509038510; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375; Zitzer A, 1997, EUR J BIOCHEM, V247, P209, DOI 10.1111/j.1432-1033.1997.00209.x; Zitzer A, 2000, BBA-BIOMEMBRANES, V1509, P264, DOI 10.1016/S0005-2736(00)00303-5	40	69	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14628	14633		10.1074/jbc.M100241200	http://dx.doi.org/10.1074/jbc.M100241200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279036	hybrid			2022-12-27	WOS:000168528800016
J	Bayless, KJ; Davis, GE				Bayless, KJ; Davis, GE			Identification of dual alpha(4)beta(1) integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR CELL-ADHESION; III CONNECTING SEGMENT; SMOOTH-MUSCLE CELL; LATE ANTIGEN-4; ALPHA-4-BETA-1 INTEGRIN; RECOGNITION SEQUENCE; ENDOTHELIAL-CELLS; MEDIATES ADHESION; MICE LACKING; FIBRONECTIN	Previous work from our laboratory demonstrates that the alpha (4)beta (1) integrin is an adhesion receptor for OPN and that alpha (4)beta (1) binding site(s) are present in the N-terminal thrombin fragment of osteopontin (OPN) (Bayless, K, J., Meininger, G. A., Scholtz, J. M,, and Davis, G, E, (1998) J, Cell Sci. 111, 1165-1174), The work presented here identifies two alpha (4)beta (1) binding sites within a recombinantly produced N-terminal thrombin fragment of human OPN, Initial experiments, using wild-type OPN containing an RGD sequence or an OPN-RGE mutant, showed identical alpha (4)beta (1)-dependent cell adhesive activity. A strategy to localize alpha (4)beta (1) binding sites within the thrombin fragment of osteopontin involved performing a series of truncation analyses, Removal of the last 39 amino acids (130-168) completely eliminated adhesion, indicating all binding activity was present within that portion of the molecule. Combined mutation and deletion analyses of this region revealed the involvement of dual alpha (4)beta (1) binding sites, Synthetic peptides for both regions in OPN, ELVTDFPTDLPAT (131-143) and SVVYGLR (162-168), were found to block alpha (4)beta (1)-dependent adhesion. The first peptide when coupled to Sepharose bound the alpha (4)beta (1) integrin directly whereas a mutated ELVTEFPTELPAT peptide showed a dramatically reduced ability to bind. These data collectively demonstrate that dual alpha (4)beta (1) integrin binding sites are present in a 38 amino acid domain within the N-terminal thrombin fragment of OPN.	Texas A&M Univ, Hlth Sci Ctr, Dept Pathol & Lab Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Davis, GE (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Dept Pathol & Lab Med, 255 Reynolds Med Bldg, College Stn, TX 77843 USA.	gedavis@tamu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059971] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL59971] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; Barry ST, 2000, BIOCHEM BIOPH RES CO, V267, P764, DOI 10.1006/bbrc.1999.2032; Bayless KJ, 1998, J CELL SCI, V111, P1165; Bayless KJ, 1997, PROTEIN EXPRES PURIF, V9, P309, DOI 10.1006/prep.1996.0699; BROWN LF, 1994, AM J PATHOL, V145, P610; BROWN LF, 1992, MOL BIOL CELL, V3, P1169, DOI 10.1091/mbc.3.10.1169; BUTLER WT, 1995, INT J DEV BIOL, V39, P169; CARLOS TM, 1994, BLOOD, V84, P2068; Carlson I, 1997, LAB INVEST, V77, P103; CLEMENTS JM, 1994, J CELL SCI, V107, P2127; Davis GE, 1997, J LEUKOCYTE BIOL, V62, P318, DOI 10.1002/jlb.62.3.318; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; DAVIS GE, 1993, J IMMUNOL, V151, P7138; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; DIAMOND JR, 1995, AM J PATHOL, V146, P1455; Duplaa C, 1997, CIRC RES, V80, P159; DVORAK HF, 1992, ANN NY ACAD SCI, V667, P101, DOI 10.1111/j.1749-6632.1992.tb51603.x; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Ellison JA, 1998, STROKE, V29, P1698, DOI 10.1161/01.STR.29.8.1698; Fedarko NS, 2000, J BIOL CHEM, V275, P16666, DOI 10.1074/jbc.M001123200; FRANZEN A, 1985, BIOCHN J, V215, P715; GIACHELLI CM, 1995, ANN NY ACAD SCI, V760, P109, DOI 10.1111/j.1749-6632.1995.tb44624.x; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; HIROTA S, 1993, AM J PATHOL, V143, P1003; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JONES EY, 1995, NATURE, V373, P539, DOI 10.1038/373539a0; KERR JM, 1991, GENE, V108, P237, DOI 10.1016/0378-1119(91)90439-I; KIEFER MC, 1989, NUCLEIC ACIDS RES, V17, P3306, DOI 10.1093/nar/17.8.3306; KILGER G, 1995, J MOL MED, V73, P347; KOMORIYA A, 1991, J BIOL CHEM, V266, P15075; KOVACH NL, 1992, J CELL BIOL, V116, P499, DOI 10.1083/jcb.116.2.499; LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; Liaw L, 1998, J CLIN INVEST, V101, P1468; LOBB RR, 1994, J CLIN INVEST, V94, P1722, DOI 10.1172/JCI117519; MACLAG T, 1976, P NATL ACAD SCI USA, V76, P5674; MASUMOTO A, 1993, J BIOL CHEM, V268, P228; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; MOLOSSI S, 1995, J CLIN INVEST, V95, P2601, DOI 10.1172/JCI117962; MOULD AP, 1990, J BIOL CHEM, V265, P4020; MOULD AP, 1991, J BIOL CHEM, V266, P3579; MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x; Nau GJ, 1999, INFECT IMMUN, V67, P4223, DOI 10.1128/IAI.67.8.4223-4230.1999; Nau GJ, 2000, AM J PATHOL, V157, P37, DOI 10.1016/S0002-9440(10)64514-2; NHIEU GTV, 1991, J BIOL CHEM, V266, P24367; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; OSBORN L, 1994, J CELL BIOL, V124, P601, DOI 10.1083/jcb.124.4.601; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145; QIAN F, 1994, CELL, V77, P335, DOI 10.1016/0092-8674(94)90149-X; ROOF WD, 1994, J BIOL CHEM, V269, P2902; SANCHEZAPARICIO P, 1994, J CELL BIOL, V126, P271, DOI 10.1083/jcb.126.1.271; SANCHEZMADRID F, 1986, EUR J IMMUNOL, V16, P1343, DOI 10.1002/eji.1830161106; Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5; SENGER DR, 1995, ANN NY ACAD SCI, V760, P83, DOI 10.1111/j.1749-6632.1995.tb44622.x; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Sharp JA, 1999, LAB INVEST, V79, P869; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TAICHMAN DB, 1991, CELL REGUL, V2, P347, DOI 10.1091/mbc.2.5.347; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Thalmann GN, 1999, CLIN CANCER RES, V5, P2271; Tuck AB, 1999, ONCOGENE, V18, P4237, DOI 10.1038/sj.onc.1202799; VONDERHEIDE RH, 1994, J CELL BIOL, V125, P215, DOI 10.1083/jcb.125.1.215; WAYNER EA, 1992, J CELL BIOL, V116, P489, DOI 10.1083/jcb.116.2.489; Wiener J, 1996, J VASC RES, V33, P195, DOI 10.1159/000159148; WRANA JL, 1989, NUCLEIC ACIDS RES, V17, P10119, DOI 10.1093/nar/17.23.10119; YANG XD, 1993, P NATL ACAD SCI USA, V90, P10494, DOI 10.1073/pnas.90.22.10494; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328	77	90	97	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13483	13489		10.1074/jbc.M011392200	http://dx.doi.org/10.1074/jbc.M011392200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278897	hybrid			2022-12-27	WOS:000168198600138
J	Margittai, M; Fasshauer, D; Pabst, S; Jahn, R; Langen, R				Margittai, M; Fasshauer, D; Pabst, S; Jahn, R; Langen, R			Homo- and heterooligomeric SNARE complexes studied by site-directed spin labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE FUSION PROTEIN; SYNAPTIC VESICLE DOCKING; N-TERMINAL DOMAIN; ANGSTROM RESOLUTION; STRUCTURAL-CHANGES; T4 LYSOZYME; IN-VITRO; SYNTAXIN; EXOCYTOSIS; SYNAPTOBREVIN	SNARE (soluble NSF acceptor protein receptor) proteins are thought to mediate membrane fusion by assem bling into heterooligomeric complexes that connect the fusing membranes and initiate the fusion reaction. Here we used site-directed spin labeling to map conformational changes that occur upon homo- and heterooligomeric complex formation of neuronal SNARE proteins. We found that the soluble domains of synaptobrevin, SNAP-25, and syntaxin 1 are unstructured. At higher concentrations, the SNARE motif of syntaxin 1 forms homooligomeric helical bundles with at least some of the alpha -helices aligned in parallel. In the assembled SNARE complex, mapping of thirty side chain positions yielded spectra which are in good agreement with the recently published crystal structure. The loop region of SNAP-25 that connects the two SNARE motifs is largely unstructured. C-terminal truncation of synaptobrevin resulted in complexes that are completely folded N-terminal of the truncation but become unstructured at the C-terminal end. The binary complex of syntaxin and SNAP-25 consists of a parallel four helix-bundle with properties resembling that of the ternary complex.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Univ So Calif, Inst Med Genet, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Univ So Calif, Neurogenet Inst, Los Angeles, CA 90033 USA	Max Planck Society; University of Southern California; University of Southern California	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.		Margittai, Martin/D-5039-2014; Fasshauer, Dirk/B-1563-2013	Margittai, Martin/0000-0003-1903-5927; Fasshauer, Dirk/0000-0002-1040-4282; Jahn, Reinhard/0000-0003-1542-3498				Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Brunger AT, 2000, CURR OPIN NEUROBIOL, V10, P293, DOI 10.1016/S0959-4388(00)00098-2; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; FEIX JB, 1998, BIO MAGN RE, V14, P251; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Hanson MA, 2000, NAT STRUCT BIOL, V7, P687, DOI 10.1038/77997; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hao JC, 1997, J NEUROSCI, V17, P1596; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; Langen R, 2000, BIOCHEMISTRY-US, V39, P8396, DOI 10.1021/bi000604f; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Rice LM, 1997, FEBS LETT, V415, P49, DOI 10.1016/S0014-5793(97)01091-0; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Terrian DM, 1997, EUR J CELL BIOL, V73, P198; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; ZHONG P, 1997, BIOCHEMISTRY-US, V36, P4137	46	100	100	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13169	13177		10.1074/jbc.M010653200	http://dx.doi.org/10.1074/jbc.M010653200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278719	hybrid, Green Published			2022-12-27	WOS:000168198600098
J	Lamb, JR; Fu, V; Wirtz, E; Bangs, JD				Lamb, JR; Fu, V; Wirtz, E; Bangs, JD			Functional analysis of the trypanosomal AAA protein TbVCP with trans-dominant ATP hydrolysis mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE FUSION PROTEIN; TRANSITIONAL ENDOPLASMIC-RETICULUM; VALOSIN-CONTAINING PROTEIN; MITOTIC GOLGI FRAGMENTS; MEMBRANE-FUSION; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; PEROXISOME BIOGENESIS; VESICULAR TRANSPORT; GENE-EXPRESSION	TbVCP is a member of the AAA ((A) under bar TPases (A) under bar ssociated with a variety of cellular (A) under bar ctivities) family of proteins containing two ATPase domains. Southern analysis indicates TbVCP to have a single-locus, two-copy, genomic organization. One copy, but not both, can be disrupted by targeted gene replacement, suggesting that TbVCP is essential for trypanosome viability, Site-directed mutagenesis of the ATP hydrolysis motifs indicates that the second conserved ATPase domain is essential for TbVCP activity. Constitutive overexpression of TbVCP with a single mutation in the second hydrolysis motif or with mutations in both hydrolysis motifs was not possible. Regulated overexpression of these mutants resulted in cell death as a dominant negative phenotype, In each case cell growth arrested at 24-h post-induction and at all stages of the cell cycle as judged by replication of nuclear and kinetoplast genomes. Onset of growth arrest coincided with the development of severe and characteristic morphological alterations for each mutant. Neither constitutive nor regulated overexpression of wild type TbVCP or the single first hydrolysis domain mutant had any overt effect on cell viability or morphology, However, the distinct phenotype of the double mutant indicates that the first hydrolysis domain, although not essential, does modulate overall TbVCP function. Finally, yeast complementation studies demonstrated that TbVCP can functionally replace the yeast homologue Cdc48p, indicating that protein protein interactions essential to function have been maintained over great phylogenetic distances.	Univ Wisconsin, Sch Med, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA	University of Wisconsin System; University of Wisconsin Madison; Rockefeller University	Bangs, JD (corresponding author), Univ Wisconsin, Sch Med, Dept Med Microbiol & Immunol, 1300 Univ Ave, Madison, WI 53706 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI035739, T32AI007414, R01AI035739] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI035739, AI07414, AI35739] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Bangs JD, 1997, EMBO J, V16, P4285, DOI 10.1093/emboj/16.14.4285; BECKERS CJM, 1989, NATURE, V339, P397, DOI 10.1038/339397a0; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BOOTHROYD JC, 1989, NUCL ACIDS MOL BIOL, V3, P216; CONFALONIERI F, 1994, J MOL BIOL, V235, P396, DOI 10.1016/S0022-2836(05)80047-6; CORMACK B, 1997, CURRENT PROTOCOLS MO; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; FEILER HS, 1995, EMBO J, V14, P5626, DOI 10.1002/j.1460-2075.1995.tb00250.x; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Golbik R, 1999, BIOL CHEM, V380, P1049, DOI 10.1515/BC.1999.131; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KOLLER KJ, 1987, NATURE, V325, P542, DOI 10.1038/325542a0; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; KRAUSE T, 1994, YEAST, V10, P1613, DOI 10.1002/yea.320101210; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; MADEO F, 1997, GENE, V204, P9456; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; MINET M, 1992, PLANT J, V2, P417; MOIR D, 1982, GENETICS, V100, P547; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Patel SK, 1998, CELL, V92, P611, DOI 10.1016/S0092-8674(00)81129-0; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; PLEASURE IT, 1993, NATURE, V365, P459, DOI 10.1038/365459a0; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Roggy JL, 1999, MOL BIOCHEM PARASIT, V98, P1, DOI 10.1016/S0166-6851(98)00114-5; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Roy L, 2000, MOL BIOL CELL, V11, P2529, DOI 10.1091/mbc.11.8.2529; RUDENKO G, 1994, EMBO J, V13, P5470, DOI 10.1002/j.1460-2075.1994.tb06882.x; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; TSCHUDI C, 1994, INFECT AGENT DIS, V3, P181; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49; ZHANG L, 1994, J CELL BIOL, V127, P1871, DOI 10.1083/jcb.127.6.1871; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	48	56	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21512	21520		10.1074/jbc.M100235200	http://dx.doi.org/10.1074/jbc.M100235200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279035	hybrid			2022-12-27	WOS:000169297900096
J	Cleverley, RM; Zheng, N; Gierasch, LM				Cleverley, RM; Zheng, N; Gierasch, LM			The cost of exposing a hydrophobic loop and implications for the functional role of 4.5 S RNA in the Escherichia coli signal recognition particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TARGETING PATHWAYS; PROTEIN; SRP; DOMAIN; SEQUENCE; BINDING; COMPONENTS; SUBUNIT; LENGTH	The signal recognition particle (SRP) is an RNA-protein complex that directs ribosomes to the rough endoplasmic reticulum membrane by binding to targeting signals found on the nascent chain of proteins destined for export to the endoplasmic reticulum. We found evidence from studies with fragments of the protein component of the Escherichia coli SRP that a long hydrophobic loop (the so-called "finger loop") is detrimental to the stability of its signal peptide-binding domain, the M domain. This hydrophobic loop is highly conserved and thus may have a critical role in the function of the SRP. Given our previously reported evidence that 4.5 S RNA stabilizes the tertiary fold of the M domain (Zheng, N., and Gierasch, L. M. (1997) Mol. Cell 1, 79-87), we now propose that the functional requirement for 4.5 S RNA resides in its ability to counteract the destabilizing influence of the finger loop.	Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Rm 814,Lederle Grad Res Tower,710 N Pleasant St, Amherst, MA 01003 USA.		Gierasch, Lila M/D-1494-2009		NIGMS NIH HHS [GM34962] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034962] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTHOFF S, 1994, NUCLEIC ACIDS RES, V22, P1933, DOI 10.1093/nar/22.11.1933; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Clemons WM, 1999, J MOL BIOL, V292, P697, DOI 10.1006/jmbi.1999.3090; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P179; DeGier JWL, 1997, FEBS LETT, V408, P1, DOI 10.1016/S0014-5793(97)00402-X; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Ladurner AG, 1997, J MOL BIOL, V273, P330, DOI 10.1006/jmbi.1997.1304; LENTZEN G, 1994, FEBS LETT, V348, P233, DOI 10.1016/0014-5793(94)00599-0; Martin ACR, 1995, PROTEIN ENG, V8, P1093; Nagi AD, 1997, FOLD DES, V2, P67, DOI 10.1016/S1359-0278(97)00007-2; Nagi AD, 1999, J MOL BIOL, V286, P257, DOI 10.1006/jmbi.1998.2474; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; SCOULICA E, 1987, EUR J BIOCHEM, V163, P519, DOI 10.1111/j.1432-1033.1987.tb10899.x; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; Viguera AR, 1997, NAT STRUCT BIOL, V4, P939, DOI 10.1038/nsb1197-939; Zheng N, 1997, MOL CELL, V1, P79, DOI 10.1016/S1097-2765(00)80009-X; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x; [No title captured]	23	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19327	19331		10.1074/jbc.M011130200	http://dx.doi.org/10.1074/jbc.M011130200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278844	hybrid			2022-12-27	WOS:000169091000092
J	Kajkowski, EM; Lo, CF; Ning, XP; Walker, S; Sofia, HJ; Wang, W; Edris, W; Chanda, P; Wagner, E; Vile, S; Ryan, K; McHendry-Rinde, B; Smith, SC; Wood, A; Rhodes, KJ; Kennedy, JD; Bard, J; Jacobsen, JS; Ozenberger, BA				Kajkowski, EM; Lo, CF; Ning, XP; Walker, S; Sofia, HJ; Wang, W; Edris, W; Chanda, P; Wagner, E; Vile, S; Ryan, K; McHendry-Rinde, B; Smith, SC; Wood, A; Rhodes, KJ; Kennedy, JD; Bard, J; Jacobsen, JS; Ozenberger, BA			beta-amyloid peptide-induced apoptosis regulated by a novel protein containing a G protein activation module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; FIBRIL FORMATION; CELL-DEATH; NEUROTOXICITY; RECEPTOR; NEURONS; NEURODEGENERATION; SEQUENCE; INVITRO	Degeneration of neurons in Alzheimer's disease is mediated by beta -amyloid peptide by diverse mechanisms, which include a putative apoptotic component stimulated by unidentified signaling events. This report describes a novel beta -amyloid peptide-binding protein (denoted BBP) containing a G protein-coupling module. BBP is one member of a family of three proteins containing this conserved structure. The BBP subtype bound human beta -amyloid peptide in vitro with high affinity and specificity. Expression of BBP in cell culture induced caspase-dependent vulnerability to beta -amyloid peptide toxicity. Expression of a signaling-deficient dominant negative BBP mutant suppressed sensitivity of human Ntera-2 neurons to beta -amyloid peptide mediated toxicity. These findings suggest that BBP is a target of neurotoxic beta -amyloid peptide and provide new insight into the molecular pathophysiology of Alzheimer's disease.	Wyeth Ayerst Res, Wyeth Neurosci, Princeton, NJ 08543 USA	Pfizer	Ozenberger, BA (corresponding author), Wyeth Ayerst Res, Wyeth Neurosci, CN 8000,865 Ridge Rd, Monmouth Junction, NJ 08852 USA.		Edris, Wade/AAL-9216-2021					Acharya S, 1996, J BIOL CHEM, V271, P25406, DOI 10.1074/jbc.271.41.25406; AKITA EM, 1992, J FOOD SCI, V57, P629, DOI 10.1111/j.1365-2621.1992.tb08058.x; Althoefer H, 1997, J BIOL CHEM, V272, P24380, DOI 10.1074/jbc.272.39.24380; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Brouillet E, 1999, J NEUROSCI, V19, P1717; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; COTMAN CW, 1995, MOL NEUROBIOL, V10, P19, DOI 10.1007/BF02740836; Du YS, 1998, J NEUROCHEM, V70, P1182; ElKhoury J, 1996, NATURE, V382, P716; Giambarella U, 1997, EMBO J, V16, P4897, DOI 10.1093/emboj/16.16.4897; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Ivins KJ, 1999, J BIOL CHEM, V274, P2107, DOI 10.1074/jbc.274.4.2107; JONES PG, 1995, EUR J PHARM-MOLEC PH, V288, P251, DOI 10.1016/0922-4106(95)90036-5; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; Mark RJ, 1996, MOL NEUROBIOL, V12, P211, DOI 10.1007/BF02755589; Matsubara E, 1996, BIOCHEM J, V316, P671, DOI 10.1042/bj3160671; MCKEE AC, 1991, ANN NEUROL, V30, P156, DOI 10.1002/ana.410300206; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Narita M, 1997, J NEUROCHEM, V69, P1904; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OZENBERGER BA, 1995, MOL ENDOCRINOL, V9, P1321, DOI 10.1210/me.9.10.1321; Pike CJ, 1997, J NEUROCHEM, V69, P1601; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Rhodes KJ, 1996, J NEUROSCI, V16, P4846; Russo C, 1998, P NATL ACAD SCI USA, V95, P15598, DOI 10.1073/pnas.95.26.15598; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; TATUSOV RL, 1994, P NATL ACAD SCI USA, V91, P12091, DOI 10.1073/pnas.91.25.12091; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troy CM, 2000, J NEUROSCI, V20, P1386; WADEHARPER J, 1993, CELL, V75, P805; WATT JA, 1994, BRAIN RES, V661, P147, DOI 10.1016/0006-8993(94)91191-6; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Yamatsuji T, 1996, SCIENCE, V272, P1349, DOI 10.1126/science.272.5266.1349; YAN GM, 1995, J NEUROCHEM, V65, P2425; Yan SD, 1997, NATURE, V389, P689; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; YOCUM RR, 1984, MOL CELL BIOL, V4, P1985, DOI 10.1128/MCB.4.10.1985	46	48	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18748	18756		10.1074/jbc.M011161200	http://dx.doi.org/10.1074/jbc.M011161200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278849	hybrid			2022-12-27	WOS:000169091000016
J	Spirito, F; Chavanas, S; Prost-Squarcioni, C; Pulkkinen, L; Fraitag, S; Bodemer, C; Ortonne, JP; Meneguzzi, G				Spirito, F; Chavanas, S; Prost-Squarcioni, C; Pulkkinen, L; Fraitag, S; Bodemer, C; Ortonne, JP; Meneguzzi, G			Reduced expression of the epithelial adhesion ligand laminin 5 in the skin causes intradermal tissue separation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; BASEMENT-MEMBRANE; CELL-ADHESION; GENE-TRANSFER; VII COLLAGEN; INTEGRIN; KERATINOCYTES; MUTATIONS; HEMIDESMOSOMES; KALININ	Laminin 5, the major keratinocyte adhesion ligand, is found in the lamina lucida subregion of the epidermal basement membrane of the skin, where it colocalizes with the anchoring filaments. Mutations in the genes encoding laminin 5 cause junctional epidermolysis bullosa, an inherited skin blistering disease characterized by abnormal hemidesmosomes and cleavage of the lamina lucida leading to epidermal detachment. In this work we describe the genetic basis of a new subtype of lethal inherited epidermolysis bullosa associated with reduced skin reactivity to laminin 5, presence of mature hemidesmosomes, and intradermal cleavage of the skin. The epidermolysis bullosa patients were heterozygous for a nonsense mutation (Q896X) and a splice site mutation (764-10T -->G) in the gene (LAMC2) for the gamma2 chain of laminin 5. The nonsense mutation causes accelerated decay of the corresponding mRNA, while the splice site mutation results in maturation of a cryptic wild-type gamma2 mRNA leading to reduced expression of wild-type laminin 5. In vitro studies using the probands' keratinocytes showed that secretion of reduced amounts of functional laminin 5 in the patient, although permitting formation of hemidesmosomes, fail to restore efficient cell adhesion. Our results provide the first evidence that laminin 5 contributes to the firm adhesion of the epithelial basement membrane to the underlying stroma, They also show that a low expression level of laminin 5 induces assembly of mature hemidesmosomes in vivo but fails to assure a stable cohesion of the dermal-epidermal junction.	Fac Med, UFR Med, INSERM U385, F-06107 Nice 2, France; Hop Necker Enfants Malad, Serv Dermatol, F-75730 Paris 15, France; Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA; Fac Med Lariboisiere, Dept Histol Embryol & Cytogenet, F-75730 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Jefferson University; UDICE-French Research Universities; Universite Paris Cite	Meneguzzi, G (corresponding author), Fac Med, UFR Med, INSERM U385, Ave Valombrose, F-06107 Nice 2, France.	meneguzz@unice.fr	Chavanas, stephane/K-1183-2014	Meneguzzi, Guerrino/0000-0002-1609-6540; chavanas, stephane/0000-0003-4323-2656				ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; Baker SE, 1996, J CELL SCI, V109, P2509; BAUDOIN C, 1994, HUM MOL GENET, V3, P1909, DOI 10.1093/hmg/3.10.1909; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Champliaud MF, 1996, J CELL BIOL, V132, P1189, DOI 10.1083/jcb.132.6.1189; Chavanas S, 1999, HUM MOL GENET, V8, P2097, DOI 10.1093/hmg/8.11.2097; Chen M, 1997, J BIOL CHEM, V272, P14516, DOI 10.1074/jbc.272.23.14516; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Cooper D. N., 1993, HUMAN GENE MUTATION; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DELWEL GO, 1993, J BIOL CHEM, V268, P25865; El-Ghannam A, 1998, J BIOMED MATER RES, V41, P30, DOI 10.1002/(SICI)1097-4636(199807)41:1<30::AID-JBM4>3.0.CO;2-R; Fine JD, 2000, J AM ACAD DERMATOL, V42, P1051, DOI 10.1016/S0190-9622(00)90302-5; Fleischmajer R, 1998, J CELL SCI, V111, P1929; Gache Y, 1996, J CLIN INVEST, V97, P2289, DOI 10.1172/JCI118671; GagnouxPalacios L, 1996, J BIOL CHEM, V271, P18437, DOI 10.1074/jbc.271.31.18437; GagnouxPalacios L, 1997, LAB INVEST, V77, P459; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Gardella R, 1996, AM J HUM GENET, V59, P292; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; HORMIA M, 1995, J INVEST DERMATOL, V105, P557, DOI 10.1111/1523-1747.ep12323451; KIKKAWA Y, 1994, J BIOCHEM-TOKYO, V116, P862, DOI 10.1093/oxfordjournals.jbchem.a124608; Koshikawa N, 1999, CANCER RES, V59, P5596; LEIGH IM, 1988, J INVEST DERMATOL, V90, P639, DOI 10.1111/1523-1747.ep12560795; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MARINKOVICH MP, 1992, J CELL BIOL, V119, P695, DOI 10.1083/jcb.119.3.695; MATSUI C, 1995, J BIOL CHEM, V270, P23496, DOI 10.1074/jbc.270.40.23496; Mellerio JE, 1999, CLIN EXP DERMATOL, V24, P25; Meneguzzi G, 2001, SKIN AND GENE THERAPY, P97; NIESSEN CM, 1994, EXP CELL RES, V211, P360, DOI 10.1006/excr.1994.1099; Nievers MG, 1999, MATRIX BIOL, V18, P5, DOI 10.1016/S0945-053X(98)00003-1; OToole EA, 1997, EXP CELL RES, V233, P330, DOI 10.1006/excr.1997.3586; Pulkkinen L, 1997, MOL MED, V3, P124, DOI 10.1007/BF03401804; PYKE C, 1995, CANCER RES, V55, P4132; PYKE C, 1994, AM J PATHOL, V145, P782; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; Rheinwald JG., 1989, CELL GROWTH DIVISION, P81; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719; Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309; Shimizu H, 1997, LAB INVEST, V76, P753; SMITH LT, 1993, ARCH DERMATOL, V129, P1578, DOI 10.1001/archderm.129.12.1578; SONNENBERG A, 1993, J CELL SCI, V106, P1083; SONNENBERG A, 1987, J BIOL CHEM, V262, P10376; Spirito F, 2001, J GENE MED, V3, P21, DOI 10.1002/1521-2254(2000)9999:9999<::AID-JGM156>3.0.CO;2-I; Stahl S, 1997, J CELL SCI, V110, P55; TIDMAN MJ, 1986, J INVEST DERMATOL, V86, P51, DOI 10.1111/1523-1747.ep12283807; VAILLY J, 1994, EUR J BIOCHEM, V219, P209, DOI 10.1111/j.1432-1033.1994.tb19932.x; Vailly J, 1998, GENE THER, V5, P1322, DOI 10.1038/sj.gt.3300730; van der Neut R, 1999, J CELL SCI, V112, P3911; VERRANDO P, 1993, J INVEST DERMATOL, V101, P738, DOI 10.1111/1523-1747.ep12371685; VERRANDO P, 1991, LAB INVEST, V64, P85; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; ZAMBRUNO G, 1998, DIAGNOSTIC IMMUNOHIS, P126; Zhang K, 1996, EXP CELL RES, V227, P309, DOI 10.1006/excr.1996.0280	56	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18828	18835		10.1074/jbc.M100381200	http://dx.doi.org/10.1074/jbc.M100381200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279058	hybrid			2022-12-27	WOS:000169091000025
J	Leong, GM; Subramaniam, N; Figueroa, J; Flanagan, JL; Hayman, MJ; Eisman, JA; Kouzmenko, AP				Leong, GM; Subramaniam, N; Figueroa, J; Flanagan, JL; Hayman, MJ; Eisman, JA; Kouzmenko, AP			Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; CO-REPRESSOR; ONCOPROTEIN INTERACTS; SKELETAL-MUSCLE; COACTIVATORS; DNA; ACTIVATION; ONCOGENE; CBP/P300; COMPLEX	Transforming growth factor-beta (TGF-beta) signaling requires the action of Smad proteins in association with other DNA-binding factors and coactivator and corepressor proteins to modulate target gene transcription. Smad2 and Smad3 both associate with the c-Ski and Sno oncoproteins to repress transcription of Smad target genes via recruitment of a nuclear corepressor complex. Ski-interacting protein (SKIP), a nuclear hormone receptor coactivator, was examined as a possible modulator of transcriptional regulation of the TGF-beta -responsive promoter from the plasminogen activator inhibitor gene-1. SKIP augmented TGF-beta -dependent transactivation in contrast to Ski/Sno-dependent repression of this reporter. SKIP interacted with Smad2 and Smad3 proteins in vivo in yeast and in mammalian cells through a region of SKIP between amino acids 201-333. In vitro, deletion of the Mad homology domain 2 (MH2) domain of Smad3 abrogated SKIP binding, like Ski/Sno, but the MH2 domain of Smad3 alone was not sufficient for protein-protein interaction. Overexpression of SKIP partially overcame Ski/Sno-dependent repression, whereas Ski/Sno overexpression attenuated SKIP augmentation of TGF-beta -dependent transcription. Our results suggest a potential mechanism for transcriptional control of TGF-beta signaling that involves the opposing and competitive actions of SKIP and Smad MH2-interacting factors, such as Ski and/or Sno. Thus, SKIP appears to modulate both TGF-beta and nuclear hormone receptor signaling pathways.	St Vincents Hosp, Garvan Inst Med Res, Bone & Mineral Res Program, Darlinghurst, NSW 2010, Australia; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	Garvan Institute of Medical Research; St Vincents Hospital Sydney; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Leong, GM (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Bone & Mineral Res Program, 384 Victoria St, Darlinghurst, NSW 2010, Australia.		Eisman, John A/C-2886-2014	Leong, Gary/0000-0001-5763-095X; Flanagan, Judith/0000-0002-4053-3288	NATIONAL CANCER INSTITUTE [P01CA028146, R01CA042573] Funding Source: NIH RePORTER; NCI NIH HHS [CA42573, CA28146] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Baudino TA, 1998, J BIOL CHEM, V273, P16434, DOI 10.1074/jbc.273.26.16434; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; CARCAMO J, 1995, MOL CELL BIOL, V15, P1573; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; COLMENARES C, 1991, J VIROL, V65, P4929, DOI 10.1128/JVI.65.9.4929-4935.1991; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; Dahl R, 1998, P NATL ACAD SCI USA, V95, P11187, DOI 10.1073/pnas.95.19.11187; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hua XX, 1999, P NATL ACAD SCI USA, V96, P13130, DOI 10.1073/pnas.96.23.13130; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Leong GM, 1998, J BIOL CHEM, V273, P2296, DOI 10.1074/jbc.273.4.2296; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Shi XM, 1999, J BIOL CHEM, V274, P13711, DOI 10.1074/jbc.274.19.13711; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Subramaniam N, 2001, J BIOL CHEM, V276, P15741, DOI 10.1074/jbc.M011033200; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000; Zhou SF, 2000, J VIROL, V74, P1939, DOI 10.1128/JVI.74.4.1939-1947.2000	35	74	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18243	18248		10.1074/jbc.M010815200	http://dx.doi.org/10.1074/jbc.M010815200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278756	hybrid			2022-12-27	WOS:000168866500085
J	Nasser, W; Schneider, R; Travers, A; Muskhelishvili, G				Nasser, W; Schneider, R; Travers, A; Muskhelishvili, G			CRP modulates fis transcription by alternate formation of activating and repressing nucleoprotein complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMP RECEPTOR PROTEIN; STABLE RNA OPERONS; COLI HOST FACTOR; ESCHERICHIA-COLI; CYCLIC-AMP; DNA INVERSION; STRINGENT CONTROL; PROMOTER REGION; GROWTH; GENE	The DNA architectural proteins FIS and CRP are global regulators of transcription in Escherichia coli involved in the adjustment of cellular metabolism to varying growth conditions. We have previously demonstrated that FIS modulates the expression of the clp gene by functioning as its transcriptional repressor. Here we show that in turn, CRP is required to maintain the growth phase pattern of fis expression. We demonstrate the existence of a divergent promoter in the fis regulatory region, which reduces transcription of the fis promoter. In the absence of FIS, CRP activates fis transcription, thereby displacing the polymerase from the divergent promoter, whereas together FIS and CRP synergistically repress fis gene expression. These results provide evidence for a direct cross-talk between global regulators of cellular transcription during the growth phase. This cross-talk is manifested in alternate formation of functional nucleoprotein complexes exerting either activating or repressing effects on transcription.	Univ Munich, Inst Genet & Mikrobiol, D-80638 Munich, Germany; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Munich; MRC Laboratory Molecular Biology	Muskhelishvili, G (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str, D-35043 Marburg, Germany.		NASSER, William/C-9611-2019	NASSER, William/0000-0001-9848-3597				AIBA H, 1983, CELL, V32, P141, DOI 10.1016/0092-8674(83)90504-4; BALKE VL, 1987, J BACTERIOL, V169, P4499, DOI 10.1128/jb.169.10.4499-4506.1987; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; Browning DF, 2000, MOL MICROBIOL, V37, P1258, DOI 10.1046/j.1365-2958.2000.02087.x; Buettner M. J., 1973, J BACTERIOL, V14, P1068; Caramel A, 2000, MOL MICROBIOL, V36, P85, DOI 10.1046/j.1365-2958.2000.01827.x; CASHEL M, 1996, STRINGENT RESPONSE E, P1458; Claret L, 1996, J MOL BIOL, V263, P126, DOI 10.1006/jmbi.1996.0564; DECROMBRUGGHE B, 1984, SCIENCE, V224, P831, DOI 10.1126/science.6372090; Deufel A, 1997, NUCLEIC ACIDS RES, V25, P3832, DOI 10.1093/nar/25.19.3832; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; DUMITRU I, 1994, NUCLEIC ACIDS RES, V22, P1450; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Froelich JM, 1996, J BACTERIOL, V178, P6006, DOI 10.1128/jb.178.20.6006-6012.1996; GASTON K, 1990, CELL, V62, P733, DOI 10.1016/0092-8674(90)90118-X; GomezGomez JM, 1996, J BACTERIOL, V178, P3331, DOI 10.1128/jb.178.11.3331-3334.1996; Gonzalez-Gil G, 1998, EMBO J, V17, P2877, DOI 10.1093/emboj/17.10.2877; GonzalezGil G, 1996, MOL MICROBIOL, V22, P21, DOI 10.1111/j.1365-2958.1996.tb02652.x; HANAMURA A, 1991, NUCLEIC ACIDS RES, V19, P4413, DOI 10.1093/nar/19.16.4413; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; ISHIZUKA H, 1993, MOL MICROBIOL, V10, P341, DOI 10.1111/j.1365-2958.1993.tb01960.x; KOCH C, 1986, J BIOL CHEM, V261, P5673; KOCH C, 1988, P NATL ACAD SCI USA, V85, P4237, DOI 10.1073/pnas.85.12.4237; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LAZARUS LR, 1993, EMBO J, V12, P2483, DOI 10.1002/j.1460-2075.1993.tb05903.x; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; McLeod SM, 2000, J BACTERIOL, V182, P4180, DOI 10.1128/JB.182.15.4180-4187.2000; METZGER W, 1993, J MOL BIOL, V232, P35, DOI 10.1006/jmbi.1993.1368; Miller J.H., 1972, EXPT MOL GENETICS; MUSKHELISHVILI G, 1995, EMBO J, V14, P1446, DOI 10.1002/j.1460-2075.1995.tb07131.x; NILSSON L, 1990, EMBO J, V9, P727, DOI 10.1002/j.1460-2075.1990.tb08166.x; NILSSON L, 1992, J BACTERIOL, V174, P921, DOI 10.1128/jb.174.3.921-929.1992; NINNEMANN O, 1992, EMBO J, V11, P1075, DOI 10.1002/j.1460-2075.1992.tb05146.x; OSUNA R, 1995, J BACTERIOL, V177, P2021, DOI 10.1128/jb.177.8.2021-2032.1995; Pemberton IK, 2000, J MOL BIOL, V299, P859, DOI 10.1006/jmbi.2000.3780; Pratt TS, 1997, J BACTERIOL, V179, P6367, DOI 10.1128/jb.179.20.6367-6377.1997; Richet E, 2000, EMBO J, V19, P5222, DOI 10.1093/emboj/19.19.5222; ROSS W, 1990, EMBO J, V9, P3733, DOI 10.1002/j.1460-2075.1990.tb07586.x; SADLER JR, 1965, J MOL BIOL, V12, P305, DOI 10.1016/S0022-2836(65)80255-8; Schneider R, 1999, MOL MICROBIOL, V34, P953, DOI 10.1046/j.1365-2958.1999.01656.x; Schneider R, 1997, MOL MICROBIOL, V26, P519, DOI 10.1046/j.1365-2958.1997.5951971.x; Schneider R, 2000, MOL MICROBIOL, V38, P167, DOI 10.1046/j.1365-2958.2000.02129.x; Travers A, 1998, J MOL BIOL, V279, P1027, DOI 10.1006/jmbi.1998.1834; ULLMANN A, 1983, ADV CYCL NUCL RES<D>, V15, P1; VANET A, 1993, J BACTERIOL, V175, P7178, DOI 10.1128/JB.175.22.7178-7188.1993; Walker KA, 1999, J BACTERIOL, V181, P1269, DOI 10.1128/JB.181.4.1269-1280.1999; XU JM, 1995, J BACTERIOL, V177, P938, DOI 10.1128/jb.177.4.938-947.1995; XU JM, 1995, J BACTERIOL, V177, P3166, DOI 10.1128/jb.177.11.3166-3175.1995; ZHANG X, 1996, J MOL BIOL, V259, P276	50	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17878	17886		10.1074/jbc.M100632200	http://dx.doi.org/10.1074/jbc.M100632200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279109	hybrid			2022-12-27	WOS:000168866500037
J	Sun, YJ; Chang, NCA; Hung, SI; Chang, AC; Chou, CC; Hsiao, CD				Sun, YJ; Chang, NCA; Hung, SI; Chang, AC; Chou, CC; Hsiao, CD			The crystal structure of a novel mammalian lectin, Ym1, suggests a saccharide binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIOSE PHOSPHATE ISOMERASE; HEPARAN-SULFATE; 3-DIMENSIONAL STRUCTURE; PROTEIN; CHITINASE; RESOLUTION; IDENTIFICATION; GLYCOPROTEIN; RECOGNITION; CHITOSANASE	Ym1, a secretory protein synthesized by activated murine peritoneal macrophages, is a novel mammalian lectin with a binding specificity to GlcN, Lectins are responsible for carbohydrate recognition and for mediating cell-cell and cell-extracellular matrix interactions in microbes, plants, and animals. Glycosaminoglycan heparin/heparan sulfate binding ability was also detected in Ym1, We report here the three-dimensional structure of Ym1 at 2.5-Angstrom resolution by x-ray crystallography. The crystal structure of Ym1 consists of two globular domains, a beta/alpha triose-phosphate isomerase barrel domain and a small alpha + beta folding domain. A notable electron density of sugar is detected in the Ym1 crystal structure. The saccharide is located inside the triosephosphate isomerase domain at the COOH terminale nd of the beta -strands, Both hydrophilic and hydrophobic interactions are noted in the sugar-binding site in Ym1. Despite the fact that Ym1 is not a chitinase, structurally, Ym1 shares significant homology with chitinase A of Serratia marcescens, Ym1 and chitinase A have a similar carbohydrate binding cleft. This study provides new structure information, which will lead to better understanding of the biological significance of Ym1 and its putative gene members.	Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; Natl Yang Ming Univ, Sch Life Sci, Inst Neurosci, Taipei 112, Taiwan; Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Defense Medical Center; Academia Sinica - Taiwan; National Tsing Hua University	Chang, NCA (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	acchang@ym.edu.tw; mbhsiao@ccvax.sinica.edu.tw	Hsiao, Chwan-Deng/AAZ-8869-2021; Hung, Shuen-Iu/HHS-9012-2022; Hung, Shuen-Iu/ABB-2139-2021; Hsiao, Chwan-Deng/D-7327-2013	Hsiao, Chwan-Deng/0000-0002-7012-1532; Hung, Shuen-Iu/0000-0001-6531-5538; 				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Boucher I, 1995, J BIOL CHEM, V270, P31077, DOI 10.1074/jbc.270.52.31077; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CELADA A, 1994, IMMUNOL TODAY, V15, P100, DOI 10.1016/0167-5699(94)90150-3; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Epstein J, 1996, CURR OPIN IMMUNOL, V8, P29, DOI 10.1016/S0952-7915(96)80101-4; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Freedman SJ, 1996, BIOCHEMISTRY-US, V35, P13733, DOI 10.1021/bi9610257; Fry EE, 1999, EMBO J, V18, P543, DOI 10.1093/emboj/18.3.543; Gordon S, 1998, RES IMMUNOL, V149, P685, DOI 10.1016/S0923-2494(99)80039-X; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; HENNIG M, 1992, FEBS LETT, V306, P80, DOI 10.1016/0014-5793(92)80842-5; HENNIG M, 1995, J MOL BIOL, V254, P237, DOI 10.1006/jmbi.1995.0614; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Iversen LF, 1997, NAT STRUCT BIOL, V4, P265, DOI 10.1038/nsb0497-265; Jin HM, 1998, GENOMICS, V54, P316, DOI 10.1006/geno.1998.5593; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kirkpatrick RB, 1997, EXP CELL RES, V237, P46, DOI 10.1006/excr.1997.3764; KIRKPATRICK RB, 1995, GENE, V153, P147, DOI 10.1016/0378-1119(94)00756-I; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEODINAS DD, 1998, BIOCHEMISTRY-US, V37, P13930; MALETTE B, 1995, MOL REPROD DEV, V41, P384, DOI 10.1002/mrd.1080410315; Marcotte EM, 1996, NAT STRUCT BIOL, V3, P155, DOI 10.1038/nsb0296-155; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MUIRHEAD H, 1983, TRENDS BIOCHEM SCI, V8, P326, DOI 10.1016/0968-0004(83)90103-2; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; NYIRKOS P, 1990, BIOCHEM J, V269, P265, DOI 10.1042/bj2690265; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; POWELL LD, 1995, J BIOL CHEM, V270, P14243, DOI 10.1074/jbc.270.24.14243; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198; Rini JM, 1999, CURR OPIN STRUC BIOL, V9, P578, DOI 10.1016/S0959-440X(99)00008-1; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; Saito J, 1999, J BIOL CHEM, V274, P30818, DOI 10.1074/jbc.274.43.30818; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; Skinner R, 1997, J MOL BIOL, V266, P601, DOI 10.1006/jmbi.1996.0798; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WATANABE T, 1993, J BIOL CHEM, V268, P18567; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301	62	81	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17507	17514		10.1074/jbc.M010416200	http://dx.doi.org/10.1074/jbc.M010416200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278670	hybrid			2022-12-27	WOS:000168730400122
J	Aloy, P; Companys, V; Vendrell, J; Aviles, FX; Fricker, LD; Coll, M; Gomis-Ruth, FX				Aloy, P; Companys, V; Vendrell, J; Aviles, FX; Fricker, LD; Coll, M; Gomis-Ruth, FX			The crystal structure of the inhibitor-complexed carboxypeptidase D domain II and the modeling of regulatory carboxypeptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROHORMONE-PROCESSING ENZYMES; B VIRUS-PARTICLES; METALLOCARBOXYPEPTIDASE-D; SEQUENCE-ANALYSIS; MESSENGER-RNA; GENE FAMILY; PROTEIN; CLONING; CDNA; EXPRESSION	The three-dimensional crystal structure of duck carboxypeptidase D domain II has been solved in a complex with the peptidomimetic inhibitor, guanidinoethylmercaptosuccinic acid, occupying the specificity pocket. This structure allows a dear definition of the substrate binding sites and the substrate funnel-like access. The structure of domain II is the only one available from the regulatory carboxypeptidase family and can be used as a general template for its members. Here, it has been used to model the structures of domains I and III from the former protein and of human carboxypeptidase E. The models obtained show that the overall topology is similar in all cases, the main differences being local and because of insertions in non-regular loops. In both carboxypeptidase D domain I and carboxypeptidase E slightly different shapes of the access to the active site are predicted, implying some kind of structural selection of protein or peptide substrates. Furthermore, emplacement of the inhibitor structure in the active site of the constructed models showed that the inhibitor fits very well in all of them and that the relevant interactions observed with domain Hare conserved in domain I and carboxypeptidase E but not in the non-active domain III because of the absence of catalytically indispensable residues in the latter protein. However, in domain III some of the residues potentially involved in substrate binding are well preserved, together with others of unknown roles, which also are highly conserved among all carboxypeptidases. These observations, taken together with others, suggest that domain III might play a role in the binding and presentation of proteins or peptide substrates, such as the pre-S domain of the large envelope protein of duck hepatitis B virus.	Univ Autonoma Barcelona, Inst Biol Fonamental, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Ciencies, E-08193 Barcelona, Spain; Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; CSIC, Ctr Invest & Desenvolerpament, Inst Biol Mol Barcelona, ES-08034 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Yeshiva University; Albert Einstein College of Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Fricker, LD (corresponding author), Univ Autonoma Barcelona, Inst Biol Fonamental, E-08193 Barcelona, Spain.		Aloy, Patrick/AAB-3538-2019; Vendrell, Josep/A-6731-2010; Aviles, Francesc Xavier/F-3482-2019; Avilés, Francesc Xavier/A-2664-2015; Coll, Miquel/L-5999-2014	Vendrell, Josep/0000-0002-9378-4742; Aviles, Francesc Xavier/0000-0002-1399-6789; Avilés, Francesc Xavier/0000-0002-1399-6789; Coll, Miquel/0000-0003-4471-8674; Aloy, Patrick/0000-0002-3557-0236; Gomis-Ruth, F. Xavier/0000-0002-6848-6874	NIDA NIH HHS [DA-00194] Funding Source: Medline; NIDDK NIH HHS [DK-51271] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051271] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aloy P, 2000, J COMPUT AID MOL DES, V14, P83, DOI 10.1023/A:1008197831529; AVILES FX, 1993, EUR J BIOCHEM, V211, P381, DOI 10.1111/j.1432-1033.1993.tb17561.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COLL M, 1991, EMBO J, V10, P1; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eng FJ, 1998, J BIOL CHEM, V273, P8382, DOI 10.1074/jbc.273.14.8382; Fan XM, 1999, DNA CELL BIOL, V18, P121, DOI 10.1089/104454999315501; Fan XM, 1996, DNA CELL BIOL, V15, P937, DOI 10.1089/dna.1996.15.937; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FRICKER LD, 1986, NATURE, V323, P461, DOI 10.1038/323461a0; Fricker LD, 1996, J BIOL CHEM, V271, P30619, DOI 10.1074/jbc.271.48.30619; FRICKER LD, 1983, J BIOL CHEM, V258, P950; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; FRICKER LD, 1989, MOL ENDOCRINOL, V3, P666, DOI 10.1210/mend-3-4-666; FRICKER LD, 1991, PEPTIDE BIOSYNTHESIS, P199; Gomis-Ruth FX, 1999, EMBO J, V18, P5817, DOI 10.1093/emboj/18.21.5817; GREENE D, 1992, BIOCHEM J, V285, P613, DOI 10.1042/bj2850613; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; HOURDOU ML, 1993, BIOCHEM J, V292, P563, DOI 10.1042/bj2920563; Ishikawa T, 1998, GENE, V215, P361, DOI 10.1016/S0378-1119(98)00270-4; KUROKI K, 1995, J BIOL CHEM, V270, P15022, DOI 10.1074/jbc.270.25.15022; Lei YH, 1999, DNA CELL BIOL, V18, P175, DOI 10.1089/104454999315565; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; MANSER E, 1990, BIOCHEM J, V267, P517, DOI 10.1042/bj2670517; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Novikova EG, 1999, J BIOL CHEM, V274, P28887, DOI 10.1074/jbc.274.41.28887; ORENGO CA, 1992, PROTEINS, V14, P139, DOI 10.1002/prot.340140203; PARKINSON D, 1990, J BIOL CHEM, V265, P17101; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; RODRIGUEZ C, 1989, J BIOL CHEM, V264, P5988; ROTH WW, 1991, MOL CELL ENDOCRINOL, V78, P171, DOI 10.1016/0303-7207(91)90120-H; ROUSSEL A, 1989, TURBO FRODO SILICON, P77; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SETTLE SH, 1995, P NATL ACAD SCI USA, V92, P9470, DOI 10.1073/pnas.92.21.9470; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Skidgel R. A., 1996, ZINC METALLOPROTEASE, P241; SKIDGEL RA, 1988, TRENDS PHARMACOL SCI, V9, P299, DOI 10.1016/0165-6147(88)90015-6; Song LX, 1997, J BIOL CHEM, V272, P10543; SONG LX, 1995, J BIOL CHEM, V270, P25007, DOI 10.1074/jbc.270.42.25007; Tan FL, 1997, BIOCHEM J, V327, P81, DOI 10.1042/bj3270081; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Xin XN, 1997, DNA CELL BIOL, V16, P897, DOI 10.1089/dna.1997.16.897; Xin XN, 1998, DNA CELL BIOL, V17, P897, DOI 10.1089/dna.1998.17.897	45	61	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16177	16184		10.1074/jbc.M011457200	http://dx.doi.org/10.1074/jbc.M011457200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278909	hybrid			2022-12-27	WOS:000168623100082
J	Broad, LM; Braun, FJ; Lievremont, JP; Bird, GSJ; Kurosaki, T; Putney, JW				Broad, LM; Braun, FJ; Lievremont, JP; Bird, GSJ; Kurosaki, T; Putney, JW			Role of the phospholipase C-inositol 1,4,5-trisphosphate pathway in calcium release-activated calcium current and capacitative calcium entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; XENOPUS OOCYTES; INFLUX FACTOR; DIFFUSIBLE MESSENGER; HUMAN PLATELETS; ACINAR-CELLS; CA2+ ENTRY; RECEPTOR; TRISPHOSPHATE; DROSOPHILA	We investigated the putative roles of phospholipase C, polyphosphoinositides, and inositol 1,4,5-trisphosphate (IP3) in capacitative calcium entry and calcium release-activated calcium current (I-crac) in lacrimal acinar cells, rat basophilic leukemia cells, and DT40 B-lymphocytes, Inhibition of phospholipase C with U73122 blocked calcium entry and I-crac activation whether in response to a phospholipase C-coupled agonist or to calcium store depletion with thapsigargin. Run-down of cellular polyphosphoinositides by concentrations of wortmannin that block phosphatidylinositol 4-kinase completely blocked calcium entry and I-crac. The membrane-permeant IP3 receptor inhibitor, 2-aminoethoxydiphenyl borane, blocked both capacitative calcium entry and I-crac. However, it is likely that 2-aminoethoxydipheny1 borane does not inhibit through an action on the IP3 receptor because the drug was equally effective in wild-type DT40 B-cells and in DT40 B-cells whose genes for all three IP3 receptors had been disrupted. Intracellular application of another potent IP3 receptor antagonist, heparin, failed to inhibit activation of I-crac. Finally, the inhibition of I-crac activation by U73122 or wortmannin was not reversed or prevented by direct intracellular application of IP3. These findings indicate a requirement for phospholipase C and for polyphosphoinositides for activation of capacitative calcium entry. However, the results call into question the previously suggested roles of IP3 and IP3 receptor in this mechanism, at least in these particular cell types.	NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Kansai Medical University	Putney, JW (corresponding author), NIEHS, Lab Signal Transduct, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.		Putney, James W/F-7247-2019; Bird, Gary/AAI-8186-2021; Kurosaki, Tomohiro/D-1306-2009	Putney, James W/0000-0002-3379-4789; Bird, Gary/0000-0003-1389-8748; Kurosaki, Tomohiro/0000-0002-6352-304X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090087, Z01ES090087] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; ANDERSON KE, 1999, SIGNAL TRANSDUCTION, P283; Auger K. R., 1990, METHODS INOSITIDE RE, P159; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; BERVEN LA, 1995, BIOCHEM PHARMACOL, V49, P1373, DOI 10.1016/0006-2952(95)00050-A; BIRD GS, 1991, NATURE, V352, P162, DOI 10.1038/352162a0; Bird GS, 1999, J BIOL CHEM, V274, P20643, DOI 10.1074/jbc.274.29.20643; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BRAOD LM, 1999, J PHYSIOL-LONDON, V517, P121; Braun FJ, 2001, J BIOL CHEM, V276, P1063, DOI 10.1074/jbc.M008348200; CHOI OH, 1993, J IMMUNOL, V151, P5586; Csutora P, 1999, P NATL ACAD SCI USA, V96, P121, DOI 10.1073/pnas.96.1.121; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Jaconi M, 1997, CURR BIOL, V7, P599, DOI 10.1016/S0960-9822(06)00259-4; Jenner S, 1996, FEBS LETT, V381, P249, DOI 10.1016/0014-5793(96)00130-5; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; KWAN CY, 1990, AM J PHYSIOL, V258, pC1006, DOI 10.1152/ajpcell.1990.258.6.C1006; Linseman DA, 1998, J NEUROCHEM, V70, P940; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; MCKAY RR, 1995, J BIOL CHEM, V270, P13271, DOI 10.1074/jbc.270.22.13271; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; OLDERSHAW KA, 1993, BIOCHEM J, V292, P631, DOI 10.1042/bj2920631; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; PAROD RJ, 1980, AM J PHYSIOL, V239, pG99, DOI 10.1152/ajpgi.1980.239.2.G99; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Petersen CCH, 1996, PFLUG ARCH EUR J PHY, V432, P286, DOI 10.1007/s004240050135; Putney Jr JW, 1997, CAPACITATIVE CALCIUM; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Rosado JA, 2000, J BIOL CHEM, V275, P9110, DOI 10.1074/jbc.275.13.9110; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; THOMAS D, 1995, J BIOL CHEM, V270, P6429, DOI 10.1074/jbc.270.12.6429; Trepakova ES, 2000, J BIOL CHEM, V275, P26158, DOI 10.1074/jbc.M004666200; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC920, DOI 10.1152/ajpcell.1994.267.4.C920; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Zubov AI, 1999, J BIOL CHEM, V274, P25983, DOI 10.1074/jbc.274.37.25983	44	183	189	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15945	15952		10.1074/jbc.M011571200	http://dx.doi.org/10.1074/jbc.M011571200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278938	hybrid			2022-12-27	WOS:000168623100052
J	Ek-von Mentzer, BA; Zhang, FL; Hamilton, JA				Ek-von Mentzer, BA; Zhang, FL; Hamilton, JA			Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins - Implications for transmembrane and intracellular transport and for protection from lipid peroxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ARACHIDONIC-ACID; ESCHERICHIA-COLI; SERUM-ALBUMIN; BILE-ACIDS; RAT-LIVER; FLIP-FLOP; LIGAND; EXPRESSION; ACTIVATION	Transport and utilization of fatty acids (FA) in cells is a multistep process that includes adsorption to and movement across the plasma membrane and binding to intracellular fatty acid binding proteins (FABP) in the cytosol. We monitored the transbilayer movement of several polyunsaturated FA and oxidation products (13-hydroxy octadecadienoic acid (HODE) and 15-hydroxytetraenoic acid (HETE)) in unilamellar protein-free phospholipid vesicles containing a fluorescent pH probe. All FA diffused rapidly by the flip-flop mechanism across the model membrane, as revealed by pH changes inside the vesicle. This result suggests that FA oxidation products generated in the cell could cross the plasma or nuclear membrane spontaneously without a membrane transporter. To illuminate features of extra- and intracellular transport, the partitioning of unsaturated FA and oxidized FA between phospholipid vesicles and albumin or FABP was studied by the pyranin assay. These experiments showed that all polyunsaturated FA and oxidized FA (13-HODE and 15-HETE) desorbed rapidly from the phospholipid bilayer to bind to bovine serum albumin, which showed a slight preference for the unsaturated FA over the oxidized FA. FABP rapidly bound FA in the presence of phospholipid bilayers, with a preference of 13-HODE over the unsaturated FA and with a specificity depending on the type of FABP. Liver FABP was significantly more effective than intestinal FABP in binding 13-HODE in the presence of vesicles. The more effective binding of the FA metabolite, 13-HODE, than its precursor 18:2 by FABP may help protect cellular membranes from potential damage by monohydroxy fatty acids and may contribute a pathway for entry of 13-HODE into the nucleus.	Boston Univ, Sch Med, Ctr Adv Biochem Res, Dept Biophys, Boston, MA 02118 USA; Astrazeneca, Dept Preclin Res, S-43183 Molndal, Sweden; Astrazeneca, Dept Dev, S-43183 Molndal, Sweden	Boston University; AstraZeneca; AstraZeneca	Hamilton, JA (corresponding author), Boston Univ, Sch Med, Ctr Adv Biochem Res, Dept Biophys, 715 Albany St, Boston, MA 02118 USA.	hamilton@med-biophd.bu.edu		Hamilton, James/0000-0002-4747-7071	NHLBI NIH HHS [HL26635] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abumrad N, 1998, J LIPID RES, V39, P2309; ASHBROOK JD, 1975, J BIOL CHEM, V250, P2333; CABRAL DJ, 1987, BIOCHEMISTRY-US, V26, P1801, DOI 10.1021/bi00381a002; CISTOLA DP, 1987, J BIOL CHEM, V262, P10980; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; DUTTAROY AK, 1987, EUR J BIOCHEM, V162, P615, DOI 10.1111/j.1432-1033.1987.tb10683.x; Ek BA, 1997, BBA-LIPID LIPID MET, V1346, P75, DOI 10.1016/S0005-2760(97)00021-0; GLATZ JF, 1995, CHEM PHYS LIPIDS, V38, P115; GLATZ JFC, 1993, PROSTAG LEUKOTR ESS, V48, P33, DOI 10.1016/0952-3278(93)90007-J; Glatz JFC, 1997, PROSTAG LEUKOTR ESS, V57, P3, DOI 10.1016/S0952-3278(97)90485-3; GLATZ JFC, 1995, PROSTAG LEUKOTR ESS, V52, P121, DOI 10.1016/0952-3278(95)90010-1; Hamilton JA, 1998, J LIPID RES, V39, P467; Jezek P, 1997, FEBS LETT, V408, P161, DOI 10.1016/S0014-5793(97)00334-7; KAMP F, 1993, BIOCHEMISTRY-US, V32, P11074, DOI 10.1021/bi00092a017; KAMP F, 1995, BIOCHEMISTRY-US, V34, P11928, DOI 10.1021/bi00037a034; LOWE JB, 1987, J BIOL CHEM, V262, P5931; Lucke C, 1996, STRUCTURE, V4, P785, DOI 10.1016/S0969-2126(96)00086-X; Massey JB, 1997, BIOPHYS J, V72, P1732, DOI 10.1016/S0006-3495(97)78819-2; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NEMECZ G, 1991, J BIOL CHEM, V266, P17180; NIELSEN SU, 1993, J LIPID RES, V34, P1355; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; RAZA H, 1989, BIOCHEM BIOPH RES CO, V161, P448, DOI 10.1016/0006-291X(89)92619-3; RICHIERI GV, 1994, J BIOL CHEM, V269, P23918; SACCHETTINI JC, 1993, J BIOL CHEM, V268, P18399; SACCHETTINI JC, 1987, J BIOL CHEM, V262, P5428; SACCHETTINI JC, 1990, J BIOL CHEM, V265, P19199; Sundaram RK, 1996, CLIN SCI, V90, P255, DOI 10.1042/cs0900255; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; VANDERVUSSE GJ, 1989, MOL CELL BIOCHEM, V88, P1; VEERKAMP JH, 1995, PROG LIPID RES, V34, P17, DOI 10.1016/0163-7827(94)00005-7; VORK MM, 1993, J THEOR BIOL, V160, P207, DOI 10.1006/jtbi.1993.1014; Wolfrum C, 1999, J LIPID RES, V40, P708; YAMAMOTO S, 1991, FREE RADICAL BIO MED, V10, P149, DOI 10.1016/0891-5849(91)90008-Q; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975; ZHANG F, 1997, BIOCHEMISTRY-US, V35, P16055; Zhang FL, 1997, J BIOMOL NMR, V9, P213, DOI 10.1023/A:1018666522787	37	59	59	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15575	15580		10.1074/jbc.M011623200	http://dx.doi.org/10.1074/jbc.M011623200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278949	hybrid			2022-12-27	WOS:000168623100004
J	Burke, TW; Cook, JG; Asano, M; Nevins, JR				Burke, TW; Cook, JG; Asano, M; Nevins, JR			Replication factors MCM2 and ORC1 interact with the histone acetyltransferase HBO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; DIVISION-CYCLE MUTANTS; ZINC-FINGER PROTEIN; CELL-CYCLE; S-PHASE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; BUDDING YEAST; HUMAN GENES; RAT-LIVER	The minichromosome maintenance (MCM) proteins, together with the origin recognition complex (ORC) proteins and Cdc6, play an essential role in eukaryotic DNA replication through the formation of a pre-replication complex at origins of replication. We used a yeast two-hybrid screen to identify MCM2-interacting proteins. One of the proteins we identified is identical to the ORC1-interacting protein termed HBO1. HBO1 belongs to the MYST family, characterized by a highly conserved C2HC zinc finger and a putative histone acetyltransferase domain. Biochemical studies confirmed the interaction between MCM2 and HBO1 in vitro and in vivo. An N-terminal domain of MCM2 is necessary for binding to HBO1, and a C2HC zinc finger of HBO1 is essential for binding to MCM2. A reverse yeast two-hybrid selection was performed to isolate an allele of MCM2 that is defective for interaction with HBO1; this allele was then used to isolate a suppressor mutant of HBO1 that restores the interaction with the mutant MCM2. This suppressor mutation was located in the HBO1 zinc finger. Taken together, these findings strongly suggest that the interaction between MCM2 and HBO1 is direct and mediated by the C2HC zinc finger of HBO1. The biochemical and genetic interactions of MYST family protein HBO1 with two components of the replication apparatus, MCM2 and ORC1, suggest that HBO1-associated HAT activity may play a direct role in the process of DNA replication.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Genet, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute	Nevins, JR (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Genet, Durham, NC 27710 USA.	j.nevins@duke.edu		Burke, Thomas/0000-0003-0592-5822; Cook, Jeanette/0000-0003-0849-7405	NCI NIH HHS [CA09111-25] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexiadis V, 1997, CHROMOSOMA, V105, P324; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; ALTABA AR, 1987, EMBO J, V6, P3065, DOI 10.1002/j.1460-2075.1987.tb02613.x; Aoki F, 1999, ZYGOTE, V7, P165, DOI 10.1017/S0967199499000532; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Asano M, 1999, EMBO J, V18, P2435, DOI 10.1093/emboj/18.9.2435; BALDARELLI RM, 1988, DEV BIOL, V125, P85, DOI 10.1016/0012-1606(88)90061-9; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Belyaev ND, 1996, EXP CELL RES, V225, P277, DOI 10.1006/excr.1996.0177; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Champagne N, 1999, J BIOL CHEM, V274, P28528, DOI 10.1074/jbc.274.40.28528; Chong JPJ, 1996, TRENDS BIOCHEM SCI, V21, P102, DOI 10.1016/0968-0004(96)10013-X; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; COXON A, 1992, NUCLEIC ACIDS RES, V20, P5571, DOI 10.1093/nar/20.21.5571; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; DALTON S, 1995, P NATL ACAD SCI USA, V92, P2514, DOI 10.1073/pnas.92.7.2514; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Donaldson AD, 1999, CURR OPIN GENET DEV, V9, P62, DOI 10.1016/S0959-437X(99)80009-4; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; EhrenhoferMurray AE, 1997, GENETICS, V145, P923; FEGER G, 1995, EMBO J, V14, P5387, DOI 10.1002/j.1460-2075.1995.tb00223.x; Fujita M, 1996, J BIOL CHEM, V271, P4349; GIBSON SI, 1990, MOL CELL BIOL, V10, P5707, DOI 10.1128/MCB.10.11.5707; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HENNESSY K, 1990, GENE DEV, V4, P2262; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; KIMURA H, 1994, EMBO J, V13, P4311, DOI 10.1002/j.1460-2075.1994.tb06751.x; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; MAINE GT, 1984, GENETICS, V106, P365; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; MIYAKE S, 1993, MOL BIOL CELL, V4, P1003, DOI 10.1091/mbc.4.10.1003; MOIR D, 1982, GENETICS, V100, P547; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Nevins JR, 1997, METHOD ENZYMOL, V283, P205; Newlon CS, 1997, CELL, V91, P717, DOI 10.1016/S0092-8674(00)80459-6; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Reynolds A., 1997, CURRENT PROTOCOLS MO; Richter A, 1998, BIOL CHEM, V379, P1181; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; STILLMAN B, 1994, J BIOL CHEM, V269, P7047; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; TALASZ H, 1990, FEBS LETT, V264, P141, DOI 10.1016/0014-5793(90)80785-H; TODOROV IT, 1994, J CELL SCI, V107, P253; TREISMAN JE, 1995, GENE DEV, V9, P1709, DOI 10.1101/gad.9.14.1709; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; VIDAL M, 1997, YEAST 2 HYBRID SYSTE, P109; WEISS G, 1988, FEBS LETT, V238, P205, DOI 10.1016/0014-5793(88)80257-6; WHITBREAD LA, 1995, GENE, V155, P113, DOI 10.1016/0378-1119(94)00925-I; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; YAN H, 1991, GENE DEV, V5, P944, DOI 10.1101/gad.5.6.944; YAN H, 1993, GENE DEV, V7, P2149, DOI 10.1101/gad.7.11.2149	69	156	161	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15397	15408		10.1074/jbc.M011556200	http://dx.doi.org/10.1074/jbc.M011556200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278932	hybrid			2022-12-27	WOS:000168528800115
J	Benayoun, B; Esnard-Feve, A; Castella, S; Courty, Y; Esnard, F				Benayoun, B; Esnard-Feve, A; Castella, S; Courty, Y; Esnard, F			Rat seminal vesicle FAD-dependent sulfhydryl oxidase - Biochemical characterization and molecular cloning of a member of the new sulfhydryl oxidase/quiescin Q6 gene family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER PHODOPUS-SUNGORUS; DISULFIDE BOND FORMATION; EGG-WHITE; QUIESCIN Q6; TESTICULAR SULPHYDRYLOXIDASE; CYSTEINE PROTEINASES; CYSTATIN-C; LOCALIZATION; PURIFICATION; INHIBITORS	Rat FAD-dependent sulfhydryl oxidase was purified; partial sequencing indicated that it was homologous to human quiescin Q6. A cDNA (GenBank(TM) accession no. AF285078) was cloned from rat seminal vesicles, and active recombinant sulfhydryl oxidase was expressed in Chinese hamster ovary epithelial cells. This 2472-nucleotide cDNA has an open reading frame of 1710 base pairs, encoding a protein of 570 amino acids including a 32-amino acid leader sequence and two potential sites for N-glycosylation One of them is used and the 64,000 M-r purified protein was transformed to 61,000 by the action of endoglycosidase F, Northern blotting and reverse transcription-polymerase chain reaction analyses showed that there were small amounts of sulfhydryl oxidase in the rat testis, prostate, lung, heart, kidney, spleen, and liver, and that the gene was highly expressed in seminal vesicles and epididymis. Rat sulfhydryl oxidase cDNA corresponds to the human cell growth inhibiting factor cDNA, which could be a differently spliced form of quiescin Q6, Comparing sulfhydryl oxidase sequences with those of human quiescin Q6 and mammalian and Caenorhabditis elegans quiescin Q6-related genes established the existence of a new family of FAD-dependent sulfhydryl oxidase/quiescin Q6-related genes containing protein-disulfide isomerase-type thioredoxin and yeast ERV1 domains.	Univ Francois Rabelais, Fac Med, INSERM,EMI U0010, Equip Proteases & Vectorisat, F-37032 Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Esnard, F (corresponding author), Univ Francois Rabelais, Fac Med, INSERM,EMI U0010, Equip Proteases & Vectorisat, 2 Bis Blvd Tonnelle, F-37032 Tours, France.			Courty, Yves/0000-0003-3694-8517				AUMULLER G, 1991, CELL TISSUE RES, V266, P23, DOI 10.1007/BF00678707; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BERGMANN M, 1992, CELL TISSUE RES, V267, P209, DOI 10.1007/BF00302957; BERGMANN M, 1991, J REPROD FERTIL, V91, P259, DOI 10.1530/jrf.0.0910259; BERGMANN M, 1990, INT J ANDROL, V13, P488, DOI 10.1111/j.1365-2605.1990.tb01055.x; BUTTLE DJ, 1989, BIOCHEM J, V261, P469, DOI 10.1042/bj2610469; CHANG TSK, 1975, BIOCHEM BIOPH RES CO, V66, P309, DOI 10.1016/S0006-291X(75)80329-9; CHANG TSK, 1978, BIOL REPROD, V18, P745, DOI 10.1095/biolreprod18.5.745; CLARE DA, 1988, ARCH BIOCHEM BIOPHYS, V265, P351, DOI 10.1016/0003-9861(88)90138-5; Coppock D, 2000, BIOCHEM BIOPH RES CO, V269, P604, DOI 10.1006/bbrc.2000.2324; COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483; Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605; DELAMOTTE RS, 1987, BIOCHEMISTRY-US, V26, P7363, DOI 10.1021/bi00397a025; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ESNARD A, 1988, BIOL CHEM H-S, V369, P219; ESNARD A, 1988, FEBS LETT, V236, P475, DOI 10.1016/0014-5793(88)80080-2; ESNARD F, 1990, BIOL CHEM H-S, V371, P161; FROHMAN MA, 1994, PCR METH APPL, V4, P40; GOLDSMITH LA, 1987, METHOD ENZYMOL, V143, P510; Hawke D, 1987, APPL BIOSYSTEMS B, V28; Hofhaus G, 1999, EUR J CELL BIOL, V78, P349, DOI 10.1016/S0171-9335(99)80069-7; Hoober KL, 1999, BIOCHEMISTRY-US, V38, P3211, DOI 10.1021/bi9820816; Hoober KL, 1999, J BIOL CHEM, V274, P31759, DOI 10.1074/jbc.274.45.31759; Hoober KL, 1999, J BIOL CHEM, V274, P22147, DOI 10.1074/jbc.274.32.22147; Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510; ISAACS CE, 1984, PEDIATR RES, V18, P532, DOI 10.1203/00006450-198406000-00010; JANOLINO VG, 1975, J BIOL CHEM, V250, P2532; Kaul D, 1996, MOL CELL BIOCHEM, V159, P81; KUMARI M, 1990, HISTOCHEMISTRY, V94, P365; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASH LH, 1984, BIOCHIM BIOPHYS ACTA, V779, P191, DOI 10.1016/0304-4157(84)90008-X; LASH LH, 1986, ARCH BIOCHEM BIOPHYS, V247, P120, DOI 10.1016/0003-9861(86)90540-0; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; OSTROWSKI MC, 1980, BIOCHEMISTRY-US, V19, P2639, DOI 10.1021/bi00553a016; OSTROWSKI MC, 1979, BIOCHEM BIOPH RES CO, V87, P171, DOI 10.1016/0006-291X(79)91662-0; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMELZER CH, 1982, BIOCHEM BIOPH RES CO, V107, P196, DOI 10.1016/0006-291X(82)91688-6; TAKAMORI K, 1980, BIOCHIM BIOPHYS ACTA, V615, P309, DOI 10.1016/0005-2744(80)90499-4; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121	41	63	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13830	13837		10.1074/jbc.M010933200	http://dx.doi.org/10.1074/jbc.M010933200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278790	hybrid			2022-12-27	WOS:000168356600047
J	Yoneda, T; Imaizumi, K; Oono, K; Yui, D; Gomi, F; Katayama, T; Tohyama, M				Yoneda, T; Imaizumi, K; Oono, K; Yui, D; Gomi, F; Katayama, T; Tohyama, M			Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN-KINASE; SIGNAL-TRANSDUCTION; CELL-DEATH; JUN KINASE; KAPPA-B; C-JUN; APOPTOSIS; JNK; PATHWAY; INDUCTION	When accumulation of a malfolded protein in the endoplastic reticulum (ER) is induced by various adverse conditions, such as hypoxia, glucose starvation, and perturbation of calcium homeostasis, cells respond to the stress by increasing transcription of genes encoding ER molecular chaperones, a process known as unfolded protein response. The signaling is initiated by IRE1s, ER stress sensors. Alternatively, excessive stress to the ER results in apoptosis, Caspase la is known to be essential for this ER stress-induced apoptosis. In this study, we analyzed the detailed regulatory mechanisms of IRE1s during ER stress. We identified c-Jun N-terminal inhibitory kinase (JIK) as a binding partner of IRE1 alpha, and JIK was seen to modulate IRE1 alpha -TRAF2 (tumor necrosis factor receptor associated factor 2) complex formation and the resultant alteration to c-Jun N-terminal kinase signaling from IRE1s in response to ER stress. We also demonstrated that TRAF2 interacts with procaspase-12 and promotes the clustering of procaspase-12 and its activation by cleavage in response to ER stress. These results indicate that TRAF2 plays crucial roles not only in the signaling of the c-Jun N-terminal kinase pathway but also in activation of caspase-12 to transduce signals from IRE1s. Thus, we provide a missing link in the ER stress induced apoptosis-signaling pathway, one which connects the stress sensor molecule IRE1 and the activation of caspase-12.	Osaka Univ, Sch Med, Dept Anat & Neurosci, Suita, Osaka 5650871, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cellular & Struct Biol, Nara 6300101, Japan; Japan Sci & Technol, Core Res Evolutional Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Osaka University; Nara Institute of Science & Technology; Japan Science & Technology Agency (JST)	Yoneda, T (corresponding author), Osaka Univ, Sch Med, Dept Anat & Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Longo, Kenneth A/A-5631-2010	Gomi, Fumi/0000-0003-0807-8817				Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Colussi PA, 1998, J BIOL CHEM, V273, P26566, DOI 10.1074/jbc.273.41.26566; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Latinis KM, 1996, BLOOD, V87, P871, DOI 10.1182/blood.V87.3.871.bloodjournal873871; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; MORI K, 1993, CELL, V74, P743; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tassi E, 1999, J BIOL CHEM, V274, P33287, DOI 10.1074/jbc.274.47.33287; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; WESTWICK JK, 1994, J BIOL CHEM, V269, P26396; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Yoneda T, 2000, J BIOL CHEM, V275, P11114, DOI 10.1074/jbc.275.15.11114	25	649	692	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13935	13940		10.1074/jbc.M010677200	http://dx.doi.org/10.1074/jbc.M010677200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278723	hybrid			2022-12-27	WOS:000168356600060
J	Schroeder, JA; Thompson, MC; Gardner, MM; Gendler, SJ				Schroeder, JA; Thompson, MC; Gardner, MM; Gendler, SJ			Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation ill the mouse mammary gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; CARCINOMA-ASSOCIATED ANTIGEN; ERBB SIGNALING NETWORK; BREAST-CANCER; EPITHELIAL MUCIN; EPISIALIN MUC1; CELL-ADHESION; MONOCLONAL-ANTIBODIES; REGULATED KINASE; BETA-CATENIN	MUC1 is a large (>400 kDa), heavily glycosylated transmembrane protein that is aberrantly expressed on greater than 90% of human breast carcinomas and subsequent metastases. The precise function of MUC1 overexpression in tumorigenesis is unknown, although various domains of MUC1 have been implicated in cell adhesion, cell signaling, and immunoregulation. Stimulation of the MDA-MB-468 breast cancer line as well as mouse mammary glands with epidermal growth factor results in the co-immunoprecipitation of MUC1 with a tyrosine-phosphorylated protein of similar to 180 kDa, We have generated transgenic lines overexpressing full-length (MMF), cytoplasmic tail deleted (Delta CT), or tandem repeat deleted (Delta TR)-human MUC1 under the control of the mouse mammary tumor virus promoter to further examine the role of MUC1 in signaling and tumorigenesis, Immunoprecipitation experiments revealed that full-length transgenic MUC1 physically associates with all four erbB receptors, and co-localizes with erbB1 in the lactating gland. Furthermore, we detected a sharp increase in ERK1/2 activation in MUC1 transgenic mammary glands compared with Mud null and wild-type animals. These results point to a novel function of increased MUC1 expression, potentiation of erbB signaling through the activation of mitogenic MAP kinase pathways.	Mayo Clin Scottsdale, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Gendler, SJ (corresponding author), Mayo Clin Scottsdale, SC Johnson Res Bldg,13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	gendler.sandra@mayo.edu		schroeder, joyce/0000-0003-1277-5172	NCI NIH HHS [CA64389, CA81703] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA081703, R01CA064389] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Amundadottir LT, 1998, ONCOGENE, V16, P737, DOI 10.1038/sj.onc.1201829; BRAGA VMM, 1992, DEVELOPMENT, V115, P427; BURCHELL J, 1983, J IMMUNOL, V131, P508; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Carraway KL, 1999, J BIOL CHEM, V274, P5263, DOI 10.1074/jbc.274.9.5263; Carraway KL, 2000, FRONT BIOSCI, V5, pD95, DOI 10.2741/Carraway; Chapman RS, 2000, ADV EXP MED BIOL, V480, P129; Chen YH, 2000, MOL BIOL CELL, V11, P849, DOI 10.1091/mbc.11.3.849; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Daly JM, 1999, ONCOGENE, V18, P3440, DOI 10.1038/sj.onc.1202700; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Fabian CJ, 1996, J CELL BIOCHEM, P112; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HILKENS J, 1995, CANCER LETT, V90, P27, DOI 10.1016/0304-3835(94)03674-8; Ishikawa Y, 1999, BIOCHEM BIOPH RES CO, V264, P696, DOI 10.1006/bbrc.1999.1542; Kam JL, 1998, CANCER RES, V58, P5577; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; LUNDY J, 1991, AM J PATHOL, V138, P1527; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; PANDEY P, 1995, CANCER RES, V55, P4000; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; PEMBERTON L, 1992, BIOCHEM BIOPH RES CO, V185, P167, DOI 10.1016/S0006-291X(05)80971-4; Pemberton LF, 1996, J BIOL CHEM, V271, P2332, DOI 10.1074/jbc.271.4.2332; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Price MR, 1998, TUMOR BIOL, V19, P1, DOI 10.1159/000056500; Regimbald LH, 1996, CANCER RES, V56, P4244; SANDGREN EP, 1995, CANCER RES, V55, P3915; Schroeder JA, 1998, CELL GROWTH DIFFER, V9, P451; Schroeder JA, 1997, J MAMMARY GLAND BIOL, V2, P119, DOI 10.1023/A:1026347629876; Sikut R, 1998, TUMOR BIOL, V19, P122, DOI 10.1159/000056513; SPICER AP, 1995, J BIOL CHEM, V270, P30093; SPICER AP, 1995, MAMM GENOME, V6, P885, DOI 10.1007/BF00292441; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Wesseling J, 1996, MOL BIOL CELL, V7, P565, DOI 10.1091/mbc.7.4.565; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Zhu XY, 2000, ONCOGENE, V19, P4354, DOI 10.1038/sj.onc.1203781; ZOTTER S, 1988, Cancer Reviews, V11-12, P55; ZRIHANLICHT S, 1994, FEBS LETT, V356, P130, DOI 10.1016/0014-5793(94)01251-2	47	282	305	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13057	13064		10.1074/jbc.M011248200	http://dx.doi.org/10.1074/jbc.M011248200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278868	hybrid			2022-12-27	WOS:000168198600084
J	Fazio, IK; Bolger, TA; Gill, G				Fazio, IK; Bolger, TA; Gill, G			Conserved regions of the Drosophila erect wing protein contribute both positively and negatively to transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA-URCHIN EMBRYO; NUCLEAR RESPIRATORY FACTOR-1; GENE REGULATORY FACTORS; DNA-BINDING PROTEIN; MUSCLE DEVELOPMENT; ACTIVATION DOMAINS; INITIATION; EXPRESSION; FAMILY; NRF-1	Genetic studies of the Drosophila erect wing (ewg) gene have revealed that ewg has an essential function in the embryonic nervous system and is required for the specification of certain muscle cells, We have found that EWG is a site-specific transcriptional activator, and we report here that evolutionarily conserved regions of EWG contribute both positively and negatively to transcriptional activity. Using gel mobility shift assays, we have shown that an EWG dimer binds specifically to DNA. In transfection assays, EWG activated expression of a reporter gene bearing specific binding sites. Analysis of deletion mutants and fusions of EWG to the Gal4 DNA binding domain has identified a transcriptional activation domain in the C terminus of EWG, Deletion analysis also revealed a novel inhibitory region in the N terminus of EWG, Strikingly, both the activation domain and the inhibitory region are conserved in EWG homologs including human nuclear respiratory factor 1 (NRF-1) and the sea urchin P3A2 protein, The strong conservation of elements that determine transcriptional activity suggests that the EWG, NRF-1, and P3A2 family of proteins shares common mechanisms of action and has maintained common functions across evolution.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Gill, G (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.							Becker TS, 1998, DEVELOPMENT, V125, P4369; Bogarad LD, 1998, P NATL ACAD SCI USA, V95, P14827, DOI 10.1073/pnas.95.25.14827; CALZONE FJ, 1991, DEVELOPMENT, V112, P335; DeSimone S, 1996, DEVELOPMENT, V122, P31; DESIMONE SM, 1993, MOL CELL BIOL, V13, P3641, DOI 10.1128/MCB.13.6.3641; EFIOK BJS, 1994, J BIOL CHEM, V269, P18921; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; FLEMING RJ, 1983, DEV GENET, V3, P347; GOMEZCUADRADO A, 1995, MOL CELL BIOL, V15, P6670; GOMEZCUADRADO A, 1992, EMBO J, V11, P1857, DOI 10.1002/j.1460-2075.1992.tb05237.x; Gugneja S, 1997, J BIOL CHEM, V272, P18732, DOI 10.1074/jbc.272.30.18732; Gugneja S, 1996, MOL CELL BIOL, V16, P5708; HAVIV I, 1995, MOL CELL BIOL, V15, P1079; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Herzig RP, 2000, J CELL SCI, V113, P4263; HOOG C, 1991, DEVELOPMENT, V112, P351; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; Kirchhamer CV, 1996, DEVELOPMENT, V122, P333; Koushika SP, 1999, MOL CELL BIOL, V19, P3998; Kumari D, 2001, J BIOL CHEM, V276, P4357, DOI 10.1074/jbc.M009629200; Myers SJ, 1998, J NEUROSCI, V18, P6723; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	25	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18710	18716		10.1074/jbc.M100080200	http://dx.doi.org/10.1074/jbc.M100080200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278998	hybrid			2022-12-27	WOS:000169091000010
J	Lin, SR; McLennan, AG; Ying, K; Wang, Z; Gu, SH; Jin, H; Wu, CQ; Liu, WP; Yuan, YZ; Tang, R; Xie, Y; Mao, YM				Lin, SR; McLennan, AG; Ying, K; Wang, Z; Gu, SH; Jin, H; Wu, CQ; Liu, WP; Yuan, YZ; Tang, R; Xie, Y; Mao, YM			Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the ITPA gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXANTHINE-DNA GLYCOSYLASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; RANDOM MUTAGENESIS; 6-N-HYDROXYLAMINOPURINE; YEAST; DITP; RNA; PYROPHOSPHOHYDROLASE; NUCLEOTIDE	ITP and dITP exist in all cells. dITP is potentially mutagenic, and the levels of these nucleotides are controlled by inosine triphosphate pyrophosphatase (EC 3,6,1,19), Here we report the cloning, expression, and characterization of a 21,5-kDa human inosine triphosphate pyrophosphatase (hITPase), an enzyme whose activity has been reported in many animal tissues and studied in populations but whose protein sequence has not been determined before. At the optimal pH of 10.0, recombinant hITPase hydrolyzed ITP, dITP, and xanthosine 5'-triphosphate to their respective monophosphates whereas activity with other nucleoside triphosphates was low. K-m values for ITP, dITP, and xanthosine 5'-triphosphate were 0,51, 0,31, and 0.57 mM, respectively, and k(cat) values were 580, 360, and 640 s(-1) respectively. A divalent cation was absolutely required for activity. The gene encoding the hITPase cDNA sequence was localized by radiation hybrid mapping to chromosome 20p in the interval D20S113-D20S97, the same interval in which the ITPA inosine triphosphatase gene was previously localized. A BLAST search revealed the existence of many similar sequences in organisms ranging from bacteria to mammals. The function of this ubiquitous protein family is proposed to be the elimination of minor potentially mutagenic or clastogenic purine nucleoside triphosphates from the cell.	Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Genet Inst, Shanghai 200433, Peoples R China; United Gene Holding Ltd, Shanghai 200092, Peoples R China; Univ Liverpool, Sch Biol Sci, Cell Regulat & Signalling Grp, Liverpool L69 7ZB, Merseyside, England	Fudan University; University of Liverpool	Xie, Y (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Genet Inst, Shanghai 200433, Peoples R China.			Wang, Zhao/0000-0002-9904-9538				ABDULMASIH MT, 1986, J BIOL CHEM, V261, P2020; AKIYAMA M, 1989, P NATL ACAD SCI USA, V86, P3949, DOI 10.1073/pnas.86.11.3949; ALEXANDER RR, 1985, BSAIC BIOCH METHODS, P182; AUCLAIR C, 1990, ARCH BIOCHEM BIOPHYS, V278, P238, DOI 10.1016/0003-9861(90)90253-U; Auer T, 1996, NUCLEIC ACIDS RES, V24, P5021, DOI 10.1093/nar/24.24.5021; Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; CAIN DF, 1963, BIOCHIM BIOPHYS ACTA, V74, P735, DOI 10.1016/0006-3002(63)91425-2; CHANDA PK, 1988, VIROLOGY, V129, P225; CHERN CJ, 1969, J BIOL CHEM, V244, P5489; CLEMENT B, 1990, BIOCHEM PHARMACOL, V39, P925, DOI 10.1016/0006-2952(90)90209-4; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Decosterd LA, 1999, ANAL BIOCHEM, V270, P59, DOI 10.1006/abio.1999.4066; DIANOV G, 1991, NUCLEIC ACIDS RES, V19, P3829, DOI 10.1093/nar/19.14.3829; DULEY JA, 1990, CLIN CHIM ACTA, V188, P243, DOI 10.1016/0009-8981(90)90206-8; Emerit I, 1996, P NATL ACAD SCI USA, V93, P12799, DOI 10.1073/pnas.93.23.12799; HERSHKO A, 1969, ISRAEL J MED SCI, V5, P991; Hwang KY, 1999, NAT STRUCT BIOL, V6, P691; Klinker JF, 1997, BIOCHEM PHARMACOL, V54, P551, DOI 10.1016/S0006-2952(97)00205-0; Kozmin SG, 1998, MUTAT RES-FUND MOL M, V402, P41, DOI 10.1016/S0027-5107(97)00280-7; Kozmin SG, 1998, ACTA BIOCHIM POL, V45, P645, DOI 10.18388/abp.1998_4202; Kuipers O P, 1996, Methods Mol Biol, V57, P351; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; McIntosh EM, 1997, ACTA BIOCHIM POL, V44, P159; McLennan AG, 1999, INT J MOL MED, V4, P79; MOHANDAS T, 1980, CYTOGENET CELL GENET, V26, P28, DOI 10.1159/000131418; Morris A J, 1978, Methods Enzymol, V51, P275; Morse DP, 1999, P NATL ACAD SCI USA, V96, P6048, DOI 10.1073/pnas.96.11.6048; MYRNES B, 1982, NUCLEIC ACIDS RES, V10, P3693, DOI 10.1093/nar/10.12.3693; Noskov VN, 1996, YEAST, V12, P17, DOI 10.1002/(SICI)1097-0061(199601)12:1<17::AID-YEA875>3.0.CO;2-I; PAVLOV YI, 1991, MUTAT RES, V253, P33, DOI 10.1016/0165-1161(91)90343-7; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; SAPARBAEV M, 1994, P NATL ACAD SCI USA, V91, P5873, DOI 10.1073/pnas.91.13.5873; Seifert R, 1999, MOL PHARMACOL, V56, P348, DOI 10.1124/mol.56.2.348; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; SIEKEVITZ P, 1955, J BIOL CHEM, V215, P221; SPEE JH, 1993, NUCLEIC ACIDS RES, V21, P777, DOI 10.1093/nar/21.3.777; STRIMMER K, 1996, MOL BIOL EVOL, V13, P946; THOMAS DH, 1978, AM ANTIQUITY, V43, P231, DOI 10.2307/279247; TSUTSUI T, 1985, MUTAT RES, V148, P107, DOI 10.1016/0027-5107(85)90213-1; VANDERHEIDEN BS, 1970, BIOCHIM BIOPHYS ACTA, V215, P555, DOI 10.1016/0304-4165(70)90109-1; VANDERHEIDEN BS, 1979, J CELL PHYSIOL, V98, P41, DOI 10.1002/jcp.1040980106; VANDERHEIDEN BS, 1980, BIOCHEM MED METAB B, V23, P76, DOI 10.1016/0006-2944(80)90057-5; VANDERHEIDEN BS, 1979, BIOCHEM MED METAB B, V21, P22, DOI 10.1016/0006-2944(79)90051-6; VANDERHEIDEN BS, 1965, BIOCHEM BIOPH RES CO, V21, P265, DOI 10.1016/0006-291X(65)90281-0; VANDERHEIDEN BS, 1969, BIOCHEM GENET, V3, P289, DOI 10.1007/BF00521144; VANDERHEIDEN BS, 1975, J CELL PHYSL, V86, P165; VANWAEG G, 1988, CLIN CHIM ACTA, V171, P279, DOI 10.1016/0009-8981(88)90154-4; WANG JK, 1974, ARCH BIOCHEM BIOPHYS, V161, P118, DOI 10.1016/0003-9861(74)90241-0; WORTMANN RL, 1988, PEDIATR RES, V24, P148; ZACHARA B, 1974, BIOCHIM BIOPHYS ACTA, V353, P253, DOI 10.1016/0005-2787(74)90190-7	51	109	113	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18695	18701		10.1074/jbc.M011084200	http://dx.doi.org/10.1074/jbc.M011084200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278832	hybrid			2022-12-27	WOS:000169091000008
J	Betti, M; Petrucco, S; Bolchi, A; Dieci, G; Ottonello, S				Betti, M; Petrucco, S; Bolchi, A; Dieci, G; Ottonello, S			A plant 3 '-phosphoesterase involved in the repair of DNA strand breaks generated by oxidative damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL-POLYPHOSPHATE 1-PHOSPHATASE; NUCLEOTIDE EXCISION-REPAIR; IN-VIVO TARGET; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; 3'(2'),5'-BISPHOSPHATE NUCLEOTIDASE; METHIONINE BIOSYNTHESIS; POLYNUCLEOTIDE KINASE; MOLECULAR-BIOLOGY; SALT TOLERANCE	Two novel, structurally and functionally distinct phosphatases have been identified through the functional complementation, by maize cDNAs, of an Escherichia coli diphosphonucleoside phosphatase mutant strain. The first, ZmDP1, is a classical Mg2+-dependent and Li+-sensitive diphosphonucleoside phosphatase that dephosphorylates both 3'-phosphoadenosine 5'-phosphate (3'-PAP) and 2'-PAP without any discrimination between the 3'- and 2'-positions. The other, ZmDP2, is a distinct phosphatase that also catalyzes diphosphonucleoside dephosphorylation, but with a 12-fold lower Li+ sensitivity, a strong preference for 3'-PAP, and the unique ability to utilize double-stranded DNA molecules with 3'-phosphate- or 3'-phosphoglycolate-blocking groups as substrates, Importantly, ZmDP2, but not ZmDP1, conferred resistance to a DNA repair-deficient E, coli strain against oxidative DNA-damaging agents generating 3'-phosphate- or 3'-phosphoglycolate-blocked single strand breaks. ZmDP2 shares a partial amino acid sequence similarity with a recently identified human polynucleotide kinase 3'-phosphatase that is thought to be involved in DNA repair, but is devoid of 5'-kinase activity. ZmDP2 is the first DNA 3'-phosphoesterase thus far identified in plants capable of converting 3'-blocked termini into priming sites for reparative DNA polymerization.	Univ Parma, Ist Sci Biochim, I-43100 Parma, Italy	University of Parma	Ottonello, S (corresponding author), Univ Parma, Ist Sci Biochim, I-43100 Parma, Italy.		Betti, Marco/E-6304-2010; Dieci, Giorgio/B-3434-2012; Bolchi, Angelo/GOJ-9730-2022	Betti, Marco/0000-0002-7334-5734; Dieci, Giorgio/0000-0002-8792-3961; 				Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; BABIYCHUK E, 1994, P NATL ACAD SCI USA, V91, P3299, DOI 10.1073/pnas.91.8.3299; BARZILAY G, 1995, BIOESSAYS, V17, P713, DOI 10.1002/bies.950170808; Bertrand P, 1998, P NATL ACAD SCI USA, V95, P14278, DOI 10.1073/pnas.95.24.14278; Bick JA, 1998, CURR OPIN PLANT BIOL, V1, P240, DOI 10.1016/S1369-5266(98)80111-8; Brocchieri L, 1998, J MOL BIOL, V276, P249, DOI 10.1006/jmbi.1997.1527; CAMERON V, 1977, BIOCHEMISTRY-US, V16, P5120, DOI 10.1021/bi00642a027; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; DEMPLE B, 1986, P NATL ACAD SCI USA, V83, P7731, DOI 10.1073/pnas.83.20.7731; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Freeling M., 1994, MAIZE HDB; Gil-Mascarell R, 1999, PLANT J, V17, P373, DOI 10.1046/j.1365-313X.1999.00385.x; GLASER HU, 1993, EMBO J, V12, P3105, DOI 10.1002/j.1460-2075.1993.tb05979.x; GU LY, 1994, J BIOL CHEM, V269, P32685; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Kaneko T, 2000, DNA RES, V7, P217, DOI 10.1093/dnares/7.3.217; Karimi-Busheri F, 1998, NUCLEIC ACIDS RES, V26, P4395, DOI 10.1093/nar/26.19.4395; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lopez-Coronado JM, 1999, J BIOL CHEM, V274, P16034, DOI 10.1074/jbc.274.23.16034; MASSELOT M, 1975, MOL GEN GENET, V139, P121, DOI 10.1007/BF00264692; Miyamoto R, 2000, J BACTERIOL, V182, P3619, DOI 10.1128/JB.182.13.3619-3625.2000; MURGUIA JR, 1995, SCIENCE, V267, P232; Murguia JR, 1996, J BIOL CHEM, V271, P29029, DOI 10.1074/jbc.271.46.29029; NEUWALD AF, 1992, J BACTERIOL, V174, P415, DOI 10.1128/jb.174.2.415-425.1992; PENG ZH, 1995, J BIOL CHEM, V270, P29105, DOI 10.1074/jbc.270.49.29105; Petrucco S, 1996, PLANT CELL, V8, P69, DOI 10.1105/tpc.8.1.69; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; Ramotar D, 1997, BIOCHEM CELL BIOL, V75, P327, DOI 10.1139/bcb-75-4-327; Sambrook J., 2002, MOL CLONING LAB MANU; SANDER M, 1995, BIOCHEMISTRY-US, V34, P1267, DOI 10.1021/bi00004a021; Spiegelberg BD, 1999, J BIOL CHEM, V274, P13619, DOI 10.1074/jbc.274.19.13619; Swanson RL, 1999, MOL CELL BIOL, V19, P2929; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; Varin L, 1997, FASEB J, V11, P517, DOI 10.1096/fasebj.11.7.9212075; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; WILKINSON JQ, 1991, PLANT CELL, V3, P461, DOI 10.1105/tpc.3.5.461; Xiao W, 1998, CURR GENET, V33, P92, DOI 10.1007/s002940050313; Yenush L, 2000, FEBS LETT, V467, P321, DOI 10.1016/S0014-5793(00)01183-2	40	27	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18038	18045		10.1074/jbc.M010648200	http://dx.doi.org/10.1074/jbc.M010648200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278717	hybrid			2022-12-27	WOS:000168866500057
J	Ghosh, D; Sawicki, M; Pletnev, V; Erman, M; Ohno, S; Nakajin, S; Duax, WL				Ghosh, D; Sawicki, M; Pletnev, V; Erman, M; Ohno, S; Nakajin, S; Duax, WL			Porcine carbonyl reductase - Structural basis for a functional monomer in short chain dehydrogenases/reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL PIG TESTIS; HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-1; X-RAY-DIFFRACTION; 20-BETA-HYDROXYSTEROID DEHYDROGENASE; CRYSTAL-STRUCTURE; 3-ALPHA,20-BETA-HYDROXYSTEROID DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASE; DROSOPHILA-LEBANONENSIS; 3-DIMENSIONAL STRUCTURE; ALCOHOL-DEHYDROGENASE	Porcine testicular carbonyl reductase (PTCR) belongs to the short chain dehydrogenases/reductases (SDR) superfamily and catalyzes the NADPH-dependent reduction of ketones on steroids and prostaglandins. The enzyme shares nearly 85% sequence identity with the NADPH-dependent human 15-hydroxyprostaglandin dehydrogenase/carbonyl reductase. The tertiary structure of the enzyme at 2.3 Angstrom reveals a fold characteristic of the SDR superfamily that uses a Tyr-Lys-Ser triad as catalytic residues, but exhibits neither the functional homotetramer nor the homodimer that distinguish all SDRs. It is the first known monomeric structure in the SDR superfamily. In PTCR, which is also active as a monomer, a 41-residue insertion immediately before the catalytic Tyr describes an ah-helix subdomain that packs against interfacial helices, eliminating the four-helix bundle interface conserved in the superfamily, An additional anti-parallel strand in the PTCR structure also blocks the other strand-mediated interface. These novel structural features provide the basis for the scaffolding of one catalytic site within a single molecule of the enzyme.	Hauptman Woodward Med Res Inst, Dept Biol Struct, Buffalo, NY 14203 USA; Roswell Pk Canc Inst, Dept Mol & Cellular Biophys, Buffalo, NY 14263 USA; Nihon Univ, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Chiba 2748555, Japan; Hoshi Univ, Fac Pharmaceut Sci, Dept Biochem, Shinagawa Ku, Tokyo 1428501, Japan	Hauptman Woodward Medical Research Institute; Roswell Park Cancer Institute; Nihon University; Hoshi University	Ghosh, D (corresponding author), Hauptman Woodward Med Res Inst, Dept Biol Struct, 73 High St, Buffalo, NY 14203 USA.	ghosh@hwi.buffalo.edu	Pletnev, Vladimir/Q-6151-2016		NIDDK NIH HHS [DK26546] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026546, R01DK026546] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benach J, 1998, J MOL BIOL, V282, P383, DOI 10.1006/jmbi.1998.2015; BRUNGER A, 1992, T X PLOR USERS GUIDE; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FUREY W, 1990, AM CRYSTALLOGR ASS 2, V18, P73; GHOSH D, 1994, STRUCTURE, V2, P973, DOI 10.1016/S0969-2126(94)00099-9; GHOSH D, 1993, J STEROID BIOCHEM, V46, P103, DOI 10.1016/0960-0760(93)90214-H; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Ghosh D, 2001, CHEM-BIOL INTERACT, V130, P637, DOI 10.1016/S0009-2797(00)00255-6; GHOSH D, 1995, STRUCTURE, V3, P503, DOI 10.1016/S0969-2126(01)00183-6; Grimm C, 2000, J BIOL CHEM, V275, P41333, DOI 10.1074/jbc.M007559200; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; KROOK M, 1993, P NATL ACAD SCI USA, V90, P502, DOI 10.1073/pnas.90.2.502; LAKSHMI V, 1988, ENDOCRINOLOGY, V123, P2390, DOI 10.1210/endo-123-5-2390; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Nakajin S, 1997, BIOL PHARM BULL, V20, P1215; NAKAJIN S, 1987, CHEM PHARM BULL, V35, P2490; NAKAJIN S, 1988, J BIOCHEM-TOKYO, V104, P565, DOI 10.1093/oxfordjournals.jbchem.a122511; OHNO S, 1991, J STEROID BIOCHEM, V38, P787, DOI 10.1016/0960-0760(91)90093-K; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Puranen T, 1997, MOL ENDOCRINOL, V11, P77, DOI 10.1210/me.11.1.77; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; Sawicki MW, 1999, P NATL ACAD SCI USA, V96, P840, DOI 10.1073/pnas.96.3.840; TANAKA M, 1992, J BIOL CHEM, V267, P13451; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; VARUGHESE KI, 1992, P NATL ACAD SCI USA, V89, P6080, DOI 10.1073/pnas.89.13.6080; VILLARROYA A, 1989, EUR J BIOCHEM, V180, P191, DOI 10.1111/j.1432-1033.1989.tb14632.x; WERMUTH B, 1981, J BIOL CHEM, V256, P1206	31	83	86	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18457	18463		10.1074/jbc.M100538200	http://dx.doi.org/10.1074/jbc.M100538200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279087	hybrid			2022-12-27	WOS:000168866500112
J	Loo, BM; Kreuger, J; Jalkanen, M; Lindahl, U; Salmivirta, M				Loo, BM; Kreuger, J; Jalkanen, M; Lindahl, U; Salmivirta, M			Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; CRYSTAL-STRUCTURE; N-SULFATE; FGF; AFFINITY; LIGAND; OLIGOSACCHARIDES; DOMAINS; COMPLEX; DEPOLYMERIZATION	Fibroblast growth factors (FGFs) are heparin-binding polypeptides that affect the growth, differentiation, and migration of many cell types. FGFs signal by binding and activating cell surface FGF receptors (FGFRs) with intracellular tyrosine kinase domains. The signaling involves ligand-induced receptor dimerization and autophosphorylation, followed by downstream transfer of the signal. The sulfated glycosaminoglycans heparin and heparan sulfate bind both FGFs and FGFRs and enhance FGF signaling by mediating complex formation between the growth factor and receptor components. Whereas the heparin/heparan sulfate structures involved in FGF binding have been studied in some detail, little information has been available on saccharide structures mediating binding to FGFRs. We have performed structural characterization of heparin/heparan sulfate oligosaccharides with affinity toward FGFR4. The binding of heparin oligosaccharides to FGFR4 increased with increasing fragment length, the minimal binding domains being contained within eight monosaccharide units. The FGFR4-binding saccharide domains contained both 2-O-sulfated iduronic acid and 6-O-sulfated N-sulfoglucosamine residues, as shown by experiments with selectively desulfated heparin, compositional disaccharide analysis, and a novel exoenzyme-based sequence analysis of heparan sulfate oligosaccharides. Structurally distinct heparan sulfate octasaccharides differed in binding to FGFR4. Sequence analysis suggested that the affinity of the interaction depended on the number of 6-O-sulfate groups but not on their precise location.	Univ Turku, Turku Ctr Biotechnol, FIN-20521 Turku, Finland; Abo Akad Univ, FIN-20521 Turku, Finland; Uppsala Univ, Dept Med Biochem & Miobiol, S-75123 Uppsala, Sweden; BioTie Therapies Corp, FIN-20520 Turku, Finland	University of Turku; Abo Akademi University; Uppsala University	Salmivirta, M (corresponding author), Univ Turku, Turku Ctr Biotechnol, POB 123, FIN-20521 Turku, Finland.	markku.salmivirta@btk.utu.fi	Kreuger, Johan/HDM-1503-2022					BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BIENKOWSKI MJ, 1985, J BIOL CHEM, V260, P356; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; BRICKMAN YG, 1995, J BIOL CHEM, V270, P24941, DOI 10.1074/jbc.270.42.24941; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Feyzi E, 1997, J BIOL CHEM, V272, P5518, DOI 10.1074/jbc.272.9.5518; GAO GX, 1995, EMBO J, V14, P2183, DOI 10.1002/j.1460-2075.1995.tb07212.x; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HOOK M, 1982, ANAL BIOCHEM, V119, P236, DOI 10.1016/0003-2697(82)90580-2; HOOK M, 1976, FEBS LETT, V66, P90, DOI 10.1016/0014-5793(76)80592-3; ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P451, DOI 10.1093/glycob/4.4.451; ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P817, DOI 10.1093/glycob/4.6.817; ISHIHARA M, 1993, J BIOL CHEM, V268, P4675; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Kan M, 1996, J BIOL CHEM, V271, P26143, DOI 10.1074/jbc.271.42.26143; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kreuger J, 1999, GLYCOBIOLOGY, V9, P723, DOI 10.1093/glycob/9.7.723; KUSCHE M, 1990, J BIOL CHEM, V265, P7292; KUSCHE M, 1988, BIOCHEM J, V253, P885, DOI 10.1042/bj2530885; LaRochelle WJ, 1999, BIOCHEMISTRY-US, V38, P1765, DOI 10.1021/bi982092z; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; Loo BM, 2000, INT J BIOCHEM CELL B, V32, P489, DOI 10.1016/S1357-2725(99)00145-4; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; MACCARANA M, 1993, GLYCOBIOLOGY, V3, P271, DOI 10.1093/glycob/3.3.271; MACH H, 1993, BIOCHEMISTRY-US, V32, P5480, DOI 10.1021/bi00071a026; McKeehan WL, 1999, J BIOL CHEM, V274, P21511, DOI 10.1074/jbc.274.31.21511; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; Nurcombe V, 2000, J BIOL CHEM, V275, P30009, DOI 10.1074/jbc.M003038200; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; Patstone G, 1996, J BIOL CHEM, V271, P3343; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rapraeger AC, 1993, CURR OPIN CELL BIOL, V5, P844, DOI 10.1016/0955-0674(93)90034-N; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; RUSNATI M, 1994, BIOCHEM BIOPH RES CO, V203, P450, DOI 10.1006/bbrc.1994.2203; Safaiyan F, 2000, BIOCHEMISTRY-US, V39, P10823, DOI 10.1021/bi000411s; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vives RR, 1999, BIOCHEM J, V339, P767, DOI 10.1042/0264-6021:3390767; WANG F, 1995, J BIOL CHEM, V270, P10231, DOI 10.1074/jbc.270.17.10231; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zimmermann P, 1999, FASEB J, V13, pS91	53	71	73	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16868	16876		10.1074/jbc.M011226200	http://dx.doi.org/10.1074/jbc.M011226200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278860	hybrid			2022-12-27	WOS:000168730400037
J	Mazur, DJ; Perrino, FW				Mazur, DJ; Perrino, FW			Excision of 3 ' termini by the Trex1 and TREX2 3 '-> 5 ' exonucleases - Characterization of the recombinant proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; CYTOSINE-ARABINOSIDE MONOPHOSPHATE; WERNER SYNDROME PROTEIN; COLI RNASE-T; ESCHERICHIA-COLI; MISMATCH REPAIR; IN-VIVO; 3'-5' EXONUCLEASE; CRYSTAL-STRUCTURE; USTILAGO-MAYDIS	The excision of nucleotides from DNA 3' termini is an important step in DNA replication, repair, and recombination pathways to generate correctly base paired termini for subsequent processing. The mammalian TREX1 and TREX2 proteins contain potent 3'-->5' exonucleases capable of functioning in this capacity. To study the activities of these exonucleases we have developed strategies to express and purify the recombinant mouse Trex1 and human TREX2 proteins in Escherichia coli in quantities sufficient for biochemical characterization. The Trex1 and TREX2 proteins are homodimers that exhibit robust 3' excision activities with very similar preferred reaction conditions and preferences for specific DNA substrates. In a steady-state kinetic analysis, oligonucleotide substrates were used to measure 3' nucleotide excision by Trex1 and TREX2. The Michaelis constants derived from these data indicate similar apparent k(cat) values of 22 s(-1) for Trex1 and 16 s(-1) for TREX2 using single-stranded oligonucleotides. The apparent K, values of 19 nM for Trex1 and 190 nM for TREX2 suggest relatively high affinities for DNA for both Trex1 and TREX2. An exonuclease competition assay was designed using heparin as a nonsubstrate inhibitor with a series of partial duplex DNAs to delineate the substrate structure preferences for 3' nucleotide excision by Trex1 and TREX2. The catalytic properties of the TREX proteins suggest roles for these enzymes in the 3' end-trimming processes necessary for producing correctly base paired 3' termini.	Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University	Perrino, FW (corresponding author), Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.				NCI NIH HHS [CA12197, CA75350] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA075350] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albrechtsen N, 1999, ONCOGENE, V18, P7706, DOI 10.1038/sj.onc.1202952; BARNES MH, 1995, GENE, V165, P45, DOI 10.1016/0378-1119(95)00530-J; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bessho T, 2000, J BIOL CHEM, V275, P7451, DOI 10.1074/jbc.275.11.7451; Breyer WA, 2000, NAT STRUCT BIOL, V7, P1125; BRODY RS, 1986, J BIOL CHEM, V261, P7136; Bzymek M, 1999, J BACTERIOL, V181, P477, DOI 10.1128/JB.181.2.477-482.1999; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DERBYSHIRE V, 1991, EMBO J, V10, P17, DOI 10.1002/j.1460-2075.1991.tb07916.x; DEUTSCHER MP, 1985, J BIOL CHEM, V260, P7067; FENG WY, 1995, GENETICS, V140, P1175; FERSHT A, 1985, ENZYME STRUCTURE MEC, P150; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gorman MA, 1997, EMBO J, V16, P6548, DOI 10.1093/emboj/16.21.6548; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Huang YP, 1997, FEBS LETT, V400, P94, DOI 10.1016/S0014-5793(96)01361-0; Ito J, 1998, MOL MICROBIOL, V27, P235, DOI 10.1046/j.1365-2958.1998.00673.x; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2521, DOI 10.1093/nar/21.10.2521; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LEHMAN IR, 1960, J BIOL CHEM, V235, P1479; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; Li ZW, 1996, J BIOL CHEM, V271, P1133, DOI 10.1074/jbc.271.2.1133; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Miller H, 1996, BIOCHEMISTRY-US, V35, P12919, DOI 10.1021/bi960326d; Modrich P, 1997, J BIOL CHEM, V272, P24727, DOI 10.1074/jbc.272.40.24727; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Mummenbrauer T, 1996, CELL, V85, P1089, DOI 10.1016/S0092-8674(00)81309-4; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; Onel K, 1996, GENETICS, V143, P165; Parker AE, 1998, J BIOL CHEM, V273, P18332, DOI 10.1074/jbc.273.29.18332; PARSONAGE D, 1993, J BIOL CHEM, V268, P3161; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; Perrino Fred W., 1999, Cell Biochemistry and Biophysics, V30, P331, DOI 10.1007/BF02738118; PERRINO FW, 1994, J BIOL CHEM, V269, P16357; PERRINO FW, 1992, J BIOL CHEM, V267, P23043; PETRINI JHJ, 1995, GENOMICS, V29, P80, DOI 10.1006/geno.1995.1217; Razavy H, 1996, GENETICS, V142, P333; REHAKRANTZ LJ, 1993, J BIOL CHEM, V268, P27100; REHAKRANTZ LJ, 1991, P NATL ACAD SCI USA, V88, P2417, DOI 10.1073/pnas.88.6.2417; Russell P, 1998, TRENDS BIOCHEM SCI, V23, P399, DOI 10.1016/S0968-0004(98)01291-2; SANDIGURSKY M, 1992, NUCLEIC ACIDS RES, V20, P4699, DOI 10.1093/nar/20.18.4699; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; SEGEL IH, 1975, ENZYME KINETICS, P118; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Strauss BS, 1997, NUCLEIC ACIDS RES, V25, P806, DOI 10.1093/nar/25.4.806; Taft-Benz SA, 1998, NUCLEIC ACIDS RES, V26, P4005, DOI 10.1093/nar/26.17.4005; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; THELEN MP, 1994, J BIOL CHEM, V269, P747; Thelen MP, 1999, CELL, V96, P769, DOI 10.1016/S0092-8674(00)80587-5; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Viswanathan M, 1999, J BIOL CHEM, V274, P30094, DOI 10.1074/jbc.274.42.30094; Viswanathan M, 1998, J BIOL CHEM, V273, P35126, DOI 10.1074/jbc.273.52.35126; Viswanathan M, 1999, GENETICS, V151, P929; Viswanathan M, 1998, GENETICS, V149, P7; Wang J, 1996, BIOCHEMISTRY-US, V35, P8110, DOI 10.1021/bi960178r	65	115	122	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17022	17029		10.1074/jbc.M100623200	http://dx.doi.org/10.1074/jbc.M100623200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279105	hybrid			2022-12-27	WOS:000168730400056
J	Saveanu, C; Fromont-Racine, M; Harington, A; Ricard, F; Namane, A; Jacquier, A				Saveanu, C; Fromont-Racine, M; Harington, A; Ricard, F; Namane, A; Jacquier, A			Identification of 12 new yeast mitochondrial ribosomal proteins including 6 that have no prokaryotic homologues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL ACTIVATOR; SMALL-SUBUNIT; FUNCTIONAL-ANALYSIS; SCALE ANALYSIS; GENE DELETION; NUCLEAR GENE; RNA; GENOME	Mitochondrial ribosomal proteins were studied best in yeast, where the small subunit was shown to contain about 35 proteins. Yet, genetic and biochemical studies identified only 14 proteins, half of which were predictable by sequence homology with prokaryotic ribosomal components of the small subunit. Using a recently described affinity purification technique and tagged versions of yeast Ykl155c and Mrp1, we isolated this mitochondrial ribosomal subunit and identified a total of 20 proteins, of which 12 are new. For a subset of the newly described ribosomal proteins, we showed that they are localized in mitochondria and are required for the respiratory competency of the yeast cells. This brings to 26 the total number of proteins described as components of the mitochondrial small ribosomal subunit. Remarkably, almost half of the previously and newly identified mitochondrial ribosomal components showed no similarity to any known ribosomal protein. Homologues could be found, however, in predicted protein sequences from Schizosaccharomyces pombe. In more distant species, putative homologues were detected for Ykl155c, which shares conserved motifs with uncharacterized proteins of higher eukaryotes including humans. Another newly identified ribosomal protein, Ygl129c, was previously shown to be a member of the DAP-3 family of mitochondrial apoptosis mediators.	Inst Pasteur, CNRS, URA Genet Interact Macromol 2171, F-75724 Paris, France; Inst Pasteur, CNRS, URA Genet Interact Macromol, F-75724 Paris, France; Inst Pasteur, CNRS, URA Genet Mol Levures 2171, F-75724 Paris, France; Inst Pasteur, CNRS, URA Chim Struct Macromol 2185, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Jacquier, A (corresponding author), Inst Pasteur, CNRS, URA Genet Interact Macromol 2171, 25-28 Rue Dr Roux, F-75724 Paris, France.		Saveanu, Cosmin/K-6494-2015; Saveanu, Cosmin/Q-1251-2019; Namane, Abdelkader/O-1857-2013	Saveanu, Cosmin/0000-0002-1677-7936; Saveanu, Cosmin/0000-0002-1677-7936; Namane, Abdelkader/0000-0001-7180-7619; JACQUIER, ALAIN/0000-0001-5707-9184; Fromont-Racine, Micheline/0000-0001-9906-0334				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berger T, 2000, J CELL SCI, V113, P3603; Biswas TK, 1999, BIOCHEMISTRY-US, V38, P13042, DOI 10.1021/bi990058u; BOGUTA M, 1992, MOL CELL BIOL, V12, P402, DOI 10.1128/MCB.12.1.402; Brachat A, 2000, YEAST, V16, P241, DOI 10.1002/(SICI)1097-0061(200002)16:3<241::AID-YEA517>3.0.CO;2-T; Bullerwell CE, 2000, TRENDS BIOCHEM SCI, V25, P363, DOI 10.1016/S0968-0004(00)01612-1; DANG H, 1990, NUCLEIC ACIDS RES, V18, P6895, DOI 10.1093/nar/18.23.6895; DANG H, 1990, J BIOL CHEM, V265, P7449; DAVIS SC, 1995, MOL GEN GENET, V247, P379, DOI 10.1007/BF00293206; DAVIS SC, 1992, J BIOL CHEM, V267, P5508; DOIGNON F, 1993, YEAST, V9, P1131, DOI 10.1002/yea.320091014; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; FAYE G, 1977, MOL GEN GENET, V155, P27, DOI 10.1007/BF00268557; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; Green-Willms NS, 1998, MOL CELL BIOL, V18, P1826, DOI 10.1128/MCB.18.4.1826; GROOT GSP, 1979, MOL GEN GENET, V174, P339, DOI 10.1007/BF00267808; GUERIN MF, 1981, BIOCHIMIE, V63, P685, DOI 10.1016/S0300-9084(81)80217-9; HAFFTER P, 1990, GENETICS, V125, P495; HAFFTER P, 1992, MOL GEN GENET, V235, P64, DOI 10.1007/BF00286182; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jin C, 1997, CURR GENET, V31, P228, DOI 10.1007/s002940050199; Johnson DF, 1998, GENOMICS, V52, P363, DOI 10.1006/geno.1998.5448; Kitakawa M, 1997, EUR J BIOCHEM, V245, P449, DOI 10.1111/j.1432-1033.1997.t01-2-00449.x; Koc EC, 2000, J BIOL CHEM, V275, P32585, DOI 10.1074/jbc.M003596200; Koc EC, 1999, BIOCHEM BIOPH RES CO, V266, P141, DOI 10.1006/bbrc.1999.1785; KOTTER P, 1995, CURR GENET, V28, P26, DOI 10.1007/BF00311878; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; MCMULLIN TW, 1990, MOL CELL BIOL, V10, P4590, DOI 10.1128/MCB.10.9.4590; MIESZCZAK M, 1988, ACTA BIOCHIM POL, V35, P105; MYERS AM, 1987, J BIOL CHEM, V262, P3388; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; O'Brien TW, 2000, J BIOL CHEM, V275, P18153, DOI 10.1074/jbc.M909762199; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; PARTALEDIS JA, 1988, MOL CELL BIOL, V8, P3647, DOI 10.1128/MCB.8.9.3647; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TERPSTRA P, 1979, J BIOL CHEM, V254, P2653; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tizon B, 1999, YEAST, V15, P145, DOI 10.1002/(SICI)1097-0061(19990130)15:2<145::AID-YEA346>3.0.CO;2-J; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	49	65	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15861	15867		10.1074/jbc.M010864200	http://dx.doi.org/10.1074/jbc.M010864200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278769	hybrid			2022-12-27	WOS:000168623100040
J	Lehman, K; Ho, CK; Shuman, S				Lehman, K; Ho, CK; Shuman, S			Importance of homodimerization for the in vivo function of yeast RNA triphosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXY-TERMINAL DOMAIN; MESSENGER-RNA; CAPPING APPARATUS; POLYMERASE-II; GUANYLYLTRANSFERASE COMPONENT; MECHANISM; ENZYMES; PHOSPHORYLATION; TRANSCRIPTION; ASSOCIATION	Saccharomyces cerevisiae RNA triphosphatase Cet1 is an essential component of the yeast mRNA capping apparatus. The active site of Cet1 resides within a topologically closed hydrophilic beta -barrel (the triphosphate tunnel) that is supported by a globular hydrophobic core. The homodimeric quaternary structure of Cet1 is formed by a network of contacts between the partner protomers. By studying the effects of alanine-cluster mutations, we highlight the contributions of two separate facets of the crystallographic dimer interface to Cet1 function in vivo. One essential facet of the interface entails hydrophobic cross dimer interactions of Cys(330) and Val(331) and a cross-dimer hydrogen bond of Asp(280) with the backbone amide of Gln(329). The second functionally relevant dimer interface involves hydrophobic side-chain interactions of Phe(272) and Leu(273). Ala-cluster mutations involving these residues elicited lethal or severe temperature-sensitive phenotypes that were suppressed completely by fusion of the mutated triphosphatases to the guanylyltransferase domain of mammalian capping enzyme. The recombinant D279A-D280A and F272A-L273A proteins retained phosphohydrolase activity but sedimented as monomers. These results indicate that a disruption of the dimer interface is uniquely deleterious when the yeast RNA triphosphatase must function in concert with the endogenous yeast guanylyltransferase. We also identify key residue pairs in the hydrophobic core of the Cet1 protomer that support the active site tunnel and stabilize the triphosphatase in vivo.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.		Ho, KIong/GPP-6051-2022					Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Ho CK, 1998, J BIOL CHEM, V273, P34151, DOI 10.1074/jbc.273.51.34151; Ho CK, 1999, NUCLEIC ACIDS RES, V27, P4671, DOI 10.1093/nar/27.24.4671; Ho CK, 1998, MOL CELL BIOL, V18, P5189, DOI 10.1128/MCB.18.9.5189; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lehman K, 1999, J BIOL CHEM, V274, P22668, DOI 10.1074/jbc.274.32.22668; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Pei Y, 1999, J BIOL CHEM, V274, P28865, DOI 10.1074/jbc.274.41.28865; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1	13	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14996	15002		10.1074/jbc.M100588200	http://dx.doi.org/10.1074/jbc.M100588200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279098	hybrid			2022-12-27	WOS:000168528800064
J	Napper, CE; Dyson, MH; Taylor, ME				Napper, CE; Dyson, MH; Taylor, ME			An extended conformation of the macrophage mannose receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; CARBOHYDRATE-RECOGNITION DOMAINS; MEMBRANE-RECEPTOR; BINDING PROTEIN; LECTIN; OLIGOSACCHARIDES; SUPERFAMILY; EXPRESSION; LUTROPIN; CLONING	The macrophage mannose receptor mediates phagocytosis of pathogenic microorganisms and endocytosis of potentially harmful soluble glycoproteins by recognition of their defining carbohydrate structures. The mannose receptor is the prototype for a family of receptors each having an extracellular region consisting of 8-10 domains related to C-type carbohydrate recognition domains (CRDs), a fibronectin type II repeat and an N-terminal cysteine-rich domain. Hydrodynamic analysis and proteolysis experiments performed on fragments of the extracellular region of the receptor have been used to investigate its conformation. Size and shape parameters derived from sedimentation and diffusion coefficients indicate that the receptor is a monomeric, elongated and asymmetric molecule. Proteolysis experiments indicate the presence of close contacts between several pairs of domains and exposed linker regions separating CRDs 3 and 6 from their neighboring domains. Hydrodynamic coefficients predicted for modeled receptor conformations are consistent with an extended conformation with close contacts between three pairs of CRDs, The N-terminal cysteine rich domain and the fibronectin type II repeat appear to increase the rigidity of the molecule. The rigid, extended conformation of the receptor places domains with different functions at distinct positions with respect to the membrane.	Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England	University of Oxford	Taylor, ME (corresponding author), Univ Oxford, Dept Biochem, Glycobiol Inst, S Parks Rd, Oxford OX1 3QU, England.			Taylor, Maureen/0000-0001-8300-4987				ANCIEN P, 1995, BIOCHEMISTRY-US, V44, P13146; Behrendt N, 2000, J BIOL CHEM, V275, P1993, DOI 10.1074/jbc.275.3.1993; BOURSIER JP, 1993, J BIOL CHEM, V268, P2013; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; Crocker PR, 1996, BIOCHEM SOC T, V24, P150, DOI 10.1042/bst0240150; DELATORRE JG, 1997, HYDRO USERS MANUAL V; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; Fiete D, 1997, J BIOL CHEM, V272, P14629, DOI 10.1074/jbc.272.23.14629; Fiete D, 1997, P NATL ACAD SCI USA, V94, P11256, DOI 10.1073/pnas.94.21.11256; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; HARDING SE, 1995, ANAL BIOCHEM, V228, P131, DOI 10.1006/abio.1995.1324; HENSLEY P, 1994, J BIOL CHEM, V269, P23949; ISHIZAKI J, 1994, J BIOL CHEM, V269, P5897; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Mullin NP, 1997, J BIOL CHEM, V272, P5668, DOI 10.1074/jbc.272.9.5668; Ng KKS, 1998, BIOCHEMISTRY-US, V37, P17965, DOI 10.1021/bi981972a; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NICOLAS JP, 1995, J BIOL CHEM, V270, P28869, DOI 10.1074/jbc.270.48.28869; Pickford AR, 1997, STRUCTURE, V5, P359, DOI 10.1016/S0969-2126(97)00193-7; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; Sheikh H, 2000, J CELL SCI, V113, P1021; Simpson DZ, 1999, BIOCHEM J, V343, P403, DOI 10.1042/0264-6021:3430403; Sober H. A., 1970, HDB BIOCH SELECTED D; Tanford C., 1961, PHYS CHEM MACROMOLEC; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Taylor ME, 1997, GLYCOBIOLOGY, V7, pR5; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x	41	51	54	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14759	14766		10.1074/jbc.M100425200	http://dx.doi.org/10.1074/jbc.M100425200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279067	hybrid			2022-12-27	WOS:000168528800032
J	Woodard, RL; Lee, KJ; Huang, J; Dynan, WS				Woodard, RL; Lee, KJ; Huang, J; Dynan, WS			Distinct roles for Ku protein in transcriptional reinitiation and DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; KINASE CATALYTIC SUBUNIT; C-TERMINAL DOMAIN; COCKAYNE-SYNDROME; HEAT-SHOCK; TATA BOX; COMPLEX; INITIATION; ACTIVATION; BINDING	Transcriptional reinitiation is a distinct phase of the RNA polymerase II transcription cycle. Prior work has shown that reinitiation is deficient in nuclear extracts from Chinese hamster ovary cells lacking the 80-kDa subunit of Ku, a double-strand break repair protein, and that activity is rescued by expression of the corresponding cDNA We now show that Ku increases the amount or availability of a soluble factor that is limiting for reinitiation, that the factor increases the number of elongation complexes associated with the template at all times during the reaction, and that the factor itself does not form a tight complex with DNA. The factor may consist of a preformed complex of transcription proteins that is stabilized by Ku, A Ku mutant, lacking residues 687-728 in the 80-kDa subunit, preferentially suppresses transcription in Ku-containing extracts, suggesting that Ku interacts directly with proteins required for reinitiation, The Ku mutant functions normally in a DNA end-joining system, indicating that the functions of Ku in transcription and repair are genetically separable, Based on our results, we present a model in which Ku is capable of undergoing a switch between a transcription factor-associated and a repair-active state.	Med Coll Georgia, Inst Mol Med & Genet, Gene Regulat Program, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Dynan, WS (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Gene Regulat Program, Rm CB-2803,1120 15th St, Augusta, GA 30912 USA.	wdynan@mail.mcg.edu		Dynan, William/0000-0002-4045-5662	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035866] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 35866] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Archambault J, 1998, J BIOL CHEM, V273, P27593, DOI 10.1074/jbc.273.42.27593; ARIAS JA, 1989, J BIOL CHEM, V264, P3223; Balajee AS, 1997, P NATL ACAD SCI USA, V94, P4306, DOI 10.1073/pnas.94.9.4306; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; Chan DW, 1999, BIOCHEMISTRY-US, V38, P1819, DOI 10.1021/bi982584b; Chao DM, 1996, NATURE, V380, P82, DOI 10.1038/380082a0; Chen FQ, 1996, MUTAT RES-DNA REPAIR, V362, P9, DOI 10.1016/0921-8777(95)00026-7; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Chi TH, 1996, GENE DEV, V10, P2540, DOI 10.1101/gad.10.20.2540; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Dianov GL, 1997, NUCLEIC ACIDS RES, V25, P3636, DOI 10.1093/nar/25.18.3636; DVIR A, 1993, J BIOL CHEM, V268, P10440; DYNAN WS, 1979, BIOCHEMISTRY-US, V18, P4581, DOI 10.1021/bi00588a019; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Grande MA, 1997, J CELL SCI, V110, P1781; Hahn S, 1998, COLD SPRING HARB SYM, V63, P181, DOI 10.1101/sqb.1998.63.181; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Hampsey M, 1999, CURR OPIN GENET DEV, V9, P132, DOI 10.1016/S0959-437X(99)80020-3; Han ZY, 1996, J BIOL CHEM, V271, P14098, DOI 10.1074/jbc.271.24.14098; Huang JR, 1997, J BIOL CHEM, V272, P26009, DOI 10.1074/jbc.272.41.26009; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; JEGGO PA, 1983, MUTAT RES, V112, P313, DOI 10.1016/0167-8817(83)90026-3; KAN ZY, 1995, MOL CELL BIOL, V15, P5849; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Lee KJ, 2000, J BIOL CHEM, V275, P34787, DOI 10.1074/jbc.M004011200; Lei L, 1998, MOL CELL BIOL, V18, P2130, DOI 10.1128/MCB.18.4.2130; Litingtung Y, 1999, MOL GEN GENET, V261, P100, DOI 10.1007/s004380050946; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Myer VE, 1998, J BIOL CHEM, V273, P27757, DOI 10.1074/jbc.273.43.27757; Nueda A, 1999, J BIOL CHEM, V274, P14988, DOI 10.1074/jbc.274.21.14988; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; OBRIEN T, 1993, MOL CELL BIOL, V13, P3456, DOI 10.1128/MCB.13.6.3456; Oelgeschlager T, 1998, MOL CELL, V1, P925, DOI 10.1016/S1097-2765(00)80092-1; ONO M, 1994, NUCLEIC ACIDS RES, V22, P3918, DOI 10.1093/nar/22.19.3918; PAILLARD S, 1993, PROTEINS, V15, P330, DOI 10.1002/prot.340150310; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; REINBERG D, 1987, J BIOL CHEM, V262, P3322; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Singleton BK, 1997, MOL CELL BIOL, V17, P1264, DOI 10.1128/MCB.17.3.1264; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; SVEJSTRUP JQ, 1995, CELL, V80, P21, DOI 10.1016/0092-8674(95)90447-6; Szentirmay MN, 2000, NUCLEIC ACIDS RES, V28, P2019, DOI 10.1093/nar/28.10.2019; SZENTIRMAY MN, 1993, EMBO J, V12, P4677, DOI 10.1002/j.1460-2075.1993.tb06156.x; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Woodard RL, 1999, J BIOL CHEM, V274, P478, DOI 10.1074/jbc.274.1.478; Yean D, 1997, MOL CELL BIOL, V17, P3809, DOI 10.1128/MCB.17.7.3809; Yean D, 1999, NUCLEIC ACIDS RES, V27, P831, DOI 10.1093/nar/27.3.831; Yoo S, 1998, BIOCHEMISTRY-US, V37, P1336, DOI 10.1021/bi972100w; Yoo S, 1999, J BIOL CHEM, V274, P20034, DOI 10.1074/jbc.274.28.20034; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zeng CQ, 1997, EMBO J, V16, P1401, DOI 10.1093/emboj/16.6.1401	60	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15423	15433		10.1074/jbc.M010752200	http://dx.doi.org/10.1074/jbc.M010752200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278739	hybrid			2022-12-27	WOS:000168528800118
J	Horton, LE; James, P; Craig, EA; Hensold, JO				Horton, LE; James, P; Craig, EA; Hensold, JO			The yeast hsp70 homologue Ssa is required for translation and interacts with Sis1 and Pab1 on translating ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) BINDING-PROTEIN; MESSENGER-RNA DECAY; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL INTERACTION; MOLECULAR CHAPERONES; IN-VIVO; DEPENDENT TRANSLATION; ATPASE ACTIVITY; INITIATION; TRANSLOCATION	The 70-kDa heat shock proteins are molecular chaperones that participate in a variety of cellular functions. This chaperone function is stimulated by interaction with hsp40 proteins. The Saccharomyces cerevisiae gene encoding the essential hsp40 homologue, SIS1, appears to function in translation initiation. Mutations in ribosomal protein L39 (rpl39) complement loss-of-function mutations in SIS1 as well as PAB1 (poly(A)-binding protein), suggesting a functional interaction between these proteins. However, while a direct interaction between Sis1 and Pab1 is not detectable, both of these proteins physically interact with the essential Ssa land not Ssb) family of hsp70 proteins. This interaction is mediated by the variable C-terminal domain of Ssa. Subcellular fractionations demonstrate that the binding of Ssa to ribosomes is dependent upon its C terminus and that its interaction with Sis1 and Pab1 occurs preferentially on translating ribosomes. Consistent with a function in translation, depletion of Ssa protein produces a general translational defect that appears similar to loss of Sis1 and Pab1 function. This translational effect of Ssa appears mediated, at least in part, by its affect on the interaction of Pab1 with the translation initiation factor, eIF4G, which is dramatically reduced in the absence of functional Ssa protein.	Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Dept Med, Cleveland, OH 44106 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; University of Wisconsin System; University of Wisconsin Madison	Hensold, JO (corresponding author), Dept Hematol & Oncol, 10900 Euclid Ave,BRB309B, Cleveland, OH 44106 USA.				NIDDK NIH HHS [DK09915] Funding Source: Medline; NIGMS NIH HHS [R01 GM31107] Funding Source: Medline; PHITPO CDC HHS [HK07147-21A1] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031107] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHITPO CDC HHS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; BECKER D M, 1991, P182; Becker J, 1996, MOL CELL BIOL, V16, P4378; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Caldas T, 2000, J BIOL CHEM, V275, P855, DOI 10.1074/jbc.275.2.855; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Choi SK, 1998, SCIENCE, V280, P1757, DOI 10.1126/science.280.5370.1757; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Deardorff JA, 1997, J MOL BIOL, V269, P67, DOI 10.1006/jmbi.1997.1013; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; Hensold JO, 1996, J BIOL CHEM, V271, P23246, DOI 10.1074/jbc.271.38.23246; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; Kim S, 1998, P NATL ACAD SCI USA, V95, P12860, DOI 10.1073/pnas.95.22.12860; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lopez-Buesa P, 1998, P NATL ACAD SCI USA, V95, P15253, DOI 10.1073/pnas.95.26.15253; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; LUKE MM, 1991, J CELL BIOL, V114, P623, DOI 10.1083/jcb.114.4.623; MARTIN TE, 1970, J BIOL CHEM, V245, P1504; Mayer MP, 1998, BIOL CHEM, V379, P261; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; NELSON RJ, 1992, GENETICS, V131, P277; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Oka M, 1998, J BIOL CHEM, V273, P29727, DOI 10.1074/jbc.273.45.29727; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Preiss T, 1998, NATURE, V392, P516, DOI 10.1038/33192; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; Smith Donald B., 1993, Methods in Molecular and Cellular Biology, V4, P220; STONE DE, 1990, MOL CELL BIOL, V10, P1622, DOI 10.1128/MCB.10.4.1622; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Yan W, 1999, MOL CELL BIOL, V19, P7751; ZHONG T, 1993, CELL, V73, P1175, DOI 10.1016/0092-8674(93)90646-8	44	60	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14426	14433		10.1074/jbc.M100266200	http://dx.doi.org/10.1074/jbc.M100266200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11279042	hybrid			2022-12-27	WOS:000168356600121
J	Kihara, A; Akiyama, Y; Ito, K				Kihara, A; Akiyama, Y; Ito, K			Revisiting the lysogenization control of bacteriophage lambda - Identification and characterization of a new host component, HflD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CII PROTEIN STABILITY; ESCHERICHIA-COLI; PHAGE-LAMBDA; FTSH HFLB; TRANSCRIPTIONAL ACTIVATOR; MEMBRANE; COMPLEX; SECY; DEGRADATION; PROTEOLYSIS	Upon infection to the Escherichia coli cell, the genome of bacteriophage Lambda either replicates to form new progenies (lytic growth) or integrates into the host chromosome (lysogenization). The lambda CII protein is a key determinant in the lysis-lysogeny decision. It is a short-lived transcription activator for the Lambda genes essential for lysogeny establishment. In this study, we isolated a new class of hfl (high frequency lysogenization) mutants of E. coli, using a new selection for enhancement of CII-stimulated transcription. The gene affected was termed hflD, which encodes a protein of 213 amino acids, An hflD-disrupted mutant indeed showed an Hfl phenotype, indicating that HflD acts to down-regulate lysogenization, HflD is associated peripherally with the cytoplasmic membrane. Its interaction with CII was demonstrated in vitro using purified proteins as well as in vivo using the bacterial two-hybrid system. Pulse-chase examinations demonstrated that the HflD function is required for the rapid in vivo degradation of CII, although it interfered with FtsH-mediated CII proteolysis in an in vitro reaction system using detergent-solubilized components. We suggest that HflD is a factor that sequesters CII from the target promoters and recruits it to the membrane where the FtsH protease is localized.	Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Ito, K (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan.	kito@virus.kyoto-u.ac.jp	KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788				Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Akiyama Y, 1998, J BIOL CHEM, V273, P22326, DOI 10.1074/jbc.273.35.22326; AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; AKIYAMA Y, 1994, J BIOL CHEM, V269, P5218; BANUETT F, 1986, J MOL BIOL, V187, P213, DOI 10.1016/0022-2836(86)90229-9; BANUETT F, 1987, J BACTERIOL, V169, P4076, DOI 10.1128/jb.169.9.4076-4085.1987; Becker G, 1999, P NATL ACAD SCI USA, V96, P6439, DOI 10.1073/pnas.96.11.6439; BELFORT M, 1971, BACTERIOPHAGE LAMBDA, P739; BRODY H, 1988, J BACTERIOL, V170, P2040, DOI 10.1128/jb.170.5.2040-2044.1988; CHENG HH, 1988, P NATL ACAD SCI USA, V85, P7882, DOI 10.1073/pnas.85.21.7882; Davis R., 1980, ADV BACTERIAL GENETI; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; GAUTSCH JW, 1974, GENETICS, V77, P435; GOTTESMAN S, 1981, CELL, V24, P225, DOI 10.1016/0092-8674(81)90518-3; Green SM, 1996, MICROBIOL-UK, V142, P3219, DOI 10.1099/13500872-142-11-3219; HERMAN C, 1993, P NATL ACAD SCI USA, V90, P10861, DOI 10.1073/pnas.90.22.10861; Herman C, 1997, J BACTERIOL, V179, P358, DOI 10.1128/jb.179.2.358-363.1997; HO YS, 1988, GENE DEV, V2, P184, DOI 10.1101/gad.2.2.184; HO YS, 1982, J BIOL CHEM, V257, P9128; HOYT MA, 1982, CELL, V31, P565, DOI 10.1016/0092-8674(82)90312-9; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kihara A, 1996, EMBO J, V15, P6122, DOI 10.1002/j.1460-2075.1996.tb01000.x; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Kihara A, 1998, J MOL BIOL, V279, P175, DOI 10.1006/jmbi.1998.1781; Kihara A, 1998, J BIOL CHEM, V273, P29770, DOI 10.1074/jbc.273.45.29770; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; Neuwald AF, 1999, GENOME RES, V9, P27; NOBLE JA, 1993, P NATL ACAD SCI USA, V90, P10866, DOI 10.1073/pnas.90.22.10866; Schumann W, 1999, FEMS MICROBIOL REV, V23, P1; Shotland Y, 1997, MOL MICROBIOL, V24, P1303, DOI 10.1046/j.1365-2958.1997.4231796.x; STAHL FW, 1986, GENETICS, V113, P215; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAURA T, 1993, J BACTERIOL, V175, P7771, DOI 10.1128/JB.175.24.7771-7775.1993; TILLY K, 1989, J BACTERIOL, V171, P1585, DOI 10.1128/jb.171.3.1585-1589.1989; TOMOYASU T, 1993, J BACTERIOL, V175, P1352, DOI 10.1128/JB.175.5.1352-1357.1993; WEBER K, 1969, J BIOL CHEM, V244, P4406; WULFF DL, 1980, J MOL BIOL, V138, P209, DOI 10.1016/0022-2836(80)90284-3; Yoshihisa T, 1996, J BIOL CHEM, V271, P9429, DOI 10.1074/jbc.271.16.9429; ZORICK TS, 1991, J BACTERIOL, V173, P6307, DOI 10.1128/jb.173.19.6307-6310.1991	44	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13695	13700		10.1074/jbc.M011699200	http://dx.doi.org/10.1074/jbc.M011699200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278968	hybrid			2022-12-27	WOS:000168356600028
J	Huppertz, C; Fischer, BM; Kim, YB; Kotani, K; Vidal-Puig, A; Slieker, LJ; Sloop, KW; Lowell, BB; Kahn, BB				Huppertz, C; Fischer, BM; Kim, YB; Kotani, K; Vidal-Puig, A; Slieker, LJ; Sloop, KW; Lowell, BB; Kahn, BB			Uncoupling protein 3 (UCP3) stimulates glucose uptake in muscle cells through a phosphoinositide 3-kinase-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; SKELETAL-MUSCLE; PHOSPHATIDYLINOSITOL 3-KINASE; GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; L6 MYOTUBES; FAT-CELLS; SIGNAL-TRANSDUCTION; ENERGY-EXPENDITURE; MAMMALIAN-CELLS	UCP3 is a mitochondrial membrane protein expressed in humans selectively in skeletal muscle. To determine the mechanisms by which UCP3 plays a role in regulating glucose metabolism, we expressed human UCP3 in L6 myotubes by adenovirus-mediated gene transfer and in H9C2 cardiomyoblasts by stable transfection with a tetracycline-repressible UCP3 construct. Expression of UCP3 in L6 myotubes increased 2-deoxyglucose uptake S-fold and cell surface GLUT4 2.3-fold, thereby reaching maximally insulin-stimulated levels in control myotubes. Wortmannin, LY 294002, or the tyrosine kinase inhibitor genistein abolished the effect of UCP3 on glucose uptake, and wortmannin inhibited UCP3-induced GLUT4 cell surface recruitment. UCP3 overexpression increased phosphotyrosine-associated phosphoinositide 3-kinase (PI3K) activity 2.2-fold compared with control cells (p < 0.05). UCP3 overexpression increased lactate release 1.5- to 2-fold above control cells, indicating increased glucose metabolism. In H9C2 cardiomyoblasts stably transfected with UCP3 under control of a tetracycline-repressible promotor, removal of doxycycline resulted in detectable levels of UCP3 at 12 h and 2.2-fold induction at 7 days compared with 12 h, In parallel, glucose transport increased 1.3- and 8-fold at 12 h and 7 days, respectively, and the stimulation was inhibited by wortmannin or genistein, p85 association with membranes was increased 5.5-fold and phosphotyrosine-associated PI3K activity 3.8-fold. In contrast, overexpression of UCP3 in 3T3-L1 adipocytes did not alter glucose uptake, suggesting tissue-specific effects of human UCP3. Thus, UCP3 stimulates glucose transport and GLUT4 translocation to the cell surface in cardiac and skeletal muscle cells by activating a PI3K dependent pathway.	Beth Israel Deaconess Med Ctr, Diabet Unit, Dept Med, Div Endocrinol & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Eli Lilly & Co, Lilly Res Labs, Endocrine Res Div, Indianapolis, IN 46285 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Eli Lilly	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Diabet Unit, Dept Med, Div Endocrinol & Metab, Res N 325E,99 Brookline Ave, Boston, MA 02215 USA.			Vidal-Puig, Antonio/0000-0003-4220-9577	NIDDK NIH HHS [DK 49569, DK 43051, R01 DK043051, R37 DK053477] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049569, R01DK043051, R37DK043051, R37DK053477] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; AZEVEDO JL, 1995, DIABETES, V44, P695, DOI 10.2337/diabetes.44.6.695; BASHAN N, 1993, AM J PHYSIOL, V264, pC430, DOI 10.1152/ajpcell.1993.264.2.C430; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Boss O, 1998, J BIOL CHEM, V273, P5, DOI 10.1074/jbc.273.1.5; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Chen D, 1997, J BIOL CHEM, V272, P27401, DOI 10.1074/jbc.272.43.27401; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Frevert EU, 1997, MOL CELL BIOL, V17, P190, DOI 10.1128/MCB.17.1.190; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Hinz W, 1999, FEBS LETT, V448, P57, DOI 10.1016/S0014-5793(99)00331-2; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; Khayat ZA, 1998, AM J PHYSIOL-CELL PH, V275, pC1487, DOI 10.1152/ajpcell.1998.275.6.C1487; Khayat ZA, 2000, J CELL SCI, V113, P279; Khayat ZA, 1998, BIOCHEM J, V333, P713, DOI 10.1042/bj3330713; Kim YB, 1999, DIABETES, V48, P310, DOI 10.2337/diabetes.48.2.310; KONO T, 1982, J BIOL CHEM, V257, P942; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V209, P343, DOI 10.1006/bbrc.1995.1509; Kozlovsky N, 1997, FREE RADICAL BIO MED, V23, P859, DOI 10.1016/S0891-5849(97)00069-5; Krook A, 1998, DIABETES, V47, P1528, DOI 10.2337/diabetes.47.9.1528; LEMARCHANDBRUSTEL Y, 1995, ENDOCRINOLOGY, V136, P3564, DOI 10.1210/en.136.8.3564; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; MAHER F, 1992, BIOCHEM BIOPH RES CO, V182, P703, DOI 10.1016/0006-291X(92)91789-S; Marchisio M, 1998, BIOCHEM BIOPH RES CO, V253, P346, DOI 10.1006/bbrc.1998.9787; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; Nagase I, 1999, FEBS LETT, V461, P319, DOI 10.1016/S0014-5793(99)01477-5; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; OBrien K, 1997, GENE, V184, P115, DOI 10.1016/S0378-1119(96)00583-5; OKADA T, 1994, J BIOL CHEM, V269, P3568; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Schrauwen P, 1999, OBES RES, V7, P97, DOI 10.1002/j.1550-8528.1999.tb00396.x; Schrauwen P, 1999, DIABETES, V48, P146, DOI 10.2337/diabetes.48.1.146; Solanes G, 1997, J BIOL CHEM, V272, P25433, DOI 10.1074/jbc.272.41.25433; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tanaka K, 1999, J BIOL CHEM, V274, P3919, DOI 10.1074/jbc.274.7.3919; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; TSAKIRIDIS T, 1995, BIOCHEM J, V309, P1; VALLERAND AL, 1990, AM J PHYSIOL, V259, pR1043, DOI 10.1152/ajpregu.1990.259.5.R1043; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; YEH JI, 1995, J BIOL CHEM, V270, P2107, DOI 10.1074/jbc.270.5.2107; ZHANG CY, 1999, IN PRESS FEBS LETT; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	51	72	79	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12520	12529		10.1074/jbc.M011708200	http://dx.doi.org/10.1074/jbc.M011708200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278970	hybrid			2022-12-27	WOS:000168198600010
J	Ma, ZM; Ramanadham, S; Wohltmann, M; Bohrer, A; Hsu, FF; Turk, J				Ma, ZM; Ramanadham, S; Wohltmann, M; Bohrer, A; Hsu, FF; Turk, J			Studies of insulin secretory responses and of arachidonic acid incorporation into phospholipids of stably transfected insulinoma cells that overexpress group VIA phospholipase A(2) (iPLA(2)beta) indicate a signaling rather than a housekeeping role for iPLA(2)beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HUMAN PANCREATIC-ISLETS; MASS-SPECTROMETRIC ANALYSES; INTRACELLULAR CA2+ STORES; BETA-CELLS; PROTEIN-KINASE; PHOSPHATIDATE PHOSPHOHYDROLASE; SUICIDE INHIBITION; NUCLEAR-ENVELOPE; DISTINCT ROLES; CYCLIC-AMP	A cytosolic 84-kDa group VLA phospholipase A(2) (iPLA(2)beta) that does not require Ca2+ for catalysis has been cloned from several sources, including rat and human pancreatic islet beta -cells and murine P388D1 cells. Many potential iPLA(2)beta functions have been proposed, including a signaling role in beta -cell insulin secretion and a role in generating lysophosphatidylcholine accepters for arachidonic acid incorporation into P388D1 cell phosphatidylcholine (PC). Proposals for iPLA(2)beta function rest in part on effects of inhibiting iPLA(2)beta activity with a bromoenol lactone (BEL) suicide substrate, but EEL also inhibits phosphatidate phosphohydrolase-1 and a group VIB phospholipase A(2). Manipulation of iPLA(2)beta expression by molecular biologic means is an alternative approach to study iPLA(2)beta functions, and we have used a retroviral construct containing iPLA(2)beta cDNA to prepare two INS-1 insulinoma cell clonal lines that stably overexpress iPLA(2)beta. Compared with parental INS-I cells or cells transfected with empty vector, both iPLA(2)beta -overexpressing lines exhibit amplified insulin secretory responses to glucose and cAMP-elevating agents, and EEL substantially attenuates stimulated secretion. Electrospray ionization mass spectrometric analyses of arachidonic acid incorporation into INS-1 cell PC indicate that neither overexpression nor inhibition of iPLA(2)beta affects the rate or extent of this process in INS-1 cells. Immunocytofluorescence studies with antibodies directed against iPLA(2)beta indicate that cAMP-elevating agents increase perinuclear fluorescence in INS-1 cells, suggesting that iPLA(2)beta associates with nuclei. These studies are more consistent with a signaling than with a housekeeping role for iPLA(2)beta in insulinsecreting 13-cells.	Washington Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA	Washington University (WUSTL)	Turk, J (corresponding author), Washington Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, 660 S Euclid Ave,Box 8127, St Louis, MO 63110 USA.	jturk@imgate.wustl.edu		Hsu, Fong-Fu/0000-0001-5368-0183	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK056341, R37DK034388] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR00954] Funding Source: Medline; NHLBI NIH HHS [P01-HL57278] Funding Source: Medline; NIDDK NIH HHS [R37-DK-34388, P30-DK56341, P60-DK20579] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahren B, 1999, AM J PHYSIOL-ENDOC M, V277, pE996, DOI 10.1152/ajpendo.1999.277.6.E996; Ahren B, 1999, AM J PHYSIOL-REG I, V277, pR959, DOI 10.1152/ajpregu.1999.277.4.R959; Akiba S, 1998, FEBS LETT, V437, P225, DOI 10.1016/S0014-5793(98)01236-8; Akiba S, 1999, J BIOL CHEM, V274, P19906, DOI 10.1074/jbc.274.28.19906; Alzola E, 1998, J BIOL CHEM, V273, P30208, DOI 10.1074/jbc.273.46.30208; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; AssimacopoulosJeannet F, 1997, J BIOL CHEM, V272, P1659, DOI 10.1074/jbc.272.3.1659; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Balboa MA, 1998, J BIOL CHEM, V273, P7684, DOI 10.1074/jbc.273.13.7684; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Balsinde J, 1997, J BIOL CHEM, V272, P16069, DOI 10.1074/jbc.272.26.16069; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Barbour SE, 1999, BBA-MOL CELL BIOL L, V1439, P77, DOI 10.1016/S1388-1981(99)00078-5; BASAK A, 1995, J PEPT SCI, V6, P385; BECKER TC, 1994, J BIOL CHEM, V269, P21234; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chilton FH, 1996, BBA-LIPID LIPID MET, V1299, P1, DOI 10.1016/0005-2760(95)00169-7; Clark SA, 1997, DIABETES, V46, P958, DOI 10.2337/diabetes.46.6.958; COFFIN JM, 1996, RETROVIRUS; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DENNIS EA, 1992, METHOD ENZYMOL, V209, P1; Derrickson BH, 1997, AM J PHYSIOL-RENAL, V272, pF781, DOI 10.1152/ajprenal.1997.272.6.F781; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Dukes I. D., 1997, CURR OPIN ENDOCRINOL, V4, P262; Filipsson K, 1998, J BIOL CHEM, V273, P32602, DOI 10.1074/jbc.273.49.32602; Flamez D, 1999, DIABETES, V48, P1979, DOI 10.2337/diabetes.48.10.1979; Forsell PKAL, 1998, FEBS LETT, V434, P295, DOI 10.1016/S0014-5793(98)00999-5; Forsell PKAL, 1999, EUR J BIOCHEM, V262, P575, DOI 10.1046/j.1432-1327.1999.00418.x; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; GROSS RW, 1993, BIOCHEMISTRY-US, V32, P327, DOI 10.1021/bi00052a041; Han P, 1999, J BIOL CHEM, V274, P22337, DOI 10.1074/jbc.274.32.22337; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hohmeier HE, 1997, DIABETES, V46, P968, DOI 10.2337/diabetes.46.6.968; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Hsu FF, 1998, J AM SOC MASS SPECTR, V9, P516, DOI 10.1016/S1044-0305(98)00012-9; Hsu FF, 2000, J BIOL CHEM, V275, P16579, DOI 10.1074/jbc.M908342199; HUGHES SD, 1992, P NATL ACAD SCI USA, V89, P688, DOI 10.1073/pnas.89.2.688; Hugl SR, 1998, J BIOL CHEM, V273, P17771, DOI 10.1074/jbc.273.28.17771; Isenovic E, 2000, HYPERTENSION, V35, P249, DOI 10.1161/01.HYP.35.1.249; Jamen F, 2000, J CLIN INVEST, V105, P1307, DOI 10.1172/JCI9387; Lands W., 1976, ENZYMES BIOL MEMBRAN, V2, P3; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Leech CA, 1997, J BIOL CHEM, V272, P17987, DOI 10.1074/jbc.272.29.17987; MA Z, 2001, IN PRESS PROGR NUCL, V67; Ma ZM, 1998, BBA-LIPID LIPID MET, V1391, P384, DOI 10.1016/S0005-2760(98)00027-7; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Ma ZM, 1997, J BIOL CHEM, V272, P11118; Ma ZM, 1996, J BIOL CHEM, V271, P1029, DOI 10.1074/jbc.271.2.1029; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; METZ SA, 1991, BIOCHEM PHARMACOL, V41, pR1, DOI 10.1016/0006-2952(91)90470-P; Molloy GY, 1998, NEUROSCI LETT, V258, P139, DOI 10.1016/S0304-3940(98)00838-6; Morgan DG, 1998, DIABETOLOGIA, V41, P1482, DOI 10.1007/s001250051095; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Noel RJ, 1997, J BIOL CHEM, V272, P18621, DOI 10.1074/jbc.272.30.18621; Nofer JR, 2000, ARCH BIOCHEM BIOPHYS, V374, P213, DOI 10.1006/abbi.1999.1588; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; Olivero J, 2000, TOXICOL APPL PHARM, V163, P9, DOI 10.1006/taap.1999.8827; Owada S, 1999, J BIOL CHEM, V274, P2000, DOI 10.1074/jbc.274.4.2000; Pages C, 1999, BIOCHEM BIOPH RES CO, V265, P572, DOI 10.1006/bbrc.1999.1726; PetersGolden M, 1996, BIOCHEM J, V318, P797, DOI 10.1042/bj3180797; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P824, DOI 10.1210/endo-117-3-824; Poitout V, 1996, DIABETES METAB, V22, P7; Pouliot M, 1996, EUR J BIOCHEM, V238, P250, DOI 10.1111/j.1432-1033.1996.0250q.x; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P13499, DOI 10.1021/bi00212a015; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; Ramanadham S, 1998, BIOCHEMISTRY-US, V37, P4553, DOI 10.1021/bi9722507; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; Ramanadham S, 1997, BBA-LIPID LIPID MET, V1344, P153, DOI 10.1016/S0005-2760(96)00139-7; Ramanadham S, 2000, BBA-MOL CELL BIOL L, V1484, P251, DOI 10.1016/S1388-1981(00)00022-6; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Robertson RP, 2000, NEW ENGL J MED, V343, P289, DOI 10.1056/NEJM200007273430409; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; SEAQUIST ER, 1994, J LAB CLIN MED, V123, P338; Sekine N, 1997, DIABETES, V46, P1424, DOI 10.2337/diabetes.46.9.1424; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Simonsson E, 2000, BIOCHEM BIOPH RES CO, V269, P242, DOI 10.1006/bbrc.2000.2248; Simonsson E, 1998, DIABETES, V47, P1436, DOI 10.2337/diabetes.47.9.1436; Stafforini DM, 1997, J BIOL CHEM, V272, P17895, DOI 10.1074/jbc.272.29.17895; Suga S, 1997, DIABETES, V46, P1755, DOI 10.2337/diabetes.46.11.1755; Tanaka H, 2000, BIOCHEM BIOPH RES CO, V272, P320, DOI 10.1006/bbrc.2000.2776; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Thams P, 1997, BIOCHEM PHARMACOL, V53, P1077, DOI 10.1016/S0006-2952(96)00813-1; Tischfield JA, 1997, J BIOL CHEM, V272, P17247, DOI 10.1074/jbc.272.28.17247; Tithof PK, 1998, J IMMUNOL, V160, P953; TURK J, 1993, DIABETES, V42, P367, DOI 10.2337/diabetes.42.3.367; TURK J, 1992, BIOCHIM BIOPHYS ACTA, V1125, P280, DOI 10.1016/0005-2760(92)90057-3; WAKEV I, 2000, J IMMUNOL, V164, P5120; Weinhaus AJ, 1998, DIABETES, V47, P1426, DOI 10.2337/diabetes.47.9.1426; WOLF BA, 1986, J BIOL CHEM, V261, P3501; Xu GG, 1999, J BIOL CHEM, V274, P18067, DOI 10.1074/jbc.274.25.18067; Yaekura K, 1996, DIABETES, V45, P295, DOI 10.2337/diabetes.45.3.295; Yang HC, 1999, J NEUROCHEM, V73, P1278, DOI 10.1046/j.1471-4159.1999.0731278.x; Yang HC, 1999, ANAL BIOCHEM, V269, P278, DOI 10.1006/abio.1999.4053; Zhou YP, 1998, J CLIN INVEST, V101, P1623, DOI 10.1172/JCI1245; ZUPAN LA, 1993, J MED CHEM, V36, P95, DOI 10.1021/jm00053a012	105	74	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13198	13208		10.1074/jbc.M010423200	http://dx.doi.org/10.1074/jbc.M010423200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278673	hybrid			2022-12-27	WOS:000168198600102
J	Doliana, R; Bot, S; Mungiguerra, G; Canton, A; Cilli, SP; Colombatti, A				Doliana, R; Bot, S; Mungiguerra, G; Canton, A; Cilli, SP; Colombatti, A			Isolation and characterization of EMILIN-2, a new component of the growing EMILINs family and a member of the EMI domain-containing superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-BINDING-PROTEIN; MOLECULAR-CLONING; SIGNAL PEPTIDES; NECROSIS-FACTOR; VIII COLLAGEN; ELASTIC FIBER; COILED COILS; IN-VITRO; GLYCOPROTEIN; MICROFIBRILS	EMILIN (elastin microfibril interfase located Protein) is an elastic fiber-associated glycoprotein consisting of a self-interacting globular C1q domain at the C terminus, a short collagenous stalk, an extended region of potential coiled-coil structure, and an N-terminal cysteine-rich domain (EMI domain). Using the globular C1q domain as a bait in the yeast two-hybrid system, we have isolated a cDNA encoding a novel protein. Determination of the entire primary structure demonstrated that this EMILIN-binding polypeptide is highly homologous to EMILIN. The domain organization is superimposable, one important difference being a proline-rich (41%) segment of 56 residues between the potential coiled-coil region and the collagenous domain absent in EMILIN. The entire gene (localized on chromosome 18p11.3) was isolated from a BAC clone, and it is structurally almost identical to that of EMILIN (8 exons, 7 introns with identical phases at the exon/intron boundaries) but much larger (about 40 versus 8 kilobases) than that of EMILIN. Given these findings we propose to name the novel protein EMILIN-2 and the prototype member of this family EMILIN-1 (formerly EMILIN). The mRNA expression of EMILIN-2 is more restricted compared with that of EMILIN-1; highest levels are present in fetal heart and adult lung, whereas, differently from EMILIN-1, adult aorta, small intestine, and appendix show very low expression, and adult uterus and fetal kidney are negative. Finally, the EMILIN-2 protein is secreted extracellularly by in vitro-grown cells, and in accordance with the partial coexpression in fetal and adult tissues, the two proteins shown extensive but not absolute immunocolocalization in vitro.	Ctr Riferimento Oncol, Div Oncol Sperimentale, I-33081 Aviano, Italy; Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy	IRCCS Aviano (CRO); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine	Colombatti, A (corresponding author), Ctr Riferimento Oncol, Div Oncol Sperimentale, I-33081 Aviano, Italy.	acolombatti@cro.it	Doliana, Roberto/AAA-1479-2019	Doliana, Roberto/0000-0002-8324-7564; colombatti, alfonso/0000-0002-3676-2379	Telethon [E.1256] Funding Source: Medline	Telethon(Fondazione Telethon)		ABRAMS WR, 1995, GENOMICS, V26, P47, DOI 10.1016/0888-7543(95)80081-V; Barber RE, 1996, BIOCHEM J, V320, P479, DOI 10.1042/bj3200479; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Bork P, 1996, CURR OPIN STRUC BIOL, V6, P366, DOI 10.1016/S0959-440X(96)80057-1; BRESSAN GM, 1993, J CELL BIOL, V121, P201, DOI 10.1083/jcb.121.1.201; BRESSAN GM, 1983, J BIOL CHEM, V258, P3262; Chan D, 1996, J BIOL CHEM, V271, P13566, DOI 10.1074/jbc.271.23.13566; Colombatti A, 2000, MATRIX BIOL, V19, P289, DOI 10.1016/S0945-053X(00)00074-3; COLOMBATTI A, 1985, COLLAGEN REL RES, V5, P181; COLOMBATTI A, 1988, J BIOL CHEM, V263, P17534; COLOMBATTI A, 1985, J CELL BIOL, V100, P18, DOI 10.1083/jcb.100.1.18; COLOMBATTI A, 1987, COLLAGEN REL RES, V7, P259; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Doliana R, 1999, J BIOL CHEM, V274, P16773, DOI 10.1074/jbc.274.24.16773; Doliana R, 2000, J BIOL CHEM, V275, P785, DOI 10.1074/jbc.275.2.785; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Frischholz S, 1998, J BIOL CHEM, V273, P4547, DOI 10.1074/jbc.273.8.4547; Gibson MA, 1996, J BIOL CHEM, V271, P1096, DOI 10.1074/jbc.271.2.1096; GIBSON MA, 1995, MOL CELL BIOL, V15, P6932; HAYWARD CPM, 1991, BLOOD, V77, P2556; Henderson M, 1996, J HISTOCHEM CYTOCHEM, V44, P1389, DOI 10.1177/44.12.8985131; Illidge C, 1998, J BIOL CHEM, V273, P22091, DOI 10.1074/jbc.273.34.22091; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; KITTELBERGER R, 1989, BIOCHEM BIOPH RES CO, V159, P414, DOI 10.1016/0006-291X(89)90007-7; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Mongiat M, 2000, J BIOL CHEM, V275, P25471, DOI 10.1074/jbc.M001426200; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Nicholson-Weller A, 1999, CURR OPIN IMMUNOL, V11, P42, DOI 10.1016/S0952-7915(99)80008-9; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; Polgar J, 1998, THROMB HAEMOSTASIS, V80, P645; Raghunath M, 1999, J INVEST DERMATOL, V112, P97, DOI 10.1046/j.1523-1747.1999.00483.x; Reid K B, 1989, Behring Inst Mitt, P8; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; ROAK EF, 1995, J HISTOCHEM CYTOCHEM, V43, P401; Rosenblum ND, 1996, BIOCHEM BIOPH RES CO, V227, P205, DOI 10.1006/bbrc.1996.1490; SAGE H, 1980, BIOCHEMISTRY-US, V19, P5747, DOI 10.1021/bi00566a013; Saharinen J, 1998, J BIOL CHEM, V273, P18459, DOI 10.1074/jbc.273.29.18459; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SCHUPPAN D, 1980, FEBS LETT, V115, P297, DOI 10.1016/0014-5793(80)81191-4; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; SMITH KF, 1994, BIOCHEM J, V301, P249, DOI 10.1042/bj3010249; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; YIN WS, 1995, J BIOL CHEM, V270, P10147, DOI 10.1074/jbc.270.17.10147; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855; ZHAO ZY, 1995, HUM MOL GENET, V4, P589, DOI 10.1093/hmg/4.4.589	48	45	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12003	12011		10.1074/jbc.M011591200	http://dx.doi.org/10.1074/jbc.M011591200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278945	hybrid			2022-12-27	WOS:000168081800076
J	Berton, A; Rigot, V; Huet, E; Decarme, M; Eeckhout, Y; Patthy, L; Godeau, G; Hornebeck, W; Bellon, G; Emonard, H				Berton, A; Rigot, V; Huet, E; Decarme, M; Eeckhout, Y; Patthy, L; Godeau, G; Hornebeck, W; Bellon, G; Emonard, H			Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; IV COLLAGENASE GELATINASE; MATRIX METALLOPROTEINASES; BINDING SITE; OLEIC-ACID; FIBROBLAST COLLAGENASE; TISSUE INHIBITORS; ACTIVATION; DOMAIN; ELASTASE	The matrix metalloproteinases gelatinase A (MMP-2) and gelatinase B (MMP-9) are implicated in the physiological and pathological breakdown of several extracellular matrix proteins. In the present study, we show that long-chain fatty acids (e.g. oleic acid, elaidic acid, and cis- and trans-parinaric acids) inhibit gelatinase A as well as gelatinase B with K-i values in the micromolar range but had only weak inhibitory effect on collagenase-1 (MMP-1), as assessed using synthetic or natural substrates, The inhibition of gelatinases depended on fatty acid chain length (with C18 > C16, C14, and C10), and the presence of unsaturations increased their inhibitory capacity on both types of gelatinase, Ex vivo experiments on human shin tissue sections have shown that micromolar concentrations of a long-chain unsaturated fatty acid (elaidic acid) protect collagen and elastin fibers against degradation by gelatinases A and B, respectively. In order to understand why gelatinases are more susceptible than collagenase-1 to inhibition by long-chain fatty acids, the possible role of the fibronectin-like domain (a domain unique to gelatinases) in binding inhibitory fatty acids was investigated. Affinity and kinetic studies with a recombinant fibronectin-like domain of gelatinase A and with a recombinant mutant of gelatinase A from which this domain had been deleted pointed to an interaction of long-chain fatty acids with the fibronectin-like domain of the protease, Surface plasmon resonance studies on the interaction of long-chain fatty acids with the three individual type II modules of the fibronectin-like domain of gelatinase A revealed that the first type II module is primarily responsible for binding these compounds.	Fac Med, CNRS, FRE 2260, IFR Biomol 53, F-51100 Reims, France; Inst Cellular Pathol, Cell Biol Unit, B-1200 Brussels, Belgium; Catholic Univ Louvain, B-1200 Brussels, Belgium; Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1518 Budapest, Hungary; Univ Paris 05, Fac Odontol, Biochem Lab, F-92120 Montrouge, France	Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne; Universite Catholique Louvain; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; UDICE-French Research Universities; Universite Paris Cite	Emonard, H (corresponding author), Fac Med, CNRS, FRE 2260, 51 Rue Cognacq Jay, F-51095 Reims, France.		HUET, Eric/R-3178-2018; Emonard, Herve/R-9718-2019; Patthy, Laszlo/Q-6058-2019; Patthy, Laszlo/A-2353-2013; Emonard, Hervé/AAD-5432-2019	HUET, Eric/0000-0002-5541-5954; 				ADLER RR, 1990, DEVELOPMENT, V110, P211; ASHE BM, 1977, BIOCHEM BIOPH RES CO, V75, P194, DOI 10.1016/0006-291X(77)91308-0; Banyai L, 1996, J BIOL CHEM, V271, P12003, DOI 10.1074/jbc.271.20.12003; BANYAI L, 1994, BIOCHEM J, V298, P403, DOI 10.1042/bj2980403; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447; Berton A, 2000, MATRIX BIOL, V19, P139, DOI 10.1016/S0945-053X(00)00057-3; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; BORKAKOTI N, 1994, NAT STRUCT BIOL, V1, P106, DOI 10.1038/nsb0294-106; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Briknarova K, 1999, STRUCTURE, V7, P1235, DOI 10.1016/S0969-2126(00)80057-X; BROWNER MF, 1995, BIOCHEMISTRY-US, V34, P6602, DOI 10.1021/bi00020a004; Carmeliet P, 1998, THROMB RES, V91, P255, DOI 10.1016/S0049-3848(98)00122-4; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; Coussens LM, 1996, CHEM BIOL, V3, P895, DOI 10.1016/S1074-5521(96)90178-7; Curtis CL, 2000, J BIOL CHEM, V275, P721, DOI 10.1074/jbc.275.2.721; DEAN DD, 1989, J CLIN INVEST, V84, P678, DOI 10.1172/JCI114215; Dobrin P B, 1994, Cardiovasc Surg, V2, P484; EECKHOUT Y, 1986, BIOCHEM J, V239, P793, DOI 10.1042/bj2390793; Emonard H, 1997, BIOL CHEM, V378, P265, DOI 10.1515/bchm.1997.378.3-4.265; Emonard H, 1999, ANN NY ACAD SCI, V878, P647, DOI 10.1111/j.1749-6632.1999.tb07751.x; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; HIGAZI AA, 1992, BIOCHEM J, V282, P863, DOI 10.1042/bj2820863; HIGAZI AA, 1994, BIOCHEM J, V300, P251, DOI 10.1042/bj3000251; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; KATSUDA S, 1994, AM J PATHOL, V145, P1208; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; MARBAIX E, 1992, P NATL ACAD SCI USA, V89, P11789, DOI 10.1073/pnas.89.24.11789; Massaro M, 1999, Cardiologia, V44, P507; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; MURPHY G, 1994, J BIOL CHEM, V269, P6632; MURPHY G, 1995, METHOD ENZYMOL, V248, P496; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagase H, 1997, BIOL CHEM, V378, P151; PATTHY L, 1984, FEBS LETT, V171, P131, DOI 10.1016/0014-5793(84)80473-1; Polette M, 1999, INT J CANCER, V80, P751, DOI 10.1002/(SICI)1097-0215(19990301)80:5<751::AID-IJC20>3.3.CO;2-M; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Salvesen, 1986, PROTEINASE INHIBITOR, P23; Shah PK, 1997, CIRCULATION, V96, P2115; Shipley JM, 1996, J BIOL CHEM, V271, P4335; STANISLAWSKI L, 1988, BIOCHEM INT, V16, P661; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Steffensen B, 1998, J BIOL CHEM, V273, P20622, DOI 10.1074/jbc.273.32.20622; Suzuki I, 1997, INT J CANCER, V73, P607, DOI 10.1002/(SICI)1097-0215(19971114)73:4<607::AID-IJC24>3.0.CO;2-4; Terp GE, 2000, J BIOMOL STRUCT DYN, V17, P933, DOI 10.1080/07391102.2000.10506582; Tordai H, 1999, EUR J BIOCHEM, V259, P513, DOI 10.1046/j.1432-1327.1999.00070.x; TYAGI SC, 1991, J BIOL CHEM, V266, P15185; WILHELM SM, 1989, J BIOL CHEM, V264, P17213	50	72	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20458	20465		10.1074/jbc.M011664200	http://dx.doi.org/10.1074/jbc.M011664200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278959	hybrid			2022-12-27	WOS:000169135100106
J	Cocolakis, E; Lemay, S; Ali, S; Lebrun, JJ				Cocolakis, E; Lemay, S; Ali, S; Lebrun, JJ			The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TGF-BETA RECEPTOR; SIGNAL-TRANSDUCTION PATHWAY; MAMMARY EPITHELIAL-CELLS; INDUCED TRANSCRIPTION; INHIBIN/ACTIVIN SUBUNITS; GENE-EXPRESSION; FAMILY MEMBERS; SMAD PROTEINS; DNA-BINDING	Activin, a member of the TGF beta family inhibits cell growth in various target tissues. Activin interacts with a complex of two receptors that upon activation phosphorylate specific intracellular mediators, the Smad proteins. The activated Smads interact with diverse DNA binding proteins and co-activators of transcription in a cell-specific manner, thus leading to various activin biological effects. In this study, we investigated the role and mechanism of action of activin in the human breast cancer T47D cells. We found that activin treatment of T47D cells leads to a dramatic decrease in cell growth. Thus activin appears as a potent cell growth inhibitor of these breast cancer cells. We show that activin induces the Smad pathway in these cells but also activates the p38-mitogen-activated protein kinase pathway, further leading to phosphorylation of the transcription factor ATF2. Finally, specific inhibitors of the p38 kinase (SB202190, SB203580, and PD169316) but not an inactive analogue (SB202474) or the MEK-1 inhibitor PD98059 completely abolish the activin-mediated cell growth inhibition of T47D cells. Together, these results define a new role for activin in human breast cancer T47D cells and highlight a new pathway utilized by this growth factor in the mediation of its biological effects in cell growth arrest.	McGill Univ, Royal Victoria Hosp, Dept Med, Mol Endocrinol Lab, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital	Lebrun, JJ (corresponding author), McGill Univ, Royal Victoria Hosp, Dept Med, Mol Endocrinol Lab, 687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.		Lebrun, Jean-Jacques/GNP-5222-2022					Alam J, 2000, J BIOL CHEM, V275, P27694; Attisano L, 1996, MOL CELL BIOL, V16, P1066; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Chen TP, 1998, CANCER RES, V58, P4805; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen Y, 1996, P NATL ACAD SCI USA, V93, P12992, DOI 10.1073/pnas.93.23.12992; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; deWinter JP, 1997, ONCOGENE, V14, P1891, DOI 10.1038/sj.onc.1201017; Di Loreto C, 1999, EUR J ENDOCRINOL, V141, P190, DOI 10.1530/eje.0.1410190; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lebrun JJ, 1999, MOL ENDOCRINOL, V13, P15, DOI 10.1210/me.13.1.15; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Liu QY, 1996, CANCER RES, V56, P1155; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MATHEWS LS, 1993, J BIOL CHEM, V268, P19013; Moriguchi T, 1996, J BIOL CHEM, V271, P26981, DOI 10.1074/jbc.271.43.26981; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pouliot F, 1999, INT J CANCER, V81, P98, DOI 10.1002/(SICI)1097-0215(19990331)81:1<98::AID-IJC17>3.0.CO;2-9; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Segev DL, 2000, J BIOL CHEM, V275, P28371, DOI 10.1074/jbc.M004554200; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; ten Dijke P, 2000, TRENDS BIOCHEM SCI, V25, P64, DOI 10.1016/S0968-0004(99)01519-4; Willis SA, 1996, MOL ENDOCRINOL, V10, P367, DOI 10.1210/me.10.4.367; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu RY, 1997, MOL CELL BIOL, V17, P2521, DOI 10.1128/MCB.17.5.2521; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Yang SH, 1999, MOL CELL BIOL, V19, P4028; Ying SY, 1996, BREAST CANCER RES TR, V37, P151, DOI 10.1007/BF01806496; Zauberman A, 1997, ONCOGENE, V15, P1705, DOI 10.1038/sj.onc.1201348; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; ZERVOS AS, 1995, P NATL ACAD SCI USA, V92, P10531, DOI 10.1073/pnas.92.23.10531; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	55	103	105	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18430	18436		10.1074/jbc.M010768200	http://dx.doi.org/10.1074/jbc.M010768200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278744	hybrid			2022-12-27	WOS:000168866500108
J	Kim, YC; Masutani, H; Yamaguchi, Y; Itoh, K; Yamamoto, M; Yodoi, J				Kim, YC; Masutani, H; Yamaguchi, Y; Itoh, K; Yamamoto, M; Yodoi, J			Hemin-induced activation of the thioredoxin gene by Nrf2 - A differential regulation of the antioxidant responsive element by a switch of its binding factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; PROTEIN-KINASE-C; OXIDATIVE STRESS; NF-E2-RELATED FACTOR-2; MEDIATED EXPRESSION; OXYGENASE-1 GENE; ENCODING GENE; SUBUNIT GENE; FACTOR ADF; MAF	Thioredoxin plays an important role in various cellular processes through redox regulation. Here, we have demonstrated that thioredoxin expression is transcriptionally induced in K562 cells by hemin (ferriprotoporphyrin IX) through activation of a regulatory region positioned from -452 to -420 bp of the thioredoxin gene. Insertion of a mutation in the antioxidant responsive element (ARE)/AP-1 consensus binding sequence in this region abolished the response to hemin. With electrophoretic mobility shift and DNA affinity assays, we have shown that the NF-E2p45/small Maf complex constitutively binds to the ARE. The binding of the Nrf2/small Maf complex to ARE was induced by hemin, whereas the binding of Jun/Fos proteins to ARE was induced by phorbol 12-myristate 13-acetate, but not hemin, Hemin induced nuclear translocation of Nrf2 but did not affect nuclear expression of Jun/Fos proteins. Overexpression of Nrf2 augmented the response to hemin in a dose-dependent manner. In contrast, overexpression of the dominant negative mutant of Nrf2 suppressed hemin-induced activation through the ARE. We show here hemin-induced activation of the thioredoxin gene by Nrf2 through the ARE and propose a novel mechanism of the regulation of the ARE through a switch of its binding factors.	Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058577, Japan	Kyoto University; University of Tsukuba; University of Tsukuba	Masutani, H (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, 53 Shogoin,Kawahara Cho, Kyoto 6068507, Japan.	hmasutan@virusl.virus.kyoto-u.ac.jp	Itoh, Ken/B-9506-2013; Masutani, Hiroshi/B-5114-2014; Yamamoto, Masayuki/A-4873-2010	Itoh, Ken/0000-0002-5518-0729; Yamamoto, Masayuki/0000-0002-9073-9436				Alam J, 2000, J BIOL CHEM, V275, P27694; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; BENSIMON C, 1989, J IMMUNOL, V142, P2290; CHUI DHK, 1995, BIOCHEM BIOPH RES CO, V209, P40, DOI 10.1006/bbrc.1995.1467; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; Hashimoto S, 1999, BIOCHEM BIOPH RES CO, V258, P443, DOI 10.1006/bbrc.1999.0658; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Hoshino H, 2000, J BIOL CHEM, V275, P15370, DOI 10.1074/jbc.275.20.15370; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; IGARASHI K, 1995, P NATL ACAD SCI USA, V92, P7445, DOI 10.1073/pnas.92.16.7445; Inamdar NM, 1996, BIOCHEM BIOPH RES CO, V221, P570, DOI 10.1006/bbrc.1996.0637; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; KAGHAD M, 1994, GENE, V140, P273, DOI 10.1016/0378-1119(94)90557-6; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; KATAOKA K, 1995, MOL CELL BIOL, V15, P2180; Leppa S, 1997, J BIOL CHEM, V272, P30400, DOI 10.1074/jbc.272.48.30400; Masutani H, 1997, ONCOGENE, V15, P1661, DOI 10.1038/sj.onc.1201328; MASUTANI H, 1999, ANTIOXIDANT REDOX RE, P297; MATSUDA M, 1991, J IMMUNOL, V147, P3837; MATSUI M, 1995, GENE, V152, P165, DOI 10.1016/0378-1119(94)00707-Y; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; MITSUI A, 1992, BIOCHEM BIOPH RES CO, V186, P1220, DOI 10.1016/S0006-291X(05)81536-0; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; NAKAMURA H, 1994, IMMUNOL LETT, V42, P75, DOI 10.1016/0165-2478(94)90038-8; OHIRA A, 1994, LAB INVEST, V70, P279; PACKER L, 1999, REDOX REGULATION CEL, P251; PADMANABAN G, 1989, TRENDS BIOCHEM SCI, V14, P492, DOI 10.1016/0968-0004(89)90182-5; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; SAVOYSKY E, 1994, ONCOGENE, V9, P1839; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; Takagi Y, 1999, P NATL ACAD SCI USA, V96, P4131, DOI 10.1073/pnas.96.7.4131; Taniguchi Y, 1996, NUCLEIC ACIDS RES, V24, P2746, DOI 10.1093/nar/24.14.2746; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; THEODORAKIS NG, 1989, MOL CELL BIOL, V9, P3166, DOI 10.1128/MCB.9.8.3166; Toki T, 1997, ONCOGENE, V14, P1901, DOI 10.1038/sj.onc.1201024; TONISSEN KF, 1991, GENE, V102, P221, DOI 10.1016/0378-1119(91)90081-L; Ueno M, 1999, J BIOL CHEM, V274, P35809, DOI 10.1074/jbc.274.50.35809; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; WADA H, 1995, CHEST, V108, P810, DOI 10.1378/chest.108.3.810; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Wiesel P, 2000, J BIOL CHEM, V275, P24840, DOI 10.1074/jbc.M000835200; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; WOLLMAN EE, 1988, J BIOL CHEM, V263, P15506; Yu R, 2000, J BIOL CHEM, V275, P9612, DOI 10.1074/jbc.275.13.9612	52	253	263	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18399	18406		10.1074/jbc.M100103200	http://dx.doi.org/10.1074/jbc.M100103200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279008	hybrid			2022-12-27	WOS:000168866500104
J	Silversmith, RE; Smith, JG; Guanga, GP; Les, JT; Bourret, RB				Silversmith, RE; Smith, JG; Guanga, GP; Les, JT; Bourret, RB			Alteration of a nonconserved active site residue in the chemotaxis response regulator CheY affects phosphorylation and interaction with CheZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CHEMOTAXIS; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; PHOSPHATASE-ACTIVITY; PROTEIN CHEY; KINETIC CHARACTERIZATION; BINDING; SWITCH; OLIGOMERIZATION; PHOSPHODONORS	CheY is a response regulator in the well studied two-component system that mediates bacterial chemotaxis, Phosphorylation of CheY at Asp(57) enhances its interaction with the flagellar motor. Asn(59) is located near the phosphorylation site, and possible roles this residue may play in CheY function were explored by mutagenesis. Cells containing CheY59NR or CheY59NH exhibited hyperactive phenotypes (clockwise flagellar rotation), and CheY59NR was characterized biochemically, A continuous enzyme-linked spectroscopic assay that monitors Pi concentration was the primary method for kinetic analysis of phosphorylation and dephosphorylation, CheY59NR autodephosphorylated at the same rate as wild-type CheY and phosphorylated similarly to wild type with acetyl phosphate and faster (4-14x) with phosphoramidate and monophosphoimidazole. CheY59NR was extremely resistant to CheZ, requiring at least 250 times more CheZ than wild-type CheY to achieve the same dephosphorylation rate enhancement, whereas CheY59NA was CheZ-sensitive, However, several independent approaches demonstrated that CheY59NR bound tightly to CheZ, A submicromolar Kd for CheZ binding to CheY59NR-P or CheY.BeF3- was inferred from fluorescence anisotropy measurements of fluoresceinated-CheZ. A complex between CheY59NR-P and CheZ was isolated by analytical gel filtration, and the elution position from the column was indistinguishable from that of the CheZ dimer, Therefore, we were not able to detect large CheY-P.CheZ complexes that have been inferred using other methods. Possible structural explanations for the specific inhibition of CheZ activity as a result of the arginyl substitution at CheY position 59 are discussed.	Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Bourret, RB (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	bourret@med.unc.edu	Bourret, Robert/X-3606-2019	Bourret, Robert/0000-0002-6666-9220	NIGMS NIH HHS [R01 GM050860, GM50860] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Appleby JL, 1998, J BACTERIOL, V180, P3563, DOI 10.1128/JB.180.14.3563-3569.1998; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; BELLSOLELL L, 1994, J MOL BIOL, V238, P489, DOI 10.1006/jmbi.1994.1308; Blat Y, 1998, J MOL BIOL, V284, P1191, DOI 10.1006/jmbi.1998.2224; Blat Y, 1996, J BIOL CHEM, V271, P1232, DOI 10.1074/jbc.271.2.1232; Blat Y, 1996, J BIOL CHEM, V271, P1226, DOI 10.1074/jbc.271.2.1226; Blat Y, 1996, BIOCHEMISTRY-US, V35, P5679, DOI 10.1021/bi9530447; Boesch KC, 2000, J BACTERIOL, V182, P3544, DOI 10.1128/JB.182.12.3544-3552.2000; BOURRET RB, 1990, P NATL ACAD SCI USA, V87, P41, DOI 10.1073/pnas.87.1.41; BRAY D, 1993, MOL BIOL CELL, V4, P469, DOI 10.1091/mbc.4.5.469; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Cho HS, 2000, J MOL BIOL, V297, P543, DOI 10.1006/jmbi.2000.3595; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Djordjevic S, 1998, J STRUCT BIOL, V124, P189, DOI 10.1006/jsbi.1998.4034; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; Gouet P, 1999, STRUCTURE, V7, P1517, DOI 10.1016/S0969-2126(00)88342-2; HERSCHLAG D, 1990, J AM CHEM SOC, V112, P1942, DOI 10.1021/ja00161a046; HESS JF, 1991, METHOD ENZYMOL, V200, P188; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUO SC, 1987, J BACTERIOL, V169, P1307, DOI 10.1128/jb.169.3.1307-1314.1987; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; LUKAT GS, 1990, BIOCHEMISTRY-US, V29, P5436, DOI 10.1021/bi00475a004; Mayover TL, 1999, BIOCHEMISTRY-US, V38, P2259, DOI 10.1021/bi981707p; McEvoy MM, 1999, J MOL BIOL, V289, P1423, DOI 10.1006/jmbi.1999.2830; RATHLEV T, 1956, ARCH BIOCHEM BIOPHYS, V65, P319, DOI 10.1016/0003-9861(56)90197-7; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; SANNA MG, 1995, MOL MICROBIOL, V15, P1069, DOI 10.1111/j.1365-2958.1995.tb02282.x; Schuster M, 2000, J BIOL CHEM, V275, P19752, DOI 10.1074/jbc.M909908199; SEGALL JE, 1982, NATURE, V296, P855, DOI 10.1038/296855a0; Sheridan R. C., 2007, INORG SYN, P23; Silversmith RE, 1997, BIOCHEMISTRY-US, V36, P14965, DOI 10.1021/bi9715573; Silversmith RE, 1999, TRENDS MICROBIOL, V7, P16, DOI 10.1016/S0966-842X(98)01409-7; Silversmith RE, 1998, PROTEIN ENG, V11, P205, DOI 10.1093/protein/11.3.205; Spiro PA, 1997, P NATL ACAD SCI USA, V94, P7263, DOI 10.1073/pnas.94.14.7263; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK AM, 1987, J BACTERIOL, V169, P3301, DOI 10.1128/jb.169.7.3301-3311.1987; STOCK AM, 1993, BIOCHEMISTRY-US, V32, P13375, DOI 10.1021/bi00212a001; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; WOLFE AJ, 1989, P NATL ACAD SCI USA, V86, P6973, DOI 10.1073/pnas.86.18.6973; Yan D, 1999, P NATL ACAD SCI USA, V96, P14789, DOI 10.1073/pnas.96.26.14789; Zapf J, 1998, BIOCHEMISTRY-US, V37, P7725, DOI 10.1021/bi9729615; Zhu XY, 1997, J BIOL CHEM, V272, P23758, DOI 10.1074/jbc.272.38.23758	45	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18478	18484		10.1074/jbc.M011418200	http://dx.doi.org/10.1074/jbc.M011418200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278903	hybrid, Green Published			2022-12-27	WOS:000168866500115
J	Tibbles, HE; Vassilev, A; Wendorf, H; Schonhoff, D; Zhu, D; Lorenz, D; Waurzyniak, B; Liu, XP; Uckun, FM				Tibbles, HE; Vassilev, A; Wendorf, H; Schonhoff, D; Zhu, D; Lorenz, D; Waurzyniak, B; Liu, XP; Uckun, FM			Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUTONS-TYROSINE-KINASE; THROMBIN-STIMULATED PLATELETS; RECEPTOR GLYCOPROTEIN-VI; COLLAGEN; ASSOCIATION; CELLS; MICE; SYK; LYN; BTK	Here we provide experimental evidence that identifies JAK3 as one of the regulators of platelet function. Treatment of platelets with thrombin induced tyrosine phosphorylation of the JAK3 target substrates STAT1 and STAT3. Platelets from JAK3-deficient mice displayed a decrease in tyrosine phosphorylation of STAT1 and STAT3. In accordance with these data, pretreatment of human platelets with the JAK3 inhibitor WHI-P1E1 markedly decreased the base-line enzymatic activity of constitutively active JAK3 and abolished the thrombin-induced tyrosine phosphorylation of STAT1 and STAT3. Following thrombin stimulation, WHI-P131-treated platelets did not undergo shape changes indicative of activation such as pseudopod formation. WHI-P131 inhibited thrombin-induced degranulation/serotonin release as well as platelet aggregation. Highly effective platelet inhibitory plasma concentrations of WHI-P131 were achieved in mice without toxicity. WHI-P131 prolonged the bleeding time of mice in a dose-dependent manner and improved event-free survival in a mouse model of thromboplastin-induced generalized and invariably fatal thromboembolism. To our knowledge, WHI-P131 is the first anti-thrombotic agent that prevents platelet aggregation by inhibiting JAK3.	Parker Hughes Inst, Parker Hughes Canc Ctr, St Paul, MN 55113 USA; Parker Hughes Inst, Dept Hematol, St Paul, MN 55113 USA; Parker Hughes Inst, Dept Biochem, St Paul, MN 55113 USA; Parker Hughes Inst, Dept Chem, St Paul, MN 55113 USA; Parker Hughes Inst, Dept Expt Pathol, St Paul, MN 55113 USA; Parker Hughes Inst, Discovery Program, St Paul, MN 55113 USA		Uckun, FM (corresponding author), Parker Hughes Inst, Parker Hughes Canc Ctr, 2665 Long Lake Rd,Suite 330, St Paul, MN 55113 USA.			Uckun, Fatih M./0000-0001-9334-183X				Asselin J, 1997, BLOOD, V89, P1235, DOI 10.1182/blood.V89.4.1235; D'Cruz OJ, 1998, BIOL REPROD, V59, P503, DOI 10.1095/biolreprod59.3.503; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Goodman PA, 1998, J BIOL CHEM, V273, P17742, DOI 10.1074/jbc.273.28.17742; Hammes SR, 1999, BIOCHEMISTRY-US, V38, P2486, DOI 10.1021/bi982527i; Hirao A, 1997, EMBO J, V16, P2342, DOI 10.1093/emboj/16.9.2342; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Laffargue M, 1999, FEBS LETT, V443, P66, DOI 10.1016/S0014-5793(98)01680-9; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; Melford SK, 1997, J BIOL CHEM, V272, P27539, DOI 10.1074/jbc.272.44.27539; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; ODA A, 1992, J BIOL CHEM, V267, P20075; Pasquet JM, 2000, J BIOL CHEM, V275, P28526, DOI 10.1074/jbc.M001531200; Quek LS, 1998, CURR BIOL, V8, P1137, DOI 10.1016/S0960-9822(98)70471-3; Sada K, 1997, EUR J BIOCHEM, V248, P827, DOI 10.1111/j.1432-1033.1997.00827.x; Sato K, 1998, JPN J PHARMACOL, V78, P191, DOI 10.1254/jjp.78.191; Sudbeck EA, 1999, CLIN CANCER RES, V5, P1569; Teng CM, 1997, EUR J PHARMACOL, V320, P161, DOI 10.1016/S0014-2999(96)00911-9; TOHYAMA Y, 1994, J BIOL CHEM, V269, P32796; TRECO DA, 1995, CURRENT PROTOCOLS MO, V1; Uckun FM, 1996, J BIOL CHEM, V271, P6389, DOI 10.1074/jbc.271.11.6389; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; Vassilev A, 1999, J BIOL CHEM, V274, P1646, DOI 10.1074/jbc.274.3.1646; WHITE JG, 1983, MEASUREMENTS PLATELE, P1; Witthuhn BA, 1999, LEUKEMIA LYMPHOMA, V32, P289, DOI 10.3109/10428199909167389	27	51	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17815	17822		10.1074/jbc.M011405200	http://dx.doi.org/10.1074/jbc.M011405200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278899	hybrid			2022-12-27	WOS:000168866500028
J	Bolduc, L; Labrecque, B; Cordeau, M; Blanchette, M; Chabot, B				Bolduc, L; Labrecque, B; Cordeau, M; Blanchette, M; Chabot, B			Dimethyl sulfoxide affects the selection of splice sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; CELL-ADHESION MOLECULE; MURINE ERYTHROLEUKEMIA-CELLS; RETINOIC ACID; C-MYC; MOUSE ERYTHROLEUKEMIA; HNRNP A1; N-CAM; DIFFERENTIATION; DMSO	Depending on the cell lines and cell types, dimethyl sulfoxide (Me2SO) can induce or block cell differentiation and apoptosis, Although Me2SO treatment alters many levels of gene expression, the molecular processes that are directly affected by Me2SO have not been clearly identified. Here, we report that Me2SO affects splice site selection on model pre-mRNAs incubated in a nuclear extract prepared from HeLa cells. A shift toward the proximal pair of splice sites was observed on pre-mRNAs carrying competing 5'-splice sites or competing 3'-splice sites. Because the activity of recombinant hnRNP Al protein was similar when added to extracts containing or lacking Me2SO, the activity of endogenous Al proteins is probably not affected by Me2SO. Notably, in a manner reminiscent of SR proteins, Me2SO activated splicing in a HeLa S100 extract. Moreover, the activity of recombinant SR proteins in splice site selection in vitro was improved by Me2SO, Polar solvents like DMF and formamide similarly modulated splice site selection in vitro but formamide did not activate a HeLa S100 extract. We propose that Me2SO improves ionic interactions between splicing factors that contain RS-domains, The direct impact of Me2SO on alternative splicing may explain, at least in part, the different and sometimes opposite effects of Me2SO on cell differentiation and apoptosis.	Univ Sherbrooke, Fac Med, Dept Microbiol & Infectiol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Chabot, B (corresponding author), Univ Sherbrooke, Fac Med, Dept Microbiol & Infectiol, Sherbrooke, PQ J1H 5N4, Canada.	b.chabot@courrier.usherb.ca	Chabot, Benoit/A-8943-2008	Chabot, Benoit/0000-0003-0994-0042				BAHLER DW, 1985, J IMMUNOL, V134, P2790; BENDORI R, 1987, VIROLOGY, V161, P607, DOI 10.1016/0042-6822(87)90159-0; Blanchette M, 1999, EMBO J, V18, P1939, DOI 10.1093/emboj/18.7.1939; BLAU HM, 1979, CELL, V17, P95, DOI 10.1016/0092-8674(79)90298-8; CAMPBELL PL, 1990, GENE DEV, V4, P1252, DOI 10.1101/gad.4.7.1252; Chabot B, 1997, MOL CELL BIOL, V17, P1776, DOI 10.1128/MCB.17.4.1776; Chabot B., 1994, RNA PROCESSING PRACT, VI, P1; DARLING D, 1989, ONCOGENE, V4, P175; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EICK D, 1990, NUCLEIC ACIDS RES, V18, P1199, DOI 10.1093/nar/18.5.1199; EMERIT MB, 1995, J NEUROCHEM, V65, P1917; EPERON IC, 1993, EMBO J, V12, P3607, DOI 10.1002/j.1460-2075.1993.tb06034.x; Fiore M, 1999, EXP CELL RES, V251, P102, DOI 10.1006/excr.1999.4542; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; GRUNT TW, 1992, J CELL SCI, V103, P501; HOOSEIN NM, 1988, EXP CELL RES, V175, P125, DOI 10.1016/0014-4827(88)90260-1; Jiang ZH, 1999, P SOC EXP BIOL MED, V220, P64, DOI 10.1046/j.1525-1373.1999.d01-11.x; KLINKEN SP, 1988, EXP CELL RES, V178, P185, DOI 10.1016/0014-4827(88)90390-4; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; MAKOWSKE M, 1988, J BIOL CHEM, V263, P3402; MANDUCA P, 1988, DEV BIOL, V125, P234, DOI 10.1016/0012-1606(88)90078-4; Marthyn P, 1998, EXP CELL RES, V243, P94, DOI 10.1006/excr.1998.4149; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x; Melkonyan H, 1996, NUCLEIC ACIDS RES, V24, P4356, DOI 10.1093/nar/24.21.4356; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; NICHOLSON DW, 1992, J BIOL CHEM, V267, P17849; PAN JB, 1993, MOL BRAIN RES, V18, P259, DOI 10.1016/0169-328X(93)90198-X; PISE CA, 1992, J GEN VIROL, V73, P3257, DOI 10.1099/0022-1317-73-12-3257; POLLERBERG EG, 1985, J CELL BIOL, V101, P1921, DOI 10.1083/jcb.101.5.1921; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; Prasad J, 1999, MOL CELL BIOL, V19, P6991; PRENTICE HM, 1987, EMBO J, V6, P1859, DOI 10.1002/j.1460-2075.1987.tb02444.x; SCHMITT P, 1987, CELL, V50, P31, DOI 10.1016/0092-8674(87)90659-3; SHEN QC, 1994, BLOOD, V84, P3902, DOI 10.1182/blood.V84.11.3902.bloodjournal84113902; SRINIVAS S, 1991, EXP CELL RES, V196, P279, DOI 10.1016/0014-4827(91)90262-S; TACKE R, 1991, GENE DEV, V5, P1416, DOI 10.1101/gad.5.8.1416; Tam SP, 1997, J LIPID RES, V38, P2090; Teraoka H, 1996, EXP CELL RES, V222, P218, DOI 10.1006/excr.1996.0027; Trubiani O, 1999, CELL PROLIFERAT, V32, P119, DOI 10.1046/j.1365-2184.1999.32230119.x; WANG H, 1993, CELL PROLIFERAT, V26, P55, DOI 10.1111/j.1365-2184.1993.tb00006.x; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; YENOFSKY R, 1983, MOL CELL BIOL, V3, P1197, DOI 10.1128/MCB.3.7.1197; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAMORE PD, 1991, EMBO J, V10, P207, DOI 10.1002/j.1460-2075.1991.tb07937.x	46	20	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17597	17602		10.1074/jbc.M011769200	http://dx.doi.org/10.1074/jbc.M011769200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278983	hybrid			2022-12-27	WOS:000168730400133
J	Kotamraju, S; Hogg, N; Joseph, J; Keefer, LK; Kalyanaraman, B				Kotamraju, S; Hogg, N; Joseph, J; Keefer, LK; Kalyanaraman, B			Inhibition of oxidized low-density lipoprotein-induced apoptosis in endothelial cells by nitric oxide - Peroxyl radical scavenging as an antiapoptotic mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ATHEROSCLEROTIC INTIMA; SMOOTH-MUSCLE CELLS; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; IN-VITRO; REACTIVE OXYGEN; OXIDATIVE MODIFICATION; ALPHA-TOCOPHEROL; UP-REGULATION; LDL	Proatherogenic oxidized low-density lipoprotein (oxLDL) induces endothelial apoptosis, We investigated the anti-apoptotic effects of intracellular and extracellular nitric oxide ((NO)-N-.) donors, iron chelators, cell-permeable superoxide dismutase (SOD), glutathione peroxidase mimetics, and nitrone spin traps. Peroxynitrite (ONOO-)-modified oxLDL induced endothelial apoptosis was measured by DNA fragmentation, TUNEL assay, and caspase-3 activation. Results indicated the following: (i) the lipid fraction of oxLDL was primarily responsible for endothelial apoptosis, (ii) Endothelial apoptosis was potently inhibited by (NO)-N-. donors and lipophilic phenolic antioxidants, OxLDL severely depleted Bcl-2 levels in endothelial cells and (NO)-N-. donors restored Bcl-2 protein in oxLDL-treated cells. (iii) The pretreatment of a lipid fraction derived from oxLDL with sodium borohydride or potassium iodide completely abrogated apoptosis in endothelial cells, suggesting that lipid hydroperoxides induce apoptosis, (iv) Metalloporphyrins dramatically inhibited oxLDL-induced apoptosis in endothelial cells. Neither S-nitrosation of caspase-3 nor induction of Hsp70 appeared to play a significant role in the antiapoptotic mechanism of (NO)-N-. in oxLDL-induced endothelial apoptosis, We propose that cellular lipid peroxyl radicals or lipid hydroperoxides induce an apoptotic signaling cascade in endothelial cells exposed to oxLDL, and that (NO)-N-. inhibits apoptosis by scavenging cellular lipid peroxyl radicals.	Med Coll Wisconsin, Biophys Res Inst, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Free Rad Res Ctr, Milwaukee, WI 53226 USA; NCI, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA	Medical College of Wisconsin; Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Biophys Res Inst, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.		Keefer, Larry K/N-3247-2014	Keefer, Larry K/0000-0001-7489-9555	NCRR NIH HHS [RR01008] Funding Source: Medline; NHLBI NIH HHS [HL47250-09, HL63119] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063119, R01HL047250] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Blair A, 1999, J BIOL CHEM, V274, P32512, DOI 10.1074/jbc.274.45.32512; Carr AC, 2000, ARTERIOSCL THROM VAS, V20, P1716, DOI 10.1161/01.ATV.20.7.1716; CATHCART MK, 1991, J LIPID RES, V32, P63; CATHCART MK, 1995, J LIPID RES, V36, P1857; Chisolm GM, 1999, J BIOL CHEM, V274, P25959, DOI 10.1074/jbc.274.37.25959; Cominacini L, 1998, J HYPERTENS, V16, P1913, DOI 10.1097/00004872-199816121-00010; DARLEYUSMAR VM, 1992, FREE RADICAL RES COM, V17, P9, DOI 10.3109/10715769209061085; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; Devaraj S, 1996, INT J CLIN LAB RES, V26, P178, DOI 10.1007/BF02592979; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Dimmeler S, 1998, EUR CYTOKINE NETW, V9, P697; Dimmeler S, 1997, CIRC RES, V81, P970; EHRENWALD E, 1994, J CLIN INVEST, V93, P1493, DOI 10.1172/JCI117127; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; FIELD L, 1978, J CHEM SOC CHEM COMM, P249, DOI 10.1039/c39780000249; FOLCIK VA, 1995, J CLIN INVEST, V96, P504, DOI 10.1172/JCI118062; Girotti AW, 1998, J LIPID RES, V39, P1529; Goss SPA, 1997, J BIOL CHEM, V272, P21647, DOI 10.1074/jbc.272.34.21647; GRAHAM A, 1993, FEBS LETT, V330, P181, DOI 10.1016/0014-5793(93)80269-Z; HABERLAND ME, 1988, SCIENCE, V241, P215, DOI 10.1126/science.2455346; Haendeler J, 1997, NITRIC OXIDE-BIOL CH, V1, P282, DOI 10.1006/niox.1997.0134; Hajjar DP, 1997, J BIOL CHEM, V272, P22975, DOI 10.1074/jbc.272.37.22975; HAMILTON RJ, 1980, LIPID ANAL PRACTICAL; Hatch F T, 1968, Adv Lipid Res, V6, P1; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; HEINECKE JW, 1984, J CLIN INVEST, V74, P1890, DOI 10.1172/JCI111609; Heinecke JW, 1998, ATHEROSCLEROSIS, V141, P1, DOI 10.1016/S0021-9150(98)00173-7; HOGG N, 1993, FEBS LETT, V334, P170, DOI 10.1016/0014-5793(93)81706-6; Hogg N, 1996, BIOCHEM BIOPH RES CO, V224, P696, DOI 10.1006/bbrc.1996.1086; HUI RE, 1993, FREE RADICAL RES COM, V18, P195; JESSUP W, 1992, BIOCHIM BIOPHYS ACTA, V1180, P73, DOI 10.1016/0925-4439(92)90029-M; Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402; Konorev EA, 1999, ARCH BIOCHEM BIOPHYS, V368, P421, DOI 10.1006/abbi.1999.1337; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; KUHN H, 1994, J EXP MED, V179, P1903, DOI 10.1084/jem.179.6.1903; Lee JB, 1998, J AM CHEM SOC, V120, P7493, DOI 10.1021/ja980507y; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433; Li CY, 2000, J BIOL CHEM, V275, P25665, DOI 10.1074/jbc.M906383199; LIAO JK, 1995, J BIOL CHEM, V270, P319, DOI 10.1074/jbc.270.1.319; Lizard G, 2000, FREE RADICAL BIO MED, V28, P743, DOI 10.1016/S0891-5849(00)00163-5; Lizard G, 1996, AM J PATHOL, V148, P1625; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALORANTA U, 1994, FEBS LETT, V337, P179, DOI 10.1016/0014-5793(94)80269-6; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Natarajan R, 1999, CARDIOVASC RES, V41, P489, DOI 10.1016/S0008-6363(98)00312-5; Nishio E, 1996, BIOCHEM BIOPH RES CO, V223, P413, DOI 10.1006/bbrc.1996.0907; ODonnell VB, 1997, BIOCHEMISTRY-US, V36, P15216, DOI 10.1021/bi971891z; PADMAJA S, 1993, BIOCHEM BIOPH RES CO, V195, P539, DOI 10.1006/bbrc.1993.2079; Parnham M, 2000, EXPERT OPIN INV DRUG, V9, P607, DOI 10.1517/13543784.9.3.607; PARTHASARATHY S, 1989, P NATL ACAD SCI USA, V86, P1046, DOI 10.1073/pnas.86.3.1046; Patel M, 1999, TRENDS PHARMACOL SCI, V20, P359, DOI 10.1016/S0165-6147(99)01336-X; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Saavedra JE, 2000, J MED CHEM, V43, P261, DOI 10.1021/jm9903850; Sata M, 1998, J BIOL CHEM, V273, P33103, DOI 10.1074/jbc.273.50.33103; Seelos C, 1997, BIOCHEM MOL BIOL INT, V42, P1015; SMITH C, 1992, BIOCHEM J, V286, P901, DOI 10.1042/bj2860901; SPARROW CP, 1988, J LIPID RES, V29, P745; Steinberg D, 1999, J CLIN INVEST, V103, P1487, DOI 10.1172/JCI7298; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1990, FREE RADICAL BIO MED, V9, P155, DOI 10.1016/0891-5849(90)90119-4; STRUCK AT, 1995, FEBS LETT, V361, P291, DOI 10.1016/0014-5793(95)00178-C; Suschek CV, 1999, J BIOL CHEM, V274, P6130, DOI 10.1074/jbc.274.10.6130; THOMAS JP, 1994, ARCH BIOCHEM BIOPHYS, V315, P244, DOI 10.1006/abbi.1994.1496; Vieira O, 1998, BRIT J PHARMACOL, V123, P565, DOI 10.1038/sj.bjp.0701624; Wever RMF, 1998, CIRCULATION, V97, P108, DOI 10.1161/01.CIR.97.1.108; Xing XY, 1998, J LIPID RES, V39, P2201	73	59	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17316	17323		10.1074/jbc.M011731200	http://dx.doi.org/10.1074/jbc.M011731200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278975	hybrid			2022-12-27	WOS:000168730400096
J	Charbaut, E; Curmi, PA; Ozon, S; Lachkar, S; Redeker, V; Sobel, A				Charbaut, E; Curmi, PA; Ozon, S; Lachkar, S; Redeker, V; Sobel, A			Stathmin family proteins display specific molecular and tubulin binding properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-ASSOCIATED PROTEINS; MICROTUBULE-DESTABILIZING ACTIVITY; NEURON-ENRICHED PHOSPHOPROTEIN; ADULT-RAT BRAIN; IN-VITRO; MESSENGER-RNAS; NERVOUS-SYSTEM; GENE FAMILY; SCG10; PHOSPHORYLATION	Stathmin family phosphoproteins (stathmin, SCG10, SCLIP, and RB3/RB3'/RB3") are involved in signal transduction and regulation of microtubule dynamics. With the exception of stathmin, they are expressed exclusively in the nervous system, where they display different spatio-temporal and functional regulations and hence play at least partially distinct and possibly complementary roles in relation to the control of development, plasticity, and neuronal activities. At the molecular level, each possesses a specific "stathmin-like domain" and, with the exception of stathmin, various combinations of N-terminal extensions involved in their association with intracellular membrane compartments, We show here that each stathmin-like domain also displays specific biochemical and tubulin interaction properties. They are all able to sequester two alpha/beta tubulin heterodimers as revealed by their inhibitory action on tubulin polymerization and by gel filtration. However, they differ in the stabilities of the complexes formed as well as in their interaction kinetics with tubulin followed by surface plasmon resonance as follows: strong stability and slow kinetics for RB3; medium for SCG10, SCLIP, and stathmin; and weak stability and rapid kinetics for RB3'. These results suggest that the fine-tuning of their stathmin-like domains contributes to the specific functional roles of stathmin family proteins in the regulation of microtubule dynamics within the various cell types and subcellular compartments of the developing or mature nervous system.	Inst Fer Moulin, INSERM, U440, F-75005 Paris, France; Ecole Super Phys & Chim Ind, CNRS, UMR 7637, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Sobel, A (corresponding author), Inst Fer Moulin, INSERM, U440, 17 Rue Fer Moulin, F-75005 Paris, France.		Redeker, Virginie/L-8929-2018; CURMI, Patrick/G-4036-2013	Redeker, Virginie/0000-0003-2694-8388; CURMI, Patrick A./0000-0001-5045-8501				ANDERSON DJ, 1985, CELL, V42, P649, DOI 10.1016/0092-8674(85)90122-9; Antonsson B, 1998, J BIOL CHEM, V273, P8439, DOI 10.1074/jbc.273.14.8439; Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; Beilharz EJ, 1998, J NEUROSCI, V18, P9780; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; CARLIER MF, 1978, BIOCHEMISTRY-US, V17, P1908, DOI 10.1021/bi00603a017; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; CURMI PA, 1994, BIOCHEM J, V300, P331, DOI 10.1042/bj3000331; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Di Paolo G, 1997, J NEUROSCI RES, V50, P1000, DOI 10.1002/(SICI)1097-4547(19971215)50:6<1000::AID-JNR10>3.0.CO;2-8; DiPaolo G, 1997, J BIOL CHEM, V272, P5175, DOI 10.1074/jbc.272.8.5175; DOYE V, 1989, J BIOL CHEM, V264, P12134; Gavet O, 1998, J CELL SCI, V111, P3333; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; HAILAT N, 1990, ONCOGENE, V5, P1615; HIMI T, 1994, NEUROSCIENCE, V60, P907, DOI 10.1016/0306-4522(94)90271-2; HIMI T, 1994, BRAIN RES, V655, P177, DOI 10.1016/0006-8993(94)91612-8; Horwitz SB, 1997, J BIOL CHEM, V272, P8129, DOI 10.1074/jbc.272.13.8129; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Lawler S, 1998, CURR BIOL, V8, pR212, DOI 10.1016/S0960-9822(98)70128-9; LEE FJS, 1990, J BIOL CHEM, V265, P11576; Manceau V, 1999, ELECTROPHORESIS, V20, P409, DOI 10.1002/(SICI)1522-2683(19990201)20:2<409::AID-ELPS409>3.3.CO;2-E; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; MAUCUER A, 1990, FEBS LETT, V264, P275, DOI 10.1016/0014-5793(90)80266-L; MAUCUER A, 1995, P NATL ACAD SCI USA, V92, P3100, DOI 10.1073/pnas.92.8.3100; McNeill TH, 1999, NEUROSCIENCE, V90, P1349, DOI 10.1016/S0306-4522(98)00482-5; Nakazawa T, 2000, BRAIN RES, V861, P399, DOI 10.1016/S0006-8993(00)02056-4; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 1999, J NEUROSCI RES, V56, P553, DOI 10.1002/(SICI)1097-4547(19990601)56:5<553::AID-JNR11>3.0.CO;2-J; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Redeker V, 2000, J BIOL CHEM, V275, P6841, DOI 10.1074/jbc.275.10.6841; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; Sambrook J., 2002, MOL CLONING LAB MANU; SCHUBART UK, 1989, DNA-J MOLEC CELL BIO, V8, P389, DOI 10.1089/dna.1.1989.8.389; SCHUBART UK, 1987, J BIOL CHEM, V262, P11871; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SOBEL A, 1989, J BIOL CHEM, V264, P3765; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sugiura Y, 1995, DEV BRAIN RES, V90, P73, DOI 10.1016/0165-3806(96)83488-2; VIOLAND BN, 1994, PROTEIN SCI, V3, P1097; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858	48	141	152	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16146	16154		10.1074/jbc.M010637200	http://dx.doi.org/10.1074/jbc.M010637200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278715	hybrid			2022-12-27	WOS:000168623100078
J	Hilton, JM; Plomann, M; Ritter, B; Modregger, J; Freeman, HN; Falck, JR; Krishna, UM; Tobin, AB				Hilton, JM; Plomann, M; Ritter, B; Modregger, J; Freeman, HN; Falck, JR; Krishna, UM; Tobin, AB			Phosphorylation of a synaptic vesicle-associated protein by an inositol hexakisphosphate-regulated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS CHANGES; BINDING; CELLS; STIMULATION; PENTAKISPHOSPHATE; POLYPHOSPHATES; TRANSDUCTION; ENDOCYTOSIS; PHOSPHATES; INHIBITION	Despite the fact that inositol hexakisphosphate (InsP(6)) is the most abundant inositol metabolite in cells, its cellular function has remained an enigma. In the present study, we present the first evidence of a protein kinase identified in rat cerebral cortex/hippocampus that is activated by InsP(6). The substrate for the InsP(6)-regulated protein kinase was found to be the synaptic vesicle-associated protein, pacsin/syndapin I. This brain-specific protein, which is highly enriched at nerve terminals, is proposed to act as a molecular link coupling components of the synaptic vesicle endocytic machinery to the cytoskeleton. We show here that the association between pacsin/syndapin I and dynamin I can be increased by InsP(6)-dependent phosphorylation of pacsin/syndapin I. These data provide a model by which InsP(6)-dependent phosphorylation regulates synaptic vesicle recycling by increasing the interaction between endocytic proteins at the synapse.	Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; Univ Cologne, Fac Med, Inst Biochem 2, D-50931 Cologne, Germany; Glaxo Wellcome Res & Dev Ltd, Med Res Ctr, Stevenage SG1 2NY, Herts, England; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA	University of Leicester; University of Cologne; GlaxoSmithKline; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Tobin, AB (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, POB 138,Med Sci Bldg,Univ Rd, Leicester LE1 9HN, Leics, England.			Falck, John/0000-0002-9219-7845; Modregger, Jan/0000-0001-6209-5891	NIGMS NIH HHS [GM31278] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert C, 1997, BIOCHEM J, V327, P553, DOI 10.1042/bj3270553; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; GUSE AH, 1993, J BIOL CHEM, V268, P7129; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; Hughes P J, 1993, Curr Opin Neurobiol, V3, P383, DOI 10.1016/0959-4388(93)90132-I; Irvine Robin F., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P161; Larsson O, 1997, SCIENCE, V278, P471, DOI 10.1126/science.278.5337.471; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Modregger J, 2000, J CELL SCI, V113, P4511; PALCZEWSKI K, 1992, NEURON, V8, P117, DOI 10.1016/0896-6273(92)90113-R; PITTET D, 1989, J BIOL CHEM, V264, P18489; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; SASAKAWA N, 1995, BIOCHEM PHARMACOL, V50, P137, DOI 10.1016/0006-2952(95)00059-9; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; SZWERGOLD BS, 1987, BIOCHEM BIOPH RES CO, V149, P874, DOI 10.1016/0006-291X(87)90489-X; TOBIN AB, 1993, J BIOL CHEM, V268, P9817; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VOGLMAIER SM, 1992, BIOCHEM BIOPH RES CO, V187, P158, DOI 10.1016/S0006-291X(05)81473-1; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	30	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16341	16347		10.1074/jbc.M011122200	http://dx.doi.org/10.1074/jbc.M011122200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278843	hybrid			2022-12-27	WOS:000168623100103
J	Galigniana, MD; Radanyi, C; Renoir, JM; Housley, PR; Pratt, WB				Galigniana, MD; Radanyi, C; Renoir, JM; Housley, PR; Pratt, WB			Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; TETRATRICOPEPTIDE REPEAT DOMAIN; REQUIRES INTACT CYTOSKELETON; STEROID-RECEPTOR; PROGESTERONE-RECEPTOR; FK506-BINDING PROTEIN; BINDING-SITE; IN-VIVO; HSP90; COMPLEXES	We have previously shown that immunoadsorption of the FKBP52 immunophilin component of steroid receptor.hsp90 heterocomplexes is accompanied by coadsorption of cytoplasmic dynein, a motor protein involved in retrograde transport of vesicles toward the nucleus. Coimmunoadsorption of dynein is competed by an expressed fragment of FKBP52 comprising its peptidylprolyl isomerase (PPIase) domain (Silverstein, A. M,, Galigniana, M, D., Kanelakis, K. C,, Radanyi, C,, Renoir, J.-M,, and Pratt, W, B, (1999) J, Biol. Chem. 52, 36980-36986), Here we show that cotransfection of 3T3 cells with the FKBP52 PPIase domain and a green fluorescent protein (GFP) glucocorticoid receptor (GR) chimera inhibits dexamethasone-dependent movement of the GFP-GR from the cytoplasm to the nucleus. Cotransfection with FKBP12 does not affect GFP-GR movement. Inhibition of movement by the FKBP52 PPIase domain is abrogated in cells treated with colcemid to eliminate microtubules prior to steroid addition, After withdrawal of colcemid, microtubules reform, and PPIase inhibition of GFP-GR movement is restored. These observations are consistent with the notion that FRBP52 targets retrograde movement of the GFP-GR along microtubules by linking the receptor to the dynein motor. Here, we also show that native GR.hsp90 heterocomplexes immunoadsorbed from L cell cytosol contain dynein and that GR.hsp90 heterocomplexes assembled in reticulocyte lysate contain cytoplasmic dynein in a manner that is competed by the PPIase domain of FKBP52.	Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; Fac Pharm, CNRS, UMR 8612, Chatenay Malabry, France; Univ S Carolina, Sch Med, Dept Physiol & Pharmacol, Columbia, SC 29208 USA	University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Pratt, WB (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, MSRB III, Ann Arbor, MI 48109 USA.		RADANYI, Christine/A-8921-2008	GALIGNIANA, MARIO/0000-0002-9130-8574	NCI NIH HHS [CA28010] Funding Source: Medline; NIDDK NIH HHS [DK47951] Funding Source: Medline; CSAP SAMHSA HHS [SP60 DK205972] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA028010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047951] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CSAP SAMHSA HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKNER G, 1995, J STEROID BIOCHEM, V52, P1, DOI 10.1016/0960-0760(94)00155-F; Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; Bloom GS, 1998, J CELL BIOL, V140, P1277, DOI 10.1083/jcb.140.6.1277; CALLEBAUT I, 1992, P NATL ACAD SCI USA, V89, P6270, DOI 10.1073/pnas.89.14.6270; CHAMBRAUD B, 1993, BIOCHEM BIOPH RES CO, V196, P160, DOI 10.1006/bbrc.1993.2229; Chambraud B, 1996, J BIOL CHEM, V271, P32923, DOI 10.1074/jbc.271.51.32923; CHANDRAN UR, 1992, MOL ENDOCRINOL, V6, P837, DOI 10.1210/me.6.5.837; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Czar MJ, 1997, BIOCHEMISTRY-US, V36, P7776, DOI 10.1021/bi970648x; CZAR MJ, 1995, MOL ENDOCRINOL, V9, P1549, DOI 10.1210/me.9.11.1549; CZAR MJ, 1994, MOL ENDOCRINOL, V8, P1731, DOI 10.1210/me.8.12.1731; DAUVOIS S, 1993, J CELL SCI, V106, P1377; DeFranco DB, 1995, VITAM HORM, V51, P315, DOI 10.1016/S0083-6729(08)61043-2; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; Galigniana MD, 1999, J BIOL CHEM, V274, P16222, DOI 10.1074/jbc.274.23.16222; GUICHONMANTEL A, 1991, EMBO J, V10, P3851; KANG KI, 1994, P NATL ACAD SCI USA, V91, P340, DOI 10.1073/pnas.91.1.340; LANGFORD GM, 1995, CURR OPIN CELL BIOL, V7, P82, DOI 10.1016/0955-0674(95)80048-4; LEBEAU MC, 1994, BIOCHEM BIOPH RES CO, V203, P750, DOI 10.1006/bbrc.1994.2246; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MADAN AP, 1993, P NATL ACAD SCI USA, V90, P3588, DOI 10.1073/pnas.90.8.3588; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; PERROTAPPLANAT M, 1992, J CELL BIOL, V119, P337, DOI 10.1083/jcb.119.2.337; PERROTAPPLANAT M, 1995, J CELL SCI, V108, P2037; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Pratt WB, 1999, CELL SIGNAL, V11, P839, DOI 10.1016/S0898-6568(99)00064-9; PRATT WB, 1993, J STEROID BIOCHEM, V46, P269, DOI 10.1016/0960-0760(93)90216-J; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; QI M, 1989, MOL ENDOCRINOL, V3, P1279, DOI 10.1210/mend-3-8-1279; RAAKA BM, 1985, J BIOL CHEM, V260, P4009; RADANYI C, 1994, P NATL ACAD SCI USA, V91, P11197, DOI 10.1073/pnas.91.23.11197; RUFF VA, 1992, J BIOL CHEM, V267, P21285; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; VALLEE RB, 1991, ANNU REV NEUROSCI, V14, P59, DOI 10.1146/annurev.ne.14.030191.000423; Yang J, 1996, MOL ENDOCRINOL, V10, P3, DOI 10.1210/me.10.1.3	41	193	199	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14884	14889		10.1074/jbc.M010809200	http://dx.doi.org/10.1074/jbc.M010809200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278753	hybrid			2022-12-27	WOS:000168528800049
J	Li, SL; Taylor, KB; Kelly, SJ; Jedrzejas, MJ				Li, SL; Taylor, KB; Kelly, SJ; Jedrzejas, MJ			Vitamin C inhibits the enzymatic activity of Streptococcus pneumoniae hyaluronate lyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCORBIC-ACID; CRYSTAL-STRUCTURE; PURIFICATION; BIOCHEMISTRY; BINDING; GENE	Enzyme activity measurement showed that L-ascorbic acid (vitamin C (Vc)) competitively inhibits the hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase. The complex crystal structure of this enzyme with Vc was determined at 2.0 Angstrom resolution. One Vc molecule was found to bind to the active site of the enzyme. The Vc carboxyl group provides the negative charges that lead the molecule into the highly positively charged cleft of the enzyme. The Vc ring system forms hydrophobic interactions with the side chain of Trp-292, which is one of the aromatic patch residues of this enzyme responsible for the selection of the cleavage sites on the substrate chain. The binding of Vc inhibits the substrate binding at hyaluronan 1, 2, and 3 (HA1, HA2, and HA3) catalytic positions. The high concentration of Vc in human tissues probably provides a low level of natural resistance to the pneumococcal invasion. This is the first time that Vc the direct inhibition on the bacterial "spreading factor" was reported, and Ve is also the first chemical that has been shown experimentally to have an inhibitory effect on bacterial hyaluronate lyase, These studies also highlight the possible structural requirement for the design of a stronger inhibitor of bacterial hyaluronate lyase.	Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Jedrzejas, MJ (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 933 19th St S,545 CHSB-19, Birmingham, AL 35294 USA.	jedrzejas@uab.edu			NIAID NIH HHS [AI 44079] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044079] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERGSTEN P, 1990, J BIOL CHEM, V265, P2584; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; BERRY AM, 1994, INFECT IMMUN, V62, P1101, DOI 10.1128/IAI.62.3.1101-1108.1994; Brubaker RF, 2000, INVEST OPHTH VIS SCI, V41, P1681; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Brunger AT, 1997, METHOD ENZYMOL, V277, P243, DOI 10.1016/S0076-6879(97)77015-0; Bursey EH, 2000, BIOCHEMISTRY-US, V39, P7374, DOI 10.1021/bi000446s; CARRELL HL, 1998, P NATL ACAD SCI USA, V86, P4440; HVOSLEF J, 1968, ACTA CRYSTALL B-STRU, VB 24, P1431, DOI 10.1107/S0567740868004449; Hwang J, 2000, ATHEROSCLEROSIS, V150, P275, DOI 10.1016/S0021-9150(99)00376-7; Jedrzejas MJ, 2000, CRIT REV BIOCHEM MOL, V35, P221, DOI 10.1080/10409230091169195; Jedrzejas MJ, 1998, J STRUCT BIOL, V121, P73, DOI 10.1006/jsbi.1998.3963; Jedrzejas MJ, 1998, PROTEIN EXPRES PURIF, V13, P83, DOI 10.1006/prep.1997.0864; Jedrzejas MJ, 2000, ACTA CRYSTALLOGR D, V56, P460, DOI 10.1107/S0907444900000706; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kalka K, 2000, SKIN PHARMACOL APPL, V13, P143, DOI 10.1159/000029919; Khurana S, 1998, P NATL ACAD SCI USA, V95, P6768, DOI 10.1073/pnas.95.12.6768; LESTER P, 1997, VITAMIN C HLTH DIS; LEVINE M, 1986, NEW ENGL J MED, V314, P892, DOI 10.1056/NEJM198604033141407; Li MW, 1997, BIOL REPROD, V56, P1383, DOI 10.1095/biolreprod56.6.1383; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ponnuraj K, 2000, J MOL BIOL, V299, P885, DOI 10.1006/jmbi.2000.3817; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Rolland K, 1999, J CLIN MICROBIOL, V37, P1892, DOI 10.1128/JCM.37.6.1892-1898.1999; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; WASHKO PW, 1993, J BIOL CHEM, V268, P15531	28	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15125	15130		10.1074/jbc.M011102200	http://dx.doi.org/10.1074/jbc.M011102200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278838	hybrid			2022-12-27	WOS:000168528800080
J	Schlondorff, J; Lum, L; Blobel, CP				Schlondorff, J; Lum, L; Blobel, CP			Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF FAMILY MEMBER; OSTEOCLAST DIFFERENTIATION FACTOR; MEMBRANE-PROTEIN SECRETASES; AMYLOID PRECURSOR PROTEIN; MATRIX-METALLOPROTEINASE; CELL-SURFACE; DENDRITIC-CELL; OSTEOPROTEGERIN-LIGAND; DISINTEGRIN-METALLOPROTEASE; STRUCTURAL REQUIREMENTS	A number of structurally and functionally diverse membrane proteins are released from the plasma membrane in a process termed protein ectodomain shedding. Ectodomain shedding may activate or inactivate a substrate or change its properties, such as converting a juxtacrine into a paracrine signaling molecule. Here we have characterized the activities involved in protein ectodomain shedding of the tumor necrosis factor family member TRANCE/OPGL in different cell types. The criteria used to evaluate these activities include (a) cleavage site usage, (b) response to activators and inhibitors of intracellular signaling pathways, and (c) sensitivity to tissue inhibitors of metalloproteases (TIMPs), At least two TRANCE shedding activities emerged, both of which are distinct from the tumor necrosis factor alpha convertase. One of the TRANCE sheddases is induced by the tyrosine phosphatase inhibitor pervanadate but not by phorbol esters, whereas the other is refractory to both of these stimuli. Furthermore, the pervanadate-regulated sheddase activity is sensitive to TIMP-2 but not TIMP-1, which is consistent with the properties of a membrane typo matrix metalloprotease. This study provides insights into the properties of different activities involved in protein ectodomain shedding and has implications for the functional regulation of TRANCE by potentially more than one protease.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Tri Inst Cornell Univ Rockefeller Univ Sloan Kett, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Blobel, CP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cellular Biochem & Biophys Program, Box 368,1275 York Ave, New York, NY 10021 USA.			Schlondorff, Johannes/0000-0002-9973-9731	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM058668] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM58668, 5T32GM07739-17] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arribas J, 1997, J BIOL CHEM, V272, P17160, DOI 10.1074/jbc.272.27.17160; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; AUSUBEL FM, 1997, CURRENT PROTOCOLS MO, V1; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; BRAKEBUSCH C, 1994, J BIOL CHEM, V269, P32488; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Butler GS, 1997, EUR J BIOCHEM, V244, P653, DOI 10.1111/j.1432-1033.1997.t01-1-00653.x; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Chan YM, 1998, CELL, V94, P423, DOI 10.1016/S0092-8674(00)81583-4; CHENG HJ, 1994, MOL BIOL CELL, V5, P943, DOI 10.1091/mbc.5.9.943; Codony-Servat J, 1999, CANCER RES, V59, P1196; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; CROWE PD, 1995, J EXP MED, V181, P1205, DOI 10.1084/jem.181.3.1205; Deng P, 1996, J BIOL CHEM, V271, P16338, DOI 10.1074/jbc.271.27.16338; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P10065, DOI 10.1021/bi00106a001; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Haro H, 2000, J CLIN INVEST, V105, P143, DOI 10.1172/JCI7091; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Kinoshita T, 1996, CANCER RES, V56, P2535; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kong YY, 1999, IMMUNOL CELL BIOL, V77, P188, DOI 10.1046/j.1440-1711.1999.00815.x; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lum L, 1999, J BIOL CHEM, V274, P13613, DOI 10.1074/jbc.274.19.13613; Lunn CA, 1997, FEBS LETT, V400, P333, DOI 10.1016/S0014-5793(96)01410-X; MARIANI SM, 1995, EUR J IMMUNOL, V25, P2303, DOI 10.1002/eji.1830250828; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Matsumoto SI, 1997, BBA-GENE STRUCT EXPR, V1354, P159, DOI 10.1016/S0167-4781(97)00120-6; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; MIGAKI GI, 1995, J EXP MED, V182, P549, DOI 10.1084/jem.182.2.549; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; Rosendahl MS, 1997, J BIOL CHEM, V272, P24588, DOI 10.1074/jbc.272.39.24588; Schlondorff J, 1999, J CELL SCI, V112, P3603; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; SHIRAKABE K, 2000, J BIOL CHEM; Sotillos S, 1997, DEVELOPMENT, V124, P4769; Tang P, 1996, BIOCHEMISTRY-US, V35, P8226, DOI 10.1021/bi952183l; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; Turner AJ, 1999, BIOCHEM SOC T, V27, P255, DOI 10.1042/bst0270255; Wen CH, 1997, DEVELOPMENT, V124, P4759; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1999, J LEUKOCYTE BIOL, V65, P715, DOI 10.1002/jlb.65.6.715; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	68	110	115	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14665	14674		10.1074/jbc.M010741200	http://dx.doi.org/10.1074/jbc.M010741200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278735	hybrid			2022-12-27	WOS:000168528800021
J	Vance, JR; Wilson, TE				Vance, JR; Wilson, TE			Uncoupling of 3 '-phosphatase and 5 '-kinase functions in budding yeast - Characterization of Saccharomyces cerevisiae DNA 3 '-phosphatase (TPP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; APURINIC-APYRIMIDINIC ENDONUCLEASE; T4 POLYNUCLEOTIDE KINASE; TRANSFER-RNA LIGASE; SUBSTRATE-SPECIFICITY; STRAND BREAKS; CALF THYMUS; GENE; SEQUENCE; PROTEIN	Polynucleotide kinase is a bifunctional enzyme containing both DNA 3'-phosphatase and 5'-kinase activities seemingly suited to the coupled repair of single-strand nicks in which the phosphate has remained with the 3'-base. We show that the yeast Saccharomyces cerevisiae is able to repair transformed dephosphorylated linear plasmids by non-homologous end joining with considerable efficiency independently of the end-processing. polymerase Pol4p. Homology searches and biochemical assays did not reveal a 5'-kinase that would account for this repair, however. Instead, open reading frame YMR156C (here named TPP1) is shown to encode only a polynucleotide kinase-type 3'-phosphatase. Tpp1p bears extensive similarity to the ancient L-2-haloacid dehalogenase and DDDD phosphohydrolase superfamilies, but is specific for double-stranded DNA. It is present at high levels in cell extracts in a functional form and so does not represent a pseudogene. Moreover, the phosphatase-only nature of this gene is shared by Saccharomyces mikatae YMR156C and Arabidopsis thaliana K15M2.3. Repair of 3'-phosphate and 5'-hydroxyl lesions is thus uncoupled in budding yeast as compared with metazoans. Repair of transformed dephosphorylated plasmids, and 5'-hydroxyl blocking lesions more generally, likely proceeds by a cycle of base removal and resynthesis.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Wilson, TE (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd,M4214 Med Sci I,POB 0602, Ann Arbor, MI 48109 USA.				NHLBI NIH HHS [5T32HL07157] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Bhagwat M, 1996, BIOCHEMISTRY-US, V35, P659, DOI 10.1021/bi9522662; Brachmann CB, 1998, YEAST, V14, P115; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Featherstone C, 1999, CURR BIOL, V9, pR759, DOI 10.1016/S0960-9822(00)80005-6; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Girard PM, 1997, NUCLEIC ACIDS RES, V25, P3204, DOI 10.1093/nar/25.16.3204; Halas A, 1997, CURR GENET, V31, P292, DOI 10.1007/s002940050208; ICHIMURA M, 1971, J BIOCHEM-TOKYO, V69, P823, DOI 10.1093/oxfordjournals.jbchem.a129533; Jilani A, 1999, J CELL BIOCHEM, V73, P188, DOI 10.1002/(SICI)1097-4644(19990501)73:2<188::AID-JCB5>3.3.CO;2-8; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; JOHNSON AW, 1988, J BIOL CHEM, V263, P18017; Karimi-Busheri F, 1998, NUCLEIC ACIDS RES, V26, P4395, DOI 10.1093/nar/26.19.4395; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; KarimiBusheri F, 1997, J CELL BIOCHEM, V64, P258, DOI 10.1002/(SICI)1097-4644(199702)64:2<258::AID-JCB9>3.0.CO;2-W; KOONIN EV, 1990, FEBS LETT, V268, P231, DOI 10.1016/0014-5793(90)81015-G; Launhardt H, 1998, YEAST, V14, P935, DOI 10.1002/(SICI)1097-0061(199807)14:10<935::AID-YEA289>3.0.CO;2-9; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; MIDGLEY CA, 1985, EMBO J, V4, P2695, DOI 10.1002/j.1460-2075.1985.tb03989.x; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; Ozier-Kalogeropoulos O, 1998, NUCLEIC ACIDS RES, V26, P5511, DOI 10.1093/nar/26.23.5511; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Piersen CE, 2000, MUTAT RES-DNA REPAIR, V459, P43, DOI 10.1016/S0921-8777(99)00054-3; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; PRASAD R, 1993, NUCLEIC ACIDS RES, V21, P5301, DOI 10.1093/nar/21.23.5301; Ramotar D, 1997, BIOCHEM CELL BIOL, V75, P327, DOI 10.1139/bcb-75-4-327; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WESTAWAY SK, 1988, J BIOL CHEM, V263, P3171; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599; Wood RD, 1997, CARCINOGENESIS, V18, P605, DOI 10.1093/carcin/18.4.605	47	51	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15073	15081		10.1074/jbc.M011075200	http://dx.doi.org/10.1074/jbc.M011075200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278831	hybrid			2022-12-27	WOS:000168528800074
J	Lavulo, LT; Sossong, TM; Brigham-Burke, MR; Doyle, ML; Cox, JD; Christianson, DW; Ash, DE				Lavulo, LT; Sossong, TM; Brigham-Burke, MR; Doyle, ML; Cox, JD; Christianson, DW; Ash, DE			Subunit-subunit interactions in trimeric arginase - Generation of active monomers by mutation of a single amino acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER ARGINASE; BINUCLEAR MANGANESE CLUSTER; ESCHERICHIA-COLI; MOLECULAR-BASIS; PROTEIN; HYPERARGININEMIA; DEFICIENCY; ARGININEMIA; GENE; PURIFICATION	The structure of the trimeric, manganese metalloenzyme, rat liver arginase, has been previously determined at 2.1-Angstrom resolution (Kanyo, Z. F., Scolnick, L. R., Ash, D. E., and Christianson, D. W., (1996) Nature 383, 554-557). A key feature of this structure is a novel S-shaped oligomerization motif at the carboxyl terminus of the protein that mediates similar to 54% of the intermonomer contacts. Arg-308, located within this oligomerization motif, nucleates a series of intramonomer and intermonomer salt links. In contrast to the trimeric wild-type enzyme, the R308A, R308E, and R308K variants of arginase exist as monomeric species, as determined by gel filtration and analytical ultracentrifugation, indicating that mutation of Arg-308 shifts the equilibrium for trimer dissociation by at least a factor of 10(5). These monomeric arginase variants are catalytically active, with k(cat)/K-m values that are 13-17% of the value for wild-type enzyme. The arginase variants are characterized by decreased temperature stability relative to the wild-type enzyme. Differential scanning calorimetry shows that the midpoint; temperature for unfolding of the Arg-308 variants is in the range of 63.6-65.5 degreesC, while the corresponding value for the wild-type enzyme is 70 degreesC. The three dimensional structure of the R308K variant has been determined at 3-Angstrom resolution. At the high protein concentrations utilized in the crystallizations, this variant exists as a trimer, but weakened salt, link interactions are observed for Lys-308.	Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; SmithKline Beecham Pharmaceut, Dept Anti Infect Res, Collegeville, PA 19426 USA; SmithKline Beecham Pharmaceut, Dept Biol Struct, King Of Prussia, PA 19406 USA; Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; GlaxoSmithKline; GlaxoSmithKline; University of Pennsylvania	Ash, DE (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3420 N Broad St, Philadelphia, PA 19140 USA.			Doyle, Michael/0000-0003-4569-6315	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067788] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK44841] Funding Source: Medline; NIGMS NIH HHS [GM49758, R01 GM067788] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGUIRRE R, 1983, EUR J BIOCHEM, V130, P373, DOI 10.1111/j.1432-1033.1983.tb07163.x; Ash DE, 1998, MOL GENET METAB, V64, P243, DOI 10.1006/mgme.1998.2677; Backmann J, 1998, J MOL BIOL, V284, P817, DOI 10.1006/jmbi.1998.2216; BERNAR J, 1986, J PEDIATR-US, V108, P432, DOI 10.1016/S0022-3476(86)80891-5; Bewley MC, 1999, STRUCT FOLD DES, V7, P435, DOI 10.1016/S0969-2126(99)80056-2; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUSILOW SW, 1995, UREA CYCLE ENZYMES, P1187; CARVAJAL N, 1977, BIOCHIM BIOPHYS ACTA, V481, P177, DOI 10.1016/0005-2744(77)90149-8; CAVALLI RC, 1994, BIOCHEMISTRY-US, V33, P10652, DOI 10.1021/bi00201a012; CEDERBAUM SD, 1979, PEDIATR RES, V13, P827, DOI 10.1203/00006450-197907000-00007; *COL COMP PROJ 4, 1994, ACTA CRYSTALLOGR D, V50, P760; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; GARGANTA CL, 1986, ANAL BIOCHEM, V154, P388, DOI 10.1016/0003-2697(86)90003-5; GRODY WW, 1992, AM J HUM GENET, V50, P1281; HARAGUCHI Y, 1987, P NATL ACAD SCI USA, V84, P412, DOI 10.1073/pnas.84.2.412; IKEMOTO M, 1990, BIOCHEM J, V270, P697, DOI 10.1042/bj2700697; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanyo ZF, 1996, NATURE, V383, P554, DOI 10.1038/383554a0; KANYO ZF, 1992, J MOL BIOL, V224, P1175, DOI 10.1016/0022-2836(92)90479-4; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mora A, 2000, BBA-PROTEIN STRUCT M, V1476, P181, DOI 10.1016/S0167-4838(99)00256-3; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PENNINCKX M, 1974, EUR J BIOCHEM, V49, P429, DOI 10.1111/j.1432-1033.1974.tb03848.x; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; RECZKOWSKI RS, 1992, J AM CHEM SOC, V114, P10992, DOI 10.1021/ja00053a064; RECZKOWSKI RS, 1994, ARCH BIOCHEM BIOPHYS, V312, P31, DOI 10.1006/abbi.1994.1276; RUEGG UT, 1980, ANAL BIOCHEM, V102, P206, DOI 10.1016/0003-2697(80)90340-1; Scolnick LR, 1997, BIOCHEMISTRY-US, V36, P10558, DOI 10.1021/bi970800v; SNYDERMAN SE, 1977, J PEDIATR-US, V90, P563, DOI 10.1016/S0022-3476(77)80367-3; TABOR DE, 1994, 6 INT C INB ERR MET; Tamura A, 1997, J MOL BIOL, V273, P1048, DOI 10.1006/jmbi.1997.1368; TERHEGGE.HG, 1970, Z KINDERHEILKD, V107, P298, DOI 10.1007/BF00438892; UCHINO T, 1995, HUM GENET, V96, P255; UCHINO T, 1992, AM J HUM GENET, V51, P1406; Vockley JG, 1996, BIOCHEM MOL MED, V59, P44, DOI 10.1006/bmme.1996.0063; VOCKLEY JG, 1994, HUM MUTAT, V4, P150, DOI 10.1002/humu.1380040210; [No title captured]	41	47	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14242	14248		10.1074/jbc.M010575200	http://dx.doi.org/10.1074/jbc.M010575200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278703	hybrid			2022-12-27	WOS:000168356600097
J	Abner, CW; Lau, AY; Ellenberger, T; Bloom, LB				Abner, CW; Lau, AY; Ellenberger, T; Bloom, LB			Base excision and DNA binding activities of human alkyladenine DNA glycosylase are sensitive to the base paired with a lesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRUCTURAL BASIS; REPAIR ENZYME; CRYSTAL-STRUCTURE; N-GLYCOSYLASE; DAMAGED DNA; 3-METHYLADENINE; 1,N-6-ETHENOADENINE; SUBSTRATE; KINETICS	The human alkyladenine DNA glycosylase has a broad substrate specificity, excising a structurally diverse group of damaged purines from DNA. To more clearly define the structural and mechanistic bases for substrate specificity of human alkyladenine DNA glycosylase, kinetics of excision and DNA binding activities were measured for several different damaged and undamaged purines within identical DNA sequence contexts. We found that 1,N-6-ethenoadenine (epsilonA) and hypoxanthine (Hx) were excised relatively efficiently, whereas 7,8-dihydro-8-oxoguanine, O-6-methylguanine, adenine, and guanine were not. Single-turnover kinetics of excision of Hx and epsilonA paired with T showed that excision of Hx was about four times faster than epsilonA whereas binding assays showed that the binding affinity was about five times greater for epsilonA than for fix, The opposing pyrimidine base had a significant effect on the kinetics of excision and DNA binding affinity of Hx but a small effect on those for EA. Surprisingly, replacing a T with a U opposite Hx dramatically reduced the excision rate by a factor of 15 and increased the affinity by a factor of 7-8, The binding affinity of human alkyladenine DNA glycosylase to a DNA product containing an abasic site was similar to that for an Hx lesion.	Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	State University System of Florida; University of Florida; Harvard University; Harvard Medical School	Bloom, LB (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.		Bloom, Linda B/F-3684-2014	Lau, Albert/0000-0002-0967-7558				Asaeda A, 2000, BIOCHEMISTRY-US, V39, P1959, DOI 10.1021/bi9917075; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; BESSHO T, 1993, P NATL ACAD SCI USA, V90, P8901, DOI 10.1073/pnas.90.19.8901; CHAKRAVARTI D, 1991, J BIOL CHEM, V266, P15710; DOSANJH MK, 1994, BIOCHEMISTRY-US, V33, P1624, DOI 10.1021/bi00173a002; DOSANJH MK, 1994, P NATL ACAD SCI USA, V91, P1024, DOI 10.1073/pnas.91.3.1024; Fasman GD., 1975, HDB BIOCH MOL BIOL N, V1, P589; Hollis T, 2000, MUTAT RES-DNA REPAIR, V460, P201, DOI 10.1016/S0921-8777(00)00027-6; Kartalou M, 2000, BIOCHEMISTRY-US, V39, P8032, DOI 10.1021/bi000417h; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1820, DOI 10.1021/bi00221a014; Labahn J, 1996, CELL, V86, P321, DOI 10.1016/S0092-8674(00)80103-8; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Miao F, 1998, NUCLEIC ACIDS RES, V26, P4034, DOI 10.1093/nar/26.17.4034; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; Mol CD, 1999, ANNU REV BIOPH BIOM, V28, P101, DOI 10.1146/annurev.biophys.28.1.101; OCONNOR TR, 1993, NUCLEIC ACIDS RES, V21, P5561; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Petronzelli F, 2000, J BIOL CHEM, V275, P32422, DOI 10.1074/jbc.M004535200; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Roy R, 1998, BIOCHEMISTRY-US, V37, P580, DOI 10.1021/bi972313l; Roy R, 1996, CARCINOGENESIS, V17, P2177, DOI 10.1093/carcin/17.10.2177; SAMSON L, 1991, P NATL ACAD SCI USA, V88, P9127, DOI 10.1073/pnas.88.20.9127; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; SAPARBAEV M, 1994, P NATL ACAD SCI USA, V91, P5873, DOI 10.1073/pnas.91.13.5873; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; SECRIST JA, 1972, BIOCHEMISTRY-US, V11, P3499, DOI 10.1021/bi00769a001; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Wyatt MD, 2000, CARCINOGENESIS, V21, P901, DOI 10.1093/carcin/21.5.901; Yamagata Y, 1996, CELL, V86, P311, DOI 10.1016/S0092-8674(00)80102-6	34	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13379	13387		10.1074/jbc.M010641200	http://dx.doi.org/10.1074/jbc.M010641200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278716	hybrid			2022-12-27	WOS:000168198600125
J	Chen, S; Liang, MC; Chia, JN; Ngsee, JK; Ting, AE				Chen, S; Liang, MC; Chia, JN; Ngsee, JK; Ting, AE			Rab8b and its interacting partner TRIP8b are involved in regulated secretion in AtT20 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; ATT-20 CELLS; PTS1 RECEPTOR; TPR DOMAIN; ALPHA-PAK; MEMBRANE; ACTH; EXPRESSION; TRANSPORT; COMPLEX	Rab proteins are a family of small GTPases that regulate intracellular vesicle traffic. Rab8b, because of its homology with Rab8, has been suggested to function in vesicle transport to the plasma membrane. Using the yeast two-hybrid system, we identified a Rab8b interacting clone, termed TRIP8b, from a rat brain cDNA library. The gene encodes a 66-kDa protein with homology to the peroxisomal targeting signal 1 receptor. The interaction between Rab8b and TRIP8b was further verified by in vitro binding assays and co-immunoprecipitation studies. Additional experiments with Rab8b mutants demonstrated that Rab8b requires a guanine nucleotide but not prenylation for its interaction with TRIP8b. Western immunoblot analysis showed that TRIP8b was primarily expressed in brain. Subcellular fractionation of AtT20 cells revealed that TRIP8b was present in both cytosolic and membrane fractions. To investigate the function of Rab8b and TRIP8b in secretion, we examined the release of ACTH from AtT20 cells, Results from stable cell lines expressing Rab8b or TRIP8b indicated that both proteins had a stimulatory effect on cAMP-induced secretion of ACTH. In summary, these data suggest that Rab8b and TRIP8b interact with each other and are involved in the regulated secretory pathway in AtT20 cells.	Inst Mol & Cell Biol, Singapore 117609, Singapore; Univ Ottawa, Loeb Hlth Res Inst, Dept Biochem, Ottawa, ON K1Y 4E9, Canada	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Ottawa; Ottawa Hospital Research Institute	Ting, AE (corresponding author), Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.			Liang, Mui Cheng/0000-0003-1208-0733; Ting, Anthony/0000-0002-5058-9576				Armstrong J, 1996, J CELL SCI, V109, P1265; Baldini G, 1998, J CELL BIOL, V140, P305, DOI 10.1083/jcb.140.2.305; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Dumermuth E, 1998, METHODS, V16, P188, DOI 10.1006/meth.1998.0666; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; HUBER LA, 1995, MOL CELL BIOL, V15, P918; Hutt DM, 2000, J BIOL CHEM, V275, P18511, DOI 10.1074/jbc.M909309199; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; KINSELLA BT, 1991, J BIOL CHEM, V266, P8540; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Mains RE, 1999, J BIOL CHEM, V274, P2929, DOI 10.1074/jbc.274.5.2929; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Martincic I, 1997, J BIOL CHEM, V272, P26991, DOI 10.1074/jbc.272.43.26991; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; MATSUUCHI L, 1991, J CELL BIOL, V112, P843, DOI 10.1083/jcb.112.5.843; MATSUUCHI L, 1988, J CELL BIOL, V106, P239, DOI 10.1083/jcb.106.2.239; MOORE HP, 1983, NATURE, V302, P434, DOI 10.1038/302434a0; NGSEE JK, 1993, MOL BIOL CELL, V4, P747, DOI 10.1091/mbc.4.7.747; Olkkonen VM, 1997, INT REV CYTOL, V176, P1, DOI 10.1016/S0074-7696(08)61608-3; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Ponting CCP, 1996, BIOCHEM J, V314, P1053, DOI 10.1042/bj3141053; Ren MD, 1996, P NATL ACAD SCI USA, V93, P5151, DOI 10.1073/pnas.93.10.5151; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; SCHNABEL E, 1989, MOL ENDOCRINOL, V3, P1223, DOI 10.1210/mend-3-8-1223; TAKAI Y, 1993, CIBA F SYMP, V176, P128; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	42	54	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13209	13216		10.1074/jbc.M010798200	http://dx.doi.org/10.1074/jbc.M010798200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278749	hybrid			2022-12-27	WOS:000168198600103
J	Porsch-Ozcurumez, M; Langmann, T; Heimerl, S; Borsukova, H; Kaminski, WE; Drobnik, W; Honer, C; Schumacher, C; Schmitz, G				Porsch-Ozcurumez, M; Langmann, T; Heimerl, S; Borsukova, H; Kaminski, WE; Drobnik, W; Honer, C; Schumacher, C; Schmitz, G			The zinc finger protein 202 (ZNF202) is a transcriptional repressor of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANGIER-DISEASE PATIENTS; DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX; MOLECULAR-CLONING; PLASMA-MEMBRANE; APOA-I; PROMOTER; DOMAIN; COREPRESSOR; MACROPHAGES	The zinc finger gene 202 (ZNF202) located within a hypoalphalipoproteinemia susceptibility locus on chromosome 11q23 is a transcriptional repressor of various genes involved in lipid metabolism. To provide further evidence for a functional linkage between ZNF202 and hypoalphalipoproteinemia, we investigated the effect of ZNF202 expression on ATP binding cassette transporter A1 (ABCA1) and ABCG1, ABCA1 is a key regulator of the plasma high density lipoprotein pool size, whereas ABCG1 is another mediator of cellular cholesterol and phospholipid efflux in human macrophage. We demonstrate here that the full-length ZNF202m1 isoform binds to GnT repeats within the promoters of ABCA1 (-229/ -210) and ABCG1 (-572/-552), ZNF202m1 expression in HepG2 cells dose-dependently repressed the promotor activities of ABCA1 and ABCG1, This transcriptional effect required the presence of the SCAN domain in ZNF202 and the functional integrity of a TATA box at position -24 of ABCA1, whereas the presence of GnT binding motifs was nonessential. The state of ZNF202 SCAN domain oligomerization affected the ability of the adjacent ZNF202 Kruppel-associated box domain to recruit the transcriptional corepressor KAP1, Overexpression of ZNF202m1 in RAW264.7 macrophages prevented the induction of ABCA1 gene expression by 20(S)OH-cholesterol and 9-cis-retinoic acid, further substantiating the interference of ZNF202 in critical elements of transcriptional activation, Finally, HDL and apoAI-mediated lipid efflux was significantly reduced in RAW264.7 cells stably expressing ZNF202m1, In conclusion, we have identified ABCA1 and ABCG1 as target genes for ZNF202-mediated repression and thus, provide evidence for a functional linkage between ZNF202 and hypoalphalipoproteinemia.	Univ Regensburg, Inst Clin Chem, D-8400 Regensburg, Germany; Novartis Inst Biomed Res, Summit, NJ 07901 USA	University of Regensburg; Novartis	Schmitz, G (corresponding author), Univ Klinikum Regensburg, Inst Klin Chem & Blutbank, Franz Josef Strauss Allee 11, D-93042 Regensburg, Germany.		Özcürümez, Mustafa K./GRS-4840-2022; Langmann, Thomas/HHZ-9814-2022; Özcürümez, Mustafa/AAQ-3250-2021	Özcürümez, Mustafa K./0000-0002-4360-5005; Langmann, Thomas/0000-0001-6826-529X; Özcürümez, Mustafa/0000-0002-4360-5005; Schmitz, Gerd/0000-0002-1325-1007				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BHAKDI S, 1995, J EXP MED, V182, P1959, DOI 10.1084/jem.182.6.1959; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Costet P, 2000, J BIOL CHEM, V275, P28240; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Funke H, 1997, CURR OPIN LIPIDOL, V8, P189, DOI 10.1097/00041433-199706000-00010; Honer C, 2001, BBA-GENE STRUCT EXPR, V1517, P441, DOI 10.1016/S0167-4781(00)00274-8; Kardassis D, 1996, HYPERTENSION, V27, P980, DOI 10.1161/01.HYP.27.4.980; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Langmann T, 2000, BBA-GENE STRUCT EXPR, V1494, P175, DOI 10.1016/S0167-4781(00)00215-3; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Monaco C, 1998, GENOMICS, V52, P358, DOI 10.1006/geno.1998.5419; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; PENGUE G, 1994, NUCLEIC ACIDS RES, V22, P2908, DOI 10.1093/nar/22.15.2908; Pengue G, 1996, P NATL ACAD SCI USA, V93, P1015, DOI 10.1073/pnas.93.3.1015; Repa JJ, 1999, CURR OPIN BIOTECH, V10, P557, DOI 10.1016/S0958-1669(99)00031-2; ROGLER G, 1995, ARTERIOSCL THROM VAS, V15, P683, DOI 10.1161/01.ATV.15.5.683; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Schumacher C, 2000, J BIOL CHEM, V275, P17173, DOI 10.1074/jbc.M000119200; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Wagner S, 2000, J BIOL CHEM, V275, P15685, DOI 10.1074/jbc.M910152199; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; WILLIAMS SC, 1986, MOL CELL BIOL, V6, P3807, DOI 10.1128/MCB.6.11.3807	26	82	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12427	12433		10.1074/jbc.M100218200	http://dx.doi.org/10.1074/jbc.M100218200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11279031	hybrid			2022-12-27	WOS:000168081800131
J	Cipollo, JF; Trimble, RB; Chi, JH; Yan, Q; Dean, N				Cipollo, JF; Trimble, RB; Chi, JH; Yan, Q; Dean, N			The yeast ALG11 gene specifies addition of the terminal alpha 1,2-Man to the Man(5)GlcNAc(2)-PP-dolichol N-glycosylation intermediate formed on the cytosolic side of the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; MAGNETIC-RESONANCE SPECTROSCOPY; SACCHAROMYCES-CEREVISIAE ENCODES; GLYCOPROTEIN-BIOSYNTHESIS; PROTEIN GLYCOSYLATION; H-1-NMR SPECTROSCOPY; MUTANTS DEFICIENT; HIGH-RESOLUTION; HIGH MANNOSE; OUTER CHAIN	The initial steps in N-linked glycosylation involve the synthesis of a lipid-linked core oligosaccharide followed by the transfer of the core glycan to nascent polypeptides in the endoplasmic reticulum (ER). Here, we describe alg11, a new yeast glycosylation mutant that is defective in the last step of the synthesis of the Man(5)GlcNAc(2)-PP-dolichol core oligosaccharide on the cytosolic face of the ER. A deletion of the ALG11 gene leads to poor growth and temperature-sensitive lethality. In an alg11 lesion, both Man(3)GlcNAc(2)-PP-dolichol and Man(4)GlcNAc(2)-PP-dolichol are translocated into the ER lumen as substrates for the Man-P-dolichol-dependent sugar transferases in this compartment. This leads to a unique family of oligosaccharide structures lacking one or both of the lower arm alpha1,2-linked Man residues. The former are elongated to mannan, whereas the latter are poor substrates for outerchain initiation by Ochlp (Nakayama, K.-I., Nakanishi-Shindo, Y., Tanaka, A, Haga-Toda, Y,, and Jigami, Y. (1997) FEES Lett. 412, 547-550) and accumulate largely as truncated biosynthetic end products. The ALG11 gene is predicted to encode a 63.1-kDa membrane protein that by indirect immunofluorescence resides in the ER. The Alg11 protein is highly conserved, with homologs in fission yeast, worms, flies, and plants. In addition to these Alg11-related proteins, Alg11p is also similar to Alg2p, a protein that regulates the addition of the third mannose to the core oligosaccharide. All of these Alg11-related proteins share a 23-amino acid sequence that is found in over 60 proteins from bacteria to man whose function is in sugar metabolism, implicating this sequence as a potential sugar nucleotide binding motif.	SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA; New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center	Dean, N (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA.	ndean@notes.cc.sunysb.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048467, R01GM033184, R01GM023900] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48467, GM33184, GM23900] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; ALBRIGHT CF, 1990, J BIOL CHEM, V265, P7042; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BALLOU CE, 1990, METHOD ENZYMOL, V185, P440; BALLOU L, 1991, P NATL ACAD SCI USA, V88, P3209, DOI 10.1073/pnas.88.8.3209; BEARDEN JC, 1978, BIOCHIM BIOPHYS ACTA, V533, P525, DOI 10.1016/0005-2795(78)90398-7; BRISSON JR, 1983, BIOCHEMISTRY-US, V22, P3680, DOI 10.1021/bi00284a022; Burda P, 1998, GLYCOBIOLOGY, V8, P455, DOI 10.1093/glycob/8.5.455; Burda P, 1996, P NATL ACAD SCI USA, V93, P7160, DOI 10.1073/pnas.93.14.7160; BYRD JC, 1982, J BIOL CHEM, V257, P4657; CARVER JP, 1981, BIOCHEMISTRY-US, V20, P6607, DOI 10.1021/bi00526a014; Chi JH, 1996, J BIOL CHEM, V271, P3132, DOI 10.1074/jbc.271.6.3132; Cipollo JF, 2000, J BIOL CHEM, V275, P4267, DOI 10.1074/jbc.275.6.4267; Cipollo JF, 2000, ANAL BIOCHEM, V278, P52, DOI 10.1006/abio.1999.4414; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; COHEN RE, 1980, BIOCHEMISTRY-US, V19, P4345, DOI 10.1021/bi00559a031; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; DEAN N, 1995, P NATL ACAD SCI USA, V92, P1287, DOI 10.1073/pnas.92.5.1287; DORLAND L, 1981, J BIOL CHEM, V256, P7708; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; HELLER L, 1992, P NATL ACAD SCI USA, V89, P7013, DOI 10.1073/pnas.89.15.7013; HERNANDEZ LM, 1989, J BIOL CHEM, V264, P13648; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; HUFFAKER TC, 1982, J BIOL CHEM, V257, P3203; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACKSON BJ, 1993, GLYCOBIOLOGY, V3, P357, DOI 10.1093/glycob/3.4.357; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; KEPES F, 1988, J BIOL CHEM, V263, P9155; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; LEHLE L, 1980, EUR J BIOCHEM, V109, P589, DOI 10.1111/j.1432-1033.1980.tb04832.x; Lehle L., 1995, GLYCOPROTEINS A, V29a, P475; Lussier M, 1996, J BIOL CHEM, V271, P11001, DOI 10.1074/jbc.271.18.11001; NAKANISHISHINDO Y, 1993, J BIOL CHEM, V268, P26338; Nakayama K, 1997, FEBS LETT, V412, P547, DOI 10.1016/S0014-5793(97)00634-0; Neiman AM, 1997, GENETICS, V145, P637; ORLEAN P, 1988, J BIOL CHEM, V263, P17499; Poster JB, 1996, J BIOL CHEM, V271, P3837; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Reiss G, 1996, GLYCOBIOLOGY, V6, P493, DOI 10.1093/glycob/6.5.493; Romero PA, 1999, GLYCOBIOLOGY, V9, P1045, DOI 10.1093/glycob/9.10.1045; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; STAGLJAR I, 1994, P NATL ACAD SCI USA, V91, P5977, DOI 10.1073/pnas.91.13.5977; STANLEY P, 1988, J BIOL CHEM, V263, P11374; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; TEHEESEN S, 1994, EUR J BIOCHEM, V224, P71, DOI 10.1111/j.1432-1033.1994.tb19996.x; TRIMBLE RB, 1991, J BIOL CHEM, V266, P22807; TRIMBLE RB, 1980, J BIOL CHEM, V255, P232; TRIMBLE RB, 1986, J BIOL CHEM, V261, P9815; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; TRIMBLE RB, 1980, J BIOL CHEM, V255, P1892; TRIMBLE RB, 1992, GLYCOBIOLOGY, V2, P57, DOI 10.1093/glycob/2.1.57; TRIMBLE RB, 1983, J BIOL CHEM, V258, P2562; TRUMBLY RJ, 1985, J BIOL CHEM, V260, P5683; TURCO SJ, 1977, P NATL ACAD SCI USA, V74, P4411, DOI 10.1073/pnas.74.10.4411; Umeda K, 2000, YEAST, V16, P1261, DOI 10.1002/1097-0061(200010)16:14<1261::AID-YEA620>3.0.CO;2-9; Verostek MF, 2000, ANAL BIOCHEM, V278, P111, DOI 10.1006/abio.1999.4433; VEROSTEK MF, 1993, J BIOL CHEM, V268, P12104; VEROSTEK MF, 1993, J BIOL CHEM, V268, P12095; VEROSTEK MF, 1995, GLYCOBIOLOGY, V5, P671, DOI 10.1093/glycob/5.7.671; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; WINNIK FM, 1982, J ORG CHEM, V47, P2701, DOI 10.1021/jo00135a004; ZIEGLER F D, 1991, Glycobiology, V1, P605, DOI 10.1093/glycob/1.6.605	72	54	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21828	21840		10.1074/jbc.M010896200	http://dx.doi.org/10.1074/jbc.M010896200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11278778	hybrid			2022-12-27	WOS:000169297900134
J	Pirola, L; Zvelebil, MJ; Bulgarelli-Leva, G; Van Obberghen, E; Waterfield, MD; Wymann, MP				Pirola, L; Zvelebil, MJ; Bulgarelli-Leva, G; Van Obberghen, E; Waterfield, MD; Wymann, MP			Activation loop sequences confer substrate specificity to phosphoinositide 3-kinase alpha (PI3K alpha) - Functions of lipid kinase-deficient PI3K alpha in signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; HUMAN PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-KINASE; C2 DOMAIN; SERINE KINASE; GROWTH-FACTOR; FYVE DOMAIN; HUMAN-NEUTROPHILS; HUMAN PLATELETS; WORTMANNIN	Phosphoinositide 3-kinases (PI3Ks) are dual specificity lipid and protein kinases. While the lipid-dependent PI3K downstream signaling is well characterized, little is known about PI3K protein kinase signaling and structural determinants of lipid substrate specificity across the various PI3K classes. Here we show that sequences C-terminal to the PI3K ATP-binding site determine the lipid substrate specificity of the class IA PI3K alpha (p85/p110 alpha). Transfer of such activation loop sequences from class II PI3Ks, class III PI3Ks, and a related mammalian target of rapamycin (FRaP) into p110 alpha turns the lipid substrate specificity of the resulting hybrid protein into that of the donor protein, while leaving the protein kinase activity unaffected. All resulting hybrids lacked the ability to produce phosphatidylinositol 3,4,5-trisphosphate in intact cells. Amino acid substitutions and structure modeling showed that two conserved positively charged (Lys and Arg) residues in the activation loop are crucial for the functionality of class I PI3Ks as phosphatidylinositol 4,5-bisphosphate kinases. By transient transfecion of 293 cells, we show that p110 alpha hybrids, although unable to support lipid-dependent PI3K signaling, such as activation of protein kinase B/Akt and p70(S6k), retain the capability to associate with and phosphorylate insulin receptor substrate-1, with the same specificity and higher efficacy than wild type PI3K alpha. Our data lay the basis for the understanding of the class I PI3K substrate selectivity and for the use of PI3K alpha hybrids to dissect PI3K alpha function as lipid and protein kinase.	Univ Fribourg, Inst Biochem, CH-1700 Fribourg, Switzerland; Ludwig Inst Canc Res, London W1W 7BS, England; Fac Med Nice, IFR 50, INSERM, U145, F-06107 Nice 2, France; UCL, Dept Biochem & Mol Biol, London WCE 6BT, England	University of Fribourg; Ludwig Institute for Cancer Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of London; University College London	Wymann, MP (corresponding author), Univ Fribourg, Inst Biochem, Rue Musee 5, CH-1700 Fribourg, Switzerland.	MatthiasPaul.Wymann@UniFR.ch	Wymann, Matthias P/C-3227-2008; Pirola, Luciano/I-5250-2018	Wymann, Matthias P/0000-0003-3349-4281; Zvelebil, Marketa/0000-0001-8018-5591; Pirola, Luciano/0000-0001-6539-5435				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Arcaro A, 1998, J BIOL CHEM, V273, P33082, DOI 10.1074/jbc.273.49.33082; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brown RA, 1997, BIOCHEM BIOPH RES CO, V233, P537, DOI 10.1006/bbrc.1997.6495; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gual P, 1998, ENDOCRINOLOGY, V139, P884, DOI 10.1210/en.139.3.884; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; HU P, 1993, MOL CELL BIOL, V13, P7677, DOI 10.1128/MCB.13.12.7677; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KELLER SR, 1993, BIOCHIM BIOPHYS ACTA, V1172, P323, DOI 10.1016/0167-4781(93)90222-Y; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Klippel A, 1996, MOL CELL BIOL, V16, P4117; KUCERA GL, 1990, J BIOL CHEM, V265, P5345; Kular G, 1997, BIOCHEM J, V325, P299, DOI 10.1042/bj3250299; Kunz J, 2000, MOL CELL, V5, P1, DOI 10.1016/S1097-2765(00)80398-6; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; LAM K, 1994, J BIOL CHEM, V269, P20648; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Macdougall LK, 1995, CURR BIOL, V5, P1404, DOI 10.1016/S0960-9822(95)00278-8; Misawa H, 1998, BIOCHEM BIOPH RES CO, V244, P531, DOI 10.1006/bbrc.1998.8294; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Molz L, 1996, J BIOL CHEM, V271, P13892, DOI 10.1074/jbc.271.23.13892; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; NOLAN RD, 1991, BIOCHEM BIOPH RES CO, V174, P524, DOI 10.1016/0006-291X(91)91448-L; Paz K, 1999, J BIOL CHEM, V274, P28816, DOI 10.1074/jbc.274.40.28816; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; SIMOES AP, 1995, BIOCHEMISTRY-US, V34, P5113, DOI 10.1021/bi00015a023; STACK JH, 1994, J BIOL CHEM, V269, P31552; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Stoyanova S, 1997, BIOCHEM J, V324, P489, DOI 10.1042/bj3240489; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAYNORKAPLAN AE, 1989, J BIOL CHEM, V264, P15668; Uddin S, 1997, J IMMUNOL, V158, P2390; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 1999, EMBO J, V18, P1292, DOI 10.1093/emboj/18.5.1292; Virbasius JV, 1996, J BIOL CHEM, V271, P13304, DOI 10.1074/jbc.271.23.13304; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; YU FX, 1992, J BIOL CHEM, V267, P14616; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8	76	77	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21544	21554		10.1074/jbc.M011330200	http://dx.doi.org/10.1074/jbc.M011330200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11278889	hybrid			2022-12-27	WOS:000169297900100
J	Albert, T; Wells, J; Funk, JO; Pullner, A; Raschke, EE; Stelzer, G; Meisterernst, I; Farnham, PJ; Eick, D				Albert, T; Wells, J; Funk, JO; Pullner, A; Raschke, EE; Stelzer, G; Meisterernst, I; Farnham, PJ; Eick, D			The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ZINC-FINGER PROTEIN; TARGET GENE SPECIFICITY; YEAST SWI/SNF COMPLEX; TRANSCRIPTIONAL REPRESSION; PREMATURE TERMINATION; REMODELING COMPLEX; FAMILY PROTEINS; HISTONE OCTAMER; BINDING SITE	The proto-oncogene c-myc is transcribed from a dual promoter P1/P2, with transcription initiation sites 160 base pairs apart. Here we have studied the transcriptional activation of both promoters on chromatin templates, c-myc chromatin was reconstituted on stably transfected, episomal, Epstein-Barr virus-derived vectors in a B cell line. Episomal P1 and P2 promoters showed only basal activity but were strongly inducible by histone deacetylase inhibitors. The effect of promoter mutations on c-myc activity, chromatin structure, and E2F binding was studied, The ME1a1 binding site between PI and P2 was required for the maintenance of an open chromatin configuration of the dual c-myc promoters. Mutation of this site strongly reduced the sensitivity of the core promoter region of P1/P2 to micrococcal nuclease and prevented binding of polymerase II (pol II) at the P2 promoter, In contrast, mutation of the P2 TATA box also abolished binding of pol II at the P2 promoter but did not affect the chromatin structure of the P1/P2 core promoter region. The E2F binding site adjacent to ME1a1 is required for repression of the P2 promoter but not the p1 promoter, likely by recruitment of histone deacetylase activity. Chromatin precipitation experiments with E2F-specific antibodies revealed binding of E2F-1, E2F-2, and E2F-4 to the E2F site of the c-myc promoter in vivo if the E2F site was intact. Taken together, the analyses support a model with a functional hierarchy for regulatory elements in the c-myc promoter region; binding of proteins to the ME1a1 site provides a nncleosome-free region of chromatin near the P2 start site, binding of E2F results in transcriptional repression without affecting polymerase recruitment, and the TATA box is required for polymerase recruitment.	GSF Munich, Res Ctr Environm & Hlth, Inst Clin Mol Biol & Tumor Genet, D-81377 Munich, Germany; GSF Munich, Res Ctr Environm & Hlth, Dept Prot Chem, D-81377 Munich, Germany; Univ Wisconsin, Sch Med, Mcardle Lab Canc Res, Madison, WI 53706 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Wisconsin System; University of Wisconsin Madison	Eick, D (corresponding author), GSF Munich, Res Ctr Environm & Hlth, Inst Clin Mol Biol & Tumor Genet, Marchioninistr 25, D-81377 Munich, Germany.	eick@gsf.de		Albert, Thomas Karl/0000-0002-2488-0706; Farnham, Peggy/0000-0003-4469-7914				Albert T, 1997, MOL CELL BIOL, V17, P4363, DOI 10.1128/MCB.17.8.4363; Bazett-Jones DP, 1999, MOL CELL BIOL, V19, P1470; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; DESJARDINS E, 1993, MOL CELL BIOL, V13, P5710, DOI 10.1128/MCB.13.9.5710; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; DUFORT D, 1994, MOL CELL BIOL, V14, P4251, DOI 10.1128/MCB.14.6.4251; DUNCAN DD, 1995, MOL CELL BIOL, V15, P3179; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; Facchini LM, 1997, MOL CELL BIOL, V17, P100, DOI 10.1128/MCB.17.1.100; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x; Geltinger C, 1996, GENE EXPRESSION, V6, P113; HAMEL PA, 1992, MOL CELL BIOL, V12, P3431, DOI 10.1128/MCB.12.8.3431; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Komatsu M, 1997, ONCOGENE, V15, P1123, DOI 10.1038/sj.onc.1201283; Krumm A, 1998, P NATL ACAD SCI USA, V95, P13501, DOI 10.1073/pnas.95.23.13501; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; LAVENU A, 1995, MOL CELL BIOL, V15, P4410; Levens D, 1997, CURR TOP MICROBIOL, V224, P33; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Lutz M, 2000, NUCLEIC ACIDS RES, V28, P1707, DOI 10.1093/nar/28.8.1707; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; MEULIA T, 1992, MOL CELL BIOL, V12, P4590, DOI 10.1128/MCB.12.10.4590; MOBERG KH, 1992, ONCOGENE, V7, P411; OSWALD F, 1994, ONCOGENE, V9, P2029; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; PLET A, 1995, ONCOGENE, V10, P319; Pullner A, 1996, J BIOL CHEM, V271, P31452, DOI 10.1074/jbc.271.49.31452; Raschke EE, 1999, J IMMUNOL, V163, P4375; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; ROUSSEL MF, 1994, ONCOGENE, V9, P405; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SINGH P, 1994, EMBO J, V13, P3329, DOI 10.1002/j.1460-2075.1994.tb06635.x; SPENCER CA, 1991, ADV CANCER RES, V56, P1; STROBL LJ, 1993, ONCOGENE, V8, P1437; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Takahashi Y, 2000, GENE DEV, V14, P804; Uchida S, 2000, MOL CELL BIOL, V20, P7319, DOI 10.1128/MCB.20.19.7319-7331.2000; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; WOLF DA, 1995, NUCLEIC ACIDS RES, V23, P3373, DOI 10.1093/nar/23.17.3373; Xie J, 2000, EMBO J, V19, P672, DOI 10.1093/emboj/19.4.672; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4	52	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20482	20490		10.1074/jbc.M100265200	http://dx.doi.org/10.1074/jbc.M100265200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279041	hybrid			2022-12-27	WOS:000169135100109
J	Laniel, MA; Poirier, GG; Guerin, SL				Laniel, MA; Poirier, GG; Guerin, SL			Nuclear factor 1 interferes with Sp1 binding through a composite element on the rat poly(ADP-ribose) polymerase promoter to modulate its activity in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LEVELS; ADRENERGIC-RECEPTOR GENE; HUMAN GROWTH-HORMONE; TRANSCRIPTIONAL REGULATION; DOWN-REGULATION; DNA-REPLICATION; EXPRESSION; DIFFERENTIATION; ACTIVATION; PROTEINS	Poly(ADP-ribose) polymerase-1 (PARP-1) catalyzes the rapid and extensive poIy(ADP-ribosyl)ation of nuclear proteins in response to DNA strand breaks, and its expression, although ubiquitous, is modulated from tissue to tissue and during cellular differentiation. PARP-1 gene promoters from human, rat, and mouse have been cloned, and they share a structure common to housekeeping genes, as they lack a functional TATA box and contain multiple GC boxes, which bind the transcriptional activator Sp1. We have previously shown that, although Spl is important for rat PARP1 (rPARP) promoter activity, its finely tuned modulation is likely dependent on other transcription factors that bind the rPARP proximal promoter in vitro. In this study, we identified one such factor as NF1-L, a rat Liver isoform of the nuclear factor 1 family of transcription factors. The NF1-L site on the rPARP promoter overlaps one of the Spl binding sites previously identified, and we demonstrated that binding of both factors to this composite element is mutually exclusive. Furthermore, me provide evidence that NF1-L has no effect by itself on rPARP promoter activity, but rather down-regulates the Spl activity by interfering with its ability to bind the rPARP promoter in order to modulate transcription of the rPARP gene.	CHU Laval, Res Ctr, Oncol & Mol Endocrinol Res Ctr, Ste Foy, PQ G1V 4G2, Canada; CHU Laval, Res Ctr, Unit Hlth & Environm, Ste Foy, PQ G1V 4G2, Canada	Laval University; Laval University	Guerin, SL (corresponding author), CHU Laval, Res Ctr, Oncol & Mol Endocrinol Res Ctr, Ste Foy, PQ G1V 4G2, Canada.	sylvain.guerin@crchul.ulaval.ca		Poirier, Guy/0000-0002-4869-1424; Guerin, Sylvain/0000-0002-6767-5833				ADAMS AD, 1995, J BIOL CHEM, V270, P6975, DOI 10.1074/jbc.270.12.6975; Alroy I, 1999, MOL CELL BIOL, V19, P1961; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Bergeron MJ, 1997, EUR J BIOCHEM, V250, P342, DOI 10.1111/j.1432-1033.1997.0342a.x; BHATIA K, 1990, J CELL PHYSIOL, V144, P345, DOI 10.1002/jcp.1041440221; BHATIA M, 1995, BIOCHEM J, V308, P131, DOI 10.1042/bj3080131; CESARONE CF, 1990, BIOCHIM BIOPHYS ACTA, V1087, P241, DOI 10.1016/0167-4781(90)90211-J; CHABERT MG, 1992, BIOCHIM BIOPHYS ACTA, V1136, P196, DOI 10.1016/0167-4889(92)90257-C; Chan H, 1999, MOL CELL BIOL, V19, P2098, DOI 10.1128/mcb.19.3.2098; Chen JP, 1997, J BIOL CHEM, V272, P23144, DOI 10.1074/jbc.272.37.23144; Chen TT, 1997, MOL CELL BIOL, V17, P3056, DOI 10.1128/MCB.17.6.3056; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; COURTOIS SJ, 1990, NUCLEIC ACIDS RES, V18, P57, DOI 10.1093/nar/18.1.57; das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946; DEMURCIA G, 1988, BIOCHEM CELL BIOL, V66, P626, DOI 10.1139/o88-072; DEVRIES E, 1987, EMBO J, V6, P161, DOI 10.1002/j.1460-2075.1987.tb04734.x; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; FARZANEH F, 1982, NATURE, V300, P362, DOI 10.1038/300362a0; Gao B, 1998, J BIOL CHEM, V273, P31784, DOI 10.1074/jbc.273.48.31784; Gao B, 1996, MOL CELL BIOL, V16, P5997; GIL G, 1988, P NATL ACAD SCI USA, V85, P8963, DOI 10.1073/pnas.85.23.8963; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAVES RA, 1991, GENE DEV, V5, P428, DOI 10.1101/gad.5.3.428; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; GUERIN SL, 1988, MOL ENDOCRINOL, V2, P1101, DOI 10.1210/mend-2-11-1101; HARVEY M, 1993, BIOTECHNIQUES, V14, P942; Herceg Z, 1999, MOL CELL BIOL, V19, P5124; JOHNSTONE AP, 1982, NATURE, V300, P368, DOI 10.1038/300368a0; KAMESHITA I, 1984, J BIOL CHEM, V259, P4770; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; KEL OV, 1995, NUCLEIC ACIDS RES, V23, P4097, DOI 10.1093/nar/23.20.4097; KRUSE U, 1994, FEBS LETT, V348, P46, DOI 10.1016/0014-5793(94)00585-0; Laniel MA, 2000, METH MOL B, V148, P13; Laniel MA, 1997, BIOCHEM CELL BIOL, V75, P427, DOI 10.1139/bcb-75-4-427; LAUTIER D, 1993, MOL CELL BIOCHEM, V122, P171, DOI 10.1007/BF01076101; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; MCNERNEY R, 1989, BIOCHIM BIOPHYS ACTA, V1009, P185, DOI 10.1016/0167-4781(89)90099-7; Meisterernst M, 1997, P NATL ACAD SCI USA, V94, P2261, DOI 10.1073/pnas.94.6.2261; MENEGAZZI M, 1988, BIOCHEM BIOPH RES CO, V156, P995, DOI 10.1016/S0006-291X(88)80942-2; MENEGAZZI M, 1992, FEBS LETT, V297, P59, DOI 10.1016/0014-5793(92)80327-D; MENEGAZZI M, 1991, EXP CELL RES, V197, P66, DOI 10.1016/0014-4827(91)90480-I; Morrison C, 1997, NAT GENET, V17, P479, DOI 10.1038/ng1297-479; NEHLS MC, 1991, MOL CELL BIOL, V11, P4065, DOI 10.1128/MCB.11.8.4065; Oei SL, 1997, BIOCHEM BIOPH RES CO, V240, P108, DOI 10.1006/bbrc.1997.7621; OGURA T, 1990, BIOCHEM BIOPH RES CO, V172, P377, DOI 10.1016/0006-291X(90)90683-E; OGURA T, 1990, BIOCHEM BIOPH RES CO, V167, P701, DOI 10.1016/0006-291X(90)92082-B; Osada S, 1999, BIOCHEM J, V342, P189, DOI 10.1042/0264-6021:3420189; Pacini A, 1999, J BIOL CHEM, V274, P35107, DOI 10.1074/jbc.274.49.35107; PAONESSA G, 1988, EMBO J, V7, P3115, DOI 10.1002/j.1460-2075.1988.tb03178.x; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; POTHIER F, 1992, DNA CELL BIOL, V11, P83, DOI 10.1089/dna.1992.11.83; POTVIN F, 1993, EUR J BIOCHEM, V215, P73, DOI 10.1111/j.1432-1033.1993.tb18008.x; POTVIN F, 1992, FEBS LETT, V302, P269, DOI 10.1016/0014-5793(92)80457-R; PRASAD SC, 1990, CANCER RES, V50, P38; ROY RJ, 1991, BIOTECHNIQUES, V11, P770; ROY RJ, 1992, NUCLEIC ACIDS RES, V20, P401, DOI 10.1093/nar/20.3.401; ROY RJ, 1994, EUR J BIOCHEM, V219, P799, DOI 10.1111/j.1432-1033.1994.tb18560.x; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Salminen A, 1997, BIOCHEM BIOPH RES CO, V238, P712, DOI 10.1006/bbrc.1997.7371; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SATOH MS, 1993, J BIOL CHEM, V268, P5480; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; Simbulan-Rosenthal CM, 1998, BIOCHEMISTRY-US, V37, P9363, DOI 10.1021/bi9731089; SimbulanRosenthal CM, 1996, BIOCHEMISTRY-US, V35, P11622, DOI 10.1021/bi953010z; SLATTERY E, 1983, J BIOL CHEM, V258, P5955; SMULSON ME, 1995, J BIOL CHEM, V270, P119, DOI 10.1074/jbc.270.1.119; Soldatenkov VA, 1999, ONCOGENE, V18, P3954, DOI 10.1038/sj.onc.1202778; SUZUKI H, 1987, BIOCHEM BIOPH RES CO, V146, P403, DOI 10.1016/0006-291X(87)90543-2; TAKIGUCHI M, 1991, J BIOL CHEM, V266, P9186; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; THIBODEAU J, 1989, BIOCHEM CELL BIOL, V67, P653, DOI 10.1139/o89-097; WEIN KH, 1993, BIOCHIM BIOPHYS ACTA, V1176, P69, DOI 10.1016/0167-4889(93)90179-S; YOKOYAMA Y, 1990, EUR J BIOCHEM, V194, P521, DOI 10.1111/j.1432-1033.1990.tb15647.x; YU CY, 1990, MOL CELL BIOL, V10, P282, DOI 10.1128/MCB.10.1.282	79	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20766	20773		10.1074/jbc.M010360200	http://dx.doi.org/10.1074/jbc.M010360200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278663	hybrid			2022-12-27	WOS:000169135100145
J	You, JX; Pickart, CM				You, JX; Pickart, CM			A HECT domain E3 enzyme assembles novel polyubiquitin chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; MULTIUBIQUITIN CHAIN; CONJUGATING ENZYME; 26S PROTEASOME; ESCHERICHIA-COLI; LYSINE; COMPLEX; P53; E6; IDENTIFICATION	Although polyubiquitin chains linked through Lys(29) of ubiquitin have been implicated in the targeting of certain substrates to proteasomes, the signaling properties of these chains are poorly understood. We previously described a ubiquitin-protein isopeptide ligase (E3) from erythroid cells that assembles polyubiquitin chains through either Lys(29) Or LyS(48) of ubiquitin (Mastrandrea, L. D., You, J., Niles, E. G., and Pickart, C. M. (1999) J. Biol. Chem. 274, 27299-27306). Here we describe the purification of this E3 based on its affinity for a linear fusion of ubiquitin to the ubiquitin conjugating enzyme UbcH5A. Among five major polypeptides in the affinity column eluate, the activity of interest was assigned to the product of a previously cloned human cDNA known as KIAA10 (Nomura, N., Miyajima, N., Sazuka, T., Tanaka, A., Kawarabayasi, Y., Sato, S., Nagase, T., Seki, N., Ishikawa, K., and Tabata, S. (1994) DNA Res. 1, 27-35). The KIAA10 protein is a member of the HECT ((h) under bar omologous to (E) under bar6-AP (c) under bar arboxyl (t) under bar erminus) domain family of E3s. These E3s share a conserved C-terminal (HECT) domain that functions in the catalysis of ubiquitination, while their divergent N-terminal domains function in cognate substrate binding (Huibregtse, J. M., Scheffner, M., Beaudenon, S., and Howley, P. M. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 2563-2567). Recombinant KIAA10 catalyzed the assembly of both Lys(29)- and Lys(48)-linked polyubiquitin chains. Surprisingly, the C-terminal 428 residues of KIAA10 were both necessary and sufficient for this activity, suggesting that the ability to assemble polyubiquitin chains may be a general property of HECT domains. The N-terminal domain of KIAA10 interacted in vitro with purified 26 S proteasomes and with the isolated S2/Rpn1 subunit of the proteasome's 19 S regulatory complex, suggesting that the N-terminal domains of HECT E3s may function in proteasome binding as well as substrate binding.	Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Pickart, CM (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046984] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46984] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aoki T, 1999, BIOCHEM BIOPH RES CO, V261, P911, DOI 10.1006/bbrc.1999.1147; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; GREGORI L, 1990, J BIOL CHEM, V265, P8354; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kao WH, 2000, J VIROL, V74, P6408, DOI 10.1128/JVI.74.14.6408-6417.2000; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu Z, 1996, J BIOL CHEM, V271, P2817, DOI 10.1074/jbc.271.5.2817; Makino Y, 1999, GENES CELLS, V4, P529, DOI 10.1046/j.1365-2443.1999.00277.x; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27; Patra AK, 2000, PROTEIN EXPRES PURIF, V18, P182, DOI 10.1006/prep.1999.1179; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; PICKART CM, 1992, J BIOL CHEM, V267, P14418; PICKART CM, 1988, J BIOL CHEM, V263, P12028; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Schwarz SE, 1998, J BIOL CHEM, V273, P12148, DOI 10.1074/jbc.273.20.12148; SIEPMANN TJ, 1996, FASEB J, V10, P1402; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; You JX, 1999, BIOTECHNIQUES, V27, P950, DOI 10.2144/99275st01	46	106	110	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19871	19878		10.1074/jbc.M100034200	http://dx.doi.org/10.1074/jbc.M100034200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278995	hybrid			2022-12-27	WOS:000169135100027
J	Harris, MN; Madura, JD; Ming, LJ; Harwood, VJ				Harris, MN; Madura, JD; Ming, LJ; Harwood, VJ			Kinetic and mechanistic studies of prolyl oligopeptidase from the hyperthermophile Pyrococcus furiosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE CLEAVING ENZYME; BOVINE BRAIN; ACTIVE-SITE; ENDOPEPTIDASE; PURIFICATION; SUBSTRATE; CATALYSIS; SERINE; FLAVOBACTERIUM; SPECIFICITY	Prolyl oligopeptidase (POP) is widely distributed in mammals, where it is implicated in neuropeptide processing. It is also present in some bacteria and archaea, Because POP is found in mesophilic and hyperthermophilic organisms, and is distributed among all three phylogenetic domains, studies of its function and structure could lead to new insights about the evolution of enzyme mechanisms and thermostability, Kinetic studies were conducted on the POP of the hyperthermophilic archaeon Pyrococcus furiosus (Pfu) 85 degreesC in both H2O and D2O. Pfu POP displayed many similarities to mammalian POPs, however the solvent isotope effect (k(0)/k(1)) was 2.2 at both high and low pH, indicating that general base/acid catalysis is the rate-limiting step. The pH-rate profiles indicated a three-deprotonation process with pK(a) values of 4.3, 7.2, and 9.1. The temperature dependence of these values revealed a heat of ionization of 4.7 kJ/mol for pK(es1) and 22 kJ/mol for pK(es2), suggesting the catalytic involvement of a carboxyl group and an imidazole group, respectively. Temperature dependence of the catalytic rate was assessed at pH 6.0 and 7.6. Entropy values of -119 and - 143 Jmol(-1)K(-1) were calculated at the respective pH values, with a corresponding difference in enthalpy of 8.5 kJ/mol, These values suggest that two or three hydrogen bonds are broken during the transition state of the acidic enzyme form, whereas only one or two are broken during the transition state of the basic enzyme form. A model has been constructed for Pfu POP based on the crystal structure of porcine POP and the sequence alignment. The similarities demonstrated for POPs from these two organisms reflect the most highly conserved characteristics of this class of serine protease, whereas the differences between these enzymes highlights the large evolutionary distance between them. Such fundamental information is crucial to our understanding of the function of proteins at high temperature.	Univ S Florida, Dept Chem, Tampa, FL 33620 USA; Univ S Florida, Inst Biomol Sci, Tampa, FL 33620 USA; Univ S Florida, Dept Biol, Tampa, FL 33620 USA; Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Duquesne University	Harwood, VJ (corresponding author), Univ S Florida, Dept Chem, 4202 E Fowler Ave, Tampa, FL 33620 USA.	vharwood@chuma1.cas.usf.edu	Harwood, Valerie J./AAM-2600-2021	Madura, Jeffry/0000-0001-6117-2218	NIGMS NIH HHS [R15 GM55902-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM055902] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bauer MW, 1998, BIOCHEMISTRY-US, V37, P17170, DOI 10.1021/bi9814944; BENDER ML, 1964, J AM CHEM SOC, V86, P3680, DOI 10.1021/ja01072a017; BLUMBERG S, 1980, BRAIN RES, V192, P477, DOI 10.1016/0006-8993(80)90898-7; BRITTON KL, 1995, EUR J BIOCHEM, V229, P688, DOI 10.1111/j.1432-1033.1995.tb20515.x; BURLINI N, 1992, BIOCHIM BIOPHYS ACTA, V1122, P283, DOI 10.1016/0167-4838(92)90406-4; CHEVALLIER S, 1992, J BIOL CHEM, V267, P8192; CORNISHBOWDEN A, 1995, FUNDAMENTALS ENZYME, P112; COWAN DA, 1982, BIOCHIM BIOPHYS ACTA, V705, P293, DOI 10.1016/0167-4838(82)90251-5; FECHTELER T, 1995, J MOL BIOL, V253, P114, DOI 10.1006/jmbi.1995.0540; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Harwood VJ, 1997, J BACTERIOL, V179, P3613, DOI 10.1128/jb.179.11.3613-3618.1997; HERSH LB, 1979, BRAIN RES, V168, P553, DOI 10.1016/0006-8993(79)90309-3; Izatt R. M., 1976, HDB BIOCH MOL BIOL P, VI, P151; Kabashima T, 1998, ARCH BIOCHEM BIOPHYS, V358, P141, DOI 10.1006/abbi.1998.0836; KANTANI A, 1993, J BIOCH, V113, P790; Kaper T, 2000, BIOCHEMISTRY-US, V39, P4963, DOI 10.1021/bi992463r; KOIDA M, 1976, J BIOL CHEM, V251, P7593; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; MORIYAMA A, 1988, J BIOCHEM, V104, P112, DOI 10.1093/oxfordjournals.jbchem.a122404; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Pauling L., 1948, NATURE CHEM BOND; POLGAR L, 1993, FEBS LETT, V322, P227, DOI 10.1016/0014-5793(93)81575-K; POLGAR L, 1992, BIOCHEM J, V283, P647, DOI 10.1042/bj2830647; POLGAR L, 1991, EUR J BIOCHEM, V197, P441, DOI 10.1111/j.1432-1033.1991.tb15930.x; POLGAR L, 1992, BIOCHEMISTRY-US, V31, P7729, DOI 10.1021/bi00148a038; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; RENNEX D, 1991, BIOCHEMISTRY-US, V30, P2195, DOI 10.1021/bi00222a025; RIORDAN JF, 1979, MOL CELL BIOCHEM, V14, P4699; ROBINSON KA, 1995, GENE, V152, P103, DOI 10.1016/0378-1119(94)00688-O; SATTAR AKMA, 1990, J BIOCHEM, V107, P256, DOI 10.1093/oxfordjournals.jbchem.a123035; SEGAL IH, 1975, ENZYME KINETICS, P1; SHAPIRO R, 1983, BIOCHEMISTRY-US, V22, P3850, DOI 10.1021/bi00285a021; SZWAJCERDEY E, 1992, J BACTERIOL, V174, P2454, DOI 10.1128/jb.174.8.2454-2459.1992; VENKATASUBBAN KS, 1986, CRC CRIT REV BIOCH, V17, P1; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; WALTER R, 1978, BIOCHEMISTRY-US, V17, P4139, DOI 10.1021/bi00613a006; WALTER R, 1971, SCIENCE, V173, P828, DOI 10.1126/science.173.3999.827; YANG JJ, 1994, BIOCHEMISTRY-US, V33, P6516, DOI 10.1021/bi00187a019; YOSHIMOTO T, 1981, J BIOCHEM, V90, P325, DOI 10.1093/oxfordjournals.jbchem.a133477; YOSHIMOTO T, 1987, J PHARMACOBIO-DYNAM, V10, P730, DOI 10.1248/bpb1978.10.730; YOSHIMOTO T, 1983, J BIOCHEM, V94, P1179, DOI 10.1093/oxfordjournals.jbchem.a134463; YOSHIMOTO T, 1980, J BIOL CHEM, V255, P4786; YOSHIMOTO T, 1988, J BIOCHEM, V104, P622, DOI 10.1093/oxfordjournals.jbchem.a122522	44	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19310	19317		10.1074/jbc.M010489200	http://dx.doi.org/10.1074/jbc.M010489200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278687	hybrid			2022-12-27	WOS:000169091000090
J	Marabotti, A; De Biase, D; Tramonti, A; Bettati, S; Mozzarelli, A				Marabotti, A; De Biase, D; Tramonti, A; Bettati, S; Mozzarelli, A			Allosteric communication of tryptophan synthase - Functional and regulatory properties of the beta S178P mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(2)BETA(2) COMPLEX REVEALS; ALPHA-SUBUNIT; SALMONELLA-TYPHIMURIUM; INTERSUBUNIT COMMUNICATION; ESCHERICHIA-COLI; BIENZYME COMPLEX; INDOLE-3-GLYCEROL PHOSPHATE; 3-DIMENSIONAL STRUCTURE; CONFORMATIONAL-CHANGES; MONOVALENT CATIONS	The alpha (2)beta (2) tryptophan synthase complex is a model enzyme for understanding allosteric regulation. We report the functional and regulatory properties of the beta S178P mutant. Ser-178 is located at the end of helix 6 of the beta subunit, belonging to the domain involved in intersubunit signaling. The carbonyl group of beta Ser-178 is hydrogen bonded to Gly-181 of loop 6 of the alpha subunit only when alpha subunit ligands are bound. An analysis by molecular modeling of the structural effects caused by the beta S178P mutation suggests that the hydrogen bond involving alpha Gly-181 is disrupted as a result of localized structural perturbations. The ratio of alpha to beta subunit concentrations was calculated to be 0.7, as for the wild type, indicating the maintenance of a tight alpha-beta complex. Both the activity of the alpha subunit and the inhibitory effect of the alpha subunit ligands indole-3-acetylglycine and D,L-alpha -glycerol-3-phosphate were found to be the same for the mutant and wild type enzyme, whereas the beta subunit activity of the mutant exhibited a 2-fold decrease. In striking contrast to that observed for the wild type, the allosteric effecters indole-3-acetylglycine and D,L-alpha -glycerol-3-phosphate do not affect the beta activity. Accordingly, the distribution of L-serine intermediates at the beta -site, dominated by the alpha -aminoacrylate, is only slightly influenced by alpha subunit ligands. Binding of sodium ions is weaker in the mutant than in the wild type and leads to a limited increase of the amount of the external aldimine intermediate, even at high pH, whereas binding of cesium ions exhibits the same affinity and effects as in the wild type, leading to an increase of the alpha -aminoacrylate tautomer absorbing at 450 nm, Crystals of the beta S178P mutant were grown, and their functional and regulatory properties were investigated by polarized absorption microspectrophotometry. These findings indicate that (i) the reciprocal activation of the alpha and beta activity in the alpha2 beta2 complex with respect to the isolated subunits results from interactions that involve residues different from beta Ser-178 and (ii) beta Ser178 is a critical residue in ligand-triggered signals between alpha and beta active sites.	Univ Parma, Inst Biochem Sci, I-43100 Parma, Italy; Univ Parma, Natl Inst Phys Matter, I-43100 Parma, Italy; Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, I-00185 Rome, Italy	University of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Parma; Sapienza University Rome	Mozzarelli, A (corresponding author), Univ Parma, Inst Biochem Sci, Parco Area Sci, I-43100 Parma, Italy.	biochim@unipr.it	De Biase, Daniela/H-3678-2019; Messier, Claude/A-2322-2008; Bettati, Stefano/V-9975-2018; Tramonti, Angela/K-5325-2019; Mozzarelli, Andrea/C-3615-2014	De Biase, Daniela/0000-0003-3536-9927; Messier, Claude/0000-0002-4791-1763; Bettati, Stefano/0000-0001-6787-0594; Tramonti, Angela/0000-0002-5625-1170; Mozzarelli, Andrea/0000-0003-3762-0062; Marabotti, Anna/0000-0002-9510-5205				ANDERSON KS, 1991, J BIOL CHEM, V266, P8020; Bahar I, 1999, BIOCHEMISTRY-US, V38, P3478, DOI 10.1021/bi982697v; Bruno S, 2001, J BIOL CHEM, V276, P16, DOI 10.1074/jbc.C000588200; BRZOVIC PS, 1993, BIOCHEMISTRY-US, V32, P10404, DOI 10.1021/bi00090a016; COOK PF, 1992, BIOCHEMISTRY-US, V31, P2298, DOI 10.1021/bi00123a013; DUNN MF, 1987, INDIAN J BIOCHEM BIO, V24, P44; DUNN MF, 1990, BIOCHEMISTRY-US, V29, P8598, DOI 10.1021/bi00489a015; GOLDBERG ME, 1968, BIOCHEMISTRY-US, V7, P3662, DOI 10.1021/bi00850a045; HIGGINS W, 1979, BIOCHEMISTRY-US, V18, P4827, DOI 10.1021/bi00589a010; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g; KIRSCHNER K, 1975, EUR J BIOCHEM, V60, P513, DOI 10.1111/j.1432-1033.1975.tb21030.x; KIRSCHNER K, 1991, BIOCHEMISTRY-US, V30, P472, DOI 10.1021/bi00216a024; Marabotti A, 2000, BBA-PROTEIN STRUCT M, V1476, P287, DOI 10.1016/S0167-4838(99)00242-3; Miles E W, 1995, Subcell Biochem, V24, P207; Miles E W, 1979, Adv Enzymol Relat Areas Mol Biol, V49, P127; MILES EW, 1991, ADV ENZYMOL RAMB, V64, P93; MILES EW, 1987, METHOD ENZYMOL, V142, P398; MOZZARELLI A, 1989, J BIOL CHEM, V264, P15774; Mozzarelli A, 2000, J BIOL CHEM, V275, P6956, DOI 10.1074/jbc.275.10.6956; OGASAHARA K, 1992, J BIOL CHEM, V267, P5222; PERACCHI A, 1995, BIOCHEMISTRY-US, V34, P9459, DOI 10.1021/bi00029a022; Peracchi A, 1996, BIOCHEMISTRY-US, V35, P1872, DOI 10.1021/bi951889c; Rhee S, 1998, J BIOL CHEM, V273, P8553, DOI 10.1074/jbc.273.15.8553; Rhee S, 1998, BIOCHEMISTRY-US, V37, P10653, DOI 10.1021/bi980779d; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; Rhee S, 1996, BIOCHEMISTRY-US, V35, P4211, DOI 10.1021/bi952506d; Rowlett R, 1998, BIOCHEMISTRY-US, V37, P2961, DOI 10.1021/bi972286z; ROY M, 1988, BIOCHEMISTRY-US, V27, P8661, DOI 10.1021/bi00423a023; Schneider TR, 1998, BIOCHEMISTRY-US, V37, P5394, DOI 10.1021/bi9728957; STRAMBINI GB, 1992, BIOCHEMISTRY-US, V31, P7535, DOI 10.1021/bi00148a014; STRAMBINI GB, 1992, BIOCHEMISTRY-US, V31, P7527, DOI 10.1021/bi00148a013; WEISCHET WO, 1976, EUR J BIOCHEM, V65, P365, DOI 10.1111/j.1432-1033.1976.tb10350.x; Weyand M, 1999, BIOCHEMISTRY-US, V38, P16469, DOI 10.1021/bi9920533; Weyand M, 2000, J BIOL CHEM, V275, P41058, DOI 10.1074/jbc.C000479200; WOEHL EU, 1995, BIOCHEMISTRY-US, V34, P9466, DOI 10.1021/bi00029a023; Yang LH, 1996, PROTEIN EXPRES PURIF, V8, P126, DOI 10.1006/prep.1996.0082; YANG XJ, 1992, J BIOL CHEM, V267, P7520; YANG XJ, 1993, J BIOL CHEM, V268, P22269	40	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17747	17753		10.1074/jbc.M011781200	http://dx.doi.org/10.1074/jbc.M011781200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278986	Green Published, hybrid			2022-12-27	WOS:000168866500019
J	Handa, P; Acharya, N; Varshney, U				Handa, P; Acharya, N; Varshney, U			Chimeras between single-stranded DNA-binding proteins from Escherichia coli and Mycobacterium tuberculosis reveal that their C-terminal domains interact with uracil DNA glycosylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; SSB-GENE; REPLICATION; PURIFICATION; MUTAGENESIS; EXPRESSION; OLIGOMERS; SEQUENCE; COMPLEX; NMR	Uracil, a promutagenic base in DNA can arise by spontaneous deamination of cytosine or incorporation of dUMP by DNA polymerase. Uracil is removed from DNA by uracil DNA glycosylase (UDG), the first enzyme in the uracil excision repair pathway. We recently reported that the Escherichia coli single-stranded DNA binding protein (SSB) facilitated uracil excision from certain structured substrates by E, coli UDG; (EcoUDG) and suggested the existence of interaction between SSB and UDG. In this study, we have made use of the chimeric proteins obtained by fusion of N- and C-terminal domains of SSBs from E, coli and Mycobacterium tuberculosis to investigate interactions between SSBs and UDGs, The EcoSSB or a chimera containing its C-terminal domain interacts with EcoUDG in a binary (SSB-UDG) or a ternary (DNA-SSB-UDG) complex. However, the chimera containing the N-terminal domain from EcoSSB showed no interactions with EcoUDG. Thus, the C-terminal domain (48 amino acids) of EcoSSB is necessary and sufficient for interaction with EcoUDG. The data also suggest that the C-terminal domain (34 amino acids) of MtuSSB is a predominant determinant for mediating its interaction with MtuUDG. The mechanism of how the interactions between SSB and UDG could be important in uracil excision repair pathway has been discussed.	Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Varshney, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.		Varshney, Umesh/Q-6914-2019; Varshney, Umesh/A-8062-2009					Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; Genschel J, 2000, BIOL CHEM, V381, P183, DOI 10.1515/BC.2000.025; Ghosh M, 1999, NUCLEIC ACIDS RES, V27, P3938, DOI 10.1093/nar/27.19.3938; Ghosh M, 2000, NUCLEIC ACIDS RES, V28, P1906, DOI 10.1093/nar/28.9.1906; Handa P, 2001, J BIOL CHEM, V276, P17324, DOI 10.1074/jbc.M011166200; Handa P, 2000, NUCLEIC ACIDS RES, V28, P3823, DOI 10.1093/nar/28.19.3823; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; Krokan HE, 1997, BIOCHEM J, V325, P1; KUMAR NV, 1994, NUCLEIC ACIDS RES, V22, P3737, DOI 10.1093/nar/22.18.3737; Kumar NV, 1997, NUCLEIC ACIDS RES, V25, P2336, DOI 10.1093/nar/25.12.2336; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Matsumoto T, 2000, J BIOCHEM, V127, P329, DOI 10.1093/oxfordjournals.jbchem.a022611; Matsunaga T, 1996, J BIOL CHEM, V271, P11047, DOI 10.1074/jbc.271.19.11047; Nagelhus TA, 1997, J BIOL CHEM, V272, P6561, DOI 10.1074/jbc.272.10.6561; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Purnapatre K, 1999, NUCLEIC ACIDS RES, V27, P3487, DOI 10.1093/nar/27.17.3487; Purnapatre K, 1999, EUR J BIOCHEM, V264, P591, DOI 10.1046/j.1432-1327.1999.00684.x; QUINONES A, 1987, J BASIC MICROB, V27, P263, DOI 10.1002/jobm.3620270508; Roy S, 1998, PROTEIN EXPRES PURIF, V13, P155, DOI 10.1006/prep.1998.0878; Sambrook J., 2002, MOL CLONING LAB MANU; SANCAR A, 1981, P NATL ACAD SCI-BIOL, V78, P4274, DOI 10.1073/pnas.78.7.4274; Sarov-Blat L, 1998, J BIOL CHEM, V273, P5520, DOI 10.1074/jbc.273.10.5520; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; SLUPPHAUG G, 1991, NUCLEIC ACIDS RES, V19, P5131, DOI 10.1093/nar/19.19.5131; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TROVCEVIC Z, 1991, BIOCHIMIE, V73, P515, DOI 10.1016/0300-9084(91)90122-H; VARSHNEY U, 1991, BIOCHEMISTRY-US, V30, P4055, DOI 10.1021/bi00230a033; WEINER JH, 1975, J BIOL CHEM, V250, P1972; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	34	66	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16992	16997		10.1074/jbc.M100393200	http://dx.doi.org/10.1074/jbc.M100393200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279060	hybrid			2022-12-27	WOS:000168730400052
J	Johnstone, RW; Tainton, KM; Ruefli, AA; Froelich, CJ; Cerruti, L; Jane, SM; Smyth, MJ				Johnstone, RW; Tainton, KM; Ruefli, AA; Froelich, CJ; Cerruti, L; Jane, SM; Smyth, MJ			P-glycoprotein does not protect cells against cytolysis induced by pore-forming proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED MULTIDRUG-RESISTANCE; HUMAN MDR-1 PROTEIN; MONOCLONAL-ANTIBODIES; CHLORIDE CHANNELS; DRUG-RESISTANCE; TUMOR-CELLS; EXPRESSION; GENE; COMPLEMENT; DEATH	P-glycoprotein (P-gp) is an ATP-dependent drug pump that confers multidrug resistance (MDR), In addition to its ability to efflux toxins, P-gp can also inhibit apoptosis induced by a wide array of cell death stimuli that rely on activation of intracellular caspases for full function. We therefore hypothesized that P-gp may have additional functions in addition to its role in effluxing xenotoxins that could provide protection to tumor cells against a host response. There have been a number of contradictory reports concerning the role of P-gp in regulating complement activation. Given the disparate results obtained by different laboratories and our published results demonstrating that P-gp does not affect cell death induced by another membranolytic protein, perforin, we decided to assess the role of P-gp in regulating cell lysis induced by a number of different pore-forming proteins. Testing a variety of different P-gp-expressing MDR cell lines produced following exposure of cells to chemotherapeutic agents or by retroviral gene transduction in the complete absence of any drug selection, we found no difference in sensitivity of P-gp(+ve) or P-gp(-ve) cells to the pore-forming proteins complement, perforin, or pneumolysin. Based on these results, we conclude that P-gp does not affect cell lysis induced by pore-forming proteins.	Peter MacCallum Canc Inst, Trescowthick Res Labs, Melbourne, Vic 3002, Australia; Evanston NW Healthcare Res Inst, Evanston, IL 60201 USA; Royal Melbourne Hosp Res Fdn, Rotary Bone Marrow Res Lab, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; Royal Melbourne Hospital	Johnstone, RW (corresponding author), Peter MacCallum Canc Inst, Trescowthick Res Labs, St Andrews Pl, Melbourne, Vic 3002, Australia.	r.johnstone@pmci.unimelb.edu.au	Johnstone, Ricky w/H-3748-2014; Jane, Stephen/D-6659-2011; Smyth, Mark J/H-8709-2014	Johnstone, Ricky w/0000-0001-7053-9237; Smyth, Mark J/0000-0001-7098-7240; Jane, Stephen Marsden/0000-0002-1045-0481	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044941] Funding Source: NIH RePORTER; NIAID NIH HHS [AI/GM 44941-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AIHARA M, 1991, BLOOD, V77, P2079; Bomstein Y, 1997, EUR J IMMUNOL, V27, P2204, DOI 10.1002/eji.1830270913; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Debry P, 1997, J BIOL CHEM, V272, P1026, DOI 10.1074/jbc.272.2.1026; Froelich CJ, 1996, BIOCHEM BIOPH RES CO, V229, P44, DOI 10.1006/bbrc.1996.1755; GILL DR, 1992, CELL, V71, P23, DOI 10.1016/0092-8674(92)90263-C; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HARDY SP, 1995, EMBO J, V14, P68, DOI 10.1002/j.1460-2075.1995.tb06976.x; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; IERINO FL, 1993, J IMMUNOL, V150, P1794; Johnstone RW, 1999, BLOOD, V93, P1075, DOI 10.1182/blood.V93.3.1075.403k35_1075_1085; Johnstone RW, 2000, TRENDS BIOCHEM SCI, V25, P1, DOI 10.1016/S0968-0004(99)01493-0; KLIMECKI WT, 1994, BLOOD, V83, P2451; Luker GD, 1999, J BIOL CHEM, V274, P6979, DOI 10.1074/jbc.274.11.6979; MORGAN PB, 1999, COMPLEMENT REGULATOR, P1; Panwala CM, 1998, J IMMUNOL, V161, P5733; Randolph GJ, 1998, P NATL ACAD SCI USA, V95, P6924, DOI 10.1073/pnas.95.12.6924; Robinson LJ, 1997, BIOCHEMISTRY-US, V36, P11169, DOI 10.1021/bi9627830; Roepe PD, 2000, CURR PHARM DESIGN, V6, P241, DOI 10.2174/1381612003401163; Ruefli AA, 2000, BLOOD, V95, P2378, DOI 10.1182/blood.V95.7.2378.007k10_2378_2385; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Smyth MJ, 1998, P NATL ACAD SCI USA, V95, P7024, DOI 10.1073/pnas.95.12.7024; Tainton KM, 2000, BIOCHEM BIOPH RES CO, V276, P231, DOI 10.1006/bbrc.2000.3459; Trapani JA, 2000, CURR OPIN IMMUNOL, V12, P323, DOI 10.1016/S0952-7915(00)00094-7; TSCHOPP J, 1986, NATURE, V322, P831, DOI 10.1038/322831a0; TSURUO T, 1989, JPN J CANCER RES, V80, P627, DOI 10.1111/j.1349-7006.1989.tb01688.x; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Wadkins RM, 1997, INT REV CYTOL, V171, P121; Weisburg JH, 1999, J BIOL CHEM, V274, P10877, DOI 10.1074/jbc.274.16.10877; Weisburg JH, 1996, J EXP MED, V183, P2699, DOI 10.1084/jem.183.6.2699; YAMAMOTO T, 1993, BLOOD, V81, P1342; YOUNG JDE, 1986, SCIENCE, V233, P184, DOI 10.1126/science.2425429; ZALCBERG JR, 1994, INT J CANCER, V57, P522, DOI 10.1002/ijc.2910570414; Zhou WL, 2000, MOL CELL BIOL, V20, P7662, DOI 10.1128/MCB.20.20.7662-7672.2000	37	23	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16667	16673		10.1074/jbc.M010774200	http://dx.doi.org/10.1074/jbc.M010774200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278745	hybrid			2022-12-27	WOS:000168730400012
J	Tong, LQ; Thornton, PL; Balazs, R; Cotman, CW				Tong, LQ; Thornton, PL; Balazs, R; Cotman, CW			beta-Amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM-MEMORY; AMYLOID-BETA-PEPTIDE; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; TRANSGENIC MICE; TRANSCRIPTIONAL REGULATION; NEUROTROPHIC FACTOR; MULTIPLE PROMOTERS; PRECURSOR PROTEIN; CORTICAL-NEURONS	Cognitive impairment is a major feature of Alzheimer's disease and is accompanied by beta -amyloid (A beta) deposition. Transgenic animal models that overexpress A beta exhibit learning and memory impairments, but neuronal degeneration is not a consistent characteristic. We report that levels of A beta-(1- 42), which do not compromise the survival of cortical neurons, may indeed interfere with functions critical for neuronal plasticity. Pretreatment with A beta-(1-42), at sublethal concentrations, resulted in a suppression of cAMP-response element-binding protein (CREB) phosphorylation, induced by exposure to either 30 mM KCl or 10 muM N-methyl-D-aspartate. The effects of A beta-(1-42) seem to involve mechanisms unrelated to degenerative changes, since AP-(25-35), a toxic fragment of A beta, at sublethal concentrations did not interfere with activity-dependent CREB phosphorylation. Furthermore, caspase inhibitors failed to counteract the A beta-(1-42)-evoked suppression of CREB activation. A beta-(1-42) also interfered with events downstream of activated CREB, The A beta-(1-42) treatment suppressed the activation of the cAMP response element-containing brain-derived neurotrophic factor (BDNF) exon III promoter and the expression of BDNF exon IIII mRNA induced by neuronal depolarization. In view of the critical role of CREB and BDNF in neuronal plasticity, including learning and memory, the observations indicate a novel pathway through which A beta may interfere with neuronal functions and contribute to cognitive deficit in Alzheimer's disease before the stage of massive neuronal degeneration.	Univ Calif Irvine, Inst Brain & Dementia, Irvine, CA 92697 USA	University of California System; University of California Irvine	Tong, LQ (corresponding author), Univ Calif Irvine, Inst Brain & Dementia, Irvine, CA 92697 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040953] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS-40953] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Black IB, 1999, J NEUROBIOL, V41, P108, DOI 10.1002/(SICI)1097-4695(199910)41:1<108::AID-NEU14>3.0.CO;2-U; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BURDICK D, 1992, J BIOL CHEM, V267, P546; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; COTMAN CW, 1999, ALZHEIMER DIS, P347; Cribbs DH, 1997, J BIOL CHEM, V272, P7431, DOI 10.1074/jbc.272.11.7431; Czech C, 2000, PROG NEUROBIOL, V60, P363, DOI 10.1016/S0301-0082(99)00033-7; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Fu WM, 1999, J BIOL CHEM, V274, P7264, DOI 10.1074/jbc.274.11.7264; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1998, EXP GERONTOL, V33, P883, DOI 10.1016/S0531-5565(98)00045-X; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Ikezu T, 1996, EMBO J, V15, P2468, DOI 10.1002/j.1460-2075.1996.tb00604.x; Ivins KJ, 1999, NEUROBIOL DIS, V6, P440, DOI 10.1006/nbdi.1999.0268; Ivins KJ, 1998, NEUROBIOL DIS, V5, P365, DOI 10.1006/nbdi.1998.0228; Ivins KJ, 1999, J BIOL CHEM, V274, P2107, DOI 10.1074/jbc.274.4.2107; Kesslak JP, 1998, BEHAV NEUROSCI, V112, P1012, DOI 10.1037/0735-7044.112.4.1012; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lu B, 1999, J NEUROSCI RES, V58, P76, DOI 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.0.CO;2-0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; McDonald DR, 1998, J NEUROSCI, V18, P4451; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; MORAN PM, 1995, P NATL ACAD SCI USA, V92, P5341, DOI 10.1073/pnas.92.12.5341; Morris JC, 1996, NEUROLOGY, V46, P707, DOI 10.1212/WNL.46.3.707; Myers SJ, 1998, J NEUROSCI, V18, P6723; Namgung U, 2000, J NEUROSCI, V20, P6442, DOI 10.1523/JNEUROSCI.20-17-06442.2000; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Sato N, 1997, BIOCHEM BIOPH RES CO, V232, P637, DOI 10.1006/bbrc.1997.6341; SELKOE DJ, 1999, ALZHEIMER DIS, P293; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Troy CM, 2000, J NEUROSCI, V20, P1386; Tully T, 1997, P NATL ACAD SCI USA, V94, P4239, DOI 10.1073/pnas.94.9.4239; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	48	179	192	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17301	17306		10.1074/jbc.M010450200	http://dx.doi.org/10.1074/jbc.M010450200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278679	hybrid, Green Published			2022-12-27	WOS:000168730400094
J	Greenall, A; Willingham, N; Cheung, E; Boam, DS; Sharrocks, AD				Greenall, A; Willingham, N; Cheung, E; Boam, DS; Sharrocks, AD			DNA binding by the ETS-domain transcription factor PEA3 is regulated by intramolecular and intermolecular protein protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX-FORMATION; FACTOR ELK-1; MOLECULAR CHARACTERIZATION; AUTO-INHIBITION; GENE-EXPRESSION; MURINE ETS-1; FACTOR USF; PHOSPHORYLATION; ACTIVATION; FAMILY	The control of DNA binding by eukaryotic transcription factors represents an important regulatory mechanism. Many transcription factors are controlled by cis-acting autoinhibitory modules that are thought to act by blocking promiscuous DNA binding in the absence of appropriate regulatory cues. Here, we have investigated the determinants and regulation of the autoinhibitory mechanism employed by the ETS-domain transcription factor, PEA3. DNA binding is inhibited by a module composed of a combination of two short motifs located on either side of the ETS DNA-binding domain. A second type of protein, Ids, can act in trans to mimic the effect of these cia-acting inhibitory motifs and reduce DNA binding by PEA3. By using a one-hybrid screen, we identified the basic helix-loop-helix-leucine zipper transcription factor USF-1 as an interaction partner for PEA3. PEA3 and USF-1 form DNA complexes in a cooperative manner. Moreover, the formation of ternary PEA3 USF-1 DNA complexes requires parts of the same motifs in PEA3 that form the autoinhibitory module. Thus the binding of USF-1 to PEA3 acts as a switch that modifies the autoinhibitory motifs in PEA3 to first relieve their inhibitory action, and second, promote ternary nucleoprotein complex assembly.	Univ Newcastle Upon Tyne, Sch Med, Sch Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	Newcastle University - UK; University of Manchester	Sharrocks, AD (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Sch Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.							Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Brown LA, 1998, ONCOGENE, V17, P93, DOI 10.1038/sj.onc.1201911; Cheung E, 1999, BIOCHEM J, V344, P145, DOI 10.1042/0264-6021:3440145; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; Deed RW, 1997, MOL CELL BIOL, V17, P6815, DOI 10.1128/MCB.17.12.6815; deLaunoit Y, 1997, BIOCHEM MOL MED, V61, P127, DOI 10.1006/bmme.1997.2605; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Graves BJ, 1998, COLD SPRING HARB SYM, V63, P621, DOI 10.1101/sqb.1998.63.621; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; JANKNECHT R, 1994, ONCOGENE, V9, P1273; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Laget MP, 1996, ONCOGENE, V12, P1325; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; Luo X, 1996, MOL CELL BIOL, V16, P1367; MEIER JL, 1994, MOL CELL BIOL, V14, P6896, DOI 10.1128/MCB.14.10.6896; Munchberg SR, 1999, MECH DEVELOP, V88, P233, DOI 10.1016/S0925-4773(99)00179-3; Norton JD, 1998, MOL CELL BIOL, V18, P2371, DOI 10.1128/MCB.18.4.2371; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; SHARROCKS AD, 1993, NUCLEIC ACIDS RES, V21, P215, DOI 10.1093/nar/21.2.215; SHARROCKS AD, 1993, MOL CELL BIOL, V13, P123, DOI 10.1128/MCB.13.1.123; Shore P, 1996, MOL CELL BIOL, V16, P3338; SHORE P, 1995, J BIOL CHEM, V270, P5805, DOI 10.1074/jbc.270.11.5805; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Sieweke MH, 1998, EMBO J, V17, P1728, DOI 10.1093/emboj/17.6.1728; Skalicky JJ, 1996, PROTEIN SCI, V5, P296; Taylor JM, 1997, MOL CELL BIOL, V17, P5550, DOI 10.1128/MCB.17.9.5550; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; XIN JH, 1992, GENE DEV, V6, P481, DOI 10.1101/gad.6.3.481; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yates PR, 1999, EMBO J, V18, P968, DOI 10.1093/emboj/18.4.968; ZHAO LJ, 1993, GENE, V137, P345, DOI 10.1016/0378-1119(93)90032-X	42	53	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16207	16215		10.1074/jbc.M011582200	http://dx.doi.org/10.1074/jbc.M011582200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278941	hybrid			2022-12-27	WOS:000168623100086
J	Ogra, Y; Suzuki, K; Gong, PF; Otsuka, F; Koizumi, S				Ogra, Y; Suzuki, K; Gong, PF; Otsuka, F; Koizumi, S			Negative regulatory role of Sp1 in metal responsive element-mediated transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOTHIONEIN-IIA GENE; BOX-BINDING-PROTEINS; LONG TERMINAL REPEAT; I GENE; GLUCOCORTICOID RECEPTOR; PROMOTER SEQUENCES; DNA; EXPRESSION; INTERACTS; CLONING	Transcription of mammalian metallothionein (MT) genes is activated by heavy metals via multiple copies of a cis-acting DNA element, the metal-responsive element (MRE), Our previous studies have shown that certain MREs of the human MT-IIA gene (MREb, MREc, MREd, and MREf) are less active than the others (MREa, MREe, and MREg). Gel shift analysis of HeLa cell nuclear proteins revealed that whereas the active MREs strongly bind the transcription factor MTF-1 essential for metal regulation, the less active MREs bind another distinct protein, MREb-BF. This protein recognizes the GC-rich region of MREb rather than the MRE core required for MTF-1 binding. All the MREs recognized by MREb-BF contain the CGCCC and/or CACCC motif, suggesting that the MREb-BF-MRE complex contains Sp1 or related proteins. Supershift analysis using antibodies against Sp1 family proteins as well as gel shift analysis using the recombinant Sp1 demonstrated that Sp1 represents the majority of MREb-BF activity. An MREb mutant with reduced affinity to Sp1 mediated zinc-inducible transcription much more actively than the wild-type MREb, Furthermore, when placed in the native promoter, this mutant MREb raised the overall promoter activity. These results strongly suggest that Sp1 acts as a negative regulator of transcription mediated by specific MREs.	Natl Inst Ind Hlth, Div Hazard Assessment, Tama Ku, Kawasaki, Kanagawa 2148585, Japan; Natl Inst Ind Hlth, Div Hlth Effects Res, Tama Ku, Kawasaki, Kanagawa 2148585, Japan; Teikyo Univ, Fac Pharmaceut Sci, Dept Environm Toxicol, Kanagawa 1990195, Japan	Teikyo University	Koizumi, S (corresponding author), Natl Inst Ind Hlth, Div Hazard Assessment, Tama Ku, 6-21-1 Nagao, Kawasaki, Kanagawa 2148585, Japan.	koizumi@niih.go.jp	Ogra, Yasumitsu/A-2747-2017	Ogra, Yasumitsu/0000-0002-8268-1828				Apt D, 1996, VIROLOGY, V224, P281, DOI 10.1006/viro.1996.0530; BOISCLAIR YR, 1993, J BIOL CHEM, V268, P24892; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CARTER AD, 1984, P NATL ACAD SCI-BIOL, V81, P7392, DOI 10.1073/pnas.81.23.7392; CHEN LI, 1994, MOL CELL BIOL, V14, P4380, DOI 10.1128/MCB.14.7.4380; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; CULOTTA VC, 1989, MOL CELL BIOL, V9, P1376, DOI 10.1128/MCB.9.3.1376; DATTA PK, 1995, MOL CELL BIOL, V15, P5444; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; DYNAN WS, 1986, NATURE, V319, P246, DOI 10.1038/319246a0; DYNAN WS, 1985, P NATL ACAD SCI USA, V82, P4915, DOI 10.1073/pnas.82.15.4915; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Husmann M, 1996, EUR J IMMUNOL, V26, P3008, DOI 10.1002/eji.1830261228; INOUYE C, 1994, DNA CELL BIOL, V13, P731, DOI 10.1089/dna.1994.13.731; JONES KA, 1985, NATURE, V317, P179, DOI 10.1038/317179a0; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KARIN M, 1987, MOL CELL BIOL, V7, P606, DOI 10.1128/MCB.7.2.606; KARIN M, 1982, NATURE, V299, P797, DOI 10.1038/299797a0; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KOIZUMI S, 1991, CHEM-BIOL INTERACT, V80, P145, DOI 10.1016/0009-2797(91)90021-X; Koizumi S, 1999, EUR J BIOCHEM, V259, P635, DOI 10.1046/j.1432-1327.1999.00069.x; KOIZUMI S, 1995, GENETIC RESPONSE TO METALS, P397; KOIZUMI S, 1992, EUR J BIOCHEM, V210, P555, DOI 10.1111/j.1432-1033.1992.tb17454.x; KOIZUMI S, 1993, METALLOTHIONEIN, V3, P457; Kumar AP, 1997, NUCLEIC ACIDS RES, V25, P2012, DOI 10.1093/nar/25.10.2012; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Li RG, 1996, J BIOL CHEM, V271, P18925, DOI 10.1074/jbc.271.31.18925; Madsen CS, 1997, J BIOL CHEM, V272, P6332, DOI 10.1074/jbc.272.10.6332; MAJELLO B, 1994, NUCLEIC ACIDS RES, V22, P4914, DOI 10.1093/nar/22.23.4914; MINOWA T, 1994, J BIOL CHEM, V269, P11656; MURATA Y, 1994, J BIOL CHEM, V269, P20674; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; Okumura K, 1996, J BIOL CHEM, V271, P12944, DOI 10.1074/jbc.271.22.12944; OTSUKA F, 1994, J BIOL CHEM, V269, P23700; OTSUKA F, 1993, IND HEALTH, V31, P133, DOI 10.2486/indhealth.31.133; PALMITER RD, 1994, P NATL ACAD SCI USA, V91, P1219, DOI 10.1073/pnas.91.4.1219; SCHULE R, 1988, NATURE, V332, P87, DOI 10.1038/332087a0; Searle P F, 1987, Experientia Suppl, V52, P407; Shou YP, 1998, J BIOL CHEM, V273, P5716, DOI 10.1074/jbc.273.10.5716; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; STUART GW, 1984, P NATL ACAD SCI-BIOL, V81, P7318, DOI 10.1073/pnas.81.23.7318; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; SUZUKI M, 1995, MOL CELL BIOL, V15, P5423; XU C, 1993, DNA CELL BIOL, V12, P517, DOI 10.1089/dna.1993.12.517; YU CY, 1991, J BIOL CHEM, V266, P8907	51	52	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16534	16539		10.1074/jbc.M100570200	http://dx.doi.org/10.1074/jbc.M100570200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279094	hybrid			2022-12-27	WOS:000168623100128
J	Sun, JH; Eu, JP; Stamler, JS; Meissner, G				Sun, JH; Eu, JP; Stamler, JS; Meissner, G			Classes of thiols that influence the activity of the skeletal muscle calcium release channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RYANODINE RECEPTOR; SARCOPLASMIC-RETICULUM; NITRIC-OXIDE; CA2+ RELEASE; ENDOGENOUS EFFECTORS; REDOX SENSOR; PEROXYNITRITE; OXIDATION; PROTEIN; NITROSYLATION	The skeletal muscle Ca2+ release channel/ryanodine receptor (RyR1) is a prototypic redox-responsive ion channel. Nearly half of the 101 cysteines per RyR1 subunit are kept in a reduced (free thiol) state under conditions comparable with resting muscle. Here we assessed the effects of physiological determinants of cellular redox state (oxygen tension, reduced (GSH) or oxidized (GSSG) glutathione, and NO/O-2(<(<bullet>)over bar>) (released by 3-morpholinosydnonimine)) on RyR1 redox state and activity. Oxidation of similar to 10 RyR1 thiols (from similar to 48 to similar to 38 thiols/RyR1 subunit) had little effect on channel activity. Channel activity increased reversibly as the number of thiols was further reduced to similar to 23/subunit, whereas more extensive oxidation (to similar to 13 thiols/subunit) inactivated the channel irreversibly. Neither S-nitrosylation nor tyrosine nitration contributed to these effects. The results identify at least three functional classes of RyR1 thiols and suggest that 1) the channel may be protected from oxidation by a large reservoir of functionally inert thiols, 2) the channel may be designed to respond to moderate oxidative stress by a change in activation setpoint, and 3) the channel is susceptible to oxidative injury under more extensive conditions.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med,Div Pulm, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med,Div Cardiovasc Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; Duke University	Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.		Sun, Junhui/C-3499-2011	Stamler, Jonathan/0000-0002-6866-1572	NHLBI NIH HHS [HL04053, HL27430, HL59130, HL52529] Funding Source: Medline; NIAMS NIH HHS [AR18687] Funding Source: Medline; NIEHS NIH HHS [ES-09206] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052529, P01HL027430, R01HL059130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR018687, R37AR018687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009206] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABRAMSON JJ, 1989, J BIOENERG BIOMEMBR, V21, P283, DOI 10.1007/BF00812073; Aghdasi B, 1997, J BIOL CHEM, V272, P25462, DOI 10.1074/jbc.272.41.25462; Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Ducrocq C, 1999, CELL MOL LIFE SCI, V55, P1068, DOI 10.1007/s000180050357; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Eu JP, 1999, BIOCHEM PHARMACOL, V57, P1079, DOI 10.1016/S0006-2952(98)00360-8; FAVERO TG, 1995, J BIOL CHEM, V270, P25557, DOI 10.1074/jbc.270.43.25557; Feng W, 2000, J BIOL CHEM, V275, P35902, DOI 10.1074/jbc.C000523200; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; GORCZYNSKI RJ, 1978, AM J PHYSIOL, V235, pH505, DOI 10.1152/ajpheart.1978.235.5.H505; HONIG CR, 1993, AM J PHYSIOL, V265, pH868, DOI 10.1152/ajpheart.1993.265.3.H868; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Kawakami M, 1998, MOL PHARMACOL, V53, P497, DOI 10.1124/mol.53.3.497; KIRCHGESSER M, 1990, J CLIN CHEM CLIN BIO, V28, P407; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Marechal G, 1999, CELL MOL LIFE SCI, V55, P1088, DOI 10.1007/s000180050359; Marengo JJ, 1998, BIOPHYS J, V74, P1263, DOI 10.1016/S0006-3495(98)77840-3; MEISSNER G, 1983, MOL CELL BIOCHEM, V55, P65; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Meszaros LG, 1996, FEBS LETT, V380, P49, DOI 10.1016/0014-5793(96)00003-8; Oba T, 1998, AM J PHYSIOL-CELL PH, V274, pC914, DOI 10.1152/ajpcell.1998.274.4.C914; REID MB, 1993, J APPL PHYSIOL, V75, P1081, DOI 10.1152/jappl.1993.75.3.1081; SAREN M, 1990, FREE RADICAL RES COM, V10, P221; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Uppu RM, 1996, METHOD ENZYMOL, V269, P285; Viner RI, 1999, BIOCHEM J, V340, P657, DOI 10.1042/0264-6021:3400657; Viner RI, 1999, BIOCHEMISTRY-US, V38, P12408, DOI 10.1021/bi9909445; Wang W, 1998, PHARMACOL REV, V50, P335; Xia RH, 2000, J BIOL CHEM, V275, P36556, DOI 10.1074/jbc.M007613200; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Zable AC, 1997, J BIOL CHEM, V272, P7069, DOI 10.1074/jbc.272.11.7069; Zahradnikova A, 1997, CELL CALCIUM, V22, P447, DOI 10.1016/S0143-4160(97)90072-5; Zhang JZ, 1999, AM J PHYSIOL-CELL PH, V276, pC46; Zucchi R, 1997, PHARMACOL REV, V49, P1	42	144	149	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15625	15630		10.1074/jbc.M100083200	http://dx.doi.org/10.1074/jbc.M100083200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278999	Green Published, hybrid			2022-12-27	WOS:000168623100010
J	Tran, SEF; Holmstrom, TH; Ahonen, M; Kahari, VM; Eriksson, JE				Tran, SEF; Holmstrom, TH; Ahonen, M; Kahari, VM; Eriksson, JE			MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; MEDIATED APOPTOSIS; JNK ACTIVATION; DEATH DOMAIN; CELL-DEATH; PHOSPHATIDYLINOSITOL 3-KINASE; TUMORICIDAL ACTIVITY; T-CELLS; FADD	The tumor necrosis factor (TNF), Fas, and TNF-related apoptosis-inducing ligand (TRAIL) receptors (R) are highly specific physiological mediators of apoptotic signaling. We observed earlier that a number of FasR-insensitive cell lines could redirect the proapoptotic signal to an anti-apoptotic ERK1/2 signal resulting in inhibition of caspase activation. Here we determine that similar mechanisms are operational in regulating the apoptotic signaling of other death receptors, Activation of the FasR, TNF-R1, and TRAIL-R, respectively, rapidly induced subsequent ERK1/2 activation, an event independent from caspase activity. Whereas inhibition of the death receptor-mediated ERK1/2 activation was sufficient to sensitize the cells to apoptotic signaling from FasR and TRAIL-R, cells were still protected from apoptotic TNF-R1 signaling. The latter seemed to be due to the strong activation of the anti-apoptotic factor NF-kappaB, which remained inactive in FasR or TRAIL-R signaling However, when the cells were sensitized with cycloheximide, which is sufficient to sensitize the cells also to apoptosis by TNF-R1 stimulation, we noticed that adenovirus-mediated expression of constitutively active MKK1 could rescue the cells from apoptosis induced by the respective receptors by preventing caspase-8 activation. Taken together, our results show that ERK1/2 has a dominant protecting effect over apoptotic signaling from the death receptors, This protection, which is independent of newly synthesized proteins, acts in all cases by suppressing activation of the caspase effector machinery.	Univ Turku, Dept Biol, Physiol Anim Lab, FIN-20014 Turku, Finland; Turku Ctr Biotechnol, FIN-20521 Turku, Finland; Abo Akad Univ, Dept Biol, Turku GRad Sch Biomed Sci, FIN-20520 Turku, Finland; Univ Turku, FIN-20520 Turku, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku	Eriksson, JE (corresponding author), Univ Turku, Dept Biol, Physiol Anim Lab, Sci Bldg 1, FIN-20014 Turku, Finland.		Kähäri, Veli-Matti/E-5144-2011; Kahari, Veli-Matti/T-4925-2019	Kähäri, Veli-Matti/0000-0003-2421-9368; Kahari, Veli-Matti/0000-0003-2421-9368				Ahonen M, 1998, CANCER RES, V58, P2310; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BEUTLER B, 1995, J INVEST MED, V43, P227; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; FRIED J, 1978, J HISTOCHEM CYTOCHEM, V26, P921, DOI 10.1177/26.11.82573; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; Goillot E, 1997, P NATL ACAD SCI USA, V94, P3302, DOI 10.1073/pnas.94.7.3302; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Hayne C, 2000, J BIOL CHEM, V275, P31876, DOI 10.1074/jbc.M002766200; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Holmstrom TH, 1998, J IMMUNOL, V160, P2626; Holmstrom TH, 1999, MOL CELL BIOL, V19, P5991; Holmstrom TH, 2000, CRIT REV IMMUNOL, V20, P121; Holmstrom TH, 2000, EMBO J, V19, P5418, DOI 10.1093/emboj/19.20.5418; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Li Y, 2000, INT J CANCER, V87, P473, DOI 10.1002/1097-0215(20000815)87:4<473::AID-IJC3>3.0.CO;2-1; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; MacFarlane M, 2000, BIOCHEM J, V348, P93, DOI 10.1042/0264-6021:3480093; Mandal M, 1996, J BIOL CHEM, V271, P30354, DOI 10.1074/jbc.271.48.30354; Marsters SA, 1996, CURR BIOL, V6, P750, DOI 10.1016/S0960-9822(09)00456-4; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Muhlenbeck F, 2000, J BIOL CHEM, V275, P32208, DOI 10.1074/jbc.M000482200; Muhlenbeck F, 1998, J BIOL CHEM, V273, P33091, DOI 10.1074/jbc.273.49.33091; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Petrache I, 1999, AM J PHYSIOL-LUNG C, V277, pL589, DOI 10.1152/ajplung.1999.277.3.L589; Ponton A, 1996, J BIOL CHEM, V271, P8991, DOI 10.1074/jbc.271.15.8991; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Sedger LM, 1999, J IMMUNOL, V163, P920; Seino KI, 1997, NAT MED, V3, P165, DOI 10.1038/nm0297-165; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; VIETOR I, 1993, J BIOL CHEM, V268, P18994; Wajant H, 2000, J BIOL CHEM, V275, P24357, DOI 10.1074/jbc.M000811200; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; WILKINSON GWG, 1992, NUCLEIC ACIDS RES, V20, P2233, DOI 10.1093/nar/20.9.2233; Wilson DJ, 1999, CELL IMMUNOL, V194, P67, DOI 10.1006/cimm.1999.1486; WINSTON BW, 1995, P NATL ACAD SCI USA, V92, P1614, DOI 10.1073/pnas.92.5.1614; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349; Yeh JH, 1998, J EXP MED, V188, P1795, DOI 10.1084/jem.188.10.1795; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954	69	280	288	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16484	16490		10.1074/jbc.M010384200	http://dx.doi.org/10.1074/jbc.M010384200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278665	hybrid			2022-12-27	WOS:000168623100122
J	Garriga-Canut, M; Roopra, A; Buckley, NJ				Garriga-Canut, M; Roopra, A; Buckley, NJ			The basic helix-loop-helix protein, SHARP-1, represses transcription by a histone deacetylase-dependent and histone deacetylase-independent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR GENE; RESTRICTIVE SILENCER FACTOR; BASAL PROMOTER ELEMENTS; DNA-BINDING; RETINOBLASTOMA PROTEIN; NEURONAL DIFFERENTIATION; NERVOUS-SYSTEM; RETINOIC ACID; EXPRESSION; COMPLEX	Many aspects of neurogenesis and neuronal differentiation are controlled by basic helix-loop-helix (bHLH) proteins. One such factor is SHARP-1, initially identified on the basis of its sequence similarity to hairy. Unlike hairy, and atypically for bHLHs, SHARP-1 is expressed late in development, suggestive of a role in terminal aspects of differentiation. Nevertheless, the role of SHARP-1 and the identity of its target genes remain unknown. During the course of a one-hybrid screen for transcription factors that bind to regulatory domains of the M(1) muscarinic acetylcholine receptor gene, we isolated the bHLH transcription factor SHARP-1. In this study, we investigated the functional role of SHARP-1 in regulating transcription, Fusion proteins of SHARP-1 tethered to the ga14 DNA binding domain repress both basal and activated transcription when recruited to either a TATA-containing or a TATAless promoter. Furthermore, we identified two independent repression domains that operate via distinct mechanisms. Repression by a domain in the C terminus is sensitive to the histone deacetylase inhibitor trichostatin A, whereas repression by the bHLH domain is insensitive to TSA Furthermore, overexpression of SHARP-1 represses transcription from the M(1) promoter. This study represents the first report to assign a function to, and to identify a target gene for, the bHLH transcription factor SHARP-1.	Univ Leeds, Fac Biol Sci, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; UCL, Dept Pharmacol, Wellcome Lab Mol Pharmacol, London WC1E 6BT, England	University of Leeds; University of Leeds; University of London; University College London	Buckley, NJ (corresponding author), Univ Leeds, Fac Biol Sci, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	n.j.buckley@leeds.ac.uk	Buckley, Noel J/B-9675-2012	Buckley, Noel J/0000-0003-1152-0653				Anderson DJ, 1999, CURR OPIN NEUROBIOL, V9, P517, DOI 10.1016/S0959-4388(99)00015-X; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Bartel P. L., 1993, CELLULAR INTERACTION, P153; Bessis A, 1997, P NATL ACAD SCI USA, V94, P5906, DOI 10.1073/pnas.94.11.5906; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C; CAMPOSORTEGA JA, 1995, MOL NEUROBIOL, V10, P75, DOI 10.1007/BF02740668; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Giebel B, 1997, P NATL ACAD SCI USA, V94, P6250, DOI 10.1073/pnas.94.12.6250; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; HOHMANN CF, 1995, J COMP NEUROL, V358, P88, DOI 10.1002/cne.903580106; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Kageyama R, 1997, INT J BIOCHEM CELL B, V29, P1389, DOI 10.1016/S1357-2725(97)89968-2; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Liu Jingdong, 1993, Methods (Orlando), V5, P125, DOI 10.1006/meth.1993.1017; Liu YZ, 1996, J BIOL CHEM, V271, P20853, DOI 10.1074/jbc.271.34.20853; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; Mieda M, 1996, J BIOL CHEM, V271, P5177; Mieda M, 1997, J BIOL CHEM, V272, P5854, DOI 10.1074/jbc.272.9.5854; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; OHSAKO S, 1994, GENE DEV, V8, P2743, DOI 10.1101/gad.8.22.2743; Pengue G, 1996, P NATL ACAD SCI USA, V93, P1015, DOI 10.1073/pnas.93.3.1015; Pepitoni S, 1997, J BIOL CHEM, V272, P17112, DOI 10.1074/jbc.272.27.17112; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; Rosoff ML, 1996, P NATL ACAD SCI USA, V93, P14889, DOI 10.1073/pnas.93.25.14889; Rossner MJ, 1997, MOL CELL NEUROSCI, V9, P460, DOI 10.1006/mcne.1997.0640; SAUER F, 1993, NATURE, V364, P454, DOI 10.1038/364454a0; SAUER F, 1995, NATURE, V375, P162, DOI 10.1038/375162a0; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; TURNER EE, 1994, NEURON, V12, P205, DOI 10.1016/0896-6273(94)90164-3; WALL SJ, 1992, DEV BRAIN RES, V66, P181, DOI 10.1016/0165-3806(92)90078-B; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; Wood IC, 1999, BIOCHEM J, V340, P475, DOI 10.1042/0264-6021:3400475; Wood IC, 1995, J BIOL CHEM, V270, P30933, DOI 10.1074/jbc.270.52.30933; Wood IC, 1996, J BIOL CHEM, V271, P14221, DOI 10.1074/jbc.271.24.14221; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510	52	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14821	14828		10.1074/jbc.M011619200	http://dx.doi.org/10.1074/jbc.M011619200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278948	hybrid			2022-12-27	WOS:000168528800040
J	Bandwar, RP; Patel, SS				Bandwar, RP; Patel, SS			Peculiar 2-aminopurine fluorescence monitors the dynamics of open complex formation by bacteriophage T7 RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION INITIATION; KINETIC MECHANISM; DNA-POLYMERASE; PROMOTER; TRANSITIONS; OLIGOMER; BINDING; HELIX; SITE	The kinetics of promoter binding and open complex formation in bacteriophage T7 RNA polymerase was investigated using a-aminopurine (2-AP) modified promoters. 2-AP serves as an ideal probe to measure the kinetics of open complex formation because its fluorescence is sensitive to both base-unpairing and base-unstacking and to the nature of the neighboring bases. All four 2-AP bases in the TATA box showed an increase in fluorescence with similar kinetics upon binding to the T7 RNA polymerase, indicating that the TATA sequence becomes unpaired in a concerted manner. The 2-AP at -4 showed a peculiarly large increase in fluorescence upon binding to the T7 RNA polymerase, Based on the recent crystal structure of the T7 RNA polymerase-DNA complex, we propose that the large fluorescence increase is due to unstacking of the 2-AP base at -4 from the guanine at -5, during open complex formation. The unstacking may be a critical event in directing and placing the template strand correctly in the T7 RNA polymerase active site upon promoter melting for template directed RNA synthesis. Based on equilibrium fluorescence and stopped-flow kinetic studies, we propose that a fast form of T7 RNA polymerase binds promoter double-stranded DNA by a three-step mechanism, The initial collision complex or a closed complex, EDc is formed with a K-d of 1.8 muM. This complex isomerizes to an open complex, EDo1 in an energetically unfavorable reaction with an equilibrium constant of 0.12. The EDo1 further isomerizes to a more stable open complex, EDo2 with a rate constant around 300 s(-1), Thus, in the absence of the initiating nucleotide, GTP, the overall equilibrium constant for closed to open complex conversion is 0.5 and the net rate of open complex formation is nearly 150 s(-1).	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Ln, Piscataway, NJ 08854 USA.			Bandwar, Rajiv/0000-0002-8081-8958	NIGMS NIH HHS [GM51966] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051966, R37GM051966] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan BW, 1998, J BIOL CHEM, V273, P2368, DOI 10.1074/jbc.273.4.2368; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 2000, CURR OPIN STRUC BIOL, V10, P117, DOI 10.1016/S0959-440X(99)00058-5; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; HOCHSTRASSER RA, 1994, BIOCHEMISTRY-US, V33, P11971, DOI 10.1021/bi00205a036; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; Jia YP, 1997, J BIOL CHEM, V272, P30147, DOI 10.1074/jbc.272.48.30147; Kelley SO, 1999, SCIENCE, V283, P375, DOI 10.1126/science.283.5400.375; Law SM, 1996, BIOCHEMISTRY-US, V35, P12329, DOI 10.1021/bi9614545; MCLAUGHLIN LW, 1987, BIOCHEMISTRY-US, V26, P7238, DOI 10.1021/bi00397a007; Millar DP, 1996, CURR OPIN STRUC BIOL, V6, P637, DOI 10.1016/S0959-440X(96)80030-3; Millar DP, 1996, CURR OPIN STRUC BIOL, V6, P322, DOI 10.1016/S0959-440X(96)80050-9; MULLER DK, 1989, BIOCHEMISTRY-US, V28, P3306, DOI 10.1021/bi00434a028; NORDLUND TM, 1989, BIOCHEMISTRY-US, V28, P9095, DOI 10.1021/bi00449a021; Otto MR, 1998, BIOCHEMISTRY-US, V37, P10156, DOI 10.1021/bi9800754; Sastry SS, 1996, BIOCHEMISTRY-US, V35, P15715, DOI 10.1021/bi960729d; Ujvari A, 1996, BIOCHEMISTRY-US, V35, P14574, DOI 10.1021/bi961165g; Villemain J, 1997, J MOL BIOL, V273, P958, DOI 10.1006/jmbi.1997.1358; WARD DC, 1969, J BIOL CHEM, V244, P1228; XU DG, 1994, BIOCHEMISTRY-US, V33, P9592, DOI 10.1021/bi00198a027	21	67	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14075	14082		10.1074/jbc.M011289200	http://dx.doi.org/10.1074/jbc.M011289200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278877	hybrid			2022-12-27	WOS:000168356600078
J	Aleksandrov, L; Mengos, A; Chang, XB; Aleksandrov, A; Riordan, JR				Aleksandrov, L; Mengos, A; Chang, XB; Aleksandrov, A; Riordan, JR			Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANCE PROTEIN MRP1; SULFONYLUREA RECEPTOR; CHLORIDE CHANNEL; ATP HYDROLYSIS; P-GLYCOPROTEIN; ACTIVE ATPASE; CFTR; SITES; KINASE; PHOSPHORYLATION	After phosphorylation by protein kinase A, gating of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel is regulated by the interaction of ATP with its nucleotide binding domains (NBDs), Models of this gating regulation have proposed that ATP hydrolysis at NBD1 and NBD2 may drive channel opening and closing, respectively (reviewed in Nagel, G. (1999) Biochim, Biophys, Acta: 1461, 263-274), However, as yet there has been little biochemical confirmation of the predictions of these models. We have employed photoaffinity labeling with 8-azido-ATP, which supports channel gating as effectively as ATP to evaluate interactions with each NBD in intact membrane-bound CFTR, Mutagenesis of Walker A lysine residues crucial for azido-ATP hydrolysis to generate the azido-ADP that is trapped by vanadate indicated a greater role of NBD1 than NBD2, Separation of the domains by limited trypsin digestion and enrichment by immunoprecipitation confirmed greater and more stable nucleotide trapping at NBD1, This asymmetry of the two domains in interactions with nucleotides was reflected most emphatically in the response to the nonhydrolyzable ATP analogue, 5 ' -adenylyl-beta,gamma -imidodiphosphate (AMP-PNP), which in the gating models was proposed to bind with high affinity to NBD2 causing inhibition of ATP hydrolysis there postulated to drive channel closing. Instead we found a strong competitive inhibition of nucleotide hydrolysis and trapping at NBD1 and a simultaneous enhancement at NBD2, This argues strongly that AMP-PNP does not inhibit ATP hydrolysis at NBD2 and thereby questions the relevance of hydrolysis at that domain to channel closing.	Mayo Clin Scottsdale, SC Johnson Med Res Ctr, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix; SC Johnson & Son	Riordan, JR (corresponding author), Mayo Clin Scottsdale, SC Johnson Med Res Ctr, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.				NIDDK NIH HHS [DK51619] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051619] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleksandrov AA, 2000, J PHYSIOL-LONDON, V528, P259, DOI 10.1111/j.1469-7793.2000.00259.x; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Julien M, 2000, BIOCHEMISTRY-US, V39, P4559, DOI 10.1021/bi992744z; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; KO YH, 1995, J BIOL CHEM, V270, P22093, DOI 10.1074/jbc.270.38.22093; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; Nagata K, 2000, J BIOL CHEM, V275, P17626, DOI 10.1074/jbc.M000792200; Nagel G, 1999, BBA-BIOMEMBRANES, V1461, P263, DOI 10.1016/S0005-2736(99)00162-5; Ostedgaard LS, 1997, BIOCHEMISTRY-US, V36, P1287, DOI 10.1021/bi962174s; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Randak C, 1997, FEBS LETT, V410, P180, DOI 10.1016/S0014-5793(97)00574-7; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Szabo K, 1999, J BIOL CHEM, V274, P12209, DOI 10.1074/jbc.274.18.12209; Ueda K, 1999, BBA-BIOMEMBRANES, V1461, P305, DOI 10.1016/S0005-2736(99)00157-1; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; Urbatsch IL, 2000, J BIOL CHEM, V275, P25031, DOI 10.1074/jbc.M003962200; Weinreich F, 1999, J GEN PHYSIOL, V114, P55, DOI 10.1085/jgp.114.1.55	29	86	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12918	12923		10.1074/jbc.M100515200	http://dx.doi.org/10.1074/jbc.M100515200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11279083	hybrid			2022-12-27	WOS:000168198600065
J	Kroeger, KM; Hanyaloglu, AC; Seeber, RM; Miles, LEC; Eidne, KA				Kroeger, KM; Hanyaloglu, AC; Seeber, RM; Miles, LEC; Eidne, KA			Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor - Detection in living cells using bioluminescence resonance energy transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TAGGED FORMS; BETA-ARRESTIN; MOLECULAR CHARACTERIZATION; INTERNALIZATION KINETICS; HETEROMERIC COMPLEXES; RAPID DESENSITIZATION; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; DOPAMINE-RECEPTOR; SPLICE VARIANT	The ability of G-protein-coupled receptors (GPCRs) to interact to form new functional structures, either forming oligomers with themselves or forming associations with other intracellular proteins, has important implications for the regulation of cellular events; however, little is known about how this occurs. Here, we have employed a newly emerging technology, bioluminescence resonance energy transfer (BRET), used to study protein-protein interactions in living cells, to demonstrate that the thyrotropin-releasing hormone receptor (TRHR) forms constitutive homo-oligomers. This formation of TRHR homo-oligomers in the absence of ligand was shown by demonstration of an energy transfer between TRHR molecules fused to either donor, Renilla luciferase (Rluc) or acceptor, enhanced yellow fluorescent protein (EYFP) molecules. This interaction was shown to be specific, since energy transfer was not detected between co-expressed tagged TRHRs and either complementary tagged gonadotropin-releasing hormone (GnRH) or beta (2)-adrenergic receptors, Furthermore, generation of a BRET signal between the TRHRs could only be inhibited by co-expression of the wild-type TRHR and not by other GPCRs, Agonist stimulation led to a time- and dose-dependent increase in the amount of energy transfer, Inhibition of receptor internalization by co-expression of dynamin mutant K44A did not affect the interaction between TRHRs, suggesting that clustering of receptors within clathrin-coated pits is not sufficient for energy transfer to occur. BRET also provided evidence for the agonist-induced oligomerization of another GPCR, the GnRH receptor (GnRHR), and the presence of an agonist-induced interaction of the adaptor protein, beta -arrestin, with TRHR and the absence of an interaction of beta -arrestin with GnRHR, This study supports the usefulness of BRET as a powerful tool for studying GPCR aggregations and receptor/protein interactions in general and presents evidence that the functioning unit of TRHRs exists as homomeric complexes.	Sir Charles Gairdner Hosp, Western Australian Inst Med Res, Keogh Inst Med Res, Perth, WA 6009, Australia; Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Eidne, KA (corresponding author), Sir Charles Gairdner Hosp, Western Australian Inst Med Res, Keogh Inst Med Res, B Block,Hosp Ave, Perth, WA 6009, Australia.	keidne@waimr.uwa.edu.au	Seeber, Ruth/AAS-9411-2021	Seeber, Ruth/0000-0003-3265-7931; /0000-0003-4206-737X				AbdAlla S, 1999, J BIOL CHEM, V274, P26079, DOI 10.1074/jbc.274.37.26079; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; ASHWORTH R, 1995, P NATL ACAD SCI USA, V92, P512, DOI 10.1073/pnas.92.2.512; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; BRAMLEY TA, 1992, PLACENTA, V13, P555, DOI 10.1016/0143-4004(92)90020-T; Buck F, 2000, ENDOCRINOLOGY, V141, P3717, DOI 10.1210/en.141.10.3717; Cook JVF, 1996, ENDOCRINOLOGY, V137, P2851, DOI 10.1210/en.137.7.2851; Cornea A, 2001, J BIOL CHEM, V276, P2153, DOI 10.1074/jbc.M007850200; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; DELAPENA P, 1992, BIOCHEM J, V284, P891, DOI 10.1042/bj2840891; Drmota T, 2000, BIOCHEM J, V346, P711, DOI 10.1042/0264-6021:3460711; Drmota T, 1998, J BIOL CHEM, V273, P24000, DOI 10.1074/jbc.273.37.24000; DUTHIE SM, 1993, MOL CELL ENDOCRINOL, V95, pR11, DOI 10.1016/0303-7207(93)90043-J; Elmhurst JL, 2000, MOL BRAIN RES, V80, P63, DOI 10.1016/S0169-328X(00)00120-0; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; George SR, 1998, J BIOL CHEM, V273, P30244, DOI 10.1074/jbc.273.46.30244; Gines S, 2000, P NATL ACAD SCI USA, V97, P8606, DOI 10.1073/pnas.150241097; Groarke DA, 1999, J BIOL CHEM, V274, P23263, DOI 10.1074/jbc.274.33.23263; Grosse R, 1997, MOL ENDOCRINOL, V11, P1305, DOI 10.1210/me.11.9.1305; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Heding A, 1998, J BIOL CHEM, V273, P11472, DOI 10.1074/jbc.273.19.11472; Heding A, 2000, ENDOCRINOLOGY, V141, P299, DOI 10.1210/en.141.1.299; JinsiParimoo A, 1997, ENDOCRINOLOGY, V138, P1471, DOI 10.1210/en.138.4.1471; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jordan BA, 2000, NEUROPSYCHOPHARMACOL, V23, pS5, DOI 10.1016/S0893-133X(00)00143-3; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee SP, 2000, MOL PHARMACOL, V58, P120, DOI 10.1124/mol.58.1.120; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Maggio R, 1996, J BIOL CHEM, V271, P31055, DOI 10.1074/jbc.271.49.31055; McLean AJ, 2000, BRIT J PHARMACOL, V130, P1825, DOI 10.1038/sj.bjp.0703506; Monnot C, 1996, J BIOL CHEM, V271, P1507, DOI 10.1074/jbc.271.3.1507; MOORE RH, 1995, J CELL SCI, V108, P2983; Ng GYK, 1996, BIOCHEM BIOPH RES CO, V227, P200, DOI 10.1006/bbrc.1996.1489; Ray K, 1999, J BIOL CHEM, V274, P27642, DOI 10.1074/jbc.274.39.27642; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; SELLAR RE, 1993, J MOL ENDOCRINOL, V10, P199, DOI 10.1677/jme.0.0100199; STRAUB RE, 1990, P NATL ACAD SCI USA, V87, P9514, DOI 10.1073/pnas.87.24.9514; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vrecl M, 1998, MOL ENDOCRINOL, V12, P1818, DOI 10.1210/me.12.12.1818; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Willars GB, 1999, J BIOL CHEM, V274, P30146, DOI 10.1074/jbc.274.42.30146; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Yu R, 1998, MOL ENDOCRINOL, V12, P737, DOI 10.1210/me.12.5.737; Yu R, 1999, J BIOL CHEM, V274, P15745, DOI 10.1074/jbc.274.22.15745; Zaltsman I, 2000, BRIT J PHARMACOL, V130, P315, DOI 10.1038/sj.bjp.0703291; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; ZHAO DY, 1992, ENDOCRINOLOGY, V130, P3529, DOI 10.1210/en.130.6.3529; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z	54	163	181	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12736	12743		10.1074/jbc.M011311200	http://dx.doi.org/10.1074/jbc.M011311200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278883	hybrid			2022-12-27	WOS:000168198600038
J	Riboni, L; Viani, P; Bassi, R; Giussani, P; Tettamanti, G				Riboni, L; Viani, P; Bassi, R; Giussani, P; Tettamanti, G			Basic fibroblast growth factor-induced proliferation of primary astrocytes - Evidence for the involvement of sphingomyelin biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CEREBELLAR GRANULE CELLS; NF-KAPPA-B; GLUCOSYLCERAMIDE SYNTHESIS; PHOSPHOLIPASE-C; BREFELDIN-A; SPHINGOLIPID METABOLISM; RAT-LIVER; GANGLIOSIDE METABOLISM; PLASMA-MEMBRANES	We recently reported that the marked decrease in cellular ceramide in primary astrocytes is an early event associated with the mitogenic activity of basic fibroblast growth factor (bFGF) (Riboni, L,, Viani, P,, Bassi, R,, Stabieini, A., and Tettamanti, G, (2000) GLIA 32, 137-145), Here we show that a rapid activation of sphingomyelin biosynthesis appears to be the major mechanism responsible for the fall in ceramide levels induced by bFGF, When quiescent astrocytes were treated with bFGF, an increased amount of newly synthesized ceramide (from either L-[H-3]serine or [H-3]sphingosine) was directed toward the biosynthesis of sphingomyelin, Conversely, bFGF did not appear to affect ceramide levels by other metabolic pathways involved in ceramide turnover such as sphingomyelin degradation and ceramide biosynthesis, degradation, and glucosylation, Enzymatic studies demonstrating a relevant and rapid increase in sphingomyelin synthase activity after bFGF treatment have provided a convincing explanation for the activation of sphingomyelin biosynthesis, The bFGF-induced increase in sphingomyelin synthase appears to depend on a post-translational activation mechanism. Moreover, in the presence of brefeldin A, the activation of sphingomyelin biosynthesis was abolished, suggesting that the enzyme is located in a compartment other than the Golgi apparatus. Also the phosphatidylcholine-specific phospholipase C inhibitor D609 exerted a potent inhibitory effect on sphingomyelin biosynthesis. Finally, we demonstrate that inhibition of sphingomyelin biosynthesis by brefeldin A or D609 led to a significant inhibition of bFGF-stimulated mitogenesis. All this supports that, in primary astrocytes, the early activation of sphingomyelin synthase is involved in the bFGF signaling pathway leading to proliferation.	Univ Milan, Study Ctr Funct Biochem Brain Lipids, Dept Med Chem & Biochem, LITA Segrate, I-20090 Milan, Italy	University of Milan	Riboni, L (corresponding author), Univ Milan, Study Ctr Funct Biochem Brain Lipids, Dept Med Chem & Biochem, LITA Segrate, Via Fratelli Cervi 93, I-20090 Milan, Italy.	laura.riboni@unimi.it	Riboni, Laura/R-4281-2017; VIANI, PAOLA/Q-5955-2017; Giussani, Paola/R-4268-2017	Riboni, Laura/0000-0002-4149-8226; VIANI, PAOLA/0000-0002-5728-6631; Giussani, Paola/0000-0002-7793-1757; BASSI, ROSARIA/0000-0001-7409-4730				Albi E, 1999, FEBS LETT, V460, P369, DOI 10.1016/S0014-5793(99)01378-2; ALLAN D, 1999, BIOCHIM BIOPHYS ACTA, V1459, P277; ANDIEUABADIE N, 1998, BIOCHEM J, V333, P91; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Boldin S, 1997, J NEUROCHEM, V68, P882; Boldin SA, 2000, J BIOL CHEM, V275, P9905, DOI 10.1074/jbc.275.14.9905; Bourteele S, 1998, J BIOL CHEM, V273, P31245, DOI 10.1074/jbc.273.47.31245; BRUNING A, 1992, J BIOL CHEM, V267, P5052; CAI H, 1993, MOL CELL BIOL, V13, P7645, DOI 10.1128/MCB.13.12.7645; COOK HW, 1988, ANAL BIOCHEM, V174, P552, DOI 10.1016/0003-2697(88)90055-3; Coroneos E, 1996, BIOCHEM J, V316, P13, DOI 10.1042/bj3160013; COSTE H, 1986, BIOCHIM BIOPHYS ACTA, V858, P6, DOI 10.1016/0005-2736(86)90285-3; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; DODGE JT, 1967, J LIPID RES, V8, P667; DUTTON GR, 1981, J NEUROSCI METH, V3, P421, DOI 10.1016/0165-0270(81)90029-7; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Futerman AH, 1998, BIOCHEMISTRY-MOSCOW+, V63, P74; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; HATCH GM, 1992, J BIOL CHEM, V267, P12443; Huwiler A, 2000, BBA-MOL CELL BIOL L, V1485, P63, DOI 10.1016/S1388-1981(00)00042-1; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jayadev S, 1996, J LIPID MEDIAT CELL, V14, P295, DOI 10.1016/0929-7855(96)00538-X; JECKEL D, 1990, FEBS LETT, V261, P155, DOI 10.1016/0014-5793(90)80659-7; KALLEN KJ, 1993, BIOCHEM J, V289, P307, DOI 10.1042/bj2890307; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kobayashi H, 2000, J NEUROCHEM, V74, P2167, DOI 10.1046/j.1471-4159.2000.0742167.x; KOBAYASHI T, 1989, J BIOL CHEM, V264, P5966; Levade T, 1999, BBA-MOL CELL BIOL L, V1438, P1, DOI 10.1016/S1388-1981(99)00038-4; LIPSKY NG, 1983, P NATL ACAD SCI-BIOL, V80, P2608, DOI 10.1073/pnas.80.9.2608; LIPSKY NG, 1985, SCIENCE, V228, P745, DOI 10.1126/science.2581316; LOGAN A, 1992, J NEUROSCI, V12, P3828; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Luberto C, 2000, J BIOL CHEM, V275, P14760, DOI 10.1074/jbc.275.19.14760; MALGAT M, 1986, J LIPID RES, V27, P251; Mangoura D, 1998, J NEUROCHEM, V70, P130; MARGGRAF WD, 1982, BIOCHIM BIOPHYS ACTA, V710, P314, DOI 10.1016/0005-2760(82)90114-X; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; MOREAU P, 1994, BBA-REV BIOMEMBRANES, V1197, P257; Mufson RA, 1998, EXP CELL RES, V240, P228, DOI 10.1006/excr.1998.3932; MULLERDECKER K, 1989, BIOCHEM BIOPH RES CO, V162, P198, DOI 10.1016/0006-291X(89)91981-5; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Obradors MJM, 1997, BBA-MOL CELL RES, V1359, P1; PERRY DK, 1998, BIOCHIM BIOPHYS ACTA, V1426, P233; PHILIBERT RA, 1988, J NEUROCHEM, V51, P122, DOI 10.1111/j.1471-4159.1988.tb04844.x; REDEKOP GJ, 1995, J NEUROSURG, V82, P83, DOI 10.3171/jns.1995.82.1.0083; Riboni L, 2000, GLIA, V32, P137, DOI 10.1002/1098-1136(200011)32:2<137::AID-GLIA30>3.0.CO;2-2; Riboni L, 1997, PROG LIPID RES, V36, P153, DOI 10.1016/S0163-7827(97)00008-8; RIBONI L, 1992, FEBS LETT, V300, P188, DOI 10.1016/0014-5793(92)80193-K; Riboni L, 1999, BIOCHEM J, V338, P147, DOI 10.1042/0264-6021:3380147; Riboni L, 2000, J NEUROCHEM, V75, P503, DOI 10.1046/j.1471-4159.2000.0750503.x; RIBONI L, 1995, J BIOL CHEM, V270, P26868, DOI 10.1074/jbc.270.45.26868; Riboni L, 1996, FEBS LETT, V391, P336, DOI 10.1016/0014-5793(96)00772-7; RIBONI L, 1994, J BIOCHEM-TOKYO, V116, P140, DOI 10.1093/oxfordjournals.jbchem.a124486; Riboni L, 2000, METHOD ENZYMOL, V311, P656; Sadeghlar F, 2000, FEBS LETT, V478, P9, DOI 10.1016/S0014-5793(00)01818-4; Schinkmann KA, 2000, J NEUROCHEM, V74, P1931, DOI 10.1046/j.1471-4159.2000.0741931.x; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SCHWEIZER A, 1994, J BIOL CHEM, V269, P4035; Sillence DJ, 1998, BIOCHEM J, V331, P251, DOI 10.1042/bj3310251; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; TAKAHASHI JA, 1992, J NEUROSURG, V76, P792, DOI 10.3171/jns.1992.76.5.0792; Tettamanti G, 1996, J LIPID MEDIAT CELL, V14, P263, DOI 10.1016/0929-7855(96)00535-4; TRINCHERA M, 1991, J BIOL CHEM, V266, P20907; VAN HELVOORT A, 1994, J BIOL CHEM, V269, P1763; VANDENHILL A, 1985, BIOCHIM BIOPHYS ACTA, V833, P354, DOI 10.1016/0005-2760(85)90210-3; vanDijk MCM, 1997, J BIOL CHEM, V272, P11011; VANHELVOORT A, 1995, FEBS LETT, V369, P18, DOI 10.1016/0014-5793(95)00616-H; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; Vos JP, 1997, J NEUROCHEM, V68, P1252	73	80	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12797	12804		10.1074/jbc.M011570200	http://dx.doi.org/10.1074/jbc.M011570200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278937	hybrid			2022-12-27	WOS:000168198600048
J	Szick-Miranda, K; Bailey-Serres, J				Szick-Miranda, K; Bailey-Serres, J			Regulated heterogeneity in 12-kDa P-protein phosphorylation and composition of ribosomes in maize (Zea mays L.)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ACIDIC PHOSPHOPROTEINS; RAT-LIVER; POSTTRANSCRIPTIONAL REGULATION; ARTEMIA-SALINA; BINDING; RNA; ENDOSPERM; SUBUNIT; KINASE	Maize (Zea mays L.) possesses four distinct similar to 12-kDa P-proteins (P1, P2a, P2b, P3) that form the tip of a lateral stalk on the 60 S ribosomal subunit, RNA blot analyses suggested that the expression of these proteins was developmentally regulated. Western blot analysis of ribosomal proteins isolated from various organs, kernel tissues during seed development, and root tips deprived of oxygen (anoxia) revealed significant heterogeneity in the levels of these proteins. P1 and P3 were detected in ribosomes of all samples at similar levels relative to ribosomal protein S6, whereas P2a and P2b levels showed considerable developmental regulation. Both forms of P2 were present in ribosomes of some organs, whereas only one form was detected in other organs. Considerable tissue specific variation was observed in levels of monomeric and multimeric forms of P2a. P2b was not detected in root tips, accumulated late in seed embryo and endosperm development, and was detected in soluble ribosomes but not in membrane-associated ribosomes that copurified with zein protein bodies of the kernel endosperm. The phosphorylation of the 12-kDa P-proteins was also developmentally and environmentally regulated. The potential role of P2 heterogeneity in P-protein composition in the regulation of translation is discussed.	Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Bailey-Serres, J (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, 2130 Batchelor Hall, Riverside, CA 92521 USA.		Bailey-Serres, Julia/A-2470-2010	Bailey-Serres, Julia/0000-0002-8568-7125				Bailey-Serres J, 1998, LOOK BEYOND TRANSCRIPTION, P125; BaileySerres J, 1997, PLANT PHYSIOL, V114, P1293, DOI 10.1104/pp.114.4.1293; Ballesta JPG, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P115; Ballesta JPG, 1996, PROG NUCLEIC ACID RE, V55, P157, DOI 10.1016/S0079-6603(08)60193-2; Bargis-Surgey P, 1999, EUR J BIOCHEM, V262, P606, DOI 10.1046/j.1432-1327.1999.00434.x; Bou G, 2000, ARCH BIOCHEM BIOPHYS, V375, P83, DOI 10.1006/abbi.1999.1639; CONE KC, 1986, P NATL ACAD SCI USA, V83, P9631, DOI 10.1073/pnas.83.24.9631; CRUZALVAREZ M, 1991, MOL GEN GENET, V225, P331, DOI 10.1007/BF00269866; Doehlert DC, 1994, SEED SCI RES, V4, P299, DOI 10.1017/S0960258500002336; ELKON K, 1986, P NATL ACAD SCI USA, V83, P7419, DOI 10.1073/pnas.83.19.7419; FENNOY SL, 1995, PLANT J, V7, P287, DOI 10.1046/j.1365-313X.1995.7020287.x; HASLER P, 1991, J BIOL CHEM, V266, P13815; ISSINGER OG, 1977, BIOCHIM BIOPHYS ACTA, V477, P185, DOI 10.1016/0005-2787(77)90234-9; MACCONNELL WP, 1982, J BIOL CHEM, V257, P5359; Manjunath S, 1999, PLANT J, V19, P21, DOI 10.1046/j.1365-313X.1999.00489.x; MOLLER W, 1990, RIBOSOME, P380; MOLLER W, 1975, P NATL ACAD SCI USA, V72, P4774; MOSINGER E, 1983, PLANTA, V158, P501, DOI 10.1007/BF00397241; Muench DG, 1998, PLANT PHYSIOL, V116, P559, DOI 10.1104/pp.116.2.559; PILECKI M, 1992, EUR J BIOCHEM, V206, P259, DOI 10.1111/j.1432-1033.1992.tb16924.x; Pilecki M, 2000, J BASIC MICROB, V40, P251, DOI 10.1002/1521-4028(200008)40:4<251::AID-JOBM251>3.0.CO;2-H; REMACHA M, 1990, MOL CELL BIOL, V10, P2182, DOI 10.1128/MCB.10.5.2182; REMACHA M, 1992, J BIOL CHEM, V267, P12061; REMACHA M, 1995, MOL CELL BIOL, V15, P4754; REMACHA M, 1988, J BIOL CHEM, V263, P9094; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; SAMBROOK J, 1989, MOL CLONING, V2, P9; SANCHEZMADRID F, 1981, EUR J BIOCHEM, V114, P609, DOI 10.1111/j.1432-1033.1981.tb05187.x; SANCHEZMADRID F, 1979, EUR J BIOCHEM, V98, P49; SANTOS C, 1995, J BIOL CHEM, V270, P20608, DOI 10.1074/jbc.270.35.20608; STANKOVIC B, 1993, PROTOPLASMA, V177, P66, DOI 10.1007/BF01403400; Szick K, 1998, P NATL ACAD SCI USA, V95, P2378, DOI 10.1073/pnas.95.5.2378; Szyszka R, 1996, BBA-PROTEIN STRUCT M, V1293, P213, DOI 10.1016/0167-4838(95)00246-4; TSURUGI K, 1985, J BIOCHEM-TOKYO, V98, P1427, DOI 10.1093/oxfordjournals.jbchem.a135410; TSURUGI K, 1991, BIOCHEM BIOPH RES CO, V174, P1318, DOI 10.1016/0006-291X(91)91566-U; UCHIUMI T, 1990, J BIOL CHEM, V265, P89; UCHIUMI T, 1986, EUR J BIOCHEM, V156, P37, DOI 10.1111/j.1432-1033.1986.tb09545.x; UCHIUMI T, 1992, J BIOL CHEM, V267, P19179; UCHIUMI T, 1987, P NATL ACAD SCI USA, V84, P5580, DOI 10.1073/pnas.84.16.5580; VANAGTHOVEN A, 1978, EUR J BIOCHEM, V91, P553; Vard C, 1997, J BIOL CHEM, V272, P20259, DOI 10.1074/jbc.272.32.20259; Young TE, 2000, PLANT MOL BIOL, V42, P397, DOI 10.1023/A:1006333103342; Zambrano R, 1997, BIOCHEMISTRY-US, V36, P14439, DOI 10.1021/bi971494o; ZINKER S, 1980, BIOCHIM BIOPHYS ACTA, V606, P76, DOI 10.1016/0005-2787(80)90099-4; Zurdo J, 2000, BIOCHEMISTRY-US, V39, P8929, DOI 10.1021/bi000362j	45	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10921	10928		10.1074/jbc.M011002200	http://dx.doi.org/10.1074/jbc.M011002200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11278810	hybrid			2022-12-27	WOS:000167980900049
J	Karpen, HE; Bukowski, JT; Hughes, T; Gratton, JP; Sessa, WC; Gailani, MR				Karpen, HE; Bukowski, JT; Hughes, T; Gratton, JP; Sessa, WC; Gailani, MR			The sonic hedgehog receptor patched associates with caveolin-1 in cholesterol-rich microdomains of the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL-CELL CARCINOMAS; NITRIC-OXIDE SYNTHASE; HUMAN HOMOLOG; PROTEIN; COMPLEX; DOMAIN; RAS; IDENTIFICATION; TRAFFICKING; MUTATIONS	The hedgehog signaling pathway is involved in early embryonic patterning as well as in cancer; however, little is known about the subcellular localization of the Hedgehog receptor complex of Patched and Smoothened. Since Hh has been found in lipid rafts in Drosophila, we hypothesized that Patched and Smoothened might also be found in these cholesterol-rich microdomains. In this study, we demonstrate that both Smoothened and Patched are in caveolin-1-enriched/raft microdomains. Immunoprecipitation studies show that Patched specifically interacts with caveolin-1, whereas Smoothened does not. Fractionation studies show that Patched and caveolin-1 can be co-isolated from buoyant density fractions that represent caveolae/raft microdomains and that Patched and caveolin-1 co-localize by confocal microscopy, Glutathione S-transferase fusion protein experiments show that the interaction between Patched and caveolin-1 involves the caveolin-1 scaffolding domain and a Patched consensus binding site. Immunocytochemistry data and fractionation studies also show that Patched seems to be required for transport of Smoothened to the membrane. Depletion of plasmalemmal cholesterol influences the distribution of the Hh receptor complex in the caveolin-enriched/raft microdomains. These data suggest that caveolin-1 may be integral for sequestering the Hh receptor complex in these caveolin-enriched microdomains, which act as a scaffold for the interactions with the Hh protein.	USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pharmacol, New Haven, CT 06536 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine; Yale University; Yale University; Yale University	Karpen, HE (corresponding author), USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Dept Pediat, 1100 Bates St,Suite 10070, Houston, TX 77030 USA.	hkarpen@bcm.tmc.edu	Sessa, William C/B-6844-2011	Sessa, William C/0000-0001-5759-1938; Hughes, Thomas/0000-0001-5880-9951; Gratton, Jean-Philippe/0000-0001-9877-8520; Hughes, Thomas/0000-0002-8430-070X				CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Fielding CJ, 1997, P NATL ACAD SCI USA, V94, P3753, DOI 10.1073/pnas.94.8.3753; Fielding CJ, 1997, J LIPID RES, V38, P1503; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Hahn H, 1999, J MOL MED-JMM, V77, P459, DOI 10.1007/s001099900018; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hailstones D, 1998, J LIPID RES, V39, P369; Incardona JP, 2000, CURR OPIN CELL BIOL, V12, P193, DOI 10.1016/S0955-0674(99)00076-9; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lam CW, 1999, ONCOGENE, V18, P833, DOI 10.1038/sj.onc.1202360; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Sowa G, 1999, J BIOL CHEM, V274, P22524, DOI 10.1074/jbc.274.32.22524; Sternberg PW, 1999, NAT CELL BIOL, V1, pE35, DOI 10.1038/10028; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; TAYLOR AM, 1993, MECH DEVELOP, V42, P89, DOI 10.1016/0925-4773(93)90101-3; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	35	98	103	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19503	19511		10.1074/jbc.M010832200	http://dx.doi.org/10.1074/jbc.M010832200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278759	hybrid			2022-12-27	WOS:000169091000113
J	Saunders, MA; Sansores-Garcia, L; Gilroy, DW; Wu, KK				Saunders, MA; Sansores-Garcia, L; Gilroy, DW; Wu, KK			Selective suppression of CCAAT/enhancer-binding protein beta finding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTIONAL INHIBITORY PROTEIN; PROSTAGLANDIN-H SYNTHASE-2; NITRIC-OXIDE SYNTHASE; HUMAN COLON-CANCER; C/EBP-BETA; GENE-EXPRESSION; MESSENGER-RNA; ASPIRIN; ACTIVATION	The anti-inflammatory actions of salicylates cannot be explained by inhibition of cyclooxygenase (COX) activity. This study demonstrates that sodium salicylate at a therapeutic concentration suppressed COX-2 gene transcription induced by phorbol 12-myristate 13-acetate and interleukin 1 beta by inhibiting the binding of CCAAT/ enhancer-binding protein beta to its promoter region of COX-2. By contrast, salicylate did not inhibit nuclear factor kappa beta -dependent COX-2 induction by tumor necrosis factor alpha. The inhibitory effect of sodium salicylate was restricted to serum-deprived quiescent cells. These findings indicate that contrary to the current view that salicylate acts via inhibition of nuclear factor kappa beta the pharmacological actions of aspirin and salicylates are mediated by inhibiting CCAAT/enhancer-binding protein beta binding and transactivation. These findings have a major impact on the conceptual understanding of the mechanism of action of salicylates and on new drug discovery and design.	Univ Texas, Sch Med, Vasc Biol Res Ctr, Houston, TX 77030 USA; Univ Texas, Sch Med, Div Hematol, Houston, TX 77030 USA	University of Texas System; University of Texas System	Wu, KK (corresponding author), Univ Texas, Sch Med, Vasc Biol Res Ctr, 6431 Fannin St, Houston, TX 77030 USA.		Gilroy, Derek/AAP-7227-2020; Wu, Kenneth Kun-Yu/B-1070-2010; Gilroy, Derek W/C-2588-2009	Gilroy, Derek/0000-0003-3476-0844; Sansores-Garcia, Leticia/0000-0003-2510-225X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023327] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-50675] Funding Source: Medline; NINDS NIH HHS [NS-23327] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Chinery R, 1997, J BIOL CHEM, V272, P30356, DOI 10.1074/jbc.272.48.30356; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; Cromlish WA, 1996, BIOCHEM PHARMACOL, V52, P1777, DOI 10.1016/S0006-2952(96)00599-0; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DIEHL AM, 1994, HEPATOLOGY, V19, P447; Eberhardt W, 1998, J IMMUNOL, V160, P4961; Fawcett TW, 1996, J BIOL CHEM, V271, P14285, DOI 10.1074/jbc.271.24.14285; FRANTZ B, 1995, SCIENCE, V270, P2017, DOI 10.1126/science.270.5244.2017; Gilroy DW, 2001, FASEB J, V15, P288; GUPTA AK, 1999, AM J PHYSIOL, V276, P599; Jobin C, 1998, IMMUNOLOGY, V95, P537; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; Law BK, 2000, J BIOL CHEM, V275, P38261, DOI 10.1074/jbc.M005545200; Mitchell JA, 1997, MOL PHARMACOL, V51, P907, DOI 10.1124/mol.51.6.907; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Pan Z, 1999, J BIOL CHEM, V274, P23242, DOI 10.1074/jbc.274.33.23242; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Pope R, 2000, CYTOKINE, V12, P1171, DOI 10.1006/cyto.2000.0691; Schwenger P, 1999, J CELL PHYSIOL, V179, P109, DOI 10.1002/(SICI)1097-4652(199904)179:1<109::AID-JCP13>3.0.CO;2-W; Schwenger P, 1996, J BIOL CHEM, V271, P8089, DOI 10.1074/jbc.271.14.8089; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Stevenson MA, 1999, J IMMUNOL, V163, P5608; TAZAWA R, 1994, BIOCHEM BIOPH RES CO, V203, P190, DOI 10.1006/bbrc.1994.2167; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; TRAUTWEIN C, 1994, J CLIN INVEST, V93, P2554, DOI 10.1172/JCI117266; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Wadleigh DJ, 1999, BIOCHEM BIOPH RES CO, V264, P865, DOI 10.1006/bbrc.1999.1606; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259; WEDEL A, 1995, IMMUNOBIOLOGY, V193, P171, DOI 10.1016/S0171-2985(11)80541-3; Welm AL, 2000, J BIOL CHEM, V275, P27406; WU KK, 1991, P NATL ACAD SCI USA, V88, P2384, DOI 10.1073/pnas.88.6.2384; Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; Yin M, 1996, J BIOL CHEM, V271, P17974, DOI 10.1074/jbc.271.30.17974; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948	43	83	88	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18897	18904		10.1074/jbc.M011147200	http://dx.doi.org/10.1074/jbc.M011147200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278846	hybrid			2022-12-27	WOS:000169091000034
J	Tang, CJC; Chuang, CK; Hu, HM; Tang, TK				Tang, CJC; Chuang, CK; Hu, HM; Tang, TK			The zinc finger domain of Tzfp binds to the tbs motif located at the upstream flanking region of the Aie1 (aurora-C) kinase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; CHROMOSOME SEGREGATION REGULATORS; CYCLE-DEPENDENT EXPRESSION; HUMAN PROTEIN-KINASE; DNA-BINDING; YEAST IPL1; RAR-ALPHA; PLZF; LOCALIZATION; DROSOPHILA	Our previous studies showed that Aiel (aurora-C), is a novel. testis kinase belonging to the aurora kinase family (1). In this report, we describe a testis zinc finger protein (Tzfp) that binds to the upstream flanking sequence of the Aiel gene. The mouse Tzfp gene, mapped to chromosome 7 B2-B3, encodes a 465-amino acid transcription factor containing a conserved N-terminal BTB/POZ domain and three C-terminal PLZF-like C2H2 zinc fingers. The zinc finger domain of Tzfp binds to the TGTA-CAGTGT motif (Tzfp binding site, termed tbs) located at the upstream flanking sequence of the Aiel gene by gel mobility shift, DNase I footprinting, and competition analyses. When the C-terminal zinc fingers of Tzfp were fused to the transactivation domain of VP16, the chimera activated transcription of a reporter construct containing multiple copies of the tbs. In contrast, the same chimera did not activate the reporter gene when an essential nucleotide fifth C was mutated to A at the tbs. Furthermore, we showed that the N-terminal BTB/POZ domain of TZFP has a repressor activity. Taken together, our results indicate that Tzfp recognizes a sequence-specific motif (tbs) and may play a role in the regulation of the genes carrying the tbs.	Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Academia Sinica - Taiwan	Tang, TK (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Yen Chiu Yuan Rd,Sec 2, Taipei 115, Taiwan.		Tang, Tang K./S-7012-2018	Tang, Tang K./0000-0002-3660-0695				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bernard M, 1998, GENOMICS, V53, P406, DOI 10.1006/geno.1998.5522; BICKMORE WA, 1992, SCIENCE, V257, P235, DOI 10.1126/science.1321494; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Giet R, 1999, J CELL SCI, V112, P3591; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gopalan G, 1997, J CELL BIOL, V138, P643, DOI 10.1083/jcb.138.3.643; Hoatlin ME, 1999, BLOOD, V94, P3737, DOI 10.1182/blood.V94.11.3737.423k39_3737_3747; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Hu HM, 2000, DNA CELL BIOL, V19, P679, DOI 10.1089/10445490050199063; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Kimura M, 1999, J BIOL CHEM, V274, P7334, DOI 10.1074/jbc.274.11.7334; Kimura M, 1998, CYTOGENET CELL GENET, V82, P147, DOI 10.1159/000015089; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; Lin WC, 1999, BIOCHEM BIOPH RES CO, V264, P789, DOI 10.1006/bbrc.1999.1594; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Shindo M, 1998, BIOCHEM BIOPH RES CO, V244, P285, DOI 10.1006/bbrc.1998.8250; Sitterlin D, 1997, ONCOGENE, V14, P1067, DOI 10.1038/sj.onc.1200916; Tang CJC, 1998, BLOOD, V92, P1442, DOI 10.1182/blood.V92.4.1442.416k14_1442_1447; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Tseng TC, 1998, DNA CELL BIOL, V17, P823, DOI 10.1089/dna.1998.17.823; WANG ZY, 1993, P NATL ACAD SCI USA, V90, P8896, DOI 10.1073/pnas.90.19.8896; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375	31	35	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19631	19639		10.1074/jbc.M100170200	http://dx.doi.org/10.1074/jbc.M100170200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279021	hybrid			2022-12-27	WOS:000169091000129
J	Triplett, TL; Sgrignoli, AR; Gao, FB; Yang, YB; Tai, PC; Gierasch, LM				Triplett, TL; Sgrignoli, AR; Gao, FB; Yang, YB; Tai, PC; Gierasch, LM			Functional signal peptides bind a soluble n-terminal fragment of SecA and inhibit its ATPase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI MEMBRANE-VESICLES; ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; WILD-TYPE; RECOGNITION PARTICLE; SECONDARY STRUCTURE; PRECURSOR PROTEINS; HYDROPHOBIC REGION; PLASMA-MEMBRANE; MODEL MEMBRANES	The selective recognition of pre-secretory proteins by SecA is essential to the process of protein export from Escherichia coli, yet very little is known about the requirements for recognition and the mode of binding of precursors to SecA, The major reason for this is the lack of a soluble system suitable for biophysical study of the SecA-precursor complex. Complicating the development of such a system is the likelihood that SecA interacts with the precursor in a high affinity, productive manner only when it is activated by binding to membrane and SecYEG. A critical aspect of the precursor/SecA interaction is that it is regulated by various SecA ligands (nucleotide, lipid, SecYEG) to facilitate the release of the precursor, most likely in a stepwise fashion, for translocation, Several recent reports show that functions of SecA can be studied using separated domains. Using this approach, we have isolated a proteolytically generated N-terminal fragment of SecA, which is stably folded, has high ATPase activity, and represents an activated version of SecA, We report here that this fragment, termed SecA64, binds signal peptides with significantly higher affinity than does SecA, Moreover, the ATPase activity of SecA64 is inhibited by signal peptides to an extent that correlates with the ability of these signal peptides to inhibit either SecA translocation ATPase or in vitro protein translocation, arguing that the interaction with SecA64 is functionally significant. Thus, SecA64 offers a soluble, well defined system to study the mode of recognition of signal peptides by SecA and the regulation of signal peptide release.	Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Program Mol Biophys, Dallas, TX 75235 USA; Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University System of Georgia; Georgia State University	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu	Gierasch, Lila M/D-1494-2009		NIGMS NIH HHS [GM08297, GM34766, GM34962] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008297, R01GM034962, R01GM034766] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKITA M, 1990, J BIOL CHEM, V265, P8164; BLONDELGUINDI S, 1993, J BIOL CHEM, V268, P12730; BRIGGS MS, 1986, SCIENCE, V233, P206, DOI 10.1126/science.2941862; BRIGGS MS, 1984, BIOCHEMISTRY-US, V23, P3111, DOI 10.1021/bi00309a001; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; CHEN L, 1986, J BACTERIOL, V167, P389, DOI 10.1128/jb.167.1.389-392.1986; CHEN LL, 1987, J BIOL CHEM, V262, P1427; CHEN LL, 1985, P NATL ACAD SCI USA, V82, P4384, DOI 10.1073/pnas.82.13.4384; Chen XC, 1996, J BIOL CHEM, V271, P29698, DOI 10.1074/jbc.271.47.29698; CUNNINGHAM K, 1989, P NATL ACAD SCI USA, V86, P8630, DOI 10.1073/pnas.86.22.8630; Dapic V, 2000, J BIOL CHEM, V275, P25000, DOI 10.1074/jbc.M001100200; DenBlaauwen T, 1996, ARCH MICROBIOL, V165, P1, DOI 10.1007/s002030050289; Duong F, 1997, CELL, V91, P567, DOI 10.1016/S0092-8674(00)80444-4; Eichler J, 1997, P NATL ACAD SCI USA, V94, P5574, DOI 10.1073/pnas.94.11.5574; EMR SD, 1983, P NATL ACAD SCI-BIOL, V80, P4599, DOI 10.1073/pnas.80.15.4599; ERNST F, 1994, J BIOL CHEM, V269, P12840; FIKES JD, 1989, J BACTERIOL, V171, P402, DOI 10.1128/jb.171.1.402-409.1989; GELLER BL, 1986, P NATL ACAD SCI USA, V83, P4219, DOI 10.1073/pnas.83.12.4219; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; GOLDSTEIN J, 1991, J BIOL CHEM, V266, P14413; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HOYT DW, 1991, J BIOL CHEM, V266, P14406; HOYT DW, 1991, BIOCHEMISTRY-US, V30, P10155, DOI 10.1021/bi00106a012; Izard JW, 1996, J BIOL CHEM, V271, P21579, DOI 10.1074/jbc.271.35.21579; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; KIMURA E, 1991, J BIOL CHEM, V266, P6600; LAFORET GA, 1991, J BIOL CHEM, V266, P1326; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LEHNHARDT S, 1987, J BIOL CHEM, V262, P1716; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; MCKNIGHT CJ, 1989, J BIOL CHEM, V264, P17293; Miller A, 1998, J BIOL CHEM, V273, P11409, DOI 10.1074/jbc.273.19.11409; MILLER JD, 1994, NATURE, V367, P657, DOI 10.1038/367657a0; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; MORI H, 1998, BIOCHIM BIOPHYS ACTA, V1326, P23; NORBY JG, 1988, J BACTERIOL, V176, P4197; OLIVER DB, 1993, MOL MICROBIOL, V7, P159, DOI 10.1111/j.1365-2958.1993.tb01107.x; Price A, 1996, J BIOL CHEM, V271, P31580, DOI 10.1074/jbc.271.49.31580; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wang LG, 2000, J BIOL CHEM, V275, P10154, DOI 10.1074/jbc.275.14.10154; WEAVER AJ, 1992, J STRUCT BIOL, V109, P87, DOI 10.1016/1047-8477(92)90040-H; Weinkauf S, 2001, ACTA CRYSTALLOGR D, V57, P559, DOI 10.1107/S0907444901001202; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.bi.60.070191.000533	50	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19648	19655		10.1074/jbc.M100098200	http://dx.doi.org/10.1074/jbc.M100098200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279006	hybrid			2022-12-27	WOS:000169091000131
J	Liu, SH; Bugge, TH; Leppla, SH				Liu, SH; Bugge, TH; Leppla, SH			Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BOUND UROKINASE; LEWIS LUNG-CARCINOMA; SPONTANEOUS METASTASIS MODEL; HUMAN BREAST-CANCER; PROTECTIVE ANTIGEN; LETHAL FACTOR; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; MESSENGER-RNA; CATALYTIC DOMAIN	Urokinase plasminogen activator receptor (uPAR) binds pro-urokinase plasminogen activator (pro-uPA) and thereby localizes it near plasminogen, causing the generation of active uPA and plasmin on the cell surface. uPAR and uPA are overexpressed in a variety of human tumors and tumor cell lines, and expression of uPAR and uPA is highly correlated to tumor invasion and metastasis. To exploit these characteristics in the design of tumor cell-selective cytotoxins, we constructed mutated anthrax toxin-protective antigen (PrAg) proteins in which the furin cleavage site is replaced by sequences cleaved specifically by uPA. These uPA-targeted PrAg proteins were activated selectively on the surface of uPAR-expressing tumor cells in the presence of pro-uPA and plasminogen. The activated PrAg proteins caused internalization of a recombinant cytotoxin, FP59, consisting of anthrax toxin lethal factor residues 1-254 fused to the ADP-ribosylation domain of Pseudomonas exotoxin A, thereby killing the uPAR-expressing tumor cells. The activation and cytotoxicity of these uPA-targeted PrAg proteins were strictly dependent on the integrity of the tumor cell surface-associated plasminogen activation system. We also constructed a mutated PrAg protein that selectively killed tissue plasminogen activator-expressing cells. These mutated PrAg proteins may be useful as new therapeutic agents for cancer treatment.	NIDCR, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Leppla, SH (corresponding author), NIDCR, Oral Infect & Immun Branch, NIH, 30 Convent Dr,MSC 4350,Bldg 30,Rm 303, Bethesda, MD 20892 USA.			Liu, Shihui/0000-0003-3444-1069	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000929] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; ARORA N, 1993, J BIOL CHEM, V268, P3334; ARORA N, 1992, J BIOL CHEM, V267, P15542; ASTEDT B, 1976, NATURE, V261, P595, DOI 10.1038/261595a0; BAKER MS, 1990, CANCER RES, V50, P4676; BEALL FA, 1962, J BACTERIOL, V83, P1274, DOI 10.1128/JB.83.6.1274-1280.1962; BEHRENDT N, 1991, J BIOL CHEM, V266, P7842; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; Bugge TH, 1997, BLOOD, V90, P4522; Carmeliet P, 1998, J CELL BIOL, V140, P233, DOI 10.1083/jcb.140.1.233; Carriero MV, 1997, CLIN CANCER RES, V3, P1299; COLLEN D, 1991, BLOOD, V78, P3114; CUBELLIS MV, 1989, P NATL ACAD SCI USA, V86, P4828, DOI 10.1073/pnas.86.13.4828; Dano K, 1999, APMIS, V107, P120, DOI 10.1111/j.1699-0463.1999.tb01534.x; De Petro G, 1998, CANCER RES, V58, P2234; deVries TJ, 1996, MELANOMA RES, V6, P79, DOI 10.1097/00008390-199604000-00001; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; ELLIS V, 1991, J BIOL CHEM, V266, P12752; ELLIS V, 1993, J BIOL CHEM, V268, P4806; ELLIS V, 1990, J BIOL CHEM, V265, P9904; ELLIS V, 1989, J BIOL CHEM, V264, P2185; ESCUYER V, 1991, INFECT IMMUN, V59, P3381, DOI 10.1128/IAI.59.10.3381-3386.1991; EZZELL JW, 1984, INFECT IMMUN, V45, P761, DOI 10.1128/IAI.45.3.761-767.1984; Fabbrini MS, 1997, FASEB J, V11, P1169, DOI 10.1096/fasebj.11.13.9367352; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Gordon VM, 1997, INFECT IMMUN, V65, P4130, DOI 10.1128/IAI.65.10.4130-4134.1997; HALL SW, 1991, J BIOL CHEM, V266, P12329; HANNA PC, 1992, MOL BIOL CELL, V3, P1269, DOI 10.1091/mbc.3.11.1269; Hudson MA, 1997, J NATL CANCER I, V89, P709, DOI 10.1093/jnci/89.10.709; Ippoliti R, 2000, FASEB J, V14, P1335, DOI 10.1096/fj.14.10.1335; Ke SH, 1997, J BIOL CHEM, V272, P16603, DOI 10.1074/jbc.272.26.16603; Ke SH, 1997, J BIOL CHEM, V272, P20456, DOI 10.1074/jbc.272.33.20456; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; KOBAYASHI H, 1994, THROMB HAEMOSTASIS, V71, P474; KOBAYASHI H, 1994, INT J CANCER, V57, P727, DOI 10.1002/ijc.2910570520; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Kreitman RJ, 1999, CURR OPIN IMMUNOL, V11, P570, DOI 10.1016/S0952-7915(99)00005-9; Lamba D, 1996, J MOL BIOL, V258, P117, DOI 10.1006/jmbi.1996.0238; Lanza F, 1998, BRIT J HAEMATOL, V103, P110; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; LEPPLA SH, 1995, HANDB NAT T, V8, P543; LEPPLA SH, 1999, COMPREHENSIVE SOURCE, P243; Leppla SH, 1988, BACTERIAL PROTEIN TO, P111; LIOTTA LA, 1981, CANCER RES, V41, P4629; Liu SH, 2000, CANCER RES, V60, P6061; MEISSAUER A, 1992, EXP CELL RES, V199, P179, DOI 10.1016/0014-4827(92)90423-6; Mignatti P, 1996, ENZYME PROTEIN, V49, P117, DOI 10.1159/000468621; MILES LA, 1985, J BIOL CHEM, V260, P4303; MILNE JC, 1994, J BIOL CHEM, V269, P20607; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Montuori N, 2000, FEBS LETT, V476, P166, DOI 10.1016/S0014-5793(00)01713-0; Morita S, 1998, INT J CANCER, V78, P286, DOI 10.1002/(SICI)1097-0215(19981029)78:3<286::AID-IJC4>3.0.CO;2-R; Nielsen BS, 1996, LAB INVEST, V74, P168; NIELSEN LS, 1982, BIOCHEMISTRY-US, V21, P6410, DOI 10.1021/bi00268a014; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; PLESNER T, 1994, AM J CLIN PATHOL, V102, P835, DOI 10.1093/ajcp/102.6.835; PLOUG M, 1994, BIOCHEMISTRY-US, V33, P8991, DOI 10.1021/bi00196a017; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Ploug M, 1998, BIOCHEMISTRY-US, V37, P3612, DOI 10.1021/bi972787k; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; PYKE C, 1994, HISTOPATHOLOGY, V24, P131, DOI 10.1111/j.1365-2559.1994.tb01291.x; PYKE C, 1991, AM J PATHOL, V138, P1059; Ragno P, 1998, CANCER RES, V58, P1315; Rajagopal V, 2000, J BIOL CHEM, V275, P7566, DOI 10.1074/jbc.275.11.7566; RONNE E, 1991, FEBS LETT, V288, P233, DOI 10.1016/0014-5793(91)81042-7; Schmidt M, 1999, ACTA OTO-LARYNGOL, V119, P949; Schmitt M, 1997, THROMB HAEMOSTASIS, V78, P285; Shetty S, 1998, ARCH BIOCHEM BIOPHYS, V356, P265, DOI 10.1006/abbi.1998.0789; Sier CFM, 1998, CANCER RES, V58, P1843; SINGH Y, 1989, J BIOL CHEM, V264, P19103; Singh Y, 1990, SALISBURY MED B, V68, P46; SKRIVER L, 1984, Journal of Cell Biology, V99, P752; SMITH H, 1962, J GEN MICROBIOL, V29, P517, DOI 10.1099/00221287-29-3-517; SPRAGGON G, 1995, STRUCTURE, V3, P681, DOI 10.1016/S0969-2126(01)00203-9; STEPHENS RW, 1989, J CELL BIOL, V108, P1987, DOI 10.1083/jcb.108.5.1987; Taniguchi T, 1998, CANCER RES, V58, P4461; Varughese M, 1999, INFECT IMMUN, V67, P1860; Varughese M, 1998, MOL MED, V4, P87, DOI 10.1007/BF03401732; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; WERB Z, 1977, NEW ENGL J MED, V296, P1017, DOI 10.1056/NEJM197705052961801	81	150	182	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17976	17984		10.1074/jbc.M011085200	http://dx.doi.org/10.1074/jbc.M011085200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278833	hybrid			2022-12-27	WOS:000168866500049
J	Ahn, W; Kim, KH; Lee, JA; Kim, JY; Choi, JY; Moe, OW; Milgram, SL; Muallem, S; Lee, MG				Ahn, W; Kim, KH; Lee, JA; Kim, JY; Choi, JY; Moe, OW; Milgram, SL; Muallem, S; Lee, MG			Regulatory interaction between the cystic fibrosis transmembrane conductance regulator and HCO3- salvage mechanisms in model systems and the mouse pancreatic duct	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-MEDIATED INHIBITION; CL-/HCO3 EXCHANGE; APICAL MEMBRANE; PROTEIN; CFTR; EXPRESSION; DOMAIN; CELLS; ASSOCIATION; MUTATION	The pancreatic duct expresses cystic fibrosis transmembrane conductance regulator (CFTR) and HCO3- secretory and salvage mechanisms in the luminal membrane. Although CFTR plays a prominent role in HCO3- secretion, the role of CFTR in HCO3- salvage is not known. In the present work, we used molecular, biochemical, and functional approaches to study the regulatory interaction between CFTR and the HCO3- salvage mechanism Na+/H+ exchanger isoform 3 (NHE3) in heterologous expression systems and in the native pancreatic duct. We found that CFTR regulates NHE3 activity by both acute and chronic mechanisms. In the pancreatic duct, CFTR increases expression of NHE3 in the luminal membrane. Thus, luminal expression of NHE3 was reduced by 53% in ducts of homozygote Delta F508 mice. Accordingly, luminal Na+-dependent and HOE694-sensitive recovery from an acid load was reduced by 60% in ducts of Delta F508 mice. CFTR and NHE3 were coimmunoprecipitated from PS120 cells expressing both proteins and the pancreatic duct of wild type mice but not from PS120 cells lacking CFTR or the pancreas of Delta F508 mice. The interaction between CFTR and NHE3 required the COOH-terminal PDZ binding motif of CFTR, and mutant CFTR proteins lacking the C terminus were not co-immunoprecipitated with NHE3, Furthermore, when expressed in PS120 cells, wild type CFTR, but not CFTR mutants lacking the C-terminal PDZ binding motif, augmented cAMP-dependent inhibition of NHE3 activity by 31%. These findings reveal that CFTR controls overall HCO3- homeostasis by regulating both pancreatic ductal HCO3- secretory and salvage mechanisms.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA; Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of North Carolina; University of North Carolina Chapel Hill	Muallem, S (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.		Lee, Min Goo/AAS-4636-2020; Kim, Joo Young/X-7562-2019; Lee, Min Goo/D-5635-2012	Lee, Min Goo/0000-0001-7436-012X; Kim, Joo Young/0000-0003-2623-1491; Lee, Min Goo/0000-0001-7436-012X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL63755] Funding Source: Medline; NIDCR NIH HHS [DE12309] Funding Source: Medline; NIDDK NIH HHS [DK38938] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; Choi JY, 2000, J CLIN INVEST, V105, P1141, DOI 10.1172/JCI9260; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; JOHANSEN PG, 1968, LANCET, V1, P455; Kocher O, 1998, LAB INVEST, V78, P117; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Lee MG, 2000, J CLIN INVEST, V105, P1651, DOI 10.1172/JCI9207; Lee MG, 1998, J PHYSIOL-LONDON, V513, P341, DOI 10.1111/j.1469-7793.1998.341bb.x; Lee MG, 1999, J BIOL CHEM, V274, P14670, DOI 10.1074/jbc.274.21.14670; Mickle JE, 1998, HUM MOL GENET, V7, P729, DOI 10.1093/hmg/7.4.729; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Owyang C, 1995, TXB GASTROENTEROLOGY, P361; Park K, 1999, AM J PHYSIOL-GASTR L, V276, pG470, DOI 10.1152/ajpgi.1999.276.2.G470; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Vankeerberghen A, 1998, HUM MOL GENET, V7, P1761, DOI 10.1093/hmg/7.11.1761; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Wheat VJ, 2000, AM J PHYSIOL-CELL PH, V279, pC62, DOI 10.1152/ajpcell.2000.279.1.C62; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442; Zhang L, 1998, P NATL ACAD SCI USA, V95, P10158, DOI 10.1073/pnas.95.17.10158	30	84	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17236	17243		10.1074/jbc.M011763200	http://dx.doi.org/10.1074/jbc.M011763200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278980	hybrid			2022-12-27	WOS:000168730400085
J	Lei, WB; Talley, EM; Bayliss, DA				Lei, WB; Talley, EM; Bayliss, DA			Receptor-mediated inhibition of G protein-coupled inwardly rectifying potassium channels involves G alpha(q) family subunits, phospholipase C, and a readily diffusible messenger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; K+-CHANNEL; ION CHANNELS; RGS PROTEINS; ACTIVATION; CURRENTS; NEURONS; COMBINATIONS; BINDING; DOMAINS	G protein-coupled inwardly rectifying K+ (GIRK) channels can be activated or inhibited by distinct classes of receptor (G alpha (i/o)- and G alpha (q)-coupled), providing dynamic regulation of cellular excitability. Receptor-mediated activation involves direct effects of G betay subunits on GIRK channels, but mechanisms involved in GIRK channel inhibition have not been fully elucidated, An HEK293 cell line that stably expresses GIRK1/4 channels was used to test G protein mechanisms that mediate GIRK channel inhibition. In cells transiently or stably cotransfected with 5-HT1A (G alpha (i/o)-coupled) and TRH-R1 (G alpha (q)-coupled) receptors, 5-HT (5-hydroxytryptamine; serotonin) enhanced GIRK channel currents, whereas thyrotropin-releasing hormone (TRH) inhibited both basal and B-HT-activated GIRK channel currents. Inhibition of GIRK channel currents by TRH primarily involved signaling by G alpha (q) family subunits, rather than G beta gamma dimers: GIRK channel current inhibition was diminished by Pasteurella multocida toxin, mimicked by constitutively active members of the G alpha (q) family, and reduced by minigene constructs that disrupt G alpha (q) signaling, but was completely preserved in cells expressing constructs that interfere with signaling by G beta gamma subunits. Inhibition of GIRK channel currents by TRH and constitutively active G alpha (q) was reduced by U73122, an inhibitor of phospholipase C (PLC), Moreover, TRH-R1-mediated GIRK channel inhibition was diminished by minigene constructs that reduce membrane levels of the PLC substrate phosphatidylinositol bisphosphate, further implicating PLC. However, we found no evidence for involvement of protein kinase C, inositol trisphosphate, or intracellular calcium. Although these downstream signaling intermediaries did not contribute to receptor-mediated GIRK channel inhibition, bath application of TRH decreased GIRK channel activity in cell-attached patches. Together, these data indicate that receptor-mediated inhibition of GIRK channels involves PLC activation by G alpha subunits of the G alpha (q) family and suggest that inhibition may be communicated at a distance to GIRK channels via unbinding and diffusion of phosphatidylinositol bisphosphate away from the channel.	Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Bayliss, DA (corresponding author), Univ Virginia, Dept Pharmacol, POB 800735,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.				NIMH NIH HHS [MH12091] Funding Source: Medline; NINDS NIH HHS [NS39553, R01 NS039553] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH012091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039553] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bommakanti RK, 2000, J BIOL CHEM, V275, P38870, DOI 10.1074/jbc.M007403200; BRAUN AP, 1992, PFLUG ARCH EUR J PHY, V421, P431, DOI 10.1007/BF00370253; Bunemann M, 2000, J BIOL CHEM, V275, P12537, DOI 10.1074/jbc.275.17.12537; Cho H, 2001, J BIOL CHEM, V276, P159, DOI 10.1074/jbc.M004826200; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; CLAPHAM DE, 1994, ANNU REV NEUROSCI, V17, P441; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; Farkas RH, 1997, NEUROSCI LETT, V231, P21, DOI 10.1016/S0304-3940(97)00530-2; Fletcher JE, 1998, J BIOL CHEM, V273, P636, DOI 10.1074/jbc.273.1.636; Hill JJ, 2001, J BIOL CHEM, V276, P5505, DOI 10.1074/jbc.M008213200; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Irvine R, 1998, CURR BIOL, V8, pR557, DOI 10.1016/S0960-9822(07)00360-0; Kammermeier PJ, 1999, NEURON, V22, P819, DOI 10.1016/S0896-6273(00)80740-0; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Lei QB, 2000, P NATL ACAD SCI USA, V97, P9771, DOI 10.1073/pnas.97.17.9771; Lindorfer MA, 1998, J BIOL CHEM, V273, P34429, DOI 10.1074/jbc.273.51.34429; Melliti K, 2000, J NEUROSCI, V20, P7167; Meyer T, 2001, J BIOL CHEM, V276, P5650, DOI 10.1074/jbc.M009179200; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Ruiz-Velasco V, 2000, J NEUROSCI, V20, P2183; Sambrook J., 2002, MOL CLONING LAB MANU; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Snow BE, 1999, P NATL ACAD SCI USA, V96, P6489, DOI 10.1073/pnas.96.11.6489; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Toby G, 1998, BIOTECHNIQUES, V24, P637, DOI 10.2144/98244st05; VANNER S, 1993, J NEUROPHYSIOL, V69, P1632, DOI 10.1152/jn.1993.69.5.1632; VELIMIROVIC BM, 1995, P NATL ACAD SCI USA, V92, P1590, DOI 10.1073/pnas.92.5.1590; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WICKMAN KD, 1995, CURR OPIN NEUROBIOL, V5, P278, DOI 10.1016/0959-4388(95)80039-5; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Wilson BA, 1997, J BIOL CHEM, V272, P1268, DOI 10.1074/jbc.272.20.12961; WU DQ, 1993, J BIOL CHEM, V268, P3704; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Yamaguchi H, 1997, AM J PHYSIOL-HEART C, V273, pH1745, DOI 10.1152/ajpheart.1997.273.4.H1745; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhou JY, 2000, J NEUROSCI, V20, P7143	42	75	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16720	16730		10.1074/jbc.M100207200	http://dx.doi.org/10.1074/jbc.M100207200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279027	hybrid			2022-12-27	WOS:000168730400019
J	Castrillo, A; de las Heras, B; Hortelano, S; Rodriguez, B; Villar, A; Bosca, L				Castrillo, A; de las Heras, B; Hortelano, S; Rodriguez, B; Villar, A; Bosca, L			Inhibition of the nuclear factor kappa B (NF-kappa B) pathway by tetracyclic kaurene diterpenes in macrophages - Specific effects on NF-kappa B-inducing kinase activity and on the coordinate activation of ERK and p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); CYCLOPENTENONE PROSTAGLANDINS; BACTERIAL LIPOPOLYSACCHARIDE; MURINE MACROPHAGES; SIGNALING PATHWAY; PPAR-GAMMA; BETA; ALPHA; PHOSPHORYLATION	The anti-inflammatory action of most terpenes has been explained in terms of the inhibition of nuclear factor kappaB (NF-kappaB) activity. Ent-kaurene diterpenes are intermediates of the synthesis of gibberellins and inhibit the expression of NO synthase-2 and the release of tumor necrosis factor-alpha in J774 macrophages challenged with lipopolysaccharide. These diterpenes inhibit NF-kappaB and I kappaB kinase (IKK) activation in vivo but failed to affect in vitro the function of NF-kappaB, the phosphorylation and targeting of I kappaB alpha, and the activity of IKK-2. Transient expression of NF-kappaB-inducing kinase (NIK) activated the IKK complex and NF-kappaB, a process that was inhibited by kaurenes, indicating that the inhibition of NIK was one of the targets of these diterpenes. These results show that kaurenes impair the inflammatory signaling by inhibiting NIK, a member of the MAPK kinase superfamily that interacts with tumor necrosis factor receptor-associated factors, and mediate the activation of NF-kappaB by these receptors. Moreover, kaurenes delayed the phosphorylation of p38, ERK1, and ERK2 MAPKs, but not that of JNK, in response to lipopolysaccharide treatment of J774 cells. The absence of a coordinate activation of MAPK and IKK might contribute to a deficient activation of NF-kappaB that is involved in the anti-inflammatory activity of these molecules.	Univ Complutense, Fac Farm, Dept Farmacol, Madrid 28040, Spain; Ctr Quim Organ M Lora Tamayo, Madrid 28006, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Organic Chemistry Centre Lora-Tamayo (CENQUIOR)	Bosca, L (corresponding author), Univ Complutense, Fac Farm, Inst Bioquim, Ctr Mixto Consejo Invest Cient, Madrid 28040, Spain.	boscal@eucmax.sim.ucm.es	de las Heras, Beatriz/ABB-9645-2021; Hortelano, Sonsoles/A-7954-2010; de las Heras, Beatriz/K-1811-2014; Bosca, Lisardo/A-2059-2008	de las Heras, Beatriz/0000-0001-5089-8988; Hortelano, Sonsoles/0000-0003-2528-0072; de las Heras, Beatriz/0000-0001-5089-8988; Bosca, Lisardo/0000-0002-0253-5469				Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Batista R, 1999, PLANTA MED, V65, P283, DOI 10.1055/s-2006-960781; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Baumann B, 2000, P NATL ACAD SCI USA, V97, P4615, DOI 10.1073/pnas.080583397; Carter KB, 2000, J BIOL CHEM, V275, P27858; Castrillo A, 2000, MOL CELL BIOL, V20, P1692, DOI 10.1128/MCB.20.5.1692-1698.2000; CHEN K, 1995, BIOORGAN MED CHEM, V3, P1345, DOI 10.1016/0968-0896(95)00114-V; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; de las Heras B, 1999, BRIT J PHARMACOL, V128, P605, DOI 10.1038/sj.bjp.0702844; de Quesada T.G., 1972, TETRAHEDRON LETT, P2187; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiazGuerra MJM, 1996, J BIOL CHEM, V271, P30114, DOI 10.1074/jbc.271.47.30114; Dirsch VM, 1997, EUR J PHARMACOL, V336, P211, DOI 10.1016/S0014-2999(97)01245-4; GEPPERT TD, 1994, MOL MED, V1, P93; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Harhaj EW, 1998, J BIOL CHEM, V273, P25185, DOI 10.1074/jbc.273.39.25185; Hehner SP, 1999, J IMMUNOL, V163, P5617; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hou AJ, 2000, J NAT PROD, V63, P599, DOI 10.1021/np9903705; Jiang B, 1999, J NAT PROD, V62, P941, DOI 10.1021/np980426f; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Kosaka Y, 1999, EUR J IMMUNOL, V29, P1353, DOI 10.1002/(SICI)1521-4141(199904)29:04<1353::AID-IMMU1353>3.0.CO;2-2; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lee IS, 1996, CHEM-BIOL INTERACT, V99, P193; Lee YW, 2000, CANCER LETT, V156, P133, DOI 10.1016/S0304-3835(00)00452-3; Li JJ, 1997, CANCER RES, V57, P3569; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Manna SK, 2000, CANCER RES, V60, P3838; Matsuda H, 2000, LIFE SCI, V66, P2151, DOI 10.1016/S0024-3205(00)00542-7; Matsuda H, 1999, BIOORG MED CHEM LETT, V9, P3081, DOI 10.1016/S0960-894X(99)00536-3; Mohan R, 1998, J BIOL CHEM, V273, P25903, DOI 10.1074/jbc.273.40.25903; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Navarro A, 1997, Z NATURFORSCH C, V52, P844; NEGISHI M, 1995, J LIPID MEDIAT CELL, V12, P443, DOI 10.1016/0929-7855(95)00029-P; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; O'Connell MA, 1998, J BIOL CHEM, V273, P30410, DOI 10.1074/jbc.273.46.30410; Peter K, 1999, CIRCULATION, V100, P1533, DOI 10.1161/01.CIR.100.14.1533; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Pillinger MH, 1998, P NATL ACAD SCI USA, V95, P14540, DOI 10.1073/pnas.95.24.14540; PROEYK KJ, 2000, BLOOD, V96, P2592; Ricote M, 1999, J LEUKOCYTE BIOL, V66, P733, DOI 10.1002/jlb.66.5.733; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Tudzynski B, 1999, APPL MICROBIOL BIOT, V52, P298, DOI 10.1007/s002530051524; van der Bruggen T, 1999, INFECT IMMUN, V67, P3824, DOI 10.1128/IAI.67.8.3824-3829.1999; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Yamaguchi S, 2000, PLANT CELL PHYSIOL, V41, P251, DOI 10.1093/pcp/41.3.251; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	56	104	107	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15854	15860		10.1074/jbc.M100010200	http://dx.doi.org/10.1074/jbc.M100010200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278990	hybrid			2022-12-27	WOS:000168623100039
J	Hamilton, SE; Nathanson, NM				Hamilton, SE; Nathanson, NM			The M-1 receptor is required for muscarinic activation of mitogen-activated protein (MAP) kinase in murine cerebral cortical neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; TISSUE-SPECIFIC REGULATION; ACETYLCHOLINE-RECEPTOR; CHICK HEART; LINKED RECEPTORS; CELLS; GENE; PATHWAY; SECRETION; PIRENZEPINE	Muscarinic acetylcholine receptors (mAChR) in the central nervous system are involved in learning and memory, epileptic seizures, and processing the amyloid precursor protein. The M-1 receptor is the predominant ntAChR subtype in the cortex and hippocampus. Although the five mAChR fall into two broad functional groups, all five subtypes, when expressed in recombinant systems, can activate the mitogen-activated protein kinase (MAPK) pathway. The MAPK pathway has been implicated in learning and memory, amyloid protein processing, and neuronal plasticity. We used M-1 knock-out mice to determine the role of this receptor subtype in signal transduction in the mouse forebrain, In primary cortical cultures from mice lacking the M-1 mAChR, agonist-stimulated phosphoinositide hydrolysis was reduced by more than 60% compared with cultures from wild type mice. Although muscarinic agonists induced robust activation of MAPK in cortical cultures from wild type mice, mAChR-mediated activation of MAPK was virtually absent in cultures from M-1-deficient mice. These results indicate that the M-1, mAChR is the major subtype that mediates activation of phospholipase C and MAPK in mouse forebrain.	Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Nathanson, NM (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, POB 357750, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026920] Funding Source: NIH RePORTER; NINDS NIH HHS [NS26920] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anagnostaras S.G, 2000, SOC NEUR ABSTR, V26, P1509; Berkeley JL, 2000, J NEUROCHEM, V75, P487, DOI 10.1046/j.1471-4159.2000.0750487.x; BERSTEIN G, 1989, MOL PHARMACOL, V36, P601; Chan GCK, 1998, J NEUROSCI, V18, P5322, DOI 10.1523/JNEUROSCI.18-14-05322.1998; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Efthimiopoulos S, 1996, P NATL ACAD SCI USA, V93, P8046, DOI 10.1073/pnas.93.15.8046; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; FUKADA K, 1988, NATURE, V335, P355; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Haring R, 1998, J NEUROCHEM, V71, P2094; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; LEVEY AI, 1993, LIFE SCI, V52, P441, DOI 10.1016/0024-3205(93)90300-R; LUETJE CW, 1987, BIOCHEMISTRY-US, V26, P4876, DOI 10.1021/bi00389a040; Maggio R, 1999, J PHARMACOL EXP THER, V291, P251; Maggio R, 1996, J BIOL CHEM, V271, P31055, DOI 10.1074/jbc.271.49.31055; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; MCKINNON LA, 1995, J BIOL CHEM, V270, P20636, DOI 10.1074/jbc.270.35.20636; MESSER WS, 1991, BRAIN RES, V564, P66, DOI 10.1016/0006-8993(91)91352-2; Mills J, 1997, J NEUROSCI, V17, P9415; OFFERMANNS S, 1993, BIOCHEM J, V294, P545, DOI 10.1042/bj2940545; Orban PC, 1999, TRENDS NEUROSCI, V22, P38, DOI 10.1016/S0166-2236(98)01306-X; Rosenblum K, 2000, J NEUROSCI, V20, P977, DOI 10.1523/JNEUROSCI.20-03-00977.2000; Rossner S, 1997, EUR J NEUROSCI, V9, P2125, DOI 10.1111/j.1460-9568.1997.tb01379.x; Rouse ST, 2000, NEUROSCI LETT, V278, P61, DOI 10.1016/S0304-3940(99)00914-3; SHAPIRO RA, 1988, J BIOL CHEM, V263, P18397; SUBERS EM, 1988, J MOL CELL CARDIOL, V20, P131, DOI 10.1016/S0022-2828(88)80026-9; TIETJE KM, 1991, J BIOL CHEM, V266, P17382; TIETJE KM, 1990, J BIOL CHEM, V265, P2828; TURSKI L, 1989, SYNAPSE, V3, P154, DOI 10.1002/syn.890030207; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yan CYI, 1998, J NEUROSCI, V18, P4042	33	74	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15850	15853		10.1074/jbc.M011563200	http://dx.doi.org/10.1074/jbc.M011563200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278934	hybrid			2022-12-27	WOS:000168623100038
J	Soteropoulos, P; Valiakhmetov, A; Kashiwazaki, R; Perlin, DS				Soteropoulos, P; Valiakhmetov, A; Kashiwazaki, R; Perlin, DS			Helical stalk segments S4 and S5 of the plasma membrane H+(-)ATPase from Saccharomyces cerevisiae are optimized to impact catalytic site environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; H+-ATPASE GENE; P-TYPE ATPASES; CONFORMATIONAL CHANGE; DIRECTED MUTAGENESIS; CATION-BINDING; CALCIUM-PUMP; AMINO-ACIDS; MUTATIONS; PROTEIN	The stalk segments of P-type ion-translocating enzymes are presumed to play important roles in energy coupling. In this work, stalk segments S4 and S5 of the yeast H+-ATPase were examined for helical character, optimal length, and segment orientation by a combination of proline substitution, insertion/deletion mutagenesis, and second-site suppressor analyses. The substitution of various residues for helix-disrupting proline in both S4 (L353P,L353G; A354P; and G371P) and S5 (D676P and I684P) resulted in highly defective or inactive enzymes supporting the importance of helical character and/or the maintenance of essential interactions. The contiguous helical nature of transmembrane segment M5 and stalk element S5 was explored and found to be favorable, although not essential. The deletion or addition of one or more amino acids at positions Ala(354) in, S4 and Asp(676) in S5, which were intended to either rotate helical faces or extend/reduce the length of helical segments, resulted in enzyme destabilization that abolished most enzyme assembly. Second-site suppressor mutations were obtained to primary site mutations G371A (S4) and D676G (S5) and were analyzed with a molecular structure model of the H+-ATPase. Primary site mutations were predicted to alter the site of phosphorylation either directly or indirectly. The suppressor mutations either directly changed packing around the primary site or altered the environment of the site of phosphorylation. Overall, these data support the view that stalk segments S4 and S5 of the H+-ATPase are helical elements that are optimized for length and interactions with other stalk elements and can influence the phosphorylation domain.	Publ Hlth Res Inst City New York Inc, New York, NY 10016 USA		Perlin, DS (corresponding author), Publ Hlth Res Inst City New York Inc, 455 1st Ave, New York, NY 10016 USA.	perlin@phri.nyu.edu	Valiakhmetov, Airat/AAN-1307-2020; Perlin, David S/K-4013-2015	Valiakhmetov, Airat/0000-0002-4739-0806; 	NIGMS NIH HHS [GM 38225] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038225] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambesi A, 2000, J BIOL CHEM, V275, P20545, DOI 10.1074/jbc.M001682200; Ambesi A, 1996, J BIOL CHEM, V271, P22999, DOI 10.1074/jbc.271.38.22999; Ambesi A, 2000, J EXP BIOL, V203, P155; ANAND S, 1995, BBA-BIOMEMBRANES, V1234, P127, DOI 10.1016/0005-2736(94)00281-S; ANDERSEN JP, 1995, J BIOL CHEM, V270, P908, DOI 10.1074/jbc.270.2.908; Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; DeWitt ND, 1998, J BIOL CHEM, V273, P21744, DOI 10.1074/jbc.273.34.21744; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; Farley RA, 1997, BIOCHEMISTRY-US, V36, P941, DOI 10.1021/bi962153y; Garnett C, 1996, BIOCHEMISTRY-US, V35, P11019, DOI 10.1021/bi960718k; Gatto C, 1999, J BIOL CHEM, V274, P13737, DOI 10.1074/jbc.274.20.13737; HARRIS SL, 1991, J BIOL CHEM, V266, P24439; Jorgensen PL, 1998, BBA-BIOENERGETICS, V1365, P65, DOI 10.1016/S0005-2728(98)00043-7; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; Kaplan JH, 1998, ACTA PHYSIOL SCAND, V163, P99; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Ma HL, 1999, BIOCHEMISTRY-US, V38, P15522, DOI 10.1021/bi991523q; MCCUSKER JH, 1987, MOL CELL BIOL, V7, P4082, DOI 10.1128/MCB.7.11.4082; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; NAKAMOTO RK, 1991, J BIOL CHEM, V266, P7940; PERLIN DS, 1989, J BIOL CHEM, V264, P21857; Rice WJ, 1997, J BIOL CHEM, V272, P31412, DOI 10.1074/jbc.272.50.31412; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; SETOYOUNG D, 1992, BIOCHIM BIOPHYS ACTA, V1102, P213, DOI 10.1016/0167-4838(92)90512-C; SETOYOUNG D, 1994, J BIOL CHEM, V269, P23988; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2000, J BIOL CHEM, V275, P28954, DOI 10.1074/jbc.M004072200; Soteropoulos P, 1998, J BIOL CHEM, V273, P26426, DOI 10.1074/jbc.273.41.26426; Soteropoulos P, 1998, ACTA PHYSIOL SCAND, V163, P115; Stokes DL, 1999, CURR BIOL, V9, P672, DOI 10.1016/S0960-9822(99)80307-8; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; Wach A, 1996, BIOCHEMISTRY-US, V35, P883, DOI 10.1021/bi951998r; Wang GF, 1996, J BIOL CHEM, V271, P25438, DOI 10.1074/jbc.271.41.25438; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	38	6	6	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16265	16270		10.1074/jbc.M011115200	http://dx.doi.org/10.1074/jbc.M011115200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278840	hybrid			2022-12-27	WOS:000168623100093
J	de Nadal, E; Fadden, RP; Ruiz, A; Haystead, T; Arino, J				de Nadal, E; Fadden, RP; Ruiz, A; Haystead, T; Arino, J			A role for the ppz Ser/Thr protein phosphatases in the regulation of translation elongation factor 1B alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-II; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE EXCHANGE; YEAST-CELLS; PHENOTYPIC SUPPRESSION; FACTOR 1-BETA; FIDELITY; PHOSPHORYLATION; FACTOR-1-BETA; EXPRESSION	In vivo P-32 labeled yeast proteins from wild type and ppz1 ppz2 phosphatase mutants were resolved by bidimensional electrophoresis. A prominent phosphoprotein, which in ppz mutants showed a marked shift to acidic regions, was identified by mixed peptide sequencing as the translation elongation factor 1B alpha (formerly eEF1 beta), An equivalent shift was detected in cells overexpressing HAL3, a inhibitory regulatory subunit of Ppz1, Subsequent analysis identified the conserved Ser-86 as the in vivo phosphorylatable residue and showed that its phosphorylation was increased in pp cells. Pull-down experiments using a glutathione S-transferase (GST)-EF1B alpha fusion version allowed to identify Ppz1 as an in vivo interacting protein. Cells lacking Ppz display a higher tolerance to known translation inhibitors, such as hygromycin and paromomycin, and enhanced readthrough at all three nonsense codons, suggesting that translational fidelity might be affected. Overexpression of a GST-EF1B alpha fusion counteracted the growth defect associated to high levels of Ppz1 and this effect was essentially lost when the phosphorylatable Ser-86 is replaced by Ala. Therefore, the Ppz phosphatases appear to regulate the phosphorylation state of EF1B alpha in yeast, and this may result in modification of the translational accuracy.	Univ Autonoma Barcelona, Fac Vet, Dept Bioquim, Bellaterra 08193, Spain; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Autonomous University of Barcelona; Duke University	Arino, J (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Bioquim, Bellaterra 08193, Spain.	Joaquin.Arino@uab.es	de Nadal, Eulàlia/J-8178-2014; Ruiz, Amparo/AAZ-2317-2021; Zhang, Ning/F-1387-2014; Arino, Joaquin/D-3756-2011	de Nadal, Eulàlia/0000-0003-0039-5607; Ruiz, Amparo/0000-0002-3947-4540; Arino, Joaquin/0000-0002-6774-2987; Arino Carmona, Joaquin/0000-0002-0390-4270	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL019242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052378] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL19242] Funding Source: Medline; NIDDK NIH HHS [DK52378A] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alms GR, 1999, EMBO J, V18, P4157, DOI 10.1093/emboj/18.15.4157; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; CHEN MX, 1993, EUR J BIOCHEM, V218, P689, DOI 10.1111/j.1432-1033.1993.tb18423.x; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Clotet J, 1999, MOL CELL BIOL, V19, P2408; Clotet J, 1996, J BIOL CHEM, V271, P26349, DOI 10.1074/jbc.271.42.26349; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Damer CK, 1998, J BIOL CHEM, V273, P24396, DOI 10.1074/jbc.273.38.24396; de Nadal E, 1998, P NATL ACAD SCI USA, V95, P7357, DOI 10.1073/pnas.95.13.7357; HINNEBUSCH AG, 1991, MOL CELLULAR BIOL YE, V1, P627; HIRAGA K, 1993, FEBS LETT, V316, P165, DOI 10.1016/0014-5793(93)81208-H; JANSSEN GMC, 1988, J BIOL CHEM, V263, P11063; KINZY TG, 1994, NUCLEIC ACIDS RES, V22, P2703, DOI 10.1093/nar/22.13.2703; KINZY TG, 1995, GENETICS, V141, P481; LEE KS, 1993, MOL CELL BIOL, V13, P5843, DOI 10.1128/MCB.13.9.5843; MATSUMOTO S, 1993, BIOSCI BIOTECH BIOCH, V57, P1740, DOI 10.1271/bbb.57.1740; PALMER E, 1979, NATURE, V277, P148, DOI 10.1038/277148a0; PETERS HI, 1995, EUR J BIOCHEM, V234, P550, DOI 10.1111/j.1432-1033.1995.550_b.x; POSAS F, 1995, J BIOL CHEM, V270, P13036, DOI 10.1074/jbc.270.22.13036; POSAS F, 1993, FEBS LETT, V318, P282, DOI 10.1016/0014-5793(93)80529-4; POSAS F, 1992, J BIOL CHEM, V267, P11734; Reynolds A., 1997, CURRENT PROTOCOLS MO; RUSSO GL, 1992, J BIOL CHEM, V267, P20317; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SINGH A, 1979, NATURE, V277, P146, DOI 10.1038/277146a0; SONG JM, 1989, MOL CELL BIOL, V9, P4571, DOI 10.1128/MCB.9.10.4571; Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q; TUITE MF, 1993, BIOCHEM SOC T, V21, P857, DOI 10.1042/bst0210857; VALLEJO CG, 1989, YEAST, V5, P307, DOI 10.1002/yea.320050411; VINCENT A, 1994, GENETICS, V138, P597; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WARNER JR, 1991, METHOD ENZYMOL, V194, P423	35	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14829	14834		10.1074/jbc.M010824200	http://dx.doi.org/10.1074/jbc.M010824200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278758	hybrid			2022-12-27	WOS:000168528800041
J	Walter, J; Fluhrer, R; Hartung, B; Willem, M; Kaether, C; Capell, A; Lammich, S; Multhaup, G; Haass, C				Walter, J; Fluhrer, R; Hartung, B; Willem, M; Kaether, C; Capell, A; Lammich, S; Multhaup, G; Haass, C			Phosphorylation regulates intracellular trafficking of beta-secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; CASEIN KINASE-I; ALZHEIMERS-DISEASE; CELL-SURFACE; ECTODOMAIN PHOSPHORYLATION; ENDOCYTIC PATHWAY; MEMBRANE-PROTEIN; KIDNEY-CELLS; CLEAVAGE; PEPTIDE	beta -Secretase (BACE) is a transmembrane aspartyl protease, which generates the N terminus of Alzheimer's disease amyloid beta -peptide, Here, we report that BACE can be phosphorylated within its cytoplasmic domain at serine residue 498 by casein kinase 1. Phosphorylation exclusively occurs after full maturation of BACE by propeptide cleavage and complex N-glycosylation, Phosphorylation/dephosphorylation affects the subcellular localization of BACE, BACE wild type and an S498D mutant that mimics phosphorylated BACE are predominantly located within juxtanuclear Golgi compartments and endosomes, whereas nonphosphorylatable BACE S498A accumulates in peripheral EEA1-positive endosomes, Antibody uptake assays revealed that reinternalization of BACE from the cell surface is independent of its phosphorylation state. After reinternalization, BACE wild type as well as BACE S498D are efficiently retrieved from early endosomal compartments and further targeted to later endosomal compartments and/or the trans-Golgi network. In contrast, nonphosphorylatable BACE S498A is retained within early endosomes. Our results therefore demonstrate regulated trafficking of BACE within the secretory and endocytic pathway.	Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany; Ctr Mol Biol, D-69120 Heidelberg, Germany	University of Munich	Walter, J (corresponding author), Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, 44 Schillerstr, D-80336 Munich, Germany.	jwalter@pbm.med.uni-muenchen.de	Fluhrer, Regina/F-2642-2011	Walter, Jochen/0000-0002-4678-2912				Acquati F, 2000, FEBS LETT, V468, P59, DOI 10.1016/S0014-5793(00)01192-3; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; CHAUHAN A, 1993, BRAIN RES, V629, P47, DOI 10.1016/0006-8993(93)90479-7; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Faundez VV, 2000, MOL BIOL CELL, V11, P2591, DOI 10.1091/mbc.11.8.2591; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HUNG AY, 1993, J BIOL CHEM, V268, P22959; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; JELINEK T, 1993, BIOTECHNIQUES, V15, P628; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; LO ACY, 1994, J BIOL CHEM, V269, P30966; LUDWIG T, 1991, J CELL BIOL, V115, P1561, DOI 10.1083/jcb.115.6.1561; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; Meijer L, 2000, CHEM BIOL, V7, P51, DOI 10.1016/S1074-5521(00)00063-6; Molloy SS, 1998, J CELL BIOL, V142, P1399, DOI 10.1083/jcb.142.6.1399; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Panek HR, 1997, EMBO J, V16, P4194, DOI 10.1093/emboj/16.14.4194; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Schwab C, 2000, NEUROBIOL AGING, V21, P503, DOI 10.1016/S0197-4580(00)00110-X; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walter J, 1998, BIOCHEMISTRY-US, V37, P5961, DOI 10.1021/bi971763a; Walter J, 1999, P NATL ACAD SCI USA, V96, P1391, DOI 10.1073/pnas.96.4.1391; Walter J, 1997, J BIOL CHEM, V272, P1896, DOI 10.1074/jbc.272.3.1896; Walter J, 2000, J BIOL CHEM, V275, P23523, DOI 10.1074/jbc.M002850200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yasojima K, 2000, BRAIN RES, V865, P116, DOI 10.1016/S0006-8993(00)02200-9	45	243	250	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14634	14641		10.1074/jbc.M011116200	http://dx.doi.org/10.1074/jbc.M011116200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278841	Green Published, hybrid			2022-12-27	WOS:000168528800017
J	Peters, CS; Liang, XP; Li, SX; Kannan, S; Peng, Y; Taub, R; Diamond, RH				Peters, CS; Liang, XP; Li, SX; Kannan, S; Peng, Y; Taub, R; Diamond, RH			ATF-7, a novel bZIP protein, interacts with the PRL-1 protein-tyrosine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEINS; LEUCINE-ZIPPER PROTEINS; I-KAPPA-B; TRANSCRIPTION FACTOR; CACO-2 CELLS; SERINE/THREONINE KINASE; RESPONSE ELEMENTS; CARCINOMA-CELLS; RNA-POLYMERASE; DLK/ZIP KINASE	We have identified a novel basic leucine zipper (bZIP) protein, designated ATF-7, that physically interacts with the PRL-1 protein-tyrosine phosphatase (PTPase). PRL-1 is a predominantly nuclear, farnesylated PTPase that has been linked to the control of cellular growth and differentiation. This interaction was initially found using the yeast two-hybrid system. ATF-7 is most closely related to members of the ATF/CREB family of bZIP proteins, with highest homology to ATF-4. ATF-7 homodimers can bind specifically to CRE elements. ATF-7 is expressed in a number of different tissues and is expressed in association with differentiation in the Caco-2 cell model of intestinal differentiation We have confirmed the PRL-1 ATF-7 interaction and mapped the regions of ATF-7 and PRL-1 important for interaction to ATF-Ts bZIP region and PRL-1's phosphatase domain. Finally, we have determined that PRL-1 is able to dephosphorylate ATF-7 in vitro. Further insight into ATF-7's precise cellular roles, transcriptional function, and downstream targets are likely be of importance in understanding the mechanisms underlying the complex processes of maintenance, differentiation, and turnover of epithelial tissues.	Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Diamond, RH (corresponding author), Univ Penn, Sch Med, Dept Med, GI Div, 664 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK052216, R01DK044237] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK52216, R01 DK44237, P30 DK50306] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AVITAHL N, 1994, J BIOL CHEM, V269, P23553; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; BENBROOK DM, 1990, ONCOGENE, V5, P295; BENITO M, 1991, SCIENCE, V253, P565, DOI 10.1126/science.1857988; BOULIKAS T, 1995, CRIT REV EUKAR GENE, V5, P1; BOURBON HM, 1995, J BIOL CHEM, V270, P11130, DOI 10.1074/jbc.270.19.11130; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Cass LA, 2000, ONCOGENE, V19, P924, DOI 10.1038/sj.onc.1203393; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; CELANO P, 1993, CELL GROWTH DIFFER, V4, P341; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Diamond RH, 1996, AM J PHYSIOL-GASTR L, V271, pG121, DOI 10.1152/ajpgi.1996.271.1.G121; ESTES SD, 1995, EXP CELL RES, V220, P47, DOI 10.1006/excr.1995.1290; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; FIELD FJ, 1987, J LIPID RES, V28, P1057; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GREENBAUM LE, 1995, J CLIN INVEST, V96, P1351, DOI 10.1172/JCI118170; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; HEERDT BG, 1994, CANCER RES, V54, P3288; HOEFFLER JP, 1991, MOL ENDOCRINOL, V5, P256, DOI 10.1210/mend-5-2-256; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; JUMARIE C, 1991, J CELL PHYSIOL, V149, P24, DOI 10.1002/jcp.1041490105; Kapatos G, 2000, J BIOL CHEM, V275, P5947, DOI 10.1074/jbc.275.8.5947; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; KARPINSKI BA, 1992, P NATL ACAD SCI USA, V89, P4820, DOI 10.1073/pnas.89.11.4820; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P5479, DOI 10.1128/MCB.13.9.5479; Kharbanda S, 1998, ONCOGENE, V17, P3309, DOI 10.1038/sj.onc.1202571; Kogel D, 1998, ONCOGENE, V17, P2645, DOI 10.1038/sj.onc.1202204; Kogel D, 1999, ONCOGENE, V18, P7212, DOI 10.1038/sj.onc.1203169; KONG W, 1990, AM J PHYSIOL, V279, pG613; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Litvak DA, 1998, SURGERY, V124, P161, DOI 10.1067/msy.1998.90365; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Maruoka Y, 1997, BIOCHEM BIOPH RES CO, V238, P886, DOI 10.1006/bbrc.1997.7405; Mielnicki LM, 1996, BIOCHEM BIOPH RES CO, V228, P586, DOI 10.1006/bbrc.1996.1702; MOHN KL, 1991, MOL CELL BIOL, V11, P381, DOI 10.1128/MCB.11.1.381; Montgomery RK, 1997, AM J PHYSIOL-GASTR L, V272, pG534, DOI 10.1152/ajpgi.1997.272.3.G534; NEUBERG M, 1989, NATURE, V338, P589, DOI 10.1038/338589a0; NISHIZAWA M, 1992, FEBS LETT, V299, P36, DOI 10.1016/0014-5793(92)80094-W; Page G, 1999, ONCOGENE, V18, P7265, DOI 10.1038/sj.onc.1203170; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PINTO M, 1983, BIOL CELL, V47, P323; Potten CS, 1997, AM J PHYSIOL-GASTR L, V273, pG253, DOI 10.1152/ajpgi.1997.273.2.G253; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Ribon V, 1998, MOL CELL BIOL, V18, P872, DOI 10.1128/MCB.18.2.872; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; Sambrook J., 2002, MOL CLONING LAB MANU; Shuman JD, 1997, J BIOL CHEM, V272, P12793, DOI 10.1074/jbc.272.19.12793; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; TSUJIMOTO A, 1991, J VIROL, V65, P1420, DOI 10.1128/JVI.65.3.1420-1426.1991; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; YAMAGUCHIIWAI Y, 1990, P NATL ACAD SCI USA, V87, P8670, DOI 10.1073/pnas.87.21.8670; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zhang SH, 1999, J BIOL CHEM, V274, P17806, DOI 10.1074/jbc.274.25.17806	73	67	80	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13718	13726		10.1074/jbc.M011562200	http://dx.doi.org/10.1074/jbc.M011562200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278933	hybrid			2022-12-27	WOS:000168356600031
J	Zhang, DY; Liang, XQ; He, XY; Alipui, OD; Yang, SY; Schulz, H				Zhang, DY; Liang, XQ; He, XY; Alipui, OD; Yang, SY; Schulz, H			Delta(3,5),Delta(2,4)-dienoyl-CoA isomerase is a multifunctional isomerase - A structural and mechanistic study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNSATURATED FATTY-ACIDS; REDUCTASE-DEPENDENT PATHWAY; BETA-OXIDATION; DOUBLE-BONDS; RAT-LIVER; MITOCHONDRIA; PEROXISOMES; ENZYME	Delta (3,5),Delta (2,4)-Dienoyl-CoA isomerase (DI), an auxiliary enzyme of unsaturated fatty acid beta -oxidation, was purified from rat mitochondria and peroxisomes and subjected to N-terminal sequencing to facilitate a mechanistic study of this enzyme, The mature mitochondrial DI from rat heart was lacking its 34 N-terminal amino acid residues that have the properties of a mitochondrial targeting sequence. The peroxisomal isomerase was identified as a product of the same gene with a truncated and ragged N terminus. Expression of the cDNA coding for the mature mitochondrial DI in Escherichia coli yielded an enzyme preparation that was as active as the native DI, Because the recombinant DI also exhibited Delta (3,5,7)Delta (2,4,6)-trienoyl-CoA isomerase (TI) activity, both isomerases reside on the same protein, Mutations of any of the 3 acidic amino acid residues located at the active site (Modis, Y,, Filppula, S, A, Novikov, D, H., Norledge, B,, Hiltunen, J, K., and Wierenga, R, K, (1998) Structure 6, 957-970) caused activity losses. In contrast to only a 10-fold decrease in activity upon replacement of Asp(176) by Ala, substitutions of Asp(204) by Asn and of Glu(196) by Gin resulted in 10(5)-fold lower activities. Such activity losses are consistent with the direct involvement of these latter two residues in the proposed proton transfers at carbons 2 and 6 or 8 of the substrates, Probing of the wild-type and mutants forms of the enzyme with 2,5-octadienoyl-CoA as substrate revealed low Delta (2),Delta (3)- enoyl-CoA isomerase and Delta (5),Delta (4)-enoyl-CoA isomerase activities catalyzed by Glu(196) and Asp(204), respectively. Altogether, these data reveal that positional isomerizations of the diene and triene are facilitated by simultaneous proton transfers involving Glu(196) and Asp(204) whereas each residue alone can catalyze, albeit less efficiently, a monoene isomerization.	CUNY City Coll, Dept Chem, New York, NY 10031 USA; CUNY, Grad Sch, New York, NY 10031 USA; New York State Inst Basic Res Dev Disabil, Dept Pharmacol, Staten Isl, NY 10314 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; Institute for Basic Research in Developmental Disabilities	Schulz, H (corresponding author), CUNY City Coll, Dept Chem, Convent Ave & 138th St, New York, NY 10031 USA.	hoschu@sci.ccny.cuny.edu			NCRR NIH HHS [RR03060] Funding Source: Medline; NHLBI NIH HHS [HL30847] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030847] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bjerrum OJ, 1986, **NON-TRADITIONAL**, V86th, P315; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; de Duve C, 1995, BIOCHEM J, V60, P604; Fillgrove KL, 2000, BIOCHEMISTRY-US, V39, P7001, DOI 10.1021/bi0000566; Filppula SA, 1998, J BIOL CHEM, V273, P349, DOI 10.1074/jbc.273.1.349; HE XY, 1995, BIOCHEM BIOPH RES CO, V215, P15, DOI 10.1006/bbrc.1995.2428; KASS IJ, 1995, BIOCHEM BIOPH RES CO, V206, P688, DOI 10.1006/bbrc.1995.1097; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang XQ, 1999, J BIOL CHEM, V274, P13830, DOI 10.1074/jbc.274.20.13830; LUO MJ, 1994, J BIOL CHEM, V269, P2384; LUTHRIA DL, 1995, J BIOL CHEM, V270, P13771, DOI 10.1074/jbc.270.23.13771; MELOCHE HP, 1983, J PROTEIN CHEM, V2, P399, DOI 10.1007/BF01025238; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; Shoukry K, 1998, J BIOL CHEM, V273, P6892, DOI 10.1074/jbc.273.12.6892; SMELAND TE, 1992, P NATL ACAD SCI USA, V89, P6673, DOI 10.1073/pnas.89.15.6673	19	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13622	13627		10.1074/jbc.M011315200	http://dx.doi.org/10.1074/jbc.M011315200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278886	hybrid			2022-12-27	WOS:000168356600018
J	Cho, YK; Rios, SE; Kim, JJP; Miziorko, HM				Cho, YK; Rios, SE; Kim, JJP; Miziorko, HM			Investigation of invariant serine/threonine residues in mevalonate kinase - Tests of the functional significance of a proposed substrate binding motif and a site implicated in human inherited disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIODIC FEVER SYNDROME; ACTIVE-SITE; DIRECTED MUTAGENESIS; CATALYTIC RESIDUES; PHOSPHORIBULOKINASE; IDENTIFICATION; ROLES; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; BIOSYNTHESIS; SPECIFICITY	Mevalonate kinase serine/threonine residues have been implicated in substrate binding and inherited metabolic disease, Alignment of >20 mevalonate kinase sequences indicates that Ser-145, Ser-146, Ser-201, and Thr-243 are the only invariant residues with alcohol side chains, These residues have been individually mutated to alanine. Structural integrity of the mutants has been demonstrated by binding studies using fluorescent and spin-labeled ATP analogs. Kinetic characterization of the mutants indicates only modest changes in K-m(ATP) K-m, for mevalonate increases by - 20-fold for S146A, approximate to 40-fold for T243A, and 100-fold for S201A V-max changes for S145A, S201A, and T243A are less than or equal to3-fold. Thus, the 65-fold activity decrease associated with the inherited human T243I mutation seems attributable to the nonconservative substitution rather than any critical catalytic function. V-max for S146A is diminished by 4000-fold. In terms of V/K-MVA, this substitution produces a 10(5)-fold effect, suggesting an active site location and catalytic role for Ser-146. The large k(cat) effect suggests that Ser-146 productively orients ATP during catalysis, KD(Mg-ATP) increases by almost 40-fold for S146A, indicating a specific role for Ser-146 in liganding Mg2+-ATP, Instead of mapping within a proposed C-terminal ATP binding motif, Ser-146 is situated in a centrally located motif, which characterizes the galactokinase/homoserine kinase/mevalonate kinase/phosphomevalonate kinase protein family. These observations represent the first functional demonstration that this region is part of the active site in these related phosphotransferases.	Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Miziorko, HM (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053766] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01008] Funding Source: Medline; NIDDK NIH HHS [DK-53766] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aimes RT, 2000, BIOCHEMISTRY-US, V39, P8325, DOI 10.1021/bi992800w; BAGSHAW CR, 1988, SPECTROPHOTOMETRY SP, P91; BERGER SA, 1992, BIOCHEMISTRY-US, V31, P9237, DOI 10.1021/bi00153a017; CHARLIER HA, 1994, BIOCHEMISTRY-US, V33, P9343, DOI 10.1021/bi00197a039; DAVENPORT D, 1971, FLUORESCENCE SPECTRO, P203; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Fu Z., UNPUB; Geeganage S, 2000, BIOCHEMISTRY-US, V39, P5397, DOI 10.1021/bi992594s; Hasemann CA, 1996, STRUCTURE, V4, P1017, DOI 10.1016/S0969-2126(96)00109-8; Hinson DD, 1999, AM J HUM GENET, V65, P327, DOI 10.1086/302489; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOFFMANN GF, 1993, PEDIATRICS, V91, P915; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; KOTEICHE HA, 1995, BIOCHEMISTRY-US, V34, P15068, DOI 10.1021/bi00046a012; Lange BM, 1999, P NATL ACAD SCI USA, V96, P13714, DOI 10.1073/pnas.96.24.13714; Leatherbarrow R. J., 1992, GRAFIT VERSION 3 0; MULLERDIECKMANN HJ, 1995, J MOL BIOL, V246, P522; Potter D, 1997, J BIOL CHEM, V272, P5741, DOI 10.1074/jbc.272.9.5741; Potter D, 1997, J BIOL CHEM, V272, P25449, DOI 10.1074/jbc.272.41.25449; QURESHI N, 1981, BIOSYNTHESIS ISOPREN, V1, P47; Rohmer M, 1996, J AM CHEM SOC, V118, P2564, DOI 10.1021/ja9538344; Runquist JA, 1996, BIOCHEMISTRY-US, V35, P15049, DOI 10.1021/bi9619334; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; TANAKA RD, 1990, P NATL ACAD SCI USA, V87, P2872, DOI 10.1073/pnas.87.8.2872; TSAY YH, 1991, MOL CELL BIOL, V11, P620, DOI 10.1128/MCB.11.2.620; Uyeda K, 1997, J BIOL CHEM, V272, P7867, DOI 10.1074/jbc.272.12.7867; Vertommen D, 1996, J BIOL CHEM, V271, P17875, DOI 10.1074/jbc.271.30.17875	28	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12573	12578		10.1074/jbc.M011478200	http://dx.doi.org/10.1074/jbc.M011478200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278915	hybrid			2022-12-27	WOS:000168198600016
J	Remboutsika, E; Jacq, X; Tora, L				Remboutsika, E; Jacq, X; Tora, L			Chromatin is permissive to TATA-binding protein (TBP)-mediated transcription initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TBP-LIKE FACTOR; COMPLEX; ACTIVATION; PROMOTER; FACT; ELONGATION; FORMS	Preinitiation complex assembly is nucleated by the binding of TFIID to the promoters of protein coding genes transcribed by RNA polymerase II, TFIID is comprised of the TATA-binding protein (TBP) and TBP-associated factors (TAF(II)s), We investigated the transcription properties of TBP and TFIID on chromatin templates. On naked templates both TBP and purified TFIID are able to initiate basal transcription. However, on chromatin templates only TBP mediates transcription initiation in a heat-treated extract, whereas TFIID does not. Moreover, TBP-mediated chromatin transcription is blocked in a nontreated extract. These observations suggest that a chromatin-targeted repressor is present in crude extracts and that chromatin per se is not refractory to transcription mediated by TBP, As TSP can function through TAF(II)-independent and TAF(II)-dependent pathways, the repression of TBP-mediated basal transcription may be an additional level to the control of Pol II transcription initiation on chromatin.	ULP, INSERM, CNRS,Dept Transcript & Post Transcript Control Ge, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, Communaute Urba, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tora, L (corresponding author), ULP, INSERM, CNRS,Dept Transcript & Post Transcript Control Ge, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, Communaute Urba, France.	laszlo@igbmc.u-strasbg.fr	Tora, Laszlo/E-9999-2018	Tora, Laszlo/0000-0001-7398-2250				Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Bell B, 1999, EXP CELL RES, V246, P11, DOI 10.1006/excr.1998.4294; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; Dantonel JC, 1999, TRENDS BIOCHEM SCI, V24, P335, DOI 10.1016/S0968-0004(99)01436-X; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; KAMAKAKA RT, 1993, GENE DEV, V7, P1779, DOI 10.1101/gad.7.9.1779; KOKUBO T, 1994, P NATL ACAD SCI USA, V91, P3520, DOI 10.1073/pnas.91.9.3520; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; May M, 1996, EMBO J, V15, P3093, DOI 10.1002/j.1460-2075.1996.tb00672.x; Mitsiou DJ, 2000, MOL CELL, V6, P527, DOI 10.1016/S1097-2765(00)00052-6; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; Oelgeschlager T, 1998, MOL CELL, V1, P925, DOI 10.1016/S1097-2765(00)80092-1; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Owen-Hughes Thomas, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P403; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Wada T, 2000, MOL CELL, V5, P1067, DOI 10.1016/S1097-2765(00)80272-5; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Zhou JM, 1998, P NATL ACAD SCI USA, V95, P13483, DOI 10.1073/pnas.95.23.13483	28	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12781	12784		10.1074/jbc.M100481200	http://dx.doi.org/10.1074/jbc.M100481200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11279078	hybrid			2022-12-27	WOS:000168198600045
J	Simpson, IA; Vannucci, SJ; DeJoseph, MR; Hawkins, RA				Simpson, IA; Vannucci, SJ; DeJoseph, MR; Hawkins, RA			Glucose transporter asymmetries in the bovine blood-brain barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-TRANSPORT; RAT ADIPOSE CELL; ULTRASTRUCTURAL-LOCALIZATION; INSULIN; GLUT1; EXPRESSION; PROTEIN; MICROVESSELS; ENDOTHELIUM; ENHANCEMENT	The transport of glucose across the mammalian blood-brain barrier is mediated by the GLUT1 glucose transporter, which is concentrated in the endothelial cells of the cerebral microvessels, Several studies supported an asymmetric distribution of GLUT1 protein between the luminal and abluminal membranes (1:4) with a significant proportion of intracellular transporters. In this study we investigated the activity and concentration of GLUT1 in isolated luminal and abluminal membrane fractions of bovine brain endothelial cells, Glucose transport activity and glucose transporter concentration, as determined by cytochalasin B binding, were 2-fold greater in the luminal than in the abluminal membranes. In contrast, Western blot analysis using a rabbit polyclonal antibody raised against the C-terminal 20 amino acids of GLUT1 indicated a 1:5 luminal:abluminal distribution. Western blot analysis with antibodies raised against either the intracellular loop of GLUT1 or the purified erythrocyte protein exhibited luminal:abluminal ratios of 1:1, A similar ratio was observed when the luminal and abluminal fractions were exposed to the 2-N-4[H-3](1-azi-2,2,2,-trifluoroethyl)benzoxyl-1,3-bis-(d-mannos-4-yloxyl)-2-propylamine ([H-3]ATB-BMPA) photoaffinity label. These observations suggest that either an additional glucose transporter isoform is present in the luminal membrane of the bovine blood-brain barrier or the C-terminal epitope of GLUT1 is "masked" in the luminal membrane but not in the abluminal membranes.	Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Anat & Neurosci, Hershey, PA 17033 USA; Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Pediat, Hershey, PA 17033 USA; Finch Univ Hlth Sci Chicago Med Sch, Dept Physiol & Biophys, N Chicago, IL 60064 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Chicago Medical School	Simpson, IA (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Anat & Neurosci, H109, Hershey, PA 17033 USA.				NINDS NIH HHS [NS 31017] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031017] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CLARK AE, 1990, BIOCHEM J, V269, P615, DOI 10.1042/bj2690615; CORNFORD EM, 1995, J NEUROPATH EXP NEUR, V54, P842, DOI 10.1097/00005072-199511000-00011; CORNFORD EM, 1994, J CEREBR BLOOD F MET, V14, P106, DOI 10.1038/jcbfm.1994.15; Cornford EM, 1998, J CEREBR BLOOD F MET, V18, P26, DOI 10.1097/00004647-199801000-00003; CORNFORD EM, 1993, J CEREBR BLOOD F MET, V13, P841, DOI 10.1038/jcbfm.1993.106; CORNFORD EM, 1994, BRAIN RES, V663, P7, DOI 10.1016/0006-8993(94)90457-X; DAVIES A, 1990, BIOCHEM J, V266, P799; DELPINO MMS, 1992, J BIOL CHEM, V267, P25951; DELPINO MMS, 1995, J BIOL CHEM, V270, P14907, DOI 10.1074/jbc.270.25.14907; DELPINO MMS, 1995, J BIOL CHEM, V270, P14913, DOI 10.1074/jbc.270.25.14913; DICK APK, 1984, P NATL ACAD SCI-BIOL, V81, P7233, DOI 10.1073/pnas.81.22.7233; Doege H, 2000, J BIOL CHEM, V275, P16275, DOI 10.1074/jbc.275.21.16275; Doege H, 2000, BIOCHEM J, V350, P771, DOI 10.1042/0264-6021:3500771; FARRELL CL, 1991, J NEUROSCI METH, V37, P103, DOI 10.1016/0165-0270(91)90120-O; FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779; GERHART DZ, 1992, P NATL ACAD SCI USA, V89, P733, DOI 10.1073/pnas.89.2.733; GERHART DZ, 1989, J NEUROSCI RES, V22, P464, DOI 10.1002/jnr.490220413; GIBBS AF, 1988, BIOCHEM J, V256, P421, DOI 10.1042/bj2560421; GIBBS EM, 1986, J BIOL CHEM, V261, P6597; Ibberson M, 2000, J BIOL CHEM, V275, P4607, DOI 10.1074/jbc.275.7.4607; Lee WJ, 1996, J BIOL CHEM, V271, P19129, DOI 10.1074/jbc.271.32.19129; LEE WJ, 1997, AM J PHYSIOL, V272, pC1553; MABER F, 1994, BIOCHEM J, V301, P379; MAHER F, 1993, J CEREBR BLOOD F MET, V13, P342, DOI 10.1038/jcbfm.1993.43; MAHER F, 1992, BIOCHEM BIOPH RES CO, V182, P703, DOI 10.1016/0006-291X(92)91789-S; MANTYCH GJ, 1992, ENDOCRINOLOGY, V131, P1270, DOI 10.1210/en.131.3.1270; MANTYCH GJ, 1993, ENDOCRINOLOGY, V132, P35, DOI 10.1210/en.132.1.35; McCall AL, 1997, BRAIN RES, V744, P318, DOI 10.1016/S0006-8993(96)01122-5; NISHIMURA H, 1994, BIOCHEM J, V302, P271, DOI 10.1042/bj3020271; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; PARDRIDGE WM, 1985, J NEUROCHEM, V44, P1178, DOI 10.1111/j.1471-4159.1985.tb08741.x; PARDRIDGE WM, 1993, ANN NY ACAD SCI, V692, P126; PARDRIDGE WM, 1983, PHYSIOL REV, V63, P1481, DOI 10.1152/physrev.1983.63.4.1481; ROSENTHAL HE, 1967, ANAL BIOCHEM, V20, P525, DOI 10.1016/0003-2697(67)90297-7; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; SOGIN DC, 1980, P NATL ACAD SCI-BIOL, V77, P5725, DOI 10.1073/pnas.77.10.5725; THOREUS B, COMMUNICATION; Vannucci SJ, 1996, J CEREBR BLOOD F MET, V16, P77, DOI 10.1097/00004647-199601000-00009; VANNUCCI SJ, 1994, J NEUROCHEM, V62, P240; Vannucci SJ, 1998, DEV NEUROSCI-BASEL, V20, P369, DOI 10.1159/000017333; WARDZALA LJ, 1978, J BIOL CHEM, V253, P8002; WEBER TM, 1988, RECEPTOR BIOCH MET B, V12, P171; WHEELER TJ, 1982, BIOCHEM BIOPH RES CO, V105, P89, DOI 10.1016/S0006-291X(82)80014-4; WITTERS LA, 1985, NATURE, V315, P777, DOI 10.1038/315777a0	44	73	76	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12725	12729		10.1074/jbc.M010897200	http://dx.doi.org/10.1074/jbc.M010897200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278779	hybrid			2022-12-27	WOS:000168198600036
J	Stelmach, BA; Muller, A; Hennig, P; Gebhardt, S; Schubert-Zsilavecz, M; Weiler, EW				Stelmach, BA; Muller, A; Hennig, P; Gebhardt, S; Schubert-Zsilavecz, M; Weiler, EW			A novel class of oxylipins, sn1-O-(12-oxophytodienoyl)-sn2-O-(hexadecatrienoyl)-monogalactosyl diglyceride, from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLENE OXIDE SYNTHASE; FATTY-ACID HYDROPEROXIDES; 12-OXO-PHYTODIENOIC ACID; JASMONIC ACID; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; GENE-EXPRESSION; BIOSYNTHESIS; PLANTS; METABOLISM	The cyclic derivative of 13(S)-hydroperoxolinolenic acid, 12-oxophytodienoic acid, serves as a signal transducer in higher plants, mediating mechanotransductory processes and plant defenses against a variety of pathogens, and also serves as a precursor for the biosynthesis of jasmonic acid, a mediator of plant herbivore defense. Biosynthesis of 12-oxophytodienoic acid from alpha -linolenic acid occurs in plastids, mainly in chloroplasts, and is thought to start with free linolenic acid liberated from membrane lipids by lipase action. In Arabidopsis thaliana, the glycerolipid fraction contains esterified 12-oxophytodienoic acid, which can be released enzymatically by sn1-specific, but not by sna-specific, lipases, The 12-oxophytodienoyl glycerolipid fraction was isolated, purified, and characterized. Enzymatic, mass spectrometric, and NMR spectroscopic data allowed us to establish the structure of the novel oxylipin as sn1-O-(12-oxophytodienoyl)-sn2-O-(hexadecatrienoyl)-monogalactosyl diglyceride, The novel class of lipids is localized in plastids, Purified monogalactosyl diglyceride was not converted to the sn1-(12-oxophytodienoyl) derivative by the combined action of (soybean) lipoxygenase and (A. thaliana) allene oxide synthase, an enzyme ensemble that converts free alpha -linolenic acid to free 12-oxophytodienoic acid. When leaves were wounded, a significant and transient increase in the level of (12-oxophytodienoyl)-monogalactosyl diglyceride was observed. In A. thaliana, the major fraction of 12-oxophytodienoic acid occurs esterified at the sn1 position of the plastid-specific glycerolipid, monogalactosyl diglyceride.	Ruhr Univ Bochum, Lehrstuhl Pflanzenphysiol, D-44801 Bochum, Germany; Goethe Univ Frankfurt, Inst Pharmazeut Chem, D-60439 Frankfurt, Germany	Ruhr University Bochum; Goethe University Frankfurt	Weiler, EW (corresponding author), Ruhr Univ Bochum, Lehrstuhl Pflanzenphysiol, Univ Str 150, D-44801 Bochum, Germany.	Elmar.Weiler@ruhr-uni-bochum.de						ALBRECHT T, 1993, PLANTA, V191, P86, DOI 10.1007/BF00240899; BANAS A, 1992, PLANT SCI, V84, P137, DOI 10.1016/0168-9452(92)90127-8; Blechert S, 1999, PLANTA, V207, P470, DOI 10.1007/s004250050506; Blee E, 1996, PLANT PHYSIOL, V110, P445, DOI 10.1104/pp.110.2.445; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOHLMANN F, 1983, PHYTOCHEMISTRY, V22, P1623, DOI 10.1016/0031-9422(83)80100-9; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; BRASH AR, 1987, BIOCHEMISTRY-US, V26, P5465, DOI 10.1021/bi00391a038; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; DEMANDRE C, 1985, PHYTOCHEMISTRY, V24, P481, DOI 10.1016/S0031-9422(00)80752-9; Farmer Edward E., 1992, Trends in Cell Biology, V2, P236, DOI 10.1016/0962-8924(92)90311-A; FEUSSNER I, 1995, P NATL ACAD SCI USA, V92, P11849, DOI 10.1073/pnas.92.25.11849; HAMBERG M, 1988, BIOCHEM BIOPH RES CO, V156, P543, DOI 10.1016/S0006-291X(88)80876-3; HAMBERG M, 1993, J LIPID MEDIATOR, V6, P375; Kim YH, 1997, J MASS SPECTROM, V32, P968; KNOFEL HD, 1988, Z NATURFORSCH C, V43, P29; Kubigsteltig I, 1999, PLANTA, V208, P463, DOI 10.1007/s004250050583; Laudert D, 1997, ANAL BIOCHEM, V246, P211, DOI 10.1006/abio.1997.2012; Laudert D, 1998, PLANT J, V15, P675, DOI 10.1046/j.1365-313x.1998.00245.x; Laudert D, 1996, PLANT MOL BIOL, V31, P323, DOI 10.1007/BF00021793; MORIMOTO T, 1995, PHYTOCHEMISTRY, V5, P1423; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Mueller MJ, 1998, CHEM BIOL, V5, pR323, DOI 10.1016/S1074-5521(98)90660-3; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; Schaller F, 1997, J BIOL CHEM, V272, P28066, DOI 10.1074/jbc.272.44.28066; SCHMID HHO, 1990, PROG LIPID RES, V29, P1, DOI 10.1016/0163-7827(90)90004-5; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; SONG WC, 1991, SCIENCE, V253, P781, DOI 10.1126/science.1876834; SONG WC, 1993, P NATL ACAD SCI USA, V90, P8519, DOI 10.1073/pnas.90.18.8519; Stelmach BA, 1998, PHYTOCHEMISTRY, V47, P539, DOI 10.1016/S0031-9422(97)00547-5; Tripathy S, 1999, PLANT PHYSIOL, V121, P1299, DOI 10.1104/pp.121.4.1299; van der Stelt M, 2000, EUR J BIOCHEM, V267, P2000, DOI 10.1046/j.1432-1327.2000.01203.x; VICK BA, 1986, PLANT PHYSIOL, V80, P202, DOI 10.1104/pp.80.1.202; VICK BA, 1984, PLANT PHYSIOL, V75, P458, DOI 10.1104/pp.75.2.458; VICK BA, 1981, PLANT PHYSIOL, V67, P92, DOI 10.1104/pp.67.1.92; VICK BA, 1987, PLANT PHYSIOL, V85, P1073, DOI 10.1104/pp.85.4.1073; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9; Weiler EW, 1997, NATURWISSENSCHAFTEN, V84, P340, DOI 10.1007/s001140050407; WILLIAMS JP, 1995, J LIPID RES, V36, P1407	40	142	147	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12832	12838		10.1074/jbc.M010743200	http://dx.doi.org/10.1074/jbc.M010743200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278736	hybrid			2022-12-27	WOS:000168198600053
J	Wind-Rotolo, M; Reines, D				Wind-Rotolo, M; Reines, D			Analysis of gene induction and arrest site transcription in yeast with mutations in the transcription elongation machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; FACTOR S-II; SACCHAROMYCES-CEREVISIAE; FACTOR-SII; SUBUNIT RPB9; FACTOR TFIIS; IN-VIVO; TERMINATION; 6-AZAURACIL; HOLOENZYME	Invitro, transcript elongation by RNA polymerase II is impeded by DNA sequences, DNA-bound proteins, and small ligands. Transcription elongation factor SII (TFIIS) assists RNA polymerase II to transcribe through these obstacles. There is however, little direct evidence that SII-responsive arrest sites function in living cells nor that SII facilitates readthrough in vivo. Saccharomyces cerevisiae strains lacking elongation factor SII and/or containing a point mutation in the second largest subunit of RNA polymerase II, which slows the enzyme's RNA elongation rate, grow slowly and have defects in mRNA metabolism, particularly in the presence of nucleotide-depleting drugs. Here we have examined transcriptional induction in strains lacking SII or containing the slow polymerase mutation. Both mutants and a combined double mutant were defective in induction of GAL1 and ENA1. This was not due to an increase in mRNA degradation and was independent of any drug treatment, although treatment with the nucleotide-depleting drug 6-azauracil exacerbated the effect preferentially in the mutants. These data are consistent with mutants in the Elongator complex, which show slow inductive responses. When a potent in vitro arrest site was transcribed in these strains, there was no perceptible effect upon mRNA accumulation. These data suggest that an alternative elongation surveillance mechanism exists in vivo to overcome arrest.	Emory Univ, Sch Med, Rollins Res Ctr, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Reines, D (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	dreines@emory.edu	excellency, Your/R-2357-2019	excellency, Your/0000-0003-0832-6243	NIGMS NIH HHS [R01 GM046331, GM46331] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046331] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 1996, EMBO J, V15, P4654, DOI 10.1002/j.1460-2075.1996.tb00842.x; ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; BENGAL E, 1991, MOL CELL BIOL, V11, P1195, DOI 10.1128/MCB.11.3.1195; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; CHRISTIE KR, 1994, J BIOL CHEM, V269, P936; Costa PJ, 2000, GENETICS, V156, P535; Davie JK, 2000, MOL CELL BIOL, V20, P5960, DOI 10.1128/MCB.20.16.5960-5973.2000; DITZELMULLER G, 1983, ARCH MICROBIOL, V135, P63, DOI 10.1007/BF00419484; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GU WG, 1995, J BIOL CHEM, V270, P11238, DOI 10.1074/jbc.270.19.11238; HARO R, 1991, FEBS LETT, V291, P189, DOI 10.1016/0014-5793(91)81280-L; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Ishiguro A, 2000, MOL CELL BIOL, V20, P1263, DOI 10.1128/MCB.20.4.1263-1270.2000; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Koth CM, 2000, J BIOL CHEM, V275, P11174, DOI 10.1074/jbc.275.15.11174; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lennon JC, 1998, MOL CELL BIOL, V18, P5771, DOI 10.1128/MCB.18.10.5771; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; LOISON G, 1980, CURR GENET, V2, P39, DOI 10.1007/BF00445692; Mote J, 1998, J BIOL CHEM, V273, P16843, DOI 10.1074/jbc.273.27.16843; NAKANISHI T, 1992, J BIOL CHEM, V267, P13200; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Padilla PA, 1998, J BACTERIOL, V180, P5718, DOI 10.1128/JB.180.21.5718-5726.1998; Powell W, 1996, J BIOL CHEM, V271, P6866, DOI 10.1074/jbc.271.12.6866; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; REINES D, 1987, J MOL BIOL, V196, P299, DOI 10.1016/0022-2836(87)90691-7; REINES D, 1993, CELL MOL BIOL RES, V39, P331; Samkurashvili I, 1996, J BIOL CHEM, V271, P23495, DOI 10.1074/jbc.271.38.23495; SCAFE C, 1990, MOL CELL BIOL, V10, P1010, DOI 10.1128/MCB.10.3.1010; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shimoaraiso M, 2000, J BIOL CHEM, V275, P29623, DOI 10.1074/jbc.M910371199; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; WIEST DK, 1992, J BIOL CHEM, V267, P7733; WIEST DK, 1990, MOL CELL BIOL, V10, P5782, DOI 10.1128/MCB.10.11.5782; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X	43	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11531	11538		10.1074/jbc.M011322200	http://dx.doi.org/10.1074/jbc.M011322200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278887	Green Accepted, hybrid			2022-12-27	WOS:000168081800017
J	Hammarstrom, P; Persson, M; Carlsson, U				Hammarstrom, P; Persson, M; Carlsson, U			Protein compactness measured by fluorescence resonance energy transfer - Human carbonic anhydrase II Is considerably expanded by the interaction of GroEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES GROEL; PROBING SUBSTRUCTURE; CRYSTAL-STRUCTURE; MOLTEN GLOBULE; UNFOLDED STATE; RESIDUES; COMPLEX; BINDS; SITE; INTERMEDIATE	Nine single-cysteine mutants were labeled with 5-(2-iodoacetylaminoethylamino)naphthalene-1-sulfonic acid, an efficient acceptor of Trp fluorescence in fluorescence resonance energy transfer. The ratio between the fluorescence intensity of the 5-(2-acetylaminoethylamino)naphthalene-1-sulfonic acid (AEDANS) moiety excited at 295 nm (Trp absorption) and 350 nn (direct AEDANS absorption) was used to estimate the average distances between the seven Trp residues in human carbonic anhydrase II (HCA II) and the AEDANS label, Guanidine HCl denaturation of the HCA II variants was also performed to obtain a curve that reflected the compactness of the protein at various stages of the unfolding, which could serve as a scale of the expansion of the protein. This approach was developed in this study and was used to estimate the compactness of HCA II during heat denaturation and interaction with GroEL, It was shown that thermally induced unfolding of HCA II proceeded only to the molten globule state. Reaching this state was sufficient to allow HCA II to bind to GroEL, and the volume of the molten globule intermediate increased similar to2.2-fold compared with that of the native state. GroEL-bound HCA II expands to a volume three to four times that of the native state (to similar to 117,000 Angstrom (3)), which correlates well with a stretched and loosened-up HCA II molecule in an enlarged GroEL cavity, Recently, we found that HCA II binding causes such an inflation of the GroEL molecule, and this probably represents the mechanism by which GroEL actively stretches its protein substrates apart (Hammarstrom, P., Persson, M., Owenius, R., Lindgren, M., and Carlsson, U. (2000) J. Biol. Chem. 275, 22832-22838), thereby facilitating rearrangement of misfolded structure.	Linkoping Univ, IFM Dept Chem, SE-58183 Linkoping, Sweden	Linkoping University	Carlsson, U (corresponding author), Linkoping Univ, IFM Dept Chem, SE-58183 Linkoping, Sweden.							BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; BERGENHEM NCH, 1994, FEBS LETT, V353, P177, DOI 10.1016/0014-5793(94)01041-2; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Buckle AM, 1997, P NATL ACAD SCI USA, V94, P3571, DOI 10.1073/pnas.94.8.3571; CARLSSON U, 1995, CURR OPIN STRUC BIOL, V5, P482, DOI 10.1016/0959-440X(95)80032-8; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; ELLIS RJ, 1994, CURR OPIN STRUC BIOL, V4, P117, DOI 10.1016/S0959-440X(94)90069-8; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; Fairclough R H, 1978, Methods Enzymol, V48, P347; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GRAY TE, 1993, J MOL BIOL, V232, P1197, DOI 10.1006/jmbi.1993.1471; HAKANSSON K, 1992, J MOL BIOL, V227, P1192, DOI 10.1016/0022-2836(92)90531-N; Hammarstrom P, 1997, FEBS LETT, V420, P63, DOI 10.1016/S0014-5793(97)01488-9; Hammarstrom P, 2000, BIOCHEM BIOPH RES CO, V276, P393, DOI 10.1006/bbrc.2000.3360; Hammarstrom P, 1999, J BIOL CHEM, V274, P32897, DOI 10.1074/jbc.274.46.32897; Hammarstrom P, 2000, J BIOL CHEM, V275, P22832, DOI 10.1074/jbc.M000649200; HANSEN JE, 1993, J BIOL CHEM, V268, P21632; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; Krauss O, 1996, EUR J BIOCHEM, V241, P538, DOI 10.1111/j.1432-1033.1996.00538.x; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Mansoor SE, 1999, BIOCHEMISTRY-US, V38, P16383, DOI 10.1021/bi991331v; MARTENSSON LG, 1993, BIOCHEMISTRY-US, V32, P224, DOI 10.1021/bi00052a029; MARTENSSON LG, 1995, BIOCHEMISTRY-US, V34, P1011, DOI 10.1021/bi00003a036; Nozaki Y, 1972, Methods Enzymol, V26, P43; Persson M, 1999, BIOCHEMISTRY-US, V38, P432, DOI 10.1021/bi981442e; PERSSON M, 1995, BBA-PROTEIN STRUCT M, V1247, P195, DOI 10.1016/0167-4838(94)00227-8; Persson M, 1996, BBA-PROTEIN STRUCT M, V1298, P191, DOI 10.1016/S0167-4838(96)00125-2; Reid BG, 1996, J BIOL CHEM, V271, P7212, DOI 10.1074/jbc.271.12.7212; Sparrer H, 1996, J MOL BIOL, V258, P74, DOI 10.1006/jmbi.1996.0235; SVENSSON M, 1995, BIOCHEMISTRY-US, V34, P8606, DOI 10.1021/bi00027a010; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zahn R, 1996, SCIENCE, V271, P642, DOI 10.1126/science.271.5249.642; Zahn R, 1996, J MOL BIOL, V261, P43, DOI 10.1006/jmbi.1996.0440	36	25	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21765	21775		10.1074/jbc.M010858200	http://dx.doi.org/10.1074/jbc.M010858200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11278767	hybrid			2022-12-27	WOS:000169297900127
J	Oppenheim, EW; Adelman, C; Liu, XW; Stover, PJ				Oppenheim, EW; Adelman, C; Liu, XW; Stover, PJ			Heavy chain ferritin enhances serine hydroxymethyltransferase expression and de novo thymidine biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING-PROTEIN; ONE-CARBON METABOLISM; IRON-DEFICIENCY; FOLATE-DEFICIENCY; NEUTROPHIL HYPERSEGMENTATION; THYMIDYLATE SYNTHASE; H-SUBUNIT; C-MYC; CELLS; MIMOSINE	We have elucidated a biochemical mechanism whereby changes in iron metabolism cause changes in folate-dependent one-carbon metabolism. Although animal and clinical studies have demonstrated that perturbations in iron status and metabolism alter folate metabolism, the biochemical mechanisms underlying these associations have yet to be identified. The effect of altered ferritin expression on folate metabolism was determined in human MCF-7 cells and SH-SY5Y neuroblastoma. Cells expressing rat heavy chain ferritin (HCF) exhibited markedly increased expression of the folate-dependent enzyme cytoplasmic serine hydroxymethyltransferase (cSHMT). These effects were not seen when rat light chain ferritin was expressed. Additionally, cSHMT expression was not altered when HCF expression was induced in MCF-7 cells cultured with supplemental ferric citrate. This indicates that cSHMT expression is increased by elevated HCF concentrations, independent of increased iron availability, suggesting that cSHMT expression may respond to HCF-induced chelation of the regulatory iron pool. Increased HCF expression did not alter cSHMT mRNA levels, but did increase translation rates of cSHMT mRNA. The increase in translation was mediated, at least in part, through the cSHMT 5'-untranslated region of the transcript. MCF-7 cells with increased expression of cSHMT displayed increased efficiency of de novo thymidylate biosynthesis, indicating that thymidylate synthesis is normally limited by cSHMT activity in MCF-7 cells. Our data suggest that the iron regulatory pool may play an important role in regulating folate metabolism and thereby thymidine biosynthesis.	Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Stover, PJ (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	pjs13@cornell.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK049621, T32DK007158] Funding Source: NIH RePORTER; NICHD NIH HHS [HD35678] Funding Source: Medline; NIDDK NIH HHS [DK49621, DK07158-21] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN RH, 1993, FASEB J, V7, P1344, DOI 10.1096/fasebj.7.14.7901104; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Arosio C, 1999, HAEMATOLOGICA, V84, P560; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; BRADY MC, 1989, J INORG BIOCHEM, V35, P9, DOI 10.1016/0162-0134(89)84002-4; CHANARIN I, 1965, BMJ-BRIT MED J, V1, P480, DOI 10.1136/bmj.1.5433.480; Chu E, 1996, BIOESSAYS, V18, P191, DOI 10.1002/bies.950180306; CHU E, 1993, BIOCHEMISTRY-US, V32, P4756, DOI 10.1021/bi00069a009; CHU E, 1993, P NATL ACAD SCI USA, V90, P517, DOI 10.1073/pnas.90.2.517; DAS KC, 1978, BRIT J HAEMATOL, V39, P357, DOI 10.1111/j.1365-2141.1978.tb01108.x; EICHNER ER, 1973, J CLIN INVEST, V52, P584, DOI 10.1172/JCI107219; Fleming A, 1998, SCIENCE, V280, P2107, DOI 10.1126/science.280.5372.2107; Girgis S, 1998, GENE, V210, P315, DOI 10.1016/S0378-1119(98)00085-7; Girgis S, 1997, J BIOL CHEM, V272, P4729, DOI 10.1074/jbc.272.8.4729; Gruner BA, 1998, INVEST NEW DRUG, V16, P205, DOI 10.1023/A:1006147932159; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Heise T, 1997, J BIOL CHEM, V272, P20222, DOI 10.1074/jbc.272.32.20222; HOLLAND LJ, 1991, BIOCHEMISTRY-US, V30, P1965, DOI 10.1021/bi00221a033; JANSEN M, 1995, PEDIATR RES, V37, P681, DOI 10.1203/00006450-199506000-00001; Kalejta RF, 1997, EXP CELL RES, V231, P173, DOI 10.1006/excr.1996.3444; Kim YI, 1999, J NUTR BIOCHEM, V10, P66, DOI 10.1016/S0955-2863(98)00074-6; Kulp KS, 1996, TOXICOL APPL PHARM, V139, P356, DOI 10.1006/taap.1996.0176; KWAK EL, 1995, J BIOL CHEM, V270, P15285, DOI 10.1074/jbc.270.25.15285; LEGGETT BA, 1990, CLIN CHEM, V36, P1350; LEVI S, 1988, J BIOL CHEM, V263, P18086; Liu XW, 2000, BIOCHEMISTRY-US, V39, P11523, DOI 10.1021/bi000665d; MCNULTY H, 1993, J NUTR, V123, P1089; Melnyk S, 1999, CANCER LETT, V146, P35, DOI 10.1016/S0304-3835(99)00213-X; MILNE DB, 1983, AM J CLIN NUTR, V37, P768, DOI 10.1093/ajcn/37.5.768; MUNRO HN, 1978, PHYSIOL REV, V58, P317, DOI 10.1152/physrev.1978.58.2.317; NAKASHATRI H, 1997, GENE, V174, P79; OCONNOR DL, 1987, J NUTR, V117, P1715, DOI 10.1093/jn/117.10.1715; OCONNOR DL, 1989, J NUTR, V119, P1984, DOI 10.1093/jn/119.12.1984; OCONNOR DL, 1992, INT J VITAM NUTR RES, V62, P173; OCONNOR DL, 1990, J NUTR, V120, P499, DOI 10.1093/jn/120.5.499; Oppenheim EW, 2000, J BIOL CHEM, V275, P19268, DOI 10.1074/jbc.M001610200; PFENDNER W, 1980, ARCH BIOCHEM BIOPHYS, V200, P503, DOI 10.1016/0003-9861(80)90382-3; Picard V, 1996, BLOOD, V87, P2057; Picard V, 1998, J BIOL CHEM, V273, P15382, DOI 10.1074/jbc.273.25.15382; Ponka P, 1999, KIDNEY INT, V55, pS2, DOI 10.1046/j.1523-1755.1999.055Suppl.69002.x; ROBERTS PD, 1971, BRIT J HAEMATOL, V20, P165, DOI 10.1111/j.1365-2141.1971.tb07025.x; SCHIRCH V, 1989, ARCH BIOCHEM BIOPHYS, V269, P371, DOI 10.1016/0003-9861(89)90120-3; Smirnov IM, 1999, AM J PHYSIOL-LUNG C, V277, pL257, DOI 10.1152/ajplung.1999.277.2.L257; Suh JR, 2000, J BIOL CHEM, V275, P35646, DOI 10.1074/jbc.M005864200; THOMAS E, 1997, FASEB J, V11, P396; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; TOSKES P, 1972, GASTROENTEROLOGY, V62, P861; VITALE JJ, 1965, LANCET, V2, P393; Westerman DA, 1999, BRIT J HAEMATOL, V107, P512; Wu CG, 1997, INT J ONCOL, V11, P187; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; ZHU LJ, 1995, ENDOCRINOLOGY, V136, P4106, DOI 10.1210/en.136.9.4106; [No title captured]	53	46	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19855	19861		10.1074/jbc.M100039200	http://dx.doi.org/10.1074/jbc.M100039200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278996	hybrid			2022-12-27	WOS:000169135100025
J	Ahmad, Z; Sherman, F				Ahmad, Z; Sherman, F			Role of Arg-166 in yeast cytochrome c(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SACCHAROMYCES-CEREVISIAE; RHODOBACTER-CAPSULATUS; BC(1) COMPLEX; MEMBRANE-PROTEIN; INNER MEMBRANE; BC1 COMPLEX; DNA; BINDING; DOMAIN	A systematic screen for dominant-negative mutations of the CYT1 gene, which encodes cytochrome c(1), revealed seven mutants after testing similar to 10(4) Saccharomyces cerevisiae strains transformed with a library of mutagenized multicopy plasmids. DNA sequence analysis revealed multiple nucleotide substitutions with six of the seven altered Cyt1p having a common R166G replacement, either by itself or accompanied with other amino acid replacements. A single R166G replacement produced by site-directed mutagenesis demonstrated that this change produced a nearly nonfunctional cytochrome c(1), with diminished growth on glycerol medium and diminished respiration but with the normal or near normal level of cytochrome c(1) having an attached heme group. In contrast, R166K, R166M, or R166L replacements resulted in normal or near normal function. Arg-166 is conserved in all cytochromes c(1) and lies on the surface of Cyt1p in close proximity to the heme group but does not seem to interact directly with any of the physiological partners of the cytochrome bc(1) complex. Thus, the large size of the side chain at position 166 is critical for the function of cytochrome c(1) but not for its assembly in the cytochrome bc(1) complex.	Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Sherman, F (corresponding author), Univ Rochester, Sch Med, Dept Biochem & Biophys, POB 712, Rochester, NY 14642 USA.	Fred_Sherman@urmc.rochester.edu		Ahmad, Zulfiqar/0000-0001-7306-8151	NIGMS NIH HHS [R15 GM085771, R01 GM12702] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM085771, R01GM012702] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1985, ENZYMES BIOL MEMBRAN, DOI DOI 10.1007/978-1-4684-4604-3_10; Arnold I, 1998, J BIOL CHEM, V273, P1469, DOI 10.1074/jbc.273.3.1469; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; BOSSHARD HR, 1979, BIOCHEM BIOPH RES CO, V89, P250, DOI 10.1016/0006-291X(79)90971-9; BRANDT U, 1994, J BIOL CHEM, V269, P12947; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; BROGER C, 1983, EUR J BIOCHEM, V131, P349, DOI 10.1111/j.1432-1033.1983.tb07269.x; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; Darrouzet E, 1999, BIOCHEMISTRY-US, V38, P7908, DOI 10.1021/bi990211k; DEVRIES S, 1987, BIOCHIM BIOPHYS ACTA, V895, P205, DOI 10.1016/S0304-4173(87)80003-4; DUMONT ME, 1993, MOL CELL BIOL, V13, P6442, DOI 10.1128/MCB.13.10.6442; Gao F, 1999, BBA-PROTEIN STRUCT M, V1430, P203, DOI 10.1016/S0167-4838(98)00284-2; GENNIS RB, 1993, J BIOENERG BIOMEMBR, V25, P195, DOI 10.1007/BF00762582; GRAY KA, 1992, BIOCHEMISTRY-US, V31, P11864, DOI 10.1021/bi00162a027; HASE T, 1987, J BIOCHEM, V102, P401, DOI 10.1093/oxfordjournals.jbchem.a122067; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; HICKEY DR, 1991, GENE, V105, P73, DOI 10.1016/0378-1119(91)90515-D; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; KONISHI K, 1991, J BIOL CHEM, V266, P14270; KOPPENOL WH, 1982, J BIOL CHEM, V257, P4426; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Maniatis T., 1982, MOL CLONING; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; NAKAI M, 1993, J BIOCHEM-TOKYO, V114, P919, DOI 10.1093/oxfordjournals.jbchem.a124277; NAKAI M, 1989, J BIOCHEM-TOKYO, V106, P181, DOI 10.1093/oxfordjournals.jbchem.a122811; NAKAI M, 1990, J BIOCHEM-TOKYO, V108, P798, DOI 10.1093/oxfordjournals.jbchem.a123283; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHAGGER H, 1986, METHOD ENZYMOL, V126, P224; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SHERMAN F, 1964, BIOCHIM BIOPHYS ACTA, V90, P1, DOI 10.1016/0304-4165(64)90113-8; SHERMAN F, 1974, GENETICS, V77, P255; SHERMAN F, 1987, METHODS YEAST GENETI; Sherman F., 1997, ENCY MOL BIOL MOL ME, V6, P302; SIKORSKI RS, 1989, GENETICS, V122, P19; STONEHUERNER J, 1985, J BIOL CHEM, V260, P5392; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; VANLOON APGM, 1987, EMBO J, V6, P2441, DOI 10.1002/j.1460-2075.1987.tb02523.x; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	44	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18450	18456		10.1074/jbc.M100550200	http://dx.doi.org/10.1074/jbc.M100550200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279090	hybrid			2022-12-27	WOS:000168866500111
J	Tang, JG; Koeffler, HP				Tang, JG; Koeffler, HP			Structural and functional studies of CCAAT/enhancer-binding protein epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; HYDROPHOBIC AMINO-ACIDS; TRANSCRIPTION FACTOR; C/EBP-EPSILON; DNA-BINDING; LEUCINE ZIPPER; PU.1 SPI-1; ACTIVATION DOMAINS; MYELOID GENES; C-MYB	CCAAT/enhancer-binding protein (C/EBP) epsilon is a critical transcription factor for differentiation of myeloid cells. Structural and functional relationships of C/EBP epsilon were explored by recombinant protein studies, gene mutation, and transactivation assays. Evidence strongly suggested that C/EBP epsilon does not have disulfide bonds. Transactivation analysis of C/EBP epsilon having mutations of each of three conserved cysteines (C345, C148S, and C280S) indicated that the three mutant proteins had almost the same activity as the wild type. Dimer formation of C/EBP epsilon was not detected using both reducing and non-reducing SDS-polyacrylamide gel electrophoresis with Western blot analysis from either bacterial or mammalian expressed C/EBP epsilon, Furthermore, C/EBP epsilon mutant C280S gave a gel band similar to that for wild type, suggesting that this C-terminal, conserved cysteine is not involved in disulfide bond formation in vivo, even though previous data for C/EBP beta suggested that dimers may form in vitro utilizing this conserved cysteine residue. Mutational studies of conserved residues in the activating domain 1 (ADM1) and ADM2 of the amino region of the gene indicated that negative charge is critical for transactivational activity of C/EBP epsilon, Mutational analyses of hydrophobic amino acids in ADM1 suggested that these residues do not play a key role in transactivational activity, Further mutational studies indicated that, although the N-terminal 32-amino acid peptide of C/EBP epsilon isoform p32 did not greatly influence the transactivation activity compared with p30 isoform, this peptide does modulate transactivation activity, Domain swapping experiments substituting the ADM1 domain of various C/EBPs for C/EBP epsilon showed that the C/EBP alpha and -delta but not -beta ADM1 markedly enhanced the chimeric C/EBP epsilon transcriptional activity. Based on mutational data and possible mRNA structure, we hypothesized about the effect of mRNA structure on translation of the two major C/EBP epsilon isoforms: p32 and p30, The data suggested a very stable 8-base pair double helical structure with one strand sequence including the initial codon for p32 and complementary strand with the initial codon for p30.	Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Dept Med,Div Hematol Oncol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Koeffler, HP (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Dept Med,Div Hematol Oncol, 8700 Beverly Blvd,BM 109, Los Angeles, CA 90048 USA.							AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; ALMLOF T, 1995, J BIOL CHEM, V270, P17535, DOI 10.1074/jbc.270.29.17535; Angerer ND, 1999, J BIOL CHEM, V274, P4147, DOI 10.1074/jbc.274.7.4147; Antonson P, 1996, GENOMICS, V35, P30, DOI 10.1006/geno.1996.0319; Baer M, 1998, BLOOD, V92, P4353, DOI 10.1182/blood.V92.11.4353.423k21_4353_4365; BANNISTER AJ, 1991, ONCOGENE, V6, P1243; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BOLLAG DM, 1996, PROTEIN METHODS, P60; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chih DY, 1997, BLOOD, V90, P2987, DOI 10.1182/blood.V90.8.2987; Chumakov AM, 1997, MOL CELL BIOL, V17, P1375, DOI 10.1128/MCB.17.3.1375; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FRIEDMAN AD, 1990, GENE DEV, V4, P1416, DOI 10.1101/gad.4.8.1416; GOMBART AF, 2001, IN PRESS BLOOD; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Lekstrom-Himes JA, 1999, J EXP MED, V189, P1847, DOI 10.1084/jem.189.11.1847; MATSUI M, 1990, ONCOGENE, V5, P249; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Morosetti R, 1997, BLOOD, V90, P2591, DOI 10.1182/blood.V90.7.2591.2591_2591_2600; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NERLOV C, 1994, GENE DEV, V8, P350, DOI 10.1101/gad.8.3.350; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; NOMURA N, 1990, NUCLEIC ACIDS RES, V18, P3047, DOI 10.1093/nar/18.10.3047; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; PEI DQ, 1991, MOL CELL BIOL, V11, P1480, DOI 10.1128/MCB.11.3.1480; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; ROMAN C, 1990, GENE DEV, V4, P1404, DOI 10.1101/gad.4.8.1404; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; SCOTT LM, 1992, BLOOD, V80, P1725; SIDEROVSKI DP, 1990, DNA CELL BIOL, V9, P579, DOI 10.1089/dna.1990.9.579; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Sterneck E, 1998, J NEUROCHEM, V70, P2424; TANG JG, 1988, BIOCHEM J, V255, P451, DOI 10.1042/bj2550451; Tell G, 1998, BIOCHEM J, V329, P395, DOI 10.1042/bj3290395; TRAUTWEIN C, 1995, J BIOL CHEM, V270, P15130, DOI 10.1074/jbc.270.25.15130; Tudyka T, 1997, PROTEIN SCI, V6, P2180; Verbeek W, 1999, BLOOD, V93, P3327, DOI 10.1182/blood.V93.10.3327; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; Williamson EA, 1998, J BIOL CHEM, V273, P14796, DOI 10.1074/jbc.273.24.14796; Yamanaka R, 1998, INT J MOL MED, V1, P213; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P6462, DOI 10.1073/pnas.94.12.6462; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; ZUKER M, 2000, MFOLD VERSION 3	51	10	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17739	17746		10.1074/jbc.M011546200	http://dx.doi.org/10.1074/jbc.M011546200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278928	hybrid			2022-12-27	WOS:000168866500018
J	Field, FJ; Born, E; Murthy, S; Mathur, SN				Field, FJ; Born, E; Murthy, S; Mathur, SN			Regulation of sterol regulatory element-binding proteins in hamster intestine by changes in cholesterol flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; GENE-EXPRESSION; MESSENGER-RNAS; CULTURED-CELLS; CACO-2 CELLS; FATTY-ACIDS; LIVER; METABOLISM; MECHANISM; MEMBRANE	A control chow diet or diets containing 1% cholesterol (cholesterol-enriched) or 4% cholestyramine and 0.15% lovastatin (cholesterol-depletion) were fed to hamsters for 2 weeks. Sterol regulatory element-binding protein (SREBP)-1a, SREBP-1c, SREBP-2, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, 3-hydroxy-3-methyl-glutaryl-coenzyme A synthase, and LDL receptor mRNA levels and SREBP-1 and -2 protein expression were estimated in villus cell populations from duodenum, jejunum, and ileum, SREBP-1a was a minor transcript in hamster intestine, and its gene expression was not altered by changes in dietary cholesterol flux. In contrast, SREBP-1c gene expression was increased by dietary cholesterol and decreased by cholesterol depletion. mRNA levels for SREBP-2 and the other sterol-responsive genes were increased in intestines of animals on the cholesterol depletion diet but minimally suppressed if at all, by the diet enriched in cholesterol. In general, the amount of the precursor form of SREBP-1 was higher in cells of the upper villus and lower in cells of the lower villus, SREBP-2 precursor was higher in cells of the lower villus and lower in cells of the upper villus, Protein expression of precursor correlated with the location of gene expression for SREBPs, The amount of precursor mass of SREBP-2 was not altered by cholesterol feeding but was increased by cholesterol depletion. The mature form of SREBP-2 was in very low abundance and difficult to detect in intestines of animals fed control chow or cholesterol. It was readily detectable and increased in intestines of animals on the cholesterol-depletion diet. The diets did not significantly alter the amount of precursor or mature forms of SREBP-1, Cholesterol feeding had no effect on cholesterol or fatty acid synthesis, whereas synthesis of these lipids was increased in intestines of hamsters on the cholesterol-depleted diet. These results suggest that SREBP-1a has little or no role in regulating intestinal cholesterol synthesis. It is postulated that under basal conditions, SREBP-1c regulates intestinal fatty acid synthesis and SREBP-2 regulates cholesterol synthesis. Following marked changes in cholesterol flux across the intestine, SREBP-2 assumes the role of SREBP-1 and regulates both cholesterol and fatty acid synthesis in intestine.	Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Vet Affairs, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Field, FJ (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056032, P01HL049264] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56032, HL49264] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cartwright IJ, 1999, J LIPID RES, V40, P1357; ERICSSON J, 1996, BIOCHEM MOL BIOL INT, V38, P31; FIELD FJ, 1982, GASTROENTEROLOGY, V83, P873; FIELD FJ, 1991, J LIPID RES, V32, P1811; Field FJ, 2001, J LIPID RES, V42, P1; FIELD FJ, 1990, GASTROENTEROLOGY, V99, P539, DOI 10.1016/0016-5085(90)91040-D; Field FJ, 1995, J LIPID RES, V36, P2651; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; KAWABE Y, 1994, BIOCHEM BIOPH RES CO, V202, P1460, DOI 10.1006/bbrc.1994.2095; Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Osborne TF, 1995, CRIT REV EUKAR GENE, V5, P317, DOI 10.1615/CritRevEukarGeneExpr.v5.i3-4.50; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sadra A, 2000, ANAL BIOCHEM, V278, P235, DOI 10.1006/abio.1999.4453; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1997, P NATL ACAD SCI USA, V94, P12354, DOI 10.1073/pnas.94.23.12354; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; SPADY DK, 1983, J LIPID RES, V24, P303; STANGE EF, 1983, J BIOL CHEM, V258, P2868; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577	30	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17576	17583		10.1074/jbc.M010917200	http://dx.doi.org/10.1074/jbc.M010917200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278785	hybrid			2022-12-27	WOS:000168730400130
J	Kim, R; Saxena, S; Gordon, DM; Pain, D; Dancis, A				Kim, R; Saxena, S; Gordon, DM; Pain, D; Dancis, A			J-domain protein, Jac1p, of yeast mitochondria required for iron homeostasis and activity of Fe-S cluster proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED SIDEROBLASTIC ANEMIA; MOLECULAR CHAPERONE SYSTEM; SACCHAROMYCES-CEREVISIAE; IN-VIVO; TRANSCRIPTIONAL CONTROL; CYSTEINE DESULFURASE; ESCHERICHIA-COLI; GENE-CLUSTER; SULFUR; HOMOLOG	J-proteins are molecular chaperones with a characteristic domain predicted to mediate interaction with Hsp70 proteins. We have previously isolated yeast mutants of the mitochondrial Hsp70, Ssq1p, in a genetic screen for mutants with altered iron homeostasis. Here we describe the isolation of mutants of the J-domain protein, Jac1p, using the same screen. Mutant jac1 alleles predicted to encode severely truncated proteins (lacking 70 or 152 amino acids) were associated with phenotypes strikingly similar to the phenotypes of ssq1 mutants. These phenotypes include activation of the high affinity cellular iron uptake system and iron accumulation in mitochondria. In contrast to iron accumulation, Fe-S proteins of mitochondria were specifically deficient, In jac1 mutants, like in ssq1 mutants, processing of the Yfh1p precursor protein from intermediate to mature forms was delayed. In the genetic backgrounds used in this study, jac1 null mutants were found to be viable, permitting analysis of genetic interactions. The Delta jac1 Delta ssq1 double mutant was more severely compromised for growth than either single mutant, suggesting a synthetic or additive effect of these mutations. Overexpression of Jac1p partially suppressed ssq1 slow growth and vice verse. Similar mitochondrial localization and similar mutant phenotypes suggest that Ssq1p and Jac1p are functional partners in iron homeostasis.	Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Dancis, A (corresponding author), Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA.	adancis@mail.med.upenn.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053953, R37DK053953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011166] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL 07439-21] Funding Source: Medline; NIDDK NIH HHS [DK53953] Funding Source: Medline; NIGMS NIH HHS [GM57067] Funding Source: Medline; NINDS NIH HHS [NS11166] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Askwith CC, 1996, MOL MICROBIOL, V20, P27, DOI 10.1111/j.1365-2958.1996.tb02485.x; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1999, CURR OPIN CHEM BIOL, V3, P152, DOI 10.1016/S1367-5931(99)80027-1; Bekri S, 2000, BLOOD, V96, P3256; Brachmann CB, 1998, YEAST, V14, P115; Branda SS, 1999, J BIOL CHEM, V274, P22763, DOI 10.1074/jbc.274.32.22763; Brittenham GM, 2000, HEMATOLOGY BASIC PRI, P397; CRAIG EA, 1993, SCIENCE, V260, P1902, DOI 10.1126/science.8100364; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; Dibrov E, 1998, J BIOL CHEM, V273, P32042, DOI 10.1074/jbc.273.48.32042; GANGLOFF SP, 1990, MOL CELL BIOL, V10, P3551, DOI 10.1128/MCB.10.7.3551; Gordon DM, 1999, HUM MOL GENET, V8, P2255, DOI 10.1093/hmg/8.12.2255; Gordon DM, 2001, HUM MOL GENET, V10, P259, DOI 10.1093/hmg/10.3.259; Halliwell B., 1991, FREE RADICALS BIOL M; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; HOLM RH, 1992, ADV INORG CHEM, V38, P1, DOI 10.1016/S0898-8838(08)60061-6; Johnson JL, 1997, CELL, V90, P201, DOI 10.1016/S0092-8674(00)80327-X; Kambampati R, 2000, J BIOL CHEM, V275, P10727, DOI 10.1074/jbc.275.15.10727; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Knight SAB, 1999, AM J HUM GENET, V64, P365, DOI 10.1086/302270; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; LABBEBOIS R, 1990, J BIOL CHEM, V265, P7278; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schilke B, 1996, J CELL BIOL, V134, P603, DOI 10.1083/jcb.134.3.603; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Schulke N, 1999, J BIOL CHEM, V274, P22847, DOI 10.1074/jbc.274.32.22847; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Sherman F, 1986, LAB COURSE MANUAL ME; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Skovran E, 2000, J BACTERIOL, V182, P3896, DOI 10.1128/JB.182.14.3896-3903.2000; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Strain J, 1998, J BIOL CHEM, V273, P31138, DOI 10.1074/jbc.273.47.31138; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; Vickery LE, 1997, PROTEIN SCI, V6, P1047, DOI 10.1002/pro.5560060511; Voisine C, 2000, MOL CELL BIOL, V20, P3677, DOI 10.1128/MCB.20.10.3677-3684.2000; Westermann B, 1997, J MOL BIOL, V272, P477, DOI 10.1006/jmbi.1997.1267; WILEY JS, 2000, HEMATOLOGY BASIC PRI, P11428; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, J BIOL CHEM, V269, P18723; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	58	66	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17524	17532		10.1074/jbc.M010695200	http://dx.doi.org/10.1074/jbc.M010695200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278728	hybrid			2022-12-27	WOS:000168730400124
J	Weylandt, KH; Valverde, MA; Nobles, M; Raguz, S; Amey, JS; Diaz, M; Nastrucci, C; Higgins, CF; Sardini, A				Weylandt, KH; Valverde, MA; Nobles, M; Raguz, S; Amey, JS; Diaz, M; Nastrucci, C; Higgins, CF; Sardini, A			Human ClC-3 is not the swelling-activated chloride channel involved in cell volume regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; EPITHELIAL-CELLS; P-GLYCOPROTEIN; DENTS-DISEASE; CL CHANNELS; CURRENTS; EXPRESSION; DECREASE; VOLTAGE; MECHANISMS	Volume regulation is essential for normal cell function. A key component of the cells' response to volume changes is the activation of a channel, which elicits characteristic chloride currents (I-Cl,I-Swell) The molecular identity of this channel has been controversial. Most recently, ClC-3, a protein highly homologous to the ClC-4 and ClC-5 channel proteins, has been proposed as being responsible for I-Cl,I-Swell (1). Subsequently, however, other reports have suggested that ClC-3 may generate chloride currents with characteristics clearly distinct from I-Cl,I-Swell. Significantly different tissue distributions for ClC-3 have also been reported, and it has been suggested that two isoforms of ClC-3 may be expressed with differing functions, In this study we generated a series of cell lines expressing variants of ClC-3 to rigorously address the question of whether or not ClC-3 is responsible for I-Cl,I-Swell. The data demonstrate that ClC-3 is not responsible for I-Cl,I-Swell and has no role in regulatory volume decrease, furthermore, ClC-3 is not activated by intracellular calcium and fails to elicit chloride currents under any conditions tested. Expression of ClC-3 was shown to be relatively tissue-specific, with high levels in the central nervous system and kidney, and in contrast to previous reports, is essentially absent from heart. This distribution is also inconsistent with the previous proposed role in cell volume regulation.	Imperial Coll Sch Med, MRC, Ctr Clin Sci, London W12 0NN, England; Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona 08003, Spain; Univ La Laguna, Dept Anim Biol, E-38206 Tenerife, Spain	Imperial College London; Pompeu Fabra University; Universidad de la Laguna	Sardini, A (corresponding author), Imperial Coll Sch Med, MRC, Ctr Clin Sci, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.		Diaz, Mario/C-1916-2014; Cruzado, Raquel Marin/H-5790-2014	Diaz, Mario/0000-0001-5692-8906; Cruzado, Raquel Marin/0000-0003-0453-6892; Valverde, Miguel A./0000-0002-6961-3361				ALVAREZLEEFMANS FJ, 1995, METH NEUROSCI, V27, P361; Blott EJ, 1999, EMBO J, V18, P6800, DOI 10.1093/emboj/18.23.6800; Bond TD, 1998, J PHYSIOL-LONDON, V508, P333, DOI 10.1111/j.1469-7793.1998.333bq.x; Bond TD, 1998, J PHYSIOL-LONDON, V511, P45, DOI 10.1111/j.1469-7793.1998.045bi.x; BORSANI G, 1995, GENOMICS, V27, P131, DOI 10.1006/geno.1995.1015; Britton FC, 2000, AM J PHYSIOL-HEART C, V279, pH2225, DOI 10.1152/ajpheart.2000.279.5.H2225; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Devuyst O, 1999, HUM MOL GENET, V8, P247, DOI 10.1093/hmg/8.2.247; Duan D, 1999, J GEN PHYSIOL, V113, P57, DOI 10.1085/jgp.113.1.57; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Furst J, 2000, PFLUG ARCH EUR J PHY, V440, P100; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; HIGGINS CF, 1999, CHLORIDE CHANNELS, P35; Hoffmann EK, 1995, INT REV CYTOL, V161, P173; Jordt SE, 1997, EMBO J, V16, P1582, DOI 10.1093/emboj/16.7.1582; KAWASAKI M, 1995, NEURON, V14, P1285, DOI 10.1016/0896-6273(95)90275-9; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Li CH, 1998, J GEN PHYSIOL, V112, P727, DOI 10.1085/jgp.112.6.727; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; MORRIS AP, 1993, AM J PHYSIOL, V264, pC968, DOI 10.1152/ajpcell.1993.264.4.C968; Nguyen DHD, 2000, J BIOL CHEM, V275, P19382, DOI 10.1074/jbc.M909575199; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Park K, 1998, J MEMBRANE BIOL, V163, P87, DOI 10.1007/s002329900373; Shimada K, 2000, AM J PHYSIOL-GASTR L, V279, pG268, DOI 10.1152/ajpgi.2000.279.2.G268; STRANGE K, 1996, AM J PHYSIOL, V270, P711; STROBAWA SM, 2001, NEURON, V29, P185; Valverde MA, 1996, EMBO J, V15, P4460, DOI 10.1002/j.1460-2075.1996.tb00823.x; VALVERDE MA, 1993, PFLUG ARCH EUR J PHY, V425, P552, DOI 10.1007/BF00374885; Valverde MA, 1999, CURR OPIN CELL BIOL, V11, P509, DOI 10.1016/S0955-0674(99)80074-X; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; Wang LW, 2000, J PHYSIOL-LONDON, V524, P63, DOI 10.1111/j.1469-7793.2000.t01-1-00063.x; Xiong H, 1999, J MEMBRANE BIOL, V167, P215, DOI 10.1007/s002329900485	36	93	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17461	17467		10.1074/jbc.M011667200	http://dx.doi.org/10.1074/jbc.M011667200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278960	hybrid			2022-12-27	WOS:000168730400116
J	D'Orso, I; Frasch, ACC				D'Orso, I; Frasch, ACC			Functionally different AU- and G-rich cis-elements confer developmentally regulated mRNA stability in Trypanosoma cruzi by interaction with specific RNA-binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' UNTRANSLATED REGION; MESSENGER-RNA; 3'-UNTRANSLATED REGION; GENE-EXPRESSION; BRUCEI; DEGRADATION; TRANSLATION; LEISHMANIA; MECHANISMS; PROCYCLIN	Post-transcriptional regulatory mechanisms have been suggested to be the main point of control of gene expression in kinetoplastid parasites. We have previously shown that Trypanosoma cruzi SMUG mucin mRNA steady-state level is developmentally regulated by post-transcriptional mechanisms, being stable in the epimastigote insect vector stage, but unstable in the trypomastigote infective stage of the parasite, Its turnover is controlled by an AU-rich element (ARE) localized in the 3'-untranslated region, since a reporter gene lacking this sequence was stable in the trypomastigote stage (Di Noia, J. M., D'Orso, I., Sanchez, D. O., and Frasch, A. C. (2000) J. Biol. Chem. 275, 10218-10227). Here, we show by gel mobility shift assay that the 44-nt ARE sequence interacts with a set of stage-specific AU-rich element RNA-binding proteins (ARE-BPs). The epimastigote stage AU-rich element RNA-binding protein, named E-ARE-BP, and the trypomastigote stage ARE-BPs, named T-ARE-BPs, are efficiently competed by poly(U). UV cross-linking analysis showed that E-ARE-BP has an apparent molecular mass of 100 kDa and is different from the 45-50-kDa ARE-BPs present in other stages of the parasite. Transfection experiments allowed the identification of a novel cia-element that might be responsible for a positive effect on mRNA stability. It is a G-rich element, named GRE, composed by two contiguous CGGGG pentamers. The factors that recognize GRE were different from the ones that bind to ARE, in both molecular masses and subcellular localization. Thus, ARE and GRE are functionally different cis-elements, which might regulate mucin expression throughout the parasite life cycle.	Univ Nacl Gen San Martin, Consejo Nacl Invest Cient & Tecn, Inst Tecnol Chascomus, RA-1650 San Martin, Buenos Aires, Argentina; Univ Nacl Gen San Martin, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol, RA-1650 San Martin, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Frasch, ACC (corresponding author), Univ Nacl Gen San Martin, INTI, Inst Invest Biotecnol, Av Gral Paz S-N,Edifico 24,Casilla Correo 30, RA-1650 San Martin, Buenos Aires, Argentina.			Frasch, Alberto Carlos/0000-0001-7532-653X				Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; BENAMAR MF, 1991, NUCLEIC ACIDS RES, V19, P5857, DOI 10.1093/nar/19.21.5857; BERBEROF M, 1995, EMBO J, V14, P2925, DOI 10.1002/j.1460-2075.1995.tb07292.x; CAPPA SMG, 1981, MEDICINA-BUENOS AIRE, V41, P119; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Coughlin BC, 2000, J BIOL CHEM, V275, P12051, DOI 10.1074/jbc.275.16.12051; Cross GAM, 1998, MOL BIOCHEM PARASIT, V91, P77, DOI 10.1016/S0166-6851(97)00186-2; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Di Noia JM, 1998, J BIOL CHEM, V273, P10843, DOI 10.1074/jbc.273.18.10843; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; FOURNEY RM, 1978, FOCUS, V10, P5; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; GONZALEZ NS, 1989, BIOCHEM PHARMACOL, V38, P2873, DOI 10.1016/0006-2952(89)90444-9; Hotz HR, 1997, NUCLEIC ACIDS RES, V25, P3017, DOI 10.1093/nar/25.15.3017; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; Kiledjian M, 1997, MOL CELL BIOL, V17, P4870, DOI 10.1128/MCB.17.8.4870; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lee MGS, 1996, MOL CELL BIOL, V16, P1220; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Mahmood R, 1998, J BIOL CHEM, V273, P23729, DOI 10.1074/jbc.273.37.23729; Maranon C, 1998, MOL BIOCHEM PARASIT, V92, P313, DOI 10.1016/S0166-6851(98)00003-6; Marchetti MA, 2000, J CELL SCI, V113, P899; MartinezCalvillo S, 1997, GENE, V199, P71, DOI 10.1016/S0378-1119(97)00348-X; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; MERTZ LM, 1994, FOCUS, V16, P45; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Nozaki T, 1995, MOL BIOCHEM PARASIT, V75, P55, DOI 10.1016/0166-6851(95)02512-X; Pays E, 1998, MOL BIOCHEM PARASIT, V91, P3, DOI 10.1016/S0166-6851(97)00183-7; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Pereira-Chioccola VL, 2000, J CELL SCI, V113, P1299; Roditi I, 1998, MOL BIOCHEM PARASIT, V91, P117, DOI 10.1016/S0166-6851(97)00195-3; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; SMITH C, 1998, RNA PROTEIN INTERACT, P109; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; VANKLINKEN BJW, 1995, AM J PHYSIOL-GASTR L, V269, pG613, DOI 10.1152/ajpgi.1995.269.5.G613; VAZQUEZ MP, 1994, MOL BIOCHEM PARASIT, V64, P327, DOI 10.1016/0166-6851(94)00026-3; VAZQUEZ MP, 1998, MEM I O CRUZ, V99, P161; WANG XM, 1995, MOL CELL BIOL, V15, P1769; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; WILSON ME, 1993, J BIOL CHEM, V268, P15731; WINSTALL E, 1995, MOL CELL BIOL, V15, P3796; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zingales B, 1997, ACTA TROP, V68, P159, DOI 10.1016/S0001-706X(97)00088-0	51	45	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15783	15793		10.1074/jbc.M010959200	http://dx.doi.org/10.1074/jbc.M010959200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278796	hybrid			2022-12-27	WOS:000168623100030
J	Miyata, S; Matsushita, O; Minami, J; Katayama, S; Shimamoto, S; Okabe, A				Miyata, S; Matsushita, O; Minami, J; Katayama, S; Shimamoto, S; Okabe, A			Cleavage of a C-terminal peptide is essential for heptamerization of Clostridium perfringens epsilon-toxin in the synaptosomal membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; LAMBDA-TOXIN; AEROLYSIN; BINDING; PORE; PURIFICATION; HIPPOCAMPUS; EXPRESSION; CLONING	Activation of Clostridium perfringens epsilon -protoxin by tryptic digestion is accompanied by removal of the 13 N-terminal and 22 C-terminal amino acid residues. In this study, we examined the toxicity of four constructs: an epsilon -protoxin derivative (PD), in which a factor Xa cleavage site was generated at the C-terminal trypsin-sensitive site; PD without the 13 N-terminal residues (DeltaN-PD); PD without the 23 C-terminal residues (DeltaC-PD); and PD without either the N- or C-terminal residues (Delta NC-PD). A mouse lethality test showed that DeltaN-PD was inactive, as is PD, whereas DeltaC-PD and Delta NC-PD were equally active. DeltaC-PD and Delta NC-PD, but not the other constructs formed a large SDS-resistant complex in rat synaptosomal membranes as demonstrated by SDS-polyacrylamide gel electrophoresis. When Delta NC-PD and DeltaC-PD, both labeled with P-32 and mixed in various ratios, were incubated with membranes, eight distinct high molecular weight bands corresponding to six heteropolymers and two homopolymers were detected on a SDS-polyacrylamide gel, indicating the active toxin forms a heptameric complex. These results indicate that C-terminal processing is responsible for activation of the toxin and that it is essential for its heptamerization within the membrane.	Kagawa Med Univ, Fac Med, Dept Microbiol, Miki, Kagawa 7610793, Japan; Kagawa Prefectural Coll Hlth Sci, Dept Med Technol, Mure, Kagawa 7610123, Japan	Kagawa University	Okabe, A (corresponding author), Kagawa Med Univ, Fac Med, Dept Microbiol, 1750-1 Miki Cho, Miki, Kagawa 7610793, Japan.							Finnie JW, 1999, J COMP PATHOL, V120, P415, DOI 10.1053/jcpa.1998.0289; Fivaz M, 1999, J BIOL CHEM, V274, P37705, DOI 10.1074/jbc.274.53.37705; GARLAND WJ, 1988, INFECT IMMUN, V56, P1249, DOI 10.1128/IAI.56.5.1249-1253.1988; GRAY EG, 1962, J ANAT, V96, P79; HABEEB AFSA, 1973, BIOCHIM BIOPHYS ACTA, V322, P245, DOI 10.1016/0005-2795(73)90300-0; HUNTER SEC, 1992, INFECT IMMUN, V60, P102, DOI 10.1128/IAI.60.1.102-110.1992; Jin F, 1996, INFECT IMMUN, V64, P230, DOI 10.1128/IAI.64.1.230-237.1996; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; Lesieur C, 1999, J BIOL CHEM, V274, P36722, DOI 10.1074/jbc.274.51.36722; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Matsushita O, 1998, J BIOL CHEM, V273, P3643, DOI 10.1074/jbc.273.6.3643; Minami J, 1997, MICROBIOL IMMUNOL, V41, P527, DOI 10.1111/j.1348-0421.1997.tb01888.x; Miyamoto O, 1998, INFECT IMMUN, V66, P2501, DOI 10.1128/IAI.66.6.2501-2508.1998; Miyamoto O, 2000, FEMS MICROBIOL LETT, V189, P109, DOI 10.1111/j.1574-6968.2000.tb09215.x; Moniatte M, 1996, FEBS LETT, V384, P269, DOI 10.1016/0014-5793(96)00328-6; Nagahama M, 1998, J NAT TOXINS, V7, P291; Ohnishi M, 1998, J BIOL CHEM, V273, P453, DOI 10.1074/jbc.273.1.453; OKABE A, 1986, ANTIMICROB AGENTS CH, V30, P82, DOI 10.1128/AAC.30.1.82; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Sakurai J., 1995, Reviews in Medical Microbiology, V6, P175; Sellman BR, 1997, MOL MICROBIOL, V25, P429, DOI 10.1046/j.1365-2958.1997.4541820.x; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; WILMSEN HU, 1992, EMBO J, V11, P2457, DOI 10.1002/j.1460-2075.1992.tb05310.x	28	93	97	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13778	13783		10.1074/jbc.M011527200	http://dx.doi.org/10.1074/jbc.M011527200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278924	hybrid			2022-12-27	WOS:000168356600039
J	Pulaski, L; Landstrom, M; Heldin, CH; Souchelnytskyi, S				Pulaski, L; Landstrom, M; Heldin, CH; Souchelnytskyi, S			Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; BINDING-ELEMENT; PROTEIN; IDENTIFICATION; SUPERFAMILY; RESPONSES; SER(465); RECEPTOR; PROMOTER; PATHWAYS	Smad proteins are major components in the intracellular signaling pathway of transforming growth factor-beta (TGF-beta), and phosphorylation is an important mechanism in regulation of their functions. Smad7 was identified as a potent inhibitor of TGF-beta -dependent signaling. We have identified serine 249 in Smad7 as a major phosphorylation site, the phosphorylation of which was not affected by TGF-beta1, Abrogation of the phosphorylation by substitution of Ser-249 with alanine or aspartic acid residues did not affect the ability of Smad7 to inhibit TGF-beta1 and BMP7 signaling. No differences were found in the stability or in the intracellular distribution of Smad7 mutants compared with the wild-type molecule. However, Smad7 fused to the DNA-binding domain of GAL4 induced transcription from a reporter with mutated TATA minimal promoter in a Ser-249 dependent manner. Moreover, a reporter with the SV40 minimal promoter was inhibited by GAL4-Smad7, and this effect was also dependent on Ser-249 phosphorylation. The amplitude of effects on transcriptional regulation was dependent on cell type. Our results suggest that phosphorylation of Smad7, unlike phosphorylation of the receptor-regulated Smad7, does not regulate TGF-beta signaling but rather affects TGF-beta -independent effects of Smad7 on transcriptional regulation.	Ludwig Inst Canc Res, S-75124 Uppsala, Sweden; Univ Lodz, Dept Mol Biophys, PL-90237 Lodz, Poland	Ludwig Institute for Cancer Research; University of Lodz	Souchelnytskyi, S (corresponding author), Ludwig Inst Canc Res, Box 595, S-75124 Uppsala, Sweden.		Souchelnytskyi, Serhiy/G-6491-2011; Souchelnytskyi, Serhiy/J-9446-2014	Souchelnytskyi, Serhiy/0000-0001-8243-9276; Pulaski, Lukasz/0000-0001-8063-801X; Landstrom, Marene/0000-0001-6737-7230				Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Attisano L, 1998, CURR OPIN CELL BIOL, V10, P188, DOI 10.1016/S0955-0674(98)80141-5; Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Bitzer M, 2000, GENE DEV, V14, P187; Brown JD, 1999, J BIOL CHEM, V274, P8797, DOI 10.1074/jbc.274.13.8797; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Itoh S, 1998, J BIOL CHEM, V273, P29195, DOI 10.1074/jbc.273.44.29195; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Masuyama N, 1999, J BIOL CHEM, V274, P12163, DOI 10.1074/jbc.274.17.12163; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Shioda T, 1998, P NATL ACAD SCI USA, V95, P9785, DOI 10.1073/pnas.95.17.9785; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Topper JN, 1998, P NATL ACAD SCI USA, V95, P9506, DOI 10.1073/pnas.95.16.9506; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Zhu HJ, 1999, J BIOL CHEM, V274, P32258, DOI 10.1074/jbc.274.45.32258	27	40	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14344	14349		10.1074/jbc.M011019200	http://dx.doi.org/10.1074/jbc.M011019200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278814	hybrid			2022-12-27	WOS:000168356600110
J	Singh, P; Chan, SW; Hong, WJ				Singh, P; Chan, SW; Hong, WJ			Retinoblastoma protein is functionally distinct from its homologues in affecting glucocorticoid receptor-mediated transcription and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE FAMILY; NUCLEOSOME DISRUPTION; DNA ELEMENT; PRB-FAMILY; COMPLEX; BINDING; ACTIVATION; CLONING; DOMAIN; GROWTH	The cell cycle regulator, retinoblastoma protein, is known to potentiate glucocorticoid receptor-activated transcription through the interaction of its pocket domain with the transcription coactivator, hBRM. We now show that glucocorticoid receptor-induced apoptosis is also dependent on both the retinoblastoma protein and hBRM. p107 and p130, which share extensive sequence homology with the pocket domain of the retinoblastoma protein but not its N-terminal region, also interact with hBRM but do not support either glucocorticoid receptor-dependent activity. This difference arises from the divergent N-terminal domain of the retinoblastoma protein, which, when fused to the pocket domains, confers upon p107 and p130 the ability to influence glucocorticoid receptor activities. This effect probably results from the promotion of glucocorticoid receptor-targeted chromatin remodeling by the hBRM-containing SWI/SNF complex because the N-terminal domain of the retinoblastoma protein enhances glucocorticoid receptor-hBRM interactions. These results highlight that, besides the interaction between hBRM and the pocket; domain. of RE, the N-terminal region of the retinoblastoma protein is also essential for; glucocorticoid receptor-induced apoptosis and the potentiation of glucocorticoid receptor-mediated transcription and provide a basis for functional distinction between the retinoblastoma protein and its homologues.	Inst Mol & Cell Biol, Membrane Biol Lab, Singapore 117609, Singapore	Agency for Science Technology & Research (ASTAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Singh, P (corresponding author), Inst Mol & Cell Biol, Membrane Biol Lab, 30 Med Dr, Singapore 117609, Singapore.		HONG, Wanjin/E-9927-2010					BAXTER JD, 1971, SCIENCE, V171, P189, DOI 10.1126/science.171.3967.189; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; HARPER JW, 1993, CELL, V75, P805; HELMBERG A, 1995, EMBO J, V14, P452, DOI 10.1002/j.1460-2075.1995.tb07021.x; HENSEY CE, 1994, J BIOL CHEM, V269, P1380; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LI Q, 1993, GENE DEV, V7, P2471, DOI 10.1101/gad.7.12a.2471; LI Y, 1993, GENE DEV, V7, P2366, DOI 10.1101/gad.7.12a.2366; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Liu WH, 1995, P NATL ACAD SCI USA, V92, P12480, DOI 10.1073/pnas.92.26.12480; Lu JM, 1998, J BIOL CHEM, V273, P31528, DOI 10.1074/jbc.273.47.31528; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MAYOL X, 1993, ONCOGENE, V8, P2561; MORDACQ JC, 1989, GENE DEV, V3, P760, DOI 10.1101/gad.3.6.760; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; REIK A, 1991, EMBO J, V10, P2569, DOI 10.1002/j.1460-2075.1991.tb07797.x; Rogatsky I, 1999, MOL CELL BIOL, V19, P5036; SINGH P, 1995, NATURE, V374, P562, DOI 10.1038/374562a0; SINGH P, 1994, EMBO J, V13, P3329, DOI 10.1002/j.1460-2075.1994.tb06635.x; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268; UAUSUBEL FM, 1993, CURRENT PROTOCOLS MO; WANG JYJ, 1994, ADV CANCER RES, V64, P25, DOI 10.1016/S0065-230X(08)60834-9; Wang JYJ, 1997, CURR OPIN GENET DEV, V7, P39, DOI 10.1016/S0959-437X(97)80107-4; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	49	14	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13762	13770		10.1074/jbc.M100137200	http://dx.doi.org/10.1074/jbc.M100137200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11279017	hybrid			2022-12-27	WOS:000168356600037
J	Fujiwara, S; Takeo, N; Otani, Y; Parry, DAD; Kunimatsu, M; Lu, R; Sasaki, M; Matsuo, N; Khaleduzzaman, M; Yoshioka, H				Fujiwara, S; Takeo, N; Otani, Y; Parry, DAD; Kunimatsu, M; Lu, R; Sasaki, M; Matsuo, N; Khaleduzzaman, M; Yoshioka, H			Epiplakin, a novel member of the plakin family originally identified as a 450-kDa human epidermal autoantigen - Structure and tissue localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BULLOUS PEMPHIGOID ANTIGEN; AMINO-ACID-SEQUENCES; PARANEOPLASTIC PEMPHIGUS; INTERMEDIATE FILAMENTS; EPIDERMOLYSIS-BULLOSA; HUMAN AUTOANTIBODIES; MUSCULAR-DYSTROPHY; DESMOPLAKIN-I; CDNA CLONING; COILED-COIL	A 450-kDa human epidermal autoantigen was originally identified as a protein that reacted with the serum from an individual with a subepidermal blistering disease. Molecular cloning of this protein has now shown that it contains 5065 amino acids and has a molecular mass of 552 kDa. As reported previously this protein, which we call epiplakin, belongs to the plakin family, but it has some very unusual features. Epiplakin has 13 domains that are homologous to the B domain in the COOH-terminal region of desmoplakin. The last five of these B domains, together with their associated linker regions, are particularly strongly conserved. However, epiplakin lacks a coiled-coil rod domain and an amino-terminal domain, both of which are found in all other known members of the plakin family. Furthermore, no dimerization motif was found in the sequence. Thus, it is likely that epiplakin exists in vivo as a single-chain structure. Epitope mapping experiments showed that the original patient's serum recognized a sequence unique to epiplakin, which was not found in plectin. Immunofluorescence staining revealed the presence of epiplakin in whole sheets: of epidermis and esophagus, in glandular cells of eccrine sweat and parotid glands and in mucous epithelial cells in the stomach and colon.	Oita Med Univ, Dept Dermatol, Oita 8795593, Japan; Nagoya City Univ, Sch Med, Dept Biochem, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	Oita University; Nagoya City University; Massey University	Fujiwara, S (corresponding author), Oita Med Univ, Dept Dermatol, Oita 8795593, Japan.		Khaledian, Hossein/S-7707-2016	Khaledian, Hossein/0000-0002-4082-2987				APPEL JR, 1990, J IMMUNOL, V144, P976; Carninci P, 1998, P NATL ACAD SCI USA, V95, P520, DOI 10.1073/pnas.95.2.520; FRANK R, 1996, METHOD MOL BIOL, V66, P49; Fuchs P, 1999, HUM MOL GENET, V8, P2461, DOI 10.1093/hmg/8.13.2461; FUJIWARA S, 1994, DERMATOLOGY, V189, P120, DOI 10.1159/000246950; Fujiwara S, 1996, J INVEST DERMATOL, V106, P1125, DOI 10.1111/1523-1747.ep12340171; Fujiwara Sakuhei, 1992, Journal of Dermatology (Tokyo), V19, P610; Gache Y, 1996, J CLIN INVEST, V97, P2289, DOI 10.1172/JCI118671; GREEN KJ, 1990, J BIOL CHEM, V265, P2603; GREEN KJ, 1992, INT J BIOL MACROMOL, V14, P145, DOI 10.1016/S0141-8130(05)80004-2; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HUDSON D, 1988, J ORG CHEM, V53, P617, DOI 10.1021/jo00238a026; Keith D, 1999, HUM MOL GENET, V8, P143, DOI 10.1093/hmg/8.1.143; Kim SC, 1997, J INVEST DERMATOL, V109, P365, DOI 10.1111/1523-1747.ep12336235; Klymkowsky MW, 1999, NAT CELL BIOL, V1, pE121, DOI 10.1038/12950; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; McLean WHI, 1996, GENE DEV, V10, P1724, DOI 10.1101/gad.10.14.1724; Nikolic B, 1996, J CELL BIOL, V134, P1455, DOI 10.1083/jcb.134.6.1455; OKEEFE EJ, 1989, J BIOL CHEM, V264, P8310; OURSLER JR, 1992, J CLIN INVEST, V89, P1775, DOI 10.1172/JCI115781; PARRY DAD, 1977, J MOL BIOL, V113, P449, DOI 10.1016/0022-2836(77)90153-X; Proby C, 1999, J INVEST DERMATOL, V112, P153, DOI 10.1046/j.1523-1747.1999.00498.x; Ruhrberg C, 1997, J CELL BIOL, V139, P1835, DOI 10.1083/jcb.139.7.1835; Ruhrberg C, 1996, J CELL BIOL, V134, P715, DOI 10.1083/jcb.134.3.715; Ruhrberg C, 1997, CURR OPIN GENET DEV, V7, P392, DOI 10.1016/S0959-437X(97)80154-2; SAWAMURA D, 1991, J BIOL CHEM, V266, P17784; STAPPENBECK TS, 1993, J CELL BIOL, V123, P691, DOI 10.1083/jcb.123.3.691; TANAKA T, 1991, J BIOL CHEM, V266, P12555; Uitto J, 1996, Exp Dermatol, V5, P237, DOI 10.1111/j.1600-0625.1996.tb00124.x; WICHE G, 1991, J CELL BIOL, V114, P83, DOI 10.1083/jcb.114.1.83; WICHE G, 1993, J CELL BIOL, V121, P607, DOI 10.1083/jcb.121.3.607; Yang YM, 1999, CELL, V98, P229, DOI 10.1016/S0092-8674(00)81017-X; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5	34	50	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13340	13347		10.1074/jbc.M011386200	http://dx.doi.org/10.1074/jbc.M011386200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278896	hybrid			2022-12-27	WOS:000168198600120
J	Qiu, ZL; Wei, Y; Chen, N; Jiang, MR; Wu, JR; Liao, K				Qiu, ZL; Wei, Y; Chen, N; Jiang, MR; Wu, JR; Liao, K			DNA synthesis and mitotic clonal expansion is not a required step for 3T3-L1 preadipocyte differentiation into adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; INSULIN; KINASE; CELLS; INHIBITION; INDUCTION; TURNOVER	Upon differentiation induction of 3T3-L1 preadipocytes by a hormone mixture containing 1-isobutyl-8-methylxanthine, dexamethasone, and insulin, the preadipocytes undergo similar to2 rounds of mitotic clonal expansion, which just; precedes the adipogenic gene expression program and has been thought to be an essential early step for differentiation initiation. By inducing 3T3-L1 preadipocytes with each individual hormone, it was determined that the mitotic clonal expansion was induced only by insulin and not by 1-isobutyl-3-methylxanthine or dexamethasone. Cell number counting an fluorescence-activated cell-sorting analysis indicated that a significant fraction of 3T3-L1 preadipocytes differentiated into adipocytes without mitotic clonal expansion when induced with the combination of 1-isobutyl-3-methylxanthine and dexamethasone. Furthermore, when normally induced 3T3-L1 preadipocytes were treated with PD98059 tan inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1) to block the activation of extracellular signal-regulated kinase (Erk) 1 and Erk2, the mitotic clonal expansion was blocked, but adipocyte differentiation was not affected. These observations were confirmed by bromodeoxyuridine labeling. The differentiated adipocytes induced with 1-isobutyl-3-methylxanthine and dexamethasone or standard hormone mixture plus PD98059 were not labeled by bromodeoxyuridine. Thus, it is evident that 3T3-L1 preadipocytes could differentiate into adipocytes without DNA synthesis and mitotic clonal expansion. Our results also suggested that activation of Erk1 and Erk2 is essential to but not sufficient for induction of mitotic clonal expansion.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Lab Mol Biol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Res Ctr Life Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Liao, K (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Lab Mol Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.		Jiang, Manrong/E-6991-2011					Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Entenmann G, 1996, AM J PHYSIOL-CELL PH, V270, pC1011, DOI 10.1152/ajpcell.1996.270.4.C1011; FONT DE, 1997, MOL CELL BIOL, V17, P6068; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Jin SH, 2000, J BIOL CHEM, V275, P34344, DOI 10.1074/jbc.M004927200; Kim B, 1997, J BIOL CHEM, V272, P21268, DOI 10.1074/jbc.272.34.21268; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; LIAO K, 1995, J BIOL CHEM, V270, P12123, DOI 10.1074/jbc.270.20.12123; Lyle RE, 1998, BIOCHEM BIOPH RES CO, V247, P373, DOI 10.1006/bbrc.1998.8773; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MACKALL JC, 1976, J BIOL CHEM, V251, P6462; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285; Reichert M, 1999, ONCOGENE, V18, P459, DOI 10.1038/sj.onc.1202308; Rosen O M, 1979, Recent Prog Horm Res, V35, P477; SCHMIDT W, 1990, J BIOL CHEM, V265, P15489; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086	20	114	121	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11988	11995		10.1074/jbc.M011729200	http://dx.doi.org/10.1074/jbc.M011729200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278974	hybrid			2022-12-27	WOS:000168081800074
J	Spada, F; Steen, H; Troedsson, C; Kallesoe, T; Spriet, E; Mann, M; Thompson, EM				Spada, F; Steen, H; Troedsson, C; Kallesoe, T; Spriet, E; Mann, M; Thompson, EM			Molecular patterning of the oikoplastic epithelium of the larvacean tunicate Oikopleura dioica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATE POLYACRYLAMIDE GELS; HUMAN ARTICULAR-CARTILAGE; MUCIN GENE FAMILY; EVOLUTIONARY HISTORY; LOCALIZATION; PROTEINS; PEPTIDES; SIGNAL; SITES	Appendicularia are protochordates that rely on a complex mucous secretion, the house, to filter food particles from seawater. A monolayer of cells covering the trunk of the animal, the oikoplastic epithelium, secretes the house. This epithelium contains a fixed number of cells arranged in characteristic patterns with distinct sizes and nuclear morphologies, Certain house structures appear to be spatially related to defined, underlying groups of cells in the epithelium, We show that the house is composed of at least 20 polypeptides, a number of which are highly glycosylated, with glycosidase treatments resulting in molecular mass shifts exceeding 100 kDa. Nanoelectrospray tandem mass spectrometric microsequencing of house polypeptides was used to design oligonucleotides to screen an adult Oikopleura dioica cDNA library, This resulted in the isolation of cDNAs coding for three different proteins, oikosin 1, oikosin 2, and oikosin 3, The latter two are novel proteins unrelated to any known data base entries. Oikosin 1 has 13 repeats of a Cys domain, previously identified as a subunit of repeating sequences in some vertebrate mucins, We also find one repeat of this Cys domain in human cartilage intermediate layer protein but find no evidence of this domain in any invertebrate species, including those for which entire genomes have been sequenced, The three oikosins show distinct and complementary expression patterns restricted to the oikoplastic epithelium, This easily accessible epithelium, with differential gene expression patterns in readily identifiable groups of cells with distinctive nuclear morphologies, is a highly attractive model system for molecular studies of pattern formation.	Bergen High Technol Ctr, Sars Int Ctr Marine Mol Biol, N-5008 Bergen, Norway; Univ So Denmark Odense, Dept Biochem & Mol Biol, Prot Interact Lab, DK-5230 Odense, Denmark	University of Southern Denmark	Thompson, EM (corresponding author), Bergen High Technol Ctr, Sars Int Ctr Marine Mol Biol, N-5008 Bergen, Norway.		Spada, Fabio/J-4354-2013; Mann, Matthias/A-3454-2013	Spada, Fabio/0000-0002-7148-9013; Mann, Matthias/0000-0003-1292-4799; Steen, Hanno/0000-0003-0179-6648				ALLDREDGE AL, 1977, J ZOOL, V181, P175; BAYLISS MT, 1983, BIOCHEM J, V209, P387, DOI 10.1042/bj2090387; Buisine MP, 1998, BIOCHEM J, V332, P729, DOI 10.1042/bj3320729; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; Christen R., 1998, P265; Csikos G, 1999, J CELL SCI, V112, P2113; Desseyn JL, 1998, J MOL EVOL, V46, P102, DOI 10.1007/PL00006276; Desseyn JL, 2000, MOL BIOL EVOL, V17, P1175, DOI 10.1093/oxfordjournals.molbev.a026400; Desseyn JL, 1997, J BIOL CHEM, V272, P3168, DOI 10.1074/jbc.272.6.3168; FENAUX R, 1985, B MAR SCI, V37, P498; FENAUX R, 1971, Z MORPHOL TIERE, V69, P184; Flood Per R., 1998, P105; FLOOD PR, 1991, MAR BIOL, V111, P95, DOI 10.1007/BF01986351; JAY GD, 1990, ANAL BIOCHEM, V185, P324, DOI 10.1016/0003-2697(90)90302-P; Krieg J, 1998, MOL BIOL CELL, V9, P301, DOI 10.1091/mbc.9.2.301; Krumbach, 1933, HDB ZOOLOGIE, P15; LOCKE M, 1994, TISSUE CELL, V26, P707, DOI 10.1016/0040-8166(94)90055-8; LOHMANN H., 1926, DEUTSCHE SUDPOLAR EXPED 1901 1903, V18, P63; Lohmann H., 1899, SCHR NATURW VER SCHL, V11, P347; Lorenzo P, 1998, J BIOL CHEM, V273, P23463, DOI 10.1074/jbc.273.36.23463; MARTINI E, 1909, Z WISS ZOOL, V94, P563; MOLLER HJ, 1995, ANAL BIOCHEM, V226, P371, DOI 10.1006/abio.1995.1238; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PILAR L, 1998, J BIOL CHEM, V273, P23469; SHAGGER H, 1987, ANAL BIOCHEM, V166, P368; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHEVCHENKO A, 1997, RAPID COMMUN MASS SP, V11, P105; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519	30	50	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20624	20632		10.1074/jbc.M100438200	http://dx.doi.org/10.1074/jbc.M100438200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279070	hybrid			2022-12-27	WOS:000169135100128
J	Belyanskaya, LL; Gehrig, PM; Gehring, H				Belyanskaya, LL; Gehrig, PM; Gehring, H			Exposure on cell surface and extensive arginine methylation of ewing sarcoma (EWS) protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EWS/FLI-1 FUSION GENE; NUCLEIC-ACID BINDING; TRANSCRIPTIONAL ACTIVATOR; POLYACRYLAMIDE GELS; MALIGNANT-MELANOMA; CHIMERIC PROTEIN; SOFT PARTS; RNA; FAMILY; DOMAIN	In contrast to the knowledge regarding the function of chimeric Ewing sarcoma (EWS) fusion proteins that arise from chromosomal translocation, the cellular function of the RNA binding EWS protein is poorly characterized. EWS protein had been found mainly in the nucleus. In this report we show that EWS protein is not only found in the nucleus and cytosol but also on cell. surfaces. After cell-surface biotinylation, isoelectric focusing of membrane fraction, avidin-agarose extraction of biotinylated proteins, and SDS-polyacrylamide gel electrophoresis, EWS protein was identified by matrix-assisted laser desorption ionization and nanoelectro-spray tandem mass spectrometry of in-gel-digested peptides. These analyses revealed that the protein, having repeated RGG motifs, is extensively asymmetrically dimethylated on arginine residues, the sites of which have been mapped by mass spectrometric methods. Out of a total of 30 Arg-Gly sequences, 29 arginines were found to be at least partially methylated. The Arg-Gly-Gly sequence was present in 21 of the 29 methylation sites, and in contrast to other methylated proteins, only 11 (38%) methylated arginine residues were found in the Gly-Arg-Gly sequence. The presence of Gly on the C-terminal side of the arginine residue seems to be a prerequisite for recognition by a protein-arginine N-methyltransferase (PRMT) catalyzing this asymmetric dimethylation reaction. One monomethylarginine and no symmetrically methylated arginine residue was found. The present findings imply that RNA-binding EWS protein shuttles from the nucleus to the cell surface in a methylated form, the role of which is discussed.	Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Gehring, H (corresponding author), Univ Zurich, Inst Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.							ALTIN JG, 1995, ANAL BIOCHEM, V224, P382, DOI 10.1006/abio.1995.1054; BALDWIN GS, 1971, SCIENCE, V171, P579, DOI 10.1126/science.171.3971.579; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; BROWN AD, 1995, ONCOGENE, V10, P1749; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; de Alava E, 2000, J CLIN ONCOL, V18, P204, DOI 10.1200/JCO.2000.18.1.204; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; Deloulme JC, 1997, J BIOL CHEM, V272, P27369, DOI 10.1074/jbc.272.43.27369; Felsch JS, 1999, CURR BIOL, V9, P485, DOI 10.1016/S0960-9822(99)80214-0; Fujimura Y, 1996, ONCOGENE, V12, P159; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Guinamard R, 1997, SCAND J IMMUNOL, V45, P587, DOI 10.1046/j.1365-3083.1997.d01-447.x; Hyun YL, 2000, BIOCHEM J, V348, P573, DOI 10.1042/0264-6021:3480573; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Klein S, 2000, J BIOL CHEM, V275, P3150, DOI 10.1074/jbc.275.5.3150; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; LEE HW, 1977, BIOCHEMISTRY-US, V16, P78, DOI 10.1021/bi00620a013; LESSNICK SL, 1995, ONCOGENE, V10, P423; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MERRILL BM, 1987, INT J PEPT PROT RES, V29, P21; OHNO T, 1994, ONCOGENE, V9, P3087; OHNO T, 1993, CANCER RES, V53, P5859; OUCHIDA M, 1995, ONCOGENE, V11, P1049; PRASAD DDK, 1994, ONCOGENE, V9, P3717; RAJPUROHIT R, 1994, BIOCHEM J, V304, P903, DOI 10.1042/bj3040903; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Weighardt F, 1996, BIOESSAYS, V18, P747, DOI 10.1002/bies.950180910; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zobel-Thropp P, 1998, J BIOL CHEM, V273, P29283, DOI 10.1074/jbc.273.45.29283; ZUEMAN J, 1993, EMBO J, V12, P4481	38	71	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18681	18687		10.1074/jbc.M011446200	http://dx.doi.org/10.1074/jbc.M011446200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278906	hybrid, Green Accepted			2022-12-27	WOS:000169091000006
J	Stewart, J; Hingorani, MM; Kelmann, Z; O'Donnell, M				Stewart, J; Hingorani, MM; Kelmann, Z; O'Donnell, M			Mechanism of beta clamp opening by the delta subunit of Escherichia coli DNA polymerase III holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL REPLICATION MACHINE; SLIDING CLAMPS; CRYSTAL-STRUCTURE; PROCESSIVITY FACTOR; ACCESSORY PROTEINS; LAGGING-STRAND; COMPLEX; LOADER; CHI; TAU	The beta sliding clamp encircles the primer-template and tethers DNA polymerase III holoenzyme to DNA for processive replication of the Escherichia coli genome. The clamp is formed via hydrophobic and ionic interactions between two semicircular beta monomers, This report demonstrates that the beta dimer is a stable closed ring and is not monomerized when the gamma complex clamp loader (gamma (3)delta (1)delta (1)chi (1)psi (1)) assembles the beta ring around DNA. delta is the subunit of the gamma complex that binds beta and opens the ring; it also does not appear to monomerize beta. Point mutations were introduced at the beta dimer interface to test its structural integrity and gain insight into its interaction with delta, Mutation of two residues at the dimer interface of beta, I272A/L273A, yields a stable beta monomer, We find that delta binds the beta monomer mutant at least 50-fold tighter than the beta dimer. These findings suggest that when delta interacts with the p clamp, it binds one beta subunit with high affinity and utilizes some of that binding energy to perform work on the dimeric clamp, probably cracking one dimer interface open.	Rockefeller Univ, New York, NY 10021 USA; Cornell Univ, Med Coll, Dept Microbiol, New York, NY 10021 USA; Howard Hughes Med Inst, Lab DNA Replicat, New York, NY 10021 USA	Rockefeller University; Cornell University; Howard Hughes Medical Institute	O'Donnell, M (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.			O'Donnell, Michael/0000-0001-9002-4214	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38839] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Bertram JG, 1998, J BIOL CHEM, V273, P24564, DOI 10.1074/jbc.273.38.24564; CAI M, 1997, J BIOL CHEM, V272, P18974; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; DONG ZM, 1993, J BIOL CHEM, V268, P11758; FAY PJ, 1981, J BIOL CHEM, V256, P976; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; HINORANI MM, 2000, CURR BIOL, V10, P25; KELMAN Z, 1995, GENE, V166, P177, DOI 10.1016/0378-1119(95)00556-7; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kelman Z, 1995, METHOD ENZYMOL, V262, P430; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kornberg A., 1992, DNA REPLICATION; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; KURIYAN J, 1993, J MOL BIOL, V234, P915, DOI 10.1006/jmbi.1993.1644; LEE SH, 1987, P NATL ACAD SCI USA, V84, P2713, DOI 10.1073/pnas.84.9.2713; Leu FP, 2000, J BIOL CHEM, V275, P34609, DOI 10.1074/jbc.M005495200; MAKI H, 1985, J BIOL CHEM, V260, P2987; MAKI S, 1988, J BIOL CHEM, V263, P6555; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; MCHENRY CS, 1982, J BIOL CHEM, V257, P2657; MCHENRY CS, 1979, J BIOL CHEM, V252, P6478; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; ONRUST R, 1991, J BIOL CHEM, V266, P21681; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; ROWEN L, 1978, J BIOL CHEM, V253, P758; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; STUDWELL PS, 1990, J BIOL CHEM, V265, P1171; STUDWELLVAUGHAN PS, 1991, J BIOL CHEM, V266, P19833; STUDWELLVAUGHAN PS, 1993, J BIOL CHEM, V268, P11785; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TSUCHIHASHI Z, 1989, J BIOL CHEM, V264, P17790; Turner J, 1995, METHOD ENZYMOL, V262, P442; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; XIAO H, 1993, J BIOL CHEM, V268, P11773; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	53	53	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19182	19189		10.1074/jbc.M100592200	http://dx.doi.org/10.1074/jbc.M100592200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279099	hybrid			2022-12-27	WOS:000169091000074
J	Monchois, V; Abergel, C; Sturgis, J; Jeudy, S; Claverie, JM				Monchois, V; Abergel, C; Sturgis, J; Jeudy, S; Claverie, JM			Escherichia coli ykfE ORFan gene encodes a potent inhibitor of C-type lysozyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; PROTEINS; K-12; ELECTROPHORESIS; SECRETIONS; DEFENSE; LIPIDS; MILK	The complete nucleotide sequences of over 37 microbial and three eukaryote genomes are already publicly available, and more sequencing is in progress. Despite this accumulation of data, newly sequenced microbial genomes continue to reveal up to 50% of functionally uncharacterized "anonymous" genes. A majority of these anonymous proteins have homologues in other organisms, whereas the rest exhibit no clear similarity to any other sequence in the data bases. This set of unique, apparently species-specific, sequences are referred to as ORFans, The biochemical and structural analysis of ORFan gene products is of both evolutionary and functional interest. Here we report the cloning and expression of Escherichia coli ORFan ykfE gene and the functional characterization of the encoded protein. Under physiological conditions, the protein is a homodimer with a strong affinity for C-type lysozyme, as revealed by co-purification and co-crystallization. Activity measurements and fluorescence studies demonstrated that the YkfE gene product is a potent C-type lysozyme inhibitor (K-i approximate to 1 nM), To denote this newly assigned function, ykfE has now been registered under the new gene name Ivy (inhibitor of vertebrate lysozyme) at the E, coli genetic stock center.	AVENTIS, CNRS, UMR 1889, F-13402 Marseille 20, France; Lab Ingn Syst Macromol, UPR 9027, F-13402 Marseille, France	Centre National de la Recherche Scientifique (CNRS); Sanofi-Aventis; Sanofi France; UDICE-French Research Universities; Aix-Marseille Universite	Monchois, V (corresponding author), AVENTIS, CNRS, UMR 1889, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.		Claverie, Jean-Michel/AAG-4889-2019; Sturgis, James/F-6051-2011; Sturgis, James/AAU-8103-2020; Claverie, Jean Michel/Z-2183-2019	Claverie, Jean-Michel/0000-0003-1424-0315; Abergel, Chantal/0000-0003-1875-4049; Sturgis, James/0000-0001-5125-7699				Abergel C, 2000, ACTA CRYSTALLOGR D, V56, P1694, DOI 10.1107/S0907444900015316; Alimi JP, 2000, GENOME RES, V10, P959, DOI 10.1101/gr.10.7.959; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bondarenko V M, 1994, Zh Mikrobiol Epidemiol Immunobiol, VSuppl 1, P22; Bukharin O V, 1994, Zh Mikrobiol Epidemiol Immunobiol, VSuppl 1, P4; BUKHARIN OV, 1989, ZH MIKROBIOL EPIDEMI, V11, P16; CHARLEMAGNE D, 1970, CR HEBD ACAD SCI, P2721; Cohen M S, 1984, Scand J Urol Nephrol Suppl, V86, P13; Cole AM, 1999, INFECT IMMUN, V67, P3267, DOI 10.1128/IAI.67.7.3267-3275.1999; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; GEMSA D, 1996, NATURE, V210, P950; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HACKMAN RH, 1964, ANAL BIOCHEM, V8, P397, DOI 10.1016/0003-2697(64)90075-2; Hamosh M, 1998, BIOL NEONATE, V74, P163, DOI 10.1159/000014021; HANAMURE Y, 1986, AM J OTOLARYNG, V7, P410, DOI 10.1016/S0196-0709(86)80017-5; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; JACQUOT J, 1992, EUR RESPIR J, V5, P343; KONDO L, 1973, P SOC EXP BIOL MED, V142, P131; LENTSNER A A, 1975, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, V8, P77; LIM DJ, 1976, ANN OTO RHINOL LARYN, V85, P50, DOI 10.1177/000348947608500109; McClellan KA, 1997, SURV OPHTHALMOL, V42, P233, DOI 10.1016/S0039-6257(97)00090-8; MCNABB PC, 1981, ANNU REV MICROBIOL, V35, P477, DOI 10.1146/annurev.mi.35.100181.002401; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Murakami K, 1998, ELECTROPHORESIS, V19, P2521, DOI 10.1002/elps.1150191427; NEMTSEVA NV, 1997, ZH MIKROBIOL EPIDEMI, V4, P123; Pasquali C, 1996, ELECTROPHORESIS, V17, P547, DOI 10.1002/elps.1150170325; Pearson W R, 2000, Methods Mol Biol, V132, P185; PEETERS T, 1975, GUT, V16, P553, DOI 10.1136/gut.16.7.553; Qasba PK, 1997, CRIT REV BIOCHEM MOL, V32, P255, DOI 10.3109/10409239709082574; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; SELSTED ME, 1978, INFECT IMMUN, V20, P782, DOI 10.1128/IAI.20.3.782-791.1978; SOUMILLION P, 1995, PROTEIN ENG, V8, P451, DOI 10.1093/protein/8.5.451; Tachibana M, 1986, Auris Nasus Larynx, V13, P97; TAYLOR DC, 1992, J IMMUNOL METHODS, V146, P55, DOI 10.1016/0022-1759(92)90048-X; VEDMINA EA, 1979, ANTIBIOT MED BIOTEK, V24, P746; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Walker W A, 1979, Ciba Found Symp, P201; Wang YL, 2000, NUCLEIC ACIDS RES, V28, P243, DOI 10.1093/nar/28.1.243; Wasinger VC, 1998, FEMS MICROBIOL LETT, V169, P375, DOI 10.1111/j.1574-6968.1998.tb13343.x; WILSON KP, 1992, J BIOL CHEM, V267, P10842	42	100	109	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18437	18441		10.1074/jbc.M010297200	http://dx.doi.org/10.1074/jbc.M010297200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278658	hybrid			2022-12-27	WOS:000168866500109
J	Lemasson, I; Nyborg, JK				Lemasson, I; Nyborg, JK			Human T-cell leukemia virus type I tax repression of p73 beta is mediated through competition for the C/H1 domain of CBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; CREB BINDING-PROTEIN; WILD-TYPE P53; LONG TERMINAL REPEAT; KINASE C-ABL; HTLV-I; FUNCTIONAL IMPAIRMENT; COACTIVATOR CBP; P73 GENE; TRANSCRIPTIONAL ACTIVATION	The Tax protein, encoded by the human T-cell leukemia virus type I (HTLV-I), is required for high level viral transcription and HTLV-I-associated malignant transformation. Although the precise mechanism of malignant transformation by Tax is unclear, it is well established that Tax represses the transcription function of the tumor suppressor p53, possibly accelerating the accumulation of genetic mutations that are critical in HTLV-I-mediated malignant transformation. Tax repression of p53 transcription function appears to occur, at least in part, through competition for the cellular coactivator CBP/p300. In this study, we characterize the effect of Tax on the p53 family member, p73. We demonstrate that Tax also represses the transcription function of p73 beta and that the repression is reciprocal in vivo, consistent with the idea that both transcription factors may compete for CBP/p300 in vivo. We provide evidence showing that both Tax and p73 interact strongly with the C/H1 domain of CBP and that their binding to this region is mutually exclusive in vitro. This finding provides evidence supporting the idea that reciprocal transcriptional repression between Tax and p73 is mediated through coactivator competition.	Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Lemasson, I (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.		Lemasson, Isabelle/N-1355-2013					Agami R, 1999, NATURE, V399, P809; Akagi T, 1997, FEBS LETT, V406, P263, DOI 10.1016/S0014-5793(97)00280-9; Akagi T, 1996, ONCOGENE, V12, P1645; Aldridge DR, 1998, CANCER RES, V58, P2817; Ariumi Y, 2000, ONCOGENE, V19, P1491, DOI 10.1038/sj.onc.1203450; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BHAT NK, 1993, VIROLOGY, V196, P15, DOI 10.1006/viro.1993.1450; BRADY J, 1987, J VIROL, V61, P2175, DOI 10.1128/JVI.61.7.2175-2181.1987; Cereseto A, 1999, ONCOGENE, V18, P2441, DOI 10.1038/sj.onc.1202567; Cereseto A, 1996, BLOOD, V88, P1551, DOI 10.1182/blood.V88.5.1551.bloodjournal8851551; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; Corn PG, 1999, CANCER RES, V59, P3352; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Gartenhaus RB, 1995, LEUKEMIA, V9, P2082; Giebler HA, 2000, MOL CELL BIOL, V20, P4849, DOI 10.1128/MCB.20.13.4849-4858.2000; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; Gong JG, 1999, NATURE, V399, P806; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; Herranz M, 1999, CANCER RES, V59, P2068; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kaida A, 2000, ONCOGENE, V19, P827, DOI 10.1038/sj.onc.1203387; Kawano S, 1999, BLOOD, V94, P1113; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KINOSHITA T, 1989, P NATL ACAD SCI USA, V86, P5620, DOI 10.1073/pnas.86.14.5620; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Lee CW, 1999, ONCOGENE, V18, P4171, DOI 10.1038/sj.onc.1202793; Lemasson I, 1998, J BIOL CHEM, V273, P23598, DOI 10.1074/jbc.273.36.23598; LEVINE AJ, 1994, BRIT J CANCER, V69, P409, DOI 10.1038/bjc.1994.76; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Levrero M, 1999, CELL DEATH DIFFER, V6, P1146, DOI 10.1038/sj.cdd.4400624; Levrero M, 2000, J CELL SCI, V113, P1661; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Low KG, 1997, J VIROL, V71, P1956, DOI 10.1128/JVI.71.3.1956-1962.1997; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Mesnard JM, 1999, VIROLOGY, V257, P277, DOI 10.1006/viro.1999.9685; MIWA M, 1984, GANN, V75, P752; Mori N, 1997, BLOOD, V90, P4924, DOI 10.1182/blood.V90.12.4924.4924_4924_4932; Mori N, 1997, EUR J HAEMATOL, V58, P114; Mulloy JC, 1998, J VIROL, V72, P8852, DOI 10.1128/JVI.72.11.8852-8860.1998; MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; NAGAI H, 1991, JPN J CANCER RES, V82, P1421, DOI 10.1111/j.1349-7006.1991.tb01815.x; Neuveut C, 1998, MOL CELL BIOL, V18, P3620, DOI 10.1128/MCB.18.6.3620; Newton AL, 2000, J BIOL CHEM, V275, P15128, DOI 10.1074/jbc.M910396199; Ohtani K, 2000, J BIOL CHEM, V275, P11154, DOI 10.1074/jbc.275.15.11154; Oren M, 1997, CELL, V90, P829, DOI 10.1016/S0092-8674(00)80347-5; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pise-Masison CA, 2000, MOL CELL BIOL, V20, P3377, DOI 10.1128/MCB.20.10.3377-3386.2000; Pise-Masison CA, 1998, J VIROL, V72, P1165, DOI 10.1128/JVI.72.2.1165-1170.1998; Pise-Masison CA, 1998, J VIROL, V72, P6348, DOI 10.1128/JVI.72.8.6348-6355.1998; Pise-Masison CA, 2001, J BIOL CHEM, V276, P200, DOI 10.1074/jbc.M005601200; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; REID RL, 1993, ONCOGENE, V8, P3029; Roth J, 1998, J VIROL, V72, P8510, DOI 10.1128/JVI.72.11.8510-8516.1998; Santiago F, 1999, J VIROL, V73, P9917, DOI 10.1128/JVI.73.12.9917-9927.1999; Schmitt I, 1998, J VIROL, V72, P633, DOI 10.1128/JVI.72.1.633-640.1998; SMITH MR, 1991, J CLIN INVEST, V87, P761, DOI 10.1172/JCI115078; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Suzuki T, 1999, ONCOGENE, V18, P4137, DOI 10.1038/sj.onc.1202766; Suzuki T, 1999, VIROLOGY, V259, P384, DOI 10.1006/viro.1999.9760; Suzuki T, 1996, EMBO J, V15, P1607, DOI 10.1002/j.1460-2075.1996.tb00505.x; Takada S, 1997, ONCOGENE, V15, P1895, DOI 10.1038/sj.onc.1201369; Takemoto S, 2000, BLOOD, V95, P3939; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; Ueda Y, 1999, ONCOGENE, V18, P4993, DOI 10.1038/sj.onc.1202817; Van Orden K, 1999, J BIOL CHEM, V274, P26321, DOI 10.1074/jbc.274.37.26321; Van PL, 2001, J VIROL, V75, P396, DOI 10.1128/JVI.75.1.396-407.2001; Watanabe T, 1997, INT J HEMATOL, V66, P257; Wienzek S, 2000, J VIROL, V74, P193, DOI 10.1128/JVI.74.1.193-202.2000; YAMATO K, 1993, JPN J CANCER RES, V84, P4, DOI 10.1111/j.1349-7006.1993.tb02775.x; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; YEARGIN J, 1992, LEUKEMIA, V6, P855; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zeng XY, 2000, MOL CELL BIOL, V20, P1299, DOI 10.1128/MCB.20.4.1299-1310.2000; Zerby D, 1999, MOL CELL BIOL, V19, P1617; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445; Zhu JH, 1998, CANCER RES, V58, P5061	91	45	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15720	15727		10.1074/jbc.M100131200	http://dx.doi.org/10.1074/jbc.M100131200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279015				2022-12-27	WOS:000168623100021
J	Parmentier, JH; Muthalif, MM; Saeed, AE; Malik, KU				Parmentier, JH; Muthalif, MM; Saeed, AE; Malik, KU			Phospholipase D activation by norepinephrine is mediated by 12(S)-, 15(S)-, and 20-hydroxyeicosatetraenoic acids generated by stimulation of cytosolic phospholipase A(2) - Tyrosine phosphorylation of phospholipase D-2 in response to norepinephrine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SMOOTH-MUSCLE-CELLS; ARACHIDONIC-ACID; ANGIOTENSIN-II; SIGNAL-TRANSDUCTION; RECEPTOR; CALCIUM; ALPHA; INHIBITION; A(2)	Norepinephrine (NE) stimulates phospholipase D (PLD) through a Ras/MAPK pathway in rabbit vascular smooth muscle cells (VSMC). NE also activates calcium influx and calmodulin (CaM)-dependent protein kinase II-dependent cytosolic phospholipase A(2) (cPLA(2)). Arachidonic acid (AA) released by cPLA(2)-catalyzed phospholipid hydrolysis is then metabolized into hydroxyeicosatetraenoic acids (HETEs) through lipoxygenase and cytochrome P450 4A (CYP4A) pathways. HETEs, in turn, have been shown to stimulate Res translocation and to increase MAPK activity in VSMC. This study was conducted to determine the contribution of cPLA(2)-derived AA and its metabolites (HETEs) to the activation of PLD. NE-induced PLD activation was reduced by two structurally distinct CaM antagonists, W-7 and calmidazolium, and by CaM-dependent protein kinase II inhibition. Blockade of cPLA(2) activity or protein depletion with selective cPLA(2) antisense oligonucleotides abolished NE-induced PLD activation. The increase in PLD activity elicited by NE was also blocked by inhibitors of lipoxygenases (baicalein) and CYP4A (17-octadecynoic acid), but not of cyclooxygenase (indomethacin). AA and its metabolites (12(S)-, 15(S)-, and 20-HETEs) increased PLD activity. PLD activation by AA and HETEs was reduced by inhibitors of Res farnesyltransferase (farnesyl protein transferase III and BMS-191563) and MEK (U0126 and PD98059). These data suggest that HETEs are the mediators of cPLA(2),-dependent PLD activation by NE in VSMC. In addition to cPLA(2),, PLD was also found to contribute to AA release for prostacyclin production via the phosphatidate phosphohydrolase/diacylglycerol lipase pathway. Finally, a catalytically inactive PLD2 (but not PLD1) mutant inhibited NE-induced PLD activity, and PLD2 was tyrosine-phosphorylated in response to NE by a MAPK-dependent pathway. We conclude that NE stimulates cPLA(2)-dependent PLD2 through lipoxygenase- and CYP4A-derived HETEs via the Ras/ERK pathway by a mechanism involving tyrosine phosphorylation of PLD2 in rabbit VSMC.	Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pharmacol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Malik, KU (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	kmalik@utmem.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL019134, R01HL019134] Funding Source: NIH RePORTER; NHLBI NIH HHS [NHLBI 19134-26] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alonso-Galicia M, 1999, AM J PHYSIOL-RENAL, V277, pF790, DOI 10.1152/ajprenal.1999.277.5.F790; Balboa MA, 1998, MOL PHARMACOL, V53, P221, DOI 10.1124/mol.53.2.221; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; Booden MA, 1999, J BIOL CHEM, V274, P1423, DOI 10.1074/jbc.274.3.1423; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; DANIEL LW, 1999, BIOCHIM BIOPHYS ACTA, V1439, P1; EKOKOSKI E, 1994, BBA-MOL CELL RES, V1223, P274, DOI 10.1016/0167-4889(94)90237-2; FREEMAN EJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P84, DOI 10.1006/abbi.1995.1269; HALLAK H, 1994, J BIOL CHEM, V269, P4713; Herbertsson H, 1999, ADV EXP MED BIOL, V447, P193; HUGOU I, 1995, ATHEROSCLEROSIS, V113, P189, DOI 10.1016/0021-9150(94)05446-P; IMAMURA Y, 1995, CELL SIGNAL, V7, P45, DOI 10.1016/0898-6568(94)00059-K; Kim JH, 1999, J IMMUNOL, V163, P5462; KUMADA T, 1995, BBA-LIPID LIPID MET, V1258, P107, DOI 10.1016/0005-2760(95)00106-M; Kuwata H, 1998, J BIOL CHEM, V273, P1733, DOI 10.1074/jbc.273.3.1733; LaBelle EF, 1996, AM J PHYSIOL-HEART C, V270, pH1031, DOI 10.1152/ajpheart.1996.270.3.H1031; LARRUE J, 1983, BIOCHEM BIOPH RES CO, V112, P242, DOI 10.1016/0006-291X(83)91822-3; Leftheris K, 1996, J MED CHEM, V39, P224, DOI 10.1021/jm950642a; LISCOVITCH M, 1992, TRENDS BIOCHEM SCI, V17, P393, DOI 10.1016/0968-0004(92)90007-V; Liu SY, 1998, J MOL CELL CARDIOL, V30, P1203, DOI 10.1006/jmcc.1998.0685; LLAHI S, 1992, J BIOL CHEM, V267, P3679; MALIK KU, 1988, AM J MED SCI, V295, P280, DOI 10.1097/00000441-198804000-00011; Marcil J, 1997, J BIOL CHEM, V272, P20660, DOI 10.1074/jbc.272.33.20660; Min DS, 1998, J BIOL CHEM, V273, P29986, DOI 10.1074/jbc.273.45.29986; Muthalif MM, 2000, HYPERTENSION, V36, P604, DOI 10.1161/01.HYP.36.4.604; Muthalif MM, 1998, P NATL ACAD SCI USA, V95, P12701, DOI 10.1073/pnas.95.21.12701; Muthalif MM, 1996, J BIOL CHEM, V271, P30149, DOI 10.1074/jbc.271.47.30149; Muthalif MM, 2000, J PHARMACOL EXP THER, V293, P268; NATARAJAN R, 1994, HYPERTENSION, V23, pI142, DOI 10.1161/01.HYP.23.1_Suppl.I142; NEBIGIL C, 1993, J PHARMACOL EXP THER, V266, P1113; NEBIGIL C, 1992, J PHARMACOL EXP THER, V263, P987; Nguyen X, 1999, AM J PHYSIOL-REG I, V276, pR1691; PFISTER SL, 1991, AM J PHYSIOL, V261, pH843, DOI 10.1152/ajpheart.1991.261.3.H843; Pfister SL, 1998, J BIOL CHEM, V273, P30879, DOI 10.1074/jbc.273.47.30879; Ruan Y, 1998, J PHARMACOL EXP THER, V284, P576; SEKIYA K, 1982, BIOCHEM BIOPH RES CO, V105, P1090, DOI 10.1016/0006-291X(82)91081-6; Sermon BA, 1996, J BIOL CHEM, V271, P1566, DOI 10.1074/jbc.271.3.1566; Shome K, 2000, ENDOCRINOLOGY, V141, P2200, DOI 10.1210/en.141.6.2200; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; Slaaby R, 2000, BIOCHEM J, V351, P613, DOI 10.1042/0264-6021:3510613; Sun CW, 1998, CIRC RES, V83, P1069, DOI 10.1161/01.RES.83.11.1069; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Ueno N, 2000, FEBS LETT, V475, P242, DOI 10.1016/S0014-5793(00)01691-4; YE HP, 1994, CARDIOVASC RES, V28, P1828, DOI 10.1093/cvr/28.12.1828	45	50	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15704	15711		10.1074/jbc.M011473200	http://dx.doi.org/10.1074/jbc.M011473200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278912	hybrid			2022-12-27	WOS:000168623100019
J	Thornborrow, EC; Manfredi, JJ				Thornborrow, EC; Manfredi, JJ			The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; PROAPOPTOTIC GENE BAX; DNA-BINDING; BREAST-CANCER; CYTOCHROME-C; WILD-TYPE; IN-VIVO; INDUCED APOPTOSIS; EPITHELIAL-CELLS; GENOMIC DNA	An important regulator of the proapoptotic BAX is the tumor suppressor protein p53. Unlike the p21 gene, in which p53-dependent transcriptional activation is mediated by a response element containing two consensus p53 half-sites, it previously was reported that activation of the BAX element by p53 requires additional sequences. Here, it is demonstrated that the minimal BAX response element capable of mediating p53-dependent transcriptional activation consists of two p53 half-sites plus an adjacent 6 base pairs (5'-GGGCGT-3'). This GC-rich region constitutes a "GC box" capable both of binding members of the Sp family of transcription factors, including Sp1 in vitro, and of conferring Sp1-dependent transcriptional activation on a minimal promoter in cells. Mutations within this GC box abrogated the ability of p53 to activate transcription without affecting the affinity of p53 for its binding site, demonstrating that these 6 bases are required for p53-dependent activation. In addition, a positive correlation was observed between the ability of p53 to activate transcription in cells and the ability of Sp1 to bind this response element in vitro. Mutations that inhibited Sp1 binding also blocked the ability of p53 to activate transcription through this element. Together, these results suggest a model in which p53 requires the cooperation of Sp1 or a Sp1-like factor to mediate transcriptional activation of the human BAX promoter.	Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Manfredi, JJ (corresponding author), Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, Box 1130, New York, NY 10029 USA.				NATIONAL CANCER INSTITUTE [R29CA069161] Funding Source: NIH RePORTER; NCI NIH HHS [CA69161] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apt D, 1996, VIROLOGY, V224, P281, DOI 10.1006/viro.1996.0530; Athanikar JN, 1997, MOL CELL BIOL, V17, P5193, DOI 10.1128/MCB.17.9.5193; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; Bargonetti J, 1997, CELL MOL BIOL, V43, P935; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; Bargou RC, 1996, J CLIN INVEST, V97, P2651, DOI 10.1172/JCI118715; BARGOU RC, 1995, INT J CANCER, V60, P854, DOI 10.1002/ijc.2910600622; BORELLINI F, 1993, J BIOL CHEM, V268, P7923; Bouvard V, 2000, ONCOGENE, V19, P649, DOI 10.1038/sj.onc.1203366; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Di Como CJ, 1998, ONCOGENE, V16, P2527; Discher DJ, 1998, J BIOL CHEM, V273, P26087, DOI 10.1074/jbc.273.40.26087; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; Flaman JM, 1998, ONCOGENE, V16, P1369, DOI 10.1038/sj.onc.1201889; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Friess H, 1998, GUT, V43, P414, DOI 10.1136/gut.43.3.414; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Gascoyne RD, 1997, BLOOD, V90, P3173, DOI 10.1182/blood.V90.8.3173; GUALBERTO A, 1995, J BIOL CHEM, V270, P19680, DOI 10.1074/jbc.270.34.19680; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HOLLANDER MC, 1993, J BIOL CHEM, V268, P24385; Imhof A, 1999, MOL CELL BIOL, V19, P194; Ionov Y, 2000, P NATL ACAD SCI USA, V97, P10872, DOI 10.1073/pnas.190210897; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kim CN, 1997, CANCER RES, V57, P3115; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; KRAJEWSKI S, 1995, CANCER RES, V55, P4471; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Ohlsson C, 1998, ENDOCRINOLOGY, V139, P1101, DOI 10.1210/en.139.3.1101; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; PERRY ME, 1993, P NATL ACAD SCI USA, V90, P11623, DOI 10.1073/pnas.90.24.11623; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Resnick-Silverman L, 1998, GENE DEV, V12, P2102, DOI 10.1101/gad.12.14.2102; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Sakakura C, 1996, INT J CANCER, V67, P101, DOI 10.1002/(SICI)1097-0215(19960703)67:1<101::AID-IJC17>3.0.CO;2-H; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; Shibata MA, 1999, EMBO J, V18, P2692, DOI 10.1093/emboj/18.10.2692; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Shu HKG, 1998, P NATL ACAD SCI USA, V95, P14453, DOI 10.1073/pnas.95.24.14453; Skulachev VP, 1998, FEBS LETT, V423, P275, DOI 10.1016/S0014-5793(98)00061-1; Sturm I, 2000, INT J CANCER, V87, P517, DOI 10.1002/1097-0215(20000815)87:4<517::AID-IJC9>3.0.CO;2-B; Sturm I, 1999, J CLIN ONCOL, V17, P1364, DOI 10.1200/JCO.1999.17.5.1364; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Thornborrow EC, 1999, J BIOL CHEM, V274, P33747, DOI 10.1074/jbc.274.47.33747; Turner J, 1999, INT J BIOCHEM CELL B, V31, P1169, DOI 10.1016/S1357-2725(99)00067-9; Wagener C, 1996, INT J CANCER, V67, P138, DOI 10.1002/(SICI)1097-0215(19960703)67:1<138::AID-IJC22>3.0.CO;2-9; Wang QJ, 1998, CANCER RES, V58, P5762; WANG Y, 1993, GENE DEV, V7, P2575, DOI 10.1101/gad.7.12b.2575; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Ye JP, 1996, MOL CELL BIOL, V16, P6178; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; ZAUBERMAN A, 1995, ONCOGENE, V10, P2361; ZHAN QM, 1994, ONCOGENE, V9, P3743; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855	75	76	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15598	15608		10.1074/jbc.M011643200	http://dx.doi.org/10.1074/jbc.M011643200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278953	hybrid			2022-12-27	WOS:000168623100007
J	Shier, VK; Hancey, CJ; Benkovic, SJ				Shier, VK; Hancey, CJ; Benkovic, SJ			Identification of the active oligomeric state of an essential adenine DNA methyltransferase from Caulobacter crescentus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CELL-CYCLE; CATALYTIC PROPERTIES; HEMIMETHYLATED DNA; HOMOGENEOUS ENZYME; BINDING; METHYLATION; MECHANISM; KINETICS; BASE	Caulobacter crescentus contains one of the two known prokaryotic DNA methyltransferases that lacks a cognate endonuclease. This endogenous cell cycle regulated adenine DNA methyltransferase (CcrM) is essential for C, crescentus cellular viability. DNA methylation catalyzed by CcrM, provides an obligatory signal for the proper progression through the cell cycle. To further our understanding of the regulatory role played by CcrM, we sought to investigate its biophysical properties, In this paper we employed equilibrium ultracentrifugation, velocity ultracentrifugation, and chemical cross-linking to show that CcrM is dimeric at physiological concentrations. However, surface plasmon resonance experiments in the presence of S-adenosyl-homocysteine evince that CcrM binds as a monomer to a defined hemi-methylated DNA substrate containing the canonical methylation sequence, GANTC, Initial velocity experiments demonstrate that dimerization of CcrM does not affect DNA methylation. Collectively, these findings suggest that CcrM is active as a monomer and provides a possible in vivo role for dimerization as a means to stabilize CcrM from premature catabolism.	Penn State Univ, Dept Chem, Wartik Lab 414, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, Wartik Lab 414, University Pk, PA 16802 USA.	sjb1@psu.edu						AHMAD I, 1995, GENE, V157, P143, DOI 10.1016/0378-1119(95)00671-R; Allan BW, 1998, J BIOL CHEM, V273, P2368, DOI 10.1074/jbc.273.4.2368; BAIN DL, 1994, BIOCHEMISTRY-US, V33, P14679, DOI 10.1021/bi00253a005; Berdis AJ, 1998, P NATL ACAD SCI USA, V95, P2874, DOI 10.1073/pnas.95.6.2874; BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; BRUN YV, 1994, ANNU REV BIOCHEM, V63, P419, DOI 10.1146/annurev.bi.63.070194.002223; Cal S, 1997, J BIOL CHEM, V272, P490; Cantor C. R, 1980, BIOPHYSICAL CHEM 2, P591; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; COHN EJ, 1943, PROTEINS AMINO ACIDS, P147; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; DUBEY AK, 1992, NUCLEIC ACIDS RES, V20, P3167, DOI 10.1093/nar/20.12.3167; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; GOLDBERG RJ, 1953, J PHYS CHEM-US, V57, P194, DOI 10.1021/j150503a014; Gong WM, 1997, NUCLEIC ACIDS RES, V25, P2702, DOI 10.1093/nar/25.14.2702; Gowher H, 2000, J MOL BIOL, V303, P93, DOI 10.1006/jmbi.2000.4127; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Heitman J, 1993, Genet Eng (N Y), V15, P57; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; Huang LL, 1999, CRIT REV EUKAR GENE, V9, P175, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.20; Jackson-Fisher AJ, 1999, BIOCHEMISTRY-US, V38, P11340, DOI 10.1021/bi990911p; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KASZUBSKA W, 1992, GENE, V118, P5, DOI 10.1016/0378-1119(92)90242-H; KELLEHER JE, 1991, J MOL BIOL, V221, P431, DOI 10.1016/0022-2836(91)80064-2; KLIMASAUSKAS S, 1995, NUCLEIC ACIDS RES, V23, P1388, DOI 10.1093/nar/23.8.1388; Laue TM, 1995, METHOD ENZYMOL, V259, P427; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; MARCZYNSKI GT, 1990, J MOL BIOL, V212, P709, DOI 10.1016/0022-2836(90)90232-B; Marinus M.G., 1996, E COLI SALMONELLA CE, P782; MARINUS MG, 1987, ANNU REV GENET, V21, P113, DOI 10.1146/annurev.genet.21.1.113; OGara M, 1996, J MOL BIOL, V263, P597, DOI 10.1006/jmbi.1996.0601; Panayotou G, 1998, J BIOL CHEM, V273, P45, DOI 10.1074/jbc.273.1.45; RIGGS AD, 1992, TRENDS GENET, V8, P169, DOI 10.1016/0168-9525(92)90219-T; Robertson GT, 2000, J BACTERIOL, V182, P3482, DOI 10.1128/JB.182.12.3482-3489.2000; RUBIN RA, 1977, J BIOL CHEM, V252, P7265; Scavetta R, 2000, NUCLEIC ACIDS RES, V28, P3950, DOI 10.1093/nar/28.20.3950; Schachman H.K., 1959, ULTRACENTRIFUGATION; Siegfried Z, 1997, CURR BIOL, V7, pR305, DOI 10.1016/S0960-9822(06)00144-8; Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; Szegedi SS, 2000, NUCLEIC ACIDS RES, V28, P3962, DOI 10.1093/nar/28.20.3962; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Vertino PM, 1999, S ADENOSYLMETHIONINE, P341; Wahnon DC, 2001, J AM CHEM SOC, V123, P976, DOI 10.1021/ja003285o; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Wright R, 1997, J BACTERIOL, V179, P5869, DOI 10.1128/jb.179.18.5869-5877.1997; Wright R, 1996, GENE DEV, V10, P1532, DOI 10.1101/gad.10.12.1532; YOO H, 1987, J BIOL CHEM, V262, P8066; Zannis-Hadjopoulos M, 1999, J CELL BIOCHEM, P1; ZWEIGER G, 1994, J MOL BIOL, V235, P472, DOI 10.1006/jmbi.1994.1007	53	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14744	14751		10.1074/jbc.M010688200	http://dx.doi.org/10.1074/jbc.M010688200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278726	hybrid			2022-12-27	WOS:000168528800030
J	Tanabe, M; Nishio, K; Iko, Y; Sambongi, Y; Iwamoto-Kihara, A; Wada, Y; Futai, M				Tanabe, M; Nishio, K; Iko, Y; Sambongi, Y; Iwamoto-Kihara, A; Wada, Y; Futai, M			Rotation of a complex of the gamma subunit and c ring of Escherichia coli ATP synthase - The rotor and stator are interchangeable	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; PROTON TRANSLOCATION; EPSILON-SUBUNIT; CROSS-LINKING; F-ATPASE; ENERGY TRANSDUCTION; STRUCTURAL-CHANGES; MOLECULAR MACHINE; F1F0; OLIGOMER	ATP synthase (F0F1) transforms an electrochemical proton gradient into chemical energy (ATP) through the rotation of a subunit assembly. It has been suggested that a complex of the gamma subunit and c ring (c(10-14)) of F0F1 could rotate together during ATP hydrolysis and synthesis (Sambongi, Y., Iko, Y., Tanabe, M., Omote, H., Iwamoto-Kihara, A., Ueda, I., Yanagida, T,, Wade, Y., and Futai, M. (1899) Science 286, 1722-1724), We observed that the rotation of the c ring with the cI28T mutation (c subunit cIle-28 replaced by Thr) was less sensitive to venturicidin than that of the wild type, consistent with the antibiotic effect on the cI28T mutant and wild-type ATPase activities (Fillingame, R. H., Oldenburg, M., and Fraga, D, (1991) J, Biol. Chem. 266, 20934-20939), Furthermore, we engineered F0F1 to see the alpha (3)beta (3) hexamer rotation; a biotin tag was introduced into the alpha or beta subunit, and a His tag was introduced into the c subunit, The engineered enzymes could be purified by metal affinity chromatography and density gradient centrifugation. They were immobilized on a glass surface through the c subunit, and an actin filament was connected to the alpha or beta subunit, The filament rotated upon the addition of ATP and generated essentially the same frictional torque as one connected to the c ring. These results indicate that the gamma epsilonc(10-14) complex is a mechanical unit of the enzyme and that it can be used as a rotor or a stator experimentally, depending on the subunit immobilized.	Osaka Univ, ISIR, Div Biol Sci, Osaka 5670047, Japan; Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan	Osaka University; University of Tokyo	Futai, M (corresponding author), Osaka Univ, ISIR, Div Biol Sci, Osaka 5670047, Japan.	m-futai@sanken.osaka-u.ac.jp						ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Altendorf K, 2000, J EXP BIOL, V203, P19; BIRKENHAGER R, 1995, EUR J BIOCHEM, V230, P58, DOI 10.1111/j.1432-1033.1995.tb20534.x; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Fillingame RH, 2000, BBA-BIOENERGETICS, V1458, P387, DOI 10.1016/S0005-2728(00)00089-X; Fillingame RH, 1996, CURR OPIN STRUC BIOL, V6, P491, DOI 10.1016/S0959-440X(96)80114-X; Fillingame RH, 1997, J EXP BIOL, V200, P217; FILLINGAME RH, 1991, J BIOL CHEM, V266, P20934; FRIEDL P, 1983, EMBO J, V2, P99, DOI 10.1002/j.1460-2075.1983.tb01388.x; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; Futai M, 1996, J BIOENERG BIOMEMBR, V28, P409, DOI 10.1007/BF02113982; FUTAI M, 1974, J MEMBRANE BIOL, V15, P15, DOI 10.1007/BF01870079; FUTAI M, 1996, HDB BIOL PHYS, V2, P47; Jones PC, 1998, J BIOL CHEM, V273, P29701, DOI 10.1074/jbc.273.45.29701; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; NAKAMOTO RK, 1993, J BIOL CHEM, V268, P867; NEGRIN RS, 1980, J BIOL CHEM, V255, P5643; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; PENEFSKY HS, 1991, ADV ENZYMOL RELAT AR, V64, P173; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; SCHNEIDER E, 1985, EMBO J, V4, P515, DOI 10.1002/j.1460-2075.1985.tb03658.x; Schulenberg B, 1999, J BIOL CHEM, V274, P34233, DOI 10.1074/jbc.274.48.34233; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Singh S, 1996, FEBS LETT, V397, P30, DOI 10.1016/S0014-5793(96)01127-1; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Takeyasu K, 1996, FEBS LETT, V392, P110, DOI 10.1016/0014-5793(96)00796-X; Tsunoda SP, 2000, FEBS LETT, V470, P244, DOI 10.1016/S0014-5793(00)01336-3; VIK SB, 1994, J BIOL CHEM, V269, P30364; Wada Y, 2000, BBA-BIOENERGETICS, V1459, P499, DOI 10.1016/S0005-2728(00)00189-4; Watts SD, 1996, J BIOL CHEM, V271, P28341, DOI 10.1074/jbc.271.45.28341; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1	43	56	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15269	15274		10.1074/jbc.M100289200	http://dx.doi.org/10.1074/jbc.M100289200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279047	hybrid			2022-12-27	WOS:000168528800099
J	Lee, RT; Yamamoto, C; Feng, YJ; Potter-Perigo, S; Briggs, WH; Landschulz, KT; Turi, TG; Thompson, JF; Libby, P; Wight, TN				Lee, RT; Yamamoto, C; Feng, YJ; Potter-Perigo, S; Briggs, WH; Landschulz, KT; Turi, TG; Thompson, JF; Libby, P; Wight, TN			Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; HYALURONAN-BINDING PROTEIN; HUMAN CORONARY-ARTERIES; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; SEQUENCE-ANALYSIS; VERSICAN; BIGLYCAN; COLLAGEN; DECORIN	In the mechanically active environment of the artery, cells sense mechanical stimuli and regulate extracellular matrix structure. In this study, we explored the changes in synthesis of proteoglycans by vascular smooth muscle cells in response to precisely controlled mechanical strains. Strain increased mRNA for versican (3.2-fold), biglycan (2.0-fold), and perlecan (2.0-fold), whereas decorin mRNA levels decreased to a third of control levels. Strain also increased versican, biglycan, and perlecan core proteins, with a concomitant decrease in decorin core protein, Deformation did not alter the hydrodynamic size of proteoglycans as evidenced by molecular sieve chromatography but increased sulfate incorporation in both chondroitin/dermatan sulfate proteoglycans and heparan sulfate proteoglycans (p < 0.05 for both). Using DNA microarrays, we also identified the gene for the hyaluronan-linking protein TSG6 as mechanically induced in smooth muscle cells. Northern analysis confirmed a 4.0-fold increase in steady state mRNA for TSG6 following deformation. Size exclusion chromatography under associative conditions showed that versican-hyaluronan aggregation was enhanced following deformation. These data demonstrate that mechanical deformation increases specific vascular smooth muscle cell proteoglycan synthesis and aggregation, indicating a highly coordinated extracellular matrix response to biomechanical stimulation.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, Boston, MA 02115 USA; Pfizer Inc, Cent Res, Groton, CT 06340 USA; Hope Heart Inst, Seattle, WA 98104 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pfizer	Lee, RT (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA.		Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X; Thompson, John/0000-0001-8568-3311				BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Boren J, 1998, J CLIN INVEST, V101, P2658, DOI 10.1172/JCI2265; Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3; Buschmann MD, 1999, ARCH BIOCHEM BIOPHYS, V366, P1, DOI 10.1006/abbi.1999.1197; Castillo GM, 1996, J BIOCHEM-TOKYO, V120, P433; Chait A, 2000, CURR OPIN LIPIDOL, V11, P457, DOI 10.1097/00041433-200010000-00003; Chang MY, 1998, J BIOL CHEM, V273, P15985, DOI 10.1074/jbc.273.26.15985; Cheng GC, 1997, CIRC RES, V80, P28, DOI 10.1161/01.RES.80.1.28; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHU ML, 1982, NUCLEIC ACIDS RES, V10, P5925, DOI 10.1093/nar/10.19.5925; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DAY AA, 1987, BIOCHEM J, V248, P801, DOI 10.1042/bj2480801; DUCROS DL, 1995, J INVEST DERMATOL, V105, P426, DOI 10.1111/1523-1747.ep12321131; Durante W, 2000, FASEB J, V14, P1775, DOI 10.1096/fj.99-0960com; Feng YJ, 1999, CIRC RES, V85, P1118; FISHER LW, 1991, J BIOL CHEM, V266, P14371; GRODZINSKY AJ, 1983, CRIT REV BIOMED ENG, V9, P133; Gutierrez P, 1997, CARDIOVASC PATHOL, V6, P271, DOI 10.1016/S1054-8807(97)00001-X; HASCALL VC, 1994, METHOD ENZYMOL, V230, P390; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; KIMURA JH, 1979, J BIOL CHEM, V254, P2600; KINSELLA MG, 1988, J BIOL CHEM, V263, P19222; Lemire JM, 1999, ARTERIOSCL THROM VAS, V19, P1630, DOI 10.1161/01.ATV.19.7.1630; LEUNG DYM, 1976, SCIENCE, V191, P475; MARGOLIS RU, 1994, METHOD ENZYMOL, V245, P105; Olin KL, 1999, J BIOL CHEM, V274, P34629, DOI 10.1074/jbc.274.49.34629; RIESSEN R, 1994, AM J PATHOL, V144, P962; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SAITO H, 1968, J BIOL CHEM, V243, P1536; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; SUMPIO BE, 1988, ARCH SURG-CHICAGO, V123, P1233; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069; Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I; WIGHT TN, 1983, J CELL BIOL, V96, P167, DOI 10.1083/jcb.96.1.167; Wight TN, 1997, AM J PATHOL, V151, P963; WIGHT TN, 1989, ARTERIOSCLEROSIS, V9, P1, DOI 10.1161/01.ATV.9.1.1; WIGHT TN, 1996, ATHEROSCLEROSIS CORO, P421; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; Yang JH, 1998, J BIOL CHEM, V273, P6550, DOI 10.1074/jbc.273.11.6550; YAO LY, 1994, MATRIX BIOL, V14, P213, DOI 10.1016/0945-053X(94)90185-6; Ye L, 1997, CIRC RES, V81, P289, DOI 10.1161/01.RES.81.3.289; Zimmermann D., 2000, PROTEOGLYCANS STRUCT; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	45	138	142	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13847	13851		10.1074/jbc.M010556200	http://dx.doi.org/10.1074/jbc.M010556200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278699	hybrid			2022-12-27	WOS:000168356600049
J	Bonnet, C; Boucher, D; Lazereg, S; Pedrotti, B; Islam, K; Denoulet, P; Larcher, JC				Bonnet, C; Boucher, D; Lazereg, S; Pedrotti, B; Islam, K; Denoulet, P; Larcher, JC			Differential binding regulation of microtubule-associated proteins MAP1A, MAP1B, and MAP2 by tubulin polyglutamylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE-BRAIN NEURONS; BETA-TUBULIN; ALPHA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; IN-VITRO; REPEATED SEQUENCE; NERVOUS-SYSTEM; MESSENGER-RNA; TAU-PROTEIN; CELL-CYCLE	The major neuronal post-translational modification of tubulin, polyglutamylation, can act as a molecular potentiometer to modulate microtubule-associated proteins (MAPs) binding as a function of the polyglutamyl chain length. The relative affinity of Tau, MAP2, and kinesin has been shown to be optimal for tubulin modified by similar to3 glutamyl units. Using blot overlay assays, we have tested the ability of polyglutamylation to modulate the interaction of two other structural MAPs, MAP1A and MAP1B, with tubulin, MAP1A and MAP2 display distinct behavior in terms of tubulin binding; they do not compete with each other, even when the polyglutamyl chains of tubulin are removed, indicating that they have distinct binding sites on tubulin. Binding of MAP1A and MAP1B to tubulin is also controlled by polyglutamylation and, although the modulation of MAP1B binding resembles that of MAP2, we found that polyglutamylation can exert a different mode of regulation toward MAP1A. interestingly, although the affinity of the other MAPs tested so far decreases sharply for tubulins carrying long polyglutamyl chains, the affinity of MAP1A for these tubulins is maintained at a significant level. This differential regulation exerted by polyglutamylation toward different MAPs might facilitate their selective recruitment into distinct microtubule populations, hence modulating their functional properties.	Univ Paris 06, CNRS FRE 2219, F-75252 Paris 05, France; Arpida AG, CH-4142 Munchenstein, BL, Switzerland; Univ Milan, Dipartimento Biol, I-20133 Milan, Italy	UDICE-French Research Universities; Sorbonne Universite; University of Milan	Larcher, JC (corresponding author), Univ Paris 06, CNRS FRE 2219, 9 Quai St Bernard,Case 265, F-75252 Paris 05, France.		Pedrotti, Barbara/AGS-4795-2022					ALEXANDER JE, 1991, P NATL ACAD SCI USA, V88, P4685, DOI 10.1073/pnas.88.11.4685; AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; AUDEBERT S, 1994, J CELL SCI, V107, P2313; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; BERNSTEIN M, 1994, J CELL BIOL, V125, P1313, DOI 10.1083/jcb.125.6.1313; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BLACK MM, 1994, J NEUROSCI, V14, P857; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; BLOOM GS, 1984, J CELL BIOL, V98, P320, DOI 10.1083/jcb.98.1.320; Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.3.CO;2-3; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bosc C, 1996, P NATL ACAD SCI USA, V93, P2125, DOI 10.1073/pnas.93.5.2125; BOUCHER D, 1994, BIOCHEMISTRY-US, V33, P12471, DOI 10.1021/bi00207a014; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; Bush MS, 1996, EUR J NEUROSCI, V8, P235, DOI 10.1111/j.1460-9568.1996.tb01208.x; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; CHAPIN SJ, 1991, J CELL SCI, V98, P409; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Cosson J, 1996, CELL MOTIL CYTOSKEL, V35, P100, DOI 10.1002/(SICI)1097-0169(1996)35:2<100::AID-CM3>3.3.CO;2-U; CRAVCHIK A, 1994, J CELL SCI, V107, P661; DENOULET P, 1986, GENE, V50, P289, DOI 10.1016/0378-1119(86)90333-1; DENOULET P, 1988, STRUCTURE FUNCTIONS, V171, P231; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; EDDE B, 1991, J CELL BIOCHEM, V46, P134, DOI 10.1002/jcb.240460207; Ferhat L, 1998, J NEUROSCI, V18, P7822; FOUQUET JP, 1994, CELL MOTIL CYTOSKEL, V27, P49, DOI 10.1002/cm.970270106; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gagnon C, 1996, J CELL SCI, V109, P1545; HAMMARBACK JA, 1991, NEURON, V7, P129, DOI 10.1016/0896-6273(91)90081-A; HERZOG W, 1978, EUR J BIOCHEM, V92, P1, DOI 10.1111/j.1432-1033.1978.tb12716.x; HUBER G, 1984, J NEUROSCI, V4, P151; JOLY JC, 1990, BIOCHEMISTRY-US, V29, P8916, DOI 10.1021/bi00490a006; Klotz A, 1999, CELL MOTIL CYTOSKEL, V44, P263, DOI 10.1002/(SICI)1097-0169(199912)44:4<263::AID-CM4>3.0.CO;2-V; Kwei SL, 1998, NEUROREPORT, V9, P1035, DOI 10.1097/00001756-199804200-00015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGKOPF A, 1992, J BIOL CHEM, V267, P16561; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LITMAN P, 1993, NEURON, V10, P627, DOI 10.1016/0896-6273(93)90165-N; Luduena RF, 1998, INT REV CYTOL, V178, P207; MacRae TH, 1997, EUR J BIOCHEM, V244, P265, DOI 10.1111/j.1432-1033.1997.00265.x; MARY J, 1994, FEBS LETT, V353, P89, DOI 10.1016/0014-5793(94)01018-8; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MILLER P, 1982, P NATL ACAD SCI-BIOL, V79, P5562, DOI 10.1073/pnas.79.18.5562; MILLER RH, 1987, SCIENCE, V235, P220, DOI 10.1126/science.2432661; Million K, 1999, J CELL SCI, V112, P4357; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Pedrotti B, 1996, FEBS LETT, V384, P147, DOI 10.1016/0014-5793(96)00308-0; PEDROTTI B, 1993, CELL MOTIL CYTOSKEL, V25, P234, DOI 10.1002/cm.970250304; PEDROTTI B, 1994, BIOCHEMISTRY-US, V33, P12463, DOI 10.1021/bi00207a013; PEDROTTI B, 1995, CELL MOTIL CYTOSKEL, V30, P301, DOI 10.1002/cm.970300407; Pedrotti B, 1996, BIOCHEMISTRY-US, V35, P3016, DOI 10.1021/bi951314f; PEDROTTI B, 1994, CELL MOTIL CYTOSKEL, V29, P110, DOI 10.1002/cm.970290203; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; Redeker V, 1998, BIOCHEMISTRY-US, V37, P14838, DOI 10.1021/bi981335k; Regnard C, 1998, BIOCHEMISTRY-US, V37, P8395, DOI 10.1021/bi9804131; Regnard C, 1999, J CELL SCI, V112, P4281; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SHIOMURA Y, 1987, J CELL BIOL, V104, P1575, DOI 10.1083/jcb.104.6.1575; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vaillant AR, 1998, J BIOL CHEM, V273, P13973, DOI 10.1074/jbc.273.22.13973; WOLFF A, 1994, BIOL CELL, V81, P11, DOI 10.1016/0248-4900(94)90049-3; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	72	150	156	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12839	12848		10.1074/jbc.M011380200	http://dx.doi.org/10.1074/jbc.M011380200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278895	hybrid			2022-12-27	WOS:000168198600054
J	Grogan, G; Roberts, GA; Bougioukou, D; Turner, NJ; Flitsch, SL				Grogan, G; Roberts, GA; Bougioukou, D; Turner, NJ; Flitsch, SL			The desymmetrization of bicyclic beta-diketones by an enzymatic retro-claisen reaction - A new reaction of the crotonase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENOYL-COA HYDRATASE; ESCHERICHIA-COLI; ENANTIOSELECTIVE SYNTHESIS; PSEUDOMONAS-PUTIDA; EXPRESSION; HYDROLASE; DEHYDROGENASE; DEGRADATION; GENE; SPECIFICITY	The enzyme 6-oxocamphor hydrolase, which catalyzes the desymmetrization of 6-oxocamphor to yield (2R,4S)-alpha -campholinic acid, has been purified with a factor of 35.7 from a wild type strain of Rhodococcus sp, NCIMB 9784 grown on (LR)-(+)-camphor as the sole carbon source. The enzyme has a subunit molecular mass of 28,488 Da by electrospray mass spectrometry and a native molecular mass of similar to 83,000 Da indicating that the active protein is trimeric, The specific activity was determined to be 357.5 units mg(-1), and the K-m was determined to be 0.05 mM for the natural substrate. The N-terminal amino acid sequence was obtained from the purified protein, and using this information, the gene encoding the enzyme was cloned. The translation of the gene was found to bear significant homology to the crotonase superfamily of enzymes. The gene is closely associated with an open reading frame encoding a ferredoxin reductase that may be involved in the initial step in the biodegradation of camphor. A mechanism for 6-oxocamphor hydrolase based on sequence homology and the known mechanism of the crotonase enzymes is proposed.	Univ Edinburgh, Dept Chem, Edinburgh Ctr Prot Technol, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Edinburgh	Flitsch, SL (corresponding author), Univ Edinburgh, Dept Chem, Edinburgh Ctr Prot Technol, W Mains Rd,Kings Bldg, Edinburgh EH9 3JJ, Midlothian, Scotland.		Flitsch, Sabine/AAJ-6812-2020	Flitsch, Sabine/0000-0003-3974-646X; Roberts, Gareth/0000-0002-3726-390X; Turner, Nicholas/0000-0002-8708-0781				Bartholomew BA, 1996, APPL ENVIRON MICROB, V62, P3245, DOI 10.1128/AEM.62.9.3245-3250.1996; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boynton ZL, 1996, J BACTERIOL, V178, P3015, DOI 10.1128/jb.178.11.3015-3024.1996; CHAPMAN PJ, 1966, J AM CHEM SOC, V88, P618, DOI 10.1021/ja00955a049; COREY EJ, 1975, TETRAHEDRON LETT, V31, P2647; DAVEY JF, 1975, J BIOL CHEM, V250, P3826; EGGINK G, 1990, J MOL BIOL, V212, P135, DOI 10.1016/0022-2836(90)90310-I; GROGAN G, 2000, IN PRESS ANGEW CHEM; Haller T, 2000, BIOCHEMISTRY-US, V39, P4622, DOI 10.1021/bi992888d; HAYES JD, 1989, BIOCHEM J, V264, P437, DOI 10.1042/bj2640437; HSIANG HH, 1972, BIOCHEMISTRY-US, V11, P2098, DOI 10.1021/bi00761a016; Kawagoshi Y, 1998, WORLD J MICROB BIOT, V14, P95; KOGA H, 1985, BIOCHEM BIOPH RES CO, V130, P412, DOI 10.1016/0006-291X(85)90432-2; KULAKOVA AN, 1995, PLASMID, V33, P208, DOI 10.1006/plas.1995.1022; MULLERNEWEN G, 1995, EUR J BIOCHEM, V228, P68, DOI 10.1111/j.1432-1033.1995.tb20230.x; NAGY I, 1995, J BACTERIOL, V177, P676, DOI 10.1128/jb.177.3.676-687.1995; Pelletier DA, 1998, J BACTERIOL, V180, P2330, DOI 10.1128/JB.180.9.2330-2336.1998; Pokorny D, 1999, J BACTERIOL, V181, P5051, DOI 10.1128/JB.181.16.5051-5059.1999; Pokorny D, 1997, TRENDS BIOTECHNOL, V15, P291, DOI 10.1016/S0167-7799(97)01055-X; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schoffers E, 1996, TETRAHEDRON, V52, P3769, DOI 10.1016/S0040-4020(95)01021-1; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; SHARMA V, 1992, J BACTERIOL, V174, P5057, DOI 10.1128/JB.174.15.5057-5062.1992; SUGINO H, 1992, J BACTERIOL, V174, P2485, DOI 10.1128/jb.174.8.2485-2492.1992; TASCHNER MJ, 1988, J AM CHEM SOC, V110, P6892, DOI 10.1021/ja00228a053; Timm DE, 1999, STRUCTURE, V7, P1023, DOI 10.1016/S0969-2126(99)80170-1; WAKIL SJ, 1957, BIOCHIM BIOPHYS ACTA, V19, P497; WILLADSEN P, 1975, EUR J BIOCHEM, V54, P247, DOI 10.1111/j.1432-1033.1975.tb04134.x; Willis MC, 1999, J CHEM SOC PERK T 1, P1765; Wu WJ, 2000, J AM CHEM SOC, V122, P3987, DOI 10.1021/ja992286h; YANG YF, 1984, TETRAHEDRON LETT, V25, P4999; YOKOYAMA M, 1993, TETRAHEDRON-ASYMMETR, V4, P1081, DOI 10.1016/S0957-4166(00)80214-1	35	34	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12565	12572		10.1074/jbc.M011538200	http://dx.doi.org/10.1074/jbc.M011538200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278926	hybrid			2022-12-27	WOS:000168198600015
J	Jin, TQ; Yue, LL; Li, JX				Jin, TQ; Yue, LL; Li, JX			In vivo interaction between dynamitin and MacMARCKS detected by the fluorescent resonance energy transfer method	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-KINASE SUBSTRATE; CYTOPLASMIC DYNEIN; CELL-ADHESION; TYROSINE PHOSPHORYLATION; MOTOR PROTEINS; DYNACTIN; MARCKS; INCREASES; MOTILITY; PAXILLIN	Dynamitin is a subunit of the dynactin complex regulating microtubule-dependent motor functions, and MacMARCKS (Macrophage-enriched myristoylated alanine-rich protein kinase C substrate) is a major protein kinase C substrate regulating integrin activation. The interaction between dynamitin and MacMARCKS has been implicated in integrin-dependent cell spreading. However, the in vivo interaction of these two proteins in living cells has not been demonstrated. Spatial and temporal information about the interaction is also lacking. In this study, we used the fluorescent resonance energy transfer method to demonstrate in vivo interaction between MacMARCKS and dynamitin with cyan fluorescent protein (CFP)-conjugated dynamitin as the donor fluorophore and yellow fluorescent protein (YFP)-conjugated MacMARCKS as the acceptor fluorophore, The interaction of these two fusion proteins was studied both in vitro and in vivo, and typical fluorescent resonance energy transfer was observed; the CFP emission peak increased while the YFP emission peak decreased when protein interaction was abolished. Spatial and temporal information was obtained in RAW macrophage cells. In resting macrophage cells, dynamitin-MacMARCKS interaction is concentrated at the cell periphery, although the majority of dynamitin is distributed at the perinuclear region of the cells. When cells were treated with phorbol 12-myristate 13-acetate, both proteins concentrated to perinuclear regions of the cells, and yet the interaction disappeared as the cell spread. Similar events were also observed in 293 cells. Thus, we conclude that dynamitin and MacMARCKS indeed interact in living cells.	Univ Illinois, Coll Med, Dept Oral Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Li, JX (corresponding author), Univ Illinois, Coll Med, Dept Oral Biol, 801 S Paulina St, Chicago, IL 60612 USA.				NIGMS NIH HHS [GM54715] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054715] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan V, 1996, CURR BIOL, V6, P630, DOI 10.1016/S0960-9822(09)00434-5; BLACKSHEAR PJ, 1992, J BIOL CHEM, V267, P13540; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Holleran EA, 1998, INT REV CYTOL, V182, P69, DOI 10.1016/S0074-7696(08)62168-3; Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X; Kadi A, 1998, BIOCHEM BIOPH RES CO, V246, P690, DOI 10.1006/bbrc.1998.8536; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Li JX, 1996, J BIOL CHEM, V271, P12985, DOI 10.1074/jbc.271.22.12985; LI JX, 1992, CELL, V70, P791, DOI 10.1016/0092-8674(92)90312-Z; Lub M, 1997, MOL BIOL CELL, V8, P341, DOI 10.1091/mbc.8.2.341; Manenti S, 1997, FEBS LETT, V419, P95, DOI 10.1016/S0014-5793(97)01438-5; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Myat MM, 1997, CURR BIOL, V7, P611, DOI 10.1016/S0960-9822(06)00262-4; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Roghi C, 1999, J CELL SCI, V112, P4673; ROSEN A, 1990, J EXP MED, V172, P1211, DOI 10.1084/jem.172.4.1211; Schroer TA, 1996, TRENDS CELL BIOL, V6, P212, DOI 10.1016/0962-8924(96)20014-5; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; UMEKAGE T, 1991, FEBS LETT, V286, P147, DOI 10.1016/0014-5793(91)80961-2; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; Vallee RB, 1995, COLD SPRING HARB SYM, V60, P803, DOI 10.1101/SQB.1995.060.01.086; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; VERGERES G, 1995, J BIOL CHEM, V270, P19879, DOI 10.1074/jbc.270.34.19879; Yue LL, 1999, J CELL PHYSIOL, V181, P355, DOI 10.1002/(SICI)1097-4652(199911)181:2<355::AID-JCP17>3.0.CO;2-B; Yue LL, 2000, CELL ADHES COMMUN, V7, P359, DOI 10.3109/15419060009109018; Yue LL, 2000, J BIOL CHEM, V275, P23948, DOI 10.1074/jbc.M001845200; Zhou X., UNPUB; Zhou XM, 2000, J BIOL CHEM, V275, P20217, DOI 10.1074/jbc.M909129199	35	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12879	12884		10.1074/jbc.M010513200	http://dx.doi.org/10.1074/jbc.M010513200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278693	hybrid			2022-12-27	WOS:000168198600059
J	Konta, T; Xu, QH; Furusu, A; Nakayama, K; Kitamura, M				Konta, T; Xu, QH; Furusu, A; Nakayama, K; Kitamura, M			Selective roles of retinoic acid receptor and retinoid X receptor in the suppression of apoptosis by all-trans-retinoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; EMBRYONAL CARCINOMA-CELLS; RENAL GLOMERULUS; IN-VIVO; C-FOS; DIFFERENTIATION; JUN; ACTIVATION; INDUCTION; PATHWAYS	Retinoic acids exert profound effects on many biological processes including cell proliferation, differentiation, and morphogenesis, We previously reported that all-trans-retinoic acid (t-RA) protected mesangial cells from H(2)O(2)-triggered apoptosis by suppressing the activator protein 1 (AP-1) pathway. It was via inhibition of c-fos and c-jun expression and suppression of c-Jun N-terminal kinase (JNK) activation. In this report, we investigated the involvement of retinoic acid receptor (RAR) and retinoid X receptor (RXR) in the antiapoptotic effect of t-RA in H(2)O(2)-exposed cells. We found that pretreatment with RAR pan-antagonist (AGN193109) or RXR pan-antagonist (HX531) attenuated the antiapoptotic effect of t-RA, Similarly, transient transfection with a dominant-negative mutant of RAR or a dominant-negative RXR diminished the antiapoptotic effect of t-RA Both RAR and RXR antagonists reversed the suppressive effect of t-RA on AP-1 activity. However, the roles of RAR and RXR in the suppression of AP-1 components by t-RA were found to be different. RAR antagonist reversed the suppressive effect of t-RA on both c-fos and c-jun, whereas RXR antagonist reversed the effect of t-RA on c-fos but not c-jun, Furthermore, suppression of JNK activation by t-RA was observed even in the presence of RAR and RXR antagonists. Consistently, suppression of JNK by t-RA was not affected by overexpression of either the dominant-negative RAR or the dominant-negative RXR, These data elucidated that the antiapoptotic effect of t-RA is mediated by both nuclear receptor-dependent and -independent mechanisms.	Royal Free & UCL, Sch Med, Dept Med, Renal Bioengn Unit,Jules Thorn Inst,Middlesex Hos, London W1T 3AA, England	University of London; University College London; UCL Medical School	Kitamura, M (corresponding author), Royal Free & UCL, Sch Med, Dept Med, Renal Bioengn Unit,Jules Thorn Inst,Middlesex Hos, 7th Floor,Motimer St, London W1T 3AA, England.	m.kitamura@ucl.ac.uk	Konta, Tsuneo/AAO-9286-2021					ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chiba H, 1997, J CELL BIOL, V139, P735, DOI 10.1083/jcb.139.3.735; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DAM K, 1993, P NATL ACAD SCI USA, V90, P2989; DE LUCA LM, 1991, FASEB J, V5, P2924; Ebisawa M, 1999, CHEM PHARM BULL, V47, P1778; Herget T, 1998, J NEUROCHEM, V70, P47; Ishikawa Y, 2000, KIDNEY INT, V58, P1078, DOI 10.1046/j.1523-1755.2000.00265.x; Ishikawa Y, 1997, BIOCHEM BIOPH RES CO, V240, P496, DOI 10.1006/bbrc.1997.7665; Kang JX, 1999, CELL GROWTH DIFFER, V10, P591; Kitamura M, 1996, P NATL ACAD SCI USA, V93, P7387, DOI 10.1073/pnas.93.14.7387; KITAMURA M, 1994, J CLIN INVEST, V94, P497, DOI 10.1172/JCI117361; Klein ES, 1996, J BIOL CHEM, V271, P22692, DOI 10.1074/jbc.271.37.22692; KRUPITZA G, 1995, INT J CANCER, V61, P649, DOI 10.1002/ijc.2910610511; Lee HY, 1998, J BIOL CHEM, V273, P7066, DOI 10.1074/jbc.273.12.7066; Lee HY, 1999, MOL CELL BIOL, V19, P1973; LOVE JM, 1994, CURR OPIN CELL BIOL, V6, P825, DOI 10.1016/0955-0674(94)90051-5; MCDONNELL SE, 1990, MOL CELL BIOL, V10, P4284, DOI 10.1128/MCB.10.8.4284; Monczak Y, 1997, BLOOD, V90, P3345, DOI 10.1182/blood.V90.9.3345; Moreno-Manzano V, 1999, J BIOL CHEM, V274, P20251, DOI 10.1074/jbc.274.29.20251; Okubo Y, 1998, J BIOL CHEM, V273, P25961, DOI 10.1074/jbc.273.40.25961; Radominska-Pandya A, 2000, J BIOL CHEM, V275, P22324, DOI 10.1074/jbc.M907722199; ROBERTSON KA, 1992, MOL CELL BIOL, V12, P3743, DOI 10.1128/MCB.12.9.3743; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; Toma S, 1997, INT J CANCER, V70, P619, DOI 10.1002/(SICI)1097-0215(19970304)70:5<619::AID-IJC21>3.0.CO;2-6; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; YANG Y, 1995, J BIOL CHEM, V270, P18672, DOI 10.1074/jbc.270.31.18672; YOKOO T, 1997, AM J PHYSIOL, V273, pR206; ZHANG XK, 1994, MOL CELL BIOL, V14, P4311, DOI 10.1128/MCB.14.6.4311	32	55	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12697	12701		10.1074/jbc.M011000200	http://dx.doi.org/10.1074/jbc.M011000200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278809	hybrid			2022-12-27	WOS:000168198600032
J	Shinder, GA; Lacourse, MC; Minotti, S; Durham, HD				Shinder, GA; Lacourse, MC; Minotti, S; Durham, HD			Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACYTOPLASMIC HYALINE INCLUSIONS; MOTOR-NEURON DISEASE; SHOCK PROTEINS; MOUSE MODEL; CELL-DEATH; STRESS; HSP70; ALS; AGGREGATION; MUTATIONS	Mutations in the Cu/Zn-superoxide dismutase (SOD-I) gene are responsible for a familial form of amyotrophic lateral sclerosis, In humans and experimental models, death of motor neurons is preceded by formation of cytoplasmic aggregates containing mutant SOD-l protein. In our previous studies, heat shock protein 70 (HSP70) prolonged viability of cultured motor neurons expressing mutant human SOD-l and reduced formation of aggregates. in this paper, we report that mutant SOD-l proteins have altered solubility in cells relative to wild-type SOD-l and can form a direct association with HSP70 and other stress proteins. Whereas wild-type human and endogenous mouse SOD-1 were detergent-soluble, a portion of mutant SOD-l was detergent-insoluble in protein extracts of NIH3T3 transfected with SOD-l gene constructs, spinal cord cultures established from G93A SOD-1 transgenic mouse embryos, and lumbar spinal cord from adult G93A transgenic mice. A direct association of HSP70, HSP40, and alphaB-crystallin with mutant SOD-1 (G93A or G41S), but not wild-type or endogenous mouse SOD-1, was demonstrated by coimmunoprecipitation, Mutant SOD-1 HSP70 complexes were predominantly in the detergent-insoluble fraction. However, only a small percentage of total cellular mutant SOD-l was detergent-insoluble, suggesting that mutation-induced alteration of protein conformation may not in itself be sufficient for direct interaction with heat shock proteins.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Neurol Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Durham, HD (corresponding author), McGill Univ, Montreal Neurol Inst, Rm 649,3801 Univ St, Montreal, PQ H3A 2B4, Canada.							Arrigo AP, 1998, BIOL CHEM, V379, P19; BECKMANN RP, 1992, J CELL BIOL, V117, P1137, DOI 10.1083/jcb.117.6.1137; BORCHELT DR, 1995, J BIOL CHEM, V270, P3234, DOI 10.1074/jbc.270.7.3234; BOWLING AC, 1995, J NEUROCHEM, V64, P2366; Bromberg MB, 1999, CURR OPIN NEUROL, V12, P581, DOI 10.1097/00019052-199910000-00012; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; Hoffman EK, 1996, J NEUROL SCI, V139, P15, DOI 10.1016/S0022-510X(96)00031-7; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; KABAKOV AE, 1993, EXPERIENTIA, V49, P706, DOI 10.1007/BF01923956; KABAKOV AE, 1994, ARCH BIOCHEM BIOPHYS, V309, P247, DOI 10.1006/abbi.1994.1109; Kato S, 1996, J NEUROPATH EXP NEUR, V55, P1089, DOI 10.1097/00005072-199655100-00009; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Koide T, 1998, NEUROSCI LETT, V257, P29, DOI 10.1016/S0304-3940(98)00800-3; LA SA, 1991, NATURE, V352, P77; Manzerra P, 1996, EXP CELL RES, V229, P35, DOI 10.1006/excr.1996.0341; MANZERRA P, 1992, J NEUROSCI RES, V31, P606, DOI 10.1002/jnr.490310404; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; Morrison BM, 1999, BRAIN RES REV, V29, P121, DOI 10.1016/S0165-0173(98)00049-6; MORRISONBOGORAD M, 1994, J NEUROCHEM, V63, P857; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Okado-Matsumoto A, 2000, FREE RADICAL RES, V33, P65, DOI 10.1080/10715760000300621; Parsell DA, 1994, BIOL HEAT SHOCK PROT; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Roy J, 1998, J NEUROSCI, V18, P9673; ROY JR, UNPUB; SATOH JI, 1995, J NEUROSCI RES, V41, P805, DOI 10.1002/jnr.490410611; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wong PC, 1998, CURR OPIN NEUROBIOL, V8, P791, DOI 10.1016/S0959-4388(98)80123-2	41	165	173	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12791	12796		10.1074/jbc.M010759200	http://dx.doi.org/10.1074/jbc.M010759200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278741	hybrid			2022-12-27	WOS:000168198600047
J	Sun, L; Bittner, MA; Holz, RW				Sun, L; Bittner, MA; Holz, RW			Rab3a binding and secretion-enhancing domains in Rim1 are separate and unique - Studies in adrenal chromaffin cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC-VESICLE FUSION; PC12 CELLS; GTPASE RAB3A; REGULATED EXOCYTOSIS; DEPENDENT EXOCYTOSIS; SMG P25A; PROTEIN; RABPHILIN-3A; RAS; FAMILY	Rim1 was identified in brain by its ability to bind Rab3a-GTP and has been postulated to be a Rab3a effector protein. Like Rabphilin3, it modulates secretion and contains a zinc finger and two C2 domains. We have investigated the structural basis for the ability of Rim1 to bind Rab3a-GTP and to stimulate exocytosis in chromaffin cells. Both full-length and N-terminal Rim1 enhance secretion 40-50% in both intact and permeabilized cells. The abilities of Rim1 to enhance secretion and to bind Rab3a-GTP reside on distinct and relatively small domains that act independently. A similar to 30-amino acid sequence immediately N-terminal of the zinc finger constitutes the minimal Rab3a-GTP binding domain. This short sequence is not found in Rabphilin3 and is entirely different from the zinc finger and flanking regions of Rabphilin3 that bind Rab3a-GTP, The zinc finger domain in Rim1 is unnecessary for Rab3a-GTP binding but, alone, enhances secretion. An analysis of the characteristics of the enhancement of secretion in permeabilized chromaffin cells indicates that N-terminal Rim1 does not alter the sensitivity of secretion to Ca2+ but, instead, increases the rate of ATP-dependent priming of secretion.	Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Holz, RW (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, 1301 MSRB 3, Ann Arbor, MI 48109 USA.				NIDDK NIH HHS [R01 DK27959, R01 DK50177] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027959] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arribas M, 1997, EUR J CELL BIOL, V74, P209; BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; BITTNER MA, 1992, J BIOL CHEM, V267, P16226; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BRONDYK WH, 1995, MOL CELL BIOL, V15, P1137; BURSTEIN E, 1989, MOL CELL BIOL, V9, P4807, DOI 10.1128/MCB.9.11.4807; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; Chung SH, 1997, J NEUROCHEM, V69, P164; CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; DARCHEN F, 1995, J CELL SCI, V108, P1639; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; HOLZ RW, 1982, J NEUROCHEM, V39, P635, DOI 10.1111/j.1471-4159.1982.tb07940.x; Joberty G, 1999, J CELL SCI, V112, P3579; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McKiernan CJ, 1996, MOL CELL BIOL, V16, P4985; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SHIRATAKI H, 1994, J BIOL CHEM, V269, P32717; Stahl B, 1996, EMBO J, V15, P1799, DOI 10.1002/j.1460-2075.1996.tb00529.x; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; WICK PF, 1993, J BIOL CHEM, V268, P10983; WILSON SP, 1996, ANAL BIOCHEM, V226, P212; YAMAGUCHI T, 1993, J BIOL CHEM, V268, P27164	40	27	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12911	12917		10.1074/jbc.M011110200	http://dx.doi.org/10.1074/jbc.M011110200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278839	hybrid			2022-12-27	WOS:000168198600064
J	Arranz, V; Dreuillet, C; Crisanti, P; Tillit, J; Kress, M; Ernoult-Lange, M				Arranz, V; Dreuillet, C; Crisanti, P; Tillit, J; Kress, M; Ernoult-Lange, M			The zinc finger transcription factor, MOK2, negatively modulates expression of the interphotoreceptor retinoid-binding protein gene, IRBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR-SPECIFIC EXPRESSION; TISSUE-SPECIFIC EXPRESSION; CIS-ACTING ELEMENTS; CONE-ROD DYSTROPHY; HOMEOBOX GENE; ALVEOLAR RHABDOMYOSARCOMA; CHROMOSOME 19Q; PAX-GENES; CRX; MUTATIONS	The human and murine MOK2 orthologue genes encode Kruppel/TFIIIA-related zinc finger proteins, which are factors able to recognize both DNA and RNA through their zinc finger motifs, MOK2 proteins have been shown to bind to the same 18-base pair (bp)-specific sequence in duplex DNA. This MOK2-binding site was found within introns 7 and 2 of human PAX3 and interphotoreceptor retinoid-binding protein (IRBP) genes, respectively. As these two genes are expressed in the brain as MOK2, we have suggested that PAX3 and IRBP genes are two potentially important target genes for the MOK2 protein. In this study, we focused our attention on IRBP as a potential MOK2 target gene. Sequence comparison and binding studies of the 18-bp MOK2-binding sites present in intron 2 of human, bovine, and mouse IRBP genes show that the 3'-half sequence is the essential core element for MOK2 binding. Very interestingly, 8-bp of this core sequence are found in a reverse orientation, in the IRBP promoter. We demonstrate that MOK2 can bind to the 8-bp sequence present in the IRBP promoter and repress its transcription when transiently overexpressed in retinoblastoma Weri-RB1 cells. In the IRBP promoter, it appears that the TAAAGGCT MOK2-binding site overlaps with the photoreceptor-specific CRX-binding element. We suggest that MOK2 represses transcription by competing with the cone-rod homeobox protein (CRX) for DNA binding, thereby decreasing transcriptional activation by CRX. Furthermore, we show that Mok2 expression in the developing mouse and in the adult retina seems to be concordant with IRBP expression.	Inst Andre Lwolf, CNRS, UPR 1983, F-94801 Villejuif, France; INSERM, U450, F-75016 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Ernoult-Lange, M (corresponding author), Inst Andre Lwolf, CNRS, UPR 1983, 7 Rue Guy Moquet, F-94801 Villejuif, France.	ernoult@infobiogen.fr						Arranz V, 1997, MOL CELL BIOL, V17, P2116, DOI 10.1128/MCB.17.4.2116; Arranz V, 1996, MAMM GENOME, V7, P77, DOI 10.1007/s003359900020; ARRANZ V, 1994, GENE, V149, P293, DOI 10.1016/0378-1119(94)90164-3; Ashe HL, 2000, DEVELOPMENT, V127, P3305; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Boatright J H, 1997, Mol Vis, V3, P15; BOATRIGHT JH, 1994, INVEST OPHTH VIS SCI, V35, P1578; BOATRIGHT JH, 1996, INVESTIG OPHTHALMO S, V37, pS241; BOBOLA N, 1995, J BIOL CHEM, V270, P1289, DOI 10.1074/jbc.270.3.1289; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; BORST DE, 1989, J BIOL CHEM, V264, P1115; CARTERDAWSON L, 1986, DEV BIOL, V116, P431, DOI 10.1016/0012-1606(86)90144-2; CHADER GJ, 1989, INVEST OPHTH VIS SCI, V30, P7; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DESJARDIN LE, 1993, J BIOL CHEM, V268, P6953; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ERNOULTLANGE M, 1990, MOL CELL BIOL, V10, P418, DOI 10.1128/MCB.10.1.418; ErnoultLange M, 1995, J MOL EVOL, V41, P784, DOI 10.1007/BF00173158; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; FASSINA G, 1993, INT J ONCOL, V2, P745; Fei YJ, 1999, J BIOCHEM, V125, P1189, DOI 10.1093/oxfordjournals.jbchem.a022403; FONG SL, 1990, J BIOL CHEM, V265, P3648; FONG SL, 1993, METH NEUROSCI, V15, P322; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; GERARD M, 1995, CR ACAD SCI III-VIE, V318, P57; GREGORY CY, 1994, AM J HUM GENET, V55, P1061; Jacobson SG, 1998, INVEST OPHTH VIS SCI, V39, P2417; KIKUCHI T, 1993, MOL CELL BIOL, V13, P4400, DOI 10.1128/MCB.13.7.4400; KUTTY G, 1994, EXP EYE RES, V58, P65, DOI 10.1006/exer.1994.1195; Ladomery M, 1997, BIOESSAYS, V19, P903, DOI 10.1002/bies.950191010; LIEU GI, 1994, INVEST OPHTH VIS SCI, V35, P1083; LIOU GI, 1990, J BIOL CHEM, V265, P8373; LIOU GI, 1994, DEV BIOL, V161, P345, DOI 10.1006/dbio.1994.1036; Liou GI, 1998, J NEUROSCI, V18, P4511; LIOU GI, 1994, BIOCHEM BIOPH RES CO, V203, P1875, DOI 10.1006/bbrc.1994.2406; LIOU GI, 1992, METHODS NEUROSCIENCE, V9, P101; LIOU GIH, 1991, PROG CLIN BIOL RES, V362, P115; MACINA RA, 1995, GENOMICS, V26, P1, DOI 10.1016/0888-7543(95)80076-X; Martinez JA, 1998, BIOCHEM BIOPH RES CO, V250, P175, DOI 10.1006/bbrc.1998.9261; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; MORABITO MA, 1991, J BIOL CHEM, V266, P9667; NARFSTROM K, 1989, CELL TISSUE RES, V257, P631, DOI 10.1007/BF00221474; PEPPERBERG DR, 1993, MOL NEUROBIOL, V7, P61, DOI 10.1007/BF02780609; PORRELLO K, 1991, J HISTOCHEM CYTOCHEM, V39, P171, DOI 10.1177/39.2.1987260; Reddy JC, 1996, BBA-REV CANCER, V1287, P1, DOI 10.1016/0304-419X(95)00014-7; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; Thaker V, 1999, Methods Mol Biol, V115, P379; VANVEEN T, 1988, EXP EYE RES, V47, P291, DOI 10.1016/0014-4835(88)90012-7; WIGGERT B, 1994, CELL TISSUE RES, V278, P291, DOI 10.1007/BF00414173; Wolffe AP, 1996, INT J BIOCHEM CELL B, V28, P247, DOI 10.1016/1357-2725(95)00141-7	57	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11963	11969		10.1074/jbc.M011036200	http://dx.doi.org/10.1074/jbc.M011036200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278819	hybrid			2022-12-27	WOS:000168081800071
J	Wang, XD; Unruh, MJ; Goodman, JM				Wang, XD; Unruh, MJ; Goodman, JM			Discrete targeting signals direct Pmp47 to oleate-induced peroxisomes in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN PMP47; UBIQUITIN-CONJUGATING ENZYME; POLYMERASE CHAIN-REACTION; HANSENULA-POLYMORPHA; ENDOPLASMIC-RETICULUM; YARROWIA-LIPOLYTICA; PICHIA-PASTORIS; IMPORT; PROLIFERATION; BIOGENESIS	Pmp47 is a peroxisomal membrane protein consisting of six transmembrane domains (TMDs), We previously showed that the second matrix loop containing a basic cluster of amino acids is important for peroxisomal targeting, and similar basic targeting motifs have been found in other peroxisomal membrane proteins. However, this basic cluster by itself targets to peroxisomes very poorly. We have developed a sensitive quantitative localization assay based on the targeting of Pmp47-GFP fusion proteins to identify the important elements of the basic cluster and to search for other targeting information on Pmp47. Our data suggest that side-chain structure and position as well as charge are important for targeting by the basic cluster, Analysis of other regions of Pmp47 indicates that all TMDs except TMD2 can be eliminated or substituted without significant loss of targeting. TMD2 plus an adjacent cytoplasmic-oriented sequence is crucial for targeting. Cytoplasmic-oriented sequences from two other peroxisomal membrane proteins, ScPex15p and ScPmp22, could partially substitute for the analogous sequence in Pmp47, Targeting with high fidelity to oleate-induced peroxisomes required the following elements: the cytoplasmic-oriented sequence and TMD2, a short matrix loop containing a basic cluster, and a membrane-anchoring TMD.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Goodman, JM (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Goodman, Joel M/A-6376-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031859] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM31859] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baerends RJS, 2000, J BIOL CHEM, V275, P9986, DOI 10.1074/jbc.275.14.9986; Dyer JM, 1996, J CELL BIOL, V133, P269, DOI 10.1083/jcb.133.2.269; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Gloeckner CJ, 2000, BIOCHEM BIOPH RES CO, V271, P144, DOI 10.1006/bbrc.2000.2572; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; Hettema EH, 1999, BBA-MOL CELL RES, V1451, P17, DOI 10.1016/S0167-4889(99)00087-7; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JANK B, 1993, TRENDS BIOCHEM SCI, V18, P427; KADOWAKI H, 1989, GENE, V76, P161, DOI 10.1016/0378-1119(89)90018-8; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MCCAMMON MT, 1994, J CELL BIOL, V124, P915, DOI 10.1083/jcb.124.6.915; MCCAMMON MT, 1990, J BIOL CHEM, V265, P20098; Mullen RT, 2000, J BIOL CHEM, V275, P16337, DOI 10.1074/jbc.M001266200; Nakagawa T, 2000, J BIOL CHEM, V275, P3455, DOI 10.1074/jbc.275.5.3455; Pause B, 2000, FEBS LETT, V471, P23, DOI 10.1016/S0014-5793(00)01332-6; PRINGLE JR, 1991, GUIDE YEAST GENETICS, V194, P586; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Sakai Y, 1996, J CELL BIOL, V134, P37, DOI 10.1083/jcb.134.1.37; Sambrook J., 2002, MOL CLONING LAB MANU; SIKORSKI RS, 1989, GENETICS, V122, P19; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; Snyder WB, 1999, MOL BIOL CELL, V10, P4005, DOI 10.1091/mbc.10.12.4005; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; Titorenko VI, 2000, J CELL BIOL, V148, P29, DOI 10.1083/jcb.148.1.29; Titorenko VI, 1998, MOL CELL BIOL, V18, P2789, DOI 10.1128/MCB.18.5.2789; VALLETTE F, 1989, NUCLEIC ACIDS RES, V17, P723, DOI 10.1093/nar/17.2.723; van der Klei IJ, 1998, EMBO J, V17, P3608, DOI 10.1093/emboj/17.13.3608; VANDIJKEN JP, 1976, ARCH MICROBIOL, V111, P137; Zhang JW, 1996, J CELL BIOL, V132, P325, DOI 10.1083/jcb.132.3.325	33	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10897	10905		10.1074/jbc.M010883200	http://dx.doi.org/10.1074/jbc.M010883200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11278772	hybrid, Green Submitted			2022-12-27	WOS:000167980900046
J	Karim, MM; Hughes, JMX; Warwicker, J; Scheper, GC; Proud, CG; McCarthy, JEG				Karim, MM; Hughes, JMX; Warwicker, J; Scheper, GC; Proud, CG; McCarthy, JEG			A quantitative molecular model for modulation of mammalian translation by the eIF4E-binding protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR EIF-4E; FACTOR 4G EIF4G; RNA 5' CAP; DEPENDENT TRANSLATION; BINDING-PROTEIN; PHAS-I; PHOSPHORYLATION SITES; ESCHERICHIA-COLI; 4E-BP1; YEAST	Translation initiation is a key point of regulation in eukaryotic gene expression. 4E-binding proteins (4E-BPs) inhibit initiation by blocking the association of eIF4E with eIF4G, two integral components of the mRNA cap-binding complex. Phosphorylation of 4E-BP1 reduces its ability to bind to eIF4E and thereby to compete with eIF4G. A novel combination of biophysical and biochemical tools was used to measure the impact, of phosphorylation and acidic side chain substitution at each potentially modulatory site in 4E-BP1. For each individual site, we have analyzed the effects of modification on eIF4E binding using affinity chromatography and surface plasmon resonance analysis, and on the regulatory function of the 4E-BP1 protein using a yeast in vivo model system and a mammalian in vitro translation assay. We find that modifications at the two sites immediately flanking the eIF4E-binding domain, Thr(46) and Ser(65), consistently have the most significant effects, and that phosphorylation of Ser(65) causes the greatest reduction in binding affinity. These results establish a quantitative framework that should contribute to understanding of the molecular interactions underlying 4E-BP1-mediated translational regulation.	Univ Manchester, Dept Biomol Sci, Posttranscript Control Grp, Manchester M60 1QD, Lancs, England; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	University of Manchester; University of Dundee	McCarthy, JEG (corresponding author), Univ Manchester, Dept Biomol Sci, Posttranscript Control Grp, POB 88, Manchester M60 1QD, Lancs, England.	j.mccarthy@umist.ac.uk	Scheper, Gert C/D-7001-2014; Karim, Muhammad Manjurul/ABC-6229-2020	Karim, Muhammad Manjurul/0000-0003-0476-8239; Proud, Christopher/0000-0003-0704-6442; Warwicker, Jim/0000-0002-1302-0815				Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Fadden P, 1997, J BIOL CHEM, V272, P10240; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Grolleau A, 1999, J IMMUNOL, V162, P3491; GROSSMAN AD, 1984, CELL, V38, P383, DOI 10.1016/0092-8674(84)90493-8; Heesom KJ, 1998, BIOCHEM J, V336, P39, DOI 10.1042/bj3360039; Heesom KJ, 1999, FEBS LETT, V457, P489, DOI 10.1016/S0014-5793(99)01094-7; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hughes JMX, 1999, J BIOL CHEM, V274, P3261, DOI 10.1074/jbc.274.6.3261; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; McCarthy JEG, 1998, MICROBIOL MOL BIOL R, V62, P1492, DOI 10.1128/MMBR.62.4.1492-1553.1998; MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376; MINICH WB, 1994, P NATL ACAD SCI USA, V91, P7668, DOI 10.1073/pnas.91.16.7668; Morley SJ, 1997, RNA, V3, P1085; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; OLIVEIRA CC, 1993, MOL MICROBIOL, V9, P521, DOI 10.1111/j.1365-2958.1993.tb01713.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Ptushkina M, 1999, EMBO J, V18, P4068, DOI 10.1093/emboj/18.14.4068; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; PULLEN K, 1995, PROTEIN SCI, V4, P2478, DOI 10.1002/pro.5560041204; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; Rousseau D, 1996, ONCOGENE, V13, P2415; Schneider RJ, 2000, COLD SPRING HARBOR M, V39, P581; SCHNEPPE B, 1994, GENE, V143, P201, DOI 10.1016/0378-1119(94)90097-3; Shi Q., 1998, GEL ELECTROPHORESIS, V3rd, P1; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Viela C, 2000, EMBO J, V19, P4372; von der Haar T, 2000, J BIOL CHEM, V275, P30551, DOI 10.1074/jbc.M004565200; Yang DQ, 1999, FEBS LETT, V453, P387, DOI 10.1016/S0014-5793(99)00762-0; Youtani T, 2000, IUBMB LIFE, V49, P27, DOI 10.1080/152165400306331; ZANCHIN NIT, 1995, J BIOL CHEM, V270, P26505, DOI 10.1074/jbc.270.44.26505	51	67	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20750	20757		10.1074/jbc.M011068200	http://dx.doi.org/10.1074/jbc.M011068200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278829	hybrid			2022-12-27	WOS:000169135100143
J	Tryggvason, K; Romert, A; Eriksson, U				Tryggvason, K; Romert, A; Eriksson, U			Biosynthesis of 9-cis-retinoic acid in vivo - The roles of different retinol dehydrogenases and a structure-activity analysis of microsomal retinol dehydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOL-DEHYDROGENASE; CDNA CLONING; MEMBRANE TOPOLOGY; MESSENGER-RNA; GENE; EXPRESSION; IDENTIFICATION; LOCALIZATION; PATHWAY; ADH4	Retinoic acid is generated by a two-step mechanism. First, retinol is converted into retinal by a retinol dehydrogenase, and, subsequently, retinoic acid is formed by a retinal dehydrogenase. In vitro, several enzymes are suggested to act in this metabolic pathway. However, little is known regarding their capacity to contribute to retinoic acid biosynthesis in vivo. We have developed a versatile cell reporter system to analyze the role of several of these enzymes in 9-cis-retinoic acid biosynthesis in vivo. Using a Gal4-retinoid X receptor fusion protein-based luciferase reporter assay, the formation of 9-cis-retinoic acid from g-cis-retinol was measured in cells transfected with expression plasmids encoding different combinations of retinol and retinal dehydrogenases. The results suggested that efficient formation of 9-cis-retinoic acid required co-expression of retinol and retinal dehydrogenases. Interestingly, the cytosolic alcohol dehydrogenase 4 failed to efficiently catalyze 9-cis-retinol oxidation. A structure-activity analysis showed that mutants of two retinol dehydrogenases, devoid of the carboxyl-terminal cytoplasmic tails, displayed greatly reduced enzymatic activities in vivo, but were active in vitro. The cytoplasmic tails mediate efficient endoplasmic reticulum localization of the enzymes, suggesting that the unique milieu in the endoplasmic reticulum compartment is necessary for in vivo activity of microsomal retinol dehydrogenases.	Ludwig Inst Canc Res, S-17177 Stockholm, Sweden	Ludwig Institute for Cancer Research	Eriksson, U (corresponding author), Ludwig Inst Canc Res, Box 240, S-17177 Stockholm, Sweden.	ueri@licr.ki.se						BUBLITZ C, 1987, BIOCHEM J, V245, P263, DOI 10.1042/bj2450263; Chai XY, 1996, GENE, V169, P219, DOI 10.1016/0378-1119(95)00833-0; CHAI XY, 1995, J BIOL CHEM, V270, P3900, DOI 10.1074/jbc.270.8.3900; CHAI XY, 1995, J BIOL CHEM, V270, P28408, DOI 10.1074/jbc.270.47.28408; Chai XY, 1997, J BIOL CHEM, V272, P33125, DOI 10.1074/jbc.272.52.33125; Deltour L, 1999, DEV GENET, V25, P1, DOI 10.1002/(SICI)1520-6408(1999)25:1<1::AID-DVG1>3.0.CO;2-W; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Driessen CAGG, 2000, MOL CELL BIOL, V20, P4275, DOI 10.1128/MCB.20.12.4275-4287.2000; Duester G, 1996, BIOCHEMISTRY-US, V35, P12221, DOI 10.1021/bi961176+; Gonzalez-Fernandez F, 1999, MOL VIS, V5, pU1; Gough WH, 1998, J BIOL CHEM, V273, P19778, DOI 10.1074/jbc.273.31.19778; Hofmann Clementine, 1994, P387; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; Mangelsdorf David J., 1994, P319; Mertz JR, 1997, J BIOL CHEM, V272, P11744, DOI 10.1074/jbc.272.18.11744; MOORE T, 1957, VITAMIN A, P295; Napoli JL, 2000, PROG NUCLEIC ACID RE, V63, P139, DOI 10.1016/S0079-6603(08)60722-9; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Romert A, 2000, EXP CELL RES, V256, P338, DOI 10.1006/excr.2000.4817; Romert A, 1998, P NATL ACAD SCI USA, V95, P4404, DOI 10.1073/pnas.95.8.4404; Saari John C., 1994, P351; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Simon A, 1996, GENOMICS, V36, P424, DOI 10.1006/geno.1996.0487; Simon A, 1999, J CELL SCI, V112, P549; Su J, 1998, J BIOL CHEM, V273, P17910, DOI 10.1074/jbc.273.28.17910; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Wada Y, 2000, INVEST OPHTH VIS SCI, V41, P1894; Wang J, 1999, BIOCHEM J, V338, P23, DOI 10.1042/0264-6021:3380023; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707	32	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19253	19258		10.1074/jbc.M100215200	http://dx.doi.org/10.1074/jbc.M100215200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279029	hybrid			2022-12-27	WOS:000169091000083
J	Shi, JD; Kukar, T; Wang, CY; Li, QZ; Cruz, PE; Davoodi-Semiromi, A; Yang, P; Gu, YR; Lian, W; Wu, DH; She, JX				Shi, JD; Kukar, T; Wang, CY; Li, QZ; Cruz, PE; Davoodi-Semiromi, A; Yang, P; Gu, YR; Lian, W; Wu, DH; She, JX			Molecular cloning and characterization of a novel mammalian endo-apyrase (LALP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROFACIAL OCHOA SYNDROME; SYNDROME TYPE-1 APS1; DISEASE GENE; LOCALIZATION; EXPRESSION; ATPASES; REGION; CD39; AIRE	Here we describe the cloning, localization, and characterization of a novel mammalian endo-apyrase (LALP1) in human and mouse. The predicted human LALP1 gene encodes a 604-amino acid protein, whereas the mouse Lalp1 gene encodes a 606-amino acid protein. The human and mouse genes have 88% amino acid sequence identity. These genes share considerable homologies with hLALP70, a recently discovered mammalian lysosomal endo-apyrase, The human LALP1 gene resides on chromosome 10q23-q24 and contains 12 exons and 11 introns covering a genomic region of similar to 46 kilobase pairs. The subcellular localization and enzymatic activity of LALP1 indicated that LALP1 is indeed an endo-apyrase with substrate preference for nucleoside triphosphates UTP, GTP, and CTP.	Univ Florida, Dept Pathol Immunol & Lab Med, Ctr Mammalian Genet, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Diabet Ctr Excellence, Gainesville, FL 32610 USA; Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL 32610 USA; Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	She, JX (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Ctr Mammalian Genet, Box 100275, Gainesville, FL 32610 USA.			Wang, Cong-Yi/0000-0001-7914-168X; Kukar, Thomas/0000-0002-3750-6262	NIA NIH HHS [AG015688] Funding Source: Medline; NIDDK NIH HHS [1R01DK53266-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG015688] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Biederbick A, 1999, J CELL SCI, V112, P2473; Biederbick A, 2000, J BIOL CHEM, V275, P19018, DOI 10.1074/jbc.M001245200; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Komoszynski M, 1996, BBA-MOL CELL RES, V1310, P233, DOI 10.1016/0167-4889(95)00135-2; KYTE J, 1982, J MOL BIOL, V157, P5; LI QZ, 2001, IN PRESS GENOMICS; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; PLESNER L, 1995, INT REV CYTOL, V158, P141; Ruan QG, 1999, J AUTOIMMUN, V13, P307, DOI 10.1006/jaut.1999.0326; Wang CY, 1998, HUM GENET, V103, P681, DOI 10.1007/s004390050891; Wang CY, 1999, GENOMICS, V60, P12, DOI 10.1006/geno.1999.5908; Wang CY, 1999, AM J MED GENET, V84, P454, DOI 10.1002/(SICI)1096-8628(19990611)84:5<454::AID-AJMG9>3.3.CO;2-4; Wang CY, 1999, GENOMICS, V55, P322, DOI 10.1006/geno.1998.5656; Wang TF, 1998, J BIOL CHEM, V273, P11392, DOI 10.1074/jbc.273.18.11392; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	15	36	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17474	17478		10.1074/jbc.M011569200	http://dx.doi.org/10.1074/jbc.M011569200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278936	hybrid			2022-12-27	WOS:000168730400118
J	Zheng, Y; Pao, A; Adair, GM; Tang, MS				Zheng, Y; Pao, A; Adair, GM; Tang, MS			Cyclobutane pyrimidine dimers and bulky chemical DNA adducts are efficiently repaired in both strands of either a transcriptionally active or promoter-deleted APRT gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ADENOSINE-DEAMINASE GENE; COMPLEMENTATION GROUP-C; HAMSTER OVARY CELLS; XERODERMA-PIGMENTOSUM; ADENINE PHOSPHORIBOSYLTRANSFERASE; TRANSCRIBED STRAND; DIHYDROFOLATE-REDUCTASE; MOLECULAR MECHANISM; COCKAYNES-SYNDROME	Both prokaryotic and eukaryotic cells have the capacity to repair DNA damage preferentially in the transcribed strand of actively expressed genes. However, we have found that several types of DNA damage, including cyclobutane pyrimidine dimers (CPDs) are repaired with equal efficiency in both the transcribed and nontranscribed strands of the adenine phosphoribosyltransferase (APRT) gene in Chinese hamster ovary cells. We further found that, in two mutant cell lines in which the entire APRT promoter region has been deleted, CPDs are still efficiently repaired in both strands of the promoterless APRT gene, even though neither strand appears to be transcribed. These results suggest that efficient repair of both strands at this locus does not require transcription of the APRT gene. We have also mapped CPD repair in exon 3 of the APRT gene in each cell line at single nucleotide resolution. Again, we found similar rates of CPD repair in both strands of the APRT gene domain in both APRT promoter-deletion mutants and their parental cell line. Our findings suggest that current models of transcription-coupled repair and global genomic repair may underestimate the importance of factors other than transcription in governing the efficiency of nucleotide excision repair.	Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX 78957 USA; NYU, Sch Med, Dept Environm Med, Tuxedo Park, NY 10987 USA	University of Texas System; UTMD Anderson Cancer Center; New York University	Tang, MS (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX 78957 USA.				NIEHS NIH HHS [ES03124, ES08389, ES00260, ES077784] Funding Source: Medline; NIGMS NIH HHS [GM56165] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, R01ES003124, R01ES008389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056165] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAIR GM, 1983, P NATL ACAD SCI-BIOL, V80, P5961, DOI 10.1073/pnas.80.19.5961; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Balajee AS, 2000, GENE, V250, P15, DOI 10.1016/S0378-1119(00)00172-4; BARSALOU LS, 1994, MUTAT RES, V315, P43, DOI 10.1016/0921-8777(94)90027-2; BERKVENS TM, 1987, NUCLEIC ACIDS RES, V15, P9365, DOI 10.1093/nar/15.22.9365; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Dijkwel PA, 1999, METHODS, V18, P418, DOI 10.1006/meth.1999.0800; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Ljungman M, 1999, CARCINOGENESIS, V20, P395, DOI 10.1093/carcin/20.3.395; Maxam A M, 1980, Methods Enzymol, V65, P499; Meijer M, 1999, BIOESSAYS, V21, P596, DOI 10.1002/(SICI)1521-1878(199907)21:7<596::AID-BIES8>3.0.CO;2-5; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Pfeifer GP, 1999, METH MOL B, V113, P213; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Tang Moon-Shong, 1996, P139; TANG MS, 1994, J BIOL CHEM, V269, P12749; TANG MS, 1994, BIOCHEMISTRY-US, V33, P2726, DOI 10.1021/bi00175a048; THOMAS DC, 1985, J BIOL CHEM, V260, P9875; Tornaletti Silvia, 1996, P199; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Tu YQ, 1996, EMBO J, V15, P675, DOI 10.1002/j.1460-2075.1996.tb00400.x; Tu YQ, 1997, J BIOL CHEM, V272, P20747, DOI 10.1074/jbc.272.33.20747; van Oosterwijk MF, 1998, J BIOL CHEM, V273, P13599, DOI 10.1074/jbc.273.22.13599; VANHOFFEN A, 1995, EMBO J, V14, P360, DOI 10.1002/j.1460-2075.1995.tb07010.x; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VENEMA J, 1991, MOL CELL BIOL, V11, P4128, DOI 10.1128/MCB.11.8.4128; VENEMA J, 1992, J BIOL CHEM, V267, P8852; VREESWIJK MPG, 1994, J BIOL CHEM, V269, P31858; Wolffe A., 1998, CHROMATIN STRUCTURE; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465	37	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16786	16796		10.1074/jbc.M010973200	http://dx.doi.org/10.1074/jbc.M010973200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278801	hybrid			2022-12-27	WOS:000168730400027
J	Blank, M; Weinschenk, T; Priemer, M; Schluesener, H				Blank, M; Weinschenk, T; Priemer, M; Schluesener, H			Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels - Selective targeting of endothelial regulatory protein pigpen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT ANTIBODY FRAGMENTS; IN-VITRO SELECTION; ANGIOGENESIS; AFFINITY; VASCULATURE; MECHANISMS; COMPLEX; CANCER; CELLS	Tumor microvessels differ in structure and metabolic function from normal vasculature, and neoangiogenesis is associated with quantitative and qualitative changes in expression of endothelial proteins. Such molecules could serve as molecular addresses differentiating the tumor vasculature from those of the normal brain. We have applied Systematic Evolution of Ligands by EXponential enrichment (SELEX) against transformed endothelial cells as a complex target to select single-stranded DNA-ligands (aptamers) that function as histological markers to detect microvessels of rat experimental glioma, a fatal brain tumor that is highly vascularized. Both the SELEX selection procedure as well as subsequent deconvolution-SELEX were analyzed by fluorescence based methods (flow cytometry and fluorescence microscopy), Of 25 aptamers analyzed, one aptamer was selected that selectively bound microvessels of rat brain glioblastoma but not the vasculature of the normal rat brain including peritumoral areas. The molecular target protein of aptamer III.1 was isolated from endothelial cells by ligand-mediated magnetic DNA affinity purification. This protein was identified by mass spectrometry as rat homologue of mouse pigpen, a not widely known endothelial protein the expression of which parallels the transition from quiescent to angiogenic phenotypes in vitro, Because neoangiogenesis, the formation of new blood vessels, is a key feature of tumor development, the presented aptamer can be used as a probe to analyze pathological angiogenesis of glioblastoma, The presented data show that pigpen is highly expressed in tumor microvessels of experimental rat brain glioblastoma and may play an important role in warranting blood supply, thus growth of brain tumors.	Univ Tubingen, Inst Brain Res, D-72076 Tubingen, Germany; Univ Tubingen, Dept Immunol, Inst Cell Biol, D-72076 Tubingen, Germany; Univ Tubingen, Dept Mol Biol, Inst Cell Biol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Blank, M (corresponding author), Univ Tubingen, Inst Brain Res, Calwer Str 3, D-72076 Tubingen, Germany.	hirnforschung@uni-tuebingen.de						Alliegro MC, 1996, DEV BIOL, V174, P288, DOI 10.1006/dbio.1996.0074; Alliegro MC, 2000, EXP CELL RES, V255, P270, DOI 10.1006/excr.1999.4776; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Birchler M, 1999, NAT BIOTECHNOL, V17, P984, DOI 10.1038/13679; Brower V, 1999, NAT BIOTECHNOL, V17, P963, DOI 10.1038/13654; BROWN TA, DNA SEQUENCING BASIC; Conrad RC, 1996, METHOD ENZYMOL, V267, P336; CRAMERI A, 1993, NUCLEIC ACIDS RES, V21, P4410, DOI 10.1093/nar/21.18.4410; Davis KA, 1996, NUCLEIC ACIDS RES, V24, P702, DOI 10.1093/nar/24.4.702; Davis KA, 1998, NUCLEIC ACIDS RES, V26, P3915, DOI 10.1093/nar/26.17.3915; Ferrari D, 1996, J IMMUNOL, V156, P1531; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Hicke BJ, 1996, J CLIN INVEST, V98, P2688, DOI 10.1172/JCI119092; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Klocker N, 1999, J NEUROSCI, V19, P8517; KOCH CJ, 1995, BRIT J CANCER, V72, P869, DOI 10.1038/bjc.1995.426; Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703; LAMPSON LA, 1992, CANCER RES, V52, P1018; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Lund EL, 1998, ACTA NEUROL SCAND, V97, P52; MICHEL F, 1990, NATURE, V347, P578, DOI 10.1038/347578a0; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Neri D, 1997, NAT BIOTECHNOL, V15, P1271, DOI 10.1038/nbt1197-1271; PAN WH, 1995, P NATL ACAD SCI USA, V92, P11509, DOI 10.1073/pnas.92.25.11509; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P313, DOI 10.1097/00005072-199904000-00001; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Thorpe PE, 1997, J CONTROL RELEASE, V48, P277, DOI 10.1016/S0168-3659(97)00038-2; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Viti F, 1999, CANCER RES, V59, P347; Yamazaki Kosuke, 1995, In Vivo (Attiki), V9, P421; Zetter BR, 1997, NAT BIOTECHNOL, V15, P1243, DOI 10.1038/nbt1197-1243	36	275	322	4	65	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16464	16468		10.1074/jbc.M100347200	http://dx.doi.org/10.1074/jbc.M100347200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279054	hybrid			2022-12-27	WOS:000168623100119
J	Sun, YF; Yu, LY; Saarma, M; Timmusk, T; Arumae, U				Sun, YF; Yu, LY; Saarma, M; Timmusk, T; Arumae, U			Neuron-specific Bcl-2 homology 3 domain-only splice variant of Bak is anti-apoptotic in neurons, but pro-apoptotic in non-neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; IN-VIVO PATTERNS; BH3 DOMAIN; SYMPATHETIC NEURONS; PROTEIN FAMILY; NERVOUS-SYSTEM; IMMUNOHISTOCHEMICAL ANALYSIS; MITOCHONDRIAL-MEMBRANE; PROMOTES APOPTOSIS; MESSENGER-RNAS	We have identified and characterized N-Bak, a neuron-specific isoform of the pro-apoptotic Bcl-2 family member Bak. N-Bak is generated by neuron-specific splicing of a novel 20-base pair exon, which changes the previously described Bak, containing Bcl-2 homology (BH) domains BH1, BH2, and BH3, into a shorter BH3-only protein. ks demonstrated by reverse transcription-polymerase chain reaction and RNase protection assay, N-Bak transcripts are expressed only in central and peripheral neurons, but not in other cells, whereas the previously described Bak is expressed ubiquitously, but not in neurons. Neonatal sympathetic neurons microinjected with N-Bak resisted apoptotic death caused by nerve growth factor (NGF) removal, whereas microinjected Bak accelerated NGF deprivation-induced death. Overexpressed Bak killed sympathetic neurons in the presence of NGF, whereas N-Bak did not. N-Bak was, however, still death-promoting when overexpressed in non-neuronal cells. Thus, N-Bak is an anti-apoptotic BH3-only protein, but only in the appropriate cellular environment. This is the first example of a neuron-specific Bcl-2 family member.	Univ Helsinki, Inst Biotechnol, Program Mol Neurobiol, Viikki Bioctr, FIN-00014 Helsinki, Finland	University of Helsinki	Arumae, U (corresponding author), Univ Helsinki, Inst Biotechnol, Program Mol Neurobiol, Viikki Bioctr, POB 56, FIN-00014 Helsinki, Finland.		Arumäe, Urmas/E-8290-2016; Timmusk, Tonis/H-4889-2015	Arumäe, Urmas/0000-0003-3658-6464; Timmusk, Tonis/0000-0002-1015-3348				ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; APTE SS, 1995, GENOMICS, V26, P592, DOI 10.1016/0888-7543(95)80180-T; Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BORNER C, 1994, J CELL BIOL, V126, P1059, DOI 10.1083/jcb.126.4.1059; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chang BS, 1999, MOL CELL BIOL, V19, P6673; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cosulich SC, 1997, CURR BIOL, V7, P913, DOI 10.1016/S0960-9822(06)00410-6; Davies A. M., 1995, NEURAL CELL CULTURE, P153; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; FANG W, 1994, J IMMUNOL, V153, P4388; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; Fridman JS, 1999, CANCER RES, V59, P5999; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guo B, 2001, J BIOL CHEM, V276, P2780, DOI 10.1074/jbc.M005889200; Hamner S, 2001, MOL CELL NEUROSCI, V17, P97, DOI 10.1006/mcne.2000.0905; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herberg JA, 1998, GENE, V211, P87, DOI 10.1016/S0378-1119(98)00101-2; Holinger EP, 1999, J BIOL CHEM, V274, P13298, DOI 10.1074/jbc.274.19.13298; Hsu SY, 1998, J BIOL CHEM, V273, P30139, DOI 10.1074/jbc.273.46.30139; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jiang ZH, 1999, P SOC EXP BIOL MED, V220, P64, DOI 10.1046/j.1525-1373.1999.d01-11.x; Kaufmann SH, 2000, METHOD ENZYMOL, V322, P3; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; KIEFER MC, 1995, NATURE, V374, P736, DOI 10.1038/374736a0; Komatsu K, 2000, NAT CELL BIOL, V2, P1, DOI 10.1038/71316; Krajewski S, 1996, CANCER RES, V56, P2849; KRAJEWSKI S, 1994, CANCER RES, V54, P5501; LAZARINI F, 1991, MOL BRAIN RES, V10, P343, DOI 10.1016/0169-328X(91)90093-D; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Lou H, 1998, J ENDOCRINOL, V156, P401, DOI 10.1677/joe.0.1560401; Martinou I, 1998, NEUROREPORT, V9, P15, DOI 10.1097/00001756-199801050-00004; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Middleton G, 1996, DEVELOPMENT, V122, P695; Moshnyakov M, 1996, MOL BRAIN RES, V43, P141, DOI 10.1016/S0169-328X(96)00168-4; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; NEGRINI M, 1987, CELL, V49, P455, DOI 10.1016/0092-8674(87)90448-X; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OMALLEY EK, 1994, BRAIN RES, V647, P83, DOI 10.1016/0006-8993(94)91401-X; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schmitt E, 2000, BIOCHEM BIOPH RES CO, V270, P868, DOI 10.1006/bbrc.2000.2537; Shi B, 1999, BIOCHEM BIOPH RES CO, V254, P779, DOI 10.1006/bbrc.1998.0130; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P577, DOI 10.1073/pnas.97.2.577; Simonen M, 1997, EUR J BIOCHEM, V249, P85, DOI 10.1111/j.1432-1033.1997.t01-1-00085.x; STAMM S, 1994, NUCLEIC ACIDS RES, V22, P1515, DOI 10.1093/nar/22.9.1515; TIMMUSK T, 1993, EUR J NEUROSCI, V5, P605, DOI 10.1111/j.1460-9568.1993.tb00526.x; Ulrich E, 1997, GENOMICS, V44, P195, DOI 10.1006/geno.1997.4858; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Vekrellis K, 1997, DEVELOPMENT, V124, P1239; Wei MC, 2000, GENE DEV, V14, P2060; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yang XF, 1997, IMMUNITY, V7, P629, DOI 10.1016/S1074-7613(00)80384-2; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhou M, 1998, J BIOL CHEM, V273, P11930, DOI 10.1074/jbc.273.19.11930	71	66	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16240	16247		10.1074/jbc.M010419200	http://dx.doi.org/10.1074/jbc.M010419200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278671	hybrid			2022-12-27	WOS:000168623100090
J	Hammerle, MM; Aleksandrov, AA; Riordan, JR				Hammerle, MM; Aleksandrov, AA; Riordan, JR			Disease-associated mutations in the extracytoplasmic loops of cystic fibrosis transmembrane conductance regulator do not impede biosynthetic processing but impair chloride channel stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC LOOP; CFTR; PROTEIN; PHOSPHORYLATION	Consistent with its function as a chloride channel regulated entirely from the cytoplasmic side of the plasma membrane, the cystic fibrosis transmembrane conductance regulator (CFTR) glycoprotein exposes little of its mass on the exterior surface of cells. The first and fourth extracytoplasmic loops (ELs) contain similar to 15 and 30 residues, respectively; the other four ELs are extremely short. To examine the influence of missense mutants in ELs detected in patients with cystic fibrosis, we have expressed them in mammalian (baby hamster kidney (BHK21)) cells and assessed their biosynthetic processing and chloride channel activity. In contrast to previous findings that 18 of 30 disease-associated missense mutations in cytoplasmic loops caused retention of the nascent polypeptides in the endoplasmic reticulum, all the EL mutants studied matured and were transported to the cell surface. This pronounced asymmetry is consistent with the notion that endoplasmic reticulum quality control of nascent CFTR is exerted primarily on the cytoplasmic side of the membrane. Although this set of EL mutations has little effect on CFTR maturation, most of them seriously compromise its chloride channel activity, Substitutions at six different positions in EL1 and single positions in EL2 and EL4 all destabilized the open state, some of them severely, indicating that the ELs contribute to the stability of the CFTR ion pore.	Mayo Clin Scottsdale, SC Johnson Med Res Ctr, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix; SC Johnson & Son	Riordan, JR (corresponding author), Mayo Clin Scottsdale, SC Johnson Med Res Ctr, 13400 E shea Blvd, Scottsdale, AZ 85259 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054076] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54076] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleksandrov AA, 1998, FEBS LETT, V431, P97, DOI 10.1016/S0014-5793(98)00713-3; CHANG XB, 1993, J BIOL CHEM, V268, P11304; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Dawson David C., 1999, Physiological Reviews, V79, pS47; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; HAMMERLE M, 2001, IN PRESS GLYCOCONJ J; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Pasyk EA, 1998, J BIOL CHEM, V273, P31759, DOI 10.1074/jbc.273.48.31759; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Seibert FS, 1997, J BIOENERG BIOMEMBR, V29, P429, DOI 10.1023/A:1022478822214; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; SEIBERT FS, 1995, J BIOL CHEM, V270, P2158, DOI 10.1074/jbc.270.5.2158; Sheppard David N., 1999, Physiological Reviews, V79, pS23; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0	19	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14848	14854		10.1074/jbc.M011017200	http://dx.doi.org/10.1074/jbc.M011017200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278813	hybrid			2022-12-27	WOS:000168528800044
J	Nayak, S; Hildebrand, EL; Bryant, FR				Nayak, S; Hildebrand, EL; Bryant, FR			ADP-dependent DNA strand exchange by the mutant [P67G/E68A]RecA protein - Evidence for an involvement of ADP in RecA protein-mediated branch migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTED ATP HYDROLYSIS; ESCHERICHIA-COLI; STABLE COMPLEXES; NTP HYDROLYSIS; BINDING; INHIBITION; PHASE	We have prepared a mutant RecA protein in which proline 67 and glutamic acid 68 in the NTP binding site were replaced by a glycine and alanine residue, respectively, The [P67G/E68A]RecA protein catalyzes the single-stranded DNA-dependent hydrolysis of ATP and is able to promote the standard ATP-dependent three-strand exchange reaction between a circular bacteriophage phi X174 (phiX) single-stranded DNA molecule and a homologous linear phiX double-stranded (ds) DNA molecule (5.4 kilobase pairs). The strand exchange activity differs from that of the wild type RecA protein, however, in that it is (i) completely inhibited by an ATP regeneration system, and (ii) strongly stimulated by the addition of high concentrations of ADP to the reaction solution. These results indicate that the strand exchange activity of the [P67G/E68A]RecA protein is dependent on the presence of both ATP and ADP. The ADP dependence of the reaction is reduced or eliminated when (i) a shorter linear phiX dsDNA fragment (1.1 kilobase pairs) is substituted for the full-length linear phiX dsDNA substrate, or (ii) the Mg2+ concentration is reduced to a level just sufficient to complex the ATP present in the reaction solution. These results indicate that it is the branch migration phase (and not the initial pairing step) of the [P67G/E68A]RecA protein-promoted strand exchange reaction that is dependent on ADP. It is likely that the [P67G/E68A]RecA mutation has revealed a requirement for ADP that also exists (but is not as readily apparent) in the strand exchange reaction of the wild type RecA protein.	Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA	Johns Hopkins University	Bryant, FR (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA.				NIGMS NIH HHS [GM36516] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036516] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; COTTERILL SM, 1982, BIOCHEMISTRY-US, V21, P4332, DOI 10.1021/bi00261a023; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; COX MM, 1982, J BIOL CHEM, V257, P8523; COX MM, 1983, J BIOL CHEM, V258, P2586; LEE JW, 1990, BIOCHEMISTRY-US, V29, P7677, DOI 10.1021/bi00485a017; LEE JW, 1990, BIOCHEMISTRY-US, V29, P7666, DOI 10.1021/bi00485a016; Nayak S, 1999, J BIOL CHEM, V274, P25979, DOI 10.1074/jbc.274.37.25979; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; WEINSTOCK GM, 1979, P NATL ACAD SCI USA, V76, P126, DOI 10.1073/pnas.76.1.126	15	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14933	14938		10.1074/jbc.M100470200	http://dx.doi.org/10.1074/jbc.M100470200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279076	hybrid			2022-12-27	WOS:000168528800056
J	Strano, S; Munarriz, E; Rossi, M; Castagnoli, L; Shaul, Y; Sacchi, A; Oren, M; Sudol, M; Cesareni, G; Blandino, G				Strano, S; Munarriz, E; Rossi, M; Castagnoli, L; Shaul, Y; Sacchi, A; Oren, M; Sudol, M; Cesareni, G; Blandino, G			Physical interaction with Yes-associated protein enhances p73 transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE-RICH MOTIF; KINASE C-ABL; WW DOMAIN; P53 MUTANTS; FUNCTIONAL-ANALYSIS; APOPTOTIC RESPONSE; INDUCE APOPTOSIS; SH3 DOMAIN; DNA-DAMAGE; CELL-LINE	Specific protein-protein interactions are involved in a large number of cellular processes and are mainly mediated by structurally and functionally defined domains. Here we report that the nuclear phosphoprotein p73 can engage in a physical association with the Yes-associated protein (YAP), This association occurs under physiological conditions as shown by reciprocal co-immunoprecipitation of complexes from lysates of P19 cells. The WW domain of YAP and the PPPPY motif of p73 are directly involved in the association. Furthermore, as required for ligands to group I WW domains, the terminal tyrosine ((Y) under bar) of the PPPPY motif of p73 was shown to be essential for the association with YAP. Unlike p73(Y, p73 beta, and p63 alpha, which bind to YAP, the endogenous as well as exogenously expressed wild-type p53 (wt-p53) and the p73 gamma isoform do not interact with YAP. Indeed, we documented that YAP interacts only with those members of the p53 family that have a well conserved PPXY motif, a target sequence for WW domains. Overexpression of YAP causes an increase of p73 alpha transcriptional activity. Differential interaction of YAP with members of the p53 family may provide a molecular explanation for their functional divergence in signaling.	Regina Elena Canc Inst, Mol Oncogenesis Lab, I-00158 Rome, Italy; Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Cell Biol, IL-76100 Rehovot, Israel; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	University of Rome Tor Vergata; Weizmann Institute of Science; Weizmann Institute of Science; Icahn School of Medicine at Mount Sinai	Blandino, G (corresponding author), Regina Elena Canc Inst, Mol Oncogenesis Lab, Via Messi dOro 156, I-00158 Rome, Italy.		strano, sabrina/B-6743-2013; Rossi, Mario/E-7666-2012; Cesareni, Gianni/AAW-1382-2020; Blandino, Giovanni/B-1137-2013; Strano, Sabrina/K-9654-2016	strano, sabrina/0000-0002-6341-4230; Rossi, Mario/0000-0001-6349-8895; Blandino, Giovanni/0000-0002-6970-2241; Castagnoli, Luisa/0000-0001-5283-8671; Oren, Moshe/0000-0003-4311-7172; Munarriz, Eliana/0000-0002-3556-117X	NATIONAL CANCER INSTITUTE [R29CA045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045626] Funding Source: NIH RePORTER; NCI NIH HHS [CA45757] Funding Source: Medline; NIAMS NIH HHS [AR45626] Funding Source: Medline; Telethon [369/BI] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Telethon(Fondazione Telethon)		Agami R, 1999, NATURE, V399, P809; Almog N, 1997, BBA-REV CANCER, V1333, pF1, DOI 10.1016/S0304-419X(97)00012-7; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Bottger A, 1997, CURR BIOL, V7, P860, DOI 10.1016/S0960-9822(06)00374-5; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; COURTNEIDGE SA, 1993, EMBO J, V12, P943, DOI 10.1002/j.1460-2075.1993.tb05735.x; Damalas A, 1999, EMBO J, V18, P3054, DOI 10.1093/emboj/18.11.3054; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; De Laurenzi V, 2000, J BIOL CHEM, V275, P15226, DOI 10.1074/jbc.275.20.15226; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Dobbelstein M, 1998, J GEN VIROL, V79, P3079, DOI 10.1099/0022-1317-79-12-3079; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; ESPANEL X, 2001, IN PRESS J BIOL CHEM; Gong JG, 1999, NATURE, V399, P806; Hansen R, 1997, CURR OPIN GENET DEV, V7, P46, DOI 10.1016/S0959-437X(97)80108-6; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hollstein M, 1997, Recent Results Cancer Res, V143, P369; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Levrero M, 2000, J CELL SCI, V113, P1661; Linn H, 1997, BIOL CHEM, V378, P531, DOI 10.1515/bchm.1997.378.6.531; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; MARIN MC, 2000, BIOCHIM BIOPHYS ACTA, V1470, P93; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; MIYASHITA T, 1995, CELL, V80, P293; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Oren M, 1997, CELL, V90, P829, DOI 10.1016/S0092-8674(00)80347-5; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Pawson T, 2000, GENE DEV, V14, P1027; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rentschler S, 1999, BIOL CHEM, V380, P431, DOI 10.1515/BC.1999.057; Roth J, 1998, J VIROL, V72, P8510, DOI 10.1128/JVI.72.11.8510-8516.1998; Sambrook J., 2002, MOL CLONING LAB MANU; Santi E, 2000, J MOL BIOL, V296, P497, DOI 10.1006/jmbi.1999.3471; Scharnhorst V, 2000, J BIOL CHEM, V275, P10202, DOI 10.1074/jbc.275.14.10202; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Steegenga WT, 1999, MOL CELL BIOL, V19, P3885; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; SUDOL M, 1994, ONCOGENE, V9, P2145; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Sudol M, 1998, ONCOGENE, V17, P1469, DOI 10.1038/sj.onc.1202182; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wang YC, 1998, ONCOGENE, V17, P1923, DOI 10.1038/sj.onc.1202113; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zeng XY, 1999, MOL CELL BIOL, V19, P3257	71	343	354	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15164	15173		10.1074/jbc.M010484200	http://dx.doi.org/10.1074/jbc.M010484200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278685	hybrid			2022-12-27	WOS:000168528800085
J	Basani, RB; D'Andrea, G; Mitra, N; Vilaire, G; Richberg, M; Kowalska, MA; Bennett, JS; Poncz, M				Basani, RB; D'Andrea, G; Mitra, N; Vilaire, G; Richberg, M; Kowalska, MA; Bennett, JS; Poncz, M			RGD-containing peptides inhibit fibrinogen binding to platelet alpha(IIb)beta 3 by inducing an allosteric change in the amino-terminal portion of alpha(IIb)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; INTEGRIN-I-DOMAIN; LIGAND-BINDING; GAMMA-CHAIN; GPIIB-IIIA; MEMBRANE-RECEPTORS; ADHESION RECEPTOR; BETA(3) SUBUNIT; CROSS-LINKING; SITE	To determine the molecular basis for the insensitivity of rat alpha (IIb)beta (3) to inhibition by RGD-containing peptides, hybrids of human and rat alpha (IIb)beta (3) and chimeras of alpha (IIb)beta (3) in which alpha (IIb), was composed of portions of human and rat alpha (IIb) were expressed in Chinese hamster ovary cells and B lymphocytes, and the ability of the tetrapeptide RGDS to inhibit fibrinogen binding to the various forms of alpha (IIb)beta (3) was measured. These measurements indicated that sequences regulating the sensitivity of alpha (IIb)beta (3) to RGDS are located in the seven amino-terminal repeats of alpha (IIb). Moreover, replacing the first three or four (but not the first two) repeats of rat alpha (IIb) With the corresponding human sequences enhanced sensitivity to RGDS, whereas replacing the first two or three repeats of human alpha (IIb) with the corresponding rat sequences had little or no effect. Nevertheless, RGDS bound to Chinese hamster ovary cells expressing alpha (IIb)beta (3) regardless whether the alpha (IIb) in the heterodimers was human, rat, or a rat-human chimera, These results indicate that the sequences determining the sensitivity of alpha (IIb)beta (3) to RGD-containing peptides are located in the third and fourth amino-terminal repeats of alpha (IIb). Because RGDS binds to both human and rat alpha (IIb)beta (3), the results suggest that differences in RGDS sensitivity result from differences in the allosteric changes induced in these repeats following RGDS binding.	Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Ist Ricovero & Cura Carattere Sci Casa Sollievo S, Unita Aterosclerosi & Trombosi, I-71013 Foggia, Italy	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Poncz, M (corresponding author), Childrens Hosp Philadelphia, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL40387] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baneres JL, 1998, J BIOL CHEM, V273, P24744, DOI 10.1074/jbc.273.38.24744; Basani RB, 2000, BLOOD, V95, P180, DOI 10.1182/blood.V95.1.180.001k16_180_188; Bennett JS, 1999, J BIOL CHEM, V274, P25301, DOI 10.1074/jbc.274.36.25301; BENNETT JS, 1988, J BIOL CHEM, V263, P12948; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; BENNETT JS, 1996, TRENDS CARDIOVAS MED, V16, P31; Bitan G, 1999, BIOCHEMISTRY-US, V38, P3414, DOI 10.1021/bi981946c; CHARO IF, 1991, J BIOL CHEM, V266, P1415; CIEUTAT AM, 1993, BIOCHEM BIOPH RES CO, V193, P771, DOI 10.1006/bbrc.1993.1692; DSOUZA SE, 1988, J BIOL CHEM, V263, P3943; DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922; DSOUZA SE, 1990, J BIOL CHEM, V265, P3440; FARRELL DH, 1994, J BIOL CHEM, V269, P226; GARTNER TK, 1985, J BIOL CHEM, V260, P1891; Grimaldi CM, 1998, BLOOD, V91, P1562, DOI 10.1182/blood.V91.5.1562.1562_1562_1571; GULINO D, 1992, J BIOL CHEM, V267, P1001; HARFENIST EJ, 1988, BLOOD, V71, P132; Hu DD, 1999, J BIOL CHEM, V274, P4633, DOI 10.1074/jbc.274.8.4633; Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Jennings LK, 1995, THROMB HAEMOSTASIS, V74, P1551; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kamata T, 1996, J BIOL CHEM, V271, P18610, DOI 10.1074/jbc.271.31.18610; KLOCZEWIAK M, 1982, BIOCHEM BIOPH RES CO, V107, P181, DOI 10.1016/0006-291X(82)91686-2; KOUNS WC, 1994, BLOOD, V84, P1108; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; LEFKOVITS J, 1995, NEW ENGL J MED, V332, P1553, DOI 10.1056/NEJM199506083322306; Liddington R, 1998, STRUCT FOLD DES, V6, P937, DOI 10.1016/S0969-2126(98)00094-X; Lin ECK, 1997, J BIOL CHEM, V272, P23912, DOI 10.1074/jbc.272.38.23912; Loftus JC, 1996, J BIOL CHEM, V271, P2033, DOI 10.1074/jbc.271.4.2033; LOH E, 1995, J BIOL CHEM, V270, P18631, DOI 10.1074/jbc.270.31.18631; MACINTYRE DE, 1974, BIOCHEM SOC T, V2, P873, DOI 10.1042/bst0020873; Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; PONCZ M, 1987, J BIOL CHEM, V262, P8476; PONCZ M, 1990, BLOOD, V75, P1282; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; Qi WW, 1998, J BIOL CHEM, V273, P15271, DOI 10.1074/jbc.273.24.15271; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; RANSOM DG, 1993, DEV BIOL, V160, P265, DOI 10.1006/dbio.1993.1304; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; STEINER B, 1993, J BIOL CHEM, V268, P6870; TAYLOR DB, 1992, J BIOL CHEM, V267, P11729; Thornton MA, 1999, BLOOD, V94, P3947, DOI 10.1182/blood.V94.11.3947.423k41_3947_3950; Tozer EC, 1999, BLOOD, V93, P918, DOI 10.1182/blood.V93.3.918.403k26_918_924; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; Ward CM, 2000, BLOOD, V96, P161, DOI 10.1182/blood.V96.1.161.013k50_161_169; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Wilhide CC, 1997, BLOOD, V90, P3951, DOI 10.1182/blood.V90.10.3951; ZIMRIN AB, 1988, J CLIN INVEST, V81, P1470, DOI 10.1172/JCI113478; ZUCKER MB, 1984, THROMB HAEMOSTASIS, V51, P19	53	57	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13975	13981		10.1074/jbc.M011511200	http://dx.doi.org/10.1074/jbc.M011511200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278919	hybrid			2022-12-27	WOS:000168356600065
J	Willuda, J; Kubetzko, S; Waibel, R; Schubiger, PA; Zangemeister-Wittke, U; Pluckthun, A				Willuda, J; Kubetzko, S; Waibel, R; Schubiger, PA; Zangemeister-Wittke, U; Pluckthun, A			Tumor targeting of mono-, di-, and tetravalent Anti-p185(HER-2) miniantibodies multimerized by self-associating peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN FV; RECOMBINANT ANTIBODY FRAGMENTS; CELL-DENSITY FERMENTATION; ESCHERICHIA-COLI; IN-VIVO; CANCER-THERAPY; COILED-COIL; ANTIGEN; AFFINITY; LIBRARY	Multimerization of antibody fragments increases the valency and the molecular weight, both identified as key features in the design of the optimal targeting molecule, Here, we report the construction of mono-, di-, and tetrameric variants of the anti-tumor p185(HER-2) Single chain Fv fragment 4D5 by fusion of self-associating peptides to the carboxyl terminus. Dimeric miniantibodies with a synthetic helix-turn-helix domain and tetrameric ones with the multimerization domain of the human p53 protein were produced in functional form in the periplasm of Escherichia coli, We have directly compared these molecules and the single-chain Fv fragment in the targeting of SK-OV-3 xenografts, Tetramerization of the 4D5 antibody fragment resulted in increased serum persistence, significantly reduced off-rate, due to the avidity effect, both in surface plasmon resonance measurements on purified p185HER-2 and on SK-OV-3 cells. The (99m)technetium-tricarbonyl-labeled tetrameric 4D5-p53 miniantibody localized with the highest dose at the tumor and remained stably bound for at least 72 h, The highest total dose was 4.3% injected dose/g after 24 h, whereas the highest tumor-to-blood ratio was found to be 13.5:1 after 48 h, with a total dose of 3.2% injected dose/g, The tetramer shows no higher avidity than the dimer, presumably since the simultaneous binding to more than two antigen molecules on the surface of cells is not possible, and the improvement in performance over the dimer must at least be due in part to the molecular weight. These results demonstrate that multimerization by self-associating peptides can be used for the development of more effective targeting molecules for medical diagnostics and therapy.	Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; Univ Zurich Hosp, Dept Internal Med, Div Oncol, CH-8044 Zurich, Switzerland; Paul Scherrer Inst, Ctr Radiopharmaceut Sci, CH-5232 Villigen, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Pluckthun, A (corresponding author), Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland.	plueckthun@biocfebs.unizh.ch	Plückthun, Andreas/C-2746-2009	Plückthun, Andreas/0000-0003-4191-5306				Adams GP, 1998, CANCER RES, V58, P485; ADAMS GP, 1993, CANCER RES, V53, P4026; Adams GP, 1998, BRIT J CANCER, V77, P1405, DOI 10.1038/bjc.1998.233; Arndt KM, 2000, J MOL BIOL, V295, P627, DOI 10.1006/jmbi.1999.3352; Bass S, 1996, J BACTERIOL, V178, P1154, DOI 10.1128/jb.178.4.1154-1161.1996; Begent RHJ, 1996, NAT MED, V2, P979, DOI 10.1038/nm0996-979; Behr TM, 1998, EUR J NUCL MED, V25, P201, DOI 10.1007/s002590050216; Bloemendal HJ, 1999, EUR J CLIN INVEST, V29, P802; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CARTER P, 1992, BIO-TECHNOL, V10, P163, DOI 10.1038/nbt0292-163; Casey JL, 1996, BRIT J CANCER, V74, P1397, DOI 10.1038/bjc.1996.555; Ge L, 1995, ANTIBODY ENG, P229; Holliger P, 1998, NAT BIOTECHNOL, V16, P1015, DOI 10.1038/3460; Holliger P, 1997, CANCER IMMUNOL IMMUN, V45, P128, DOI 10.1007/s002620050414; Horn U, 1996, APPL MICROBIOL BIOT, V46, P524, DOI 10.1007/s002530050855; Hu SZ, 1996, CANCER RES, V56, P3055; Hudson PJ, 1999, CURR OPIN IMMUNOL, V11, P548, DOI 10.1016/S0952-7915(99)00013-8; HUSTON JS, 1994, CELL BIOPHYS, V24-5, P267, DOI 10.1007/BF02789238; KING DJ, 1994, CANCER RES, V54, P6176; KNAPPIK A, 1995, PROTEIN ENG, V8, P81, DOI 10.1093/protein/8.1.81; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Muller KM, 1998, FEBS LETT, V432, P45, DOI 10.1016/S0014-5793(98)00829-1; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; PACK P, 1993, BIO-TECHNOL, V11, P1271; PACK P, 1992, BIOCHEMISTRY-US, V31, P1579, DOI 10.1021/bi00121a001; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; PLUCKTHUN A, ANTIBODY ENG PRACTIC, V203, P96; Rheinnecker M, 1996, J IMMUNOL, V157, P2989; ROWLINSONBUSZA G, 1996, TUMOR TARGET, V2, P37; Tsai SW, 2000, BIOCONJUGATE CHEM, V11, P327, DOI 10.1021/bc9901292; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Viti F, 1999, CANCER RES, V59, P347; Waibel R, 1999, NAT BIOTECHNOL, V17, P897, DOI 10.1038/12890; Werlen RC, 1996, CANCER RES, V56, P809; Willuda J, 1999, CANCER RES, V59, P5758; Worn A, 1998, FEBS LETT, V427, P357, DOI 10.1016/S0014-5793(98)00463-3	36	82	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14385	14392		10.1074/jbc.M011669200	http://dx.doi.org/10.1074/jbc.M011669200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278961	hybrid			2022-12-27	WOS:000168356600115
J	Malik, B; Schlanger, L; Al-Khalili, O; Bao, HF; Yue, GC; Price, SR; Mitch, WE; Eaton, DC				Malik, B; Schlanger, L; Al-Khalili, O; Bao, HF; Yue, GC; Price, SR; Mitch, WE; Eaton, DC			ENaC degradation in A6 cells by the ubiquitin-proteosome proteolytic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; NA+ CHANNEL; LIDDLES-SYNDROME; WW DOMAINS; PROTEASOME PATHWAY; PLASMA-MEMBRANE; BETA-SUBUNIT; ENDOCYTOSIS; NEDD4; HYPERTENSION	Amiloride-sensitive epithelial Na+ channels (ENaC) are responsible for trans-epithelial Na+ transport in the kidney, lung, and colon. The channel consists of three subunits (alpha, beta, gamma) each containing a proline rich region (PPXY) in their carboxyl-terminal end. Mutations in this PPXY domain cause Liddle's syndrome, an autosomal dominant, salt-sensitive hypertension, by preventing the channel's interactions with the ubiquitin ligase Neural precursor cell-expressed developmentally down-regulated protein (Nedd4), It is postulated that this results in defective endocytosis and lysosomal degradation of ENaC leading to an increase in ENaC activity. To show the pathway that degrades ENaC in epithelial cells that express functioning ENaC channels, we used inhibitors of the proteosome and measured sodium channel activity. We found that the inhibitor, MG-132, increases amiloride-sensitive trans-epithelial current in Xenopus distal nephron A6 cells. There also is an increase of total cellular as well as membrane-associated ENaC subunit molecules by Western blotting. MG-132-treated cells also have increased channel density in patch clamp experiments. Inhibitors of lysosomal function did not reproduce these findings. Our results suggest that in native renal cells the proteosomal pathway is an important regulator of ENaC function.	Emory Univ, Dept Physiol, Ctr Cell & Mol Signaling, Atlanta, GA 30322 USA; Emory Univ, Div Renal, Atlanta, GA 30322 USA	Emory University; Emory University	Malik, B (corresponding author), Emory Univ, Dept Physiol, Ctr Cell & Mol Signaling, Physiol Bldg,Rm 074,1648 Pierce Dr, Atlanta, GA 30322 USA.			Eaton, Douglas/0000-0002-2686-6692	NIDDK NIH HHS [R37 DK037175, DK 37963-14, DK-37175, DK-50268-4, DK-50740] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050740, P01DK050268, R01DK037175, R37DK037963, R37DK037175, R01DK037963] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; ANIENTO F, 1993, J BIOL CHEM, V268, P10463; Berdiev BK, 2000, BIOPHYS J, V78, P1881, DOI 10.1016/S0006-3495(00)76737-3; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; EATON DC, 1991, MEMBRANE TRANSPORT B, P73; Egner R, 1996, FEBS LETT, V378, P177, DOI 10.1016/0014-5793(95)01450-0; Franch HA, 1997, AM J PHYSIOL-CELL PH, V273, pC843, DOI 10.1152/ajpcell.1997.273.3.C843; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; HAMILTON KL, 1985, AM J PHYSIOL, V249, pC200, DOI 10.1152/ajpcell.1985.249.3.C200; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; MARUNAKA Y, 1991, AM J PHYSIOL, V260, pC1071, DOI 10.1152/ajpcell.1991.260.5.C1071; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; O'Brodovich H M, 1995, New Horiz, V3, P240; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 1996, STRUCTURE, V4, P495, DOI 10.1016/S0969-2126(96)00054-8; Staub O, 1997, AM J PHYSIOL-CELL PH, V272, pC1871, DOI 10.1152/ajpcell.1997.272.6.C1871; Strous GJ, 1999, J CELL SCI, V112, P1417; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6	28	97	102	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12903	12910		10.1074/jbc.M010626200	http://dx.doi.org/10.1074/jbc.M010626200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278712	hybrid			2022-12-27	WOS:000168198600063
J	Fanger, CM; Rauer, H; Neben, AL; Miller, MJ; Rauer, H; Wulff, H; Rosa, JC; Ganellin, CR; Chandy, KG; Cahalan, MD				Fanger, CM; Rauer, H; Neben, AL; Miller, MJ; Rauer, H; Wulff, H; Rosa, JC; Ganellin, CR; Chandy, KG; Cahalan, MD			Calcium-activated potassium channels sustain calcium signaling in T lymphocytes - Selective blockers and manipulated channel expression levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; BIS-QUINOLINIUM CYCLOPHANES; INTRACELLULAR CA2+; CELL ACTIVATION; NONPEPTIDIC BLOCKER; CONDUCTANCE; APAMIN; PROLIFERATION; POTENT; INHIBITION	To maintain Ca2+ entry during T lymphocyte activation, a balancing efflux of cations is necessary. Using three approaches, we demonstrate that this cation efflux is mediated by Ca2+-activated K+ (K-Ca) channels, hSKCa2 in the human leukemic T cell line Jurkat and hIKCa1 in mitogen-activated human T cells. First, several recently developed, selective and potent pharmacological inhibitors of K-Ca channels but not K-V channels reduce Ca2+ entry in Jurkat and in mitogen-activated human T cells. Second, dominant negative suppression of the native K-Ca channel in Jurkat T cells by overexpression of a truncated fragment of the cloned hSKCa2 channel decreases Ca2+ influx. Finally, introduction of the hIKCa1 channel into Jurkat T cells maintains rapid Ca2+ entry despite pharmacological inhibition of the native small conductance K-Ca channel. Thus, K-Ca channels play a vital role in T cell Ca2+ signaling.	Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; 4SC AG Drug Discovery, D-82152 Martinsried, Germany; UCL, Dept Chem, London WC1H OAJ, England	University of California System; University of California Irvine; 4SC AG; University of London; University College London	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	mcahalan@uci.edu	wulff, Heike/Z-2056-2019	Fanger, Christopher/0000-0002-8268-9053; Miller, Mark/0000-0001-5676-389X	NIGMS NIH HHS [GM54221, GM41514] Funding Source: Medline; NIMH NIH HHS [MH59222] Funding Source: Medline; NINDS NIH HHS [NS14609] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041514, R01GM054221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014609, R37NS014609] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Benton DCH, 1999, BRIT J PHARMACOL, V126, P169, DOI 10.1038/sj.bjp.0702292; CAI YC, 1992, DNA CELL BIOL, V11, P163, DOI 10.1089/dna.1992.11.163; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; Chen JQ, 2000, J MED CHEM, V43, P3478, DOI 10.1021/jm000904v; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Desai R, 2000, J BIOL CHEM, V275, P39954, DOI 10.1074/jbc.M001562200; Ehring GR, 1998, J EXP MED, V188, P1593, DOI 10.1084/jem.188.9.1593; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; Fanger CM, 2000, J IMMUNOL, V164, P1153, DOI 10.4049/jimmunol.164.3.1153; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Fomina AF, 2000, J CELL BIOL, V150, P1435, DOI 10.1083/jcb.150.6.1435; FREEDMAN BD, 1992, J IMMUNOL, V149, P3784; GELFAND EW, 1991, J IMMUNOL, V147, P3452; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; GRISSMER S, 1992, J GEN PHYSIOL, V99, P63, DOI 10.1085/jgp.99.1.63; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; GRISSMER S, 1990, P NATL ACAD SCI USA, V87, P9411, DOI 10.1073/pnas.87.23.9411; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; HESS SD, 1993, J IMMUNOL, V150, P2620; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jager H, 2000, FEBS LETT, V469, P196, DOI 10.1016/S0014-5793(00)01236-9; Jensen BS, 1999, P NATL ACAD SCI USA, V96, P10917, DOI 10.1073/pnas.96.19.10917; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; Koo GC, 1999, CELL IMMUNOL, V197, P99, DOI 10.1006/cimm.1999.1569; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; Mason MJ, 1999, J MEMBRANE BIOL, V170, P79; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Peter W, 1999, J PHYSIOL-LONDON, V518, P13, DOI 10.1111/j.1469-7793.1999.0013r.x; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rauer H, 2000, J BIOL CHEM, V275, P1201, DOI 10.1074/jbc.275.2.1201; Rosa JC, 1998, J MED CHEM, V41, P2, DOI 10.1021/jm970571a; Rosa JC, 2000, J MED CHEM, V43, P420, DOI 10.1021/jm9902537; ROSA JC, 1997, Patent No. 9748705; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TU LW, 1995, BIOPHYS J, V68, P147, DOI 10.1016/S0006-3495(95)80169-4; Verheugen JAH, 1997, J PHYSIOL-LONDON, V503, P317, DOI 10.1111/j.1469-7793.1997.317bh.x; VERHEUGEN JAH, 1995, J GEN PHYSIOL, V105, P765, DOI 10.1085/jgp.105.6.765; Verheugen JAH, 1997, CELL CALCIUM, V21, P1, DOI 10.1016/S0143-4160(97)90092-0; VERHEUGEN JAH, 1995, CELL CALCIUM, V17, P287, DOI 10.1016/0143-4160(95)90075-6; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	52	142	142	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12249	12256		10.1074/jbc.M011342200	http://dx.doi.org/10.1074/jbc.M011342200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278890	hybrid, Green Submitted			2022-12-27	WOS:000168081800109
J	Salim, M; Brown-Kipphut, BA; Maines, MD				Salim, M; Brown-Kipphut, BA; Maines, MD			Human biliverdin reductase is autophosphorylated, and phosphorylation is required for bilirubin formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE; NUCLEOTIDE-BINDING; IX-ALPHA; EXPRESSION; PURIFICATION; INDUCTION; OXIDATION; CLONING; LIVER; CDNA	Biliverdin reductase (BVR) reduces heme oxygenase (HO) activity product, biliverdin, to bilirubin. BVR is unique in having dual pH/dual cofactor requirements. Using Escherichia coli-expressed human BVR and COS cells, we show that BVR is autophosphorylated and that phosphorylation is required for its activity. An "in blot" autophosphorylation assay showed that BVR is a renaturable phosphoprotein. Controls for the experiments were HO-1 and HO-2; both are phosphoproteins but are not autophosphorylated. Autophosphorylation was pH-dependent, with activity at pH 8.7 being most prominent. In addition, 2'(3')-O- (2,4,6-trinitrophenyl) adenosine 5'-triphosphate fluorescence titration of BVR gave a lower K-d at pH 8.7 than at pH 7.4 (15.5 versus 28.0 muM). Mn2+ was required for binding of the ATP analogue and for autophosphorylation; the autokinase activity was lost when treated at 60 degreesC for 10 min. The loss of transferred phosphates by alkaline treatment suggested that BVR is a serine/threonine kinase. Potato acid phosphatase treatment reversibly inactivated the enzyme. The enzyme was also inactivated by treatment with the serine/threonine phosphatase, protein phosphatase 2A; okadaic acid attenuated the inhibition. Titration of protein phosphatase 2A-released phosphates indicated a 1:6 molar ratio of BVR to phosphate. The BVR immunoprecipitated from COS cell lysates was a phosphoprotein, and its activity and phosphorylation levels increased in response to H2O2. The results define a previously unknown mechanism for regulation of BVR activity and are discussed in the context of their relevance to heme metabolism.	Univ Rochester, Sch Med, Dept Biochem Biophys, Rochester, NY 14642 USA	University of Rochester	Maines, MD (corresponding author), Univ Rochester, Sch Med, Dept Biochem Biophys, Rochester, NY 14642 USA.	maines@urmc.rochester.edu			NIEHS NIH HHS [ES04066, ES04391] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES004391, R01ES004391, R01ES004066] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Brown MC, 1998, MOL BIOL CELL, V9, P1803, DOI 10.1091/mbc.9.7.1803; BULDAIN G, 1986, EUR J BIOCHEM, V156, P179, DOI 10.1111/j.1432-1033.1986.tb09564.x; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643, DOI 10.1152/ajpheart.2000.278.2.H643; CORNEJO J, 1992, J BIOL CHEM, V267, P14790; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; Cunningham O, 2000, BIOCHEM J, V345, P393, DOI 10.1042/0264-6021:3450393; DeBruyne LA, 2000, TRANSPLANTATION, V69, P120, DOI 10.1097/00007890-200001150-00021; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; FAKHRAI H, 1992, J BIOL CHEM, V267, P4023; FERRELL JE, 1991, METHOD ENZYMOL, V200, P430; Haga Y, 1996, BBA-MOL BASIS DIS, V1316, P29, DOI 10.1016/0925-4439(96)00004-X; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hansen TWR, 1996, PEDIATR RES, V39, P1072, DOI 10.1203/00006450-199606000-00023; Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250, DOI 10.1161/01.ATV.16.2.250; HUANG TJ, 1989, J BIOL CHEM, V264, P7844; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kolenko V, 1997, J IMMUNOL, V159, P3057; KUTTY RK, 1981, J BIOL CHEM, V256, P3956; KUTTY RK, 1984, BIOCHEM BIOPH RES CO, V122, P40, DOI 10.1016/0006-291X(84)90436-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Liu Y, 2000, J BIOL CHEM, V275, P5297, DOI 10.1074/jbc.275.8.5297; MAINES MD, 1993, ARCH BIOCHEM BIOPHYS, V300, P320, DOI 10.1006/abbi.1993.1044; Maines MD, 1996, EUR J BIOCHEM, V235, P372, DOI 10.1111/j.1432-1033.1996.00372.x; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1992, HEME OXYGENASE CLIN, P1; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; MCCOUBREY WK, 1995, GENE, V160, P235, DOI 10.1016/0378-1119(95)00112-J; MCCOUBREY WK, 1977, J BIOL CHEM, V247, P725; MCDONAGH AF, 1981, BIOCHEM J, V194, P273, DOI 10.1042/bj1940273; MCDONAGH AF, 1990, CLIN PERINATOL, V17, P359, DOI 10.1016/S0095-5108(18)30572-4; Montgomery BL, 1999, PLANT PHYSIOL, V121, P629, DOI 10.1104/pp.121.2.629; O'CARRA P, 1971, Biochemical Journal, V125, p110P; Phelan D, 1998, ARCH BIOCHEM BIOPHYS, V357, P155, DOI 10.1006/abbi.1998.0814; Schluchter WM, 1997, J BIOL CHEM, V272, P13562, DOI 10.1074/jbc.272.21.13562; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; Sinal CJ, 1997, MOL PHARMACOL, V52, P590, DOI 10.1124/mol.52.4.590; SINGLETON JW, 1965, J BIOL CHEM, V240, P4780; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; TENHUNEN R, 1970, BIOCHEMISTRY-US, V9, P298, DOI 10.1021/bi00804a016; TERRY MJ, 1991, J BIOL CHEM, V266, P22215; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; Willis D, 2000, J PATHOL, V190, P627; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Woo J, 2000, TRANSPLANTATION, V69, P623, DOI 10.1097/00007890-200002270-00026; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	47	86	91	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10929	10934		10.1074/jbc.M010753200	http://dx.doi.org/10.1074/jbc.M010753200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11278740	hybrid			2022-12-27	WOS:000167980900050
J	Morris, PD; Tackett, AJ; Babb, K; Nanduri, B; Chick, C; Scott, J; Raney, KD				Morris, PD; Tackett, AJ; Babb, K; Nanduri, B; Chick, C; Scott, J; Raney, KD			Evidence for a functional monomeric form of the bacteriophage T4 Dda helicase - Dda does not form stable oligomeric structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HEPATITIS-C VIRUS; HEXAMERIC HELICASES; PCRA HELICASE; PROTEIN; REPLICATION; PURIFICATION; MECHANISM; OVEREXPRESSION; COMPLEX	The active form of many helicases is oligomeric, possibly because oligomerization provides multiple DNA binding sites needed for unwinding of DNA, In order to understand the mechanism of the bacteriophage T4 Dda helicase, the potential requirement for oligomerization was investigated. Chemical cross-linking and high pressure gel filtration chromatography provided little evidence for the formation of an oligomeric species, The specific activity for ssDNA stimulated ATPase activity was independent of Dda concentration. Dda was mutated to produce an ATPase-deficient protein (K38A Dda) by altering a residue within a conserved, nucleotide binding loop. The helicase activity of K38A Dda was inactivated, although DNA binding properties were similar to Dda, In the presence of limiting DNA substrate, the rate of unwinding by Dda was not changed; however, the amplitude of product formation was reduced in the presence of increasing concentrations of K38A Dda, The reduction was between that expected for a monomeric or dimeric helicase based on simple competition for substrate binding, When unwinding of DNA was measured in the presence of excess DNA substrate, addition of K38A Dda caused no reduction in the observed rate for strand separation, Taken together, these results indicate that oligomerization of Dda is not required for DNA unwinding.	Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	raneykevind@exchange.uams.edu			NIGMS NIH HHS [GM59400] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059400] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; AMARATUNGA M, 1993, BIOCHEMISTRY-US, V32, P6815, DOI 10.1021/bi00078a003; Bird LE, 1998, NUCLEIC ACIDS RES, V26, P2686, DOI 10.1093/nar/26.11.2686; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; DONG F, 1995, J BIOL CHEM, V270, P7462, DOI 10.1074/jbc.270.13.7462; Dong F, 1996, P NATL ACAD SCI USA, V93, P14456, DOI 10.1073/pnas.93.25.14456; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Egelman EH, 1996, STRUCTURE, V4, P759, DOI 10.1016/S0969-2126(96)00081-0; FORMOSA T, 1983, P NATL ACAD SCI-BIOL, V80, P2442, DOI 10.1073/pnas.80.9.2442; GAUSS P, 1994, J BACTERIOL, V176, P1667, DOI 10.1128/jb.176.6.1667-1672.1994; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; HACKER KJ, 1992, J BIOL CHEM, V267, P20674; Jezewska MJ, 2000, J BIOL CHEM, V275, P27865; JONGENEEL CV, 1984, J BIOL CHEM, V259, P2933; JONGENEEL CV, 1984, J BIOL CHEM, V259, P2925; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KODADEK T, 1987, NATURE, V326, P312, DOI 10.1038/326312a0; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; PATEL SS, 1993, J BIOL CHEM, V268, P10668; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Preugschat F, 2000, BIOCHEMISTRY-US, V39, P5174, DOI 10.1021/bi9923860; Raney KD, 1996, J BIOL CHEM, V271, P14074, DOI 10.1074/jbc.271.24.14074; RANEY KD, 1994, P NATL ACAD SCI USA, V91, P6644, DOI 10.1073/pnas.91.14.6644; RANEY KD, 1995, J BIOL CHEM, V270, P22236, DOI 10.1074/jbc.270.38.22236; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; SHRIMANKAR P, 1992, J BACTERIOL, V174, P7689, DOI 10.1128/JB.174.23.7689-7696.1992; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; West SC, 1996, CELL, V86, P177, DOI 10.1016/S0092-8674(00)80088-4	34	44	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19691	19698		10.1074/jbc.M010928200	http://dx.doi.org/10.1074/jbc.M010928200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278788	hybrid			2022-12-27	WOS:000169135100004
J	Piedra, J; Martinez, D; Castano, J; Miravet, S; Dunach, M; de Herreros, AG				Piedra, J; Martinez, D; Castano, J; Miravet, S; Dunach, M; de Herreros, AG			Regulation of beta-catenin structure and activity by tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; E-CADHERIN; TRANSCRIPTIONAL COACTIVATOR; MEDIATED TRANSCRIPTION; BINDING PROTEIN; COLON-CARCINOMA; IN-VITRO; COMPLEX; ARMADILLO; APC	beta -Catenin plays a dual role as a key effector in the regulation of adherens junctions and as a transcriptional coactivator. Phosphorylation of Tyr-654, a residue placed in the last armadillo repeat of beta -catenin, decreases its binding to E-cadherin. We show here that phosphorylation of Tyr-654 also stimulates the association of beta -catenin to the basal transcription factor TATA-binding protein. The structural bases of these different affinities were investigated. Our results indicate that the beta -catenin C-terminal tail interacts with the armadillo repeat domain, hindering the association of the armadillo region to the TATA-binding protein or to E-cadherin. Phosphorylation of beta -catenin Tyr-654 decreases armadillo-C-terminal tail association, uncovering the last armadillo repeats. in a C-terminal-depleted beta -catenin, the presence of a negative charge at Tyr-654 does not affect the interaction of the TATA-binding protein to the armadillo domain. However, in the case of E-cadherin, the establishment of ion pairs dominates its association with beta -catenin, and its binding is greatly dependent on the absence of a negative charge at Tyr-654. Thus, phosphorylation of Tyr-654 blocks the E-cadherin-beta -catenin interaction, even though the steric hindrance of the C-tail is no longer present. These results explain how phosphorylation of beta -catenin in Tyr-654 modifies the tertiary structure of this protein and the interaction with its different partners.	Univ Pompeu Fabra, Inst Municipal Invest Med, Unit Biol Cellular & Mol, Barcelona 08003, Spain; Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unit Biofis, Bellaterra 08193, Spain	Pompeu Fabra University; Autonomous University of Barcelona	Dunach, M (corresponding author), Univ Pompeu Fabra, Inst Municipal Invest Med, Unit Biol Cellular & Mol, C-Dr Aiguador 80, Barcelona 08003, Spain.		Cardoso, Julio Castaño/AAB-5820-2019; de Herreros, A Garcia/H-3104-2014; Dunach, Mireia/E-3604-2015	de Herreros, A Garcia/0000-0001-5270-0808; Dunach, Mireia/0000-0001-9844-5603; Castano Cardoso, Julio/0000-0002-0712-5856				ABERLE H, 1994, J CELL SCI, V107, P3655; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Baulida J, 1999, BIOCHEM J, V344, P565, DOI 10.1042/0264-6021:3440565; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cox RT, 1999, GENETICS, V153, P319; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Gallet A, 1999, EMBO J, V18, P2208, DOI 10.1093/emboj/18.8.2208; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; KINCH MS, 1995, J CELL BIOL, V130, P461, DOI 10.1083/jcb.130.2.461; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Miyagishi M, 2000, J BIOL CHEM, V275, P35170, DOI 10.1074/jbc.C000258200; Muller T, 1999, J BIOL CHEM, V274, P10173, DOI 10.1074/jbc.274.15.10173; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rosato R, 1998, MOL CELL BIOL, V18, P5762, DOI 10.1128/MCB.18.10.5762; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Skoudy A, 1996, BIOCHEM J, V317, P279, DOI 10.1042/bj3170279; Sun YN, 2000, P NATL ACAD SCI USA, V97, P12613, DOI 10.1073/pnas.220158597; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TOMITA N, 1992, CANCER RES, V52, P6840; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wahl JK, 2000, J CELL SCI, V113, P1737; Zhurinsky J, 2000, J CELL SCI, V113, P3127; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	42	208	220	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20436	20443		10.1074/jbc.M100194200	http://dx.doi.org/10.1074/jbc.M100194200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279024	hybrid			2022-12-27	WOS:000169135100103
J	Fanton, CP; McMahon, M; Pieper, RO				Fanton, CP; McMahon, M; Pieper, RO			Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; MAP KINASE; PROTEIN-KINASE; RAS; SENESCENCE; INDUCTION; TRANSFORMATION; P53; P21(WAF1/CIP1); INHIBITION	Normal human fibroblasts have been shown to undergo a p16(Ink4a)-associated senescence-like growth arrest in response to sustained activation of the Ras/Raf/ MEK/ERK pathway. We noted a similar p16(Ink4a) associated, senescence-like arrest in normal human astrocytes in response to expression of a conditional form of Raf-1. While HPV16 E7-mediated functional inactivation of the p16(Ink4a)/pRb pathway in astrocytes blocked the p16(Ink4a)-associated growth arrest in response to activation of Raf-1, it also revealed a second p21(Cip1)-associated, senescence-associated, beta -galactosidase-independent growth arrest pathway. Importantly, the p21(Cip1)-associated pathway was present not only in normal astrocytes but also in p53-, p14(ARF)-, and p16(Ink4a)/ pRb-deficient high grade glioma cells that lacked the p16(Ink4a)-dependent arrest mechanism. These results suggest that normal human cells have redundant arrest pathways, which can be activated by Raf-1, and that even tumors that have dismantled p16(Ink4a) dependent growth arrest pathways are potentially regulated by a second p21(Cip1)-dependent growth arrest pathway.	Univ Calif San Francisco, Ctr Comprehens Canc, Dept Neurol Surg, San Francisco, CA 94115 USA; Univ Calif San Francisco, Ctr Comprehens Canc, Inst Canc Res, San Francisco, CA 94115 USA; Univ Calif San Francisco, Ctr Comprehens Canc, Dept Mol & Cellular Pharmacol, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Pieper, RO (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, Dept Neurol Surg, 2340 Sutter St,Box 0875, San Francisco, CA 94115 USA.	rpieper@cc.ucsf.edu						Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Costanzi-Strauss E, 1998, EXP CELL RES, V238, P51, DOI 10.1006/excr.1997.3810; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dimri GP, 1996, MOL CELL BIOL, V16, P2987; Gartel AL, 2000, ONCOGENE, V19, P961, DOI 10.1038/sj.onc.1203411; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Gorospe M, 1996, MOL CELL BIOL, V16, P6654; Guha A, 1997, ONCOGENE, V15, P2755, DOI 10.1038/sj.onc.1201455; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Khleif SN, 1996, P NATL ACAD SCI USA, V93, P4350, DOI 10.1073/pnas.93.9.4350; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Louis DN, 1997, BRAIN PATHOL, V7, P755, DOI 10.1111/j.1750-3639.1997.tb01062.x; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Martin LG, 1998, J VIROL, V72, P975, DOI 10.1128/JVI.72.2.975-985.1998; Mitra J, 1999, MOL CELL BIOL, V19, P3916; OLSON JJ, 1995, NEUROSURGERY, V36, P740, DOI 10.1227/00006123-199504000-00015; Ravi RK, 1998, J CLIN INVEST, V101, P153, DOI 10.1172/JCI831; Ravi RK, 1999, J CELL BIOCHEM, V72, P458, DOI 10.1002/(SICI)1097-4644(19990315)72:4<458::AID-JCB2>3.0.CO;2-C; Ravi RK, 1999, AM J RESP CELL MOL, V20, P543, DOI 10.1165/ajrcmb.20.4.3406; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Stang S, 1997, MOL CELL BIOL, V17, P3047, DOI 10.1128/MCB.17.6.3047; Uhrbom L, 1997, ONCOGENE, V15, P505, DOI 10.1038/sj.onc.1201227; Weintraub SJ, 1999, AM J RESP CELL MOL, V20, P541, DOI 10.1165/ajrcmb.20.4.f147; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; YANG ZY, 1995, NAT MED, V1, P1052, DOI 10.1038/nm1095-1052; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	43	54	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18871	18877		10.1074/jbc.M011514200	http://dx.doi.org/10.1074/jbc.M011514200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278920	hybrid			2022-12-27	WOS:000169091000031
J	Kabil, O; Toaka, S; LoBrutto, R; Shoemaker, R; Banerjee, R				Kabil, O; Toaka, S; LoBrutto, R; Shoemaker, R; Banerjee, R			Pyridoxal phosphate binding sites are similar in human heme-dependent and yeast heme-independent cystathionine beta-synthases - Evidence from P-31 NMR and pulsed EPR spectroscopy that heme and PLP cofactors are not proximal in the human enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; 5-PHOSPHATE; RESONANCE; COENZYME	Two classes of cystathionine P-synthases have been identified in eukaryotes, the heme-independent enzyme found in yeast and the heme-dependent form found in mammals. Both classes of enzymes catalyze a pyridoxal phosphate (PLP)-dependent condensation of serine and homocysteine to produce cystathionine. The role of the heme in the human enzyme and its location relative to the PLP in the active site are unknown. P-31 NMR spectroscopy revealed that spin-lattice relaxation rates of the phosphorus nucleus in PLP are similar in both the paramagnetic ferric (T-1 = 6.34 +/- 0.01 s) and the diamagnetic ferrous (T-1 = 5.04 +/- 0.06 s) enzyme, suggesting that the two cofactors are not proximal to each other. This is also supported by pulsed EPR studies that do not provide any evidence for strong or weak coupling between the phosphorus nucleus and the ferric iron. However, the P-31 Signal in the reduced enzyme moved from 5.4 to 2.2 ppm, and the line width decreased from 73 to 16 Hz, providing the first structural evidence for transmission to the active site of an oxidation state change in the heme pocket. These results are consistent with a regulatory role for the heme as suggested by previous biochemical studies from our laboratory. The P-31 chemical shifts of the resting forms of the yeast and human enzymes are similar, suggesting that despite the difference in their heme content, the microenvironment of the PLP is similar in the two enzymes. The addition of the substrate, serine, resulted in an upfield shift of the phosphorus resonance in both enzymes, signaling formation of reaction intermediates. The resting enzyme spectra were recovered following addition of excess homocysteine, indicating that both enzymes retained catalytic activity during the course of the NMR experiment.	Univ Nebraska, Beadle Ctr N133, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; Arizona State Univ, Dept Plant Biol, Tempe, AZ 85287 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Arizona State University; Arizona State University-Tempe	Banerjee, R (corresponding author), Univ Nebraska, Beadle Ctr N133, Dept Biochem, Lincoln, NE 68588 USA.	rbaneljee1@unl.edu	Kabil, Omer/AAJ-1435-2020; Shoemaker, Richard/M-7409-2013	Shoemaker, Richard/0000-0002-0805-1449	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58984] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BORCSOK E, 1982, ARCH BIOCHEM BIOPHYS, V213, P695, DOI 10.1016/0003-9861(82)90600-2; Bruno S, 2001, J BIOL CHEM, V276, P16, DOI 10.1074/jbc.C000588200; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; DRUMMOND JT, 1995, ANAL BIOCHEM, V228, P323, DOI 10.1006/abio.1995.1358; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; FUNG CH, 1976, BIOCHEMISTRY-US, V15, P75, DOI 10.1021/bi00646a013; GORENSTEIN DG, 1975, J AM CHEM SOC, V97, P898, DOI 10.1021/ja00837a039; Green EL, 2001, BIOCHEMISTRY-US, V40, P459, DOI 10.1021/bi0010874; HOFER P, 1986, CHEM PHYS LETT, V132, P279, DOI 10.1016/0009-2614(86)80124-5; Jhee KH, 2000, J BIOL CHEM, V275, P11541, DOI 10.1074/jbc.C000056200; Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g; Kery V, 1999, BIOCHEMISTRY-US, V38, P2716, DOI 10.1021/bi981808n; KERY V, 1994, J BIOL CHEM, V269, P25283; MAKINEN AL, 1989, J BIOL CHEM, V264, P12148; Mildvan A S, 1978, Methods Enzymol, V49, P322; MIMS WB, 1965, PROC R SOC LON SER-A, V283, P452, DOI 10.1098/rspa.1965.0034; MIMS WB, 1972, PHYS REV B-SOLID ST, V5, P2409, DOI 10.1103/PhysRevB.5.2409; Osterman AL, 1997, BIOCHEMISTRY-US, V36, P4558, DOI 10.1021/bi962916h; Schnackerz KD, 1998, J BIOL CHEM, V273, P33247, DOI 10.1074/jbc.273.50.33247; SCHNACKERZ KD, 1989, EUR J BIOCHEM, V185, P525, DOI 10.1111/j.1432-1033.1989.tb15145.x; SCHNACKERZ KD, 1995, BIOCHEMISTRY-US, V34, P12152, DOI 10.1021/bi00038a008; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 1999, BIOCHEMISTRY-US, V38, P13155, DOI 10.1021/bi990865t	25	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19350	19355		10.1074/jbc.M100029200	http://dx.doi.org/10.1074/jbc.M100029200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278994	hybrid			2022-12-27	WOS:000169091000095
J	Miller, YI; Chang, MK; Funk, CD; Feramisco, JR; Witztum, JL				Miller, YI; Chang, MK; Funk, CD; Feramisco, JR; Witztum, JL			12/15-lipoxygenase translocation enhances site-specific actin polymerization in macrophages phagocytosing apoptotic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ATHEROSCLEROTIC LESIONS; PERITONEAL-MACROPHAGES; DEFICIENT MICE; ARP2/3 COMPLEX; MESSENGER-RNA; 15-LIPOXYGENASE; LIPOXYGENASE; PROTEIN; OXIDATION	The enzyme 12/15-lipoxygenase (12/15-LO) introduces peroxyl groups in a position-specific manner into unsaturated fatty acids in certain cells, but the role of such enzymatic lipid peroxidation remains poorly defined. Here we report a novel function for 12/15-LO in mouse peritoneal macrophages, When macrophages were coincubated with apoptotic cells, the enzyme translocated from cytosol to the plasma membrane and was more extensively concentrated at sites where macrophages bound apoptotic cells, colocalizing with polymerized actin of emerging filopodia, Disruption of F-actin did not prevent the 12/15-LO translocation. In contrast, inhibition of the 12/15-LO activity, or utilization of genetically engineered macrophages in which the 12/15-LO gene has been disrupted, greatly reduced actin polymerization in phagocytosing macrophages. Lysates of 12/15-LO-deficient macrophages had significantly lower ability to promote in vitro actin polymerization than the lysates of wild type macrophages. These studies suggest that the 12/15-LO enzyme plays a major role in local control of actin polymerization in macrophages in response to interaction with apoptotic cells.	Univ Calif San Diego, Dept Med 0682, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Penn, Ctr Expt Therapeut, Philadelphia, PA 19104 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Pennsylvania	Witztum, JL (corresponding author), Univ Calif San Diego, Dept Med 0682, Div Endocrinol & Metab, 9500 Gilman Dr,BSB 1080, La Jolla, CA 92093 USA.	jwitztum@ucsd.edu	Funk, Colin D/A-9518-2010	Funk, Colin/0000-0001-7029-4233	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053558, P50HL056989] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL53558, HL56989, HL07276] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGARD DA, 1989, METHOD CELL BIOL, V30, P353; BENZ DJ, 1995, J BIOL CHEM, V270, P5191, DOI 10.1074/jbc.270.10.5191; Bocan TMA, 1998, ATHEROSCLEROSIS, V136, P203, DOI 10.1016/S0021-9150(97)00204-9; Brinckmann R, 1998, BLOOD, V91, P64, DOI 10.1182/blood.V91.1.64.64_64_74; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; CHUN JS, 1992, MOL BIOL CELL, V3, P481, DOI 10.1091/mbc.3.5.481; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; DeFife KM, 1999, FASEB J, V13, P823, DOI 10.1096/fasebj.13.8.823; FOLCIK VA, 1995, J CLIN INVEST, V96, P504, DOI 10.1172/JCI118062; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; HOWARD TH, 1984, J CELL BIOL, V98, P1265, DOI 10.1083/jcb.98.4.1265; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Kang LT, 1999, BBA-MOL CELL BIOL L, V1438, P388, DOI 10.1016/S0167-4838(99)00100-4; Kockx MM, 2000, CARDIOVASC RES, V45, P736, DOI 10.1016/S0008-6363(99)00235-7; KUHN H, 1994, J EXP MED, V179, P1903, DOI 10.1084/jem.179.6.1903; KUHN H, 1990, J BIOL CHEM, V265, P1454; Kuhn H, 1999, LIPIDS, V34, pS273, DOI 10.1007/BF02562317; Kwiatkowska K, 1999, BIOESSAYS, V21, P422, DOI 10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; NADEL JA, 1991, J CLIN INVEST, V87, P1139, DOI 10.1172/JCI115110; NASSAR GM, 1994, J BIOL CHEM, V269, P27631; POOT M, 1991, CYTOMETRY, V12, P184, DOI 10.1002/cyto.990120214; RANKIN SM, 1991, J LIPID RES, V32, P449; Rice RL, 1998, INT J CANCER, V77, P271, DOI 10.1002/(SICI)1097-0215(19980717)77:2<271::AID-IJC17>3.0.CO;2-E; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Scheidegger KJ, 1997, J BIOL CHEM, V272, P21609, DOI 10.1074/jbc.272.34.21609; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Sendobry SM, 1998, J IMMUNOL, V161, P1477; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Tang DG, 1997, ADV EXP MED BIOL, V400, P349; Tang KQ, 2000, BIOCHEMISTRY-US, V39, P3185, DOI 10.1021/bi992664v; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; WELCH WJ, 1985, MOL CELL BIOL, V5, P1571, DOI 10.1128/MCB.5.7.1571; YLAHERTTUALA S, 1991, J CLIN INVEST, V87, P1146, DOI 10.1172/JCI115111; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959	42	61	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19431	19439		10.1074/jbc.M011276200	http://dx.doi.org/10.1074/jbc.M011276200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278875	hybrid			2022-12-27	WOS:000169091000105
J	Datta, HJ; Chan, PP; Vasquez, KM; Gupta, RC; Glazer, PM				Datta, HJ; Chan, PP; Vasquez, KM; Gupta, RC; Glazer, PM			Triplex-induced recombination in human cell-free extracts - Dependence on XPA and HsRad51	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; INTRACHROMOSOMAL HOMOLOGOUS RECOMBINATION; HELIX-FORMING OLIGONUCLEOTIDES; MAMMALIAN-CELLS; EXTRACHROMOSOMAL RECOMBINATION; SACCHAROMYCES-CEREVISIAE; EXCISION-REPAIR; GENE CONVERSION; HIGH-FREQUENCY; MOUSE CELLS	Triple helix-forming oligonucleotides (TFOs) can bind to polypurine/polypyrimidine regions in DNA in a sequence-specific manner. Triple helix formation has been shown to stimulate recombination in mammalian cells in both episomal and chromosomal targets containing direct repeat sequences. Bifunctional oligonucleotides consisting of a recombination donor domain tethered to a TFO domain were found to mediate site-specific recombination in an intracellular SV40 vector target. To elucidate the mechanism of tripler-induced recombination, we have examined the ability of intermolecular triplexes to provoke recombination within plasmid substrates in human cell-free extracts. An assay for reversion of a point mutation in the supFG1 gene in the plasmid pSupFG1/G144C was established in which recombination in the extracts was detected upon transformation into indicator bacteria. A bifunctional oligonucleotide containing a 30-nucleotide TFO domain linked to a 40-nucleotide donor domain was found to mediate gene correction in vitro at a frequency of 46 x 10(-5), at least 20-fold above background and over 4-fold greater than the donor segment alone. Physical linkage of the TFO to the donor was unnecessary, as co-mixture of separate TFO and donor segments also yielded elevated gene correction frequencies. When the recombination and repair proteins HsRad51 and XPA were depleted from the extracts using specific antibodies, the tripler-induced recombination was diminished, but was either partially or completely restored upon supplementation with the purified HsRad51 or XPA proteins, respectively. These results establish that tripler-induced, intermolecular recombination between plasmid targets and short fragments of homologous DNA can be detected in human cell extracts and that this process is dependent on both XPA and HsRadB1.	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Glazer, PM (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.		Glazer, Peter/S-7651-2019	Glazer, Peter/0000-0003-4525-5560	NATIONAL CANCER INSTITUTE [R01CA064186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054731, R37GM033504] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA64186] Funding Source: Medline; NIGMS NIH HHS [R37GM33504, R01GM54731] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Belousov ES, 1998, NUCLEIC ACIDS RES, V26, P1324, DOI 10.1093/nar/26.5.1324; Brenneman M, 1996, P NATL ACAD SCI USA, V93, P3608, DOI 10.1073/pnas.93.8.3608; Broitman S, 1999, J BIOL CHEM, V274, P21763, DOI 10.1074/jbc.274.31.21763; CAMPBELL C R, 1989, New Biologist, V1, P223; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chan PP, 1999, J BIOL CHEM, V274, P11541, DOI 10.1074/jbc.274.17.11541; Chan PP, 1997, J MOL MED, V75, P267, DOI 10.1007/s001090050112; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; Faria M, 2000, P NATL ACAD SCI USA, V97, P3862, DOI 10.1073/pnas.97.8.3862; Faruqi AF, 2000, MOL CELL BIOL, V20, P990, DOI 10.1128/MCB.20.3.990-1000.2000; Faruqi AF, 1996, MOL CELL BIOL, V16, P6820; Gamper HB, 1998, J AM CHEM SOC, V120, P2182, DOI 10.1021/ja971397i; Giovannangeli C, 1997, P NATL ACAD SCI USA, V94, P79, DOI 10.1073/pnas.94.1.79; GLAZER PM, 1987, MOL CELL BIOL, V7, P218, DOI 10.1128/MCB.7.1.218; Goncz KK, 2000, METH MOL B, V133, P85; Gunther EJ, 1996, PHOTOCHEM PHOTOBIOL, V63, P207, DOI 10.1111/j.1751-1097.1996.tb03015.x; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; HANSON KD, 1995, MOL CELL BIOL, V15, P45, DOI 10.1128/MCB.15.1.45; JONES CJ, 1993, BIOCHEMISTRY-US, V32, P12096, DOI 10.1021/bi00096a021; KUCHERLAPATI RS, 1984, COLD SPRING HARB SYM, V49, P191, DOI 10.1101/SQB.1984.049.01.022; LIN FLM, 1987, MOL CELL BIOL, V7, P129, DOI 10.1128/MCB.7.1.129; Luo ZJ, 2000, P NATL ACAD SCI USA, V97, P9003, DOI 10.1073/pnas.160004997; Majumdar A, 1998, NAT GENET, V20, P212, DOI 10.1038/2530; Oh DH, 1999, NUCLEIC ACIDS RES, V27, P4734, DOI 10.1093/nar/27.24.4734; Praseuth D, 1999, BBA-GENE STRUCT EXPR, V1489, P181, DOI 10.1016/S0167-4781(99)00149-9; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SEGAL DJ, 1995, P NATL ACAD SCI USA, V92, P806, DOI 10.1073/pnas.92.3.806; STROBEL SA, 1991, SCIENCE, V254, P1639, DOI 10.1126/science.1836279; Sung P, 2000, MUTAT RES-FUND MOL M, V451, P257, DOI 10.1016/S0027-5107(00)00054-3; Taghian DG, 1997, MOL CELL BIOL, V17, P6386, DOI 10.1128/MCB.17.11.6386; Thacker J, 1999, TRENDS GENET, V15, P166, DOI 10.1016/S0168-9525(99)01733-3; Vasquez KM, 1998, TRENDS BIOCHEM SCI, V23, P4, DOI 10.1016/S0968-0004(97)01158-4; WANG G, 1995, MOL CELL BIOL, V15, P1759; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; Yanez RJ, 1999, GENE THER, V6, P1282, DOI 10.1038/sj.gt.3300945	40	86	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18018	18023		10.1074/jbc.M011646200	http://dx.doi.org/10.1074/jbc.M011646200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278954	hybrid			2022-12-27	WOS:000168866500054
J	Liu, CH; Chang, SH; Narko, K; Trifan, OC; Wu, MT; Smith, E; Haudenschild, C; Lane, TF; Hla, T				Liu, CH; Chang, SH; Narko, K; Trifan, OC; Wu, MT; Smith, E; Haudenschild, C; Lane, TF; Hla, T			Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MAMMARY EPITHELIAL-CELLS; GENE-EXPRESSION; BREAST-CANCER; PROSTAGLANDIN SYNTHESIS; CARCINOGENESIS; TRANSFORMATION; INHIBITION; APOPTOSIS; GLANDS	The cyclooxygenase (COX)-2 gene encodes an inducible prostaglandin synthase enzyme that is overexpressed in adenocarcinomas and other tumors, Deletion of the murine Cox-2 gene in Min mice reduced the incidence of intestinal tumors, suggesting that it is required for tumorigenesis, However, it is not known if overexpression of Cox-2 is sufficient to induce tumorigenic transformation. We have derived transgenic mice that overexpress the human COX-2 gene in the mammary glands using the murine mammary tumor virus promoter. The human Cox-2 mRNA and protein are expressed in mammary glands of female transgenic mice and were strongly induced during pregnancy and lactation. Female virgin Cox-2 transgenic mice showed precocious lobuloalveolar differentiation and enhanced expression of the beta -casein gene, which was inhibited by the Cox inhibitor indomethacin, Mammary gland involution was delayed in Cox-2 transgenic mice with a decrease in apoptotic index of mammary epithelial cells. Multiparous but not virgin females exhibited a greatly exaggerated incidence of focal mammary gland hyperplasia, dysplasia, and transformation into metastatic tumors. Cox-2-induced tumor tissue expressed reduced levels of the proapoptotic proteins Bax and Bcl-X-L and an increase in the anti-apoptotic protein Bcl-2, suggesting that decreased apoptosis of mammary epithelial cells contributes to tumorigenesis, These data indicate that enhanced Cox-2 expression is sufficient to induce mammary gland tumorigenesis, Therefore, inhibition of Cox-2 may represent a mechanism-based chemopreventive approach for carcinogenesis.	Univ Connecticut, Ctr Hlth, Dept Physiol, Ctr Vasc Biol, Farmington, CT 06030 USA; Amer Red Cross, Jerome H Holland Lab, Dept Expt Pathol, Rockville, MD 20855 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	University of Connecticut; American Red Cross; University of California System; University of California Los Angeles	Hla, T (corresponding author), Univ Connecticut, Ctr Hlth, Dept Physiol, Ctr Vasc Biol, MC-3501,263 Farmington Ave, Farmington, CT 06030 USA.		Hla, Timothy/G-5873-2012; Christian, Haudenschild C/D-1602-2009	Hla, Timothy/0000-0001-8355-4065; Lane, Timothy F./0000-0002-0210-970X				APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Badawi AF, 1998, PROSTAG OTH LIPID M, V56, P167, DOI 10.1016/S0090-6980(98)00049-5; Badawi AF, 1998, CARCINOGENESIS, V19, P905, DOI 10.1093/carcin/19.5.905; Boolbol SK, 1996, CANCER RES, V56, P2556; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Cardiff RD, 1996, J MAMMARY GLAND BIOL, V1, P61, DOI 10.1007/BF02096303; Chulada PC, 2000, CANCER RES, V60, P4705; Furth PA, 1999, J MAMMARY GLAND BIOL, V4, P123, DOI 10.1023/A:1018764922082; Harris RE, 2000, CANCER RES, V60, P2101; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hla T, 1999, INT J BIOCHEM CELL B, V31, P551, DOI 10.1016/S1357-2725(98)00152-6; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; Howe LR, 1999, CANCER RES, V59, P1572; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Iizuka T, 2000, ADV EXP MED BIOL, V478, P369; IMAGAWA W, 1998, J CELL PHYSL, V135, P509; Jang BC, 2000, J BIOL CHEM, V275, P39507, DOI 10.1074/jbc.M003224200; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Langenbach R, 1999, ANN NY ACAD SCI, V889, P52, DOI 10.1111/j.1749-6632.1999.tb08723.x; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Nakatsugi S, 2000, JPN J CANCER RES, V91, P886, DOI 10.1111/j.1349-7006.2000.tb01030.x; Narko K, 1997, J BIOL CHEM, V272, P21455, DOI 10.1074/jbc.272.34.21455; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Piazza GA, 1997, CANCER RES, V57, P2452; Prescott SM, 2000, BBA-REV CANCER, V1470, pM69, DOI 10.1016/S0304-419X(00)00006-8; REDDY BS, 1992, CARCINOGENESIS, V13, P1019, DOI 10.1093/carcin/13.6.1019; SANO H, 1995, CANCER RES, V55, P3785; Shockett PE, 1996, P NATL ACAD SCI USA, V93, P5173, DOI 10.1073/pnas.93.11.5173; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; SYMPSON CJ, 1994, J CELL BIOL, V125, P681, DOI 10.1083/jcb.125.3.681; Taketo MM, 1998, JNCI-J NATL CANCER I, V90, P1609, DOI 10.1093/jnci/90.21.1609; Taketo MM, 1998, J NATL CANCER I, V90, P1529, DOI 10.1093/jnci/90.20.1529; Thun MJ, 1996, GASTROENTEROL CLIN N, V25, P333, DOI 10.1016/S0889-8553(05)70250-8; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Vadlamudi R, 1999, ONCOGENE, V18, P305, DOI 10.1038/sj.onc.1202307; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang XP, 1999, J EXP MED, V190, P451, DOI 10.1084/jem.190.4.451; Zhao Y, 1996, ENDOCRINOLOGY, V137, P5739, DOI 10.1210/en.137.12.5739	45	681	719	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18563	18569		10.1074/jbc.M010787200	http://dx.doi.org/10.1074/jbc.M010787200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278747	hybrid			2022-12-27	WOS:000168866500126
J	Mikosz, CA; Brickley, DR; Sharkey, MS; Moran, TW; Conzen, SD				Mikosz, CA; Brickley, DR; Sharkey, MS; Moran, TW; Conzen, SD			Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; INDUCIBLE KINASE; RESPONSE ELEMENT; SERUM; EXPRESSION; FAMILY; CELLS	We previously demonstrated that activation of the glucocorticoid receptor (GR) initiates an antiapoptotic signal in the immortalized human mammary epithelial cell line MCF10A that is dependent on the GR's transcriptional activity. In this study, we show that the survival role of GR activation extends to protecting human breast cancer cells undergoing apoptosis after growth factor deprivation, Serum and glucocorticoid-regulated kinase-1 (sgk), a gene previously identified as a direct transcriptional target of the activated GR in a rat mammary tumor cell line, was rapidly induced after GR activation in human mammary epithelial cells. Furthermore, in the absence of all growth factors, ectopic sgk expression inhibited apoptosis, suggesting that SGK is a survival kinase, Finally, kinase-dead SGK expression inhibited the protection from apoptosis usually seen after GR activation. These findings suggest that SGK is an important downstream target of GR-mediated survival signaling and that it is distinct from other survival kinases because it can be primarily regulated at the level of transcription.	Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Conzen, SD (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	sconzen@medicine.bsd.uchicago.edu			NATIONAL CANCER INSTITUTE [R21CA066132] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA66132] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alliston TN, 1997, MOL ENDOCRINOL, V11, P1934, DOI 10.1210/me.11.13.1934; Bell LM, 2000, J BIOL CHEM, V275, P25262, DOI 10.1074/jbc.M002076200; CAIRNS C, 1993, DNA CELL BIOL, V12, P695, DOI 10.1089/dna.1993.12.695; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Evans-Storms RB, 2000, ENDOCRINOLOGY, V141, P1854, DOI 10.1210/en.141.5.1854; HORWITZ KB, 1978, CANCER RES, V38, P2434; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; LAMONTAGNE N, 1984, ENDOCRINOLOGY, V114, P2252, DOI 10.1210/endo-114-6-2252; Moran TJ, 2000, CANCER RES, V60, P867; Naray-Fejes-Toth A, 1999, J BIOL CHEM, V274, P16973, DOI 10.1074/jbc.274.24.16973; NORDEEN SK, 1989, MOL ENDOCRINOL, V3, P1270, DOI 10.1210/mend-3-8-1270; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; RICHARDFOY H, 1987, MOL ENDOCRINOL, V1, P659, DOI 10.1210/mend-1-9-659; SCHWARTZMAN RA, 1994, INT ARCH ALLERGY IMM, V105, P347, DOI 10.1159/000236781; Shigaev A, 2000, AM J PHYSIOL-RENAL, V278, pF613, DOI 10.1152/ajprenal.2000.278.4.F613; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WU KC, 1988, MOL ENDOCRINOL, V2, P1294, DOI 10.1210/mend-2-12-1294; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	21	211	225	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16649	16654		10.1074/jbc.M010842200	http://dx.doi.org/10.1074/jbc.M010842200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278764	hybrid			2022-12-27	WOS:000168730400009
J	Thisted, T; Lyakhov, DL; Liebhaber, SA				Thisted, T; Lyakhov, DL; Liebhaber, SA			Optimized RNA targets of two closely related triple KH domain proteins, heterogeneous nuclear ribonucleoprotein K and alpha CP-2KL, suggest distinct modes of RNA recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' UNTRANSLATED REGION; FRAGILE-X-SYNDROME; MESSENGER-RNA; BINDING-PROTEIN; IN-VITRO; POLY(RC) BINDING-PROTEIN-2; 3'-UNTRANSLATED REGION; 5'-UNTRANSLATED REGION; STABILITY COMPLEX; GENE-EXPRESSION	The KH domain mediates RNA binding in a wide range of proteins. Here we investigate the RNA-binding properties of two abundant RNA-binding proteins, alpha CP-2KL and heterogeneous nuclear ribonucleoprotein (hnRNP) K, These proteins constitute the major poly(C) binding activity in mammalian cells, are closely related on the basis of the structures and positioning of their respective triplicated KH domains, and have been implicated in a variety of post-transcriptional controls. By using SELEX, we have obtained sets of high affinity RNA targets for both proteins. The primary and secondary structures necessary for optimal protein binding were inferred in each case from SELEX RNA sequence comparisons and confirmed by mutagenesis and structural mapping. The target sites for alpha CP-2KL and hnRNP K were both enriched for cytosine bases and were presented in a single-stranded conformation. In contrast to these shared characteristics, the optimal target sequence for hnRNP K is composed of a single short "C-patch" compatible with recognition by a single KH domain whereas that for alpha CP-2KL encompassed three such C-patches suggesting more extensive interactions. The binding specificities of the respective SELEX RNAs were confirmed by testing their interactions with native proteins in cell extracts, and the importance of the secondary structure in establishing an optimized alpha CP-2KL-binding site was supported by comparison of SELEX target structure with that of the native human alpha -globin 3'-untranslated region. These data indicate that modes of macromolecular interactions of arrayed KH domains can differ even among closely related KH proteins and that binding affinities are substantially dependent on the presentation of the target site within the RNA secondary structure.	Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Liebhaber, SA (corresponding author), Univ Penn, Howard Hughes Med Inst, Rm 428,Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.				NCI NIH HHS [CA72765] Funding Source: Medline; NHLBI NIH HHS [HL38632] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA072765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL038632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baber JL, 1999, J MOL BIOL, V289, P949, DOI 10.1006/jmbi.1999.2818; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; Berglund JA, 1998, RNA, V4, P998, DOI 10.1017/S1355838298980499; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chkheidze AN, 1999, MOL CELL BIOL, V19, P4572; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; CzyzykKrzeska MF, 1996, J BIOL CHEM, V271, P3293, DOI 10.1074/jbc.271.6.3293; DRAPER DE, 1995, ANNU REV BIOCHEM, V64, P593, DOI 10.1146/annurev.bi.64.070195.003113; Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293; Gamarnik AV, 1997, RNA, V3, P882; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; Graff J, 1998, J VIROL, V72, P9668, DOI 10.1128/JVI.72.12.9668-9675.1998; Hazelrigg T, 1998, CELL, V95, P451, DOI 10.1016/S0092-8674(00)81613-X; Holcik M, 1997, P NATL ACAD SCI USA, V94, P2410, DOI 10.1073/pnas.94.6.2410; Hughson FM, 1999, NAT STRUCT BIOL, V6, P499, DOI 10.1038/9264; Kanamori H, 1998, MOL CELL BIOL, V18, P3991, DOI 10.1128/MCB.18.7.3991; KILEDJIAN M, 1995, EMBO J, V14, P4357, DOI 10.1002/j.1460-2075.1995.tb00110.x; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Makeyev AV, 1999, J BIOL CHEM, V274, P24849, DOI 10.1074/jbc.274.35.24849; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MCCARTHY JEG, 1995, TRENDS BIOCHEM SCI, V20, P191, DOI 10.1016/S0968-0004(00)89006-4; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; OSTARECKLEDERER A, 1994, EMBO J, V13, P1476, DOI 10.1002/j.1460-2075.1994.tb06402.x; Paillard L, 2000, MECH DEVELOP, V93, P117, DOI 10.1016/S0925-4773(00)00279-3; Silvera D, 1999, J BIOL CHEM, V274, P38163, DOI 10.1074/jbc.274.53.38163; Siomi H, 1997, CURR OPIN GENET DEV, V7, P345, DOI 10.1016/S0959-437X(97)80148-7; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Spangberg K, 1999, J GEN VIROL, V80, P1371, DOI 10.1099/0022-1317-80-6-1371; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; THISTED T, 1994, EMBO J, V13, P1960, DOI 10.1002/j.1460-2075.1994.tb06465.x; TUERK C, 1992, P NATL ACAD SCI USA, V89, P6988, DOI 10.1073/pnas.89.15.6988; TUREK C, 1990, SCIENCE, V249, P505; Walter BL, 1999, RNA, V5, P1570, DOI 10.1017/S1355838299991483; WANG XM, 1995, MOL CELL BIOL, V15, P1769; WEISS IM, 1995, MOL CELL BIOL, V15, P2457; WITTEKIND M, 1992, BIOCHEMISTRY-US, V31, P6254, DOI 10.1021/bi00142a013; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Zamore PD, 1997, RNA, V3, P1421; ZAPP ML, 1989, NATURE, V342, P714, DOI 10.1038/342714a0; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; ZUCKER M, 1999, NATO ASI SER, P11	50	110	122	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17484	17496		10.1074/jbc.M010594200	http://dx.doi.org/10.1074/jbc.M010594200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278705	hybrid			2022-12-27	WOS:000168730400120
J	Gupta, S; Stravitz, RT; Dent, P; Hylemon, PB				Gupta, S; Stravitz, RT; Dent, P; Hylemon, PB			Down-regulation of cholesterol 7 alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LEVELS; ACTIVATED PROTEIN-KINASE; NUCLEAR RECEPTOR; PRIMARY CULTURES; TRANSCRIPTIONAL ACTIVITY; SIGNAL-TRANSDUCTION; FEEDBACK-REGULATION; DNA-SYNTHESIS; X-RECEPTOR; BIOSYNTHESIS	Cholesterol 7 alpha -hydroxylase (CYP7A1), the rate-limiting enzyme in the neutral pathway of bile acid biosynthesis, is feedback-inhibited at the transcriptional level by hydrophobic bile acids. Recent studies show that bile acids are physiological ligands for farnesoid X receptor (FXR). Activated FXR indirectly represses CYP7A1 transcription through induction of small heterodimer protein (SHP-1). In this study, we provide evidence that bile acids rapidly down-regulate CYP7A1 transcription via activation of the JNK/c-Jun pathway. Furthermore, we demonstrate that SHP-1 is also a direct target of activated c-Jun. In primary rat hepatocyte cultures, taurocholate (TCA) strongly activated JNK in a time- and concentration-dependent manner. Tumor necrosis factor-alpha, a potent activator of JNK, also rapidly activated JNK and down-regulated CYP7A1 mRNA levels. Overexpression of dominant-negative JNK1 or a transactivating domain mutant of c-Jun significantly blocked the ability of TCA to down-regulate CYP7A1 mRNA, In contrast, overexpression of wild-type c-Jun (c-Jun(wt)) enhanced the repression of CYP7A1 by TCA. Moreover, overexpression of c-Jun(wt) resulted in increased SHP-1 promoter activity. Mutation of a putative AP-1 (c-Jun) element suppressed c-dun-mediated activation of the SHP-1 promoter construct. These results indicate that the bile acid-activated JNK pathway plays a pivotal role in regulating CYP7A1 levels in primary rat hepatocytes.	Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Med Gastroenterol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Hylemon, PB (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Med Coll Virginia Campus,POB 980678, Richmond, VA 23298 USA.				NIDDK NIH HHS [P01-DK38030, R01-DK52825] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052825, P01DK038030] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Auer KL, 1998, MOL BIOL CELL, V9, P561, DOI 10.1091/mbc.9.3.561; Bissell D M, 1980, Ann N Y Acad Sci, V349, P85, DOI 10.1111/j.1749-6632.1980.tb29518.x; Brady LM, 1996, BIOCHEM J, V316, P765, DOI 10.1042/bj3160765; BROWN PH, 1993, ONCOGENE, V8, P877; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Chiang JYL, 2000, J BIOL CHEM, V275, P10918, DOI 10.1074/jbc.275.15.10918; CRISTIANO RJ, 1993, P NATL ACAD SCI USA, V90, P11548, DOI 10.1073/pnas.90.24.11548; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; del Castillo-Olivares A, 2000, NUCLEIC ACIDS RES, V28, P3587; Feingold KR, 1996, J LIPID RES, V37, P223; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Ghosh S, 1998, AM J PHYSIOL-GASTR L, V274, pG662, DOI 10.1152/ajpgi.1998.274.4.G662; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gupta S, 2000, HEPATOLOGY, V32, P341, DOI 10.1053/jhep.2000.9605; HORTON JD, 1995, J BIOL CHEM, V270, P5381, DOI 10.1074/jbc.270.10.5381; HYLEMON PB, 1992, J BIOL CHEM, V267, P16866; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; Kumar A, 1997, J LIPID RES, V38, P2240; Lee HY, 2000, J BIOL CHEM, V275, P32193, DOI 10.1074/jbc.M005490200; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Miyake JH, 2000, J BIOL CHEM, V275, P21805, DOI 10.1074/jbc.C000275200; PANDAK WM, 1994, HEPATOLOGY, V19, P941, DOI 10.1016/0270-9139(94)90295-X; Park JS, 2000, J BIOL CHEM, V275, P18, DOI 10.1074/jbc.275.1.18; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Qiao DH, 2000, J BIOL CHEM, V275, P15090, DOI 10.1074/jbc.M908890199; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; STRAVITZ RT, 1995, J LIPID RES, V36, P1359; STRAVITZ RT, 1993, J BIOL CHEM, V268, P13987; Stravitz RT, 1999, FALK SYMP, V108, P39; STRAVITZ RT, 1996, AM J PHYSIOL, V271, P293; TWISK J, 1993, BIOCHEM J, V290, P685, DOI 10.1042/bj2900685; Vlahcevic ZR, 2000, GASTROENTEROLOGY, V118, P599, DOI 10.1016/S0016-5085(00)70267-8; Vlahcevic ZR, 1999, GASTROENTEROL CLIN N, V28, P1, DOI 10.1016/S0889-8553(05)70041-8; Vlahcevic ZR, 1996, AM J PHYSIOL-GASTR L, V270, pG646, DOI 10.1152/ajpgi.1996.270.4.G646; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Zhang F, 1998, J BIOL CHEM, V273, P2424, DOI 10.1074/jbc.273.4.2424	40	258	265	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15816	15822		10.1074/jbc.M010878200	http://dx.doi.org/10.1074/jbc.M010878200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278771	hybrid			2022-12-27	WOS:000168623100034
J	Ranatunga, W; Jackson, D; Lloyd, JA; Forget, AL; Knight, KL; Borgstahl, GEO				Ranatunga, W; Jackson, D; Lloyd, JA; Forget, AL; Knight, KL; Borgstahl, GEO			Human RAD52 exhibits two modes of self-association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; COMPLEX-FORMATION; BINDING-PROTEIN; RECOMBINATION; YEAST; REPAIR; RPA; RING	The human RAD52 protein plays an important role in the earliest stages of chromosomal double-strand break repair via the homologous recombination pathway. Individual subunits of RAD52 self-associate into rings that can then form higher order complexes. RAD52 binds to double-strand DNA ends, and recent studies suggest that the higher order self-association of the rings promotes DNA end-joining. Earlier studies defined the self-association domain of RAD52 to a unique region in the N-terminal half of the protein. Here we show that there are in fact two experimentally separable self-association domains in RAD52. The N-terminal self-association domain mediates the assembly of monomers into rings, and the previously unidentified domain in the C-terminal half of the protein mediates higher order self-association of the rings.	Univ Toledo, Dept Chem, Toledo, OH 43606 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University System of Ohio; University of Toledo; University of Massachusetts System; University of Massachusetts Worcester	Borgstahl, GEO (corresponding author), Univ Toledo, Dept Chem, 2801 W Bancroft St, Toledo, OH 43606 USA.		Borgstahl, Gloria/AAZ-4114-2020		NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001777] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR01777] Funding Source: Medline; NIGMS NIH HHS [GM44772] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumann P, 1999, J MOL BIOL, V291, P363, DOI 10.1006/jmbi.1999.2954; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; JOHNSON RD, 1995, MOL CELL BIOL, V15, P4843; Kito K, 1999, BBA-GENE STRUCT EXPR, V1489, P303, DOI 10.1016/S0167-4781(99)00214-6; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Petes T. D., 1991, MOL CELLULAR BIOL YE, P407; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; Shen ZY, 1996, MUTAT RES-DNA REPAIR, V364, P81, DOI 10.1016/0921-8777(96)00025-0; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Van Dyck E, 1998, J MOL BIOL, V284, P1027, DOI 10.1006/jmbi.1998.2203; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; Wall JS, 1998, METHOD CELL BIOL, V53, P139; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61	24	55	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15876	15880		10.1074/jbc.M011747200	http://dx.doi.org/10.1074/jbc.M011747200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278978	hybrid, Green Published			2022-12-27	WOS:000168623100042
J	Angata, K; Yen, TY; El-Battari, A; Macher, BA; Fukuda, M				Angata, K; Yen, TY; El-Battari, A; Macher, BA; Fukuda, M			Unique disulfide bond structures found in ST8Sia IV polysialyltransferase are required for its activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; DEVELOPMENTALLY-REGULATED MEMBER; POLYSIALIC ACID; SYNAPTIC PLASTICITY; CYSTEINE RESIDUES; 2 POLYSIALYLTRANSFERASES; EXPRESSION CLONING; CATALYTIC DOMAIN; OLFACTORY-BULB; NERVOUS-SYSTEM	NCAM polysialylation plays a critical role in neuronal development and regeneration, Polysialylation of the neural cell adhesion molecule (NCAM) is catalyzed by two polysialyltransferases, ST8Sia II (STX) and ST8Sia IV (PST), which contain sialylmotifs L and S conserved in all members of the sialyltransferases. The members of the ST8Sia gene family, including ST8Sia II and ST8Sia IV are unique in having three cysteines in sialylmotif L, one cysteine in sialylmotif S, and one cysteine at the COOH terminus. However, structural information, including how disulfide bonds are formed, has not been determined for any of the sialyltransferases, To obtain insight into the structure/function of ST8Sia IV, we expressed human ST8Sia IV in insect cells, Trichoplusia ni, and found that the enzyme produced in the insect cells catalyzes NCAM polysialylation, although it cannot polysialylate itself ("autopolysialylation"). We also found that ST8Sia IV does not form a dimer through disulfide bonds. By using the same enzyme preparation and performing mass spectrometric analysis, we found that the first cysteine in sialylmotif L and the cysteine in sialylmotif S form a disulfide bridge, whereas the second cysteine in sialylmotif L and the cysteine at the COOH terminus form a second disulfide bridge, Site-directed mutagenesis demonstrated that mutation at cysteine residues involved in the disulfide bridges completely inactivated the enzyme, Moreover, changes in the position of the COOH-terminal cysteine abolished its activity. By contrast, the addition of green fluorescence protein at the COOH terminus of ST8Sia IV did not render the enzyme inactive. These results combined indicate that the sterical structure formed by intramolecular disulfide bonds, which bring the sialylmotifs and the COOH terminus within close proximity, is critical for the catalytic activity of ST8Sia IV.	Burnham Inst, Canc Res Ctr, Glycobiol Program, La Jolla, CA 92037 USA; San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA; Fac Med Marseille, INSERM, U260, F-13385 Marseille 5, France	Sanford Burnham Prebys Medical Discovery Institute; California State University System; San Francisco State University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Fukuda, M (corresponding author), Burnham Inst, Canc Res Ctr, Glycobiol Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	minoru@burnham.org	Angata, Kiyohiko/M-2749-2018	Angata, Kiyohiko/0000-0001-5561-1368	NCI NIH HHS [R01 CA33895] Funding Source: Medline; NCRR NIH HHS [P20 RR11805] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA033895] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR011805] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; Chen C, 2000, J BIOL CHEM, V275, P13819, DOI 10.1074/jbc.275.18.13819; CHUNG WW, 1991, J COMP NEUROL, V314, P290, DOI 10.1002/cne.903140207; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 1998, J BIOL CHEM, V273, P9608, DOI 10.1074/jbc.273.16.9608; DRICKAMER K, 1993, GLYCOBIOLOGY, V3, P2, DOI 10.1093/glycob/3.1.2; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; EDELMAN GM, 1984, ANNU REV NEUROSCI, V7, P339; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; FINNE J, 1982, J BIOL CHEM, V257, P1966; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; GILLESPIE W, 1992, J BIOL CHEM, V267, P21004; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Holmes EH, 2000, J BIOL CHEM, V275, P24237, DOI 10.1074/jbc.M000888200; Hsu TA, 1997, J BIOL CHEM, V272, P9062; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Kiss JZ, 1997, CURR OPIN NEUROBIOL, V7, P640, DOI 10.1016/S0959-4388(97)80083-9; KOJIMA N, 1995, FEBS LETT, V360, P1, DOI 10.1016/0014-5793(95)00059-I; Kono M, 1996, J BIOL CHEM, V271, P29366, DOI 10.1074/jbc.271.46.29366; Korczak B, 2000, GLYCOBIOLOGY, V10, P595, DOI 10.1093/glycob/10.6.595; Li JH, 2000, J BIOL CHEM, V275, P41476, DOI 10.1074/jbc.M007480200; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Nakayama J, 1996, J BIOL CHEM, V271, P3684; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1996, J BIOL CHEM, V271, P1829, DOI 10.1074/jbc.271.4.1829; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; Ouzzine M, 2000, J BIOL CHEM, V275, P28254; ROBBINS JB, 1974, NEW ENGL J MED, V290, P1216, DOI 10.1056/NEJM197405302902202; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; SCHACHNER M, 1995, TRENDS NEUROSCI, V18, P183, DOI 10.1016/0166-2236(95)93899-9; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; Sevigny MB, 1998, GLYCOBIOLOGY, V8, P857, DOI 10.1093/glycob/8.9.857; SIMMONS DL, 1993, CELLULAR INTERACTION, P93; Tanaka F, 2000, CANCER RES, V60, P3072; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; Windfuhr M, 2000, J BIOL CHEM, V275, P32861, DOI 10.1074/jbc.M003507200; Xu XH, 1996, J BIOL CHEM, V271, P8818, DOI 10.1074/jbc.271.15.8818; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Yen TY, 2000, J MASS SPECTROM, V35, P990, DOI 10.1002/1096-9888(200008)35:8<990::AID-JMS27>3.0.CO;2-K; YOSHIDA Y, 1995, J BIOL CHEM, V270, P14628, DOI 10.1074/jbc.270.24.14628	58	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15369	15377		10.1074/jbc.M100576200	http://dx.doi.org/10.1074/jbc.M100576200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279095	hybrid			2022-12-27	WOS:000168528800112
J	Normand, N; van Leeuwen, H; O'Hare, P				Normand, N; van Leeuwen, H; O'Hare, P			Particle formation by a conserved domain of the herpes simplex virus protein VP22 facilitating protein and nucleic acid delivery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR DELIVERY; OLIGONUCLEOTIDE; TECHNOLOGY; EXPRESSION; KINASE; CELLS; UL49; RNA; TAT	VP22, a structural protein of herpes simplex virus, exhibits unusual trafficking properties which we proposed might be exploited in gene and protein delivery applications. To pursue the use of the protein itself for cargo delivery into cells, we developed an expression system for the C-terminal half of VP22, residues 159-301 (VP22.C1), and purified the protein in high yields. Addition of short oligonucleotides (ODNs) induced the assembly of novel particles, which were regular spheres with a size range of 0.3 to 1.0 mum in diameter, incorporating both protein and ODN. Following the particles in living cells using fluorescently tagged ODNs, we show that they enter efficiently within 2-4 h, and reside stably in the cell cytoplasm for up to several days. Remarkably, however, light activation induced particle disruption and release of the protein and ODN to the nucleus and cytoplasm within seconds, a process that we have captured by time lapse microscopy. In addition to delivering antisense ODNs, ribozymes, and RNA/DNA hybrids, the VP22.C1 protein could also be modified to include peptides or proteins. These particles have the potential for delivery of a wide range of therapeutic agents in gene therapy and vaccine development.	Marie Curie Res Inst, Surrey RH8 0TL, England		O'Hare, P (corresponding author), Marie Curie Res Inst, Surrey RH8 0TL, England.		van Leeuwen, Hans/A-2371-2014					Alexeev V, 1998, NAT BIOTECHNOL, V16, P1343, DOI 10.1038/4322; Berg K, 1999, CANCER RES, V59, P1180; Dilber MS, 1999, GENE THER, V6, P12, DOI 10.1038/sj.gt.3300838; Dorange F, 2000, J GEN VIROL, V81, P2219, DOI 10.1099/0022-1317-81-9-2219; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Elliott G, 1999, J VIROL, V73, P4110, DOI 10.1128/JVI.73.5.4110-4119.1999; ELLIOTT GD, 1992, J GEN VIROL, V73, P723, DOI 10.1099/0022-1317-73-3-723; Gewirtz AM, 1996, P NATL ACAD SCI USA, V93, P3161, DOI 10.1073/pnas.93.8.3161; Harms JS, 2000, J VIROL, V74, P3301, DOI 10.1128/JVI.74.7.3301-3312.2000; HEINE JW, 1974, J VIROL, V14, P640, DOI 10.1128/JVI.14.3.640-651.1974; Hogset A, 2000, HUM GENE THER, V11, P869, DOI 10.1089/10430340050015482; Jarvis TC, 1996, RNA, V2, P419; Lau QC, 1998, ONCOGENE, V16, P1899, DOI 10.1038/sj.onc.1201709; Leslie J, 1996, VIROLOGY, V220, P60, DOI 10.1006/viro.1996.0286; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; Luft FC, 1998, J MOL MED-JMM, V76, P75, DOI 10.1007/s001090050193; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Monia BP, 1996, NAT MED, V2, P668, DOI 10.1038/nm0696-668; Phelan A, 1998, NAT BIOTECHNOL, V16, P440, DOI 10.1038/nbt0598-440; Prochiantz A, 2000, CURR OPIN CELL BIOL, V12, P400, DOI 10.1016/S0955-0674(00)00108-3; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1	21	58	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15042	15050		10.1074/jbc.M010294200	http://dx.doi.org/10.1074/jbc.M010294200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278656	hybrid			2022-12-27	WOS:000168528800070
J	Uma, S; Yun, BG; Matts, RL				Uma, S; Yun, BG; Matts, RL			The heme-regulated eukaryotic initiation factor 2 alpha kinase - A potential regulatory target for control of protein synthesis by diffusible cases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; FACTOR-2-ALPHA EIF-2-ALPHA KINASE; RABBIT RETICULOCYTE LYSATE; HEAT-SHOCK PROTEINS; INDUCED APOPTOSIS; K562 CELLS; TRANSLATION INITIATION-FACTOR-2; PHYSIOLOGICAL STRESSES; S-NITROSYLATION; CARBON-MONOXIDE	Nitric oxide (NO) has been reported to inhibit protein synthesis in eukaryotic cells by increasing the phosphorylation of the ru-subunit of eukaryotic initiation factor (eIF) 2, However, the mechanism through which this increase occurs has not been characterized. In this report, we examined the effect of the diffusible gases nitric oxide (NO) and carbon monoxide (CO) on the activation of the heme-regulated eIF2 alpha kinase (HRI) in rabbit reticulocyte Lysate. Spectral analysis indicated that both NO and CO bind to the N-terminal heme-binding domain of HRI. Although NO was a very potent activator of HRI, CO markedly suppressed NO-induced HRI activation. The NO-induced activation of HRI was transduced through the interaction of NO with the N-terminal heme-binding domain of HRI and not through S-nitrosylation of HRI, We postulate that the regulation of HRI activity by diffusible gases may be of wider physiological significance, as we further demonstrate that NO generators increase eIF2 alpha phosphorylation levels in NT2 neuroepithelial and C2C12 myoblast cells and activate HRI immunoadsorbed from extracts of these non-erythroid cell lines.	Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Matts, RL (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, 246 NRC, Stillwater, OK 74078 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004299, R29ES004299] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES-04299] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Benton PA, 1996, J VIROL, V70, P5525, DOI 10.1128/JVI.70.8.5525-5532.1996; Berlanga JJ, 1998, J BIOL CHEM, V273, P32340, DOI 10.1074/jbc.273.48.32340; BILLIAR TR, 1995, ANN SURG, V221, P339, DOI 10.1097/00000658-199504000-00003; Broillet MC, 1999, CELL MOL LIFE SCI, V55, P1036, DOI 10.1007/s000180050354; Chefalo PJ, 1998, EUR J BIOCHEM, V258, P820, DOI 10.1046/j.1432-1327.1998.2580820.x; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; CHEN JJ, 1989, J BIOL CHEM, V264, P9559; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; CHEN JJ, 1993, TRANSLATIONAL REGULA, V2, P349; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; CROSBY JS, 1994, MOL CELL BIOL, V14, P3906, DOI 10.1128/MCB.14.6.3906; DeGracia DJ, 1997, J CEREBR BLOOD F MET, V17, P1291, DOI 10.1097/00004647-199712000-00004; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; Domachowske JB, 1996, BLOOD, V88, P2980; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Ducrocq C, 1999, CELL MOL LIFE SCI, V55, P1068, DOI 10.1007/s000180050357; DUNCAN R, 1985, J BIOL CHEM, V260, P5493; Durante W, 1997, CIRC RES, V80, P557, DOI 10.1161/01.RES.80.4.557; ERNST V, 1978, J BIOL CHEM, V253, P7163; FARLASELSNER R, 1994, P NATL ACAD SCI USA, V91, P9407; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; FORESTI R, 1999, FREE RADICAL RES, V31, P549; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; Gross SS, 1999, P NATL ACAD SCI USA, V96, P9967, DOI 10.1073/pnas.96.18.9967; Hartsfield CL, 1997, AM J PHYSIOL-LUNG C, V273, pL980; Henry Y, 1999, CELL MOL LIFE SCI, V55, P1003, DOI 10.1007/s000180050351; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HUNT T, 1972, J MOL BIOL, V66, P471, DOI 10.1016/0022-2836(72)90427-5; HUNT T, 1979, WIN MIAM S GEN PROT, V16, P321; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; JACKSON RJ, 1983, EUR J BIOCHEM, V131, P313, DOI 10.1111/j.1432-1033.1983.tb07264.x; Jagus R, 1999, INT J BIOCHEM CELL B, V31, P123, DOI 10.1016/S1357-2725(98)00136-8; Juckett M, 1998, J BIOL CHEM, V273, P23388, DOI 10.1074/jbc.273.36.23388; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; KHATSENKO OG, 1993, P NATL ACAD SCI USA, V90, P11147, DOI 10.1073/pnas.90.23.11147; Kim Y M, 1995, Adv Pharmacol, V34, P277; Kim YM, 1998, MOL MED, V4, P179, DOI 10.1007/BF03401915; KIM YM, 1995, J BIOL CHEM, V270, P5710, DOI 10.1074/jbc.270.11.5710; LONDON IM, 1987, ENZYMES, V18, P359; Maccarrone M, 1998, FEBS LETT, V434, P421, DOI 10.1016/S0014-5793(98)01026-6; MACIEJEWSKI JP, 1995, J CLIN INVEST, V96, P1085, DOI 10.1172/JCI118094; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MATTS RL, 1992, J BIOL CHEM, V267, P18160; MATTS RL, 1993, BIOCHEMISTRY-US, V32, P7323, DOI 10.1021/bi00080a001; MATTS RL, 1992, J BIOL CHEM, V267, P18168; MATTS RL, 1991, J BIOL CHEM, V266, P12695; MAURIDES PA, 1989, ANAL BIOCHEM, V183, P144, DOI 10.1016/0003-2697(89)90182-6; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; MELLOR H, 1994, J BIOL CHEM, V269, P10201; Nakano R, 1996, J BIOL CHEM, V271, P8570, DOI 10.1074/jbc.271.15.8570; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; PAL JK, 1991, BIOCHEMISTRY-US, V30, P2555, DOI 10.1021/bi00223a037; Petrache I, 2000, AM J PHYSIOL-LUNG C, V278, pL312, DOI 10.1152/ajplung.2000.278.2.L312; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Rafferty SP, 1996, BLOOD, V88, P1070, DOI 10.1182/blood.V88.3.1070.bloodjournal8831070; Rafie-Kolpin M, 2000, J BIOL CHEM, V275, P5171, DOI 10.1074/jbc.275.7.5171; ROWLANDS AG, 1988, EUR J BIOCHEM, V175, P93, DOI 10.1111/j.1432-1033.1988.tb14170.x; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; Selleri C, 1997, BRIT J HAEMATOL, V99, P481, DOI 10.1046/j.1365-2141.1996.4323240.x; Shami PJ, 1996, BLOOD, V87, P977, DOI 10.1182/blood.V87.3.977.bloodjournal873977; Snyder SH, 1998, BRAIN RES REV, V26, P167, DOI 10.1016/S0165-0173(97)00032-5; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thulasiraman V, 1998, EUR J BIOCHEM, V255, P552, DOI 10.1046/j.1432-1327.1998.2550552.x; TSAI AL, 1994, FEBS LETT, V341, P141, DOI 10.1016/0014-5793(94)80445-1; Uma S, 1999, MOL CELL BIOL, V19, P5861; Uma S, 1997, J BIOL CHEM, V272, P11648; Uma S, 2000, EUR J BIOCHEM, V267, P498, DOI 10.1046/j.1432-1327.2000.01021.x; Xu ZY, 1997, EUR J BIOCHEM, V246, P461, DOI 10.1111/j.1432-1033.1997.t01-1-00461.x; YANG JM, 1992, J BIOL CHEM, V267, P20519; ZETTERBERG A, 1995, CELL CYCLE CONTROL, P206; ZHANG J, 1995, ANNU REV PHARMACOL, V35, P213; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753	74	47	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14875	14883		10.1074/jbc.M011476200	http://dx.doi.org/10.1074/jbc.M011476200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278914	hybrid			2022-12-27	WOS:000168528800048
J	Ginisty, H; Amalric, F; Bouvet, P				Ginisty, H; Amalric, F; Bouvet, P			Two different combinations of RNA-binding domains determine the RNA binding specificity of nucleolin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-RIBOSOMAL-RNA; EXTERNAL TRANSCRIBED SPACER; CRYSTAL-STRUCTURE; HNRNP A1; PROTEIN; RECOGNITION; NUCLEAR; SEQUENCE; COMPLEX; PRECURSOR	Nucleolin is an abundant nucleolar protein involved in several steps of ribosome biogenesis. The protein is highly conserved through evolution and possesses four RNA-binding domains (RBD), which are likely to determine its RNA binding specificity. Previous studies have shown that nucleolin interacts with two different RNA targets. The first is a small stem-loop structure, the nucleolin recognition element (NRE), found all along the pre-ribosomal RNA. The second is a short single-stranded RNA sequence, the evolutionary conserved motif (ECM), located five nucleotides downstream of the first processing site in the pre-ribosomal RNA 5' external transcribed spacer. Biochemical, genetic, and structural studies have shown that the first two RBD of nucleolin are necessary and sufficient for the specific interaction of nucleolin with the NRE motif. In this work, we have studied the interaction of nucleolin with the ECM sequence. Deletion and mutational analyses showed that all four RBDs of hamster nucleolin were required for the interaction with the ECM sequence. This RNA binding specificity is conserved between hamster and Xenopus laevis, whereas the Xenopus protein does not interact with the NRE. Nucleolin is the first example of a protein that requires four RBDs for its interaction with an RNA target, demonstrating that a single protein can use different combinations of RED to interact specifically with several RNA sequences.	Ecole Normale Super Lyon, CNRS, UMR 5665, F-69364 Lyon 07, France; Lab Pharmacol & Biol Struct, CNRS, UMR 5089, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Bouvet, P (corresponding author), Ecole Normale Super Lyon, CNRS, UMR 5665, 46 Allee Italie, F-69364 Lyon 07, France.	pbouvet@ens-lyon.fr	, Bouvet/AAC-8779-2020	Bouvet, Philippe/0000-0003-4524-2233				Allain FHT, 2000, J MOL BIOL, V303, P227, DOI 10.1006/jmbi.2000.4118; Allain FHT, 1996, NATURE, V380, P646, DOI 10.1038/380646a0; Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Bouvet P, 1997, EMBO J, V16, P5235, DOI 10.1093/emboj/16.17.5235; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; BURD CG, 1991, MOL CELL BIOL, V11, P3419, DOI 10.1128/MCB.11.7.3419; Busch H, 1997, J TUMOR MARKER ONCOL, V12, P5; CRAIG N, 1991, MOL CELL BIOL, V11, P458, DOI 10.1128/MCB.11.1.458; Crowder SM, 1999, P NATL ACAD SCI USA, V96, P4892, DOI 10.1073/pnas.96.9.4892; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; GHISOLFI L, 1992, EUR J BIOCHEM, V209, P541, DOI 10.1111/j.1432-1033.1992.tb17318.x; GhisolfiNieto L, 1996, J MOL BIOL, V260, P34, DOI 10.1006/jmbi.1996.0380; Ginisty H, 2000, J BIOL CHEM, V275, P18845, DOI 10.1074/jbc.M002350200; Ginisty H, 1999, J CELL SCI, V112, P761; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; GORLACH M, 1994, J BIOL CHEM, V269, P23074; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; HERRERA AH, 1986, BIOCHEMISTRY-US, V25, P6258, DOI 10.1021/bi00368a063; Inoue M, 2000, NUCLEIC ACIDS RES, V28, P1743, DOI 10.1093/nar/28.8.1743; KANAAR R, 1995, EMBO J, V14, P4530, DOI 10.1002/j.1460-2075.1995.tb00132.x; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x; MERRILL BM, 1988, J BIOL CHEM, V263, P3307; MICHOT B, 1991, EUR J BIOCHEM, V195, P601, DOI 10.1111/j.1432-1033.1991.tb15743.x; Mogridge J, 1998, MOL CELL, V1, P265, DOI 10.1016/S1097-2765(00)80027-1; MOUGEY EB, 1993, MOL CELL BIOL, V13, P5990, DOI 10.1128/MCB.13.10.5990; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; NARANDA T, 1994, J BIOL CHEM, V269, P32286; NIETFELD W, 1990, EMBO J, V9, P3699, DOI 10.1002/j.1460-2075.1990.tb07582.x; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; Serin G, 1996, BIOCHIMIE, V78, P530, DOI 10.1016/0300-9084(96)84759-6; Serin G, 1997, J BIOL CHEM, V272, P13109, DOI 10.1074/jbc.272.20.13109; Shamoo Y, 1997, NAT STRUCT BIOL, V4, P215, DOI 10.1038/nsb0397-215; SHAMOO Y, 1994, BIOCHEMISTRY-US, V33, P8272, DOI 10.1021/bi00193a014; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Varani L, 2000, NAT STRUCT BIOL, V7, P329; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zheng N, 1997, MOL CELL, V1, P79, DOI 10.1016/S1097-2765(00)80009-X; [No title captured]	47	42	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14338	14343		10.1074/jbc.M011120200	http://dx.doi.org/10.1074/jbc.M011120200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278842	Green Published, hybrid			2022-12-27	WOS:000168356600109
J	Kim, DE; Patel, SS				Kim, DE; Patel, SS			The kinetic pathway of RNA binding do the Escherichia coli transcription termination factor Rho	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICASE DNAB PROTEIN; FUNCTIONAL INTERACTIONS; CENTRAL CHANNEL; NUCLEIC-ACID; ATP; REPLICATION; RECOGNITION; SITES; HYDROLYSIS; PRIMASE	The Escherichia coli transcription termination factor Rho is structurally and functionally homologous to hexameric helicases that assemble into ring structures. Using stopped-flow fluorescence and presteady-state ATPase kinetics, me have determined the kinetic pathway of poly(C) RNA binding to Rho hexamer, both in the presence and in absence of ATP, These studies indicate a four-step sequential mechanism of RNA binding and reveal the respective roles of the primary and secondary RNA binding sites in initiation and ATPase activation of Rho, The primary RNA binding sites of Rho hexamer interact with poly(C) RNA at a diffusion-limited rate constant close to 8 x 10(8) M-1 s(-1), resulting in the Rho-RNA species PR1, which subsequently isomerizes to PR2 with a rate constant 21 s(-1). The PR2 isomerizes to PR3 with a rate constant of 32 s(-1) in the presence of ATP, and the formation of PR4 from PR3 results in a species that is fully competent in hydrolyzing ATP at the RNA-stimulated rate. The PR3 to PR4 isomerization occurs at a relatively slow rate of 4.1 s(-1); thus, the presteady-state ATPase kinetics show a distinct lag due to the slow initiation step. The interactions of the RNA with the primary sites trigger ring opening, and we propose that during the last two steps, the RNA migrates into the central channel and interacts with the secondary sites, resulting in the activation of the ATPase activity. The primary RNA binding sites, in addition to promoting sequence specific initiation, kinetically facilitate loading of the RNA into the secondary sites, which are relatively inaccessible, since they are present in the central channel. These studies reveal common features used by hexameric helicases to bind nucleic acids in an efficient and specific manner.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Ln, Piscataway, NJ 08854 USA.				NIGMS NIH HHS [GM55310] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418; ALLEN GC, 1991, J BIOL CHEM, V266, P22096; Allison TJ, 1998, NAT STRUCT BIOL, V5, P352, DOI 10.1038/nsb0598-352; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; BOROWIEC JA, 1988, P NATL ACAD SCI USA, V85, P64, DOI 10.1073/pnas.85.1.64; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Bujalowski W, 2000, J MOL BIOL, V295, P831, DOI 10.1006/jmbi.1999.3378; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; Burgess BR, 2001, J BIOL CHEM, V276, P4182, DOI 10.1074/jbc.M007066200; CERUZZI MAF, 1985, J BIOL CHEM, V260, P9412; FINGER LR, 1982, J MOL BIOL, V156, P203, DOI 10.1016/0022-2836(82)90467-3; FINGER LR, 1981, BIOCHEMISTRY-US, V20, P1640, DOI 10.1021/bi00509a036; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; Gan E, 1999, BIOCHEMISTRY-US, V38, P16882, DOI 10.1021/bi991559i; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; GEISELMANN J, 1992, PROTEIN SCI, V1, P861, DOI 10.1002/pro.5560010704; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P111, DOI 10.1021/bi00116a017; GOGOL EP, 1991, J MOL BIOL, V221, P1127, DOI 10.1016/0022-2836(91)80116-C; Kim DE, 1999, J BIOL CHEM, V274, P11623, DOI 10.1074/jbc.274.17.11623; Kusakabe T, 1998, EMBO J, V17, P1542, DOI 10.1093/emboj/17.5.1542; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE, P44; LOWERY C, 1977, J BIOL CHEM, V252, P1381; MCSWIGGEN JA, 1988, J MOL BIOL, V199, P609, DOI 10.1016/0022-2836(88)90305-1; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; MORI H, 1989, J MOL BIOL, V210, P39, DOI 10.1016/0022-2836(89)90289-1; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; PEREIRA S, 1995, J MOL BIOL, V251, P30, DOI 10.1006/jmbi.1995.0413; Picha KM, 2000, BIOCHEMISTRY-US, V39, P6401, DOI 10.1021/bi992857i; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; RICHARDSON JP, 1982, J BIOL CHEM, V257, P5760; Richardson JP, 1996, J BIOL CHEM, V271, P1251, DOI 10.1074/jbc.271.3.1251; ROBERTS JW, 1969, NATURE, V223, P480, DOI 10.1038/223480a0; STEINMETZ EJ, 1994, P NATL ACAD SCI USA, V91, P1401, DOI 10.1073/pnas.91.4.1401; Stitt BL, 1998, J BIOL CHEM, V273, P26477, DOI 10.1074/jbc.273.41.26477; STITT BL, 1988, J BIOL CHEM, V263, P11130; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; TARUMI K, 1995, J BIOL CHEM, V270, P2614, DOI 10.1074/jbc.270.6.2614; USTAV M, 1991, EMBO J, V10, P4321, DOI 10.1002/j.1460-2075.1991.tb05010.x; WANG Y, 1993, J BIOL CHEM, V268, P13947; Yu X, 2000, J MOL BIOL, V299, P1279, DOI 10.1006/jmbi.2000.3810; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	42	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13902	13910		10.1074/jbc.M011043200	http://dx.doi.org/10.1074/jbc.M011043200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278821	hybrid			2022-12-27	WOS:000168356600056
J	Plas, DR; Talapatra, S; Edinger, AL; Rathmell, JC; Thompson, CB				Plas, DR; Talapatra, S; Edinger, AL; Rathmell, JC; Thompson, CB			Akt and Bcl-x(L) promote growth factor-independent survival through distinct effects on mitochondrial physiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; GLYCOGEN-SYNTHASE KINASE-3; SERINE-THREONINE KINASE; CELL-DEATH; BCL-X; PHOSPHATIDYLINOSITOL 3-KINASE; LYMPHOCYTE SURVIVAL; KAPPA-B; PATHWAY; GENE	A comparison of Akt- and Bcl-x(L)-dependent cell survival was undertaken using interleukin-3-dependent FL5.12 cells. Expression of constitutively active Akt allows cells to survive for prolonged periods following growth factor withdrawal, This survival correlates with the expression level of activated Akt and is comparable in magnitude to the protection provided by the anti apoptotic gene Bcl-x(L). Although both genes prevent cell death, Akt-protected cells can be distinguished from Bclx(L)-protected cells on the basis of increased glucose transporter expression, glycolytic activity, mitochondrial potential, and cell size. In addition, Akt-expressing cells require high levels of extracellular nutrients to support cell survival. In contrast, Bcl-x(L)-expressing cells deprived of interleukin-3 survive in a more vegetative state, in which the cells are smaller, have lower mitochondrial potential, reduced glycolytic activity, and are less dependent on extracellular nutrients. Thus, Akt and Bcl-x(L) suppress mitochondrion-initiated apoptosis by distinct mechanisms. Akt-mediated survival is dependent on promoting glycolysis and maintaining a physiologic mitochondrial potential. In contrast, Bcl-x(L) maintains mitochondrial integrity in the face of a reduced mitochondrial membrane potential, which develops as a result of the low glycolytic rate in growth factor-deprived cells.	Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Thompson, CB (corresponding author), Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, 421 Curie Blvd, Philadelphia, PA 19104 USA.							ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BRAND K, 1989, METABOLISM, V38, P29, DOI 10.1016/0026-0495(89)90136-4; BRAND K, 1986, IMMUNOBIOLOGY, V173, P23, DOI 10.1016/S0171-2985(86)80086-9; Chang BS, 1999, MOL CELL BIOL, V19, P6673; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Deshmukh M, 1996, J CELL BIOL, V135, P1341, DOI 10.1083/jcb.135.5.1341; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Franklin JL, 1998, J CELL BIOL, V142, P1313, DOI 10.1083/jcb.142.5.1313; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Vander Heiden MG, 1999, MOL CELL, V3, P159; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zhang GJ, 1998, ANTICANCER RES, V18, P1989; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	40	262	275	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12041	12048		10.1074/jbc.M010551200	http://dx.doi.org/10.1074/jbc.M010551200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278698	hybrid			2022-12-27	WOS:000168081800082
J	Ramanathan, Y; Rajpara, SM; Reza, SM; Lees, E; Shuman, S; Mathews, MB; Pe'ery, T				Ramanathan, Y; Rajpara, SM; Reza, SM; Lees, E; Shuman, S; Mathews, MB; Pe'ery, T			Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; GENERAL TRANSCRIPTION FACTORS; FACTOR P-TEFB; MESSENGER-RNA; IN-VITRO; ACTIVATING KINASE; PROTEIN-KINASE; HIV-1 TAT; SACCHAROMYCES-CEREVISIAE; CAPPING ENZYME	CDK7, CDK8, and CDK9 are cyclin-dependent kinases (CDKs) that phosphorylate the C-terminal domain (CTD) of RNA polymerase II. They have distinct functions in transcription. Because the three CDKs target only serine 5 in the heptad repeat of model CTD substrates containing various numbers of repeats, we tested the hypothesis that the kinases differ in their ability to phosphorylate CTD heptad arrays. Our data show that the kinases display different preferences for phosphorylating individual heptads in a synthetic CTD substrate containing three heptamer repeats and specific regions of the CTD in glutathione S-transferase fusion proteins. They also exhibit differences in their ability to phosphorylate a synthetic CTD peptide that contains Ser S-PO4. This phosphorylated peptide is a poor substrate for CDK9 complexes. CDK8 and CDK9 complexes, bound to viral activators E1A and Tat, respectively, target only serine 5 for phosphorylation in the CTD peptides, and binding to the viral activators does not change the substrate preference of these kinases. These results imply that the display of different CTD heptads during transcription, as well as their phosphorylation state, can affect their phosphorylation by the different transcription-associated CDKs.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; DNAX Res Inst, Dept Cell Signaling, Palo Alto, CA 94304 USA; Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Memorial Sloan Kettering Cancer Center	Pe'ery, T (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA.				NIAID NIH HHS [AI31802] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031802] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Archambault J, 1997, P NATL ACAD SCI USA, V94, P14300, DOI 10.1073/pnas.94.26.14300; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; CHAMBERS RS, 1995, J BIOL CHEM, V270, P14962, DOI 10.1074/jbc.270.25.14962; Chen D, 1999, MOL CELL BIOL, V19, P2863; CHESNUT JD, 1992, J BIOL CHEM, V267, P10500; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; DAHMUS ME, 1994, PROG NUCLEIC ACID RE, V48, P143, DOI 10.1016/S0079-6603(08)60855-7; DAHMUS ME, 1995, BBA-GENE STRUCT EXPR, V1261, P171, DOI 10.1016/0167-4781(94)00233-S; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DEVAULT A, 1995, EMBO J, V14, P5027, DOI 10.1002/j.1460-2075.1995.tb00185.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1476; FISHER RP, 1995, CELL, V83, P47, DOI 10.1016/0092-8674(95)90233-3; FISHER RP, 1996, BIOCHIM BIOPHYS ACTA, V1288, P7; Flores OL, 1999, P NATL ACAD SCI USA, V96, P7208, DOI 10.1073/pnas.96.13.7208; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gebara MM, 1997, J CELL BIOCHEM, V64, P390; GERBER HP, 1995, NATURE, V374, P660, DOI 10.1038/374660a0; Gold MO, 1996, NUCLEIC ACIDS RES, V24, P3771, DOI 10.1093/nar/24.19.3771; GRANA X, 1994, P NATL ACAD SCI USA, V91, P3834, DOI 10.1073/pnas.91.9.3834; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Herrmann CH, 1996, NUCLEIC ACIDS RES, V24, P501, DOI 10.1093/nar/24.3.501; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; Hirose Y, 2000, GENE DEV, V14, P1415; Ho CK, 1998, J BIOL CHEM, V273, P9577, DOI 10.1074/jbc.273.16.9577; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; Isel C, 1999, J MOL BIOL, V290, P929, DOI 10.1006/jmbi.1999.2933; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Ivanov D, 1999, J MOL BIOL, V288, P41, DOI 10.1006/jmbi.1999.2663; Kobor MS, 1999, MOL CELL, V4, P55, DOI 10.1016/S1097-2765(00)80187-2; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Meininghaus M, 2000, J BIOL CHEM, V275, P24375, DOI 10.1074/jbc.M001883200; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; OSSIPOW V, 1995, CELL, V83, P137, DOI 10.1016/0092-8674(95)90242-2; Pan GH, 1997, J BIOL CHEM, V272, P24563, DOI 10.1074/jbc.272.39.24563; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; PETERSON SR, 1992, GENE DEV, V6, P426, DOI 10.1101/gad.6.3.426; Ping YH, 1999, J BIOL CHEM, V274, P7399, DOI 10.1074/jbc.274.11.7399; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Ramanathan Y, 1999, J VIROL, V73, P5448, DOI 10.1128/JVI.73.7.5448-5458.1999; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Rickert P, 1999, ONCOGENE, V18, P1093, DOI 10.1038/sj.onc.1202399; Rickert P, 1996, ONCOGENE, V12, P2631; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; SATOH M, 1994, J CLIN INVEST, V94, P1981, DOI 10.1172/JCI117550; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; TRIGON S, 1995, J BIOL CHEM, V270, P13091, DOI 10.1074/jbc.270.22.13091; WARREN SL, 1992, J CELL SCI, V103, P381; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WEST ML, 1995, GENETICS, V140, P1223; Yankulov KY, 1997, EMBO J, V16, P1638, DOI 10.1093/emboj/16.7.1638; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	65	103	104	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10913	10920		10.1074/jbc.M010975200	http://dx.doi.org/10.1074/jbc.M010975200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11278802	hybrid			2022-12-27	WOS:000167980900048
J	Patrick, SM; Turchi, JJ				Patrick, SM; Turchi, JJ			Stopped-flow kinetic analysis of replication protein A-binding DNA - Damage recognition and affinity for single-stranded DNA reveal differential contributions of k(on) and k(off) rate constants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ANTICANCER DRUG CISPLATIN; COMPLEX-FORMATION; DOMAIN; DUPLEX; RPA; NUCLEASE; ADDUCT; CONFORMATION; FLUORESCENCE	Replication protein A (RPA) is a heterotrimeric protein required for many DNA metabolic functions, including replication, recombination, and nucleotide excision repair (NER), We report the pre steady-state kinetic analysis of RPA-binding DNA substrates using a stopped-flow assay to elucidate the kinetics of DNA damage recognition. The bimolecular association rate, k(on), for RPA binding to duplex DNA substrates is great est for a 1,3d(GXG), intermediate for a 1,2d(GpG) cisplatin-DNA adduct, and least for an undamaged duplex DNA substrate. RPA displays a decreased k(on) and an increased k(off) for a single-stranded DNA substrate containing a single 1,2d(GpG) cisplatin-DNA adduct compared with an undamaged DNA substrate. The k(on) for RPA-binding single-stranded polypyrimidine sequences appears to be diffusion-limited. There is minimal difference in k(on) for varying length DNA substrates; therefore, the difference in equilibrium binding affinity is mainly attributed to the k(off). The k(on) for a purine rich 30-base DNA is reduced by a factor of 10 compared with a pyrimidine-rich DNA of identical length. These results provide insight into the mechanism of RPA-DNA binding and are consistent with RPA recognition of DNA-damage playing a critical role in NER.	Wright State Univ, Dept Biochem & Mol Biol, Sch Med, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Turchi, JJ (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, Sch Med, 3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.		Turchi, John J/B-5807-2015	Turchi, John J/0000-0001-5375-2992	NCI NIH HHS [CA82741, CA64374] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA064374, R01CA082741] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bessho T, 1997, J BIOL CHEM, V272, P3833, DOI 10.1074/jbc.272.6.3833; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 1998, J BIOL CHEM, V273, P3932, DOI 10.1074/jbc.273.7.3932; Braun KA, 1997, BIOCHEMISTRY-US, V36, P8443, DOI 10.1021/bi970473r; BROWN SJ, 1993, SCIENCE, V261, P603, DOI 10.1126/science.8342024; Burns JL, 1996, J BIOL CHEM, V271, P11607, DOI 10.1074/jbc.271.20.11607; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; Evans E, 1997, EMBO J, V16, P625, DOI 10.1093/emboj/16.3.625; FERSHT AR, 1971, J MOL BIOL, V60, P279, DOI 10.1016/0022-2836(71)90294-4; FIERKE CA, 1996, SEL METH EN, P1; GEORGAKI A, 1992, FEBS LETT, V308, P240, DOI 10.1016/0014-5793(92)81283-R; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hey T, 2001, BIOCHEMISTRY-US, V40, P2901, DOI 10.1021/bi002166i; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; Jamieson ER, 2000, BIOCHEMISTRY-US, V39, P8426, DOI 10.1021/bi000342h; Jamieson ER, 1999, J BIOL CHEM, V274, P12346, DOI 10.1074/jbc.274.18.12346; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; JONES CJ, 1993, BIOCHEMISTRY-US, V32, P12096, DOI 10.1021/bi00096a021; KIM C, 1995, BIOCHEMISTRY-US, V34, P2058, DOI 10.1021/bi00006a028; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Lao Y, 2000, BIOCHEMISTRY-US, V39, P850, DOI 10.1021/bi991704s; Lavrik OI, 1998, NUCLEIC ACIDS RES, V26, P602, DOI 10.1093/nar/26.2.602; LI L, 1995, MOL CELL BIOL, V15, P5396; MATSUDA T, 1995, J BIOL CHEM, V270, P4152, DOI 10.1074/jbc.270.8.4152; Matsunaga T, 1996, J BIOL CHEM, V271, P11047, DOI 10.1074/jbc.271.19.11047; Moggs JG, 1997, NUCLEIC ACIDS RES, V25, P480, DOI 10.1093/nar/25.3.480; Patrick SM, 1999, J BIOL CHEM, V274, P14972, DOI 10.1074/jbc.274.21.14972; Patrick SM, 1997, BBA-GENE STRUCT EXPR, V1354, P279, DOI 10.1016/S0167-4781(97)00136-X; Patrick SM, 1998, BIOCHEMISTRY-US, V37, P8808, DOI 10.1021/bi9730590; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Poklar N, 1996, P NATL ACAD SCI USA, V93, P7606, DOI 10.1073/pnas.93.15.7606; SANCAR A, 1995, J BIOL CHEM, V270, P15915, DOI 10.1074/jbc.270.27.15915; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Stigger E, 1998, J BIOL CHEM, V273, P9337, DOI 10.1074/jbc.273.15.9337; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; TAKAHARA PM, 1995, NATURE, V377, P649, DOI 10.1038/377649a0; Treuner K, 1996, J MOL BIOL, V259, P104, DOI 10.1006/jmbi.1996.0305; URBANKE C, 1990, BIOCHEMISTRY-US, V29, P1744, DOI 10.1021/bi00459a012; VANGARDEREN CJ, 1994, EUR J BIOCHEM, V225, P1169; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031	46	49	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22630	22637		10.1074/jbc.M010314200	http://dx.doi.org/10.1074/jbc.M010314200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11278662	hybrid			2022-12-27	WOS:000169412700089
J	Nagasawa, M; Kanzaki, M; Iino, Y; Morishita, Y; Kojima, I				Nagasawa, M; Kanzaki, M; Iino, Y; Morishita, Y; Kojima, I			Identification of a novel chloride channel expressed in the endoplasmic reticulum, Golgi apparatus, and nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN; CYSTIC-FIBROSIS; GENE; DOMINANT	MID-1 is a Saccharomyces cerevisiae gene encoding a stretch-activated channel. Using MID-1 as a molecular probe, we isolated rat cDNA encoding a protein with four putative transmembrane domains. This gene encoded a protein of 541 amino acids. We also cloned the human homologue, which encoded 551 amino acids. Messenger RNA for this gene was expressed abundantly in the testis and moderately in the spleen, liver, kidney, heart, brain, and lung. In the testis, immunoreactivity of the gene product was detected both in the cytoplasm and the nucleus. When expressed in Chinese hamster ovary cells, the gene product was located in intracellular compartments including endoplasmic reticulum and the Golgi apparatus. When microsome fraction obtained from the transfected cells, but not from mock-transfected cells, was incorporated into the lipid bilayer, an anion channel activity was detected. Unitary conductance was 70 picosiemens in symmetric 150 mM KCl solution. We designated this gene Mid-1-related chloride channel (MCLC). MCLC encodes a new class of chloride channel expressed in intracellular compartments.	Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gumma 3718512, Japan; Gunma Univ, Sch Med, Dept Emergency & Crit Care Med, Maebashi, Gumma 3718512, Japan; Gunma Univ, Sch Med, Dept Surg 2, Maebashi, Gumma 3718512, Japan	Gunma University; Gunma University; Gunma University	Kojima, I (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gumma 3718512, Japan.		Kanzaki, Makoto/H-6680-2017	Kanzaki, Makoto/0000-0002-6884-2955				ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; DAVID V, 1993, J BIOL CHEM, V268, P9585; EDWARDS J, 1998, AM J PHYSIOL, V276, pF398; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; FUKUHARA C, 1996, SOPHIA LIFE SCI B, V15, P79; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; JENTSCH TJ, 1994, CURR OPIN CELL BIOL, V6, P600, DOI 10.1016/0955-0674(94)90082-5; JENTSCH TJ, 1995, J PHYSIOL-LONDON, V482, P19; Kanzaki M, 1999, SCIENCE, V285, P882, DOI 10.1126/science.285.5429.882; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; KTISTAKIS NT, 1991, J CELL BIOL, V113, P1009, DOI 10.1083/jcb.113.5.1009; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MANNING SD, 1989, J MEMBRANE BIOL, V109, P113, DOI 10.1007/BF01870850; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	21	30	32	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20413	20418		10.1074/jbc.M100366200	http://dx.doi.org/10.1074/jbc.M100366200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279057	hybrid			2022-12-27	WOS:000169135100100
J	Decker, H; Ryan, M; Jaenicke, E; Terwilliger, N				Decker, H; Ryan, M; Jaenicke, E; Terwilliger, N			SDS-induced phenoloxidase activity of hemocyanins from Limulus polyphemus, Eurypelma californicum, and Cancer magister	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTHROPOD HEMOCYANIN; HORSESHOE-CRAB; SUBUNIT HETEROGENEITY; QUATERNARY STRUCTURE; PHENOL OXIDASE; CDNA CLONING; PROPHENOLOXIDASE; TYROSINASE; EVOLUTION; HEMOLYMPH	Phenoloxidase, widely distributed among animals, plants, and fungi, is involved in many biologically essential functions including sclerotization and host defense. In chelicerates, the oxygen carrier hemocyanin seems to function as the phenoloxidase. Here, we show that hemocyanins from two ancient chelicerates, the horseshoe crab Limulus polyphemus and the tarantula Eurypelma californicum, exhibit O-diphenoloxidase activity induced by submicellar concentrations of SDS, a reagent frequently used to identify phenoloxidase activity. The enzymatic activity seems to be restricted to only a few of the heterogeneous subunits. These active subunit types share similar topological positions in the quaternary structures as linkers of the two tightly connected 2 x 6-mers. Because no other phenoloxidase activity was found in the hemolymph of these animals, their hemocyanins may act as a phenoloxidase and thus be involved in the primary immune response and sclerotization of the cuticle. In contrast, hemolymph of a more recent arthropod, the crab Cancer magister, contains both hemocyanin with weak phenoloxidase activity and another hemolymph protein with relatively strong phenoloxidase activity. The chelicerate hemocyanin subunits showing phenoloxidase activity may have evolved into a separate phenoloxidase in crustaceans.	Johannes Gutenberg Univ Mainz, Inst Mol Biophys, D-55128 Mainz, Germany; Univ Oregon, Oregon Inst Marine Biol, Charleston, OR 97420 USA	Johannes Gutenberg University of Mainz; University of Oregon	Decker, H (corresponding author), Johannes Gutenberg Univ Mainz, Inst Mol Biophys, D-55128 Mainz, Germany.	decker@biophysik.biologie.uni-mainz.de	Jaenicke, Elmar/A-5317-2010	Jaenicke, Elmar/0000-0002-5157-7219				ASPAN A, 1995, P NATL ACAD SCI USA, V92, P939, DOI 10.1073/pnas.92.4.939; BRENOWITZ M, 1984, ARCH BIOCHEM BIOPHYS, V230, P238, DOI 10.1016/0003-9861(84)90105-X; BRENOWITZ M, 1981, ARCH BIOCHEM BIOPHYS, V210, P748, DOI 10.1016/0003-9861(81)90242-3; Burmester T, 1996, J MOL EVOL, V42, P713, DOI 10.1007/BF02338804; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Decker H, 1998, J BIOL CHEM, V273, P25889, DOI 10.1074/jbc.273.40.25889; Decker H, 2000, ANGEW CHEM INT EDIT, V39, P1591, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1591::AID-ANIE1591>3.0.CO;2-H; Decker H, 2000, J EXP BIOL, V203, P1777; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; Durstewitz G, 1997, MOL BIOL EVOL, V14, P266, DOI 10.1093/oxfordjournals.molbev.a025762; FUJIMOTO K, 1995, P NATL ACAD SCI USA, V92, P7769, DOI 10.1073/pnas.92.17.7769; Gollas-Galvan T, 1999, COMP BIOCHEM PHYS B, V122, P77, DOI 10.1016/S0305-0491(98)10143-8; HAZES B, 1993, PROTEIN SCI, V2, P597; Hughes AL, 1999, IMMUNOGENETICS, V49, P106, DOI 10.1007/s002510050469; KEMPTER B, 1985, BIOL CHEM H-S, V366, P77, DOI 10.1515/bchm3.1985.366.1.77; LAMY J, 1983, ARCH BIOCHEM BIOPHYS, V223, P584, DOI 10.1016/0003-9861(83)90623-9; LAMY J, 1979, H-S Z PHYSIOL CHEM, V360, P889, DOI 10.1515/bchm2.1979.360.2.889; LAMY J, 1982, BIOCHEMISTRY-US, V21, P6825, DOI 10.1021/bi00269a031; LARSON BA, 1981, BIOCHIM BIOPHYS ACTA, V667, P294, DOI 10.1016/0005-2795(81)90195-1; MAGNUS KA, 1994, PROTEINS, V19, P302, DOI 10.1002/prot.340190405; MARKL J, 1981, H-S Z PHYSIOL CHEM, V362, P1631, DOI 10.1515/bchm2.1981.362.2.1631; MARKL J, 1979, J COMP PHYSIOL, V130, P283, DOI 10.1007/BF00689845; Markl J., 1992, Advances in Comparative and Environmental Physiology, V13, P325; Nagai T, 2000, J BIOL CHEM, V275, P29264, DOI 10.1074/jbc.M002556200; NAKAHARA A, 1983, LIFE CHEM REP S1, V1, P319; Nellaiappan K, 1996, COMP BIOCHEM PHYS B, V113, P163, DOI 10.1016/0305-0491(95)02047-0; NELLAIAPPAN K, 1993, BIOTECH HISTOCHEM, V68, P193, DOI 10.3109/10520299309104697; Salvato B, 1998, BIOCHEMISTRY-US, V37, P14065, DOI 10.1021/bi980879j; SALVATO B, 1990, LIFE CHEM REPORTS, V8, P1; SALVATO B, 1983, LIFE CHEM REP S, V1, P313; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Smith V.J., 1996, Advances in Comparative and Environmental Physiology, V23, P75; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; SODERHALL K, 1985, BIOL BULL-US, V169, P661, DOI 10.2307/1541308; Soderhall K, 1997, DEV BIOLOGICALS, V90, P45; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; SOLOMON EI, 1994, CHEM REV, V94, P827, DOI 10.1021/cr00027a013; SULLIVAN B, 1974, P NATL ACAD SCI USA, V71, P2558, DOI 10.1073/pnas.71.6.2558; SUMMERS NM, 1967, COMP BIOCHEM PHYSIOL, V23, P129, DOI 10.1016/0010-406X(67)90480-X; Taveau JC, 1997, J MOL BIOL, V266, P1002, DOI 10.1006/jmbi.1996.0840; Terwilliger NB, 1999, P NATL ACAD SCI USA, V96, P2013, DOI 10.1073/pnas.96.5.2013; TERWILLIGER NB, 1982, J EXP ZOOL, V221, P181, DOI 10.1002/jez.1402210209; Terwilliger NB, 1999, AM ZOOL, V39, P589; VANBRUGGEN EFJ, 1980, FEBS LETT, V116, P207, DOI 10.1016/0014-5793(80)80645-4; VanGelder CWG, 1997, PHYTOCHEMISTRY, V45, P1309, DOI 10.1016/S0031-9422(97)00186-6; VANHEEL M, 1994, MICRON, V25, P387, DOI 10.1016/0968-4328(94)90007-8; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; VANHOLDE KE, 1982, Q REV BIOPHYS, V15, P1, DOI 10.1017/S0033583500002705; Zlateva T, 1996, FEBS LETT, V384, P251, DOI 10.1016/0014-5793(96)00326-2	49	150	165	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17796	17799		10.1074/jbc.M010436200	http://dx.doi.org/10.1074/jbc.M010436200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278677	hybrid			2022-12-27	WOS:000168866500025
J	Wang, ZY; Nolan, B; Kutschke, W; Hill, JA				Wang, ZY; Nolan, B; Kutschke, W; Hill, JA			Na+-Ca2+ exchanger remodeling in pressure overload cardiac hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA-2+-ATPASE; SODIUM-CALCIUM EXCHANGE; PROTEIN-KINASE-C; NA+/CA2+ EXCHANGER; GENE-EXPRESSION; VENTRICULAR MYOCYTES; NA/CA EXCHANGE; CALSEQUESTRIN GENES; IONIC CURRENTS; CYCLOSPORINE-A	Perturbations of Ca2+ metabolism are central to the pathogenesis of cardiac hypertrophy, The electrogenic Na+-Ca2+ exchanger mediates a substantial component of transmembrane Ca2+ movement in cardiac myocytes and is up-regulated in heart failure. However, the role of the exchanger in the pathogenesis of cardiac hypertrophy is poorly understood. Thoracic aortic banding in mice induced 50-60% increases in heart mass and cardiomyocyte size. Despite the absence of myocardial dysfunction, steady-state NCX1 transcript and protein levels were increased to an extent similar to that reported in heart failure. As recent studies indicate that calcineurin is critical to the expression of Na+-Ca2+ exchanger genes, we inhibited calcineurin with cyclosporin. Calcineurin inhibition blunted the increases in NCX1 transcript and protein levels and eliminated the increases in heart mass and cell volume normally associated with pressure overload. To examine the functional significance of these changes, we measured Na+-C2+ exchanger current in two independent ways. Surprisingly, exchanger current density was decreased in hypertrophied myocytes, and this down-regulation was eliminated by calcineurin inhibition. Together, these data reveal a role for Na+-Ca2+ exchanger current in the electrical remodeling of hypertrophy and implicate calcineurin signaling therein, In addition, these data suggest the Na+-Ca2+ exchanger is functionally regulated in hypertrophy.	Univ Iowa, Coll Med, Div Cardiovasc, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Interdisciplinary Grad Program Mol Biol, Iowa City, IA 52242 USA; Dept Vet Affairs, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Hill, JA (corresponding author), Univ Iowa, Coll Med, Div Cardiovasc, Dept Internal Med, E318gh,UIHC,200 Hawkins Dr, Iowa City, IA 52242 USA.	joseph-hill@uiowa.edu			NHLBI NIH HHS [HL-03908] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARAI M, 1993, CIRC RES, V72, P463, DOI 10.1161/01.RES.72.2.463; ARAI M, 1994, CIRC RES, V74, P555, DOI 10.1161/01.RES.74.4.555; Balke CW, 1998, CARDIOVASC RES, V37, P290, DOI 10.1016/S0008-6363(97)00272-1; Barry WH, 2000, CIRC RES, V87, P529, DOI 10.1161/01.RES.87.7.529; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Boateng SY, 2001, AM J PHYSIOL-HEART C, V280, pH1029, DOI 10.1152/ajpheart.2001.280.3.H1029; BOERTH SR, 1994, CIRC RES, V74, P354, DOI 10.1161/01.RES.74.2.354; Bowman JC, 1997, J CLIN INVEST, V100, P2189, DOI 10.1172/JCI119755; Brown DW, 2000, AM HEART J, V140, P848, DOI 10.1067/mhj.2000.111112; Carafoli E, 1999, BIOCHEM BIOPH RES CO, V266, P624, DOI 10.1006/bbrc.1999.1879; Chien KR, 2000, J CLIN INVEST, V105, P1339, DOI 10.1172/JCI10079; CLIPSTONE NA, 1994, J BIOL CHEM, V269, P26431; Dipla K, 1999, CIRC RES, V84, P435, DOI 10.1161/01.RES.84.4.435; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Flesch M, 1996, CIRCULATION, V94, P992, DOI 10.1161/01.CIR.94.5.992; FREY N, 2000, CIRC RES, V87, P731; Gaughan JP, 1999, AM J PHYSIOL-HEART C, V277, pH714, DOI 10.1152/ajpheart.1999.277.2.H714; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Hampton TG, 2000, AM J PHYSIOL-HEART C, V279, pH2846, DOI 10.1152/ajpheart.2000.279.6.H2846; Hasenfuss G, 1999, CIRCULATION, V99, P641, DOI 10.1161/01.CIR.99.5.641; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Hobai IA, 2000, CIRC RES, V87, P690, DOI 10.1161/01.RES.87.8.690; Hobai IA, 1997, AM J PHYSIOL-HEART C, V272, pH2164, DOI 10.1152/ajpheart.1997.272.5.H2164; HUSI H, 1994, J BIOL CHEM, V269, P14199; Isenberg G, 2001, CARDIOVASC RES, V49, P1, DOI 10.1016/S0008-6363(00)00284-4; Ito K, 2000, CIRC RES, V87, P588, DOI 10.1161/01.RES.87.7.588; Iwamoto T, 1996, J BIOL CHEM, V271, P13609, DOI 10.1074/jbc.271.23.13609; Janssen PML, 2000, CARDIOVASC RES, V47, P99, DOI 10.1016/S0008-6363(00)00052-3; KENT RL, 1993, AM J PHYSIOL, V265, pH1024, DOI 10.1152/ajpheart.1993.265.3.H1024; Knollmann BC, 2000, J PHYSIOL-LONDON, V525, P483, DOI 10.1111/j.1469-7793.2000.t01-1-00483.x; Ladilov Y, 1999, AM J PHYSIOL-HEART C, V276, pH1868, DOI 10.1152/ajpheart.1999.276.6.H1868; LEDERER WJ, 1990, SCIENCE, V248, P283, DOI 10.1126/science.2326638; Li L, 2000, J BIOL CHEM, V275, P20903, DOI 10.1074/jbc.M000995200; Linck B, 1996, CARDIOVASC RES, V31, P625; LOMPRE AM, 1991, CIRC RES, V69, P1380, DOI 10.1161/01.RES.69.5.1380; MERCADIER JJ, 1990, J CLIN INVEST, V85, P305, DOI 10.1172/JCI114429; Mitarai S, 2000, AM J PHYSIOL-HEART C, V279, pH139, DOI 10.1152/ajpheart.2000.279.1.H139; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2000, CIRC RES, V87, P731, DOI 10.1161/01.RES.87.9.731; MOVSESIAN MA, 1994, CIRCULATION, V90, P653, DOI 10.1161/01.CIR.90.2.653; Nabauer M, 1998, CARDIOVASC RES, V37, P324, DOI 10.1016/S0008-6363(97)00274-5; Nuss HB, 1999, AM J PHYSIOL-HEART C, V277, pH80, DOI 10.1152/ajpheart.1999.277.1.H80; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; Park KS, 1999, AM J PHYSIOL-HEART C, V276, pH865, DOI 10.1152/ajpheart.1999.276.3.H865; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Pieske B, 1999, CIRC RES, V85, P38; Pogwizd SM, 1999, CIRC RES, V85, P1009; Reed TD, 2000, J MOL CELL CARDIOL, V32, P453, DOI 10.1006/jmcc.1999.1095; Richard S, 1998, CARDIOVASC RES, V37, P300, DOI 10.1016/S0008-6363(97)00273-3; Schillinger W, 2000, CIRC RES, V87, P581, DOI 10.1161/01.RES.87.7.581; SCHOUTEN VJA, 1990, CARDIOVASC RES, V24, P758, DOI 10.1093/cvr/24.9.758; Schwartz K, 1996, CURR OPIN CARDIOL, V11, P227, DOI 10.1097/00001573-199605000-00002; SCHWINGER RHG, 1995, CIRCULATION, V92, P3220, DOI 10.1161/01.CIR.92.11.3220; Simpson PC, 1999, CIRCULATION, V99, P334, DOI 10.1161/01.CIR.99.3.334; Sipido KR, 2000, CIRCULATION, V102, P2137, DOI 10.1161/01.CIR.102.17.2137; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; Su Z, 1999, J MOL CELL CARDIOL, V31, P1125, DOI 10.1006/jmcc.1999.0949; Su Z, 1998, AM J PHYSIOL-HEART C, V275, pH1808, DOI 10.1152/ajpheart.1998.275.5.H1808; Sugden PH, 1999, CIRC RES, V84, P633, DOI 10.1161/01.RES.84.6.633; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; TAKAHASHI T, 1992, J CLIN INVEST, V90, P927, DOI 10.1172/JCI115969; Terracciano CMN, 1998, J PHYSIOL-LONDON, V512, P651, DOI 10.1111/j.1469-7793.1998.651bd.x; Terracciano CMN, 2001, CARDIOVASC RES, V49, P38, DOI 10.1016/S0008-6363(00)00205-4; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Wakimoto K, 2000, J BIOL CHEM, V275, P36991, DOI 10.1074/jbc.M004035200; Wickenden AD, 1998, CARDIOVASC RES, V37, P312, DOI 10.1016/S0008-6363(97)00256-3; Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571; Zygmunt AC, 2000, AM J PHYSIOL-HEART C, V278, pH1671, DOI 10.1152/ajpheart.2000.278.5.H1671	69	65	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17706	17711		10.1074/jbc.M100544200	http://dx.doi.org/10.1074/jbc.M100544200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279089	hybrid			2022-12-27	WOS:000168866500013
J	Vigne, JL; Hornung, D; Mueller, MD; Taylor, RN				Vigne, JL; Hornung, D; Mueller, MD; Taylor, RN			Purification and characterization of an immunomodulatory endometrial protein, glycodelin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL PROTEIN-14; IMMUNOSUPPRESSIVE FACTOR; SECRETORY PROTEINS; GENE-EXPRESSION; MENSTRUAL-CYCLE; MUCIN MUC1; RECEPTOR; RELAXIN; RESPONSES; CELLS	Human glycodelin is synthesized by endometrial cells in the late secretory phase and early pregnancy under hormonal regulation. Whereas the precise physiological functions of glycodelin are unknown, its expression during embryonic nidation and its inhibition of T cell proliferation suggest an immunomodulatory role. We purified human glycodelin from first trimester human decidual cytosol by using a rapid two-step high-performance liquid chromatography method and investigated its effects on human monocyte migration. Human U931 cells were used as a model of monocyte chemotaxis in Hoyden chamber migration assays. N-Formyl-Met-Leu-Phe and the beta -chemokine RANTES (regulated on activation normal T cell expressed and secreted) were used as monocyte chemoattractants. Purified glycodelin inhibited monocyte migration in a dose-dependent fashion (IC50 = 550 nM). Glycodelin activity was totally reversed by heat inactivation (95 degreesC x 15 min) and neutralized by pretreatment with specific anti-glycodelin antibodies. Deglycosylated glycodelin was equipotent to intact glycodelin in the monocyte migration assay. I-125-Glycodelin binding to whole U931 cells revealed a single, saturable site with a K-d = 48 +/- 21 nM by Scatchard analysis. Cross-linking studies indicated that glycodelin binds to a high molecular mass (similar to 250 kDa) protein complex at the monocyte cell surface. Our findings support the hypothesis that glycodelin reduces the local maternal inflammatory response toward the implantation of a semiallogeneic conceptus.	Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Taylor, RN (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, HSE 1689, San Francisco, CA 94143 USA.	rtaylor@socrates.ucsf.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD037321] Funding Source: NIH RePORTER; NICHD NIH HHS [U54-HD37321] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BELL SC, 1989, BAILLIERE CLIN OB GY, V3, P271, DOI 10.1016/S0950-3552(89)80022-7; Blanchard F, 1998, J BIOL CHEM, V273, P20886, DOI 10.1074/jbc.273.33.20886; BOLTON AE, 1987, LANCET, V1, P593; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; Dalton CF, 1998, HUM REPROD, V13, P3197, DOI 10.1093/humrep/13.11.3197; Damsky CH, 1998, CURR OPIN CELL BIOL, V10, P660, DOI 10.1016/S0955-0674(98)80043-4; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; DeLoia JA, 1998, HUM REPROD, V13, P2902, DOI 10.1093/humrep/13.10.2902; Fazleabas AT, 1997, HUM REPROD UPDATE, V3, P553, DOI 10.1093/humupd/3.6.553; HEY NA, 1994, J CLIN ENDOCR METAB, V78, P337, DOI 10.1210/jc.78.2.337; Hornung D, 2001, MOL HUM REPROD, V7, P163, DOI 10.1093/molehr/7.2.163; JULKUNEN M, 1991, ANN NY ACAD SCI, V626, P284; KAY GE, 1983, INFECT IMMUN, V41, P1166, DOI 10.1128/IAI.41.3.1166-1174.1983; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Lehmann M, 1996, J CELL BIOCHEM, V61, P266, DOI 10.1002/(SICI)1097-4644(19960501)61:2<266::AID-JCB10>3.0.CO;2-K; LESSEY BA, 1994, FERTIL STERIL, V62, P497; MCMASTER MT, 1998, CURRENT PROBLEMS OBS, V21, P1; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Miller RE, 1998, FEBS LETT, V436, P455, DOI 10.1016/S0014-5793(98)01184-3; MORROW DM, 1994, AM J PATHOL, V145, P1485; MUELLER M, 2001, IN PRESS SEMIN REPRO; Rachmilewitz J, 1999, CELL IMMUNOL, V191, P26, DOI 10.1006/cimm.1998.1408; REN SG, 1990, J CLIN ENDOCR METAB, V70, P983, DOI 10.1210/jcem-70-4-983; Seppala M, 1995, HUM REPROD, V10, P67, DOI 10.1093/humrep/10.suppl_2.67; Seppala M, 1999, CURR OPIN OBSTET GYN, V11, P261, DOI 10.1097/00001703-199906000-00005; Stewart DR, 1997, J CLIN ENDOCR METAB, V82, P839, DOI 10.1210/jc.82.3.839; Taylor RN, 1998, J CLIN ENDOCR METAB, V83, P4006, DOI 10.1210/jc.83.11.4006; Taylor RN, 2000, AM J OBSTET GYNECOL, V182, P841, DOI 10.1016/S0002-9378(00)70333-4; Tseng L, 1999, MOL HUM REPROD, V5, P372, DOI 10.1093/molehr/5.4.372; Urvater JA, 2000, J IMMUNOL, V164, P1386, DOI 10.4049/jimmunol.164.3.1386; VIGNE JL, 2001, IN PRESS REFER GYNEC; WESTWOOD OMR, 1988, J REPROD FERTIL, V82, P493	32	42	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17101	17105		10.1074/jbc.M010451200	http://dx.doi.org/10.1074/jbc.M010451200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278680	hybrid			2022-12-27	WOS:000168730400067
J	Miramar, MD; Costantini, P; Ravagnan, L; Saraiva, LM; Haouzi, D; Brothers, G; Penninger, JM; Peleato, ML; Kroemer, G; Susin, SA				Miramar, MD; Costantini, P; Ravagnan, L; Saraiva, LM; Haouzi, D; Brothers, G; Penninger, JM; Peleato, ML; Kroemer, G; Susin, SA			NADH oxidase activity of mitochondrial apoptosis-inducing factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; CASPASE ACTIVATION; FACTOR AIF; PURIFICATION; SUPEROXIDE; OXIDOREDUCTASE; IDENTIFICATION; GENERATION; FERREDOXIN; REDUCTASE	Apoptosis-inducing factor (AIF) is a mitochondrial flavoprotein, which translocates to the nucleus during apoptosis and causes chromatin condensation and large scale DNA fragmentation. Here we report the biochemical characterization of AIF's redox activity. Natural AIF purified from mitochondria and recombinant AIF purified from bacteria (AIF Delta1-120) exhibit NADH oxidase activity, whereas superoxide anion (O-2(-)) is formed. AIF Delta1-120 is a monomer of 57 kDa containing 1 mol of noncovalently bound FAD/mol of protein. ApoATF Delta1-120, which lacks FAD, has no NADH oxidase activity. However, native AIF Delta1-120, apoAIF Delta1-120, and the reconstituted (FAD-containing) holoAIF Delta1-120 protein exhibit a similar apoptosis-inducing potential when microinjected into the cytoplasm of intact cells. inhibition of the redox function, by external addition of superoxide dismutase or covalent derivatization of FAD with diphenyleneiodonium, failed to affect the apoptogenic function of AIF Delta1-120 assessed on purified nuclei in a cell-free system. Conversely, blockade of the apoptogenic function of AIF Delta1-120 with the thiol reagent para-chloromercuriphenylsulfonic acid did not affect its NADH oxidase activity. Altogether, these data indicate that AIF has a marked oxidoreductase activity which can be dissociated from its apoptosis-inducing function.	Inst Gustave Roussy, CNRS, UMR 1599, F-94805 Villejuif, France; Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780 Oeiras, Portugal; Univ Toronto, Dept Med Biophys & Immunol, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys & Immunol, Amgen Inst, Toronto, ON M5G 2C1, Canada	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; University of Zaragoza; Universidade Nova de Lisboa; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Kroemer, G (corresponding author), Inst Gustave Roussy, CNRS, UMR 1599, Pavillon Rech I,39 Rue Camille Desmoulins, F-94805 Villejuif, France.	kroemer@igr.fr	Saraiva, Ligia M/H-8537-2012; Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013; Susin, Santos A/Q-6754-2017; Penninger, Josef M/I-6860-2013	Saraiva, Ligia M/0000-0002-0675-129X; KROEMER, Guido/0000-0002-9334-4405; Susin, Santos A/0000-0002-3366-1628; Penninger, Josef M/0000-0002-8194-3777; /0000-0002-2742-3711				AHMED SA, 1989, J BIOL CHEM, V264, P19856; Arcari P, 2000, J BIOL CHEM, V275, P895, DOI 10.1074/jbc.275.2.895; Bai JX, 2000, J BIOL CHEM, V275, P19241, DOI 10.1074/jbc.M000438200; Bes MT, 1999, STRUCT FOLD DES, V7, P1201, DOI 10.1016/S0969-2126(00)80054-4; BOHME H, 1987, BIOCHIM BIOPHYS ACTA, V891, P1, DOI 10.1016/0005-2728(87)90076-4; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; CAVALLINI D, 1966, NATURE, V212, P294, DOI 10.1038/212294a0; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Coulter CV, 2000, FREE RADICAL BIO MED, V28, P1547, DOI 10.1016/S0891-5849(00)00255-0; Coves J, 1999, BIOCHEM J, V342, P465, DOI 10.1042/0264-6021:3420465; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ferri KF, 2000, J EXP MED, V192, P1081, DOI 10.1084/jem.192.8.1081; GLASS GA, 1986, J BIOL CHEM, V261, P3247; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GREEN MJ, 1984, METHOD ENZYMOL, V105, P3; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; JARASCH ED, 1981, CELL, V25, P67, DOI 10.1016/0092-8674(81)90232-4; Kampranis SC, 2000, J BIOL CHEM, V275, P29207, DOI 10.1074/jbc.M002359200; Kluck RM, 2000, J BIOL CHEM, V275, P16127, DOI 10.1074/jbc.275.21.16127; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; LINKE B, 1993, RENAL PHYSIOL BIOCH, V16, P244; LINKE B, 1993, REN PHYSL BIOCH, V16, P44; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; LUMPER L, 1967, BIOL CHEM H-S, V348, P323; MAJANDER A, 1994, J BIOL CHEM, V269, P21037; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MohazzabH KM, 1997, CIRCULATION, V96, P614; NIIMURA Y, 1993, J BACTERIOL, V175, P7945, DOI 10.1128/JB.175.24.7945-7950.1993; NIIMURA Y, 1995, J BIOL CHEM, V270, P25645, DOI 10.1074/jbc.270.43.25645; NIIMURA Y, 1994, BIOSCI BIOTECH BIOCH, V58, P2310, DOI 10.1271/bbb.58.2310; NOHL H, 1987, EUR J BIOCHEM, V169, P585, DOI 10.1111/j.1432-1033.1987.tb13649.x; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; OHNISHI K, 1994, J BIOL CHEM, V269, P31418; Patterson SD, 2000, CELL DEATH DIFFER, V7, P137, DOI 10.1038/sj.cdd.4400640; PEZHUERTAS EL, 1999, BIOCHEM J, V337, P531; Poot M, 1999, CYTOMETRY, V35, P311, DOI 10.1002/(SICI)1097-0320(19990401)35:4<311::AID-CYTO3>3.3.CO;2-5; SANCHO J, 1988, ARCH BIOCHEM BIOPHYS, V260, P200, DOI 10.1016/0003-9861(88)90441-9; Susin SA, 2000, METHOD ENZYMOL, V322, P205; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1997, EXP CELL RES, V236, P397, DOI 10.1006/excr.1997.3733; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; TERNYNCK TH, 1989, TECNICAS INMUNOLOGIA; Toomey D, 1998, EUR J BIOCHEM, V251, P935, DOI 10.1046/j.1432-1327.1998.2510935.x; VANDEPLASSCHE G, 1989, J MOL CELL CARDIOL, V21, P383, DOI 10.1016/0022-2828(89)90649-4; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Zalba G, 2000, HYPERTENSION, V35, P1055, DOI 10.1161/01.HYP.35.5.1055; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZANETTI G, 1982, EUR J BIOCHEM, V126, P453, DOI 10.1111/j.1432-1033.1982.tb06801.x; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615	61	313	337	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16391	16398		10.1074/jbc.M010498200	http://dx.doi.org/10.1074/jbc.M010498200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278689	hybrid			2022-12-27	WOS:000168623100109
J	Shen, ZM; Wang, L; Pike, J; Jue, CK; Zhao, H; de Nobel, H; Kurjan, J; Lipke, PN				Shen, ZM; Wang, L; Pike, J; Jue, CK; Zhao, H; de Nobel, H; Kurjan, J; Lipke, PN			Delineation of functional regions within the subunits of the Saccharomyces cerevisiae cell adhesion molecule a-agglutinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ALPHA-AGGLUTININ; SEXUAL AGGLUTINATION; IMMUNOGLOBULIN SUPERFAMILY; SHUTTLE VECTORS; GENE FAMILY; WALL; DOMAINS; EXPRESSION; CLONING; PATHWAY	a-Agglutinin from Saccharomyces cerevisiae is a cell adhesion glycoprotein expressed on the surface of cells of a mating type and consists of an anchorage subunit Aga1p and a receptor binding subunit Aga2p. Cell wall attachment of Agap is mediated through two disulfide bonds to Aga1p (Cappellaro, C., Baldermann, C., Rachel, R., and Tanner, W. (1994) EMBO J. 13, 4737-4744). We report here that purified Aga2p was unstable and had low molar specific activity relative to its receptor alpha -agglutinin, Aga2p co-expressed with a 149-residue fragment of Aga1p formed a disulfide-linked complex with specific activity 43-fold higher than Aga2p expressed alone. Circular dichroism of the complex revealed a mixed alpha/beta structure, whereas Aga2p alone had no periodic secondary structure. A 30-residue Cys-rich Aga1p fragment was partially active in stabilization of Aga2p activity. Mutation of either or both Aga2p cysteine residues eliminated stabilization of Aga2p. Thus the roles of Aga1p include both cell wall anchorage and cysteine-dependent conformational restriction of the binding subunit Aga2p. Mutagenesis of AGA2 identified only C-terminal residues of Aga2p as being essential for binding activity. Aga2p residues 45-72 are similar to sequences in soybean Nod genes, and include residues implicated in interactions with both Aga1p (including Cys(68)) and alpha -agglutinin.	CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; CUNY Hunter Coll, Inst Biomolec Struct & Funct, New York, NY 10021 USA; Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Hunter College (CUNY); University of Vermont	Lipke, PN (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	lipke@genectr.hunter.cuny.edu	Lipke, Peter N./AAW-4914-2020; Wang, Li/D-8990-2011	Lipke, Peter N./0000-0003-1733-0690; 	NCRR NIH HHS [RR-03037] Funding Source: Medline; NIGMS NIH HHS [1RO1-GM47176] Funding Source: Medline; PHS HHS [2S060654] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047176] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BHARGAVA AK, 1990, P NATL ACAD SCI USA, V87, P6798, DOI 10.1073/pnas.87.17.6798; CAPPELLARO C, 1994, EMBO J, V13, P4737, DOI 10.1002/j.1460-2075.1994.tb06799.x; CAPPELLARO C, 1991, EMBO J, V10, P4081, DOI 10.1002/j.1460-2075.1991.tb04984.x; Caro LHP, 1997, YEAST, V13, P1477, DOI 10.1002/(SICI)1097-0061(199712)13:15<1477::AID-YEA184>3.0.CO;2-L; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Creighton T.E., 1993, PROTEINS; DENOBEL H, 1995, MOL GEN GENET, V247, P409, DOI 10.1007/BF00293141; deNobel H, 1996, MOL BIOL CELL, V7, P143, DOI 10.1091/mbc.7.1.143; GANDER JE, 1984, METHOD ENZYMOL, V104, P447; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grigorescu A, 2000, IUBMB LIFE, V50, P105, DOI 10.1080/15216540050212114; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Hamada K, 1999, J BACTERIOL, V181, P3886, DOI 10.1128/JB.181.13.3886-3889.1999; HAUSER K, 1989, FEBS LETT, V255, P290, DOI 10.1016/0014-5793(89)81108-1; Hoyer LL, 1998, CURR GENET, V33, P451, DOI 10.1007/s002940050359; JACOBS FA, 1987, NUCLEIC ACIDS RES, V15, P1271, DOI 10.1093/nar/15.3.1271; Kallal L, 1997, MOL CELL BIOL, V17, P2897, DOI 10.1128/MCB.17.5.2897; KANG YS, 1990, MOL CELL BIOL, V10, P2582, DOI 10.1128/MCB.10.6.2582; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPKE PN, 1992, MICROBIOL REV, V56, P180, DOI 10.1128/MMBR.56.1.180-194.1992; LIPKE PN, 1989, MOL CELL BIOL, V9, P3155, DOI 10.1128/MCB.9.8.3155; LIPKE PN, 1987, J BACTERIOL, V169, P483, DOI 10.1128/jb.169.2.483-488.1987; LIPKE PN, 1995, PROTEIN SCI, V4, P2168, DOI 10.1002/pro.5560041023; LU CF, 1995, J CELL BIOL, V128, P333, DOI 10.1083/jcb.128.3.333; LU CF, 1994, MOL CELL BIOL, V14, P4825, DOI 10.1128/MCB.14.7.4825; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; ROY A, 1991, MOL CELL BIOL, V11, P4196, DOI 10.1128/MCB.11.8.4196; SADLER JE, 1985, P NATL ACAD SCI USA, V82, P6394, DOI 10.1073/pnas.82.19.6394; SANDAL NN, 1987, NUCLEIC ACIDS RES, V15, P1507, DOI 10.1093/nar/15.4.1507; SIJMONS PC, 1987, ARCH MICROBIOL, V148, P208, DOI 10.1007/BF00414813; SIKORSKI RS, 1989, GENETICS, V122, P19; TERRANCE K, 1981, J BACTERIOL, V148, P889, DOI 10.1128/JB.148.3.889-896.1981; Vaughn DE, 1996, NEURON, V16, P261, DOI 10.1016/S0896-6273(00)80045-8; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; WATZELE M, 1988, EMBO J, V7, P1483, DOI 10.1002/j.1460-2075.1988.tb02966.x; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WOJCIECHOWICZ D, 1989, BIOCHEM BIOPH RES CO, V161, P46, DOI 10.1016/0006-291X(89)91557-X; WOJCIECHOWICZ D, 1993, MOL CELL BIOL, V13, P2554, DOI 10.1128/MCB.13.4.2554; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Woody RW, 1996, CIRCULAR DICHROISM C, P109; YEN PH, 1974, BIOCHEMISTRY-US, V13, P2428, DOI 10.1021/bi00708a030; Zhao H, 2001, J BACTERIOL, V183, P2874, DOI 10.1128/JB.183.9.2874-2880.2001	44	22	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15768	15775		10.1074/jbc.M010421200	http://dx.doi.org/10.1074/jbc.M010421200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278672	hybrid			2022-12-27	WOS:000168623100028
J	Conkright, JJ; Bridges, JP; Na, CL; Voorhout, WF; Trapnell, B; Glasser, SW; Weaver, TE				Conkright, JJ; Bridges, JP; Na, CL; Voorhout, WF; Trapnell, B; Glasser, SW; Weaver, TE			Secretion of surfactant protein C, an integral membrane protein, requires the N-terminal propeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE SP-C; RAT TYPE-II; B SP-B; STRUCTURAL REQUIREMENTS; MULTIVESICULAR ENDOSOMES; CYTOPLASMIC TAIL; LUNG-FUNCTION; PC12 CELLS; RECEPTOR; CONTAINS	Proteolytic processing of surfactant protein C (SP-C) proprotein in multivesicular bodies of alveolar type II cells results in a 35-residue mature peptide, consisting of a transmembrane domain and a 10-residue extramembrane domain. SP-C mature peptide is stored in lamellar bodies (a lysosomal-like organelle) and secreted with surfactant phopholipids into the alveolar space. This study was designed to identify the peptide domain of SP-C required for sorting and secretion of this integral membrane peptide. Deletion analyses in transiently transfected PC12 cells and isolated mouse type II cells suggested the extramembrane domain of mature SP-C was cytosolic and sufficient for sorting to the regulated secretory pathway. Intratracheal injection of adenovirus encoding SP-C mature peptide resulted in secretion into the alveolar space of wild type mice but not SP-C (-/-) mice, SP-C secretion in null mice was restored by the addition of the N-terminal propeptide, The cytosolic domain, consisting of the N-terminal propeptide and extramembrane domain of mature SP-C peptide, supported secretion of the transmembrane domain of platelet-derived growth factor receptor, Collectively, these studies indicate that the N-terminal propeptide of SP-C is required for intracellular sorting and secretion of SP-C.	Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; Univ Utrecht, Dept Funct Morphol, NL-3508 TD Utrecht, Netherlands	Cincinnati Children's Hospital Medical Center; Utrecht University	Weaver, TE (corresponding author), Childrens Hosp, Med Ctr, Div Pulm Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.			Bridges, James P./0000-0002-4815-117X	NHLBI NIH HHS [P01-HL6164, R01-HL50046] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050046] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beers MF, 1995, AM J PHYSIOL-LUNG C, V269, pL744, DOI 10.1152/ajplung.1995.269.6.L744; Beers MF, 1998, J BIOL CHEM, V273, P15287, DOI 10.1074/jbc.273.24.15287; Blagoveshchenskaya AD, 1998, J BIOL CHEM, V273, P2729, DOI 10.1074/jbc.273.5.2729; Chuman Y, 1999, FEBS LETT, V462, P129, DOI 10.1016/S0014-5793(99)01493-3; Cool DR, 1996, ENDOCRINOLOGY, V137, P5441, DOI 10.1210/en.137.12.5441; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; CURSTEDT T, 1990, P NATL ACAD SCI USA, V87, P2985, DOI 10.1073/pnas.87.8.2985; Davis AJ, 1998, AM J RESP CRIT CARE, V157, P553, DOI 10.1164/ajrccm.157.2.97-08019; Davis AR, 1998, GENE THER, V5, P1148, DOI 10.1038/sj.gt.3300705; Denzer K, 1997, BIOCHEM J, V326, P497, DOI 10.1042/bj3260497; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; HAFNER D, 1995, BRIT J PHARMACOL, V115, P451; Hawgood S, 1996, AM J RESP CRIT CARE, V154, P484, DOI 10.1164/ajrccm.154.2.8756826; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; Ikegami M, 1996, AM J PHYSIOL-LUNG C, V270, pL650, DOI 10.1152/ajplung.1996.270.4.L650; JOHANSSON J, 1994, BIOCHEMISTRY-US, V33, P6015, DOI 10.1021/bi00185a042; JOHANSSON J, 1991, FEBS LETT, V281, P119, DOI 10.1016/0014-5793(91)80373-B; KELLER A, 1992, AM J RESP CELL MOL, V6, P601, DOI 10.1165/ajrcmb/6.6.601; KELLER A, 1991, BIOCHEM J, V277, P493, DOI 10.1042/bj2770493; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Lin S, 1996, BBA-MOL CELL RES, V1312, P177, DOI 10.1016/0167-4889(95)00201-4; Lin S, 1996, J BIOL CHEM, V271, P19689, DOI 10.1074/jbc.271.33.19689; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; Nogee LM, 1998, BBA-MOL BASIS DIS, V1408, P323, DOI 10.1016/S0925-4439(98)00078-7; Osanai K, 1998, AM J RESP CELL MOL, V19, P929, DOI 10.1165/ajrcmb.19.6.3292; Russo SJ, 1999, AM J PHYSIOL-LUNG C, V277, pL1034, DOI 10.1152/ajplung.1999.277.5.L1034; Schweitzer ES, 1996, J NEUROSCI RES, V46, P519; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sorokin S. P., 1967, J HISTOCHEM CYTOCHEM, V14, P884; Stahlman MT, 2000, LAB INVEST, V80, P395, DOI 10.1038/labinvest.3780044; STAHLMAN MT, 1992, PEDIATR RES, V31, P364, DOI 10.1203/00006450-199204000-00012; STULTS JT, 1991, AM J PHYSIOL, V261, pL118, DOI 10.1152/ajplung.1991.261.2.L118; VOORHOUT WF, 1992, AM J PHYSIOL, V263, pL479, DOI 10.1152/ajplung.1992.263.4.L479; VOORHOUT WF, 1993, MICROSC RES TECHNIQ, V26, P366, DOI 10.1002/jemt.1070260504; Vorbroker DK, 1995, AM J PHYSIOL-LUNG C, V269, pL727, DOI 10.1152/ajplung.1995.269.6.L727; VORBROKER DK, 1995, AM J PHYSIOL, V268, P647; Wang GS, 2000, AM J RESP CELL MOL, V22, P129, DOI 10.1165/ajrcmb.22.2.3938; WHITSETT JA, 1995, PHYSIOL REV, V75, P749, DOI 10.1152/physrev.1995.75.4.749	42	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14658	14664		10.1074/jbc.M011770200	http://dx.doi.org/10.1074/jbc.M011770200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278984	hybrid			2022-12-27	WOS:000168528800020
J	Kato, Y; Kuwabara, T; Warashina, M; Toda, H; Taira, K				Kato, Y; Kuwabara, T; Warashina, M; Toda, H; Taira, K			Relationships between the activities in vitro and in vivo of various kinds of ribozyme and their intracellular localization in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERICALLY CONTROLLABLE RIBOZYMES; HEPATITIS-DELTA-VIRUS; EXTERNAL GUIDE SEQUENCES; HAMMERHEAD RIBOZYME; RIBONUCLEASE-P; MESSENGER-RNA; FUNCTIONAL-ACTIVITY; NUCLEAR EXPORT; CLEAVAGE; MAXIZYMES	Nineteen different functional RNAs were synthesized for an investigation of the actions of ribozymes, in vitro and in vivo, under the control of two different promoters, tRNA or U6, which localize transcripts either in the cytoplasm or in the nucleus, No relationships were found between the activities of these RNAs in cultured cells and the kinetic parameters of their respective chemical cleavage reactions in vitro, indicating that in no case was chemical cleavage the rate-limiting step in vivo, For example, a hepatitis delta virus (HDV) ribozyme, whose activity in vitro was almost 3 orders of magnitude lower than that of a hammerhead ribozyme, still exhibited similar activity in cells when an appropriate expression system was used. As expected, external guide sequences, the actions of which depend on nuclear RNase P, were more active in the nucleus. Analysis of data obtained with cultured cells clearly demonstrated that the cytoplasmic ribozymes were significantly more active than the nuclear ribozymes, suggesting that mature mRNAs in the cytoplasm might be more accessible to antisense molecules than are pre-mRNAs in the nucleus. Our findings should be useful for the future design of intracellularly active functional molecules.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan; Natl Inst Adv Ind Sci & Technol, Gene Discovery Res Ctr, Tsukuba, Ibaraki 3058562, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Taira, K (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, 7-3-1 Hongo, Tokyo 1138656, Japan.	taira@chembio.t.u-tokyo.ac.jp	Toda, Hirofumi/U-3521-2018; Kato, Yoshio/M-1093-2018; Kuwabara, Tomoko/M-1639-2018	Toda, Hirofumi/0000-0002-6247-2826; Kato, Yoshio/0000-0001-8584-367X; Kuwabara, Tomoko/0000-0002-7668-0896				Amontov SV, 1996, J AM CHEM SOC, V118, P1624, DOI 10.1021/ja9517734; ANAVORANICH S, 1998, J BIOL CHEM, V273, P13182; Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; Atkins J.F, 1999, RNA WORLD; Bertrand E, 1997, RNA, V3, P75; Birikh KR, 1997, EUR J BIOCHEM, V245, P1, DOI 10.1111/j.1432-1033.1997.t01-3-00001.x; BUZAYAN JM, 1986, NATURE, V323, P349, DOI 10.1038/323349a0; CASTANOTTO D, 2000, RIBOZYME BIOCH BIOTE, P421; CECH TR, 1981, CELL, V27, P487, DOI 10.1016/0092-8674(81)90390-1; Conaty J, 1999, NUCLEIC ACIDS RES, V27, P2400, DOI 10.1093/nar/27.11.2400; DAS G, 1988, EMBO J, V7, P503, DOI 10.1002/j.1460-2075.1988.tb02838.x; Earnshaw DJ, 2000, BIOCHEMISTRY-US, V39, P6410; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; FU DJ, 1994, J AM CHEM SOC, V116, P4591, DOI 10.1021/ja00090a007; GuerrierTakada C, 1997, P NATL ACAD SCI USA, V94, P8468, DOI 10.1073/pnas.94.16.8468; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hampel A, 1998, PROG NUCLEIC ACID RE, V58, P1; Hertel KJ, 1996, EMBO J, V15, P3751, DOI 10.1002/j.1460-2075.1996.tb00745.x; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Koseki S, 1998, J CONTROL RELEASE, V53, P159, DOI 10.1016/S0168-3659(97)00250-2; Koseki S, 1999, J VIROL, V73, P1868, DOI 10.1128/JVI.73.3.1868-1877.1999; Kruger M, 2000, P NATL ACAD SCI USA, V97, P8566, DOI 10.1073/pnas.97.15.8566; Krummel DAP, 2000, J MOL BIOL, V295, P1113, DOI 10.1006/jmbi.1999.3424; KRUPP G, 2000, RIBOZYME BIOCH BIOTE; Kurata H, 2000, J BIOCHEM MOL BIOL, V33, P359; Kuwabara T, 2000, TRENDS BIOTECHNOL, V18, P462, DOI 10.1016/S0167-7799(00)01498-0; Kuwabara T, 2000, CURR OPIN CHEM BIOL, V4, P669, DOI 10.1016/S1367-5931(00)00150-2; Kuwabara T, 1999, P NATL ACAD SCI USA, V96, P1886, DOI 10.1073/pnas.96.5.1886; Kuwabara T, 1998, NAT BIOTECHNOL, V16, P961, DOI 10.1038/nbt1098-961; Kuwabara T, 1998, MOL CELL, V2, P617, DOI 10.1016/S1097-2765(00)80160-4; Lan N, 1998, SCIENCE, V280, P1593, DOI 10.1126/science.280.5369.1593; LONG DM, 1994, P NATL ACAD SCI USA, V91, P6977, DOI 10.1073/pnas.91.15.6977; McCall MJ, 2000, MOL BIOTECHNOL, V14, P5, DOI 10.1385/MB:14:1:5; MCCALL MJ, 1992, P NATL ACAD SCI USA, V89, P5710, DOI 10.1073/pnas.89.13.5710; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nishikawa F, 1999, NUCLEIC ACIDS RES, V27, P403, DOI 10.1093/nar/27.2.403; NOWELL PC, 1960, SCIENCE, V132, P1497; Ohkawa J, 2000, HUM GENE THER, V11, P577, DOI 10.1089/10430340050015761; OJWANG JO, 1992, P NATL ACAD SCI USA, V89, P10802, DOI 10.1073/pnas.89.22.10802; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; Roy G, 1999, NUCLEIC ACIDS RES, V27, P942, DOI 10.1093/nar/27.4.942; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; SMITH D, 1993, BIOCHEMISTRY-US, V32, P5273, DOI 10.1021/bi00071a001; SULLENGER BA, 1993, SCIENCE, V262, P1566, DOI 10.1126/science.8248806; SYMONS RH, 1992, ANNU REV BIOCHEM, V61, P641; TAKAGI Y, 2001, IN PRESS NUCL ACIDS, V29; Tanabe T, 2000, NATURE, V406, P473, DOI 10.1038/35020190; Tanabe T, 2000, BIOMACROMOLECULES, V1, P108, DOI 10.1021/bm990009x; Thomas BC, 2000, RNA, V6, P545, DOI 10.1017/S1355838200991465; TUSCHL T, 1993, P NATL ACAD SCI USA, V90, P6991, DOI 10.1073/pnas.90.15.6991; Warashina M, 2000, CURR OPIN BIOTECH, V11, P354, DOI 10.1016/S0958-1669(00)00110-5; Warashina M, 2000, STRUCTURE, V8, pR207, DOI 10.1016/S0969-2126(00)00517-7; WARASHINA M, 2001, IN PRESS P NATL ACAD, V98; Warnecke JM, 1999, J MOL BIOL, V290, P433, DOI 10.1006/jmbi.1999.2890; WU HN, 1989, SCIENCE, V243, P652, DOI 10.1126/science.2492677; Yoshinari K, 2000, NUCLEIC ACIDS RES, V28, P1730, DOI 10.1093/nar/28.8.1730; YU M, 1995, P NATL ACAD SCI USA, V92, P699, DOI 10.1073/pnas.92.3.699; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; Zhou DM, 1998, CHEM REV, V98, P991, DOI 10.1021/cr9604292	62	71	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15378	15385		10.1074/jbc.M010570200	http://dx.doi.org/10.1074/jbc.M010570200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278700	hybrid			2022-12-27	WOS:000168528800113
J	Valeva, A; Schnabel, R; Walev, I; Boukhallouk, F; Bhakdi, S; Palmer, M				Valeva, A; Schnabel, R; Walev, I; Boukhallouk, F; Bhakdi, S; Palmer, M			Membrane insertion of the heptameric staphylococcal alpha-toxin pore - A domino-like structural transition that is allosterically modulated by the target cell membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PORE; TRANSFERRIN RECEPTOR; HEMOLYSIN; AUREUS; MUTAGENESIS; OLIGOMERIZATION; ENDOCYTOSIS; CYSTEINE; RESIDUES; TERMINUS	Staphylococcal cy toxin forms heptameric pores on eukaryotic cells. After binding to the cell membrane in its monomeric form, the toxin first assembles into a heptameric pre-pore. Subsequently, the pre-pore transforms into the final pore by membrane insertion of an amphipathic beta -barrel, which comprises the "central loop" domains of all heptamer subunits, The process of membrane insertion was analyzed here using a set of functionally altered toxin mutants. The results show that insertion may be initiated within an individual protomer when its NH2 terminus activates its central loop. The activated state is then shared with the central loops of the residual heptamer subunits, which results in cooperative membrane penetration. This cooperation of the central loops commences while these are still remote from the lipid bilayer, Nevertheless, it is subject to modulation by the target membrane, which therefore acts across a distance much like an allosteric effector. However, while allosteric transitions usually are reversible, membrane insertion of alpha -toxin is an irreversible event, and we show here that it can proceed to completion in a domino-like fashion when triggered by as little as a single foreign atom within the entire heptamer.	Univ Mainz, Inst Med Microbiol & Hyg, D-55101 Mainz, Germany; Texas A&M Univ, Inst Med Biochem & Genet, College Stn, TX 77843 USA	Johannes Gutenberg University of Mainz; Texas A&M University System; Texas A&M University College Station	Valeva, A (corresponding author), Univ Mainz, Inst Med Microbiol & Hyg, Obere Zahlbacher Str 67, D-55101 Mainz, Germany.							Bayley H, 1999, CURR OPIN BIOTECH, V10, P94, DOI 10.1016/S0958-1669(99)80017-2; BHAKDI S, 1984, INFECT IMMUN, V46, P318, DOI 10.1128/IAI.46.2.318-323.1984; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; CORMACK B, 1987, CURRENT PROTOCOLS MO; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; FAIRWEATHER N, 1983, INFECT IMMUN, V41, P1112, DOI 10.1128/IAI.41.3.1112-1117.1983; FUESSLE R, 1981, Journal of Cell Biology, V91, P83; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Olson R, 1999, NAT STRUCT BIOL, V6, P134; PALMER M, 1993, J BIOL CHEM, V268, P11959; PANCHAL RG, 1995, J BIOL CHEM, V270, P23072, DOI 10.1074/jbc.270.39.23072; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; Russo MJ, 1997, NAT BIOTECHNOL, V15, P278, DOI 10.1038/nbt0397-278; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Valeva A, 1997, BBA-BIOMEMBRANES, V1325, P281, DOI 10.1016/S0005-2736(96)00266-0; Valeva A, 1997, P NATL ACAD SCI USA, V94, P11607, DOI 10.1073/pnas.94.21.11607; Valeva A, 1996, EMBO J, V15, P1857, DOI 10.1002/j.1460-2075.1996.tb00536.x; Valeva A, 1997, BIOCHEMISTRY-US, V36, P13298, DOI 10.1021/bi971075r; VALEVA A, 1995, BBA-BIOMEMBRANES, V1236, P213, DOI 10.1016/0005-2736(95)00060-G; Vandana S, 1997, J BIOL CHEM, V272, P24858, DOI 10.1074/jbc.272.40.24858; Walev I, 1996, ANTIMICROB AGENTS CH, V40, P1116, DOI 10.1128/AAC.40.5.1116; WALKER B, 1992, J BIOL CHEM, V267, P21782; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065	25	23	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14835	14841		10.1074/jbc.M100301200	http://dx.doi.org/10.1074/jbc.M100301200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279048	hybrid			2022-12-27	WOS:000168528800042
J	Yang, F; Lio, XY; Sharma, MJ; Zarnegar, M; Lim, B; Sun, Z				Yang, F; Lio, XY; Sharma, MJ; Zarnegar, M; Lim, B; Sun, Z			Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROSTATIC-CARCINOMA; ACTIVATED PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVATION; ESTROGEN-RECEPTOR; CELL-LINE; COACTIVATOR; BINDING; CDC42; CANCER; CLONING	The androgen receptor (AR) is a hormone-dependent transcription factor that plays important roles in male sexual differentiation and development. Transcription activation by steroid hormone receptors, such as the androgen receptor, is mediated through interaction with cofactors. We recently identified a novel AR-interacting protein, provisionally termed PAK6, that shares a high degree of sequence similarity with p21-activated kinases (PAKs). PAK6 is a 75-kDa protein that contains a putative amino-terminal Cdc42/Rac interactive binding motif and a carboxyl-terminal kinase domain. A domain-specific and ligand dependent interaction between AR and PAK6 was further confirmed in vivo and in vitro. Northern blot analysis revealed that PAK6 is highly expressed in testis and prostate tissues. Most importantly, immunofluorescence studies showed that PAK6 cotranslocates into the nucleus with AR in response to androgen, Transient transfection experiments showed that PAK6 specifically repressed AR-mediated transcription, This report identifies a novel function for a PAK-homologous protein and suggests a potential unique mechanism by which other signal transduction pathways may cross-talk with AR pathways to regulate AR function in normal and malignant prostate cells.	Stanford Univ, Sch Med, Dept Surg, Liem Sioc Liong Mol Biol Lab, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Liem Sioc Liong Mol Biol Lab, Stanford, CA 94305 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA	Stanford University; Stanford University; Harvard University; Beth Israel Deaconess Medical Center	Sun, Z (corresponding author), Stanford Univ, Sch Med, Dept Surg, Liem Sioc Liong Mol Biol Lab, R135,Edwards Bldg, Stanford, CA 94305 USA.				NATIONAL CANCER INSTITUTE [R01CA070297, R29CA070297, R01CA087767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061002, R01DK047636] Funding Source: NIH RePORTER; NCI NIH HHS [R29 CA070297, R01 CA087767-05, R01 CA087767, R01 CA087767-04, R01 CA070297-09, R01 CA087767-03, R01 CA087767-01A2, R01 CA070297-10, R29 CA070297-04, R01 CA070297, CA70297, R01 CA087767-02, R29 CA070297-03, R01 CA070297-08, R01 CA070297-12, R01 CA070297-06A1, R01 CA070297-07, R01 CA070297-11A2] Funding Source: Medline; NIDDK NIH HHS [R01 DK061002-04, R01 DK061002-01A1, R01 DK061002-05, R01 DK061002-02, R01 DK061002-03, DK 47636, R01 DK061002] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; CULIG Z, 1994, CANCER RES, V54, P5474; DERUITER PE, 1995, MOL CELL ENDOCRINOL, V110, pR1, DOI 10.1016/0303-7207(95)03534-E; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; HOECK W, 1992, J STEROID BIOCHEM, V41, P283, DOI 10.1016/0960-0760(92)90353-K; Hoffman GR, 2000, CELL, V102, P403, DOI 10.1016/S0092-8674(00)00045-3; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; James P, 1996, GENETICS, V144, P1425; Jenster G, 1999, SEMIN ONCOL, V26, P407; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kang HY, 1999, J BIOL CHEM, V274, P8570, DOI 10.1074/jbc.274.13.8570; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; MINK S, 1990, NUCLEIC ACIDS RES, V18, P2017, DOI 10.1093/nar/18.8.2017; Moilanen AM, 1998, MOL BIOL CELL, V9, P2527, DOI 10.1091/mbc.9.9.2527; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; ONATE SA, 1995, SCIENCE, V270, P1354; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Sullivan W. P., 1992, J STEROID BIOCHEM, V43, P37; Sun ZJ, 1999, CANCER-AM CANCER SOC, V86, P689, DOI 10.1002/(SICI)1097-0142(19990815)86:4<689::AID-CNCR19>3.0.CO;2-P; Sun ZJ, 1997, NUCLEIC ACIDS RES, V25, P3318, DOI 10.1093/nar/25.16.3318; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Tu H, 1999, MOL CELL BIOL, V19, P602; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhau HYE, 1996, P NATL ACAD SCI USA, V93, P15152, DOI 10.1073/pnas.93.26.15152; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605; ZHOU ZX, 1994, RECENT PROG HORM RES, V49, P249; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363	52	124	138	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15345	15353		10.1074/jbc.M010311200	http://dx.doi.org/10.1074/jbc.M010311200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278661	hybrid			2022-12-27	WOS:000168528800109
J	Kiefer, C; Hessel, S; Lampert, JM; Vogt, K; Lederer, MO; Breithaupt, DE; von Lintig, J				Kiefer, C; Hessel, S; Lampert, JM; Vogt, K; Lederer, MO; Breithaupt, DE; von Lintig, J			Identification and characterization of a mammalian enzyme catalyzing the asymmetric oxidative cleavage of provitamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CAROTENE; RETINOIC ACID; EXPRESSION; PIGMENT; BIOSYNTHESIS; CONVERSION; RECEPTOR; PROTEIN; BIOLOGY; CLONING	In vertebrates, symmetric versus asymmetric cleavage of beta -carotene in the biosynthesis of vitamin A and its derivatives has been controversially discussed. Recently me have been able to identify a cDNA encoding a metazoan beta,beta -carotene-15,15'-dioxygenase from the fruit fly Drosophila melanogaster, This enzyme catalyzes the key step in vitamin A biosynthesis, symmetrically cleaving beta -carotene to give two molecules of retinal, Mutations in the corresponding gene are known to lead to a blind, vitamin A-deficient phenotype, Orthologs of this enzyme have very recently been found also in vertebrates and molecularly characterized. Here we report the identification of a cDNA from mouse encoding a second type of carotene dioxygenase catalyzing exclusively the asymmetric oxidative cleavage of beta -carotene at the 9',10' double bond of beta -carotene and resulting in the formation of beta -apo-10'-carotenal and beta -ionone, a substance known as a floral scent from roses, for example. Besides beta -carotene, lycopene is also oxidatively cleaved by the enzyme. The deduced amino acid sequence shares significant sequence identity with the beta,beta -carotene-15,15' dioxygenases, and the two enzyme types have several conserved motifs, To establish its occurrence in different vertebrates, we then attempted and succeeded in cloning cDNAs encoding this new type of carotene dioxygenase from human and zebrafish as web, As regards their possible role, the apocarotenals formed by this enzyme may be the precursors for the biosynthesis of retinoic acid or exert unknown physiological effects. Thus, in contrast to Drosophila, in vertebrates both symmetric and asymmetric cleavage pathways exist for carotenes, revealing a greater complexity of carotene metabolism.	Univ Freiburg, Inst Biol Anim Physiol & Neurobiol 1, D-79104 Freiburg, Germany; Univ Hohenheim, Inst Lebensmittelchem, D-70599 Stuttgart, Germany	University of Freiburg; University Hohenheim	von Lintig, J (corresponding author), Univ Freiburg, Inst Biol Anim Physiol & Neurobiol 1, Hauptstr 1, D-79104 Freiburg, Germany.			von Lintig, Johannes/0000-0002-2079-2143				Barua AB, 2000, J NUTR, V130, P1996, DOI 10.1093/jn/130.8.1996; BAVIK CO, 1991, J BIOL CHEM, V266, P14978; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Clinton SK, 1998, NUTR REV, V56, P35, DOI 10.1111/j.1753-4887.1998.tb01691.x; DOWLING JE, 1960, P NATL ACAD SCI USA, V46, P587, DOI 10.1073/pnas.46.5.587; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GLOVER J, 1960, VITAM HORM, V18, P371; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Henry LK, 2000, J AGR FOOD CHEM, V48, P5008, DOI 10.1021/jf000503o; McCaffery P, 2000, CYTOKINE GROWTH F R, V11, P233, DOI 10.1016/S1359-6101(00)00002-2; Nagao A, 1996, ARCH BIOCHEM BIOPHYS, V328, P57, DOI 10.1006/abbi.1996.0142; NAPOLI JL, 1988, J BIOL CHEM, V263, P17372; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Russell RM, 2000, AM J CLIN NUTR, V71, P878; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; SHARMA RV, 1976, BIOCHEM J, V158, P377, DOI 10.1042/bj1580377; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; TANG GW, 1991, BIOCHEMISTRY-US, V30, P9829, DOI 10.1021/bi00105a003; VOGT K, 1984, Z NATURFORSCH C, V39, P196; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2001, P NATL ACAD SCI USA, V98, P1130, DOI 10.1073/pnas.031576398; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; WANG XD, 1991, ARCH BIOCHEM BIOPHYS, V285, P8, DOI 10.1016/0003-9861(91)90322-A; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60; WANG XD, 1996, J BIOL CHEM, V271, P26493; WOLF G, 1995, NUTR REV, V53, P134, DOI 10.1111/j.1753-4887.1995.tb01537.x; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619	31	338	359	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14110	14116		10.1074/jbc.M011510200	http://dx.doi.org/10.1074/jbc.M011510200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278918	hybrid			2022-12-27	WOS:000168356600082
J	Ulyanova, T; Shah, DD; Thomas, ML				Ulyanova, T; Shah, DD; Thomas, ML			Molecular cloning of MIS, a myeloid inhibitory siglec, that binds protein-tyrosine phosphatases SHP-1 and SHP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; LINKED LYMPHOPROLIFERATIVE-DISEASE; CUTTING EDGE; DENDRITIC CELLS; T-CELLS; RECEPTOR; ANTIGEN; ACID; CD33; SIALOADHESIN	We describe the molecular cloning and characterization of a novel myeloid inhibitory siglec, MIS, that belongs to the family of sialic acid-binding immunoglobulin-like lectins, A full-length MIS cDNA was obtained from murine bone marrow cells. MIS is predicted to contain an extracellular region comprising three immunoglobulin-like domains (V-set amino-terminal domain followed by two C-set domains), a transmembrane domain and a cytoplasmic tail with two immunoreceptor tyrosine-based inhibitory motif (ITIM)-like sequences. The closest relative of MIS in the siglec family is human siglec 8, Extracellular regions of these two siglecs share 47% identity at the amino acid level, Southern blot analysis suggests the presence of one MIS gene. MIS is expressed in the spleen, liver, heart, kidney, lung and testis tissues. Several isoforms of MIS protein exist due to the alternative splicing, In a human promonocyte cell line, MIS was able to bind Src homology a-containing protein-tyrosine phosphatases, SHP-1 and SHP-2. This binding was mediated by the membrane-proximal ITIM of MIS, Moreover, MIS exerted an inhibitory effect on Fc gamma RI receptor-induced calcium mobilization, These data suggest that MIS can play an inhibitory role through its ITIM sequences.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Ulyanova, T (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Rheumatol, POB 8045 S Euclid Ave, St Louis, MO 63110 USA.	ulyanova@pathology.wustl.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056455] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56455] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Barnes YC, 1999, BLOOD, V93, P1245, DOI 10.1182/blood.V93.4.1245.404k09_1245_1252; BRAESCHANDERSEN S, 1994, J BIOL CHEM, V269, P11783; Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066; Carretero M, 1998, EUR J IMMUNOL, V28, P1280, DOI 10.1002/(SICI)1521-4141(199804)28:04<1280::AID-IMMU1280>3.0.CO;2-O; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; Colonna M, 1998, J IMMUNOL, V160, P3096; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; Crocker P R, 1998, Glycobiology, V8, pv; Crocker PR, 1997, GLYCOCONJUGATE J, V14, P601, DOI 10.1023/A:1018588526788; Cyster JG, 1997, IMMUNITY, V6, P509, DOI 10.1016/S1074-7613(00)80339-8; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Ferlazzo G, 2000, EUR J IMMUNOL, V30, P827, DOI 10.1002/1521-4141(200003)30:3<827::AID-IMMU827>3.3.CO;2-T; Floyd H, 2000, J BIOL CHEM, V275, P861, DOI 10.1074/jbc.275.2.861; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Gupta N, 1997, J EXP MED, V186, P473, DOI 10.1084/jem.186.3.473; Ho LH, 1999, P NATL ACAD SCI USA, V96, P15086, DOI 10.1073/pnas.96.26.15086; Kelm S, 1996, GLYCOCONJUGATE J, V13, P913, DOI 10.1007/BF01053186; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; MCFARLAND EDC, 1995, J BIOL CHEM, V270, P28103; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Mingari MC, 1998, IMMUNOL TODAY, V19, P153, DOI 10.1016/S0167-5699(97)01236-X; MORETTA A, 1995, J EXP MED, V182, P875, DOI 10.1084/jem.182.3.875; Nadler MJS, 1997, J IMMUNOL, V159, P4233; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Patel N, 1999, J BIOL CHEM, V274, P22729, DOI 10.1074/jbc.274.32.22729; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Rojo S, 1997, EUR J IMMUNOL, V27, P568, DOI 10.1002/eji.1830270231; ROSALES C, 1992, J BIOL CHEM, V267, P5265; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; SIMMONS D, 1988, J IMMUNOL, V141, P2797; Takei Y, 1997, CYTOGENET CELL GENET, V78, P295, DOI 10.1159/000134676; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tangye SG, 1999, J IMMUNOL, V162, P6981; Taylor VC, 1999, J BIOL CHEM, V274, P11505, DOI 10.1074/jbc.274.17.11505; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; Timms JF, 1999, CURR BIOL, V9, P927, DOI 10.1016/S0960-9822(99)80401-1; Ulyanova T, 1999, EUR J IMMUNOL, V29, P3440, DOI 10.1002/(SICI)1521-4141(199911)29:11<3440::AID-IMMU3440>3.3.CO;2-3; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Vely F, 1997, EUR J IMMUNOL, V27, P1994, DOI 10.1002/eji.1830270825; Vely F, 1997, J IMMUNOL, V159, P2075; Vitale C, 1999, P NATL ACAD SCI USA, V96, P15091, DOI 10.1073/pnas.96.26.15091; Yu ZB, 2001, BIOCHEM J, V353, P483, DOI 10.1042/0264-6021:3530483; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187	51	48	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14451	14458		10.1074/jbc.M011650200	http://dx.doi.org/10.1074/jbc.M011650200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278955	hybrid			2022-12-27	WOS:000168356600124
J	Tozawa, R; Ishibashi, S; Osuga, J; Yamamoto, K; Yagyu, H; Ohashi, K; Tamura, Y; Yahagi, N; Iizuka, Y; Okazaki, H; Harada, K; Gotoda, T; Shimano, H; Kimura, S; Nagai, R; Yamada, N				Tozawa, R; Ishibashi, S; Osuga, J; Yamamoto, K; Yagyu, H; Ohashi, K; Tamura, Y; Yahagi, N; Iizuka, Y; Okazaki, H; Harada, K; Gotoda, T; Shimano, H; Kimura, S; Nagai, R; Yamada, N			Asialoglycoprotein receptor deficiency in mice lacking the major receptor subunit - Its obligate requirement for the stable expression of oligomeric receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC BINDING; RECOGNITION; GALACTOSE; GLYCOPROTEINS; TRANSPORT; PATHWAY; VIRUS	The asialoglycoprotein receptor is an abundant hetero-oligomeric endocytic receptor that is predominantly expressed on the sinusoidal surface of the hepatocytes, A number of physiological and pathophysiological functions have been ascribed to this hepatic lectin (HL), the removal of desialylated serum glycoproteins and apoptotic cells, clearance of lipoproteins, and the sites of entry for hepatotropic viruses. The assembly of two homologous subunits, HL-1 and HL-2, is required to form functional, high affinity receptors on the cell surface. However, the importance of the individual subunits for receptor transport to the cell surface is controversial. We have previously generated HL-S-deficient mice and showed that the expression of HL-1 was significantly reduced, and the functional activity as the asialoglycoprotein receptor was virtually eliminated. However, we failed to detect phenotypic abnormalities. To explore the significance of the major HL-1 subunit for receptor expression and function in vivo, we have disrupted the HL-1 gene in mice. Homozygous HL-1-deficient animals are superficially normal. HL-2 expression in the liver is virtually abrogated, indicating that HL-1 is strictly required for the stable expression of HL-2, Although these mice are almost unable to clear asialo-orosomucoid, a high affinity ligand for asialoglycoprotein receptor, they do not accumulate desialylated glycoproteins or lipoproteins in the plasma.	Univ Tokyo, Dept Metab Dis, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Dept Cardiovasc Med, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Dept Infect Dis, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Dept Integrated Biosci, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tsukuba, Inst Clin Med, Dept Metab Endocrinol & Atherosclerosis, Tsukuba, Ibaraki 3058575, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tsukuba	Ishibashi, S (corresponding author), Univ Tokyo, Dept Metab Dis, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ishibash-tky@umin.ac.jp	Yahagi, Naoya/D-2360-2014; Shimano, Hitoshi/AAI-5648-2020; Shimano, Hitoshi/V-1761-2019; Harada, Kenji/J-2230-2016	Yahagi, Naoya/0000-0002-1823-1865; Shimano, Hitoshi/0000-0002-5562-5572; 				ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99; BECKER S, 1995, J GEN VIROL, V76, P393, DOI 10.1099/0022-1317-76-2-393; BRAITERMAN LT, 1989, J BIOL CHEM, V264, P1682; Braun JR, 1996, J BIOL CHEM, V271, P21160, DOI 10.1074/jbc.271.35.21160; Dotzauer A, 2000, J VIROL, V74, P10950, DOI 10.1128/JVI.74.23.10950-10957.2000; DRICKAMER K, 1991, CELL, V67, P1029, DOI 10.1016/0092-8674(91)90278-7; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; GEFFEN I, 1989, EMBO J, V8, P2855, DOI 10.1002/j.1460-2075.1989.tb08433.x; HALBERG DF, 1987, J BIOL CHEM, V262, P9828; II M, 1990, J BIOL CHEM, V265, P11295; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; Kido M, 1999, FEBS LETT, V464, P75, DOI 10.1016/S0014-5793(99)01681-6; LODISH HF, 1991, TRENDS BIOCHEM SCI, V16, P374, DOI 10.1016/0968-0004(91)90154-N; MARSHALL JS, 1974, J CLIN INVEST, V54, P555, DOI 10.1172/JCI107792; ODA S, 1988, J BIOCHEM-TOKYO, V104, P600, DOI 10.1093/oxfordjournals.jbchem.a122518; Rifai A, 2000, J EXP MED, V191, P2171, DOI 10.1084/jem.191.12.2171; ROHMANN A, 1998, J CLIN INVEST, V101, P689; Rotundo RF, 1998, HEPATOLOGY, V28, P475, DOI 10.1002/hep.510280227; RUTONDO RF, 1999, AM J PHYSIOL, V277, pG1189; SAWAMURA T, 1981, GASTROENTEROLOGY, V81, P527; SCHAUER R, 1985, CLIN CHIM ACTA, V146, P119, DOI 10.1016/0009-8981(85)90050-6; SHIA MA, 1989, P NATL ACAD SCI USA, V86, P1158, DOI 10.1073/pnas.86.4.1158; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Soukharev S, 2000, GENE, V241, P233, DOI 10.1016/S0378-1119(99)00493-X; SPIESS M, 1990, BIOCHEMISTRY-US, V29, P1009, DOI 10.1021/bi00495a001; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Tozawa R, 1999, J BIOL CHEM, V274, P30843, DOI 10.1074/jbc.274.43.30843; TREICHEL U, 1994, J GEN VIROL, V75, P3021, DOI 10.1099/0022-1317-75-11-3021; WEIGEL PH, 1994, BIOESSAYS, V16, P519, DOI 10.1002/bies.950160713; WIKSTROM L, 1993, J BIOL CHEM, V268, P14412; WIKSTROM L, 1992, J BIOL CHEM, V267, P5; WINDLER E, 1991, BIOCHEM J, V276, P79, DOI 10.1042/bj2760079; Yagyu H, 1999, J LIPID RES, V40, P1677	34	67	70	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12624	12628		10.1074/jbc.M011063200	http://dx.doi.org/10.1074/jbc.M011063200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278827	hybrid			2022-12-27	WOS:000168198600022
J	Hung, W; Elliott, B				Hung, W; Elliott, B			Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; HUMAN BREAST-CARCINOMA; FACTOR SCATTER FACTOR; FACTOR GENE PROMOTER; V-SRC; TRANSCRIPTIONAL REGULATION; TRANSGENIC MICE; DNA-BINDING; FACTOR HGF; CELLULAR-TRANSFORMATION	We have previously shown coexpression of hepatocyte growth factor (HGF) and its receptor Met in the invasive tumor front of human breast carcinomas. We have also demonstrated secretion of HGF, constitutive activation of Met, and increased invasion in a murine breast carcinoma cell line, SP1. These observations suggest the presence of an HGF autocrine loop in some breast carcinoma cells, which confers increased survival, growth, and invasiveness during tumor progression and metastasis. c-Src tyrosine kinase, which is critical in regulating the expression of many genes, is activated in SP1 carcinoma cells, as well as in most human breast cancers. We therefore examined the role of c-Src kinase in HGF expression in breast carcinoma cells. Expression of activated c-Src in SP1 cells increased transcription from the HGF promoter and expression of HGF mRNA and protein, while dominant negative c-Src had the opposite effect. Using deletion analysis, we showed that the region between -254 and -70 base pairs was required for c-Src responsiveness of the HGF promoter. This region contains two putative consensus sequences (at -110 and -149 base pairs) for the Stat3 transcription factor, which bind protein complexes containing Stat3 (but not Stat1, -5A, or -5B), Coexpression of activated c-Src and Stat3 synergistically induced strong HGF promoter activity in SP1 cells, as well as in a nonmalignant epithelial cell line, HC11 (HGF negative). c-Src kinase activity correspondingly increased the tyrosine 705 phosphorylation and DNA binding affinity of Stat3 (but not Stat1, -5A, or -5B). Collectively, our data indicate a cooperative effect of c-Src kinase and Stat3 in the activation of HGF transcription and protein expression in breast carcinoma cells, This process may be important in overriding the strong repression of HGF expression in nonmalignant epithelium, and thereby promote tumorigenesis.	Queens Univ, Canc Res Labs, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Elliott, B (corresponding author), Queens Univ, Canc Res Labs, Botterell Hall, Kingston, ON K7L 3N6, Canada.							Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Andermarcher E, 1996, DEV GENET, V18, P254, DOI 10.1002/(SICI)1520-6408(1996)18:3<254::AID-DVG6>3.0.CO;2-8; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bell AW, 1998, J BIOL CHEM, V273, P6900, DOI 10.1074/jbc.273.12.6900; Beviglia L, 1997, INT J CANCER, V74, P301, DOI 10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO;2-E; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; COBB BS, 1993, ONCOGENE, V8, P2897; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; DIRENZO MF, 1995, CANCER RES, V55, P1129; DOPPLER W, 1989, P NATL ACAD SCI USA, V86, P104, DOI 10.1073/pnas.86.1.104; Fan SJ, 1998, ONCOGENE, V17, P131, DOI 10.1038/sj.onc.1201943; Fixman ED, 1996, J BIOL CHEM, V271, P13116, DOI 10.1074/jbc.271.22.13116; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; Ghoussoub RAD, 1998, CANCER, V82, P1513, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO;2-7; GUY CT, 1994, GENE DEV, V8, P23, DOI 10.1101/gad.8.1.23; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Ivanchuk SM, 1998, ONCOGENE, V16, P991, DOI 10.1038/sj.onc.1201622; Jeffers M, 1996, CELL GROWTH DIFFER, V7, P1805; Jenab S, 1997, ENDOCRINOLOGY, V138, P2740, DOI 10.1210/en.138.7.2740; Jiang JG, 1997, J BIOL CHEM, V272, P3928, DOI 10.1074/jbc.272.7.3928; Jiang JG, 1997, ONCOGENE, V14, P3039, DOI 10.1038/sj.onc.1201152; Jiang JG, 1997, MOL CELL BIOL, V17, P5758, DOI 10.1128/MCB.17.10.5758; KARAPLIS AC, 1995, J BIOL CHEM, V270, P1629, DOI 10.1074/jbc.270.4.1629; Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007; KAZANSKY AV, 1995, MOL ENDOCRINOL, V9, P1598, DOI 10.1210/me.9.11.1598; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; Liang TJ, 1996, J CLIN INVEST, V97, P2872, DOI 10.1172/JCI118744; LIU YH, 1993, BIOCHIM BIOPHYS ACTA, V1216, P299, DOI 10.1016/0167-4781(93)90159-B; LIU YH, 1994, J BIOL CHEM, V269, P4152; LIU YH, 1994, MOL CELL BIOL, V14, P7046, DOI 10.1128/MCB.14.11.7046; LIU YH, 1994, GENE, V144, P179, DOI 10.1016/0378-1119(94)90376-X; Lu LR, 1998, EUR J IMMUNOL, V28, P805, DOI 10.1002/(SICI)1521-4141(199803)28:03<805::AID-IMMU805>3.0.CO;2-G; MCLESKEY SW, 1993, CANCER RES, V53, P2168; Meiners S, 1998, ONCOGENE, V16, P9, DOI 10.1038/sj.onc.1201486; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Mohan WS, 1998, J LIPID RES, V39, P255; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; MUKHOPADHYAY D, 1995, CANCER RES, V55, P6161; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; MUTHUSWAMY SK, 1994, MOL CELL BIOL, V14, P735, DOI 10.1128/MCB.14.1.735; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; Qiao H, 2000, CELL GROWTH DIFFER, V11, P123; Rahimi N, 1996, CELL GROWTH DIFFER, V7, P263; Rahimi N, 1996, J BIOL CHEM, V271, P24850, DOI 10.1074/jbc.271.40.24850; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; Rahimi N, 1996, PROTEIN EXPRES PURIF, V7, P329, DOI 10.1006/prep.1996.0047; RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Smith PD, 1998, BIOCHEM J, V331, P381, DOI 10.1042/bj3310381; SUPERTIFURGA G, 1995, FEBS LETT, V369, P62, DOI 10.1016/0014-5793(95)00636-N; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Toi M, 1998, CLIN CANCER RES, V4, P659; Tuck AB, 1996, AM J PATHOL, V148, P225; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Wang YZ, 2000, ONCOGENE, V19, P2075, DOI 10.1038/sj.onc.1203548; WEBSTER MA, 1995, P NATL ACAD SCI USA, V92, P7849, DOI 10.1073/pnas.92.17.7849; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; YAMASHITA J, 1994, CANCER RES, V54, P1630; YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555	68	67	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12395	12403		10.1074/jbc.M010715200	http://dx.doi.org/10.1074/jbc.M010715200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278729	hybrid			2022-12-27	WOS:000168081800127
J	Yeh, RH; Lee, TR; Lawrence, DS				Yeh, RH; Lee, TR; Lawrence, DS			From consensus sequence peptide to high affinity ligand, a "library scan" strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; DEPENDENT PROTEIN-KINASE; COMBINATORIAL CHEMISTRY; ALANINE SCAN; BINDING; DOMAIN; INHIBITOR; SH2; DISCOVERY	A wide variety of proteins have been shown to recognize and bind to specific amino acid sequences on other proteins. These sequences can be readily identified using combinatorial peptide libraries. However, peptides containing these preferred sequences ("consensus sequence peptides") typically display only modest affinities for the consensus sequence-binding site on the intact protein. In this report, we describe a parallel synthesis strategy that transforms consensus sequence peptides into high affinity ligands. The work described herein has focused on the Lck SH2 domain, which binds the consensus peptide acetyl-Tyr(P)-Glu-Glu-Ile-amide with a K-D of 1.3 muM. We employed a strategy that creates a series of spatially focused libraries that challenge specific subsites on the target protein with a diverse array of functionality. The final lead compound identified in this study displayed a 3300-fold higher affinity for the Lck SH2 domain than the starting consensus sequence peptide.	Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Lawrence, DS (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	dlawrenc@aecom.yu.edu		Lee, Tae Ryong/0000-0002-6914-1237				Aitken A, 1999, MOL BIOTECHNOL, V12, P241, DOI 10.1385/MB:12:3:241; BECKSICKINGER AG, 1994, EUR J BIOCHEM, V225, P947, DOI 10.1111/j.1432-1033.1994.0947b.x; Bradshaw JM, 1999, BIOCHEMISTRY-US, V38, P5147, DOI 10.1021/bi982974y; Bridges AJ, 1995, BIOORGAN MED CHEM, V3, P1651, DOI 10.1016/0968-0896(95)00149-2; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; CHENG HC, 1985, BIOCHEM J, V231, P655, DOI 10.1042/bj2310655; Combs AP, 1996, J AM CHEM SOC, V118, P287, DOI 10.1021/ja953750v; Emili AQ, 2000, NAT BIOTECHNOL, V18, P393, DOI 10.1038/74442; Fauchere JL, 1998, CHEMOMETR INTELL LAB, V43, P43, DOI 10.1016/S0169-7439(98)00082-3; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Garcia-Echeverria C, 1999, BIOORG MED CHEM LETT, V9, P2915, DOI 10.1016/S0960-894X(99)00501-6; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Kelly ME, 2000, CURR OPIN IMMUNOL, V12, P267, DOI 10.1016/S0952-7915(00)00086-8; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Lawrence DS, 1998, PHARMACOL THERAPEUT, V77, P81, DOI 10.1016/S0163-7258(97)00052-1; LEBL M, 1995, BIOPOLYMERS, V37, P177, DOI 10.1002/bip.360370303; Lee TR, 1999, J MED CHEM, V42, P784, DOI 10.1021/jm980663f; Lee TR, 2000, J MED CHEM, V43, P1173, DOI 10.1021/jm990462r; Mayer BJ, 1998, CURR TOP MICROBIOL, V228, P1; PINILLA C, 1995, BIOPOLYMERS, V37, P221, DOI 10.1002/bip.360370306; SCHAFFHAUSEN B, 1995, BBA-REV CANCER, V1242, P61, DOI 10.1016/0304-419X(95)00004-Y; SCOTT JD, 1985, P NATL ACAD SCI USA, V82, P4379, DOI 10.1073/pnas.82.13.4379; Shackney SE, 1999, CYTOMETRY, V35, P97, DOI 10.1002/(SICI)1097-0320(19990201)35:2<97::AID-CYTO1>3.3.CO;2-X; TAM JP, 1994, PEPTIDES, V15, P703, DOI 10.1016/0196-9781(94)90099-X; Wang E, 1999, J CELL BIOCHEM, P95; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zwick MB, 2000, J MOL BIOL, V300, P307, DOI 10.1006/jmbi.2000.3850	27	23	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12235	12240		10.1074/jbc.M011232200	http://dx.doi.org/10.1074/jbc.M011232200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278862	hybrid			2022-12-27	WOS:000168081800107
J	Bhalla, SS; Robitaille, L; Nemer, M				Bhalla, SS; Robitaille, L; Nemer, M			Cooperative activation by GATA-4 and YY1 of the cardiac B-type natriuretic peptide promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR YY1; SERUM RESPONSE FACTOR; FACTOR GENE-TRANSCRIPTION; ZINC-FINGER PROTEIN; EPSILON-GLOBIN GENE; BINDING PROTEIN; ADENOVIRUS E1A; P300 PROTEIN; EXPRESSION; CELLS	YY1, a multifunctional protein essential for embryonic development, is a known repressor or activator of transcription. In cardiac and skeletal myocytes, YY1 has been described essentially as a negative regulator of muscle-specific genes. In this study, we report that YY1 is a transcriptional activator of the B-type natriuretic peptide (BNP) gene, which encodes one of the heart major secretory products. YY1 binds an element within the proximal cardiac BNP promoter, in close proximity to the high affinity binding sites for the zinc finger GATA proteins. We show that YY1 cooperates with GATA-4 to synergistically activate BNP transcription. Structure-function analysis revealed that the DNA binding domain of YY1 is sufficient for cooperative interaction with GATA-4, likely through corecruitment of the CREB-binding protein coactivator. The results suggest that YY1 and GATA factors are components of transcriptionally active complexes present in cardiac and other GATA-containing cells.	Inst Rech Clin Montreal, Lab Dev & Differenciat Cardiaques, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Dept Pharmacol, Montreal, PQ H2W 1R7, Canada; McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3A 1A3, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Nemer, M (corresponding author), Inst Rech Clin Montreal, Lab Dev & Differenciat Cardiaques, 110 Pins Ouest, Montreal, PQ H2W 1R7, Canada.				PHS HHS [MT -13057] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ARDATI A, 1993, EMBO J, V12, P5131, DOI 10.1002/j.1460-2075.1993.tb06208.x; ARGENTIN S, 1991, J BIOL CHEM, V266, P23315; ARGENTIN S, 1994, MOL CELL BIOL, V14, P777, DOI 10.1128/MCB.14.1.777; BIEKER JJ, 1995, MOL CELL BIOL, V15, P852; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; BUSHMEYER S, 1995, J BIOL CHEM, V270, P30213; Charron F, 1999, MOL CELL BIOL, V19, P4355; Charron F, 1999, SEMIN CELL DEV BIOL, V10, P85, DOI 10.1006/scdb.1998.0281; Chen CY, 1997, MOL ENDOCRINOL, V11, P812, DOI 10.1210/me.11.6.812; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Eckner R, 1996, BIOL CHEM, V377, P685; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; FARNHAM PJ, 1990, MOL CELL BIOL, V10, P1390, DOI 10.1128/MCB.10.4.1390; FLANAGAN JR, 1992, MOL CELL BIOL, V12, P38, DOI 10.1128/MCB.12.1.38; Grepin C, 1997, DEVELOPMENT, V124, P2387; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; GREPIN C, 1995, MOL CELL BIOL, V15, P4095; Grondin B, 1997, J BIOL CHEM, V272, P27877, DOI 10.1074/jbc.272.44.27877; GUALBERTO A, 1992, MOL CELL BIOL, V12, P4209, DOI 10.1128/MCB.12.9.4209; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; Hasegawa K, 1997, J BIOL CHEM, V272, P20049, DOI 10.1074/jbc.272.32.20049; Herzig TC, 1997, P NATL ACAD SCI USA, V94, P7543, DOI 10.1073/pnas.94.14.7543; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Izumo S, 1998, J Card Fail, V4, P263, DOI 10.1016/S1071-9164(98)90231-7; Jacobsen BM, 1999, J BIOL CHEM, V274, P29984, DOI 10.1074/jbc.274.42.29984; Kakita T, 1999, J BIOL CHEM, V274, P34096, DOI 10.1074/jbc.274.48.34096; Korhonen P, 1997, MOL BRAIN RES, V52, P330; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; LENARDO MJ, 1989, SCIENCE, V243, P544, DOI 10.1126/science.2536195; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; LIU R, 1994, NUCLEIC ACIDS RES, V22, P2453, DOI 10.1093/nar/22.13.2453; LU SY, 1994, MOL CELL BIOL, V14, P6253, DOI 10.1128/MCB.14.9.6253; MACLELLAN WR, 1994, J BIOL CHEM, V269, P16754; MCBRIDE K, 1993, MOL CELL BIOL, V13, P600, DOI 10.1128/MCB.13.1.600; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Molkentin JD, 1997, CIRCULATION, V96, P3833; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; MORIN S, 2001, IN PRESS MOL CELL BI, V21; NATESAN S, 1995, MOL CELL BIOL, V15, P5975; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Patten M, 1996, J BIOL CHEM, V271, P21134, DOI 10.1074/jbc.271.35.21134; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; RAICH N, 1995, EMBO J, V14, P801, DOI 10.1002/j.1460-2075.1995.tb07058.x; RAUGHT B, 1994, MOL CELL BIOL, V14, P1752, DOI 10.1128/MCB.14.3.1752; RIGGS KJ, 1993, MOL CELL BIOL, V13, P7487, DOI 10.1128/MCB.13.12.7487; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seelan RS, 1997, J BIOL CHEM, V272, P10175, DOI 10.1074/jbc.272.15.10175; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SHIH IM, 1993, J INVEST DERMATOL, V100, P196; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; VINCENT CK, 1993, MOL CELL BIOL, V13, P1264, DOI 10.1128/MCB.13.2.1264; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; YU CY, 1991, J BIOL CHEM, V266, P8907; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; ZHANG ZM, 1994, INT J INTELL SYST, V9, P1047, DOI 10.1002/int.4550091202	63	60	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11439	11445		10.1074/jbc.M100208200	http://dx.doi.org/10.1074/jbc.M100208200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11279028	hybrid			2022-12-27	WOS:000167980900118
J	Di Rocco, G; Gavalas, A; Popperl, H; Krumlauf, R; Mavilio, F; Zappavigna, V				Di Rocco, G; Gavalas, A; Popperl, H; Krumlauf, R; Mavilio, F; Zappavigna, V			The recruitment of SOX/OCT complexes and the differential activity of HOXA1 and HOXB1 modulate the Hoxb1 auto-regulatory enhancer function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; FIBROBLAST GROWTH-FACTOR-4 ENHANCER; PROTEIN-PROTEIN INTERACTIONS; COOPERATIVE DNA-BINDING; RETINOIC ACID; HOMEOBOX GENES; PBX PROTEINS; TRANSCRIPTIONAL ACTIVATION; SEGMENTAL EXPRESSION; HOMEODOMAIN PROTEINS	Regionally restricted expression patterns of Hox genes in developing embryos rely on auto-, cross-, and para-regulatory transcriptional elements. One example is the Hoxb1 auto-regulatory element (b1-ARE), which drives expression of Hoxb1 in the fourth rhombomere of the hindbrain, We previously showed that HOXB1 and PBX1 activate transcription from the b1-ARE: by binding to sequences required for the expression of a reporter gene in rhombomere 4 in vivo, We now report: that in embryonal carcinoma cells, which retain characteristics of primitive neuroectodermal cells, the b1-ARE displays higher basal and HOX/PBX-induced activities than in other cell backgrounds. We have identified a bipartite-binding site for SOX/OCT heterodimers within the b1-ARE that accounts for its cell context-specific activity and is required for maximal transcriptional activity of HOX/PBX complexes in embryonal carcinoma cells. Furthermore, we found that in an embryonal carcinoma cell background, HOXB1 has a significantly higher transcriptional activity than its paralog HOXA1. We map the determinants for this differential activity within the HOXB1 N-terminal transcriptional activation domain. By using analysis in transgenic and HOXA1 mutant mice, we extended these findings on the differential activities of HOXA1 and HOXB1 in vivo, and we demonstrated that they are important for regulating aspects of HOXB1 expression in the hindbrain. We found that mutation of the SOX/OCT site and targeted inactivation of Hoxa1 both impair the response of the b1-ARE to retinoic acid in transgenic mice. Our results show that Hoxa1 is the primary mediator of the response of b1-ARE to retinoic acid in vivo and that this function is dependent on the binding of SOX/OCT heterodimers to the b1-ARE. These results uncover novel functional differences between Hox paralogs and their modulators.	Ist Sci HS Raffaele, DIBIT, I-20132 Milan, Italy; Univ Modena, Sch Med, Dept Biomed Sci, I-41100 Modena, Italy; Natl Inst Med Res, Div Dev Neurobiol, London NW7 1AA, England; Stowers Inst Med Res, Kansas City, MO 64110 USA	Universita di Modena e Reggio Emilia; MRC National Institute for Medical Research; Stowers Institute for Medical Research	Zappavigna, V (corresponding author), Ist Sci HS Raffaele, DIBIT, Via Olgettina 58, I-20132 Milan, Italy.		Gavalas, Anthony/F-5817-2015; Di Rocco, Giuliana/P-1413-2019; Zappavigna, Vincenzo/D-3899-2015; Di Rocco, Giuliana/G-5682-2012; Di Rocco, Giuliana/J-4776-2018; Krumlauf, Robb/AAH-5012-2019	Di Rocco, Giuliana/0000-0003-1210-6008; Zappavigna, Vincenzo/0000-0002-7384-3207; Di Rocco, Giuliana/0000-0003-1210-6008; Krumlauf, Robb/0000-0001-9102-7927; Gavalas, Anthony/0000-0003-4897-0359; Mavilio, Fulvio/0000-0003-0459-4320	Telethon [TGT00D01, E.1026, TGT06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; ANDREWS PW, 1988, BIOCHIM BIOPHYS ACTA, V948, P17, DOI 10.1016/0304-419X(88)90003-0; Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; DAILEY L, 1994, MOL CELL BIOL, V14, P7758, DOI 10.1128/MCB.14.12.7758; DESCHAMPS J, 1987, P NATL ACAD SCI USA, V84, P1304, DOI 10.1073/pnas.84.5.1304; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; DiRocco G, 1997, EMBO J, V16, P3644, DOI 10.1093/emboj/16.12.3644; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G; Dupe V, 1997, DEVELOPMENT, V124, P399; Ferretti E, 2000, DEVELOPMENT, V127, P155; FRASCH M, 1995, DEVELOPMENT, V121, P957; Gavalas A, 1998, DEVELOPMENT, V125, P1123; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Huang D, 1998, DEVELOPMENT, V125, P3235; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; KAMACHI Y, 1995, EMBO J, V14, P3510, DOI 10.1002/j.1460-2075.1995.tb07357.x; KNOEPFLER PS, 1995, MOL CELL BIOL, V15, P5811; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lu QA, 1997, ONCOGENE, V14, P75, DOI 10.1038/sj.onc.1200799; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; Maconochie MK, 1997, GENE DEV, V11, P1885, DOI 10.1101/gad.11.14.1885; MANN R, 1996, BIOESSAYS, V17, P855; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; PHELAN ML, 1995, MOL CELL BIOL, V15, P3989; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; POPPERL H, 1992, EMBO J, V11, P3673, DOI 10.1002/j.1460-2075.1992.tb05452.x; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; RAMBALDI I, 1994, NUCLEIC ACIDS RES, V22, P376, DOI 10.1093/nar/22.3.376; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sambrook J., 2002, MOL CLONING LAB MANU; Schnabel CA, 1996, MOL CELL BIOL, V16, P2678; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SIMEONE A, 1991, MECH DEVELOP, V33, P215, DOI 10.1016/0925-4773(91)90029-6; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Studer M, 1998, DEVELOPMENT, V125, P1025; VIGANO A, 1999, MOL CELL BIOL, V18, P6201; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; ZAPPAVIGNA V, 1991, EMBO J, V10, P4177, DOI 10.1002/j.1460-2075.1991.tb04996.x; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; ZAPPAVIGNA V, 1994, GENE DEV, V8, P732, DOI 10.1101/gad.8.6.732; ZHANG MB, 1994, DEVELOPMENT, V120, P2431; Zhao JJG, 1996, EMBO J, V15, P1313, DOI 10.1002/j.1460-2075.1996.tb00473.x	59	55	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20506	20515		10.1074/jbc.M011175200	http://dx.doi.org/10.1074/jbc.M011175200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278854	hybrid			2022-12-27	WOS:000169135100112
J	Scarsdale, JN; Kazanina, G; He, X; Reynolds, KA; Wright, HT				Scarsdale, JN; Kazanina, G; He, X; Reynolds, KA; Wright, HT			Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID BIOSYNTHESIS; CONDENSING ENZYME; THIOLACTOMYCIN; INHIBITION; SYSTEM; ERRORS; FABH; MAPS	Mycolic acids (alpha -alkyl-beta -hydroxy long chain fatty acids) cover the surface of mycobacteria, and inhibition of their biosynthesis is an established mechanism of action for several key front-line anti-tuberculosis drugs. In mycobacteria, long chain acyl-CoA products (C-14-C-26) generated by a type I fatty-acid synthase can be used directly for the alpha -branch of mycolic acid or can be extended by a type II fatty-acid synthase to make the meromycolic acid (C-50-C-56))-derived component, An unusual Mycobacterium tuberculosis beta -ketoacyl-acyl carrier protein (ACP) synthase III (mtFabH) has been identified, purified, and shown to catalyze a Claisen-type condensation between long chain acyl-CoA substrates such as myristoyl-CoA (C-14) and malonyl-ACP, This enzyme, presumed to play a key role in initiating meromycolic acid biosynthesis, was crystallized, and its structure was determined at 2.1-Angstrom resolution. The mtFabH homodimer is closely similar in topology and active-site structure to Escherichia coli FabH (ecFabH), with a CoA/malonyl-ACP-binding channel leading from the enzyme surface to the buried active-site cysteine residue. Unlike ecFabH, mtFabH contains a second hydrophobic channel leading from the active site, In the ecFabH structure, this channel is blocked by a phenylalanine residue, which constrains specificity to acetyl-CoA, whereas in mtFabH, this residue is a threonine, which permits binding of longer acyl chains. This same channel in mtFabH is capped by an alpha -helix formed adjacent to a 4-amino acid sequence insertion, which limits bound acyl chain length to 16 carbons. These observations offer a molecular basis for understanding the unusual substrate specificity of mtFabH and its probable role in regulating the biosynthesis of the two different length acyl chains required for generation of mycolic acids. This mtFabH presents a new target far structure-based design of novel antimycobacterial agents.	Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Dept Biochem, Richmond, VA 23219 USA; Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Dept Med Chem, Richmond, VA 23219 USA	Virginia Commonwealth University; Virginia Commonwealth University	Wright, HT (corresponding author), ISBDD, Suite 212,Virginia Biotechnol Res Pk,800 E Leigh, Richmond, VA 23219 USA.	xrdproc@hsc.vcu.edu		Reynolds, Kevin/0000-0003-0270-9809	NIAID NIH HHS [AI44772] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI044772] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BHAT T, 1998, J APPL CRYSTALLOGR, V21, P279; Bloch K, 1975, Methods Enzymol, V35, P84, DOI 10.1016/0076-6879(75)35141-0; Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CHANG SP, 1989, P NATL ACAD SCI USA, V86, P6343, DOI 10.1073/pnas.86.16.6343; Choi KH, 2000, J BIOL CHEM, V275, P28201; Choi KH, 2000, J BACTERIOL, V182, P365, DOI 10.1128/JB.182.2.365-370.2000; CLOUGH RC, 1992, J BIOL CHEM, V267, P20992; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Han L, 1998, J BACTERIOL, V180, P4481, DOI 10.1128/JB.180.17.4481-4486.1998; He X, 2000, ANAL BIOCHEM, V282, P107, DOI 10.1006/abio.2000.4594; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JACKOWSKI S, 1987, J BIOL CHEM, V262, P7927; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; NAVAZA J, 1995, ACTA CRYSTALLOGR A, V51, P445, DOI 10.1107/S0108767394011335; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Qiu XY, 1999, J BIOL CHEM, V274, P36465, DOI 10.1074/jbc.274.51.36465; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Slayden RA, 2000, MOL MICROBIOL, V38, P514, DOI 10.1046/j.1365-2958.2000.02145.x; SNIDER DE, 1994, J INFECT DIS, V169, P1189, DOI 10.1093/infdis/169.6.1189; Swaminathan S, 2000, INT J TUBERC LUNG D, V4, P839; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000	38	101	112	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20516	20522		10.1074/jbc.M010762200	http://dx.doi.org/10.1074/jbc.M010762200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278743	hybrid			2022-12-27	WOS:000169135100113
J	Harms, N; Koningstein, G; Dontje, W; Muller, M; Oudega, B; Luirink, J; de Cock, H				Harms, N; Koningstein, G; Dontje, W; Muller, M; Oudega, B; Luirink, J; de Cock, H			The early interaction of the outer membrane protein PhoE with the periplasmic chaperone Skp occurs at the cytoplasmic membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; ESCHERICHIA-COLI; TRIGGER FACTOR; SECB; PREPROTEIN; BIOGENESIS; DOMAIN; EXPORT; TRANSLOCATION; PHOSPHOLIPIDS	Spheroplasts were used to study the early interactions of newly synthesized outer membrane protein PhoE with periplasmic proteins employing a protein cross-linking approach. Newly translocated PhoE protein could be cross-linked to the periplasmic chaperone Skp at the periplasmic side of the inner membrane. To study the timing of this interaction, a PhoE-dihydrofolate reductase hybrid protein was constructed that formed translocation intermediates, which had the PhoE moiety present in the periplasm and the dihydrofolate reductase moiety tightly folded in the cytoplasm, The hybrid protein was found to cross-link to Skp, indicating that PhoE closely interacts with the chaperone when the protein is still in a transmembrane orientation in the translocase. Removal of N-terminal parts of PhoE protein affected Skp binding in a cumulative manner, consistent with the presence of two Skp-binding sites in that region. In contrast, deletion of C-terminal parts resulted in variable interactions with Skp, suggesting that interaction of Skp with the N-terminal region is influenced by parts of the C terminus of PhoE protein. Both the soluble as well as the membrane-associated Skp protein were found to interact with PhoE, The latter form is proposed to be involved in the initial interaction with the N-terminal regions of the outer membrane protein.	Bioctr Amsterdam, Inst Mol Sci, Dept Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany	University of Amsterdam; Utrecht University; University of Freiburg	Harms, N (corresponding author), Bioctr Amsterdam, Inst Mol Sci, Dept Mol Microbiol, De Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.		de Cock, Hans/B-7790-2011; Luirink, Joen/AAB-8658-2021	de Cock, Hans/0000-0002-8420-6764; Luirink, J./0000-0001-8431-0804				ARKOWITZ RA, 1993, EMBO J, V12, P243, DOI 10.1002/j.1460-2075.1993.tb05650.x; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; BOCQUETPAGES C, 1981, EUR J BIOCHEM, V118, P105, DOI 10.1111/j.1432-1033.1981.tb05491.x; BOLLA JM, 1988, EMBO J, V7, P3595, DOI 10.1002/j.1460-2075.1988.tb03237.x; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; BOSCH D, 1986, J MOL BIOL, V189, P449, DOI 10.1016/0022-2836(86)90316-5; Bothmann H, 1998, NAT BIOTECHNOL, V16, P376, DOI 10.1038/nbt0498-376; Chen R, 1996, MOL MICROBIOL, V19, P1287, DOI 10.1111/j.1365-2958.1996.tb02473.x; Danese PN, 1998, ANNU REV GENET, V32, P59, DOI 10.1146/annurev.genet.32.1.59; de Cock H, 1999, EUR J BIOCHEM, V259, P96, DOI 10.1046/j.1432-1327.1999.00010.x; DECOCK H, 1990, BIOCHIMIE, V72, P177, DOI 10.1016/0300-9084(90)90143-5; DECOCK H, 1992, J MOL BIOL, V224, P369, DOI 10.1016/0022-2836(92)91001-6; Den Blaauwen T, 1999, J BACTERIOL, V181, P5167, DOI 10.1128/JB.181.17.5167-5175.1999; Driessen AJM, 1998, CURR OPIN MICROBIOL, V1, P216, DOI 10.1016/S1369-5274(98)80014-3; Eppens EF, 1997, EMBO J, V16, P4295, DOI 10.1093/emboj/16.14.4295; GUTHRIE B, 1990, J BACTERIOL, V172, P5555, DOI 10.1128/jb.172.10.5555-5562.1990; Hesterkamp T, 1996, FEBS LETT, V385, P67, DOI 10.1016/0014-5793(96)00351-1; HIGH S, 1991, J CELL BIOL, V113, P25, DOI 10.1083/jcb.113.1.25; HOLCK A, 1988, GENE, V67, P117; HOUBEN ENG, 2000, FEBS LETT, V238, P1; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; KUSTERS R, 1989, J BIOL CHEM, V264, P20827; LECKER S, 1989, EMBO J, V8, P2703, DOI 10.1002/j.1460-2075.1989.tb08411.x; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; Missiakas D, 1997, J BACTERIOL, V179, P2465, DOI 10.1128/jb.179.8.2465-2471.1997; MOL O, 1995, MICROB PATHOGENESIS, V18, P115, DOI 10.1016/S0882-4010(95)90109-4; NOUWEN N, 1994, J BIOL CHEM, V269, P16029; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; PAGES C, 1982, EUR J BIOCHEM, V122, P381, DOI 10.1111/j.1432-1033.1982.tb05892.x; Ramm K, 2000, J BIOL CHEM, V275, P17106, DOI 10.1074/jbc.M910234199; RIED G, 1990, J BACTERIOL, V172, P6048, DOI 10.1128/jb.172.10.6048-6053.1990; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; THOME BM, 1991, MOL MICROBIOL, V5, P2815, DOI 10.1111/j.1365-2958.1991.tb01990.x; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; VANGELDER P, 1994, EUR J BIOCHEM, V226, P783; Vrije G. J. de, 1990, Molecular Microbiology, V4, P143, DOI 10.1111/j.1365-2958.1990.tb02024.x	40	90	93	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18804	18811		10.1074/jbc.M011194200	http://dx.doi.org/10.1074/jbc.M011194200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278858	hybrid, Green Published			2022-12-27	WOS:000169091000022
J	Conesa, A; van de Velde, F; van Rantwijk, F; Sheldon, RA; van den Hondel, CAMJJ; Punt, PJ				Conesa, A; van de Velde, F; van Rantwijk, F; Sheldon, RA; van den Hondel, CAMJJ; Punt, PJ			Expression of the Caldariomyces fumago chloroperoxidase in Aspergillus niger and characterization of the recombinant enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHLY ENANTIOSELECTIVE EPOXIDATION; PEROXIDASE ISOENZYME-C; ACTIVE-SITE STRUCTURES; HORSERADISH-PEROXIDASE; MANGANESE PEROXIDASE; LIGNIN PEROXIDASE; DISTAL SITE; PHANEROCHAETE-CHRYSOSPORIUM; HETEROLOGOUS EXPRESSION; HYDROGEN-PEROXIDE	The Caldariomyces fumago chloroperoxidase was successfully expressed in Aspergillus niger. The recombinant enzyme was produced in the culture medium as an active protein and could be purified by a three-step purification procedure. The catalytic behavior of recombinant chloroperoxidase (rCPO) was studied and compared with that of native CPO. The specific chlorination activity (47 units/nmol) of rCPO and its pH optimum (pH 2.75) were very similar to those of native CPO. rCPO catalyzes the oxidation of various substrates in comparable yields and selectivities to native CPO. Indole was oxidized to 2-oxindole with 99% selectivity and thioanisole to the corresponding R-sulfoxide (enantiomeric excess >98%). Incorporation of O-18 from labeled (H2O2)-O-18 into the oxidized products was 100% in both cases.	TNO, Nutr & Food Res Inst, Dept Appl Microbiol & Gene Technol, NL-3704 HE Zeist, Netherlands; Delft Univ Technol, Organ Chem & Catalysis Lab, NL-2628 BL Delft, Netherlands	Netherlands Organization Applied Science Research; Delft University of Technology	Punt, PJ (corresponding author), TNO, Nutr & Food Res Inst, Dept Appl Microbiol & Gene Technol, Utrechtseweg 48, NL-3704 HE Zeist, Netherlands.	ppunt@voeding.tno.nl	Cegarra, Ana V Conesa/A-9559-2014; punt, peter/AAI-8180-2020; moreno manzano, Victoria/B-4175-2014	Cegarra, Ana V Conesa/0000-0001-9597-311X; punt, peter/0000-0002-5689-9938; Van den Hondel, Kees/0000-0003-4782-2725; moreno manzano, Victoria/0000-0002-6035-9491				Adam W, 1999, Adv Biochem Eng Biotechnol, V63, P73; Aifa MS, 1999, BIOTECHNOL LETT, V21, P849, DOI 10.1023/A:1005541206270; ALLAIN EJ, 1993, J AM CHEM SOC, V115, P4415, DOI 10.1021/ja00063a091; BANTLEON R, 1994, J BACTERIOL, V176, P2339, DOI 10.1128/JB.176.8.2339-2347.1994; Bennett J. W., 1991, MORE GENE MANIPULATI, P441; BLACK AK, 1991, BIOCHEM BIOPH RES CO, V179, P428, DOI 10.1016/0006-291X(91)91388-S; BLANKE SR, 1988, J BIOL CHEM, V263, P18739; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; BURD W, 1995, FEMS MICROBIOL LETT, V129, P255, DOI 10.1016/0378-1097(95)00168-5; Colonna S, 1997, CHEM COMMUN, P439, DOI 10.1039/a608352h; COLONNA S, 1992, TETRAHEDRON-ASYMMETR, V3, P95, DOI 10.1016/S0957-4166(00)82316-2; Conesa A, 2000, APPL ENVIRON MICROB, V66, P3016, DOI 10.1128/AEM.66.7.3016-3023.2000; CORBETT MD, 1979, BIOCHEM J, V183, P269, DOI 10.1042/bj1830269; DAWSON JH, 1987, CHEM REV, V87, P1255, DOI 10.1021/cr00081a015; DEXTER AF, 1995, J AM CHEM SOC, V117, P6412, DOI 10.1021/ja00128a053; DOERGE DR, 1991, BIOCHEMISTRY-US, V30, P8960, DOI 10.1021/bi00101a007; DORDICK JS, 1992, TRENDS BIOTECHNOL, V10, P287, DOI 10.1016/0167-7799(92)90246-R; DRABOWICZ J, 1990, SYNTHESIS-STUTTGART, P937; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Elrod S.L., 1997, Int. Patent Appl., Patent No. [97,47746, 9747746]; GODFREY BJ, 1990, GENE, V93, P119, DOI 10.1016/0378-1119(90)90144-G; Hager LP, 1998, J MOL CATAL B-ENZYM, V5, P95, DOI 10.1016/S1381-1177(98)00013-7; Hu SH, 1999, J AM CHEM SOC, V121, P872, DOI 10.1021/ja983612g; KELLY JM, 1985, EMBO J, V4, P475, DOI 10.1002/j.1460-2075.1985.tb03653.x; KENIGSBERG P, 1987, ARCH BIOCHEM BIOPHYS, V254, P409, DOI 10.1016/0003-9861(87)90118-4; KOBAYASHI S, 1987, BIOCHEMISTRY-US, V26, P5019, DOI 10.1021/bi00390a020; KOBAYASHI S, 1995, ADV POLYM SCI, V121, P1, DOI 10.1007/BFb0018577; Lakner FJ, 1996, J ORG CHEM, V61, P3923, DOI 10.1021/jo960074m; Libby RD, 1996, J BIOL CHEM, V271, P21820, DOI 10.1074/jbc.271.36.21820; LIU HI, 1995, J BIOL CHEM, V270, P10544, DOI 10.1074/jbc.270.18.10544; MAYFIELD MB, 1994, GENE, V142, P231, DOI 10.1016/0378-1119(94)90266-6; MILLER VP, 1995, ARCH BIOCHEM BIOPHYS, V319, P333, DOI 10.1006/abbi.1995.1302; MORRIS DR, 1966, J BIOL CHEM, V241, P1763; Mukai M, 1997, J AM CHEM SOC, V119, P1758, DOI 10.1021/ja962551o; Nagano S, 1996, BIOCHEMISTRY-US, V35, P14251, DOI 10.1021/bi961740g; Nakahara K, 1996, J BIOCHEM-TOKYO, V120, P1082, DOI 10.1093/oxfordjournals.jbchem.a021525; Newmyer SL, 1996, J BIOL CHEM, V271, P14891, DOI 10.1074/jbc.271.25.14891; OZAKI S, 1995, J AM CHEM SOC, V117, P7056, DOI 10.1021/ja00132a003; OZAKI SI, 1994, J AM CHEM SOC, V116, P4487, DOI 10.1021/ja00089a052; PUNT PJ, 1991, J BIOTECHNOL, V17, P19, DOI 10.1016/0168-1656(91)90024-P; PUNT PJ, 1992, METHOD ENZYMOL, V216, P447; RodriguezLopez JN, 1996, J BIOL INORG CHEM, V1, P136, DOI 10.1007/s007750050032; RodriguezLopez JN, 1996, J BIOL CHEM, V271, P4023; SALOHEIMO M, 1991, BIO-TECHNOL, V9, P987, DOI 10.1038/nbt1091-987; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANDERS SA, 1994, EUR J BIOCHEM, V224, P1029, DOI 10.1111/j.1432-1033.1994.01029.x; Savenkova MI, 1996, J BIOL CHEM, V271, P24598, DOI 10.1074/jbc.271.40.24598; SAWAIHATANAKA H, 1995, BIOSCI BIOTECH BIOCH, V59, P1221, DOI 10.1271/bbb.59.1221; SIGLE RO, 1993, THESIS U ILLINOIS UR; Smith AT, 1998, CURR OPIN CHEM BIOL, V2, P269, DOI 10.1016/S1367-5931(98)80069-0; SMULEVICH G, 1994, BIOCHEMISTRY-US, V33, P7398, DOI 10.1021/bi00189a046; STERN JO, 1974, J BIOL CHEM, V249, P7495; Stewart P, 1996, APPL ENVIRON MICROB, V62, P860, DOI 10.1128/AEM.62.3.860-864.1996; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; Tanaka M, 1997, BIOCHEMISTRY-US, V36, P9791, DOI 10.1021/bi9706172; Tanaka M, 1996, BIOCHEM BIOPH RES CO, V227, P393, DOI 10.1006/bbrc.1996.1518; VANDEURZEN MPJ, 1994, BIOCATALYSIS, V10, P247, DOI 10.3109/10242429409065234; vanDeurzen MPJ, 1997, J MOL CATAL A-CHEM, V117, P329, DOI 10.1016/S1381-1169(96)00259-2; vanDeurzen MPJ, 1996, J MOL CATAL B-ENZYM, V2, P33, DOI 10.1016/1381-1177(96)00008-2; vanDeurzen MPJ, 1997, TETRAHEDRON, V53, P13183, DOI 10.1016/S0040-4020(97)00477-8; VANHARTINGSVELDT W, 1987, MOL GEN GENET, V206, P71, DOI 10.1007/BF00326538; VANSCHIJNDEL JWPM, 1993, BIOCHIM BIOPHYS ACTA, V1161, P249, DOI 10.1016/0167-4838(93)90221-C; VERDOES JC, 1993, TRANSGENIC RES, V2, P84, DOI 10.1007/BF01969381; Wyss M, 1999, APPL ENVIRON MICROB, V65, P359; Yi XW, 1999, P NATL ACAD SCI USA, V96, P12412, DOI 10.1073/pnas.96.22.12412; ZAKS A, 1995, J AM CHEM SOC, V117, P10419, DOI 10.1021/ja00147a001; ZHANG YZ, 1991, GENE, V97, P191, DOI 10.1016/0378-1119(91)90051-C; ZONG Q, 1995, BIOCHEMISTRY-US, V34, P12420, DOI 10.1021/bi00038a040; Zong Q, 1997, THESIS U ILLINOIS UR	69	35	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17635	17640		10.1074/jbc.M010571200	http://dx.doi.org/10.1074/jbc.M010571200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278701	hybrid, Green Published			2022-12-27	WOS:000168866500004
J	Zhu, C; Gagnidze, K; Gemberling, JHM; Plevy, SE				Zhu, C; Gagnidze, K; Gemberling, JHM; Plevy, SE			Characterization of an activation protein-1-binding site in the murine interleukin-12 p40 promoter - Demonstration of novel functional elements by a reductionist approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; CELL STIMULATORY FACTOR; GENE PROMOTER; MAP KINASE; TRANSCRIPTION FACTORS; ADAPTIVE IMMUNITY; CYTOKINE PATTERNS; NEGATIVE MUTANTS; INTERFERON-GAMMA; IL-12 PRODUCTION	Interleukin (IL)-12 is a heterodimeric cytokine produced by macrophages in response to intracellular pathogens and provides an obligatory signal for the differentiation of T-helper-l cells. We previously reported an analysis of the IL-12 p40 promoter in RAW264.7 macrophages, Multiple control elements were involved in activation of transcription by bacterial products. A critical control element, located between -96 and -88, interacts with C/EBP family members. In this study, using a strategy to demonstrate functional activity in a minimal promoter context, three novel cis-acting elements are found to have an important role in IL-12 p40 promoter activation by lipopolysaccharide. One of these elements is characterized in detail. Mutations from -79 to -74 in the murine IL-12 p40 promoter significantly reduce lipopolysaccharide-induced promoter activity. Electrophoretic mobility shift assays demonstrate binding of AP-1 family members to this region. Spacing between the C/EBP and AP-1 site is important for promoter activation, suggesting cooperativity between these elements. c-Jun and a mutant c-Jun molecule activate the IL-12 p40 promoter and synergistically activate the promoter when co-expressed with C/EBP beta. Finally, this region of the promoter is demonstrated to be a target for mitogen-activated protein kinase and toll-like receptor signaling pathways.	CUNY Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA; Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Plevy, SE (corresponding author), CUNY Mt Sinai Sch Med, Immunobiol Ctr, Box 1630,1 Gustave L Levy Pl, New York, NY 10029 USA.				NIDDK NIH HHS [K11 DK02358] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K11DK002358] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brown PH, 1996, CELL GROWTH DIFFER, V7, P1013; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; Feng GJ, 1999, J IMMUNOL, V163, P6403; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Leonard DA, 1997, P NATL ACAD SCI USA, V94, P4913, DOI 10.1073/pnas.94.10.4913; LO K, 1991, MOL CELL BIOL, V11, P5229, DOI 10.1128/MCB.11.10.5229; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Ma XJ, 1996, ANN NY ACAD SCI, V795, P357, DOI 10.1111/j.1749-6632.1996.tb52692.x; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Nikolajczyk BS, 1996, MOL CELL BIOL, V16, P4544; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; RANSONE LJ, 1990, P NATL ACAD SCI USA, V87, P3806, DOI 10.1073/pnas.87.10.3806; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Seder RA, 1996, J IMMUNOL, V157, P2745; SIELING PA, 1994, IMMUNOBIOLOGY, V191, P378, DOI 10.1016/S0171-2985(11)80443-2; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wise SC, 1998, ONCOGENE, V16, P2001, DOI 10.1038/sj.onc.1201697; WOLF SF, 1991, J IMMUNOL, V146, P3074; Wu GD, 1997, J BIOL CHEM, V272, P2396; YAN MH, 1994, NATURE, V372, P798; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200; Zagariya A, 1998, MOL CELL BIOL, V18, P2815, DOI 10.1128/MCB.18.5.2815; ZHANG M, 1994, J CLIN INVEST, V93, P1733, DOI 10.1172/JCI117157	48	80	82	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18519	18528		10.1074/jbc.M100440200	http://dx.doi.org/10.1074/jbc.M100440200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279072	hybrid			2022-12-27	WOS:000168866500121
J	Arold, ST; Ulmer, TS; Mulhern, TD; Werner, JM; Ladbury, JE; Campbell, ID; Noble, MEM				Arold, ST; Ulmer, TS; Mulhern, TD; Werner, JM; Ladbury, JE; Campbell, ID; Noble, MEM			The role of the Src homology 3-Src homology 2 interface in the regulation of Src kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; HETERONUCLEAR NMR-SPECTROSCOPY; PROTEIN-TYROSINE KINASE; CRYSTAL-STRUCTURE; SH2 DOMAIN; PHOSPHOTYROSYL PEPTIDE; CROSS-CORRELATION; TERMINAL REGION; BINDING-PROTEIN; C-SRC	The regulatory fragment of Src kinases, comprising Src homology (SH)3 and SH2 domains, is responsible for controlled repression of kinase activity. We have used a multidisciplinary approach involving crystallography, NMR, and isothermal titration calorimetry to study the regulatory fragment of Fyn (FynSH32) and its interaction with a physiological activator: a fragment of focal adhesion kinase that contains both phosphotyrosine and polyproline motifs. Although flexible, the preferred disposition of SH3 and SH2 domains in FynSH32 resembles the inactive forms of Hck and Src, differing significantly from LckSH32. This difference, which results from variation in the SH3-SH2 linker sequences, will affect the potential of the regulatory fragments to repress kinase activity. This surprising result implies that the mechanism of repression of Src family members may vary, explaining functional distinctions between Fyn and Lck, The interaction between FynSH32 and focal adhesion kinase is restricted to the canonical SH3 and SH2 binding sites and does not affect the dynamic independence of the two domains. Consequently, the interaction shows no enhancement by an avidity effect. Such an interaction may have evolved to gain specificity through an extended recognition site while maintaining rapid dissociation after signaling.	Univ Oxford, Mol Biophys Lab, Oxford OX1 3QU, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England; Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	University of Oxford; University of Oxford; University of London; University College London; University of Melbourne	Noble, MEM (corresponding author), Univ Oxford, Mol Biophys Lab, S Parks Rd, Oxford OX1 3QU, England.	martin@biop.ox.ac.uk	Werner, Joern/E-1148-2013; Arold, Stefan/T-2612-2019; Mulhern, Terrence/A-1206-2007	Ladbury, John/0000-0002-6328-7200; Werner, Jorn/0000-0002-4712-1833; Arold, Stefan T/0000-0001-5278-0668; Noble, Martin/0000-0002-3595-9807; Mulhern, Terrence/0000-0002-1609-7498				Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BOYD J, 1990, CHEM PHYS LETT, V175, P477, DOI 10.1016/0009-2614(90)85567-V; BOYD J, 1992, J MAGN RESON, V98, P660, DOI 10.1016/0022-2364(92)90021-X; Briggs SD, 2000, BIOCHEMISTRY-US, V39, P489, DOI 10.1021/bi992504j; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; FLYNN DC, 1993, MOL CELL BIOL, V13, P7892, DOI 10.1128/MCB.13.12.7892; Fushman D, 1999, BIOCHEMISTRY-US, V38, P10225, DOI 10.1021/bi990897g; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Huse M, 1998, J BIOL CHEM, V273, P18729, DOI 10.1074/jbc.273.30.18729; Ilic D, 1997, J CELL SCI, V110, P401; JAHNKE W, 1995, J MAGN RESON SER B, V106, P86, DOI 10.1006/jmrb.1995.1015; Jones RJ, 2000, EUR J CANCER, V36, P1595, DOI 10.1016/S0959-8049(00)00153-2; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Ladbury JE, 1996, BIOCHEMISTRY-US, V35, P11062, DOI 10.1021/bi960543e; MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Morton CJ, 1996, STRUCTURE, V4, P705, DOI 10.1016/S0969-2126(96)00076-7; Mulhern TD, 1997, STRUCTURE, V5, P1313, DOI 10.1016/S0969-2126(97)00283-9; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Shen Y, 1999, MOL BIOL CELL, V10, P2507, DOI 10.1091/mbc.10.8.2507; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0	39	73	74	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17199	17205		10.1074/jbc.M011185200	http://dx.doi.org/10.1074/jbc.M011185200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278857	hybrid			2022-12-27	WOS:000168730400080
J	Cui, J; Kagan, A; Qin, DM; Mathew, J; Melman, YF; McDonald, TV				Cui, J; Kagan, A; Qin, DM; Mathew, J; Melman, YF; McDonald, TV			Analysis of the cyclic nucleotide binding domain of the HERG potassium channel and interactions with KCNE2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; LONG-QT SYNDROME; I REGULATORY SUBUNIT; SITE-DIRECTED MUTAGENESIS; CARDIAC-ARRHYTHMIA; CAMP-BINDING; K+-CHANNEL; GATED CHANNEL; ACTIVATION; MUTATIONS	Mutations in the cyclic nucleotide binding domain (CNBD) of the human ether-a-go-go-related gene (HERG) K+ channel are associated with LQT2, a form of hereditary Long QT syndrome (LQTS), Elevation of cAMP can modulate HERG K+ channels both by direct binding and indirect regulation through protein kinase A. To assess the physiological significance of cAMP binding to HERG, we introduced mutations to disrupt the cyclic nucleotide binding domain. Eight mutants including two naturally occurring LQT2 mutants V822M and R823W were constructed. Relative cAMP binding capacity was reduced or absent in CNBD mutants. Mutant homotetramers carry little or no K+ current despite normal protein abundance and surface expression. Co-expression of mutant and wild-type HERG; resulted in currents with altered voltage dependence but without dominant current suppression. The data from co-expression of V822M and wild-type HERG best fit a model where one normal subunit within a tetramer allows nearly normal current expression, The presence of KCNE2, an accessory protein that associates with HERG, however, conferred a partially dominant current suppression by CNBD mutants. Thus KCNE2 plays a pivotal role in determining the phenotypic severity of some forms of LQT2, which suggests that the CNBD of HERG may be involved in its interaction with KCNE2.	Yeshiva Univ Albert Einstein Coll Med, Dept Med, Sect Mol Cardiol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McDonald, TV (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, Sect Mol Cardiol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NHLBI NIH HHS [HL 57388] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057388] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Berthet M, 1999, CIRCULATION, V99, P1464, DOI 10.1161/01.CIR.99.11.1464; BRUGGEMANN A, 1993, NATURE, V365, P445, DOI 10.1038/365445a0; BUBIS J, 1988, J BIOL CHEM, V263, P9668; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Ficker E, 2000, AM J PHYSIOL-HEART C, V279, pH1748, DOI 10.1152/ajpheart.2000.279.4.H1748; HAMMILL OP, 1981, PFLUGERS ARCH, V391, P85; Kagan A, 2000, J BIOL CHEM, V275, P11241, DOI 10.1074/jbc.275.15.11241; Kiehn J, 1998, J BIOL CHEM, V273, P25285, DOI 10.1074/jbc.273.39.25285; KUNO T, 1988, BIOCHEM BIOPH RES CO, V153, P1244, DOI 10.1016/S0006-291X(88)81361-5; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Nakajima T, 2000, FEBS LETT, V481, P197, DOI 10.1016/S0014-5793(00)01988-8; OGREID D, 1988, J BIOL CHEM, V263, P17397; RINGHEIM GE, 1990, J BIOL CHEM, V265, P19472; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; SANGUINETTI MC, 1991, CIRC RES, V69, P77; Satler CA, 1996, AM J MED GENET, V65, P27, DOI 10.1002/(SICI)1096-8628(19961002)65:1<27::AID-AJMG4>3.3.CO;2-J; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; STEINBERG RA, 1987, J BIOL CHEM, V262, P2664; STEINBERG RA, 1991, J BIOL CHEM, V266, P3547; Thomas D, 1999, J BIOL CHEM, V274, P27457, DOI 10.1074/jbc.274.39.27457; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; WOODFORD TA, 1989, J BIOL CHEM, V264, P13321; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	33	77	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17244	17251		10.1074/jbc.M010904200	http://dx.doi.org/10.1074/jbc.M010904200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278781	hybrid			2022-12-27	WOS:000168730400086
J	Vogeley, L; Palm, GJ; Mesters, JR; Hilgenfeld, R				Vogeley, L; Palm, GJ; Mesters, JR; Hilgenfeld, R			Conformational change of elongation factor Tu (EF-Tu) induced by antibiotic binding - Crystal structure of the complex between EF-Tu center dot GDP and aurodox	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TERNARY COMPLEX; KIRROMYCIN RESISTANCE; PROTEIN-BIOSYNTHESIS; THERMUS-THERMOPHILUS; TRANSFER-RNA; PROGRAM; PHE-TRNA(PHE); INHIBITION; MECHANISM	Aurodox is a member of the family of kirromycin antibiotics, which inhibit protein biosynthesis by binding to elongation factor Tu (EF-Tu), We have determined the crystal structure of the 1:1:1 complex of Thennus thermophilus EF-Tu with GDP and aurodox to 2.0-Angstrom resolution. During its catalytic cycle, EF-Tu adopts two strikingly different conformations depending on the nucleotide bound: the GDP form and the GTP form, In the present structure, a GTP complex-like conformation of EF-Tu is observed, although GDP is bound to the nucleotide-binding site. This is consistent with previous proposals that aurodox fixes EF-Tu on the ribosome by locking it in its GTP form. Binding of EF-Tu GDP to aminoacyl-tRNA and mutually exclusive binding of kirromycin and elongation factor Ts to EF-Tu can be explained on the basis of the structure. For many previously observed mutations that provide resistance to kirromycin, it can now be understood how they prevent interaction with the antibiotic. An unexpected feature of the structure is the reorientation of the His-85 side chain toward the nucleotide-binding site. We propose that this residue stabilizes the transition state of GTP hydrolysis, explaining the acceleration of the reaction by kirromycin-type antibiotics.	Inst Mol Biotechnol, Dept Struct Biol & Crystallog, D-07745 Jena, Germany		Hilgenfeld, R (corresponding author), Inst Mol Biotechnol, Dept Struct Biol & Crystallog, Beutenbergstr 11, D-07745 Jena, Germany.	hilgenfd@imb-jena.de	Palm, Gottfried J./AAC-5020-2020; Hilgenfeld, Rolf/C-9675-2011	Mesters, Jeroen/0000-0001-8532-6699				ABDULKARIM F, 1994, FEBS LETT, V352, P118, DOI 10.1016/0014-5793(94)00937-6; Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; ABRAHAMS JP, 1991, BIOCHEMISTRY-US, V30, P6705, DOI 10.1021/bi00241a010; ABRAHAMS JP, 1988, NUCLEIC ACIDS RES, V16, P10099, DOI 10.1093/nar/16.21.10099; ALEXANDER C, 1995, J BIOL CHEM, V270, P14541, DOI 10.1074/jbc.270.24.14541; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BLANK J, 1995, PROTEIN EXPRES PURIF, V6, P637, DOI 10.1006/prep.1995.1084; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHINALI G, 1981, J ANTIBIOT, V34, P1039, DOI 10.7164/antibiotics.34.1039; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; DOUGLASS J, 1979, J BIOL CHEM, V254, P5383; DUISTERWINKEL FJ, 1981, FEBS LETT, V131, P89, DOI 10.1016/0014-5793(81)80894-0; DUISTERWINKEL FJ, 1984, EMBO J, V3, P113, DOI 10.1002/j.1460-2075.1984.tb01770.x; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FASANO O, 1978, EUR J BIOCHEM, V89, P557, DOI 10.1111/j.1432-1033.1978.tb12560.x; Heffron SE, 2000, BIOCHEMISTRY-US, V39, P37, DOI 10.1021/bi9913597; Hilgenfeld R, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P347; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kristensen O, 1996, FEBS LETT, V399, P59, DOI 10.1016/S0014-5793(96)01281-1; Landini P, 1996, BIOCHEMISTRY-US, V35, P15288, DOI 10.1021/bi9610818; MAEHR H, 1980, CAN J CHEM, V58, P501, DOI 10.1139/v80-080; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MESTERS JR, 1994, EMBO J, V13, P4877, DOI 10.1002/j.1460-2075.1994.tb06815.x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARMEGGIANI A, 1985, ANNU REV MICROBIOL, V39, P557, DOI 10.1146/annurev.mi.39.100185.003013; PARMEGGIANI A, 1980, TOP ANTIBIOT CHEM, V5, P165; PINGOUD A, 1978, EUR J BIOCHEM, V86, P153, DOI 10.1111/j.1432-1033.1978.tb12294.x; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; Ravelli RBG, 1997, J APPL CRYSTALLOGR, V30, P551, DOI 10.1107/S0021889897003543; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; STOUT GH, 1968, XRAY STRUCTURE DETER, P402; VANNOORT JM, 1984, P NATL ACAD SCI-BIOL, V81, P3969; Wang Y, 1997, NAT STRUCT BIOL, V4, P650, DOI 10.1038/nsb0897-650; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; WOLF H, 1977, EUR J BIOCHEM, V75, P67, DOI 10.1111/j.1432-1033.1977.tb11504.x; WOLF H, 1974, P NATL ACAD SCI USA, V71, P4910, DOI 10.1073/pnas.71.12.4910; ZEIDLER W, 1993, FEBS LETT, V319, P185, DOI 10.1016/0014-5793(93)80064-2	50	102	105	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17149	17155		10.1074/jbc.M100017200	http://dx.doi.org/10.1074/jbc.M100017200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278992	hybrid			2022-12-27	WOS:000168730400074
J	Yang, WN; Lo, CG; Dispenza, T; Cerione, RA				Yang, WN; Lo, CG; Dispenza, T; Cerione, RA			The Cdc42 target ACK2 directly interacts with clathrin and influences clathrin assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; CULTURED HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH; TYROSINE KINASE; CELL-CYCLE; RAC; TRANSFORMATION; GTPASES; ADAPTER; GROWTH	The Res-related GTP-binding protein Cdc42 has been implicated in a diversity of biological functions including the regulation of intracellular trafficking and endocytosis. While screening for Cdc42 targets that influence these activities, we identified the protein-tyrosine kinase ACK2 (for activated Cdc42-associated kinase 2) as a new binding partner for clathrin. ACK2 binds clathrin via a domain that is conserved among a number of other clathrin-binding proteins including the arrestins and AP-2. Overexpression of ACK2 in NIH3T3 cells results in an inhibition of transferrin receptor endocytosis because of a competition between ACK2 and AP-2 for clathrin. Activated Cdc42 weakens the interaction between ACK2 and clathrin and thus reverses the ACK2-mediated inhibition of endocytosis. Overexpression of ACK2 increases the amount of clathrin present in fractions enriched in clathrin-coated vesicles. Taken together, our data suggest that ACK2 may represent a novel clathrin-assembly protein and participate in the regulation of receptor-mediated endocytosis.	Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Cerione, RA (corresponding author), Vet Med Ctr C3 155, Ithaca, NY 14853 USA.				NIGMS NIH HHS [GM40654, GM47458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654, R01GM047458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grimes ML, 1996, J NEUROSCI, V16, P7950; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Hong-Geller E, 2000, J CELL BIOL, V148, P481, DOI 10.1083/jcb.148.3.481; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Mundigl O, 1998, J NEUROSCI, V18, P93; MURPHY JE, 1992, J BIOL CHEM, V267, P10850; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; TORRE E, 1994, J BIOL CHEM, V269, P32411; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; Yang WN, 1999, J BIOL CHEM, V274, P8524, DOI 10.1074/jbc.274.13.8524; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997	32	65	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17468	17473		10.1074/jbc.M010893200	http://dx.doi.org/10.1074/jbc.M010893200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278777	hybrid			2022-12-27	WOS:000168730400117
J	Ageta, H; Kato, A; Hatakeyama, S; Nakayama, K; Isojima, Y; Sugiyama, H				Ageta, H; Kato, A; Hatakeyama, S; Nakayama, K; Isojima, Y; Sugiyama, H			Regulation of the level of vesl-1S/homer-1a proteins by ubiquitin-proteasome proteolytic systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY PROTEINS; KAPPA-B-ALPHA; P53 FUNCTION; CELL-CYCLE; FAMILY; HOMER; ASSOCIATION; BINDS	The vesl-1S/homer-1a gene is up-regulated during seizure and long term potentiation. Other members of the Vesl family, Vesl-1L, -2, and -3, are constitutively expressed in the brain. We examined the regulatory mechanisms governing the expression level of Vesl-1S protein, either an exogenously introduced one in COS7 or human embryonic kidney 293T cells or an endogenous one in rat brain neurons in cultures, In both cases, application of proteasome inhibitors increased the amount of Vesl-1S protein but not that of Vesl-1L, -2, or -3 protein. Deletion analyses revealed that the C-terminal 11-amino acid region was responsible for the proteolysis of Vesl-1S by proteasomes. Application of proteasome inhibitors promoted ubiquitination of Vesl-1S protein but not that of the Vesl-1S deletion mutant, which evaded proteasome-mediated degradation. These results indicate that ubiquitin-proteasome systems are involved in the regulation of the expression level of Vesl-1S protein.	Kyushu Univ, Grad Sch Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, Med Inst Bioregulat, Lab Embryon & Genet Engn, Dept Mol & Cellular Biol,Higashi Ku, Fukuoka 8128582, Japan; Osaka Univ, Inst Prot Res, Div Prot Metab, Suita, Osaka 5650871, Japan	Kyushu University; Kyushu University; Kyushu University; Osaka University	Sugiyama, H (corresponding author), Kyushu Univ, Grad Sch Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan.		Hatakeyama, Shigetsugu/C-8333-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979				ABRAHAM WC, 1993, NEUROSCIENCE, V56, P717, DOI 10.1016/0306-4522(93)90369-Q; Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; Ciruela F, 1999, BIOCHEM J, V341, P795, DOI 10.1042/0264-6021:3410795; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FUKAZAWA Y, 1999, 29 ANN M SOC NEUR AB; Haas AL, 1997, FASEB J, V11, P1257; Hale AJ, 1996, EUR J BIOCHEM, V237, P884; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; ISHIDA N, 1993, FEBS LETT, V324, P345, DOI 10.1016/0014-5793(93)80148-N; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Nagata Y, 1999, ONCOGENE, V18, P6037, DOI 10.1038/sj.onc.1202978; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; NISHIZAWA M, 1992, EMBO J, V11, P2433, DOI 10.1002/j.1460-2075.1992.tb05308.x; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Shirane M, 1999, J BIOL CHEM, V274, P28169, DOI 10.1074/jbc.274.40.28169; SQUIRE LR, 1973, BRAIN RES, V56, P215, DOI 10.1016/0006-8993(73)90336-3; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sun J, 1998, FEBS LETT, V437, P304, DOI 10.1016/S0014-5793(98)01256-3; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7	36	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15893	15897		10.1074/jbc.M011097200	http://dx.doi.org/10.1074/jbc.M011097200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278836	hybrid			2022-12-27	WOS:000168623100045
J	Hondal, RJ; Ma, SG; Caprioli, RM; Hill, KE; Burk, RF				Hondal, RJ; Ma, SG; Caprioli, RM; Hill, KE; Burk, RF			Heparin-binding histidine and lysine residues of rat selenoprotein P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; HIGH MOLECULAR-WEIGHT; OPEN READING FRAME; CHEMICAL MODIFICATION; MASS-SPECTROMETRY; HUMAN PLASMA; DIETHYL PYROCARBONATE; FUNCTIONAL RESIDUES; LIPID-PEROXIDATION; LIVER NECROSIS	Selenoprotein P is a plasma protein that has oxidant defense properties. It binds to heparin at pH 7.0, but most of it becomes unbound as the pH is raised to 8.5. This unusual heparin binding behavior was investigated by chemical modification of the basic amino acids of the protein. Diethylpyrocarbonate (DEPC) treatment of the protein abolished its binding to heparin. DEPC and [C-14]DEPC modification, coupled with amino acid sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry of peptides, identified several peptides in which histidine and lysine residues had been modified by DEPC. Two peptides from one region (residues 80-95) were identified by both methods. Moreover, the two peptides that constituted this sequence bound to heparin. Finally, when DEPC modification of the protein was carried out in the presence of heparin, these two peptides did not become modified by DEPC. Based on these results, the heparin-binding region of the protein sequence was identified as KHAHLKKQVS-DHIAVY. Two other peptides (residues 178-189 and 194-234) that contain histidine-rich sequences met some but not all of the criteria of heparin-binding sites, and it is possible that they and the histidine-rich sequence between them bind to heparin under some conditions. The present results indicate that histidine is a constituent of the heparin-binding site of selenoprotein P. The presence of histidine, the pK(a) of which is 7.0, explains the release of selenoprotein P from heparin binding as pH rises above 7.0. It can be speculated that this property would lead to increased binding of selenoprotein P in tissue regions that have low pH.	Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Clin Nutr Res Unit, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Biochem, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Burk, RF (corresponding author), Vanderbilt Med Ctr, C2104,Med Ctr N, Nashville, TN 37232 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002497, R37ES002497] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 26657] Funding Source: Medline; NIEHS NIH HHS [ES 02497, ES 07028] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alberdi E, 1998, BIOCHEMISTRY-US, V37, P10643, DOI 10.1021/bi9802317; Arteel GE, 2000, BIOL CHEM, V381, P265, DOI 10.1515/BC.2000.034; Arteel GE, 1998, BIOL CHEM, V379, P1201; Atkinson JB, 2001, LAB INVEST, V81, P193, DOI 10.1038/labinvest.3780227; BURCH MK, 1987, BIOCHEMISTRY-US, V26, P7477, DOI 10.1021/bi00397a042; BURK RF, 1994, J NUTR, V124, P1891, DOI 10.1093/jn/124.10.1891; BURK RF, 1980, J CLIN INVEST, V65, P1024, DOI 10.1172/JCI109754; Burk RF, 1997, HISTOCHEM CELL BIOL, V108, P11, DOI 10.1007/s004180050141; Burk RF, 1999, BIOESSAYS, V21, P231, DOI 10.1002/(SICI)1521-1878(199903)21:3<231::AID-BIES7>3.3.CO;2-4; BURK RF, 1995, HEPATOLOGY, V21, P561; BURSTEIN Y, 1974, BIOCHEMISTRY-US, V13, P205, DOI 10.1021/bi00698a030; Caldwell EEO, 1996, INT J BIOCHEM CELL B, V28, P203, DOI 10.1016/1357-2725(95)00123-9; CHANG JY, 1989, J BIOL CHEM, V264, P3111; CHANG LH, 1993, EUR J BIOCHEM, V211, P805, DOI 10.1111/j.1432-1033.1993.tb17612.x; Chittum HS, 1996, ARCH BIOCHEM BIOPHYS, V325, P124, DOI 10.1006/abbi.1996.0015; CONRAD HE, 1998, HEPARIN BINDING PROT, P198; Dage JL, 1998, ANAL BIOCHEM, V257, P176, DOI 10.1006/abio.1997.2552; Enghild JJ, 1999, J BIOL CHEM, V274, P14818, DOI 10.1074/jbc.274.21.14818; FIELDS R, 1971, BIOCHEM J, V124, P581, DOI 10.1042/bj1240581; Glocker MO, 1996, BIOCHEMISTRY-US, V35, P14625, DOI 10.1021/bi961199o; HERRMAN JL, 1977, BIOCHIM BIOPHYS ACTA, V500, P61, DOI 10.1016/0304-4165(77)90046-0; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; HILL KE, 1991, J BIOL CHEM, V266, P10050; Himeno S, 1996, J BIOL CHEM, V271, P15769, DOI 10.1074/jbc.271.26.15769; Kalkum M, 1998, BIOCONJUGATE CHEM, V9, P226, DOI 10.1021/bc970162t; Kamada Y, 2000, BRAIN RES, V868, P347, DOI 10.1016/S0006-8993(00)02286-1; KO YH, 1991, BIOCHEMISTRY-US, V30, P7451, DOI 10.1021/bi00244a012; Krell T, 1998, J PEPT RES, V51, P201; LEMAIRE M, 1994, J BIOL CHEM, V269, P27291; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MELCHIOR WB, 1970, BIOCHEMISTRY-US, V9, P251, DOI 10.1021/bi00804a010; MELLET P, 1995, BIOCHEMISTRY-US, V34, P2645, DOI 10.1021/bi00008a031; Miles E W, 1977, Methods Enzymol, V47, P431; MILES EW, 1974, J BIOL CHEM, V249, P2843; OURY TD, 1994, LAB INVEST, V70, P889; OVADI J, 1969, ACTA BIOCHIMICA B A, V4, P365; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; PASTA P, 1987, BIOCHEMISTRY-US, V26, P1247, DOI 10.1021/bi00379a007; READ R, 1990, J BIOL CHEM, V265, P17899; Saito Y, 1999, J BIOL CHEM, V274, P2866, DOI 10.1074/jbc.274.5.2866; SANDSTROM J, 1993, BIOCHEM J, V294, P853, DOI 10.1042/bj2940853; Sasisekharan R, 1996, J BIOL CHEM, V271, P3124, DOI 10.1074/jbc.271.6.3124; Wang XC, 1998, BIOCHEM MOL BIOL INT, V46, P81; YAMASAKI RB, 1980, ANAL BIOCHEM, V109, P32, DOI 10.1016/0003-2697(80)90006-8	44	60	61	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15823	15831		10.1074/jbc.M010405200	http://dx.doi.org/10.1074/jbc.M010405200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278668	hybrid			2022-12-27	WOS:000168623100035
J	Yu, ZB; Zhang, LF; Jin, JP				Yu, ZB; Zhang, LF; Jin, JP			A proteolytic NH2-terminal truncation of cardiac troponin I that is up-regulated in simulated microgravity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL VENOUS-PRESSURE; PROTEIN-KINASE-A; MONOCLONAL-ANTIBODIES; MUSCLE-CONTRACTION; MOLECULAR-CLONING; HEART; GENE; RAT; PHOSPHORYLATION; EXPRESSION	In a tail suspension rat model, we investigated changes in myofilament protein during cardiac adaptation in simulated microgravity. Contractile force and velocity of cardiac muscle were decreased in the tail suspension rats as compared with the control. Ca2+-dependent actomyosin ATPase activity was also decreased; however, sensitivity of cardiac muscle to Ca2+ activation was unchanged. There was no change in expression of myosin heavy chain, tropomyosin, troponin T, or troponin I isoforms in hearts of tail suspension rats. A novel finding is a fragment of cardiac troponin I (cTnI) that had increased amounts in the heart of tail suspension rats, Binding of this cTnI fragment by a monoclonal antibody that specifically recognizes the COOH terminus indicates an intact COOH terminus. NH2-terminal sequence analysis of the cTnI fragment revealed truncations primarily of amino acids 1-26 and 1-27 and smaller amounts of 130, including Ser(23) and Ser(24), which are substrates of protein kinase A phosphorylation, This cTnI fragment is present in normal cardiac muscle and incorporated into myofibrils, indicating a role in regulating contractility. This proteolytic modification of cTnI up-regulated during simulated microgravity suggests a potential role of the NH2-terminal segment of cTnI in functional adaptations of cardiac muscle.	Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Fourth Mil Med Univ, Dept Aerosp Physiol, Xian 710032, Peoples R China	Case Western Reserve University; Air Force Military Medical University	Jin, JP (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, 10900 Euclid Ave, Cleveland, OH 44106 USA.	jxj12@po.cwru.edu		Jin, JP/0000-0001-9932-1063				AUSONI S, 1994, J BIOL CHEM, V269, P339; BALDWIN AS, 1985, P NATL ACAD SCI USA, V82, P8080, DOI 10.1073/pnas.82.23.8080; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bhavsar PK, 1996, GENOMICS, V35, P11, DOI 10.1006/geno.1996.0317; Bodor GS, 1997, CIRCULATION, V96, P1495, DOI 10.1161/01.CIR.96.5.1495; BOTTINELLI R, 1995, AM J PHYSIOL-CELL PH, V269, pC785, DOI 10.1152/ajpcell.1995.269.3.C785; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUNGO MW, 1987, J APPL PHYSIOL, V62, P278, DOI 10.1152/jappl.1987.62.1.278; CAPASSO JM, 1982, AM J PHYSIOL, V242, pH882, DOI 10.1152/ajpheart.1982.242.5.H882; Convertino V, 1992, J Fla Med Assoc, V79, P517; Convertino VA, 1997, AM J PHYSIOL-REG I, V273, pR93, DOI 10.1152/ajpregu.1997.273.1.R93; CORIN SJ, 1994, J BIOL CHEM, V269, P10651; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; DILISA F, 1995, BIOCHEM J, V308, P57, DOI 10.1042/bj3080057; Dunlap AW, 1996, J APPL PHYSIOL, V80, P1612, DOI 10.1152/jappl.1996.80.5.1612; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; FABIATO A, 1975, J PHYSIOL-LONDON, V249, P497, DOI 10.1113/jphysiol.1975.sp011027; FITZSIMONS DP, 1990, J APPL PHYSIOL, V69, P305, DOI 10.1152/jappl.1990.69.1.305; GOLDSTEIN MA, 1992, J APPL PHYSIOL, V73, pS94, DOI 10.1152/jappl.1992.73.2.S94; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GUO XD, 1994, J BIOL CHEM, V269, P15210; Hastings KEM, 1997, CELL STRUCT FUNCT, V22, P205, DOI 10.1247/csf.22.205; Herault S, 2000, EUR J APPL PHYSIOL, V81, P384, DOI 10.1007/s004210050058; Huang QQ, 1999, J PHYSIOL-LONDON, V520, P231, DOI 10.1111/j.1469-7793.1999.00231.x; Jaquet K, 1998, J MUSCLE RES CELL M, V19, P647, DOI 10.1023/A:1005381131102; Jin JP, 2000, AM J PHYSIOL-CELL PH, V279, pC1067, DOI 10.1152/ajpcell.2000.279.4.C1067; JIN JP, 1988, J BIOL CHEM, V263, P7309; JIN JP, 1990, HYBRIDOMA, V9, P597, DOI 10.1089/hyb.1990.9.597; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Jin JP, 1996, BIOCHEM BIOPH RES CO, V225, P883, DOI 10.1006/bbrc.1996.1267; KASHIHARA H, 1994, ACTA PHYSIOL SCAND, V150, P19; KATSUME H, 1992, JPN CIRC J, V56, P201, DOI 10.1253/jcj.56.201; KESSLER KM, 1986, AM J CARDIOL, V58, P525, DOI 10.1016/0002-9149(86)90027-5; KOPPE RI, 1989, J BIOL CHEM, V264, P14327; LEAVIS PC, 1984, CRC CR REV BIOCH MOL, V16, P235, DOI 10.3109/10409238409108717; LIN JJC, 1985, HYBRIDOMA, V4, P223, DOI 10.1089/hyb.1985.4.223; Lucas DT, 1999, P NATL ACAD SCI USA, V96, P6689, DOI 10.1073/pnas.96.12.6689; MARTIN AF, 1991, J MOL CELL CARDIOL, V23, P583, DOI 10.1016/0022-2828(91)90050-V; McConnell BK, 1997, AM J PHYSIOL-HEART C, V273, pH1440, DOI 10.1152/ajpheart.1997.273.3.H1440; McDonough JL, 1999, CIRC RES, V84, P9; MOREYHOLTON ER, 1981, PHYSIOLOGIST S, V24, P45; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; MURPHY AM, 1991, BIOCHEMISTRY-US, V30, P707, DOI 10.1021/bi00217a018; Murphy AM, 1997, BIOCHEM J, V322, P393, DOI 10.1042/bj3220393; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; SAGGIN L, 1989, J BIOL CHEM, V264, P16299; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; SHELLOCK FG, 1985, AVIAT SPACE ENVIR MD, V56, P791; Socci RR, 2000, CLIN EXP HYPERTENS, V22, P155, DOI 10.1081/CEH-100100069; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; TSIKA RW, 1987, J APPL PHYSIOL, V63, P2111, DOI 10.1152/jappl.1987.63.5.2111; van der Velden J, 2000, CARDIOVASC RES, V46, P487, DOI 10.1016/S0008-6363(00)00050-X; Weil J, 1998, CARDIOVASC RES, V37, P541, DOI 10.1016/S0008-6363(97)00227-7; Westfall MV, 1999, J BIOL CHEM, V274, P22508, DOI 10.1074/jbc.274.32.22508; White RJ, 1998, J APPL PHYSIOL, V85, P738, DOI 10.1152/jappl.1998.85.2.738; WU QL, 1993, DNA SEQUENCE, V4, P113, DOI 10.3109/10425179309020150; Zakhary DR, 1999, CIRCULATION, V99, P505, DOI 10.1161/01.CIR.99.4.505; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773	60	58	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15753	15760		10.1074/jbc.M011048200	http://dx.doi.org/10.1074/jbc.M011048200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278823	hybrid			2022-12-27	WOS:000168623100026
J	Gnesutta, N; Qu, J; Minden, A				Gnesutta, N; Qu, J; Minden, A			The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RAS TRANSFORMATION; SURVIVAL SIGNALS; ADAPTER PROTEIN; JNK ACTIVATION; LIM-KINASE; FAMILY; ACTIN; CDC42; PHOSPHORYLATION	The serine/threonine kinase PAK4 was identified first as an effector molecule for the Rho GTPase Cdc42. PAK4 differs from other members of the PAK family both in sequence and function. Previously we have shown that an important function of this kinase is to mediate the induction of filopodia in response to activated Cdc42. Studies with a, constitutively active PAK4 mutant have shown that it also has a role in promoting anchorage-independent growth, an important hallmark of oncogenic transformation. Here we show that another function of PAK4 is to protect cells against apoptotic cell death. Expression of wild-type or constitutively active PAK4 delays the onset of apoptosis in response to tumor necrosis factor LY stimulation, UV irradiation, and serum starvation. Consistent with an antiapoptotic function, expression of PAK4 leads to an increase in phosphorylation of the proapoptotic protein Bad and an inhibition of caspase activation.	Columbia Univ, Dept Biol Sci, Sherman Fairchild Ctr, New York, NY 10027 USA	Columbia University	Minden, A (corresponding author), Columbia Univ, Dept Biol Sci, Sherman Fairchild Ctr, Rm 813,1212 Amsterdam Ave, New York, NY 10027 USA.		Gnesutta, Nerina/I-5432-2015	Gnesutta, Nerina/0000-0002-2465-8881	NATIONAL CANCER INSTITUTE [R01CA076342] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA76342] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Downward J, 1999, NAT CELL BIOL, V1, pE33, DOI 10.1038/10026; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Franke TF, 2000, METHOD ENZYMOL, V322, P400; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Kulms D, 1999, P NATL ACAD SCI USA, V96, P7974, DOI 10.1073/pnas.96.14.7974; Leberer E, 2000, BIOL CHEM, V381, P427, DOI 10.1515/BC.2000.055; Lee N, 1997, P NATL ACAD SCI USA, V94, P13642, DOI 10.1073/pnas.94.25.13642; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; Melzig J, 1998, CURR BIOL, V8, P1223, DOI 10.1016/S0960-9822(07)00514-3; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Michiels F, 1999, BIOCHEM SOC SYMP, V65, P125; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MINDEN A, 1997, HORMONES SIGNALING, V1, P209; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Rudel T, 1998, J IMMUNOL, V160, P7; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; Sheikh MS, 1998, ONCOGENE, V17, P2555, DOI 10.1038/sj.onc.1202292; Stanyon CA, 1999, INT J BIOCHEM CELL B, V31, P389, DOI 10.1016/S1357-2725(98)00116-2; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Walter BN, 1998, J BIOL CHEM, V273, P28733, DOI 10.1074/jbc.273.44.28733; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zeng Q, 2000, J CELL SCI, V113, P471; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	53	169	177	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14414	14419		10.1074/jbc.M011046200	http://dx.doi.org/10.1074/jbc.M011046200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278822	hybrid, Green Published			2022-12-27	WOS:000168356600119
J	Jaitovich-Groisman, I; Benlimame, N; Slagle, BL; Perez, MH; Alpert, L; Song, DJ; Fotouhi-Ardakani, N; Galipeau, J; Alaoui-Jamali, MA				Jaitovich-Groisman, I; Benlimame, N; Slagle, BL; Perez, MH; Alpert, L; Song, DJ; Fotouhi-Ardakani, N; Galipeau, J; Alaoui-Jamali, MA			Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; HBX PROTEIN; P53-MEDIATED APOPTOSIS; MEDIATED TRANSCRIPTION; CELLULAR-RESPONSE; DOWN-REGULATION; GENE-PRODUCT; IN-VIVO; P53	Human hepatitis B virus is a risk factor for the development of hepatocellular carcinoma. The hepatitis B virus x protein (HBx) has been shown to inactivate the p53 tumor suppressor protein and impair DNA repair, cell cycle, and apoptosis mechanisms. Herein we report that HBx represses two components of the transcription-repair factor TFIIH, XPB (p89), and XPD (p80), both in p53-proficient anal p53-deficient liver cells. This inhibition is observed while HBx maintains its transactivation function. Expression of HBx in liver cells results in down-regulation of endogenous XPB and XPD mRNAs and proteins; this inhibition is-not observed with other TFIIH subunits, XPA or PCNA. In liver tissue from HBx transgenics, WE and XPD proteins are down-regulated in comparison to matched normal liver tissue. HBx has been shown to interact with Sp1 transcription factor and affects its DNA binding activity. Sp1 is essential for the basal promoter activity of XPB in liver cells and Drosophila SL2 cells, In the Sp1-deficient SL2 cells, HBx-induced XPB and XPD inhibition is Sp1-dependent. In summary, our results provide evidence that HBx represses the expression of key TFIIH proteins at least in part through Sp1 elements; this repression may impair TFIIH function in DNA repair mechanisms.	McGill Univ, Sir Mortimer B Davis Jewish Hosp, Fac Med, Lady Davis Inst,Dept Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, Sir Mortimer B Davis Jewish Hosp, Fac Med, Lady Davis Inst,Dept Pharmacol & Therapeut, Montreal, PQ H3T 1E2, Canada; McGill Univ, Sir Mortimer B Davis Jewish Hosp, Fac Med, Lady Davis Inst,Dept Pathol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Sir Mortimer B Davis Jewish Hosp, Fac Med, Lady Davis Inst,Dept Oncol, Montreal, PQ H3T 1E2, Canada; Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; Baylor College of Medicine	Alaoui-Jamali, MA (corresponding author), Lady Davis Inst Med Res, Rm 523,3755 Chemin Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	malaou@po-box.mcgill.ca	Galipeau, Jacques/R-9909-2019	Galipeau, Jacques/0000-0002-9374-1996				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Bergametti F, 1999, ONCOGENE, V18, P2860, DOI 10.1038/sj.onc.1202643; Bhatia PK, 1996, CURR OPIN GENET DEV, V6, P146, DOI 10.1016/S0959-437X(96)80043-8; Capovilla A, 1997, BIOCHEM BIOPH RES CO, V232, P255, DOI 10.1006/bbrc.1997.6269; Chirillo P, 1997, P NATL ACAD SCI USA, V94, P8162, DOI 10.1073/pnas.94.15.8162; CHISARI FV, 1985, SCIENCE, V230, P1157, DOI 10.1126/science.3865369; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DRAGANI TA, 1990, CARCINOGENESIS, V11, P953, DOI 10.1093/carcin/11.6.953; Elmore LW, 1997, P NATL ACAD SCI USA, V94, P14707, DOI 10.1073/pnas.94.26.14707; FARBER E, 1987, CONCEPTS THEORIES CA, P185; Feitelson MA, 1999, J CELL PHYSIOL, V181, P188; FEITELSON MA, 1993, ONCOGENE, V8, P1109; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; Galipeau J, 1999, CANCER RES, V59, P2384; Giebler HA, 2000, MOL CELL BIOL, V20, P4849, DOI 10.1128/MCB.20.13.4849-4858.2000; Gottlob K, 1998, CANCER RES, V58, P3566; Groisman IJ, 1999, CARCINOGENESIS, V20, P479, DOI 10.1093/carcin/20.3.479; GU ZM, 1994, ONCOGENE, V9, P629; Haviv I, 1998, MOL CELL BIOL, V18, P1562, DOI 10.1128/MCB.18.3.1562; Hoeijmakers JHJ, 1996, CURR OPIN GENET DEV, V6, P26, DOI 10.1016/S0959-437X(96)90006-4; Jaitovitch-Groisman I, 2000, J BIOL CHEM, V275, P33395, DOI 10.1074/jbc.M003754200; Jia L, 1999, INT J CANCER, V80, P875, DOI 10.1002/(SICI)1097-0215(19990315)80:6<875::AID-IJC13>3.3.CO;2-Q; Kim H, 1998, J BIOL CHEM, V273, P381, DOI 10.1074/jbc.273.1.381; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; KOIKE K, 1989, MOL BIOL MED, V6, P151; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; LEE TH, 1990, J VIROL, V64, P5939, DOI 10.1128/JVI.64.12.5939-5947.1990; LEE TH, 1995, J VIROL, V69, P1107, DOI 10.1128/JVI.69.2.1107-1114.1995; Lee YI, 1998, ONCOGENE, V16, P2367, DOI 10.1038/sj.onc.1201760; Leveillard T, 1996, EMBO J, V15, P1615, DOI 10.1002/j.1460-2075.1996.tb00506.x; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin Y, 1997, J BIOL CHEM, V272, P7132, DOI 10.1074/jbc.272.11.7132; MA L, 1992, NUCLEIC ACIDS RES, V20, P217, DOI 10.1093/nar/20.2.217; Madden CR, 2000, J VIROL, V74, P5266, DOI 10.1128/JVI.74.11.5266-5272.2000; Marinoni JC, 1997, EMBO J, V16, P1093, DOI 10.1093/emboj/16.5.1093; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nigg EA, 1996, CURR OPIN CELL BIOL, V8, P312, DOI 10.1016/S0955-0674(96)80003-2; Noti JD, 1996, MOL CELL BIOL, V16, P2940; Prost S, 1998, J BIOL CHEM, V273, P33327, DOI 10.1074/jbc.273.50.33327; PUISIEUX A, 1995, P NATL ACAD SCI USA, V92, P1342, DOI 10.1073/pnas.92.5.1342; Qadri I, 1996, J BIOL CHEM, V271, P15443, DOI 10.1074/jbc.271.26.15443; Ravi R, 1998, CANCER RES, V58, P4531; Robles AI, 1999, ONCOGENE, V18, P4681, DOI 10.1038/sj.onc.1202862; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; SELL S, 1991, CANCER RES, V51, P1278; Shintani Y, 1999, J GEN VIROL, V80, P3257, DOI 10.1099/0022-1317-80-12-3257; Shirasaki F, 1999, ONCOGENE, V18, P7755, DOI 10.1038/sj.onc.1203360; Slagle BL, 1996, MOL CARCINOGEN, V15, P261, DOI 10.1002/(SICI)1098-2744(199604)15:4<261::AID-MC3>3.0.CO;2-J; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Sohn S, 2000, MUTAT RES-DNA REPAIR, V460, P17, DOI 10.1016/S0921-8777(00)00010-0; Spillare EA, 1999, GENE DEV, V13, P1355, DOI 10.1101/gad.13.11.1355; Terradillos O, 1998, ONCOGENE, V17, P2115, DOI 10.1038/sj.onc.1202432; Therrien JP, 1999, P NATL ACAD SCI USA, V96, P15038, DOI 10.1073/pnas.96.26.15038; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; TRUANT R, 1995, J VIROL, V69, P1851, DOI 10.1128/JVI.69.3.1851-1859.1995; TWU JS, 1989, P NATL ACAD SCI USA, V86, P2046, DOI 10.1073/pnas.86.6.2046; TWU JS, 1987, J VIROL, V61, P3448, DOI 10.1128/JVI.61.11.3448-3453.1987; UNSAL H, 1994, P NATL ACAD SCI USA, V91, P822, DOI 10.1073/pnas.91.2.822; Wang HD, 1998, MOL CELL BIOL, V18, P7086, DOI 10.1128/MCB.18.12.7086; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; Wang XW, 1996, GENE DEV, V10, P1219, DOI 10.1101/gad.10.10.1219; Winkler GS, 2000, J BIOL CHEM, V275, P4258, DOI 10.1074/jbc.275.6.4258; Ye JP, 1996, MOL CELL BIOL, V16, P6178; Yen L, 1997, ONCOGENE, V14, P1827, DOI 10.1038/sj.onc.1201019; ZAHM P, 1988, ONCOGENE, V3, P169; Zaid A, 1999, J BIOENERG BIOMEMBR, V31, P129, DOI 10.1023/A:1005499727732	69	56	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14124	14132		10.1074/jbc.M010852200	http://dx.doi.org/10.1074/jbc.M010852200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278765	hybrid			2022-12-27	WOS:000168356600084
J	Wong, AHT; Durbin, JE; Li, SY; Dever, TE; Decker, T; Koromilas, AE				Wong, AHT; Durbin, JE; Li, SY; Dever, TE; Decker, T; Koromilas, AE			Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; VACCINIA VIRUS; TRANSLATIONAL CONTROL; TARGETED DISRUPTION; INNATE IMMUNITY; IFN-GAMMA; INTERFERON; GENE; CELLS; ACTIVATION	We have previously reported a physical association between STAT1 and the protein kinase double-stranded RNA-activated protein kinase (PKR). PKR inhibited STAT1 function in a manner independent of PKR kinase activity. In this report, we have further characterized the properties of both molecules by mapping the sites of their interaction. A STAT1 mutant unable to interact with PKR displays enhanced interferon gamma (IFN-gamma)-induced transactivation capacity compared with STAT1. This effect appears to be mediated by the higher capacity of STAT1 mutant to heterodimerize with STAT3. Furthermore, expression of STAT1 mutant in STAT1(-/-) cells enhances both the antiviral and antiproliferative effects of IFNs as opposed to STAT1. We also provide evidence that STAT1 functions as an inhibitor of PKR in vitro and in vivo. That is, phosphorylation of eIF-2 alpha is enhanced in STAT1(-/-) than STAT1(+/+) cells in vivo, and this correlates with higher activation capacity of PKR in STAT1(-/-) cells. Genetic experiments in yeast demonstrate the inhibition of PKR activation and eIF-2 alpha phosphorylation by STAT1 but not by STAT1 mutant. These data substantiate our previous findings on the inhibitory effects of PKR on STAT1 and implicate STAT1 in translational control through the modulation of PKR activation and eIF-2 alpha phosphorylation.	Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada; Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; Ohio State Univ, Childrens Hosp Res Fdn, Columbus, OH 43205 USA; NICHD, Lab Eukaryot Gene Express, NIH, Bethesda, MD 20892 USA; Vienna Bioctr, Inst Microbiol & Genet, A-1030 Vienna, Austria	Lady Davis Institute; McGill University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Vienna Biocenter (VBC)	Koromilas, AE (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Terry Fox Mol Oncol Grp, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	akoromil@ldi.jgh.mcgill.ca		Dever, Thomas/0000-0001-7120-9678	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001010] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; BANDYOPADHYAY SK, 1995, J BIOL CHEM, V270, P19624, DOI 10.1074/jbc.270.33.19624; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Craig AWB, 1996, J BIOL CHEM, V271, P24526, DOI 10.1074/jbc.271.40.24526; Cuddihy AR, 1999, MOL CELL BIOL, V19, P2475; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dever TE, 1998, METH MOL B, V77, P167; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; EILERS A, 1994, MOL CELL BIOL, V14, P1364, DOI 10.1128/MCB.14.2.1364; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Garcia-Sastre A, 1998, J VIROL, V72, P8550; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Hoey T, 1997, SCIENCE, V278, P1578, DOI 10.1126/science.278.5343.1578; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nanduri S, 1998, EMBO J, V17, P5458, DOI 10.1093/emboj/17.18.5458; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; RendeFournier R, 1997, VIROLOGY, V238, P410, DOI 10.1006/viro.1997.8824; ROMANO PR, 1995, MOL CELL BIOL, V15, P365, DOI 10.1128/MCB.15.1.365; Ron D, 2000, COLD SPRING HARBOR M, V39, P547; Sekimoto T, 1996, J BIOL CHEM, V271, P31017, DOI 10.1074/jbc.271.49.31017; Sharp TV, 1997, EUR J BIOCHEM, V250, P85, DOI 10.1111/j.1432-1033.1997.00085.x; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stojdl DF, 2000, J VIROL, V74, P9580, DOI 10.1128/JVI.74.20.9580-9585.2000; Tam NWN, 1999, EUR J BIOCHEM, V262, P149, DOI 10.1046/j.1432-1327.1999.00360.x; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	46	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13727	13737		10.1074/jbc.M011240200	http://dx.doi.org/10.1074/jbc.M011240200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278865	hybrid			2022-12-27	WOS:000168356600032
J	Mielenz, D; Hapke, S; Poschl, E; von der Mark, H; von der Mark, K				Mielenz, D; Hapke, S; Poschl, E; von der Mark, H; von der Mark, K			The integrin alpha(7) cytoplasmic domain regulates cell migration, lamellipodia formation, and p130(CAS)/Crk coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; SIGNALING PATHWAYS; STABLE ASSOCIATION; DEPENDENT MANNER; LAMININ ISOFORMS; SATELLITE CELLS; MYOGENIC CELLS	The integrin alpha (7)beta (1) is the major laminin-binding integrin in skeletal, heart, and smooth muscle and is a receptor for laminin-l and -2, It mediates myoblast migration on laminin-l and -2 and thus might be involved in muscle development and repair. Previously we have shown that alpha B-7 as well as the alpha (7)A and -C splice variants induce cell motility on laminin when transfected into nonmotile HEK293 cells. In this study we have investigated the role of the cytoplasmic domain of alpha (7) in the laminin-induced signal transduction of alpha (7)beta (1) integrin regulating cell adhesion and migration. Deletion of the cytoplasmic domain did not affect assembly of the mutated alpha (7)Delta cyt/beta (1) heterodimer on the cell surface or adhesion of alpha (7)Delta cyt-transfected cells to laminin, The motility of these cells on the laminin-1/E8 fragment, however, was significantly reduced to the level of mock-transfected cells; lamellipodia formation and polarization of the cells were also impaired. Adhesion to the laminin-1/E8 fragment induced tyrosine phosphorylation of the focal adhesion kinase, paxillin, and p130(CAS) as well as the formation of a p130(CAS)-Crk complex in wild-type alpha B-7-transfected cells. In alpha B-7 Delta cyt cells, however, the extent of p130(CAS) tyrosine formation was reduced and formation of the p130(CAS)-Crk complex was impaired, with unaltered levels of p130(CAS) and Crk protein levels. These findings indicate adhesion-dependent regulation of p130(CAS)/Crk complex formation by the cytoplasmic domain of alpha B-7 integrin after cell adhesion to laminin-1/E8 and imply alpha B-7-controlled lamellipodia formation and cell migration through the p130(CAS)/Crk protein complex.	Univ Erlangen Nurnberg, Dept Expt Med 1, Klin Mol Biol Forschungszentrum, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	von der Mark, K (corresponding author), Univ Erlangen Nurnberg, Dept Expt Med 1, Klin Mol Biol Forschungszentrum, Gluckstr 6, D-91054 Erlangen, Germany.	kvdmark@molmed.uni-erlangen.de	von+der+Mark, Klaus/AAJ-1443-2020					AUMAILLEY M, 1990, FEBS LETT, V262, P82, DOI 10.1016/0014-5793(90)80159-G; BAUER JS, 1993, J CELL BIOL, V122, P209, DOI 10.1083/jcb.122.1.209; BELKIN AM, 1988, J CELL BIOL, V107, P545, DOI 10.1083/jcb.107.2.545; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; BRIESEWITZ R, 1993, J BIOL CHEM, V268, P2989; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; CARY LA, 1999, FRONTIERS BIOSCI, V4, pD103; Casamassima A, 1997, J BIOL CHEM, V272, P9363; Chellaiah M, 1996, ENDOCRINOLOGY, V137, P2432, DOI 10.1210/en.137.6.2432; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Cohn RD, 1999, J NEUROL SCI, V163, P140, DOI 10.1016/S0022-510X(99)00012-X; COLLO G, 1993, J BIOL CHEM, V268, P19019; COSSU G, 1980, CELL DIFFER DEV, V9, P357, DOI 10.1016/0045-6039(80)90035-4; Crawley S, 1997, EXP CELL RES, V235, P274, DOI 10.1006/excr.1997.3671; deMelker AA, 1997, BIOCHEM J, V328, P529, DOI 10.1042/bj3280529; DeMelker AA, 1996, EUR J BIOCHEM, V241, P254; Echtermeyer F, 1996, J BIOL CHEM, V271, P2071, DOI 10.1074/jbc.271.4.2071; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.3.CO;2-5; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; GOODMAN SL, 1989, J CELL BIOL, V109, P799, DOI 10.1083/jcb.109.2.799; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; ILLC D, 1995, NATURE, V377, P539; KANNER SB, 1991, EMBO J, V10, P1689, DOI 10.1002/j.1460-2075.1991.tb07693.x; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; KRAMER RH, 1991, CELL REGUL, V2, P805, DOI 10.1091/mbc.2.10.805; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lu CF, 1997, J IMMUNOL, V159, P268; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; OCALAN M, 1988, DEV BIOL, V125, P158, DOI 10.1016/0012-1606(88)90068-1; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; PATCH LA, 1995, J CELL SCI, V108, P1371; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sastry SK, 1996, J CELL BIOL, V133, P169, DOI 10.1083/jcb.133.1.169; Schober S, 2000, EXP CELL RES, V255, P303, DOI 10.1006/excr.2000.4806; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; SCHULER F, 1995, J CELL SCI, V108, P3795; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; SONG WK, 1993, J CELL SCI, V106, P1139; UEKI M, 1998, FEBS LETT, V423, P192; Velling T, 1996, DEV DYNAM, V207, P355, DOI 10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G; VONDERMARK H, 1991, J BIOL CHEM, V266, P23593; Vuori K, 1996, MOL CELL BIOL, V16, P2606; VUORI K, 1995, J BIOL CHEM, V270, P22259, DOI 10.1074/jbc.270.38.22259; Ware MF, 1998, J CELL SCI, V111, P2423; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; Yao CC, 1996, J BIOL CHEM, V271, P25598, DOI 10.1074/jbc.271.41.25598; Ziober BL, 1997, MOL BIOL CELL, V8, P1723, DOI 10.1091/mbc.8.9.1723; ZIOBER BL, 1993, J BIOL CHEM, V268, P26773	64	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13417	13426		10.1074/jbc.M011481200	http://dx.doi.org/10.1074/jbc.M011481200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278916	hybrid			2022-12-27	WOS:000168198600130
J	Zhong, SP; Zhang, YG; Jansen, C; Goto, H; Inagaki, M; Dong, ZG				Zhong, SP; Zhang, YG; Jansen, C; Goto, H; Inagaki, M; Dong, ZG			MAP kinases mediate WE-induced phosphorylation of histone H3 at serine 28	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CHROMOSOME CONDENSATION; ACTIVATED PROTEIN-KINASE; N-TERMINI; IN-VITRO; TRANSCRIPTION; ACETYLATION; DEACETYLASE; PATHWAY; YEAST; CELLS	Histone H3 phosphorylation is related closely to chromatin remodeling and chromosome condensation. H3 phosphorylation at serine 28 is coupled with mitotic chromosome condensation in diverse mammalian cell lines. However, the pathway that mediates phosphorylation of H3 at serine 28 is unknown. In the present study, ERK1, ERK2, or p38 kinase strongly phosphorylated H3 at serine 28 in vitro. JNK1 or JNK2 was able also to phosphorylate H3 at serine 28 in vitro but to a lesser degree. UVB irradiation markedly induced phosphorylation of H3 at serine 28 in JB6 Cl 41 cells. PD 98059, a MEK1 inhibitor, and SE 202190, a p38 kinase inhibitor, efficiently repressed UVB-induced H3 phosphorylation at serine 28, Expression of dominant negative mutant DNM ERK2 in JB6 Cl 41 cells totally blocked UVB-induced phosphorylation of H3 at serine 28. Additionally, DNM p38 kinase or DNM JNK1 partially blocked UVB-induced H3 phosphorylation at serine 28, Furthermore, UVB-induced H3 phosphorylation at serine 28 was inhibited in Jnk1(-/-) cells but not in Jnk2(-/-) cells. These results suggest that UVB-induced H3 phosphorylation at serine 28 may be mediated by mitogen-activated protein kinases.	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; Aichi Canc Ctr, Res Inst, Biochem Lab, Chikusa Ku, Aichi 4648681, Japan	University of Minnesota System; Aichi Cancer Center	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@smig.net	Inagaki, Masaki/B-9920-2016	Zhang, Yiguo/0000-0003-3910-2779; Goto, Hidemasa/0000-0002-6796-4467	NATIONAL CANCER INSTITUTE [R01CA077646, R29CA074916] Funding Source: NIH RePORTER; NCI NIH HHS [CA74916, CA77646] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERTS B, 1994, MOL BIOL CELL, P342; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; DANNA JA, 1974, BIOCHEMISTRY-US, V13, P4992, DOI 10.1021/bi00721a019; Davie JR, 1999, J CELL BIOCHEM, P141; de la Barre AE, 2000, EMBO J, V19, P379, DOI 10.1093/emboj/19.3.379; De Souza CPC, 2000, CELL, V102, P293, DOI 10.1016/S0092-8674(00)00035-0; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HONDA BM, 1975, J BIOL CHEM, V250, P8681; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Huang CS, 1999, J BIOL CHEM, V274, P14595, DOI 10.1074/jbc.274.21.14595; Huang CS, 1999, ONCOGENE, V18, P2828, DOI 10.1038/sj.onc.1202639; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; MOSS T, 1976, BIOCHEMISTRY-US, V15, P2261, DOI 10.1021/bi00656a003; Oh-hashi K, 1999, BIOCHEM BIOPH RES CO, V263, P504, DOI 10.1006/bbrc.1999.1237; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Roth SY, 1996, CELL, V87, P5, DOI 10.1016/S0092-8674(00)81316-1; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Sauve DM, 1999, J CELL BIOL, V145, P225, DOI 10.1083/jcb.145.2.225; Smalley KSM, 1999, BIOCHEM BIOPH RES CO, V263, P239, DOI 10.1006/bbrc.1999.1351; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; TLKOO K, 1997, BIOCHEM J, V322, P281; Van Hooser A, 1998, J CELL SCI, V111, P3497; VANHOLDE KE, 1988, CHROMATIN, P111; Watts RG, 1998, ONCOGENE, V17, P3493, DOI 10.1038/sj.onc.1202259; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Zhong SP, 2000, J BIOL CHEM, V275, P20980, DOI 10.1074/jbc.M909934199	48	53	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12932	12937		10.1074/jbc.M010931200	http://dx.doi.org/10.1074/jbc.M010931200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278789	hybrid			2022-12-27	WOS:000168198600068
J	Ulloa, L; Tabibzadeh, S				Ulloa, L; Tabibzadeh, S			Lefty inhibits receptor-regulated smad phosphorylation induced by the activated transforming growth factor-beta receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEFT-RIGHT ASYMMETRY; TGF-BETA; TUMOR-SUPPRESSOR; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTIONAL ACTIVATION; MESODERM INDUCTION; COLLAGEN-SYNTHESIS; PANCREATIC-CANCER; EPITHELIAL-CELLS; AXIS DEVELOPMENT	Transforming growth factor-beta (TGF-beta) is a pleiotropic cytokine that regulates growth and differentiation of diverse types of cells. TGF-beta actions are directed by ligand-induced activation of TGF-beta receptors with intrinsic serine/threonine kinase activity that trigger phosphorylation of receptor-regulated Smad (R-Smad) protein. Phosphorylated R-Smad proteins bind to Smad4, and the complexes formed move into the nucleus, where they act as components of a transcriptional complex. Here, we show that TGF-beta signaling is inhibited by lefty, a novel member of the TGF-beta superfamily, Lefty perturbed TGF-beta signaling by inhibiting the phosphorylation of Smad2 following activation of the TGF-beta receptor. Moreover, lefty inhibited the events that lie downstream from R-Smad phosphorylation, including heterodimerization of R-Smad proteins with Smad4 and nuclear translocation of the R-Smad Smad4 complex. Lefty repressed TGF-beta -induced expression of reporter genes for the p21, cdc25, and connective tissue growth factor promoters and of a reporter gene driven by the Smad-binding element. Similarly, lefty inhibited both BMP-mediated Smad5 phosphorylation and gene transcription. The action of lefty does not appear to depend on protein synthesis, including synthesis of inhibitory Smad proteins. Thus, lefty provides a repressed state of TGF-beta- or BMP-responsive genes and participates in negative modulation of TGF-beta and BMP signaling by inhibition of phosphorylation of R-Smad proteins.	Biomed Res Ctr, Dept Pathol, 350 Community Dr, Manhasset, NY 11030 USA; N Shore Long Isl Jewish Hlth Syst, Dept Pathol, Manhasset, NY 11030 USA	Northwell Health	Tabibzadeh, S (corresponding author), Biomed Res Ctr, Dept Pathol, 350 Community Dr, Manhasset, NY 11030 USA.	tabibzadeh@bioscience.org	Ulloa, Luis/AAE-8751-2019	Ulloa, Luis/0000-0002-7702-7549	NATIONAL CANCER INSTITUTE [R01CA046866, R29CA046866] Funding Source: NIH RePORTER; NCI NIH HHS [CA46866] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agah R, 2000, CIRC RES, V86, P1024, DOI 10.1161/01.RES.86.10.1024; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Branford WW, 2000, DEV BIOL, V223, P291, DOI 10.1006/dbio.2000.9739; Brown JD, 1999, J BIOL CHEM, V274, P8797, DOI 10.1074/jbc.274.13.8797; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Cheng AMS, 2000, DEVELOPMENT, V127, P1049; Choi BM, 1996, IMMUNOL CELL BIOL, V74, P144, DOI 10.1038/icb.1996.19; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Farina AR, 1998, INT J CANCER, V75, P721; Faure S, 2000, DEVELOPMENT, V127, P2917; FYNAN TM, 1993, CRIT REV ONCOGENESIS, V4, P493; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; Hartsough MT, 1997, PHARMACOL THERAPEUT, V75, P21, DOI 10.1016/S0163-7258(97)00020-X; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Heymer J, 1997, MECH DEVELOP, V66, P5, DOI 10.1016/S0925-4773(97)00084-1; HSU S, 1994, CELL GROWTH DIFFER, V5, P267; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Iavarone A, 1997, NATURE, V387, P417; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Ishimaru Y, 2000, MECH DEVELOP, V90, P115, DOI 10.1016/S0925-4773(99)00232-4; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; Kleeff J, 1999, BIOCHEM BIOPH RES CO, V255, P268, DOI 10.1006/bbrc.1999.0171; Kosaki K, 1999, AM J HUM GENET, V64, P712, DOI 10.1086/302289; Kothapalli R, 1997, J CLIN INVEST, V99, P2342, DOI 10.1172/JCI119415; KRASAGAKIS K, 1993, MELANOMA RES, V3, P425, DOI 10.1097/00008390-199311000-00005; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Krieglstein K, 2000, NAT NEUROSCI, V3, P1085, DOI 10.1038/80598; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Kundu SD, 1998, J UROLOGY, V160, P1883, DOI 10.1016/S0022-5347(01)62437-6; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Liu B, 1999, MOL CELL BIOL, V19, P424; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Pogoda HM, 2000, CURR BIOL, V10, P1041, DOI 10.1016/S0960-9822(00)00669-2; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; RODECK U, 1994, CANCER RES, V54, P575; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SHI Y, CELL, V94, P585; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sirotkin HI, 2000, CURR BIOL, V10, P1051, DOI 10.1016/S0960-9822(00)00679-5; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; TABIBZADEH S, 1997, FRONT BIOSCI, V2, P18; Tanegashima K, 2000, MECH DEVELOP, V99, P3, DOI 10.1016/S0925-4773(00)00465-2; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; Thisse C, 1999, DEVELOPMENT, V126, P229; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Ulloa L, 2001, J BIOL CHEM, V276, P21387, DOI 10.1074/jbc.M006933200; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; Varlet I, 1997, CURR OPIN GENET DEV, V7, P519, DOI 10.1016/S0959-437X(97)80080-9; Weisberg E, 1998, MECH DEVELOP, V79, P17, DOI 10.1016/S0925-4773(98)00160-9; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; WRIGHT JA, 1993, CRIT REV ONCOGENESIS, V4, P473; YOUNAI S, 1994, ANN PLAS SURG, V33, P148, DOI 10.1097/00000637-199408000-00005; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	91	67	78	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21397	21404		10.1074/jbc.M010783200	http://dx.doi.org/10.1074/jbc.M010783200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11278746	hybrid			2022-12-27	WOS:000169297900081
J	Huang, YZ; Wang, Q; Xiong, WC; Mei, L				Huang, YZ; Wang, Q; Xiong, WC; Mei, L			Erbin is a protein concentrated at postsynaptic membranes that interacts with PSD-95	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR SYNTHESIS; BASOLATERAL PDZ PROTEIN; SYNAPTIC BASAL LAMINA; TUMOR-SUPPRESSOR GENE; TYROSINE PHOSPHORYLATION; NEUREGULIN RECEPTORS; EXPRESSION; SUBUNIT; ARIA; KINASE	Neuregulin is a factor essential for synapse-specific transcription of acetylcholine receptor genes at the neuromuscular junction. Its receptors, ErbB receptor tyrosine kinases, are localized at the postjunctional membrane presumably to ensure localized signaling. However, the molecular mechanisms underlying synaptic localization of ErbBs are unknown. Our recent studies indicate that ErbB4 interacts with postsynaptic density (PSD)-95 (SAP90), a PDZ domain-containing protein that does not interact with ErbB2 or ErbB3. Using as bait the ErbB2 C terminus, we identified Erbin, another PDZ domain-containing protein that interacts specifically with ErbB2. Erbin is concentrated in postsynaptic membranes at the neuromuscular junction and in the central nervous system, where ErbB2 is concentrated. Expression of Erbin increases the amount of ErbB2 labeled by biotin in transfected cells, suggesting that Erbin is able to increase ErbB2 surface expression. Furthermore, we provide evidence that Erbin interacts with PSD-95 in both transfected cells and synaptosomes. Thus ErbB proteins can interact with a network of PDZ domain-containing proteins. This interaction may play an important role in regulation of neuregulin signaling and/or subcellular localization of ErbB proteins.	Univ Alabama Birmingham, Sch Med, Civitan Int Res Ctr 516, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Mei, L (corresponding author), Univ Alabama Birmingham, Sch Med, Civitan Int Res Ctr 516, Dept Neurobiol, 1719 6th Ave S, Birmingham, AL 35294 USA.	lmei@nrc.uab.edu	Mei, Lin/G-8755-2012		NINDS NIH HHS [NS34062, NS40480] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034062, R01NS040480] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTIOK N, 1995, EMBO J, V14, P4258, DOI 10.1002/j.1460-2075.1995.tb00100.x; Altiok N, 1997, EMBO J, V16, P717, DOI 10.1093/emboj/16.4.717; Apperson ML, 1996, J NEUROSCI, V16, P6839; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bredt DS, 1998, CELL, V94, P691, DOI 10.1016/S0092-8674(00)81727-4; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colledge M, 1997, J NEUROSCI, V17, P5038; CORFAS G, 1993, P NATL ACAD SCI USA, V90, P1624, DOI 10.1073/pnas.90.4.1624; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gassmann M, 1997, CURR OPIN NEUROBIOL, V7, P87, DOI 10.1016/S0959-4388(97)80125-0; GILMOUR BP, 1995, DEV BIOL, V168, P416, DOI 10.1006/dbio.1995.1091; GOODEARL ADJ, 1995, J CELL BIOL, V130, P1423, DOI 10.1083/jcb.130.6.1423; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HARLOW E, 1993, ANTIBODIES LAB MANUA; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Jaulin-Bastard F, 2001, J BIOL CHEM, V276, P15256, DOI 10.1074/jbc.M010032200; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; JO SA, 1992, DEVELOPMENT, V115, P673; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; Luck G, 2000, MOL CELL NEUROSCI, V16, P269, DOI 10.1006/mcne.2000.0873; MEI L, 1994, J BIOL CHEM, V269, P12254; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Rafael JA, 1998, NEUROREPORT, V9, P2121, DOI 10.1097/00001756-199806220-00039; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Sheng M, 2000, NAT NEUROSCI, V3, P633, DOI 10.1038/76576; Si JT, 1996, J BIOL CHEM, V271, P19752, DOI 10.1074/jbc.271.33.19752; Si JT, 1999, J NEUROSCI, V19, P8498; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tanowitz M, 1999, J NEUROSCI, V19, P9426; Tanowitz M, 1996, BRAIN RES, V712, P299, DOI 10.1016/0006-8993(95)01475-6; Tansey MG, 1996, J CELL BIOL, V134, P465, DOI 10.1083/jcb.134.2.465; Trinidad JC, 2000, J NEUROSCI, V20, P8762; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; Won S, 1999, J NEUROCHEM, V73, P2358, DOI 10.1046/j.1471-4159.1999.0732358.x; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x	57	82	88	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19318	19326		10.1074/jbc.M100494200	http://dx.doi.org/10.1074/jbc.M100494200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279080	hybrid			2022-12-27	WOS:000169091000091
J	Magdesian, MH; Giordano, R; Ulrich, H; Juliano, MA; Juliano, L; Schumacher, RI; Colli, W; Alves, MJM				Magdesian, MH; Giordano, R; Ulrich, H; Juliano, MA; Juliano, L; Schumacher, RI; Colli, W; Alves, MJM			Infection by Trypanosoma cruzi - Identification of a parasite ligand and its host cell receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-SIALIDASE; SURFACE GLYCOPROTEIN; MAMMALIAN-CELLS; METACYCLIC TRYPOMASTIGOTES; ENDOTHELIAL-CELLS; CYTOKERATIN 8; IN-VITRO; TGF-BETA; INVASION; BINDING	The infective trypomastigote stage of Trypanosoma cruzi expresses a set of surface glycoproteins that are known collectively as Tc85 and belong to the gp85/transsialidase supergene family. A member of this family, Tc85-11, with adhesive properties to laminin and cell surfaces was recently cloned. In this report, the Tc85-11 domain for cell binding and its corresponding receptor on epithelial cell LLC-MK2 are described. Using synthetic peptides corresponding to the Tc85-11 carboxyl-terminal segment, we show that the mammalian cell-binding domain colocalizes to the most conserved motif of the trypanosome gp85/trans-sialidase supergene family (VTVXNVFLYNR), Even though Tc85-11 binds to laminin, the 19-residue cell-binding peptide (peptide J) does not contain the laminin-binding site, because it does not bind to laminin or inhibit cell binding to this glycoprotein, The host cell receptor for the peptide was characterized as cytokeratin 18, Addition of anti-cytokeratin antibodies to the culture medium significantly inhibited the infection of epithelial cells by T. cruzi. Tc85-11 is a multiadhesive glycoprotein, encoding at least two different binding sites, one for laminin and one for cytokeratin 18, that allow the parasite to overcome the barriers imposed by cell membranes, extracellular matrices, and basal laminae to reach the definitive host cell. This is the first description of a direct interaction between cytokeratin and a protozoan parasite.	Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil; Univ Fed Sao Paulo, BR-04023900 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Alves, MJM (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Caixa Postal 26077, BR-05599970 Sao Paulo, Brazil.	mjmalves@iq.usp.br	Colli, Walter/ABA-5440-2021; Alves, Maria Julia/K-8976-2012; Colli, Walter/G-1188-2012; Giordano, Ricardo/A-2074-2010; Colli, Walter/AAW-7649-2021; Juliano, Luiz/D-7204-2012; Ulrich, Henning/C-5245-2013	Alves, Maria Julia/0000-0001-7211-9631; Giordano, Ricardo/0000-0001-8116-6771; Colli, Walter/0000-0001-7305-4673; Juliano, Luiz/0000-0002-5589-2822; Ulrich, Henning/0000-0002-2114-3815				Abuin G, 1996, BRAZ J MED BIOL RES, V29, P335; ABUIN G, 1989, MOL BIOCHEM PARASIT, V35, P229, DOI 10.1016/0166-6851(89)90209-0; Albericio F, 2000, SOLID-PHASE SYNTHESIS, P275; ALVES MJM, 1986, MOL BIOCHEM PARASIT, V21, P75, DOI 10.1016/0166-6851(86)90081-2; ANDREWS NW, 1984, EUR J BIOCHEM, V140, P599, DOI 10.1111/j.1432-1033.1984.tb08144.x; ANDREWS NW, 1982, J PROTOZOOL, V14, P447; ARAGUTH MF, 1988, PARASITE IMMUNOL, V10, P707, DOI 10.1111/j.1365-3024.1988.tb00256.x; BORROW P, 1992, J VIROL, V66, P7270, DOI 10.1128/JVI.66.12.7270-7281.1992; BOSCHETTI MA, 1987, MOL BIOCHEM PARASIT, V24, P175, DOI 10.1016/0166-6851(87)90104-6; Burleigh BA, 1998, CURR OPIN MICROBIOL, V1, P461, DOI 10.1016/S1369-5274(98)80066-0; BURLEIGH BA, 1993, ANNU REV MICROBIOL, V49, P175; CAVALLESCO R, 1988, J IMMUNOL, V140, P617; Cazzulo JJ, 1997, BIOL CHEM, V378, P1; COLLI W, 1993, FASEB J, V7, P1257, DOI 10.1096/fasebj.7.13.8405811; CROSS GAM, 1993, ANNU REV MICROBIOL, V47, P385, DOI 10.1146/annurev.mi.47.100193.002125; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; GIORDANO R, 1994, MOL BIOCHEM PARASIT, V65, P85, DOI 10.1016/0166-6851(94)90117-1; Giordano R, 1999, J BIOL CHEM, V274, P3461, DOI 10.1074/jbc.274.6.3461; GONCALVES MF, 1991, EXP PARASITOL, V72, P43, DOI 10.1016/0014-4894(91)90119-H; HAAS TA, 1994, CURR OPIN CELL BIOL, V6, P656, DOI 10.1016/0955-0674(94)90091-4; Hasan AAK, 1998, P NATL ACAD SCI USA, V95, P3615, DOI 10.1073/pnas.95.7.3615; HEMBROUGH TA, 1995, J CELL SCI, V108, P1071; Hembrough TA, 1996, J BIOL CHEM, V271, P25684, DOI 10.1074/jbc.271.41.25684; Hembrough TA, 1996, BIOCHEM J, V317, P763, DOI 10.1042/bj3170763; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KATZIN AM, 1983, BIOCHIM BIOPHYS ACTA, V727, P403, DOI 10.1016/0005-2736(83)90425-X; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIMA MF, 1989, MOL BIOCHEM PARASIT, V33, P159, DOI 10.1016/0166-6851(89)90030-3; MATTEY DL, 1993, BRIT J RHEUMATOL, V32, P676; Miettinen M, 2000, HUM PATHOL, V31, P1062, DOI 10.1053/hupa.2000.9843; MING M, 1995, CELL, V82, P287, DOI 10.1016/0092-8674(95)90316-X; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; MOROIANU J, 1993, P NATL ACAD SCI USA, V90, P3815, DOI 10.1073/pnas.90.9.3815; ORTEGABARRIA E, 1992, INFECT AGENT DIS, V1, P136; OUAISSI MA, 1986, SCIENCE, V234, P603, DOI 10.1126/science.3094145; OUAISSI MA, 1986, MOL BIOCHEM PARASIT, V19, P201, DOI 10.1016/0166-6851(86)90002-2; RAMIREZ MI, 1993, INFECT IMMUN, V61, P3636, DOI 10.1128/IAI.61.9.3636-3641.1993; Roth J, 1975, Methods Enzymol, V37, P223; Ruiz RC, 1998, BIOCHEM J, V330, P505; Sajjan US, 2000, INFECT IMMUN, V68, P1787, DOI 10.1128/IAI.68.4.1787-1795.2000; Sanchez A, 1998, EXP CELL RES, V242, P27, DOI 10.1006/excr.1998.4088; Santana JM, 1997, BIOCHEM J, V325, P129, DOI 10.1042/bj3250129; Scharfstein J, 2000, J EXP MED, V192, P1289, DOI 10.1084/jem.192.9.1289; SCHENKMAN S, 1991, INFECT IMMUN, V59, P645, DOI 10.1128/IAI.59.2.645-654.1991; SCHENKMAN S, 1993, PARASITOL TODAY, V9, P218, DOI 10.1016/0169-4758(93)90017-A; Tamura GS, 2000, INFECT IMMUN, V68, P2129, DOI 10.1128/IAI.68.4.2129-2134.2000; Wells MJ, 1997, J BIOL CHEM, V272, P28574, DOI 10.1074/jbc.272.45.28574; ZINGALES B, 1982, MOL BIOCHEM PARASIT, V6, P111, DOI 10.1016/0166-6851(82)90069-X	49	95	101	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19382	19389		10.1074/jbc.M011474200	http://dx.doi.org/10.1074/jbc.M011474200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278913	hybrid			2022-12-27	WOS:000169091000099
J	Towne, JE; Krane, CM; Bachurski, CJ; Menon, AG				Towne, JE; Krane, CM; Bachurski, CJ; Menon, AG			Tumor necrosis factor-alpha inhibits aquaporin 5 expression in mouse lung epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; WATER CHANNEL; FACTOR RECEPTORS; FAMILY; AQP5; GENE; PROLIFERATION; ADENOVIRUS; INDUCTION	Aquaporin 5 (AQP5), the major water channel expressed in alveolar, tracheal, and upper bronchial epithelium, is significantly down-regulated during pulmonary inflammation and edema. The mechanisms that underlie this decrease in AQP5 levels are therefore of considerable interest. Here we show that AQP5 expression in cultured lung epithelial cells is decreased 2-fold at the mRNA level and 10-fold at the protein level by the proinflammatory cytokine tumor necrosis factor alpha (TNF-alpha). Treatment of murine lung epithelial cells (MLE-12) with TNF-alpha results in a concentration- and time-dependent decrease in AQP5 mRNA and protein expression. Activation of the p55 TNF-alpha receptor (TNFR1) with an agonist antibody is sufficient to cause decreased AQP5 expression, demonstrating that the TNF-alpha effect is mediated through TNFR1. Inhibition of nuclear factor kappaB (NF-kappaB) translocation to the nucleus blocks the effect of TNF-alpha on AQP5 expression, indicating that activation of NF-kappaB is required, whereas inhibition of extracellular signal-regulated or p38 mitogen-activated protein kinases showed no effect. These data show that TNF-alpha decreases AQP5 mRNA and protein expression and that the molecular pathway for this effect involves TNFR1 and activated NF-kappaB. The ability of inflammatory cytokines to decrease aquaporin expression may help explain the connection between inflammation and edema.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Menon, AG (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way,3110 MSB,POB 670524, Cincinnati, OH 45267 USA.	Anil.Menon@UC.edu		Bachurski, Cindy/0000-0002-3118-0636	NHLBI NIH HHS [HL61781, R01 HL60907] Funding Source: Medline; NIDCR NIH HHS [R01 DE138283] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061781, R01HL060907] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Baeuerle PA, 1998, CURR BIOL, V8, pR19, DOI 10.1016/S0960-9822(98)70010-7; Beitz E, 1999, CURR MED CHEM, V6, P457; Brinkman BMN, 1999, J BIOL CHEM, V274, P30882, DOI 10.1074/jbc.274.43.30882; BROWN AM, 1994, MOL CELL BIOL, V14, P2926, DOI 10.1128/MCB.14.5.2926; Chen AP, 1999, J BIOL CHEM, V274, P35505, DOI 10.1074/jbc.274.50.35505; Chen YR, 1998, ONCOGENE, V17, P173, DOI 10.1038/sj.onc.1201941; Cooney R, 1999, AM J PHYSIOL-ENDOC M, V276, pE611, DOI 10.1152/ajpendo.1999.276.4.E611; Cross JV, 1999, J BIOL CHEM, V274, P31150, DOI 10.1074/jbc.274.44.31150; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Darnay BG, 1999, ANN RHEUM DIS, V58, P2; Deen PMT, 2000, EUR J CELL BIOL, V79, P523, DOI 10.1078/0171-9335-00075; DUDOV KP, 1984, CELL, V37, P457, DOI 10.1016/0092-8674(84)90376-3; Eder J, 1997, TRENDS PHARMACOL SCI, V18, P319, DOI 10.1016/S0165-6147(97)01097-3; Fiedler MA, 1998, AM J RESP CELL MOL, V19, P259, DOI 10.1165/ajrcmb.19.2.3149; Francis P, 2000, HUM MOL GENET, V9, P2329, DOI 10.1093/oxfordjournals.hmg.a018925; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; GINSBERG HS, 1991, P NATL ACAD SCI USA, V88, P1651, DOI 10.1073/pnas.88.5.1651; Guo DQ, 1998, J IMMUNOL, V160, P2742; Harrod KS, 1998, AM J PHYSIOL-LUNG C, V275, pL924, DOI 10.1152/ajplung.1998.275.5.L924; Hoffert JD, 2000, J BIOL CHEM, V275, P9070, DOI 10.1074/jbc.275.12.9070; King LS, 2000, MOL MED TODAY, V6, P60, DOI 10.1016/S1357-4310(99)01636-6; Kobuchi H, 1999, AM J PHYSIOL-CELL PH, V277, pC403, DOI 10.1152/ajpcell.1999.277.3.C403; Krane CM, 1999, MAMM GENOME, V10, P498, DOI 10.1007/s003359901030; Larsen GL, 2000, AM J RESP CRIT CARE, V162, pS2, DOI 10.1164/ajrccm.162.supplement_1.maic-1; Ledgerwood EC, 1999, LAB INVEST, V79, P1041; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu RY, 2000, J BIOL CHEM, V275, P21086, DOI 10.1074/jbc.M001281200; Liu RY, 1999, J BIOL CHEM, V274, P13877, DOI 10.1074/jbc.274.20.13877; Luster MI, 1999, CRIT REV TOXICOL, V29, P491, DOI 10.1080/10408449991349258; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; Marples D, 1999, AM J PHYSIOL-RENAL, V276, pF331, DOI 10.1152/ajprenal.1999.276.3.F331; Matsuzaki T, 1999, CELL TISSUE RES, V295, P513, DOI 10.1007/s004410051257; Natoli G, 1998, BIOCHEM PHARMACOL, V56, P915, DOI 10.1016/S0006-2952(98)00154-3; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; Rippe RA, 1999, DNA CELL BIOL, V18, P751, DOI 10.1089/104454999314890; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SHEEHAN KCF, 1995, J EXP MED, V181, P607, DOI 10.1084/jem.181.2.607; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Towne JE, 2000, AM J RESP CELL MOL, V22, P34, DOI 10.1165/ajrcmb.22.1.3818; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Verkman AS, 2000, EXP PHYSIOL, V85, p233S, DOI 10.1111/j.1469-445X.2000.tb00028.x; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Yang GH, 2000, FASEB J, V14, pA1428; Zsengeller Z, 2000, J VIROL, V74, P9655, DOI 10.1128/JVI.74.20.9655-9667.2000	49	111	141	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18657	18664		10.1074/jbc.M100322200	http://dx.doi.org/10.1074/jbc.M100322200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279049	hybrid			2022-12-27	WOS:000169091000003
J	Gerson, JH; Kim, E; Muhlrad, A; Reisler, E				Gerson, JH; Kim, E; Muhlrad, A; Reisler, E			Tropomyosin-troponin regulation of actin does not involve subdomain 2 motions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE THIN-FILAMENTS; RAY FIBER DIFFRACTION; CROSS-LINKED ACTIN; F-ACTIN; MYOSIN SUBFRAGMENT-1; CONFORMATIONAL CHANGE; STRUCTURAL-CHANGES; SKELETAL-MUSCLE; ATOMIC MODEL; C-TERMINUS	Dynamic properties of F-actin structure prompted suggestions (Squire, J. M., and Morris, E. P. (1998) FASEB J, 12, 761-771) that actin subdomain 2 movements play a role in thin-filament regulation. Using fluorescently labeled yeast actin mutants Q41C, Q41C/C374S, and D51C/C374S and azidonitrophenyl putrescine (ANP) Gln(41)-labeled alpha -actin, we monitored regulation-linked changes in subdomain 2, These actins had fully regulated acto-S1 ATPase activities, and emission spectra of regulated Q41C(AEDANS)/C374S and D51C(AEDANS)/C374S filaments did not reveal any calcium-dependent changes. Fluorescence energy transfer in these F-actins mostly occurred from Trp(340) and Trp(356) to 5-(2((acetyl)amino)ethyl)amino-naphthalene-1-sulfonate (AEDANS)-labeled Cys(41) or Cys(51) of adjacent same strand protomers, Our results show that fluorescence energy transfer between these residues is similar in the mostly blocked (-Ca2+) and closed (+Ca2+) states. Ca2+ also had no effect on the excimer band in the pyrene-labeled Q41C-regulated actin, indicating virtually no change in the overlap of pyrenes on Cys(41) and Cys(374). ANP quenching of rhodamine phalloidin fluorescence showed that neither Ca2+ nor S1 binding to regulated cu-actin affects the phalloidin-probe distance. Taken together, our results indicate that transitions between the blocked, closed, and open regulatory states involve no significant subdomain 2 movements, and, since the cross-linked cu-actin remains fully regulated, that subdomain 2 motions are not essential for actin regulation.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Oral Biol, IL-91120 Jerusalem, Israel	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Hebrew University of Jerusalem	Reisler, E (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	reisler@mbi.ucla.edu			NIAMS NIH HHS [AR-22031, R01 AR022031] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR022031] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BERTRAND R, 1994, FEBS LETT, V345, P113, DOI 10.1016/0014-5793(94)00398-X; BONAFE N, 1994, BIOCHEMISTRY-US, V33, P2594, DOI 10.1021/bi00175a031; COOK RK, 1993, J BIOL CHEM, V268, P2410; CROSBIE RH, 1994, BIOPHYS J, V67, P1957, DOI 10.1016/S0006-3495(94)80678-2; Doyle TC, 2001, BIOPHYS J, V80, P427, DOI 10.1016/S0006-3495(01)76025-0; Du JY, 1998, BIOCHEMISTRY-US, V37, P13276, DOI 10.1021/bi981117r; Gerson JH, 1999, J BIOL CHEM, V274, P17545, DOI 10.1074/jbc.274.25.17545; GODFREY JE, 1970, BIOCHEMISTRY-US, V9, P886, DOI 10.1021/bi00806a025; Hegyi G, 1998, BIOCHEMISTRY-US, V37, P17784, DOI 10.1021/bi981285j; HEGYI G, 1974, EUR J BIOCHEM, V44, P7, DOI 10.1111/j.1432-1033.1974.tb03452.x; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HOMSHER E, 1992, AM J PHYSIOL, V262, P714; KHAITLINA SY, 1993, EUR J BIOCHEM, V218, P911, DOI 10.1111/j.1432-1033.1993.tb18447.x; Kim E, 1996, BIOPHYS J, V70, P1439, DOI 10.1016/S0006-3495(96)79703-5; Kim E, 1998, BIOCHEMISTRY-US, V37, P17801, DOI 10.1021/bi981286b; Kim E, 2000, BIOPHYS CHEM, V86, P191, DOI 10.1016/S0301-4622(00)00143-5; Kim E, 2000, J MOL BIOL, V299, P421, DOI 10.1006/jmbi.2000.3727; Kim E, 1996, BIOPHYS J, V71, P1914, DOI 10.1016/S0006-3495(96)79390-6; Kim E, 1995, BIOPHYS J, V69, P2024, DOI 10.1016/S0006-3495(95)80072-X; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MIKI M, 1987, EUR J BIOCHEM, V168, P339, DOI 10.1111/j.1432-1033.1987.tb13425.x; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P3670, DOI 10.1021/bi952645v; Moraczewska J, 1996, BIOCHEM J, V317, P605, DOI 10.1042/bj3170605; MOSSAKOWSKA M, 1993, BIOCHEM J, V289, P897, DOI 10.1042/bj2890897; MUHLRAD A, 1994, J BIOL CHEM, V269, P11852; OOSAWA F, 1983, MUSCLE NONMUSCLE MOT, V1, P151; ORLOVA A, 1995, J MOL BIOL, V245, P582, DOI 10.1006/jmbi.1994.0048; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; OWEN C, 1993, J CELL BIOL, V123, P337, DOI 10.1083/jcb.123.2.337; PROCHNIEWICZNAKAYAMA E, 1983, J CELL BIOL, V97, P1663, DOI 10.1083/jcb.97.6.1663; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; SIKORSKI RS, 1995, GENE, V155, P51, DOI 10.1016/0378-1119(94)00915-F; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Squire JM, 1998, FASEB J, V12, P761, DOI 10.1096/fasebj.12.10.761; Stern O, 1919, PHYS Z, V20, P183; StrzeleckaGolaszewska H, 1996, BIOCHEM J, V316, P713, DOI 10.1042/bj3160713; TIRION MM, 1995, BIOPHYS J, V68, P5, DOI 10.1016/S0006-3495(95)80156-6; UMEMOTO S, 1990, J BIOL CHEM, V265, P14864; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; WEEDS AG, 1977, J MOL BIOL, V111, P129, DOI 10.1016/S0022-2836(77)80119-8; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3	49	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18442	18449		10.1074/jbc.M011070200	http://dx.doi.org/10.1074/jbc.M011070200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278830	hybrid			2022-12-27	WOS:000168866500110
J	Carr, DW; Fujita, A; Stentz, CL; Liberty, GA; Olson, GE; Narumiya, S				Carr, DW; Fujita, A; Stentz, CL; Liberty, GA; Olson, GE; Narumiya, S			Identification of sperm-specific proteins that interact with A-kinase anchoring proteins in a manner similar to the type II regulatory subunit of PKA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROUS SHEATH; MOUSE SPERM; SCAFFOLD PROTEIN; BINDING-PROTEIN; AMINO-ACIDS; RHO-KINASE; MOTILITY; RII; LOCALIZATION; ASSOCIATION	The cAMP-dependent protein kinase (PKA) is targeted to specific subcellular compartments through its interaction with A-kinase anchoring proteins (AKAPs), AKAPs contain an amphipathic helix domain that binds to the type II regulatory subunit of PKA (RII), Synthetic peptides containing this amphipathic helix domain bind to RII with high affinity and competitively inhibit the binding of PKA with AKAPs, Addition of these anchoring inhibitor peptides to spermatozoa inhibits motility (Vijayaraghavan, S., Goueli, S. A., Davey, M. P., and Carr, D. W. (1997) J. Biol, Chem. 272, 4747-4752), However, inhibition of the PKA catalytic activity does not mimic these peptides, suggesting that the peptides are disrupting the interaction of AKAP(s) with proteins other than PKA. Using the yeast two-hybrid system, we have now identified two sperm-specific human proteins that interact with the amphipathic helix region of AKAP110, These proteins, ropporin (a protein previously shown to interact with the Rho signaling pathway) and AKAP-associated sperm protein, are 39% identical to each other and share a strong sequence similarity with the conserved domain on the N terminus of RII that is involved in dimerization and AKAP binding. Mutation of conserved residues in ropporin or RII prevents binding to AKAP110. These data suggest that sperm contains several proteins that bind to AKAPs in a manner similar to RII and imply that AKAPs may have additional and perhaps unique functions in spermatozoa.	Vanderbilt Univ, Dept Cell Biol, Nashville, TN 37232 USA; Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan; Oregon Hlth Sci Univ, Portland, OR 97201 USA; Vet Affairs Med Ctr, Portland, OR 97201 USA	Vanderbilt University; Kyoto University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Carr, DW (corresponding author), Vet Adm Med Ctr, R&D-8,3710 SW Vet Hosp Rd, Portland, OR 97201 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020419, R01HD036408] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20419, HD36408] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Burton KA, 1999, J BIOL CHEM, V274, P24131, DOI 10.1074/jbc.274.34.24131; CARR DW, 1992, J BIOL CHEM, V267, P13376; CARR DW, 1991, J BIOL CHEM, V266, P14188; CARRERA A, 1994, DEV BIOL, V165, P272, DOI 10.1006/dbio.1994.1252; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Dodge KL, 1999, ENDOCRINOLOGY, V140, P5165, DOI 10.1210/en.140.11.5165; Dodge KL, 1999, MOL ENDOCRINOL, V13, P1977, DOI 10.1210/me.13.12.1977; Erlichman J, 1999, EUR J BIOCHEM, V263, P797, DOI 10.1046/j.1432-1327.1999.00561.x; Fujita A, 2000, J CELL SCI, V113, P103; Hausken ZE, 1996, J BIOL CHEM, V271, P29016, DOI 10.1074/jbc.271.46.29016; HINSCH KD, 1993, FEBS LETT, V334, P32, DOI 10.1016/0014-5793(93)81674-O; HOROWITZ JA, 1988, J BIOL CHEM, V263, P2098; JOHNSON BD, 1994, P NATL ACAD SCI USA, V91, P11492, DOI 10.1073/pnas.91.24.11492; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KONG M, 1995, BIOL REPROD, V53, P579, DOI 10.1095/biolreprod53.3.579; Lea IA, 1996, BBA-GENE STRUCT EXPR, V1307, P263, DOI 10.1016/0167-4781(96)00077-2; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; LI Y, 1995, J BIOL CHEM, V270, P1935, DOI 10.1074/jbc.270.4.1935; LIN RY, 1995, J BIOL CHEM, V270, P27804, DOI 10.1074/jbc.270.46.27804; Ling MF, 1995, NUCLEIC ACIDS RES, V23, P4924, DOI 10.1093/nar/23.23.4924; Mei XH, 1997, EUR J BIOCHEM, V246, P425, DOI 10.1111/j.1432-1033.1997.t01-1-00425.x; Miki K, 1999, J BIOL CHEM, V274, P29057, DOI 10.1074/jbc.274.41.29057; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; PARISET C, 1994, MOL REPROD DEV, V39, P415, DOI 10.1002/mrd.1080390410; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SARKAR D, 1984, J BIOL CHEM, V259, P9840; SATHE GM, 1991, NUCLEIC ACIDS RES, V19, P4775, DOI 10.1093/nar/19.17.4775; Schillace RV, 1999, J CLIN INVEST, V103, P761, DOI 10.1172/JCI6491; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; SCOTT JD, 1992, NEWS PHYSIOL SCI, V7, P143; Smith GD, 1996, BIOL REPROD, V54, P719, DOI 10.1095/biolreprod54.3.719; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Vijayaraghavan S, 1999, MOL ENDOCRINOL, V13, P705, DOI 10.1210/me.13.5.705; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Wang ZW, 1996, AM J PHYSIOL-LUNG C, V271, pL100, DOI 10.1152/ajplung.1996.271.1.L100	42	98	160	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17332	17338		10.1074/jbc.M011252200	http://dx.doi.org/10.1074/jbc.M011252200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278869	hybrid			2022-12-27	WOS:000168730400098
J	Larios, JM; Budhiraja, R; Fanburg, BL; Thannickal, VJ				Larios, JM; Budhiraja, R; Fanburg, BL; Thannickal, VJ			Oxidative protein cross-linking reactions involving L-tyrosine in transforming growth factor-beta 1-stimulated fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LUNG FIBROBLASTS; SMOOTH MUSCLE ACTIN; FACTOR-BETA INDUCTION; HYDROGEN-PEROXIDE; SIGNAL-TRANSDUCTION; PULMONARY FIBROSIS; LYSYL OXIDASE; HUMAN-DISEASE; TGF-BETA; GROWTH-FACTOR-BETA-1	The mechanisms by which ligand-stimulated generation of reactive oxygen species in nonphagocytic cells mediate biologic effects are largely unknown. The profibrotic cytokine, transforming growth factor-beta1 (TGF-beta1), generates extracellular hydrogen peroxide (H2O2) in contrast to intracellular reactive oxygen species production by certain mitogenic growth factors in human lung fibroblasts, To determine whether tyrosine residues in fibroblast-derived extracellular matrix (ECM) proteins may be targets of H2O2-mediated dityrosine-dependent cross-linking reactions in response to TGF-beta1, we utilized fluorophore-labeled tyramide, a structurally related phenolic compound that forms dimers with tyrosine, as a probe to detect such reactions under dynamic cell culture conditions. With this approach, a distinct pattern of fluorescent labeling that seems to target ECM proteins preferentially was observed in TGF-beta1-treated cells but not in control cells. This reaction required the presence of a heme peroxidase and was inhibited by catalase or diphenyliodonium (a flavoenzyme inhibitor), similar to the effect on TGF-beta1-induced dityrosine formation. Exogenous addition of H2O2 to control cells that do not release extracellular H2O2 produced a similar fluorescent labeling reaction. These results support the concept that, in the presence of heme peroxidases in vivo, TGF-beta1-induced H2O2 production by fibroblasts may mediate oxidative dityrosine-dependent cross-linking of ECM protein(s), This effect may be important in the pathogenesis of human fibrotic diseases characterized by overexpression/activation of TGF-beta1.	Tufts Univ, New England Med Ctr, Sch Med, Tupper Res Inst,Dept Med,Pulm & Crit Care Div, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Thannickal, VJ (corresponding author), Tufts Univ, New England Med Ctr, Sch Med, Tupper Res Inst,Dept Med,Pulm & Crit Care Div, 750 Washington St,NEMC 257, Boston, MA 02111 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003552, R01HL042376] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL-03552, HL-42376] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bailey AJ, 2000, WOUND REPAIR REGEN, V8, P5, DOI 10.1046/j.1524-475x.2000.00005.x; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; BORDER WA, 1995, J CLIN INVEST, V96, P655, DOI 10.1172/JCI118107; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; Brar SS, 1999, J BIOL CHEM, V274, P20017, DOI 10.1074/jbc.274.28.20017; CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526; Dalton SL, 1999, J BIOL CHEM, V274, P30139, DOI 10.1074/jbc.274.42.30139; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; ELIAS JA, 1990, CHEST, V97, P1439, DOI 10.1378/chest.97.6.1439; Finlay GA, 2000, J BIOL CHEM, V275, P27650; Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6; Gauldie J, 1999, CURR TOPICS PATHOL, V93, P35; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Gorin Y, 1997, BIOCHEM J, V321, P383, DOI 10.1042/bj3210383; HALLIWELL B, 1992, J LAB CLIN MED, V119, P598; HALLIWELL B, 1989, FREE RADICAL BIO MED, P99; HEINECKE JW, 1993, J CLIN INVEST, V91, P2866, DOI 10.1172/JCI116531; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; Hogaboam CM, 1998, P ASSOC AM PHYSICIAN, V110, P313; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; KUHN C, 1991, AM J PATHOL, V138, P1257; LABELLA F, 1967, BIOCHEM BIOPH RES CO, V26, P748, DOI 10.1016/S0006-291X(67)80137-2; LABELLA F, 1968, BIOCHEM BIOPH RES CO, V30, P333, DOI 10.1016/0006-291X(68)90746-8; LAWRENCE R, 1994, J BIOL CHEM, V269, P9603; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; MARIGO V, 1994, BIOCHEM BIOPH RES CO, V199, P1049, DOI 10.1006/bbrc.1994.1335; Narani N, 1999, CURR TOPICS PATHOL, V93, P47; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; Phan SH, 1996, KIDNEY INT, V49, pS46; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; SAUNDERS BC, 1964, PEROXIDASE PROPERTIE; SHAPIRO BM, 1991, SCIENCE, V252, P533, DOI 10.1126/science.1850548; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Speel EJM, 1999, J HISTOCHEM CYTOCHEM, V47, P281, DOI 10.1177/002215549904700302; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thannickal VJ, 1998, J BIOL CHEM, V273, P23611, DOI 10.1074/jbc.273.36.23611; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Thannickal VJ, 2000, FASEB J, V14, P1741, DOI 10.1096/fj.99-0878com; Thannickal VJ, 1998, BIOCHEM BIOPH RES CO, V251, P437, DOI 10.1006/bbrc.1998.9443; VISSERS MCM, 1985, BLOOD, V66, P161; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; Ward PA, 1998, AM J RESP CRIT CARE, V157, pS123, DOI 10.1164/ajrccm.157.4.nhlbi-10	48	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17437	17441		10.1074/jbc.M100426200	http://dx.doi.org/10.1074/jbc.M100426200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279068	hybrid			2022-12-27	WOS:000168730400112
J	Lee, JY; Sohn, KH; Rhee, SH; Hwang, D				Lee, JY; Sohn, KH; Rhee, SH; Hwang, D			Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN ENDOPEROXIDE SYNTHASE; PROLIFERATOR-ACTIVATED RECEPTORS; HUMAN COLON-CANCER; NF-KAPPA-B; GENE-EXPRESSION; PROTEIN-KINASE; BREAST-CANCER; MESSENGER-RNA; SIGNALING PATHWAYS; ARACHIDONIC-ACID	Results from our previous studies demonstrated that activation of Toll-like receptor 4 (Tlr4), the lipopolysaccharide (LPS) receptor, is sufficient to induce nuclear factor KB activation and expression of inducible cyclooxygenase (COX-2) in macrophages, Saturated fatty acids (SFAs) acylated in lipid A moiety of LPS are essential for biological activities of LPS, Thus, we determined whether these fatty acids modulate LPS-induced signaling pathways and COX-2 expression in monocyte/macrophage cells (RAW 264.7), Results show that SFAs, but not unsaturated fatty acids (UFAs), induce nuclear factor KB activation and expression of COX-2 and other inflammatory markers. This induction is inhibited by a dominant-negative Tlr4. UFAs inhibit COX-2 expression induced by SFAs, constitutively active Tlr4, or LPS. However, UFAs fail to inhibit COX-2 expression induced by activation of signaling components downstream of Tlr4, Together, these results suggest that both SFA-induced COX-2 expression and its inhibition by UFAs are mediated through a common signaling pathway derived from Tlr4, These results represent a novel mechanism by which fatty acids modulate signaling pathways and target gene expression. Furthermore, these results suggest a possibility that propensity of monocyte/macrophage activation is modulated through Tlr4 by different types of free fatty acids, which in turn can be altered by kinds of dietary fat consumed.	Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Hwang, D (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.		Eckhardt, Erik/G-1567-2010		NATIONAL CANCER INSTITUTE [R01CA075613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041868] Funding Source: NIH RePORTER; NCI NIH HHS [CA-75613] Funding Source: Medline; NIDDK NIH HHS [DK-41868] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENNETT A, 1977, LANCET, V2, P624; BENNETT A, 1983, ADV PROSTAG THROMB L, V12, P299; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; DEWITT DL, 1988, P NATL ACAD SCI USA, V85, P1421; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; FENG L, 1993, ARCH BIOCHEM BIOPHYS, V307, P361, DOI 10.1006/abbi.1993.1601; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FULTON A, 1982, PROSTAGLANDINS CANCE, P701; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Hwang D, 1997, BIOCHEM PHARMACOL, V54, P87, DOI 10.1016/S0006-2952(97)00154-8; Hwang SC, 1996, J BIOL CHEM, V271, P18342, DOI 10.1074/jbc.271.31.18342; JONES DA, 1993, J BIOL CHEM, V268, P9049; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; KARGMAN SL, 1995, CANCER RES, V55, P2556; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; LEE SH, 1992, J BIOL CHEM, V267, P25934; LEVINE L, 1981, ADV CANCER RES, V35, P49, DOI 10.1016/S0065-230X(08)60908-2; Meade EA, 1999, J BIOL CHEM, V274, P8328, DOI 10.1074/jbc.274.12.8328; MERLIE JP, 1988, J BIOL CHEM, V263, P3550; MUNFORD RS, 1986, SCIENCE, V234, P203, DOI 10.1126/science.3529396; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OBANION MK, 1991, J BIOL CHEM, V266, P23261; Paik JH, 2000, J BIOL CHEM, V275, P28173; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; POWLES TJ, 1976, LANCET, V1, P608; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; Ren B, 1997, J BIOL CHEM, V272, P26827, DOI 10.1074/jbc.272.43.26827; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; RIETSCHEL ET, 1992, SCI AM, V267, P54, DOI 10.1038/scientificamerican0892-54; SANO H, 1995, CANCER RES, V55, P3785; Schulman IG, 1998, MOL CELL BIOL, V18, P3483, DOI 10.1128/MCB.18.6.3483; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; YOKOYAMA C, 1988, FEBS LETT, V231, P347, DOI 10.1016/0014-5793(88)80847-0; YOKOYAMA C, 1989, BIOCHEM BIOPH RES CO, V165, P888, DOI 10.1016/S0006-291X(89)80049-X; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975	48	922	950	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16683	16689		10.1074/jbc.M011695200	http://dx.doi.org/10.1074/jbc.M011695200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278967	hybrid			2022-12-27	WOS:000168730400014
J	Lukong, KE; Landry, K; Elsliger, MA; Chang, Y; Lefrancois, S; Morales, CR; Pshezhetsky, AV				Lukong, KE; Landry, K; Elsliger, MA; Chang, Y; Lefrancois, S; Morales, CR; Pshezhetsky, AV			Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHERRY-RED SPOT; PROTEIN CATHEPSIN-A; BETA-GALACTOSIDASE; PROTECTIVE PROTEIN; NEURAMINIDASE DEFICIENCY; MYOCLONUS SYNDROME; CRYSTAL-STRUCTURE; GALACTOSIALIDOSIS; FIBROBLASTS; IDENTIFICATION	Sialidosis is an autosomal recessive disease caused by the genetic deficiency of lysosomal sialidase, which catalyzes the catabolism of sialoglycoconjugates. The disease is associated with progressive impaired vision, macular cherry-red spots, and myoclonus (sialidosis type I) or with skeletal dysplasia, Hurler-like phenotype, dysostosis multiplex, mental retardation, and hepatosplenomegaly (sialidosis type II). We analyzed the effect of the missense mutations G68V, S182G, G227R, F260Y, L270F, A298V, G328S, and L363P, which are identified in the sialidosis type I and sialidosis type II patients, on the activity, stability, and intracellular distribution of sialidase. We found that three mutations, F260Y, L270F, and A298V, which are clustered in the same region on the surface of the sialidase molecule, dramatically reduced the enzyme activity and caused a rapid intralysosomal degradation of the expressed protein. We suggested that this region might be involved in sialidase binding with lysosomal cathepsin A and/or P-galactosidase in the multienzyme lysosomal complex required for the expression of sialidase activity. Transgenic expression of mutants followed by density gradient centrifugation of cellular extracts confirmed this hypothesis and showed that sialidase deficiency in some sialidosis patients results from disruption of the lysosomal multienzyme complex.	Hop St Justine, Serv Genet Med, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ H3T 1C5, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	Universite de Montreal; Universite de Montreal; McGill University	Pshezhetsky, AV (corresponding author), Hop St Justine, Serv Genet Med, 3175 Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.		Morales, Carlos R./H-1055-2011	A, Pshezhetsky/0000-0002-6612-1062; Elsliger, Marc Andre/0000-0002-1989-7626				AYLSWORTH AS, 1980, J PEDIATR-US, V96, P662, DOI 10.1016/S0022-3476(80)80734-7; BECK M, 1984, EUR J PEDIATR, V143, P135, DOI 10.1007/BF00445802; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Bonten EJ, 2000, HUM MOL GENET, V9, P2715, DOI 10.1093/hmg/9.18.2715; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; CANTZ M, 1990, J INHERIT METAB DIS, V13, P523, DOI 10.1007/BF01799510; CANTZ M, 1977, BIOCHEM BIOPH RES CO, V74, P732, DOI 10.1016/0006-291X(77)90363-1; CRENNELL SJ, 1993, P NATL ACAD SCI USA, V90, P9852, DOI 10.1073/pnas.90.21.9852; d'Azzo A., 2001, METABOLIC MOL BASES, V3, P3811; DAGROSA RM, 1992, BIOCHEM J, V285, P833, DOI 10.1042/bj2850833; DAZZO A, 1982, P NATL ACAD SCI-BIOL, V79, P4535, DOI 10.1073/pnas.79.15.4535; DURAND P, 1977, HELV PAEDIATR ACTA, V32, P391; FEDERICO A, 1991, DEV NEUROSCI-BASEL, V13, P320, DOI 10.1159/000112180; FEDERICO A, 1980, J NEUROL SCI, V48, P157, DOI 10.1016/0022-510X(80)90197-5; HOOGEVEEN AT, 1983, J BIOL CHEM, V258, P2143; JOHNSON WG, 1980, AM J HUM GENET, V32, pA43; KELLY TE, 1977, AM J MED GENET, V1, P31, DOI 10.1002/ajmg.1320010105; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lukong KE, 2000, HUM MOL GENET, V9, P1075, DOI 10.1093/hmg/9.7.1075; Milner CM, 1997, J BIOL CHEM, V272, P4549, DOI 10.1074/jbc.272.7.4549; MORREAU H, 1992, J BIOL CHEM, V267, P17949; Naganawa Y, 2000, J HUM GENET, V45, P241, DOI 10.1007/s100380070034; OBRIEN JS, 1979, CLIN GENET, V14, P55; OKADA S, 1968, SCIENCE, V160, P1002, DOI 10.1126/science.160.3831.1002; OkamuraOho Y, 1996, BIOCHEM J, V313, P787, DOI 10.1042/bj3130787; OOHIRA T, 1985, HUM GENET, V70, P341, DOI 10.1007/BF00295374; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Pshezhetsky AV, 1996, J BIOL CHEM, V271, P28359, DOI 10.1074/jbc.271.45.28359; Pshezhetsky AV, 1997, NAT GENET, V15, P316, DOI 10.1038/ng0397-316; PSHEZHETSKY AV, 1995, ANAL BIOCHEM, V230, P303, DOI 10.1006/abio.1995.1478; RAPIN I, 1978, ANN NEUROL, V3, P234, DOI 10.1002/ana.410030309; ROME LH, 1979, CELL, V17, P143, DOI 10.1016/0092-8674(79)90302-7; Rudenko G, 1998, P NATL ACAD SCI USA, V95, P621, DOI 10.1073/pnas.95.2.621; SOGG RL, 1979, OPHTHALMOLOGY, V86, P1861; Thomas G., 2001, DISORDERS GLYCOPROTE, P3507; TILL JS, 1987, J CLIN NEURO-OPHTHAL, V7, P40; van der Spoel A, 1998, EMBO J, V17, P1588, DOI 10.1093/emboj/17.6.1588; VANDERHORST GTJ, 1989, J BIOL CHEM, V264, P1317; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Vinogradova MV, 1998, BIOCHEM J, V330, P641; WINTER RM, 1980, CLIN GENET, V18, P203	42	31	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17286	17290		10.1074/jbc.M100460200	http://dx.doi.org/10.1074/jbc.M100460200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279074	hybrid			2022-12-27	WOS:000168730400092
J	Diaz, V; Servert, P; Prieto, I; Gonzalez, MA; Martinez-A, C; Alonso, JC; Bernad, A				Diaz, V; Servert, P; Prieto, I; Gonzalez, MA; Martinez-A, C; Alonso, JC; Bernad, A			New insights into host factor requirements for prokaryotic beta-recombinase-mediated reactions in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; PYOGENES PLASMID PSM19035; CRE RECOMBINASE; TARGETED EXPRESSION; DNA RECOMBINATION; TRANSGENIC MICE; NUCLEAR-PROTEIN; T-CELLS; GENE; MOUSE	The prokaryotic beta -recombinase catalyzes site-specific recombination between two directly oriented minimal sit sites in mammalian cells, both on episomic and chromatin-integrated substrates. Using a specific recombination activated gene expression system, we report the site-specific recombination activity of an enhanced green fluorescent protein (EGFP) fused version of beta -recombinase (beta -EGFP). This allows expression of active beta -recombinase detectable in vivo and in fixed cells by fluorescence microscopy. In addition, cellular viability is compatible with a substantial level of expression of the beta -EGFP protein. Using fluorescence-activated cell sorting, we have been able to enrich cell populations expressing this fusion protein. Application of this strategy has allowed us to study in more depth the host factor requirements for this system. Previous work showed that eukaryotic HMG1 protein was necessary and sufficient to help beta -recombinase activity in vitro. The influence of ectopic expression of HMG1 protein in the recombination process has been analyzed, indicating that HMG1 overexpression does not lead to a significant increase on the efficiency of beta -recombinase-mediated recombination both on episomal substrates and chromatin-associated targets. In addition, beta -recombinase-mediated recombination has been demonstrated in HMG1 deficient cells at the same levels as in wild type cells. These data demonstrate the existence of cellular factors different from HMG-1 that can act as helpers for beta -recombinase activity in the eukaryotic environment.	CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, E-28049 Madrid, Spain; CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Bernad, A (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Campus Univ Autonoma Madrid, E-28049 Madrid, Spain.	abernad@cnb.uam.es	Gonzalez, Manuel A/A-3404-2013; Bernad, Antonio/P-8573-2017; Alonso, Juan Carlos/D-2595-2009	Alonso, Juan Carlos/0000-0002-5178-7179; Bernad, Antonio/0000-0003-0620-9668				Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; ALONSO JC, 1995, MOL MICROBIOL, V18, P471, DOI 10.1111/j.1365-2958.1995.mmi_18030471.x; ALONSO JC, 1995, J BIOL CHEM, V270, P2938, DOI 10.1074/jbc.270.7.2938; Barlow C, 1997, NUCLEIC ACIDS RES, V25, P2543, DOI 10.1093/nar/25.12.2543; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Brocard J, 1998, NUCLEIC ACIDS RES, V26, P4086, DOI 10.1093/nar/26.17.4086; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Canosa I, 1996, NUCLEIC ACIDS RES, V24, P2712, DOI 10.1093/nar/24.14.2712; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Diaz V, 1999, J BIOL CHEM, V274, P6634, DOI 10.1074/jbc.274.10.6634; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Falciola L, 1997, J CELL BIOL, V137, P19, DOI 10.1083/jcb.137.1.19; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gagneten S, 1997, NUCLEIC ACIDS RES, V25, P3326, DOI 10.1093/nar/25.16.3326; GOMEZMARQUEZ J, 1988, FEBS LETT, V226, P217, DOI 10.1016/0014-5793(88)81425-X; Grasser KD, 1997, EUR J BIOCHEM, V249, P70; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HOGAN B, 1986, MANIPULATING MOUSE E; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LANDY A, 1993, CURR OPIN GENET DEV, V3, P699, DOI 10.1016/S0959-437X(05)80086-3; LICA LM, 1986, J CELL BIOL, V103, P1145, DOI 10.1083/jcb.103.4.1145; Metzger D, 1999, CURR OPIN BIOTECH, V10, P470, DOI 10.1016/S0958-1669(99)00012-9; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Perry ACF, 1999, SCIENCE, V284, P1180, DOI 10.1126/science.284.5417.1180; PICHEL JG, 1993, ONCOGENE, V8, P3333; Ritt C, 1998, PLANT J, V14, P623, DOI 10.1046/j.1365-313X.1998.00154.x; ROJO F, 1995, NUCLEIC ACIDS RES, V23, P3181, DOI 10.1093/nar/23.16.3181; ROJO F, 1993, FEBS LETT, V328, P169, DOI 10.1016/0014-5793(93)80987-6; ROJO F, 1994, J MOL BIOL, V238, P159, DOI 10.1006/jmbi.1994.1278; Rossant J, 1999, GENE DEV, V13, P142, DOI 10.1101/gad.13.2.142; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Sauer Brian, 1994, Current Opinion in Biotechnology, V5, P521, DOI 10.1016/0958-1669(94)90068-X; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; SHYKIND BM, 1995, GENE DEV, V9, P1354, DOI 10.1101/gad.9.11.1354; Sutrias-Grau M, 1999, J BIOL CHEM, V274, P1628, DOI 10.1074/jbc.274.3.1628; TRAVERS AA, 1994, CELL, V77, P167, DOI 10.1016/0092-8674(94)90306-9; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; Utomo ARH, 1999, NAT BIOTECHNOL, V17, P1091, DOI 10.1038/15073; Vaccari T, 1998, GENOMICS, V49, P247, DOI 10.1006/geno.1998.5214; Yang SL, 1999, HUM GENE THER, V10, P123, DOI 10.1089/10430349950019255; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; Zubko E, 2000, NAT BIOTECHNOL, V18, P442, DOI 10.1038/74515; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	53	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16257	16264		10.1074/jbc.M011725200	http://dx.doi.org/10.1074/jbc.M011725200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278972	hybrid			2022-12-27	WOS:000168623100092
J	Jonsson, ZO; Dhar, SK; Narlikar, GJ; Auty, R; Wagle, N; Pellman, D; Pratt, RE; Kingston, R; Dutta, A				Jonsson, ZO; Dhar, SK; Narlikar, GJ; Auty, R; Wagle, N; Pellman, D; Pratt, RE; Kingston, R; Dutta, A			Rvb1p and Rvb2p are essential components of a chromatin remodeling complex that regulates transcription of over 5% of yeast genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RUVB-LIKE PROTEIN; SACCHAROMYCES-CEREVISIAE; SWI/SNF COMPLEX; NUCLEOSOME ARRAYS; BETA-CATENIN; DNA HELICASE; SWI-SNF; EXPRESSION; BINDING; HOMOLOG	Eukaryotic Rvb1p and Rvb2p are two highly conserved proteins related to the helicase subset of the AAA+ family of ATPases. Conditional mutants in both genes show rapid changes in the transcription of over 5% of yeast genes, with a similar number of genes being repressed and activated. Both Rvb1p and Rvb2p are required for maintaining the induced state of many inducible promoters. ATP binding and hydrolysis by Rvb1p and Rvb2p is individually essential in vivo, and the two proteins are associated with each other in a high molecular weight complex that shows ATP-dependent chromatin remodeling activity in vitro. Our findings show that Rvb1p and Rvb2p are essential components of a chromatin remodeling complex and determine genes regulated by the complex.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Genet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Dutta, A (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.		Jónsson, Zophonías/E-1960-2015; Jónsson, Zophonías Oddur/AAO-1354-2020; Wagle, Nikhil/Q-7428-2019; Dutta, Anindya/P-3203-2016	Jónsson, Zophonías Oddur/0000-0001-5798-9647; Dutta, Anindya/0000-0002-4319-0073	NATIONAL CANCER INSTITUTE [R01CA060499] Funding Source: NIH RePORTER; NCI NIH HHS [CA60499] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Du J, 1998, GENETICS, V150, P987; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Fillingame RH, 1999, SCIENCE, V286, P1687, DOI 10.1126/science.286.5445.1687; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kanemaki M, 1997, BIOCHEM BIOPH RES CO, V235, P64, DOI 10.1006/bbrc.1997.6729; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lim CR, 2000, J BIOL CHEM, V275, P22409, DOI 10.1074/jbc.M001031200; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Makino Y, 1999, J BIOL CHEM, V274, P15329, DOI 10.1074/jbc.274.22.15329; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Neuwald AF, 1999, GENOME RES, V9, P27; Perez-Martin J, 1999, FEMS MICROBIOL REV, V23, P503, DOI 10.1016/S0168-6445(99)00018-2; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Rose MD., 1990, METHODS YEAST GENETI; Salzer U, 1999, BBA-GENE STRUCT EXPR, V1446, P365, DOI 10.1016/S0167-4781(99)00104-9; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	39	85	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16279	16288		10.1074/jbc.M011523200	http://dx.doi.org/10.1074/jbc.M011523200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278922	hybrid			2022-12-27	WOS:000168623100095
J	Kamath-Loeb, AS; Loeb, LA; Johansson, E; Burgers, PMJ; Fry, M				Kamath-Loeb, AS; Loeb, LA; Johansson, E; Burgers, PMJ; Fry, M			Interactions between the Werner syndrome helicase and DNA polymerase delta specifically facilitate copying of tetraplex and hairpin structures of the d(CGG)(n) trinucleotide repeat sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRAGILE-X-SYNDROME; SYNDROME GENE-PRODUCT; REPLICATION PROTEIN-A; SYNTHESIS IN-VITRO; SACCHAROMYCES-CEREVISIAE; TRIPLET REPEATS; S-PHASE; ESCHERICHIA-COLI; BLOOMS-SYNDROME; DISEASE GENES	Werner syndrome (WS) is an inherited disorder characterized by premature aging and genomic instability. The protein encoded by the WS gene, WRN, possesses intrinsic 3' --> 5' DNA helicase and 3' --> 5' DNA exonuclease activities. WRN helicase resolves alternate DNA structures including tetraplex and tripler DNA, and Holliday junctions. Thus, one function of WRN may be to unwind secondary structures that impede cellular DNA transactions. We report here that hairpin and G'2 bimolecular tetraplex structures of the fragile X expanded sequence, d(CGG)(n), effectively impede synthesis by three eukaryotic replicative DNA polymerases (pol): pol alpha, pol delta, and pol epsilon. The constraints imposed on pol delta -catalyzed synthesis are relieved, however, by WRN; WRN facilitates pol delta to traverse these template secondary structures to synthesize full-length DNA products. The alleviatory effect of WRN is limited to pol delta; neither pol alpha nor pol epsilon can traverse template d(CGG)(n) hairpin and tetraplex structures in the presence of WRN, Alleviation of pausing by pol delta is observed with Escherichia coli RecQ but not with UvrD helicase, suggesting a concerted action of RecQ helicases and pol delta, Our findings suggest a possible role of WRN in rescuing pol delta -mediated replication at forks stalled by unusual DNA secondary structures.	Univ Washington, Dept Pathol, Gottstein Mem Canc Res Lab, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Gottstein Mem Canc Res Lab, Seattle, WA 98195 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Biochem Unit, IL-31096 Haifa, Israel	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Fry, M (corresponding author), Univ Washington, Dept Pathol, Gottstein Mem Canc Res Lab, Seattle, WA 98195 USA.		Burgers, Peter M/AAW-6621-2021	Johansson, Erik/0000-0002-8526-6224	NCI NIH HHS [CA80993, CA77852] Funding Source: Medline; NIGMS NIH HHS [R01 GM032431, GM58534] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080993, P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058534, R01GM032431] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARRY J, 1994, J BIOL CHEM, V269, P33063; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; CHEN FM, 1995, J BIOL CHEM, V270, P23090, DOI 10.1074/jbc.270.39.23090; CHEN XA, 1995, P NATL ACAD SCI USA, V92, P5199, DOI 10.1073/pnas.92.11.5199; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cromie GA, 2000, GENETICS, V154, P513; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; FUJIWARA Y, 1977, J CELL PHYSIOL, V92, P365, DOI 10.1002/jcp.1040920305; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; GACY AM, 1995, CELL, V81, P533; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; HAN J, 1994, NUCLEIC ACIDS RES, V22, P1735, DOI 10.1093/nar/22.9.1735; Hartung F, 2000, NUCLEIC ACIDS RES, V28, P4275, DOI 10.1093/nar/28.21.4275; HENDERSON E, 1995, TELOMERES, P11; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Hughes P, 1999, NUCLEIC ACIDS RES, V27, P2108, DOI 10.1093/nar/27.10.2108; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Kusano K, 1999, GENETICS, V151, P1027; Mangel L, 1998, J BIOL CHEM, V273, P30466, DOI 10.1074/jbc.273.46.30466; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; MITAS M, 1995, BIOCHEMISTRY-US, V34, P12803, DOI 10.1021/bi00039a041; Morozov V, 1997, TRENDS BIOCHEM SCI, V22, P417, DOI 10.1016/S0968-0004(97)01128-6; Moser MJ, 2000, NUCLEIC ACIDS RES, V28, P648, DOI 10.1093/nar/28.2.648; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; NADEL Y, 1995, J BIOL CHEM, V270, P28970, DOI 10.1074/jbc.270.48.28970; NAKAYAMA H, 1984, MOL GEN GENET, V195, P474, DOI 10.1007/BF00341449; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Poot M, 1999, HUM GENET, V104, P10, DOI 10.1007/s004390050903; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Sambrook J., 2002, MOL CLONING LAB MANU; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Suzuki N, 1997, NUCLEIC ACIDS RES, V25, P2973, DOI 10.1093/nar/25.15.2973; Szekely AM, 2000, P NATL ACAD SCI USA, V97, P11365, DOI 10.1073/pnas.97.21.11365; TAKEUCHI F, 1982, HUM GENET, V60, P365, DOI 10.1007/BF00569220; TAKEUCHI F, 1982, EXP GERONTOL, V17, P473, DOI 10.1016/S0531-5565(82)80009-0; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Watt PM, 1996, GENETICS, V144, P935; Weisman-Shomer P, 2000, J BIOL CHEM, V275, P2231, DOI 10.1074/jbc.275.3.2231; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	58	161	165	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16439	16446		10.1074/jbc.M100253200	http://dx.doi.org/10.1074/jbc.M100253200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279038	hybrid			2022-12-27	WOS:000168623100116
J	Kitazume-Kawaguchi, S; Kabata, S; Arita, M				Kitazume-Kawaguchi, S; Kabata, S; Arita, M			Differential biosynthesis of polysialic or disialic acid structure by ST8Sia II and ST8Sia IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; DEVELOPMENTALLY-REGULATED MEMBER; HUMAN POLYSIALYLTRANSFERASE; POLY(SIALIC ACID); RAINBOW-TROUT; STX; POLYSIALYLATION; EXPRESSION; GLYCOPROTEINS; CLONING	ST8Sia II (STX) and ST8Sia IV (PST) are polysialic acid (polySia) syntheses that catalyze polySia formation of neural cell adhesion molecule (NCAM) in vivo and in vitro. It still remains unclear how these structurally similar enzymes act differently in vivo. In the present study, we performed the enzymatic characterization of ST8Sia II and IV; both ST8Sia II and IV have pH optima of 5.8-6.1 and have no requirement of metal ions. Because the pH dependence of ST8Sia II and IV enzyme activities and the pK profile of His residues are similar, we hypothesized that a histidine residue would be involved in their catalytic activity. There is a conserved His residue (cf. His(348) in ST8Sia II and His(331) in ST8Sia IV, respectively) within the sialyl motif VS in all sialyltransferase genes cloned to date. Mutant ST8Sia II and IV enzymes in which this His residue was changed to Lys showed no detectable enzyme activity, even though they were folded correctly and could bind to CDP-hexanolamine, suggesting the importance of the His residue for their catalytic activity. Next, the degrees of polymerization of polySia in NCAM catalyzed by ST8Sia II and IV were compared. ST8Sia IV catalyzed larger polySia formation of NCAM than ST8Sia II. We also analyzed the (auto)polysialylated enzymes themselves. Interestingly, when ST8Sia II or IV itself was sialylated under conditions for polysialylation, the disialylated compound was the major product, even though polysialylated compounds were also observed. These results suggested that both ST8Sia II and IV catalyze polySia synthesis toward preferred acceptor substrates such as NCAM, whereas they mainly catalyze disialylation, similarly to ST8Sia III, toward unfavorable substrates such as enzyme themselves.	RIKEN, Inst Phys & Chem Res, Frontier Res Program, Glycobiol Res Grp, Wako, Saitama 3510198, Japan; Tokyo Kasei Univ, Fac Home Econ, Dept Food & Nutr, Tokyo 1730003, Japan	RIKEN	Kitazume-Kawaguchi, S (corresponding author), RIKEN, Inst Phys & Chem Res, Frontier Res Program, Glycobiol Res Grp, Wako, Saitama 3510198, Japan.			Ikehara, Sanae/0000-0001-7123-4777				Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Angata Kiyohiko, 2000, Glycoconjugate Journal, V17, P50; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 1998, J BIOL CHEM, V273, P9608, DOI 10.1074/jbc.273.16.9608; DRICKAMER K, 1993, GLYCOBIOLOGY, V3, P2, DOI 10.1093/glycob/3.1.2; EDELMAN GM, 1985, ANNU REV BIOCHEM, V54, P135, DOI 10.1146/annurev.bi.54.070185.001031; ELKHARDT M, 1995, NATURE, V373, P715; FINNE J, 1982, J BIOL CHEM, V257, P1966; Funakoshi Y, 1997, GLYCOBIOLOGY, V7, P195, DOI 10.1093/glycob/7.2.195; Geremia RA, 1997, GLYCOBIOLOGY, V7, pR5; GROGAN T, 1994, LAB INVEST, V70, P110; HALLENBECK PC, 1987, ANAL BIOCHEM, V161, P181, DOI 10.1016/0003-2697(87)90670-1; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; INOUE S, 1978, BIOCHEM BIOPH RES CO, V83, P1018, DOI 10.1016/0006-291X(78)91497-3; Kiss JZ, 1997, CURR OPIN NEUROBIOL, V7, P640, DOI 10.1016/S0959-4388(97)80083-9; KITAZUME S, 1994, J BIOL CHEM, V269, P10330; KITAZUME S, 1992, ANAL BIOCHEM, V202, P25, DOI 10.1016/0003-2697(92)90200-Q; KitazumeKawaguchi S, 1997, P NATL ACAD SCI USA, V94, P3650, DOI 10.1073/pnas.94.8.3650; KOJIMA N, 1995, FEBS LETT, V360, P1, DOI 10.1016/0014-5793(95)00059-I; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; KOJIMA N, 1996, J BIOL CHEM, V271, P22508; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; Ma JY, 1996, J BIOL CHEM, V271, P7758, DOI 10.1074/jbc.271.13.7758; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1996, J BIOL CHEM, V271, P1829, DOI 10.1074/jbc.271.4.1829; NORGARDSUMNICHT KE, 1995, J BIOL CHEM, V270, P305; PAULSON JC, 1978, J BIOL CHEM, V253, P5617; ROTH J, 1992, SCIENCE, V256, P673, DOI 10.1126/science.1585182; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Sato C, 1998, ANAL BIOCHEM, V261, P191, DOI 10.1006/abio.1998.2718; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SDATO C, 2000, J BIOL CHEM, V275, P15422; Sevigny MB, 1998, GLYCOBIOLOGY, V8, P857, DOI 10.1093/glycob/8.9.857; SIMMONS DL, 1993, CELLULAR INTERACTION, P93; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; YANG PF, 1992, J CELL BIOL, V116, P1487, DOI 10.1083/jcb.116.6.1487; Yoshida K, 1999, J NEUROSCI, V19, P794; YOSHIDA Y, 1995, J BIOCHEM-TOKYO, V118, P658, DOI 10.1093/oxfordjournals.jbchem.a124960	52	69	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15696	15703		10.1074/jbc.M010371200	http://dx.doi.org/10.1074/jbc.M010371200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278664	hybrid			2022-12-27	WOS:000168623100018
J	Lehoux, S; Abe, J; Florian, JA; Berk, BC				Lehoux, S; Abe, J; Florian, JA; Berk, BC			14-3-3 binding to Na+/H+ exchanger isoform-1 is associated with serum-dependent activation of Na+/H+ exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR-KYOTO RATS; NA-H EXCHANGE; PROTEIN-KINASE; GROWTH-FACTORS; IMMORTALIZED LYMPHOBLASTS; SIGNAL-TRANSDUCTION; PHOSPHORYLATION; CELLS	Na+/H+ exchanger isoform-1 (NHE1), the ubiquitous form of the Na+/H+ exchanger, has increased activity in hypertensive patients and in animal models of hypertension. Furthermore, NHE1 is activated in cells stimulated with growth factors. We showed previously that activation of the exchanger is dependent on phosphorylation of serine 703 (Ser(P)(703)) by p90 ribosomal S6 kinase (RSK). Because the NHE1 sequence at Ser(P)(703) (RIGSDP) is similar to a consensus sequence (RSXSXP) specific for 14-3-3 ligands, we evaluated whether serum stimulated 14-3-3 binding to NHE1. Five different GST-NHE1 fusion proteins spanning amino acids 515-815 were phosphorylated by RSK and used as ligands in a far Western analysis; only those containing Ser(P)(703) exhibited high affinity 14-3-3 binding. In PS127A cells (NHE1-overexpressing Chinese hamster fibroblasts) stimulated with 20% serum, NHE1 co-precipitation with GST-14-3-3 fusion protein increased at 5 min (5.2 +/- 0.4-fold versus control; p < 0.01) and persisted at 40 min (3.9 +/- 0.5-fold; p < 0.01). We confirmed that binding occurs at the RIGSDP motif using PS120 (NHE1 null) cells transfected with S703A-NHE1 or P705A-NHE1 (based on data indicating that 14-3-3 binding requires phosphoserine and +2 proline). Serum failed to stimulate association of 14-3-3 with these mutants. A GST-NHE1 fusion protein was phosphorylated by RSK and used as a ligand to assess the effect of 14-3-3 on protein phosphatase 1-mediated dephosphorylation of Ser(P)(703). GST-14-3-3 limited dephosphorylation (66% of initial state at 60 min) compared with GST alone (27% of initial state; p < 0.01). The protective effect of GST-14-3-3 was lost in the GST-NHE1 P705A mutant. Finally, the baseline rate of pH recovery in acid-loaded cells was equal in unstimulated cells expressing wild-type or P705A-NHE1, However, activation of NHE1 by serum was dramatically inhibited in cells expressing P705A-NHE1 compared with wild-type (0.13 +/- 0.02 versus 0.48 +/- 0.06 mmol of H+/min/liter, p < 0.01). These data suggest that 14-3-3 binding to NHE1 participates in serum-stimulated exchanger activation, a new function for 14-3-3.	Univ Rochester, Sch Med & Dent, Cardiol Res Ctr, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Berk, BC (corresponding author), Univ Rochester, Sch Med & Dent, Cardiol Res Ctr, Box 679,601 Elmwood Ave, Rochester, NY 14642 USA.			Berk, Bradford/0000-0002-2767-4115	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044721] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL44721] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aharonovitz O, 1996, J BIOL CHEM, V271, P16494, DOI 10.1074/jbc.271.28.16494; Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; BERK BC, 1989, J CLIN INVEST, V83, P822, DOI 10.1172/JCI113964; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Bianchini L, 1997, J BIOL CHEM, V272, P271; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; GOSS G, 1996, AM J PHYSIOL-CELL PH, V39, pC1493; Howe AK, 1998, J VIROL, V72, P9637, DOI 10.1128/JVI.72.12.9637-9644.1998; Kim S, 1997, BIOCHEM BIOPH RES CO, V236, P199, DOI 10.1006/bbrc.1997.6926; Kusuhara M, 1998, CIRC RES, V83, P824, DOI 10.1161/01.RES.83.8.824; LAPOINTE MS, 1995, KIDNEY INT, V47, P78, DOI 10.1038/ki.1995.9; LIFTON RP, 1991, HYPERTENSION, V17, P8, DOI 10.1161/01.HYP.17.1.8; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Lucchesi PA, 1996, CIRC RES, V78, P962, DOI 10.1161/01.RES.78.6.962; LUCCHESI PA, 1994, HYPERTENSION, V24, P734, DOI 10.1161/01.HYP.24.6.734; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; MOOLENAAR WH, 1983, NATURE, V304, P645, DOI 10.1038/304645a0; Moor AN, 1999, J BIOL CHEM, V274, P22985, DOI 10.1074/jbc.274.33.22985; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Orlov SN, 2000, BBA-MOL BASIS DIS, V1500, P169, DOI 10.1016/S0925-4439(99)00101-5; Phan VN, 1997, HYPERTENSION, V29, P1265, DOI 10.1161/01.HYP.29.6.1265; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; ROSSKOPF D, 1995, CARDIOVASC RES, V29, P254, DOI 10.1016/S0008-6363(96)88578-6; ROSSKOPF D, 1993, J CLIN INVEST, V92, P2553, DOI 10.1172/JCI116865; Sabri A, 1998, CIRC RES, V82, P1053, DOI 10.1161/01.RES.82.10.1053; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SARDET C, 1991, J BIOL CHEM, V266, P19166; SICZKOWSKI M, 1995, CIRC RES, V76, P825, DOI 10.1161/01.RES.76.5.825; SICZKOWSKI M, 1994, J HYPERTENS, V12, P775; SILVA NLCL, 1995, BIOCHEMISTRY-US, V34, P10412, DOI 10.1021/bi00033a013; Snabaitis AK, 2000, CIRC RES, V86, P214, DOI 10.1161/01.RES.86.2.214; Sweeney FP, 1997, METABOLISM, V46, P297, DOI 10.1016/S0026-0495(97)90257-2; Takahashi E, 1997, CIRC RES, V81, P268, DOI 10.1161/01.RES.81.2.268; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P5583; Wang H, 1997, BIOCHEMISTRY-US, V36, P9151, DOI 10.1021/bi970802f; Wang HN, 1998, J BIOL CHEM, V273, P16297, DOI 10.1074/jbc.273.26.16297; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhang C, 1997, J BIOL CHEM, V272, P13397, DOI 10.1074/jbc.272.20.13397; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717	45	107	108	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15794	15800		10.1074/jbc.M100410200	http://dx.doi.org/10.1074/jbc.M100410200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279064	hybrid			2022-12-27	WOS:000168623100031
J	McIntire, WE; MacCleery, G; Garrison, JC				McIntire, WE; MacCleery, G; Garrison, JC			The G protein beta subunit is a determinant in the coupling of G(s) to the beta(1)-adrenergic and A2a adenosine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACULOVIRUS EXPRESSION SYSTEM; HETEROTRIMERIC G-PROTEINS; PHOSPHOLIPASE C-BETA; ADENYLYL-CYCLASE; GAMMA-SUBUNIT; ALPHA-SUBUNITS; RAT-BRAIN; DIFFERENTIAL REGULATION; MOLECULAR-CLONING; MASS-SPECTROMETRY	The signaling specificity of five purified G protein beta gamma dimers, beta (1)gamma (2), beta (2)gamma (2), beta (3)gamma (2), beta (4)gamma (2), and beta (5)gamma (2), was explored by reconstituting them with G(s) alpha and receptors or effecters in the adenylyl cyclase cascade. The ability of the five beta gamma dimers to support receptor-alpha-beta gamma interactions was examined using membranes expressing the beta (1)-adrenergic or A2a adenosine receptors, These receptors discriminated among the defined heterotrimers based solely on the beta isoform. The beta (4)gamma (2), dimer demonstrated the highest coupling efficiency to either receptor. The beta (5)gamma (2) dimer coupled poorly to each receptor, with EC50 values 40-200-fold higher than those observed with beta (4)gamma (2). Strikingly, whereas the EC50 of the beta (1)gamma (2), dimer at the beta (1)-adrenergic receptor was similar to beta (4)gamma (2), its EC50 was 20-fold higher at the A2a adenosine receptor. Inhibition of adenylyl cyclase type I (AC1) and stimulation of type II (AC2) by the beta gamma dimers were measured. beta gamma dimers containing G beta (1-4) were able to stimulate AC2 similarly, and beta (5)gamma (2) was much less potent. beta (1)gamma (2), beta (2)gamma (2), and beta (4)gamma (2) inhibited AC1 equally; beta (3)gamma (2), was 10-fold less effective, and beta (5)gamma (2), had no effect, These data argue that the beta isoform in the beta gamma dimer can determine the specificity of signaling at both receptors and effectors.	Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	McIntire, WE (corresponding author), Univ Virginia Hlth Syst, Dept Pharmacol, POB 800735,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019952] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK-19952] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asano T, 1999, J BIOL CHEM, V274, P21425, DOI 10.1074/jbc.274.30.21425; Azpiazu I, 1999, J BIOL CHEM, V274, P35305, DOI 10.1074/jbc.274.50.35305; Bayewitch ML, 1998, FASEB J, V12, P1019, DOI 10.1096/fasebj.12.11.1019; Bayewitch ML, 1998, J BIOL CHEM, V273, P2273, DOI 10.1074/jbc.273.4.2273; Betty M, 1998, NEUROSCIENCE, V85, P475, DOI 10.1016/S0306-4522(97)00623-4; BROOKER G, 1976, SCIENCE, V194, P270, DOI 10.1126/science.184530; Chen YB, 1997, P NATL ACAD SCI USA, V94, P2711, DOI 10.1073/pnas.94.6.2711; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Dippel E, 1996, P NATL ACAD SCI USA, V93, P1391, DOI 10.1073/pnas.93.4.1391; Downes GB, 1999, GENOMICS, V62, P544, DOI 10.1006/geno.1999.5992; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; Fletcher JE, 1998, J BIOL CHEM, V273, P636, DOI 10.1074/jbc.273.1.636; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; GILMAN AG, 1995, BIOSCIENCE REP, V15, P65, DOI 10.1007/BF01200143; GRABER SG, 1994, METHOD ENZYMOL, V237, P212; GRABER SG, 1992, J BIOL CHEM, V267, P1271; GRABER SG, 1996, METH NEUROSCI, V29, P207; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Harry A, 1997, J BIOL CHEM, V272, P19017, DOI 10.1074/jbc.272.30.19017; Hildebrandt JD, 1997, BIOCHEM PHARMACOL, V54, P325, DOI 10.1016/S0006-2952(97)00269-4; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; JACOBOWITZ O, 1994, P NATL ACAD SCI USA, V91, P10630, DOI 10.1073/pnas.91.22.10630; KALKBRENNER F, 1995, EMBO J, V14, P4728, DOI 10.1002/j.1460-2075.1995.tb00154.x; Kleuss C, 1997, P NATL ACAD SCI USA, V94, P6116, DOI 10.1073/pnas.94.12.6116; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LEE RH, 1992, J BIOL CHEM, V267, P24776; LEVINE MA, 1990, P NATL ACAD SCI USA, V87, P2329, DOI 10.1073/pnas.87.6.2329; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Liang JJ, 1998, J NEUROCHEM, V71, P345; Lindorfer MA, 1996, J BIOL CHEM, V271, P18582, DOI 10.1074/jbc.271.31.18582; Lindorfer MA, 1998, J BIOL CHEM, V273, P34429, DOI 10.1074/jbc.273.51.34429; Lupi R, 2000, J BIOL CHEM, V275, P9418, DOI 10.1074/jbc.275.13.9418; MacrezLepretre N, 1997, J BIOL CHEM, V272, P10095; Maier U, 2000, J BIOL CHEM, V275, P13746, DOI 10.1074/jbc.275.18.13746; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; MULLER S, 1993, P NATL ACAD SCI USA, V90, P10439, DOI 10.1073/pnas.90.22.10439; Mundell SJ, 1997, MOL PHARMACOL, V51, P991, DOI 10.1124/mol.51.6.991; MURAMOTO S, 1995, BIOCHEM BIOPH RES CO, V206, P799, DOI 10.1006/bbrc.1995.1113; Myung CS, 2000, P NATL ACAD SCI USA, V97, P9311, DOI 10.1073/pnas.97.16.9311; Myung CS, 1999, J BIOL CHEM, V274, P16595, DOI 10.1074/jbc.274.23.16595; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nielsen MD, 1996, J BIOL CHEM, V271, P33308, DOI 10.1074/jbc.271.52.33308; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; Richardson M, 1999, J BIOL CHEM, V274, P13525, DOI 10.1074/jbc.274.19.13525; Robeva AS, 1996, BIOCHEM PHARMACOL, V51, P545, DOI 10.1016/0006-2952(95)02235-X; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; Snow BE, 1999, P NATL ACAD SCI USA, V96, P6489, DOI 10.1073/pnas.96.11.6489; SUMMERS MD, 1987, TEX AES BULL, P1; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Svenningsson P, 1999, PROG NEUROBIOL, V59, P355, DOI 10.1016/S0301-0082(99)00011-8; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Taylor JM, 1996, J BIOL CHEM, V271, P3336; UEDA N, 1994, J BIOL CHEM, V269, P4388; VONWEIZSACKER E, 1992, BIOCHEM BIOPH RES CO, V183, P350, DOI 10.1016/0006-291X(92)91650-F; Weng GZ, 1996, J BIOL CHEM, V271, P26445, DOI 10.1074/jbc.271.43.26445; WILCOX MD, 1995, J BIOL CHEM, V270, P4189, DOI 10.1074/jbc.270.9.4189; WILCOX MD, 1994, J BIOL CHEM, V269, P12508; WILCOX MD, 1995, BIOCHEM BIOPH RES CO, V212, P367, DOI 10.1006/bbrc.1995.1979; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; Yasuda H, 1998, J BIOL CHEM, V273, P21958, DOI 10.1074/jbc.273.34.21958; Yasuda H, 1996, J BIOL CHEM, V271, P18588, DOI 10.1074/jbc.271.31.18588; Yoshikawa DM, 2000, BIOCHEMISTRY-US, V39, P11340, DOI 10.1021/bi0005557; Yoshimura M, 1996, MOL PHARMACOL, V50, P43; Zhang SY, 1996, J BIOL CHEM, V271, P33575, DOI 10.1074/jbc.271.52.33575	74	87	89	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15801	15809		10.1074/jbc.M011233200	http://dx.doi.org/10.1074/jbc.M011233200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278863	hybrid			2022-12-27	WOS:000168623100032
J	Subramaniam, N; Leong, GM; Cock, TA; Flanagan, JL; Fong, C; Eisman, JA; Kouzmenko, AP				Subramaniam, N; Leong, GM; Cock, TA; Flanagan, JL; Fong, C; Eisman, JA; Kouzmenko, AP			Cross-talk between 1,25-dihydroxyvitamin D-3 and transforming growth factor-beta signaling requires binding of VDR and Smad3 proteins to their cognate DNA recognition elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; OSTEOCALCIN GENE; TRANSCRIPTIONAL ACTIVATION; NUCLEAR RECEPTORS; COACTIVATORS; PROMOTER; SPECIFICITY; SUPERFAMILY; EXPRESSION; REPRESSION	1,25-Dihydroxyvitamin D-3 (vitamin D) and transforming growth factor-beta (TGF-beta) regulate diverse biological processes including cell proliferation and differentiation through modulation of the expression of target genes. Members of the Smad family of proteins function as effecters of TGF-beta signaling pathways whereas the vitamin D receptor (VDR) confers vitamin D signaling. We investigated the molecular mechanisms by which TGF-beta and vitamin D signaling pathways interact in the regulation of the human osteocalcin promoter. Synergistic activation of the osteocalcin gene promoter by TGF-beta and vitamin D was observed in transient transfection experiments. However, in contrast to a previous report by Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., Toriyabe, T., Rawabata, M., Miyazono, K., and Kato, S. (1999) Science, 283, 1317-1321, synergistic activation was not detectable when the osteocalcin vitamin D response element (VDRE) alone was linked to a heterologous promoter. Inclusion of the Smad binding elements (SBEs) with the VDRE in the heterologous promoter restored synergistic activation. Furthermore, this synergy was dependent on the spacing between VDRE and SBEs. The Smad3-Smad4 heterodimer was found to bind in gel shift assay to two distinct DNA segments of the osteocalcin promoter: -1030 to -989 (SBE3) and -418 to -349 (SBE1). Deletion of SBE1, which is proximal to the VDRE, brit not the distal SBE3 in this promoter reporter abolished TGF-beta responsiveness and eliminated synergistic co-activation with vitamin D. Thus the molecular mechanism, whereby Smad3 and VDR mediate cross-talk between the TGF-beta acid vitamin D signaling pathways, requires both a VDRE and a SBE located in close proximity to the target promoter.	Garvan Inst Med Res, Bone Mineral Res Program, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research	Subramaniam, N (corresponding author), Childrens Med Res Inst, Muscle Dev Unit, Wentworthville, NSW 2145, Australia.	nsubramaniam@cmri.usyd.edu.au	Eisman, John A/C-2886-2014	Cock, Terrie-Anne/0000-0002-2928-0080; Flanagan, Judith/0000-0002-4053-3288; Leong, Gary/0000-0001-5763-095X				Aslam F, 1999, ENDOCRINOLOGY, V140, P63, DOI 10.1210/en.140.1.63; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1999, ENDOCRINOLOGIST, V9, P32, DOI 10.1097/00019616-199901000-00007; Ebihara K, 1996, MOL CELL BIOL, V16, P3393; Glass CK, 2000, GENE DEV, V14, P121; Hua XX, 1999, P NATL ACAD SCI USA, V96, P13130, DOI 10.1073/pnas.96.23.13130; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Issa LL, 1998, INFLAMM RES, V47, P451, DOI 10.1007/s000110050360; Issa LL, 2001, ENDOCRINOLOGY, V142, P1606, DOI 10.1210/en.142.4.1606; Lian JB, 1998, J CELL BIOCHEM, P62, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<62::AID-JCB10>3.0.CO;2-S; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1997, TRENDS CELL BIOL, V7, P187, DOI 10.1016/S0962-8924(97)01036-2; MORRISON NA, 1989, SCIENCE, V246, P1158, DOI 10.1126/science.2588000; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Qing J, 2000, J BIOL CHEM, V275, P38802, DOI 10.1074/jbc.M004731200; Rodan GA, 1997, CELL, V89, P677, DOI 10.1016/S0092-8674(00)80249-4; Sims NA, 1997, MOL ENDOCRINOL, V11, P1695, DOI 10.1210/me.11.11.1695; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Subramaniam N, 1997, DNA CELL BIOL, V16, P153, DOI 10.1089/dna.1997.16.153; Sugiyama T, 1998, MOL ENDOCRINOL, V12, P1487, DOI 10.1210/me.12.10.1487; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Wong C, 1999, MOL CELL BIOL, V19, P1821; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Yanagi Y, 1999, J BIOL CHEM, V274, P12971, DOI 10.1074/jbc.274.19.12971; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317	27	75	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15741	15746		10.1074/jbc.M011033200	http://dx.doi.org/10.1074/jbc.M011033200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278818	hybrid			2022-12-27	WOS:000168623100024
J	Yakovleva, T; Pramanik, A; Kawasaki, T; Tan-No, K; Gileva, I; Lindgren, H; Langel, U; Ekstrom, TJ; Rigler, R; Terenius, L; Bakalkin, G				Yakovleva, T; Pramanik, A; Kawasaki, T; Tan-No, K; Gileva, I; Lindgren, H; Langel, U; Ekstrom, TJ; Rigler, R; Terenius, L; Bakalkin, G			p53 latency - C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; REGULATORY REGION; MUTANT P53; PROTEIN; PEPTIDE; ACTIVATION; BIOTECHNOLOGY; MICROSCOPY; INVITRO; COMPLEX	The p53 transcription factor is either latent or activated through multi-site phosphorylation and acetylation of the negative regulatory region in its C-terminal domain (CTD). How CTD modifications activate p53 binding to target DNA sequences via its core domain is still unknown. It has been proposed that nonmodified CTD interacts either with the core domain or with DNA preventing binding of the core domain to DNA and that the fragments of the CTD regulatory region activate p53 by interfering with these interactions. We here characterized the sequence and target specificity of p53 activation by CTD fragments, interaction of activating peptides with p53 and target DNA, and interactions of "latent" p53 with. DNA by a band shift assay and by fluorescence correlation spectroscopy. In addition to CTD fragments, several long basic peptides activated p53 and also transcription factor YY1. These peptides and CTD aggregated target DNA but apparently did not interact with p53. The potency to aggregate DNA correlated with the ability to activate p53, suggesting that p53 binds to target sequences upon interactions with tightly packed DNA in aggregates. Latent full-length p53 dissociated DNA aggregates via its core and CTD, and this effect was potentiated by GTP. Latent p53 also formed complexes via both its core and CTD with long nontarget DNA molecules. Such p53-DNA interactions may occur if latent p53 binding to DNA via CTD prevents the interaction of the core domain with target DNA sites but not with nonspecific DNA sequences.	Karolinska Inst, Dept Clin Neurosci, Expt Alcohol & Drug Addict Res Sect, S-17176 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, S-17176 Stockholm, Sweden; Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17176 Stockholm, Sweden; Stockholm Univ, Dept Neurochem & Neurotoxicol, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm University	Bakalkin, G (corresponding author), Karolinska Inst, Dept Clin Neurosci, Expt Alcohol & Drug Addict Res Sect, S-17176 Stockholm, Sweden.		Ekström, Tomas/B-7764-2013	Langel, Ulo/0000-0001-6107-0844; Tan-No, Koichi/0000-0001-6724-848X; Bakalkin, Georgy/0000-0002-8074-9833				Albrechtsen N, 1999, ONCOGENE, V18, P7706, DOI 10.1038/sj.onc.1202952; Anderson ME, 1997, MOL CELL BIOL, V17, P6255, DOI 10.1128/MCB.17.11.6255; BAKALKIN G, 1995, NUCLEIC ACIDS RES, V23, P362, DOI 10.1093/nar/23.3.362; Bakalkin G, 1997, NEUROREPORT, V8, P2143; BAKALKIN G, 1994, P NATL ACAD SCI USA, V91, P413, DOI 10.1073/pnas.91.1.413; Bakalkin G, 1997, BIOCHEM BIOPH RES CO, V231, P135, DOI 10.1006/bbrc.1997.6062; BANNISTER AJ, 1992, NUCLEIC ACIDS RES, V20, P3523, DOI 10.1093/nar/20.13.3523; BAYLE JH, 1995, P NATL ACAD SCI USA, V92, P5729, DOI 10.1073/pnas.92.12.5729; Bessard ACH, 1998, ONCOGENE, V16, P883, DOI 10.1038/sj.onc.1201598; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; BRAIN R, 1994, ONCOGENE, V9, P1775; Cherny DI, 1999, J MOL BIOL, V294, P1015, DOI 10.1006/jmbi.1999.3299; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; EHRENBER.M, 1974, CHEM PHYS, V4, P390, DOI 10.1016/0301-0104(74)85005-6; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Fojta M, 1999, J BIOL CHEM, V274, P25749, DOI 10.1074/jbc.274.36.25749; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; JAYARAMAN L, 1995, CELL, V81, P1021, DOI 10.1016/S0092-8674(05)80007-8; Kerppola TK, 1997, EMBO J, V16, P2907, DOI 10.1093/emboj/16.10.2907; Kim AL, 1999, J BIOL CHEM, V274, P34924, DOI 10.1074/jbc.274.49.34924; LIVOLANT F, 1988, BIOCHEMISTRY-US, V27, P3056, DOI 10.1021/bi00408a058; LIVOLANT F, 1984, TISSUE CELL, V16, P535, DOI 10.1016/0040-8166(84)90029-6; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Meek DW, 1999, ONCOGENE, V18, P7666, DOI 10.1038/sj.onc.1202951; Muller-Tiemann BF, 1998, P NATL ACAD SCI USA, V95, P6079, DOI 10.1073/pnas.95.11.6079; Nagaich AK, 1999, P NATL ACAD SCI USA, V96, P1875, DOI 10.1073/pnas.96.5.1875; Nagaich AK, 1997, J BIOL CHEM, V272, P14830, DOI 10.1074/jbc.272.23.14830; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; Okorokov AL, 1999, MOL CELL BIOL, V19, P7501; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; REED M, 1995, P NATL ACAD SCI USA, V92, P9455, DOI 10.1073/pnas.92.21.9455; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; RIGLER R, 1995, J BIOTECHNOL, V41, P177, DOI 10.1016/0168-1656(95)00054-T; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Selivanova G, 1996, NUCLEIC ACIDS RES, V24, P3560, DOI 10.1093/nar/24.18.3560; Selivanova G, 1999, MOL CELL BIOL, V19, P3395; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Szak ST, 1999, J BIOL CHEM, V274, P3904, DOI 10.1074/jbc.274.6.3904; Tjernberg LO, 1999, CHEM BIOL, V6, P53, DOI 10.1016/S1074-5521(99)80020-9; Tseng M, 1999, J BIOL CHEM, V274, P21637, DOI 10.1074/jbc.274.31.21637; Wohland T, 1999, BIOCHEMISTRY-US, V38, P8671, DOI 10.1021/bi990366s	42	41	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15650	15658		10.1074/jbc.M100482200	http://dx.doi.org/10.1074/jbc.M100482200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279079	hybrid			2022-12-27	WOS:000168623100013
J	Yamashita, K; Discher, DJ; Hu, J; Bishopric, NH; Webster, KA				Yamashita, K; Discher, DJ; Hu, J; Bishopric, NH; Webster, KA			Molecular regulation of the endothelin-1 gene by hypoxia - Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; GROWTH-FACTOR; TRANSCRIPTIONAL REGULATION; MULTIPROTEIN COMPLEX; TYROSINE-HYDROXYLASE; CARDIAC MYOCYTES; BINDING-SITES; HEART-FAILURE; NITRIC-OXIDE; SHEAR-STRESS	Endothelin-1 (ET-1) is a peptide hormone with potent vasoconstrictor properties which is synthesized and secreted predominantly by vascular endothelial cells. Its production is regulated by numerous stimuli including ischemia and hypoxia, and the enhanced levels that occur during myocardial ischemia may contribute to the progression of heart failure. We reported previously a preliminary characterization of a hypoxia-inducible factor-1 (HIF-1) binding site in the human ET-1 promoter which contributed to the activation of ET-1 expression in endothelial cells. We report here that the HIF-1 binding site alone is not sufficient for the response to hypoxia but requires an additional 50 base pairs of flanking sequence that includes binding sites for the factors activator protein-1 (AP-1), GATA-8, and CAAT-binding factor (NF-I), Mutation of any one of these sites or the HIF-1 site eliminated induction by hypoxia, Mutations of the AP-1 and GATA-2 sites, but not the HIF-1 site, were complemented by overexpressing AP-1, GATA-2, HIF-1 alpha, or the activator protein p300/CBP, restoring the response to hypoxia, Binding studies in vitro confirmed physical associations among GATA-8, AP-1, and HIF-1 factors. Overexpression or depletion of p300/CBP modulated the level of ET-1 promoter expression as well as the endogenous ET-I transcript but did not change the fold induction by hypoxia in either case. Regulation of the ET-1 promoter by hypoxia in non-endothelial cells required overexpression of GATA-2 and HIF-1 alpha. The results support essential roles for AP-1, GATA-2, and NF-1 in stabilizing the binding of HIF-1 and promoting recruitment of p300/CBP to the ET-1 hypoxia response complex.	Univ Miami, Med Ctr, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Webster, KA (corresponding author), Univ Miami, Med Ctr, Dept Mol & Cellular Pharmacol, Rosenstiel Med Sci Bldg,Rm 6038,1600 NW 10th Ave, Miami, FL 33136 USA.	kwebster@chroma.med.miami.edu	Hu, Jing/M-3130-2014	Webster, Keith A/0000-0002-6431-3642	NHLBI NIH HHS [HL44578] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044578, R29HL044578] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANVERSA CR, 1997, AM J PHYSIOL, V273, pL848; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bishopric NH, 1997, J BIOL CHEM, V272, P20584, DOI 10.1074/jbc.272.33.20584; Bodi I, 1995, CARDIOVASC RES, V30, P975, DOI 10.1016/S0008-6363(95)00164-6; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Brockmann D, 1999, GENE EXPRESSION, V8, P1; Cowan PJ, 1998, J BIOL CHEM, V273, P11737, DOI 10.1074/jbc.273.19.11737; D'Angelo G, 2000, BIOCHEM BIOPH RES CO, V267, P334, DOI 10.1006/bbrc.1999.1947; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; German Z, 2000, J BIOL CHEM, V275, P8183, DOI 10.1074/jbc.275.11.8183; Hartsfield C, 1999, AM J PHYSIOL-LUNG C, V277, pL1133, DOI 10.1152/ajplung.1999.277.6.L1133; HIEDA HS, 1990, LIFE SCI, V47, P247, DOI 10.1016/0024-3205(90)90327-N; Hu J, 1998, BIOCHEM BIOPH RES CO, V245, P894, DOI 10.1006/bbrc.1998.8543; HU JR, 1988, EUR J PHARMACOL, V158, P275, DOI 10.1016/0014-2999(88)90079-9; IMAI T, 1992, HYPERTENSION, V19, P753, DOI 10.1161/01.HYP.19.6.753; INOUE A, 1989, J BIOL CHEM, V264, P14954; ITO H, 1991, CIRC RES, V69, P209, DOI 10.1161/01.RES.69.1.209; Kakita T, 1999, J BIOL CHEM, V274, P34096, DOI 10.1074/jbc.274.48.34096; Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197; KITAZUMI K, 1993, BIOCHEM PHARMACOL, V46, P455; KOUREMBANAS S, 1993, J CLIN INVEST, V92, P99, DOI 10.1172/JCI116604; KOUREMBANAS S, 1991, J CLIN INVEST, V88, P1054, DOI 10.1172/JCI115367; KURIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P1435, DOI 10.1016/0006-291X(89)92270-5; Laderoute KR, 1997, CIRC RES, V80, P336, DOI 10.1161/01.RES.80.3.336; LEE ME, 1990, J BIOL CHEM, V265, P10446; LEE ME, 1991, J BIOL CHEM, V266, P19034; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; MALEK AM, 1993, P NATL ACAD SCI USA, V90, P5999, DOI 10.1073/pnas.90.13.5999; MARSDEN PA, 1992, AM J PHYSIOL, V262, pC854, DOI 10.1152/ajpcell.1992.262.4.C854; MICHENKO A, 2000, MOL CELL BIOCHEM, V208, P53; Millhorn DE, 1997, KIDNEY INT, V51, P527, DOI 10.1038/ki.1997.73; MORITA T, 1994, CIRC RES, V75, P630, DOI 10.1161/01.RES.75.4.630; NORRIS ML, 1995, J BIOL CHEM, V270, P23774, DOI 10.1074/jbc.270.40.23774; OLIVER FJ, 1991, J BIOL CHEM, V266, P23251; Prentice H, 1997, CARDIOVASC RES, V35, P567, DOI 10.1016/S0008-6363(97)00158-2; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Sakai S, 1996, NATURE, V384, P353, DOI 10.1038/384353a0; Sakai S, 1996, CIRCULATION, V93, P1214, DOI 10.1161/01.CIR.93.6.1214; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SOKOLOVSKY M, 1992, J NEUROCHEM, V59, P809, DOI 10.1111/j.1471-4159.1992.tb08318.x; TONNESSEN T, 1994, CIRCULATION, V90, P426; TSUJI S, 1991, LIFE SCI, V48, P1745, DOI 10.1016/0024-3205(91)90211-S; WATANABE T, 1990, NATURE, V344, P114, DOI 10.1038/344114a0; WEBSTER KA, 1987, MOL CELL BIOCHEM, V77, P19; WEBSTER KA, 1988, NATURE, V332, P553, DOI 10.1038/332553a0; Webster KA, 1999, J CLIN INVEST, V104, P239; WINKLES JA, 1993, BIOCHEM BIOPH RES CO, V191, P1081, DOI 10.1006/bbrc.1993.1327; Wu XS, 1996, MOL CELL BIOL, V16, P1035; YOSHIZUMI M, 1990, BIOCHEM BIOPH RES CO, V166, P324, DOI 10.1016/0006-291X(90)91948-R	49	274	289	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12645	12653		10.1074/jbc.M011344200	http://dx.doi.org/10.1074/jbc.M011344200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278891	hybrid			2022-12-27	WOS:000168198600025
J	Hembrough, TA; Ruiz, JF; Papathanassiu, AE; Green, SJ; Strickland, DK				Hembrough, TA; Ruiz, JF; Papathanassiu, AE; Green, SJ; Strickland, DK			Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E RECEPTOR; PROTEIN-C RECEPTOR; VLDL RECEPTOR; ALPHA-2-MACROGLOBULIN RECEPTOR; LIGAND-BINDING; SURFACE PROTEOGLYCANS; ALZHEIMERS-DISEASE; TUMOR-GROWTH; FACTOR-XA; IN-VITRO	Tissue factor pathway inhibitor (TFPI) contains three Kunitz-type proteinase inhibitor domains and is a potent inhibitor of tissue factor-mediated coagulation. Here, we report that TFPI inhibits the proliferation of basic fibroblast growth factor-stimulated endothelial cells. A truncated form of TFPI, containing only the first two Kunitz-type proteinase inhibitor domains, has very little antiproliferative activity, suggesting that the carboxyl-terminal region of TFPI is responsible for this activity. Binding studies revealed that full-length TFPI, but not the truncated TFPI molecule, is recognized by the very low density lipoprotein receptor (VLDL receptor) indicating that this receptor is a novel high affinity endothelial cell receptor for TFPI. The antiproliferative activity of TFPI on endothelial cells is inhibited by the receptor-associated protein, a known antagonist of ligand binding by the VLDL receptor, and by anti-VLDL receptor antibodies. These results confirm that the antiproliferative activity of TFPI is mediated by the VLDL receptor and suggest that this receptor-ligand system may be a useful target for the development of new antiangiogenic and antitumor agents.	EntreMed Inc, Lab Discovery Res, Rockville, MD 20850 USA; Amer Red Cross, Jerome H Holland Lab, Dept Vasc Biol, Rockville, MD 20855 USA	American Red Cross	Hembrough, TA (corresponding author), EntreMed Inc, Lab Discovery Res, 9640 Med Ctr Dr, Rockville, MD 20850 USA.			Green, Shawn J./0000-0003-4361-5454	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009910, P01HL054710, R01HL050784] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL50784, 1F32-HL09910, HL54710] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Argraves KM, 1997, J CLIN INVEST, V100, P2170, DOI 10.1172/JCI119753; ARGRAVES KM, 1995, J BIOL CHEM, V270, P26550, DOI 10.1074/jbc.270.44.26550; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BACHARACH E, 1992, P NATL ACAD SCI USA, V89, P10686, DOI 10.1073/pnas.89.22.10686; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; CHAPPELL DA, 1993, J BIOL CHEM, V268, P14168; Christie RH, 1996, J NEUROPATH EXP NEUR, V55, P491, DOI 10.1097/00005072-199604000-00012; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dolmer K, 1998, BIOCHEMISTRY-US, V37, P17016, DOI 10.1021/bi982022s; ENJYOJI K, 1995, BIOCHEMISTRY-US, V34, P5725, DOI 10.1021/bi00017a004; Esmon CT, 2000, THROMB HAEMOSTASIS, V83, P639; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; FRYMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453; Fukudome K, 1996, J BIOL CHEM, V271, P17491, DOI 10.1074/jbc.271.29.17491; GAFVELS ME, 1993, SOMAT CELL MOLEC GEN, V19, P557, DOI 10.1007/BF01233382; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; Hamik A, 1999, J BIOL CHEM, V274, P4962, DOI 10.1074/jbc.274.8.4962; Hamuro T, 1998, FEBS LETT, V421, P197, DOI 10.1016/S0014-5793(97)01559-7; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1999, MOL CELL BIOL, V19, P5179; IRUELAARISPE ML, 1991, P NATL ACAD SCI USA, V88, P5026, DOI 10.1073/pnas.88.11.5026; Kamikubo Y, 1997, FEBS LETT, V407, P116, DOI 10.1016/S0014-5793(97)00312-8; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; Mikhailenko I, 1999, J CELL SCI, V112, P3269; MIKHAILENKO I, 1995, J BIOL CHEM, V270, P9543, DOI 10.1074/jbc.270.16.9543; Mueller BM, 1998, J CLIN INVEST, V101, P1372, DOI 10.1172/JCI930; Multhaupt HAB, 1996, AM J PATHOL, V148, P1985; REBECK GW, 1993, NEURON, V11, P575; SAKAI J, 1994, J BIOL CHEM, V269, P2173; Soff GA, 1995, J CLIN INVEST, V96, P2593, DOI 10.1172/JCI118323; STRICKLAND DK, 1995, FASEB J, V9, P890, DOI 10.1096/fasebj.9.10.7615159; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V257, P714, DOI 10.1006/bbrc.1999.0519; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Trousseau A., 1865, PHLEGMASIA ALBA DOLE, V3; VOGEL T, 1994, J CELL BIOCHEM, V54, P299, DOI 10.1002/jcb.240540306; WARSHAWSKY I, 1994, P NATL ACAD SCI USA, V91, P6664, DOI 10.1073/pnas.91.14.6664; Webb DJ, 1999, J BIOL CHEM, V274, P7412, DOI 10.1074/jbc.274.11.7412; WESSELSCHMIDT R, 1992, BLOOD, V79, P2004; Wyne KL, 1996, ARTERIOSCL THROM VAS, V16, P407, DOI 10.1161/01.ATV.16.3.407; ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451	43	68	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12241	12248		10.1074/jbc.M010395200	http://dx.doi.org/10.1074/jbc.M010395200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278667	hybrid			2022-12-27	WOS:000168081800108
J	Suzuki, T; Terasaki, M; Takemoto-Hori, C; Hanada, T; Ueda, T; Wada, A; Watanabe, K				Suzuki, T; Terasaki, M; Takemoto-Hori, C; Hanada, T; Ueda, T; Wada, A; Watanabe, K			Structural compensation for the deficit of rRNA with proteins in the mammalian mitochondrial ribosome - Systematic analysis of protein components of the large ribosomal subunit from mammalian mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORRESPONDING GENE-SEQUENCES; TANDEM-MASS-SPECTROMETRY; DIMENSIONAL GEL-ELECTROPHORESIS; 7.5 ANGSTROM RESOLUTION; ESCHERICHIA-COLI; PEPTIDYLTRANSFERASE ACTIVITY; LIVER-MITOCHONDRIA; 70S RIBOSOME; BOVINE LIVER; IDENTIFICATION	The mammalian mitochondrial ribosome (mitoribosome) is a highly protein-rich particle in which almost half of the rRNA contained in the bacterial ribosome is replaced with proteins. It is known that mitochondrial translation factors can function on both mitochondrial and Escherichia coli ribosomes, indicating that protein components in the mitoribosome compensate the reduced rRNA chain to make a bacteria-type ribosome, To elucidate the molecular basis of this compensation, we analyzed bovine mitoribosomal large subunit proteins; 31 proteins were identified including 15 newly identified proteins with their cDNA sequences from human and mouse. The results showed that the proteins with binding sites on rRNA shortened or lost in the mitoribosome were enlarged when compared with the E. coli counterparts; this suggests the structural compensation of the rRNA deficit by the enlarged proteins in the mitoribosome.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrat Biosci, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; RIKEN, Yokohama Inst, Genom Sci Ctr, Prot Res Grp, Kanagawa 2300045, Japan; Osaka Med Coll, Dept Phys, Osaka 5690084, Japan	University of Tokyo; University of Tokyo; RIKEN; Osaka Medical College	Watanabe, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrat Biosci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	suzuki@kwl.t.u-tokyo.ac.jp; kw@kwl.t.u-tokyo.ac.jp	Ueda, Takuya/K-5217-2014; Suzuki, Tsutomu/J-1776-2015	Ueda, Takuya/0000-0002-7760-8271; Suzuki, Tsutomu/0000-0002-9731-1731; Hanada, Takao/0000-0003-2732-4008				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Baranov PV, 1999, NUCLEIC ACIDS RES, V27, P184, DOI 10.1093/nar/27.1.184; BIEMANN K, 1990, METHOD ENZYMOL, V193, P455, DOI 10.1016/0076-6879(90)93433-L; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CHUNG HKJ, 1990, J BIOL CHEM, V265, P21000; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Diedrich G, 2000, EMBO J, V19, P5241, DOI 10.1093/emboj/19.19.5241; Dongre AR, 1997, TRENDS BIOTECHNOL, V15, P418, DOI 10.1016/S0167-7799(97)01110-4; EGEBJERG J, 1991, J MOL BIOL, V222, P251, DOI 10.1016/0022-2836(91)90210-W; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; GARRETT RA, 1995, RIBOSOMAL RNA STRUCT, P327; Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n; Goldschmidt-Reisin S, 1998, J BIOL CHEM, V273, P34828, DOI 10.1074/jbc.273.52.34828; Graack HR, 1999, BIOCHEMISTRY-US, V38, P16569, DOI 10.1021/bi991543s; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; GUTELL RR, 1990, NUCLEIC ACIDS RES, V18, P2319, DOI 10.1093/nar/18.suppl.2319; HAMILTON MG, 1974, BIOCHEMISTRY-US, V13, P5400, DOI 10.1021/bi00723a024; HAMPL H, 1981, J BIOL CHEM, V256, P2284; Koc EC, 2000, J BIOL CHEM, V275, P32585, DOI 10.1074/jbc.M003596200; Koc EC, 1999, BIOCHEM BIOPH RES CO, V266, P141, DOI 10.1006/bbrc.1999.1785; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; LIAO HX, 1991, J BIOL CHEM, V266, P20714; Ma JH, 1996, J BIOL CHEM, V271, P5805, DOI 10.1074/jbc.271.10.5805; Mao M, 1998, P NATL ACAD SCI USA, V95, P8175, DOI 10.1073/pnas.95.14.8175; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Marty L, 1996, J BIOL CHEM, V271, P11468, DOI 10.1074/jbc.271.19.11468; Matadeen R, 1999, STRUCTURE, V7, P1575, DOI 10.1016/S0969-2126(00)88348-3; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; Mueller F, 2000, J MOL BIOL, V298, P35, DOI 10.1006/jmbi.2000.3635; Muth GW, 2000, SCIENCE, V289, P947, DOI 10.1126/science.289.5481.947; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; O'Brien TW, 1999, J BIOL CHEM, V274, P36043, DOI 10.1074/jbc.274.51.36043; O'Brien TW, 2000, J BIOL CHEM, V275, P18153, DOI 10.1074/jbc.M909762199; OBRIEN TW, 1971, J BIOL CHEM, V246, P3409; OU JH, 1987, NUCLEIC ACIDS RES, V15, P8919, DOI 10.1093/nar/15.21.8919; Patel VB, 2001, J BIOL CHEM, V276, P6739, DOI 10.1074/jbc.M005781200; PIETROMONACO SF, 1991, BIOCHIMIE, V73, P827, DOI 10.1016/0300-9084(91)90062-6; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SCHULZE H, 1982, EMBO J, V1, P609, DOI 10.1002/j.1460-2075.1982.tb01216.x; Schwartzbach C J, 1996, Methods Enzymol, V264, P248, DOI 10.1016/S0076-6879(96)64025-7; SCHWARTZBACH CJ, 1989, J BIOL CHEM, V264, P19125; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tocilj A, 1999, P NATL ACAD SCI USA, V96, P14252, DOI 10.1073/pnas.96.25.14252; TSANG P, 1995, HUM MOL GENET, V4, P1499, DOI 10.1093/hmg/4.9.1499; WADA A, 1986, J BIOCHEM, V100, P1583, DOI 10.1093/oxfordjournals.jbchem.a121866; WADA A, 1990, P NATL ACAD SCI USA, V87, P2657, DOI 10.1073/pnas.87.7.2657; WADA A, 1986, J BIOCHEM-TOKYO, V100, P1595, DOI 10.1093/oxfordjournals.jbchem.a121867; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	54	99	147	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21724	21736		10.1074/jbc.M100432200	http://dx.doi.org/10.1074/jbc.M100432200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11279069	hybrid			2022-12-27	WOS:000169297900123
J	Baldwin, ME; Catimel, B; Nice, EC; Roufail, S; Hall, NE; Stenvers, KL; Karkkainen, MJ; Alitalo, K; Stacker, SA; Achen, MG				Baldwin, ME; Catimel, B; Nice, EC; Roufail, S; Hall, NE; Stenvers, KL; Karkkainen, MJ; Alitalo, K; Stacker, SA; Achen, MG			The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOGENESIS IN-VIVO; VEGF-C; TUMOR ANGIOGENESIS; FACTOR FAMILY; INSTRUMENTAL BIOSENSORS; LYMPHATIC ENDOTHELIUM; TYROSINE KINASES; EXPRESSION; LIGAND; GENE	Human vascular endothelial growth factor-D (VEGF-D) binds and activates VEGFR-2 and VEGFR-3, receptors expressed on vascular and lymphatic endothelial cells. As VEGFR-2 signals for angiogenesis and VEGFR-3 is thought to signal for lymphangiogenesis, it was proposed that VEGF-D stimulates growth of blood vessels and lymphatic vessels into regions of embryos and tumors. Here we report the unexpected finding that mouse VEGF-D fails to bind mouse VEGFR-2 but binds and cross-links VEGFR-3 as demonstrated by biosensor analysis with immobilized receptor domains and bioassays of VEGFR-2 and VEGFR-3 cross-linking. Mutation of amino acids in mouse VEGF-D to those in the human homologue indicated that residues important for the VEGFR-2 interaction are clustered at, or are near, the predicted receptor-binding surface. Coordinated expression of VEGF-D and VEGFR-3 in mouse embryos was detected in the developing skin where the VEGF-D gene was expressed in a layer of cells beneath the developing epidermis and VEGFR-3 was localized on a network of vessels immediately beneath the VEGF-D-positive cells. This suggests that VEGF-D and VEGFR-3 may play a role in establishing vessels of the skin by a paracrine mechanism. Our study of receptor specificity suggests that VEGF-D may have different biological functions in mouse and man.	Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia; Univ Helsinki Hosp, FIN-00014 Helsinki, Finland; Haartman Inst, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland	Ludwig Institute for Cancer Research; Royal Melbourne Hospital; University of Helsinki; Helsinki University Central Hospital	Achen, MG (corresponding author), Royal Melbourne Hosp, Ludwig Inst Canc Res, POB 2008, Melbourne, Vic 3050, Australia.		Nice, Edouard C/B-1026-2011; Alitalo, Kari K/J-5013-2014	Alitalo, Kari K/0000-0002-7331-0902; Achen, Marc/0000-0002-3791-803X; CATIMEL, Bruno/0000-0002-4350-6875; Hall, Nathan/0000-0001-8942-0498; Stacker, Steven/0000-0003-4096-9273				Achen MG, 2000, EUR J BIOCHEM, V267, P2505, DOI 10.1046/j.1432-1327.2000.01257.x; Achen MG, 1998, INT J EXP PATHOL, V79, P255, DOI 10.1046/j.1365-2613.1998.700404.x; Achen MG, 2001, J PATHOL, V193, P147, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO;2-G; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Avantaggiato V, 1998, MECH DEVELOP, V73, P221, DOI 10.1016/S0925-4773(98)00049-5; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Catimel B, 1999, PROTEIN PEPTIDE LETT, V6, P319; Catimel B, 1997, J CHROMATOGR A, V776, P15, DOI 10.1016/S0021-9673(97)00087-3; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joukov V, 1996, EMBO J, V15, P290; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kubo H, 2000, BLOOD, V96, P546; Kukk E, 1996, DEVELOPMENT, V122, P3829; LI XM, 1993, NUCLEIC ACIDS RES, V21, P3745, DOI 10.1093/nar/21.16.3745; Lymboussaki A, 1998, AM J PATHOL, V153, P395, DOI 10.1016/S0002-9440(10)65583-6; Marconcini L, 1999, P NATL ACAD SCI USA, V96, P9671, DOI 10.1073/pnas.96.17.9671; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Millauer B, 1996, CANCER RES, V56, P1615; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Nice EC, 1999, BIOESSAYS, V21, P339, DOI 10.1002/(SICI)1521-1878(199904)21:4<339::AID-BIES11>3.0.CO;2-C; Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639; Orlandini M, 1996, P NATL ACAD SCI USA, V93, P11675, DOI 10.1073/pnas.93.21.11675; Paavonen K, 2000, AM J PATHOL, V156, P1499, DOI 10.1016/S0002-9440(10)65021-3; PACIFICI RE, 1994, J BIOL CHEM, V269, P1571; Partanen TA, 1999, CANCER-AM CANCER SOC, V86, P2406, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2406::AID-CNCR31>3.3.CO;2-5; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; PLATE KH, 1994, BRAIN PATHOL, V4, P207, DOI 10.1111/j.1750-3639.1994.tb00835.x; PLATE KH, 1993, CANCER RES, V53, P5822; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Saleh M, 1996, CANCER RES, V56, P393; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 1999, J BIOL CHEM, V274, P34884, DOI 10.1074/jbc.274.49.34884; Stacker SA, 2000, GROWTH FACTORS, V18, P177, DOI 10.3109/08977190009003243; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Taipale J, 1999, CURR TOP MICROBIOL, V237, P85; Valtola R, 1999, AM J PATHOL, V154, P1381, DOI 10.1016/S0002-9440(10)65392-8; WALKER F, 1990, BIOCHEMISTRY-US, V29, P10635, DOI 10.1021/bi00499a009; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Wise LM, 1999, P NATL ACAD SCI USA, V96, P3071, DOI 10.1073/pnas.96.6.3071; Witzenbichler B, 1998, AM J PATHOL, V153, P381, DOI 10.1016/S0002-9440(10)65582-4	50	141	146	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19166	19171		10.1074/jbc.M100097200	http://dx.doi.org/10.1074/jbc.M100097200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279005	hybrid			2022-12-27	WOS:000169091000072
J	Jheon, AH; Ganss, B; Cheifetz, S; Sodek, J				Jheon, AH; Ganss, B; Cheifetz, S; Sodek, J			Characterization of a novel KRAB/C2H2 zinc finger transcription factor involved in bone development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; MESSENGER-RNA; SMAD PROTEINS; KRUPPEL-TYPE; DOMAIN; REPRESSION; MATRIX; EXPRESSION; GENE; RECEPTORS	Osteogenic differentiation involves a cascade of coordinated gene expression that regulates cell proliferation and matrix protein formation in a defined temporo-spatial manner. Here we have used differential display to identify a novel zinc finger transcription factor (AJ18) that is induced during differentiation of bone cells in vitro and in vivo, The 64-kDa protein, encoded by a 7-kilobase mRNA, contains a Kruppel-associated box (KRAB) domain followed by 11 successive C2H2 zinc finger motifs, AJ18 mRNA, which is also expressed in kidney and brain, is developmentally regulated in embryonic tibiae and calvariae, with little expression in neonate and adult animals. During osteogenic differentiation in vitro AJ18 mRNA is expressed as cells approach confluence and declines as bone formation occurs. Using bacterially expressed, His-tagged AJ18 in a target detection assay, we identified a consensus binding sequence of 5'-CCACA-3', which forms part of the consensus element for Runx2, a master gene for osteogenic differentiation. Overexpression of AJ18 suppressed Runx2-mediated transactivation of an osteocalcin promoter construct in transient transfection assays and reduced alkaline phosphatase activity in bone morphogenetic protein-induced C3H10T1/2 cells. These studies, therefore, have identified a novel zinc finger transcription factor in bone that can modulate Runx2 activity and osteogenic differentiation.	Univ Toronto, CIHR Grp Periodontal Physiol, Toronto, ON M5S 3E2, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 3E2, Canada	University of Toronto; University of Toronto	Jheon, AH (corresponding author), Univ Toronto, CIHR Grp Periodontal Physiol, Rm 239,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; BELLEFROID EJ, 1989, DNA-J MOLEC CELL BIO, V8, P377, DOI 10.1089/dna.1.1989.8.377; CHEN JK, 1992, J BONE MINER RES, V7, P987; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Derynck R, 1998, NATURE, V393, P737, DOI 10.1038/31593; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; DUCY P, 1995, MOL CELL BIOL, V15, P31; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Grondin B, 1996, J BIOL CHEM, V271, P15458, DOI 10.1074/jbc.271.26.15458; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; JHEON A, 2000, CHEM BIOL MINERALIZE, P87; Ji CH, 1998, J CELL BIOCHEM, V69, P353, DOI 10.1002/(SICI)1097-4644(19980601)69:3<353::AID-JCB12>3.3.CO;2-W; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kawai S, 2000, BIOCHEM BIOPH RES CO, V271, P682, DOI 10.1006/bbrc.2000.2704; Kim RH, 1999, CANCER RES, V59, P565; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Le Douarin B, 1998, J STEROID BIOCHEM, V65, P43, DOI 10.1016/S0960-0760(97)00175-1; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Li IWS, 1996, J CELL PHYSIOL, V169, P115, DOI 10.1002/(SICI)1097-4652(199610)169:1<115::AID-JCP12>3.0.CO;2-C; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Mark C, 1999, DNA CELL BIOL, V18, P381, DOI 10.1089/104454999315277; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Moosmann P, 1997, BIOL CHEM, V378, P669, DOI 10.1515/bchm.1997.378.7.669; MORRIS JF, 1995, BLOOD, V86, P3640; Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PENGUE G, 1994, NUCLEIC ACIDS RES, V22, P2908, DOI 10.1093/nar/22.15.2908; PIELER T, 1994, MOL BIOL REP, V20, P1, DOI 10.1007/BF00999848; Rodan GA, 1997, CELL, V89, P677, DOI 10.1016/S0092-8674(00)80249-4; SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599; Stein Gary S., 1993, P47; SUKEGAWA J, 1993, CELL, V72, P29, DOI 10.1016/0092-8674(93)90047-T; tenDijke P, 1996, CURR OPIN CELL BIOL, V8, P139; THEUNISSEN O, 1992, CELL, V71, P679, DOI 10.1016/0092-8674(92)90601-8; THIESEN HJ, 1990, NUCLEIC ACIDS RES, V18, P3203, DOI 10.1093/nar/18.11.3203; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; YAO KL, 1994, J BONE MINER RES, V9, P231; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7	47	77	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18282	18289		10.1074/jbc.M010885200	http://dx.doi.org/10.1074/jbc.M010885200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278774	hybrid			2022-12-27	WOS:000168866500090
J	Wartenberg, M; Ling, FC; Schallenberg, M; Baumer, AT; Petrat, K; Hescheler, J; Sauer, H				Wartenberg, M; Ling, FC; Schallenberg, M; Baumer, AT; Petrat, K; Hescheler, J; Sauer, H			Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG RESISTANCE-1 GENE; LASER-SCANNING MICROSCOPY; POLYMERASE CHAIN-REACTION; C-FOS EXPRESSION; HYDROGEN-PEROXIDE; GROWTH-STIMULATION; BUTHIONINE SULFOXIMINE; CANCER SPHEROIDS; CELL-DEATH; DOXORUBICIN	Intrinsic expression of the multidrug resistance (MDR) transporter P-glycoprotein (Pgp) may be regulated by reactive oxygen species (ROS), A transient expression of Pgp was observed during the growth of multicellular tumor spheroids. Maximum Pgp expression occurred in tumor spheroids with a high percentage of quiescent, Ki-67-negative cells, elevated glutathione levels, increased expression of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(WAF-1) as well as reduced ROS levels and minor activity of the mitogen-activated kinase (MAPK) members c-Jun amino-terminal kinase (JNK), extracellular signal-regulated kinase ERK1,2, and p38 MAPK, Raising intracellular ROS by depletion of glutathione with buthionine sulfoximine (BSO) or glutamine starvation resulted in down-regulation of Pgp and p27(Kip1), whereas ERK1,S and JNK were activated. Down-regulation of Pgp was furthermore observed with low concentrations of hydrogen peroxide and epidermal growth factor, indicating that ROS may regulate Pgp expression. The down-regulation of Pgp following BSO treatment was abolished by agents interfering with receptor tyrosine kinase signaling pathways, i,e, the protein kinase C inhibitors bisindolylmaleimide I (BIM-1) and Ro-31-8220, the p21(ras) farnesyl protein transferase inhibitor III, the c-Raf inhibitor ZM 336372 and PD98059, which inhibits ERK1,2 activation. ROS involved as second messengers in receptor tyrosine kinase signaling pathways may act as negative regulators of Pgp expression.	Univ Cologne, Dept Neurophysiol, D-50931 Cologne, Germany; Univ Cologne, Dept Internal Med 3, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Sauer, H (corresponding author), Univ Cologne, Dept Neurophysiol, Robert Koch Str 39, D-50931 Cologne, Germany.	hs@physiologie.uni-koeln.de						Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Beedassy A, 1999, SEMIN ONCOL, V26, P428; Burdon RH, 1996, FREE RADICAL RES, V24, P81, DOI 10.3109/10715769609088004; Burdon RH, 1996, BIOCHEM SOC T, V24, P1028, DOI 10.1042/bst0241028; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; DHAR DK, 1995, J SURG ONCOL, V60, P50, DOI 10.1002/jso.2930600110; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; FRENKEL K, 1991, FREE RADICAL RES COM, V12-3, P783, DOI 10.3109/10715769109145860; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Johnstone RW, 1999, BLOOD, V93, P1075, DOI 10.1182/blood.V93.3.1075.403k35_1075_1085; Kojima H, 1998, J BIOL CHEM, V273, P16647, DOI 10.1074/jbc.273.27.16647; MAIORINO M, 1992, ARCH BIOCHEM BIOPHYS, V295, P404, DOI 10.1016/0003-9861(92)90534-4; MIYAZAKI M, 1992, BIOCHEM BIOPH RES CO, V187, P677, DOI 10.1016/0006-291X(92)91248-O; Naito S, 1999, INT J UROL, V6, P427, DOI 10.1046/j.1442-2042.1999.00088.x; NOONAN KE, 1990, P NATL ACAD SCI USA, V87, P7160, DOI 10.1073/pnas.87.18.7160; Oda Y, 1996, DIAGN MOL PATHOL, V5, P98, DOI 10.1097/00019606-199606000-00004; ODwyer PJ, 1996, J CLIN ONCOL, V14, P249, DOI 10.1200/JCO.1996.14.1.249; PILARSKI LM, 1995, LEUKEMIA LYMPHOMA, V17, P367, DOI 10.3109/10428199509056847; Sarkadi B, 1997, SEMIN CANCER BIOL, V8, P171, DOI 10.1006/scbi.1997.0069; Sauer H, 1997, FEBS LETT, V419, P201, DOI 10.1016/S0014-5793(97)01456-7; Sauer H, 1997, BRIT J CANCER, V75, P1481, DOI 10.1038/bjc.1997.253; SIMON SM, 1994, P NATL ACAD SCI USA, V91, P3497, DOI 10.1073/pnas.91.9.3497; Smeets MEP, 1999, BLOOD, V94, P2414, DOI 10.1182/blood.V94.7.2414.417k01_2414_2423; Smyth MJ, 1998, P NATL ACAD SCI USA, V95, P7024, DOI 10.1073/pnas.95.12.7024; StCroix B, 1996, JNCI-J NATL CANCER I, V88, P1285, DOI 10.1093/jnci/88.18.1285; StCroix B, 1996, NAT MED, V2, P1204; Stein U, 1997, JNCI-J NATL CANCER I, V89, P807, DOI 10.1093/jnci/89.11.807; SZATROWSKI TP, 1991, CANCER RES, V51, P794; UCHIUMI T, 1993, CELL GROWTH DIFFER, V4, P147; Volm M, 1998, ANTICANCER RES, V18, P2905; Wartenberg M, 1999, J BIOL CHEM, V274, P27759, DOI 10.1074/jbc.274.39.27759; Wartenberg M, 1996, ANTICANCER RES, V16, P573; Wartenberg M, 1998, INT J CANCER, V75, P855, DOI 10.1002/(SICI)1097-0215(19980316)75:6<855::AID-IJC7>3.3.CO;2-2; Wartenberg M, 1998, CYTOMETRY, V31, P137, DOI 10.1002/(SICI)1097-0320(19980201)31:2<137::AID-CYTO9>3.0.CO;2-J; Wartenberg M, 2000, INT J CANCER, V85, P267, DOI 10.1002/(SICI)1097-0215(20000115)85:2<267::AID-IJC19>3.0.CO;2-H; Wartenberg M, 1997, AM J PHYSIOL-REG I, V272, pR1677, DOI 10.1152/ajpregu.1997.272.5.R1677; WEI LY, 1994, BIOCHEMISTRY-US, V33, P7229, DOI 10.1021/bi00189a027; Yamane Y, 1998, J BIOL CHEM, V273, P31075, DOI 10.1074/jbc.273.47.31075; Ziemann C, 1999, CARCINOGENESIS, V20, P407, DOI 10.1093/carcin/20.3.407	42	99	108	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17420	17428		10.1074/jbc.M100141200	http://dx.doi.org/10.1074/jbc.M100141200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279018	hybrid			2022-12-27	WOS:000168730400110
J	Deng, JT; Van Lierop, JE; Sutherland, C; Walsh, MP				Deng, JT; Van Lierop, JE; Sutherland, C; Walsh, MP			Ca2+-independent smooth muscle contraction - A novel function for integrin-linked kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN LIGHT-CHAIN; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; CA2+ SENSITIZATION; ARACHIDONIC-ACID; RHO-KINASE; PHOSPHORYLATION; PHOSPHATASE; CALCIUM; INHIBITION	Smooth muscle contraction follows an increase in cytosolic Ca2+ concentration, activation of myosin light chain kinase, and phosphorylation of the 20-kDa light chain of myosin at Ser(19). Several agonists acting via G protein-coupled receptors elicit a contraction without a change in [Ca2+](i) via inhibition of myosin light chain phosphatase and increased myosin phosphorylation. We showed that microcystin (phosphatase inhibitor)-induced contraction of skinned smooth muscle occurred in the absence of Ca2+ and correlated with phosphorylation of myosin light chain at Ser(19) and Thr(18) by a kinase distinct from myosin light chain kinase. In this study, we identify this kinase as integrin-linked kinase. Chicken gizzard integrin-linked kinase cDNA was cloned, sequenced, expressed in E. coli, and shown to phosphorylate myosin light chain in the absence of Ca2+ at Ser(19) and Thr(18). Subcellular fractionation revealed two distinct populations of integrin-linked kinase, including a Triton X-100-insoluble component that phosphorylates myosin in a Ca2+-independent manner. These results suggest a novel function for integrin-linked kinase in the regulation of smooth muscle contraction via Ca2+-independent phosphorylation of myosin, raise the possibility that integrin-linked kinase may also play a role in regulation of nonmuscle motility, and confirm that integrin-linked kinase is indeed a functional protein-serine/threonine kinase.	Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Smooth Muscle Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Canadian Inst,Hlth Res Grp Regulat Vasc Contracti, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Walsh, MP (corresponding author), Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Smooth Muscle Res Grp, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.							ALLEN BG, 1994, TRENDS BIOCHEM SCI, V19, P362, DOI 10.1016/0968-0004(94)90112-0; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; COLBURN JC, 1988, J BIOL CHEM, V263, P19166; Dedhar S, 1999, TRENDS CELL BIOL, V9, P319, DOI 10.1016/S0962-8924(99)01612-8; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; EDELMAN AM, 1990, MOL CELL BIOCHEM, V97, P87; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; FOSTER CJ, 1990, ARCH BIOCHEM BIOPHYS, V280, P397, DOI 10.1016/0003-9861(90)90348-3; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Gailly P, 1997, J PHYSIOL-LONDON, V500, P95, DOI 10.1113/jphysiol.1997.sp022002; GALLAGHER PJ, 1993, J BIOL CHEM, V268, P26578; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; GONG MC, 1992, J BIOL CHEM, V267, P21492; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; HATHAWAY DR, 1983, ANAL BIOCHEM, V135, P37, DOI 10.1016/0003-2697(83)90726-1; HERMAN PK, 1991, CELL, V64, P425, DOI 10.1016/0092-8674(91)90650-N; Ichikawa K, 1996, BIOCHEMISTRY-US, V35, P6313, DOI 10.1021/bi960208q; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; IKEBE M, 1989, J BIOL CHEM, V264, P6967; IKEBE M, 1990, BIOCHEM BIOPH RES CO, V168, P714, DOI 10.1016/0006-291X(90)92380-I; IKEBE M, 1986, J BIOL CHEM, V261, P36; IKEBE M, 1985, J BIOL CHEM, V260, P27; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kitazawa T, 2000, J BIOL CHEM, V275, P9897, DOI 10.1074/jbc.275.14.9897; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; Kolodney MS, 1999, J PHYSIOL-LONDON, V515, P87, DOI 10.1111/j.1469-7793.1999.087ad.x; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Li L, 1998, J PHYSIOL-LONDON, V508, P871, DOI 10.1111/j.1469-7793.1998.871bp.x; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Lynch DK, 1999, ONCOGENE, V18, P8024, DOI 10.1038/sj.onc.1203258; MISSIAEN L, 1992, PHARMACOL THERAPEUT, V56, P191, DOI 10.1016/0163-7258(92)90017-T; NGAI PK, 1984, BIOCHEM J, V218, P863, DOI 10.1042/bj2180863; PERSECHINI A, 1981, SCIENCE, V213, P1381; SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589; SCHWABE W, 1998, FOCUS, V20, P30; SETO M, 1990, PFLUG ARCH EUR J PHY, V415, P484, DOI 10.1007/BF00373627; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; STULTS JT, 1995, CURR OPIN STRUC BIOL, V5, P691, DOI 10.1016/0959-440X(95)80063-8; Sward K, 2000, J PHYSIOL-LONDON, V522, P33, DOI 10.1111/j.1469-7793.2000.0033m.x; Weber LP, 1999, J PHYSIOL-LONDON, V516, P805, DOI 10.1111/j.1469-7793.1999.0805u.x; WILLIAMS DA, 1987, SCIENCE, V235, P1644, DOI 10.1126/science.3103219; WILLIAMS DA, 1986, AM J PHYSIOL, V250, pC779, DOI 10.1152/ajpcell.1986.250.5.C779; WINDER SJ, 1990, J BIOL CHEM, V265, P10148	48	203	217	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16365	16373		10.1074/jbc.M011634200	http://dx.doi.org/10.1074/jbc.M011634200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278951	hybrid			2022-12-27	WOS:000168623100106
J	Goobes, R; Minsky, A				Goobes, R; Minsky, A			Contextual equilibrium effects in DNA molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX FORMATION; ADENINE TRACTS; DEPENDENT CURVATURE; PACKAGING PROCESSES; FLANKING SEQUENCES; NUCLEIC-ACIDS; TRANSITION; DUPLEX; CONFORMATION; CONDENSATION	The thermodynamic parameters of DNA triplex formation between oligonucleotides and double-stranded DNA segments containing adenine runs (A-tracts) were investigated to explore equilibrium structural effects exerted by flanking segments upon the A-tracts. Results obtained from isothermal titration calorimetry, temperature-dependent circular dichroism (CD), and UV melting experiments indicate that A-tracts, considered as a uniquely robust and inflexible DNA motif, can be structurally perturbed by neighboring sequences in a way that significantly affects the propensity of this motif to interact with triplex-forming oligonucleotides. These contextual equilibrium effects, which depend upon the composition and location of the flanking sequences, are likely to apply not only to the interaction of A-tracts with single-stranded DNA molecules but also to interactions with drugs and proteins. As such, the current results refine the guidelines for the design of triplex-forming oligonucleotides used for antigene strategies. More generally, they substantiate the notion that significant data might be encoded by structural DNA parameters.	Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Minsky, A (corresponding author), Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel.	avi.minsky@weizmann.ac.il						ARNOTT S, 1974, J MOL BIOL, V88, P509, DOI 10.1016/0022-2836(74)90498-7; BURD JF, 1975, J BIOL CHEM, V250, P5109; CHOMILIER J, 1992, BIOPHYS CHEM, V45, P143, DOI 10.1016/0301-4622(92)87006-5; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; Dickerson RE, 1996, J MOL BIOL, V256, P108, DOI 10.1006/jmbi.1996.0071; DIGABRIELE AD, 1993, J MOL BIOL, V231, P1024, DOI 10.1006/jmbi.1993.1349; EFTINK MR, 1983, BIOCHEMISTRY-US, V22, P3884, DOI 10.1021/bi00285a025; FRANK HS, 1945, J CHEM PHYS, V13, P507, DOI 10.1063/1.1723985; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; HOPKINS HP, 1993, J PHYS CHEM-US, V97, P6555, DOI 10.1021/j100126a036; JAWORSKI A, 1987, SCIENCE, V238, P773, DOI 10.1126/science.3313728; Kamiya M, 1996, J AM CHEM SOC, V118, P4532, DOI 10.1021/ja952287j; KANG S, 1992, J BIOL CHEM, V267, P19435; KOHWISHIGEMATSU T, 1985, CELL, V43, P199, DOI 10.1016/0092-8674(85)90024-8; LevinZaidman S, 1996, BIOCHEMISTRY-US, V35, P2985, DOI 10.1021/bi9525482; MA CL, 1995, BIOCHEMISTRY-US, V34, P3521, DOI 10.1021/bi00011a005; Nejedly K, 1996, J BIOMOL STRUCT DYN, V13, P1007, DOI 10.1080/07391102.1996.10508915; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; PARK HS, 1987, J MOL BIOL, V197, P513, DOI 10.1016/0022-2836(87)90561-4; Plum GE, 1997, BIOPOLYMERS, V44, P241, DOI 10.1002/(SICI)1097-0282(1997)44:3<241::AID-BIP4>3.3.CO;2-W; Praseuth D, 1999, BBA-GENE STRUCT EXPR, V1489, P181, DOI 10.1016/S0167-4781(99)00149-9; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; RAJAGOPALAN M, 1990, J BIOL CHEM, V265, P17294; REICH Z, 1991, BIOCHEMISTRY-US, V30, P7828, DOI 10.1021/bi00245a024; REICH Z, 1993, J BIOL CHEM, V268, P8261; REICH Z, 1992, J BIOMOL STRUCT DYN, V9, P1097, DOI 10.1080/07391102.1992.10507981; Schnell JR, 1998, BIOPHYS J, V74, P1484, DOI 10.1016/S0006-3495(98)77860-9; Sen A, 2000, BIOPHYS CHEM, V88, P69, DOI 10.1016/S0301-4622(00)00200-3; ShatzkySchwartz M, 1997, J MOL BIOL, V267, P595, DOI 10.1006/jmbi.1996.0878; SULLIVAN KM, 1986, CELL, V47, P817, DOI 10.1016/0092-8674(86)90524-6; SUN JS, 1993, CURR OPIN STRUC BIOL, V3, P345, DOI 10.1016/S0959-440X(05)80105-8; WELLS RD, 1988, J BIOL CHEM, V263, P1095; WILSON WD, 1994, J AM CHEM SOC, V116, P3607, DOI 10.1021/ja00087a060; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Young MA, 1998, J MOL BIOL, V281, P675, DOI 10.1006/jmbi.1998.1962	35	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16155	16160		10.1074/jbc.M100619200	http://dx.doi.org/10.1074/jbc.M100619200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279103	hybrid			2022-12-27	WOS:000168623100079
J	Hanson, BJ; Carrozzo, R; Piemonte, F; Tessa, A; Robinson, BH; Capaldi, RA				Hanson, BJ; Carrozzo, R; Piemonte, F; Tessa, A; Robinson, BH; Capaldi, RA			Cytochrome c oxidase-deficient patients have distinct subunit assembly profiles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN; OXIDATIVE-PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL-DNA; HEPATIC-FAILURE; NEONATAL-ONSET; COX DEFICIENCY; GENE; MUTATION; DISEASE	Cytochrome c oxidase (COX) deficiency is the most common respiratory chain defect in childhood and is clinically heterogeneous. We report a study of six patients with COX deficiencies. Two of the patients had as yet undefined defects, three patients had Surf-1 mutations, and one patient had a 15-base pair deletion in the COX III subunit, We show that quantitative measurements of steady-state levels of subunits by monoclonal antibody reactivity, when used in combination with a discontinuous sucrose gradient methods, provide an improved diagnosis of COX deficiencies by distinguishing between kinetic, stability, and assembly defects. The two mutants of undefined etiology had a full complement of subunits with one stable and the other partially unstable to detergent solubilization, Both are likely to carry mutations in nuclear-encoded subunits of the complex. The three Surf-1 mutants and the COX III mutant each had reduced steady-state levels of subunits but variable associations of the residual subunits. This information, as well as aiding in diagnosis, helps in understanding the genotype-phenotype relationships of COX deficiencies and provides insight into the mechanism of assembly of the enzyme complex.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Osped Pediat Bambino Gesu, Unita Med Mol, I-00165 Rome, Italy; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Oregon; IRCCS Bambino Gesu; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Capaldi, RA (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.		Tessa, Alessandra/AAA-4442-2021; Tessa, Alessandra/K-2325-2016; Piemonte, Fiorella/A-2809-2014; Carrozzo, Rosalba/A-2808-2014	Tessa, Alessandra/0000-0002-1445-6434; Tessa, Alessandra/0000-0002-1445-6434; Piemonte, Fiorella/0000-0003-1825-9347; Carrozzo, Rosalba/0000-0002-3327-4054	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024526] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL24526] Funding Source: Medline; NIGMS NIH HHS [GM07759] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONNEFOY N, 1994, P NATL ACAD SCI USA, V91, P11978, DOI 10.1073/pnas.91.25.11978; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Caruso U, 1996, J INHERIT METAB DIS, V19, P143, DOI 10.1007/BF01799415; Church C, 1996, J BIOL CHEM, V271, P18499, DOI 10.1074/jbc.271.31.18499; CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408; Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119; CORMIER V, 1991, J PEDIATR-US, V119, P951, DOI 10.1016/S0022-3476(05)83054-9; Dickinson EK, 2000, J BIOL CHEM, V275, P26780; DIMAURO S, 1990, PEDIATR RES, V28, P536, DOI 10.1203/00006450-199011000-00025; GLERUM DM, 1995, J BIOL CHEM, V270, P15585, DOI 10.1074/jbc.270.26.15585; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; HANSON BJ, 2001, IN PRESS ELECTROPHOR; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Hoffbuhr KC, 2000, J BIOL CHEM, V275, P13994, DOI 10.1074/jbc.275.18.13994; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIGHTOWLERS R, 1991, J BIOL CHEM, V266, P7688; MALATESTA F, 1986, BIOCHEM J, V234, P569, DOI 10.1042/bj2340569; Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6; MCEWEN JE, 1986, J BIOL CHEM, V261, P11862; NAECZ KA, 1985, BIOCHIM BIOPHYS ACTA, V808, P259; Napiwotzki J, 1998, BIOL CHEM, V379, P335, DOI 10.1515/bchm.1998.379.3.335; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; NIJTMANS LGJ, 1995, BBA-MOL BASIS DIS, V1270, P193, DOI 10.1016/0925-4439(95)00044-5; Papadopoulou LC, 1999, NAT GENET, V23, P333; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590; Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591; Robinson BH, 2000, PEDIATR RES, V48, P581, DOI 10.1203/00006450-200011000-00004; Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1; Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4; TAANMAN JW, 1994, BIOCHEMISTRY-US, V33, P11833, DOI 10.1021/bi00205a020; Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533; Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Triepels RH, 2001, J BIOL CHEM, V276, P8892, DOI 10.1074/jbc.M009903200; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Valnot I, 2000, AM J HUM GENET, V67, P1104; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; von Kleist-Retzow JC, 1999, BBA-MOL BASIS DIS, V1455, P35, DOI 10.1016/S0925-4439(99)00050-2; WILSON KS, 1990, ARCH BIOCHEM BIOPHYS, V282, P413, DOI 10.1016/0003-9861(90)90137-N; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	46	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16296	16301		10.1074/jbc.M011162200	http://dx.doi.org/10.1074/jbc.M011162200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278850	hybrid			2022-12-27	WOS:000168623100097
J	Witting, PK; Mauk, AG				Witting, PK; Mauk, AG			Reaction of human myoglobin and H2O2 - Electron transfer between tyrosine 103 phenoxyl radical and cysteine 110 yields a protein-thiyl radical	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; SPERM WHALE MYOGLOBIN; HYDROGEN-PEROXIDE; ENZYME CATALYSIS; COMPOUND-I; CROSS-LINKING; CYTOCHROME-C; OXIDATION; METMYOGLOBIN; IDENTIFICATION	The sequence of human myoglobin (Mb) is similar to that of other species except for a unique cysteine at position 110 (Cys(110)). Adding hydrogen peroxide (H2O2) to human Rib affords Trp(14)-peroxyl, Tyr(103)-phenoxyl, and Cys(110)-thiyl radicals and coupling of Cys(110)-thiyl radicals yields a homodimer through intermolecular disulfide bond formation (Witting, P, K,, Douglas, D, J,, and Mauk, A. G, (2000) J, Biol, Chem, 275, 20391-20398); Treating a solution of wild type Mb and H2O2 with 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) at DMPO:protein less than or equal to 10 mol/mol yields DMPO-Cys(110) adducts as determined by EPR, At DMPO:protein ratios (25-50 mol/mol), both DMPO-Tyr(103) and DMPO-Cys(110) adducts were detected, whereas at DMPO:protein greater than or equal to 100 mol/mol only DMPO-Tyr(103) radicals were present. The DMPO-dependent decrease in DMPO-Cys(110) was matched by a near 1:1 stoichiometric increase in DMPO-Tyr(103). In contrast, reaction of the Y103F human Mb with H2O2 gave no DMPO-Cys(110) at DMPO:protein less than or equal to 10 mol/mol, and only trace DMPO-Cys(110) at DMPO:protein greater than or equal to 100 mol/mol (i.e. conditions that consistently gave DMPO-Tyr(103) in the case of wild type Mb), No detectable homodimer was formed by incubation of the Y103F variant with H2O2. However, the homodimer was detected in a mixture of both the Y103F and C110A variants of human Mb upon treatment with H2O2 (C110A:Y103F:H2O2 2:1:5 mol/mol/ mel); the yield of this homodimer increased with increasing ratios of C110A:Y103F, Together, these data suggest that addition of H2O2 to human Mb can produce Cys(110)-thiyl radicals through an intermolecular electron transfer reaction from Cys(110) to a Tyr(103)-phenoxyl radical.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Mauk, AG (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.		Witting, Paul/ABD-2053-2020; Witting, Paul/L-9786-2019	Witting, Paul/0000-0003-2237-7004; 				Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, P40; Barr DP, 1996, CHEM RES TOXICOL, V9, P318, DOI 10.1021/tx9501501; Barr DP, 1996, J BIOL CHEM, V271, P15498, DOI 10.1074/jbc.271.26.15498; BUETTNER GR, 1990, METHOD ENZYMOL, V186, P125; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; DAVIES MJ, 1990, FREE RADICAL RES COM, V10, P361, DOI 10.3109/10715769009149905; DAVIES MJ, 1991, BIOCHIM BIOPHYS ACTA, V1077, P86, DOI 10.1016/0167-4838(91)90529-9; Dean RT, 1997, BIOCHEM J, V324, P1; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; Egawa T, 2000, J BIOL CHEM, V275, P34858, DOI 10.1074/jbc.M004026200; EVANS SV, 1988, J BIOL CHEM, V263, P4263; Fenwick CW, 1996, J AM CHEM SOC, V118, P12236, DOI 10.1021/ja962764d; GEORGE P, 1952, BIOCHEM J, V52, P511, DOI 10.1042/bj0520511; Gunther MR, 1998, BIOCHEM J, V330, P1293; HALLIWELL B, 1992, FREE RADICALS BIOL M; HOGG N, 1994, ARCH BIOCHEM BIOPHYS, V314, P39, DOI 10.1006/abbi.1994.1409; HUBBARD SR, 1990, J MOL BIOL, V213, P215, DOI 10.1016/S0022-2836(05)80181-0; Irwin JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P94, DOI 10.1006/abbi.1998.0987; KELMAN DJ, 1994, J BIOL CHEM, V269, P7458; KOTAKE Y, 1994, FREE RADICAL BIO MED, V17, P215, DOI 10.1016/0891-5849(94)90077-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASSMANN G, 1991, J BIOL CHEM, V266, P20045; LASSMANN G, 1992, J BIOL CHEM, V267, P6449; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; LLOYDRAVEN E, 2000, ADV INORGANIC CHEM H, V51, P1; Mallett TC, 1999, BIOCHEMISTRY-US, V38, P3000, DOI 10.1021/bi9817717; Matsui T, 1999, J AM CHEM SOC, V121, P9952, DOI 10.1021/ja9914846; Matsui T, 1997, J BIOL CHEM, V272, P32735, DOI 10.1074/jbc.272.52.32735; Maurus R, 1997, BBA-PROTEIN STRUCT M, V1341, P1, DOI 10.1016/S0167-4838(97)00064-2; MAYO SL, 1986, SCIENCE, V233, P948, DOI 10.1126/science.3016897; Miller YI, 1997, BIOCHEMISTRY-US, V36, P12189, DOI 10.1021/bi970258a; Miller YI, 1996, ARCH BIOCHEM BIOPHYS, V326, P252, DOI 10.1006/abbi.1996.0073; Moore KP, 1998, J BIOL CHEM, V273, P31731, DOI 10.1074/jbc.273.48.31731; NEUZIL J, 1993, BIOCHEM J, V293, P601; RAGAVAN V, 1985, P NATL ACAD SCI USA, V82, P5681; RAO SI, 1994, J BIOL CHEM, V269, P7210; RAO SI, 1993, J BIOL CHEM, V268, P803; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; STUBBE J, 1988, BIOCHEMISTRY-US, V27, P3893, DOI 10.1021/bi00411a001; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Sturgeon BE, 1998, J BIOL CHEM, V273, P30116, DOI 10.1074/jbc.273.46.30116; TAKANO T, 1977, J MOL BIOL, V110, P537, DOI 10.1016/S0022-2836(77)80111-3; TEW D, 1988, J BIOL CHEM, V263, P17880; TURNER JJO, 1991, BIOCHEM J, V277, P833, DOI 10.1042/bj2770833; VanderZee J, 1996, FREE RADICAL BIO MED, V20, P199, DOI 10.1016/0891-5849(95)02031-4; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; WILKS A, 1992, J BIOL CHEM, V267, P8827; Witting PK, 1999, CHEM RES TOXICOL, V12, P1173, DOI 10.1021/tx9900472; Witting PK, 2000, J BIOL CHEM, V275, P20391, DOI 10.1074/jbc.M000373200; ZOLLER MJ, 1987, METHOD ENZYMOL, V154, P329	50	60	64	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16540	16547		10.1074/jbc.M011707200	http://dx.doi.org/10.1074/jbc.M011707200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278969	hybrid			2022-12-27	WOS:000168623100129
J	Hayashi, M; Taniguchi, S; Ishizuka, Y; Kim, HS; Wataya, Y; Yamamoto, A; Moriyama, Y				Hayashi, M; Taniguchi, S; Ishizuka, Y; Kim, HS; Wataya, Y; Yamamoto, A; Moriyama, Y			A homologue of N-ethylmaleimide-sensitive factor in the malaria parasite Plasmodium falciparum is exported and localized in vesicular structures in the cytoplasm of infected erythrocytes in the brefeldin A-sensitive pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITOPHOROUS VACUOLE MEMBRANE; ADP-RIBOSYLATION FACTOR; HOST-CELL CYTOPLASM; VESICLE FORMATION; SURFACE-MEMBRANE; FUSION PROTEIN; IDENTIFICATION; TRAFFICKING; SPHINGOMYELIN; SECRETION	N-Ethylmaleimide-sensitive factor (NSF) and its homologues play a central role in vesicular trafficking in eukaryotic cells. We have identified a NSF homologue in Plasmodium falciparum (PfNSF), The reported PfNSF gene sequence (GenBank(TM) accession number CAB10575) indicated that PfNSF comprises 783 amino acids with a calculated molecular weight of 89,133, The overall identities of its gene and amino acid sequences with those of rat NSF are 50.9 and 48.8%, respectively. Reverse transcription-polymerase chain reaction analysis and Northern blotting with total P, falciparum RNA indicated expression of the PfNSF gene. Polyclonal. antibodies against a conserved region of NSF specifically recognized an 89-kDa polypeptide in the parasite cells. After homogenization of the parasite cells, similar to 90% of an 89-kDa polypeptide is associated with particulate fraction, suggesting membrane-bound nature of PfNSF. PfNSF was present within both the parasite cells and the vesicular structure outside of the parasite cells, The export of PfNSF outside of the parasite cells appears to occur at the early trophozoite stage and to terminate at the merozoite stage. The export of PfNSF is inhibited by brefeldin A, with 9 muM causing 50% inhibition. Immuno-electromicroscopy indicated that intracellular PfNSF was associated with organelles such as food vacuoles and that extracellular PfNSF was associated with vesicular structures in the erythrocyte cytoplasm, These results indicate that PfNSF expressed in the malaria parasite is exported to the extracellular space and then localized in intraerythrocytic vesicles in a brefeldin A-sensitive manner. It is suggested that a vesicular transport mechanism is involved in protein export targeted to erythrocyte membranes during intraerythrocytic development of the malaria parasite.	Okayama Univ, Fac Pharmaceut Sci, Dept Biochem, Okayama 7008530, Japan; Okayama Univ, Fac Pharmaceut Sci, Dept Med Informat, Okayama 7008530, Japan; Kansai Med Univ, Dept Physiol, Osaka 5708506, Japan	Okayama University; Okayama University; Kansai Medical University	Moriyama, Y (corresponding author), Okayama Univ, Fac Pharmaceut Sci, Dept Biochem, Okayama 7008530, Japan.	moriyama@pheasant.pharm.okayama-u.ac.jp	KIM, HYE-SOOK/B-2044-2011					AIKAWA M, 1986, AM J TROP MED HYG, V35, P30, DOI 10.4269/ajtmh.1986.35.30; Albano FR, 1999, EUR J CELL BIOL, V78, P453, DOI 10.1016/S0171-9335(99)80072-7; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENTING J, 1994, BIOCHEM J, V300, P821, DOI 10.1042/bj3000821; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; BURRY RW, 1992, J HISTOCHEM CYTOCHEM, V40, P1849, DOI 10.1177/40.12.1453003; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Chaturvedi S, 1999, J BIOL CHEM, V274, P2424, DOI 10.1074/jbc.274.4.2424; CRARY JL, 1992, MOL BIOCHEM PARASIT, V53, P185, DOI 10.1016/0166-6851(92)90020-K; DAS A, 1994, BIOCHEM J, V302, P487, DOI 10.1042/bj3020487; deCastro FA, 1996, MOL BIOCHEM PARASIT, V80, P77, DOI 10.1016/0166-6851(96)02670-9; Deitsch KW, 1996, MOL BIOCHEM PARASIT, V76, P1, DOI 10.1016/0166-6851(95)02575-8; ELMENDORF HG, 1994, J CELL BIOL, V124, P449, DOI 10.1083/jcb.124.4.449; ELMENDORF HG, 1992, MOL BIOCHEM PARASIT, V52, P215, DOI 10.1016/0166-6851(92)90054-N; ELMENDORF HG, 1993, EMBO J, V12, P4763, DOI 10.1002/j.1460-2075.1993.tb06165.x; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; GORMLEY JA, 1992, J CELL BIOL, V119, P1481, DOI 10.1083/jcb.119.6.1481; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; HALDAR K, 1994, PARASITOL TODAY, V10, P393, DOI 10.1016/0169-4758(94)90230-5; Haldar K, 1996, TRENDS CELL BIOL, V6, P398, DOI 10.1016/0962-8924(96)10032-5; Hayashi M, 2000, J BIOL CHEM, V275, P34353, DOI 10.1074/jbc.M003323200; HINTERBERG K, 1994, EXP PARASITOL, V79, P279, DOI 10.1006/expr.1994.1091; HONG RM, 1994, FEBS LETT, V350, P253, DOI 10.1016/0014-5793(94)00778-0; HUGUENEY P, 1995, P NATL ACAD SCI USA, V92, P5630, DOI 10.1073/pnas.92.12.5630; Jambou R, 1996, BIOL CELL, V88, P113, DOI 10.1016/S0248-4900(97)83526-5; JENSEN JB, 1979, EXP PARASITOL, V48, P36, DOI 10.1016/0014-4894(79)90052-3; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KARA UAK, 1988, EUR J CELL BIOL, V46, P9; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; Lauer SA, 1997, SCIENCE, V276, P1122, DOI 10.1126/science.276.5315.1122; Lee FJS, 1997, MOL BIOCHEM PARASIT, V87, P217, DOI 10.1016/S0166-6851(97)00061-3; Lingelbach K, 1998, J CELL SCI, V111, P1467; Luo SH, 1999, FEBS LETT, V460, P217, DOI 10.1016/S0014-5793(99)01353-8; MORIYAMA Y, 1987, J BIOL CHEM, V262, P9175; MORIYAMA Y, 1995, NEUROREPORT, V6, P1757, DOI 10.1097/00001756-199509000-00012; Ngo HM, 2000, TRENDS CELL BIOL, V10, P67, DOI 10.1016/S0962-8924(99)01698-0; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stafford WHL, 1996, EUR J BIOCHEM, V242, P104, DOI 10.1111/j.1432-1033.1996.0104r.x; STENZEL DJ, 1989, EUR J CELL BIOL, V49, P311; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trelka DP, 2000, MOL BIOCHEM PARASIT, V106, P131, DOI 10.1016/S0166-6851(99)00207-8; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Ward GE, 1997, PARASITOL TODAY, V13, P57, DOI 10.1016/S0169-4758(96)10080-6; Wiser MF, 1997, P NATL ACAD SCI USA, V94, P9108, DOI 10.1073/pnas.94.17.9108	46	64	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15249	15255		10.1074/jbc.M011709200	http://dx.doi.org/10.1074/jbc.M011709200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278971	hybrid			2022-12-27	WOS:000168528800096
J	Kimura, Y; Schmitt, A; Fukushima, N; Ishii, I; Kimura, H; Nebreda, AR; Chun, J				Kimura, Y; Schmitt, A; Fukushima, N; Ishii, I; Kimura, H; Nebreda, AR; Chun, J			Two novel Xenopus homologs of mammalian LPA1/EDG-2 function as lysophosphatidic acid receptors in Xenopus oocytes and mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; MOLECULAR-CLONING; BIOACTIVE LYSOPHOSPHOLIPIDS; EXPRESSION; GENE; BETA; CURRENTS; PATHWAY; FAMILY; SYSTEM	Lysophosphatidic acid (LPA) induces diverse biological responses in many types of cells and tissues by activating its specific G protein-coupled receptors (GPCRs). Previously, three cognate LPA GPCRs (LPA1/NZG-1/ EDG-2, LPA2/EDG-4, and LPA3/EDG-7) were identified in mammals. By contrast, an unrelated GPCR, PSP24, was reported to be a high affinity LPA receptor in Xenopus laevis oocytes, raising the possibility that Xenopus uses a very different form of LPA signaling. Toward addressing this issue, we report two novel Xenopus genes, xlp(A1)-1 and xlp(A1)-2, encoding LPA1 homologs (similar to 90% amino acid sequence identity with mammalian LPA1). Both xlp(A1)-1 and xlp(A1)-2 are expressed in oocytes and the nervous system. Overexpression of either gene in oocytes potentiated LPA-induced oscillatory chloride ion currents through a pertussis toxin-insensitive pathway. Injection of antisense oligonucleotides designed to inhibit xlp(A1)-1 and xlp(A1)-2 expression in oocytes eliminated their endogenous response to LPA. Furthermore, retrovirus-mediated heterologous expression of xlp(A1)-1 or xlp(A1)-2 in B103 rat neuroblastoma cells that are unresponsive to LPA conferred LPA-induced cell rounding and adenylyl cyclase inhibition. These results indicate that XLPA1-1 and XLPA1-2 are functional Xenopus LPA receptors and demonstrate the evolutionary conservation of LPA signaling over a range of vertebrate phylogeny.	Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Program Biomed Sci, La Jolla, CA 92093 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Natl Inst Neurosci, Div Mol Genet, Tokyo 1878502, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; European Molecular Biology Laboratory (EMBL); National Center for Neurology & Psychiatry - Japan	Chun, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Nebreda, Angel Rodriguez/R-9594-2019; Chun, Jerold/Y-4670-2019; Kimura, Hideo/AGK-0606-2022; Kimura, Hideo/J-6811-2016	Kimura, Hideo/0000-0002-6069-0475; Ishii, Isao/0000-0002-5367-205X; Kimura, Yuka/0000-0001-9072-9329				An SZ, 1998, MOL PHARMACOL, V54, P881, DOI 10.1124/mol.54.5.881; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chun J, 1999, CRIT REV NEUROBIOL, V13, P151, DOI 10.1615/CritRevNeurobiol.v13.i2.20; Chun Jerold, 1999, Cell Biochemistry and Biophysics, V30, P213, DOI 10.1007/BF02738068; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; DAGLE JM, 1990, NUCLEIC ACIDS RES, V18, P4751, DOI 10.1093/nar/18.16.4751; Dardalhon V, 1999, HUM GENE THER, V10, P5, DOI 10.1089/10430349950019147; DURIEUX ME, 1992, AM J PHYSIOL, V263, P896; Erickson JP, 1998, J BIOL CHEM, V273, P1506, DOI 10.1074/jbc.273.3.1506; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; FERNHOUT BJH, 1992, EUR J PHARMACOL, V213, P313, DOI 10.1016/0014-2999(92)90698-4; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Guo Z, 1996, P NATL ACAD SCI USA, V93, P14367, DOI 10.1073/pnas.93.25.14367; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; HOSBACH HA, 1983, CELL, V32, P45, DOI 10.1016/0092-8674(83)90495-6; Im DS, 2000, MOL PHARMACOL, V57, P753, DOI 10.1124/mol.57.4.753; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; Kakizawa K, 1998, MOL BRAIN RES, V61, P232, DOI 10.1016/S0169-328X(98)00229-0; Kawasawa Y, 2000, BIOCHEM BIOPH RES CO, V276, P957, DOI 10.1006/bbrc.2000.3570; Kawasawa Y, 2000, BIOCHEM BIOPH RES CO, V276, P952, DOI 10.1006/bbrc.2000.3569; KIMURA H, 1993, P NATL ACAD SCI USA, V90, P7508, DOI 10.1073/pnas.90.16.7508; Liliom K, 1996, MOL PHARMACOL, V50, P616; Liliom K, 1996, AM J PHYSIOL-CELL PH, V270, pC772, DOI 10.1152/ajpcell.1996.270.3.C772; Marchese A, 1999, GENOMICS, V56, P12, DOI 10.1006/geno.1998.5655; MAY FEB, 1983, J MOL BIOL, V168, P229, DOI 10.1016/S0022-2836(83)80016-3; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1; Noh SJ, 1998, J CELL PHYSIOL, V176, P412, DOI 10.1002/(SICI)1097-4652(199808)176:2<412::AID-JCP20>3.0.CO;2-3; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; STEELE RE, 1989, J BIOL CHEM, V264, P10649; TIGYI G, 1992, J BIOL CHEM, V267, P21360; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WAHLI W, 1982, P NATL ACAD SCI-BIOL, V79, P6832, DOI 10.1073/pnas.79.22.6832; Weiner JA, 1999, P NATL ACAD SCI USA, V96, P5233, DOI 10.1073/pnas.96.9.5233	38	35	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15208	15215		10.1074/jbc.M011588200	http://dx.doi.org/10.1074/jbc.M011588200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278944	hybrid			2022-12-27	WOS:000168528800091
J	DiBella, LM; Benashski, SE; Tedford, HW; Karrison, A; Patel-King, RS; King, SM				DiBella, LM; Benashski, SE; Tedford, HW; Karrison, A; Patel-King, RS; King, SM			The Tctex1/Tctex2 class of dynein light chains - Dimerization, differential expression, and interaction with the LC8 protein family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER ARM DYNEIN; CYTOPLASMIC DYNEIN; INTERMEDIATE CHAIN; CHLAMYDOMONAS HOMOLOG; TCTEX-1; BINDING; IDENTIFICATION; GENE; PHOSPHORYLATION; STERILITY	The Tctex1/Tctex2 family of dynein light chains associates with the intermediate chains at the base of the soluble dynein particle. These components are essential for dynein assembly and participate in specific motor-cargo interactions. To further address the role of these light chains in dynein activity, the structural and biochemical properties of several members of this polypeptide class mere examined. Gel filtration chromatography and native gel electrophoresis indicate that recombinant Chlamydomonas flagellar Tctex1 exists as a dimer in solution. Furthermore, yeast two-hybrid analysis suggests that this association also occurs in vivo. In contrast, both murine and Chlamydomonas Tctex2 are monomeric. To investigate protein-protein interactions involving these light chains, outer arm dynein from Chlamydomonas flagella was cross-linked using dimethylpimelimidate. Immunoblot analysis of the resulting products revealed the interaction of LC2 (Tctex2) with LC6, which is closely related to the highly conserved LC8 protein found in many enzyme systems, including dynein, Northern dot blot analysis demonstrated that Tctex1/Tctex2 family light chains are differentially expressed both in a tissue-specific and developmentally regulated manner in humans. These data provide further support for the existence of functionally distinct populations of cytoplasmic dynein with differing light chain content.	Univ Connecticut, Ctr Hlth, Dept Biochem, Farmington, CT 06030 USA	University of Connecticut	King, SM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Biochem, 263 Farmington Ave, Farmington, CT 06030 USA.	steve@king2.uchc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051293] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM51293] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Benashski SE, 2000, METHODS, V22, P365, DOI 10.1006/meth.2000.1088; Bowman AB, 1999, J CELL BIOL, V146, P165; CHEN YH, 1971, BIOCHEM BIOPH RES CO, V44, P1285, DOI 10.1016/S0006-291X(71)80225-5; Dick T, 1996, MOL CELL BIOL, V16, P1966; DILLMAN JF, 1994, J CELL BIOL, V127, P1671, DOI 10.1083/jcb.127.6.1671; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Fossella J, 2000, MAMM GENOME, V11, P8, DOI 10.1007/s003350010003; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Harrison A, 1998, J CELL BIOL, V140, P1137, DOI 10.1083/jcb.140.5.1137; HEDRICK JL, 1968, ARCH BIOCHEM BIOPHYS, V126, P155, DOI 10.1016/0003-9861(68)90569-9; Herrmann BG, 1999, NATURE, V402, P141, DOI 10.1038/45970; HUW LY, 1995, DEV BIOL, V170, P183, DOI 10.1006/dbio.1995.1206; Inaba K, 1999, BIOCHEM BIOPH RES CO, V256, P177, DOI 10.1006/bbrc.1999.0309; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Kai N, 1997, J NEUROSCI RES, V48, P407, DOI 10.1002/(SICI)1097-4547(19970601)48:5<407::AID-JNR3>3.3.CO;2-F; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; KING SM, 1986, METHOD ENZYMOL, V134, P291; KING SM, 1990, J BIOL CHEM, V265, P19807; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; King SM, 1996, J BIOL CHEM, V271, P32281, DOI 10.1074/jbc.271.50.32281; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; KING SM, 1991, J BIOL CHEM, V266, P8401; King SM, 2000, J CELL SCI, V113, P2521; Koonce MP, 1997, J BIOL CHEM, V272, P19714, DOI 10.1074/jbc.272.32.19714; LADER E, 1989, CELL, V58, P969, DOI 10.1016/0092-8674(89)90948-3; Liang J, 1999, NAT STRUCT BIOL, V6, P735; MITCHELL DR, 1993, J CELL SCI, V105, P1069; Mou T, 1998, FEBS LETT, V435, P275, DOI 10.1016/S0014-5793(98)01069-2; Nagano F, 1998, J BIOL CHEM, V273, P30065, DOI 10.1074/jbc.273.46.30065; Niclas J, 1996, J CELL BIOL, V133, P585, DOI 10.1083/jcb.133.3.585; Olds-Clarke P, 1997, Rev Reprod, V2, P157, DOI 10.1530/ror.0.0020157; OLMSTED JB, 1986, METHOD ENZYMOL, V134, P467; PASCHAL BM, 1992, J CELL BIOL, V118, P1133, DOI 10.1083/jcb.118.5.1133; PatelKing RS, 1997, J CELL BIOL, V137, P1081, DOI 10.1083/jcb.137.5.1081; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pazour GJ, 1999, MOL BIOL CELL, V10, P3507, DOI 10.1091/mbc.10.10.3507; PFISTER KK, 1982, CELL MOTIL CYTOSKEL, V2, P525, DOI 10.1002/cm.970020604; Pfister KK, 1996, J BIOL CHEM, V271, P1687, DOI 10.1074/jbc.271.3.1687; Planchart A, 2000, GENETICS, V155, P803; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; ROUX AF, 1994, HUM MOL GENET, V3, P257, DOI 10.1093/hmg/3.2.257; SAKAKIBARA H, 1993, J CELL BIOL, V122, P653, DOI 10.1083/jcb.122.3.653; SALE WS, 1985, J CELL BIOL, V101, P1400, DOI 10.1083/jcb.101.4.1400; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; TAKADA S, 1994, J CELL BIOL, V126, P737, DOI 10.1083/jcb.126.3.737; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Watanabe TK, 1996, CYTOGENET CELL GENET, V73, P153, DOI 10.1159/000134329; WILKERSON CG, 1995, J CELL BIOL, V129, P169, DOI 10.1083/jcb.129.1.169; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; WITMAN GB, 1991, SERONO SYM, V75, P439; Yang W, 1999, BBA-PROTEIN STRUCT M, V1432, P13, DOI 10.1016/S0167-4838(99)00089-8; Ye FC, 2000, J BIOL CHEM, V275, P27172	57	56	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14366	14373		10.1074/jbc.M011456200	http://dx.doi.org/10.1074/jbc.M011456200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278908	hybrid			2022-12-27	WOS:000168356600113
J	Keller, JE; Neale, EA				Keller, JE; Neale, EA			The role of the synaptic protein SNAP-25 in the potency of botulinum neurotoxin type A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT NEUROMUSCULAR-JUNCTION; BOVINE CHROMAFFIN CELLS; MEMBRANE-FUSION COMPLEX; SPINAL-CORD CELLS; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; TETANUS TOXIN; CLOSTRIDIAL NEUROTOXINS; VESICLE DOCKING; SEROTYPE-A	Botulinum neurotoxin serotype A (BoNT/A) is distinguished from BoNT/E by longer duration of paralysis and greater potency. The proteolytic activity of BoNT/A in cultures of dissociated spinal cord neurons persists beyond 80 days, whereas BoNT/E activity persists for less than 1 day (Keller, J, E,, Neale, E, A Oyler, G., and Adler, M, (1999) FEES Lett. 456, 137-142), This single quality of toxin activity can account for the differences observed in the duration of muscle block. In the present work we sought to understand the basis for the apparent greater potency of BoNT/A BoNT/E cleaves a 26-amino acid fragment from the C terminus of the synaptic protein SNAP-25 whereas BoNT/A removes only nine residues creating a 197-amino acid fragment (P197) that is 95% the length of SNAP-25, We show that inhibition of neurotransmitter release by BoNT/E is equivalent to the damage caused to SNAP-25, However, synaptic blockade by BoNT/A is greater than the extent of SNAP-25 proteolysis. These findings can be explained if P197 produces an inhibitory effect on neurotransmitter release. A mathematical model of the experimentally determined relationship between SNAP-25 damage and blockade of neurotransmission supports this interpretation. Furthermore, neurotransmitter release following complete cleavage of SNAP-25 can be achieved by P197, but with about 5-fold less sensitivity to external Ca2+. In this case, vesicular release is restored by increasing intracellular Ca2+. These data demonstrate that P197 competes with intact SNAP-25, but is unable to initiate normal synaptic vesicle fusion in physiological concentrations of Ca2+.	NICHD, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Keller, JE (corresponding author), NICHD, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000704] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adler M, 2000, TOXICON, V38, P1381, DOI 10.1016/S0041-0101(99)00231-7; Adler M, 1996, TOXICON, V34, P237, DOI 10.1016/0041-0101(95)00127-1; Adler M, 2001, TOXICON, V39, P233, DOI 10.1016/S0041-0101(00)00120-3; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; BANDYOPADHYAY S, 1987, J BIOL CHEM, V262, P2660; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; BARTELS F, 1994, J BIOL CHEM, V269, P8122; BINZ T, 1994, J BIOL CHEM, V269, P1617; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BRAYDEN DJ, 1989, BRIT J PHARMACOL, V98, P809, DOI 10.1111/j.1476-5381.1989.tb14609.x; BROOKS VB, 1956, J PHYSIOL-LONDON, V134, P264, DOI 10.1113/jphysiol.1956.sp005642; BROOKS VB, 1954, J PHYSIOL-LONDON, V123, P501, DOI 10.1113/jphysiol.1954.sp005067; BURGEN ASV, 1949, J PHYSIOL-LONDON, V109, P10, DOI 10.1113/jphysiol.1949.sp004364; Capogna M, 1996, J NEUROPHYSIOL, V75, P2017, DOI 10.1152/jn.1996.75.5.2017; Capogna M, 1997, J NEUROSCI, V17, P7190; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; CULLCANDY SG, 1976, J PHYSIOL-LONDON, V260, P177, DOI 10.1113/jphysiol.1976.sp011510; de Paiva A, 1999, P NATL ACAD SCI USA, V96, P3200, DOI 10.1073/pnas.96.6.3200; DREYER F, 1983, PFLUG ARCH EUR J PHY, V399, P228, DOI 10.1007/BF00656720; Eleopra R, 1998, NEUROSCI LETT, V256, P135, DOI 10.1016/S0304-3940(98)00775-7; ERDAL E, 1995, N-S ARCH PHARMACOL, V351, P67; Fassio A, 1999, NEUROSCIENCE, V90, P893, DOI 10.1016/S0306-4522(98)00475-8; Ferrer-Montiel AV, 1998, FEBS LETT, V435, P84, DOI 10.1016/S0014-5793(98)01012-6; FITZGERALD SC, 1989, DISSECTION TISSUE CU, P219; FUJII N, 1992, TOXICON, V30, P1486, DOI 10.1016/0041-0101(92)90525-A; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Gil A, 1998, EUR J NEUROSCI, V10, P3369, DOI 10.1046/j.1460-9568.1998.00341.x; Gutierrez LM, 1997, J BIOL CHEM, V272, P2634, DOI 10.1074/jbc.272.5.2634; GUTIERREZ LM, 1995, FEBS LETT, V372, P39, DOI 10.1016/0014-5793(95)00944-5; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Huang XH, 1998, MOL ENDOCRINOL, V12, P1060, DOI 10.1210/me.12.7.1060; KAO I, 1976, SCIENCE, V193, P1256, DOI 10.1126/science.785600; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence GW, 1997, BIOCHEMISTRY-US, V36, P3061, DOI 10.1021/bi9622478; Lonart G, 2000, J BIOL CHEM, V275, P27703; LUNDH H, 1976, BRAIN RES, V110, P194, DOI 10.1016/0006-8993(76)90222-5; MOLGO J, 1989, J PHYSIOL-LONDON, V411, P195, DOI 10.1113/jphysiol.1989.sp017568; MOLGO J, 1984, BRAIN RES, V297, P309, DOI 10.1016/0006-8993(84)90572-9; MOLGO J, 1980, EUR J PHARMACOL, V61, P25, DOI 10.1016/0014-2999(80)90378-7; MOLGO J, 1989, ACTA PHYSIOL SCAND, V137, P497, DOI 10.1111/j.1748-1716.1989.tb08786.x; Moser T, 1997, J NEUROSCI, V17, P2314; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Olafsson P, 1997, MOL BRAIN RES, V44, P73, DOI 10.1016/S0169-328X(96)00188-X; OTTO H, 1995, BIOCHEM BIOPH RES CO, V212, P945, DOI 10.1006/bbrc.1995.2061; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; Raciborska DA, 1998, EUR J NEUROSCI, V10, P2617, DOI 10.1046/j.1460-9568.1998.00270.x; Raciborska DA, 1999, CAN J PHYSIOL PHARM, V77, P679, DOI 10.1139/cjpp-77-9-679; RANSOM BR, 1977, J NEUROPHYSIOL, V40, P1132, DOI 10.1152/jn.1977.40.5.1132; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; SELLIN LC, 1983, ACTA PHYSIOL SCAND, V119, P127, DOI 10.1111/j.1748-1716.1983.tb07317.x; SELLIN LC, 1983, MED BIOL, V61, P120; SIMPSON LL, 1978, J PHARMACOL EXP THER, V206, P661; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; Trudeau LE, 1998, P NATL ACAD SCI USA, V95, P7163, DOI 10.1073/pnas.95.12.7163; VANRUDEN L, 1993, SCIENCE, V262, P1061; Wei SH, 2000, EMBO J, V19, P1279, DOI 10.1093/emboj/19.6.1279; Williams N, 1996, SCIENCE, V271, P694; WILLIAMSON LC, 1992, J NEUROCHEM, V59, P2148; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764	72	81	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13476	13482		10.1074/jbc.M010992200	http://dx.doi.org/10.1074/jbc.M010992200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278807	hybrid			2022-12-27	WOS:000168198600137
J	Sjogren, T; Hajdu, J				Sjogren, T; Hajdu, J			Structure of the bound dioxygen species in the cytochrome oxidase reaction of cytochrome cd(1) nitrite reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGATION; BINDING; ENZYME	Reduction of dioxygen to water is a key process in aerobic life, but atomic details of this reaction have been elusive because of difficulties in observing active oxygen intermediates by crystallography, Cytochrome cd(1) is a bifunctional enzyme, capable of catalyzing the one-electron reduction of nitrite to nitric oxide, and the four-electron reduction of dioxygen to water. The latter is a cytochrome oxidase reaction, Here we describe the structure of an active dioxygen species in the enzyme captured by cryo-trapping, The productive binding mode of dioxygen in the active site is very similar to that of nitrite and suggests that the catalytic mechanisms of oxygen reduction and nitrite reduction are closely related. This finding has implications to the understanding of the evolution of oxygen-reducing enzymes, Comparison of the dioxygen complex to complexes of cytochrome cd(1) with stable diatomic ligands shows that nitric oxide and cyanide bind in a similar bent conformation to the iron as dioxygen whereas carbon monoxide forms a linear complex. The significance of these differences is discussed.	Uppsala Univ, Ctr Biomed, Dept Biochem, S-75123 Uppsala, Sweden	Uppsala University	Hajdu, J (corresponding author), Uppsala Univ, Ctr Biomed, Dept Biochem, Box 576, S-75123 Uppsala, Sweden.	janos@xray.bmc.uu.se						Allen JWA, 2000, NAT STRUCT BIOL, V7, P885; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker SC, 1997, J MOL BIOL, V269, P440, DOI 10.1006/jmbi.1997.1070; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARLSSON G, UNPUB; CASTRESANA J, 1994, EMBO J, V13, P2516, DOI 10.1002/j.1460-2075.1994.tb06541.x; Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623; FULOP V, 1993, J MOL BIOL, V232, P1211, DOI 10.1006/jmbi.1993.1473; FULOP V, 1995, CELL, V81, P369, DOI 10.1016/0092-8674(95)90390-9; HADFIELD A, 1993, J APPL CRYSTALLOGR, V26, P839, DOI 10.1107/S0021889893005552; Hajdu J, 2000, CURR OPIN STRUC BIOL, V10, P569, DOI 10.1016/S0959-440X(00)00133-0; Jafferji A, 2000, J BIOL CHEM, V275, P25089, DOI 10.1074/jbc.M001377200; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Koppenhofer A, 2000, BIOCHEMISTRY-US, V39, P4028, DOI 10.1021/bi991912k; LAM Y, 1969, BIOCHIM BIOPHYS ACTA, V180, P459, DOI 10.1016/0005-2728(69)90025-5; MOIR JWB, 1993, EUR J BIOCHEM, V212, P377, DOI 10.1111/j.1432-1033.1993.tb17672.x; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ranghino G, 2000, BIOCHEMISTRY-US, V39, P10958, DOI 10.1021/bi000178y; SARASTE M, 1994, FEBS LETT, V341, P1, DOI 10.1016/0014-5793(94)80228-9; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sjogren T, 2000, BIOCHEMISTRY-US, V39, P10967, DOI 10.1021/bi000179q; Steensma E, 2001, J BIOL CHEM, V276, P5846, DOI 10.1074/jbc.M007345200; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; YAMANAKA T, 1963, BIOCHIM BIOPHYS ACTA, V67, P379	27	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13072	13076		10.1074/jbc.M011312200	http://dx.doi.org/10.1074/jbc.M011312200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278884	hybrid			2022-12-27	WOS:000168198600086
J	Takata, Y; Kitami, Y; Okura, T; Hiwada, K				Takata, Y; Kitami, Y; Okura, T; Hiwada, K			Peroxisome proliferator-activated receptor-gamma activation inhibits interleukin-1 beta-mediated platelet-derived growth factor-alpha receptor gene expression via CCAAT/enhancer-binding protein-delta in vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; MOLECULAR-STRUCTURE; MITOGENIC ACTIVITY; HYPERTENSIVE RATS; INTERLEUKIN-1; PDGF; ATHEROSCLEROSIS; FIBROBLASTS; MIGRATION; NUMBER	CCAAT/enhancer-binding protein (C/EBP)-binding motifs have been identified in the promoter regions of interleukin (IL)-6, tumor necrosis factor-alpha, and platelet-derived growth factor-alpha receptor (PDGF alphaR), Recently, peroxisome proliferator-activated receptors (PPARs) have been suggested to be important immunomodulatory mediators. Although many studies have demonstrated that the interaction between C/EBPs and PPARs plays a central role in lipid metabolism, expression and function of these factors are unknown in vascular smooth muscle cells (VSMCs), In the present study, we clarified a functional relationship between C/EBPs and PPAR gamma in the regulation of IL-1 beta -induced PDGF alphaR expression in VSMCs, PPAR gamma activators, troglitazone and 15-deoxy-Delta (12,14)-prostaglandin J(2), inhibited IL-1 beta -induced PDGF alphaR expression and suppressed PDGF-induced proliferation activity of VSMCs, Electromobility shift and supershift assays for a C/EBP motif in the PDGF alphaR promoter region revealed that PPAR gamma activators suppressed IL-1 beta -induced DNA binding activity of C/EBP delta and beta. PPAR gamma activators also suppressed IL-1 beta -induced C/EBP delta expression. In contrast, overexpression of C/EBP delta reversed the suppressive effect of PPAR gamma activators on PDGF alphaR expression almost completely. From these results, we conclude that the inhibitory effect of PPAR gamma activators on PDGF alphaR expression is mainly mediated by C/EBP delta suppression. Regulation of C/EBP delta by PPAR gamma activators probably plays critical roles in modulating inflammatory responses in the arterial wall.	Ehime Univ, Sch Med, Dept Internal Med 2, Shigenobu, Ehime 7910295, Japan	Ehime University	Kitami, Y (corresponding author), Ehime Univ, Sch Med, Dept Internal Med 2, Shigenobu, Ehime 7910295, Japan.							BITTERMAN PB, 1986, J CLIN INVEST, V77, P700, DOI 10.1172/JCI112364; BONIN PD, 1989, EXP CELL RES, V181, P475, DOI 10.1016/0014-4827(89)90104-3; Bonner JC, 1998, AM J PHYSIOL-LUNG C, V274, pL72, DOI 10.1152/ajplung.1998.274.1.L72; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fukuoka T, 1997, BIOCHEM BIOPH RES CO, V231, P30, DOI 10.1006/bbrc.1996.6031; Fukuoka T, 1999, J BIOL CHEM, V274, P25576, DOI 10.1074/jbc.274.36.25576; Goetze S, 1999, J CARDIOVASC PHARM, V33, P798, DOI 10.1097/00005344-199905000-00018; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; IKEDA U, 1990, ATHEROSCLEROSIS, V84, P183, DOI 10.1016/0021-9150(90)90089-2; INUI H, 1993, J BIOL CHEM, V268, P17045; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; JORIS I, 1983, AM J PATHOL, V113, P341; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; Kitami Y, 1999, CIRC RES, V84, P64; KITAMI Y, 1995, J CLIN INVEST, V96, P558, DOI 10.1172/JCI118068; Kolyada AY, 1995, AM J PHYSIOL-CELL PH, V269, pC1408, DOI 10.1152/ajpcell.1995.269.6.C1408; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Law RE, 1996, J CLIN INVEST, V98, P1897, DOI 10.1172/JCI118991; LIBBY P, 1988, J CLIN INVEST, V81, P487, DOI 10.1172/JCI113346; LIBBY P, 1985, ARTERIOSCLEROSIS, V5, P186, DOI 10.1161/01.ATV.5.2.186; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; MULVANY MJ, 1978, CIRC RES, V43, P854, DOI 10.1161/01.RES.43.6.854; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Okura T, 1998, BBA-MOL CELL RES, V1403, P245, DOI 10.1016/S0167-4889(98)00065-2; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; SPAET TH, 1975, CIRC RES, V36, P58, DOI 10.1161/01.RES.36.1.58; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701	32	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12893	12897		10.1074/jbc.M011655200	http://dx.doi.org/10.1074/jbc.M011655200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278956	hybrid			2022-12-27	WOS:000168198600061
J	Yokomizo, T; Kato, K; Hagiya, H; Izumi, T; Shimizu, T				Yokomizo, T; Kato, K; Hagiya, H; Izumi, T; Shimizu, T			Hydroxyeicosanoids bind to and activate the low affinity leukotriene B-4 receptor, BLT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							12(S)-HYDROXYEICOSATETRAENOIC ACID; PHARMACOLOGICAL PROFILE; ARACHIDONIC-ACID; IN-VITRO; CLONING; POTENT; CELLS; EOSINOPHILS; SITES; ALPHA	Leukotriene B-4, an arachidonate metabolite, is a potent chemoattractant of leukocytes involved in various inflammatory diseases. Two G-protein-coupled receptors for leukotriene B-4 have been cloned and characterized. BLT1 (Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., and Shimizu, T. (1997) Nature 387, 620-624) is a high affinity receptor exclusively expressed in leukocytes, and BLT2 (Yokomizo, T., Rate, K., Terawaki, K., Izumi, T., and Shimizu, T. (2000) J. Exp. Med. 192, 421-432) is a low affinity receptor expressed more ubiquitously. Here we report the binding profiles of various BLT antagonists and eicosanoids to either BLT1 or BLT2 using the membrane fractions of Chinese hamster ovary cells stably expressing the receptor. BLT antagonists are grouped into three classes: BLT1-specific U-75302, BLT2-specific LY255283, and BLT1/BLT2 dual-specific ZK 158252 and CP 195543. We also show that 12(S)-hydroxyeicosatetraenoic acid, 12(S)-hydroperxyeicosatetraenoic acid, and 15(S)-hydroxyeicosatetraenoic acid competed with [H-3]LTB4 binding to BLT2, but not BLT1, dose dependently. These eicosanoids also cause calcium mobilization and chemotaxis through BLT2, again in contrast to BLT1. These findings suggest that BLT2 functions as a low affinity receptor, with broader ligand specificity for various eicosanoids, and mediates distinct biological and pathophysiological roles from BLT1.	Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Corp, CREST, Tokyo 1130033, Japan; Meiji Seika Kaisha Ltd, Pharmaceut Res Ctr, Yokohama, Kanagawa 2228567, Japan; Gunma Univ, Fac Med, Dept Biochem, Maebashi, Gumma 3718511, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Meiji Holdings Co., Ltd.; Gunma University	Yokomizo, T (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Yokomizo, Takehiko/P-5673-2016	Yokomizo, Takehiko/0000-0002-5219-1553				ARENBERGER P, 1991, SKIN PHARMACOL, V4, P272; ARENBERGER P, 1992, EUR J IMMUNOL, V22, P2469, DOI 10.1002/eji.1830220944; ARENBERGER P, 1993, EPITHELIAL CELL BIOL, V2, P1; Boie Y, 1999, EUR J PHARMACOL, V380, P203, DOI 10.1016/S0014-2999(99)00514-2; Cole AT, 1996, GUT, V39, P248, DOI 10.1136/gut.39.2.248; FALCONE RC, 1991, EUR J PHARM-MOLEC PH, V206, P333, DOI 10.1016/0922-4106(91)90118-2; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; Iversen L, 1997, SKIN PHARMACOL, V10, P169, DOI 10.1159/000211501; Kamohara M, 2000, J BIOL CHEM, V275, P27000; Kato K, 2000, J EXP MED, V192, P413, DOI 10.1084/jem.192.3.413; Kurahashi Y, 2000, P NATL ACAD SCI USA, V97, P5779, DOI 10.1073/pnas.97.11.5779; LIU B, 1995, P NATL ACAD SCI USA, V92, P9323, DOI 10.1073/pnas.92.20.9323; Martin V, 1999, J BIOL CHEM, V274, P8597, DOI 10.1074/jbc.274.13.8597; Masuda K, 1999, BIOCHEM J, V342, P79, DOI 10.1042/0264-6021:3420079; Nilsson NE, 2000, BIOCHEM BIOPH RES CO, V274, P383, DOI 10.1006/bbrc.2000.3153; Noiri E, 2000, P NATL ACAD SCI USA, V97, P823, DOI 10.1073/pnas.97.2.823; Owman C, 1997, BIOCHEM BIOPH RES CO, V240, P162, DOI 10.1006/bbrc.1997.7628; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SEHMI R, 1992, IMMUNOLOGY, V77, P129; Serhan CN, 1996, FASEB J, V10, P1147, DOI 10.1096/fasebj.10.10.8751717; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; Showell HJ, 1996, BRIT J PHARMACOL, V117, P1127, DOI 10.1111/j.1476-5381.1996.tb16706.x; Showell HJ, 1998, J PHARMACOL EXP THER, V285, P946; Surette ME, 1999, MOL PHARMACOL, V56, P1055, DOI 10.1124/mol.56.5.1055; Toda A, 1999, BIOCHEM BIOPH RES CO, V262, P806, DOI 10.1006/bbrc.1999.1284; Tryselius Y, 2000, BIOCHEM BIOPH RES CO, V274, P377, DOI 10.1006/bbrc.2000.3152; Turner CR, 1996, J CLIN INVEST, V97, P381, DOI 10.1172/JCI118426; WANG S, 2000, J BIOL CHEM; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	33	159	173	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12454	12459		10.1074/jbc.M011361200	http://dx.doi.org/10.1074/jbc.M011361200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278893	hybrid			2022-12-27	WOS:000168081800135
J	Zapata, JM; Pawlowski, K; Haas, E; Ware, CF; Godzik, A; Reed, JC				Zapata, JM; Pawlowski, K; Haas, E; Ware, CF; Godzik, A; Reed, JC			A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; UBIQUITIN-SPECIFIC PROTEASE; POLYCYSTIC KIDNEY-DISEASE; RING FINGER PROTEIN; FACTORS TRAFS; JNK/SAPK ACTIVATION; CYTOPLASMIC DOMAIN; STRUCTURAL BASIS; BINDING-PROTEIN; POZ DOMAIN	We have identified three new tumor necrosis factor-receptor associated factor (TRAF) domain-containing proteins in humans using bioinformatics approaches, including: MUL, the product of the causative gene in Mulibrey Nanism syndrome; USP7 (HAUSP), an ubiquitin protease; and SPOP, a POZ domain-containing protein. Unlike classical TRAF family proteins involved in TNF family receptor (TNFR) signaling, the TRAF domains (TDs) of MUL, USP7, and SPOP are located near the NR, termini or central region of these proteins, rather than carboxyl end. MUL and USP7 are capable of binding in vitro via their TDs to all of the previously identified TRAF family proteins (TRAF1, TRAF2, TRAF3, TRAF4, TRAF5, and TRAF6), whereas the TD of SPOP interacts weakly with TRAF1 and TRAF6 only. The TD of MUL also interacted with itself, whereas the TDs of USP7: and SPOP did not self-associate, Analysis of various MUL and USP7 mutants by transient transfection assays indicated that the TDs of these proteins are necessary and sufficient for suppressing NF-kappaB induction by TRAF2 and TRAF6 as well as certain TRAF-binding TNF family receptors. In contrast, the TIP of SPOP did not inhibit NF-kappaB induction. Immunofluorescence confocal microscopy indicated that MUL localizes to cytosolic bodies, with targeting to these structures mediated by a RBCC tripartite domain within the MUL protein. USP7 localized predominantly to the nucleus, in a TD-dependent manner. Data base searches revealed multiple proteins containing TDs homologous to those found in MUL, USP7, and SPOP throughout eukaryotes, including yeast, protists, plants, invertebrates, and mammals, suggesting that this branch of the TD family arose from an ancient gene. We propose the moniker TEFs (TD-encompassing factors) for this large family of proteins.	Burnham Inst, La Jolla, CA 92037 USA; La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA	Sanford Burnham Prebys Medical Discovery Institute; La Jolla Institute for Immunology	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jreed@burnham-inst.org	Pawlowski, Krzysztof/E-3262-2012; Pawłowski, Krzysztof/C-2949-2013; Godzik, Adam/A-7279-2009; Zapata, Juan M/J-6304-2014; Godzik, Adam/AAW-1467-2020	Pawłowski, Krzysztof/0000-0002-5367-0935; Godzik, Adam/0000-0002-2425-852X; Zapata, Juan M/0000-0002-0110-0009; Godzik, Adam/0000-0002-2425-852X	NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NCI NIH HHS [CA-69381] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansieau S, 1996, P NATL ACAD SCI USA, V93, P14053, DOI 10.1073/pnas.93.24.14053; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Avela K, 2000, NAT GENET, V25, P298, DOI 10.1038/77053; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bloch DB, 1999, MOL CELL BIOL, V19, P4423; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Boucher LM, 1997, BIOCHEM BIOPH RES CO, V233, P592, DOI 10.1006/bbrc.1997.6509; Cao TY, 1997, J CELL SCI, V110, P1563; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chelbi-Alix MK, 1999, ONCOGENE, V18, P935, DOI 10.1038/sj.onc.1202366; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Devergne O, 1996, MOL CELL BIOL, V16, P7098; El-Husseini AE, 1999, J BIOL CHEM, V274, P19771, DOI 10.1074/jbc.274.28.19771; El-Husseini AED, 2000, BIOCHEM BIOPH RES CO, V267, P906, DOI 10.1006/bbrc.1999.2045; ElHodiri HM, 1997, J BIOL CHEM, V272, P20463, DOI 10.1074/jbc.272.33.20463; Eussen BHJ, 2000, J MED GENET, V37, P287, DOI 10.1136/jmg.37.4.287; Everett RD, 1999, TRENDS BIOCHEM SCI, V24, P293, DOI 10.1016/S0968-0004(99)01433-4; Everett RD, 1999, J VIROL, V73, P417, DOI 10.1128/JVI.73.1.417-426.1999; Everett RD, 1997, EMBO J, V16, P566, DOI 10.1093/emboj/16.3.566; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; GALANG CK, 1994, ONCOGENE, V9, P2913; Gedrich RW, 1996, J BIOL CHEM, V271, P12852, DOI 10.1074/jbc.271.22.12852; Gibbons RJ, 1996, MEDICINE, V75, P45, DOI 10.1097/00005792-199603000-00001; HARRIS PC, 1995, J AM SOC NEPHROL, V6, P1125; Hoeflich KP, 1999, ONCOGENE, V18, P5814, DOI 10.1038/sj.onc.1202975; Holinski-Feder E, 2000, AM J HUM GENET, V66, P16, DOI 10.1086/302703; Holt BF, 2000, CURR BIOL, V10, pR5, DOI 10.1016/S0960-9822(99)00273-0; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; INITIATIVE TAG, 2000, NATURE, V408, P796, DOI DOI 10.1038/35048692; Jaroszewski L, 1998, PROTEIN SCI, V7, P1431; Jin YS, 1997, CANCER RES, V57, P404; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Krajewska M, 1998, AM J PATHOL, V152, P1549; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Leo E, 1999, EUR J IMMUNOL, V29, P3908, DOI 10.1002/(SICI)1521-4141(199912)29:12<3908::AID-IMMU3908>3.0.CO;2-E; Leo E, 1999, J BIOL CHEM, V274, P22414, DOI 10.1074/jbc.274.32.22414; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; MIYASHITA T, 1995, CELL, V80, P293; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nagai Y, 1997, FEBS LETT, V418, P23, DOI 10.1016/S0014-5793(97)01340-9; Ni CZ, 2000, P NATL ACAD SCI USA, V97, P10395, DOI 10.1073/pnas.97.19.10395; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Panagopoulos I, 2000, GENE CHROMOSOME CANC, V28, P415, DOI 10.1002/1098-2264(200008)28:4<415::AID-GCC7>3.0.CO;2-I; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Petrij F, 2000, AM J MED GENET, V92, P47, DOI 10.1002/(SICI)1096-8628(20000501)92:1<47::AID-AJMG8>3.0.CO;2-H; PULLEN S, 1998, BIOCHEMISTRY-US, V37, P11330; Pullen SS, 1999, BIOCHEMISTRY-US, V38, P10168, DOI 10.1021/bi9909905; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; REGNIER C, 1985, J BIOL CHEM, V270, P25715; Robinson PA, 1998, CYTOGENET CELL GENET, V83, P100, DOI 10.1159/000015142; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi CS, 1999, J IMMUNOL, V163, P3279; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Uren AG, 1996, TRENDS BIOCHEM SCI, V21, P244, DOI 10.1016/S0968-0004(96)30022-4; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wallerstein R, 1997, J MED GENET, V34, P203, DOI 10.1136/jmg.34.3.203; Wang ZG, 1998, SCIENCE, V279, P1547; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Yamamoto H, 1998, J IMMUNOL, V161, P4753; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202; Zapata JM, 2000, J BIOL CHEM, V275, P12102, DOI 10.1074/jbc.275.16.12102; Zheng PP, 2000, CANCER GENET CYTOGEN, V122, P18, DOI 10.1016/S0165-4608(00)00265-X	77	169	174	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24242	24252		10.1074/jbc.M100354200	http://dx.doi.org/10.1074/jbc.M100354200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11279055	hybrid			2022-12-27	WOS:000169531100133
J	Toure, A; Morin, L; Pineau, C; Becq, F; Dorseuil, O; Gacon, G				Toure, A; Morin, L; Pineau, C; Becq, F; Dorseuil, O; Gacon, G			Tat1, a novel sulfate transporter specifically expressed in human male germ cells and potentially linked to RhoGTPase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; GENE ENCODES; SERTOLI CELLS; RHO GTPASES; MGCRACGAP; SPERMATOGENESIS; IDENTIFICATION; GLYCOPROTEIN; SECRETION; GROWTH	RhoGTPases (Rho, Rac, and Cdc42) are known to regulate multiple functions, including cell motility, adhesion, and proliferation; however, the signaling pathways underlying these pleiotropic effects are far from fully understood. We have recently described a new RhoGAP (GTPase activating protein for RhoGTPases) gene, MgcRacGAP, primarily expressed in male germ cells, at the spermatocyte stage. We report here the isolation, through two-hybrid cloning, of a new partner of MgcRacGAP, very specifically expressed in the male germ line and showing structural features of anion transporters. This large protein (970 amino acids and a predicted size of 109 kDa), we provisionally designated Tat1 (for testis anion transporter 1), is closely related to a sulfate permease family comprising three proteins in human (DRA Pendrin, and DTD); it is predicted to be an integral membrane protein with 14 transmembrane helices and intracytoplasmic NH2 and COOH termini. In situ hybridization studies demonstrate that Tat1 and MgcRacGAP genes are coexpressed in male germ cells at the spermatocyte stage. On testis sections, Tat1 protein can be immunodetected in spermatocytes and spermatids associated with plasma membrane. Two-hybrid and in vitro binding assays demonstrate that MgcRacGAP stably interacts through its NH2-terminal domain with the Tat1 COOH-terminal region. Expression of Tat1 protein in COS7 cells generates a 4,4'-diisothiocyano-2,2'-disulfonic acid stilbene and chloride-sensitive sulfate transport. Therefore we conclude that Tat1 is a novel sulfate transporter specifically expressed in spermatocytes and spermatids and interacts with MgcRacGAP in these cells. These observations raise the possibility of a new regulatory pathway linking sulfate transport to Rho signaling in male germ cells.	Inst Cochin Genet Mol, Dept Genet Dev & Pathol Mol, INSERM, U257, F-75014 Paris, France; Univ Rennes 1, GERM, INSERM, U435, F-35042 Rennes, France; Univ Poitiers, Lab Physiol Regulat Cellulaires, UMR 6558, F-86022 Poitiers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Poitiers	Gacon, G (corresponding author), Inst Cochin Genet Mol, Dept Genet Dev & Pathol Mol, INSERM, U257, 24 Rue Faubourg St-Jacques, F-75014 Paris, France.		Becq, Frederic/P-9233-2016; TOURE, Aminata/B-3236-2018; Pineau, Charles G/D-9185-2013	Becq, Frederic/0000-0003-3915-0973; TOURE, Aminata/0000-0001-5629-849X; Pineau, Charles G/0000-0002-7461-5433				AGNEL M, 1992, MOL CELL BIOL, V12, P5111, DOI 10.1128/MCB.12.11.5111; AHMED S, 1990, BIOCHEM J, V272, P767, DOI 10.1042/bj2720767; Arar C, 1999, BIOCHEM J, V343, P225, DOI 10.1042/0264-6021:3430225; Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Becq F, 1997, J BIOL CHEM, V272, P2695, DOI 10.1074/jbc.272.5.2695; Byeon MK, 1998, PROTEIN EXPRES PURIF, V12, P67, DOI 10.1006/prep.1997.0809; Byeon MK, 1996, ONCOGENE, V12, P387; Coyle B, 1998, HUM MOL GENET, V7, P1105, DOI 10.1093/hmg/7.7.1105; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; ELGAVISH A, 1992, AM J PHYSIOL, V263, pC176, DOI 10.1152/ajpcell.1992.263.1.C176; Galdieri M, 1981, J ANDROL, V5, P249; Guichard A, 1997, MECH DEVELOP, V61, P49, DOI 10.1016/S0925-4773(96)00619-3; GUILLAUME EDA, 2001, IN PRESS PROTEOME; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hastbacka J, 1999, EUR J HUM GENET, V7, P664, DOI 10.1038/sj.ejhg.5200361; Herscovics A, 1999, BBA-GEN SUBJECTS, V1473, P96, DOI 10.1016/S0304-4165(99)00171-3; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Hoglund P, 1996, GENOME RES, V6, P202, DOI 10.1101/gr.6.3.202; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; KAISER C, 1989, METHODS YEAST GENETI; Kawashima T, 2000, BLOOD, V96, P2116; Kozma R, 1996, MOL CELL BIOL, V16, P5069; Marshall C, 1999, CURR OPIN CELL BIOL, V11, P732, DOI 10.1016/S0955-0674(99)00044-7; Moseley RH, 1999, AM J PHYSIOL-GASTR L, V276, pG185, DOI 10.1152/ajpgi.1999.276.1.G185; PINEAU C, 1993, J ANDROL, V14, P87; Satoh H, 1998, J BIOL CHEM, V273, P12307, DOI 10.1074/jbc.273.20.12307; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; Scott DA, 1999, NAT GENET, V21, P440, DOI 10.1038/7783; SKINNER MK, 1985, P NATL ACAD SCI USA, V82, P114, DOI 10.1073/pnas.82.1.114; SupertiFurga A, 1996, AM J MED GENET, V63, P144, DOI 10.1002/(SICI)1096-8628(19960503)63:1<144::AID-AJMG25>3.0.CO;2-N; TOEBOSCH AMW, 1989, J ENDOCRINOL, V122, P757, DOI 10.1677/joe.0.1220757; Toure A, 1998, J BIOL CHEM, V273, P6019, DOI 10.1074/jbc.273.11.6019; VAN AL, 1997, GENE DEV, V11, P2295; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WEBER JE, 1987, AM J ANAT, V180, P1, DOI 10.1002/aja.1001800102; WILKINSON DG, 1990, POST IMPLANTATION MA, P55	37	71	73	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20309	20315		10.1074/jbc.M011740200	http://dx.doi.org/10.1074/jbc.M011740200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278976	hybrid			2022-12-27	WOS:000169135100087
J	Wu, YM; Huang, CL; Kung, HJ; Huang, CYF				Wu, YM; Huang, CL; Kung, HJ; Huang, CYF			Proteolytic activation of Etk/Bmx tyrosine kinase by caspases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; FOCAL ADHESION KINASE; PROSTATE-CANCER CELLS; FAS-INDUCED APOPTOSIS; FACTOR-KAPPA-B; MEDIATED ACTIVATION; ENDOTHELIAL-CELLS; TEC FAMILY; ICE-LIKE; C-DELTA	Etk/Bmx is a member of the Btk/Tec family of kinases, which are characterized by having a pleckstrin homology domain at the N terminus, in addition to the Src homology 3 (SH3), SH2, and the catalytic domains, shared with the Src family kinases, Etk, or Btk kinases in general, has been implicated in the regulation of apoptosis. To test whether Etk is the substrate for caspases during apoptosis, in vitro translated [S-35]methionine-labeled Etk was incubated with different apoptotic extracts and recombinant caspases, respectively. Results showed that Etk was proteolyzed in all conditions tested with identical cleavage patterns. Caspase-mediated cleavage of Etk generated a C-terminal fragment, containing the complete SH2 and tyrosine kinase domains, but without intact pleckstrin homology and SH3 domains. This fragment has 4-fold higher kinase activity than that of the full-length Etk, Ectopic expression of the C-terminal fragment of Etk sensitized the PC3 prostate cancer cells to apoptosis in response to apoptosis-inducing stimuli. The finding, together with an earlier report that Etk is potentially anti-apoptotic, suggests that Etk may serve as an apoptotic switch, depending on the forms of Etk existing inside the cells. To our knowledge, this is the first case where the activity of a tyrosine kinase is induced by caspase cleavage.	Natl Hlth Res Inst, Div Mol & Genom Med, Taipei 115, Taiwan; Univ Calif Davis, Dept Biol Chem, Sacramento, CA 95817 USA; Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	National Health Research Institutes - Taiwan; University of California System; University of California Davis; University of California System; University of California Davis	Huang, CYF (corresponding author), Natl Hlth Res Inst, Div Mol & Genom Med, Taipei 115, Taiwan.		Huang, Chi-Ying/AFL-7729-2022; Kung, Hsing-Jien/C-7651-2013; Huang, Chi-Ying/AAG-7672-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937				Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Bajpai UD, 2000, J EXP MED, V191, P1735, DOI 10.1084/jem.191.10.1735; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; Bokoch GM, 1998, CELL DEATH DIFFER, V5, P637, DOI 10.1038/sj.cdd.4400405; Bombeli T, 1999, BLOOD, V93, P3831, DOI 10.1182/blood.V93.11.3831; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Datta R, 1997, J BIOL CHEM, V272, P20317, DOI 10.1074/jbc.272.33.20317; Dusi S, 1996, J IMMUNOL, V157, P4615; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; EISCHEN CM, 1994, J IMMUNOL, V153, P1947; Ekman N, 1997, CIRCULATION, V96, P1729, DOI 10.1161/01.CIR.96.6.1729; Ekman N, 2000, ONCOGENE, V19, P4151, DOI 10.1038/sj.onc.1203763; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fry AM, 1999, J BIOL CHEM, V274, P16304, DOI 10.1074/jbc.274.23.16304; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Grafe M, 1999, CLIN CHEM LAB MED, V37, P505, DOI 10.1515/CCLM.1999.081; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hsueh RC, 2000, ADV IMMUNOL, V75, P283, DOI 10.1016/S0065-2776(00)75007-3; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jui HY, 2000, J BIOL CHEM, V275, P41124, DOI 10.1074/jbc.M007772200; Kaukonen J, 1996, BRIT J HAEMATOL, V94, P455; Kitaura J, 2000, J EXP MED, V192, P729, DOI 10.1084/jem.192.5.729; Lee N, 1997, P NATL ACAD SCI USA, V94, P13642, DOI 10.1073/pnas.94.25.13642; Levkau B, 1998, J EXP MED, V187, P579, DOI 10.1084/jem.187.4.579; Mano H, 1999, CYTOKINE GROWTH F R, V10, P267, DOI 10.1016/S1359-6101(99)00019-2; Na SQ, 1996, J BIOL CHEM, V271, P11209, DOI 10.1074/jbc.271.19.11209; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Rawlings D J, 1995, Semin Immunol, V7, P237, DOI 10.1006/smim.1995.0028; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Rokhlin OW, 1997, CANCER RES, V57, P3941; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; SATO K, 1994, LEUKEMIA, V8, P1663; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1034/j.1600-065X.2000.017504.x; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; Simon HU, 1998, BLOOD, V92, P547, DOI 10.1182/blood.V92.2.547.414k02_547_557; Smith GCM, 1999, MOL CELL BIOL, V19, P6076; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Stroh C, 1998, CELL DEATH DIFFER, V5, P997, DOI 10.1038/sj.cdd.4400451; TAMAGNONE L, 1994, ONCOGENE, V9, P3683; Tan XQ, 1998, TRENDS CELL BIOL, V8, P116, DOI 10.1016/S0962-8924(97)01208-7; Tang TK, 1998, J CELL BIOCHEM, V70, P442, DOI 10.1002/(SICI)1097-4644(19980915)70:4<442::AID-JCB2>3.3.CO;2-N; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Uckun FM, 1998, BIOCHEM PHARMACOL, V56, P683, DOI 10.1016/S0006-2952(98)00122-1; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; Vassilev A, 1999, J BIOL CHEM, V274, P1646, DOI 10.1074/jbc.274.3.1646; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Walter J, 1999, P NATL ACAD SCI USA, V96, P1391, DOI 10.1073/pnas.96.4.1391; WEBER C, 1995, J IMMUNOL, V155, P445; Weil D, 1997, BLOOD, V90, P4332, DOI 10.1182/blood.V90.11.4332.4332_4332_4340; Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056; Wen X, 1999, J BIOL CHEM, V274, P38204, DOI 10.1074/jbc.274.53.38204; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Xue LY, 1999, ONCOGENE, V18, P3391, DOI 10.1038/sj.onc.1202687	65	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17672	17678		10.1074/jbc.M010964200	http://dx.doi.org/10.1074/jbc.M010964200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278797	hybrid			2022-12-27	WOS:000168866500008
J	Chen, T; Bolland, S; Chen, I; Parker, J; Pantelic, M; Grunert, F; Zimmermann, W				Chen, T; Bolland, S; Chen, I; Parker, J; Pantelic, M; Grunert, F; Zimmermann, W			The CGM1a (CEACAM3/CD66d)-mediated phagocytic pathway of Neisseria gonorrhoeae expressing opacity proteins is also the pathway to cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOEMBRYONIC ANTIGEN FAMILY; TYROSINE-PHOSPHATASE SHP-1; EPITHELIAL-CELLS; ACTIVATION MOTIF; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOLIPASE C-GAMMA-2; BILIARY GLYCOPROTEIN; INFECTED MACROPHAGES; CA2+ MOBILIZATION; DISTINCT PATHWAYS	Phagocytosis of Opa(+) Neisseria gonorrhoeae (gonococcus, GC) by neutrophils is in part dependent on the interaction of Opa proteins with CGM1a (CEACAM3/CD66d) antigens, a neutrophil-specific receptor. However, the signaling pathways leading to phagocytosis have not been characterized. Here we show that interaction of Opal bacteria with neutrophils or CGM1a-transfected DT40 cells induces calcium flux, which correlates with phagocytosis of bacteria. We identified an immunoreceptor tyrosine-based activation motif (ITAM) in CGM1a, and showed that the ability of CGM1a to transduce signals and mediate phagocytosis was abolished by mutation of the ITAM tyrosines. We also demonstrated that CGM1a-ITAM-mediated bacterial phagocytosis is dependent on Syk and phospholipase C activity in DT40 cells. Unexpectedly, the activation of the CGM1a-ITAM phagocytic pathway by Opa(+) GC results in induction of cell death.	Indiana Univ, Sch Med, Dept Med Microbiol & Immunol, Walther Oncol Ctr, Indianapolis, IN 46202 USA; Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany	Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Rockefeller University; Rockefeller University; University of Freiburg	Chen, T (corresponding author), Indiana Univ, Sch Med, Dept Med Microbiol & Immunol, Walther Oncol Ctr, MS 252,635 Barnhill Dr, Indianapolis, IN 46202 USA.		Zimmermann, Wolfgang/L-9277-2013	Chen, Ines/0000-0002-1405-9703	NIAID NIH HHS [AI 26558, AI 47736] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026558, R01AI047736] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beauchemin N, 1999, EXP CELL RES, V252, P243; Beauchemin N, 1997, ONCOGENE, V14, P783, DOI 10.1038/sj.onc.1200888; BELLAND RJ, 1992, MOL MICROBIOL, V6, P1729, DOI 10.1111/j.1365-2958.1992.tb01345.x; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; BIJSTERBOSCH MK, 1985, CELL, V41, P999, DOI 10.1016/S0092-8674(85)80080-5; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; *CDC, 1993, MMWR-MORBID MORTAL W, V42, P55; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Combadiere B, 1996, J EXP MED, V183, P2109, DOI 10.1084/jem.183.5.2109; Cox D, 1996, J BIOL CHEM, V271, P16597, DOI 10.1074/jbc.271.28.16597; deAos I, 1997, J BIOL CHEM, V272, P25310, DOI 10.1074/jbc.272.40.25310; EVANS BA, 1977, J INFECT DIS, V136, P248, DOI 10.1093/infdis/136.2.248; FISCHER SH, 1988, INFECT IMMUN, V56, P1574, DOI 10.1128/IAI.56.6.1574-1579.1988; GORBY G, 1994, ANN NY ACAD SCI, V730, P286, DOI 10.1111/j.1749-6632.1994.tb44267.x; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hauck CR, 1999, INFECT IMMUN, V67, P5490, DOI 10.1128/IAI.67.10.5490-5494.1999; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; Maeda A, 1998, J EXP MED, V188, P991, DOI 10.1084/jem.188.5.991; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; NAGEL G, 1993, EUR J BIOCHEM, V214, P27, DOI 10.1111/j.1432-1033.1993.tb17892.x; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; PAXTON RJ, 1987, P NATL ACAD SCI USA, V84, P920, DOI 10.1073/pnas.84.4.920; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RETH M, 1995, SEMIN IMMUNOL, V7, P21; SHAFER WM, 1989, ANNU REV MICROBIOL, V43, P121; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; SWANSON J, 1983, J EXP MED, V157, P1405, DOI 10.1084/jem.157.5.1405; SWANSON J, 1975, INFECT IMMUN, V11, P65, DOI 10.1128/IAI.11.1.65-68.1975; SWANSON J, 1975, INFECT IMMUN, V11, P1352, DOI 10.1128/IAI.11.6.1352-1361.1975; SWANSON J, 1988, J EXP MED, V168, P2121, DOI 10.1084/jem.168.6.2121; SWANSON J, 1991, P 7 INT PATH NEISS C, P391; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Tseng J, 1997, BLOOD, V89, P1513, DOI 10.1182/blood.V89.5.1513.1513_1513_1520; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; VIRJI M, 1986, J GEN MICROBIOL, V132, P503; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; VIRJI M, 1981, INFECT IMMUN, V31, P965, DOI 10.1128/IAI.31.3.965-970.1981; WARD ME, 1972, J INFECT DIS, V126, P601, DOI 10.1093/infdis/126.6.601; YAO XR, 1995, J IMMUNOL, V155, P652; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	51	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17413	17419		10.1074/jbc.M010609200	http://dx.doi.org/10.1074/jbc.M010609200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278708	hybrid			2022-12-27	WOS:000168730400109
J	Connor, MK; Irrcher, I; Hood, DA				Connor, MK; Irrcher, I; Hood, DA			Contractile activity-induced transcriptional activation of cytochrome c involves Sp1 and is proportional to mitochondrial ATP synthesis in C2C12 muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY GENE-EXPRESSION; RAT SKELETAL-MUSCLE; ELECTRICAL-STIMULATION; DEPENDENT REGULATION; CARDIAC MYOCYTES; MESSENGER-RNAS; NUCLEAR; PROTEINS; CALCIUM; DIFFERENTIATION	Contractile activity induces adaptations in the expression of genes encoding skeletal muscle mitochondrial proteins; however, the putative signals responsible for these adaptations remain unknown. We used electrical stimulation (5 Hz, 65 V) of C2C12 muscle cells in culture to define some of the mechanisms involved in contractile activity-induced changes in cytochrome c gene expression. Chronic contractile activity (4 days, 3 h/day) augmented cytochrome c mRNA by 1.6-fold above control cells. This was likely mediated by increases in transcriptional activation, because cells transfected with full-length (-726 base pairs) or minimal (-66 base pairs) cytochrome c promoter/chloramphenicol acetyltransferase reporter constructs demonstrated contractile activity-induced 1.5-1.7-fold increases in the absence of contractile activity-induced increases in mRNA stability. Transcriptional activation of the -726 promoter was abolished when muscle contraction was inhibited at various subcellular locations by pretreatment with either the Na+ channel blocker tetrodotoxin, the intracellular Ca2+ chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetra(acetoxymethyl) ester, or the myosin ATPase inhibitor 2,3-butanedione monoxime. It was further reduced in unstimulated cells when mitochondrial ATP synthesis was impaired using the uncoupler 2,4-dinitrophenol. Because the contractile activity-induced response was evident within the minimal promoter, electromobility shift assays performed within the first intron (+75 to +104 base pairs) containing Sp1 sites revealed an elevated DNA binding in response to contractile activity. This was paralleled by increases in Sp1 protein levels. Sp1 overexpression studies also led to increases in cytochrome c transactivation and mRNA levels. These data suggest that variations in the rate of mitochondrial ATP synthesis are important in determining cytochrome c gene expression in muscle cells and that this is mediated, in part, by Sp1-induced increases in cytochrome c transcription.	York Univ, Dept Biol, N York, ON M3J 1P3, Canada; York Univ, Dept Kinesiol & Hlth Sci, N York, ON M3J 1P3, Canada	York University - Canada; York University - Canada	Hood, DA (corresponding author), York Univ, Dept Biol, 4700 Keele St, N York, ON M3J 1P3, Canada.	dhood@yorku.ca						ABUSHAKRA SR, 1993, MOL BRAIN RES, V18, P216, DOI 10.1016/0169-328X(93)90192-R; ABUSHAKRA SR, 1994, MOL BRAIN RES, V26, P55, DOI 10.1016/0169-328X(94)90073-6; Aronson D, 1997, J BIOL CHEM, V272, P25636, DOI 10.1074/jbc.272.41.25636; BERG JM, 1992, P NATL ACAD SCI USA, V89, P11109, DOI 10.1073/pnas.89.23.11109; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREVET A, 1976, SCIENCE, V193, P1152, DOI 10.1126/science.959833; Byron KL, 1996, AM J PHYSIOL-CELL PH, V271, pC1447, DOI 10.1152/ajpcell.1996.271.5.C01447; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; Connor MK, 1996, ARCH BIOCHEM BIOPHYS, V333, P103, DOI 10.1006/abbi.1996.0369; Eble DM, 1998, AM J PHYSIOL-CELL PH, V274, pC1226, DOI 10.1152/ajpcell.1998.274.5.C1226; Essig D A, 1996, Exerc Sport Sci Rev, V24, P289; EVANS MJ, 1988, MOL CELL BIOL, V8, P35, DOI 10.1128/MCB.8.1.35; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; Fields RD, 1997, J NEUROSCI, V17, P7252; Freyssenet D, 1999, J BIOL CHEM, V274, P9305, DOI 10.1074/jbc.274.14.9305; Freyssenet D, 1999, AM J PHYSIOL-ENDOC M, V277, pE26, DOI 10.1152/ajpendo.1999.277.1.E26; Goodyear LJ, 1996, AM J PHYSIOL-ENDOC M, V271, pE403, DOI 10.1152/ajpendo.1996.271.2.E403; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; HOOD DA, 1989, EUR J BIOCHEM, V179, P275, DOI 10.1111/j.1432-1033.1989.tb14551.x; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Huang RP, 1997, J CELL BIOCHEM, V66, P489, DOI 10.1002/(SICI)1097-4644(19970915)66:4<489::AID-JCB8>3.0.CO;2-H; Khayat ZA, 1998, AM J PHYSIOL-CELL PH, V275, pC1487, DOI 10.1152/ajpcell.1998.275.6.C1487; MCDONOUGH PM, 1992, J BIOL CHEM, V267, P11665; MICHEL JB, 1994, J CLIN INVEST, V94, P277, DOI 10.1172/JCI117318; NELSON BD, 1995, BBA-MOL BASIS DIS, V1271, P85, DOI 10.1016/0925-4439(95)00014-U; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Robey RB, 1996, BIOTECHNIQUES, V20, P40; SCHMIDT J, 1995, REV PHYSL BIOCH PHAR, V127, P251; SELLIN LC, 1994, PHARMACOL TOXICOL, V74, P305, DOI 10.1111/j.1600-0773.1994.tb01365.x; Silverman ES, 1997, AM J PHYSIOL-HEART C, V273, pH1415, DOI 10.1152/ajpheart.1997.273.3.H1415; WEHRLE U, 1994, DIFFERENTIATION, V58, P37, DOI 10.1046/j.1432-0436.1994.5810037.x; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; Xia Y, 1998, J BIOL CHEM, V273, P12593, DOI 10.1074/jbc.273.20.12593; Xia Y, 1996, J BIOL CHEM, V271, P12082, DOI 10.1074/jbc.271.20.12082; Xia Y, 1997, P NATL ACAD SCI USA, V94, P11399, DOI 10.1073/pnas.94.21.11399; Yan Z, 1996, AM J PHYSIOL-CELL PH, V271, pC1157, DOI 10.1152/ajpcell.1996.271.4.C1157; Zaid A, 1999, J BIOENERG BIOMEMBR, V31, P129, DOI 10.1023/A:1005499727732	38	43	47	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15898	15904		10.1074/jbc.M100272200	http://dx.doi.org/10.1074/jbc.M100272200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279044	hybrid			2022-12-27	WOS:000168623100046
J	Lim, HW; New, L; Han, JH; Molkentin, JD				Lim, HW; New, L; Han, JH; Molkentin, JD			Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-PROTEIN-KINASE; INDUCED CARDIOMYOCYTE HYPERTROPHY; SIGNAL-REGULATED KINASE; GENE-TRANSCRIPTION; TRANSGENIC MICE; HEART-FAILURE; GROWTH-FACTOR; CELL-GROWTH; IN-VIVO; PATHWAYS	Multiple intracellular signaling pathways have been shown to regulate the hypertrophic growth of cardiac myocytes including mitogen-activated protein kinase (MAPK) and calcineurin-nuclear factor of activated T-cells. However, it is uncertain if individual regulatory pathways operate in isolation or if interconnectivity between unrelated pathways is required for the orchestration of the entire hypertrophic response. To this end, we investigated the interconnectivity between calcineurin-mediated cardiac myocyte hypertrophy and p38 MAPK signaling in vitro and in vivo. We show that calcineurin promotes down-regulation of p38 MAPK activity and enhances expression of the dual specificity phosphatase MAPK phosphatase-1 (MKP-1). Transgenic mice expressing activated calcineurin in the heart were characterized by inactivation of p38 and increased MKP-1 expression during early postnatal development, before the onset of cardiac hypertrophy, In vitro, cultured neonatal cardiomyocytes infected with a calcineurin-expressing adenovirus and stimulated with phenylephrine demonstrated reduced p38 phosphorylation and increased MKP-1 protein levels. Activation of endogenous calcineurin with the calcium ionophore A23187 decreased p38 phosphorylation and increased MKP-1 protein levels. Inhibition of endogenous calcineurin with cyclosporin A decreased MKP-1 protein levels and increased p38 activation in response to agonist stimulation. To further investigate potential cross-talk between calcineurin and p38 through alteration in MKP-1 expression, the MKP-1 promoter was characterized and determined to be calcineurin-responsive. These data suggest that calcineurin enhances MKP-1 expression in cardiac myocytes, which is associated with p38 inactivation.	Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Scripps Research Institute	Molkentin, JD (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat, Div Mol Cardiovasc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.		Han, J/G-4671-2010	Molkentin, Jeffery/0000-0002-3558-6529				ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Bueno OF, 2001, CIRC RES, V88, P88, DOI 10.1161/01.RES.88.1.88; Chajry N, 1996, EUR J BIOCHEM, V235, P97, DOI 10.1111/j.1432-1033.1996.00097.x; Choukroun G, 1998, J CLIN INVEST, V102, P1311, DOI 10.1172/JCI3512; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Clerk A, 1998, J CELL BIOL, V142, P523, DOI 10.1083/jcb.142.2.523; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; Durham PL, 2000, MOL ENDOCRINOL, V14, P1570, DOI 10.1210/me.14.10.1570; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Haneda M, 1999, EUR J PHARMACOL, V365, P1, DOI 10.1016/S0014-2999(98)00857-7; HINES WA, 1999, AM J PHYSIOL, V277, pH311; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Hutter D, 2000, BIOCHEM J, V352, P155, DOI 10.1042/0264-6021:3520155; Li CH, 1999, J BIOL CHEM, V274, P25273, DOI 10.1074/jbc.274.36.25273; Liang FQ, 2000, HYPERTENSION, V35, P188, DOI 10.1161/01.HYP.35.1.188; Liang FQ, 1999, J CLIN INVEST, V104, P1603, DOI 10.1172/JCI7362; MASADU ES, 1995, MOL CELL BIOL, V15, P267; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2000, CIRC RES, V87, P731, DOI 10.1161/01.RES.87.9.731; Nemoto S, 1998, MOL CELL BIOL, V18, P3518, DOI 10.1128/MCB.18.6.3518; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Parameswaran N, 2000, EUR J PHARMACOL, V388, P133, DOI 10.1016/S0014-2999(99)00848-1; Sommer A, 2000, FEBS LETT, V474, P146, DOI 10.1016/S0014-5793(00)01566-0; Sugden PH, 1998, CIRC RES, V83, P345, DOI 10.1161/01.RES.83.4.345; Sussman MA, 1999, AM J PATHOL, V155, P2101, DOI 10.1016/S0002-9440(10)65528-9; Taigen T, 2000, P NATL ACAD SCI USA, V97, P1196, DOI 10.1073/pnas.97.3.1196; van Zwieten PA, 2000, CARDIOVASC RES, V45, P82, DOI 10.1016/S0008-6363(99)00291-6; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Xia Y, 2000, J BIOL CHEM, V275, P1855, DOI 10.1074/jbc.275.3.1855; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037	34	74	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15913	15919		10.1074/jbc.M100452200	http://dx.doi.org/10.1074/jbc.M100452200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279073	hybrid			2022-12-27	WOS:000168623100048
J	Petit, L; Maier, E; Gibert, M; Popoff, MR; Benz, R				Petit, L; Maier, E; Gibert, M; Popoff, MR; Benz, R			Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HEMOLYSIN; MATRIX PROTEIN PORIN; ALPHA-TOXIN; AEROLYSIN; PORES; EXPRESSION; TOXICITY; BINDING; CLYA	Epsilon toxin is a potent toxin produced by Clostridium perfringens types B and D, which are responsible for a rapidly fatal enterotoxemia in animals. One of the main properties of epsilon toxin is the production of edema. We have previously found that epsilon toxin causes a rapid swelling of Madin-Darby canine kidney cells and that the toxin does not enter the cytosol and remains associated with the cell membrane by forming a large complex (Petit, L., Gibert, M., Gillet, D., Laurent-Winter, C., Boquet, P., and Popoff, M. R. (1997) J. Bacteriol. 179, 6480-6487). Here, we report that epsilon toxin induced in Madin-Darby canine kidney cells a rapid decrease of intracellular K+, and an increase of Cl- and Na+, whereas the increase of Ca2+ occurred later. The entry of propidium iodide that was correlated with the loss of cell viability monitored by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test indicates that epsilon toxin formed large pores. In artificial lipid bilayers, epsilon toxin caused current steps with a single-channel conductance of 60 pS in 100 mM KCl, which represented general diffusion pores. The channels were slightly selective for anions, but cations could also penetrate. Epsilon toxin formed wide and water-filled channels permeable to hydrophilic solutes up to a molecular mass of at least 1 kDa, which probably represents the basic mechanism of toxin action on target cells.	Inst Pasteur, Ctr Natl Reference Anaerobies, F-75724 Paris 15, France; Univ Wurzburg, Biozentrum, Theodor Boveri Inst, Lehrstuhl Biotechnol, D-97074 Wurzburg, Germany	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Wurzburg	Popoff, MR (corresponding author), Inst Pasteur, Ctr Natl Reference Anaerobies, 28 Rue Dr Roux, F-75724 Paris 15, France.	mpopoff@pasteur.fr	Blasi, Juan/K-7943-2014	Blasi, Juan/0000-0002-0482-9444; Benz, Roland/0000-0002-9510-9265				BALLARD J, 1993, MOL MICROBIOL, V10, P627, DOI 10.1111/j.1365-2958.1993.tb00934.x; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1989, INFECT IMMUN, V57, P887, DOI 10.1128/IAI.57.3.887-895.1989; BENZ R, 1994, EUR J BIOCHEM, V220, P339, DOI 10.1111/j.1432-1033.1994.tb18630.x; Benz R., 1994, BACTERIAL CELL WALL, P397; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Bhakdi S, 2000, HANDB EXP PHARM, V145, P509; BUCKLEY JT, 1992, FEBS LETT, V307, P30, DOI 10.1016/0014-5793(92)80896-O; Cabiaux V, 1997, BIOCHEMISTRY-US, V36, P15224, DOI 10.1021/bi971216p; CHAKRABORTY T, 1990, INFECT IMMUN, V58, P2127, DOI 10.1128/IAI.58.7.2127-2132.1990; Finnie JW, 1999, J COMP PATHOL, V120, P415, DOI 10.1053/jcpa.1998.0289; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; HUNTER SEC, 1992, INFECT IMMUN, V60, P102, DOI 10.1128/IAI.60.1.102-110.1992; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; LINDSAY CD, 1995, TOXICOL IN VITRO, V9, P213, DOI 10.1016/0887-2333(95)00006-T; Lindsay CD, 1996, HUM EXP TOXICOL, V15, P904, DOI 10.1177/096032719601501107; Ludwig A, 1999, MOL MICROBIOL, V31, P557, DOI 10.1046/j.1365-2958.1999.01196.x; Maier E, 1996, INFECT IMMUN, V64, P4415, DOI 10.1128/IAI.64.11.4415-4423.1996; Merzlyak PG, 1999, BIOPHYS J, V77, P3023, DOI 10.1016/S0006-3495(99)77133-X; Minami J, 1997, MICROBIOL IMMUNOL, V41, P527, DOI 10.1111/j.1348-0421.1997.tb01888.x; Miyamoto O, 1998, INFECT IMMUN, V66, P2501, DOI 10.1128/IAI.66.6.2501-2508.1998; Miyamoto O, 2000, FEMS MICROBIOL LETT, V189, P109, DOI 10.1111/j.1574-6968.2000.tb09215.x; NAGAHAMA M, 1992, INFECT IMMUN, V60, P1237, DOI 10.1128/IAI.60.3.1237-1240.1992; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; Nagahama M, 1998, J NAT TOXINS, V7, P291; NAGAHAMA M, 1993, MICROBIOL IMMUNOL, V37, P447, DOI 10.1111/j.1348-0421.1993.tb03235.x; Nelson KL, 2000, J BIOL CHEM, V275, P19839, DOI 10.1074/jbc.M002785200; Payne D, 1997, REV MED MICROBIOL, V8, pS28; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; ROPELE M, 1989, BIOCHIM BIOPHYS ACTA, V985, P9, DOI 10.1016/0005-2736(89)90096-5; SAKURAI J, 1983, INFECT IMMUN, V42, P1183, DOI 10.1128/IAI.42.3.1183-1186.1983; SCHERRER R, 1971, J BACTERIOL, V107, P718, DOI 10.1128/JB.107.3.718-735.1971; Shortt SJ, 2000, HUM EXP TOXICOL, V19, P108, DOI 10.1191/096032700678815710; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0	37	109	112	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15736	15740		10.1074/jbc.M010412200	http://dx.doi.org/10.1074/jbc.M010412200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278669	hybrid			2022-12-27	WOS:000168623100023
J	Rosenberg, MF; Mao, QC; Holzenburg, A; Ford, RC; Deeley, RG; Cole, SPC				Rosenberg, MF; Mao, QC; Holzenburg, A; Ford, RC; Deeley, RG; Cole, SPC			The structure of the multidrug resistance protein 1 (MRP1/ABCC1) - Crystallization and single-particle analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; TRANSMEMBRANE CONDUCTANCE REGULATOR; P-GLYCOPROTEIN; ELECTRON-MICROSCOPY; LEUKOTRIENE C-4; CYSTIC-FIBROSIS; MRP GENE; FUNCTIONAL RECONSTITUTION; VINCRISTINE TRANSPORT; MEMBRANE-PROTEINS	Multidrug resistance protein 1 (MRP1/ABCC1) is an ATP-binding cassette (ABC) polytopic membrane transporter of considerable clinical importance that confers multidrug resistance on tumor cells by reducing drug accumulation by active efflux. MRP1 is also an efficient transporter of conjugated organic anions, Like other ABC proteins, including the drug resistance conferring 170-kDa P-glycoprotein (ABCB1), the 190-kDa MRP1 has a core structure consisting of two membrane-spanning domains (MSDs), each followed by a nucleotide binding domain (NBD). However, unlike P-glycoprotein and most other ABC superfamily members, MRP1 contains a third MSD with five predicted transmembrane segments with an extracytosolic NH2 terminus. Moreover, the two nucleotide-binding domains of MRP1 are considerably more divergent than those of P-glycoprotein. In the present study, the first structural details of MRP1 purified from drug-resistant lung cancer cells have been obtained by electron microscopy of negatively stained single particles and two-dimensional crystals formed after reconstitution of purified protein with lipids. The crystals display p2 symmetry with a single dimer of MRP1 in the unit cell. The overall dimensions of the MRP1 monomer are similar to 80 x 100 Angstrom. The MRP1 monomer shows some pseudo-2-fold symmetry in projection, and in some orientations of the detergent-solubilized particles, displays a stain filled depression (putative pore) appearing toward the center of the molecule, presumably to enable transport of substrates. These data represent the first structural information of this transporter to similar to 22-Angstrom resolution and provide direct structural evidence for a dimeric association of the transporter in a reconstituted lipid bilayer.	Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, Manchester M60 1QD, Lancs, England; Queens Univ, Canc Res Labs, Kingston, ON K7L 3N6, Canada; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Texas A&M Univ, Ctr Electron Microscopy, College Stn, TX 77843 USA	University of Manchester; Queens University - Canada; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Rosenberg, MF (corresponding author), Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, Manchester M60 1QD, Lancs, England.	mark.rosenberg@umist.ac.uk	Deeley, Roger/J-4828-2012; Cole, Susan P.C./I-6389-2017	Cole, Susan P.C./0000-0001-6571-6884; Ford, Robert/0000-0002-0958-1505				Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4; Bryan J, 1997, CURR OPIN CELL BIOL, V9, P553, DOI 10.1016/S0955-0674(97)80033-6; Chan HSL, 1997, CANCER RES, V57, P2325; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J., 1996, 3 DIMENSIONAL ELECT, Ved, ppp 54; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Gao M, 1998, J BIOL CHEM, V273, P10733, DOI 10.1074/jbc.273.17.10733; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; Higgins CF, 1997, SEMIN CANCER BIOL, V8, P135, DOI 10.1006/scbi.1997.0067; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1999, J BIOL CHEM, V274, P15420, DOI 10.1074/jbc.274.22.15420; Hipfner DR, 1996, CANCER RES, V56, P3307; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Kast C, 1998, BIOCHEMISTRY-US, V37, P2305, DOI 10.1021/bi972332v; Kreisholt J, 1998, BRIT J CANCER, V77, P1469, DOI 10.1038/bjc.1998.241; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; LEIER I, 1994, J BIOL CHEM, V269, P27807; Loe DW, 1998, CANCER RES, V58, P5130; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Manciu L, 2000, BIOCHEMISTRY-US, V39, P13026, DOI 10.1021/bi001043v; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; Mao QC, 1999, BBA-BIOMEMBRANES, V1461, P69, DOI 10.1016/S0005-2736(99)00150-9; MARSHALL J, 1994, J BIOL CHEM, V269, P2987; Nagata K, 2000, J BIOL CHEM, V275, P17626, DOI 10.1074/jbc.M000792200; Nooter K, 1995, CLIN CANCER RES, V1, P1301; Norris MD, 1996, NEW ENGL J MED, V334, P231, DOI 10.1056/NEJM199601253340405; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Renes J, 1999, BRIT J PHARMACOL, V126, P681, DOI 10.1038/sj.bjp.0702360; Rosenberg MF, 1997, BBA-BIOENERGETICS, V1319, P119, DOI 10.1016/S0005-2728(96)00124-7; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Sharom FJ, 1997, J MEMBRANE BIOL, V160, P161, DOI 10.1007/s002329900305; Soszynski M, 1998, ARCH BIOCHEM BIOPHYS, V354, P311, DOI 10.1006/abbi.1998.0687; Stride BD, 1996, MOL PHARMACOL, V49, P962; VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445; Walz T, 1998, J STRUCT BIOL, V121, P142, DOI 10.1006/jsbi.1998.3945; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; ZAMAN GJR, 1994, P NATL ACAD SCI USA, V91, P8822, DOI 10.1073/pnas.91.19.8822; Zerhusen B, 1999, J BIOL CHEM, V274, P7627, DOI 10.1074/jbc.274.12.7627; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	52	117	117	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16076	16082		10.1074/jbc.M100176200	http://dx.doi.org/10.1074/jbc.M100176200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279022	hybrid			2022-12-27	WOS:000168623100070
J	Duchene, AM; Peeters, N; Dietrich, A; Cosset, A; Small, ID; Wintz, H				Duchene, AM; Peeters, N; Dietrich, A; Cosset, A; Small, ID; Wintz, H			Overlapping destinations for two dual targeted glycyl-tRNA synthetases in Arabidopsis thaliana and Phaseolus vulgaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; PLANT-MITOCHONDRIA; IMPORT; GENES; PURIFICATION; TRNA(GLY); PROTEINS; POTATO; AMINOACYLATION; IDENTIFICATION	In plant mitochondria, some of the tRNAs are encoded by the mitochondrial genome and resemble their prokaryotic counterparts, whereas the remaining tRNAs are encoded by the nuclear genome and imported from the cytosol, Generally, mitochondrial isoacceptor tRNAs all have the same genetic origin. One known exception to this rule is the group of tRNA(Gly) isoacceptors in dicotyledonous plants. A mitochondrion-encoded tRNA(Gly) and at least one nucleus-encoded tRNA(Gly) coexist in the mitochondria of these plants, and both are required to allow translation of all four GGN glycine codons, We have taken advantage of this atypical situation to address the problem of tRNA/aminoacyl-tRNA synthetase coevolution in plants. In this work, we show that two different nucleus-encoded glycyl-tRNA synthetases (GlyRSs) are imported into Arabidopsis thaliana and Phaseolus vulgaris mitochondria, The first one, GlyRS-1, is similar to human or yeast glycyl-tRNA synthetase, whereas the second, GlyRS-2, is similar to Escherichia coli glycyl-tRNA synthetase. Both enzymes are dual targeted, GlyRS-1 to mitochondria and to the cytosol and GlyRS-2 to mitochondria and chloroplasts. Unexpectedly, GlyRS-1 seems to be active in the cytosol but inactive in mitochondrial fractions, whereas GlyRS-2 is likely to glycylate both the organelle-encoded tRNA(Gly) and the imported tRNA(Gly) present in mitochondria.	Univ Strasbourg, CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; INRA, Genet & Ameliorat Plantes Stn, F-78026 Versailles, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Duchene, AM (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	anne-marie.duchene@ibmp-ulp.u-strasbg.fr	Small, Ian/AAR-5506-2021; Small, Ian D/C-1168-2008; Peeters, Nemo M/A-2488-2012; Peeters, Nemo/R-5834-2019	Small, Ian/0000-0001-5300-1216; Small, Ian D/0000-0001-5300-1216; Peeters, Nemo M/0000-0002-1802-0769; Peeters, Nemo/0000-0002-1802-0769				Akashi K, 1998, NUCLEIC ACIDS RES, V26, P2168, DOI 10.1093/nar/26.9.2168; Akashi K, 1998, FEBS LETT, V431, P39, DOI 10.1016/S0014-5793(98)00717-0; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Bjork GR, 1995, TRNA STRUCTURE BIOSY, P165; Brubacher-Kauffmann S, 1999, NUCLEIC ACIDS RES, V27, P2037, DOI 10.1093/nar/27.9.2037; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; dePouplana LR, 1996, P NATL ACAD SCI USA, V93, P166, DOI 10.1073/pnas.93.1.166; Dietrich A, 1996, PLANT J, V10, P913, DOI 10.1046/j.1365-313X.1996.10050913.x; Dietrich A, 1996, BIOCHIMIE, V78, P518, DOI 10.1016/0300-9084(96)84758-4; Doolittle RF, 1998, CURR OPIN GENET DEV, V8, P630, DOI 10.1016/S0959-437X(98)80030-0; DUCHENE AM, 1997, PLANT PHYSIOL, V115, P1730; Duchene M, 1998, PLANT MITOCHONDRIA: FROM GENE TO FUNCTION, P121; Gaume B, 1998, EMBO J, V17, P6497, DOI 10.1093/emboj/17.22.6497; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; GOODALL GJ, 1990, METHOD ENZYMOL, V181, P148; Huang SH, 1999, NAT STRUCT BIOL, V6, P1132; JOYCE PBM, 1989, NUCLEIC ACIDS RES, V17, P5461, DOI 10.1093/nar/17.14.5461; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kumar R, 1996, MOL GEN GENET, V252, P404, DOI 10.1007/BF02173005; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Magrath C, 1999, GENETICS, V152, P129; Mahapatra S, 1998, NUCLEIC ACIDS RES, V26, P2037, DOI 10.1093/nar/26.9.2037; MarechalDrouard L, 1995, METHOD ENZYMOL, V260, P310, DOI 10.1016/0076-6879(95)60148-1; MARECHALDROUARD L, 1990, NUCLEIC ACIDS RES, V18, P3689, DOI 10.1093/nar/18.13.3689; MARECHALDROUARD L, 1993, ANNU REV PLANT PHYS, V44, P13, DOI 10.1146/annurev.pp.44.060193.000305; Menand B, 1998, P NATL ACAD SCI USA, V95, P11014, DOI 10.1073/pnas.95.18.11014; Millar AH, 1999, EUR J BIOCHEM, V264, P973, DOI 10.1046/j.1432-1327.1999.00707.x; Millar AH, 1998, BIOCHEM J, V334, P571, DOI 10.1042/bj3340571; Mireau H, 1996, PLANT CELL, V8, P1027, DOI 10.1105/tpc.8.6.1027; Mudge SJ, 1998, GENE, V209, P45, DOI 10.1016/S0378-1119(98)00007-9; NAGY JI, 1976, Z PFLANZENPHYSIOL, V78, P453, DOI 10.1016/S0044-328X(76)80093-1; Nameki N, 1997, J MOL BIOL, V268, P640, DOI 10.1006/jmbi.1997.0993; NEUBURGER M, 1982, ARCH BIOCHEM BIOPHYS, V217, P312, DOI 10.1016/0003-9861(82)90507-0; NEWMAN T, 1994, PLANT PHYSIOL, V106, P1241, DOI 10.1104/pp.106.4.1241; NGUYEN NY, 1981, GEL ELECTROPHORESIS, P150; Peeters NM, 2000, J MOL EVOL, V50, P413, DOI 10.1007/s002390010044; Rhoads DM, 1998, J BIOL CHEM, V273, P30750, DOI 10.1074/jbc.273.46.30750; ROBINSON C, 1988, PLANT MOL BIOL PRACT, P67; Rubino L, 2001, J GEN VIROL, V82, P29, DOI 10.1099/0022-1317-82-1-29; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sarkar S, 1999, P NATL ACAD SCI USA, V96, P14366, DOI 10.1073/pnas.96.25.14366; Schock I, 1998, MOL GEN GENET, V257, P554, DOI 10.1007/s004380050681; SHIBA K, 1994, J BIOL CHEM, V269, P30049; SHIPTON CA, 1995, J BIOL CHEM, V270, P566, DOI 10.1074/jbc.270.2.566; SOUCIET G, 1982, J BIOL CHEM, V257, P9598; SOUCIET G, 1999, EUR J BIOCHEM, V266, P1; Struglics A, 1999, EUR J BIOCHEM, V262, P765, DOI 10.1046/j.1432-1327.1999.00432.x; Struglics A, 2000, FEBS LETT, V475, P213, DOI 10.1016/S0014-5793(00)01680-X; Tarassov IA, 1996, BIOCHIMIE, V78, P502, DOI 10.1016/0300-9084(96)84756-0; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Uwer U, 1998, PLANT CELL, V10, P1277, DOI 10.1105/tpc.10.8.1277; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; von Stedingk E, 1999, PLANT MOL BIOL, V41, P505, DOI 10.1023/A:1006375123496; WISCHMANN C, 1995, FEBS LETT, V374, P152, DOI 10.1016/0014-5793(95)01100-S; Yanofsky C, 1996, BIOCHIMIE, V78, P1017, DOI 10.1016/S0300-9084(97)86725-9	57	48	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15275	15283		10.1074/jbc.M011525200	http://dx.doi.org/10.1074/jbc.M011525200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278923	hybrid, Green Published			2022-12-27	WOS:000168528800100
J	Herring, BP; Kriegel, AR; Hoggatt, AM				Herring, BP; Kriegel, AR; Hoggatt, AM			Identification of Barx2B, a serum response factor-associated homeodomain protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN GENE; CHROMOSOMAL LOCALIZATION; EXPRESSION; ELEMENTS; PROMOTER; CELLS; DIFFERENTIATION; TRANSCRIPTION	CC(A/T)(6)GG or serum response elements represent at common regulatory motif important for regulating the expression of many smooth muscle-specific genes, They are multifunctional elements that bind serum response factor (SRF) and are important for serum induction of genes, expression of muscle-specific genes, and differentiation of vascular smooth muscle cells. In the current study, a yeast two-hybrid screen was used to identify proteins from mouse intestine that interact with SRF, A novel homeodomain-containing transcription factor, called Barx2b, was identified that specifically interacts with SRF and promotes the DNA binding activity of SRF. Northern blotting, RNase protection analysis, and Western blotting revealed that Barx2b mRNA and protein are expressed in several smooth muscle-containing tissues, as well as in skeletal muscle and brain. In vitro binding studies using bacterial fusion proteins revealed that the DNA-binding domain of SRF interacts with a region of Barx2b located amino-terminal of the homeobox domain. The results of these studies support the hypothesis that interaction of SRF with different homeodomain-containing proteins may play a critical role in determining the cell-specific functions of SRF.	Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Herring, BP (corresponding author), Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058571] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-58571] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ausubel FM, 1994, CURRENT PROTOCOLS MO; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Browning CL, 1998, DEV BIOL, V194, P18, DOI 10.1006/dbio.1997.8808; Carson JA, 2000, J BIOL CHEM, V275, P39061, DOI 10.1074/jbc.M006532200; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Edelman DB, 2000, J BIOL CHEM, V275, P21737, DOI 10.1074/jbc.M909998199; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23936; GRUENEBERG DA, 1992, SCIENCE, V257, P1089, DOI 10.1126/science.257.5073.1089; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Hautmann MB, 1998, J BIOL CHEM, V273, P8398, DOI 10.1074/jbc.273.14.8398; Herring BP, 1997, AM J PHYSIOL-CELL PH, V272, pC1394, DOI 10.1152/ajpcell.1997.272.4.C1394; Herring BP, 1996, AM J PHYSIOL-CELL PH, V270, pC1656, DOI 10.1152/ajpcell.1996.270.6.C1656; Hjalt TA, 1999, GENOMICS, V62, P456, DOI 10.1006/geno.1999.6037; Jones FS, 1997, P NATL ACAD SCI USA, V94, P2632, DOI 10.1073/pnas.94.6.2632; Kim JY, 1997, J ELECTROCERAM, V1, P27, DOI 10.1023/A:1009994230779; Krasner A, 2000, GENE, V250, P171, DOI 10.1016/S0378-1119(00)00169-4; Landerholm TE, 1999, DEVELOPMENT, V126, P2053; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; MA JT, 1994, BIOCHEM BIOPH RES CO, V200, P1742, DOI 10.1006/bbrc.1994.1654; Mack CP, 1999, CIRC RES, V84, P852; Madsen CS, 1997, J BIOL CHEM, V272, P6332, DOI 10.1074/jbc.272.10.6332; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; MOSS JB, 1994, J BIOL CHEM, V269, P12731; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Owens GK, 1998, ACTA PHYSIOL SCAND, V164, P623, DOI 10.1111/j.1365-201X.1998.tb10706.x; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Smith AF, 1998, AM J PHYSIOL-CELL PH, V274, pC1188, DOI 10.1152/ajpcell.1998.274.5.C1188; Smith DM, 1999, MECH DEVELOP, V80, P203, DOI 10.1016/S0925-4773(98)00216-0; STOFLET ES, 1992, MOL BIOL CELL, V3, P1073, DOI 10.1091/mbc.3.10.1073; Zilberman A, 1998, CIRC RES, V82, P566, DOI 10.1161/01.RES.82.5.566	30	45	46	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14482	14489		10.1074/jbc.M011585200	http://dx.doi.org/10.1074/jbc.M011585200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278942	hybrid			2022-12-27	WOS:000168356600128
J	Tortorella, LL; Milasincic, DJ; Pilch, PF				Tortorella, LL; Milasincic, DJ; Pilch, PF			Critical proliferation-independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE DIFFERENTIATION; HELIX-LOOP-HELIX; IGF-I RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; MYOBLAST DIFFERENTIATION; PC12 CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; FACTOR-BETA	In many cell types including myoblasts, growth factors control proliferation and differentiation, in part, via the mitogen-activated protein kinase (MAPK) pathway (also known as the extracellular regulated kinase (Erk) pathway). In C2C12 myoblast cells, insulin-like growth factor-1 and basic fibroblast growth factor (bFGF) activate MAPK/Erk, and both growth factors promote myoblast proliferation. However, these factors have opposing roles with respect to differentiation; insulin-like growth factor-1 enhances muscle cell differentiation, whereas bFGF inhibits the expression of the muscle specific transcription factors MyoD and myogenin, Cells treated with bFGF and PD98059, a specific inhibitor of the MAPK pathway, show enhanced expression of the muscle-specific transcription factors MyoD and myogenin as compared with cells not exposed to this inhibitor. Inhibiting MAPK activity also enhances myoblast fusion and the expression of the late differentiation marker myosin heavy chain. Basic FGF mediated repression of muscle-specific genes does not result from continued cell proliferation, since bFGF-treated cells progress through only one round of cell division, We have identified a critical boundary 16 to 20 h after plating during which bFGF induced MAPK activity is able to repress myogenic gene expression and differentiation. Thus, the targets of MAPK that regulate myogenesis are functional at this time and their identification is in progress.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Pilch, PF (corresponding author), Boston Univ, Sch Med, Dept Biochem, 80 E Concord St, Boston, MA 02118 USA.			Pilch, Paul/0000-0003-1997-0499	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049147, R01DK030425] Funding Source: NIH RePORTER; NIA NIH HHS [AG00115] Funding Source: Medline; NIDDK NIH HHS [DK-30425, DK-49147] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ALLEN RE, 1990, P SOC EXP BIOL MED, V194, P81; Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BRUNETTI A, 1990, J BIOL CHEM, V265, P5960; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; deMora JF, 1997, MOL CELL BIOL, V17, P6068, DOI 10.1128/MCB.17.10.6068; DIKE LE, 1988, P NATL ACAD SCI USA, V85, P6792, DOI 10.1073/pnas.85.18.6792; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRODIN M, 1994, J BIOL CHEM, V269, P6207; FUKUDA M, 1995, ONCOGENE, V11, P239; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Haneda M, 1999, EUR J PHARMACOL, V365, P1, DOI 10.1016/S0014-2999(98)00857-7; HARDY S, 1993, MOL CELL BIOL, V13, P5943, DOI 10.1128/MCB.13.10.5943; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Jiang BH, 1998, P NATL ACAD SCI USA, V95, P14179, DOI 10.1073/pnas.95.24.14179; Kaliman P, 1998, MOL ENDOCRINOL, V12, P66, DOI 10.1210/mend.12.1.0047; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Layne MD, 1999, EXP CELL RES, V249, P177, DOI 10.1006/excr.1999.4465; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; Ludolph DC, 1995, FASEB J, V9, P1595, DOI 10.1096/fasebj.9.15.8529839; Milasincic DJ, 1996, IN VITRO CELL DEV-AN, V32, P90; Milasincic DJ, 1996, MOL CELL BIOL, V16, P5964; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; PERALDI P, 1993, ENDOCRINOLOGY, V132, P2578, DOI 10.1210/en.132.6.2578; Prudovsky IA, 1996, J BIOL CHEM, V271, P14198, DOI 10.1074/jbc.271.24.14198; RAO SS, 1995, J BIOL CHEM, V270, P4093, DOI 10.1074/jbc.270.8.4093; ROSEN KM, 1993, ENDOCRINOLOGY, V133, P474, DOI 10.1210/en.133.2.474; ROSENTHAL SM, 1991, MOL ENDOCRINOL, V5, P678, DOI 10.1210/mend-5-5-678; Sarbassov DD, 1997, MOL ENDOCRINOL, V11, P2038, DOI 10.1210/me.11.13.2038; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Stewart CEH, 1996, J BIOL CHEM, V271, P11330, DOI 10.1074/jbc.271.19.11330; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; TOLLEFSEN SE, 1989, P NATL ACAD SCI USA, V86, P1543, DOI 10.1073/pnas.86.5.1543; TOLLEFSEN SE, 1989, J BIOL CHEM, V264, P13810; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VAIDYA TB, 1989, MOL CELL BIOL, V9, P3576, DOI 10.1128/MCB.9.8.3576; VAILLANCOURT RR, 1995, MOL CELL BIOL, V15, P3644; Weyman CM, 1998, ENDOCRINOLOGY, V139, P1794, DOI 10.1210/en.139.4.1794; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	55	79	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13709	13717		10.1074/jbc.M100091200	http://dx.doi.org/10.1074/jbc.M100091200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11279003	hybrid			2022-12-27	WOS:000168356600030
J	Burmeister, R; Boe, IM; Nykjaer, A; Jacobsen, C; Moestrup, SK; Verroust, P; Christensen, EI; Lund, J; Willnow, TE				Burmeister, R; Boe, IM; Nykjaer, A; Jacobsen, C; Moestrup, SK; Verroust, P; Christensen, EI; Lund, J; Willnow, TE			A two-receptor pathway for catabolism of Clara cell secretory protein in the kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIPHENYL METABOLITE 4,4'-BIS(METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL; FACTOR VITAMIN-B-12 RECEPTOR; HIGH-DENSITY-LIPOPROTEIN; RENAL PROXIMAL TUBULE; BINDING-PROTEIN; POLYCHLORINATED-BIPHENYLS; TERATOGENIC ANTIBODIES; YOLK-SAC; PROGESTERONE-BINDING; EPITHELIAL-CELLS	Clara cell secretory protein (CCSP) is a transport protein for lipophilic substances in bronchio-alveolar fluid, plasma, and uterine secretion. It acts as a carrier for steroid hormones and polychlorinated biphenyl metabolites. Previously, the existence of receptors for uptake of CCSP ligand complexes into the renal proximal tubules had been suggested. Using surface plasmon resonance analysis, we demonstrate that CCSP binds to cubilin, a peripheral membrane protein on the surface of proximal tubular cells. Binding to cubilin results in uptake and lysosomal degradation of CCSP in cultured cells. Surprisingly, internalization of CCSP is blocked not only by cubilin antagonists but also by antibodies directed against megalin, an endocytic receptor that does not bind CCSP but associates with cubilin, Consistent with a role of both receptors in renal uptake of CCSP in vivo, patients deficient for cubilin or mice lacking megalin exhibit a defect in tubular uptake of the protein and excrete CCSP into the urine. These findings identify a cellular pathway consisting of a CCSP-binding protein (cubilin) and an endocytic coreceptor (megalin) responsible for tissue-specific uptake of CCSP and associated ligands.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Univ Bergen, Dept Anat & Cell Biol, N-5009 Bergen, Norway; Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus, Denmark; Aarhus Univ, Dept Cell Biol, DK-8000 Aarhus, Denmark; INSERM, U538, F-75012 Paris, France; AstraZeneca, Dept Mol Sci, S-22187 Lund, Sweden	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Bergen; Aarhus University; Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); AstraZeneca	Willnow, TE (corresponding author), Max Delbruck Ctr Mol Med, R Roessle Str 10, D-13125 Berlin, Germany.		Moestrup, Søren Kragh/AAD-1735-2019; Moestrup, Søren Kragh/A-1403-2014	Moestrup, Søren Kragh/0000-0003-3862-2107; Nykjaer, Anders/0000-0001-6422-6736; Willnow, Thomas/0000-0001-9515-7921				Aminoff M, 1999, NAT GENET, V21, P309, DOI 10.1038/6831; ANDERSSON O, 1991, AM J RESP CELL MOL, V5, P6, DOI 10.1165/ajrcmb/5.1.6; BEIER HM, 1968, BIOCHIM BIOPHYS ACTA, V160, P289, DOI 10.1016/0005-2795(68)90108-6; BERNARD A, 1994, PEDIATR RES, V36, P771, DOI 10.1203/00006450-199412000-00015; BERNARD AM, 1994, EUR RESPIR J, V7, P1932; BERNARD AM, 1994, KIDNEY INT S, V47, P34; Birn H, 1997, J BIOL CHEM, V272, P26497, DOI 10.1074/jbc.272.42.26497; Birn H, 2000, J CLIN INVEST, V105, P1353, DOI 10.1172/JCI8862; BOCHSKANL R, 1988, CELL TISSUE RES, V252, P625, DOI 10.1007/BF00216650; BOCHSKANL R, 1984, HISTOCHEMISTRY, V80, P581, DOI 10.1007/BF00553721; BORK P, 1991, FEBS LETT, V282, P9, DOI 10.1016/0014-5793(91)80433-4; BRANDT I, 1985, DRUG METAB DISPOS, V13, P490; CARDOSO WV, 1993, AM J PHYSIOL, V264, pL543, DOI 10.1152/ajplung.1993.264.6.L543; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; Christensen EI, 1998, INT REV CYTOL, V180, P237; Christensen EI, 1999, J AM SOC NEPHROL, V10, P2224; DUNKEL R, 1995, PROTEIN ENG, V8, P71, DOI 10.1093/protein/8.1.71; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HACKETT BP, 1992, AM J PHYSIOL, V262, pL399, DOI 10.1152/ajplung.1992.262.4.L399; Hammad SM, 2000, J BIOL CHEM, V275, P12003, DOI 10.1074/jbc.275.16.12003; Hammad SM, 1999, P NATL ACAD SCI USA, V96, P10158, DOI 10.1073/pnas.96.18.10158; HARD T, 1995, NAT STRUCT BIOL, V2, P983, DOI 10.1038/nsb1195-983; Harris DA, 1999, CLIN MICROBIOL REV, V12, P429, DOI 10.1128/CMR.12.3.429; Ji CM, 1998, AM J PHYSIOL-LUNG C, V275, pL870, DOI 10.1152/ajplung.1998.275.5.L870; Kozyraki R, 1999, NAT MED, V5, P656, DOI 10.1038/9504; KRISHNAN RS, 1967, SCIENCE, V158, P490, DOI 10.1126/science.158.3800.490; Kristiansen M, 1999, J BIOL CHEM, V274, P20540, DOI 10.1074/jbc.274.29.20540; LePanse S, 1997, EUR J CELL BIOL, V72, P257; LUND J, 1988, DRUG METAB DISPOS, V16, P590; LUND J, 1988, BIOCHEMISTRY-US, V27, P7895, DOI 10.1021/bi00420a047; LUND J, 1985, MOL PHARMACOL, V27, P314; MOESTRUP SK, 1993, J BIOL CHEM, V268, P16564; Moestrup SK, 1998, J BIOL CHEM, V273, P5235, DOI 10.1074/jbc.273.9.5235; Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; SAFE S, 1993, ENVIRON HEALTH PERSP, V100, P259, DOI 10.2307/3431532; SAHALI D, 1988, J EXP MED, V167, P213, DOI 10.1084/jem.167.1.213; SAHALI D, 1993, AM J PATHOL, V142, P1654; Seetharam B, 1997, J CLIN INVEST, V99, P2317, DOI 10.1172/JCI119411; SINGH G, 1985, BIOCHIM BIOPHYS ACTA, V829, P156, DOI 10.1016/0167-4838(85)90184-0; Singh G, 1997, AM J RESP CELL MOL, V17, P141, DOI 10.1165/ajrcmb.17.2.f138; SOUSA MM, 2000, J BIOL CHEM; Stripp BR, 1996, AM J PHYSIOL-LUNG C, V271, pL656, DOI 10.1152/ajplung.1996.271.4.L656; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	45	56	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13295	13301		10.1074/jbc.M010679200	http://dx.doi.org/10.1074/jbc.M010679200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278724	hybrid			2022-12-27	WOS:000168198600114
J	Shan, Q; Haddrill, JL; Lynch, JW				Shan, Q; Haddrill, JL; Lynch, JW			Ivermectin, an unconventional agonist of the glycine receptor chloride channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; CAENORHABDITIS-ELEGANS; FUNCTIONAL EXPRESSION; BETA-ALANINE; AVERMECTIN; SUBUNIT; BINDING; STRYCHNINE; RAT; HYPEREKPLEXIA	The effects of the antihelmintic, ivermectin, were investigated in recombinantly expressed human alpha (1) homomeric and alpha (1)beta heteromeric glycine receptors (GlyRs), At low (0.03 muM) concentrations ivermectin potentiated the response to sub-saturating glycine concentrations, and at higher (greater than or equal to0.03 muM) concentrations it irreversibly activated both alpha (1) homomeric and alpha (1)beta heteromeric GlyRs. Relative to glycine-gated currents, ivermectin-gated currents exhibited a dramatically reduced sensitivity to inhibition by strychnine, picrotoxin, and zinc. The insensitivity to strychnine could not be explained by ivermectin preventing the access of strychnine to its binding site. Furthermore, the elimination of a known glycine- and strychnine-binding site by site-directed mutagenesis had little effect on ivermectin sensitivity, demonstrating that the ivermectin- and glycine-binding sites were not identical. Ivermectin strongly and irreversibly activated a fast-desensitizing mutant GlyR after it had been completely desensitized by a saturating concentration of glycine. Finally, a mutation known to impair dramatically the glycine signal transduction mechanism had little effect on the apparent affinity or efficacy of ivermectin, Together, these findings indicate that ivermectin activates the GlyR by a novel mechanism.	Univ Queensland, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia	University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia.		Lynch, Joseph/C-8636-2009					Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; AMMANDOLA D, 1988, EXP BIOL, V48, P13; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CRICHLOW EC, 1986, NEUROPHARMACOLOGY, V25, P1085, DOI 10.1016/0028-3908(86)90154-1; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; Dawson GR, 2000, J PHARMACOL EXP THER, V295, P1051; Etter A, 1999, J NEUROCHEM, V72, P318, DOI 10.1111/jnc.1999.72.1.318; FISHER MH, 1992, ANNU REV PHARMACOL, V32, P537, DOI 10.1146/annurev.pa.32.040192.002541; GRAHAM D, 1982, NEUROSCI LETT, V29, P173, DOI 10.1016/0304-3940(82)90349-4; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Kane NS, 2000, P NATL ACAD SCI USA, V97, P13949, DOI 10.1073/pnas.240464697; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; KRUSEK J, 1994, EUR J PHARMACOL, V259, P121, DOI 10.1016/0014-2999(94)90500-2; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LAUBE B, 1995, NEUROREPORT, V6, P897, DOI 10.1097/00001756-199504190-00018; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; LYNCH JW, 1995, J BIOL CHEM, V270, P13799, DOI 10.1074/jbc.270.23.13799; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Ottesen EA, 1999, PARASITOL TODAY, V15, P382, DOI 10.1016/S0169-4758(99)01486-6; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; RAJENDRA S, 1994, J BIOL CHEM, V269, P18739; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; ROBERTSON B, 1989, BRIT J PHARMACOL, V98, P167, DOI 10.1111/j.1476-5381.1989.tb16878.x; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; SIGEL E, 1987, MOL PHARMACOL, V32, P749; Supplisson S, 2000, MOL PHARMACOL, V58, P763, DOI 10.1124/mol.58.4.763; VANDENBERG RJ, 1992, P NATL ACAD SCI USA, V89, P1765, DOI 10.1073/pnas.89.5.1765; VANDENBERG RJ, 1992, NEURON, V9, P491, DOI 10.1016/0896-6273(92)90186-H; VanLaethem Y, 1996, DRUGS, V52, P861, DOI 10.2165/00003495-199652060-00007; Vassilatis DK, 1997, J BIOL CHEM, V272, P33167, DOI 10.1074/jbc.272.52.33167; Vassilatis DK, 1997, J MOL EVOL, V44, P501, DOI 10.1007/PL00006174; YOUNG AB, 1973, P NATL ACAD SCI USA, V70, P2832, DOI 10.1073/pnas.70.10.2832	41	158	167	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12556	12564		10.1074/jbc.M011264200	http://dx.doi.org/10.1074/jbc.M011264200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278873	hybrid			2022-12-27	WOS:000168198600014
J	Bertin, J; Wang, L; Guo, Y; Jacobson, MD; Poyet, JL; Srinivasula, SM; Merriam, S; DiStefano, PS; Alnemri, ES				Bertin, J; Wang, L; Guo, Y; Jacobson, MD; Poyet, JL; Srinivasula, SM; Merriam, S; DiStefano, PS; Alnemri, ES			CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING PROTEIN; COILED COILS; RECEPTOR; RIP; PATHWAY; GENE	The caspase recruitment domain (CARD) is a protein-binding module that mediates the assembly of CARD-containing proteins into apoptosis and NF-kappaB signaling complexes. We report here that CARD protein II (CARD11) and CARD protein 14 (CARD14) are novel CARD-containing proteins that belong to the membrane associated guanylate kinase (MAGUK) family, a class of proteins that functions as molecular scaffolds for the assembly of multiprotein complexes at specialized regions of the plasma membrane. CARD11 and CARD14 have homologous structures consisting of an N-terminal CARD domain, a central coiled-coil domain, and a C-terminal tripartite domain comprised of a PDZ domain, an Src homology 3 domain, and a GUK domain with homology to guanylate kinase, The CARD domains of both CARD11 and CARD14 associate specifically with the CARD domain of BCL10, a signaling protein that activates NF-kappaB through the I kappaB kinase complex in response to upstream stimuli. When expressed in cells, CARD11 and CARD14 activate NF-kappaB and induce the phosphorylation of BCL10. These findings suggest that CARD11 and CARD14 are novel MAGUK family members that function as upstream activators of BCL10 and NF-kappaB signaling.	Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; Thomas Jefferson Univ, Ctr Apoptosis Res, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Inst, Philadelphia, PA 19107 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Jefferson University; Jefferson University	Bertin, J (corresponding author), Millennium Pharmaceut Inc, 640 Mem Dr, Cambridge, MA 02139 USA.	bertin@mpi.com	Poyet, Jean-Luc/G-7114-2017; Alnemri, Emad S/B-4526-2010	Poyet, Jean-Luc/0000-0002-3747-255X; 	NATIONAL CANCER INSTITUTE [R01CA085421] Funding Source: NIH RePORTER; NCI NIH HHS [CA85421] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad M, 1997, CANCER RES, V57, P615; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Costanzo A, 1999, J BIOL CHEM, V274, P20127, DOI 10.1074/jbc.274.29.20127; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guiet C, 2000, J CELL BIOL, V148, P1131, DOI 10.1083/jcb.148.6.1131; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Koseki T, 1999, J BIOL CHEM, V274, P9955, DOI 10.1074/jbc.274.15.9955; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Pawson T, 2000, GENE DEV, V14, P1027; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Srinivasula SM, 1999, J BIOL CHEM, V274, P17946, DOI 10.1074/jbc.274.25.17946; Thome M, 1999, J BIOL CHEM, V274, P9962, DOI 10.1074/jbc.274.15.9962; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Ye HT, 2000, AM J PATHOL, V157, P1147, DOI 10.1016/S0002-9440(10)64630-5; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	27	267	284	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11877	11882		10.1074/jbc.M010512200	http://dx.doi.org/10.1074/jbc.M010512200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278692	hybrid			2022-12-27	WOS:000168081800061
J	Feil, IK; Malfois, M; Hendle, J; van der Zandt, H; Svergun, DI				Feil, IK; Malfois, M; Hendle, J; van der Zandt, H; Svergun, DI			A novel quaternary structure of the dimeric alpha-crystallin domain with chaperone-like activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; SCATTERING-DATA TREATMENT; RAY SOLUTION SCATTERING; A-CRYSTALLIN; MOLECULAR CHAPERONE; B-CRYSTALLIN; X-RAY; NEUTRON-SCATTERING; SUBUNIT; LACTALBUMIN	alphaB-crystallin, a member of the small heat-shock protein family and a major eye lens protein, is a high molecular mass assembly and can act as a molecular chaperone. We report a synchrotron radiation x-ray solution scattering study of a truncation mutant from the human alphaB-crystallin (alpha B57-151), a dimeric protein that comprises the alpha -crystallin domain of the alphaB-crystallin and retains a significant chaperone-like activity. According to the sequence analysis (more than 23% identity), the monomeric fold of the alpha -crystallin domain should be close to that of the small heat-shock protein from Methanococcus jannaschii (MjHSP16.5). The theoretical scattering pattern computed from the crystallographic model of the dimeric MjHSP16.5 deviates significantly from the experimental scattering by the alpha -crystallin domain, pointing to different quaternary structures of the two proteins. A rigid body modeling against the solution scattering data yields a model of the alpha -crystallin domain revealing a new dimerization interface. The latter consists of a strand-turn-strand motif contributed by each of the monomers, which form a four-stranded, antiparallel, intersubunit composite beta -sheet. This model agrees with the recent spin labeling results and suggests that the alphaB-crystallin is composed by flexible building units with an extended surface area. This flexibility may be important for biological activity and for the formation of alphaB-crystallin complexes of variable sizes and compositions.	Deutsch Elektronen Synchrotron, European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; European Mol Biol Lab, Prot Express & Purificat Unit, D-69012 Heidelberg, Germany; Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); European Molecular Biology Laboratory (EMBL); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Svergun, DI (corresponding author), Deutsch Elektronen Synchrotron, European Mol Biol Lab, Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany.		Malfois, Marc/L-2974-2014	Malfois, Marc/0000-0001-5231-1896; Svergun, Dmitri/0000-0003-0830-5696				Aleshin AE, 1999, BIOCHEMISTRY-US, V38, P8359, DOI 10.1021/bi990523n; Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Berengian AR, 1999, J BIOL CHEM, V274, P6305, DOI 10.1074/jbc.274.10.6305; BOULIN C, 1986, NUCL INSTRUM METH A, V249, P399, DOI 10.1016/0168-9002(86)90694-7; BOULIN CJ, 1988, NUCL INSTRUM METH A, V269, P312, DOI 10.1016/0168-9002(88)90895-9; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; CLORE GM, 1995, FASEB J, V9, P57, DOI 10.1096/fasebj.9.1.7821760; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Demeler B, 1997, BIOPHYS J, V72, P397, DOI 10.1016/S0006-3495(97)78680-6; Ehrnsperger M, 1999, J BIOL CHEM, V274, P14867, DOI 10.1074/jbc.274.21.14867; Feigin L.A., 1987, STRUCTURE ANAL SMALL; GABRIEL A, 1982, NUCL INSTRUM METHODS, V201, P223, DOI 10.1016/0167-5087(82)90031-X; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Haley DA, 2000, J MOL BIOL, V298, P261, DOI 10.1006/jmbi.2000.3657; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KANTOROW M, 1995, J BIOL CHEM, V270, P17215, DOI 10.1074/jbc.270.29.17215; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9; Kokke BPA, 1998, FEBS LETT, V433, P228, DOI 10.1016/S0014-5793(98)00917-X; Krueger JK, 1997, BIOCHEMISTRY-US, V36, P6017, DOI 10.1021/bi9702703; KUNTZ ID, 1971, ARCH BIOCHEM BIOPHYS, V142, P660, DOI 10.1016/0003-9861(71)90532-7; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Lindner RA, 1997, J BIOL CHEM, V272, P27722, DOI 10.1074/jbc.272.44.27722; MERCK KB, 1992, BIOCHIM BIOPHYS ACTA, V1130, P267, DOI 10.1016/0167-4781(92)90439-7; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Mornon JP, 1998, INT J BIOL MACROMOL, V22, P219, DOI 10.1016/S0141-8130(98)00019-1; Muchowski PJ, 1999, J BIOL CHEM, V274, P30190, DOI 10.1074/jbc.274.42.30190; Muchowski PJ, 1999, J MOL BIOL, V289, P397, DOI 10.1006/jmbi.1999.2759; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Rajaraman K, 1998, BIOCHEM BIOPH RES CO, V249, P917, DOI 10.1006/bbrc.1998.9242; Shroff NP, 2000, BIOCHEMISTRY-US, V39, P1420, DOI 10.1021/bi991656b; SIEZEN RJ, 1983, BIOCHIM BIOPHYS ACTA, V748, P56, DOI 10.1016/0167-4838(83)90027-4; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1998, BIOPHYS J, V75, P2212, DOI 10.1016/S0006-3495(98)77665-9; Svergun DI, 2000, J BIOL CHEM, V275, P297, DOI 10.1074/jbc.275.1.297; SVERGUN DI, 1988, ACTA CRYSTALLOGR A, V44, P244, DOI 10.1107/S0108767387011255; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1997, PROTEINS, V27, P110; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; VERETOUT F, 1989, J MOL BIOL, V205, P713, DOI 10.1016/0022-2836(89)90316-1	46	106	106	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12024	12029		10.1074/jbc.M010856200	http://dx.doi.org/10.1074/jbc.M010856200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278766	hybrid			2022-12-27	WOS:000168081800079
J	Graeff, R; Munshi, C; Aarhus, R; Johns, M; Lee, HC				Graeff, R; Munshi, C; Aarhus, R; Johns, M; Lee, HC			A single residue at the active site of CD38 determines its NAD cyclizing and hydrolyzing activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYL CYCLASE; CALCIUM-MOBILIZING METABOLITE; ENZYMATIC-SYNTHESIS; CRYSTAL-STRUCTURE; NAADP; MOLECULE; GLYCOPROTEIN; LOCALIZATION; INTERMEDIATE; CYCLIZATION	CD38 is a multifunctional enzyme involved in metabolizing two Ca2+ messengers, cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP). When incubated with NAD, CD38 predominantly hydrolyzes it to ADP-ribose (NAD glycohydrolase), but a trace amount of cADPR is also produced through cyclization of the substrate. Site-directed mutagenesis was used to investigate the amino acid important for controlling the hydrolysis and cyclization reactions. CD38 and its mutants were produced in yeast, purified, and characterized by immunoblot, Glu-146 is a conserved residue present in the active site of CD38. Its replacement with Phe greatly enhanced the cyclization activity to a level similar to that of the NAD hydrolysis activity. A series of additional replacements was made at the Glu-146 position including Ala, Asn, Gly, Asp, and Leu. All the mutants exhibited enhanced cyclase activity to various degrees, whereas the hydrolysis activity was inhibited greatly. E146A showed the highest cyclase activity, which was more than 3-fold higher than its hydrolysis activity. All mutants also cyclized nicotinamide guanine dinucleotide to produce cyclic GDP. This activity was enhanced likewise, with E146A showing more than g-fold higher activity than the wild type. In addition to NAD, CD38 also hydrolyzed cADPR effectively, and this activity was correspondingly depressed in the mutants. When all the mutants were considered, the two cyclase activities and the two hydrolase activities were correlated linearly. The Glu-146 replacements, however, only minimally affected the base-exchange activity that is responsible for synthesizing NAADP. Homology modeling was used to assess possible structural changes at the active site of E146A. These results are consistent with Glu-146 being crucial in controlling specifically and selectively the cyclase and hydrolase activities of CD38.	Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lee, HC (corresponding author), Univ Minnesota, Dept Pharmacol, 321 Church St SE,4-145 Jackson Hall, Minneapolis, MN 55455 USA.		Graeff, Richard Milton/B-3425-2011; Lee, Hon Cheung/C-4329-2009		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060333] Funding Source: NIH RePORTER; NICHD NIH HHS [HD17484] Funding Source: Medline; NIGMS NIH HHS [GM60333] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Fernandez JE, 1998, J BIOL REG HOMEOS AG, V12, P81; Ferrero E, 1999, J LEUKOCYTE BIOL, V65, P151, DOI 10.1002/jlb.65.2.151; GLICK DL, 1991, CELL REGUL, V2, P211, DOI 10.1091/mbc.2.3.211; Graeff RM, 1996, BIOCHEMISTRY-US, V35, P379, DOI 10.1021/bi952083f; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Khoo KM, 1999, BRAIN RES, V821, P17, DOI 10.1016/S0006-8993(98)01347-X; KOGUMA T, 1994, BBA-MOL CELL RES, V1223, P160, DOI 10.1016/0167-4889(94)90087-6; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lee HC, 1999, BIOL CHEM, V380, P785, DOI 10.1515/BC.1999.098; Lee HC, 2000, CHEM IMMUNOL, V75, P39; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 1999, MOL CELL BIOCHEM, V193, P89; LEE HC, 1994, NAT STRUCT BIOL, V1, P143, DOI 10.1038/nsb0394-143; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Lee HC, 2000, J MEMBRANE BIOL, V173, P1, DOI 10.1007/s002320001001; MALAVASI F, 1994, IMMUNOL TODAY, V15, P95, DOI 10.1016/0167-5699(94)90148-1; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Munshi CB, 1997, METHOD ENZYMOL, V280, P318; Prasad GS, 1996, NAT STRUCT BIOL, V3, P957, DOI 10.1038/nsb1196-957; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Sauve AA, 2000, J AM CHEM SOC, V122, P7855, DOI 10.1021/ja001139c; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; TOHGO A, 1994, J BIOL CHEM, V269, P28555; Yamada M, 1997, BRAIN RES, V756, P52, DOI 10.1016/S0006-8993(97)00117-0	29	52	54	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12169	12173		10.1074/jbc.M011299200	http://dx.doi.org/10.1074/jbc.M011299200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278881	hybrid			2022-12-27	WOS:000168081800099
J	Boehr, DD; Thompson, PR; Wright, GD				Boehr, DD; Thompson, PR; Wright, GD			Molecular mechanism of aminoglycoside antibiotic kinase APH(3 ')-IIIa - Roles of conserved active site residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; 16S RIBOSOMAL-RNA; MODIFYING ENZYMES; TRANSITION-STATE; A-SITE; PHOSPHOTRANSFERASE; RESISTANCE; MUTAGENESIS; CATALYSIS; VISCOSITY	The aminoglycoside antibiotic kinases (APHs) constitute a clinically important group of antibiotic resistance enzymes. APHs share structural and functional homology with Ser/Thr and Tyr kinases, yet only five amino acids are invariant between the two groups of enzymes and these residues are all located within the nucleotide binding regions of the proteins. We have performed site-directed mutagenesis on all five conserved residues in the aminoglycoside kinase APH(3 ')-IIIa: Lys(44) and Glu(60) involved in ATP capture, a putative active site base required for deprotonating the incoming aminoglycoside hydroxyl group Asp(190), and the Mg2+ ligands Asn(195) and Glu(208), which coordinate two Mg2+ ions, Mg1 and Mg2. Previous structural and mutagenesis evidence have demonstrated that Lys(44) interacts directly with the phosphate groups of ATP; mutagenesis of invariant Glu(60), which forms a salt bridge with the epsilon -amino group of Lys44, demonstrated that this residue does not play a critical role in ATP recognition or catalysis, Results of mutagenesis of Asp(190) were consistent with a role in proper positioning of the aminoglycoside hydroxyl during phosphoryl transfer but not as a general base. The Mg1 and Mg2 ligand Asp(208) was found to be absolutely required for enzyme activity and the Mg2 ligand Asn(195) is important for Mg ATP recognition. The mutagenesis results together with solvent isotope, solvent viscosity, and divalent cation requirements are consistent with a dissociative mechanism of phosphoryl transfer where initial substrate deprotonation is not essential for phosphate transfer and where Mg2 and Asp(208) likely play a critical role in stabilization of a metaphosphate-like transition state. These results lay the foundation for the synthesis of transition state mimics that could reverse aminoglycoside antibiotic resistance in vivo.	McMaster Univ, Dept Biochem, Antimicrobial Res Ctr, Hamilton, ON L8N 3Z5, Canada	McMaster University	Wright, GD (corresponding author), McMaster Univ, Dept Biochem, Antimicrobial Res Ctr, Hamilton, ON L8N 3Z5, Canada.		Wright, G/ABB-7666-2021; Boehr, David/A-2068-2010	Wright, Gerard/0000-0002-9129-7131				Adediran SA, 1996, BIOCHEMISTRY-US, V35, P3604, DOI 10.1021/bi952107i; Admiraal SJ, 1999, BIOCHEMISTRY-US, V38, P4701, DOI 10.1021/bi9827565; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CLELAND WW, 1987, BIOORG CHEM, V15, P283, DOI 10.1016/0045-2068(87)90026-5; Daigle DM, 1999, CHEM BIOL, V6, P11, DOI 10.1016/S1074-5521(99)80016-7; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; Grant BD, 1996, PROTEIN SCI, V5, P1316, DOI 10.1002/pro.5560050710; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; KARSTEN WE, 1995, J AM CHEM SOC, V117, P5914, DOI 10.1021/ja00127a002; Kim K, 1997, J AM CHEM SOC, V119, P11096, DOI 10.1021/ja972110k; Kim K, 1998, J AM CHEM SOC, V120, P6851, DOI 10.1021/ja9808393; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEATHERBARROW RJ, 1992, GRAFIT VER 3 0; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P14115, DOI 10.1021/bi00251a021; McKay GA, 1996, BIOCHEMISTRY-US, V35, P8680, DOI 10.1021/bi9603884; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Northrop DB, 2000, BIOPHYS J, V79, P1621, DOI 10.1016/S0006-3495(00)76412-5; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Thompson PR, 1999, J BIOL CHEM, V274, P30697, DOI 10.1074/jbc.274.43.30697; Thompson PR, 1996, BIOCHEMISTRY-US, V35, P8686, DOI 10.1021/bi960389w; WOODCOCK J, 1991, EMBO J, V10, P3099, DOI 10.1002/j.1460-2075.1991.tb07863.x; Wright GD, 1999, CURR OPIN MICROBIOL, V2, P499, DOI 10.1016/S1369-5274(99)00007-7; Wright GD, 1998, ADV EXP MED BIOL, V456, P27; Wright Gerard D., 1999, Frontiers in Bioscience, V4, pD9, DOI 10.2741/Wright; Yoshizawa S, 1998, EMBO J, V17, P6437, DOI 10.1093/emboj/17.22.6437	36	60	65	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23929	23936		10.1074/jbc.M100540200	http://dx.doi.org/10.1074/jbc.M100540200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11279088	hybrid			2022-12-27	WOS:000169531100094
J	Zhang, PN; McAlinden, A; Li, S; Schumacher, T; Wang, HL; Hu, SS; Sandell, L; Crouch, E				Zhang, PN; McAlinden, A; Li, S; Schumacher, T; Wang, HL; Hu, SS; Sandell, L; Crouch, E			The amino-terminal heptad repeats of the coiled-coil neck domain of pulmonary surfactant protein D are necessary for the assembly of trimeric subunits and dodecamers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; I COLLAGEN; OSTEOGENESIS IMPERFECTA; ANTIINFLUENZA ACTIVITY; PRO-ALPHA-1(I) CHAIN; CRYSTAL-STRUCTURE; IIA PROCOLLAGEN; HELIX FORMATION; LECTIN DOMAINS; HOST-DEFENSE	Pulmonary surfactant protein D (SP-D), a lung host defense protein, is assembled as multimers of trimeric subunits. Trimerization of SP-D monomers is required for high affinity saccharide binding, and the oligomerization of trimers is required for many of its functions. A peptide containing the alpha -helical neck region can spontaneously trimerize in vitro. However, it is not known whether this sequence is necessary for the complete cellular assembly of disulfide-cross-linked, trimeric subunits and dodecamers, For the present studies, me synthesized mutant cDNAs with deletions or site-directed substitutions in the neck domain of rat SP-D, and examined the assembly of the newly synthesized proteins after transfection of CHO-K1 cells. The neck domain contains three "classical" heptad repeat motifs with leucine residues at the "d position," and a distinctive C-terminal repeat previously suggested to drive trimeric chain association, Deletion of the highly conserved core of the latter repeat (FSRYLKK) did not interfere with the secretion of dodecamers with lectin activity. Ey contrast, deletion of the entire neck domain or deletion of one or two amino-terminal repeats resulted in defective molecular assembly. The secreted proteins eluted in the position of monomers by gel filtration under nondenaturing conditions, In addition, the neck + carbohydrate recognition domain of SP-D was necessary and sufficient for the trimerization of a heterologous collagen sequence located amino-terminal to the trimeric coiled-coil. These studies provide strong evidence that the amino-terminal heptad repeats of the neck. domain are necessary for the intracellular, trimeric association of SP-D monomers and for the assembly and secretion of functional dodecamers.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Crouch, E (corresponding author), Barnes Jewish Hosp N, Dept Pathol & Immunol, Surg Pathol Mailstop 90-31-649,216 S Kingshighway, St Louis, MO 63110 USA.	crouch@path.wustl.edu		McAlinden, Audrey/0000-0001-8433-4224	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044015, P01HL029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036994] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-29594, HL-44015] Funding Source: Medline; NIAMS NIH HHS [AR-36994] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Botas C, 1998, P NATL ACAD SCI USA, V95, P11869, DOI 10.1073/pnas.95.20.11869; BrownAugsburger P, 1996, J BIOL CHEM, V271, P13724, DOI 10.1074/jbc.271.23.13724; BrownAugsburger P, 1996, J BIOL CHEM, V271, P18912, DOI 10.1074/jbc.271.31.18912; Bulleid NJ, 1997, EMBO J, V16, P6694, DOI 10.1093/emboj/16.22.6694; Cai GZ, 1999, AM J PHYSIOL-LUNG C, V276, pL131, DOI 10.1152/ajplung.1999.276.1.L131; CHESSLER SD, 1993, J BIOL CHEM, V268, P18218; CROUCH E, 1994, J BIOL CHEM, V269, P17311; CROUCH E, 1993, J BIOL CHEM, V268, P2976; CROUCH E, 1994, J BIOL CHEM, V269, P15808; Crouch E C, 2000, Respir Res, V1, P93; Crouch EC, 1998, AM J RESP CELL MOL, V19, P177, DOI 10.1165/ajrcmb.19.2.140; CURRAN S, 1982, BIOCHEMISTRY-US, V21, P1482, DOI 10.1021/bi00536a003; DOEGE KJ, 1986, J BIOL CHEM, V261, P8924; DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x; Eggleton P, 1999, CURR OPIN IMMUNOL, V11, P28, DOI 10.1016/S0952-7915(99)80006-5; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Engel J, 2000, MATRIX BIOL, V19, P283, DOI 10.1016/S0945-053X(00)00075-5; FISHER LW, 1987, J BIOL CHEM, V262, P13457; Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672; Frischholz S, 1998, J BIOL CHEM, V273, P4547, DOI 10.1074/jbc.273.8.4547; Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Hartshorn KL, 1996, BLOOD, V87, P3450, DOI 10.1182/blood.V87.8.3450.bloodjournal8783450; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; Hartshorn KL, 2000, AM J PHYSIOL-LUNG C, V278, pL90, DOI 10.1152/ajplung.2000.278.1.L90; Hickling TP, 1999, EUR J IMMUNOL, V29, P3478, DOI 10.1002/(SICI)1521-4141(199911)29:11<3478::AID-IMMU3478>3.0.CO;2-W; Holmskov UL, 2000, APMIS, V108, P7; HOPPE HJ, 1994, STRUCTURE, V2, P1129, DOI 10.1016/S0969-2126(94)00115-4; HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1; Ikegami M, 2000, AM J PHYSIOL-LUNG C, V279, pL468, DOI 10.1152/ajplung.2000.279.3.L468; Kishore U, 1996, BIOCHEM J, V318, P505, DOI 10.1042/bj3180505; Korfhagen TR, 1998, J BIOL CHEM, V273, P28438, DOI 10.1074/jbc.273.43.28438; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; LIM BL, 1994, BIOCHEM BIOPH RES CO, V202, P1674, DOI 10.1006/bbrc.1994.2127; Mazzorana M, 1996, J BIOL CHEM, V271, P29003, DOI 10.1074/jbc.271.46.29003; Oganesian A, 1997, J HISTOCHEM CYTOCHEM, V45, P1469, DOI 10.1177/002215549704501104; PERSSON A, 1989, BIOCHEMISTRY-US, V28, P6361, DOI 10.1021/bi00441a031; QUESENBERRY M S, 1991, Glycobiology, V1, P615, DOI 10.1093/glycob/1.6.615; SANDELL LJ, 1991, J CELL BIOL, V114, P1307, DOI 10.1083/jcb.114.6.1307; SANDELL LJ, 1990, EXTRACELLULAR MATRIX, P1; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; Snellman A, 2000, EMBO J, V19, P5051, DOI 10.1093/emboj/19.19.5051; SPISSINGER T, 1991, EUR J BIOCHEM, V199, P65, DOI 10.1111/j.1432-1033.1991.tb16092.x; WANG JY, 1995, FEBS LETT, V376, P6, DOI 10.1016/0014-5793(95)01232-4; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; White MR, 2000, J IMMUNOL, V165, P2108, DOI 10.4049/jimmunol.165.4.2108; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069	51	43	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19862	19870		10.1074/jbc.M100597200	http://dx.doi.org/10.1074/jbc.M100597200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279100	hybrid			2022-12-27	WOS:000169135100026
J	Ren, YS; Liao, WSL				Ren, YS; Liao, WSL			Transcription factor AP-2 functions as a repressor that contributes to the liver-specific expression of serum amyloid A1 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTIVE SILENCER FACTOR; C-REACTIVE PROTEIN; NF-KAPPA-B; DNA-BINDING; MESSENGER-RNAS; C/EBP-LIKE; ACTIVATION; SEQUENCE; CELLS; IDENTIFICATION	We previously identified transcription factor AP-2 as the nuclear factor that interacts with the tissue-specific repressor element in the rat serum amyloid Al (SAA1) promoter. In this report, we provide evidence for a second AP-2-binding site and show that both AP-2 sites participate in mediating the transcription repression of SAA1 promoter. This proximal AP-2 site overlaps with the NF kappaB-binding site known to be essential for SAA1 promoter activity. Protein binding competition experiments demonstrated that AP-2 and NF kappaB binding to these overlapping sites were mutually exclusive. Furthermore, the addition of AP-2 easily displaced prebound NF kappaB, whereas NF kappaB could not displace AP-2, These results thus suggest that one mechanism by which AP-2 negatively regulates SAA1 promoter activity may be by antagonizing the function of NF kappaB, Consistent with a repression function, transient expression of AP-2 in HepG2 cells inhibited conditioned medium-induced SAA1 promoter activation. This inhibition was dependent on functional AP-2-binding sites, since mutation of AP-a-binding sites abolished inhibitory effects of AP-2 in HepG2 cells as well as resulted in derepression of the SAA1 promoter in HeLa cells. In addition to SAA1, we found that several other liver gene promoters also contain putative AP-2-binding sites. Some of these sequences could specifically inhibit AP-2-DNA complex formation, and for the human complement C3 promoter, overexpression of AP-2 also could repress its cytokine-mediated activation. Finally, stable expression of AP-2 in hepatoma cells significantly reduced the expression of endogenous SAA, albumin, and alpha -fetoprotein genes. Taken together, our results suggest that AP-2 may function as a transcription repressor to inhibit the expression of not only SAA1 gene but also other liver genes in nonhepatic cells.	Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Program Genes & Dev, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Liao, WSL (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Program Genes & Dev, Box 117, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038858, R29AR038858] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 38858] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEALE EG, 1985, J BIOL CHEM, V260, P748; BENSON MD, 1980, J IMMUNOL, V124, P495; Bisgrove DA, 1997, MOL CELL BIOL, V17, P5935, DOI 10.1128/MCB.17.10.5935; BLACKHART BD, 1986, J BIOL CHEM, V261, P5364; Butler A, 1996, IMMUNOGENETICS, V44, P468, DOI 10.1007/BF02602809; Chen AP, 1996, J BIOL CHEM, V271, P25994, DOI 10.1074/jbc.271.42.25994; Chen TT, 1997, MOL CELL BIOL, V17, P3056, DOI 10.1128/MCB.17.6.3056; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; CORCORAN LM, 1993, GENE DEV, V7, P570, DOI 10.1101/gad.7.4.570; DEBEER MC, 1994, J BIOL CHEM, V269, P4661; DEBEER MC, 1991, BIOCHEM J, V280, P45, DOI 10.1042/bj2800045; EDBROOKE MR, 1989, MOL CELL BIOL, V9, P1908, DOI 10.1128/MCB.9.5.1908; FONG KY, 1990, GENOMICS, V7, P579, DOI 10.1016/0888-7543(90)90202-6; FOWLKES DM, 1984, P NATL ACAD SCI-BIOL, V81, P2313, DOI 10.1073/pnas.81.8.2313; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; GANAPATHI MK, 1991, J IMMUNOL, V147, P1261; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; GETMAN DK, 1995, J BIOL CHEM, V270, P23511, DOI 10.1074/jbc.270.40.23511; Goodrich JA, 1996, CELL, V84, P825, DOI 10.1016/S0092-8674(00)81061-2; GOREVIC PD, 1981, ANNU REV MED, V32, P261, DOI 10.1146/annurev.me.32.020181.001401; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; HERSCHBACH BM, 1993, ANNU REV CELL BIOL, V9, P479, DOI 10.1146/annurev.cellbio.9.1.479; HUANG JH, 1990, MOL CELL BIOL, V10, P3619, DOI 10.1128/MCB.10.7.3619; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3467, DOI 10.1073/pnas.95.7.3467; JIANG SL, 1995, J IMMUNOL, V154, P825; JOHNSON AD, 1995, CELL, V81, P655, DOI 10.1016/0092-8674(95)90524-3; JOHNSON FB, 1992, GENE DEV, V6, P2177, DOI 10.1101/gad.6.11.2177; KAKKIS E, 1989, NATURE, V339, P718, DOI 10.1038/339718a0; KANNAN F, 1994, GENE DEV, V8, P1258, DOI 10.1101/gad.8.11.1258; Latchman DS, 1996, INT J BIOCHEM CELL B, V28, P965, DOI 10.1016/1357-2725(96)00039-8; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Li L, 1999, BIOCHEM BIOPH RES CO, V264, P395, DOI 10.1006/bbrc.1999.1527; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LI X, 1992, NUCLEIC ACIDS RES, V20, P4765, DOI 10.1093/nar/20.18.4765; LI XX, 1991, J BIOL CHEM, V266, P15192; LOWELL CA, 1986, J BIOL CHEM, V261, P8442; LOWELL CA, 1986, J BIOL CHEM, V261, P8453; LU SY, 1994, MOL CELL BIOL, V14, P6253, DOI 10.1128/MCB.14.9.6253; LUCERO MA, 1986, NUCLEIC ACIDS RES, V14, P8692; Maytin EV, 1999, DEV BIOL, V216, P164, DOI 10.1006/dbio.1999.9460; McKnight SL, 1996, GENE DEV, V10, P367, DOI 10.1101/gad.10.4.367; MCLEAN J, 1986, NUCLEIC ACIDS RES, V14, P9397, DOI 10.1093/nar/14.23.9397; MEIER P, 1995, DEV BIOL, V169, P1, DOI 10.1006/dbio.1995.1121; Meijer OC, 2000, J NEUROENDOCRINOL, V12, P245; MISKIMINS WK, 1986, J CELL BIOL, V103, P1781, DOI 10.1083/jcb.103.5.1781; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; OHSAKO S, 1994, GENE DEV, V8, P2743, DOI 10.1101/gad.8.22.2743; PAHO CO, 1992, ANNU REV BIOCHEM, V61, P1053; PAIK YK, 1985, P NATL ACAD SCI USA, V82, P3445, DOI 10.1073/pnas.82.10.3445; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pena P, 1999, MOL ENDOCRINOL, V13, P1402, DOI 10.1210/me.13.8.1402; PROTTER AA, 1984, DNA-J MOLEC CELL BIO, V3, P449, DOI 10.1089/dna.1.1984.3.449; REINKE R, 1985, J BIOL CHEM, V260, P4397; Ren YS, 1999, J BIOL CHEM, V274, P37154, DOI 10.1074/jbc.274.52.37154; RIENHOFF HY, 1990, MOL BIOL MED, V7, P287; Rietveld LEG, 1999, BIOCHEM J, V338, P799, DOI 10.1042/0264-6021:3380799; ROBERTS SGE, 1995, NATURE, V375, P105, DOI 10.1038/375105a0; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; SAUER F, 1993, NATURE, V364, P454, DOI 10.1038/364454a0; SAUER F, 1995, NATURE, V375, P162, DOI 10.1038/375162a0; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SMITH JW, 1992, CLIN EXP IMMUNOL, V90, P293; Steel DM, 1996, SCAND J IMMUNOL, V44, P493, DOI 10.1046/j.1365-3083.1996.d01-341.x; TJIAN R, 1981, CELL, V26, P1, DOI 10.1016/0092-8674(81)90026-X; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; WILSON DR, 1990, MOL CELL BIOL, V10, P6181, DOI 10.1128/MCB.10.12.6181; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	77	23	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17770	17778		10.1074/jbc.M010307200	http://dx.doi.org/10.1074/jbc.M010307200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278660	hybrid			2022-12-27	WOS:000168866500022
J	Stuart, JA; Harper, JA; Brindle, KM; Jekabsons, MB; Brand, MD				Stuart, JA; Harper, JA; Brindle, KM; Jekabsons, MB; Brand, MD			Physiological levels of mammalian uncoupling protein 2 do not uncouple yeast mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; RAT SKELETAL-MUSCLE; PROTON LEAK; UCP1-ABLATED MICE; INNER MEMBRANE; MESSENGER-RNA; UCP3; NUCLEOTIDES; TRANSPORT; HOMOLOG	assessed the ability of human uncoupling protein 2 (UCP2) to uncouple mitochondrial oxidative phosphorylation when expressed in yeast at physiological and supraphysiological levels. We used three different inducible UCP2 expression constructs to achieve mitochondrial UCP2 expression levels in yeast of 33, 283, and 4100 ng of UCP2/mg of mitochondrial protein. Yeast mitochondria expressing UCP2 at 33 or 283 ng/mg showed no increase in proton conductance, even in the presence of various putative effecters, including palmitate and all-trans-retinoic acid. Only when UCP2 expression in yeast mitochondria was increased to 4 mug/mg, more than an order of magnitude greater than the highest known physiological concentration, was proton conductance increased. This increased proton conductance was not abolished by GDP, At this high level of UCP2 expression, an inhibition of substrate oxidation was observed, which cannot be readily explained by an uncoupling activity of UCP2. Quantitatively, even the uncoupling seen at 4 mug/mg was insufficient to account for the basal proton conductance of mammalian mitochondria, These observations suggest that uncoupling of yeast mitochondria by UCP2 is an overexpression artifact leading to compromised mitochondrial integrity.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge	Brand, MD (corresponding author), MRC, Dunn Human Nutr Unit, Hills Rd, Cambridge CB2 2XY, England.		Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153				ARECHAGA I, 1993, BIOCHEM J, V296, P693, DOI 10.1042/bj2960693; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; BOUILLAUD F, 1994, EMBO J, V13, P1990, DOI 10.1002/j.1460-2075.1994.tb06468.x; Brand M. D., 1995, BIOENERGETICS, V154, P62; Brand MD, 1999, INT J OBESITY, V23, pS4, DOI 10.1038/sj.ijo.0800936; BRAND MD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P128, DOI 10.1016/0005-2728(90)90232-S; Brookes PS, 1997, BBA-BIOMEMBRANES, V1330, P157, DOI 10.1016/S0005-2736(97)00160-0; Cadenas S, 2000, BIOCHEM J, V348, P209, DOI 10.1042/0264-6021:3480209; Cadenas S., 2000, International Journal of Obesity, V24, pS187; Cadenas S, 1999, FEBS LETT, V462, P257, DOI 10.1016/S0014-5793(99)01540-9; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Echtay KS, 1999, FEBS LETT, V450, P8, DOI 10.1016/S0014-5793(99)00460-3; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Guerin B, 1979, Methods Enzymol, V55, P149; Hagen T, 2000, BIOCHEMISTRY-US, V39, P5845, DOI 10.1021/bi992980+; HEIDKAEMPER D, 2000, FEBS LETT, V406, P1; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; Hinz W, 1999, FEBS LETT, V462, P411, DOI 10.1016/S0014-5793(99)01568-9; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Jekabsons MB, 2001, BBA-BIOENERGETICS, V1503, P314, DOI 10.1016/S0005-2728(00)00209-7; Jekabsons MB, 1999, AM J PHYSIOL-ENDOC M, V277, pE380, DOI 10.1152/ajpendo.1999.277.2.E380; Jezek P, 1998, INT J BIOCHEM CELL B, V30, P1163, DOI 10.1016/S1357-2725(98)00076-4; Klingenberg M, 2001, BBA-BIOENERGETICS, V1504, P128, DOI 10.1016/S0005-2728(00)00242-5; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Matthias A, 1999, J BIOL CHEM, V274, P28150, DOI 10.1074/jbc.274.40.28150; Monemdjou S, 1999, AM J PHYSIOL-ENDOC M, V276, pE1073, DOI 10.1152/ajpendo.1999.276.6.E1073; Nedergaard J, 1999, J BIOENERG BIOMEMBR, V31, P475, DOI 10.1023/A:1005400507802; NICHOLLS DG, 1979, BIOCHIM BIOPHYS ACTA, V549, P1, DOI 10.1016/0304-4173(79)90016-8; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Prieto S, 1996, ARCH BIOCHEM BIOPHYS, V334, P43, DOI 10.1006/abbi.1996.0427; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; Stuart J. A., 2000, International Journal of Obesity, V24, pS187; Stuart JA, 2001, BBA-BIOENERGETICS, V1504, P144, DOI 10.1016/S0005-2728(00)00243-7; STUART JA, 2001, IN PRESS BIOCH J; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; Yu XX, 2000, AM J PHYSIOL-ENDOC M, V279, pE433, DOI 10.1152/ajpendo.2000.279.2.E433; Zhang CY, 1999, FEBS LETT, V449, P129, DOI 10.1016/S0014-5793(99)00441-X	46	81	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18633	18639		10.1074/jbc.M011566200	http://dx.doi.org/10.1074/jbc.M011566200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278935	hybrid			2022-12-27	WOS:000168866500134
J	Oyedotun, KS; Lemire, BD				Oyedotun, KS; Lemire, BD			The quinone-binding sites of the Saccharomyces cerevisiae succinate-ubiquinone oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE FLAVOPROTEIN SUBUNIT; COLI FUMARATE REDUCTASE; MEMBRANE-INTEGRAL DOMAIN; RESPIRATORY COMPLEX-II; ESCHERICHIA-COLI; ELECTRON-TRANSFER; PROTON TRANSLOCATION; CYTOCHROME-B; ENERGY TRANSDUCTION; REACTION CENTERS	The Saccharomyces cerevisiae succinate dehydrogenase (SDH) of the mitochondrial electron transport chain oxidizes succinate and reduces ubiquinone, Using a random mutagenesis approach, we identified functionally important amino acid residues in one of the anchor subunits, Sdh4p, We analyzed three point mutations (F69V, S71A, and H99L) and one nonsense mutation (Y890CH) that truncates the Sdh4p subunit at the third predicted transmembrane segment, The F69V and the S71A mutations result in greatly impaired respiratory growth in vivo and quinone reductase activities in vitro, with negligible effects on enzyme stability. In contrast, the Y89OCH and the H99L mutations elicit large structural perturbations that impair assembly as evidenced by reduced covalent FAD levels, membrane-associated succinate-phenazine methosulfate reductase activities, and thermal stability. We propose that the Phe-69 and the Ser-71 residues are involved in the formation of a quinone-binding site, whereas the His-99 residue is at the interface of the peripheral and the membrane domains. In addition, the properties of the Y890CH mutation are consistent with the interpretation that the third transmembrane segment is not involved in catalysis but rather plays an important structural role. The mutant enzymes are differentially sensitive to a quinone analog inhibitor, providing further evidence for a two-quinone binding model in the yeast SDH.	Univ Alberta, Canadian Inst Hlth Res Grp Mol Biol Membrane Prot, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Lemire, BD (corresponding author), Univ Alberta, Canadian Inst Hlth Res Grp Mol Biol Membrane Prot, Dept Biochem, Edmonton, AB T6G 2H7, Canada.							ABRAHAM PR, 1994, MOL GEN GENET, V242, P708, DOI 10.1007/BF00283426; Ackrell B. A.C, 1992, CHEM BIOCH FLAVOPROT, V3, P229; Ackrell BAC, 2000, FEBS LETT, V466, P1, DOI 10.1016/S0014-5793(99)01749-4; ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P5730, DOI 10.1073/pnas.84.16.5730; Allen JP, 1998, FEBS LETT, V438, P5, DOI 10.1016/S0014-5793(98)01245-9; BRANDT U, 1988, EUR J BIOCHEM, V173, P499, DOI 10.1111/j.1432-1033.1988.tb14026.x; Bruel C, 1995, J BIOENERG BIOMEMBR, V27, P527, DOI 10.1007/BF02110192; BULLIS BL, 1994, J BIOL CHEM, V269, P6543; CHAPMAN KB, 1992, GENE, V118, P131, DOI 10.1016/0378-1119(92)90260-V; Cleland W W, 1979, Methods Enzymol, V63, P103; COLE ST, 1985, BIOCHIM BIOPHYS ACTA, V811, P381, DOI 10.1016/0304-4173(85)90008-4; COLSON AM, 1993, J BIOENERG BIOMEMBR, V25, P211, DOI 10.1007/BF00762583; DAIGNANFORNIER B, 1994, J BIOL CHEM, V269, P15469; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hagerhall C, 1996, FEBS LETT, V389, P25, DOI 10.1016/0014-5793(96)00529-7; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Hederstedt L, 1998, BIOCHEM SOC T, V26, P408, DOI 10.1042/bst0260408; HEDERSTEDT L, 1992, MOL MECHANISMS BIOEN, P163; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; LEE GY, 1995, J BIOL CHEM, V270, P6193, DOI 10.1074/jbc.270.11.6193; LOMBARDO A, 1990, J BIOL CHEM, V265, P10419; LOMBARDO A, 1989, J BIOL CHEM, V264, P18874; MITCHELL P, 1987, ADV MEMBRANE BIOCH B, P25; MIYOSHI H, 1990, BIOCHIM BIOPHYS ACTA, V1016, P99, DOI 10.1016/0005-2728(90)90011-R; Oyedotun KS, 1999, FEBS LETT, V442, P203, DOI 10.1016/S0014-5793(98)01657-3; Oyedotun KS, 1999, BBA-BIOENERGETICS, V1411, P170, DOI 10.1016/S0005-2728(99)00040-7; Oyedotun KS, 1999, J BIOL CHEM, V274, P23956, DOI 10.1074/jbc.274.34.23956; Oyedotun KS, 1997, J BIOL CHEM, V272, P31382, DOI 10.1074/jbc.272.50.31382; PADDOCK ML, 1989, P NATL ACAD SCI USA, V86, P6602, DOI 10.1073/pnas.86.17.6602; RICH PR, 1977, BIOCHIM BIOPHYS ACTA, V462, P501, DOI 10.1016/0005-2728(77)90097-4; RICH PR, 1978, BIOCHIM BIOPHYS ACTA, V504, P345, DOI 10.1016/0005-2728(78)90059-2; Robinson KM, 1995, METHOD ENZYMOL, V260, P34, DOI 10.1016/0076-6879(95)60128-7; ROBINSON KM, 1991, J BIOL CHEM, V266, P21347; ROBINSON KM, 1994, EUR J BIOCHEM, V222, P983, DOI 10.1111/j.1432-1033.1994.tb18949.x; ROBINSON KM, 1992, J BIOL CHEM, V267, P10101; SAITOH I, 1992, EUR J BIOCHEM, V209, P73, DOI 10.1111/j.1432-1033.1992.tb17262.x; Scheffler IE, 1998, PROG NUCLEIC ACID RE, V60, P267, DOI 10.1016/S0079-6603(08)60895-8; SCHULKE N, 1992, P NATL ACAD SCI USA, V89, P8011, DOI 10.1073/pnas.89.17.8011; Shenoy SK, 1999, J BIOL CHEM, V274, P8717, DOI 10.1074/jbc.274.13.8717; Shenoy SK, 1997, J BIOL CHEM, V272, P17867, DOI 10.1074/jbc.272.28.17867; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; VANHELLEMOND JJ, 1994, BIOCHEM J, V304, P321, DOI 10.1042/bj3040321; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; WESTENBERG DJ, 1990, J BIOL CHEM, V265, P19560; WIKSTROM M, 1984, BIOENERGETICS, P49; Wu JW, 1998, BIOCHEM J, V335, P181, DOI 10.1042/bj3350181; Yang XD, 1998, J BIOL CHEM, V273, P31916, DOI 10.1074/jbc.273.48.31916; Yankovskaya V, 1996, J BIOL CHEM, V271, P21020, DOI 10.1074/jbc.271.35.21020; YU CA, 1980, BIOCHEMISTRY-US, V19, P3579, DOI 10.1021/bi00556a025; YU CA, 1985, BIOCHEMISTRY-US, V24, P3897, DOI 10.1021/bi00336a013; YU L, 1981, BIOCHIM BIOPHYS ACTA, V637, P383, DOI 10.1016/0005-2728(81)90177-8	54	37	38	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16936	16943		10.1074/jbc.M100184200	http://dx.doi.org/10.1074/jbc.M100184200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279023	hybrid			2022-12-27	WOS:000168730400045
J	Hirata, K; Ishida, T; Penta, K; Rezaee, M; Yang, E; Wohlgemuth, J; Quertermous, T				Hirata, K; Ishida, T; Penta, K; Rezaee, M; Yang, E; Wohlgemuth, J; Quertermous, T			Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-JUNCTIONS; SUPERFAMILY; ANGIOGENESIS; RECEPTOR; PROTEIN; MEMBER; MEMBRANE; PECAM-1; SURFACE; CTX	To gain fundamental information regarding the molecular basis of endothelial cell adhesive interactions during vascular formation, we have cloned and characterized a unique cell adhesion molecule. This molecule, named endothelial cell-selective adhesion molecule (ESAM), is a new member of the immunoglobulin superfamily. The conceptual protein encoded by cDNA clones consists of V-type and C2-type immunoglobulin domains as well as a hydrophobic signal sequence, a single transmembrane region, and a cytoplasmic domain. Northern blot analysis showed ESAM to be selectively expressed in cultured human and murine vascular endothelial cells and revealed high level expression in lung and heart and low level expression in kidney and skin. In situ hybridization analysis indicated that ESAM is primarily expressed in the developing vasculature of the embryo in an endothelial cell-restricted pattern. Epitope-tagged ESAM was shown to co-localize with cadherins and catenins in cell-cell junctions. In aggregation assays employing ESAM-expressing Chinese hamster ovary cells, this novel molecule was shown to mediate cell-cell adhesion through homophilic interactions. The endothelial cell-selective expression of this immunoglobulin-like adhesion molecule coupled with its in vitro functional profile strongly suggests a role in cell-cell interactions that is critical for vascular development or function.	Stanford Univ, Sch Med, Div Cardiovasc Med, Falk CVRC, Stanford, CA 94305 USA; Kobe Univ, Sch Med, Dept Internal Med 1, Kobe, Hyogo 6500017, Japan	Stanford University; Kobe University	Quertermous, T (corresponding author), Stanford Univ, Sch Med, Div Cardiovasc Med, Falk CVRC, 300 Pasteur Dr, Stanford, CA 94305 USA.			Quertermous, Thomas/0000-0002-7645-9067				BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; Bischoff J, 1997, J CLIN INVEST, V99, P373, DOI 10.1172/JCI119168; Bosenberg MW, 1993, CURR OPIN CELL BIOL, V5, P832, DOI 10.1016/0955-0674(93)90032-L; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chretien I, 1996, EUR J IMMUNOL, V26, P780, DOI 10.1002/eji.1830260409; Chretien I, 1998, EUR J IMMUNOL, V28, P4094; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; DeLisser HM, 1997, AM J PATHOL, V151, P671; DRAKE CJ, 1995, J CELL SCI, V108, P2655; Duncan GS, 1999, J IMMUNOL, V162, P3022; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Heath JK, 1997, P NATL ACAD SCI USA, V94, P469, DOI 10.1073/pnas.94.2.469; Hidai C, 1998, GENE DEV, V12, P21, DOI 10.1101/gad.12.1.21; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Hogan B., 1994, MANIPULATING MOUSE E, P344; Huang YQ, 1997, J CELL BIOL, V138, P143, DOI 10.1083/jcb.138.1.143; Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; Katevuo K, 1999, J IMMUNOL, V162, P5685; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Newman PJ, 1997, J CLIN INVEST, V100, pS25; Newman PJ, 1999, J CLIN INVEST, V103, P5, DOI 10.1172/JCI5928; Palmeri D, 2000, J BIOL CHEM, V275, P19139, DOI 10.1074/jbc.M003189200; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PIMENTA AF, 1995, NEURON, V15, P287, DOI 10.1016/0896-6273(95)90034-9; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Robert J, 1997, EXP CELL RES, V235, P227, DOI 10.1006/excr.1997.3672; SHIMOYAMA Y, 1992, CANCER RES, V52, P5770; Stromblad S, 1996, CHEM BIOL, V3, P881, DOI 10.1016/S1074-5521(96)90176-3; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; Telo P, 1998, J BIOL CHEM, V273, P17565, DOI 10.1074/jbc.273.28.17565; Vaughn DE, 1996, NEURON, V16, P261, DOI 10.1016/S0896-6273(00)80045-8; VONHEIJNE G, 1987, SEQUENCE ANAL MOL BI, P112; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387	45	143	151	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16223	16231		10.1074/jbc.M100630200	http://dx.doi.org/10.1074/jbc.M100630200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279107	hybrid			2022-12-27	WOS:000168623100088
J	Ivanova, AV; Ivanov, SV; Danilkovitch-Miagkova, A; Lerman, MI				Ivanova, AV; Ivanov, SV; Danilkovitch-Miagkova, A; Lerman, MI			Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; NUCLEAR-PORE COMPLEX; TRANSFORMING-GROWTH-FACTOR; GTPASE-ACTIVATING PROTEIN; RENAL-CELL CARCINOMA; MOLECULAR CHARACTERIZATION; HUMAN HOMOLOG; C-JUN; GENE; UBC9	In this study, we focus on different modes of regulation of STRA13, a human ortholog of the mouse basic helix-loop-helix transcriptional factor, previously identified by us as a new von Hippel-Lindau tumor suppressor gene (VHL) target. The gene was overexpressed in VHL-deficient cell lines and tumors, specifically clear cell renal carcinomas and hemangioblastomas, Introduction of wild type VHL transgene into clear cell renal carcinoma restored low level expression of STRA13, Overexpression was also detected in many common malignancies with an intact VHL gene, suggesting the existence of another, VHL-independent pathway of STRA13 regulation, Similar to many other von Hippel-Lindau tumor-suppressor protein (pVHL) targets, the expression of STRA13 on the mRNA level was hypoxia-sensitive, indicating oxygen-dependent regulation of the gene, presumably through the pVHL/hypoxia-inducible factor 1 (HIF-1) pathway. The yeast two-hybrid screening revealed interaction of the STRA13 protein with the human ubiquitin-conjugating enzyme (UBC9) protein, the specificity of which was confirmed in mammalian cells. By adding the proteasome inhibitor acetyl-leucinyl-leucinyl-norleucinal, we demonstrated that the 26 S proteasome pathway regulates the stability of pSTRA13, Go-expression of STRA13 and UBC9 led to an increase of the pSTRA13 ubiquitination and subsequent degradation. These data established that UBC9/STRA13 association in cells is of physiological importance, presenting direct proof of UBC9 involvement in the ubiquitin-dependent degradation of pSTRA13, Hypoxia treatment of mammalian cells transiently expressing STRA13 protein showed that stability of pSTRA13 is not affected by hypoxia or VHL, Thus, STRA13, a new pVHL target, is regulated in cells on multiple levels. We propose that STRA13 may play a critical role in carcinogenesis, since it is a potent transcriptional regulator, abundant in a variety of common tumors.	NCI, Immunobiol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; NCI, Intamural Res Support Program, SAIC Frederick, Frederick Canc Res & Dev Ctr,Lab Immunobiol, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Ivanova, AV (corresponding author), NCI, Immunobiol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA.			Ivanov, Sergey/0000-0001-9770-7237	NCI NIH HHS [N01-CO-56000] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Ananth S, 1999, CANCER RES, V59, P2210; Boddy MN, 1996, ONCOGENE, V13, P971; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Chakrabarti SR, 1999, P NATL ACAD SCI USA, V96, P7467, DOI 10.1073/pnas.96.13.7467; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Firestein R, 1998, J BIOL CHEM, V273, P5892, DOI 10.1074/jbc.273.10.5892; Fogt F, 1998, ONCOL REP, V5, P923; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; Gottlicher M, 1996, STEROIDS, V61, P257, DOI 10.1016/0039-128X(96)00032-3; Hahn SL, 1997, ONCOGENE, V15, P1489, DOI 10.1038/sj.onc.1201301; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; Hateboer G, 1996, J BIOL CHEM, V271, P25906, DOI 10.1074/jbc.271.42.25906; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HOOD JK, 2000, BIOCHIM BIOPHYS ACTA, V1471, P31; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; ISHIBASHI M, 1993, EUR J BIOCHEM, V215, P645, DOI 10.1111/j.1432-1033.1993.tb18075.x; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Ivanov SV, 1998, P NATL ACAD SCI USA, V95, P12596, DOI 10.1073/pnas.95.21.12596; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kho CJ, 1997, J BIOL CHEM, V272, P3845, DOI 10.1074/jbc.272.6.3845; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Knebelmann B, 1998, CANCER RES, V58, P226; Kohler M, 1999, EXP NEPHROL, V7, P290; Kovalenko OV, 1996, P NATL ACAD SCI USA, V93, P2958, DOI 10.1073/pnas.93.7.2958; Kroll SL, 1999, J BIOL CHEM, V274, P30109, DOI 10.1074/jbc.274.42.30109; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LITTLEWOOD TD, 1995, PROTEIN PROFILE, V2, P649; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Masson M, 1997, GENE, V190, P287, DOI 10.1016/S0378-1119(97)00015-2; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Semenza GL, 2000, GENE DEV, V14, P1983; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Shen ZY, 1996, GENOMICS, V37, P183, DOI 10.1006/geno.1996.0540; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; WALLACE AC, 1972, CANCER, V29, P977, DOI 10.1002/1097-0142(197204)29:4<977::AID-CNCR2820290444>3.0.CO;2-P; WANG GL, 1993, J BIOL CHEM, V268, P21513; Wang ZY, 1996, J BIOL CHEM, V271, P24811, DOI 10.1074/jbc.271.40.24811; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; Yasugi T, 1996, NUCLEIC ACIDS RES, V24, P2005, DOI 10.1093/nar/24.11.2005	53	94	99	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15306	15315		10.1074/jbc.M010516200	http://dx.doi.org/10.1074/jbc.M010516200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278694	hybrid			2022-12-27	WOS:000168528800104
J	Dinudom, A; Harvey, KF; Komwatana, P; Jolliffe, CN; Young, JA; Kumar, S; Cook, DI				Dinudom, A; Harvey, KF; Komwatana, P; Jolliffe, CN; Young, JA; Kumar, S; Cook, DI			Roles of the C termini of alpha-, beta-, and gamma-subunits of epithelial Na+ channels (ENaC) in regulating ENaC and mediating its inhibition by cytosolic Na+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; LIDDLES-SYNDROME; INTRACELLULAR NA+; MISSENSE MUTATION; CELL-SURFACE; DUCT CELLS; WW DOMAINS; G-PROTEIN; PY MOTIF; NEDD4	The amiloride-sensitive epithelial Na+ channels (ENaC) in the intralobular duct cells of mouse mandibular glands are inhibited by the ubiquitin-protein ligase, Nedd4, which is activated by increased intracellular Nat. In this study we have used whole-cell patch clamp methods in mouse mandibular duct cells: to investigate the role of the C termini of the alpha-, beta-, and gamma -subunits of ENaC in mediating this inhibition. We found that peptides corresponding to the C termini of the beta- and gamma -subunits, but not the alpha -subunit, inhibited the activity of the Na+ channels. This mechanism did not involve Nedd4 and probably resulted from the exogenous C termini interfering competitively with the protein-protein interactions that keep the channels active. In the case of the C terminus of mouse beta -ENaC, the interacting motif in eluded beta Ser(631), beta Asp(632) and beta Ser(633). In the C terminus of mouse gamma -ENaC, it included gamma Ser(640). Once these motifs were deleted, we were able to use the C termini of beta- and gamma -ENaC to prevent Nedd4-mediated down-regulation of Na+ channel activity. The C terminus of the alpha -subunit, on the contrary, did not prevent Nedd4-mediated inhibition of the Na+ channels. We conclude that mouse Nedd4 interacts with the beta- and gamma -subunits of ENaC.	Univ Sydney, Dept Physiol F13, Sydney, NSW 2006, Australia; Inst Med & Vet Sci, Hanson Ctr Canc Res, Adelaide, SA 5000, Australia	University of Sydney; Institute Medical & Veterinary Science Australia	Cook, DI (corresponding author), Univ Sydney, Dept Physiol F13, Sydney, NSW 2006, Australia.		Kumar, Sharad/AAX-7787-2020; Harvey, Kieran/AAD-5268-2022	Kumar, Sharad/0000-0001-7126-9814; Harvey, Kieran/0000-0001-7845-369X				Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Awayda MS, 1997, AM J PHYSIOL-CELL PH, V273, pC1889; Awayda MS, 1999, AM J PHYSIOL-CELL PH, V277, pC216, DOI 10.1152/ajpcell.1999.277.2.C216; Barker PM, 1998, J CLIN INVEST, V102, P1634, DOI 10.1172/JCI3971; Berdiev BK, 1997, AM J PHYSIOL-CELL PH, V272, pC1262, DOI 10.1152/ajpcell.1997.272.4.C1262; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; COOK DI, 1994, PHYSL GASTROINTESTIN, V2, P1061; DINUDOM A, 1995, J PHYSIOL-LONDON, V487, P549, DOI 10.1113/jphysiol.1995.sp020899; DINUDOM A, 1993, PFLUG ARCH EUR J PHY, V423, P164, DOI 10.1007/BF00374977; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Farr TJ, 2000, BIOCHEM J, V345, P503, DOI 10.1042/0264-6021:3450503; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; GRUBER WD, 1973, PFLUG ARCH EUR J PHY, V344, P33, DOI 10.1007/BF00587440; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; HUBER M, 1999, FEBS LETT, V459, P443; Hummler E, 1999, AM J PHYSIOL-GASTR L, V276, pG567, DOI 10.1152/ajpgi.1999.276.3.G567; Ismailov II, 1999, BIOCHEMISTRY-US, V38, P354, DOI 10.1021/bi981979s; Ismailov II, 1996, AM J PHYSIOL-CELL PH, V270, pC214, DOI 10.1152/ajpcell.1996.270.1.C214; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Kerem E, 1999, NEW ENGL J MED, V341, P156, DOI 10.1056/NEJM199907153410304; Komwatana P, 1998, J MEMBRANE BIOL, V162, P225, DOI 10.1007/s002329900360; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; Pradervand S, 1999, J AM SOC NEPHROL, V10, P2527; ROTIN D, 1994, EMBO J, V13, P4440, DOI 10.1002/j.1460-2075.1994.tb06766.x; Schepens J, 1997, FEBS LETT, V409, P53, DOI 10.1016/S0014-5793(97)00481-X; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Shimkets RA, 1998, P NATL ACAD SCI USA, V95, P3301, DOI 10.1073/pnas.95.6.3301; Snyder PM, 2000, J CLIN INVEST, V105, P45, DOI 10.1172/JCI7869; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Strautnieks SS, 1996, NAT GENET, V13, P248, DOI 10.1038/ng0696-248; Tamura H, 1996, J CLIN INVEST, V97, P1780, DOI 10.1172/JCI118606	44	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13744	13749		10.1074/jbc.M011273200	http://dx.doi.org/10.1074/jbc.M011273200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278874	hybrid			2022-12-27	WOS:000168356600034
J	Naryshkina, T; Mustaev, A; Darst, SA; Severinov, K				Naryshkina, T; Mustaev, A; Darst, SA; Severinov, K			The beta ' subunit of Escherichia coli RNA polymerase is not required for interaction with initiating nucleotide but is necessary for interaction with rifampicin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-CENTER; BINDING-SITE; ELONGATION	Using a modification of a highly selective affinity labeling protocol, we demonstrated that the alpha (2)beta subassembly of Escherichia coli RNA polymerase efficiently and specifically interacts with the initiating purine nucleotide, Isolated beta is also active in this reaction. In contrast, neither beta nor alpha (2)beta is able to interact with a chimeric molecule composed of rifampicin attached to an initiation substrate. Based on these results, we conclude that the RNA polymerase initiation site, specific for purine nucleotides, which ultimately become the 5'-end of the transcript, is essentially complete in the absence of the largest subunit, beta'. However, the rifampicin binding center is formed only in the alpha (2)beta beta' core enzyme. We interpret our results in light of the high resolution structure of core RNA polymerase from Thermus aquaticus.	Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; Publ Hlth Res Inst, New York, NY 10016 USA; Rockefeller Univ, New York, NY 10021 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rockefeller University	Severinov, K (corresponding author), Waksman Inst Microbiol, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.		Severinov, Konstantin/C-8545-2016		NIGMS NIH HHS [GM37017, GM53759] Funding Source: Medline; PHS HHS [R01 59295] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; BORUKHOV S, 1993, PROTEIN EXPRES PURIF, V4, P503, DOI 10.1006/prep.1993.1066; GRACHEV MA, 1987, EUR J BIOCHEM, V163, P113, DOI 10.1111/j.1432-1033.1987.tb10743.x; HEUMANN H, 1987, BIOCHIM BIOPHYS ACTA, V909, P126, DOI 10.1016/0167-4781(87)90034-0; HUAIFENG M, 1983, EUR J BIOCHEM, V131, P113, DOI 10.1111/j.1432-1033.1983.tb07237.x; Ishihama A, 1981, Adv Biophys, V14, P1; KASHLEV M, 1990, SCIENCE, V248, P1006, DOI 10.1126/science.1693014; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KOZLOV M, UNPUB; LOWDER JF, 1987, BIOCHEM BIOPH RES CO, V147, P1129, DOI 10.1016/S0006-291X(87)80187-0; Markov D, 1999, GENE DEV, V13, P2439, DOI 10.1101/gad.13.18.2439; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; MUSTAEV A, 1991, J BIOL CHEM, V266, P23927; MUSTAEV A, 1993, J BIOL CHEM, V268, P19185; MUSTAEV A, 1994, P NATL ACAD SCI USA, V91, P12036, DOI 10.1073/pnas.91.25.12036; MUSTAEV A, UNPUB; Naryshkina T, 2000, J BIOL CHEM, V275, P31183, DOI 10.1074/jbc.M003884200; SEVERINOV K, 1995, J BIOL CHEM, V270, P29428, DOI 10.1074/jbc.270.49.29428; SEVERINOV K, 1995, J BIOL CHEM, V270, P23926, DOI 10.1074/jbc.270.41.23926; SEVERINOV K, 1993, J BIOL CHEM, V268, P14280; SEVERINOV K, UNPUB; STENDER W, 1975, EUR J BIOCHEM, V56, P129, DOI 10.1111/j.1432-1033.1975.tb02215.x; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Wang Y, 1997, J MOL BIOL, V270, P648, DOI 10.1006/jmbi.1997.1139; WU CW, 1969, BIOCHEMISTRY-US, V8, P4458, DOI 10.1021/bi00839a035; WU CW, 1969, BIOCHEMISTRY-US, V8, P4450, DOI 10.1021/bi00839a034; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; ZILLIG W, 1976, RNA POLYMERASE, P10	30	26	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13308	13313		10.1074/jbc.M011041200	http://dx.doi.org/10.1074/jbc.M011041200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278820	hybrid			2022-12-27	WOS:000168198600116
J	Neumann, J; Schach, N; Koch, N				Neumann, J; Schach, N; Koch, N			Glycosylation signals that separate the trimerization from the MHC class II-binding domain control intracellular degradation of invariant chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN PRESENTATION; SURFACE EXPRESSION; CATHEPSIN-S; COMPLEX; MOLECULES; SEQUENCE; PROTEIN; POLYPEPTIDES; MATURATION; PROTEASES	Invariant chain (Ii) serves as a chaperone for folding and intracellular transport of major histocompatibility complex class II (MHCII) molecules. Early in biosynthesis, Ii associates with MHCII molecules and directs their intracellular transport to endocytic compartments where vesicular proteinases sequentially release Ii from the MHCII heterodimer. The detachment of Ii makes the MHCII groove susceptible for binding of antigenic peptides. We investigated the role of N-linked glycosylation in the controlled intracellular degradation of Ii. Motifs for asparagine-linked glycosylation were altered, and mutated Ii (IiNmut) was transiently expressed in COS cells. The half-life of IiNmut was strongly reduced compared with wild-type Ii although the sensitivity of the N glycan-free polypeptide to in vitro proteinase digestion was not substantially increased. Inhibition of vesicular proteinases revealed endosomal degradation of IiNmut. Intracellular proteolysis of IiNmut is substantially impaired by serine proteinase inhibitors. Thus, a considerable amount of IiNmut is degraded in nonacidic intracellular compartments. The data suggest that N-linked glycosylation of Ii hinders premature proteolysis in nonacidic vesicles resulting in Ii degradation in acidic MHC class II-processing compartments.	Univ Bonn, Immunobiol Sect, D-53117 Bonn, Germany	University of Bonn	Koch, N (corresponding author), Univ Bonn, Immunobiol Sect, Romerstr 164, D-53117 Bonn, Germany.	norbert.koch@uni-bonn.de						AMIGORENA S, 1995, J EXP MED, V181, P1729, DOI 10.1084/jem.181.5.1729; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; ARNESON LS, 1995, J CELL BIOL, V129, P1217, DOI 10.1083/jcb.129.5.1217; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BENAROCH P, 1995, EMBO J, V14, P37, DOI 10.1002/j.1460-2075.1995.tb06973.x; BERTOLINO P, 1995, J IMMUNOL, V154, P5620; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; Bremnes T, 1998, J BIOL CHEM, V273, P8638, DOI 10.1074/jbc.273.15.8638; BROSTERHUS H, 1994, POST TRANSLATIONAL M; Busch R, 2000, CURR OPIN IMMUNOL, V12, P99, DOI 10.1016/S0952-7915(99)00057-6; Busch R, 1996, EMBO J, V15, P418, DOI 10.1002/j.1460-2075.1996.tb00372.x; FREISEWINKEL IM, 1993, P NATL ACAD SCI USA, V90, P9703, DOI 10.1073/pnas.90.20.9703; GeddeDahl M, 1997, J BIOL CHEM, V272, P8281, DOI 10.1074/jbc.272.13.8281; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HITZEL C, 1995, J IMMUNOL, V154, P1048; Jasanoff A, 1998, EMBO J, V17, P6812, DOI 10.1093/emboj/17.23.6812; KOCH N, 1987, EMBO J, V6, P1677, DOI 10.1002/j.1460-2075.1987.tb02417.x; KOCH N, 1982, NATURE, V299, P644, DOI 10.1038/299644a0; KOCH N, 1991, J IMMUNOL, V147, P2643; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Riese RJ, 2000, CURR OPIN IMMUNOL, V12, P107, DOI 10.1016/S0952-7915(99)00058-8; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROMAGNOLI P, 1995, J EXP MED, V182, P2027, DOI 10.1084/jem.182.6.2027; Schroder K, 1999, EMBO J, V18, P4804, DOI 10.1093/emboj/18.17.4804; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; Siebenkotten IM, 1998, J IMMUNOL, V160, P3355; SINGER PA, 1984, EMBO J, V3, P873, DOI 10.1002/j.1460-2075.1984.tb01899.x; Stumptner P, 1997, EMBO J, V16, P5807, DOI 10.1038/sj.emboj.7590555; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; Villadangos JA, 2000, IMMUNITY, V12, P233, DOI 10.1016/S1074-7613(00)80176-4; Villadangos JA, 1999, IMMUNOL REV, V172, P109, DOI 10.1111/j.1600-065X.1999.tb01360.x; Villadangos JA, 2000, EMBO J, V19, P882, DOI 10.1093/emboj/19.5.882; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Wolf PR, 1998, EUR J IMMUNOL, V28, P2605, DOI 10.1002/(SICI)1521-4141(199809)28:09<2605::AID-IMMU2605>3.0.CO;2-B; WRAIGHT CJ, 1990, J BIOL CHEM, V265, P5787	44	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13469	13475		10.1074/jbc.M010629200	http://dx.doi.org/10.1074/jbc.M010629200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278714	hybrid			2022-12-27	WOS:000168198600136
J	Wang, XY; He, C; Moore, SC; Ausio, J				Wang, XY; He, C; Moore, SC; Ausio, J			Effects of histone acetylation on the solubility and folding of the chromatin fiber	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION IN-VIVO; GENE-EXPRESSION; NUCLEOSOMAL DNA; H1; CELLS; AGGREGATION; BUTYRATE; BINDING; CANCER; YEAST	The folding ability of chromatin fractions containing approximately identical nucleosome numbers and the same linker histone composition, but with different extents of core histone acetylation, were analyzed by analytical ultracentrifugation. It was found that the acetylated fractions consistently exhibited a relatively small but significantly lower extent of compaction than that of their native nonacetylated counterparts. This was regardless of the extent of the size distribution heterogeneity of the fractions analyzed. Furthermore the acetylated chromatin fibers exhibited an enhanced solubility in both NaCl and MgCl2, which is neither the result of a differential binding affinity of the linker histones to chromatin nor of an alteration in the relative amounts of the histone H1 variants.	Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	University of Victoria	Ausio, J (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055,Petch Bldg 220, Victoria, BC V8W 3P6, Canada.	jausio@uvic.ca						Albig W, 1998, FEBS LETT, V435, P245, DOI 10.1016/S0014-5793(98)01084-9; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Archer SY, 1999, CURR OPIN GENET DEV, V9, P171, DOI 10.1016/S0959-437X(99)80026-4; AUSIO J, 1992, J CELL SCI, V102, P1; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1421, DOI 10.1021/bi00354a035; AUSIO J, 1984, J MOL BIOL, V177, P373, DOI 10.1016/0022-2836(84)90291-2; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1981, DOI 10.1021/bi00356a022; Ausio J, 1998, METHODS, V15, P333, DOI 10.1006/meth.1998.0637; Ausio J, 2000, BIOPHYS CHEM, V86, P141, DOI 10.1016/S0301-4622(00)00144-7; BROWN DT, 1993, J BIOL CHEM, V268, P713; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Conley BA, 1998, CLIN CANCER RES, V4, P629; DANNA JA, 1980, BIOCHEMISTRY-US, V19, P2656, DOI 10.1021/bi00553a019; Davie JR, 2001, PROG NUCLEIC ACID RE, V65, P299; Davie JR, 1999, BIOCHEM CELL BIOL, V77, P265, DOI 10.1139/bcb-77-4-265; DIMITROV S, 1986, FEBS LETT, V197, P217, DOI 10.1016/0014-5793(86)80329-5; Dou YL, 2000, MOL CELL, V6, P225, DOI 10.1016/S1097-2765(00)00024-1; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; GUO XW, 1989, J BIOL CHEM, V264, P16873; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Jacobson S, 1999, CURR OPIN GENET DEV, V9, P175, DOI 10.1016/S0959-437X(99)80027-6; JIN YI, 1986, J BIOL CHEM, V261, P3420; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; LI W, 1993, BIOCHEM J, V296, P737, DOI 10.1042/bj2960737; MCGHEE JD, 1983, NUCLEIC ACIDS RES, V11, P4065, DOI 10.1093/nar/11.12.4065; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Moore SC, 1997, BIOCHEM J, V328, P409; Mutskov V, 1998, MOL CELL BIOL, V18, P6293, DOI 10.1128/MCB.18.11.6293; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; PARSEGHIAN MH, 1994, PROTEIN SCI, V3, P575; PERRY M, 1982, J BIOL CHEM, V257, P7336; PERRY M, 1981, J BIOL CHEM, V256, P3313; PHILLIPS DM, 1963, BIOCHEM J, V87, P258, DOI 10.1042/bj0870258; Rabbani A, 1999, J BIOL CHEM, V274, P18401, DOI 10.1074/jbc.274.26.18401; RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0; SHAW BR, 1981, BIOCHEMISTRY-US, V20, P4971, DOI 10.1021/bi00520a025; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van Holde K.E., 1988, CHROMATIN; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wang XY, 2000, J BIOL CHEM, V275, P35013, DOI 10.1074/jbc.M004998200; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007	45	76	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12764	12768		10.1074/jbc.M100501200	http://dx.doi.org/10.1074/jbc.M100501200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11279082	hybrid			2022-12-27	WOS:000168198600042
J	Koenderink, JB; Swarts, HGP; Stronks, HC; Hermsen, HPH; Willems, PHGM; De Pont, JJHHM				Koenderink, JB; Swarts, HGP; Stronks, HC; Hermsen, HPH; Willems, PHGM; De Pont, JJHHM			Chimeras of X+,K+-ATPases - The M1-M6 region of Na+,K+-atpase is required for Na+-activated ATPase activity, whereas the M7-M10 region of H+,K+-atpase is involved in K+ de-occlusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA,K-ATPASE ALPHA-SUBUNIT; BETA-SUBUNIT; GASTRIC H+,K+-ATPASE; TRANSMEMBRANE SEGMENT; EXTRACELLULAR DOMAIN; CATION SELECTIVITY; SODIUM-PUMP; AMINO-ACIDS; H,K-ATPASE; RESIDUES	In this study we reveal regions of Na+,K+-ATPase and H+,K+-ATPase that are involved in cation selectivity. A chimeric enzyme in which transmembrane hairpin M5-M6 of H+,K+-ATPase was replaced by that of Na+,K+- ATPase was phosphorylated in the absence of Naf and showed no K+-dependent reactions. Next, the part originating from Na+,K+-ATPase was gradually increased in the N-terminal direction. We demonstrate that chimera HN16, containing the transmembrane segments one to six and intermediate loops of Na+,K+-ATPase, harbors the amino acids responsible for Na+ specificity. Compared with Na+,K+-ATPase, this chimera displayed a similar apparent Na+ affinity, a lower apparent K+ affinity, a higher apparent ATP affinity, and a lower apparent vanadate affinity in the ATPase reaction. This indicates that the E2K form of this chimera is less stable than that of Na+,K+-ATPase, suggesting that it, like H+,K+-ATPase, de-occludes K+ ions very rapidly. Comparison of the structures of these chimeras with those of the parent enzymes suggests that the C-terminal 187 amino acids and the beta -subunit are involved in K+ occlusion, Accordingly, chimera HN16 is not only a chimeric enzyme in structure, but also in function. On one hand it possesses the Na+-stimulated ATPase reaction of Na+,K+-ATPase, while on the other hand it has the K+ occlusion properties of H+,K+-ATPase.	Univ Nijmegen, Inst Cellular Signalling, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	De Pont, JJHHM (corresponding author), Univ Nijmegen, Inst Cellular Signalling, Dept Biochem, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.depont@bioch.kun.nl	Willems, P.H.G.M./L-4759-2015; Stronks, H. Christiaan/G-1737-2019; Koenderink, Jan/N-3578-2014	Willems, P.H.G.M./0000-0002-0915-1599; Stronks, H. Christiaan/0000-0003-1251-8176; 				ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Asano S, 2000, J BIOCHEM, V127, P993, DOI 10.1093/oxfordjournals.jbchem.a022716; BEAUGE LA, 1979, NATURE, V280, P510, DOI 10.1038/280510a0; Blostein R, 1999, J BIOL CHEM, V274, P18374, DOI 10.1074/jbc.274.26.18374; Canfield VA, 1998, BIOCHEMISTRY-US, V37, P7509, DOI 10.1021/bi980174h; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CHOW DC, 1993, AM J PHYSIOL, V265, pC1562, DOI 10.1152/ajpcell.1993.265.6.C1562; CHOW DC, 1992, AM J PHYSIOL, V263, pC39, DOI 10.1152/ajpcell.1992.263.1.C39; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; FALLER LD, 1991, BIOCHEMISTRY-US, V30, P3503, DOI 10.1021/bi00228a022; Geering K, 2000, J MEMBRANE BIOL, V174, P181, DOI 10.1007/s002320001042; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; GOTTARDI CJ, 1993, J CELL BIOL, V121, P283, DOI 10.1083/jcb.121.2.283; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; Hermsen HPH, 1998, BIOCHEM J, V331, P465, DOI 10.1042/bj3310465; Ishii T, 1997, BIOCHEMISTRY-US, V36, P442, DOI 10.1021/bi960644c; KLAASSEN CHW, 1995, BIOCHEM BIOPH RES CO, V210, P907, DOI 10.1006/bbrc.1995.1743; KLAASSEN CHW, 1993, FEBS LETT, V329, P277, DOI 10.1016/0014-5793(93)80237-O; Koenderink JB, 2000, P NATL ACAD SCI USA, V97, P11209, DOI 10.1073/pnas.200109597; Koenderink JB, 2000, BIOCHEMISTRY-US, V39, P9959, DOI 10.1021/bi0001168; Koenderink JB, 1999, J BIOL CHEM, V274, P11604, DOI 10.1074/jbc.274.17.11604; Kuntzweiler TA, 1996, J BIOL CHEM, V271, P29682, DOI 10.1074/jbc.271.47.29682; LEMAS MV, 1994, J BIOL CHEM, V269, P8255; LEMAS MV, 1992, J BIOL CHEM, V267, P20987; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; Lutsenko S, 1997, J BIOL CHEM, V272, P5249, DOI 10.1074/jbc.272.8.5249; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; Melle-Milovanovic D, 1998, J BIOL CHEM, V273, P11075, DOI 10.1074/jbc.273.18.11075; Mense M, 2000, J BIOL CHEM, V275, P1749, DOI 10.1074/jbc.275.3.1749; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; NING G, 1993, FEBS LETT, V336, P521, DOI 10.1016/0014-5793(93)80868-U; Or E, 1998, BIOCHEMISTRY-US, V37, P8197, DOI 10.1021/bi9730442; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PETERS WHM, 1984, J BIOENERG BIOMEMBR, V16, P223, DOI 10.1007/BF00751051; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; PRICE SJ, 1989, FAMILY SCI REV, V2, P219; RABON EC, 1993, J BIOL CHEM, V268, P8012; RABON EC, 1990, J BIOL CHEM, V265, P19594; Schneider H, 1997, J BIOL CHEM, V272, P16158, DOI 10.1074/jbc.272.26.16158; Shainskaya A, 1998, J BIOL CHEM, V273, P7311, DOI 10.1074/jbc.273.13.7311; Shainskaya A, 2000, J BIOL CHEM, V275, P2019, DOI 10.1074/jbc.275.3.2019; SWARTS HGP, 1995, J BIOL CHEM, V270, P7890, DOI 10.1074/jbc.270.14.7890; Swarts HGP, 1996, J BIOL CHEM, V271, P29764, DOI 10.1074/jbc.271.47.29764; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Wang SG, 1997, AM J PHYSIOL-CELL PH, V272, pC923, DOI 10.1152/ajpcell.1997.272.3.C923	48	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11705	11711		10.1074/jbc.M010804200	http://dx.doi.org/10.1074/jbc.M010804200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278751	hybrid, Green Published			2022-12-27	WOS:000168081800039
J	Mahale, SD; Cavanagh, J; Schmidt, A; MacColl, R; Dias, JA				Mahale, SD; Cavanagh, J; Schmidt, A; MacColl, R; Dias, JA			Autologous biological response modification of the gonadotropin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; HUMAN CHORIONIC-GONADOTROPIN; PROTEIN SECONDARY STRUCTURE; AMINO-ACID-RESIDUES; EXTRACELLULAR DOMAIN; GLYCOPROTEIN HORMONES; CIRCULAR-DICHROISM; LIGAND-BINDING; BETA-SUBUNIT	It is generally held with respect to heterotrimeric guanine nucleotide binding protein-coupled receptors that binding of ligand stabilizes a conformation of receptor that activates adenylyl cyclase, It is not formally appreciated if, in the case of G-protein-coupled receptors with large extracellular domains (ECDs), ECDs directly participate in the activation process. The large ECD of the glycoprotein hormone receptors (GPHRs) is 350 amino acids in length, composed of seven leucine-rich repeat domains, and necessary and sufficient: for high affinity binding of the glycoprotein hormones. Peptide challenge experiments to identify regions in the follicle-stimulating hormone (FSH) receptor (FSHR) ECD that could bind its cognate ligand identified only a single synthetic peptide corresponding to residues 221-252, which replicated a leucine-rich repeat domain of the FSHR ECD and which had intrinsic activity. This peptide inhibited human FSH binding to the human FSHR (hFSHR) and also inhibited human FSH-induced signal transduction in Y-1 cells expressing recombinant hFSHR. The hFSRR-(221-252) domain was not accessible to anti-peptide antibody probes, suggesting that this domain resides at an interface between the hFSHR ECD and transmembrane domains. CD spectroscopy of the peptide in dodecyl phosphocholine micelles showed an increase in the ordered structure of the peptide. CD and NMR spectroscopies of the peptide in trifluoroethanol confirmed that hFSRR-(221-252) has the propensity to form ordered secondary structure. Importantly and consistent with the foregoing results, dodecyl phosphocholine induced a significant increase in the ordered secondary structure of the purified hFSHR ECD as well. These data provide biophysical evidence of the influence of environment on GPHR ECD subdomain secondary structure and identify a specific activation domain that; can autologously modify GPHR activity.	New York State Dept Hlth, David Axelrod Inst Publ Hlth, Wadsworth Ctr, Albany, NY 12208 USA	State University of New York (SUNY) System; Wadsworth Center	Dias, JA (corresponding author), New York State Dept Hlth, David Axelrod Inst Publ Hlth, Wadsworth Ctr, 120 New Scotland Ave, Albany, NY 12208 USA.			Schmidt, Anja/0000-0002-2304-8774; Dias, James A/0000-0002-9792-5469	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018407] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 18407] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Bhowmick N, 1996, MOL ENDOCRINOL, V10, P1147, DOI 10.1210/me.10.9.1147; Bhowmick N, 1999, ENDOCRINOLOGY, V140, P4558, DOI 10.1210/en.140.10.4558; DATTATREYAMURTY B, 1992, MOL CELL ENDOCRINOL, V87, P9, DOI 10.1016/0303-7207(92)90228-X; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GRISWOLD MD, 1993, SERTOLI CELL, P494; Hileman MR, 1997, FEBS LETT, V415, P145, DOI 10.1016/S0014-5793(97)01113-7; HUANG JN, 1995, J BIOL CHEM, V270, P30023; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Jiang XL, 1995, STRUCTURE, V3, P1341, DOI 10.1016/S0969-2126(01)00272-6; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; KELTON CA, 1992, MOL CELL ENDOCRINOL, V89, P141, DOI 10.1016/0303-7207(92)90220-Z; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU XB, 1993, J BIOL CHEM, V268, P1513; LIU XX, 1994, ENDOCRINOLOGY, V135, P682, DOI 10.1210/en.135.2.682; Massi C, 1998, BIOCHEM BIOPH RES CO, V246, P160, DOI 10.1006/bbrc.1998.8580; MATTHEWS CH, 1993, NAT GENET, V5, P83, DOI 10.1038/ng0993-83; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Means G.E., 1971, CHEM MODIFICATION PR, P214; MINEGISH T, 1991, BIOCHEM BIOPH RES CO, V175, P1125, DOI 10.1016/0006-291X(91)91682-3; MORRIS JC, 1993, J BIOL CHEM, V268, P10900; Moudgal NR, 1997, ENDOCRINOLOGY, V138, P3065, DOI 10.1210/en.138.7.3065; Moudgal NR, 1997, HUM REPROD, V12, P457; MOUDGAL NR, 1992, J REPROD FERTIL, V96, P91; MOYLE WR, 1995, J BIOL CHEM, V270, P20020, DOI 10.1074/jbc.270.34.20020; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Peterson AJ, 2000, MOL CELL ENDOCRINOL, V160, P203, DOI 10.1016/S0303-7207(99)00204-X; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; RANCE M, 1987, J MAGN RESON, V74, P557, DOI 10.1016/0022-2364(87)90277-0; RICHARDS JS, 1980, PHYSIOL REV, V60, P51, DOI 10.1152/physrev.1980.60.1.51; ROCHE PC, 1992, ENDOCRINOLOGY, V131, P268, DOI 10.1210/en.131.1.268; ROTH KE, 1995, MOL CELL ENDOCRINOL, V109, P143, DOI 10.1016/0303-7207(95)03494-R; RYAN RJ, 1988, FASEB J, V2, P2661, DOI 10.1096/fasebj.2.11.2456242; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Sreerama N, 1999, PROTEINS, V36, P400, DOI 10.1002/(SICI)1097-0134(19990901)36:4<400::AID-PROT3>3.0.CO;2-B; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; Tapanainen JS, 1997, NAT GENET, V15, P205, DOI 10.1038/ng0297-205; TAYLOR JW, 1987, METHOD ENZYMOL, V154, P473; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; WATERHOUS DV, 1994, BIOCHEMISTRY-US, V33, P2121, DOI 10.1021/bi00174a019; WEINER RS, 1991, ENDOCRINOLOGY, V128, P1485, DOI 10.1210/endo-128-3-1485; YANAGISHITA M, 1978, ANAL BIOCHEM, V88, P1, DOI 10.1016/0003-2697(78)90393-7	48	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12410	12419		10.1074/jbc.M100115200	http://dx.doi.org/10.1074/jbc.M100115200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11279009	hybrid			2022-12-27	WOS:000168081800129
J	Gerszten, RE; Friedrich, EB; Matsui, T; Hung, RR; Li, L; Force, T; Rosenzweig, A				Gerszten, RE; Friedrich, EB; Matsui, T; Hung, RR; Li, L; Force, T; Rosenzweig, A			Role of phosphoinositide 3-kinase in monocyte recruitment under flow conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; NEUTROPHIL MIGRATION; SIGNAL-TRANSDUCTION; T-LYMPHOCYTES; BETA-GAMMA; IN-VITRO; CELLS; ACTIVATION; ADHESION; CHEMOKINES	Chemokines such as the monocyte chemol attractant protein-1. MCP-1) convert monocyte rolling to firm arrest under physiological flow conditions via integrin activation and simultaneously activate phosphoinositide 3-kinase (PI3K). Here we used adenoviral gene transfer and biochemical inhibitors to manipulate PI3K-dependent pathways in human monocytes. In in vitro lipid kinase assays from purified human monocytes, we showed that MCP-1 activates the "classical" PI3K alpha pathway and not PI3K gamma, a PI3K isoform thought to be activated only by the py complex of heterotrimeric G proteins. The activity of PI3K alpha in purified human monocytes was evident within 30 s. MCP-1-induced monocyte arrest was significantly inhibited both by wortmannin (n = 4;p < 0.01) and LY294002 (n = 4;p< 0.01) with restoration of the rolling phenotype (p < 0.05 for both inhibitors, compared with rolling of control monocytes after MCP-1 treatment). To test the hypothesis that activation of PI3K is sufficient to induce monocyte adhesion, we transduced the monocytic THP-1 cell line with a recombinant adenovirus (Ad) carrying a constitutively active mutant of PI3K (Ad.BD110). me examined the ability of these cells to adhere to human vascular endothelium (HUVEC) transduced with adenoviruses carrying E-selectin, intercellular adhesion molecule-1 (ICAM-1), and VCAM-1, Under flow conditions, ICAM-1- and VCAM-1-dependent firm adhesion of Ad.BD110-transduced THP-1 cells was enhanced compared with THP-1 cells infected with control Ad (n = 4;p < 0.01 for both),Adhesion augmented by constitutive PI3K activation was entirely abrogated by pretreatment with wortmannin (n = 3;p < 0.01). In contrast, a constitutively active Akt construct had no effect on THP-1 adhesion (n = 3;p = NS). We conclude that PI3K activation is necessary and sufficient to enhance monocytic adhesion under physiological now conditions, BD110-expressing TRP-1 cells should provide a useful tool for identifying the signaling pathways downstream of PI3K that are necessary for monocyte recruitment relevant to a variety of human vascular pathologies.	Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Program Cardiovasc Gene Therapy, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA USA; Tufts Univ, Sch Med, New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Tufts Medical Center; Tufts University	Gerszten, RE (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, E 8307 149 13th St, Charlestown, MA 02129 USA.			Force, Thomas/0000-0002-0450-8659	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065584, R01HL054202, R01HL061688, K08HL003348, R01HL059521, R29HL054202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK050282, R55DK050282] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54202, HL65584, HL61688, HL59521, HL03348] Funding Source: Medline; NIAID NIH HHS [AI40970] Funding Source: Medline; NIDDK NIH HHS [DK50282] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Aoukaty A, 1999, J IMMUNOL, V162, P3249; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Coffer PJ, 1998, BIOCHEM J, V335, P1; Dekker LV, 2000, SCIENCE, V287, P982, DOI 10.1126/science.287.5455.982; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gerszten RE, 1996, CIRC RES, V79, P1205, DOI 10.1161/01.RES.79.6.1205; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Loike JD, 1999, J CELL BIOL, V144, P1047, DOI 10.1083/jcb.144.5.1047; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Nagel W, 1998, J BIOL CHEM, V273, P14853, DOI 10.1074/jbc.273.24.14853; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Sotsios Y, 1999, J IMMUNOL, V163, P5954; TURNER L, 1995, J IMMUNOL, V155, P2437; Turner SJ, 1998, J BIOL CHEM, V273, P25987, DOI 10.1074/jbc.273.40.25987; VADDI K, 1994, J LEUKOCYTE BIOL, V55, P756, DOI 10.1002/jlb.55.6.756; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang XZ, 2000, J VIROL, V74, P11296, DOI 10.1128/JVI.74.23.11296-11303.2000	22	57	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 20	2001	276	29					26846	26851		10.1074/jbc.M011235200	http://dx.doi.org/10.1074/jbc.M011235200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	454HJ	11278864	hybrid			2022-12-27	WOS:000169966900017
J	Yigzaw, Y; Cartin, L; Pierre, S; Scholich, K; Patel, TB				Yigzaw, Y; Cartin, L; Pierre, S; Scholich, K; Patel, TB			The C terminus of sprouty is important for modulation of cellular migration and proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TRANSDUCTION; DROSOPHILA SPROUTY; FGF; EXPRESSION; ANTAGONIST; INHIBITOR; DELIVERY; HOMOLOG; MOUSE; CELLS	The Drosophila Sprouty (SPRY) protein has been shown to inhibit the actions of epidermal growth factor and fibroblast growth factor. However, the role of mammalian SPRY proteins has not been clearly elucidated. We postulated that human Sprouty2 (hSPRY2) is an inhibitor of cellular migration and proliferation. Indeed, using stably transfected HeLa cells, which expressed hemagglutinin (HA)-tagged hSPRY2 or hSPRY2 tagged at the C terminus with red fluorescent protein, we demonstrated that hSPRY2 inhibits the migration of cells in response to serum, epidermal growth factor, fibroblast growth factor, and platelet-derived growth factor. Additionally, hSPRY2 also inhibited the growth of HeLa cells in response to serum. Previously, two C-terminal domains on hSPRY2, which are necessary for its colocalization with microtubules (residues 123-177) or translocation to membrane ruffles (residues 178-194), have been identified (Lim, J., Wong, E. S., Ong, S. H., Yusoff, P., Low, B. C., and Guy, G. R. (2000) J. Biol. Chem. 275, 32837-32845), Therefore, using TAT-tagged hSPRY2 and its mutants, we determined the role of these two C-terminal domains in the inhibition of cell migration and proliferation. Our data show that the deletion of either of these two regions in hSPRY2 abrogates its ability to modulate cell migration in response to different growth factors and proliferation in response to serum. Therefore, we conclude that hSPRY2 inhibits the actions of a number of growth factors, and its C terminus, which is homologous among various SPRY isoforms, is important in mediating its biological activity.	Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr Excellence, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Patel, TB (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.				NHLBI NIH HHS [HL48308, HL07641] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048308] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brown C, 1999, CIRC RES, V84, P655, DOI 10.1161/01.RES.84.6.655; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Kramer S, 1999, DEVELOPMENT, V126, P2515; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Lu RQ, 2000, P NATL ACAD SCI USA, V97, P3993, DOI 10.1073/pnas.97.8.3993; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Reich A, 1999, DEVELOPMENT, V126, P4139; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Vocero-Akbani A, 2000, METHOD ENZYMOL, V322, P508	15	95	100	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22742	22747		10.1074/jbc.M100123200	http://dx.doi.org/10.1074/jbc.M100123200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11279012	hybrid			2022-12-27	WOS:000169412700102
J	Pu, HX; Cluzeaud, F; Goldshleger, R; Karlish, SJD; Farman, N; Blostein, R				Pu, HX; Cluzeaud, F; Goldshleger, R; Karlish, SJD; Farman, N; Blostein, R			Functional role and immunocytochemical localization of the gamma(a) and gamma(b) forms of the Na,K-ATPase gamma subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-PUMP REGULATION; RENAL NA,K-ATPASE; EXPRESSION; CELLS; NA+,K+-ATPASE; OUABAIN; NA+; PURIFICATION; POLYPEPTIDE; COMPONENT	The gamma subunit of the Na,K-ATPase is a member of the FXYD family of type 2 transmembrane proteins that probably function as regulators of ion transport. Rat gamma is present primarily in the kidney as two main splice variants, gamma (a) and gamma (b), which differ only at their extracellular N termini (TELSANH and MDRWYL, respectively; Kuster, B., Shainskaya, A., Pu, H. X., Goldshleger, R., Blostein, R., Mann, M., and Karlish, S. J. D. (2000) J. Biol. Chem. 275, 18441-18446). Expression in cultured cells indicates that both variants affect catalytic properties, without a detectable difference between gamma (a) and gamma (b). At least two singular effects are seen, irrespective of whether the variants are expressed in HeLa or rat alpha1-transfected HeLa cells, i.e. (i) an increase in apparent affinity for ATP, probably secondary to a left shift in E-1 <-> E-2 conformational. equilibrium and (ii) an increase in K+ antagonism of cytoplasmic Na+ activation. Antibodies against the C terminus common to both variants (anti-gamma) abrogate the first effect but not the second. In contrast, gamma (a) and gamma (b) show differences in their localization along the kidney tubule. Using anti-gamma (C-terminal) and antibodies to the rat alpha subunit as well as antibodies to identify cell types, double immunofluorescence showed gamma in the basolateral membrane of several tubular segments. Highest expression is in the medullary portion of the thick ascending limb (TAL), which contains both gamma (a) and gamma (b). In fact, TAL is the only positive tubular segment in the medulla. In the cortex, most tubules express gamma but at lower levels. Antibodies specific for gamma (a) and gamma (b) showed differences in their cortical location; gamma (a) is specific for cells in the macula densa and principal cells of the cortical collecting duct but not cortical TAL. In contrast, gamma (b) but not gamma (a) is present in the cortical TAL only. Thus, the importance of gamma (a) and gamma (b) may be related to their partially overlapping but distinct expression patterns and tissue-specific functions of the pump that these serve.	McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; Univ Paris 07, Inst Fed Rech 02, INSERM, U478, Paris 18, France; Weizmann Inst Sci, Dept Biol Chem, IL-761001 Rehovot, Israel	McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Weizmann Institute of Science	Blostein, R (corresponding author), Montreal Gen Hosp, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	Rhoda.Blostein@mcgill.ca						Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; Blostein R, 1997, J BIOL CHEM, V272, P24987, DOI 10.1074/jbc.272.40.24987; Capurro C, 1996, AM J PHYSIOL-CELL PH, V271, pC753, DOI 10.1152/ajpcell.1996.271.3.C753; COLLINS JH, 1982, BIOCHIM BIOPHYS ACTA, V686, P7, DOI 10.1016/0005-2736(82)90145-6; DETOMASO AW, 1993, J BIOL CHEM, V268, P1470; FORBUSH B, 1978, BIOCHEMISTRY-US, V17, P3667, DOI 10.1021/bi00610a037; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; Garty H, 2001, BIOPHYS J, V80, p501A; HARDWICKE PMD, 1981, BIOCHEM BIOPH RES CO, V102, P250, DOI 10.1016/0006-291X(81)91514-X; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Jones DH, 1997, J CELL BIOL, V139, P1545, DOI 10.1083/jcb.139.6.1545; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; Kim JW, 1997, BBA-GENE STRUCT EXPR, V1350, P133, DOI 10.1016/S0167-4781(96)00219-9; Kuster B, 2000, J BIOL CHEM, V275, P18441, DOI 10.1074/jbc.M001411200; Meij IC, 2000, NAT GENET, V26, P265, DOI 10.1038/81543; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; Minor NT, 1998, P NATL ACAD SCI USA, V95, P6521, DOI 10.1073/pnas.95.11.6521; MUNZER JS, 1994, J BIOL CHEM, V269, P16668; Or E, 1996, BIOCHEMISTRY-US, V35, P6853, DOI 10.1021/bi960093q; REEVES AS, 1980, BIOCHEM BIOPH RES CO, V95, P1591, DOI 10.1016/S0006-291X(80)80080-5; SCHEINERBOBIS G, 1994, BBA-BIOMEMBRANES, V1193, P226, DOI 10.1016/0005-2736(94)90157-0; Shi HK, 2001, AM J PHYSIOL-RENAL, V280, pF505, DOI 10.1152/ajprenal.2001.280.3.F505; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Therien AG, 1999, AM J PHYSIOL-CELL PH, V277, pC891, DOI 10.1152/ajpcell.1999.277.5.C891; Therien AG, 1997, J BIOL CHEM, V272, P32628, DOI 10.1074/jbc.272.51.32628; Therien AG, 1999, J BIOL CHEM, V274, P12252, DOI 10.1074/jbc.274.18.12252; Therien AG, 2000, INT CONGR SER, V1207, P481; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Vijayakumar S, 1999, J CELL BIOL, V144, P1057, DOI 10.1083/jcb.144.5.1057; Zhang GH, 1996, J BIOL CHEM, V271, P29067, DOI 10.1074/jbc.271.46.29067	31	106	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20370	20378		10.1074/jbc.M010836200	http://dx.doi.org/10.1074/jbc.M010836200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278761	hybrid			2022-12-27	WOS:000169135100095
J	Dong, Z; Venkatachalam, MA; Wang, JZ; Patel, Y; Saikumar, P; Semenza, GL; Force, T; Nishiyama, J				Dong, Z; Venkatachalam, MA; Wang, JZ; Patel, Y; Saikumar, P; Semenza, GL; Force, T; Nishiyama, J			Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia - HIF-1-independent mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; CASPASE ACTIVATION; PUTATIVE MEMBERS; GENE-EXPRESSION; OXYGEN; COMPLEX; FAMILY; SELECTION; HOMOLOGS	Hypoxia is a key determinant of tissue pathology during tumor development and organ ischemia. However, little is known regarding hypoxic regulation of genes that are directly involved in cell death or death resistance. Here we report the striking induction by severe hypoxia of the anti-apoptotic protein IAP-2. Hypoxic cells with IAP-2 up-regulation became resistant to apoptosis. IAP-2 was induced by hypoxia per se rather than by the secondary effects of hypoxia, including ATP depletion and cell injury. The inductive response did not relate to alterations of cellular redox status or arrest of mitochondrial respiration. On the other hand, IAP-2 induction was attenuated by actinomycin D, suggesting a role for gene transcription. In vitro nuclear run-on assays demonstrated specific increases in IAP-2 transcriptional activity after hypoxia exposure. HIF-1, the primary transcription factor that is responsible for multiple gene activation under hypoxia, does not have a role in IAP-2 expression. HIF-1 and IAP-2 were induced by different degrees of hypoxia; severe hypoxia or anoxia was required for IAP-2 induction. Moreover, cobalt chloride and desferrioxamine activated HIF-1 but not IAP-2. Finally, IAP-2 was induced by severe hypoxia in mouse embryonic stem cells that were deficient of HIF-1. Thus, this study not only provides the first demonstration of hypoxic regulation of an anti-apoptotic gene but also suggests the participation of novel hypoxia-responsive transcription mechanisms.	Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21287 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA	University of Texas System; University of Texas Health San Antonio; Johns Hopkins University; Harvard University; Massachusetts General Hospital	Dong, Z (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Pathol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	dong@uthscsa.edu		Force, Thomas/0000-0002-0450-8659	NIDDK NIH HHS [R01 DK054472-02, R01 DK054472] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054472] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACKER H, 1994, ANN NY ACAD SCI, V718, P3; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Brown JM, 1999, CANCER RES, V59, P5863; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1997, J BIOL CHEM, V272, P18808, DOI 10.1074/jbc.272.30.18808; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chandel NS, 2000, J APPL PHYSIOL, V88, P1880, DOI 10.1152/jappl.2000.88.5.1880; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; COTRAN RS, 1998, ROBBINS PATHOLOGIC B, P1; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dong Z, 2000, BIOCHEM J, V347, P669, DOI 10.1042/0264-6021:3470669; Dong Z, 1998, LAB INVEST, V78, P657; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Ehleben W, 1998, RESP PHYSIOL, V114, P25, DOI 10.1016/S0034-5687(98)00078-4; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Khan S, 1999, LAB INVEST, V79, P1089; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Morel Y, 1999, BIOCHEM J, V342, P481, DOI 10.1042/0264-6021:3420481; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Neumcke I, 1999, ENDOCRINOLOGY, V140, P641, DOI 10.1210/en.140.2.641; PIPER HM, 1994, CARDIOVASC RES, V28, P1, DOI 10.1093/cvr/28.1.1; Porwol T, 1998, EUR J BIOCHEM, V256, P16, DOI 10.1046/j.1432-1327.1998.2560016.x; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Saikumar P, 1998, ONCOGENE, V17, P3341, DOI 10.1038/sj.onc.1202579; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; SPECTOR DL, 1998, CELLS LAB MANUAL NUC; Sutherland RM, 1998, ACTA ONCOL, V37, P567, DOI 10.1080/028418698430278; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Yan SF, 1998, P NATL ACAD SCI USA, V95, P8298, DOI 10.1073/pnas.95.14.8298; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	59	125	134	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18702	18709		10.1074/jbc.M011774200	http://dx.doi.org/10.1074/jbc.M011774200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278985	hybrid, Green Accepted			2022-12-27	WOS:000169091000009
J	Yang, Y; Cheng, JZ; Singhal, SS; Saini, M; Pandya, U; Awasthi, S; Awasthi, YC				Yang, Y; Cheng, JZ; Singhal, SS; Saini, M; Pandya, U; Awasthi, S; Awasthi, YC			Role of glutathione S-transferases in protection against lipid peroxidation - Overexpression of hgsta2-2 in k562 cells protects against hydrogen peroxide-induced apoptosis and inhibits JNK and caspase 3 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LEUKEMIA-CELLS; OXIDATIVE STRESS; C-JUN; REACTIVE OXYGEN; KINASE PATHWAY; HETEROLOGOUS EXPRESSION; TISSUE DISTRIBUTION; CATALYTIC ACTIVITY; CYTOCHROME-C; HUMAN-PLASMA	The physiological significance of the selenium-independent glutathione peroxidase (GPx) activity of glutathione S-transferases (GSTs), associated with the major Alpha class isoenzymes hGSTA1-1 and hGSTA2-2, is not known. In the present studies we demonstrate that these isoenzymes show high GPx activity toward phospholipid hydroperoxides (PL-OOH) and they can catalyze GSH-dependent reduction of PL-OOH in situ in biological membranes. A major portion of GPx activity of human liver and testis toward phosphatidylcholine hydroperoxide (PC-OOH) is contributed by the Alpha class GSTs. Overexpression of hGSTA2-2 in K562 cells attenuates lipid peroxidation under normal conditions as well as during the oxidative stress and confers about 1.5-fold resistance to these cells from H2O2 cytotoxicity. Treatment with 30 muM H2O2 for 48 h or 40 muM PC-OOH for 8 h causes apoptosis in control cells, whereas hGSTA2-2-overexpressing cells are protected from apoptosis under these conditions. In control cells, H2O2 treatment causes an early (within 2 h), robust, and persistent (at least 24 h) activation of JNK, whereas in hGSTA2-2-overexpressing cells, only a slight activation of JNK activity is observed at 6 h which declines to basal levels within 24 h. Caspase 3-mediated poly(ADP-ribose) polymerase cleavage is also inhibited in cells overexpressing hGSTA2-2. hGSTA2 transfection does not affect the function of antioxidant enzymes including C:Px activity toward H2O2 suggesting that the Alpha class GSTs play an important role in regulation of the intracellular concentrations of the lipid peroxidation products that may be involved in the signaling mechanisms of apoptosis.	Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA; Univ Texas, Dept Chem & Biochem, Arlington, TX 76019 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Arlington	Awasthi, YC (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, 7-138 Med Res Bldg, Galveston, TX 77555 USA.	ycawasth@utmb.edu	Awasthi, Sanjay/R-4904-2019	Awasthi, Sanjay/0000-0002-5214-5717	NATIONAL CANCER INSTITUTE [R01CA077495] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY004396, R55EY004396] Funding Source: NIH RePORTER; NCI NIH HHS [CA 77495] Funding Source: Medline; NEI NIH HHS [EY 04396] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Awasthi S, 1998, BIOCHEMISTRY-US, V37, P5231, DOI 10.1021/bi972130z; AWASTHI YC, 1994, INT J BIOCHEM, V26, P295, DOI 10.1016/0020-711X(94)90050-7; AWASTHI YC, 1980, BIOCHEM J, V191, P1; Bao YP, 1997, BIOCHEM SOC T, V25, pS557, DOI 10.1042/bst025s557; BEERS RF, 1952, J BIOL CHEM, V195, P133; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Board PG, 1997, BIOCHEM J, V328, P929; Boekhorst PAW, 1992, CANCER CHEMOTHER PHA, V30, P238; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chau YP, 1998, FREE RADICAL BIO MED, V24, P660, DOI 10.1016/S0891-5849(97)00337-7; Chen SH, 2000, GLIA, V31, P249, DOI 10.1002/1098-1136(200009)31:3<249::AID-GLIA60>3.0.CO;2-L; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Cheng JZ, 1999, ARCH BIOCHEM BIOPHYS, V372, P29, DOI 10.1006/abbi.1999.1479; CHU FF, 1993, J BIOL CHEM, V268, P2571; DiPietrantonio AM, 1999, BIOCHEM BIOPH RES CO, V255, P477, DOI 10.1006/bbrc.1999.0208; Gajate C, 1998, MOL PHARMACOL, V53, P602, DOI 10.1124/mol.53.4.602; GIROTTI AW, 1985, ARCH BIOCHEM BIOPHYS, V236, P238, DOI 10.1016/0003-9861(85)90623-X; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hijikata M, 1999, FEBS LETT, V457, P405, DOI 10.1016/S0014-5793(99)01077-7; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; LARRICK JW, 1990, FASEB J, V4, P3215, DOI 10.1096/fasebj.4.14.2172061; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Liu SX, 1998, ARCH BIOCHEM BIOPHYS, V352, P306, DOI 10.1006/abbi.1998.0608; Liu W, 2000, J CELL SCI, V113, P635; Maccarrone M, 1999, EUR J BIOCHEM, V265, P27, DOI 10.1046/j.1432-1327.1999.00630.x; MADDIPATI KR, 1987, ARCH BIOCHEM BIOPHYS, V254, P9, DOI 10.1016/0003-9861(87)90075-0; MAIRORINO M, 1986, ARCH BIOCHEM BIOPHYS, V251, P600; Malecki A, 2000, J NEUROCHEM, V74, P2278, DOI 10.1046/j.1471-4159.2000.0742278.x; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Matsura T, 1999, FREE RADICAL RES, V30, P73, DOI 10.1080/10715769900300081; MILLS GC, 1957, J BIOL CHEM, V229, P189; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; PAOLETTI F, 1990, METHOD ENZYMOL, V186, P209; Pemble SE, 1996, BIOCHEM J, V319, P749, DOI 10.1042/bj3190749; PROHASKA JR, 1977, BIOCHEM BIOPH RES CO, V76, P437, DOI 10.1016/0006-291X(77)90744-6; Rao AVSK, 2000, FREE RADICAL BIO MED, V29, P1015, DOI 10.1016/S0891-5849(00)00408-1; Rowe JD, 1997, BIOCHEM J, V325, P481, DOI 10.1042/bj3250481; SATO K, 1989, ADV CANCER RES, V52, P205; SEELIG GF, 1984, J BIOL CHEM, V259, P3534; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SINGHAL SS, 1994, ARCH BIOCHEM BIOPHYS, V311, P242, DOI 10.1006/abbi.1994.1233; SINGHAL SS, 1992, ARCH BIOCHEM BIOPHYS, V299, P232, DOI 10.1016/0003-9861(92)90269-3; Singhal SS, 1999, BIOCHEM ARCH, V15, P163; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; Soh YJ, 2000, MOL PHARMACOL, V58, P535, DOI 10.1124/mol.58.3.535; STENBERG G, 1992, BIOCHEM J, V284, P313, DOI 10.1042/bj2840313; Stridh H, 1998, FEBS LETT, V429, P351, DOI 10.1016/S0014-5793(98)00630-9; Suzuki S, 1999, ONCOGENE, V18, P6380, DOI 10.1038/sj.onc.1203024; Tada-Oikawa S, 1999, FEBS LETT, V442, P65, DOI 10.1016/S0014-5793(98)01618-4; TAKAHASHI K, 1987, ARCH BIOCHEM BIOPHYS, V256, P677, DOI 10.1016/0003-9861(87)90624-2; TAN KH, 1984, BIOCHEM J, V220, P243, DOI 10.1042/bj2200243; THOMAS JP, 1990, J BIOL CHEM, V265, P454; Turner NA, 1998, J MOL CELL CARDIOL, V30, P1789, DOI 10.1006/jmcc.1998.0743; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; URSINI F, 1982, BIOCHIM BIOPHYS ACTA, V710, P197, DOI 10.1016/0005-2760(82)90150-3; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Vieira O, 2000, FASEB J, V14, P532, DOI 10.1096/fasebj.14.3.532; Wagner BA, 2000, J BIOL CHEM, V275, P22461, DOI 10.1074/jbc.M001434200; Yin ZM, 2000, CANCER RES, V60, P4053; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X; Zhao TJ, 1999, ARCH BIOCHEM BIOPHYS, V367, P216, DOI 10.1006/abbi.1999.1277; ZIMNIAK P, 1994, J BIOL CHEM, V269, P992	74	263	274	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19220	19230		10.1074/jbc.M100551200	http://dx.doi.org/10.1074/jbc.M100551200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279091	hybrid			2022-12-27	WOS:000169091000079
J	Cheung, WMW; Chu, AH; Chu, PWK; Ip, NY				Cheung, WMW; Chu, AH; Chu, PWK; Ip, NY			Cloning and expression of a novel nuclear matrix-associated protein that is regulated during the retinoic acid-induced neuronal differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; BINDING-PROTEIN; RECEPTOR; IDENTIFICATION; GENES; PHOSPHORYLATION; ACTIVATION; INDUCTION; SUBUNIT; MAP	Retinoic acid (RA), a derivative of vitamin A, is essential for the normal patterning and neurogenesis during development. RA treatment induces growth arrest and terminal differentiation of a human embryonal carcinoma cell line (NT2) into postmitotic central nervous system neurons. Using RNA fingerprinting by arbitrarily primed polymerase chain reaction, we identified a novel serine/threonine-rich protein, RA-regulated nuclear matrix-associated protein (Ramp), that was down-regulated during the RA-induced differentiation of NT2 cells. Prominent mRNA expression of ramp could be detected in adult placenta and testis as well as in ah human fetal tissues examined. The genomic clone of ramp has been mapped to the telomere of chromosome arm 1q, corresponding to band 1q32.1-32.2. Associated with the nuclear matrix of NT2 cells, Ramp translocates from the interphase nucleus to the metaphase cytoplasm during mitosis, During the late stage of cytokinesis, Ramp concentrates at the midzone of the dividing daughter cells. The transcript expression of ramp is closely correlated with the cell proliferation rate of NT2 cells. Moreover, overexpression of Ramp induces a transient increase in the proliferation rate of NT2 cells. Taken together, our data suggest that Ramp plays a role in the proliferation of the human embryonal carcinoma cells.	Hong Kong Univ Sci & Technol, Dept Biochem, Biotechnol Res Inst, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Biotechnol Res Inst, Hong Kong, Hong Kong, Peoples R China.	BOIP@UST.HK	Chu, Wai Keung/C-4686-2009					ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Berube NG, 2000, HUM MOL GENET, V9, P539, DOI 10.1093/hmg/9.4.539; BOLLAG W, 1994, LEUKEMIA, V8, P1453; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; BRECKLER J, 1994, CELL MOTIL CYTOSKEL, V29, P312, DOI 10.1002/cm.970290404; Cheung WMW, 1999, BIOTECHNIQUES, V26, P946, DOI 10.2144/99265rr04; Cheung WMW, 1998, MOL CELLS, V8, P496; Cheung WMW, 2000, J NEUROCHEM, V75, P34, DOI 10.1046/j.1471-4159.2000.0750034.x; Cheung WMW, 1997, J NEUROCHEM, V68, P1882; Cheung WMW, 1996, NEUROREPORT, V7, P1204, DOI 10.1097/00001756-199604260-00022; Cheung WMW, 2000, FEBS LETT, V486, P291, DOI 10.1016/S0014-5793(00)02317-6; Chiba H, 1997, J CELL BIOL, V139, P735, DOI 10.1083/jcb.139.3.735; Collas P, 1999, J CELL BIOL, V147, P1167, DOI 10.1083/jcb.147.6.1167; COLLINS SJ, 1990, MOL CELL BIOL, V10, P2154, DOI 10.1128/MCB.10.5.2154; COMPTON DA, 1994, CURR OPIN CELL BIOL, V6, P343, DOI 10.1016/0955-0674(94)90024-8; CONLON RA, 1995, TRENDS GENET, V11, P314, DOI 10.1016/S0168-9525(00)89089-7; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; DE LUCA LM, 1991, FASEB J, V5, P2924; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; HeineSuner D, 1997, IMMUNOGENETICS, V45, P422, DOI 10.1007/s002510050224; IP NY, 1994, NEURON, V13, P443, DOI 10.1016/0896-6273(94)90359-X; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Metzger D, 1999, EMBO J, V18, P4823, DOI 10.1093/emboj/18.17.4823; MILLER WH, 1990, ONCOGENE, V5, P511; MOASSER MM, 1994, ONCOGENE, V9, P833; Nakshatri H, 1996, GENE, V174, P79, DOI 10.1016/0378-1119(96)00391-5; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Plateroti M, 1997, J CELL SCI, V110, P1227; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; QIAN YW, 1995, J BIOL CHEM, V270, P25507, DOI 10.1074/jbc.270.43.25507; Salvarezza SB, 1997, CELL PROLIFERAT, V30, P71; Salvatore P, 1998, J BIOL CHEM, V273, P6989, DOI 10.1074/jbc.273.12.6989; Si JT, 1997, J BIOL CHEM, V272, P10367; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SMITH MA, 1992, J CLIN ONCOL, V10, P839, DOI 10.1200/JCO.1992.10.5.839; Straight AF, 2000, CURR BIOL, V10, pR760, DOI 10.1016/S0960-9822(00)00746-6; Xie P, 1997, NEUROREPORT, V8, P1067, DOI 10.1097/00001756-199703240-00001; Yudkovsky Y, 2000, BIOCHEM BIOPH RES CO, V271, P299, DOI 10.1006/bbrc.2000.2622; ZHU XL, 1995, MOL CELL BIOL, V15, P5017	42	31	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17083	17091		10.1074/jbc.M010802200	http://dx.doi.org/10.1074/jbc.M010802200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278750	hybrid			2022-12-27	WOS:000168730400065
J	Le Lay, S; Krief, S; Farnier, C; Lefrere, I; Le Liepvre, X; Bazin, R; Ferre, P; Dugail, I				Le Lay, S; Krief, S; Farnier, C; Lefrere, I; Le Liepvre, X; Bazin, R; Ferre, P; Dugail, I			Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHETASE; MEMBRANE LIPID ORDER; ADIPOSE-TISSUE; INSULIN-RESISTANCE; DENSITY-LIPOPROTEIN; PLASMA-MEMBRANE; OBESE SUBJECTS; RECEPTOR; RAT; ACTIVATION	Enlarged fat cells exhibit modified metabolic capacities, which could be involved in the metabolic complications of obesity at the whole body level. We show here that sterol regulatory element-binding protein 2 (SREBP-2) and its target genes are induced in the adipose tissue of several models of rodent obesity, suggesting cholesterol imbalance in enlarged adipocytes. Within a particular fat pad, larger adipocytes have reduced membrane cholesterol concentrations compared with smaller fat cells, demonstrating that altered cholesterol distribution is characteristic of adipocyte hypertrophy per se. We show that treatment with methyl-beta -cyclodextrin, which mimics the membrane cholesterol reduction of hypertrophied adipocytes, induces insulin resistance. We also produced cholesterol depletion by mevastatin treatment, which activates SREBP-2 and its target genes. The analysis of 40 adipocyte genes showed that the response to cholesterol depletion implicated genes involved in cholesterol traffic (caveolin 2, scavenger receptor BI, and ATP binding cassette 1 genes) but also adipocyte-derived secretion products (tumor necrosis factor cu, angiotensinogen, and interleukin-g) and proteins involved in energy metabolism (fatty acid synthase, GLUT 4, and UCP3), These data demonstrate that altering cholesterol balance profoundly modifies adipocyte metabolism in a way resembling that seen in hypertrophied fat cells from obese rodents or humans. This is the first evidence that intracellular cholesterol might serve as a link between fat cell size and adipocyte metabolic activity.	Univ Paris 06, INSERM, U465, Ctr Rech Biomed Cordeliers, F-75270 Paris 06, France; Ctr Rech Smithklin Beecham, F-35260 St Gregoire, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Dugail, I (corresponding author), Univ Paris 06, INSERM, U465, Ctr Rech Biomed Cordeliers, 15 Rue Ecole Med, F-75270 Paris 06, France.		Le Lay, Soazig/AAI-2442-2021; Ferré, Pascal/K-1250-2013; Le Lay, Soazig/N-6862-2018; Dugail, Isabelle/L-1567-2017	Le Lay, Soazig/0000-0003-2456-2422; Ferré, Pascal/0000-0003-0115-7045; Dugail, Isabelle/0000-0003-3631-2252; Krief, Stephane/0000-0002-5543-731X				Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Boizard M, 1998, J BIOL CHEM, V273, P29164, DOI 10.1074/jbc.273.44.29164; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHLOUVERAKIS C, 1974, STEROIDS LIPID RES, V5, P351; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Costet P, 2000, J BIOL CHEM, V275, P28240; Engeli S, 2000, HYPERTENSION, V35, P1270, DOI 10.1161/01.HYP.35.6.1270; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foretz M, 1999, MOL CELL BIOL, V19, P3760; FREDERICH RC, 1992, HYPERTENSION, V19, P339, DOI 10.1161/01.HYP.19.4.339; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GUERREMILLO M, 1994, LIPIDS, V29, P205, DOI 10.1007/BF02536730; GUERREMILLO M, 1985, J CLIN INVEST, V76, P109, DOI 10.1172/JCI111932; GUICHARD C, 1992, J LIPID RES, V33, P679; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; HAINAULT I, 1991, J CLIN INVEST, V87, P1127, DOI 10.1172/JCI115077; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; KOVANEN PT, 1975, J LIPID RES, V16, P211; KRAUSE BR, 1984, J LIPID RES, V25, P97; Lopez D, 1999, ENDOCRINOLOGY, V140, P5669, DOI 10.1210/en.140.12.5669; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; MOLINA JM, 1989, DIABETES, V38, P991, DOI 10.2337/diabetes.38.8.991; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; OLEFSKY JM, 1977, ENDOCRINOLOGY, V100, P1169; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rothblat GH, 1999, J LIPID RES, V40, P781; Schrauwen P, 1999, OBES RES, V7, P97, DOI 10.1002/j.1550-8528.1999.tb00396.x; SCHREIBMAN PH, 1975, J CLIN INVEST, V55, P986, DOI 10.1172/JCI108028; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; STORCH J, 1989, J BIOL CHEM, V264, P10527; VAN HV, 2000, OBES RES, V8, P337; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693; 1999, BULLETIN, V2	46	188	193	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16904	16910		10.1074/jbc.M010955200	http://dx.doi.org/10.1074/jbc.M010955200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278795	hybrid			2022-12-27	WOS:000168730400041
J	Xu, YB; Heath, RJ; Li, ZM; Rock, CO; White, SW				Xu, YB; Heath, RJ; Li, ZM; Rock, CO; White, SW			The Fadr DNA complex - Transcriptional control of fatty acid metabolism in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COENZYME; CRYSTAL-STRUCTURE; GENE FADR; BINDING; PROTEIN; DEGRADATION; SYSTEM; REGULATOR; ACTIVATOR	In Escherichia coli, the expression of fatty acid metabolic genes is controlled by the transcription factor, FadR, The affinity of FadR for DNA is controlled by long chain acyl-CoA molecules, which bind to the protein and modulate gene expression. The crystal structure of FadR reveals a two domain dimeric molecule where the N-terminal domains bind DNA, and the C-terminal domains bind acyl-CoA. The DNA binding domain has a winged-helix motif, and the C-terminal domain resembles the sensor domain of the Tet repressor, The FadR DNA complex reveals how the protein interacts with DNA and specifically recognizes a palindromic sequence. Structural and functional similarities to the Tet repressor and the BmrR transcription factors suggest how the binding of the acyl-CoA effector molecule to the C-terminal domain may affect the DNA binding affinity of the N-terminal domain. We suggest that the binding of acyl-CoA disrupts a buried network of charged and polar residues in the C-terminal domain, and the resulting conformational change is transmitted to the N-terminal domain via a domain-spanning alpha -helix.	St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	White, SW (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	stephen.white@stjude.org	White, Stephen W/N-8164-2018	Heath, Richard/0000-0002-1795-1254	NCI NIH HHS [CA21765] Funding Source: Medline; NIGMS NIH HHS [GM34496] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BETRAND KP, 1988, GENE, V23, P149; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; Cronan JE, 1997, J BACTERIOL, V179, P1819, DOI 10.1128/jb.179.5.1819-1823.1997; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; DiRusso CC, 1999, PROG LIPID RES, V38, P129, DOI 10.1016/S0163-7827(98)00022-8; DIRUSSO CC, 1988, NUCLEIC ACIDS RES, V16, P7995, DOI 10.1093/nar/16.16.7995; DiRusso CC, 1998, J BIOL CHEM, V273, P33652, DOI 10.1074/jbc.273.50.33652; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; DiRusso CC, 1998, MOL MICROBIOL, V27, P1, DOI 10.1046/j.1365-2958.1998.00645.x; DIRUSSO CC, 1985, J BACTERIOL, V161, P583, DOI 10.1128/JB.161.2.583-588.1985; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Gui LZ, 1996, J BACTERIOL, V178, P4704, DOI 10.1128/jb.178.15.4704-4709.1996; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; HENRY MF, 1991, J MOL BIOL, V222, P843, DOI 10.1016/0022-2836(91)90574-P; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEIN K, 1971, EUR J BIOCHEM, V19, P442, DOI 10.1111/j.1432-1033.1971.tb01334.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NUNN WD, 1983, J BACTERIOL, V154, P554, DOI 10.1128/JB.154.2.554-560.1983; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVERATH P, 1969, EUR J BIOCHEM, V7, P559; OVERATH P, 1967, BIOCHEM BIOPH RES CO, V29, P28, DOI 10.1016/0006-291X(67)90535-9; Raman N, 1997, J BIOL CHEM, V272, P30645, DOI 10.1074/jbc.272.49.30645; RAMAN N, 1995, J BIOL CHEM, V270, P1092, DOI 10.1074/jbc.270.3.1092; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SIMONS RW, 1980, J BACTERIOL, V142, P621, DOI 10.1128/JB.142.2.621-632.1980; SIMONS RW, 1980, J BACTERIOL, V143, P726, DOI 10.1128/JB.143.2.726-730.1980; van Aalten DMF, 2000, EMBO J, V19, P5167, DOI 10.1093/emboj/19.19.5167; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6; [No title captured]	38	96	110	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17373	17379		10.1074/jbc.M100195200	http://dx.doi.org/10.1074/jbc.M100195200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279025	hybrid			2022-12-27	WOS:000168730400104
J	Bajaj, SP; Schmidt, AE; Mathur, A; Padmanabhan, K; Zhong, DG; Mastri, M; Fay, PJ				Bajaj, SP; Schmidt, AE; Mathur, A; Padmanabhan, K; Zhong, DG; Mastri, M; Fay, PJ			Factor IXa : factor VIIIA interaction - Helix 330-338 of factor IX interacts with residues 558-565 and spatially adjacent regions of the A2 subunit of factor VIIIa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR-IX; ACTIVATED PROTEIN-C; PORCINE FACTOR-VIII; X-RAY STRUCTURE; BLOOD-COAGULATION; HEMOPHILIA-B; BINDING-SITE; DOMAIN; CERULOPLASMIN; PROTEOLYSIS	The physiologic activator of factor X consists of a complex of factor IXa, factor VIIIa, Ca2+ and a suitable phospholipid surface. In one study, helix 330 (162 in chymotrypsin) of the protease domain of factor IXa was implicated in binding to factor VIIIa. In another study, residues 558-565 of the A2 subunit of factor VIIIa were implicated in binding to factor IXa. We now provide data, which indicate that the helix 330 of factor IXa interacts with the 558-565 region of the A2 subunit, Thus, the ability of the isolated A2 subunit was severely impaired in potentiating factor X activation by IXa(R333Q) and by a helix replacement mutant (IXa(helixVII) in which helix 330-338 is replaced by that of factor VII) but it was normal for an epidermal growth factor 1 replacement mutant (IXa(PCEGF1) in which epidermal growth factor 1 domain is replaced by that of protein C). Further, affinity of each 5-dimethylaminonaphthalene-1-sulfonyl (dansyl)-Glu-Gly-Arg-IXa (dEGR-IXa) with the A2 subunit was determined from its ability to inhibit wild-type IXa in the tenase assay and from the changes in dansyl fluorescence emission signal upon its binding to the A2 subunit. Apparent K-d(A2) values are: dEGR-IXa(WT) or dEGR-IXa(PCEGF1) similar to 100 nM, dEGR-IXa(R333Q) similar to1.8 muM, and dEGR-IXa(helixVII) >10 muM. In additional experiments, we measured the affinities of these factor IXa molecules for a peptide comprising residues 558-565 of the A2 subunit, Apparent K-d(peptide) values are: dEGR-IXa(WT) or dEGR-IXa(PCEGF1) similar to4 muM, and dEGR-IXa(R333Q) similar to 62 muM. Thus as compared with the wild-type or PCEGF1 mutant, the affinity of the R333Q mutant for the A2 subunit or the A2 558-565 peptide is similarly reduced. These data support a conclusion that the helix 330 of factor IXa interacts with the A2 558-565 sequence. This information was used to model the interface between the IXa protease domain and the A2 subunit, which is also provided herein.	St Louis Univ, Sch Med, Dept Med, St Louis, MO 63104 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	Saint Louis University; Michigan State University; University of Rochester	Bajaj, SP (corresponding author), St Louis Univ, Hlth Sci Ctr, Div Hematol & Oncol, 3635 Vista Ave,POB 15250, St Louis, MO 63110 USA.				NHLBI NIH HHS [HL36365] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL036365, R01HL036365, R55HL036365] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARNI RK, 1994, CHEM PHYS LIPIDS, V67-8, P59, DOI 10.1016/0009-3084(94)90124-4; BAJAJ SP, 1993, METHOD ENZYMOL, V222, P96; BAJAJ SP, 1981, PREP BIOCHEM, V11, P397, DOI 10.1080/00327488108065531; Bajaj SP, 1999, SEMIN THROMB HEMOST, V25, P407, DOI 10.1055/s-2007-994943; Bajaj SP, 1999, THROMB HAEMOSTASIS, V82, P218; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDSTETTER H, 1995, P NATL ACAD SCI USA, V92, P9796, DOI 10.1073/pnas.92.21.9796; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHURCH WR, 1984, P NATL ACAD SCI-BIOL, V81, P6934, DOI 10.1073/pnas.81.22.6934; CRAIG DA, 1993, TRENDS PHARMACOL SCI, V14, P89, DOI 10.1016/0165-6147(93)90070-Z; CURTIS JE, 1994, J BIOL CHEM, V269, P6246; DISCIPIO RG, 1978, J CLIN INVEST, V61, P1528, DOI 10.1172/JCI109073; FAY PJ, 1993, J BIOL CHEM, V268, P17861; Fay PJ, 1999, J BIOL CHEM, V274, P29826, DOI 10.1074/jbc.274.42.29826; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; FAY PJ, 1994, J BIOL CHEM, V269, P20522; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1991, J BIOL CHEM, V266, P8957; FREEDMAN SJ, 1996, J BIOL CHEM, V272, P22037; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Halfman C J, 1981, Methods Enzymol, V74 Pt C, P481; Hopfner KP, 1999, STRUCTURE, V7, P989, DOI 10.1016/S0969-2126(99)80125-7; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; Kolkman JA, 1999, BIOCHEM J, V339, P217, DOI 10.1042/0264-6021:3390217; Lapan KA, 1997, J BIOL CHEM, V272, P2082; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; LOLLAR P, 1994, J CLIN INVEST, V93, P2494; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Mathur A, 1997, J BIOL CHEM, V272, P23418, DOI 10.1074/jbc.272.37.23418; Mathus A, 1999, J BIOL CHEM, V274, P18477, DOI 10.1074/jbc.274.26.18477; Mertens K, 1999, THROMB HAEMOSTASIS, V82, P209; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Pemberton S, 1997, BLOOD, V89, P2413, DOI 10.1182/blood.V89.7.2413; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; REGAN LM, 1994, J BIOL CHEM, V269, P9445; Stoylova SS, 1999, J BIOL CHEM, V274, P36573, DOI 10.1074/jbc.274.51.36573; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P15, DOI 10.1007/s007750050018; ZHONG DG, 1993, BIOTECHNIQUES, V15, P874; ZHONG DG, 1994, P NATL ACAD SCI USA, V91, P3574, DOI 10.1073/pnas.91.9.3574	49	65	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16302	16309		10.1074/jbc.M011680200	http://dx.doi.org/10.1074/jbc.M011680200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278963	hybrid			2022-12-27	WOS:000168623100098
J	Yoshida, M; Kashiwagi, K; Kawai, G; Ishihama, A; Igarashi, K				Yoshida, M; Kashiwagi, K; Kawai, G; Ishihama, A; Igarashi, K			Polyamine enhancement of the synthesis of adenylate cyclase at the translational level and the consequential stimulation of the synthesis of the RNA polymerase sigma(28) subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP RECEPTOR PROTEIN; OLIGOPEPTIDE-BINDING-PROTEIN; GLUCOSE-LACTOSE DIAUXIE; CELL-FREE SYSTEM; ESCHERICHIA-COLI; INITIATION CODON; INTRACELLULAR LEVELS; BOVINE LYMPHOCYTES; MESSENGER-RNA; H-NS	The effects of polyamines on the synthesis of various a subunits of RNA polymerase were studied using Western blot analysis. Synthesis of sigma (28) was stimulated 4.0-fold and that of sigma (38) was stimulated 2.3-fold by polyamines, whereas synthesis of other a subunits was not influenced by polyamines. Stimulation of sigma (28) synthesis was due to an increase in the level of cAMP, which occurred through polyamine stimulation of the synthesis of adenylate cyclase at the level of translation. Polyamines were found to increase the translation of adenylate cyclase mRNA by facilitating the UUG codon-dependent initiation. Analysis of RNA secondary structure suggests that exposure of the Shine-Dalgarno sequence of mRNA is a prerequisite for polyamine stimulation of the UUG codon-dependent initiation.	Chiba Univ, Grad Sch Pharmaceut Sci, Inage Ku, Chiba 2638522, Japan; Chiba Inst Technol, Fac Engn, Dept Ind Chem, Narashino, Chiba 2758588, Japan; Natl Inst Genet, Dept Mol Genet, Shizuoka 4110801, Japan	Chiba University; Chiba Institute of Technology; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Igarashi, K (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.			Igarashi, Kazuei/0000-0003-3751-3187				AIBA H, 1984, NUCLEIC ACIDS RES, V12, P9427, DOI 10.1093/nar/12.24.9427; AIBA H, 1982, NUCLEIC ACIDS RES, V10, P1345, DOI 10.1093/nar/10.4.1345; AIBA H, 1985, J BIOL CHEM, V260, P3063; ARNOSTI DN, 1990, J BACTERIOL, V172, P4106, DOI 10.1128/jb.172.7.4106-4108.1990; ATKINS JF, 1975, J BIOL CHEM, V250, P5688; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791, DOI 10.1128/JB.124.2.791-799.1975; DESMIT MH, 1994, J MOL BIOL, V235, P173, DOI 10.1016/S0022-2836(05)80024-5; DUBE SK, 1968, NATURE, V218, P232, DOI 10.1038/218232a0; ECHANDI G, 1975, BIOCHEM BIOPH RES CO, V67, P1185, DOI 10.1016/0006-291X(75)90798-6; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; GENTRY DR, 1995, J BACTERIOL, V177, P3890, DOI 10.1128/jb.177.13.3890-3893.1995; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Igarashi K, 1997, J BIOL CHEM, V272, P4058, DOI 10.1074/jbc.272.7.4058; IGARASHI K, 1984, CANCER RES, V44, P5326; IGARASHI K, 1979, BIOCHEM BIOPH RES CO, V91, P440, DOI 10.1016/0006-291X(79)91541-9; IGARASHI K, 1979, EUR J BIOCHEM, V93, P345, DOI 10.1111/j.1432-1033.1979.tb12829.x; IGARASHI K, 1974, EUR J BIOCHEM, V48, P495, DOI 10.1111/j.1432-1033.1974.tb03790.x; Imamura R, 1996, J BIOL CHEM, V271, P25423, DOI 10.1074/jbc.271.41.25423; Inada T, 1996, GENES CELLS, V1, P293, DOI 10.1046/j.1365-2443.1996.24025.x; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; Ishihama A, 1997, CURR OPIN GENET DEV, V7, P582, DOI 10.1016/S0959-437X(97)80003-2; ISHIZUKA H, 1993, MOL MICROBIOL, V10, P341, DOI 10.1111/j.1365-2958.1993.tb01960.x; ITO K, 1990, ARCH BIOCHEM BIOPHYS, V278, P277, DOI 10.1016/0003-9861(90)90260-6; ITO K, 1986, EUR J BIOCHEM, V156, P505, DOI 10.1111/j.1432-1033.1986.tb09609.x; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; KAKEGAWA T, 1986, EUR J BIOCHEM, V158, P265, DOI 10.1111/j.1432-1033.1986.tb09746.x; KASHIWAGI K, 1990, J BIOL CHEM, V265, P8387; KASHIWAGI K, 1994, BIOCHEM BIOPH RES CO, V200, P591, DOI 10.1006/bbrc.1994.1489; Kimata K, 1997, P NATL ACAD SCI USA, V94, P12914, DOI 10.1073/pnas.94.24.12914; Kutsukake K, 1997, MOL GEN GENET, V254, P440, DOI 10.1007/s004380050437; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; LIBERMAN E, 1985, J BIOL CHEM, V260, P4075; LINDEROTH N, 1983, BIOCHEM BIOPH RES CO, V117, P616, DOI 10.1016/0006-291X(83)91245-7; Maeda H, 2000, J BACTERIOL, V182, P1181, DOI 10.1128/JB.182.4.1181-1184.2000; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; Mytelka DS, 1996, J BACTERIOL, V178, P24, DOI 10.1128/jb.178.1.24-34.1996; Nielsen L D, 1974, Methods Enzymol, V38, P249; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; PHILIPSON L, 1978, CELL, V13, P189, DOI 10.1016/0092-8674(78)90149-6; PON CL, 1988, MOL GEN GENET, V212, P199, DOI 10.1007/BF00334684; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; REDDY P, 1985, P NATL ACAD SCI USA, V82, P5656, DOI 10.1073/pnas.82.17.5656; Sacerdot C, 1996, MOL MICROBIOL, V21, P331, DOI 10.1046/j.1365-2958.1996.6361359.x; SARUBBI E, 1989, J BIOL CHEM, V264, P15074; SHAPIRA SK, 1983, GENE, V25, P71, DOI 10.1016/0378-1119(83)90169-5; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; SPURIO R, 1992, MOL GEN GENET, V231, P201, DOI 10.1007/BF00279792; Sussman JK, 1996, MOL MICROBIOL, V21, P347, DOI 10.1046/j.1365-2958.1996.6371354.x; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; Ueguchi C, 1996, J MOL BIOL, V263, P149, DOI 10.1006/jmbi.1996.0566; Van Etten WJ, 1998, MOL MICROBIOL, V27, P987, DOI 10.1046/j.1365-2958.1998.00744.x; WATANABE S, 1991, J BIOL CHEM, V266, P20803; WATANABE Y, 1981, BIOCHIM BIOPHYS ACTA, V656, P134, DOI 10.1016/0005-2787(81)90078-2; Yoshida M, 1999, J BIOL CHEM, V274, P22723, DOI 10.1074/jbc.274.32.22723; ZUCKER M, 1981, NUCLEIC ACIDS RES, V9, P133	62	42	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16289	16295		10.1074/jbc.M011059200	http://dx.doi.org/10.1074/jbc.M011059200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278825	hybrid			2022-12-27	WOS:000168623100096
J	Beaudoin, J; Labbe, S				Beaudoin, J; Labbe, S			The fission yeast copper-sensing transcription factor Cuf1 regulates the copper transporter gene expression through an Ace1/Amt1-like recognition sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; FACTOR MAC1; METALLOTHIONEIN EXPRESSION; MOLECULAR CHARACTERIZATION; SUPEROXIDE-DISMUTASE; PHYSIOLOGICAL-ROLE; CANDIDA-GLABRATA; IRON UPTAKE	Transcriptional regulation of genes encoding critical components of copper transport is essential for copper homeostasis and growth in yeast. Analysis of regulatory regions in the promoter of the ctr4(+) copper transporter gene in fission yeast Schizosaccharomyces pombe reveals the identity of a conserved copper-signaling element (CuSE), which is recognized by the transcription factor Cuf1. We demonstrate that CuSE is necessary for transcriptional activation in response to copper deprivation conditions. Interestingly, the CuSE element bears a strong sequence similarity to the recognition site, denoted MRE (metal regulatory element), which is recognized by a distinct class of copper sensors required for copper detoxification, including Ace1 from Saccharomyces cerevisiae and Amt1 from Candida glabrata. When a consensus MRE from S. cerevisiae is introduced into S. pombe, transcription is induced by copper deprivation in a Cuf1-dependent manner, similar to regulation by Mad, the nuclear sensor for regulating the expression of genes encoding components involved in copper transport in S. cerevisiae. UV-cross-linking experiments show that the Cuf1 protein directly binds the CuSE. These results demonstrate that the Cuf1 nutritional copper-sensing factor possesses a module that functions similarly to domains found in the Ace1/Amt1 class of metalloregulatory factors, which allows the protein to act through a closely related MRE-like sequence to regulate copper transport gene expression in S. pombe.	Univ Sherbrooke, Dept Biochim, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Labbe, S (corresponding author), Univ Sherbrooke, Dept Biochim, Sherbrooke, PQ J1H 5N4, Canada.			Labbe, Simon/0000-0002-4947-523X				ALFA C, 1993, EXPT FISSION YEAST L, P1; Borghouts C, 1998, MOL GEN GENET, V260, P492, DOI 10.1007/s004380050922; BUCHMAN C, 1989, MOL CELL BIOL, V9, P4091, DOI 10.1128/MCB.9.9.4091; BUTLER G, 1991, MOL CELL BIOL, V11, P476, DOI 10.1128/MCB.11.1.476; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; CULOTTA VC, 1994, J BIOL CHEM, V269, P25295; CULOTTA VC, 1995, J BIOL CHEM, V270, P29991; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DANCIS A, 1994, J BIOL CHEM, V269, P25660; DANCIS A, 1998, J PEDIAT S132, V132, P24; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; Farrell RA, 1996, BIOCHEMISTRY-US, V35, P1571, DOI 10.1021/bi9517087; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; Graden JA, 1996, BIOCHEMISTRY-US, V35, P14583, DOI 10.1021/bi961642v; GRALLA EB, 1991, P NATL ACAD SCI USA, V88, P8558, DOI 10.1073/pnas.88.19.8558; Gross C, 2000, J BIOL CHEM, V275, P32310, DOI 10.1074/jbc.M005946200; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; HU S, 1990, New Biologist, V2, P544; Iacovoni JS, 1999, GENE, V232, P53, DOI 10.1016/S0378-1119(99)00116-X; Jensen LT, 1998, J BIOL CHEM, V273, P23805, DOI 10.1074/jbc.273.37.23805; Jensen LT, 1998, EMBO J, V17, P5400, DOI 10.1093/emboj/17.18.5400; Joshi A, 1999, J BIOL CHEM, V274, P218, DOI 10.1074/jbc.274.1.218; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; KAISER C, 1994, METHODS YEAST GENETI, P1; Keller G, 2000, J BIOL CHEM, V275, P29193, DOI 10.1074/jbc.M001552200; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Koch KA, 1997, CHEM BIOL, V4, P549, DOI 10.1016/S1074-5521(97)90241-6; Koch KA, 1996, MOL CELL BIOL, V16, P724; Kumagai, 1997, FOREIGN GENE EXPRESS, P3; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Labbe S, 1999, TRENDS MICROBIOL, V7, P500, DOI 10.1016/S0966-842X(99)01638-8; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; LIN SY, 1974, P NATL ACAD SCI USA, V71, P947, DOI 10.1073/pnas.71.3.947; Lippard SJ, 1999, SCIENCE, V284, P748, DOI 10.1126/science.284.5415.748; Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716; McDaniels CPJ, 1999, J BIOL CHEM, V274, P26962, DOI 10.1074/jbc.274.38.26962; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Perego P, 1996, MOL PHARMACOL, V50, P1080; Radisky D, 1999, J BIOL CHEM, V274, P4481, DOI 10.1074/jbc.274.8.4481; Serpe M, 1999, J BIOL CHEM, V274, P29211, DOI 10.1074/jbc.274.41.29211; THIELE DJ, 1988, MOL CELL BIOL, V8, P2745, DOI 10.1128/MCB.8.7.2745; Turner RB, 1998, NAT STRUCT BIOL, V5, P551, DOI 10.1038/805; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; Winge DR, 1998, PROG NUCLEIC ACID RE, V58, P165; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; ZHOU PB, 1993, BIOFACTORS, V4, P105; ZHOU PB, 1991, P NATL ACAD SCI USA, V88, P6112, DOI 10.1073/pnas.88.14.6112; Zhu ZW, 1996, CELL, V87, P459, DOI 10.1016/S0092-8674(00)81366-5; Zhu ZW, 1998, J BIOL CHEM, V273, P1277, DOI 10.1074/jbc.273.3.1277	55	55	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15472	15480		10.1074/jbc.M011256200	http://dx.doi.org/10.1074/jbc.M011256200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278870	hybrid			2022-12-27	WOS:000168528800125
J	Datta, AK; Chammas, R; Paulson, JC				Datta, AK; Chammas, R; Paulson, JC			Conserved cysteines in the sialyltransferase sialylmotifs form an essential disulfide bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; NH2-TERMINAL SIGNAL ANCHOR; POLYMERASE CHAIN-REACTION; NIGRA L BARK; MOLECULAR-CLONING; EXPRESSION CLONING; GOLGI-APPARATUS; GAL-BETA-1,3GALNAC ALPHA-2,3-SIALYLTRANSFERASE; GALNAC ALPHA-2,6-SIALYLTRANSFERASE	The sialyltransferase gene family is comprised of 16 cloned enzymes. All members contain two conserved protein domains, termed the S- and L-sialylmotifs, that participate in substrate binding. Of only six invariant amino acids, two are cysteines, with one found in each sialylmotif. Although the recombinant soluble form of ST6Gal I has six cysteines, quantitative analysis indicated the presence of only one disulfide linkage, and thiol reducing agents dithiothreitol and beta -mercaptoethanol inactivated the enzyme. Analysis of site-directed mutants showed that alanine or serine mutants of invariant Cys(181) or Cys(332) exhibit no detectable activity, either by direct assay or by staining of the transfected cells with Sambucus nigra agglutinin, which recognizes the product NeuAc alpha2,6Gal beta1,4GlcNAc on glycoproteins. In contrast, alanine mutations of charged residues adjacent to either cysteine showed little or no effect on enzyme activity. Immunofluorescence microscopy showed that although the wild type sialyltransferase is properly localized in the Golgi apparatus, the inactive cysteine mutants are retained in the endoplasmic reticulum. The results suggest that the invariant cysteine residues in the L and S-sialylmotifs participate in the formation of an intradisulfide linkage that is essential for proper conformation and activity of ST6Gal I.	Scripps Res Inst, Dept Mol Biol & Mol & Expt Med, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Mol Genet, San Diego, CA 92121 USA	Scripps Research Institute; University of California System; University of California San Diego	Paulson, JC (corresponding author), Dept Mol Biol, MEM-L71,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jpaulson@scripps.edu	Paulson, James/AAG-3565-2019; Chammas, Roger/A-8004-2011	Chammas, Roger/0000-0003-0342-8726	NIGMS NIH HHS [GM27904] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027904] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; BOEGGEMAN EE, 1993, PROTEIN ENG, V6, P779, DOI 10.1093/protein/6.7.779; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; Breton C, 1998, GLYCOBIOLOGY, V8, P87, DOI 10.1093/glycob/8.1.87; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; BROCKHAUSEN I, 1992, CARBOHYD RES, V236, P281, DOI 10.1016/0008-6215(92)85022-R; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; BROEKAERT WF, 1984, BIOCHEM J, V221, P163, DOI 10.1042/bj2210163; CAVALLINI D, 1966, NATURE, V212, P294, DOI 10.1038/212294a0; COLLEY KJ, 1989, J BIOL CHEM, V264, P17619; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 1998, J BIOL CHEM, V273, P9608, DOI 10.1074/jbc.273.16.9608; DATTA AK, 1995, NUCLEIC ACIDS RES, V23, P4530, DOI 10.1093/nar/23.21.4530; DATTA AK, 1993, J BIOL CHEM, V268, P12663; Datta AK, 1997, INDIAN J BIOCHEM BIO, V34, P157; DRICKAMER K, 1993, GLYCOBIOLOGY, V3, P2, DOI 10.1093/glycob/3.1.2; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FISHMAN PH, 1976, SCIENCE, V194, P906, DOI 10.1126/science.185697; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; GILLESPIE W, 1992, J BIOL CHEM, V267, P21004; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harlow E., 1988, ANTIBODIES LAB MANUA; HOLMES EH, 1995, J BIOL CHEM, V270, P8145, DOI 10.1074/jbc.270.14.8145; HSUEH EC, 1986, J BIOL CHEM, V261, P4940; Imberty A, 1997, PROTEIN ENG, V10, P1353, DOI 10.1093/protein/10.12.1353; Ishii A, 1998, J BIOL CHEM, V273, P31652, DOI 10.1074/jbc.273.48.31652; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kono M, 1998, BIOCHEM BIOPH RES CO, V253, P170, DOI 10.1006/bbrc.1998.9768; Kudo T, 1998, J BIOL CHEM, V273, P26729, DOI 10.1074/jbc.273.41.26729; KUROSAWA N, 1994, J BIOL CHEM, V269, P19048; KUROSAWA N, 1994, J BIOL CHEM, V269, P1402; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE EU, 1989, J BIOL CHEM, V264, P13848; Lee YC, 1999, J BIOL CHEM, V274, P11958, DOI 10.1074/jbc.274.17.11958; LEE YC, 1994, J BIOL CHEM, V269, P10028; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; Lowe JB, 1997, KIDNEY INT, V51, P1418, DOI 10.1038/ki.1997.194; Ma JY, 1996, J BIOL CHEM, V271, P7758, DOI 10.1074/jbc.271.13.7758; Nakamura K, 1997, FEBS LETT, V417, P375, DOI 10.1016/S0014-5793(97)01326-4; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PETERS J, 1996, ALL ABOUT ALBUMIN, P9; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI K, 1994, J BIOL CHEM, V269, P15950; Schmid K., 1975, PLASMA PROTEINS, P183; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Sjoberg ER, 1996, J BIOL CHEM, V271, P7450, DOI 10.1074/jbc.271.13.7450; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; Svennerholm L, 1980, Adv Exp Med Biol, V125, P533; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Tsuji S, 1996, GLYCOBIOLOGY, V6, pR5; WANG Y, 1994, BIOCHEM BIOPH RES CO, V204, P701, DOI 10.1006/bbrc.1994.2516; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; WEN DX, 1992, J BIOL CHEM, V267, P21011; WILLIAMS MA, 1995, GLYCOCONJ J, V12, P765; YADAV S, 1990, J BIOL CHEM, V265, P14163; YADAV SP, 1991, J BIOL CHEM, V266, P698; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; YOSHIDA Y, 1995, J BIOL CHEM, V270, P14628, DOI 10.1074/jbc.270.24.14628	65	48	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15200	15207		10.1074/jbc.M010542200	http://dx.doi.org/10.1074/jbc.M010542200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278697	hybrid			2022-12-27	WOS:000168528800090
J	Meehan, HA; Connell, GJ				Meehan, HA; Connell, GJ			The hairpin loop but not the bulged C of the iron responsive element is essential for high affinity binding to iron regulatory protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRITIN MESSENGER-RNA; TRANSLATIONAL REGULATION; TRANSFERRIN RECEPTOR; POSTTRANSCRIPTIONAL REGULATION; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; INTERNAL LOOP/BULGE; SECONDARY STRUCTURE; ACONITASE ACTIVITY; SELECTION	Vertebrates control intracellular iron concentration principally through the interaction of iron regulatory proteins with mRNAs that contain an iron responsive element, a small hairpin with a bulged C, The hairpin loop and bulged C have previously been assumed to be critical for binding and have been proposed to make direct contact with the iron regulatory proteins. However, we show here that a U or G can be substituted for the bulged C provided that specific nucleotides are also present within internal loops. The K-d, IC50 and chemical modifications of the iron responsive element variants are similar to the wild-type. Results are more consistent with a role in which the C-bulge functions to orient the hairpin for optimal protein binding rather than to directly contact the protein. Characterization of these novel iron responsive element variants may facilitate the identification of additional mRNAs whose expression is controlled by iron regulatory proteins, as well as provide insight into the nature of a critical RNA-protein interaction.	Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Connell, GJ (corresponding author), Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA.	gconnell@lenti.med.umn.edu			NIGMS NIH HHS [T32GM07994] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007994] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; Alen C, 1999, P NATL ACAD SCI USA, V96, P10412, DOI 10.1073/pnas.96.18.10412; BARTON HA, 1990, J BIOL CHEM, V265, P7000; BETTANY AJE, 1992, J BIOL CHEM, V267, P16531; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; Ciesiolka J, 1996, METHOD ENZYMOL, V267, P315; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; DIX DJ, 1993, J MOL BIOL, V231, P230, DOI 10.1006/jmbi.1993.1278; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; GAUTHERET D, 1990, COMPUT APPL BIOSCI, V6, P325; Gdaniec Z, 1998, BIOCHEMISTRY-US, V37, P1505, DOI 10.1021/bi9719814; Gray NK, 1996, P NATL ACAD SCI USA, V93, P4925, DOI 10.1073/pnas.93.10.4925; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; GUO B, 1994, J BIOL CHEM, V269, P24252; HAILE DJ, 1989, MOL CELL BIOL, V9, P5055, DOI 10.1128/MCB.9.11.5055; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; HENDERSON BR, 1993, J BIOL CHEM, V268, P27327; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; HENTZE MW, 1987, P NATL ACAD SCI USA, V84, P6730, DOI 10.1073/pnas.84.19.6730; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; Huang TS, 1999, INSECT BIOCHEM MOLEC, V29, P1, DOI 10.1016/S0965-1748(98)00097-6; IRVINE D, 1991, J MOL BIOL, V222, P739, DOI 10.1016/0022-2836(91)90509-5; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; JAFFREY SR, 1993, NUCLEIC ACIDS RES, V21, P4627, DOI 10.1093/nar/21.19.4627; KAPTAIN S, 1991, P NATL ACAD SCI USA, V88, P10109, DOI 10.1073/pnas.88.22.10109; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Ke YH, 2000, BIOCHEMISTRY-US, V39, P6235, DOI 10.1021/bi9924765; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KIKINIS Z, 1995, NUCLEIC ACIDS RES, V23, P4190, DOI 10.1093/nar/23.20.4190; KROL A, 1989, METHOD ENZYMOL, V180, P212; Laing LG, 1996, BIOCHEMISTRY-US, V35, P13586, DOI 10.1021/bi961310q; Lebruska LL, 1999, BIOCHEMISTRY-US, V38, P3168, DOI 10.1021/bi982515x; LEIBOLD EA, 1990, NUCLEIC ACIDS RES, V18, P1819, DOI 10.1093/nar/18.7.1819; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Schlegl J, 1997, RNA, V3, P1159; Tang Y, 1999, MICROBIOL-SGM, V145, P3069, DOI 10.1099/00221287-145-11-3069; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; THEIL EC, 1990, ENZYME, V44, P68, DOI 10.1159/000468748; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; WANG YH, 1990, NUCLEIC ACIDS RES, V18, P4463, DOI 10.1093/nar/18.15.4463; Yamashita M, 1996, J BIOL CHEM, V271, P26908, DOI 10.1074/jbc.271.43.26908; YOON C, 1990, BIOCHEMISTRY-US, V29, P2116, DOI 10.1021/bi00460a022	51	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14791	14796		10.1074/jbc.M010295200	http://dx.doi.org/10.1074/jbc.M010295200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278657	hybrid			2022-12-27	WOS:000168528800036
J	Sung, JY; Shin, SW; Ahn, YS; Chung, KC				Sung, JY; Shin, SW; Ahn, YS; Chung, KC			Basic fibroblast growth factor-induced activation of novel CREB kinase during the differentiation of immortalized hippocampal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; CAMP RESPONSE ELEMENT; EARLY GENE PIP92; TYROSINE-HYDROXYLASE GENE; CYCLIC-AMP; S6 KINASE; SIGNALING PATHWAYS; NEURONAL CELLS; MAP KINASE; TRANSCRIPTIONAL REGULATION	Growth factors bind to their specific receptors on the responsive cell surface and thereby initiate dramatic changes in the proliferation, differentiation, and survival of their target cells. In the present study we have examined the mechanism by which growth factor-induced signals are propagated to the nucleus, leading to the activation of transcription factor, cis-acting cAMP response element (CRE)-binding protein (CREB), in immortalized hippocampal progenitor cells (H19-7). During the differentiation of H19-7 cells by basic fibroblast growth factor (bFGF) a critical regulatory Ser(133) residue of CREB was phosphorylated followed by an increase of CRE-mediated gene transcription. Expression of S133A CREB mutants blocked the differentiation of H19-7 cells by bFGF. Although the kinetics of CREB phosphorylation by EGF was transient, bFGF induced a prolonged pattern of CREB phosphorylation. Interestingly bFGF-induced CREB phosphorylation and subsequent CRE-mediated gene transcription is not Likely to be mediated by any of previously known signaling pathways that lead to phosphorylation of CREB, such as mitogen-activated protein kinases, protein kinase A, protein kinase C, phosphatidylinositol 3-kinase-p70(S6K), calcium/calmodulindependent protein kinase, and casein kinase 2, By using in vitro in gel kinase assay the presence of a novel 120-kDa bFGF-inducible CREB kinase was identified. These findings identify a new growth factor-activated signaling pathway that regulates gene expression at the CRE.	Yonsei Univ, Coll Med, Dept Pharmacol, Inst Brain Res, Seoul 120752, South Korea; Yonsei Univ, Coll Med, Brain Korea Projects Med Sci 21, Seoul 120752, South Korea; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University System of Maryland; University of Maryland Baltimore	Chung, KC (corresponding author), Yonsei Univ, Coll Med, Dept Pharmacol, Inst Brain Res, Shinchon Dong 134, Seoul 120752, South Korea.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033858] Funding Source: NIH RePORTER; NINDS NIH HHS [NS33858] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beitner-Johnson D, 1998, J BIOL CHEM, V273, P19834, DOI 10.1074/jbc.273.31.19834; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Chao TSO, 1997, CANCER RES, V57, P3168; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Chung KC, 2000, EUR J BIOCHEM, V267, P4676, DOI 10.1046/j.1432-1327.2000.01517.x; Chung KC, 1998, MOL CELL BIOL, V18, P2272, DOI 10.1128/MCB.18.4.2272; Chung KC, 2000, J NEUROCHEM, V75, P9, DOI 10.1046/j.1471-4159.2000.0750009.x; DEGROOT RP, 1994, CELL, V79, P81, DOI 10.1016/0092-8674(94)90402-2; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; EVES EM, 1994, BRAIN RES, V656, P396, DOI 10.1016/0006-8993(94)91484-2; EVES EM, 1992, P NATL ACAD SCI USA, V89, P4373, DOI 10.1073/pnas.89.10.4373; Ghil SH, 2000, J NEUROCHEM, V74, P151, DOI 10.1046/j.1471-4159.2000.0740151.x; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HAWLEY RJ, 1992, J NEUROSCI, V12, P2573; Iordanov M, 1997, EMBO J, V16, P1009, DOI 10.1093/emboj/16.5.1009; KIM KS, 1993, J BIOL CHEM, V268, P15689; Kuo WL, 1997, MOL CELL BIOL, V17, P4633, DOI 10.1128/MCB.17.8.4633; Kuo WL, 1996, MOL CELL BIOL, V16, P1458; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679, DOI 10.1128/MCB.6.5.1679; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; NagamotoCombs K, 1997, J BIOL CHEM, V272, P6051, DOI 10.1074/jbc.272.9.6051; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Pende M, 1997, J NEUROSCI, V17, P1291; PINNA LA, 1995, BIOCH CELL MEMBRANES, P15; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Saeki K, 1999, BIOCHEM J, V338, P49, DOI 10.1042/0264-6021:3380049; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shimomura A, 1998, J NEUROCHEM, V70, P1029; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TRAVERSE S, 1992, BIOCHEM J, V288, P251; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	53	38	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13858	13866		10.1074/jbc.M010610200	http://dx.doi.org/10.1074/jbc.M010610200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278709	hybrid			2022-12-27	WOS:000168356600051
J	van Montfort, BA; Schuurman-Wolters, GK; Duurkens, RH; Mensen, R; Poolman, B; Robillard, GT				van Montfort, BA; Schuurman-Wolters, GK; Duurkens, RH; Mensen, R; Poolman, B; Robillard, GT			Cysteine cross-linking defines part of the dimer and B/C domain interface of the Escherichia coli mannitol permease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PHOSPHOTRANSFERASE SYSTEM; PHOSPHORYLATION SITE MUTANTS; TRANSPORT PROTEIN; ENZYME-IIMTL; SUBSTRATE-BINDING; C-DOMAIN; B-DOMAIN; PHOSPHOENOLPYRUVATE; MEMBRANE; STATE	Part of the dimer and B/C domain interface of the Escherichia coli mannitol permease (EIImtl) has been identified by the generation of disulfide bridges in a single-cysteine EIImtl, with only the activity linked Cys(384) in the B domain, and in a double-cysteine EIImtl with cysteines at positions 384 and 124 in the first cytoplasmic loop of the C domain. The disulfide bridges were formed in the enzyme in inside-out membrane vesicles and in the purified enzyme by oxidation with Cu(II)-(1,10-phenanthroline)(3), and they were visualized by SDS-polyacrylamide gel electrophoresis, Discrimination between possible disulfide bridges in the dimeric double-cysteine EIImtl was done by partial digestion of the protein and the formation of heterodimers, in which the cysteines were located either on different subunits or on one subunit, The disulfide bridges that were identified are an intersubunit Cys(384)-Cys(384), an intersubunit Cys(124)-Cys(124), an intersubunit Cys(384)-Cys(384), and an intrasubunit Cys(384)-Cys(124). The disulfide bridges between the B and C domain were observed with purified enzyme and confirmed by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Mannitol did not influence the formation of the disulfide between Cys(384) and Cys(124). The close proximity of the two cysteines 124 was further confirmed with a separate C domain by oxidation with Cu(II)-(1,10-phenanthroline)(3) or by reactions with dimaleimides of different length. The data in combination with other work show that the first cytoplasmic loop around residue 124 is located at the dimer interface and involved in the interaction between the B and C domain.	Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; Univ Groningen, Dept Biochem, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Robillard, GT (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.		Poolman, Bert/D-1882-2012					BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOER H, 1995, BIOCHEMISTRY-US, V34, P3239, DOI 10.1021/bi00010a013; BOER H, 1994, J BIOL CHEM, V269, P17863; Boer H, 1996, BIOCHEMISTRY-US, V35, P12901, DOI 10.1021/bi9611016; Broos J, 1998, J BIOL CHEM, V273, P3865, DOI 10.1074/jbc.273.7.3865; Broos J, 1999, BIOCHEMISTRY-US, V38, P9798, DOI 10.1021/bi991157a; Broos J, 2000, BIOCHEMISTRY-US, V39, P10877, DOI 10.1021/bi000803z; BROUWER M, 1982, BIOCHEMISTRY-US, V21, P82, DOI 10.1021/bi00530a015; Dijkstra DS, 1997, BIOCHEMISTRY-US, V36, P4860, DOI 10.1021/bi9629081; Dijkstra DS, 1996, BIOCHEMISTRY-US, V35, P6628; ELFERINK MGL, 1990, J BACTERIOL, V172, P7119, DOI 10.1128/jb.172.12.7119-7125.1990; Friesen RHE, 2000, J BIOL CHEM, V275, P33527, DOI 10.1074/jbc.M004066200; Friesen RHE, 2000, J BIOL CHEM, V275, P40658; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Henstra SA, 1996, J BACTERIOL, V178, P5586, DOI 10.1128/jb.178.19.5586-5591.1996; Koning RI, 1999, J MOL BIOL, V287, P845, DOI 10.1006/jmbi.1999.2650; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENGELER JW, 1990, PHILOS T ROY SOC B, V326, P489, DOI 10.1098/rstb.1990.0027; LOLKEMA JS, 1993, BIOCHEMISTRY-US, V32, P1396, DOI 10.1021/bi00057a002; LOLKEMA JS, 1991, BIOCHEMISTRY-US, V30, P6721, DOI 10.1021/bi00241a013; LOLKEMA JS, 1990, BIOCHEMISTRY-US, V29, P10659, DOI 10.1021/bi00499a012; LOLKEMA JS, 1991, BIOCHEMISTRY-US, V30, P6716, DOI 10.1021/bi00241a012; Meijberg W, 1998, J BIOL CHEM, V273, P20785, DOI 10.1074/jbc.273.33.20785; Meijberg W, 1998, J BIOL CHEM, V273, P7949, DOI 10.1074/jbc.273.14.7949; PAS HH, 1987, BIOCHEMISTRY-US, V26, P6689, DOI 10.1021/bi00395a019; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; ROBILLARD GT, 1987, BIOCHEMISTRY-US, V26, P5796, DOI 10.1021/bi00392a032; ROBILLARD GT, 1993, BIOCHEMISTRY-US, V32, P9553, DOI 10.1021/bi00088a006; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; ROBILLARD GT, 1979, BIOCHEMISTRY-US, V18, P2984, DOI 10.1021/bi00581a012; ROOSSIEN FF, 1986, FEBS LETT, V196, P284, DOI 10.1016/0014-5793(86)80264-2; ROOSSIEN FF, 1984, BIOCHEMISTRY-US, V23, P5682, DOI 10.1021/bi00319a003; RUIJTER GJG, 1992, J BACTERIOL, V174, P2843, DOI 10.1128/JB.174.9.2843-2850.1992; SaraceniRichards CA, 1997, J BACTERIOL, V179, P1135, DOI 10.1128/jb.179.4.1135-1142.1997; SaraceniRichards CA, 1997, J BACTERIOL, V179, P5171, DOI 10.1128/jb.179.16.5171-5177.1997; STEPHAN MM, 1986, BIOCHEMISTRY-US, V25, P8230, DOI 10.1021/bi00373a016; STEPHAN MM, 1986, BIOCHEMISTRY-US, V25, P4046, DOI 10.1021/bi00362a009; SUGIYAMA JE, 1991, P NATL ACAD SCI USA, V88, P9603, DOI 10.1073/pnas.88.21.9603; VANDIJK AA, 1990, BIOCHEMISTRY-US, V29, P8164, DOI 10.1021/bi00487a026; VANWEEGHEL RP, 1991, BIOCHEMISTRY-US, V30, P1768, DOI 10.1021/bi00221a006; WENG QP, 1992, J BIOL CHEM, V267, P19529; WENG QP, 1993, BIOCHEMISTRY-US, V32, P11211, DOI 10.1021/bi00092a034	42	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12756	12763		10.1074/jbc.M010728200	http://dx.doi.org/10.1074/jbc.M010728200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278734	hybrid, Green Published			2022-12-27	WOS:000168198600041
J	Wong, M; Uddin, S; Majchrzak, B; Huynh, T; Proudfoot, AEI; Platanias, LC; Fish, EN				Wong, M; Uddin, S; Majchrzak, B; Huynh, T; Proudfoot, AEI; Platanias, LC; Fish, EN			RANTES activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; I INTERFERON RECEPTOR; FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; CHEMOKINE RECEPTORS; ALPHA-SUBUNIT; INFLAMMATION; GROWTH; HIV-1; CCR5	The chemokine RANTES (regulated on activation normal T cell expressed and secreted) and its cognate receptor CC chemokine receptor 5 (CCR5) have been implicated in regulating immune cell function, Previously we reported that in T cells, RANTES activation of CCR5 results in Stat1 and Stat3 phosphorylation-activation, leading to Stat1:1 and Stat1:3 dimers that exhibit DNA binding activity and the transcriptional induction of a Stat-inducible gene, c-fos. Given that RANTES and CCR5 have been implicated in T cell activation, we have studied RANTES-induced signaling events in a CCR5-expressing T cell line, PM1. RANTES treatment of PM1 T cells results in the rapid phosphorylation-activation of CCR5, Jak2, and Jak3. RANTES-inducible Jak phosphorylation is insensitive to pertussis toxin inhibition, indicating that RANTES-CCR5-mediated tyrosine phosphorylation events are not coupled directly to G(alphai) protein-mediated events. In addition to Jaks, several other proteins are rapidly phosphorylated on tyrosine residues in a RANTES-dependent manner, including the Src kinase p56(Ick), which associates with Jak3. Additionally our data confirm that the amino-terminally modified RANTES proteins, aminooxypentane-RANTES and Met-RANTES, are agonists for CCR5 and induce early tyrosine phosphorylation events that are indistinguishable from those inducible by RANTES with similar kinetics. Our data also demonstrate that RANTES activates the p38 mitogen-activated protein (MAP) kinase pathway. This is evidenced by the rapid RANTES-dependent phosphorylation and activation of p38 MAP kinase as well as the activation of the downstream effector of p38, MAP kinase-activated protein (MAPKAP) kinase-2. Pharmacological inhibition of RANTES-dependent p38 MAP kinase activation blocks MAPKAP kinase-2 activity. Thus, activation of Jak kinases and p38 MAP kinase by RANTES regulates the engagement of multiple signaling pathways.	Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2M1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada; W Side Vet Affairs Hosp, Chicago, IL 60607 USA; Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Fish, EN (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Blood Serv Bldg,67 Coll St,Rm 424, Toronto, ON M5G 2M1, Canada.	en.fish@utoronto.ca		Uddin, Shahab/0000-0003-1886-6710	NCI NIH HHS [CA73381, CA77816] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA073381, R01CA077816] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad S, 1997, J BIOL CHEM, V272, P29991, DOI 10.1074/jbc.272.48.29991; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bacon KB, 1998, J IMMUNOL, V160, P1894; Bacon KB, 1996, J EXP MED, V184, P873, DOI 10.1084/jem.184.3.873; BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902; Baggiolini M, 2000, IMMUNOL TODAY, V21, P418, DOI 10.1016/S0167-5699(00)01672-8; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Berg NN, 1997, J IMMUNOL, V159, P1753; Broxmeyer HE, 1999, EXP HEMATOL, V27, P1113, DOI 10.1016/S0301-472X(99)00045-4; COLAMONICI O, 1994, MOL CELL BIOL, V14, P8133, DOI 10.1128/MCB.14.12.8133; Dairaghi DJ, 1998, J IMMUNOL, V160, P426; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; Devalaraja MN, 1999, TRENDS PHARMACOL SCI, V20, P151, DOI 10.1016/S0165-6147(99)01342-5; Dubois PM, 1996, J IMMUNOL, V156, P1356; Foltz IN, 1997, J BIOL CHEM, V272, P3296, DOI 10.1074/jbc.272.6.3296; GHISLAIN J, 1994, J IMMUNOL, V153, P3655; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; GRAHAM GJ, 1990, NATURE, V344, P442, DOI 10.1038/344442a0; Grone HJ, 1999, FASEB J, V13, P1371, DOI 10.1096/fasebj.13.11.1371; Kampen GT, 2000, BLOOD, V95, P1911, DOI 10.1182/blood.V95.6.1911; Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6, DOI 10.1002/jlb.65.1.6; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Lisanti MP, 1999, METH MOL B, V116, P51; Lloyd GM, 1997, J EXP MED, V185, P1371, DOI 10.1084/jem.185.7.1371; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; LUSTER AD, 1995, J EXP MED, V182, P219, DOI 10.1084/jem.182.1.219; MAGUIRE JE, 1995, J EXP MED, V182, P2079, DOI 10.1084/jem.182.6.2079; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Mellado M, 1998, J IMMUNOL, V161, P805; Miotti S, 2000, J CELL SCI, V113, P349; Murphy Philip M., 1996, Cytokine and Growth Factor Reviews, V7, P47, DOI 10.1016/1359-6101(96)00009-3; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Pandey P, 1999, J BIOL CHEM, V274, P10140, DOI 10.1074/jbc.274.15.10140; PlaterZyberk C, 1997, IMMUNOL LETT, V57, P117, DOI 10.1016/S0165-2478(97)00075-8; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rodriguez-Frade JM, 1999, J CELL BIOL, V144, P755, DOI 10.1083/jcb.144.4.755; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Schaller MD, 1996, J ENDOCRINOL, V150, P1, DOI 10.1677/joe.0.1500001; SHARPE RJ, 1990, JNCI-J NATL CANCER I, V82, P848, DOI 10.1093/jnci/82.10.848; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Somani AK, 1997, J BIOL CHEM, V272, P21113, DOI 10.1074/jbc.272.34.21113; STRIETER RM, 1995, J LEUKOCYTE BIOL, V57, P752, DOI 10.1002/jlb.57.5.752; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Vadlamudi R, 1999, ONCOGENE, V18, P7253, DOI 10.1038/sj.onc.1203163; Ward SG, 1998, BIOCHEM J, V333, P457, DOI 10.1042/bj3330457; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wong M, 1998, J BIOL CHEM, V273, P309, DOI 10.1074/jbc.273.1.309; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496; Zlotnik A, 1999, CRIT REV IMMUNOL, V19, P1	56	89	97	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11427	11431		10.1074/jbc.M010750200	http://dx.doi.org/10.1074/jbc.M010750200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11278738	hybrid			2022-12-27	WOS:000167980900116
J	Orivel, J; Redeker, V; Le Caer, JP; Krier, F; Revol-Junelles, AM; Longeon, A; Chaffotte, A; Dejean, A; Rossier, J				Orivel, J; Redeker, V; Le Caer, JP; Krier, F; Revol-Junelles, AM; Longeon, A; Chaffotte, A; Dejean, A; Rossier, J			Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; METAPLEURAL GLANDS; MYRMECIA-GULOSA; MELITTIN; PROTEIN; CECROPIN; FAMILY; SKIN; HYMENOPTERA; PREDICTION	The antimicrobial, insecticidal, and hemolytic properties of peptides isolated from the venom of the predatory ant Pachycondyla goeldii, a member of the subfamily Ponerinae, were investigated. Fifteen novel peptides, named ponericins, exhibiting antibacterial and insecticidal properties were purified, and their amino acid sequences were characterized. According to their primary structure similarities, they can be classified into three families: ponericin G, W, and L, Ponericins share high sequence similarities with known peptides: ponericins G with cecropin-like peptides, ponericins W with gaegurins and melittin, and ponericins L with dermaseptins, Ten peptides were synthesized for further analysis. Their antimicrobial activities against Gram-positive and Gram-negative bacteria strains were analyzed together with their insecticidal activities against cricket larvae and their hemolytic activities. Interestingly, within each of the three families, several peptides present differences in their biological activities. The comparison of the structural features of ponericins with those of well-studied peptides suggests that the ponericins may adopt an amphipathic alpha -helical structure in polar environments, such as cell membranes. In the venom, the estimated peptide concentrations appear to be compatible with an antibacterial activity in vivo. This suggests that in the ant colony, the peptides exhibit a defensive role against microbial pathogens arising from prey introduction and/or ingestion.	Ecole Super Phys & Chim Ind Ville Paris, Lab Neurobiol & Divers Cellulaire, CNRS, UMR 7637, F-75005 Paris, France; Univ Paris 13, Lab Ethol Expt & Comparee, CNRS, ESA 7025, F-93430 Villetaneuse, France; Inst Natl Polytech Lorraine, Ecole Natl Super Agron & Ind Alimentaires, Lab Fermentat & Bioconvers Ind, F-54505 Vandoeuvre Les Nancy, France; Museum Natl Hist Nat, Lab Chim Subst Nat, CNRS, ESA 8041, F-75005 Paris, France; Inst Pasteur, CNRS, URA 1129, Unite Biochim Cellulaire, F-75015 Paris, France; Univ Toulouse 3, Lab Ecol Terr, CNRS, UMR 5552, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); Universite Paris 13; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Redeker, V (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, Lab Neurobiol & Divers Cellulaire, CNRS, UMR 7637, 10 Rue Vauquelin, F-75005 Paris, France.	virginie.redeker@espci.fr	Redeker, Virginie/L-8929-2018; Orivel, Jerome/C-4034-2011; Dejean, Anne/L-5145-2018	Redeker, Virginie/0000-0003-2694-8388; Orivel, Jerome/0000-0002-5636-3228; Dejean, Alain/0000-0002-3561-2248				Amiche M, 1999, FEBS LETT, V456, P352, DOI 10.1016/S0014-5793(99)00964-3; Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; Banks B.E.C., 1986, P329; Blaylock RSM, 2000, TOXICON, V38, P1529, DOI 10.1016/S0041-0101(00)00085-4; Blum M. S., 1978, Arthropod venoms., P801; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; BROWN C A, 1979, Journal of the Kansas Entomological Society, V52, P119; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; EhretSabatier L, 1996, J BIOL CHEM, V271, P29537, DOI 10.1074/jbc.271.47.29537; Ekengren S, 1999, INSECT BIOCHEM MOLEC, V29, P965, DOI 10.1016/S0965-1748(99)00071-5; FERNANDES A, 1996, J VENOM ANIM TOXINS, V3, P287; Finney DJ., 1962, PROBIT ANAL STAT TRE; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Giacometti A, 1999, PEPTIDES, V20, P1265, DOI 10.1016/S0196-9781(99)00131-X; Holldobler B., 1990, pi; Houston ME, 1998, J PEPT RES, V52, P81; Hu┬lldobler, 1985, PSYCHE CAMBRIDGE, V91, P201, DOI DOI 10.1155/1984/70141; JOUVENAZ DP, 1972, ANTIMICROB AGENTS CH, V2, P291, DOI 10.1128/AAC.2.4.291; Juvvadi P, 1996, J AM CHEM SOC, V118, P8989, DOI 10.1021/ja9542911; Krishnakumari V, 1997, J PEPT RES, V50, P88; Lowenberger C, 1999, J BIOL CHEM, V274, P20092, DOI 10.1074/jbc.274.29.20092; Mackintosh JA, 1999, AUST J ENTOMOL, V38, P124, DOI 10.1046/j.1440-6055.1999.00092.x; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MASCHWITZ U, 1970, J INSECT PHYSIOL, V16, P387, DOI 10.1016/0022-1910(70)90180-0; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; MOR A, 1994, EUR J BIOCHEM, V219, P145, DOI 10.1111/j.1432-1033.1994.tb19924.x; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; Orivel J, 2000, SOCIOBIOLOGY, V35, P131; PARK JM, 1994, BIOCHEM BIOPH RES CO, V205, P948, DOI 10.1006/bbrc.1994.2757; Rosengaus RB, 1998, J CHEM ECOL, V24, P1697, DOI 10.1023/A:1020872729671; Schmidt J.O., 1986, P425; Seon AA, 2000, J BIOL CHEM, V275, P5934, DOI 10.1074/jbc.275.8.5934; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Silvestro L, 1997, BIOCHEMISTRY-US, V36, P11452, DOI 10.1021/bi9630826; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Sun DX, 1998, BIOCHEM BIOPH RES CO, V249, P410, DOI 10.1006/bbrc.1998.9150; Takei J, 1999, FEBS LETT, V442, P11, DOI 10.1016/S0014-5793(98)01617-2; Takei J, 1998, BIOCHEMISTRY-US, V37, P5699, DOI 10.1021/bi9729007; VEAL DA, 1992, J APPL BACTERIOL, V72, P188, DOI 10.1111/j.1365-2672.1992.tb01822.x; Wang CC, 1998, J ELECTROCERAM, V2, P273, DOI 10.1023/A:1009978607621; Yans LZ, 1998, J BIOL CHEM, V273, P2059, DOI 10.1074/jbc.273.4.2059	42	163	195	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17823	17829		10.1074/jbc.M100216200	http://dx.doi.org/10.1074/jbc.M100216200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279030	hybrid			2022-12-27	WOS:000168866500029
J	Gatei, M; Zhou, BD; Hobson, K; Scott, S; Young, D; Khanna, KH				Gatei, M; Zhou, BD; Hobson, K; Scott, S; Young, D; Khanna, KH			Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites - In vivo assessment using phospho-specific antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; EARLY EMBRYONIC LETHALITY; IONIZING-RADIATION; PROTEIN; P53; CHECKPOINT; DISRUPTION; LEADS; CELLS	Recent studies have provided evidence that breast cancer susceptibility gene products (Brca1 and Brca2) suppress cancer, at least in part, by participating in DNA damage signaling and DNA repair. Brca1 is hyperphosphorylated in response to DNA damage and co-localizes with Rad51, a protein involved in homologous-recombination, and Nbs1.Mre11.Rad50, a complex required for both homologous-recombination and nonhomologous end joining repair of damaged DNA. Here, we report that there is a qualitative difference in the phosphorylation states of Brca1 between ionizing radiation (IR) and UV radiation. Brca1 is phosphorylated at Ser-1423 and Ser-1524 after IR and W; however, Ser-1387 is specifically phosphorylated after IR, and Ser-1457 is predominantly phosphorylated after W. These results suggest that different types of DNA-damaging agents might signal to Brca1 in different ways. We also provide evidence that the rapid phosphorylation of Brca1 at Ser-1423 and Ser-1524 after IR (but not after W) is largely ataxia telangiectasia mutated (ATM) kinase-dependent. The overexpression of catalytically inactive ATM and Rad3 related (ATR) kinase inhibited the UV-induced phosphorylation of Brca1 at these sites, indicating that ATR controls Brca1 phosphorylation in vivo after the exposure of cells to UV light. Moreover, ATR associates with Brca1; ATR and Brca1 foci co-localize both in cells synchronized in S phase and after exposure of cells to DNA-damaging agents. ATR can itself phosphorylate the region of Brca1 phosphorylated by ATM (Ser-Gln cluster in the C terminus of Brca1, amino acids 1241-1530), However, there are additional uncharacterized ATR phosphorylation site(s) between residues 521 and 757 of Brca1, Taken together, our results support a model in which ATM and ATR act in parallel but somewhat overlapping pathways of DNA damage signaling but respond primarily to different types of DNA lesion.	Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Glaxo SmithKline Beecham, Dept Oncol Res, King Of Prussia, PA 19406 USA; Univ Queensland, Dept Pathol, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute; GlaxoSmithKline; University of Queensland	Khanna, KH (corresponding author), Queensland Inst Med Res, PO Royal Brisbane Hosp, Brisbane, Qld 4029, Australia.		Hobson, Keith/Q-9306-2019; Khanna, Kum Kum/I-1747-2013	Khanna, Kum Kum/0000-0001-8650-5381				Brown EJ, 2000, GENE DEV, V14, P397; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen JJ, 2000, CANCER RES, V60, P5037; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Gatei M, 2000, CANCER RES, V60, P3299; KHANNA KK, 1993, ONCOGENE, V8, P3307; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; KNANNA KK, 2000, J NATL CANCER I, V92, P795; Lavin LF, 1999, INT J RADIAT BIOL, V75, P1201; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Liu QH, 2000, GENE DEV, V14, P1448; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wang Y, 2000, GENE DEV, V14, P927; Zhang HB, 1998, CELL, V92, P433, DOI 10.1016/S0092-8674(00)80936-8; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	23	153	160	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17276	17280		10.1074/jbc.M011681200	http://dx.doi.org/10.1074/jbc.M011681200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278964	hybrid			2022-12-27	WOS:000168730400090
J	Reddy, S; Hama, S; Grijalva, V; Hassan, K; Mottahedeh, R; Hough, G; Wadleigh, DJ; Navab, M; Fogelman, AM				Reddy, S; Hama, S; Grijalva, V; Hassan, K; Mottahedeh, R; Hough, G; Wadleigh, DJ; Navab, M; Fogelman, AM			Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE CELLS; RECEPTOR-DEFICIENT MICE; CHEMOATTRACTANT PROTEIN-1; MAP KINASE; STRUCTURAL IDENTIFICATION; REDUCES ATHEROSCLEROSIS; INDUCED EXPRESSION; ARACHIDONIC-ACID; MKP-1	Entrapment and oxidation of low density lipoproteins (LDL) in the sub-endothelial space is a key process in the initiation of atherosclerotic lesion development. Functional changes induced by oxidized lipids in endothelial cells are early events in the pathogenesis of atherosclerosis, Oxidized-L-alpha -1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (ox-PAPC), a major component of minimally modified/oxidized-LDL (MM-LDL) mimics the biological activities assigned to MP-LDL both in vitro in a co-culture model as well as in vivo in mice. We hypothesized that ox-PAPC initiates gene expression changes in endothelial cells that result in enhanced endothelial/monocyte interactions. To analyze the gene expression changes that oxidized lipids induce in endothelial cells, we used a suppression subtractive hybridization procedure to compare mRNA from PAPC-treated human aortic endothelial cells (HAEC) with that of ox-PAPC-treated cells. We report here the identification of a gene, mitogen-activated protein kinase phosphatase 1 (MKP-1), that is rapidly and transiently induced in ox-PAPC-treated HAEC. Inhibition of MKP-1 using either the phosphatase inhibitor sodium orthovanadate or antisense oligonucleotides prevents the accumulation of monocyte chemotactic activity in ox-PAPC-treated HAEC supernatants, Furthermore, we show that decreased monocyte chemotactic activity in HAEC treated with sodium orthovanadate or MKP-1 antisense oligonucleotides is due to decreased MCP-1 protein. Our results implicate a direct role for MKP-1 in ox-PAPC-induced signaling pathways that result in the production of MCP-1 protein by ox-PAPC-treated HAEC.	Univ Calif Los Angeles, Dept Med, Atherosclerosis Res Unit, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Reddy, S (corresponding author), Univ Calif Los Angeles, Dept Med, Atherosclerosis Res Unit, 650 Charles E Young Dr S,A8-131,CHS, Los Angeles, CA 90095 USA.	sreddy@mednet.ucla.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 30568] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aiello RJ, 1999, ARTERIOSCL THROM VAS, V19, P1518, DOI 10.1161/01.ATV.19.6.1518; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; CHARLES CH, 1993, P NATL ACAD SCI USA, V90, P5292, DOI 10.1073/pnas.90.11.5292; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; De Keulenaer GW, 2000, ARTERIOSCL THROM VAS, V20, P385, DOI 10.1161/01.ATV.20.2.385; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dorfman K, 1996, ONCOGENE, V13, P925; DUFF JL, 1995, J BIOL CHEM, V270, P7161, DOI 10.1074/jbc.270.13.7161; FOGELMAN AM, 1988, J LIPID RES, V29, P1243; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Goebeler M, 1999, BLOOD, V93, P857, DOI 10.1182/blood.V93.3.857.403k03_857_865; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; Hu HM, 2000, J BIOL CHEM, V275, P16373, DOI 10.1074/jbc.M910269199; Hutter D, 2000, BIOCHEM J, V352, P155, DOI 10.1042/0264-6021:3520155; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kim F, 2000, BIOCHEM BIOPH RES CO, V273, P539, DOI 10.1006/bbrc.2000.2951; Kojima S, 2000, INFECT IMMUN, V68, P2791, DOI 10.1128/IAI.68.5.2791-2796.2000; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Lee H, 2000, CIRC RES, V87, P516; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Leitinger N, 1999, ARTERIOSCL THROM VAS, V19, P1291, DOI 10.1161/01.ATV.19.5.1291; Lin WW, 2000, CELL SIGNAL, V12, P457, DOI 10.1016/S0898-6568(00)00090-5; Metzler B, 1998, J BIOL CHEM, V273, P33320, DOI 10.1074/jbc.273.50.33320; Metzler B, 1999, ARTERIOSCL THROM VAS, V19, P1862, DOI 10.1161/01.ATV.19.8.1862; Navab M, 2000, J LIPID RES, V41, P1481; NAVAB M, 1991, J CLIN INVEST, V88, P2039, DOI 10.1172/JCI115532; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Reddy ST, 1997, J BIOL CHEM, V272, P13591, DOI 10.1074/jbc.272.21.13591; Rovin BH, 1999, CYTOKINE, V11, P118, DOI 10.1006/cyto.1998.0409; Sasayama S, 2000, CARDIOVASC RES, V45, P267, DOI 10.1016/S0008-6363(99)00381-8; Schliess F, 2000, GASTROENTEROLOGY, V118, P929, DOI 10.1016/S0016-5085(00)70179-X; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Subbanagounder G, 2000, FREE RADICAL BIO MED, V28, P1751, DOI 10.1016/S0891-5849(00)00233-1; Tournier C, 1997, EUR J BIOCHEM, V244, P587, DOI 10.1111/j.1432-1033.1997.00587.x; VALENTE AJ, 1988, BIOCHEMISTRY-US, V27, P4162, DOI 10.1021/bi00411a039; Valledor AF, 1999, J IMMUNOL, V163, P2452; Watson AD, 1999, J BIOL CHEM, V274, P24787, DOI 10.1074/jbc.274.35.24787; WATSON AD, 1995, J CLIN INVEST, V95, P774, DOI 10.1172/JCI117726; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597	45	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17030	17035		10.1074/jbc.M011663200	http://dx.doi.org/10.1074/jbc.M011663200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278958	hybrid			2022-12-27	WOS:000168730400057
J	Chen, K; Vita, JA; Berk, BC; Keaney, JF				Chen, K; Vita, JA; Berk, BC; Keaney, JF			c-jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves Src-dependent epidermal growth factor receptor transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; OXIDATIVE STRESS; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; REVERSIBLE INACTIVATION; SIGNALING PATHWAYS; REDOX REGULATION; JNK ACTIVATION; MAP KINASES; P38	The phenotypic properties of the endothelium are subject to modulation by oxidative stress, and the c-dun N-terminal kinase (JNK) pathway is important in mediating cellular responses to stress, although activation of this pathway in endothelial cells has not been fully characterized. Therefore, we exposed endothelial cells to hydrogen peroxide (H2O2) and observed rapid activation of JNK within 15 min that involved phosphorylation of JNK and c-Jun and induction of AP-1 DNA binding activity, Inhibition of protein kinase C and phosphoinositide 3-kinase did not effect JNK activation. In contrast, the tyrosine kinase inhibitors, genistein, herbimycin A, and 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-D]pyrimidine (PP2) significantly attenuated H2O2-induced JNK activation as did endothelial cell adenoviral transfection with a dominant-negative form of Src, implicating Src as an upstream activator of JNK, Activation of JNK by H2O2 was also inhibited by AG1478 and antisense oligonucleotides directed against the epidermal growth factor receptor (EGFR), implicating the EGFR in this process. Consistent with this observation, H2O2 stimulated EGFR tyrosine phosphorylation and complex formation with Shc-Grb2 that was abolished by PP2, implicating Src in H2O2-induced EGFR activation. Tyrosine phosphorylation of the EGFR by H2O2 did not involve receptor autophosphorylation at Tyr(1173) as assessed by an autophosphorylation-specific antibody. These data indicate that H2O2-induced JNK activation in endothelial cells involves the EGFR through an Src-dependent pathway that is distinct from EGFR ligand activation. These data represent one potential pathway for mediating oxidative stress-induced phenotypic changes in the endothelium.	Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; Boston Univ, Sch Med, Evans Mem Dept Med, Boston, MA 02118 USA; Univ Rochester, Med Ctr, Cardiovasc Res Ctr, Rochester, NY 14642 USA	Boston University; Boston University; University of Rochester	Keaney, JF (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 715 Albany St,Rm W507, Boston, MA 02118 USA.	jkeaney@bu.edu		Vita, Joseph/0000-0001-5607-1797; Berk, Bradford/0000-0002-2767-4115; Keaney, John/0000-0002-0866-1837	NHLBI NIH HHS [HL59346, HL55854, HL53398, HL52936, HL49192, HL18645] Funding Source: Medline; NIDDK NIH HHS [DK55656] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, P01HL055854, R01HL049192, R01HL053398, R01HL052936, R01HL059346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055656] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Abe JI, 2000, J BIOL CHEM, V275, P1739, DOI 10.1074/jbc.275.3.1739; BAAS AS, 1995, CIRC RES, V77, P29, DOI 10.1161/01.RES.77.1.29; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Bouloumie A, 1999, FASEB J, V13, P1231, DOI 10.1096/fasebj.13.10.1231; Brauchle M, 2000, EXP CELL RES, V258, P135, DOI 10.1006/excr.2000.4913; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Chen K, 2000, CELL MOL BIOL, V46, P609; Chen K, 1996, BIOCHEM BIOPH RES CO, V224, P703, DOI 10.1006/bbrc.1996.1087; Davis RJ, 1999, BIOCHEM SOC SYMP, P1; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; DEVARY Y, 1992, CELL, V71, P1081, DOI 10.1016/S0092-8674(05)80058-3; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GAMOU S, 1995, FEBS LETT, V357, P161, DOI 10.1016/0014-5793(94)01335-X; Go YM, 1998, AM J PHYSIOL-HEART C, V275, pH1898, DOI 10.1152/ajpheart.1998.275.5.H1898; Goldkorn T, 1998, AM J RESP CELL MOL, V19, P786, DOI 10.1165/ajrcmb.19.5.3249; Griendling KK, 1997, CIRCULATION, V96, P3264; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Huang A, 2000, J BIOL CHEM, V275, P17399, DOI 10.1074/jbc.M002248200; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Metzler B, 2000, AM J PATHOL, V156, P1875, DOI 10.1016/S0002-9440(10)65061-4; Mietus-Snyder M, 1998, ARTERIOSCL THROM VAS, V18, P1440, DOI 10.1161/01.ATV.18.9.1440; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nagao M, 1998, J BIOL CHEM, V273, P22892, DOI 10.1074/jbc.273.36.22892; NAKAMURA K, 1993, ONCOGENE, V8, P3133; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PRYOR WA, 1994, NATURAL ANTIOXIDANTS, P1; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Takeyama K, 2000, J IMMUNOL, V164, P1546, DOI 10.4049/jimmunol.164.3.1546; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450; Turner NA, 1998, J MOL CELL CARDIOL, V30, P1789, DOI 10.1006/jmcc.1998.0743; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Wang NP, 1999, CIRC RES, V85, P387, DOI 10.1161/01.RES.85.5.387; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Zhang JH, 1998, AM J RESP CELL MOL, V19, P324, DOI 10.1165/ajrcmb.19.2.3209; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	45	172	182	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16045	16050		10.1074/jbc.M011766200	http://dx.doi.org/10.1074/jbc.M011766200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278982	hybrid			2022-12-27	WOS:000168623100065
J	Feng, ZP; Hamid, J; Doering, C; Bosey, GM; Snutch, TP; Zamponi, GW				Feng, ZP; Hamid, J; Doering, C; Bosey, GM; Snutch, TP; Zamponi, GW			Residue Gly(1326) of the N-type calcium channel alpha(1B) subunit controls reversibility of omega-conotoxin GVIA and MVIIA block	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL DETERMINANTS; GRAMMOTOXIN-SIA; NA+-CHANNELS; SYMPATHETIC NEURONS; SODIUM-CHANNEL; PEPTIDE; MUSCLE; BINDING; RECEPTORS; SUBTYPES	We recently reported that amino acid residues contained within a putative EF hand motif in the domain ill S5-H5 region of the alpha (1B) subunit affected the relative barium:calcium permeability of N-type calcium channels (Feng, Z. P., Hamid, J., Doering, C., Jarvis, S. E., Bosey, G. M., Bourinet, E., Snutch, T. P., and Zamponi, G. W. (2001) J. Biol. Chem. 276, 5726-5730). Since this region partially overlaps with residues previously implicated in block of the channel by omega -conotoxin GVIA, we assessed the effects of mutations in the putative EF hand domain on channel block by omega -conotoxin GVIA and the structurally related omega -conotoxin MVILA. Both of the toxins irreversibly block the activity of wild type alpha (1B) N-type channels. We find that in addition to previously identified amino acid residues, residues in positions 1326 and 1332 are important determinants of omega -conotoxin GVIA blockade. Substitution of residue Glu(1332) to arginine slows the time course of development of block. Point mutations in position Gly(1326) to either arginine, glutamic acid, or proline dramatically decrease the time constant for development of the block. Additionally, in the G1326P mutant channel activity was almost completely recovered following washout. A qualitatively similar result was obtained with omega -conotoxin MVIIA, suggesting that common molecular determinants underlie block by these two toxins. Taken together the data suggest that residue Gly(1326) may form a barrier, which controls the access of peptide toxins to their blocking site within the outer vestibule of the channel pore and also stabilizes the toxin-channel interaction.	Univ Calgary, Dept Physiol & Biophys, Neurosci Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Pharmacol & Therapeut, Neurosci Res Grp, Calgary, AB T2N 4N1, Canada; NeuroMed Technol Inc, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1Z3, Canada	University of Calgary; University of Calgary; University of British Columbia	Zamponi, GW (corresponding author), Univ Calgary, Dept Physiol & Biophys, Neurosci Res Grp, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.		Snutch, Terrance P/L-3464-2019	Snutch, Terrance P/0000-0001-5182-1296; Zamponi, Gerald W./0000-0002-0644-9066				ADAMS ME, 1993, BIOCHEMISTRY-US, V32, P12566, DOI 10.1021/bi00210a003; BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; Beedle AM, 2000, BIOPHYS J, V79, P260, DOI 10.1016/S0006-3495(00)76288-6; BOLAND LM, 1993, J NEUROSCI, V13, P516; BOLAND LM, 1994, J NEUROSCI, V14, P5011; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chahine M, 1998, BIOPHYS J, V75, P236, DOI 10.1016/S0006-3495(98)77510-1; ELLINOR PT, 1994, NATURE, V372, P272, DOI 10.1038/372272a0; ERTEL EA, 1994, BIOCHEMISTRY-US, V33, P5098, DOI 10.1021/bi00183a013; Favreau P, 1999, Acta Physiol Pharmacol Ther Latinoam, V49, P257; Feng ZP, 2001, J BIOL CHEM, V276, P5726, DOI 10.1074/jbc.C000791200; FOX JA, 1995, PFLUG ARCH EUR J PHY, V429, P873, DOI 10.1007/BF00374813; French RJ, 1996, NEURON, V16, P407, DOI 10.1016/S0896-6273(00)80058-6; Kulak JM, 1997, J NEUROSCI, V17, P5263; LAMPE RA, 1993, MOL PHARMACOL, V44, P451; Li RA, 1997, BIOPHYS J, V73, P1874, DOI 10.1016/S0006-3495(97)78218-3; Li RK, 2000, J BIOL CHEM, V275, P27551; Luo SQ, 1998, J NEUROSCI, V18, P8571; McDonough SI, 1996, J NEUROSCI, V16, P2612; McDonough SI, 1997, BIOPHYS J, V72, P2117, DOI 10.1016/S0006-3495(97)78854-4; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; MINTZ IM, 1994, J NEUROSCI, V14, P2844; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MOCZYDLOWSKI E, 1986, P NATL ACAD SCI USA, V83, P5321, DOI 10.1073/pnas.83.14.5321; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; Penn RD, 2000, PAIN, V85, P291, DOI 10.1016/S0304-3959(99)00254-7; PISER TM, 1995, MOL PHARMACOL, V48, P131; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; QUIK M, 1992, MOL NEUROBIOL, V6, P19, DOI 10.1007/BF02935565; Ridgeway B, 2000, PAIN, V85, P287, DOI 10.1016/S0304-3959(99)00255-9; STEA A, 1995, HDB RECEPTORS CHANNE, P113; Tenenholz TC, 2000, REV PHYSIOL BIOCH P, V140, P135, DOI 10.1007/BFb0035552; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WOPPMANN A, 1994, MOL CELL NEUROSCI, V5, P350, DOI 10.1006/mcne.1994.1042	36	73	76	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15728	15735		10.1074/jbc.M100406200	http://dx.doi.org/10.1074/jbc.M100406200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279062	hybrid			2022-12-27	WOS:000168623100022
J	Han, JH; Nicholson, AC; Zhou, XY; Feng, JW; Gotto, AM; Hajjar, DP				Han, JH; Nicholson, AC; Zhou, XY; Feng, JW; Gotto, AM; Hajjar, DP			Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SR-BI; SELECTIVE UPTAKE; GENE-EXPRESSION; CHOLESTEROL; CD36; LIVER; CLA-1; ATHEROSCLEROSIS; IDENTIFICATION; CYCLODEXTRINS	Scavenger receptor class B type I (SR-BI) has recently been identified as a high density lipoprotein (HDL) receptor that mediates bidirectional flux of cholesterol across the plasma membrane. We have previously demonstrated that oxidized low density lipoprotein (OxLDL) will increase expression of another class B scavenger receptor, CD36 (Han, J,, Haijar, D, P,, Febbraio, M,, and Nicholson, A. C, (1997) J, Biol, Chem, 272, 21654-21659). In studies reported herein, we evaluated the effects of OxLDL on expression of SR-BI in macrophages to determine how exposure to this modified lipoprotein could alter SR-BI expression and cellular lipid flux. OxLDL decreased SR-BI expression in a dose- and time-dependent manner. Incubation with OxLDL had no effect on the membrane distribution of SB-BI, and it decreased expression of both cytosolic and membrane protein. Consistent with its effect on SR-BI protein expression, OxLDL decreased SR-BI mRNA in a dose-dependent manner. The ability of OxLDL to decrease SR-BI expression was dependent on the degree of LDL oxidation, OxLDL decreased both [C-14]cholesteryl oleate/HDL uptake and efflux of [C-14]cholesterol to HDL in a time-dependent manner, Incubation of macrophages with 7-ketocholesterol, but not free cholesterol, also inhibited expression of SR-BI. Finally, we demonstrate that the effect of OxLDL on SR-BI is dependent on the differentiation state of the monocyte/macrophage, These results imply that in addition to its effect in inducing foam cell formation in macrophages through increased uptake of oxidized lipids, OxLDL may also enhance foam cell formation by altering SR-BI-mediated lipid flux across the cell membrane.	Cornell Univ, Weill Med Coll, Ctr Vasc Biol, New York, NY 10021 USA	Cornell University	Hajjar, DP (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol, 1300 York Ave, New York, NY 10021 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056987] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50-HL56987] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Buechler C, 1999, BIOCHEM BIOPH RES CO, V262, P251, DOI 10.1006/bbrc.1999.1193; CALVO D, 1993, J BIOL CHEM, V268, P18929; Cao GP, 1997, J BIOL CHEM, V272, P33068, DOI 10.1074/jbc.272.52.33068; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; Christian AE, 1997, J LIPID RES, V38, P2264; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; de la Llera-Moya M, 1999, J LIPID RES, V40, P575; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Fluiter K, 1998, J BIOL CHEM, V273, P8434, DOI 10.1074/jbc.273.14.8434; GLOMSET JA, 1968, J LIPID RES, V9, P155; HABERLAND ME, 1988, SCIENCE, V241, P215, DOI 10.1126/science.2455346; Han JH, 1999, J LIPID RES, V40, P830; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Hirano K, 1999, CIRC RES, V85, P108; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nakata A, 1999, ARTERIOSCL THROM VAS, V19, P1333, DOI 10.1161/01.ATV.19.5.1333; PITHA J, 1988, LIFE SCI, V43, P493, DOI 10.1016/0024-3205(88)90150-6; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Sun Y, 1999, J LIPID RES, V40, P1799; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; TANAKA M, 1993, BIOL PHARM BULL, V16, P538, DOI 10.1248/bpb.16.538; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; VEGA MA, 1991, J BIOL CHEM, V266, P16818; Wang N, 1998, J BIOL CHEM, V273, P32920, DOI 10.1074/jbc.273.49.32920; Wang N, 1996, J BIOL CHEM, V271, P21001, DOI 10.1074/jbc.271.35.21001; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; YLAHERTTUALA S, 1991, J CLIN INVEST, V87, P1146, DOI 10.1172/JCI115111; Yoshida H, 1998, ARTERIOSCL THROM VAS, V18, P794, DOI 10.1161/01.ATV.18.5.794	41	56	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16567	16572		10.1074/jbc.M011302200	http://dx.doi.org/10.1074/jbc.M011302200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278882	hybrid			2022-12-27	WOS:000168623100133
J	Jason, LJM; Moore, SC; Ausio, J; Lindsey, G				Jason, LJM; Moore, SC; Ausio, J; Lindsey, G			Magnesium-dependent association and folding of oligonucleosomes reconstituted with ubiquitinated H2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGAROSE-GEL ELECTROPHORESIS; HIGHER-ORDER STRUCTURE; HISTONE H2B; NUCLEOSOMAL ARRAYS; ANALYTICAL ULTRACENTRIFUGATION; CHROMATIN FIBER; GENE-EXPRESSION; CORE PARTICLES; TRANSCRIPTION; IDENTIFICATION	The MgCl2-induced folding of defined 12-mer nucleosomal arrays, in which ubiquitinated histone H2A (uH2A) replaced H2A, was analyzed by quantitative agarose gel electrophoresis and analytical centrifugation, Both types of analysis showed that uH2A arrays attained a degree of compaction similar to that of control. arrays in 2 mM MgCl2. These results indicate that attachment of ubiquitin to H2A has little effect on the ability of nucleosomal arrays to form higher order folded structures in the ionic conditions tested, In contrast, uH2A arrays were found to oligomerize at lower MgCl2 concentrations than control nucleosomal arrays, suggesting that histone ubiquitination may play a role in nucleosomal fiber association.	Univ Cape Town, Dept Biochem, ZA-7701 Rondebosch, South Africa; Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	University of Cape Town; University of Victoria	Jason, LJM (corresponding author), Univ Cape Town, Dept Biochem, ZA-7701 Rondebosch, South Africa.	laure@molbiol.uct.ac.za						ALLAN J, 1981, J CELL BIOL, V90, P279, DOI 10.1083/jcb.90.2.279; Ausio J, 1998, METHODS, V15, P333, DOI 10.1006/meth.1998.0637; Ausio J, 2000, BIOPHYS CHEM, V86, P141, DOI 10.1016/S0301-4622(00)00144-7; Baarends WM, 1999, DEV BIOL, V207, P322, DOI 10.1006/dbio.1998.9155; BARSOUM J, 1985, J BIOL CHEM, V260, P7688; BOHM L, 1980, EUR J BIOCHEM, V106, P525, DOI 10.1111/j.1432-1033.1980.tb04599.x; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Chen HY, 1998, J BIOL CHEM, V273, P13165, DOI 10.1074/jbc.273.21.13165; DAVIE JR, 1990, BIOCHEMISTRY-US, V29, P4752, DOI 10.1021/bi00472a002; Davie JR, 1998, CURR OPIN GENET DEV, V8, P173, DOI 10.1016/S0959-437X(98)80138-X; DAVIE JR, 1994, BIOCHEM BIOPH RES CO, V203, P344, DOI 10.1006/bbrc.1994.2188; DAVIES N, 1994, BBA-GENE STRUCT EXPR, V1218, P187, DOI 10.1016/0167-4781(94)90009-4; DAWSON BA, 1991, J CELL BIOCHEM, V46, P166, DOI 10.1002/jcb.240460210; DONG F, 1990, P NATL ACAD SCI USA, V87, P5724, DOI 10.1073/pnas.87.15.5724; ERICSSON C, 1986, EXP CELL RES, V167, P127, DOI 10.1016/0014-4827(86)90210-7; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; FLETCHER TM, 1994, BIOCHEMISTRY-US, V33, P10859, DOI 10.1021/bi00202a002; FLETCHER TM, 1994, BIOCHEMISTRY-US, V33, P2226, DOI 10.1021/bi00174a032; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P5492, DOI 10.1073/pnas.74.12.5492; GOLDKNOPF IL, 1980, J BIOL CHEM, V255, P555; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HANSEN JC, 1993, J BIOL CHEM, V268, P5840; Hansen JC, 1997, METHODS, V12, P62, DOI 10.1006/meth.1997.0448; HUANG SY, 1986, P NATL ACAD SCI USA, V83, P3738, DOI 10.1073/pnas.83.11.3738; IZQUIERDO M, 1994, CHROMOSOMA, V103, P193, DOI 10.1007/BF00368012; JENNISSEN HP, 1995, EUR J BIOCHEM, V231, P1; KLEINSCHMIDT AM, 1981, NUCLEIC ACIDS RES, V9, P2423, DOI 10.1093/nar/9.11.2423; LEVINGER L, 1980, P NATL ACAD SCI-BIOL, V77, P3244, DOI 10.1073/pnas.77.6.3244; LEVINGER L, 1982, CELL, V28, P375, DOI 10.1016/0092-8674(82)90355-5; MATSUI SI, 1979, P NATL ACAD SCI USA, V76, P6386, DOI 10.1073/pnas.76.12.6386; MEERSSEMAN G, 1991, J MOL BIOL, V220, P89, DOI 10.1016/0022-2836(91)90383-H; Moore SC, 1997, BIOCHEM BIOPH RES CO, V230, P136, DOI 10.1006/bbrc.1996.5903; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; MUELLER RD, 1985, J BIOL CHEM, V260, P5147; PARLOW MH, 1990, J BIOL CHEM, V265, P7507; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Rechsteiner M., 1988, UBIQUITIN; Schachman H.K., 1959, ULTRACENTRIFUGATION; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; SEALE RL, 1981, NUCLEIC ACIDS RES, V9, P3151, DOI 10.1093/nar/9.13.3151; SHAW OJ, 1969, ELECTROPHORESIS; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TATCHELL K, 1977, BIOCHEMISTRY-US, V16, P5295, DOI 10.1021/bi00643a021; THORNE AW, 1987, EMBO J, V6, P1005, DOI 10.1002/j.1460-2075.1987.tb04852.x; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; Tse C, 1998, P NATL ACAD SCI USA, V95, P12169, DOI 10.1073/pnas.95.21.12169; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; van Holde KE., 1989, SPRINGER SERIES MOL; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; VONHOLT C, 1989, METHOD ENZYMOL, V170, P431; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; WU RS, 1981, J BIOL CHEM, V256, P5916	58	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14597	14601		10.1074/jbc.M011153200	http://dx.doi.org/10.1074/jbc.M011153200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278847	hybrid, Green Published			2022-12-27	WOS:000168528800011
J	Kato, K; Kishi, T; Kamachi, T; Akisada, M; Oka, T; Midorikawa, R; Takio, K; Dohmae, N; Bird, PI; Sun, JR; Scott, F; Miyake, Y; Yamamoto, K; Machida, A; Tanaka, T; Matsumoto, K; Shibata, M; Shiosaka, S				Kato, K; Kishi, T; Kamachi, T; Akisada, M; Oka, T; Midorikawa, R; Takio, K; Dohmae, N; Bird, PI; Sun, JR; Scott, F; Miyake, Y; Yamamoto, K; Machida, A; Tanaka, T; Matsumoto, K; Shibata, M; Shiosaka, S			Serine proteinase inhibitor 3 and murinoglobulin I are potent inhibitors of neuropsin in adult mouse brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; RECEPTOR-RELATED PROTEIN; CELL-ADHESION MOLECULES; MESSENGER-RNA; ALPHA-MACROGLOBULIN; ALPHA-2-MACROGLOBULIN RECEPTOR; PLASMINOGEN-ACTIVATOR; ALZHEIMERS-DISEASE; MURINE HIPPOCAMPUS; PLASMA-PROTEINS	Extracellular serine protease neuropsin (NP) is expressed in the forebrain limbic area of adult brain and is implicated in synaptic plasticity. We screened for endogenous NP inhibitors with recombinant NP (r-NP) from extracts of the hippocampus and the cerebral cortex in adult mouse brain. Two SDS-stable complexes were detected, and after their purification, peptide sequences were determined by amino acid sequencing and mass spectrometry, revealing that target molecules were serine proteinase inhibitor-3 (SPI3) and murinoglobulin I (MUG I). The addition of the recombinant SPI3 to r-NP resulted in an SDS-stable complex, and the complex formation followed bimolecular kinetics with an association rate constant of 3.4 +/- 0.22 x 10(6) M-(1) s(-1), showing that SPI3 was a slow, tight binding inhibitor of NP, In situ hybridization histochemistry showed that SPI3 mRNA was expressed in pyramidal neurons in the hippocampal CA1-CA3 subfields, as was NP mRNA. Alternatively, the addition of purified plasma MUG I to r-NP resulted in an SDS-stable complex, and MUG I inhibited degradation of fibronectin by r-NP to 24% at a r-NP/MUG I molar ratio of 1:2, Immunofluorescence histochemistry showed that MUG I localized in the hippocampal neurons. These findings indicate that SPI3 and MUG I serve to inactivate NP and control the level of NP in adult brain, respectively.	Nara Inst Sci & Technol, Div Struct Cell Biol, Nara 6300101, Japan; RIKEN, Inst Phys & Chem Res, Biomol Characterizat Div, Wako, Saitama 3510198, Japan; Monash Univ, Dept Biochem & Mol Biol, Canberra, ACT 3800, Australia; Kinki Univ, Fac Pharmaceut Sci, Osaka 5778502, Japan; Kinki Univ, Sch Med, Dept Biochem, Osaka 5898511, Japan; Osaka Univ, Grad Sch Med, Ctr Res & Educ, Suita, Osaka 5650871, Japan; Medial & Biol Labs Co Ltd, Dept Pharmaceut Dev, Ina Nagano 3960002, Japan	Nara Institute of Science & Technology; RIKEN; Monash University; Kindai University (Kinki University); Kindai University (Kinki University); Osaka University	Kato, K (corresponding author), Nara Inst Sci & Technol, Div Struct Cell Biol, 8916-5 Takayama, Nara 6300101, Japan.		Dohmae, Naoshi/C-2040-2011; Shiosaka, Sadao/B-1142-2008	Dohmae, Naoshi/0000-0002-5242-9410; Bird, Phillip/0000-0002-6695-606X				ABE K, 1989, J BIOCHEM-TOKYO, V106, P564; Akita H, 1997, BRAIN RES, V769, P86, DOI 10.1016/S0006-8993(97)00674-4; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; ARENDT T, 1995, J COMP NEUROL, V351, P223, DOI 10.1002/cne.903510204; Bahr BA, 1997, J NEUROSCI, V17, P1320; BAKER JB, 1980, CELL, V21, P37, DOI 10.1016/0092-8674(80)90112-9; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; Bird P I, 1998, Results Probl Cell Differ, V24, P63; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; BLONDEAU X, 1993, BIOL CHEM H-S, V374, P651, DOI 10.1515/bchm3.1993.374.7-12.651; Cavus I, 1996, J NEUROSCI RES, V43, P282; CHEN ZL, 1995, J NEUROSCI, V15, P5088; CHOI DW, 1994, PROG BRAIN RES, V100, P47; COUGHLIN P, 1993, P NATL ACAD SCI USA, V90, P9417, DOI 10.1073/pnas.90.20.9417; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; DZIEGIELEWSKA KM, 1986, DEV BIOL, V115, P93, DOI 10.1016/0012-1606(86)90231-9; Giannakopoulos P, 1997, BRAIN RES REV, V25, P217, DOI 10.1016/S0165-0173(97)00023-4; Harlow E., 1988, ANTIBODIES LAB MANUA; Hyman BT, 2000, ARCH NEUROL-CHICAGO, V57, P646, DOI 10.1001/archneur.57.5.646; KAWASAKI H, 1990, ANAL BIOCHEM, V191, P332, DOI 10.1016/0003-2697(90)90227-Z; Kishi A, 1999, J BIOL CHEM, V274, P4220, DOI 10.1074/jbc.274.7.4220; Komai S, 2000, EUR J NEUROSCI, V12, P1479, DOI 10.1046/j.1460-9568.2000.00035.x; Krueger SR, 1997, J NEUROSCI, V17, P8984; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauri SE, 1999, J NEUROSCI, V19, P1226; LIU HM, 1989, ACTA NEUROPATHOL, V78, P16, DOI 10.1007/BF00687397; LORENT K, 1994, DIFFERENTIATION, V55, P213, DOI 10.1046/j.1432-0436.1994.5530213.x; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P44, DOI 10.1016/0005-2744(81)90106-6; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; MCDONALD JA, 1980, J BIOL CHEM, V255, P8848; Mizuguchi H, 1996, BIOCHEM BIOPH RES CO, V218, P402, DOI 10.1006/bbrc.1996.0070; Momota Y, 1998, EUR J NEUROSCI, V10, P760, DOI 10.1046/j.1460-9568.1998.00068.x; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Nakaya N, 1998, NEUROSCI RES, V32, P221, DOI 10.1016/S0168-0102(98)00091-1; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe A, 1996, BRAIN RES, V728, P116, DOI 10.1016/S0006-8993(96)00473-8; Osterwalder T, 1998, J BIOL CHEM, V273, P2312, DOI 10.1074/jbc.273.4.2312; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; OVERBERGH L, 1994, GENOMICS, V22, P530, DOI 10.1006/geno.1994.1426; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; SAITO A, 1985, J BIOL CHEM, V260, P775; Salvesen G, 1989, PROTEOLYTIC ENZYMES, P83; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Scott FL, 1996, J BIOL CHEM, V271, P1605, DOI 10.1074/jbc.271.3.1605; Scott FL, 1999, BLOOD, V93, P2089, DOI 10.1182/blood.V93.6.2089.406k10_2089_2097; SCOTT RW, 1985, J BIOL CHEM, V260, P7029; Segal M, 2000, TRENDS NEUROSCI, V23, P53, DOI 10.1016/S0166-2236(99)01499-X; Shimizu C, 1998, J BIOL CHEM, V273, P11189, DOI 10.1074/jbc.273.18.11189; Shiosaka S, 2000, NEUROSCI RES, V37, P85, DOI 10.1016/S0168-0102(00)00115-2; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Staubli U, 1998, J NEUROSCI, V18, P3460; Stockinger W, 1998, J BIOL CHEM, V273, P32213, DOI 10.1074/jbc.273.48.32213; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; SUN JR, 1995, BBA-PROTEIN STRUCT M, V1252, P28, DOI 10.1016/0167-4838(95)00108-7; SUN JR, 1995, J BIOL CHEM, V270, P16089, DOI 10.1074/jbc.270.27.16089; SUZUKI J, 1995, NEUROSCI RES, V23, P345, DOI 10.1016/0168-0102(95)00960-2; Takahashi N, 1999, GLYCOCONJUGATE J, V16, P405, DOI 10.1023/A:1007082612019; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; TOHYAMA Y, 1994, J BIOL CHEM, V269, P32796; TOOYAMA I, 1993, MOL CHEM NEUROPATHOL, V18, P153, DOI 10.1007/BF03160029; Toth Z, 1998, J NEUROSCI, V18, P4285; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Umans L, 1999, AM J PATHOL, V155, P983, DOI 10.1016/S0002-9440(10)65198-X; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; YAMAMOTO K, 1985, BIOCHEM INT, V10, P463; Zhou Q, 1997, BIOCHEM J, V324, P361, DOI 10.1042/bj3240361	70	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14562	14571		10.1074/jbc.M010725200	http://dx.doi.org/10.1074/jbc.M010725200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278732	hybrid			2022-12-27	WOS:000168528800007
J	Arora, PD; Silvestri, L; Ganss, B; Sodek, J; McCulloch, CAG				Arora, PD; Silvestri, L; Ganss, B; Sodek, J; McCulloch, CAG			Mechanism of cyclosporin-induced inhibition of intracellular collagen degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED GINGIVAL OVERGROWTH; CA2+ STORES; PERMEABILITY TRANSITION; IN-SITU; PHAGOCYTOSIS; CALCIUM; CELLS; RAT; MITOCHONDRIA; FIBROBLASTS	The immunosuppressant cyclosporin A (CsA) markedly inhibits collagen degradation by an intracellular phagocytic pathway in fibroblasts, an: effect that can lead to massive gingival overgrowth. We used a collagen bead model of collagen phagocytosis to determine whether CsA inhibits internalization by blocking efflux of calcium from endoplasmic reticulum (ER) and mitochondrial calcium stores. CsA caused dose-dependent inhibition of phagocytosis of collagen-coated (but not bovine serum albumin-coated) beads. Chelation of intracellular Ca2+ with BAPTA/AM or inhibition of Ca2+ ATPase of ER stores with thapsigargin reduced collagen bead phagocytosis. Measurement of intracellular calcium by ratio fluorometry showed increases in response to collagen-coated beads. Preincubation with CsA or thapsipargin caused a >3-fold decrease in intracellular calcium elevations in response to stimulation with collagen beads. Direct measurements of Ca2+ in mitochondrial and ER stores showed that CsA only slightly inhibited collagen bead-induced discharge of calcium from mitochondria, but almost completely blocked discharge from ER stores. We reduced the numbers of mitochondria with chronic ethidium bromide treatment to test for the importance of ER/mitochondrial interactions. In these cells, CsA delayed collagen bead-induced calcium discharge from mitochondria. Collectively, these data indicate that CsA inhibits collagen phagocytosis by blocking calcium release from ER stores and may perturb functional interactions between the ER and mitochondria that regulate calcium stores.	Univ Toronto, Fac Dent, Canadian Inst Hlth, Res Grp Periodontal Physiol, Toronto, ON M5S 3E2, Canada	University of Toronto	McCulloch, CAG (corresponding author), Univ Toronto, Fac Dent, Canadian Inst Hlth, Res Grp Periodontal Physiol, Fitzgerald Bldg,Rm 244,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca						Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; Ayanoglou CM, 1999, J PERIODONTAL RES, V34, P7, DOI 10.1111/j.1600-0765.1999.tb02216.x; Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; BENGTSSON T, 1993, EUR J CELL BIOL, V62, P49; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Bultynck G, 2000, J PHYSIOL-LONDON, V525, P681, DOI 10.1111/j.1469-7793.2000.t01-1-00681.x; CARRANZA FA, 1996, CINICAL PERIODONTOLO; CROMPTON M, 1988, BIOCHEM J, V255, P357; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; Favre CJ, 1996, BIOCHEM J, V316, P137, DOI 10.1042/bj3160137; Fomina AF, 2000, J CELL BIOL, V150, P1435, DOI 10.1083/jcb.150.6.1435; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; Gordjani N, 2000, PFLUG ARCH EUR J PHY, V439, P627, DOI 10.1007/s004240050986; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hofer AM, 1998, EMBO J, V17, P1986, DOI 10.1093/emboj/17.7.1986; Hofer AM, 1996, FASEB J, V10, P302, DOI 10.1096/fasebj.10.2.8641563; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; Hui MZ, 1997, J CELL PHYSIOL, V172, P323, DOI 10.1002/(SICI)1097-4652(199709)172:3<323::AID-JCP6>3.0.CO;2-Q; Kataoka M, 2000, J CELL PHYSIOL, V182, P351, DOI 10.1002/(SICI)1097-4652(200003)182:3<351::AID-JCP5>3.3.CO;2-L; KAY JE, 1989, CYCLOSPORN MODE ACTI, P4; KNOWLES GC, 1991, J CELL SCI, V98, P551; Kristian T, 2000, J NEUROCHEM, V74, P1999, DOI 10.1046/j.1471-4159.2000.0741999.x; KULKARNI GV, 1995, J CELL PHYSIOL, V165, P119, DOI 10.1002/jcp.1041650115; Kulkarni GV, 1998, EXP CELL RES, V245, P170, DOI 10.1006/excr.1998.4245; Landolfi B, 1998, J CELL BIOL, V142, P1235, DOI 10.1083/jcb.142.5.1235; Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X; MCGAW WT, 1988, ORAL SURG ORAL MED O, V65, P186, DOI 10.1016/0030-4220(88)90164-8; MCKEOWN M, 1990, CELL TISSUE RES, V262, P523, DOI 10.1007/BF00305249; Misra UK, 1998, J IMMUNOL, V161, P6122; NARAYANAN AS, 1983, COLLAGEN REL RES, V3, P33; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; OLBRICH HG, 1990, INT J CARDIOL, V27, P319, DOI 10.1016/0167-5273(90)90288-G; Onley DJ, 2000, J BIOL CHEM, V275, P24560, DOI 10.1074/jbc.M004111200; Park KS, 1999, AM J PHYSIOL-HEART C, V276, pH865, DOI 10.1152/ajpheart.1999.276.3.H865; PENDER N, 1991, J CELL SCI, V100, P187; Redlich M, 1997, ARCH ORAL BIOL, V42, P277, DOI 10.1016/S0003-9969(97)00015-0; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; SCHWARTZ MA, 1993, J CELL BIOL, V120, P1003, DOI 10.1083/jcb.120.4.1003; SJAASTAD MD, 1994, P NATL ACAD SCI USA, V91, P8214, DOI 10.1073/pnas.91.17.8214; Sjaastad MD, 1996, MOL BIOL CELL, V7, P1025, DOI 10.1091/mbc.7.7.1025; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; SODEK J, 1988, COLLAGEN REL RES, V8, P11; SODEK J, 1978, ARCH ORAL BIOL, V23, P977, DOI 10.1016/0003-9969(78)90252-2; STENDAHL O, 1994, SCIENCE, V265, P1439, DOI 10.1126/science.8073285; THIRU S, 1989, CYCLOSPORIN MODE ACT, P324; Thorp M, 2000, TRANSPLANTATION, V69, P1218, DOI 10.1097/00007890-200003270-00029; TIPTON DA, 1991, J CELL BIOCHEM, V46, P152, DOI 10.1002/jcb.240460209; Trollinger DR, 2000, BIOPHYS J, V79, P39, DOI 10.1016/S0006-3495(00)76272-2; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	51	38	39	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14100	14109		10.1074/jbc.M010298200	http://dx.doi.org/10.1074/jbc.M010298200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278659	hybrid			2022-12-27	WOS:000168356600081
J	Jones, P				Jones, P			Roles of water in heme peroxidase and catalase mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPOUND-I; HORSERADISH-PEROXIDASE; CRYSTAL-STRUCTURE; THYROID PEROXIDASE; BOUND NADPH; CHLOROPEROXIDASE; KINETICS; IRON(III)-PORPHYRINS; DEUTEROFERRIHEME; MYELOPEROXIDASE	A water molecule is coproduced with the Compound I intermediate in the reactions of native heme peroxidases and catalases with hydrogen peroxide. As a result of water release/rebinding from/to the coproduct formation site the Compound I intermediate may exist in two forms: a "wet" form, Compound I(H2O), in which a water molecule is present at or near the site of coproduct water formation, and Compound I, in which the coproduct water formation site is "dry." It is postulated that the absence or presence of a water molecule at this site provides the structural basis for a redox pathway switching mechanism, such that the transition states for a-electron equivalent reduction of Compound I intermediates are accessible in the dry form, but that in the wet form only 1-electron equivalent processes are possible, unless release of water can be stimulated. This concept provides the basis of a general mechanism in which the classical functional distinction between catalases and peroxidases, as well as the more complex behavior ob served in halide oxidation and halogenation reactions, appear as particular cases in which variations in the degree of retention of water at the coproduct formation site influence Compound I reactivity.	Univ Newcastle Upon Tyne, Dept Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Jones, P (corresponding author), Univ Newcastle Upon Tyne, Dept Chem, Bedson Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.							ADEDIRAN SA, 1983, EUR J BIOCHEM, V132, P147, DOI 10.1111/j.1432-1033.1983.tb07339.x; ARAISO T, 1980, BIOCHEM BIOPH RES CO, V94, P1177, DOI 10.1016/0006-291X(80)90543-4; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V788, P1, DOI 10.1016/0167-4838(84)90290-5; BRETSCHER KR, 1988, J CHEM SOC DALTON, P2273, DOI 10.1039/dt9880002273; BRETSCHER KR, 1988, J CHEM SOC DALTON, P2267, DOI 10.1039/dt9880002267; CHANCE B, 1950, BIOCHEM J, V46, P387, DOI 10.1042/bj0460387; COTTON ML, 1973, CAN J CHEM, V51, P582, DOI 10.1139/v73-088; Dunford H. B., 1999, HEME PEROXIDASES; DUNFORD HB, 1999, HEME PEROXIDASES, P80; FELTON RH, 1973, ANN NY ACAD SCI, V206, P504, DOI 10.1111/j.1749-6632.1973.tb43233.x; FITA I, 1985, J MOL BIOL, V185, P21, DOI 10.1016/0022-2836(85)90180-9; FREW JE, 1983, J INORG BIOCHEM, V18, P33, DOI 10.1016/0162-0134(83)85037-5; FULOP V, 1994, STRUCTURE, V2, P201, DOI 10.1016/S0969-2126(00)00021-6; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; GOUET P, 1995, J MOL BIOL, V249, P933, DOI 10.1006/jmbi.1995.0350; HOOGLAND H, 1988, BIOCHIM BIOPHYS ACTA, V955, P337, DOI 10.1016/0167-4838(88)90213-0; JONES P, 1977, J THEOR BIOL, V69, P457, DOI 10.1016/0022-5193(77)90152-7; JONES P, 1982, J INORG BIOCHEM, V17, P293, DOI 10.1016/S0162-0134(00)80090-2; JONES P, 1977, J CHEM SOC DALTON, P1849, DOI 10.1039/dt9770001849; JONES P, 1974, BIOCHEM J, V143, P473, DOI 10.1042/bj1430473; JONES P, 1968, BIOCHEM J, V110, P621, DOI 10.1042/bj1100621; JONES P, 1968, BIOCHEM J, V110, P617, DOI 10.1042/bj1100617; JONES P, 1972, BIOCHEM J, V130, P411, DOI 10.1042/bj1300411; JONES P, 1978, MET IONS BIOL SYST, V7, P185; KIRKMAN HN, 1984, P NATL ACAD SCI-BIOL, V81, P4343, DOI 10.1073/pnas.81.14.4343; KIRKMAN HN, 1987, J BIOL CHEM, V262, P660; LAMBEIR AM, 1983, J BIOL CHEM, V258, P3558; LANIR A, 1975, FEBS LETT, V55, P254, DOI 10.1016/0014-5793(75)81004-0; MAGNUSSON RP, 1984, J BIOL CHEM, V259, P3783; MAGNUSSON RP, 1984, J BIOL CHEM, V259, P197; MARQUEZ LA, 1994, BIOCHEMISTRY-US, V33, P1447, DOI 10.1021/bi00172a022; MURSHUDOV GN, 1992, FEBS LETT, V312, P127, DOI 10.1016/0014-5793(92)80919-8; OBINGER C, 1999, PLANT PEROXIDASE NEW, V13, P73; PALCIC MM, 1980, J BIOL CHEM, V255, P6128; PALCIC MM, 1980, BIOCHEM BIOPH RES CO, V94, P1123, DOI 10.1016/0006-291X(80)90535-5; POULOS TL, 1994, MET IONS BIOL SYST, V30, P25; SCHONBAUM GR, 1972, J BIOL CHEM, V247, P3353; SCHONBAUM GR, 1976, ENZYMES, V13, P313; SUN WM, 1994, BIOCHEM CELL BIOL, V72, P321, DOI 10.1139/o94-045; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X	40	49	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13791	13796		10.1074/jbc.M011413200	http://dx.doi.org/10.1074/jbc.M011413200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278901	hybrid			2022-12-27	WOS:000168356600041
J	Kehlenbach, RH; Assheuer, R; Kehlenbach, A; Becker, J; Gerace, L				Kehlenbach, RH; Assheuer, R; Kehlenbach, A; Becker, J; Gerace, L			Stimulation of nuclear export and inhibition of nuclear import by a Ran mutant deficient in binding to Ran-binding protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEX GLYCOPROTEINS; RAN/TC4 GTPASE; NUCLEOPORIN NUP153; TERMINAL DOMAIN; BETA; CRM1; TRANSPORT; LOCALIZATION; VIRUS; RCC1	Receptor-mediated nucleocytoplasmic transport is dependent on the GTPase Ran and Ran-binding protein 1 (RanBP1), The acidic C terminus of Ran is required for high affinity interaction between Ran and RanBP1. We found that a novel Ran mutant with four of its five acidic C-terminal amino acids modified to alanine (RanC4A) has an similar to 20-fold reduced affinity for RanBP1, We investigated the effects of RanC4A on nuclear import and export in permeabilized HeLa cells. Although RanC4A promotes accumulation of the nuclear export receptor CRM1 at the cytoplasmic nucleoporin Nup214, it strongly stimulates nuclear export of GFP-NFAT, Since RanC4A exhibits an elevated affinity for CRM1 and other nuclear transport receptors, this suggests that formation of the export complex containing CRM1, Ran-GTP, and substrate is a rate-limiting step in export, not release from Nup214. Conversely, importin alpha/beta -dependent nuclear import of bovine serum albumin, coupled to a classical nuclear localization sequence is strongly inhibited by RanC4A Inhibition can be reversed by additional importin alpha, which promotes the formation of an importin alpha/beta complex. These results provide physiological evidence that release of Ran-GTP from importin beta by RanBP1 and importin alpha is critical for the recycling of importin beta to a transport-competent state.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Scripps Research Institute; Scripps Research Institute; Max Planck Society	Kehlenbach, RH (corresponding author), Univ Heidelberg, Abt Virol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.			Kehlenbach, Ralph/0000-0003-4920-9916	NIGMS NIH HHS [GM41955] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041955] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; ASSHEER R, 1997, MUTATIONAL STRUCTURE; BECKER J, 1995, J BIOL CHEM, V270, P11860, DOI 10.1074/jbc.270.20.11860; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Bodendorf U, 1999, J VIROL, V73, P7769, DOI 10.1128/JVI.73.9.7769-7779.1999; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Carey KL, 1996, J CELL BIOL, V133, P985, DOI 10.1083/jcb.133.5.985; COUTAVAS E, 1993, NATURE, V366, P585, DOI 10.1038/366585a0; FEUERSTEIN J, 1987, J BIOL CHEM, V262, P8455; Floer M, 1997, J BIOL CHEM, V272, P19538, DOI 10.1074/jbc.272.31.19538; Fornerod M, 1997, CELL, V90, P1051; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Geyer M, 1999, BIOCHEMISTRY-US, V38, P11250, DOI 10.1021/bi9904306; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Haberland J, 1997, J BIOL CHEM, V272, P24717, DOI 10.1074/jbc.272.39.24717; Henderson BR, 1997, J MOL BIOL, V274, P693, DOI 10.1006/jmbi.1997.1420; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; JOHN J, 1989, J BIOL CHEM, V264, P13086; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; KLEBE C, 1993, BIOCHEMISTRY-US, V32, P11923, DOI 10.1021/bi00095a023; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kuhlmann J, 1997, BIOCHEMISTRY-US, V36, P12027, DOI 10.1021/bi970524k; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Lounsbury KM, 1996, J BIOL CHEM, V271, P2357, DOI 10.1074/jbc.271.5.2357; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MELCHIOR F, 1995, J CELL BIOL, V131, P571, DOI 10.1083/jcb.131.3.571; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; REN MD, 1995, MOL CELL BIOL, V15, P2117; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Shah S, 1998, CURR BIOL, V8, P1376, DOI 10.1016/S0960-9822(98)00018-9; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Truant R, 1999, MOL CELL BIOL, V19, P1210; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yaseen NR, 1999, J BIOL CHEM, V274, P26493, DOI 10.1074/jbc.274.37.26493; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7	50	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14524	14531		10.1074/jbc.M011087200	http://dx.doi.org/10.1074/jbc.M011087200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278834	hybrid			2022-12-27	WOS:000168356600133
J	Ma, W; Lim, W; Gee, K; Aucoin, S; Nandan, D; Kozlowski, M; Diaz-Mitoma, F; Kumar, A				Ma, W; Lim, W; Gee, K; Aucoin, S; Nandan, D; Kozlowski, M; Diaz-Mitoma, F; Kumar, A			The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; HUMAN-IMMUNODEFICIENCY-VIRUS; EPIDERMAL GROWTH-FACTOR; PROTEIN-KINASE; SIGNALING PATHWAY; FACTOR-ALPHA; CYTOKINE PRODUCTION; T-CELLS; BACTERIAL LIPOPOLYSACCHARIDE	Interleukin-10 (IL-10), a pleiotropic cytokine that inhibits inflammatory and cell-mediated immune responses, is produced by a wide variety of cell types including T and B cells and monocytes/macrophages. Regulation of pro- and anti-inflammatory cytokines has been suggested to involve distinct signaling pathways. In this study, we investigated the regulation of the human IL-10 (hIL-10) promoter in the human monocytic cell line THP-1 following activation with lipopolysaccharide (LPS). Analysis of hIL-10 promoter sequences revealed that DNA sequences located between base pairs -652 and -571 are necessary for IL-10 transcription. A computer analysis of the promoter sequence between base pairs -652 and -571 revealed the existence of consensus sequences for Sp1, PEA1, YY1, and Epstein-Parr virus-specific nuclear antigen-2 (EBNA-2)-like transcription factors. THP-1 cells transfected with a plasmid containing mutant Sp1 abrogated the promoter activity, whereas plasmids containing the sequences for PEA1, YY1, and EBNA-2-like transcription factors did not influence hIL-10 promoter activity. To understand the events upstream of Sp1 activation, we investigated the role of p38 and extracellular signal-regulated kinase mitogen-activated protein kinases by using their specific inhibitors. SB202190 and SB203580, the p38-specific inhibitors, inhibited LPS-induced IL-10 production. In contrast, PD98059, a specific inhibitor of extracellular signal-regulated kinase kinases, failed to modulate IL-10 production. Furthermore, SB203580 inhibited LPS-induced activation of Sp1, as well as the promoter activity in cells transfected with a plasmid containing the Sp1 consensus sequence. These results suggest that p38 mitogen-activated protein kinase regulates LPS-induced activation of Sp1, which in turn regulates transcription of the hIL-10 gene.	Univ Ottawa, Dept Pediat, Ottawa, ON K1H 8L1, Canada; Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L1, Canada; Childrens Hosp Eastern Ontario, Res Inst, Div Virol & Mol Immunol, Ottawa, ON K1H 8L1, Canada; Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Infect Dis, Vancouver, BC V5Z 3J5, Canada; Hlth Canada, Therapeut Prod Programme, Div Res Serv, Ottawa, ON K1A 0L2, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of British Columbia; Health Canada	Kumar, A (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Div Virol, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.		Gee, Katrina/H-3093-2016	Diaz-Mitoma, Francisco/0000-0003-0292-4859; Gee, Katrina/0000-0002-7535-2882				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Agematsu K, 1998, BLOOD, V91, P173, DOI 10.1182/blood.V91.1.173; Ammanamanchi S, 1998, J BIOL CHEM, V273, P16527, DOI 10.1074/jbc.273.26.16527; Bell LM, 2000, J BIOL CHEM, V275, P25262, DOI 10.1074/jbc.M002076200; Bettelli E, 1998, J IMMUNOL, V161, P3299; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bondeson J, 1999, J IMMUNOL, V162, P2939; BRIERE F, 1994, J CLIN INVEST, V94, P97, DOI 10.1172/JCI117354; Brightbill HD, 2000, J IMMUNOL, V164, P1940, DOI 10.4049/jimmunol.164.4.1940; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Daftarian PM, 1996, J IMMUNOL, V157, P12; de Waal MR, 1991, J EXP MED, V174, P915, DOI DOI 10.1084/JEM.174.4.915; DE WMR, 1991, J EXP MED, V174, P1209; DELPRETE G, 1993, J IMMUNOL, V150, P353; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Eskdale J, 1997, IMMUNOGENETICS, V46, P120, DOI 10.1007/s002510050250; Foey AD, 1998, J IMMUNOL, V160, P920; Graves JD, 1996, P NATL ACAD SCI USA, V93, P13814, DOI 10.1073/pnas.93.24.13814; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Hagenbaugh A, 1997, J EXP MED, V185, P2101, DOI 10.1084/jem.185.12.2101; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; HEMPEL L, 1995, SCAND J IMMUNOL, V41, P462, DOI 10.1111/j.1365-3083.1995.tb03593.x; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; ISHIDA H, 1992, J EXP MED, V175, P1213, DOI 10.1084/jem.175.5.1213; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; KAMBAYASHI T, 1995, J IMMUNOL, V155, P4909; KUBE D, 1995, CYTOKINE, V7, P1, DOI 10.1006/cyto.1995.1001; Kumar A, 1998, CLIN EXP IMMUNOL, V114, P78; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; LI L, 1994, J IMMUNOL, V153, P3967; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lindroos PM, 1998, J IMMUNOL, V161, P3464; LIU MK, 1994, J IMMUNOL, V153, P2642; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; Makarov SS, 1997, GENE THER, V4, P846, DOI 10.1038/sj.gt.3300461; MARCHANT A, 1994, LANCET, V343, P707, DOI 10.1016/S0140-6736(94)91584-9; Meisel C, 1996, EUR J IMMUNOL, V26, P1580, DOI 10.1002/eji.1830260726; MERCHANT JL, 1995, J BIOL CHEM, V270, P6314, DOI 10.1074/jbc.270.11.6314; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Morrison D C, 1979, Adv Immunol, V28, P293; Mortensen ER, 1997, J BIOL CHEM, V272, P16540, DOI 10.1074/jbc.272.26.16540; Muller F, 1998, BLOOD, V92, P3721, DOI 10.1182/blood.V92.10.3721.422k11_3721_3729; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Naar AM, 1998, COLD SPRING HARB SYM, V63, P189, DOI 10.1101/sqb.1998.63.189; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Piedrafita FJ, 1997, MOL CELL BIOL, V17, P6348, DOI 10.1128/MCB.17.11.6348; PLATZER C, 1995, INT IMMUNOL, V7, P517, DOI 10.1093/intimm/7.4.517; Pouliot M, 1997, J IMMUNOL, V158, P4930; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Salmon RA, 1997, J IMMUNOL, V159, P5309; Sen J, 1996, J IMMUNOL, V156, P4535; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tanaka T, 2000, J MOL CELL CARDIOL, V32, P1955, DOI 10.1006/jmcc.2000.1228; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; VENEPALLY P, 1995, J BIOL CHEM, V270, P25402, DOI 10.1074/jbc.270.43.25402; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; Vinals F, 1997, J BIOL CHEM, V272, P12913, DOI 10.1074/jbc.272.20.12913; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang RB, 1999, J IMMUNOL, V163, P639; Yang X, 1999, J IMMUNOL, V162, P1010	74	272	283	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13664	13674		10.1074/jbc.M011157200	http://dx.doi.org/10.1074/jbc.M011157200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278848	hybrid			2022-12-27	WOS:000168356600024
J	Schneider, I; Reverse, D; Dewachter, I; Ris, L; Caluwaerts, N; Kuiperi, C; Gilis, M; Geerts, H; Kretzschmar, H; Godaux, E; Moechars, D; Van Leuven, F; Herms, J				Schneider, I; Reverse, D; Dewachter, I; Ris, L; Caluwaerts, N; Kuiperi, C; Gilis, M; Geerts, H; Kretzschmar, H; Godaux, E; Moechars, D; Van Leuven, F; Herms, J			Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; KAINIC ACID; GENETIC DISSECTION; PEPTIDE; RAT; CA1; HIPPOCAMPUS; PLASTICITY; MUTATIONS	Mutant human presenilin-1 (PS1) causes an Alzheimer's-related phenotype in the brain of transgenic mice in combination with mutant human amyloid precursor protein by means of increased production of amyloid peptides (Dewachter, I., Van Dorpe, J., Smeijers, L., Gilis, M., Kuiperi, C., Laenen, I., Caluwaerts, N., Moechars, D., Checler, F., Vanderstichele, H. & Van Leuven, F. (2000) J. Neurosci. 20, 6452-6458) that aggravate plaques and cerebrovascular amyloid (Van Dorpe, J., Smeijers, L., Dewachter, I., Nuyens, D., Spittaels, K., van den Haute, C., Mercken, M., Moechars, D., Laenen, I., Kuiperi, C., Bruynseels, K., Tesseur, I., Loos, R., Vanderstichele, H., Checler, F., Sciot, R. & Van Leuven, F. (2000) J. Am. Pathol. 157, 1283-1298). This gain of function of mutant PS1 is approached here in three paradigms that relate to glutamate neurotransmission. Mutant but not wild-type human PS1 (i) lowered the excitotoxic threshold for kainic acid in vivo, (ii) facilitated hippocampal long-term potentiation in brain slices, and (iii) increased glutamate-induced intracellular calcium levels in isolated neurons. Prominent higher calcium responses were triggered by thapsigargin and bradykinin, indicating that mutant PS modulates the dynamic release and storage of calcium ions in the endoplasmatic reticulum. In reaction to glutamate, overfilled Ca2+ stores resulted in higher than normal cytosolic Ca2+ levels, explaining the facilitated long-term potentiation and enhanced excitotoxicity. The lowered excitotoxic threshold for kainic acid was also observed in mice transgenic for mutant human PS2[N141I] and was prevented by dantrolene, an inhibitor of Ca2+ release from the endoplasmic reticulum.	Catholic Univ Louvain, Ctr Human Genet, Expt Genet Grp, B-3000 Louvain, Belgium; Univ Munich, Dept Neuropathol, D-81377 Munich, Germany; Janssen Res Fdn, B-2340 Beerse, Belgium	Universite Catholique Louvain; University of Munich; Johnson & Johnson	Van Leuven, F (corresponding author), Catholic Univ Louvain, Ctr Human Genet, Expt Genet Grp, Campus Gasthuisberg O&N 06, B-3000 Louvain, Belgium.	fredvl@med.kuleuven.ac.be	Herms, Jochen/D-3518-2011	, Ilse Dewachter/0000-0001-7202-515X				Barrow PA, 2000, NEUROBIOL DIS, V7, P119, DOI 10.1006/nbdi.1999.0276; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Begley JG, 1999, J NEUROCHEM, V72, P1030, DOI 10.1046/j.1471-4159.1999.0721030.x; BEHNISCH T, 1995, NEUROSCI LETT, V192, P185, DOI 10.1016/0304-3940(95)11641-9; BERG M, 1995, J NEUROSCI RES, V40, P641, DOI 10.1002/jnr.490400509; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Campbell LW, 1996, J NEUROSCI, V16, P6286; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; COLLINGRIDGE G, 1987, NATURE, V330, P604, DOI 10.1038/330604a0; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Dewachter I, 2000, J NEUROSCI, V20, P6452, DOI 10.1523/JNEUROSCI.20-17-06452.2000; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Duff K, 1998, CURR OPIN BIOTECH, V9, P561, DOI 10.1016/S0958-1669(98)80132-8; Futatsugi A, 1999, NEURON, V24, P701, DOI 10.1016/S0896-6273(00)81123-X; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Guo Q, 1997, J NEUROSCI, V17, P4212; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hardy J, 1998, NAT NEUROSCI, V1, P355, DOI 10.1038/1565; ITO E, 1994, P NATL ACAD SCI USA, V91, P534, DOI 10.1073/pnas.91.2.534; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1991, MOL CHEM NEUROPATHOL, V15, P117, DOI 10.1007/BF03159951; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; MCCOY KR, 1993, NEUROBIOL AGING, V14, P447, DOI 10.1016/0197-4580(93)90103-I; Moechars D, 1996, EMBO J, V15, P1265, DOI 10.1002/j.1460-2075.1996.tb00468.x; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Morrison RS, 1996, J NEUROSCI, V16, P1337; Muller W, 1998, BRAIN PATHOL, V8, P641; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; Parent A, 1999, NEUROBIOL DIS, V6, P56, DOI 10.1006/nbdi.1998.0207; POLLARD H, 1994, NEUROSCIENCE, V63, P7, DOI 10.1016/0306-4522(94)90003-5; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4550, DOI 10.1021/bi00181a016; SCHELLENBERG GD, 1995, P NATL ACAD SCI USA, V92, P8552, DOI 10.1073/pnas.92.19.8552; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Van Dorpe J, 2000, AM J PATHOL, V157, P1283, DOI 10.1016/S0002-9440(10)64644-5; Wang XS, 1997, J CELL PHYSIOL, V173, P73, DOI 10.1002/(SICI)1097-4652(199710)173:1<73::AID-JCP9>3.3.CO;2-B; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Zaman SH, 2000, NEUROBIOL DIS, V7, P54, DOI 10.1006/nbdi.1999.0271	49	112	117	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11539	11544		10.1074/jbc.M010977200	http://dx.doi.org/10.1074/jbc.M010977200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278803	hybrid			2022-12-27	WOS:000168081800018
J	Wade, N; Bryant, NJ; Connolly, LM; Simpson, RJ; Luzio, JP; Piper, RC; James, DE				Wade, N; Bryant, NJ; Connolly, LM; Simpson, RJ; Luzio, JP; Piper, RC; James, DE			Syntaxin 7 complexes with mouse Vps10p tail interactor 1b, Syntaxin 6, vesicle-associated membrane protein (VAMP)8, and VAMP7 in B16 melanoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATE ENDOSOME-LYSOSOME; V-SNARE VTI1P; TRANSPORT PATHWAYS; MYOSIN-V; SUBCELLULAR-LOCALIZATION; VESICULAR TRANSPORT; MOLECULAR-CLONING; PLASMA-MEMBRANE; T-SNARE; FUSION	Syntaxin 7 is a mammalian target soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) involved in membrane transport between late endosomes and lysosomes. The aim of the present study was to use immunoaffinity techniques to identify proteins that interact with Syntaxin 7. We reasoned that this would be facilitated by the use of cells producing high levels of Syntaxin 7, Screening of a large number of tissues and cell lines revealed that Syntaxin 7 is expressed at very high levels in B16 melanoma cells. Moreover, the expression of Syntaxin 7 increased in these cells as they underwent melanogenesis. From a large scale Syntaxin 7 immunoprecipitation, we have identified six polypeptides using a combination of electrospray mass spectrometry and immunoblotting. These polypeptides corresponded to Syntaxin 7, Syntaxin 6, mouse Vps10p tail interactor 1b (mVti1b), alpha -synaptosome-associated protein (SNAP), vesicle-associated membrane protein (VAMP)8, VAMP7, and the protein phosphatase 1M regulatory subunit. We also observed partial colocalization between Syntaxin 6 and Syntaxin 7, between Syntaxin 6 and mVti1b, but not between Syntaxin 6 and the early endosomal t-SNARE Syntaxin 13. Based on these and data reported previously, we propose that Syntaxin 7/mVti1b/Syntaxin 6 may form discrete SNARE complexes with either VAMP7 or VAMPS to regulate fusion events within the late endosomal pathway and that these events may play a critical role in melanogenesis.	Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; Univ Queensland, Dept Physiol & Pharmacol, St Lucia, Qld 4072, Australia; Ludwig Inst Canc Res, Joint Prot Struct Lab, Parkville, Vic 3052, Australia; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; Univ Cambridge, Addenbrookes Hosp, Welcome Trust Ctr Mol Mech Dis, Cambridge CB2 2XY, England; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	University of Queensland; University of Queensland; Ludwig Institute for Cancer Research; Walter & Eliza Hall Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Iowa	James, DE (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.		Wade, Nick/F-8087-2013; Bryant, Nia/AAS-5637-2021	Wade, Nick/0000-0001-7235-6274; James, David/0000-0001-5946-5257; Bryant, Nia Jane/0000-0001-7431-3809; Simpson, Richard/0000-0002-9834-0796; Piper, Robert/0000-0001-9995-5699				Abeliovich H, 1998, J BIOL CHEM, V273, P11719, DOI 10.1074/jbc.273.19.11719; Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; Antonin W, 2000, J NEUROSCI, V20, P5724, DOI 10.1523/JNEUROSCI.20-15-05724.2000; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Bock JB, 1997, NATURE, V387, P133, DOI 10.1038/387133a0; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; Coco S, 1999, J NEUROSCI, V19, P9803; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Hibi T, 2000, BIOCHEM BIOPH RES CO, V271, P36, DOI 10.1006/bbrc.2000.2591; Lupashin VV, 1997, MOL BIOL CELL, V8, P2659, DOI 10.1091/mbc.8.12.2659; MANI F, 1994, BRAZ J MED BIOL RES, V27, P2639; Martin-Martin B, 2000, BLOOD, V96, P2574; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Moritz RL, 1996, ELECTROPHORESIS, V17, P907, DOI 10.1002/elps.1150170512; Mullock BM, 2000, MOL BIOL CELL, V11, P3137, DOI 10.1091/mbc.11.9.3137; Nakamura N, 2000, J BIOL CHEM, V275, P6523, DOI 10.1074/jbc.275.9.6523; Nascimento AAC, 1997, MOL BIOL CELL, V8, P1971, DOI 10.1091/mbc.8.10.1971; Ota A, 1998, BRIT J DERMATOL, V139, P207; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; SAMMAK PJ, 1992, J CELL BIOL, V117, P57, DOI 10.1083/jcb.117.1.57; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Subramaniam VN, 2000, J CELL SCI, V113, P997; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang BL, 1998, BIOCHEM BIOPH RES CO, V242, P673, DOI 10.1006/bbrc.1997.8029; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; von Mollard GF, 1998, J BIOL CHEM, V273, P2624, DOI 10.1074/jbc.273.5.2624; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; Ward DM, 2000, MOL BIOL CELL, V11, P2327, DOI 10.1091/mbc.11.7.2327; Watson RT, 2000, J BIOL CHEM, V275, P1261, DOI 10.1074/jbc.275.2.1261; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wong SH, 1998, MOL BIOL CELL, V9, P1549, DOI 10.1091/mbc.9.6.1549; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	45	67	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19820	19827		10.1074/jbc.M010838200	http://dx.doi.org/10.1074/jbc.M010838200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278762	hybrid			2022-12-27	WOS:000169135100021
J	Clark, KD; Volkman, BF; Thoetkiattikul, H; King, D; Hayakawa, Y; Strand, MR				Clark, KD; Volkman, BF; Thoetkiattikul, H; King, D; Hayakawa, Y; Strand, MR			Alanine-scanning mutagenesis of plasmatocyte spreading peptide identifies critical residues for biological activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-BLOCKING PEPTIDE; MOTH PSEUDOPLUSIA-INCLUDENS; PARALYTIC PEPTIDES; MANDUCA-SEXTA; HEMOLYMPH; HEMOCYTES; THROMBIN; PROTEIN; INSECTS	Plasmatocyte spreading peptide (PSP) is a 23-amino acid cytokine that induces a class of insect immune cells called plasmatocytes to spread on foreign surfaces. The structure of PSP consists of a disordered N terminus (residues 1-6) and a well-defined core (residues 7-23) stabilized by a disulfide bridge between Cys(7) and Cys(19), hydrophobic interactions, and a short beta -hairpin, Structural comparisons also indicate that the core region of PSP adopts an epidermal growth factor (EGF)-like fold very similar to the C-terminal subdomain of EGF-like module 5 of thrombomodulin, To identify residues important for plasmatocyte spreading activity, we bioassayed PSP mutants in which amino acids were either replaced with alanine or deleted. Within the well-defined core of PSP, alanine replacement of Cys(7) and Cys(19) (C7.19A) eliminated all activity. Alanine replacement of Arg(13) reduced activity similar to 1000-fold in comparison to wildtype PSP, whereas replacement of the other charged residues (Asp(16), Arg(18), Lys(20)) surrounding Cys(19) diminished activity to a lesser degree. The point mutants Y11A, T14A, T22A, and F23A had activity identical or only slightly reduced to that of wild-type PSP, The mutant PSP-(7-23) lacked the entire unstructured domain of PSP and was found to have no plasmatocyte spreading activity. Surprisingly, E1A and N2A had higher activity than wild-type PSP, but F3A had almost no activity. We thus concluded that the lack of activity for PSP-(7-23) was largely due to the critical importance of Phe(3). To determine whether reductions in activity correlated with alterations in tertiary structure, we compared the C7.19A, R13A, R18A, and F3A mutants to wildtype PSP by NMR spectroscopy. As expected, the simultaneous replacement of Cys(7) and Cys(19) profoundly affected tertiary structure, but the R13A, R18A, and F3A mutants did not differ from wild-type PSP, Collectively, these results indicate that residues in both the unstructured and structured domains of PSP are required for plasmatocyte-spreading activity.	Univ Wisconsin, Dept Entomol, Russell Labs 237, Madison, WI 53706 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Univ Calif Berkeley, Dept Biochem, Berkeley, CA 94702 USA; Hokkaido Univ, Inst Low Temp Sci, Biochem Lab, Sapporo, Hokkaido 0600819, Japan	University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; University of California System; University of California Berkeley; Hokkaido University	Strand, MR (corresponding author), Univ Wisconsin, Dept Entomol, Russell Labs 237, Madison, WI 53706 USA.		Volkman, Brian F./ABE-7312-2020; Volkman, Brian F./ABE-7306-2020; Clark, Kevin/GQA-9811-2022	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; 	NIAID NIH HHS [AI32917] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032917] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Clark KD, 1998, BIOCHEM BIOPH RES CO, V250, P479, DOI 10.1006/bbrc.1998.9145; CUNNINGHAM BC, 1989, SCIENCE, V244, P1801; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Furuya K, 1999, PEPTIDES, V20, P53, DOI 10.1016/S0196-9781(98)00148-X; Gardiner EMM, 1999, J INSECT PHYSIOL, V45, P113, DOI 10.1016/S0022-1910(98)00092-4; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Hayakawa Y, 1998, BIOCHEM BIOPH RES CO, V250, P194, DOI 10.1006/bbrc.1998.8959; HAYAKAWA Y, 1991, J BIOL CHEM, V266, P7982; Hrabal R, 1996, PROTEIN SCI, V5, P195; KING DS, 1990, INT J PEPT PROT RES, V36, P255; LAVINE MD, 2001, IN PRESS J INSECT PH; Loret SM, 1998, EUR J CELL BIOL, V76, P146, DOI 10.1016/S0171-9335(98)80028-9; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P13547, DOI 10.1021/bi00250a006; McInnes C, 1997, BIOPOLYMERS, V43, P339, DOI 10.1002/(SICI)1097-0282(1997)43:5<339::AID-BIP2>3.0.CO;2-W; NAGASHIMA M, 1993, J BIOL CHEM, V268, P2888; PECH LL, 1994, CELL TISSUE RES, V277, P159, DOI 10.1007/BF00303092; Seino Atsushi, 1998, Journal of Sericultural Science of Japan, V67, P473; SKINNER WS, 1991, J BIOL CHEM, V266, P12873; SKINNER WS, 1993, COMP BIOCHEM PHYS C, V104, P133, DOI 10.1016/0742-8413(93)90124-4; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Strand MR, 1999, ARCH INSECT BIOCHEM, V42, P213, DOI 10.1002/(SICI)1520-6327(199911)42:3&lt;213::AID-ARCH5&gt;3.0.CO;2-4; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; STRAND MR, 1990, ANN ENTOMOL SOC AM, V83, P538, DOI 10.1093/aesa/83.3.538; Volkman BF, 1999, J BIOL CHEM, V274, P4493, DOI 10.1074/jbc.274.8.4493; Wang Y, 1999, INSECT BIOCHEM MOLEC, V29, P1075, DOI 10.1016/S0965-1748(99)00086-7	26	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18491	18496		10.1074/jbc.M100579200	http://dx.doi.org/10.1074/jbc.M100579200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279096	hybrid			2022-12-27	WOS:000168866500117
J	Marheineke, K; Hyrien, O				Marheineke, K; Hyrien, O			Aphidicolin triggers a block to replication origin firing in Xenopus egg extracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; DNA-REPLICATION; DROSOPHILA-MELANOGASTER; MIDBLASTULA TRANSITION; CHROMOSOME-REPLICATION; CHECKPOINT CONTROL; PROTEIN-KINASE; EARLY EMBRYOS; S-PHASE; INITIATION	DNA replication origins are located at random with respect to DNA sequence in Xenopus early embryos and on DNA replicated in Xenopus egg extracts. We have recently shown that origins fire throughout the S phase in Xenopus egg extracts. To study the temporal regulation of origin firing, we have analyzed origin activation in sperm nuclei treated with the DNA polymerase inhibitor aphidicolin, Sperm chromatin was incubated in Xenopus egg extracts in the presence of aphidicolin and transferred to a fresh extract, and digoxigenin-dUTP and biotin-dUTP were added at various times after aphidicolin release to selectively label early and late replicating DNA. Molecular combing analysis of single DNA fibers showed that only a fraction of potential origins were able to initiate in the presence of aphidicolin, After release from aphidicolin, the remaining origins fired asynchronously throughout the S phase. Therefore, initiation during the S phase depends on the normal progression of replication forks assembled at earlier activated origins. Caffeine, an inhibitor of the checkpoint kinases ATR and ATM, did not relieve the aphidicolin-induced block to origin firing. We conclude that a caffeine-insensitive intra-S phase checkpoint regulates origin activation when DNA synthesis is inhibited in Xenopus egg extracts.	Ecole Normale Super, Genet Mol Lab, F-75230 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Hyrien, O (corresponding author), Ecole Normale Super, Genet Mol Lab, 46 Rue Ulm, F-75230 Paris 05, France.	hyrien@wotan.ens.fr	Hyrien, Olivier/R-5108-2017; Marheineke, Kathrin/C-1797-2008	Hyrien, Olivier/0000-0001-8879-675X; Marheineke, Kathrin/0000-0002-1514-0167				Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Blow JJ, 2001, J CELL BIOL, V152, P15, DOI 10.1083/jcb.152.1.15; Blumenthal AB, 1974, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/sqb.1974.038.01.024; Costanzo V, 2000, MOL CELL, V6, P649, DOI 10.1016/S1097-2765(00)00063-0; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; Gilbert DM, 1998, CURR OPIN GENET DEV, V8, P194; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; Herrick J, 2000, J MOL BIOL, V300, P1133, DOI 10.1006/jmbi.2000.3930; HUBERMAN JA, 1968, J MOL BIOL, V32, P327, DOI 10.1016/0022-2836(68)90013-2; HYRIEN O, 1995, SCIENCE, V270, P994, DOI 10.1126/science.270.5238.994; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; Jares P, 2000, GENE DEV, V14, P1528; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; LASKEY RA, 1985, J EMBRYOL EXP MORPH, V89, P285; Lucas I, 2000, J MOL BIOL, V296, P769, DOI 10.1006/jmbi.2000.3500; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Maric C, 1999, J MOL BIOL, V291, P775, DOI 10.1006/jmbi.1999.3017; MCKNIGHT SL, 1977, CELL, V12, P795, DOI 10.1016/0092-8674(77)90278-1; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; MILLS AD, 1989, J CELL SCI, V94, P471; NAKAMURA H, 1986, EXP CELL RES, V165, P291, DOI 10.1016/0014-4827(86)90583-5; NETHANEL T, 1990, J VIROL, V64, P5912, DOI 10.1128/JVI.64.12.5912-5918.1990; NEWPORT J, 1989, J CELL SCI, P149; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Pasero P, 2000, CURR OPIN GENET DEV, V10, P178, DOI 10.1016/S0959-437X(00)00067-8; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Rhind N, 2000, J CELL SCI, V113, P3889; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Santocanale C, 1999, GENE DEV, V13, P2360, DOI 10.1101/gad.13.18.2360; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sasaki T, 1999, MOL CELL BIOL, V19, P547; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; SHINOMIYA T, 1991, NUCLEIC ACIDS RES, V19, P3935, DOI 10.1093/nar/19.14.3935; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	51	52	56	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17092	17100		10.1074/jbc.M100271200	http://dx.doi.org/10.1074/jbc.M100271200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279043	hybrid			2022-12-27	WOS:000168730400066
J	Strobeck, M; Kim, S; Zhang, JCL; Clendenin, C; Du, KL; Parmacek, MS				Strobeck, M; Kim, S; Zhang, JCL; Clendenin, C; Du, KL; Parmacek, MS			Binding of serum response factor to CArG box sequences is necessary but not sufficient to restrict gene expression to arterial smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN GENE; FACTOR PLAYS; SM22 ALPHA; PROMOTER; TRANSCRIPTION; ACTIVATION; PATHWAYS; RHOA; SRF; PROLIFERATION	Serum response factor (SRF) plays an important role in regulating smooth muscle cell (SMC) development and differentiation. To understand the molecular mechanisms underlying the activity of SRF in SMCs, the two CArG box-containing elements in the arterial SMC-specific SM22 alpha promoter, SME-1 and SME-4, were functionally and biochemically characterized. Mutations that abolish binding of SRF to the SM22 alpha promoter totally abolish promoter activity in transgenic mice. Moreover, a multimerized copy of either SME-1 or SME-4 subcloned 5' of the minimal SM22 alpha promoter (base pairs -90 to +41) is necessary and sufficient to restrict transgene expression to arterial SMCs in transgenic mice. In contrast, a multimerized copy of the c-fos SRE is totally inactive in arterial SMCs and substitution of the c-fos SRE for the CArG motifs within the SM22 alpha promoter inactivates the 441-base pair SM22 alpha promoter in transgenic mice. Deletion analysis revealed that the SME-4 CArG box alone is insufficient to activate transcription in SMCs and additional 5'-flanking nucleotides are required. Nuclear protein binding assays revealed that SME-4 binds SRF, YY1, and four additional SMC nuclear proteins. Taken together, these data demonstrate that binding of SRF to specific CArG boxes is necessary, but not sufficient, to restrict transgene expression to SMCs in vivo.	Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Pennsylvania; University of Chicago	Parmacek, MS (corresponding author), Univ Penn, Sch Med, Dept Med, 9123 Founders pavil, Philadelphia, PA 19104 USA.	parmacek@mail.med.upenn.edu		Parmacek, Michael/0000-0003-1449-4665	PHS HHS [R0156915] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Belaguli NS, 1999, MOL CELL BIOL, V19, P4582; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Browning CL, 1998, DEV BIOL, V194, P18, DOI 10.1006/dbio.1997.8808; CAMPBELL GR, 1988, ARCH PATHOL LAB MED, V112, P977; CHODOSH LA, 1996, CURRENT PROTOCOLS MO; Croissant JD, 1996, DEV BIOL, V177, P250, DOI 10.1006/dbio.1996.0160; GRUENEBERG DA, 1992, SCIENCE, V257, P1089, DOI 10.1126/science.257.5073.1089; Herring BP, 1997, AM J PHYSIOL-CELL PH, V272, pC1394, DOI 10.1152/ajpcell.1997.272.4.C1394; Herring BP, 1996, AM J PHYSIOL-CELL PH, V270, pC1656, DOI 10.1152/ajpcell.1996.270.6.C1656; Kemp PR, 2000, BIOCHEM J, V345, P445, DOI 10.1042/0264-6021:3450445; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Landerholm TE, 1999, DEVELOPMENT, V126, P2053; LEESMILLER JP, 1987, BIOCHEM J, V244, P705, DOI 10.1042/bj2440705; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Mack CP, 1999, CIRC RES, V84, P852; Madsen CS, 1998, CIRC RES, V82, P908; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; Moessler H, 1996, DEVELOPMENT, V122, P2415; MOSS JB, 1994, J BIOL CHEM, V269, P12731; MUELLER CGF, 1991, EMBO J, V10, P4219, DOI 10.1002/j.1460-2075.1991.tb05000.x; Newby AC, 1999, CARDIOVASC RES, V41, P345, DOI 10.1016/S0008-6363(98)00286-7; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; OSBOURN JK, 1995, GENE, V154, P249, DOI 10.1016/0378-1119(94)00847-L; Owens GK, 1998, ACTA PHYSIOL SCAND, V164, P623, DOI 10.1111/j.1365-201X.1998.tb10706.x; Parmacek MS, 2001, CURR TOP DEV BIOL, V51, P69, DOI 10.1016/S0070-2153(01)51002-9; PARMACEK MS, 1999, HEART DEV, P291; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Price MA, 1996, PHILOS T ROY SOC B, V351, P551, DOI 10.1098/rstb.1996.0054; Qian J, 1996, DEV DYNAM, V207, P135; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; SARTORELLI V, 1990, GENE DEV, V4, P1811, DOI 10.1101/gad.4.10.1811; Schwartz SM, 1998, ANNU REV MED, V49, P437; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; SHANAHAN CM, 1997, ARTERIOSCL THROM VAS, V183, P333; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; TREISMAN R, 1995, NATURE, V376, P468, DOI 10.1038/376468a0; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Wei L, 1998, J BIOL CHEM, V273, P30287, DOI 10.1074/jbc.273.46.30287; Yang Y, 2000, J CLIN INVEST, V106, P1321, DOI 10.1172/JCI8893; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001; [No title captured]	48	36	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16418	16424		10.1074/jbc.M100631200	http://dx.doi.org/10.1074/jbc.M100631200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279108	hybrid			2022-12-27	WOS:000168623100113
J	Lu, CF; Takagi, J; Springer, TA				Lu, CF; Takagi, J; Springer, TA			Association of the membrane proximal regions of the alpha and beta subunit cytoplasmic domains constrains an integrin in the inactive state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; INTERCELLULAR-ADHESION MOLECULE-1; POLYMERASE CHAIN-REACTION; I-DOMAIN; CELL-ADHESION; MAC-1 CD11B/CD18; LIGAND-BINDING; T-CELL; CR3-DEPENDENT ADHESION; MONOCLONAL-ANTIBODY	The adhesiveness of integrins is regulated through a process termed "inside-out" signaling. To understand the molecular mechanism of integrin inside-out signaling, we generated K562 stable cell lines that expressed LFA-1 (alpha (L)beta (2)) Or Mac-1 (alpha (M)beta (2)) with mutations in the cytoplasmic domain. Complete truncation of the beta (2) cytoplasmic domain, but not a truncation that retained the membrane proximal eight residues, resulted in constitutive activation of alpha (L)beta (2) and alpha (M)beta (2) demonstrating the importance of this membrane proximal region in the regulation of integrin adhesive function. Furthermore, replacement of the alpha (L) and beta (2) cytoplasmic domains with acidic and basic peptides that form an alpha -helical coiled coil caused inactivation of alpha (L)beta (2). Association of these artificial cytoplasmic domains was directly demonstrated. By contrast, replacement of the alpha (L) and beta (2) cytoplasmic domains with two basic peptides that do not form an alpha -helical coiled coil activated alpha (L)beta (2). Induction of ligand binding by the activating cytoplasmic domain mutations correlated with the induction of activation epitopes in the extracellular domain. Our data demonstrate that cytoplasmic, membrane proximal association between integrin alpha and beta subunits, constrains an integrin in the inactive conformation.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [R01CA031799, R01CA031798, R37CA031798, R37CA031799] Funding Source: NIH RePORTER; NCI NIH HHS [CA31799, CA31798] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Chang DD, 1997, J CELL BIOL, V138, P1149, DOI 10.1083/jcb.138.5.1149; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; COPPOLINO M, 1995, J BIOL CHEM, V270, P23132, DOI 10.1074/jbc.270.39.23132; DIAMOND MS, 1993, J CELL BIOL, V120, P545, DOI 10.1083/jcb.120.2.545; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; HIBBS ML, 1991, J EXP MED, V174, P1227, DOI 10.1084/jem.174.5.1227; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; HUANG CC, 1995, J BIOL CHEM, V270, P19008, DOI 10.1074/jbc.270.32.19008; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Kashiwagi H, 1997, J CELL BIOL, V137, P1433, DOI 10.1083/jcb.137.6.1433; KEIZER GD, 1988, J IMMUNOL, V140, P1393; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Krauss K, 1999, J BIOL CHEM, V274, P36921, DOI 10.1074/jbc.274.52.36921; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; LU C, 2001, IN PRESS J IMMUNOL; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398; Lu CF, 1997, J IMMUNOL, V159, P268; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Lub M, 1997, MOL BIOL CELL, V8, P719, DOI 10.1091/mbc.8.4.719; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; PETRUZZELLI L, 1995, J IMMUNOL, V155, P854; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; Stewart MP, 1996, J IMMUNOL, V156, P1810; VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6; VANKOOYK Y, 1994, J CELL BIOL, V124, P1061, DOI 10.1083/jcb.124.6.1061; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; WEISEL JW, 1992, J BIOL CHEM, V267, P16637	50	137	144	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14642	14648		10.1074/jbc.M100600200	http://dx.doi.org/10.1074/jbc.M100600200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279101	hybrid			2022-12-27	WOS:000168528800018
J	Brokx, RD; Lopez, MM; Vogel, HJ; Makhatadze, GI				Brokx, RD; Lopez, MM; Vogel, HJ; Makhatadze, GI			Energetics of target peptide binding by calmodulin reveals different modes of binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; NITRIC-OXIDE SYNTHASE; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ENTHALPY-ENTROPY COMPENSATION; SMALL-ANGLE SCATTERING; MOLAR HEAT-CAPACITY; COLD-SHOCK PROTEIN; TROPONIN-C; TRANSLATIONAL ENTROPY; DOMAIN ORGANIZATION	Thermodynamic parameters of interactions of calcium-saturated calmodulin (Ca2+CaM) with melittin, C-terminal fragment of melittin, or peptides derived from the CaM binding regions of constitutive (cerebellar) nitric-oxide synthase, cyclic nucleotide phosphodiesterase, calmodulin-dependent protein kinase I, and caldesmon (CaD-A, CaD-A*) have been measured using isothermal titration calorimetry. The peptides could be separated into two groups according to the change in heat capacity upon complex formation, DeltaC(p). The calmodulin-dependent protein kinase I, constitutive (cerebellar) nitric-oxide synthase, and melittin peptides have DeltaC(p) values clustered around -3.2 kJ.mol(-1).K-1, consistent with the formation of a globular CaM-peptide complex in the canonical fashion. In contrast, phosphodiesterase, the C-terminal fragment of melittin, CaD-A, and CaD-A* have DeltaC(p) values clustered around -1.6 kJ.mol(-1).K-1, indicative of interactions between the peptide and mostly one lobe of CaM, probably the C-terminal lobe, It is also shown that the interactions for different peptides with Ca2+-CaM can be either enthalpically or entropically driven. The difference in the energetics of peptide/Ca2+-CaM complex formation appears to be due to the coupling of peptide/Ca2+-CaM complex formation to the coil-helix transition of the peptide. The binding of a helical peptide to Ca2+-CaM is dominated by favorable entropic effects, which are probably mostly due to hydrophobic interactions between nonpolar groups of the peptide and Ca2+-CaM. Applications of these findings to the design of potential CaM inhibitors are discussed.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol H171, Hershey, PA 17111 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Calgary	Makhatadze, GI (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol H171, 500 Univ Dr, Hershey, PA 17111 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054537] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54537] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amzel LM, 1997, PROTEINS, V28, P144; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; BLUMENTHAL DK, 1982, BIOCHEMISTRY-US, V21, P2386, DOI 10.1021/bi00539a017; CHARBONNEAU H, 1991, BIOCHEMISTRY-US, V30, P7931, DOI 10.1021/bi00246a009; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; COMTE M, 1983, BIOCHEM J, V209, P269, DOI 10.1042/bj2090269; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; DEGRADO WF, 1985, J CELL BIOCHEM, V29, P83, DOI 10.1002/jcb.240290204; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; ERICKSONVIITANEN S, 1987, METHOD ENZYMOL, V139, P455; FERRARI ME, 1994, BIOCHEMISTRY-US, V33, P12896, DOI 10.1021/bi00209a022; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.0.CO;2-E; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Gomes AV, 2000, ARCH BIOCHEM BIOPHYS, V379, P28, DOI 10.1006/abbi.2000.1827; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Gribenko AV, 1998, J MOL BIOL, V283, P679, DOI 10.1006/jmbi.1998.2116; HEIDORN DB, 1988, BIOCHEMISTRY-US, V27, P909, DOI 10.1021/bi00403a011; HEIDORN DB, 1989, BIOCHEMISTRY-US, V28, P6757, DOI 10.1021/bi00442a032; HOLTZER A, 1995, BIOPOLYMERS, V35, P595, DOI 10.1002/bip.360350605; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Krueger JK, 2000, BIOCHEMISTRY-US, V39, P3979, DOI 10.1021/bi992638x; Krueger JK, 1998, BIOCHEMISTRY-US, V37, P13997, DOI 10.1021/bi981311d; Krueger JK, 1997, BIOCHEMISTRY-US, V36, P6017, DOI 10.1021/bi9702703; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lazaridis T, 1995, ADV PROTEIN CHEM, V47, P231, DOI 10.1016/S0065-3233(08)60547-1; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Lopez MM, 1999, J BIOL CHEM, V274, P33601, DOI 10.1074/jbc.274.47.33601; LUMRY R, 1970, BIOPOLYMERS, V9, P1125, DOI 10.1002/bip.1970.360091002; Luque I, 1998, BIOCHEMISTRY-US, V37, P5791, DOI 10.1021/bi9802521; MAKHATADZE GI, 1990, J MOL BIOL, V213, P375, DOI 10.1016/S0022-2836(05)80197-4; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; MAKHATADZE GI, 1995, NAT STRUCT BIOL, V2, P852, DOI 10.1038/nsb1095-852; Makhatadze GI, 1998, PROTEIN SCI, V7, P689, DOI 10.1002/pro.5560070318; McCrary BS, 1998, J MOL BIOL, V276, P203, DOI 10.1006/jmbi.1998.1500; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MILOS M, 1987, J BIOL CHEM, V262, P2746; Montigiani S, 1996, J MOL BIOL, V258, P6, DOI 10.1006/jmbi.1996.0229; MURPHY KP, 1993, PROTEINS, V15, P113, DOI 10.1002/prot.340150203; MURPHY KP, 1994, PROTEINS, V18, P63, DOI 10.1002/prot.340180108; Nelson MR, 1998, PROTEIN SCI, V7, P270; Ohki SY, 1997, BIOCHEMISTRY-US, V36, P4309, DOI 10.1021/bi962759m; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Petrosian SA, 2000, PROTEIN SCI, V9, P387; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; Protasevich I, 1997, BIOCHEMISTRY-US, V36, P2017, DOI 10.1021/bi962538g; PUTKEY JA, 1983, J BIOL CHEM, V258, P1864; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Richardson JM, 1999, BIOCHEMISTRY-US, V38, P12869, DOI 10.1021/bi990724r; Rohl CA, 1998, METHOD ENZYMOL, V295, P1; SCHOLTZ JM, 1992, ANNU REV BIOPH BIOM, V21, P95, DOI 10.1146/annurev.bb.21.060192.000523; SIIVARI K, 1995, FEBS LETT, V366, P104, DOI 10.1016/0014-5793(95)00504-3; Sonnenburg WK, 1995, J BIOL CHEM, V270, P30989, DOI 10.1074/jbc.270.52.30989; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Tamura A, 1997, J MOL BIOL, V273, P1048, DOI 10.1006/jmbi.1997.1368; Todd MJ, 1999, PROTEINS, V36, P147, DOI 10.1002/(SICI)1097-0134(19990801)36:2<147::AID-PROT2>3.0.CO;2-3; TORCHINSKI YM, 1980, SULPHUR PROTEINS; Torok K, 1998, BIOCHEMISTRY-US, V37, P6188, DOI 10.1021/bi972773e; TREWHELLA J, 1990, BIOCHEMISTRY-US, V29, P9316, DOI 10.1021/bi00492a003; TSALKOVA TN, 1985, J MOL BIOL, V181, P533, DOI 10.1016/0022-2836(85)90425-5; VOGEL HJ, 1983, FEBS LETT, V157, P241, DOI 10.1016/0014-5793(83)80554-7; VOGEL HJ, 1995, MOL CELL BIOCHEM, V149, P3, DOI 10.1007/BF01076558; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; VORHERR T, 1993, BIOCHEMISTRY-US, V32, P6081, DOI 10.1021/bi00074a020; WALTERSSON Y, 1993, BIOCHEMISTRY-US, V32, P7866, DOI 10.1021/bi00082a005; Wang EZ, 1997, BIOCHEMISTRY-US, V36, P15026, DOI 10.1021/bi963075h; Weljie AM, 2000, PROTEIN ENG, V13, P59, DOI 10.1093/protein/13.1.59; WILCOX W, 1992, PROTEIN SCI, V1, P641, DOI 10.1002/pro.5560010510; WINDER AF, 1971, BIOPOLYMERS, V10, P1243, DOI 10.1002/bip.360100713; Wintrode PL, 1997, J MOL BIOL, V266, P1050, DOI 10.1006/jmbi.1996.0785; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wyman J., 1990, BINDING LINKAGE; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; Yuan T, 1999, BIOCHEMISTRY-US, V38, P1446, DOI 10.1021/bi9816453; Yuan T, 2001, BIOPOLYMERS, V58, P50, DOI 10.1002/1097-0282(200101)58:1<50::AID-BIP60>3.0.CO;2-S; ZHAN Q, 1991, J BIOL CHEM, V266, P21810; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; ZHANG MJ, 1993, J BIOL CHEM, V268, P22420; ZHANG MJ, 1994, J BIOL CHEM, V269, P15546; Zhang MJ, 1997, PROTEIN PEPTIDE LETT, V4, P291; ZHANG MJ, 1994, J BIOL CHEM, V269, P981; ZHANG MJ, 1995, J BIOL CHEM, V270, P20901, DOI 10.1074/jbc.270.36.20901; Zhou N, 1997, BIOCHEMISTRY-US, V36, P2817, DOI 10.1021/bi9625713	95	103	105	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14083	14091		10.1074/jbc.M011026200	http://dx.doi.org/10.1074/jbc.M011026200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278815	hybrid			2022-12-27	WOS:000168356600079
J	Cominacini, L; Rigoni, A; Fratta Pasini, A; Garbin, U; Davoli, A; Campagnola, R; Pastorino, AM; Lo Cascio, V; Sawamura, T				Cominacini, L; Rigoni, A; Fratta Pasini, A; Garbin, U; Davoli, A; Campagnola, R; Pastorino, AM; Lo Cascio, V; Sawamura, T			The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; L-ARGININE; DEPENDENT RELAXATION; SIGNAL-TRANSDUCTION; CORONARY-ARTERIES; RELAXING FACTOR; SYNTHASE; ATHEROSCLEROSIS; 2',7'-DICHLOROFLUORESCIN; INVOLVEMENT	Oxidized low density lipoprotein (ox-LDL) has been suggested to affect endothelium-dependent vascular tone through a decreased biological activity of endothelium-derived nitric oxide (NO). Oxidative inactivation of NO is regarded as an important cause of its decreased biological activity, and in this context superoxide (O-2(radical anion)) is known to inactivate NO in a chemical reaction during which peroxynitrite is formed. In this study we examined the effect of ox-LDL on the intracellular NO concentration in bovine aortic endothelial cells and whether this effect is influenced by ox-LDL binding to the endothelial receptor lectin-like ox-LDL receptor-1 (LOX-1) through the formation of reactive oxygen species and in particular of O-2(radical anion). ox-LDL induced a significant; dose-dependent decrease in intracellular NO concentration both in basal and stimulated conditions after less than 1 min of incubation with bovine aortic endothelial cells (p < 0.01). In the same experimental conditions ox-LDL also induced O-2(radical anion) generation (p < 0.001). In the presence of radical scavengers and anti-LOX-l monoclonal antibody, O-2(radical anion) formation induced by ox-LDL was reduced (p < 0.001) with st contemporary rise in intracellular NO concentration (p < 0.001). ox-LDL did not significantly modify the ability of endothelial nitric oxide synthase to metabolize L-arginine to L-citrulline, The results of this study show that one of the pathophysiological consequences of ox-LDL binding to LOX-1 may be the inactivation of NO through an increased cellular production of O-2(radical anion).	Univ Verona, Osped Policlin, Dipartimento Sci Biomed & Chirurg, I-37134 Verona, Italy; Natl Cardiovasc Ctr, Res Inst, Dept Biosci, Osaka 5658565, Japan	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; National Cerebral & Cardiovascular Center - Japan	Cominacini, L (corresponding author), Univ Verona, Osped Policlin, Dipartimento Sci Biomed & Chirurg, I-37134 Verona, Italy.	comina@medicinad.univr.it	cominacini, luciano/B-2775-2011; Sawamura, Tatsuya/E-7103-2010					BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Berry C, 2000, CIRCULATION, V101, P2206, DOI 10.1161/01.CIR.101.18.2206; Bhunia AK, 1997, J BIOL CHEM, V272, P15642, DOI 10.1074/jbc.272.25.15642; Boger RH, 1996, ATHEROSCLEROSIS, V127, P1, DOI 10.1016/S0021-9150(96)05953-9; COMINACINI L, 1991, J LIPID RES, V32, P349; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Cominacini L, 1996, J LIPID MEDIAT CELL, V13, P19, DOI 10.1016/0929-7855(95)00011-9; COOKE JP, 1991, CIRCULATION, V83, P1057, DOI 10.1161/01.CIR.83.3.1057; DREXLER H, 1991, LANCET, V338, P1546, DOI 10.1016/0140-6736(91)92372-9; GINSBURG R, 1984, CIRCULATION, V69, P430, DOI 10.1161/01.CIR.69.2.430; GIRERD XJ, 1990, CIRC RES, V67, P1301, DOI 10.1161/01.RES.67.6.1301; GREENE B, 1993, AM J PHYSIOL, V264, P351; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; GUERRA R, 1989, BLOOD VESSELS, V26, P300; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; HABERLAND ME, 1985, P NATL ACAD SCI USA, V82, P2693, DOI 10.1073/pnas.82.9.2693; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; IGNARRO RJ, 1990, ANN REV PHARM TOXICO, V30, P535; Kojima H, 1998, NEUROREPORT, V9, P3345, DOI 10.1097/00001756-199810260-00001; KUGIYAMA K, 1990, NATURE, V66, P18; Kume N, 1998, CIRC RES, V83, P322, DOI 10.1161/01.RES.83.3.322; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; LIAO JK, 1994, J BIOL CHEM, V269, P12987; LO YYC, 1995, J BIOL CHEM, V270, P11727, DOI 10.1074/jbc.270.20.11727; LUSCHER TF, 1988, NEW ENGL J MED, V319, P462, DOI 10.1056/NEJM198808253190802; MACLOUF J, 1977, BIOMEDICINE, V26, P362; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MUGGE A, 1994, J CARDIOVASC PHARM, V24, P994, DOI 10.1097/00005344-199424060-00019; Murase T, 1998, CIRC RES, V83, P328, DOI 10.1161/01.RES.83.3.328; NOLL G, 1994, THROMB RES, V74, pS45, DOI 10.1016/S0049-3848(10)80006-4; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PLANE F, 1990, BIOCHEM SOC T, V18, P1177, DOI 10.1042/bst0181177; POU S, 1992, J BIOL CHEM, V267, P24173; ROSENKRANZWEISS P, 1994, J CLIN INVEST, V93, P2236, DOI 10.1172/JCI117221; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; SALVEMINI D, 1991, EUR J PHARMACOL, V199, P15, DOI 10.1016/0014-2999(91)90631-Y; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; SCHNEIDER NR, 1973, AM J VET RES, V34, P133; SCHROEDER JS, 1977, AM J CARDIOL, V40, P487, DOI 10.1016/0002-9149(77)90060-1; SESSA WC, 1993, HYPERTENSION, V21, P934, DOI 10.1161/01.HYP.21.6.934; SESSA WC, 1993, CIRC RES, V72, P921, DOI 10.1161/01.RES.72.4.921; SHIMOKAWA H, 1983, SCIENCE, V221, P560, DOI 10.1126/science.6408736; SMITH PK, 1985, ANAL BIOCHEM, V105, P293; SNEDDON JM, 1988, P NATL ACAD SCI USA, V85, P2800, DOI 10.1073/pnas.85.8.2800; SPARROW CP, 1989, J BIOL CHEM, V264, P2599; STEINBRECHER UP, 1988, BIOCHIM BIOPHYS ACTA, V959, P20, DOI 10.1016/0005-2760(88)90145-2; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TANNER FC, 1991, CIRCULATION, V83, P2012, DOI 10.1161/01.CIR.83.6.2012; THANNICKAL VJ, 1995, J BIOL CHEM, V270, P3033; VANHOUTTE PM, 1989, CIRCULATION, V80, P1, DOI 10.1161/01.CIR.80.1.1; Vergnani L, 2000, CIRCULATION, V101, P1261, DOI 10.1161/01.CIR.101.11.1261; VITA JA, 1990, CIRCULATION, V81, P491, DOI 10.1161/01.CIR.81.2.491; WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9; ZHOU M, 1997, ANAL BIOCHEM, V15, P162; ZULUETA JJ, 1997, AM J PHYSIOL, V272, P897	61	278	296	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13750	13755		10.1074/jbc.M010612200	http://dx.doi.org/10.1074/jbc.M010612200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278710	hybrid			2022-12-27	WOS:000168356600035
J	Kennedy, BN; Vihtelic, TS; Checkley, L; Vaughan, KT; Hyde, DR				Kennedy, BN; Vihtelic, TS; Checkley, L; Vaughan, KT; Hyde, DR			Isolation of a zebrafish rod opsin promoter to generate a transgenic zebrafish line expressing enhanced green fluorescent protein in rod photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; TRANSCRIPTION FACTOR NRL; RHODOPSIN PROMOTER; HOMEOBOX GENE; DANIO-RERIO; BRACHYDANIO-RERIO; BINDING PROTEIN; ADULT GOLDFISH; EYE; MUTATIONS	To exploit zebrafish as a transgenic model, tissue-specific promoters must be identified. We isolated a 20-kilobase (kbp) zebrafish rod opsin genomic clone, which consists of 18 kbp of 5'-flanking region, the entire coding region, and 0.5 kbp of 3'-flanking sequence. Polymerase chain reaction, Southern blotting, and DNA sequencing revealed the rod opsin gene lacks introns, The transcription start site was localized 94 nucleotides upstream of the translation initiation site. Sequence alignment with orthologous promoters revealed conserved cis-elements including glass, NRE, OTX/Bat-1, Ret-1/PCE-1, Ret-4, and TATA box. A 1.2-kbp promoter fragment was cloned upstream of the enhanced green fluorescent protein (EGFP) cDNA and microinjected into 1- to 2-cell stage zebrafish embryos. EGFP expression was detected in the ventral-nasal eye at 3 days postfertilization and spread throughout the eye. Progeny of the positive founder fish, which were identified by polymerase chain reaction amplification of fin genomic DNA, exhibited EGFP expression in the retina, confirming the germline transmission of the transgene, Frozen eye sections demonstrated the EGFP expression was rod-specific and exhibited a similar developmental expression profile as the rod opsin protein, This stable transgenic line provides a novel tool for identification of genes regulating development and maintenance of rod photoreceptors.	Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Hyde, DR (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.		kennedy, Breandan/H-5643-2019	kennedy, Breandan/0000-0001-7991-4689				Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980; Becker TS, 1998, DEVELOPMENT, V125, P4369; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Brockerhoff SE, 1997, J NEUROSCI, V17, P4236; BROWN T, 1993, CURRENT PROTOCOLS MO; Chen SM, 1996, J BIOL CHEM, V271, P28549, DOI 10.1074/jbc.271.45.28549; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; DETRICH HW, 1999, ZEBRAFISH GENETICS G, V60; Fadool JM, 1998, P NATL ACAD SCI USA, V95, P5182, DOI 10.1073/pnas.95.9.5182; FITZGIBBON J, 1995, GENE, V164, P273, DOI 10.1016/0378-1119(95)00458-I; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gal A, 1997, PROG RETIN EYE RES, V16, P51, DOI 10.1016/S1350-9462(96)00021-3; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; JOHNS PR, 1977, J COMP NEUROL, V176, P343, DOI 10.1002/cne.901760304; JOHNS PR, 1981, NATURE, V293, P141, DOI 10.1038/293141a0; JOHNS PR, 1982, J NEUROSCI, V2, P178; Kennedy BN, 1998, J BIOL CHEM, V273, P5591, DOI 10.1074/jbc.273.10.5591; Kimura A, 2000, J BIOL CHEM, V275, P1152, DOI 10.1074/jbc.275.2.1152; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; Li L, 1997, P NATL ACAD SCI USA, V94, P11645, DOI 10.1073/pnas.94.21.11645; Linney E, 1999, DEV BIOL, V213, P207, DOI 10.1006/dbio.1999.9376; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Long QM, 1997, DEVELOPMENT, V124, P4105; Malicki J, 1996, DEVELOPMENT, V123, P263; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; MCLAUCHLAN J, 1985, NUCLEIC ACIDS RES, V13, P1348; Moritz OL, 1999, INVEST OPHTH VIS SCI, V40, P3276; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; NATHANS J, 1992, BIOCHEMISTRY-US, V31, P4923, DOI 10.1021/bi00136a001; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Raz E, 1998, CURR BIOL, V8, P82, DOI 10.1016/S0960-9822(98)70038-7; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; ROBINSON J, 1995, VISUAL NEUROSCI, V12, P895, DOI 10.1017/S0952523800009457; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Seidman J, 1994, CURRENT PROTOCOLS MO; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; SHESHBERADARAN H, 1994, MOL CELL NEUROSCI, V5, P309, DOI 10.1006/mcne.1994.1037; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; WESTERFIELD M, 1995, ZEBROFISH BOOK GUIDE; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; WOODFORD BJ, 1994, EXP EYE RES, V58, P631, DOI 10.1006/exer.1994.1058; Yu X, 1996, J NEUROCHEM, V67, P2494; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4	58	59	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14037	14043		10.1074/jbc.M010490200	http://dx.doi.org/10.1074/jbc.M010490200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278688	hybrid			2022-12-27	WOS:000168356600073
J	Knee, DA; Froesch, BA; Nuber, U; Takayama, S; Reed, JC				Knee, DA; Froesch, BA; Nuber, U; Takayama, S; Reed, JC			Structure-function analysis of Bag1 proteins - Effects on androgen receptor transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; NEGATIVE REGULATOR; CHAPERONE ACTIVITY; APOPTOSIS; PROLIFERATION; AFFINITY; CLONING; FAMILY; GROWTH; RAP46	Bag1 is a regulator of heat shock protein 70 kDa (Hsp70/Hsc70) family proteins that interacts with steroid hormone receptors, Four isoforms of Bag1 have been recognized: Bag1, Bag1S, Bag1M (RAP46/HAP46), and Bag1L, Although Bag1L, Bag1M, and Bag1 can bind the androgen receptor (AR) in vitro, only Bag1L enhanced AR transcriptional activity. Bag1L was determined to be a nuclear protein by immunofluorescence microscopy, whereas Bag1, Bag1S, and Bag1M were predominantly cytoplasmic. Forced nuclear targeting of Bag1M, but not Bag1 or Bag1S, resulted in potent AR coactivation, indicating that Bag1M possesses the necessary structural features provided it is expressed within the nucleus. The ability of Bag1L to enhance AR activity was reduced with the removal of an NH2-terminal domain of Bag1L, which was found to be required for efficient nuclear localization and/or retention. In contrast, deletion of a conserved ubiquitin-like domain from Bag1L did not interfere with its nuclear targeting or AR regulatory activity, Thus, both the unique NH2-terminal domain and the COOH-terminal Hsc70-binding domain of Bag1L are simultaneously required for its function as an AR regulator, whereas the conserved ubiquitin-like domain is expendable.	Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jreed@burnham-inst.org			NCI NIH HHS [CA-67329] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA067329] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bardelli A, 1996, EMBO J, V15, P6205, DOI 10.1002/j.1460-2075.1996.tb01009.x; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Clevenger CV, 1997, MOL ENDOCRINOL, V11, P608, DOI 10.1210/me.11.5.608; DEVERE WR, 1997, CANCER RES, V57, P314; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Froesch BA, 1998, J BIOL CHEM, V273, P11660, DOI 10.1074/jbc.273.19.11660; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; LEE HJ, 1993, BIOCHEM BIOPH RES CO, V194, P97, DOI 10.1006/bbrc.1993.1790; LEPOR H, 1982, J UROLOGY, V128, P335, DOI 10.1016/S0022-5347(17)52915-8; Liu R, 1998, J BIOL CHEM, V273, P16985, DOI 10.1074/jbc.273.27.16985; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Ma H, 1999, MOL CELL BIOL, V19, P6164; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; MOWSZOWICZ I, 1993, MOL ENDOCRINOL, V7, P861, DOI 10.1210/me.7.7.861; Naishiro Y, 1999, ONCOGENE, V18, P3244, DOI 10.1038/sj.onc.1202661; NIELSEN DA, 1989, ANAL BIOCHEM, V179, P19, DOI 10.1016/0003-2697(89)90193-0; Nollen EAA, 2000, MOL CELL BIOL, V20, P1083, DOI 10.1128/MCB.20.3.1083-1088.2000; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Schneikert J, 1999, J CELL BIOL, V146, P929, DOI 10.1083/jcb.146.5.929; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 1996, GENOMICS, V35, P494, DOI 10.1006/geno.1996.0389; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Takayama S, 1998, CANCER RES, V58, P3116; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; THOMPSON TC, 1990, CANCER CELL-MON REV, V2, P345; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; WESTIN P, 1995, AM J PATHOL, V146, P1368; WOLF DA, 1992, MOL ENDOCRINOL, V6, P753, DOI 10.1210/me.6.5.753; Zeiner M, 1997, EMBO J, V16, P5483, DOI 10.1093/emboj/16.18.5483; ZEINER M, 1995, P NATL ACAD SCI USA, V92, P11465, DOI 10.1073/pnas.92.25.11465	37	54	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12718	12724		10.1074/jbc.M010841200	http://dx.doi.org/10.1074/jbc.M010841200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278763	hybrid			2022-12-27	WOS:000168198600035
J	Leteux, C; Chai, WG; Nagai, K; Herbert, CG; Lawson, AM; Feizi, T				Leteux, C; Chai, WG; Nagai, K; Herbert, CG; Lawson, AM; Feizi, T			10E4 antigen of scrapie lesions contains an unusual nonsulfated heparan motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATE PROTEOGLYCANS; AMYLOID PLAQUES; PRION PROTEIN; NEOGLYCOLIPIDS; LIGANDS; GROWTH; PROBES; BIND	The carbohydrate antigen on heparan sulfate recognized by monoclonal antibody 10E4 is uniquely codistributed with the abnormal prion protein, PrPSc, even in the earliest detectable brain lesions of scrapie-infected mice. Determining the chemical structure of 10E4 antigen is, therefore, an important aspect of structure elucidation of scrapie lesions, and a prerequisite for designing experiments to understand its role in scrapie pathogenesis, Toward this aim, we have examined preparations of heparan sulfate, with differing sulfate contents, for binding by 10E4 antibody. The highest antigenicity was observed in a preparation (HS-1) with the lowest sulfate content. HS-1 was partially depolymerized with heparin lyase III, and oligosaccharide fragments examined for 10E4 antigen expression by the neoglycolipid technology. An antigen-positive and two antigen-negative tetrasaccharides were isolated and examined by electrospray mass spectrometry, The antigen-positive tetrasaccharide sequence on heparan sulfate was thus deduced to contain a unique unsulfated motif that includes an N-unsubstituted glucosamine in the sequence, UA-GlcN-UA-GlcNAc. Antibody binding experiments with neoglycolipids prepared from a series of heparin/heparan sulfate disaccharides, and the trisaccharide derived from the antigen-positive tetrasaccharide after removal of the terminal hexuronic acid, show that both the penultimate glucosamine and the outer nonsulfated hexuronic acid are important for 10E4 antigenicity.	Northwick Pk Hosp & Clin Res Ctr, Glycosci Lab, Imperial Coll, Sch Med, Harrow HA1 3UJ, Middx, England	Imperial College London	Feizi, T (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Glycosci Lab, Imperial Coll, Sch Med, Watford Rd, Harrow HA1 3UJ, Middx, England.	t.feizi@ic.ac.uk		Feizi, Ten/0000-0001-6495-0329				BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; BRANDLEY BK, 1990, CELL, V63, P861, DOI 10.1016/0092-8674(90)90487-Y; CAUGHEY B, 1994, PHILOS T R SOC B, V343, P399, DOI 10.1098/rstb.1994.0035; Chai WG, 1996, ANAL BIOCHEM, V237, P88, DOI 10.1006/abio.1996.0205; CHAI WG, 1995, CARBOHYD RES, V269, P111, DOI 10.1016/0008-6215(94)00350-O; Chai WG, 1998, ANAL CHEM, V70, P2060, DOI 10.1021/ac9712761; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; FEIZI T, 1994, METHOD ENZYMOL, V230, P484; Feizi Ten, 1993, Current Opinion in Structural Biology, V3, P701, DOI 10.1016/0959-440X(93)90053-N; GABIZON R, 1993, J CELL PHYSIOL, V157, P319, DOI 10.1002/jcp.1041570215; Gallagher JT, 1998, TRENDS GLYCOSCI GLYC, V10, P137, DOI 10.4052/tigg.10.137; GRIFFIN CC, 1995, CARBOHYD RES, V276, P183, DOI 10.1016/0008-6215(95)00166-Q; HARRIS DA, 1999, PRIONS MOL CELLULAR; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Lander AD, 1996, PERSPECT DEV NEUROBI, V3, P347; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; LOVELESS RW, 1992, EMBO J, V11, P813, DOI 10.1002/j.1460-2075.1992.tb05118.x; Lyon M, 1998, MATRIX BIOL, V17, P485, DOI 10.1016/S0945-053X(98)90096-8; McBride PA, 1998, EXP NEUROL, V149, P447, DOI 10.1006/exnr.1997.6740; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; SNOW AD, 1990, LAB INVEST, V63, P601; Stoll MS, 2000, EUR J BIOCHEM, V267, P1795, DOI 10.1046/j.1432-1327.2000.01178.x; STOLL MS, 1988, BIOCHEM J, V256, P661, DOI 10.1042/bj2560661; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537	36	61	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12539	12545		10.1074/jbc.M010291200	http://dx.doi.org/10.1074/jbc.M010291200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278655	hybrid			2022-12-27	WOS:000168198600012
J	Scott, DC; Cao, ZH; Qi, ZB; Bauler, M; Igo, JD; Newton, SMC; Klebba, PE				Scott, DC; Cao, ZH; Qi, ZB; Bauler, M; Igo, JD; Newton, SMC; Klebba, PE			Exchangeability of N termini in the ligand-gated porins of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRIC ENTEROBACTIN RECEPTOR; INDUCED CONFORMATIONAL CHANGE; BACTERIAL OUTER-MEMBRANE; MEDIATED DRUG DELIVERY; IRON-TRANSPORT; CRYSTAL-STRUCTURE; CELL-ENVELOPE; ANTIBACTERIAL ACTIVITY; ENERGY TRANSDUCTION; SALMONELLA-TYPHI	The ferric siderophore transporters of the Gram-negative bacterial outer membrane manifest a unique architecture: Their N termini fold into a globular domain that lodges within, and physically obstructs, a transmembrane porin p-barrel formed by their C termini, We exchanged and deleted the N termini of two such siderophore receptors, FepA and FhuA, which recognize and transport ferric enterobactin and ferrichrome, respectively. The resultant chimeric proteins and empty beta -barrels avidly bound appropriate ligands, including iron complexes, protein toxins, and viruses. Thus, the ability to recognize and discriminate these molecules fully originates in the transmembrane beta -barrel domain. Both the hybrid and the deletion proteins also transported the ferric siderophore that they bound. The FepA constructs showed less transport activity than wild type receptor protein, but the FhuA constructs functioned with turnover numbers that were equivalent to wild type. The mutant proteins displayed the full range of transport functionalities, despite their aberrant or missing N termini, confirming (Braun, M., Killmann, H;, and Braun, V, (1999) Mel. Microbiol. 33, 1037-1049) that the globular domain within the pore is dispensable to the siderophore internalization reaction, and when present, acts without specificity during solute uptake. These and other data suggest a transport process in which siderophore receptors undergo multiple conformational states that ultimately expel the N terminus from the channel concomitant with solute internalization.	Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Klebba, PE (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	peklebba@ou.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053836] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53836] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Bearden SW, 1999, MOL MICROBIOL, V32, P403, DOI 10.1046/j.1365-2958.1999.01360.x; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; Braun M, 1999, MOL MICROBIOL, V33, P1037, DOI 10.1046/j.1365-2958.1999.01546.x; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cadieux N, 1999, P NATL ACAD SCI USA, V96, P10673, DOI 10.1073/pnas.96.19.10673; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Cao ZH, 2000, MOL MICROBIOL, V37, P1306, DOI 10.1046/j.1365-2958.2000.02093.x; Cho SS, 1999, BRAIN RES, V816, P229, DOI 10.1016/S0006-8993(98)01117-2; Cope LD, 2000, INFECT IMMUN, V68, P4092, DOI 10.1128/IAI.68.7.4092-4101.2000; Cornelissen CN, 1998, MOL MICROBIOL, V27, P611, DOI 10.1046/j.1365-2958.1998.00710.x; COULTON JA, COMMUNICATION; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DIMASI DR, 1973, J BACTERIOL, V115, P506, DOI 10.1128/JB.115.2.506-513.1973; DOLENCE EK, 1991, J MED CHEM, V34, P968, DOI 10.1021/jm00107a014; DOLENCE EK, 1990, J MED CHEM, V33, P461, DOI 10.1021/jm00164a001; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2000, PROTEIN SCI, V9, P956, DOI 10.1110/ps.9.5.956; FERNANDEZBEROS ME, 1989, INFECT IMMUN, V57, P1271, DOI 10.1128/IAI.57.4.1271-1275.1989; FURMAN M, 1994, INFECT IMMUN, V62, P4091, DOI 10.1128/IAI.62.9.4091-4094.1994; GUDMUNDSDOTTIR A, 1989, J BACTERIOL, V171, P6526, DOI 10.1128/jb.171.12.6526-6533.1989; GUTERMAN SK, 1971, BIOCHEM BIOPH RES CO, V44, P1149, DOI 10.1016/S0006-291X(71)80206-1; GUTERMAN SK, 1973, J BACTERIOL, V114, P1225, DOI 10.1128/JB.114.3.1225-1230.1973; GUTFREUND H., 1967, ESSAYS BIOCHEM, VVol. 3-3, P25; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; HELLER KJ, 1988, GENE, V64, P147, DOI 10.1016/0378-1119(88)90488-X; Jiang XQ, 1997, SCIENCE, V276, P1261, DOI 10.1126/science.276.5316.1261; Jurado RL, 1997, CLIN INFECT DIS, V25, P888, DOI 10.1086/515549; KILLMANN H, 1993, EMBO J, V12, P3007, DOI 10.1002/j.1460-2075.1993.tb05969.x; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; Klebba PE, 1998, CURR OPIN MICROBIOL, V1, P238, DOI 10.1016/S1369-5274(98)80017-9; Klug CS, 1998, BIOCHEMISTRY-US, V37, P9016, DOI 10.1021/bi980144e; KLUG CS, 1995, BIOCHEMISTRY-US, V34, P14230, DOI 10.1021/bi00043a030; LARSEN RA, 1993, MOL MICROBIOL, V10, P943, DOI 10.1111/j.1365-2958.1993.tb00966.x; Larsen RA, 1997, J BACTERIOL, V179, P3213, DOI 10.1128/jb.179.10.3213-3221.1997; LIU J, 1993, P NATL ACAD SCI USA, V90, P10653, DOI 10.1073/pnas.90.22.10653; LIU J, 1994, BIOCHEMISTRY-US, V33, P13274, DOI 10.1021/bi00249a014; Locher KP, 1997, EUR J BIOCHEM, V247, P770, DOI 10.1111/j.1432-1033.1997.t01-1-00770.x; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Locher KP, 1997, J BIOL CHEM, V272, P1448, DOI 10.1074/jbc.272.3.1448; MCINTOSH MA, 1976, BIOCHEM BIOPH RES CO, V70, P315, DOI 10.1016/0006-291X(76)91144-X; MCKEE JA, 1991, BIOCONJUGATE CHEM, V2, P281, DOI 10.1021/bc00010a013; Merianos HJ, 2000, NAT STRUCT BIOL, V7, P205; MILLER MJ, 1991, BIOL MET, V4, P62, DOI 10.1007/BF01135559; MIZUSHIMA S, 1974, BIOCHEM BIOPH RES CO, V61, P1221, DOI 10.1016/S0006-291X(74)80414-6; Moeck GS, 1996, MOL MICROBIOL, V22, P459, DOI 10.1046/j.1365-2958.1996.00112.x; Moeck GS, 1997, J BIOL CHEM, V272, P28391, DOI 10.1074/jbc.272.45.28391; MURPHY CK, 1990, J BACTERIOL, V172, P2736, DOI 10.1128/jb.172.5.2736-2746.1990; NEILANDS JB, 1982, ANNU REV MICROBIOL, V36, P285, DOI 10.1146/annurev.mi.36.100182.001441; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; Newton SMC, 1997, P NATL ACAD SCI USA, V94, P4560, DOI 10.1073/pnas.94.9.4560; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Occhino DA, 1998, MOL MICROBIOL, V29, P1493, DOI 10.1046/j.1365-2958.1998.01034.x; Payne MA, 1997, J BIOL CHEM, V272, P21950, DOI 10.1074/jbc.272.35.21950; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; POSTLE K, 1983, P NATL ACAD SCI-BIOL, V80, P5235, DOI 10.1073/pnas.80.17.5235; PUGSLEY AP, 1976, J BACTERIOL, V127, P218, DOI 10.1128/JB.127.1.218-228.1976; RAYMOND KN, 1994, PURE APPL CHEM, V66, P773, DOI 10.1351/pac199466040773; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; RUTZ JM, 1992, SCIENCE, V258, P471, DOI 10.1126/science.1411544; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SCHNAITMAN CA, 1973, ARCH BIOCHEM BIOPHYS, V157, P541, DOI 10.1016/0003-9861(73)90673-5; SCHRAMM E, 1987, J BACTERIOL, V169, P3350, DOI 10.1128/jb.169.7.3350-3357.1987; SKARE JT, 1993, J BIOL CHEM, V268, P16302; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Sprencel C, 2000, J BACTERIOL, V182, P5359, DOI 10.1128/JB.182.19.5359-5364.2000; Thulasiraman P, 1998, J BACTERIOL, V180, P6689, DOI 10.1128/JB.180.24.6689-6696.1998; van der Helm D, 1998, MET IONS BIOL SYST, V35, P355; WANG CC, 1971, J BIOL CHEM, V246, P2147; WAYNE R, 1975, J BACTERIOL, V121, P497, DOI 10.1128/JB.121.2.497-503.1975; WAYNE R, 1976, J BACTERIOL, V126, P7, DOI 10.1128/JB.126.1.7-12.1976; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Zhu WM, 2000, J BACTERIOL, V182, P439, DOI 10.1128/JB.182.2.439-447.2000	76	56	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13025	13033		10.1074/jbc.M011282200	http://dx.doi.org/10.1074/jbc.M011282200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278876	hybrid			2022-12-27	WOS:000168198600080
J	Wakarchuk, WW; Watson, D; St Michael, F; Li, JJ; Wu, YY; Brisson, JR; Young, NM; Gilbert, M				Wakarchuk, WW; Watson, D; St Michael, F; Li, JJ; Wu, YY; Brisson, JR; Young, NM; Gilbert, M			Dependence of the bi-functional nature of a sialyltransferase from Neisseria meningitidis on a single amino acid substitution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL LIPOPOLYSACCHARIDE STRUCTURE; HAEMOPHILUS-INFLUENZAE; CAMPYLOBACTER-JEJUNI; PHASE VARIATION; ENZYMATIC-SYNTHESIS; GENETIC-BASIS; LIPOOLIGOSACCHARIDE; BIOSYNTHESIS; EXPRESSION; ALPHA-2,3-SIALYLTRANSFERASE	The L1 immunotype strain 126E of Neisseria meningitidis has been shown to have an N-acetyl-neuraminic acid-containing lipooligosaccharide in which an alpha -linked galactose from a pk epitope is substituted at the O6 position (Wakarchuk, W, W,, Gilbert, M,, Martin, A., Wu, Y,, Brisson, J, R,, Thibault, P,, and Richards, J, C, (1998) Eur. J, Biochem. 254, 626-633), Using a synthetic pk-epitope containing acceptor in glycosyltransferase reactions, we were able to show by NMR analysis of the reaction product that the 126E(L1)-derived sialyltransferase can make both alpha -2,3 and alpha -2,6 linkages to the terminal galactose, Gene disruption experiments showed that the Ist gene in 126E(L1) was responsible for the in vivo addition of the alpha -2,6-linked N-acetyl-neuraminic acid residue. By site-directed mutagenesis it was possible to change the MC58(L3)-derived enzyme into a bifunctional enzyme with a single amino acid change at position 168, where a glycine was changed to an isoleucine. We performed a gene replacement experiment where the 126E(L1) alpha -2,3/6-sialyltransferase was replaced by allelic exchange with the monofunctional MC58(L3) alpha -2,3-sialyltransferase and with the mutant MC58(L3) allele G168I, We observed that the level of LOS sialylation with the G168I allele was very similar to that of the wild type 126E(Ll), indicating that residue 168 is the critical residue for the alpha -2,6-sialyltransferase activity in vitro as well as in vivo.	Natl Res Council Canada, Inst Biol Sci, Immunochem Program, Ottawa, ON K1A 0R6, Canada	National Research Council Canada	Wakarchuk, WW (corresponding author), Natl Res Council Canada, Inst Biol Sci, Immunochem Program, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.		Wakarchuk, Warren/AAO-2774-2020; Wakarchuk, Warren/Q-9514-2017	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Li, Jianjun/0000-0002-6531-3687; Gilbert, Michel/0000-0002-0204-4408				ASPINALL GO, 1994, INFECT IMMUN, V62, P2122, DOI 10.1128/IAI.62.5.2122-2125.1994; Burch CL, 1997, J BACTERIOL, V179, P982, DOI 10.1128/jb.179.3.982-986.1997; Gilbert M, 1997, EUR J BIOCHEM, V249, P187, DOI 10.1111/j.1432-1033.1997.t01-1-00187.x; Gilbert M, 1996, J BIOL CHEM, V271, P28271, DOI 10.1074/jbc.271.45.28271; Gilbert M, 2000, J BIOL CHEM, V275, P3896, DOI 10.1074/jbc.275.6.3896; Griffiss JM, 2000, J BIOL CHEM, V275, P9716, DOI 10.1074/jbc.275.13.9716; GRONBERG G, 1994, CARBOHYD RES, V257, P35, DOI 10.1016/0008-6215(94)84106-3; Harvey HA, 2000, MOL MICROBIOL, V36, P1059, DOI 10.1046/j.1365-2958.2000.01938.x; Hood DW, 1996, P NATL ACAD SCI USA, V93, P11121, DOI 10.1073/pnas.93.20.11121; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; Hood DW, 2001, MOL MICROBIOL, V39, P341, DOI 10.1046/j.1365-2958.2001.02204.x; Jennings MP, 1999, MICROBIOL-UK, V145, P3013, DOI 10.1099/00221287-145-11-3013; Jennings MP, 1995, MOL MICROBIOL, V18, P729, DOI 10.1111/j.1365-2958.1995.mmi_18040729.x; Kahler CM, 1998, INFECT IMMUN, V66, P5939, DOI 10.1128/IAI.66.12.5939-5947.1998; Kahler CM, 1998, CRIT REV MICROBIOL, V24, P281, DOI 10.1080/10408419891294216; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Li J, 1998, J CHROMATOGR A, V817, P325, DOI 10.1016/S0021-9673(98)00341-0; Linton D, 2000, MOL MICROBIOL, V37, P501, DOI 10.1046/j.1365-2958.2000.02020.x; LOBAU S, 1995, MOL MICROBIOL, V18, P391, DOI 10.1111/j.1365-2958.1995.mmi_18030391.x; Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x; Preston A, 1996, CRIT REV MICROBIOL, V22, P139, DOI 10.3109/10408419609106458; SABESAN S, 1986, J AM CHEM SOC, V108, P2068, DOI 10.1021/ja00268a056; SCHNEIDER H, 1991, J EXP MED, V174, P1601, DOI 10.1084/jem.174.6.1601; Wakarchuk W, 1996, J BIOL CHEM, V271, P19166, DOI 10.1074/jbc.271.32.19166; WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467; Wakarchuk WW, 1998, EUR J BIOCHEM, V254, P626, DOI 10.1046/j.1432-1327.1998.2540626.x; Weiser JN, 1998, MOL MICROBIOL, V30, P767, DOI 10.1046/j.1365-2958.1998.01108.x	27	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12785	12790		10.1074/jbc.M011293200	http://dx.doi.org/10.1074/jbc.M011293200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278878	hybrid			2022-12-27	WOS:000168198600046
J	Graf, R; Schiesser, M; Scheele, GA; Marquardt, K; Frick, TW; Ammann, RW; Bimmler, D				Graf, R; Schiesser, M; Scheele, GA; Marquardt, K; Frick, TW; Ammann, RW; Bimmler, D			A family of 16-kDa pancreatic secretory stress proteins form highly organized fibrillar structures upon tryptic activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGENERATING GENE PROTEIN; STONE PROTEIN; ISLET NEOGENESIS; REG PROTEIN; EXPRESSION; LITHOSTATHINE; CLONING; PAP; IDENTIFICATION; AMELIORATION	A group of 16-kDa proteins, synthesized and secreted by rat pancreatic acinar cells and composed of pancreatic stone protein (PSP/reg) and isoforms of pancreatitis-associated protein (PAP), show structural homologies, including conserved amino acid sequences, cysteine residues, and highly sensitive N-terminal trypsin cleavage sites, as well as conserved functional responses in conditions of pancreatic stress. Trypsin activation of recombinant stress proteins or counterparts contained in rat pancreatic juice (PSP/reg, PAP I and PAP III) resulted in conversion of 16-kDa soluble proteins into 14-kDa soluble isoforms (pancreatic thread protein and pancreatitis-associated thread protein, respectively) that rapidly polymerize into insoluble sedimenting structures, Activated thread proteins show long lived resistance to a wide spectrum of proteases contained in pancreatic juice, including serine proteases and metalloproteinases, In contrast, PAP II, following activation with trypsin or pancreatic juice, does not form insoluble structures and is rapidly digested by pancreatic proteases, Scanning and transmission electron microscopy indicate that activated thread proteins polymerize into highly organized fibrillar structures with helical configurations. Through bundling, branching, and extension processes, these fibrillar structures form dense matrices that span large topological surfaces. These findings suggest that PSP/reg and PAP I and III isoforms consist of a family of highly regulated soluble secretory stress proteins, which, upon trypsin activation, convert into a family of insoluble helical thread proteins. Dense extracellular matrices, composed of helical thread proteins organized into higher ordered matrix structures, may serve physiological functions within luminal compartments in the exocrine pancreas.	Univ Zurich Hosp, Dept Visceral & Transplantat Surg, Pancreatitis Res Lab, CH-8091 Zurich, Switzerland; Inst Genom Med, La Jolla, CA 92037 USA; Spital Zollikerberg, CH-8125 Zollikerberg, Switzerland; Univ Zurich Hosp, Dept Internal Med, Div Gastroenterol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Graf, R (corresponding author), Univ Zurich Hosp, Dept Visceral & Transplantat Surg, Pancreatitis Res Lab, DL36,Sternwartstr 14, CH-8091 Zurich, Switzerland.	rgf@chi.usz.ch		Graf, Rolf/0000-0001-7449-7302				Bimmler D, 1999, PANCREAS, V19, P255, DOI 10.1097/00006676-199910000-00006; Bimmler D, 1999, PANCREAS, V18, P417, DOI 10.1097/00006676-199905000-00015; BIMMLER D, 1995, PANCREAS, V11, P63, DOI 10.1097/00006676-199507000-00007; Bimmler D, 1997, J BIOL CHEM, V272, P3073, DOI 10.1074/jbc.272.5.3073; BIMMLER D, 1999, DIGESTION, V60, P369; BRENNER S, 1959, BIOCHIM BIOPHYS ACTA, V34, P103, DOI 10.1016/0006-3002(59)90237-9; Cerini C, 1999, J BIOL CHEM, V274, P22266, DOI 10.1074/jbc.274.32.22266; De Reggi M, 1998, J BIOL CHEM, V273, P4967, DOI 10.1074/jbc.273.9.4967; DECARO A, 1979, BIOCHEM BIOPH RES CO, V87, P1176, DOI 10.1016/S0006-291X(79)80031-5; DRICKAMER K, 1993, CURR OPIN STRUC BIOL, V3, P393, DOI 10.1016/S0959-440X(05)80112-5; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FRIGERIO JM, 1993, BIOCHIM BIOPHYS ACTA, V1216, P329, DOI 10.1016/0167-4781(93)90167-C; FRIGERIO JM, 1993, BIOCHEMISTRY-US, V32, P9236, DOI 10.1021/bi00086a032; Fukui H, 1998, GASTROENTEROLOGY, V115, P1483, DOI 10.1016/S0016-5085(98)70027-7; Githens Sherwood, 1993, P21; Gross DJ, 1998, ENDOCRINOLOGY, V139, P2369, DOI 10.1210/en.139.5.2369; GROSS J, 1985, P NATL ACAD SCI USA, V82, P5627, DOI 10.1073/pnas.82.17.5627; GROSS J, 1985, J CLIN INVEST, V76, P2115, DOI 10.1172/JCI112216; HEERY DM, 1990, TRENDS GENET, V6, P173; IOVANNA J, 1991, J BIOL CHEM, V266, P24664; IOVANNA J, 1993, PANCREAS, V8, P597, DOI 10.1097/00006676-199309000-00011; IOVANNA JL, 1991, AM J PHYSIOL, V261, pG485, DOI 10.1152/ajpgi.1991.261.3.G485; KEIM V, 1994, DIGESTION, V55, P65, DOI 10.1159/000201127; KEIM V, 1984, DIGESTION, V29, P242, DOI 10.1159/000199041; KEIM V, 1992, GASTROENTEROLOGY, V103, P248, DOI 10.1016/0016-5085(92)91120-S; KEIM V, 1986, CLIN PHYSIOL BIOCH, V4, P136; Keim V, 1999, PANCREAS, V19, P248, DOI 10.1097/00006676-199910000-00005; KEIM V, 1991, GASTROENTEROLOGY, V100, P775, DOI 10.1016/0016-5085(91)80025-5; Kobayashi S, 2000, J BIOL CHEM, V275, P10723, DOI 10.1074/jbc.275.15.10723; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Rafaeloff R, 1997, J CLIN INVEST, V99, P2100, DOI 10.1172/JCI119383; SARLES H, 1990, GASTROENTEROLOGY, V99, P900, DOI 10.1016/0016-5085(90)90999-H; Sasahara K, 2000, BBA-MOL BASIS DIS, V1500, P142, DOI 10.1016/S0925-4439(99)00095-2; SATOMURA Y, 1993, INT J PANCREATOL, V13, P59; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; SCHEELE GA, 1975, J BIOL CHEM, V250, P5375; Schiesser M, 2001, PANCREAS, V22, P186, DOI 10.1097/00006676-200103000-00012; SMITH FE, 1994, DIABETOLOGIA, V37, P994, DOI 10.1007/s001250050209; Stephanova E, 1996, CYTOGENET CELL GENET, V72, P83, DOI 10.1159/000134168; Su SB, 1999, PANCREAS, V19, P239, DOI 10.1097/00006676-199910000-00004; TERAZONO K, 1990, DIABETOLOGIA, V33, P250, DOI 10.1007/BF00404804; UNNO M, 1992, ADV EXP MED BIOL, V321, P61; WATANABE T, 1994, P NATL ACAD SCI USA, V91, P3589, DOI 10.1073/pnas.91.9.3589; Zenilman ME, 1996, GASTROENTEROLOGY, V110, P1208, DOI 10.1053/gast.1996.v110.pm8613011	44	41	46	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21028	21038		10.1074/jbc.M010717200	http://dx.doi.org/10.1074/jbc.M010717200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11278730	hybrid			2022-12-27	WOS:000169297900033
J	Basak, S; Olsen, L; Hattman, S; Nagaraja, V				Basak, S; Olsen, L; Hattman, S; Nagaraja, V			Intrinsic DNA distortion of the bacteriophage Mu momP1 promoter is a negative regulator of its transcription - A novel mode of regulation of toxic gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RNA-POLYMERASE; ACTIVATOR PROTEIN-C; ESCHERICHIA-COLI; BINDING-SITE; -35 REGIONS; UPSTREAM; SEQUENCE; OPERON; STRENGTH; INVIVO	The momP1 promoter of the bacteriophage Mu mom operon is an example of a weak promoter. It contains a 19-base pair suboptimal spacer between the -35 (ACCACA) and -10 (TAGAAT) hexamers, Escherichia coli RNA polymerase is unable to bind to momP1 on its own. DNA distortion caused by the presence of a run of six T nucleotides overlapping the 5' end of the -10 element might prevent RNA polymerase from binding to momP1, To investigate the influence of the T-6 run on momP1 expression, defined substitution mutations were introduced by site-directed mutagenesis. In vitro probing experiments with copper phenanthroline ((OP)(2)Cu) and DNase I revealed distinct differences in cleavage patterns among the various mutants; in addition, compared with the wild type, the mutants showed an increase (variable) in momP1 promoter activity in vivo. Promoter strength analyses were in agreement with the ability of these mutants to form open complexes as well as to produce momP1-specific transcripts, No significant role is attributed to the overlapping and divergently organized promoter, momP2, in the expression of momP1 activity, as determined by promoter disruption analysis. These data support the view that an intrinsic DNA distortion in the spacer region of momP1 acts in cis as a negative element in mom operon transcription. This is a novel mechanism of regulation of toxic gene expression.	Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Indian Institute of Science (IISC) - Bangalore; University of Rochester	Nagaraja, V (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.				NIGMS NIH HHS [GM29227] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADHYA S, 1989, ANNU REV GENET, V23, P227, DOI 10.1146/annurev.genet.23.1.227; AUBLE DT, 1986, J BIOL CHEM, V261, P1202; AUBLE DT, 1988, J MOL BIOL, V202, P471, DOI 10.1016/0022-2836(88)90279-3; BALKE V, 1992, NUCLEIC ACIDS RES, V20, P2777, DOI 10.1093/nar/20.11.2777; Basak S, 1998, J MOL BIOL, V284, P893, DOI 10.1006/jmbi.1998.2213; BERTRANDBURGGRAF E, 1990, EMBO J, V9, P2265, DOI 10.1002/j.1460-2075.1990.tb07397.x; BOLKER M, 1989, J BACTERIOL, V171, P2019; BOSSI L, 1984, CELL, V39, P643, DOI 10.1016/0092-8674(84)90471-9; Burr T, 2000, NUCLEIC ACIDS RES, V28, P1864, DOI 10.1093/nar/28.9.1864; CALLADINE CR, 1986, J MOL BIOL, V192, P907, DOI 10.1016/0022-2836(86)90036-7; Cheema AK, 1999, J BACTERIOL, V181, P5296, DOI 10.1128/JB.181.17.5296-5302.1999; CHIANG LW, 1993, GENETICS, V135, P619; Dai X, 1999, CURR OPIN MICROBIOL, V2, P126, DOI 10.1016/S1369-5274(99)80022-8; De A, 1998, BIOCHEMISTRY-US, V37, P3831, DOI 10.1021/bi972171v; DEUSCHLE U, 1986, EMBO J, V5, P2987, DOI 10.1002/j.1460-2075.1986.tb04596.x; DUTTA AK, 1995, NUCLEIC ACIDS RES, V23, P4530; ELLINGER T, 1994, J MOL BIOL, V239, P466, DOI 10.1006/jmbi.1994.1389; Giladi H, 1996, J MOL BIOL, V260, P484, DOI 10.1006/jmbi.1996.0416; GINDLESPERGER TL, 1994, J BACTERIOL, V176, P2885, DOI 10.1128/JB.176.10.2885-2891.1994; GOODRICH JA, 1991, TRENDS BIOCHEM SCI, V16, P394, DOI 10.1016/0968-0004(91)90162-O; GRALLA JD, 1985, P NATL ACAD SCI USA, V82, P3078, DOI 10.1073/pnas.82.10.3078; HATTMAN S, 1985, GENE, V39, P71, DOI 10.1016/0378-1119(85)90109-X; HATTMAN S, 1984, GENE, V29, P185, DOI 10.1016/0378-1119(84)90179-3; Hattman S, 1999, PHARMACOL THERAPEUT, V84, P367, DOI 10.1016/S0163-7258(99)00042-X; HEISIG P, 1986, GENE, V43, P59, DOI 10.1016/0378-1119(86)90008-9; HSU LM, 1991, BIOCHEMISTRY-US, V30, P813, DOI 10.1021/bi00217a035; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; KAHMANN R, 1985, GENE, V39, P61, DOI 10.1016/0378-1119(85)90108-8; KEILTY S, 1987, J BIOL CHEM, V262, P6389; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; KUWABARA MD, 1987, BIOCHEMISTRY-US, V26, P7234, DOI 10.1021/bi00397a006; LAVIGNE M, 1992, J MOL BIOL, V224, P293, DOI 10.1016/0022-2836(92)90995-V; LOZINSKI T, 1991, NUCLEIC ACIDS RES, V19, P2947, DOI 10.1093/nar/19.11.2947; MCALLISTER CF, 1989, J BIOL CHEM, V264, P10451; Miller JH., 1992, SHORT COURSE BACTERI, P72; MULLIGAN ME, 1985, J BIOL CHEM, V260, P3529; MYERS RM, 1985, SCIENCE, V229, P242, DOI 10.1126/science.2990046; NAGARAJA V, 1993, J BIOSCIENCE, V18, P13, DOI 10.1007/BF02703034; OHYAMA T, 1992, NUCLEIC ACIDS RES, V20, P1617, DOI 10.1093/nar/20.7.1617; PerezMartin J, 1997, ANNU REV MICROBIOL, V51, P593, DOI 10.1146/annurev.micro.51.1.593; PLASKON RR, 1987, NUCLEIC ACIDS RES, V15, P785, DOI 10.1093/nar/15.2.785; RAMESH V, 1994, PROTEIN ENG, V7, P1053, DOI 10.1093/protein/7.8.1053; Ramesh V, 1996, J MOL BIOL, V260, P22, DOI 10.1006/jmbi.1996.0379; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Sambrook J., 2002, MOL CLONING LAB MANU; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; SPASSKY A, 1985, BIOCHEMISTRY-US, V24, P8050, DOI 10.1021/bi00348a032; SPASSKY A, 1988, EMBO J, V7, P1871, DOI 10.1002/j.1460-2075.1988.tb03020.x; STEFANO JE, 1982, P NATL ACAD SCI-BIOL, V79, P1069, DOI 10.1073/pnas.79.4.1069; Sun WY, 1998, J MOL BIOL, V284, P885, DOI 10.1006/jmbi.1998.2228; Sun WY, 1997, J MOL BIOL, V273, P765, DOI 10.1006/jmbi.1997.1349; ZENGEL JM, 1980, CELL, V21, P523, DOI 10.1016/0092-8674(80)90490-0	53	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19836	19844		10.1074/jbc.M011790200	http://dx.doi.org/10.1074/jbc.M011790200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278987	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000169135100023
J	Holst, B; Hastrup, H; Raffetseder, U; Martini, L; Schwartz, TW				Holst, B; Hastrup, H; Raffetseder, U; Martini, L; Schwartz, TW			Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG SPLICE VARIANT; AGONIST EFFICACY; BINDING-SITES; SUBSTANCE-P; BETA-GAMMA; G(S); ACTIVATION; G(S)ALPHA; LIGAND; ALPHA	The NK1 neurokinin receptor presents two non-ideal binding phenomena, two-component binding curves for all agonists and significant differences between agonist affinity determined by homologous versus heterologous competition binding. Whole cell binding with fusion proteins constructed between either G alpha (s) or G alpha (q), and the NK1 receptor with a truncated tail, which secured non-promiscuous G-protein interaction, demonstrated monocomponent agonist binding closely corresponding to either of the two affinity states found in the wild-type receptor. High affinity binding of both substance P and neurokinin A was observed in the tail-truncated G alpha (s) fusion construct, whereas the lower affinity component was displayed by the tail-truncated G alpha (q) fusion. The elusive difference between the affinity determined in heterologous versus homologous binding assays for substance P and especially for neurokinin A was eliminated in the G-protein fusions, An NK1 receptor mutant with a single substitution at the extracellular end of TM-III(F111S), which totally uncoupled the receptor from G alpha (s) signaling, showed binding properties that were monocomponent and otherwise very similar to those observed in the tail-truncated G alpha (q) fusion construct. Thus, the heterogenous pharmacological phenotype displayed by the NK1 receptor is a reflection of the occurrence of two active conformations or molecular phenotypes representing complexes with the G alpha (s) and G alpha (q) species, respectively. We propose that these molecular forms do not interchange readily, conceivably because of the occurrence of microdomains or "signal-transductosomes" within the cell membrane.	Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; Pharma AS 7TM, DK-2100 Copenhagen, Denmark	University of Copenhagen	Schwartz, TW (corresponding author), Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Pharmacol Lab, Bldg 18-6,Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	schwartz@molpharm.dk		Schwartz, Thue W./0000-0002-0261-6904; Holst, Birgitte/0000-0001-7432-097X				Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; ALLGEIER A, 1994, J BIOL CHEM, V269, P13733; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BERTIN B, 1994, P NATL ACAD SCI USA, V91, P8827, DOI 10.1073/pnas.91.19.8827; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CASCIERI MA, 1992, MOL PHARMACOL, V42, P458; CHABRE O, 1994, J BIOL CHEM, V269, P5730; Edwards SW, 2000, TRENDS PHARMACOL SCI, V21, P304, DOI 10.1016/S0165-6147(00)01513-3; Fishburn CS, 2000, P NATL ACAD SCI USA, V97, P1085, DOI 10.1073/pnas.97.3.1085; GETHER U, 1993, NATURE, V362, P345, DOI 10.1038/362345a0; GETHER U, 1993, J BIOL CHEM, V268, P7893; Hastrup H, 1996, FEBS LETT, V399, P264, DOI 10.1016/S0014-5793(96)01337-3; Herrlich A, 1996, J BIOL CHEM, V271, P16764, DOI 10.1074/jbc.271.28.16764; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; Kenakin T, 1999, TRENDS PHARMACOL SCI, V20, P400, DOI 10.1016/S0165-6147(99)01361-9; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P188, DOI 10.1016/S0165-6147(00)89020-3; Leff P, 1997, TRENDS PHARMACOL SCI, V18, P355, DOI 10.1016/S0165-6147(97)90664-7; Loisel TP, 1999, J BIOL CHEM, V274, P31014, DOI 10.1074/jbc.274.43.31014; Maggi CA, 1997, TRENDS PHARMACOL SCI, V18, P351, DOI 10.1016/S0165-6147(97)90663-5; MAGGI CA, 1995, GEN PHARMACOL-VASC S, V26, P911, DOI 10.1016/0306-3623(94)00292-U; Milligan G, 2000, TRENDS PHARMACOL SCI, V21, P24, DOI 10.1016/S0165-6147(99)01404-2; NAKAJIMA Y, 1992, J BIOL CHEM, V267, P2437; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Onaran HO, 1997, ANN NY ACAD SCI, V812, P98, DOI 10.1111/j.1749-6632.1997.tb48150.x; PRADIER L, 1994, MOL PHARMACOL, V45, P287; REGOLI D, 1994, PHARMACOL REV, V46, P551; Rosenkilde MM, 2000, MOL PHARMACOL, V57, P602, DOI 10.1124/mol.57.3.602; Sagan S, 1999, J BIOL CHEM, V274, P23770, DOI 10.1074/jbc.274.34.23770; Sautel M, 1998, FEBS LETT, V436, P46, DOI 10.1016/S0014-5793(98)01094-1; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; Seifert R, 1999, TRENDS PHARMACOL SCI, V20, P383, DOI 10.1016/S0165-6147(99)01368-1; Small KM, 2000, BIOCHEMISTRY-US, V39, P2815, DOI 10.1021/bi992497z; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Unson CG, 2000, J BIOL CHEM, V275, P21631, DOI 10.1074/jbc.M002093200; Waldhoer M, 1999, J BIOL CHEM, V274, P30571, DOI 10.1074/jbc.274.43.30571; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954, DOI 10.1124/mol.58.5.954; Wenzel-Seifert K, 1998, J BIOL CHEM, V273, P24181, DOI 10.1074/jbc.273.37.24181; Wenzel-Seifert K, 1998, BIOCHEM J, V334, P519, DOI 10.1042/bj3340519; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Wise A, 1997, J BIOL CHEM, V272, P24673, DOI 10.1074/jbc.272.39.24673; Wise A, 1997, FEBS LETT, V419, P141, DOI 10.1016/S0014-5793(97)01431-2; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8	44	82	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19793	19799		10.1074/jbc.M100621200	http://dx.doi.org/10.1074/jbc.M100621200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279104	hybrid			2022-12-27	WOS:000169135100017
J	Stunkel, W; Ait-Si-Ali, S; Jones, PL; Wolffe, AP				Stunkel, W; Ait-Si-Ali, S; Jones, PL; Wolffe, AP			Programming the transcriptional state of replicating methylated DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; CPG ISLANDS; CHROMATIN; DEMETHYLATION; COMPLEX; EXPRESSION; BINDING; REPRESSION; ORIGINS; TARGET	CpG methylation is maintained in daughter chromatids by the action of DNA methyltransferase at the replication fork. An opportunity exists for transcription factors at replication forks to bind their cognate sequences and thereby prevent remethylation by DNA methyltransferase. To test this hypothesis, we injected a linearized, methylated, and partially single-stranded re. porter plasmid into the nuclei of Xenopus oocytes and followed changes in the transcriptional activity after DNA replication. We find that dependent on Gal4-VP16, the action of DNA methyltransferase, and replication-coupled chromatin assembly DNA replication provides a window of time in which regulatory factors can activate or repress gene activity. Demethylation in the promoter region near the GAL4 binding sites of the newly synthesized DNA did not occur even though the Gal4 binding sites were occupied and transcription was activated. We conclude that "passive" demethylation at the replication fork is not simply dependent on the presence of DNA binding transcriptional activators.	NICHD, NIH, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Stunkel, W (corresponding author), NICHD, NIH, Bldg 6,Rm 3A17, Bethesda, MD 20814 USA.	stunkelw@mail.nih.gov						ALMOUZNI G, 1990, EMBO J, V9, P573, DOI 10.1002/j.1460-2075.1990.tb08145.x; ALMOUZNI G, 1993, GENE DEV, V7, P2033, DOI 10.1101/gad.7.10.2033; Antequera F, 1999, CURR BIOL, V9, pR661, DOI 10.1016/S0960-9822(99)80418-7; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Feil R, 1997, AM J HUM GENET, V61, P1213, DOI 10.1086/301655; HARE JT, 1989, CELL BIOPHYS, V15, P29, DOI 10.1007/BF02991577; HARLAND RM, 1983, NATURE, V302, P38, DOI 10.1038/302038a0; Hsieh CL, 1999, MOL CELL BIOL, V19, P46; Hsieh CL, 2000, CURR OPIN GENET DEV, V10, P224, DOI 10.1016/S0959-437X(00)00064-2; HSIEH CL, 1992, EMBO J, V11, P315, DOI 10.1002/j.1460-2075.1992.tb05054.x; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Knox JD, 2000, J BIOL CHEM, V275, P17986, DOI 10.1074/jbc.C900894199; Kundu TK, 1999, J BIOCHEM, V125, P217, DOI 10.1093/oxfordjournals.jbchem.a022276; Leonhardt H, 1998, J CELL BIOCHEM, P243, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<243::AID-JCB30>3.0.CO;2-6; Li Q, 1999, EMBO J, V18, P5634, DOI 10.1093/emboj/18.20.5634; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; Matsuo K, 1998, EMBO J, V17, P1446, DOI 10.1093/emboj/17.5.1446; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Muller C, 2000, MOL CELL BIOL, V20, P3316, DOI 10.1128/MCB.20.9.3316-3329.2000; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Rein T, 1999, J BIOL CHEM, V274, P25792, DOI 10.1074/jbc.274.36.25792; Richardson B, 1999, J LAB CLIN MED, V134, P333, DOI 10.1016/S0022-2143(99)90147-6; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Song SH, 2000, INT J CANCER, V87, P236, DOI 10.1002/1097-0215(20000715)87:2<236::AID-IJC14>3.0.CO;2-M; Srivastava M, 2000, GENE DEV, V14, P1186; Tatematsu K, 2000, GENES CELLS, V5, P677, DOI 10.1046/j.1365-2443.2000.00359.x; Volkers N, 2000, J NATL CANCER I, V92, P789, DOI 10.1093/jnci/92.10.789; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; WANG JC, 1993, CURR OPIN GENET DEV, V3, P764, DOI 10.1016/S0959-437X(05)80096-6; Wolffe AP, 2000, CURR BIOL, V10, pR463, DOI 10.1016/S0960-9822(00)00534-0; Wolffe AP, 1999, P NATL ACAD SCI USA, V96, P5894, DOI 10.1073/pnas.96.11.5894	38	3	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20743	20749		10.1074/jbc.M010967200	http://dx.doi.org/10.1074/jbc.M010967200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278800	hybrid			2022-12-27	WOS:000169135100142
J	Wu, G; Vuletich, JL; Kulmacz, RJ; Osawa, Y; Tsai, AL				Wu, G; Vuletich, JL; Kulmacz, RJ; Osawa, Y; Tsai, AL			Peroxidase self-inactivation in prostaglandin H synthase-1 pretreated with cyclooxygenase inhibitors or substituted with mangano protoporphyrin IX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME PROSTHETIC GROUP; VESICULAR GLAND MICROSOMES; HIGHER OXIDATION-STATES; ENDOPEROXIDE SYNTHETASE; TYROSYL RADICALS; FATTY-ACIDS; BIOSYNTHESIS; HYDROPEROXIDASE; MECHANISM; MYOGLOBIN	Self-inactivation imposes an upper limit on bioactive prostanoid synthesis by prostaglandin H synthase (PGHS). Inactivation of PGHS peroxidase activity has been found to begin with Intermediate II, which contains a tyrosyl radical. The structure of this radical is altered by cyclooxygenase inhibitors, such as indomethacin and flurbiprofen, and by replacement of heme by manganese protoporphyrin IX (forming MnPGHS-1). Peroxidase self-inactivation in inhibitor-treated PGHS-1 and MnPGHS-1 was characterized by stopped-flow spectroscopic techniques and by chromatographic and mass spectrometric analysis of the metalloporphyrin. The rate of peroxidase inactivation was about 0.3 s(-1) in inhibitor-treated PGHS-1 and much slower in MnPGHS-1 (0.05 s(-1)); as with PGHS-1 itself, the peroxidase inactivation rates were independent of peroxide concentration and structure, consistent with an inactivation process beginning with Intermediate II. The changes in metalloporphyrin absorbance spectra during inactivation of inhibitor-treated PGHS-1 were similar to those observed with PGHS-1 but were rather distinct in MnPGHS-1; the kinetics of the spectral transition from Intermediate II to the next species were comparable to the inactivation kinetics in each case. In contrast to the situation with PGHS-1 itself, significant amounts of heme degradation occurred during inactivation of inhibitor-treated PGHS-1, producing iron chlorin and heme-protein adduct species. Structural perturbations at the peroxidase site (MnPGHS-1) or at the cyclooxygenase site (inhibitor-treated PGHS-1) thus can influence markedly the kinetics and the chemistry of PGHS-1 peroxidase inactivation.	Univ Texas, Hlth Sci Ctr, Dept Internal Med, Div Hematol, Houston, TX 77030 USA; Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan	Tsai, AL (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Internal Med, Div Hematol, POB 20708, Houston, TX 77225 USA.				NCI NIH HHS [CA165954] Funding Source: Medline; NIEHS NIH HHS [ES08365] Funding Source: Medline; NIGMS NIH HHS [GM44911, GM07767, GM52170] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052170] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN YNP, 1987, J BIOL CHEM, V262, P16892; CHEN YNP, 1989, FASEB J, V3, P2294, DOI 10.1096/fasebj.3.11.2506093; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; EGAN RW, 1976, J BIOL CHEM, V251, P7329; GRAFF G, 1990, ANAL BIOCHEM, V188, P38, DOI 10.1016/0003-2697(90)90525-E; HEMLER ME, 1980, J BIOL CHEM, V255, P6253; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; KARTHEIN R, 1988, EUR J BIOCHEM, V171, P313, DOI 10.1111/j.1432-1033.1988.tb13792.x; KULMACZ RJ, 1991, MOL PHARMACOL, V40, P833; KULMACZ RJ, 1990, BIOCHEMISTRY-US, V29, P8760, DOI 10.1021/bi00489a037; KULMACZ RJ, 1994, BIOCHEMISTRY-US, V33, P5428, DOI 10.1021/bi00184a011; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; KULMACZ RJ, 1989, J BIOL CHEM, V264, P14136; KULMACZ RJ, 1982, BIOCHEM BIOPH RES CO, V104, P758, DOI 10.1016/0006-291X(82)90702-1; Kulmacz RJ, 1987, PROSTAGLANDINS RELAT, P209; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARKEY CM, 1987, J BIOL CHEM, V262, P6266; MARSHALL PJ, 1987, J BIOL CHEM, V262, P3510; MIZUNO K, 1982, PROSTAGLANDINS, V23, P743; ODENWALLER R, 1992, J BIOL CHEM, V267, P13863; OGINO N, 1978, J BIOL CHEM, V253, P5061; OHKI S, 1979, J BIOL CHEM, V254, P829; Osawa Y, 1996, FREE RADICAL BIO MED, V21, P35, DOI 10.1016/0891-5849(95)02215-5; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; Shi WJ, 2000, BIOCHEMISTRY-US, V39, P4112, DOI 10.1021/bi992561c; SMITH WL, 1972, BIOCHEMISTRY-US, V11, P3276, DOI 10.1021/bi00767a024; STRIEDER S, 1992, J BIOL CHEM, V267, P13870; Sugiyama K, 1997, P NATL ACAD SCI USA, V94, P796, DOI 10.1073/pnas.94.3.796; TSAI AL, 1994, J BIOL CHEM, V269, P5085; TSAI AL, 1992, J BIOL CHEM, V267, P17753; Tsai AL, 1998, J BIOL CHEM, V273, P3888, DOI 10.1074/jbc.273.7.3888; Tsai AL, 1997, J BIOL CHEM, V272, P8885; TSAI AL, 1995, J BIOL CHEM, V270, P10503, DOI 10.1074/jbc.270.18.10503; Vuletich JL, 1998, ANAL BIOCHEM, V265, P375, DOI 10.1006/abio.1998.2926; Wu G, 1999, J BIOL CHEM, V274, P9231, DOI 10.1074/jbc.274.14.9231	36	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19879	19888		10.1074/jbc.M100628200	http://dx.doi.org/10.1074/jbc.M100628200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279106	hybrid			2022-12-27	WOS:000169135100028
J	Crosas, B; Cederlund, E; Torres, D; Jornvall, H; Farres, J; Pares, X				Crosas, B; Cederlund, E; Torres, D; Jornvall, H; Farres, J; Pares, X			A vertebrate aldo-keto reductase active with retinoids and ethanol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ALCOHOL-DEHYDROGENASE; SITE-DIRECTED MUTAGENESIS; OMEGA-HYDROXYFATTY ACIDS; MOUSE VAS-DEFERENS; CRYSTAL-STRUCTURE; DROSOPHILA-MELANOGASTER; SUBSTRATE-SPECIFICITY; ENZYMATIC-PROPERTIES; CDNA SEQUENCE; HUMAN STOMACH	Enzymes of the short chain and medium chain dehydrogenase/reductase families have been demonstrated to participate in the oxidoreduction of ethanol and retinoids. Mammals and amphibians contain, in the upper digestive tract mucosa, alcohol dehydrogenases of the medium chain dehydrogenase/reductase family, active with ethanol and retinol, In the present work, we searched for a similar enzyme in an avian species (Gallus domesticus), We found that chicken does not contain the homologous enzyme from the medium chain dehydrogenase/reductase family but an oxidoreductase from the aldo-keto reductase family, with retinal reductase and alcohol dehydrogenase activities, The amino acid sequence shows 66-69% residue identity with the aldose reductase and aldose reductase-like enzymes. Chicken aldo-keto reductase is a monomer of M-r 36,000 expressed in eye, tongue, and esophagus. The enzyme can oxidize aliphatic alcohols, such as ethanol, and it is very efficient in all-trans- and 9-cis-retinal reduction (k(cat)/K-m = 5,300 and 32,000 mM(-1).min(-1), respectively). This finding represents the inclusion of the aldo-keto reductase family, with the (alpha/beta)(8) barrel structure, into the scenario of retinoid metabolism and, therefore, of the regulation of vertebrate development and tissue differentiation.	Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Bellaterra, Barcelona, Spain; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Autonomous University of Barcelona; Karolinska Institutet	Pares, X (corresponding author), Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Bellaterra, Barcelona, Spain.		Farrés, Jaume/F-8648-2016; Pares, Xavier/K-8228-2017	Farrés, Jaume/0000-0001-9069-3987; Torres Navarro, Damaso/0000-0003-3272-6079; Pares, Xavier/0000-0002-5071-9465				ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Allali-Hassani A, 1998, FEBS LETT, V426, P362, DOI 10.1016/S0014-5793(98)00374-3; Altamirano MM, 2000, NATURE, V403, P617, DOI 10.1038/35001001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ang HL, 1996, ALCOHOL CLIN EXP RES, V20, P1050, DOI 10.1111/j.1530-0277.1996.tb01946.x; Bennett MJ, 1997, STRUCTURE, V5, P799, DOI 10.1016/S0969-2126(97)00234-7; BOHREN KM, 1992, J BIOL CHEM, V267, P20965; BOLEDA MD, 1993, ARCH BIOCHEM BIOPHYS, V307, P85, DOI 10.1006/abbi.1993.1564; BOLEDA MD, 1989, ARCH BIOCHEM BIOPHYS, V274, P74, DOI 10.1016/0003-9861(89)90416-5; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crosas B, 2000, J BIOL CHEM, V275, P25180, DOI 10.1074/jbc.M910040199; DEWINTER HL, 1995, BIOCHEMISTRY-US, V34, P8299, DOI 10.1021/bi00026a011; DONOHUE PJ, 1994, J BIOL CHEM, V269, P8604; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Duester G, 1999, BIOCHEM PHARMACOL, V58, P389, DOI 10.1016/S0006-2952(99)00065-9; ESTONIUS M, 1990, EUR J BIOCHEM, V194, P593, DOI 10.1111/j.1432-1033.1990.tb15657.x; FARRES J, 1994, EUR J BIOCHEM, V224, P549, DOI 10.1111/j.1432-1033.1994.00549.x; Fernandez MR, 1999, J BIOL CHEM, V274, P37869, DOI 10.1074/jbc.274.53.37869; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; GABBAY KH, 1975, ANNU REV MED, V26, P521, DOI 10.1146/annurev.me.26.020175.002513; GRIMSHAW CE, 1992, BIOCHEMISTRY-US, V31, P10139, DOI 10.1021/bi00157a001; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Hyndman DJ, 1998, BBA-GENE STRUCT EXPR, V1399, P198, DOI 10.1016/S0167-4781(98)00109-2; Hyndman DJ, 1997, J BIOL CHEM, V272, P13286, DOI 10.1074/jbc.272.20.13286; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; JORNVALL H, 1995, ALCOHOL ALCOHOLISM, V30, P153; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; JORNVALL H, 1981, P NATL ACAD SCI-BIOL, V78, P4226, DOI 10.1073/pnas.78.7.4226; JORNVALL H, 1994, MOL BASIS ALCOHOL US, P221; JULIA P, 1986, EXP EYE RES, V42, P305, DOI 10.1016/0014-4835(86)90023-0; JULIA P, 1987, EUR J BIOCHEM, V162, P179, DOI 10.1111/j.1432-1033.1987.tb10559.x; Kawamura M, 1999, BIOCHEM PHARMACOL, V58, P517, DOI 10.1016/S0006-2952(99)00121-5; Kedishvili NY, 1997, J BIOL CHEM, V272, P7494, DOI 10.1074/jbc.272.11.7494; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lefrancois-Martinez AM, 1999, J BIOL CHEM, V274, P32875, DOI 10.1074/jbc.274.46.32875; MORENO A, 1991, J BIOL CHEM, V266, P1128; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Nau H., 1999, RETINOIDS BIOCH MOL; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PAILHOUX EA, 1990, J BIOL CHEM, V265, P19932; PARES X, 1990, METHOD ENZYMOL, V189, P436; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peralba JM, 1999, J BIOL CHEM, V274, P26021, DOI 10.1074/jbc.274.37.26021; PETRASH JM, 1992, J BIOL CHEM, V267, P24833; Petrash JM, 1997, ADV EXP MED BIOL, V414, P465; Popescu G, 2000, BBA-PROTEIN STRUCT M, V1476, P43, DOI 10.1016/S0167-4838(99)00230-7; RONDEAU JM, 1992, NATURE, V355, P469, DOI 10.1038/355469a0; SCHWARTZ MF, 1976, EUR J BIOCHEM, V68, P159, DOI 10.1111/j.1432-1033.1976.tb10774.x; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Sporn M.B., 1994, RETINOIDS BIOL CHEM; Svensson S, 1999, J BIOL CHEM, V274, P29712, DOI 10.1074/jbc.274.42.29712; TARLE I, 1993, J BIOL CHEM, V268, P25687; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDERJAGT DL, 1992, J BIOL CHEM, V267, P4364; Varnai P, 1999, PROTEINS, V37, P218, DOI 10.1002/(SICI)1097-0134(19991101)37:2<218::AID-PROT7>3.0.CO;2-E; WERMUTH B, 1982, EUR J BIOCHEM, V127, P279, DOI 10.1111/j.1432-1033.1982.tb06867.x; WILSON DK, 1995, BIOCHEMISTRY-US, V34, P14323, DOI 10.1021/bi00044a009; WILSON DK, 1992, SCIENCE, V257, P458; WINBERG JO, 1982, BIOCHIM BIOPHYS ACTA, V704, P7, DOI 10.1016/0167-4838(82)90125-X; YANG ZN, 1994, ALCOHOL CLIN EXP RES, V18, P587, DOI 10.1111/j.1530-0277.1994.tb00914.x; Ye QL, 2000, PROTEINS, V38, P41, DOI 10.1002/(SICI)1097-0134(20000101)38:1<41::AID-PROT5>3.0.CO;2-M	63	30	30	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19132	19140		10.1074/jbc.M010478200	http://dx.doi.org/10.1074/jbc.M010478200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278684	hybrid			2022-12-27	WOS:000169091000068
J	Masuda, T; Goto, F; Yoshihara, T				Masuda, T; Goto, F; Yoshihara, T			A novel plant ferritin subunit from soybean that is related to a mechanism in iron release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; H-CHAIN; NODULE DEVELOPMENT; ESCHERICHIA-COLI; CORE FORMATION; PISUM-SATIVUM; BEAN-LEAVES; GENE; IDENTIFICATION; PURIFICATION	Ferritin is a multimeric iron storage protein composed of 24 subunits. Ferritin purified from dried soybean seed resolves into two peptides of 26.5 and 28 kDa. To date, the 26.5-kDa subunit has been supposed to be generated from the 28-kDa subunit by cleavage of the N-terminal region. We performed amino acid sequence analysis of the 28-kDa subunit and found that it had a different sequence from the 26.5-kDa subunit, thus rendering it novel among known soybean ferritins, We cloned a cDNA encoding this novel subunit from 10-day-old seedlings, each of which contained developed bifoliates, an epicotyl and a terminal bud. The 26.5-kDa subunit was found to be identical to that identified previously lacking the C-terminal 16 residues that correspond to the E helix of mammalian ferritin. However, the corresponding region in the 28-kDa soybean ferritin subunit identified in this study was not susceptible to cleavage. We present evidence that the two different ferritin subunits in soybean dry seeds show differential sensitivity to protease digestions and that the novel, uncleaved 28-kDa ferritin subunit appears to stabilize the ferritin shell by co-existing with the cleaved 26.5-kDa subunit. These data demonstrate that soybean ferritin is composed of at least two different subunits, which have cooperative functional roles in soybean seeds.	Cent Res Inst Elect Power Ind, Dept Biosci, Chiba 2701194, Japan	Central Research Institute of Electric Power Industry - Japan	Goto, F (corresponding author), Cent Res Inst Elect Power Ind, Dept Biosci, 1646 Abiko, Chiba 2701194, Japan.		Masuda, Taro/G-4276-2011	Masuda, Taro/0000-0002-5549-375X				ANDERSEN O, 1995, MOL MAR BIOL BIOTECH, V4, P164; AROSIO P, 1978, J BIOL CHEM, V253, P4451; Barcelo F, 1997, J INORG BIOCHEM, V66, P23, DOI 10.1016/S0162-0134(96)00155-9; Briat J. F., 1995, Iron nutrition in soils and plants. Proceedings of the Seventh International Symposium on Iron Nutrition and Interactions in Plants, Zaragoza, Spain, 27 June-2 July 1993., P265; CHASTEEN ND, 1982, J BIOL CHEM, V257, P7672; COLLAWN JF, 1984, COMP BIOCHEM PHYS B, V78, P653, DOI 10.1016/0305-0491(84)90113-5; DICKEY LF, 1988, J BIOL CHEM, V263, P3071; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Goto F, 1998, TRANSGENIC RES, V7, P173, DOI 10.1023/A:1008836812714; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; KIMATA Y, 1994, PLANT PHYSIOL, V104, P263, DOI 10.1104/pp.104.1.263; LAULHERE JP, 1993, BIOCHEM J, V290, P693, DOI 10.1042/bj2900693; LAULHERE JP, 1989, J BIOL CHEM, V264, P3629; LAULHERE JP, 1995, BIOMETALS, V9, P303; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; LESCURE AM, 1991, P NATL ACAD SCI USA, V88, P8222, DOI 10.1073/pnas.88.18.8222; LEVI S, 1988, J BIOL CHEM, V263, P18086; LEVI S, 1992, BIOCHEM J, V288, P591, DOI 10.1042/bj2880591; LEVI S, 1989, BIOCHEM J, V264, P381, DOI 10.1042/bj2640381; LOBREAUX S, 1991, BIOCHEM J, V274, P601, DOI 10.1042/bj2740601; LOBREAUX S, 1992, PLANT MOL BIOL, V19, P563, DOI 10.1007/BF00026783; LOBREAUX S, 1992, BIOCHEM J, V288, P931, DOI 10.1042/bj2880931; LUZZAGO A, 1989, EMBO J, V8, P569, DOI 10.1002/j.1460-2075.1989.tb03411.x; MERTZ JR, 1983, J BIOL CHEM, V258, P1719; NOKIHARA K, 1995, J BIOCHEM-TOKYO, V118, P895, DOI 10.1093/jb/118.5.895; PAQUES EP, 1980, EUR J BIOCHEM, V107, P447; Proudhon D, 1996, J MOL EVOL, V42, P325, DOI 10.1007/BF02337543; RAGLAND M, 1990, J BIOL CHEM, V265, P18339; RAGLAND M, 1993, PLANT MOL BIOL, V21, P555, DOI 10.1007/BF00028813; STEFANINI S, 1989, BIOCHEMISTRY-US, V28, P378, DOI 10.1021/bi00427a052; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; TREFFRY A, 1993, BIOCHEM J, V296, P721, DOI 10.1042/bj2960721; TRIKHA J, 1994, PROTEINS, V18, P107, DOI 10.1002/prot.340180204; VANDERMARK F, 1982, PLANTA, V156, P341, DOI 10.1007/BF00397472; VANDERMARK F, 1985, PLANT SCI, V39, P55, DOI 10.1016/0168-9452(85)90192-X; VANDERMARK F, 1983, BIOCHEM J, V214, P943, DOI 10.1042/bj2140943; VANDERMARK F, 1981, PLANTA, V153, P338, DOI 10.1007/BF00384252; VANWUYTSWINKEL O, 1995, BIOCHEM J, V305, P253, DOI 10.1042/bj3050253; Wardrop AJ, 1999, BIOCHEM J, V337, P523, DOI 10.1042/0264-6021:3370523; Wei JZ, 2000, J BIOL CHEM, V275, P17488, DOI 10.1074/jbc.M910334199; WICKS RE, 1993, BIOCHEM BIOPH RES CO, V192, P813, DOI 10.1006/bbrc.1993.1487; YABLONSKI MJ, 1992, BIOCHEMISTRY-US, V31, P9680, DOI 10.1021/bi00155a022	47	102	114	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19575	19579		10.1074/jbc.M011399200	http://dx.doi.org/10.1074/jbc.M011399200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278898	hybrid			2022-12-27	WOS:000169091000121
J	Chaves, SR; Blobel, G				Chaves, SR; Blobel, G			Nuclear import of Spo12p, a protein essential for meiosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; LOCALIZATION; TRANSPORT; YEAST; DISTINCT; RECOGNITION; RESISTANCE; RECEPTOR; PATHWAY; COMPLEX	In Saccharomyces cerevisiae, Spo12p is involved in mitosis and is essential for meiosis. We found that Spo12p is imported into the nucleus by the karyopherin Kap121p, A complex containing Spo12p and Kap121p was isolated from cytosol and was also reconstituted with recombinant proteins, indicating that this interaction is direct. Spo12p was mislocalized to the cytosol in pse1-1, a temperature-sensitive strain harboring a mutation of Kap121p, at the permissive temperature, confirming an essential role for Kap121p in Spo12p import. Spo12p was also mislocalized in a pse1-1/pse1-1 homozygous strain, suggesting it is imported via the same pathway in diploid cells. Furthermore, we found that pse1-1/pse1-1 shows a sporulation defect similar to that of spo12 Delta /spo12 Delta. In addition, we have characterized the Spo12p nuclear localization signal, mapped it to residues 76-130, and identified residues within this region that are important for nuclear localization signal function.	Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Blobel, G (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, 1230 York Ave, New York, NY 10021 USA.	blobel@rockvax.rockefeller.edu	Chaves, Susana R/H-8786-2013	Chaves, Susana R/0000-0002-6004-9872				Aerne BL, 1998, MOL BIOL CELL, V9, P945, DOI 10.1091/mbc.9.4.945; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Albertini M, 1998, J CELL BIOL, V143, P1447, DOI 10.1083/jcb.143.6.1447; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Delahodde A, 2001, MOL MICROBIOL, V39, P304, DOI 10.1046/j.1365-2958.2001.02182.x; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Gharahdaghi F, 1996, ANAL BIOCHEM, V233, P94, DOI 10.1006/abio.1996.0012; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Grether ME, 1999, MOL BIOL CELL, V10, P3689, DOI 10.1091/mbc.10.11.3689; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; KLAPHOLZ S, 1980, GENETICS, V96, P567; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; PARKES V, 1992, NUCLEIC ACIDS RES, V20, P5617, DOI 10.1093/nar/20.21.5617; Pemberton LF, 1999, J CELL BIOL, V145, P1407, DOI 10.1083/jcb.145.7.1407; Pemberton LF, 1997, J CELL BIOL, V139, P1645, DOI 10.1083/jcb.139.7.1645; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; Rosenblum JS, 1998, J CELL BIOL, V143, P887, DOI 10.1083/jcb.143.4.887; Rosenblum JS, 1997, J CELL BIOL, V139, P1655, DOI 10.1083/jcb.139.7.1655; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Seedorf M, 1997, P NATL ACAD SCI USA, V94, P8590, DOI 10.1073/pnas.94.16.8590; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; Titov AA, 1999, J CELL BIOL, V147, P235, DOI 10.1083/jcb.147.2.235; TOYN JH, 1993, GENETICS, V135, P963; Yoshida K, 2001, J CELL BIOL, V152, P729, DOI 10.1083/jcb.152.4.729	30	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17712	17717		10.1074/jbc.M010760200	http://dx.doi.org/10.1074/jbc.M010760200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278742	hybrid			2022-12-27	WOS:000168866500014
J	Lee, HJ; Lloyd, MD; Clifton, IJ; Harlos, K; Dubus, A; Baldwin, JE; Frere, JM; Schofield, CJ				Lee, HJ; Lloyd, MD; Clifton, IJ; Harlos, K; Dubus, A; Baldwin, JE; Frere, JM; Schofield, CJ			Alteration of the co-substrate selectivity of deacetoxycephalosporin C synthase - The role of arginine 258	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC MUTAGENESIS; ALPHA-KETOGLUTARATE; CHEMICAL RESCUE; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; SUBSTRATE-SPECIFICITY; BINDING-SITE; ENZYME; CEPHALOSPORIN; BIOSYNTHESIS; PURIFICATION	Deacetoxycephalosporin C synthase is an iron(II) 2-oxoglutaratedependent oxygenase that catalyzes the oxidative ring-expansion of penicillin N to deacetoxycephalosporin C, The wild-type enzyme is only able to efficiently utilize 2-oxoglutarate and 2-oxoadipate as a 2-oxoacid co-substrate, Mutation of arginine 258, the side chain of which forms an electrostatic interaction with the 5-carboxylate of the 2-oxoglutarate co-substrate, to a glutamine residue reduced activity to about 5% of the wild-type enzyme with 2-oxoglutarate, However, other aliphatic 2-oxoacids, which were not cosubstrates for the wild-type enzyme, were utilized by the R258Q mutant. These 2-oxoacids "rescued" catalytic activity to the level observed for the wild-type enzyme as judged by penicillin N and G conversion. These cosubstrates underwent oxidative decarboxylation as observed for 2-oxoglutarate in the normal reaction with the wild-type enzyme. Crystal structures of the iron(II)-2-oxo-3-methylbutanoate (1.5 Angstrom), and iron(II)-2-oxo-4-methylpentanoate (1.6 Angstrom) enzyme complexes were obtained, which reveal the molecular basis for this "chemical co-substrate rescue" and help to rationalize the co-substrate selectivity of 2-oxoglutaratedependent oxygenases.	Oxford Ctr Mol Sci, Oxford OX1 3QY, England; Dyson Perrins Lab, Oxford OX1 3QY, England; Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; Wellcome Trust Ctr Human Genet, Struct Biol Div, Oxford OX3 7BN, England; Oxford Ctr Mol Sci, Oxford OX3 7BN, England; Univ Liege, Inst Chim B6, CIP, Enzymol Lab, B-4000 Liege, Belgium	University of Oxford; University of Oxford; National Defense Medical Center; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Liege	Lloyd, MD (corresponding author), Oxford Ctr Mol Sci, S Parks Rd, Oxford OX1 3QY, England.	matthew.lloyd@chem.ox.ac.uk	Lloyd, Matthew/AAX-6048-2021	Lloyd, Matthew/0000-0002-4821-4361; Schofield, Christopher/0000-0002-0290-6565				Adlington RM, 1996, BIOORG MED CHEM LETT, V6, P2003, DOI 10.1016/0960-894X(96)00362-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALDWIN JE, 1988, NAT PROD REP, V5, P129, DOI 10.1039/np9880500129; BALDWIN JE, 1987, FEBS LETT, V214, P357, DOI 10.1016/0014-5793(87)80087-X; BALDWIN JE, 1992, CHEM BETA LACTAMS; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burzlaff NI, 1999, NATURE, V401, P721, DOI 10.1038/44400; Cooper R D, 1993, Bioorg Med Chem, V1, P1, DOI 10.1016/S0968-0896(00)82098-2; CORTES J, 1987, J GEN MICROBIOL, V133, P3165; Crouch NP, 1996, BIOORG MED CHEM LETT, V6, P1503, DOI 10.1016/S0960-894X(96)00257-0; Crouch NP, 1997, TETRAHEDRON, V53, P6993, DOI 10.1016/S0040-4020(97)00398-0; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; ELSON SW, 1987, J CHEM SOC CHEM COMM, P1736, DOI 10.1039/c39870001736; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FUKUMORI F, 1993, J BIOL CHEM, V268, P24311; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; Hayden BM, 1999, BIOCHEM J, V340, P555, DOI 10.1042/0264-6021:3400555; Huang SQ, 1997, BIOCHEMISTRY-US, V36, P14609, DOI 10.1021/bi9722554; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KUPKA J, 1983, CAN J MICROBIOL, V29, P488, DOI 10.1139/m83-078; Lee HJ, 2000, BIOCHEM BIOPH RES CO, V267, P445, DOI 10.1006/bbrc.1999.1957; Lee HJ, 2001, J MOL BIOL, V308, P937, DOI 10.1006/jmbi.2001.4649; LESLIE AGW, 1992, JOINT CCP4 ESF EAMBC, V26; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; Lloyd MD, 1999, J MOL BIOL, V287, P943, DOI 10.1006/jmbi.1999.2594; Loke P, 1998, FEMS MICROBIOL LETT, V164, P107; Loke P, 1998, FEMS MICROBIOL LETT, V165, P353, DOI 10.1111/j.1574-6968.1998.tb13169.x; MAJAMAA K, 1984, EUR J BIOCHEM, V138, P239, DOI 10.1111/j.1432-1033.1984.tb07907.x; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; NG SF, 1991, J BIOL CHEM, V266, P1526; Pearson MA, 1998, BIOCHEMISTRY-US, V37, P6214, DOI 10.1021/bi980021u; PRESCOTT AG, 1993, J EXP BOT, V44, P849, DOI 10.1093/jxb/44.5.849; Prescott AG, 2000, NAT PROD REP, V17, P367, DOI 10.1039/a902197c; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; Ryle MJ, 1999, BIOCHEMISTRY-US, V38, P15278, DOI 10.1021/bi9912746; Rynkiewicz MJ, 1996, BIOCHEMISTRY-US, V35, P16174, DOI 10.1021/bi961311i; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Serre L, 1999, STRUCTURE, V7, P977, DOI 10.1016/S0969-2126(99)80124-5; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; Viladot JL, 1998, BIOCHEMISTRY-US, V37, P11332, DOI 10.1021/bi980586q; Williams R.J.P., 1996, NATURAL SELECTION CH; XIAO XF, 1991, BIOCHEM J, V280, P471, DOI 10.1042/bj2800471; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127; Zhou J, 1998, J AM CHEM SOC, V120, P13539, DOI 10.1021/ja983534x	49	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18290	18295		10.1074/jbc.M100085200	http://dx.doi.org/10.1074/jbc.M100085200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279000	hybrid			2022-12-27	WOS:000168866500091
J	Diaz, JF; Kralicek, A; Mingorance, J; Palacios, JM; Vicente, M; Andreu, JM				Diaz, JF; Kralicek, A; Mingorance, J; Palacios, JM; Vicente, M; Andreu, JM			Activation of cell division protein FtsZ - Control of switch loop T3 conformation by the nucleotide gamma-phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATION; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TUBULIN DIMER; BETA-TUBULIN; BINDING; TRANSITION; GDP; MICROTUBULES	The effect of bound nucleotide on the conformation of cell division protein FtsZ from Methanococcus jannaschii has been investigated using molecular dynamics and site-directed mutagenesis, The molecular dynamics indicate that the gamma -phosphate of GTP induces a conformational perturbation in loop T3 (Gly(88)-Gly(99) segment), in a position structurally equivalent to switch II of Ha-ras-p21, In the simulated GTP-bound state, loop T3 is pulled by the gamma -phosphate into a more compact conformation than with GDP, related to that observed in the homologous proteins alpha- and beta -tubulin, The existence of a nucleotide-induced structural change in loop T3 has been confirmed by mutating Thr(92) into Trp (T92W-W319Y FtsZ), This tryptophan (12 Angstrom away from gamma -phosphate) shows large differences in fluorescence emission, depending on which nucleotide is bound to FtsZ monomers, Loop T3 is located at a side of the contact interface between two FtsZ monomers in the current model of FtsZ filament. Such a structural change may bend the GDP filament upon hydrolysis by pushing against helix HS of next monomer, thus, generating force on the membrane during cell division. A related curvature mechanism may operate in tubulin activation.	CSIC, Ctr Invest Biol, E-28006 Madrid, Spain; CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Diaz, JF (corresponding author), CSIC, Ctr Invest Biol, Velazquez 144, E-28006 Madrid, Spain.	fer@akilonia.cib.csic.es	Díaz, J. Fernando/U-3532-2017; Kralicek, Andrew/R-4391-2016; Díaz, J. Fernando/M-6853-2019; Mingorance, Jesus/B-7562-2009	Díaz, J. Fernando/0000-0003-2743-3319; Kralicek, Andrew/0000-0002-0432-565X; Díaz, J. Fernando/0000-0003-2743-3319; Mingorance, Jesus/0000-0001-6173-5711; Andreu, Jose M/0000-0001-8064-6933				ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; AMOS LA, 1974, J CELL SCI, V14, P523; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; CORREIA JJ, 1987, J BIOL CHEM, V262, P17278; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; dePereda JM, 1996, BIOCHEMISTRY-US, V35, P14203, DOI 10.1021/bi961357b; DIAZ JF, 1994, J MOL BIOL, V238, P214, DOI 10.1006/jmbi.1994.1282; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P2747, DOI 10.1021/bi00062a003; Diaz JF, 1997, PROTEINS, V28, P434; DIAZ JF, 1995, BIOCHEMISTRY-US, V34, P12038, DOI 10.1021/bi00037a047; Diaz JF, 1997, J BIOL CHEM, V272, P23138, DOI 10.1074/jbc.272.37.23138; Diaz JF, 2000, PROTEIN SCI, V9, P361; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Erickson HP, 2000, J CELL BIOL, V148, P1103, DOI 10.1083/jcb.148.6.1103; FUSI P, 1997, PROTEIN-STRUCT FUNCT, V25, P381; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRUGER P, 1991, COMPUT PHYS COMMUN, V62, P371, DOI 10.1016/0010-4655(91)90108-W; Kuppens S, 1999, PROTEIN SCI, V8, P1860, DOI 10.1110/ps.8.9.1860; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKOWICZ JR, 1984, PRINCIPLES FLUORESCE, P341; LEE JC, 1975, BIOCHEMISTRY-US, V14, P5183, DOI 10.1021/bi00694a025; LEE JC, 1977, BIOCHEMISTRY-US, V16, P1754, DOI 10.1021/bi00627a037; LEVITT M, 1969, J MOL BIOL, V46, P269, DOI 10.1016/0022-2836(69)90421-5; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Lowe J, 1998, J STRUCT BIOL, V124, P235, DOI 10.1006/jsbi.1998.4041; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; MADIGAN MT, 1997, BROCK BIOL MICROORGA, P741; Margolin W, 2000, CURR BIOL, V10, pR328, DOI 10.1016/S0960-9822(00)00458-9; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; Minton A.P., 1994, MODERN ANAL ULTRACEN, P81; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Pace C. N., 1997, PROTEIN STRUCTURE PR, P253; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SAGE CR, 1995, BIOCHEMISTRY-US, V34, P7409, DOI 10.1021/bi00022a014; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Sillen A, 2000, PROTEIN SCI, V9, P158; TONG L, 1991, J MOL BIOL, V217, P503, DOI 10.1016/0022-2836(91)90753-S; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; VANGUNSTEREN WF, 1997, BIOMOLECULAR SIMULAT; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6	58	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17307	17315		10.1074/jbc.M010920200	http://dx.doi.org/10.1074/jbc.M010920200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278786	hybrid, Green Published			2022-12-27	WOS:000168730400095
J	Gu, Y; Jia, BQ; Yang, FC; D'Souza, M; Harris, CE; Derrow, CW; Zheng, Y; Williams, DA				Gu, Y; Jia, BQ; Yang, FC; D'Souza, M; Harris, CE; Derrow, CW; Zheng, Y; Williams, DA			Biochemical and biological characterization of a human Rac2 GTPase mutant associated with phagocytic immunodeficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL NADPH OXIDASE; CELL-CYCLE PROGRESSION; BINDING-PROTEIN; ACTIN CYTOSKELETON; GENE-TRANSFER; RHO-FAMILY; HEMATOPOIETIC-CELLS; CDC42 GTPASES; HOST-DEFENSE; MAST-CELLS	The Rho GTPase, Rac2, is expressed only in hematopoietic cell lineages, suggesting a specific cellular function in these cells. Genetic targeting studies in mice showed that Rac2 is an essential regulator of neutrophil chemotaxis, L-selectin capture and rolling, and superoxide production. Recently, a dominant negative mutation of Rac2, D57N, has been reported to be associated with a human phagocytic immunodeficiency. To understand further the cellular phenotypes associated with this D57N Rac2 mutant we examined its biochemical characteristics and functional effects when expressed in primary murine bone marrow cells. When compared with wild type (WT) Rac2, D57N Rac2 displayed similar to 10% GTP binding ability resulting from a markedly enhanced rate of GTP dissociation and did not respond to the guanine nucleotide exchange factors. These results suggest that D57N Rac2 may act in a dominant negative fashion in cells by sequestering endogenous guanine nucleotide exchange factors, When expressed in hematopoietic cells, D57N Rac2 reduced endogenous activities of not only Rac2, but also Rad and decreased cell expansion in vitro in the presence of growth factors due to increased cell apoptosis, Unexpectedly, D57N expression had no effect on proliferation. In contrast, expansion of cells transduced with WT Rac2 and a dominant active mutant, Q61L, was associated with significantly increased proliferation. Transplantation of transduced bone marrow cells into lethally irradiated recipients showed that the percentage of D57N-containing peripheral blood cells decreased markedly from 40% at 1 month to <5% by 3 months postinjection. Neutrophils derived in vitro from the transduced progenitor cells containing D57N demonstrated markedly impaired migration and O-2(-) responses to formyl-methionyl-leucyl-phenylalanine, reflecting the same cellular phenotype in these differentiated cells as those described previously in patient cells. These data suggest that the phenotypic abnormalities associated with D57N Rac2 may involve not only neutrophil cellular functions, but also abnormal cell survival in other hematopoietic cells and that overexpression of Rac leads to increased proliferation of normal cells in vitro, whereas deficiency of Rac leads to increased apoptosis.	Indiana Univ, Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; Univ Tennessee, Dept Biochem, Memphis, TN 38163 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Tennessee System; University of Tennessee Health Science Center	Williams, DA (corresponding author), Howard Hughes Med Inst, 1044 W Walnut St,Rm 402, Indianapolis, IN 46202 USA.		Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	NIGMS NIH HHS [GM60523] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060523] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABO A, 1992, J BIOL CHEM, V267, P16767; ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Allen WE, 1997, J CELL SCI, V110, P707; Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BENGTSSON T, 1990, P NATL ACAD SCI USA, V87, P2921, DOI 10.1073/pnas.87.8.2921; Bjorgvinsdottir H, 1997, BLOOD, V89, P41, DOI 10.1182/blood.V89.1.41.41_41_48; BOKOCH GM, 1993, FASEB J, V7, P750, DOI 10.1096/fasebj.7.9.8330683; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CHUANG TH, 1994, BIOCHEM J, V303, P761, DOI 10.1042/bj3030761; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Dorseuil O, 1996, J BIOL CHEM, V271, P83, DOI 10.1074/jbc.271.1.83; FELTS K, 1999, STRATEGIES NEWSLETTE, V12, P74; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; JUNG V, 1994, MOL CELL BIOL, V14, P3707, DOI 10.1128/MCB.14.6.3707; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; KRECK ML, 1994, J BIOL CHEM, V269, P4161; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; MENARD L, 1992, EUR J BIOCHEM, V206, P537, DOI 10.1111/j.1432-1033.1992.tb16957.x; MOLL J, 1991, ONCOGENE, V6, P863; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; REIBEL L, 1991, BIOCHEM BIOPH RES CO, V175, P451, DOI 10.1016/0006-291X(91)91585-Z; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Seipel K, 1999, J CELL SCI, V112, P1825; SHIRSAT NV, 1990, ONCOGENE, V5, P769; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Williams DA, 2000, HUM GENE THER, V11, P2059, DOI 10.1089/104303400750001372; Williams DA, 2000, BLOOD, V96, P1646; Xu XM, 1997, BIOCHEMISTRY-US, V36, P626, DOI 10.1021/bi962059h; XU XM, 1994, J BIOL CHEM, V269, P23569; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1; YEE NS, 1994, J EXP MED, V179, P1777, DOI 10.1084/jem.179.6.1777; Zhu KJ, 2000, J BIOL CHEM, V275, P25993, DOI 10.1074/jbc.M003780200	47	78	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15929	15938		10.1074/jbc.M010445200	http://dx.doi.org/10.1074/jbc.M010445200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278678	hybrid			2022-12-27	WOS:000168623100050
J	McDonald, ER; Chui, PC; Martelli, PF; Dicker, DT; El-Deiry, WS				McDonald, ER; Chui, PC; Martelli, PF; Dicker, DT; El-Deiry, WS			Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FADD-DEPENDENT APOPTOSIS; TRAIL-INDUCED APOPTOSIS; NF-KAPPA-B; DECOY RECEPTOR; CELL-DEATH; GENE; LIGAND; FAS; CASPASE-8; FAMILY	The Fas/tumor necrosis factor (TNF)/TRAIL receptors signal death through a cytoplasmic death domain (DD) containing six alpha -helices with positively charged helix 2 interacting with negatively charged helix 3 of another DD, DD mutation occurs in head/neck and lung cancer (TRAIL receptor KILLER/DR5) and in Epr mice (Fas). We examined the apoptotic potential of known KILLER DR5 lung tumor-derived mutants (n = 6) and DD mutants (n = 18) generated based on conservation with DR4, Fas, Fas-associated death domain (FADD), and tumor necrosis factor receptor 1 (TNFR1), With the exception of Arg-330 required in Fas or FADD for aggregation or for TNFR1 cytotoxicity, surprisingly major loss-of-function KILLER/DR5 alleles (W325A, L334A (Epr-like), I339A, and W360A) contained hydrophobic residues. Loss-of function of I339A (highly conserved) has not been reported in DDs. Charged residue mutagenesis revealed the following points. 1) E326A, conserved in DR4, is dispensable for death; the homologous residue is positively charged in Fas, TNFR1, and FADD and is critical for DD interactions, 2) K331A, D336A, E338A, K340A, K343A, and D351A have partial loss-of-function suggesting multiple charges stabilize receptor-adapter interactions. Analysis of the tumor-derived KILLER/DR5 mutants revealed the following. 1) L334F has partial loss-of-function versus L334A, whereas E338K has major loss-of-function versus E338A, examples where alanine and tumor-specific substitutions have divergent phenotypes. 2) Unexpectedly, S324F, E326K, K386N, and D407Y have no loss-of-function with tumor-specific or alanine substitutions. Loss-of-function KILLER/DR5 mutants were deficient in recruitment of FADD and caspase 8 to TRAIL death-inducing signaling complexes. The results reveal determinants within KILLER/DR5 for death signaling and drug design.	Univ Penn, Sch Med, Dept Med,Lab Mol Oncol & Cell Cycle Regulat, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Canc, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	El-Deiry, WS (corresponding author), Univ Penn, Sch Med, Dept Med,Lab Mol Oncol & Cell Cycle Regulat, Howard Hughes Med Inst, 415 Curie Blvd, Philadelphia, PA 19104 USA.	wafik@mail.med.upenn.edu	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266	NCI NIH HHS [CA75454, CA75138] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075454, P01CA075138] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; Kim KH, 2000, CLIN CANCER RES, V6, P335; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lee SH, 1999, CANCER RES, V59, P5683; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Meng RD, 2000, MOL THER, V1, P130, DOI 10.1006/mthe.2000.0025; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Ozoren N, 2000, INT J ONCOL, V16, P917; Pai SI, 1998, CANCER RES, V58, P3513; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1998, FEBS LETT, V424, P41, DOI 10.1016/S0014-5793(98)00135-5; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Schneider P, 1997, FEBS LETT, V416, P329, DOI 10.1016/S0014-5793(97)01231-3; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Sheikh MS, 1999, ONCOGENE, V18, P4153, DOI 10.1038/sj.onc.1202763; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Zhang XD, 1999, CANCER RES, V59, P2747	44	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14939	14945		10.1074/jbc.M100399200	http://dx.doi.org/10.1074/jbc.M100399200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279061	hybrid			2022-12-27	WOS:000168528800057
J	Tierney, MJ; Medcalf, RL				Tierney, MJ; Medcalf, RL			Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region - Sequence homology to coding region instability determinants in other mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYC MESSENGER-RNA; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL GROWTH-FACTOR; BINDING-PROTEIN; PHORBOL ESTER; MESOTHELIOMA CELLS; RESPONSIVE GENES; DOWN-REGULATION; LYMPHOMA-CELLS; C-FOS	Plasminogen activator inhibitor type 2 (PAI-2) is a serine protease inhibitor that inhibits urokinase. Constitutive and regulated PAI-2 gene expression involves post-transcriptional events, and an AU-rich mRNA instability motif within the 3'-untranslated region of PAI-2 mRNA is required for this process (Maurer, F., Tierney, M., and Medcalf, R. L. (1999) Nucleic Acids Res. 27, 1664-1673). Here we show that instability determinants are present within various exons of the PAI-2 coding region, most notably within exon 4. Deletion of exon 4 from the full-length PAI-2 cDNA results in a doubling in the half-life of PAI-2 mRNA, whereas a 28-nucleotide region within exon 4 contains binding sites for cytoplasmic proteins. Inducible stabilization of PAI-2 mRNA in HT-1080 cells treated with phorbol ester and tumor necrosis factor does not alter the binding of proteins to the exon 4 instability determinant, but resulted in a transient increase in the binding of factors to the AU-rich RNA instability element. Hence, PAI-2 mRNA stability is influenced by elements located within both the coding region and the S'-untranslated region and that cytoplasmic mRNA binding factors may influence steady state and inducible PAI-2 mRNA expression. Finally a 10-nucleotide region flanking the exon 4 protein-binding site is homologous to instability elements within five other transcripts, suggesting that a common coding region determinant may exist.	Monash Univ, Box Hill Hosp, Dept Med, Box Hill, Vic 3128, Australia	Box Hill Hospital; Monash University	Medcalf, RL (corresponding author), Monash Univ, Box Hill Hosp, Dept Med, Box Hill, Vic 3128, Australia.		Medcalf, Robert L/E-9632-2011					ALONSO S, 1983, J MOL EVOL, V167, P77; Antalis TM, 1996, BLOOD, V88, P3686, DOI 10.1182/blood.V88.10.3686.bloodjournal88103686; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; CAPONIGRO G, 1993, MOL CELL BIOL, V13, P5141, DOI 10.1128/MCB.13.9.5141; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLEN D, 1995, THROMB HAEMOSTASIS, V74, P167; Costa M, 1996, EUR J BIOCHEM, V237, P532, DOI 10.1111/j.1432-1033.1996.00532.x; Coulis CM, 2000, MOL PHARMACOL, V57, P485, DOI 10.1124/mol.57.3.485; Dear AE, 1996, EUR J BIOCHEM, V241, P93, DOI 10.1111/j.1432-1033.1996.0093t.x; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; Dickinson JL, 1998, CELL DEATH DIFFER, V5, P163, DOI 10.1038/sj.cdd.4400324; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; GAY DA, 1987, CELL, V50, P671, DOI 10.1016/0092-8674(87)90325-4; GENTON C, 1987, J CELL BIOL, V104, P705, DOI 10.1083/jcb.104.3.705; HARLAND R, 1988, DEVELOPMENT, V102, P837; Hennigan AN, 1996, MOL CELL BIOL, V16, P3833; Hibino T, 1999, J INVEST DERMATOL, V112, P85, DOI 10.1046/j.1523-1747.1999.00466.x; Ioannidis P, 1996, NUCLEIC ACIDS RES, V24, P4969, DOI 10.1093/nar/24.24.4969; JENSEN PJ, 1995, EXP CELL RES, V217, P65, DOI 10.1006/excr.1995.1064; KABNICK KS, 1988, MOL CELL BIOL, V8, P3244, DOI 10.1128/MCB.8.8.3244; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Maurer F, 1999, NUCLEIC ACIDS RES, V27, P1664, DOI 10.1093/nar/27.7.1664; Maurer F, 1996, J BIOL CHEM, V271, P26074, DOI 10.1074/jbc.271.42.26074; MEDCALF RL, 1986, EMBO J, V5, P2217, DOI 10.1002/j.1460-2075.1986.tb04487.x; MEDCALF RL, 1992, J BIOL CHEM, V267, P12220; MEDCALF RL, 1988, J EXP MED, V168, P751, DOI 10.1084/jem.168.2.751; PARKER R, 1990, P NATL ACAD SCI USA, V87, P2780, DOI 10.1073/pnas.87.7.2780; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; PYTEL BA, 1990, J CELL PHYSIOL, V144, P416, DOI 10.1002/jcp.1041440308; SAMBROOK J, 1989, MOL CLONING LABORATO, V2, P16; SCHLEUNING WD, 1987, MOL CELL BIOL, V7, P4564, DOI 10.1128/MCB.7.12.4564; SCHWARTZ BS, 1988, BLOOD, V71, P734; Shafren DR, 1999, J VIROL, V73, P7193, DOI 10.1128/JVI.73.9.7193-7198.1999; Shetty S, 1998, ARCH BIOCHEM BIOPHYS, V356, P265, DOI 10.1006/abbi.1998.0789; Shetty S, 1997, MOL CELL BIOL, V17, P1075, DOI 10.1128/MCB.17.3.1075; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; Suzuki T, 2000, BLOOD, V96, P2584; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; Yang JH, 1999, BIOCHEM BIOPH RES CO, V257, P259, DOI 10.1006/bbrc.1999.0451; Yeilding NM, 1997, MOL CELL BIOL, V17, P2698, DOI 10.1128/MCB.17.5.2698; Yeilding NM, 1996, MOL CELL BIOL, V16, P3511; YEN TJ, 1988, MOL CELL BIOL, V8, P1224, DOI 10.1128/MCB.8.3.1224	45	52	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13675	13684		10.1074/jbc.M010627200	http://dx.doi.org/10.1074/jbc.M010627200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278713	hybrid			2022-12-27	WOS:000168356600025
J	Hashimoto, M; Donald, CD; Yannone, SM; Chen, DJ; Roy, R; Kow, YW				Hashimoto, M; Donald, CD; Yannone, SM; Chen, DJ; Roy, R; Kow, YW			A possible role of Ku in mediating sequential repair of closely opposed lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLY DAMAGED SITES; COLI ENDONUCLEASE-III; ESCHERICHIA-COLI; IONIZING-RADIATION; DNA-DAMAGE; PROTEIN; COMPLEX; IDENTIFICATION; MECHANISM; EXCISION	One of the hallmarks of ionizing radiation exposure is the formation of clustered damage that includes closely opposed lesions. We show that the Ku70/80 complex (Ku) has a role in the repair of closely opposed lesions in DNA. DNA containing a dihydrouracil (DHU) close to an opposing single strand break was used as a model substrate. It was found that gu has no effect on the enzymatic activity of human endonuclease III when the substrate DNA contains only DHU, However, with DNA containing a DHU that is closely opposed to a single strand break, Ku inhibited the nicking activity of human endonuclease III as well as the amount of free double strand breaks induced by the enzyme, The inhibition on the formation of a free double strand break by Ku was found to be much greater than the inhibition of human endonuclease III-nicking activity by Ku, Furthermore, there was a concomitant increase in the formation of Ku-DNA complexes when endonuclease III was present. Similar results were also observed with Escherichia coli endonuclease III. These results suggest that Ku reduces the formation of endonuclease III-induced free double strand breaks by sequestering the double strand breaks formed as a Ku-DNA complex. In doing so, Ku helps to avoid the formation of the intermediary free double strand breaks, possibly helping to reduce the mutagenic event that might result from the misjoining of frank double strand breaks.	Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30335 USA; Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	Emory University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Texas System; University of Texas Medical Branch Galveston	Kow, YW (corresponding author), Emory Univ, Sch Med, Dept Radiat Biol, Div Canc Biol, 145 Edgewood Ave, Atlanta, GA 30335 USA.	ykow@emory.edu	Yannone, Steven/G-1927-2011; Yannone, Steven/ABA-3524-2021		NATIONAL CANCER INSTITUTE [R01CA050519, R37CA050519, R01CA080917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037216, R01GM054163] Funding Source: NIH RePORTER; NCI NIH HHS [CA50519, CA80917] Funding Source: Medline; NIGMS NIH HHS [GM37216, GM 54163] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASAHARA H, 1989, BIOCHEMISTRY-US, V28, P4444, DOI 10.1021/bi00436a048; BLIER PR, 1993, J BIOL CHEM, V268, P7594; Bliss TM, 1997, J BIOL CHEM, V272, P5765, DOI 10.1074/jbc.272.9.5765; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; Bourdat AG, 1999, NUCLEIC ACIDS RES, V27, P1015, DOI 10.1093/nar/27.4.1015; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; CHAUDHRY MA, 1995, J MOL BIOL, V249, P914; Chen FQ, 1996, MUTAT RES-DNA REPAIR, V362, P9, DOI 10.1016/0921-8777(95)00026-7; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; David-Cordonnier MH, 2000, J BIOL CHEM, V275, P11865, DOI 10.1074/jbc.275.16.11865; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; FREIDBERG EC, 1995, DNA REPAIR MUTAGENES; Frit P, 1998, J MOL BIOL, V284, P963, DOI 10.1006/jmbi.1998.2257; HALL EJ, 1994, RADIOBIOLOGY RADIOBI, P17; Harrison L, 1998, NUCLEIC ACIDS RES, V26, P932, DOI 10.1093/nar/26.4.932; Huttermann J., 1978, EFFECTS IONIZING RAD; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; KOW YW, 1987, BIOCHEMISTRY-US, V26, P8200, DOI 10.1021/bi00399a027; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; RATHMELL WK, 1994, P NATL ACAD SCI USA, V91, P7623, DOI 10.1073/pnas.91.16.7623; Rathmell WK, 1998, CONT CANC RES, P299; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Sutherland BM, 2000, BIOCHEMISTRY-US, V39, P8026, DOI 10.1021/bi9927989; TAKESHITA M, 1987, J BIOL CHEM, V262, P10171; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; WARD JF, 1981, RADIAT RES, V86, P185, DOI 10.2307/3575500; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; YAO M, 1995, J BIOL CHEM, V270, P28609, DOI 10.1074/jbc.270.48.28609	30	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12827	12831		10.1074/jbc.M010906200	http://dx.doi.org/10.1074/jbc.M010906200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278783	hybrid			2022-12-27	WOS:000168198600052
J	Shakibaei, M; Schulze-Tanzil, G; de Souza, P; John, T; Rahmanzadeh, M; Rahmanzadeh, R; Merker, HJ				Shakibaei, M; Schulze-Tanzil, G; de Souza, P; John, T; Rahmanzadeh, M; Rahmanzadeh, R; Merker, HJ			Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE; (ADP-RIBOSE)N BIOSYNTHESIS; SIGNAL-TRANSDUCTION; CYTOCHROME-C; DNA-REPAIR; EXPRESSION; GROWTH; DEATH; CELLS; DIFFERENTIATION	We previously have reported that the mitogen-activated protein kinase (MAPK) pathway is stimulated by adhesion of human chondrocytes to anti-beta (1)-integrin antibodies or collagen type II in vitro. These mechanisms most likely prevent chondrocyte dedifferentiation to fibroblast-like cells and chondrocyte death. To investigate whether this pathway plays an essential role for the differentiation, phenotype, and survival of chondrocytes, we blocked mitogen-activated protein kinase/extracellular signal-regulated kinase (Erk) (MEK), a kinase upstream of the kinase Erk by using U0126, Exposure of chondrocytes to U0126 caused activation of caspase-3 in a dose-dependent manner, Western blot analysis with an antibody specific for dually phosphorylated Erk shows that collagen type II induced phosphorylation of Erkl/2 was specifically blocked by U0126 in a dose-dependent manner. Immunohistochemical analysis showed that treated chondrocytes were caspase-3 positive. In treated chondrocytes, the cleavage of 116-kDa poly(ADP-ribose)polymerase resulted in the 85-kDa apoptosis-related cleavage fragment and was associated with caspase-3 activity, Analysis by electron microscopy showed typical morphological signs of apoptosis, such as crescent-shaped clumps of heterochromatin, and a degraded' pericellular matrix. Thus, these results indicate that the MEK/Erk signal transduction pathway is involved in the maintenance of chondrocytes differentiation and survival. These data stimulate further investigations on the role of mitogen-activated protein kinase pathways in human chondrocytes.	Free Univ Berlin, Inst Anat, D-14195 Berlin, Germany; Free Univ Berlin, Dept Trauma Surg, Med Ctr Benjamin Franklin, D-12200 Berlin, Germany; Charite, Trauma & Reconstruct Surg, D-13353 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Shakibaei, M (corresponding author), Free Univ Berlin, Inst Anat, Konigin Luise Str 15, D-14195 Berlin, Germany.		Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020; de Souza, Paul/P-5069-2019	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; 				BIANCO FJ, 1995, AM J PATHOL, V146, P75; Blanco FJ, 1998, ARTHRITIS RHEUM, V41, P284, DOI 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; Cao L, 1999, MATRIX BIOL, V18, P343, DOI 10.1016/S0945-053X(99)00027-X; CHEN QM, 1994, J BIOL CHEM, V269, P26602; Chen Y, 1998, J BIOL CHEM, V273, P19809, DOI 10.1074/jbc.273.31.19809; DURKACZ BW, 1981, EUR J BIOCHEM, V121, P65, DOI 10.1111/j.1432-1033.1981.tb06430.x; DURKACZ BW, 1981, BIOCHEM BIOPH RES CO, V101, P1433, DOI 10.1016/0006-291X(81)91607-7; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; FARNUM CE, 1989, J ORTHOPAED RES, V7, P654, DOI 10.1002/jor.1100070505; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gebauer G, 1999, J CELL BIOCHEM, V75, P547, DOI 10.1002/(SICI)1097-4644(19991215)75:4<547::AID-JCB1>3.3.CO;2-X; Hashimoto S, 1997, ARTHRITIS RHEUM-US, V40, P1749, DOI 10.1002/art.1780401004; Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357; Horton WE, 1998, MATRIX BIOL, V17, P107, DOI 10.1016/S0945-053X(98)90024-5; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kim HA, 1999, ARTHRITIS RHEUM, V42, P1528, DOI 10.1002/1529-0131(199907)42:7<1528::AID-ANR28>3.0.CO;2-9; Kim HA, 2000, J RHEUMATOL, V27, P455; Lee KKH, 1999, DEV BIOL, V207, P14; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; Manni A, 1997, INT J CANCER, V70, P175, DOI 10.1002/(SICI)1097-0215(19970117)70:2<175::AID-IJC7>3.3.CO;2-D; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; MORINO N, 1995, J BIOL CHEM, V270, P269, DOI 10.1074/jbc.270.1.269; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; ROACH HI, 1995, J CELL BIOL, V131, P483, DOI 10.1083/jcb.131.2.483; Rosenthal DS, 1997, EXP CELL RES, V232, P313, DOI 10.1006/excr.1997.3536; Samali A, 1998, FEBS LETT, V431, P167, DOI 10.1016/S0014-5793(98)00740-6; Shah GM, 1996, BIOCHEM BIOPH RES CO, V229, P838, DOI 10.1006/bbrc.1996.1889; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; Shakibaei M, 1997, CELL BIOL INT, V21, P75, DOI 10.1006/cbir.1996.0119; Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615; Simbulan-Rosenthal CM, 1998, BIOCHEMISTRY-US, V37, P9363, DOI 10.1021/bi9731089; STADLER J, 1991, J IMMUNOL, V147, P3915; Svoboda KKH, 1998, MICROSC RES TECHNIQ, V43, P111, DOI 10.1002/(SICI)1097-0029(19981015)43:2<111::AID-JEMT4>3.0.CO;2-O; TANAKA Y, 1984, J BIOL CHEM, V259, P6579; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Wang FL, 2000, OSTEOARTHR CARTILAGE, V8, P161, DOI 10.1053/joca.1999.0295; YAMAMOTO H, 1981, NATURE, V294, P284, DOI 10.1038/294284a0; Yang CL, 1997, EXP CELL RES, V235, P370, DOI 10.1006/excr.1997.3692; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhai DY, 2000, FEBS LETT, V472, P293, DOI 10.1016/S0014-5793(00)01471-X; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536	45	131	133	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13289	13294		10.1074/jbc.M010859200	http://dx.doi.org/10.1074/jbc.M010859200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278768	hybrid			2022-12-27	WOS:000168198600113
J	Ardley, HC; Tan, NGS; Rose, SA; Markham, AF; Robinson, PA				Ardley, HC; Tan, NGS; Rose, SA; Markham, AF; Robinson, PA			Features of the Parkin/ariadne-like ubiquitin ligase, HHARI, that regulate its interaction with the ubiquitin-conjugating enzyme, UbcH7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; GROWTH-FACTOR RECEPTOR; RING FINGER PROTEINS; C-CBL; GENE; FAMILY; PARKIN; LOCALIZATION; DOMAIN; APC11	We recently reported the identification of a RING finger-containing protein, HHARI (human homologue of Drosophiba ariadne), which binds to the human ubiquitin-conjugating enzyme UbcH7 in vitro, We now demonstrate that HHARI interacts and co-localizes with UbcH7 in mammalian cells, particularly in the perinuclear region, We have further defined a minimal interaction region of HHARI comprising residues 186-254, identified individual amino acid residues essential for the interaction, and determined that the distance between the RING1 finger and IBR (in between RING fingers) domains is critical to maintaining binding. We have also established that the RING1 finger of HHARI cannot be substituted for by the highly homologous RING finger domains of either of the ubiquitin-protein ligase components c-CBL or Parkin, despite their similarity in structure and their independent capabilities to bind UbcH7, Furthermore, mutation of the RING1 finger domain of HHARI from a RING-HC to a RING-HP type abolishes interaction with UbcH7. These studies demonstrate that very subtle changes to the domains that regulate recognition between highly conserved components of the ubiquitin pathway can dramatically affect their ability to interact.	Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, St Jamess Univ Hosp, Leeds Dent Inst, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds	Ardley, HC (corresponding author), Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Level 6,Clin Sci Bldg, Leeds LS9 7TF, W Yorkshire, England.	rmrhca@stjames.leeds.ac.uk						Aguilera M, 2000, GENETICS, V155, P1231; Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Ardley HC, 1997, CYTOGENET CELL GENET, V79, P188, DOI 10.1159/000134717; Ardley HC, 2000, BBA-GENE STRUCT EXPR, V1491, P57, DOI 10.1016/S0167-4781(00)00024-5; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kahle PJ, 2000, TRENDS BIOCHEM SCI, V25, P524, DOI 10.1016/S0968-0004(00)01682-0; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Martinez-Noel G, 1999, FEBS LETT, V454, P257, DOI 10.1016/S0014-5793(99)00823-6; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Morett E, 1999, TRENDS BIOCHEM SCI, V24, P229, DOI 10.1016/S0968-0004(99)01381-X; Moynihan TP, 1998, GENOMICS, V51, P124, DOI 10.1006/geno.1998.5257; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Moynihan TP, 1999, MAMM GENOME, V10, P977, DOI 10.1007/s003359901143; OH CE, 1994, J NEUROSCI, V14, P3166; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Orian A, 1999, MOL CELL BIOL, V19, P3664; Rivett AJ, 1998, CURR OPIN IMMUNOL, V10, P110, DOI 10.1016/S0952-7915(98)80040-X; ROBINSON PA, 1995, MAMM GENOME, V6, P725, DOI 10.1007/BF00354295; Scheffner M., 1998, UBIQUITIN BIOL CELL, P65; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Torii KU, 1999, J BIOL CHEM, V274, P27674, DOI 10.1074/jbc.274.39.27674; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; VANDERREIJDEN BA, 1998, BLOOD S1, V92; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Yin XY, 1999, ONCOGENE, V18, P6621, DOI 10.1038/sj.onc.1203097; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	48	68	70	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19640	19647		10.1074/jbc.M011028200	http://dx.doi.org/10.1074/jbc.M011028200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278816	hybrid			2022-12-27	WOS:000169091000130
J	Cavelier, LB; Qiu, Y; Bielicki, JK; Afzal, V; Cheng, JF; Rubin, EM				Cavelier, LB; Qiu, Y; Bielicki, JK; Afzal, V; Cheng, JF; Rubin, EM			Regulation and activity of the human ABCA1 gene in transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-BINDING CASSETTE; DENSITY-LIPOPROTEIN CHOLESTEROL; TANGIER-DISEASE PATIENTS; ORPHAN NUCLEAR RECEPTOR; APOLIPOPROTEIN-A-I; CELLULAR CHOLESTEROL; HDL CHOLESTEROL; EFFLUX; TRANSPORTER-1; PHOSPHOLIPIDS	The ABCA1 transporter is one of the limiting steps in cellular cholesterol efflux, To study the expression and activity of the human ABCA1 gene in vivo we have examined mice containing two human BAC transgenes with different 5' ends. Mice containing a 255-kilobase (kb) BAC transgene, including 70 kb upstream of the previously defined exon I, demonstrated a pattern of tissue-specific expression mimicking that of the endogenous mouse gene. Compared with macrophages from control mice, macrophages from these transgenics had increases in apoA-I cholesterol efflux heightened in response to increases in cell cholesterol content. The observed increase in macrophage apoA-I-mediated cholesterol efflux was not accompanied by alterations in plasma high density lipoprotein in the transgenics. Although mice containing a smaller 171-kb human BAC transgene, lacking the previously described exon 1 and ABCA1 promoter, did not express human ABCA1 in macrophages, they did express the human transgene in liver at levels comparable with those of the orthologous mouse gene. Analysis by 5' rapid amplification of cDNA ends of liver mRNA from these animals revealed a new ABCA1 exon 1 (exon 1A) and a previously unrecognized promoter. Analysis of human tissue revealed that exon 1A containing transcripts accounted for a high proportion of the ABCA1 mRNAs present in human liver, This analysis of ABCA1 transgenics showed that the expression of human ABCA1 transgenes can result in increased cholesterol efflux from macrophages, unaccompanied by changes in plasma high density lipoprotein, and identified a new ABCA1 promoter in humans.	Univ Calif Berkeley, Lawrence Berkeley Lab, Genome Sci Dept, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cheng, JF (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genome Sci Dept, 1 Cyclotron Rd,MS-84-171, Berkeley, CA 94720 USA.			Cheng, Jan-Fang/0000-0001-7315-7613	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066728, R01HL059483] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL6398-01, HL66728-01, HL59483-01A2] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; ASSMANN G, 1995, METABOLIC MOL BASES, P2053; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Broccardo C, 1999, BBA-BIOMEMBRANES, V1461, P395, DOI 10.1016/S0005-2736(99)00170-4; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brousseau ME, 2000, J LIPID RES, V41, P1125; Christiansen-Weber TA, 2000, AM J PATHOL, V157, P1017, DOI 10.1016/S0002-9440(10)64614-7; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Costet P, 2000, J BIOL CHEM, V275, P28240; FIELDING CJ, 1995, J LIPID RES, V36, P211; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; GLOMSET JA, 1968, J LIPID RES, V9, P155; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hamon Y, 1997, BLOOD, V90, P2911, DOI 10.1182/blood.V90.8.2911; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; Lala DS, 1997, P NATL ACAD SCI USA, V94, P4895, DOI 10.1073/pnas.94.10.4895; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Mendez AJ, 1997, J LIPID RES, V38, P1807; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 1996, J LIPID RES, V37, P2473; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; QIU Y, 2001, IN PRESS GENOMICS; Remaley AT, 1997, ARTERIOSCL THROM VAS, V17, P1813, DOI 10.1161/01.ATV.17.9.1813; Remaley AT, 1999, P NATL ACAD SCI USA, V96, P12685, DOI 10.1073/pnas.96.22.12685; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Santamarina-Fojo S, 2000, P NATL ACAD SCI USA, V97, P7987, DOI 10.1073/pnas.97.14.7987; Schoonjans K, 2000, BBA-MOL CELL BIOL L, V1529, P114, DOI 10.1016/S1388-1981(00)00141-4; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; SERFATYLACROSNIERE C, 1994, ATHEROSCLEROSIS, V107, P85, DOI 10.1016/0021-9150(94)90144-9; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; von Eckardstein A, 1998, J LIPID RES, V39, P987; von Eckardstein A, 2000, CURR OPIN LIPIDOL, V11, P627, DOI 10.1097/00041433-200012000-00010	41	76	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18046	18051		10.1074/jbc.M100565200	http://dx.doi.org/10.1074/jbc.M100565200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279093	hybrid, Green Submitted			2022-12-27	WOS:000168866500058
J	Guo, Q; Xie, J; Chang, XW; Du, HM				Guo, Q; Xie, J; Chang, XW; Du, HM			Prostate apoptosis response-4 enhances secretion of amyloid beta peptide 1-42 in human neuroblastoma IMR-32 cells by a caspase-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; KNOCK-IN MICE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; INCREASED VULNERABILITY; HIPPOCAMPAL-NEURONS; PRESENILIN; APP; MUTATION; CLEAVAGE	Prostate apoptosis response-4 (Par-4) is a leucine zipper protein that promotes neuronal cell death in Alzheimer's disease (AD). Neuronal degeneration in AD may result from extracellular accumulation of amyloid beta peptide (A beta) 1-42. To examine the effect of Par-4 on A beta secretion and to reconcile amyloid/apoptosis hypotheses of AD, we generated IMR-32 cell lines that overexpress Par-4 and/or its leucine zipper domain. Overexpression of Par-4 did not significantly affect levels of the endogenously expressed beta amyloid precursor protein but drastically increased the A beta (1-42)/A beta (total) ratio in the conditioned media about 6-8 h after trophic factor withdrawal. Time course analysis of caspase activation reveals that Par-4 overexpression exacerbated caspase activation, which is detectable within 2 h after trophic factor withdrawal. Furthermore, inhibition of caspase activity by the broad spectrum caspase inhibitor BD-fmk significantly attenuated the Par-4-induced increase in A beta 1-42 production. In addition, the effects of Par-4 on secretion of A beta 1-42 were consistently blocked by co-expression of the leucine zipper domain, indicating that the effect of Par-4 on A beta secretion may require its interaction with other protein(s). These results suggest that Par-4 increases secretion of A beta 1-42 largely through a caspase-dependent pathway after apoptotic cascades are initiated.	NE Ohio Univ, Coll Med, Dept Neurobiol & Pharmacol, Rootstown, OH 44272 USA	Northeast Ohio Medical University (NEOMED)	Guo, Q (corresponding author), NE Ohio Univ, Coll Med, Dept Neurobiol & Pharmacol, 4209 State Route 44,POB 95, Rootstown, OH 44272 USA.							ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; Daly J, 1999, PROG NEURO-PSYCHOPH, V23, P861, DOI 10.1016/S0278-5846(99)00046-9; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; Galli C, 1998, P NATL ACAD SCI USA, V95, P1247, DOI 10.1073/pnas.95.3.1247; Greenfield JP, 2000, FRONT BIOSCI, V5, pD72, DOI 10.2741/Greenfield; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Guo Q, 1997, J NEUROSCI, V17, P4212; Guo Q, 1999, J NEUROCHEM, V72, P1019, DOI 10.1046/j.1471-4159.1999.0721019.x; Guo Q, 1999, P NATL ACAD SCI USA, V96, P4125, DOI 10.1073/pnas.96.7.4125; Guo Q, 2000, BRAIN RES, V874, P221, DOI 10.1016/S0006-8993(00)02559-2; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; LeBlanc A, 1995, J NEUROSCI, V15, P7837; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; NEILL D, 1994, J NEUROSCI RES, V39, P482, DOI 10.1002/jnr.490390415; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; Rossner S, 2000, EUR J NEUROSCI, V12, P3191, DOI 10.1046/j.1460-9568.2000.00211.x; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Sisodia SS, 2000, SCIENCE, V289, P2296, DOI 10.1126/science.289.5488.2296; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Spampinato S, 1999, NEUROSCI LETT, V273, P167, DOI 10.1016/S0304-3940(99)00661-8; Steiner H, 1999, EUR ARCH PSY CLIN N, V249, P266, DOI 10.1007/s004060050098; Tanzi RE, 1999, NAT NEUROSCI, V2, P585, DOI 10.1038/10133; Vestling M, 1999, BBA-MOL BASIS DIS, V1453, P341, DOI 10.1016/S0925-4439(99)00003-4; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Weihl CC, 1999, NEUROREPORT, V10, P2527, DOI 10.1097/00001756-199908200-00017; Wolozin B, 1996, SCIENCE, V274, P1710, DOI 10.1126/science.274.5293.1710; Xia W, 2000, EXP GERONTOL, V35, P453, DOI 10.1016/S0531-5565(00)00111-X; Yankner BA, 1996, NAT MED, V2, P850, DOI 10.1038/nm0896-850; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	32	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16040	16044		10.1074/jbc.M010996200	http://dx.doi.org/10.1074/jbc.M010996200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278808	hybrid			2022-12-27	WOS:000168623100064
J	Walsh, AB; Bar-Sagi, D				Walsh, AB; Bar-Sagi, D			Differential activation of the pac pathway by Ha-Ras and K-Ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PLASMA-MEMBRANE; RHO-GTPASES; GUANOSINE TRIPHOSPHATASES; ACTIN POLYMERIZATION; INOSITOL PHOSPHATES; KINASE ACTIVATION; EPITHELIAL-CELLS; CAAX MOTIF; N-RAS	Ras proteins are key regulators of cell growth and differentiation. Mammalian cells express three closely related Ras proteins: Ha-Ras, K-Ras, and N-Ras. We have compared the abilities of the Ha-Res and K-Ras isoforms to activate the Rac effector pathway, using three Rac-dependent readouts: induction of membrane ruffling and pinocytosis, stimulation of cell motility, and Pak binding. The total surface area of membrane ruffles induced by K-RasV12 was 2-fold greater than that induced by Ha-RasV12. Likewise, the number of K-RasV12-induced pinocytic vesicles per cell was similar to2-fold greater than that induced by Ha-RasV12. In a wound healing assay, K-RasV12-injected cells migrated twice as fast as Ha-RasV12-injected cells. Moreover, the Pak binding activity of Rac, which is indicative of the amount of GTP-bound Rac, was higher in K-RasV12-expressing cells than Ha-RasV12-expressing cells. These results suggest that K-Ras activates Rac more efficiently than Ha-Ras. The preferential activation of Rac by K-Ras is dependent on the mode of membrane anchoring and impacts on the ability of K-Ras to regulate cell survival.	SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Grad Program Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bar-Sagi, D (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.			Bar-Sagi, Dafna/0000-0003-2597-8948	NCI NIH HHS [CA55360] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R56CA055360, R01CA055360, R37CA055360] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Booden MA, 2000, J BIOL CHEM, V275, P23559, DOI 10.1074/jbc.M001368200; BOS JL, 1989, CANCER RES, V49, P4682; BRASELMANN S, 1997, CURR BIOL, V7, P470; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; FINKELSTEIN SD, 1993, ARCH SURG-CHICAGO, V128, P526; GLOMSET JA, 1994, ANNU REV CELL BIOL, V10, P181, DOI 10.1146/annurev.cellbio.10.1.181; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Joneson T, 1997, J MOL MED-JMM, V75, P587, DOI 10.1007/s001090050143; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Joneson T, 1999, MOL CELL BIOL, V19, P5892; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; QUI RG, 1995, NATURE, V374, P457; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SUCHY B, 1992, INT J CANCER, V52, P30, DOI 10.1002/ijc.2910520107; Thissen JA, 1997, J BIOL CHEM, V272, P30362, DOI 10.1074/jbc.272.48.30362; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Walsh AB, 1997, ONCOGENE, V15, P2553, DOI 10.1038/sj.onc.1201424; Whitehead IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P1; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yan ZF, 1997, J BIOL CHEM, V272, P27902, DOI 10.1074/jbc.272.44.27902; Zheng Y, 1996, J BIOL CHEM, V271, P19017, DOI 10.1074/jbc.271.32.19017	50	139	143	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15609	15615		10.1074/jbc.M010573200	http://dx.doi.org/10.1074/jbc.M010573200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278702	hybrid			2022-12-27	WOS:000168623100008
J	You, SY; Falgout, B; Markoff, L; Padmanabhan, R				You, SY; Falgout, B; Markoff, L; Padmanabhan, R			In vitro RNA synthesis from exogenous dengue viral RNA templates requires long range interactions between 5 '- and 3 '-terminal regions that influence RNA structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-LOOP STRUCTURE; YELLOW-FEVER VIRUS; PUTATIVE METHYLTRANSFERASE DOMAIN; BORNE ENCEPHALITIS-VIRUS; FLAVIVIRUS GENOMIC RNA; MINUS-STRAND SYNTHESIS; SMALL NUCLEAR RNAS; SECONDARY STRUCTURE; 3'-UNTRANSLATED REGION; MESSENGER-RNA	Viral replicases of many positive-strand RNA viruses are membrane-bound complexes of cellular and viral proteins that include viral RNA-dependent RNA polymerase (RdRP). The in vitro RdRP assay system that utilizes cytoplasmic extracts from dengue viral-infected cells and exogenous RNA templates was developed to understand the mechanism of viral replication in vivo. Our results indicated that in vitro RNA synthesis at the 5'-untranslated region (UTR) required the presence of the 5'-terminal region (TR) and the two cyclization (CYC) motifs suggesting a functional interaction between the TRs. In this study, using a psoralen-UV crosslinking method and an in vitro RdRP assay, we analyzed structural determinants for physical and functional interactions. Exogenous RNA templates that were used in the assays contained deletion mutations in the 5'-TR and substitution mutations in the 3'-stem-loop structure including those that would disrupt the predicted pseudoknot structure. Our results indicate that there is physical interaction between the 5'-TR and 3'-UTR that requires only the CYC motifs. RNA synthesis at the 3'-UTR, however, requires long range interactions involving the 5'-UTR, CYC motifs, and the 3'-stem-loop region that includes the tertiary pseudoknot structure.	Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; US FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Rockville, MD 20852 USA	University of Kansas; University of Kansas Medical Center; US Food & Drug Administration (FDA)	Padmanabhan, R (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	yous@rockefeller.edu; rpadmana@kumc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032078, R21AI032078, R01AI045623] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-32078, AI-45623] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAZAN JF, 1989, VIROLOGY, V171, P637, DOI 10.1016/0042-6822(89)90639-9; Bisaillon M, 1997, VIROLOGY, V236, P1, DOI 10.1006/viro.1997.8698; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BLACKWELL JL, 1995, J VIROL, V69, P5650, DOI 10.1128/JVI.69.9.5650-5658.1995; Blight KJ, 1997, J VIROL, V71, P7345, DOI 10.1128/JVI.71.10.7345-7352.1997; BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7; BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0; CAHOUR A, 1992, J VIROL, V66, P1535, DOI 10.1128/JVI.66.3.1535-1542.1992; CALVET JP, 1981, CELL, V26, P363, DOI 10.1016/0092-8674(81)90205-1; CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991; CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chapman MR, 1998, VIROLOGY, V252, P458, DOI 10.1006/viro.1998.9473; CHATTERJEE PK, 1978, NUCLEIC ACIDS RES, V5, P3619, DOI 10.1093/nar/5.10.3619; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715; DATTA B, 1991, NATURE, V352, P821, DOI 10.1038/352821a0; Deiman BALM, 1997, J VIROL, V71, P5990, DOI 10.1128/JVI.71.8.5990-5996.1997; Diez J, 2000, P NATL ACAD SCI USA, V97, P3913, DOI 10.1073/pnas.080072997; ESTEBAN R, 1989, EMBO J, V8, P947, DOI 10.1002/j.1460-2075.1989.tb03456.x; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; GARRETTWHEELER E, 1984, NUCLEIC ACIDS RES, V12, P3405, DOI 10.1093/nar/12.7.3405; Goodfellow I, 2000, J VIROL, V74, P4590, DOI 10.1128/JVI.74.10.4590-4600.2000; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P3889, DOI 10.1093/nar/17.10.3889; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Haldeman-Cahill R, 1998, J VIROL, V72, P4072, DOI 10.1128/JVI.72.5.4072-4079.1998; Hsue B, 1997, J VIROL, V71, P7567, DOI 10.1128/JVI.71.10.7567-7578.1997; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; Ito T, 1997, J VIROL, V71, P8698, DOI 10.1128/JVI.71.11.8698-8706.1997; JACOBSON SJ, 1993, J VIROL, V67, P2961, DOI 10.1128/JVI.67.6.2961-2971.1993; Kadare G, 1997, J VIROL, V71, P2583; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kautner I, 1997, J PEDIATR-US, V131, P516, DOI 10.1016/S0022-3476(97)70054-4; Klovins J, 1998, RNA, V4, P948, DOI 10.1017/S1355838298980177; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90338-A; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; LAHSER FC, 1993, J VIROL, V67, P3295, DOI 10.1128/JVI.67.6.3295-3303.1993; MARKOFF L, 1989, J VIROL, V63, P3345, DOI 10.1128/JVI.63.8.3345-3352.1989; McKnight KL, 1998, RNA, V4, P1569, DOI 10.1017/S1355838298981006; MOHAN PM, 1991, GENE, V108, P185, DOI 10.1016/0378-1119(91)90433-C; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Murthy HMK, 1999, J BIOL CHEM, V274, P5573, DOI 10.1074/jbc.274.9.5573; NAKHASI HL, 1991, J VIROL, V65, P5961, DOI 10.1128/JVI.65.11.5961-5967.1991; NOWAK T, 1989, VIROLOGY, V169, P365, DOI 10.1016/0042-6822(89)90162-1; O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463; PARDIGON N, 1992, J VIROL, V66, P1007, DOI 10.1128/JVI.66.2.1007-1015.1992; PLEIJ CWA, 1985, NUCLEIC ACIDS RES, V13, P1717, DOI 10.1093/nar/13.5.1717; PLETNEV AG, 1990, VIROLOGY, V174, P250, DOI 10.1016/0042-6822(90)90073-Z; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; POGUE GP, 1992, J VIROL, V66, P674, DOI 10.1128/JVI.66.2.674-684.1992; PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990; Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; ROHLL JB, 1994, J VIROL, V68, P4384, DOI 10.1128/JVI.68.7.4384-4391.1994; ROHLL JB, 1995, J VIROL, V69, P7835, DOI 10.1128/JVI.69.12.7835-7844.1995; ROZANOV MN, 1992, J GEN VIROL, V73, P2129, DOI 10.1099/0022-1317-73-8-2129; Schuppli D, 1998, J MOL BIOL, V283, P585, DOI 10.1006/jmbi.1998.2123; Shi PY, 1996, BIOCHEMISTRY-US, V35, P4222, DOI 10.1021/bi952398v; Shi PY, 1996, J VIROL, V70, P6278, DOI 10.1128/JVI.70.9.6278-6287.1996; SMITH TJ, 1970, J VIROL, V5, P524, DOI 10.1128/JVI.5.4.524-532.1970; SONG CZ, 1995, J MOL BIOL, V254, P6, DOI 10.1006/jmbi.1995.0594; Stewart SR, 1998, NUCLEIC ACIDS RES, V26, P5318, DOI 10.1093/nar/26.23.5318; SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992; SVITKIN YV, 1984, VIROLOGY, V135, P536, DOI 10.1016/0042-6822(84)90207-1; THOMPSON JF, 1983, CELL, V32, P1355, DOI 10.1016/0092-8674(83)90316-1; Tsai CH, 1999, J VIROL, V73, P2703, DOI 10.1128/JVI.73.4.2703-2709.1999; Wang SP, 1997, P NATL ACAD SCI USA, V94, P9573, DOI 10.1073/pnas.94.18.9573; WASSARMAN DA, 1992, SCIENCE, V257, P1918, DOI 10.1126/science.1411506; WATKINS KP, 1994, CELL, V76, P171, DOI 10.1016/0092-8674(94)90181-3; WENGLER G, 1991, J GEN VIROL, V72, P851, DOI 10.1099/0022-1317-72-4-851; WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587; WESTAWAY EG, 1987, ADV VIRUS RES, V33, P45, DOI 10.1016/S0065-3527(08)60316-4; YAEGASHI T, 1986, GENE, V46, P257, DOI 10.1016/0378-1119(86)90410-5; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998; ZHANG L, 1993, GENE, V129, P197, DOI 10.1016/0378-1119(93)90269-9; ZHANG LW, 1992, J VIROL, V66, P7549, DOI 10.1128/JVI.66.12.7549-7554.1992; ZUKER M, 1991, NUCLEIC ACIDS RES, V19, P2707, DOI 10.1093/nar/19.10.2707	81	153	163	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15581	15591		10.1074/jbc.M010923200	http://dx.doi.org/10.1074/jbc.M010923200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278787	hybrid			2022-12-27	WOS:000168623100005
J	Hellauer, K; Sirard, E; Turcotte, B				Hellauer, K; Sirard, E; Turcotte, B			Decreased expression of specific genes in yeast cells lacking histone H1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LINKER HISTONE; IN-VIVO; NUCLEOSOME; TRANSCRIPTION; CHROMATIN; MICE; RNA; DNA; SPERMATOGENESIS	Chromatin plays an important role in regulating eukaryotic gene expression. Chromatin is composed of DNA wrapped around a nucleosome core (consisting of two copies of the well conserved histones H2A, H2B, H3, and H4) and a more variable linker histone H1. Various in vitro and in vivo studies have implicated histone H1 as a repressor of gene expression or as an activator, but its exact role is still unclear. Sequencing of the yeast genome has led to the identification of a putative histone H1 gene. Biochemical studies demonstrated that yeast does indeed possess a bona fide histone H1. However, deletion of the unique yeast H1 gene is not associated with any phenotypes, and it was questioned whether it plays any role. To address this issue, we performed whole-genome microarray analysis to identify genes that are affected by H1 removal, Surprisingly, deletion of the gene encoding histone H1 does not result in increased gene expression but rather in a modest reduction, Northern blot analysis of selected genes confirmed the results obtained with the microarray analysis. A similar effect was observed with an integrated lacZ reporter. Thus, our data demonstrate that removal of yeast histone H1 only results in decreased gene expression.	McGill Univ, Royal Victoria Hosp, Dept Med, Montreal, PQ H3A 1A1, Canada; McGill Univ, Royal Victoria Hosp, Dept Biochem, Montreal, PQ H3A 1A1, Canada; McGill Univ, Royal Victoria Hosp, Dept Microbiol & Immunol, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital	Turcotte, B (corresponding author), McGill Univ, Royal Victoria Hosp, Dept Med, Montreal, PQ H3A 1A1, Canada.	turcotte@lan1.molonc.mcgill.ca						Ausubel FM, 1988, MOL REPROD DEV; Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; Belikov S, 1998, FEBS LETT, V441, P161, DOI 10.1016/S0014-5793(98)01512-9; Brachmann CB, 1998, YEAST, V14, P115; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; Dou YL, 2000, MOL CELL, V6, P225, DOI 10.1016/S1097-2765(00)00024-1; Escher D, 1997, MOL GEN GENET, V256, P456, DOI 10.1007/s004380050589; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Ha N, 1996, NUCLEIC ACIDS RES, V24, P1453, DOI 10.1093/nar/24.8.1453; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HORGEN PA, 1978, ANNU REV MICROBIOL, V32, P249, DOI 10.1146/annurev.mi.32.100178.001341; Howe L, 1998, J BIOL CHEM, V273, P20693, DOI 10.1074/jbc.273.33.20693; KANDOLF H, 1994, P NATL ACAD SCI USA, V91, P7257, DOI 10.1073/pnas.91.15.7257; Karrer KM, 1999, J BIOL CHEM, V274, P33020, DOI 10.1074/jbc.274.46.33020; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Landsman D, 1996, TRENDS BIOCHEM SCI, V21, P287, DOI 10.1016/S0968-0004(96)30030-3; Lin QC, 2000, MOL CELL BIOL, V20, P2122, DOI 10.1128/MCB.20.6.2122-2128.2000; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Patterton HG, 1998, J BIOL CHEM, V273, P7268, DOI 10.1074/jbc.273.13.7268; PHILIPPSEN P, 1991, METHOD ENZYMOL, V194, P169; Puig S, 1999, CURR MICROBIOL, V39, P168, DOI 10.1007/s002849900440; Rabini S, 2000, EXP CELL RES, V255, P114, DOI 10.1006/excr.1999.4767; Ramakrishnan V, 1997, ANNU REV BIOPH BIOM, V26, P83, DOI 10.1146/annurev.biophys.26.1.83; Ramon A, 2000, MOL MICROBIOL, V35, P223, DOI 10.1046/j.1365-2958.2000.01702.x; SANDALTZOPOULOS R, 1994, EMBO J, V13, P373, DOI 10.1002/j.1460-2075.1994.tb06271.x; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takami Y, 1997, J MOL BIOL, V265, P394, DOI 10.1006/jmbi.1996.0733; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; Travers A, 1999, TRENDS BIOCHEM SCI, V24, P4, DOI 10.1016/S0968-0004(98)01339-5; Ushinsky SC, 1997, YEAST, V13, P151, DOI 10.1002/(SICI)1097-0061(199702)13:2<151::AID-YEA94>3.0.CO;2-5; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; Wolffe A., 1998, CHROMATIN STRUCTURE; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	41	69	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13587	13592		10.1074/jbc.M011196200	http://dx.doi.org/10.1074/jbc.M011196200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278859	hybrid			2022-12-27	WOS:000168356600013
J	Horiguchi, H; Yurimoto, H; Kato, N; Sakai, Y				Horiguchi, H; Yurimoto, H; Kato, N; Sakai, Y			Antioxidant system within yeast peroxisome - Biochemical and physiological characterization of CbPmp20 in the methylotrophic yeast Candida boidinii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL-SPECIFIC ANTIOXIDANT; RAT-LIVER PEROXISOMES; THIOREDOXIN PEROXIDASE; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; SACCHAROMYCES-CEREVISIAE; HYDROGEN-PEROXIDE; SEQUENCE-ANALYSIS; MEMBRANE; PROTEINS	Candida boidinii Pmp20 (CbPmp20), a protein associated with the inner side of peroxisomal membrane, belongs to a recently identified protein family of antioxidant enzymes, the peroxiredoxins, which contain one cysteine residue. Pmp20 homologs containing the putative peroxisome targeting signal type 1 have also been identified in mammals and lower eukaryotes. However, the physiological function of these Pmp20 family proteins has been unclear. In this study, we investigated the biochemical and physiological functions of recombinant CbPmp20 protein in methanol-induced peroxisomes of C. boidinii using the PMP20-deleted strain of C. boidinii (pmp20 Delta strain). The His(6)-tagged CbPmp20 fusion protein was found to have glutathione peroxidase activity in vitro toward alkyl hydroperoxides and H2O2. Catalytic activity and dimerization of His(6)-CbPmp20 depended on the only cysteine residue corresponding to Cys(53). The pmp20 Delta strain was found to have lost growth ability on methanol as a carbon and energy source. The pmp20 Delta growth defect was rescued by CbPmp20, but neither CbPmp20 lacking the peroxisome targeting signal type 1 sequence nor CbPmp20 haboring the C53S mutation retrieved the growth defect. Interestingly, the pmp20 Delta strain had a more severe growth defect than the cta1 Delta strain, which lacks catalase, another antioxidant enzyme within the peroxisome. During incubation of these strains in methanol medium, the cta1 Delta strain accumulated H2O2, whereas the pmp20 Delta strain did not. Therefore, it is speculated to be the main function of CbPmp20 is to decompose reactive oxygen species generated at peroxisomal membrane surface, e.g. lipid hydroperoxides, rather than to decompose H2O2. In addition, we detected a physiological level of reduced glutathione in peroxisomal fraction of C. boidinii. These results may indicate a physiological role for CbPmp20 as an antioxidant enzyme within peroxisomes rich in reactive oxygen species.	Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Sakai, Y (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kitashirakawa Oiwake, Kyoto 6068502, Japan.	ysakai@kais.kyoto-u.ac.jp	Yurimoto, Hiroya/N-6538-2018	Yurimoto, Hiroya/0000-0001-7506-6184				BERGMEYER HU, 1955, BIOCHEM Z, V327, P255; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUINENBERG PG, 1982, FEMS MICROBIOL LETT, V15, P45, DOI 10.1111/j.1574-6968.1982.tb00035.x; CADENAS E, 1992, ADV ENZYMOL RAMB, V65, P97; CASALONE E, 1988, A VAN LEEUW J MICROB, V54, P367, DOI 10.1007/BF00393527; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DHAUNSI GS, 1992, J BIOL CHEM, V267, P6870; Farcasanu IC, 1999, BIOSCI BIOTECH BIOCH, V63, P1871, DOI 10.1271/bbb.63.1871; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fisher AB, 1999, J BIOL CHEM, V274, P21326, DOI 10.1074/jbc.274.30.21326; GARRARD LJ, 1989, J BIOL CHEM, V264, P13929; GOODMAN JM, 1984, J BIOL CHEM, V259, P8485; GOODMAN JM, 1990, J CELL SCI, V97, P193; GUILBAULT GG, 1968, ANAL CHEM, V40, P1256, DOI 10.1021/ac60264a027; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HARMAN LS, 1986, J BIOL CHEM, V261, P1642; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Jeong JS, 1999, BIOCHEMISTRY-US, V38, P776, DOI 10.1021/bi9817818; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; KATO N, 1990, METHOD ENZYMOL, V188, P455; KELLER GA, 1991, P NATL ACAD SCI USA, V88, P7381, DOI 10.1073/pnas.88.16.7381; KLEI, 1990, METHOD ENZYMOL, V188, P420; Knoops B, 1999, J BIOL CHEM, V274, P30451, DOI 10.1074/jbc.274.43.30451; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; Mano J, 2000, EUR J BIOCHEM, V267, P3661, DOI 10.1046/j.1432-1327.2000.01398.x; MINCEY T, 1980, P NATL ACAD SCI-BIOL, V77, P7099, DOI 10.1073/pnas.77.12.7099; Montemartini M, 1998, J BIOL CHEM, V273, P4864, DOI 10.1074/jbc.273.9.4864; Munz B, 1997, BIOCHEM J, V326, P579, DOI 10.1042/bj3260579; Nakagawa T, 2000, J BIOL CHEM, V275, P3455, DOI 10.1074/jbc.275.5.3455; Netto LES, 1996, J BIOL CHEM, V271, P15315, DOI 10.1074/jbc.271.26.15315; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; RANDEZGIL F, 1994, FEMS MICROBIOL LETT, V122, P153, DOI 10.1111/j.1574-6968.1994.tb07158.x; ROBINSON J, 1970, ANAL BIOCHEM, V20, P525; SAKAI Y, 1993, J BACTERIOL, V175, P3556, DOI 10.1128/jb.175.11.3556-3562.1993; Sakai Y, 1996, BBA-GENE STRUCT EXPR, V1308, P81, DOI 10.1016/0167-4781(96)00075-9; SAKAI Y, 1992, J BACTERIOL, V174, P5988, DOI 10.1128/jb.174.18.5988-5993.1992; SAKAI Y, 1991, J BACTERIOL, V173, P7458, DOI 10.1128/jb.173.23.7458-7463.1991; SAKAI Y, 1994, BIO-TECHNOL, V12, P291, DOI 10.1038/nbt0394-291; Sakai Y, 1998, YEAST, V14, P1175, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1175::AID-YEA319>3.3.CO;2-Z; Sakai Y, 1996, J CELL BIOL, V134, P37, DOI 10.1083/jcb.134.1.37; SAKAI Y, 1995, J BACTERIOL, V177, P6773, DOI 10.1128/jb.177.23.6773-6781.1995; SAKAI Y, 1988, APPL ENVIRON MICROB, V54, P485, DOI 10.1128/AEM.54.2.485-489.1988; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schrader M, 1999, J HISTOCHEM CYTOCHEM, V47, P1141, DOI 10.1177/002215549904700906; Schroder E, 1998, PROTEIN SCI, V7, P2465, DOI 10.1002/pro.5560071125; SINGH AK, 1994, ARCH BIOCHEM BIOPHYS, V315, P331, DOI 10.1006/abbi.1994.1508; Singh AK, 1998, J BIOL CHEM, V273, P26171, DOI 10.1074/jbc.273.40.26171; Singh I, 1996, ANN NY ACAD SCI, V804, P612, DOI 10.1111/j.1749-6632.1996.tb18648.x; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tolbert N E, 1974, Methods Enzymol, V31, P734; TOWBIN H, 1979, P NATL ACAD SCI USA, V77, P5201; UEDA M, 1990, METHOD ENZYMOL, V188, P463; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; VANVELDHOVEN PP, 1987, J BIOL CHEM, V262, P4310; VEENHUIS M, 1990, J CELL SCI, V96, P583; Verdoucq L, 1999, J BIOL CHEM, V274, P19714, DOI 10.1074/jbc.274.28.19714; WANDERS RJA, 1992, BIOCHIM BIOPHYS ACTA, V1115, P259, DOI 10.1016/0304-4165(92)90063-Z; Yamashita H, 1999, J BIOL CHEM, V274, P29897, DOI 10.1074/jbc.274.42.29897; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yeldandi AV, 2000, MUTAT RES-FUND MOL M, V448, P159, DOI 10.1016/S0027-5107(99)00234-1; YIM MB, 1994, J BIOL CHEM, V269, P1621; Yurimoto H, 2000, BBA-GENE STRUCT EXPR, V1493, P56, DOI 10.1016/S0167-4781(00)00157-3; Zhou Y, 2000, BIOCHEM BIOPH RES CO, V268, P921, DOI 10.1006/bbrc.2000.2231	68	59	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14279	14288		10.1074/jbc.M011661200	http://dx.doi.org/10.1074/jbc.M011661200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278957	hybrid			2022-12-27	WOS:000168356600102
J	Matsuda, E; Agata, Y; Sugai, M; Katakai, T; Gonda, H; Shimizu, A				Matsuda, E; Agata, Y; Sugai, M; Katakai, T; Gonda, H; Shimizu, A			Targeting of Kruppel-associated box-containing zinc finger proteins to centromeric heterochromatin - Implication for the gene silencing mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; HP1 PROTEINS; HISTONE DEACETYLATION; CHROMODOMAIN PROTEINS; MAMMALIAN-CELLS; DOMAIN; CHROMATIN; COMPLEX; IKAROS; FAMILY	Kruppel-associated box-containing zinc finger proteins (KRAB-ZFPs) repress transcription via functional interaction with the corepressor KRAB-associated protein-1 (KAP-1). KAP-1 directly interacts with heterochromatin protein 1 (HP1), a dose-dependent regulator of heterochromatin-mediated silencing. Here we show that two KRAB-ZFPs that we previously identified, KRAZ1 and KRAZ2, are targeted to foci of centromeric heterochromatin containing HP1 alpha through the interaction with KAP-1, Centromeric targeting potential of KRAZ1 and KAP-1 is strictly correlated with their silencing activities; a KRAB mutant of KRAZ1 that is unable to bind KAP-1 and KAP-1 deletions unable to bind HP1 cannot localize to centromeric foci nor repress transcription. We provide evidence that this correlation is likely to be functionally relevant, First, overexpression of the VP16 transactivation domain fused with the KAP-1 deletion that binds to KRAB but not to HP1 leads to dramatic redistribution of KRAZ1 from centromeric foci and simultaneously converts KRAZ1-mediated silencing into strong transcriptional activation. Second, a specific inhibitor of histone deacetylases, trichostatin A, effectively redistributes KRAZ1 and KAP-1 from centromeric foci and partially relieves their silencing activities. These data strongly suggest that KRAB-ZFPs/KAP-1 silence transcription by dynamic recruitment of the target locus to the specific gene silencing compartment, centromeric heterochromatin, in a histone deacetylase-dependent manner.	Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Shimizu, A (corresponding author), Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068501, Japan.		Katakai, Tomoya/AAX-1434-2021	Sugai, Manabu/0000-0003-1668-7647; Katakai, Tomoya/0000-0002-4290-7028; Agata, Yasutoshi/0000-0001-9642-6994				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Agata Y, 1999, J BIOL CHEM, V274, P16412, DOI 10.1074/jbc.274.23.16412; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chang CJ, 1998, MOL CELL BIOL, V18, P5880, DOI 10.1128/MCB.18.10.5880; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Horsley D, 1996, CYTOGENET CELL GENET, V73, P308, DOI 10.1159/000134363; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Sambrook J., 2002, MOL CLONING LAB MANU; SAUNDERS WS, 1993, J CELL SCI, V104, P573; Schreiber-Agus N, 1998, BIOESSAYS, V20, P808, DOI 10.1002/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U; Schubeler D, 2000, GENE DEV, V14, P940; SINGH PB, 1991, NUCLEIC ACIDS RES, V19, P789, DOI 10.1093/nar/19.4.789; VISSING H, 1995, FEBS LETT, V369, P153, DOI 10.1016/0014-5793(95)00728-R; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983	39	55	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14222	14229		10.1074/jbc.M010663200	http://dx.doi.org/10.1074/jbc.M010663200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278721	hybrid			2022-12-27	WOS:000168356600095
J	Schiller, PC; D'Ippolito, G; Brambilla, R; Roos, BA; Howard, GA				Schiller, PC; D'Ippolito, G; Brambilla, R; Roos, BA; Howard, GA			Inhibition of gap-junctional communication induces the trans-differentiation of osteoblasts to an adipocytic phenotype in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONNEXIN-43 GENE-EXPRESSION; INTERCELLULAR COMMUNICATION; BONE-MARROW; GLYCYRRHETINIC ACID; HORMONAL-REGULATION; LIPID OLEAMIDE; CELLS; CULTURE; RESPONSIVENESS; INVOLVEMENT	Osteoblasts and adipocytes are thought to differentiate from a common stromal progenitor cell. These two phenotypically mature cell types show a high degree of plasticity, which can be observed when cells are grown under specific culture conditions. Gap junctions are abundant among osteoblastic cells in vivo and in vitro, whereas they are down-regulated during adipogenesis, Gap junctional communication (GJC) modulates the expression of genes associated with the mature osteoblastic phenotype. Inhibition of GJC utilizing 18-alpha -glycyrrhetinic acid (AGRA) blocks the maturation of preosteoblastic cells in vitro, Moreover, cytoplasmic lipid droplets are detectable at the end of the culture period, suggesting that GJC inhibition may favor an adipocytic phenotype, We used several human osteoblastic cell lines, as well as bone-derived primary osteoblastic cells, to show that confluent cultures of human osteoblastic cells grown under osteogenic conditions developed an adipocytic phenotype after 3 days of complete inhibition of GJC using AGRA or oleamide, two dissimilar nontoxic reversible inhibitors. Development of an adipogenic phenotype was confirmed by the accumulation of triglyceride droplets and the increase in mRNA expression of the adipocytic markers peroxisome proliferator-activated receptor gamma2 and lipoprotein lipase, Glycyrrhizic acid, a noninhibitory AGRA analog, or alpha -bromopalmitate, a nondegradable fatty acid, had no effect. Modulation of skeletal GJC may represent a new pharmacological target by which inhibition of marrow adipogenesis can take place with the parallel enhancement of osteoblastogenesis, thus providing a novel therapeutic approach to the treatment of human age-related osteopenic diseases and postmenopausal osteoporosis.	Univ Miami, Vet Adm Med Ctr, Sch Med, GRECC 11GRC, Miami, FL 33125 USA; Vet Affairs Med Ctr, Res Serv, Miami, FL 33125 USA; Univ Miami, Sch Med, Dept Med, Miami, FL 33125 USA; Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33125 USA; Univ Miami, Sch Med, Dept Neurol, Miami, FL 33125 USA; Stein Gerontol Inst, Miami, FL 33125 USA	University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Miami; University of Miami; University of Miami	Schiller, PC (corresponding author), Univ Miami, Vet Adm Med Ctr, Sch Med, GRECC 11GRC, 1201 NW 16th St, Miami, FL 33125 USA.	pschille@med.miami.edu						AMRI EZ, 1994, J LIPID RES, V35, P930; Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005; Bani-Yaghoub M, 1999, EXP NEUROL, V156, P16, DOI 10.1006/exnr.1998.6950; Boger DL, 1998, P NATL ACAD SCI USA, V95, P4810, DOI 10.1073/pnas.95.9.4810; BURKHARDT R, 1987, BONE, V8, P157, DOI 10.1016/8756-3282(87)90015-9; CHIBA H, 1994, CELL STRUCT FUNCT, V19, P173, DOI 10.1247/csf.19.173; CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; DAVIDSON JS, 1986, BIOCHEM BIOPH RES CO, V134, P29, DOI 10.1016/0006-291X(86)90522-X; Grandolfo M, 1998, J BONE MINER RES, V13, P443, DOI 10.1359/jbmr.1998.13.3.443; Guan XJ, 1997, J CELL BIOL, V139, P1785, DOI 10.1083/jcb.139.7.1785; HEIDER JG, 1978, J LIPID RES, V19, P514; JONES SJ, 1993, ANAT EMBRYOL, V187, P343; Kodama HA., 1981, JPN J ORAL BIOL, V23, P899, DOI DOI 10.2330/JORALBIOSCI1965.23.899; Krenacs T, 1998, AM J PATHOL, V152, P993; Lecanda F, 1998, MOL BIOL CELL, V9, P2249, DOI 10.1091/mbc.9.8.2249; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; LECANDA F, 1998, BONE, V23, pS150; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; MENDEZ AJ, 1986, ANAL BIOCHEM, V156, P386, DOI 10.1016/0003-2697(86)90269-1; MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197110000-00021; MUNARISILEM Y, 1995, J CLIN INVEST, V95, P1429, DOI 10.1172/JCI117813; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; OWEN M, 1988, J CELL SCI, P63; Park SR, 1999, BONE, V24, P549, DOI 10.1016/S8756-3282(99)00084-8; QUARLES LD, 1992, J BONE MINER RES, V7, P683; RINGBOMANDERSON T, 1994, J BONE MINER RES, V9, P661; Schiller PC, 1999, J BONE MINER RES, V14, P1504, DOI 10.1359/jbmr.1999.14.9.1504; SCHILLER PC, 1992, MOL ENDOCRINOL, V6, P1433, DOI 10.1210/me.6.9.1433; Schiller PC, 2001, BONE, V28, P38, DOI 10.1016/S8756-3282(00)00412-9; Schiller PC, 1997, J BONE MINER RES, V12, P2005, DOI 10.1359/jbmr.1997.12.12.2005; SCHILLER PC, 1998, BONE, V23, pS325; SCHILLER PC, 1993, GERONTOLOGIST, V33, P138; SCHIRRMACHER K, 1992, CALCIFIED TISSUE INT, V51, P285, DOI 10.1007/BF00334489; TOMASETTO C, 1993, J CELL BIOL, V122, P157, DOI 10.1083/jcb.122.1.157; UMEZAWA A, 1992, CELL STRUCT FUNCT, V17, P177, DOI 10.1247/csf.17.177; VanderMolen MA, 1996, J BIOL CHEM, V271, P12165, DOI 10.1074/jbc.271.21.12165; YAMAGUCHI DT, 1994, J BONE MINER RES, V9, P791	41	84	92	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14133	14138		10.1074/jbc.M011055200	http://dx.doi.org/10.1074/jbc.M011055200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278824	hybrid			2022-12-27	WOS:000168356600085
J	Ohgami, N; Nagai, R; Miyazaki, A; Ikemoto, M; Arai, H; Horiuchi, S; Nakayama, H				Ohgami, N; Nagai, R; Miyazaki, A; Ikemoto, M; Arai, H; Horiuchi, S; Nakayama, H			Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS; MONOCYTE-DERIVED MACROPHAGES; GLUCOSE-MODIFIED PROTEINS; INDUCED DIABETIC RAT; APOPROTEIN-A-I; ADVANCED GLYCOSYLATION; SR-BI; SELECTIVE UPTAKE; MAILLARD REACTION	Cellular interactions of advanced glycation end products (AGE) are mediated by AGE receptors, We demonstrated previously that class A scavenger receptor types I and II (SR-A) and CD36, a member of class B scavenger receptor family, serve as the AGE receptors, In this study, we investigated whether scavenger receptor class B type I (SR-BI), another receptor belonging to class B scavenger receptor family, was also an AGE receptor. We used Chinese hamster ovary (CHO) cells overexpressed hamster SR-BI (CHO-SR-BI cells). I-125-AGE-bovine serum albumin (AGE-BSA) was endocytosed in a dose-dependent fashion and underwent lysosomal degradation by CHO-SR-BI cells. I-125-AGE-BSA exhibited saturable binding to CHO-SR-BI cells (K-d = 8.3 mug/ml). Endocytic uptake of I-125-AGE-BSA by CHO-SR-BI cells was completely inhibited by oxidized low density lipoprotein (LDL) and acetylated LDL, whereas LDL exerted only a weak inhibitory effect (<20%). Cross-competition experiments showed that AGE-BSA had no effect on HDL binding to these cells and vice verse. Interestingly, however, SR-BI-mediated selective uptake of HDL-CE was completely inhibited by AGE-BSA in a dose-dependent manner (IC50 <10 mug/ml). Furthermore, AGE-BSA partially inhibited (by <30%) the selective uptake of HDL-CE in human hepatocarcinoma HepG2 cells (IC50 <30 mug/ml). In addition, [H-3]cholesterol efflux from CHO-SR-BI cells to HDL was significantly inhibited by AGE-BSA in a dose-dependent manner (IC50 <30 <mu>g/ml), Our results indicate that AGE proteins, as ligands for SR-BI, effectively inhibit both SR-BI-mediated selective uptake of HDL-CE and cholesterol efflux from peripheral cells to HDL, suggesting that AGE proteins might modulate SR-BI-mediated cholesterol metabolism in vivo.	Kumamoto Univ, Sch Med, Dept Biochem, Kumamoto 8600811, Japan; Kumamoto Univ, Fac Pharmaceut Sci, Dept Biofunct Chem, Kumamoto 8620973, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, Tokyo 1130033, Japan	Kumamoto University; Kumamoto University; University of Tokyo	Horiuchi, S (corresponding author), Kumamoto Univ, Sch Med, Dept Biochem, 2-2-1 Honjo, Kumamoto 8600811, Japan.		Ohgami, Nobutaka/I-4572-2014					Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Arai T, 1999, P NATL ACAD SCI USA, V96, P12050, DOI 10.1073/pnas.96.21.12050; ARAKI N, 1995, EUR J BIOCHEM, V230, P408, DOI 10.1111/j.1432-1033.1995.0408h.x; ARAKI N, 1992, J BIOL CHEM, V267, P10211; Azhar S, 1998, J LIPID RES, V39, P1616; Calvo D, 1997, ARTERIOSCL THROM VAS, V17, P2341, DOI 10.1161/01.ATV.17.11.2341; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; ESPOSITO C, 1989, J EXP MED, V170, P1387, DOI 10.1084/jem.170.4.1387; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Finot P. A., 1982, Advances in Chemistry Series, V198, P91; Fukasawa M, 1996, EXP CELL RES, V222, P246, DOI 10.1006/excr.1996.0030; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; GLASS C, 1985, J BIOL CHEM, V260, P744; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Hirano K, 1999, CIRC RES, V85, P108; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Iwashima Y, 1999, BIOCHEM BIOPH RES CO, V264, P441, DOI 10.1006/bbrc.1999.1539; Iwashima Y, 2000, BIOCHEM BIOPH RES CO, V277, P368, DOI 10.1006/bbrc.2000.3685; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; KIRSTEIN M, 1992, J CLIN INVEST, V90, P439, DOI 10.1172/JCI115879; KIRSTEIN M, 1990, P NATL ACAD SCI USA, V87, P9010, DOI 10.1073/pnas.87.22.9010; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; KUME S, 1995, AM J PATHOL, V147, P654; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Li YM, 1996, P NATL ACAD SCI USA, V93, P11047, DOI 10.1073/pnas.93.20.11047; Ling X, 1998, LAB INVEST, V78, P1591; LYONS TJ, 1994, DIABETES, V43, P1090, DOI 10.2337/diabetes.43.9.1090; Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; Matsumoto K, 2000, BIOCHEM J, V352, P233, DOI 10.1042/0264-6021:3520233; MITSUHASHI T, 1993, DIABETES, V42, P826, DOI 10.2337/diabetes.42.6.826; MIYATA T, 1993, J CLIN INVEST, V92, P1243, DOI 10.1172/JCI116696; MIYATA T, 1994, J CLIN INVEST, V93, P521, DOI 10.1172/JCI117002; MIYAZAKI A, 1994, J BIOL CHEM, V269, P5264; Nagai R, 1998, FEBS LETT, V425, P355, DOI 10.1016/S0014-5793(98)00263-4; NAKAMURA Y, 1993, AM J PATHOL, V143, P1649; NAKAYAMA H, 1993, DIABETES, V42, P345, DOI 10.2337/diabetes.42.2.345; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ohgami N, 2000, BIOCHEM BIOPH RES CO, V277, P417, DOI 10.1006/bbrc.2000.3681; Ohgami N, 2001, J BIOL CHEM, V276, P3195, DOI 10.1074/jbc.M006545200; PFEUFFER MA, 1992, ARTERIOSCLER THROMB, V12, P870, DOI 10.1161/01.ATV.12.7.870; Rhainds D, 1999, EUR J BIOCHEM, V261, P227, DOI 10.1046/j.1432-1327.1999.00264.x; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; SAKAI M, 1994, J BIOL CHEM, V269, P31430; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; SCHMIDT AM, 1993, J CLIN INVEST, V91, P2155, DOI 10.1172/JCI116442; Sehayek E, 1998, P NATL ACAD SCI USA, V95, P10194, DOI 10.1073/pnas.95.17.10194; SILVERSTEIN RL, 1989, J CLIN INVEST, V84, P546, DOI 10.1172/JCI114197; SKOLNIK EY, 1991, J EXP MED, V174, P931, DOI 10.1084/jem.174.4.931; Stitt AW, 2000, FASEB J, V14, P2390; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Swarnakar S, 1999, J BIOL CHEM, V274, P29733, DOI 10.1074/jbc.274.42.29733; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Temel RE, 1997, P NATL ACAD SCI USA, V94, P13600, DOI 10.1073/pnas.94.25.13600; TEZUKA M, 1993, BIOCHEM BIOPH RES CO, V193, P674, DOI 10.1006/bbrc.1993.1677; Uittenbogaard A, 2000, J BIOL CHEM, V275, P11278, DOI 10.1074/jbc.275.15.11278; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604; VLASSARA H, 1988, SCIENCE, V240, P1546, DOI 10.1126/science.3259727; VLASSARA H, 1994, LAB INVEST, V70, P138; Williams DL, 1999, CURR OPIN LIPIDOL, V10, P329, DOI 10.1097/00041433-199908000-00007; YAMADA K, 1994, CLIN NEPHROL, V42, P354; YUI S, 1994, J IMMUNOL, V152, P1943	72	131	132	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13348	13355		10.1074/jbc.M011613200	http://dx.doi.org/10.1074/jbc.M011613200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278947	hybrid			2022-12-27	WOS:000168198600121
J	Puente, E; Saint-Laurent, N; Torrisani, J; Furet, C; Schally, AV; Vaysse, N; Buscail, L; Susini, C				Puente, E; Saint-Laurent, N; Torrisani, J; Furet, C; Schally, AV; Vaysse, N; Buscail, L; Susini, C			Transcriptional activation of mouse sst2 somatostatin receptor promoter by transforming growth factor-beta - Involvement of Smad4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-CANCER CELLS; TUMOR-SUPPRESSOR GENE; TYROSINE PHOSPHATASE SHP-1; TGF-BETA; P21(WAF1) EXPRESSION; SIGNALING PATHWAYS; SEQUENCE-ANALYSIS; BINDING PROTEIN; UP-REGULATION; C/EBP FAMILY	The sst2 somatostatin receptor is an inhibitory G protein-coupled receptor, which exhibits anti-tumor properties. Expression of sst2 is lost in most human pancreatic cancers. We have cloned 2090 base pairs corresponding to the genomic DNA region upstream of the mouse sst2 (msst2) translation initiation codon (ATG). Deletion reporter analyses in mouse pituitary AtT-20 and human pancreatic cancer PANC-1, BxPC-3, and Capan-1 cells identify a region from nucleotide -260 to the ATC: codon (325 base pairs) showing maximal activity, and a region between nucleotides -2025 and -260 likely to comprise silencer or transcriptional suppressor elements. In PANC-1 and AtT-20 cells, transforming growth factor (TGF)-beta up-regulates msst2 transcription. Transactivation is mediated by Smad4 and Smad3, The cis-acting region responsible for such regulation is comprised between nucleotides -1115 and -972 and includes Spl and CAGA-box sequences. Expression of Smad4 in Smad l-deficient Capan-1 and BxPC-3 cells restores TGF-beta -dependent and -independent msst2 transactivation. Expression of Smad4 in BxPC-3 cells reestablishes both endogenous sst2 expression and somatostatin-mediated inhibition of cell growth. These findings demonstrate that msst2 is a new target gene for TGF-beta transcription regulation and underlie the possibility that loss of Smad4 contributes to the lack of sst2 expression in human pancreatic cancer, which in turn may contribute to a stimulation of tumor growth.	Inst Louis Bugnard, INSERM, U531, F-31403 Toulouse, France; Tulane Univ, Dept Med, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Vet Affairs Med Ctr, New Orleans, LA 70112 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Tulane University; Tulane University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Susini, C (corresponding author), Inst Louis Bugnard, INSERM, U531, IFR 311,Av Jean Poulhes,CHU Rangueil Bat L3, F-31403 Toulouse, France.		Nathalie, Saint-Laurent/G-5487-2017; Torrisani, Jérôme/M-6203-2014	Torrisani, Jérôme/0000-0001-6880-9357; Schally, Andrew/0000-0003-1273-6747				Baldwin RL, 1996, INT J CANCER, V67, P283, DOI 10.1002/(SICI)1097-0215(19960717)67:2<283::AID-IJC21>3.0.CO;2-B; Bottinger EP, 1997, EMBO J, V16, P2621, DOI 10.1093/emboj/16.10.2621; Bousquet C, 1998, J BIOL CHEM, V273, P7099, DOI 10.1074/jbc.273.12.7099; BRUNO JF, 1994, BIOCHEM BIOPH RES CO, V202, P1738, DOI 10.1006/bbrc.1994.2136; BUSCAIL L, 1995, P NATL ACAD SCI USA, V92, P1580, DOI 10.1073/pnas.92.5.1580; Buscail L, 1996, CANCER RES, V56, P1823; BUSCAIL L, 1994, P NATL ACAD SCI USA, V91, P2315, DOI 10.1073/pnas.91.6.2315; CASTRILLO JL, 1991, SCIENCE, V253, P197, DOI 10.1126/science.1677216; CHEN QK, 1995, COMPUT APPL BIOSCI, V11, P563; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Delesque N, 1997, CANCER RES, V57, P956; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DROLET DW, 1991, GENE DEV, V5, P1739, DOI 10.1101/gad.5.10.1739; EPELBAUM J, 1994, CRIT REV NEUROBIOL, V8, P25; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIESS H, 1993, GASTROENTEROLOGY, V105, P846; Grau AM, 1997, CANCER RES, V57, P3929; GREENWOOD MT, 1995, GENE, V159, P291, DOI 10.1016/0378-1119(95)00059-F; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; HAUSER F, 1994, FEBS LETT, V345, P225, DOI 10.1016/0014-5793(94)00444-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hunt KK, 1998, CANCER RES, V58, P5656; Jiang JG, 1997, MOL CELL BIOL, V17, P5758, DOI 10.1128/MCB.17.10.5758; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kleeff J, 1998, J BIOL CHEM, V273, P7495, DOI 10.1074/jbc.273.13.7495; Korc M, 1998, Surg Oncol Clin N Am, V7, P25; Kraus J, 1998, FEBS LETT, V428, P165, DOI 10.1016/S0014-5793(98)00520-1; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; LEDAI J, 1998, CANCER RES, V58, P4592; LI JM, 1995, J BIOL CHEM, V270, P26750, DOI 10.1074/jbc.270.45.26750; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Lopez F, 1997, J BIOL CHEM, V272, P24448, DOI 10.1074/jbc.272.39.24448; Luo X, 1996, P NATL ACAD SCI USA, V93, P1308, DOI 10.1073/pnas.93.3.1308; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Osada S, 1996, J BIOL CHEM, V271, P3891; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Pscherer A, 1996, EMBO J, V15, P6680, DOI 10.1002/j.1460-2075.1996.tb01058.x; Rochaix P, 1999, HUM GENE THER, V10, P995, DOI 10.1089/10430349950018391; Sambrook J., 2002, MOL CLONING LAB MANU; Sarret P, 1999, J BIOL CHEM, V274, P19294, DOI 10.1074/jbc.274.27.19294; Takeba Y, 1997, ARTHRITIS RHEUM, V40, P2128, DOI 10.1002/art.1780401206; Taylor LM, 2000, J BIOL CHEM, V275, P16709, DOI 10.1074/jbc.275.22.16709; VIDAL C, 1994, MOL PHARMACOL, V46, P97; Villanueva A, 1998, ONCOGENE, V17, P1969, DOI 10.1038/sj.onc.1202118; Vindevoghel L, 1998, J BIOL CHEM, V273, P13053, DOI 10.1074/jbc.273.21.13053; Wagner M, 1998, INT J CANCER, V78, P255, DOI 10.1002/(SICI)1097-0215(19981005)78:2<255::AID-IJC21>3.0.CO;2-8; WEDEL A, 1995, IMMUNOBIOLOGY, V193, P171, DOI 10.1016/S0171-2985(11)80541-3; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; XU Y, 1995, ENDOCRINOLOGY, V136, P5070, DOI 10.1210/en.136.11.5070; Xu Y, 1998, MOL CELL ENDOCRINOL, V139, P71, DOI 10.1016/S0303-7207(98)00072-0; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	57	26	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13461	13468		10.1074/jbc.M010981200	http://dx.doi.org/10.1074/jbc.M010981200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278805	hybrid			2022-12-27	WOS:000168198600135
J	Sabri, A; Bare, G; Jacques, P; Jabrane, A; Ongena, M; Van Heugen, JC; Devreese, B; Thonart, P				Sabri, A; Bare, G; Jacques, P; Jabrane, A; Ongena, M; Van Heugen, JC; Devreese, B; Thonart, P			Influence of moderate temperatures on myristoyl-CoA metabolism and acyl-CoA thioesterase activity in the psychrophilic antarctic yeast Rhodotorula aurantiaca	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-SYNTHETASE; PROTEIN N-MYRISTOYLTRANSFERASE; COENZYME-A CARBOXYLASE; SACCHAROMYCES-CEREVISIAE; RAT-LIVER; COLD ADAPTATION; BINDING-PROTEIN; PURIFICATION; HYDROLASE; ESTERS	The inability of psychrophilic microorganisms to grow at moderate temperatures (>20 degreesC) presently represents an unresolved thermodynamic paradox. Here we report for the psychrophilic yeast Rhodotorula aurantiaca A19, isolated from Antarctic ice, that the inability to grow at temperatures close to 20 degreesC is associated with profound alterations in cell morphology and integrity. High performance liquid chromatography analysis of the intracellular acyl-CoA esters revealed an abnormal accumulation of myristoyl-CoA (C14-CoA) in cells cultivated close to the nonpermissive temperature. Its concentration (500 muM) was found to be 28-fold higher than in cells cultivated at 0 degreesC, If one considers its ability to disrupt membrane bilayers and to inhibit many cellular enzymes and functions, intracellular myristoyl-CoA accumulation in the psychrophile R, aurantiaca represents one of the principal causes of growth arrest at moderate temperatures. Intracellular acyl-CoA concentrations are believed to be regulated by thioesterase activity. Thus in an attempt to explore the mechanism by which temperature disrupts myristoyl-CoA metabolism, we isolated and characterized a long chain acyl-CoA thioesterase, The monomeric 80-kDa thioesterase from the psychrophilic yeast shows a very strong specificity for myristoyl-CoA The affinity for substrate and the catalytic efficiency of the thioesterase are optimal below 5 degreesC (temperatures habitually experienced by the strain) and dramatically decrease with increasing temperature. The loss of affinity for substrate is related to the intracellular increase of myristoyl-CoA concentration. Our observations reveal one of the probable mechanisms by which temperature fixes the limit of growth for this psychrophilic yeast.	Univ Liege, Ctr Wallon Biol Ind B40, B-4000 Liege, Belgium; Univ Liege, CHU Sart Tilman, Lab Chim Med B35, B-4000 Liege, Belgium; Lab Eiwitbiochem Eiwitengn, B-9000 Ghent, Belgium	University of Liege; University of Liege	Sabri, A (corresponding author), Univ Liege, Ctr Wallon Biol Ind B40, B40,Sart Tilman, B-4000 Liege, Belgium.		Devreese, Bart/B-2011-2009; Devreese, Bart/K-2841-2019	Devreese, Bart/0000-0002-9764-2581; Devreese, Bart/0000-0002-9764-2581				BERGE RK, 1985, BIOCHIM BIOPHYS ACTA, V837, P141, DOI 10.1016/0005-2760(85)90237-1; BERGE RK, 1979, EUR J BIOCHEM, V96, P393, DOI 10.1111/j.1432-1033.1979.tb13051.x; BERGE RK, 1979, BIOCHIM BIOPHYS ACTA, V574, P321, DOI 10.1016/0005-2760(79)90013-4; BHAKOO M, 1979, ARCH MICROBIOL, V121, P121, DOI 10.1007/BF00689975; BHAKOO M, 1980, ARCH MICROBIOL, V126, P51, DOI 10.1007/BF00421890; BOYLAN JG, 1992, BIOCHEMISTRY-US, V31, P557, DOI 10.1021/bi00117a037; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAVAIL S, 1994, J BIOL CHEM, V269, P17448; DURONIO RJ, 1992, J CELL BIOL, V117, P515, DOI 10.1083/jcb.117.3.515; DURONIO RJ, 1991, J CELL BIOL, V113, P1313, DOI 10.1083/jcb.113.6.1313; EKENA K, 1995, MOL CELL BIOL, V15, P1671; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Feller G, 1997, CELL MOL LIFE SCI, V53, P830, DOI 10.1007/s000180050103; Feller G, 1996, FEMS MICROBIOL REV, V18, P189, DOI 10.1016/0168-6445(96)00011-3; FELLER G, 1992, J BIOL CHEM, V267, P5217; HAMAMOTO T, 1995, FEMS MICROBIOL LETT, V129, P51; HENRY SA, 1971, MOL GEN GENET, V113, P1; Hochachka P.W., 1984, BIOCHEMICAL ADAPTATI, P355; HORI T, 1987, J BIOCHEM-TOKYO, V101, P949, DOI 10.1093/oxfordjournals.jbchem.a121964; INNISS WE, 1975, ANNU REV MICROBIOL, V29, P445, DOI 10.1146/annurev.mi.29.100175.002305; JOHNSON DR, 1994, J BIOL CHEM, V269, P18037; KNOLL LJ, 1992, J BIOL CHEM, V267, P5366; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; KUHN L, 1972, EUR J BIOCHEM, V24, P492, DOI 10.1111/j.1432-1033.1972.tb19711.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; MISHINA M, 1980, EUR J BIOCHEM, V111, P79; MORITA RY, 1975, BACTERIOL REV, V39, P144, DOI 10.1128/MMBR.39.2.144-167.1975; NORWOOD DL, 1990, J CHROMATOGR-BIOMED, V527, P289, DOI 10.1016/S0378-4347(00)82113-1; PALTAUF F, 1992, MOL CELLULAR BIOL YE, V2, P415; PRASAD MR, 1987, ANAL BIOCHEM, V162, P202, DOI 10.1016/0003-2697(87)90028-5; ROE CR, 1986, J PEDIATR-US, V108, P13, DOI 10.1016/S0022-3476(86)80762-4; ROTHMAN JH, 1990, CELL, V61, P1063, DOI 10.1016/0092-8674(90)90070-U; RUOHO AE, 1989, J BIOL CHEM, V264, P41168; RUSSELL NJ, 1990, PHILOS T ROY SOC B, V326, P595, DOI 10.1098/rstb.1990.0034; RUSSELL NJ, 1990, FEMS MICROBIOL LETT, V75, P171, DOI 10.1016/0378-1097(90)90530-4; Sabri A, 2000, APPL BIOCHEM BIOTECH, V84-6, P391, DOI 10.1385/ABAB:84-86:1-9:391; SHUG AL, 1975, AM J PHYSIOL, V228, P639; SINGH N, 1985, BIOCHEMISTRY-US, V24, P6598, DOI 10.1021/bi00344a044; SOMERO GN, 1968, BIOCHEM J, V110, P395, DOI 10.1042/bj1100395; SOMERO GN, 1975, J EXP ZOOL, V194, P175, DOI 10.1002/jez.1401940111; SRERE PA, 1959, BIOCHIM BIOPHYS ACTA, V33, P313, DOI 10.1016/0006-3002(59)90118-0; Svensson LT, 1998, BIOCHEM J, V329, P601, DOI 10.1042/bj3290601; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; WAKU K, 1992, BIOCHIM BIOPHYS ACTA, V1124, P101, DOI 10.1016/0005-2760(92)90085-A	45	10	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12691	12696		10.1074/jbc.M100155200	http://dx.doi.org/10.1074/jbc.M100155200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11279019	hybrid			2022-12-27	WOS:000168198600031
J	Cabral, A; Voskamp, P; Cleton-Jansen, AM; South, A; Nizetic, D; Backendorf, C				Cabral, A; Voskamp, P; Cleton-Jansen, AM; South, A; Nizetic, D; Backendorf, C			Structural organization and regulation of the small proline-rich family of cornified envelope precursors suggest a role in adaptive barrier function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL DIFFERENTIATION COMPLEX; TRANSGLUTAMINASE SUBSTRATE PROPERTIES; CELL-ENVELOPE; EXPRESSION; PROTEINS; GENES; KERATINOCYTE; INVOLUCRIN; EVOLUTION; MARKERS	The protective barrier provided by stratified squamous epithelia relies on the cornified cell envelope (CE), a structure synthesized at late stages of keratinocyte differentiation. It is composed of structural proteins, including involucrin, loricrin, and the small proline-rich (SPRR) proteins, all encoded by genes localized at human chromosome 1q21, The genetic characterization of the SPRR locus reveals that the various members of this multigene family can be classified into two distinct groups with separate evolutionary histories. Whereas group 1 genes have diverged in protein structure and are composed of three different classes (SPRR1 (2x), SPRR3, and SPRR4), an active process of gene conversion has counteracted diversification of the protein sequences of group 2 genes (SPRR2 class, seven genes). Contrasting with this homogenization process, all individual members of the SPRR gene family show specific in vivo and in vitro expression patterns and react selectively to UV irradiation. Apparently, creation of regulatory rather than structural diversity has been the driving force behind the evolution of the SPRR gene family. Differential regulation of highly homologous genes underlines the importance of SPRR protein dosage in providing optimal barrier function to different epithelia, while allowing adaptation to diverse external insults.	Leiden Inst Chem, Dept Mol Genet, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; Univ London, Sch Pharm, Ctr Appl Mol Biol, London WC1N 1AX, England	Leiden University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; University of London School of Pharmacy	Backendorf, C (corresponding author), Gorlaeus Labs, Mol Genet Lab, POB 9502, NL-2300 RA Leiden, Netherlands.	Backendo@chem.leidenuniv.ni	Cabral, Adriana/AAX-3284-2021; Nizetic, Dean/F-9509-2015	Nizetic, Dean/0000-0001-5486-5761				Abraham JM, 1996, CELL GROWTH DIFFER, V7, P855; AN G, 1993, J BIOL CHEM, V268, P10977; BACKENDORF C, 1992, NAT GENET, V2, P91, DOI 10.1038/ng1092-91; BELT PBGM, 1989, GENE, V84, P407, DOI 10.1016/0378-1119(89)90515-5; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Candi E, 1999, J BIOL CHEM, V274, P7226, DOI 10.1074/jbc.274.11.7226; Candi E, 1999, BIOCHEM BIOPH RES CO, V262, P395, DOI 10.1006/bbrc.1999.1215; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; Fischer DF, 1999, GENOMICS, V55, P88, DOI 10.1006/geno.1998.5622; Fischer DF, 1996, MOL CELL BIOL, V16, P5365, DOI 10.1128/mcb.16.10.5365; FUJIMOTO W, 1993, J INVEST DERMATOL, V101, P268, DOI 10.1111/1523-1747.ep12365200; GARMYN M, 1992, J INVEST DERMATOL, V99, P743, DOI 10.1111/1523-1747.ep12614470; GIBBS S, 1990, NUCLEIC ACIDS RES, V18, P4401, DOI 10.1093/nar/18.15.4401; GIBBS S, 1993, GENOMICS, V16, P630, DOI 10.1006/geno.1993.1240; Gosden R, 1997, BRIT MED BULL, V53, P644; HOHL D, 1990, DERMATOLOGICA, V180, P201, DOI 10.1159/000248031; HOHL D, 1995, J INVEST DERMATOL, V104, P902, DOI 10.1111/1523-1747.ep12606176; ISHIDAYAMAMOTO A, 1995, ARCH DERMATOL RES, V287, P705, DOI 10.1007/BF01105793; IVENS AC, 1995, DNA CLONING, V3, P1; Jarnik M, 1996, J CELL SCI, V109, P1381; Jetten AM, 1996, MOL CELL ENDOCRINOL, V123, P7, DOI 10.1016/0303-7207(96)03871-3; Kartasova T, 1996, J INVEST DERMATOL, V106, P294, DOI 10.1111/1523-1747.ep12340741; KARTASOVA T, 1988, MOL CELL BIOL, V8, P2195, DOI 10.1128/MCB.8.5.2195; KARTASOVA T, 1988, MOL CELL BIOL, V8, P2204, DOI 10.1128/MCB.8.5.2204; KARTASOVA T, 1995, J INVEST DERMATOL, V104, P611; Lee CH, 2000, FEBS LETT, V477, P268, DOI 10.1016/S0014-5793(00)01806-8; Lee YS, 1998, J INVEST DERMATOL, V111, P762, DOI 10.1046/j.1523-1747.1998.00365.x; Li W. H, 1997, MOL EVOLUTION; Lohman FP, 1997, EXP CELL RES, V231, P141, DOI 10.1006/excr.1996.3458; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; Marshall D, 2000, J INVEST DERMATOL, V114, P967, DOI 10.1046/j.1523-1747.2000.00955.x; MARTINET N, 1988, J BIOL CHEM, V263, P4236; MATOLTSY AG, 1966, J INVEST DERMATOL, V46, P127, DOI 10.1038/jid.1966.19; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; NIZETIC D, 1994, MAMM GENOME, V5, P801, DOI 10.1007/BF00292017; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; Salamonsen LA, 1999, BEST PRACT RES CL OB, V13, P161, DOI 10.1053/beog.1999.0015; Sark MWJ, 1998, J BIOL CHEM, V273, P24683, DOI 10.1074/jbc.273.38.24683; SAUNDERS NA, 1993, BIOCHEM BIOPH RES CO, V197, P46, DOI 10.1006/bbrc.1993.2439; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Song HJ, 1999, GENOMICS, V55, P28, DOI 10.1006/geno.1998.5607; South AP, 1999, J INVEST DERMATOL, V112, P910, DOI 10.1046/j.1523-1747.1999.00613.x; Steinert PM, 1998, J STRUCT BIOL, V122, P76, DOI 10.1006/jsbi.1998.3957; Steinert PM, 1999, MOL BIOL CELL, V10, P4247, DOI 10.1091/mbc.10.12.4247; Steinert PM, 1998, J BIOL CHEM, V273, P11758, DOI 10.1074/jbc.273.19.11758; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Steinert PM, 1997, J BIOL CHEM, V272, P2021, DOI 10.1074/jbc.272.3.2021; Tarcsa E, 1998, J BIOL CHEM, V273, P23297, DOI 10.1074/jbc.273.36.23297; Tesfaigzi J, 1996, EXP CELL RES, V228, P277, DOI 10.1006/excr.1996.0327; VOLZ A, 1993, GENOMICS, V18, P92, DOI 10.1006/geno.1993.1430; Xu XC, 1999, CLIN CANCER RES, V5, P1503; YAAR M, 1995, EXP CELL RES, V217, P217, DOI 10.1006/excr.1995.1081	54	132	143	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19231	19237		10.1074/jbc.M100336200	http://dx.doi.org/10.1074/jbc.M100336200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279051	hybrid			2022-12-27	WOS:000169091000080
J	Roszmusz, E; Patthy, A; Trexler, M; Patthy, L				Roszmusz, E; Patthy, A; Trexler, M; Patthy, L			Localization of disulfide bonds in the frizzled module of Ror1 receptor tyrosine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE ROBINOW-SYNDROME; BRACHYDACTYLY TYPE-B; STRUCTURAL FEATURES; NEURAL NETWORKS; NERVOUS-SYSTEM; CRD DOMAIN; PROTEIN; MUSK; FAMILY; MUTATIONS	The frizzled (FRZ) module is a novel module type that was first identified in G-protein-coupled receptors of the frizzled and smoothened families and has since been shown to be present in several secreted frizzled-related proteins, in some modular proteases, in collagen XVIII, and in various receptor tyrosine kinases of the Bor family, The FRZ modules constitute the extracellular ligand-binding region of frizzled receptors and are known to mediate signals of WNT family members through these receptors, With an eye toward defining the structure of this important module family, we have expressed the FRZ domain of rat Ror1 receptor tyrosine kinase in Pichia pastoris, By proteolytic digestion and amino acid sequencing the disulfide bonds were found to connect the 10 conserved cysteines in a 1-5, 2-4, 3-8, 6-10, and 7-9 pattern. Circular dichroism and differential scanning calorimetry studies on the recombinant protein indicate that the disulfide-bonded FRZ module corresponds to a single, compact, and remarkably stable folding domain possessing both alpha -helices and beta -strands.	Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1518 Budapest, Hungary; Agr Biotechnol Ctr, H-2100 Godollo, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Patthy, L (corresponding author), Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, POB 7, H-1518 Budapest, Hungary.		Patthy, Laszlo/A-2353-2013; Patthy, Laszlo/Q-6058-2019					Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; GRINNA LS, 1989, YEAST, V5, P107, DOI 10.1002/yea.320050206; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Oishi I, 1997, J BIOL CHEM, V272, P11916, DOI 10.1074/jbc.272.18.11916; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Rehn M, 1998, TRENDS BIOCHEM SCI, V23, P415, DOI 10.1016/S0968-0004(98)01290-0; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Rost B, 1996, METHOD ENZYMOL, V266, P525; ROST B, 1995, 3 INT C INT SYST MOL, P314; Saldanha J, 1998, PROTEIN SCI, V7, P1632, DOI 10.1002/pro.5560070718; Steinlein LM, 1998, BIOCHEMISTRY-US, V37, P13696, DOI 10.1021/bi980318s; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Tomita Y, 1998, J BIOCHEM-TOKYO, V124, P784, DOI 10.1093/oxfordjournals.jbchem.a022180; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; WILSON C, 1993, P NATL ACAD SCI USA, V90, P7109, DOI 10.1073/pnas.90.15.7109; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	30	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18485	18490		10.1074/jbc.M100100200	http://dx.doi.org/10.1074/jbc.M100100200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279007	hybrid			2022-12-27	WOS:000168866500116
J	Binder, RJ; Blachere, NE; Srivastava, PK				Binder, RJ; Blachere, NE; Srivastava, PK			Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOTOXIC-T-CELLS; ANTIGEN PRESENTATION; IMMUNOSUPPRESSANT 15-DEOXYSPERGUALIN; ENDOPLASMIC-RETICULUM; GP96; TAP; PURIFICATION; LYMPHOCYTES; BINDING; ELICIT	The studies reported here bear on the events in the cytosol that lead to trafficking of peptides during antigen processing and presentation by major histocompatibility complex (MHC) I molecules. We have introduced free antigenic peptides or antigenic peptides bound to serum albumin or to cytosolic heat shock proteins hsp90 (and its endoplasmic reticular homologue gp96) or hsp70 into the cytosol of living cells and have monitored the presentation of the peptides by appropriate MHC I molecules. The experiments show that (i) free peptides or serum albumin-bound peptides, introduced into the cytosol, become ligands of MHC I molecules at a far lower efficiency than peptides chaperoned by any of the heat shock proteins tested and (ii) treatment of cells with deoxyspergualin, a drug that binds hsp70 and hsp90 with apparent specificity, abrogates the ability of cells to present antigenic peptides through MHC I molecules, and introduction of additional hsp70 into the cytosol overcomes this abrogation. These results suggest for the first time a functional role font cytosolic chaperones in antigen processing.	Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT 06030 USA	University of Connecticut	Srivastava, PK (corresponding author), Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, MC1601, Farmington, CT 06030 USA.	srivastava@nso2.uchc.edu			NATIONAL CANCER INSTITUTE [R01CA064394, R29CA044786, R01CA044786] Funding Source: NIH RePORTER; NCI NIH HHS [CA44786, CA64394] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Arnold D, 1997, J EXP MED, V186, P461, DOI 10.1084/jem.186.3.461; ARNOLD D, 1995, J EXP MED, V182, P885, DOI 10.1084/jem.182.3.885; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Breloer M, 1998, EUR J IMMUNOL, V28, P1016, DOI 10.1002/(SICI)1521-4141(199803)28:03<1016::AID-IMMU1016>3.0.CO;2-G; CLEAVELAND JS, 1993, BIOCHEM BIOPH RES CO, V195, P455, DOI 10.1006/bbrc.1993.2065; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; DENIS M, 1988, ANAL BIOCHEM, V173, P405, DOI 10.1016/0003-2697(88)90207-2; Ellis RJ, 1999, CURR BIOL, V9, pR137; Forster C, 1998, FEMS MICROBIOL LETT, V167, P209; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; HEIKE M, 1994, J IMMUNOTHER, V15, P165, DOI 10.1097/00002371-199404000-00002; HOSKEN NA, 1992, J EXP MED, V175, P719, DOI 10.1084/jem.175.3.719; Ishii T, 1999, J IMMUNOL, V162, P1303; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LUNGGREN HG, 1985, J EXP MED, V162, P1745; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; NADEAU K, 1994, BIOCHEMISTRY-US, V33, P2561, DOI 10.1021/bi00175a027; NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548; Nadler SG, 1998, BIOCHEM BIOPH RES CO, V253, P176, DOI 10.1006/bbrc.1998.9775; Nieland TJF, 1996, P NATL ACAD SCI USA, V93, P6135, DOI 10.1073/pnas.93.12.6135; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Peng P, 1997, J IMMUNOL METHODS, V204, P13, DOI 10.1016/S0022-1759(97)00017-3; PUDDINGTON L, 1986, J VIROL, V60, P708, DOI 10.1128/JVI.60.2.708-717.1986; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Spee P, 1997, EUR J IMMUNOL, V27, P2441, DOI 10.1002/eji.1830270944; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; SRIVASTAVA PK, 1991, CURR TOP MICROBIOL, V167, P109; SRIVASTAVA PK, 1997, IMMUNOLOGY METHODS M, P739; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; TEVETHIA SS, 1990, J VIROL, V64, P1192, DOI 10.1128/JVI.64.3.1192-1200.1990; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; Wells AD, 1998, INT IMMUNOL, V10, P609, DOI 10.1093/intimm/10.5.609; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266	38	175	193	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17163	17171		10.1074/jbc.M011547200	http://dx.doi.org/10.1074/jbc.M011547200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278929	hybrid			2022-12-27	WOS:000168730400076
J	Kleifeld, O; Kotra, LP; Gervasi, DC; Brown, S; Bernardo, MM; Fridman, R; Mobashery, S; Sagi, I				Kleifeld, O; Kotra, LP; Gervasi, DC; Brown, S; Bernardo, MM; Fridman, R; Mobashery, S; Sagi, I			X-ray absorption studies of human matrix metalloproteinase-2 (MMP-2) bound to a highly selective mechanism-based inhibitor - Comparison with the latent and active forms of the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FIBROBLAST COLLAGENASE; C-TERMINAL DOMAIN; CATALYTIC DOMAIN; TISSUE INHIBITOR; CRYSTAL-STRUCTURE; EXTRACELLULAR-MATRIX; GELATINASE-B; BINDING; STROMELYSIN-1; ZINC	Malignant tumors express high levels of zinc-dependent endopeptidases called matrix metalloproteinases (MMPs), which are thought to facilitate tumor metastasis and angiogenesis by hydrolyzing components of the extracellular matrix. Of these enzymes, gelatinases A (MMP-2) and B (MMP-9), have especially been implicated in malignant processes, and thus, they have been a target for drugs designed to block their activity. Therefore, understanding their molecular structure is key for a rational approach to inhibitor design. Here, we have conducted x-ray absorption spectroscopy of the full-length human MMP-2 in its latent, active, and inhibited states and report the structural changes at the zinc ion site upon enzyme activation and inhibition. We have also examined the molecular structure of MMP-2 in com plex with SB-3CT, a recently reported novel mechanism-based synthetic inhibitor that was designed to be highly selective in gelatinases (1). It is shown that SB-3CT directly binds the catalytic zinc ion of MMP-2. Interestingly, the novel mode of binding of the inhibitor to the catalytic zinc reconstructs the conformational environment around the active site metal ion back to that of the proenzyme.	Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; Wayne State Univ, Dept Chem Pharmacol & Biochem & Mol Biol, Detroit, MI 48202 USA	Weizmann Institute of Science; Wayne State University; Wayne State University	Sagi, I (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.		Kleifeld, Oded/G-7304-2012	Kotra, Lakshmi P./0000-0002-7071-4637	NCI NIH HHS [CA-82298, CA-61986] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061986, R01CA082298] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbruzzese TA, 1998, SURGERY, V124, P328, DOI 10.1016/S0039-6060(98)70138-2; Akizawa T, 1999, ANN NY ACAD SCI, V878, P622, DOI 10.1111/j.1749-6632.1999.tb07744.x; Almstead NG, 1999, J MED CHEM, V42, P4547, DOI 10.1021/jm990330y; BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; Betz M, 1997, EUR J BIOCHEM, V247, P356, DOI 10.1111/j.1432-1033.1997.00356.x; Bigatel DA, 1999, J VASC SURG, V29, P130, DOI 10.1016/S0741-5214(99)70354-X; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Campbell DA, 1998, BIOORG MED CHEM LETT, V8, P1157, DOI 10.1016/S0960-894X(98)00185-1; CASE DA, 1999, AMBER 6 0 COMPUTER P; CRABBE T, 1992, BIOCHEMISTRY-US, V31, P8500, DOI 10.1021/bi00151a017; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; GRAMS F, 1995, BIOCHEMISTRY-US, V34, P14012, DOI 10.1021/bi00043a007; Kiyama R, 1999, J MED CHEM, V42, P1723, DOI 10.1021/jm980514x; Kleifeld O, 2000, J BIOL CHEM, V275, P34335, DOI 10.1074/jbc.M005714200; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; LOVEJOY B, 1994, BIOCHEMISTRY-US, V33, P8207, DOI 10.1021/bi00193a006; LOVEJOY B, 1994, SCIENCE, V263, P375, DOI 10.1126/science.8278810; LOWRY CL, 1992, PROTEINS, V12, P42, DOI 10.1002/prot.340120106; Massova I, 1998, BIOORG MED CHEM LETT, V8, P853, DOI 10.1016/S0960-894X(98)00128-0; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MURPHY G, 1995, METHOD ENZYMOL, V248, P470; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; REHR JJ, 1991, J AM CHEM SOC, V113, P5135, DOI 10.1021/ja00014a001; SALOWE SP, 1992, BIOCHEMISTRY-US, V31, P4535, DOI 10.1021/bi00134a001; SCOTT RA, 1985, METHOD ENZYMOL, V117, P414; SPRINGMAN EB, 1995, BIOCHEMISTRY-US, V34, P15713, DOI 10.1021/bi00048a016; STERN EA, 1995, PHYSICA B, V208, P117, DOI 10.1016/0921-4526(94)00826-H; Tyagi SC, 1996, J CELL PHYSIOL, V167, P137, DOI 10.1002/(SICI)1097-4652(199604)167:1<137::AID-JCP16>3.0.CO;2-8; Vallon R, 1997, EUR J BIOCHEM, V244, P81, DOI 10.1111/j.1432-1033.1997.00081.x; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WILLENBROCK F, 1995, FEBS LETT, V358, P189, DOI 10.1016/0014-5793(94)01421-V; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995	43	63	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17125	17131		10.1074/jbc.M011604200	http://dx.doi.org/10.1074/jbc.M011604200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278946	hybrid			2022-12-27	WOS:000168730400071
J	Dalle, S; Ricketts, W; Imamura, T; Vollenweider, P; Olefsky, JM				Dalle, S; Ricketts, W; Imamura, T; Vollenweider, P; Olefsky, JM			Insulin and insulin-like growth factor I receptors utilize different G protein signaling components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE ACTIVATION; CLATHRIN-MEDIATED ENDOCYTOSIS; INDUCED GLUT4 TRANSLOCATION; INDUCED GLUCOSE-TRANSPORT; TYROSINE-KINASE; COUPLED RECEPTORS; BETA-ARRESTIN; PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 ADIPOCYTES; C-SRC	We examined the role of heterotrimeric G protein signaling components in insulin and insulin-like growth factor I (IGF-I) action. In HIRcB cells and in 3T3L1 adipocytes, treatment with the G alpha (i) inhibitor (pertussis toxin) or microinjection of the G beta gamma inhibitor (glutathione S-transferase-beta ARK) inhibited IGF-I and lysophosphatidic acid-stimulated mitogenesis but had no effect on epidermal growth factor (EGF) or insulin action. In basal state, G alpha (i) and G beta were associated with the IGF-I receptor (IGF-IR), and after ligand stimulation the association of IGF-IR with G alpha (1) increased concomitantly with a decrease in G beta association. No association of Ga-i was found with either the insulin or EGF receptor. Microinjection of anti-beta -arrestin-1 antibody specifically inhibited IGF-I mitogenic action but had no effect on EGF or insulin action. beta -Arrestin-1 was associated with the receptors for IGF-I, insulin, and EGF in a ligand-dependent manner. We demonstrated that G alpha (i), beta gamma subunits, and beta -arrestin-1 all play a critical role in IGF-I mitogenic signaling. In contrast, neither metabolic, such as GLUT4 translocation, nor mitogenic signaling by insulin is dependent on these protein components. These results suggest that insulin receptors and IGF-IRs can function as G protein-coupled receptors and engage different G protein partners for downstream signaling.	Univ Calif San Diego, Dept Med 0673, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Whittier Inst Diabet, La Jolla, CA 92037 USA; San Diego Vet Adm Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med 0673, Div Endocrinol & Metab, 9500 Gilman Dr, La Jolla, CA 92093 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, R01DK033651] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK33651] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; CHEN YH, 1994, J BIOL CHEM, V269, P27372; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dhanasekaran N., 1995, Endocrine Reviews, V16, P259; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; GARCIAHIGUERA I, 1994, J CLIN INVEST, V93, P937, DOI 10.1172/JCI117099; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HARUTA T, 1995, J BIOL CHEM, V270, P27991; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Imamura T, 1999, J BIOL CHEM, V274, P33691, DOI 10.1074/jbc.274.47.33691; Imamura T, 1999, MOL CELL BIOL, V19, P6765; Janez A, 2000, J BIOL CHEM, V275, P26870; KLIP A, 1984, AM J PHYSIOL, V247, pE291, DOI 10.1152/ajpendo.1984.247.3.E291; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; LUTTRELL LM, 1995, J BIOL CHEM, V270, P16495, DOI 10.1074/jbc.270.28.16495; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Myers MG, 1996, ANNU REV PHARMACOL, V36, P615, DOI 10.1146/annurev.pa.36.040196.003151; PACE AM, 1995, MOL BIOL CELL, V6, P1685, DOI 10.1091/mbc.6.12.1685; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; PIPPIG S, 1993, J BIOL CHEM, V268, P3201; Sasaoka T, 1996, ENDOCRINOLOGY, V137, P4427, DOI 10.1210/en.137.10.4427; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; SEELY BL, 1995, ENDOCRINOLOGY, V136, P1635, DOI 10.1210/en.136.4.1635; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Valentinis, 1997, BIOCHIM BIOPHYS ACTA, V1332, P105; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Vollenweider P, 1997, ENDOCRINOLOGY, V138, P4941, DOI 10.1210/en.138.11.4941; Watson S., 1994, G PROTEIN LINKED REC; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999	47	125	127	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15688	15695		10.1074/jbc.M010884200	http://dx.doi.org/10.1074/jbc.M010884200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278773	hybrid			2022-12-27	WOS:000168623100017
J	Iwai, H; Lingel, A; Pluckthun, A				Iwai, H; Lingel, A; Pluckthun, A			Cyclic green fluorescent protein produced in vivo using an artificially split PI-PfuI intein from Pyrococcus furiosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CYCLIZATION; STABILITY	A cyclic protein was produced in vivo using the intein from Pyrococcus furiosus PI-PfuI in a novel approach to create a circular permutation of the precursor protein by introducing new termini in the intein domain. Green fluorescent protein (GFP) was cyclized with this method in vivo on milligram scales. There was no by-product of linear or polymerized species isolated, unlike with other in vitro or in vivo cyclization methods utilizing inteins. Cyclized GFP unfolded at half the rate of the linear form upon chemical denaturation and required >2 days in 7 M guanidine hydrochloride until a residual fast folding phase (consistent with a persistent cis-proline) had disappeared. Cyclic GFP might become a novel tool for studying the role of termini and backbone topology in various biological processes such as protein degradation and translocation in vivo as well as in vitro.	Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Pluckthun, A (corresponding author), Univ Zurich, Inst Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Plückthun, Andreas/C-2746-2009; Iwaï, Hideo/A-6416-2009; Wood, David W/B-2992-2012; Lingel, Andreas/AAP-5078-2021	Plückthun, Andreas/0000-0003-4191-5306; Iwaï, Hideo/0000-0001-7376-5264; 				Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Camarero JA, 1999, J AM CHEM SOC, V121, P5597, DOI 10.1021/ja990929n; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; Evans TC, 1999, J BIOL CHEM, V274, P18359, DOI 10.1074/jbc.274.26.18359; Evans TC, 1998, PROTEIN SCI, V7, P2256, DOI 10.1002/pro.5560071103; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Ge L, 1995, ANTIBODY ENG, P229; GOLDENBERG DP, 1985, J CELL BIOCHEM, V29, P321, DOI 10.1002/jcb.240290406; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Ichiyanagi K, 2000, J MOL BIOL, V300, P889, DOI 10.1006/jmbi.2000.3873; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; KOLLY R, 1999, THESIS ECOLE SUPERIE; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Otomo T, 1999, J BIOMOL NMR, V14, P105, DOI 10.1023/A:1008308128050; Palm GJ, 1997, NAT STRUCT BIOL, V4, P361, DOI 10.1038/nsb0597-361; Perler FB, 2000, CURR OPIN BIOTECH, V11, P377, DOI 10.1016/S0958-1669(00)00113-0; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; WARD WW, 1982, PHOTOCHEM PHOTOBIOL, V35, P803, DOI 10.1111/j.1751-1097.1982.tb02651.x; Yakhnin AV, 1998, PROTEIN EXPRES PURIF, V14, P382, DOI 10.1006/prep.1998.0981; Yamazaki T, 1998, J AM CHEM SOC, V120, P5591, DOI 10.1021/ja980776o; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; [No title captured]	29	114	126	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16548	16554		10.1074/jbc.M011639200	http://dx.doi.org/10.1074/jbc.M011639200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278952	hybrid			2022-12-27	WOS:000168623100130
J	Southall, MD; Vasko, MR				Southall, MD; Vasko, MR			Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E-2-induced cAMP production and sensitization of sensory neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL TAIL; PROSTANOID RECEPTORS; MESSENGER-RNA; E-2 RECEPTOR; MOLECULAR-CLONING; EP(3) SUBTYPE; SPINAL-CORD; ANTISENSE OLIGONUCLEOTIDES; PGE(2)-INDUCED ENHANCEMENT; PROSTACYCLIN RECEPTOR	Although a number of prostaglandin E-2 (PGE(2)) receptor subtypes have been cloned, limited studies have been performed to elucidate subtypes that subserve specific actions of this eicosanoid, in part because of a paucity of selective receptor antagonists. Using reverse transcription-polymerase chain reaction (PCR) and antisense oligonucleotides, we examined which prostaglandin E-2 receptor (EP receptor) subtypes are expressed in sensory neurons and which mediate the PGE(2)-induced increase in cAMP production and augmentation of peptide release. Reverse transcription-PCR of cDNA isolated from rat sensory neurons grown in culture revealed PCR products for the EP1, EP2, EP3C, and EP4 receptor subtypes but not the EP3A or EP3B. Preexposing neuronal cultures for 48 h to antisense oligonucleotides of EP3C and EP4 mRNA diminished expression of the respective receptors by similar to 80%, abolished the PGE(2)-stimulated production of cAMP, and blocked the ability of PGE(2) to augment release of immunoreactive substance P and calcitonin gene-related peptide. Pretreating with individual antisense against the EP2, EP3C, or EP4 receptors or combinations of missense oligonucleotides had no effect on PGE(2)-induced activity. Treatment with antisense to EPIC and EP4 receptor subtypes did not alter the ability of forskolin to increase cAMP or enhance peptide release. These results demonstrate that sensory neurons are capable of expressing multiple EP receptor subtypes but that only the EPIC and EP4 receptors mediate PGE(2)-induced sensitization of sensory neurons.	Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Vasko, MR (corresponding author), Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034159] Funding Source: NIH RePORTER; NINDS NIH HHS [R01--NS34159] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREEVA L, 1993, BRIT J PHARMACOL, V108, P185, DOI 10.1111/j.1476-5381.1993.tb13460.x; Arakawa T, 1996, J BIOL CHEM, V271, P29569, DOI 10.1074/jbc.271.47.29569; Beiche F, 1998, J NEUROIMMUNOL, V89, P26, DOI 10.1016/S0165-5728(98)00061-7; Bhattacharya M, 1998, P NATL ACAD SCI USA, V95, P15792, DOI 10.1073/pnas.95.26.15792; Bhattacharya M, 1999, J BIOL CHEM, V274, P15719, DOI 10.1074/jbc.274.22.15719; Blaschke V, 1996, FEBS LETT, V394, P39, DOI 10.1016/0014-5793(96)00928-3; Boie Y, 1997, EUR J PHARMACOL, V340, P227, DOI 10.1016/S0014-2999(97)01383-6; BRYSCH W, 1994, CELL MOL NEUROBIOL, V14, P557, DOI 10.1007/BF02088837; CAMPBELL WB, 1996, GOODMAN GILMANS PHAR, P601; CHUNG SW, 1995, P NATL ACAD SCI USA, V92, P5955, DOI 10.1073/pnas.92.13.5955; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; COLEMAN RA, 1990, COMPREHENSIVE MED CH, V3, P643; CUI M, 1995, NEUROSCIENCE, V66, P459, DOI 10.1016/0306-4522(94)00567-O; FERREIRA SH, 1979, PROSTAGLANDINS, V18, P179, DOI 10.1016/0090-6980(79)90103-5; Fleming EF, 1998, AM J PHYSIOL-RENAL, V275, pF955, DOI 10.1152/ajprenal.1998.275.6.F955; FUNK CD, 1993, J BIOL CHEM, V268, P26767; HAMBERG M, 1973, ACTA PHYSIOL SCAND, V87, P240, DOI 10.1111/j.1748-1716.1973.tb05386.x; Hayes JS, 1999, J BIOL CHEM, V274, P23707, DOI 10.1074/jbc.274.34.23707; HEBERT RL, 1990, AM J PHYSIOL, V259, pF318, DOI 10.1152/ajprenal.1990.259.2.F318; HINGTGEN CM, 1995, J NEUROSCI, V15, P5411; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; HUANG CF, 1995, BIOCHEM J, V307, P493, DOI 10.1042/bj3070493; IRIE A, 1993, EUR J BIOCHEM, V217, P313, DOI 10.1111/j.1432-1033.1993.tb18248.x; KATSUYAMA M, 1995, FEBS LETT, V372, P151, DOI 10.1016/0014-5793(95)00966-D; KELLEY MR, 1993, ALCOHOL, V10, P185, DOI 10.1016/0741-8329(93)90033-K; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; Kita K, 1999, INT J CANCER, V80, P553, DOI 10.1002/(SICI)1097-0215(19990209)80:4<553::AID-IJC12>3.0.CO;2-6; Konger RL, 1998, BBA-MOL CELL RES, V1401, P221, DOI 10.1016/S0167-4889(97)00114-6; Kumazawa T, 1996, J NEUROPHYSIOL, V75, P2361, DOI 10.1152/jn.1996.75.6.2361; KUMAZAWA T, 1993, BRAIN RES, V632, P321, DOI 10.1016/0006-8993(93)91169-S; KUMAZAWA T, 1994, NEUROSCI LETT, V175, P71, DOI 10.1016/0304-3940(94)91080-4; KUNAPULI SP, 1994, BIOCHEM J, V298, P263, DOI 10.1042/bj2980263; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Lopshire JC, 1998, J NEUROSCI, V18, P6081; Mao GF, 1996, PROSTAGLANDINS, V52, P175, DOI 10.1016/S0090-6980(96)00095-0; MARTIN HA, 1987, NEUROSCIENCE, V22, P651, DOI 10.1016/0306-4522(87)90360-5; MATSUMURA K, 1992, BRAIN RES, V581, P292, DOI 10.1016/0006-8993(92)90720-T; Morath R, 1999, J AM SOC NEPHROL, V10, P1851; Mukhopadhyay P, 1997, BIOCHEM PHARMACOL, V53, P1249, DOI 10.1016/S0006-2952(97)00011-7; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nemoto K, 1997, PROSTAG OTH LIPID M, V54, P713, DOI 10.1016/S0090-6980(97)00145-7; Nguyen MT, 1997, NATURE, V390, P78, DOI 10.1038/36342; NICOL GD, 1994, J PHYSIOL-LONDON, V480, P485, DOI 10.1113/jphysiol.1994.sp020377; NISHIGAKI N, 1995, FEBS LETT, V364, P339, DOI 10.1016/0014-5793(95)00421-5; OIDA H, 1995, BRIT J PHARMACOL, V116, P2828, DOI 10.1111/j.1476-5381.1995.tb15933.x; PANG IH, 1986, BRAIN RES, V376, P268, DOI 10.1016/0006-8993(86)90189-7; Perl E. R., 1984, HDB PHYSL 2 1, VIII, P915; Rage F, 1997, J NEUROSCI, V17, P9145; SCHMID A, 1995, EUR J BIOCHEM, V228, P23, DOI 10.1111/j.1432-1033.1995.tb20223.x; Smith JAM, 1998, BRIT J PHARMACOL, V124, P513, DOI 10.1038/sj.bjp.0701853; Stucky CL, 1996, NEUROSCIENCE, V74, P1111, DOI 10.1016/S0306-4522(96)00264-3; Suda M, 1996, ENDOCRINOLOGY, V137, P1698, DOI 10.1210/en.137.5.1698; SUGIMOTO Y, 1994, NEUROSCIENCE, V62, P919, DOI 10.1016/0306-4522(94)90483-9; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; TAKEUCHI K, 1993, BIOCHEM BIOPH RES CO, V194, P885, DOI 10.1006/bbrc.1993.1904; TAKEUCHI K, 1994, BIOCHEM BIOPH RES CO, V199, P834, DOI 10.1006/bbrc.1994.1304; Takeuchi K, 1997, GASTROENTEROLOGY, V113, P1553, DOI 10.1053/gast.1997.v113.pm9352857; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; VASKO MR, 1994, J NEUROSCI, V14, P4987; WANG S, 1995, P NATL ACAD SCI USA, V92, P3318, DOI 10.1073/pnas.92.8.3318	62	153	162	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16083	16091		10.1074/jbc.M011408200	http://dx.doi.org/10.1074/jbc.M011408200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278900	hybrid			2022-12-27	WOS:000168623100071
J	Wang, HM; Mao, Y; Zhou, N; Hu, T; Hsieh, TS; Liu, LF				Wang, HM; Mao, Y; Zhou, N; Hu, T; Hsieh, TS; Liu, LF			ATP-bound topoisomerase II as a target for antitumor drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHINESE-HAMSTER-CELLS; GLUCOSE-REGULATED STRESSES; INDUCED DNA-DAMAGE; CANCER-CELLS; RESISTANCE; TRANSCRIPTION; EXPRESSION; ETOPOSIDE; ALPHA; YEAST	Topoisomerase II (TOP2) poisons interfere with the breakage/reunion reaction of TOP2 resulting in DNA cleavage. In the current studies, we show that two different classes (ATP-sensitive and -insensitive) of TOP2 poisons can be identified based on their differential sensitivity to the ATP-bound conformation of TOP2. First, in the presence of 1 mM ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma -imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected. In addition, ADP was shown to strongly antagonize TOP2-mediated DNA cleavage induced by ATP-sensitive but not ATP-insensitive TOP2 poisons. Second, C427A mutant human TOP2 alpha, which exhibits reduced ATPase activity, was shown to exhibit cross-resistance to all ATP-sensitive but not ATP-insensitive TOP2 poisons. Third, using ciprofloxacin competition assay, TOP2-mediated DNA cleavage induced by ATP-sensitive but not ATP-insensitive poisons was shown to be antagonized by ciprofloxacin. These results suggest that ATP-bound TOP2 may be the specific target of ATP-sensitive TOP2 poisons. Using Lac repressor-operator complexes as roadblocks, we show that ATP-bound TOP2 acts as a circular clamp capable of entering DNA ends and sliding on unobstructed duplex DNA.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Duke University	Liu, LF (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.		Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012	Liu, Leroy/0000-0001-9396-763X	NATIONAL CANCER INSTITUTE [R01CA039662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029006, R01GM027731] Funding Source: NIH RePORTER; NCI NIH HHS [CA39662] Funding Source: Medline; NIGMS NIH HHS [GM27731, GM29006] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECK WT, 1994, DNA TOPOISOMERASES T, P145; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; BI X, 1994, J MOL BIOL, V235, P414, DOI 10.1006/jmbi.1994.1002; BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; CHATTERJEE S, 1994, CANCER RES, V54, P4405; COLOFIORE JR, 1982, CANCER RES, V42, P3934; Danks M K, 1989, Cancer Commun, V1, P101; Elsea SH, 1997, BIOCHEMISTRY-US, V36, P2919, DOI 10.1021/bi962488f; HALLIGAN BD, 1985, J BIOL CHEM, V260, P2475; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; HORABIN JI, 1993, MOL CELL BIOL, V13, P1408, DOI 10.1128/MCB.13.3.1408; HSIEH LS, 1991, J MOL BIOL, V219, P443, DOI 10.1016/0022-2836(91)90185-9; HSIEH LS, 1991, J BACTERIOL, V173, P3914, DOI 10.1128/JB.173.12.3914-3917.1991; HUGHES CS, 1989, CANCER RES, V49, P4452; JENKINS JR, 1992, NUCLEIC ACIDS RES, V20, P5587, DOI 10.1093/nar/20.21.5587; Kang Y, 1996, BIOCHEM PHARMACOL, V52, P669, DOI 10.1016/0006-2952(96)00343-7; KENNEDY KA, 1987, ANTI-CANCER DRUG DES, V2, P181; Kupfer G, 1987, NCI Monogr, P37; Li TK, 1998, ANTIMICROB AGENTS CH, V42, P1022, DOI 10.1128/AAC.42.5.1022; LINDSLEY JE, 1991, P NATL ACAD SCI USA, V88, P10485, DOI 10.1073/pnas.88.23.10485; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; LIU LF, 1981, NUCLEIC ACIDS RES, V9, P3979, DOI 10.1093/nar/9.16.3979; Mao Y, 1999, BIOCHEMISTRY-US, V38, P10793, DOI 10.1021/bi9909804; OSHEROFF N, 1986, J BIOL CHEM, V261, P9944; OSHEROFF N, 1983, J BIOL CHEM, V258, P9536; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; SHEN J, 1987, P NATL ACAD SCI USA, V84, P3278, DOI 10.1073/pnas.84.10.3278; SHEN JW, 1989, MOL CELL BIOL, V9, P3284, DOI 10.1128/MCB.9.8.3284; SUMNER AT, 1991, CHROMOSOMA, V100, P410, DOI 10.1007/BF00337519; SUZUKI H, 1995, MUTAT RES-FUND MOL M, V328, P151, DOI 10.1016/0027-5107(95)00005-4; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; UTSUMI H, 1990, CANCER RES, V50, P2577; WASSERMAN RA, 1993, CANCER RES, V53, P3591; WU HY, 1991, J MOL BIOL, V219, P615, DOI 10.1016/0022-2836(91)90658-S; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; WYCKOFF E, 1988, P NATL ACAD SCI USA, V85, P6272, DOI 10.1073/pnas.85.17.6272; YAMAUCHI T, 1987, CANCER CHEMOTH PHARM, V19, P282; YANG L, 1987, P NATL ACAD SCI USA, V84, P950, DOI 10.1073/pnas.84.4.950; Yun J, 1995, ONCOL RES, V7, P583	41	48	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15990	15995		10.1074/jbc.M011143200	http://dx.doi.org/10.1074/jbc.M011143200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278845	hybrid			2022-12-27	WOS:000168623100058
J	Chuang, YJ; Swanson, R; Raja, SM; Olson, ST				Chuang, YJ; Swanson, R; Raja, SM; Olson, ST			Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence - Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL CHANGE; TARGET PROTEINASE; RAY STRUCTURE; HIGH-AFFINITY; BINDING-SITE; III COMPLEX; SERPIN; INHIBITOR; MECHANISM; ACCELERATION	Heparin activates the primary serpin inhibitor of blood clotting proteinases, antithrombin, both by an allosteric conformational change mechanism that specifically enhances factor Xa inactivation and by a ternary complex bridging mechanism that promotes the inactivation of thrombin and other target proteinases. To determine whether the factor Xa specificity of allosterically activated antithrombin is encoded in the reactive center loop sequence, we attempted to switch this specificity by mutating the P6-P3' proteinase binding sequence excluding P1-P1' to a more optimal thrombin recognition sequence. Evaluation of 12 such antithrombin variants showed that the thrombin specificity of the serpin allosterically activated by a heparin pentasaccharide could be enhanced as much as 55-fold by changing P3, P2, and P2' residues to a consensus thrombin recognition sequence. However, at most 9-fold of the enhanced thrombin specificity was due to allosteric activation, the remainder being realized without activation. Moreover, thrombin specificity enhancements were attenuated to at most 5-fold with a bridging heparin activator. Surprisingly, none of the reactive center loop mutations greatly affected the factor Xa specificity of the unactivated serpin or the several hundred-fold enhancement in factor Xa specificity due to activation by pentasaccharide or bridging heparins, Together, these results suggest that the specificity of both native and heparin-activated antithrombin for thrombin and factor Xa is only weakly dependent on the P6-P3' residues flanking the primary P1-P1' recognition site in the serpin-reactive center loop and that heparin enhances serpin specificity for both enzymes through secondary interaction sites outside the P6-P3' region, which involve a bridging site on heparin in the case of thrombin and a previously unrecognized exosite on antithrombin in the case of factor Xa.	Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Olson, ST (corresponding author), Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Rm 530E Dent M C 860,801 S Paulina St, Chicago, IL 60612 USA.		Chuang, Yung-Jen/D-2362-2013	Chuang, Yung-Jen/0000-0002-6022-0107	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888, R01HL039888, R29HL039888] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 39888] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bjork I, 1997, ADV EXP MED BIOL, V425, P17; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Chang WSW, 1996, BIOCHEM J, V314, P647, DOI 10.1042/bj3140647; CHOAY J, 1983, BIOCHEM BIOPH RES CO, V116, P492, DOI 10.1016/0006-291X(83)90550-8; Chuang YJ, 1999, J BIOL CHEM, V274, P28142, DOI 10.1074/jbc.274.40.28142; CHUANG YJ, 2001, IN PRESS BIOCHEMISTR; DANIELSSON A, 1983, BIOCHEM J, V213, P345, DOI 10.1042/bj2130345; DANIELSSON A, 1986, J BIOL CHEM, V261, P5467; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; Djie MZ, 1997, J BIOL CHEM, V272, P16268, DOI 10.1074/jbc.272.26.16268; Elliott PR, 1996, NAT STRUCT BIOL, V3, P676, DOI 10.1038/nsb0896-676; EMPIE MW, 1982, BIOCHEMISTRY-US, V21, P2274, DOI 10.1021/bi00539a002; ERSDALBADJU E, 1995, BIOCHEM J, V310, P323, DOI 10.1042/bj3100323; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; GETTINS PGW, 1993, BIOCHEMISTRY-US, V32, P8385, DOI 10.1021/bi00084a001; Han JH, 1998, BIOCHEMISTRY-US, V37, P3203, DOI 10.1021/bi9722195; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; HOPKINS PCR, 1995, J BIOL CHEM, V270, P11866, DOI 10.1074/jbc.270.20.11866; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; JESTY J, 1979, J BIOL CHEM, V254, P44; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Kaslik G, 1997, BIOCHEMISTRY-US, V36, P5455, DOI 10.1021/bi962931m; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lapatto R, 1997, EMBO J, V16, P5151, DOI 10.1093/emboj/16.17.5151; LAWRENCE DA, 1990, J BIOL CHEM, V265, P20293; LEBONNIEC BF, 1991, J BIOL CHEM, V266, P13796; LeBonniec BF, 1996, BIOCHEMISTRY-US, V35, P7114, DOI 10.1021/bi952701s; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1981, J BIOL CHEM, V256, P1065; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Plotnick MI, 1997, BIOCHEMISTRY-US, V36, P14601, DOI 10.1021/bi971530j; Plotnick MI, 1996, BIOCHEMISTRY-US, V35, P7586, DOI 10.1021/bi960233w; READ RJ, 1986, PROTEINASE INHIBITOR, P301; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; Rezaie AR, 1998, PROTEIN SCI, V7, P349; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; THEUNISSEN HJM, 1993, J BIOL CHEM, V268, P9035; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; TURKO IV, 1993, FEBS LETT, V335, P9, DOI 10.1016/0014-5793(93)80429-X; VANBOECKEL CAA, 1994, NAT STRUCT BIOL, V1, P423, DOI 10.1038/nsb0794-423; WALLACE A, 1989, BIOCHEM J, V257, P191, DOI 10.1042/bj2570191; WEI AZ, 1994, NAT STRUCT BIOL, V1, P251, DOI 10.1038/nsb0494-251; Wei AZ, 1998, J MOL BIOL, V283, P147, DOI 10.1006/jmbi.1998.2069; YUNG BY, 1975, BIOCHEM BIOPH RES CO, V65, P927, DOI 10.1016/S0006-291X(75)80474-8	51	121	127	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14961	14971		10.1074/jbc.M011550200	http://dx.doi.org/10.1074/jbc.M011550200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278930	hybrid			2022-12-27	WOS:000168528800060
J	Miller, BG; Snider, MJ; Wolfenden, R; Short, SA				Miller, BG; Snider, MJ; Wolfenden, R; Short, SA			Dissecting a charged network at the active site of orotidine-5 '-phosphate decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE; TRANSITION-STATE ANALOG; PROFICIENT ENZYME; MECHANISM; CATALYSIS; ABSENCE	The crystal structure of yeast orotidine-5'-phosphate decarboxylase in complex with the postulated transition state analog, 6-hydroxyuridine-5'-phosphate, reveals contacts between this inhibitor and a novel quartet of charged residues (Lys-59, Asp-91, Lys-93, and Asp-96) within the active site. The structure also suggests a possible interaction between O-2 of the 6-hydroxyuridine-5'-phosphate pyrimidine ring and Gln-215, Here we report the results of mutagenesis of each of the charged active site residues and Gln-215, The activities of the Q215A and wild-type enzymes were equal indicating that any interactions between this residue and the pyrimidine ring are dispensable for efficient decarboxylation. For the D91A and K93A mutant enzymes, activity was reduced by more than 5 orders of magnitude and substrate binding could not be detected by isothermal calorimetry. For the D96A mutant enzyme, k(cat) was reduced by more than 5 orders of magnitude, and isothermal calorimetry indicated an Ii-fold decrease in the affinity of this enzyme for the substrate in the ground state. For the K59A enzyme, k(cat) was reduced by a factor of 130, and K-m had increased by a factor of 900. These results indicate that the integrity of the network of charged residues is essential for transition state stabilization.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; GlaxoWellcome, Mol Sci, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline	Short, SA (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.		Wolfenden, Richard/CAH-1293-2022	Snider, Mark/0000-0003-1054-1276	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008570] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-08570, GM-18324] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHESON SA, 1990, BIOCHEMISTRY-US, V29, P3198, DOI 10.1021/bi00465a007; Appleby TC, 2000, P NATL ACAD SCI USA, V97, P2005, DOI 10.1073/pnas.259441296; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CLELAND WW, 1967, ANNU REV BIOCHEM, V36, P77, DOI 10.1146/annurev.bi.36.070167.000453; Harris P, 2000, BIOCHEMISTRY-US, V39, P4217, DOI 10.1021/bi992952r; Jones M E, 1978, Methods Enzymol, V51, P155; LEVINE HL, 1980, BIOCHEMISTRY-US, V19, P365; Miller BG, 2000, BIOCHEMISTRY-US, V39, P8113, DOI 10.1021/bi000818x; Miller BG, 1999, J BIOL CHEM, V274, P23841, DOI 10.1074/jbc.274.34.23841; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; Porter DJT, 2000, BIOCHEMISTRY-US, V39, P11788, DOI 10.1021/bi001199v; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; SMILEY JA, 1992, BIOCHEMISTRY-US, V31, P12162, DOI 10.1021/bi00163a027; Traut TW, 2000, J BIOL CHEM, V275, P28675, DOI 10.1074/jbc.M003468200; Warshel A, 2000, BIOCHEMISTRY-US, V39, P14728, DOI 10.1021/bi000987h; WOLFENDE.R, 1969, NATURE, V223, P704, DOI 10.1038/223704a0; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797	17	57	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15174	15176		10.1074/jbc.M011429200	http://dx.doi.org/10.1074/jbc.M011429200			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278904	Green Published, hybrid			2022-12-27	WOS:000168528800086
J	Mourton, T; Hellberg, CB; Burden-Gulley, SM; Hinman, J; Rhee, A; Brady-Kalnay, SM				Mourton, T; Hellberg, CB; Burden-Gulley, SM; Hinman, J; Rhee, A; Brady-Kalnay, SM			The PTP mu protein-tyrosine phosphatase binds and recruits the scaffolding protein RACK1 to cell-cell contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C; HOMOPHILIC BINDING; BETA-SUBUNIT; RECEPTOR; ASSOCIATION; CADHERINS; ADHESION; ACTIVATION; INTERACTS; CATENINS	PTP mu, an Ig superfamily receptor protein-tyrosine phosphatase, promotes cell-cell adhesion and interacts with the cadherin-catenin complex. The signaling pathway downstream of PTP mu is unknown; therefore, we used a yeast two-hybrid screen to identify additional PTP mu interacting proteins. The membrane-proximal catalytic domain of PTP mu was used as bait, Sequencing of two positive clones identified the scaffolding protein RACK1 (receptor for activated protein C kinase) as a PTP mu interacting protein. We demonstrate that RACK1 interacts with PTP mu when co-expressed in a recombinant baculovirus expression system. RACK1 is known to bind to the are protein-tyrosine kinase, This study demonstrates that PTP mu association with RACK1 is disrupted by the presence of constituitively active src, RACK1 is thought to be a scaffolding protein that recruits proteins to the plasma membrane via an unknown mechanism. We have shown that the association of endogenous PTP mu and RACK1 in a lung cell line is increased at high cell density. We also demonstrate that the recruitment of RACK1 to both the plasma membrane and cell-cell contact sites is dependent upon the presence of the PTP mu protein in these cells. Therefore, PTP mu may be one of the proteins that recruits RACK1 to points of cell-cell contact, which may be important for PTP mu -dependent signaling in response to cell-cell adhesion.	Case Western Reserve Univ, Dept Mol Biol & Microbiol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Brady-Kalnay, SM (corresponding author), Case Western Reserve Univ, Dept Mol Biol & Microbiol, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	smb4@po.cwru.edu		Burden-Gulley, Susan/0000-0001-7419-9073	NATIONAL EYE INSTITUTE [R01EY012251, P30EY011373] Funding Source: NIH RePORTER; NEI NIH HHS [P0-EY11373, 1RO1-EY12251] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; BRADYKALNAY S, 1998, CELL ADHES COMMUN S, V6, P133; BRADYKALNAY SM, 1995, CURR OPIN CELL BIOL, V7, P650, DOI 10.1016/0955-0674(95)80106-5; BRADYKALNAY SM, 1993, J CELL BIOL, V122, P961, DOI 10.1083/jcb.122.4.961; BRADYKALNAY SM, 1994, J BIOL CHEM, V269, P28472; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; BRADYKALNAY SM, 2001, IN PRESS CELL ADHESI; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; DISATNIK MH, 1994, P NATL ACAD SCI USA, V91, P559, DOI 10.1073/pnas.91.2.559; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; GEBBINK MFBG, 1995, J CELL BIOL, V131, P251, DOI 10.1083/jcb.131.1.251; GEBBINK MFBG, 1993, J BIOL CHEM, V268, P16101; Geiges D, 1997, BIOCHEM PHARMACOL, V53, P865, DOI 10.1016/S0006-2952(96)00885-4; Geijsen N, 1999, ONCOGENE, V18, P5126, DOI 10.1038/sj.onc.1202896; GOLEMIS EA, 1997, CURRENT PROTOCOLS MO, pCH20; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hiscox S, 1998, INT J ONCOL, V13, P1077; Keegan K, 1996, ONCOGENE, V12, P1537; LEWIS JE, 1994, J CELL SCI, V107, P3615; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Mochly-Rosen D, 1998, ADV PHARMACOL, V44, P91, DOI 10.1016/S1054-3589(08)60126-X; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; TONKS NK, 1992, COLD SPRING HARB SYM, V57, P87, DOI 10.1101/SQB.1992.057.01.012; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; ZONDAG GCM, 1995, J BIOL CHEM, V270, P14247, DOI 10.1074/jbc.270.24.14247	32	91	94	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14896	14901		10.1074/jbc.M010823200	http://dx.doi.org/10.1074/jbc.M010823200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278757	hybrid			2022-12-27	WOS:000168528800051
J	Thoden, JB; Wohlers, TM; Fridovich-Keil, JL; Holden, HM				Thoden, JB; Wohlers, TM; Fridovich-Keil, JL; Holden, HM			Human UDP-galactose 4-epimerase - Accommodation of UDP-N-acetylglucosamine within the active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIMERASE-DEFICIENCY GALACTOSEMIA; ESCHERICHIA-COLI; HUMAN UDP-GALACTOSE-4-EPIMERASE; MACROMOLECULAR STRUCTURES; EXPRESSION; GLUCOSE; MECHANISM; PROGRAM; BINDING	UDP-galactose 4-epimerase catalyzes the interconversion of UDP-galactose and UDP-glucose during normal galactose metabolism. One of the key structural features in the proposed reaction mechanism for the enzyme is the rotation of a 4'-ketopyranose intermediate within the active site pocket. Recently, the three-dimensional structure of the human enzyme with bound NADH and UDP-glucose was determined, Unlike that observed for the protein isolated from Escherichia coli, the human enzyme can also turn over UDP-GlcNAc to UDP-GalNAc and vice versa, Here we describe the three-dimensional structure of human epimerase complexed with NADH and UDP-GlcNAc. To accommodate the additional N-acetyl group at the C2 position of the sugar, the side chain of Asn-207 rotates toward the interior of the protein and interacts with Glu-199, Strikingly, in the human enzyme, the structural equivalent of Tyr-299 in the E, coli protein is replaced with a cysteine residue (Cys-307) and the active site volume for the human protein is calculated to be similar to 15% larger than that observed for the bacterial epimerase, This combination of a larger active site cavity and amino acid residue replacement most likely accounts for the inability of the E, coli enzyme to interconvert UDP-GlcNAc and UDP-GalNAc.	Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA	University of Wisconsin System; University of Wisconsin Madison; Emory University; Emory University	Holden, HM (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	hazel_holden@biochem.wisc.edu			NIDDK NIH HHS [DK47814, DK46403] Funding Source: Medline; NIGMS NIH HHS [T32 GM008490, GM08490] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047814, R56DK047814, R29DK046403, R01DK046403] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alano A., 1997, Journal of Investigative Medicine, V45, p191A; Duax WL, 2000, VITAM HORM, V58, P121, DOI 10.1016/S0083-6729(00)58023-6; Duax WL, 1996, CURR OPIN STRUC BIOL, V6, P813, DOI 10.1016/S0959-440X(96)80012-1; ESNOUF R, 1996, ACTA CRYSTALLOGR A, V55, P938; GITZELMANN R, 1977, HELV PAEDIATR ACTA, V31, P441; Holton J. B., 2000, METABOLIC MOL BASES, P1553; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KLEYWEGT GJ, 1993, ESF CCP4 NEWSLETTER, V29, P26; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MALEY F, 1959, BIOCHIM BIOPHYS ACTA, V31, P577, DOI 10.1016/0006-3002(59)90047-2; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PILLER F, 1983, J BIOL CHEM, V258, P774; Quimby BB, 1997, AM J HUM GENET, V61, P590, DOI 10.1086/515517; ROUSSEL A, 1991, SILICON GRPHICS GEOM; Shin YS, 2000, J INHERIT METAB DIS, V23, P383, DOI 10.1023/A:1005699719068; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P10685, DOI 10.1021/bi9704313; Thoden JB, 2000, BIOCHEMISTRY-US, V39, P5691, DOI 10.1021/bi000215l; Thoden JB, 1996, PROTEIN SCI, V5, P2149, DOI 10.1002/pro.5560051102; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P2557, DOI 10.1021/bi952715y; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P5137, DOI 10.1021/bi9601114; Thoden JB, 1998, BIOCHEMISTRY-US, V37, P11469, DOI 10.1021/bi9808969; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Walter JH, 1999, ARCH DIS CHILD, V80, P374, DOI 10.1136/adc.80.4.374; Wohlers TM, 2000, J INHERIT METAB DIS, V23, P713, DOI 10.1023/A:1005682913784; Wohlers TM, 1999, AM J HUM GENET, V64, P462, DOI 10.1086/302263	28	106	110	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15131	15136		10.1074/jbc.M100220200	http://dx.doi.org/10.1074/jbc.M100220200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279032	hybrid			2022-12-27	WOS:000168528800081
J	Williams, TE; Nagarajan, S; Selvaraj, P; Zhu, C				Williams, TE; Nagarajan, S; Selvaraj, P; Zhu, C			Quantifying the impact of membrane microtopology on effective two-dimensional affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; LIGAND-BINDING; CELL-ADHESION; CONCURRENT BINDING; KINETIC RATES; RECEPTORS; SURFACE; CD2; NEUTROPHILS; ADHERENCE	Just as interactions of soluble proteins are affected by the solvent, membrane protein binding is influenced by the surface environment. This is particularly true for adhesion receptors because their function requires tightly apposed membranes. We sought to demonstrate, and further, to quantify the possible scale of this phenomenon by comparing the effective affinity and kinetic rates of an adhesion receptor (CD16b) placed in three distinct environments: red blood cells (RBCs), detached Chinese hamster ovary (CHO) cells, and K562 cells. Effective affinity reflects both the intrinsic receptor-ligand kinetics and the effectiveness of their presentation by the host membranes. Expression of CD16b, a low affinity Fc gamma receptor, was established by either transfection or spontaneous insertion via its glycosylphosphatidylinositol anchor. Binding to IgG-coated RBCs, measured using a micropipette method, indicated a 50-fold increase in effective affinity for receptors on RBCs over CHO and K562 cells, whereas the off rates were similar for all three. Electron microscopy confirmed that specific tight contacts were broad in RBC RBC conjugates but sparse in CHO-RBC conjugates, We suggest that through modulation of surface roughness the cytoskeleton can greatly impact the effectiveness of adhesion molecules, oven those with no cytoplasmic structures. Implications for locomotion and static adhesion are discussed.	Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University	Zhu, C (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.		Zhu, Cheng/A-5724-2011	Zhu, Cheng/0000-0002-1718-565X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038282, R29AI038282, R29AI030631] Funding Source: NIH RePORTER; NIAID NIH HHS [AI38282, AI30631] Funding Source: Medline; NIGMS NIH HHS [GM08433] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; CHAN PY, 1991, J CELL BIOL, V115, P245, DOI 10.1083/jcb.115.1.245; CHESLA S, UNPUB; Chesla SE, 2000, J BIOL CHEM, V275, P10235, DOI 10.1074/jbc.275.14.10235; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; DEMSEY A, 1976, CANCER RES, V36, P384; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; Finger EB, 1996, J IMMUNOL, V157, P5085; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; LAUFFENBURGER DA, 1993, RECEPTORS MODELS BIN, P143; Lee J, 1997, J CELL SCI, V110, P2833; MEGE JL, 1987, BIOPHYS J, V52, P177, DOI 10.1016/S0006-3495(87)83205-8; NAGARAJAN S, 1995, J IMMUNOL METHODS, V184, P241, DOI 10.1016/0022-1759(95)00095-R; REGEN CM, 1992, J CELL BIOL, V119, P1347, DOI 10.1083/jcb.119.5.1347; Sheikh S, 1998, J CELL PHYSIOL, V174, P206, DOI 10.1002/(SICI)1097-4652(199802)174:2<206::AID-JCP8>3.3.CO;2-L; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Tamm A, 1996, J IMMUNOL, V157, P1576; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; WECHEZAK AR, 1989, J CELL PHYSIOL, V139, P136, DOI 10.1002/jcp.1041390120; WEISZ OA, 1991, J CELL BIOL, V115, P495, DOI 10.1083/jcb.115.2.495; Williams TE, 2000, BIOPHYS J, V79, P1867, DOI 10.1016/S0006-3495(00)76436-8; Williams TE, 2000, BIOPHYS J, V79, P1858, DOI 10.1016/S0006-3495(00)76435-6; Zhu C, 2000, BIOPHYS J, V79, P1850, DOI 10.1016/S0006-3495(00)76434-4	25	58	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13283	13288		10.1074/jbc.M010427200	http://dx.doi.org/10.1074/jbc.M010427200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278674	hybrid			2022-12-27	WOS:000168198600112
J	Li, WD; Okano, A; Tian, QB; Nakayama, K; Furihata, T; Nawa, H; Suzuki, T				Li, WD; Okano, A; Tian, QB; Nakayama, K; Furihata, T; Nawa, H; Suzuki, T			Characterization of a novel synGAP isoform, synGAP-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY FRACTIONS; LONG-TERM POTENTIATION; PROTEIN-KINASE-II; SYNAPTIC TRANSMISSION; NEOCORTICAL NEURONS; ADHESION MOLECULE; SIGNALING PATHWAY; CEREBRAL-CORTEX; RAT-BRAIN; EXPRESSION	We cloned a cDNA encoding a novel synGAP, syn-GAP-d (GenBank(TM) accession number AB016962), from a rat brain cDNA library. The clone consisted of 4801 nucleotides with a coding sequence of 3501 nucleotides, encoded a protein consisting of 1166 amino acids with >99% homology with 1092 amino acid overlaps to synGAP, and contained a 13-nucleotide insertion to the previously reported synGAP mRNAs, which suggested that the clone was a splice variant of synGAP, We also found that there are at least seven variants in the 3' portion of the synGAP mRNA and that they encoded five different protein isoforms, The coding sequence of these C-terminal variants were classified into alpha1, alpha2, beta1, beta2, beta3, beta4, and gamma, and synGAP-d was classified as the beta1 form, The previously reported synGAPs (synGAP-a, -b, and -c and p135synGAP) can be classified as the alpha1 isoform, All isoforms were expressed specifically in the brain. Unexpectedly, the beta isoform, which lacks a C-terminal PSD-95-binding motif ((ST)XV), was more restricted to the postsynaptic density fraction than the motif-containing alpha1 isoform, The beta isoform did not interact with PSD-95 but specifically interacted with a nonphosphorylated alpha subunit of Ca2+/calmodulin-dependent protein kinase II through its unique C-terminal tail.	Shinshu Univ, Sch Med, Res Ctr Aging & Adaptat, Dept Neuroplast, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Anat 2, Matsumoto, Nagano 3908621, Japan; Niigata Univ, Sch Med, Brain Res Inst, Dept Mol Neurobiol, Niigata 9518585, Japan	Shinshu University; Shinshu University; Niigata University	Suzuki, T (corresponding author), Shinshu Univ, Sch Med, Res Ctr Aging & Adaptat, Dept Neuroplast, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	suzukit@sch.md.shinshu-u.ac.jp		Li, Weidong/0000-0001-5384-4838				Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; COHEN RS, 1977, J CELL BIOL, V74, P181, DOI 10.1083/jcb.74.1.181; Garner CC, 1996, TRENDS CELL BIOL, V6, P429, DOI 10.1016/S0962-8924(96)10036-2; GRABS D, 1994, EUR J NEUROSCI, V6, P1765, DOI 10.1111/j.1460-9568.1994.tb00569.x; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manabe T, 2000, J NEUROSCI, V20, P2504; Narisawa-Saito M, 1999, NEUROSCIENCE, V88, P1009, DOI 10.1016/S0306-4522(98)00496-5; Narisawa-Saito M, 1999, P NATL ACAD SCI USA, V96, P2461, DOI 10.1073/pnas.96.5.2461; Orban PC, 1999, TRENDS NEUROSCI, V22, P38, DOI 10.1016/S0166-2236(98)01306-X; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Suen P, 1998, MOL BRAIN RES, V59, P215, DOI 10.1016/S0169-328X(98)00157-0; Suzuki T, 1999, BRAIN RES, V840, P36, DOI 10.1016/S0006-8993(99)01762-X; Suzuki T, 1998, MOL BRAIN RES, V61, P69, DOI 10.1016/S0169-328X(98)00199-5; SUZUKI T, 1994, J NEUROCHEM, V63, P1529, DOI 10.1046/j.1471-4159.1994.63041529.x; SUZUKI T, 1992, P NATL ACAD SCI USA, V89, P109, DOI 10.1073/pnas.89.1.109; Suzuki T, 2001, MOL BRAIN RES, V89, P20, DOI 10.1016/S0169-328X(01)00051-1; SUZUKI T, 1995, NEUROSCI RES, V22, P277, DOI 10.1016/0168-0102(95)00902-6; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; WU K, 1986, J NEUROCHEM, V46, P831, DOI 10.1111/j.1471-4159.1986.tb13047.x	28	48	50	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21417	21424		10.1074/jbc.M010744200	http://dx.doi.org/10.1074/jbc.M010744200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11278737	hybrid			2022-12-27	WOS:000169297900084
J	Cheltsov, AV; Barber, MJ; Ferreira, GC				Cheltsov, AV; Barber, MJ; Ferreira, GC			Circular permutation of 5-aminolevulinate synthase - Mapping the polypeptide chain to its function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; IN-VIVO; ESCHERICHIA-COLI; 8-AMINO-7-OXONONANOATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; SWISS-MODEL; PROTEIN; SUBSTRATE	5-Aminolevulinate synthase is the first enzyme of the heme biosynthetic pathway in non-plant eukaryotes and some prokaryotes, The enzyme functions as a homodimer and requires pyridoxal 5'-phosphate as a cofactor, Although the roles of defined amino acids in the active site and catalytic mechanism have been recently explored using site-directed mutagenesis, much less is known about the role of the ii-aminolevulinate synthase polypeptide chain arrangement in folding, structure, and ultimately, function. To assess the importance of the continuity of the polypeptide chain, circularly permuted 5-aminolevulinate synthase variants were constructed through either rational design or screening of an engineered random library. One percent of the random library clones were active, and a total of 21 active variants had sequences different from that of the wild type 5-aminolevulinate synthase. Out of these 21 variants, 9 displayed unique circular permutations of the 5-aminolevulinate synthase polypeptide chain. The new termini of the active variants disrupted secondary structure elements and loop regions and fell in 100 amino acid regions from each terminus. This indicates that the natural continuity of the 5-aminolevulinate synthase polypeptide chain and the sequential arrangement of the secondary structure elements are not requirements for proper folding, binding of the cofactor, or assembly of the two subunits, Furthermore, the order of two identified functional elements (i.e. the catalytic and the glycine-binding domains) is apparently irrelevant for proper functioning of the enzyme. Although the wild type B-aminolevulinate synthase and the circularly permuted variants appear to have similar, predicted overall tertiary structures, they exhibit differences in the arrangement of the secondary structure elements and in the cofactor-binding site environment, Taken together, the data lead us to propose that the 5-aminolevulinate synthase overall structure can be reached through multiple or alternative folding pathways.	Univ S Florida, Coll Med, Dept Biochem & Mol Biol, Tampa, FL 33612 USA; Univ S Florida, Inst Biomol Sci, Tampa, FL 33612 USA; Univ S Florida, H Lee Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Ferreira, GC (corresponding author), Univ S Florida, Coll Med, Dept Biochem & Mol Biol, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	gferreir@hsc.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063191, R01DK052053] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK063191, DK52053] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; BOTTOMLEY SS, 1995, J BIOENERG BIOMEMBR, V27, P161, DOI 10.1007/BF02110031; BOTTOMLEY SS, 1999, WINTROBES CLIN HEMAT, P1022; BUCHWALDER A, 1992, BIOCHEMISTRY-US, V31, P1621, DOI 10.1021/bi00121a006; CHEN GC, 1977, ANAL LETT, V10, P1195, DOI 10.1080/00032717708067855; Cotter PD, 1999, BLOOD, V93, P1757, DOI 10.1182/blood.V93.5.1757.405a12_1757_1769; COTTER PD, 1992, GENOMICS, V13, P211, DOI 10.1016/0888-7543(92)90223-F; FANICAGA.M, 1973, EUR J BIOCHEM, V40, P19, DOI 10.1111/j.1432-1033.1973.tb03164.x; FERREIRA GC, 1993, PROTEIN SCI, V2, P1959, DOI 10.1002/pro.5560021117; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P151, DOI 10.1007/BF02110030; FERREIRA GC, 1993, J BIOL CHEM, V268, P584; Ferreira GC, 2000, BIOCHEMISTRY AND MOLECULAR BIOLOGY OF VITAMIN B6 AND PQQ-DEPENDENT PROTEINS, P257; FERREIRA GC, 1995, PROTEIN SCI, V4, P1001; Ferreira GC., 1999, IRON METABOLISM, P15, DOI [10.1002/9783527613700.CH02., DOI 10.1002/9783527613700.CH02]; FLORES TP, 1994, PROTEIN ENG, V7, P31, DOI 10.1093/protein/7.1.31; GABRIEL D, 1971, METHOD ENZYMOL, V22, P568; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GOLDENBERG DP, 1983, J MOL BIOL, V165, P407, DOI 10.1016/S0022-2836(83)80265-4; Gong J, 1998, BIOCHEMISTRY-US, V37, P3509, DOI 10.1021/bi9719298; Graf R, 1996, P NATL ACAD SCI USA, V93, P11591, DOI 10.1073/pnas.93.21.11591; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gutknecht R, 1998, J BIOL CHEM, V273, P25745, DOI 10.1074/jbc.273.40.25745; HAHN M, 1994, P NATL ACAD SCI USA, V91, P10417, DOI 10.1073/pnas.91.22.10417; Harigae H, 1999, BRIT J HAEMATOL, V106, P175, DOI 10.1046/j.1365-2141.1999.01479.x; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Hennecke J, 1998, BIOCHEMISTRY-US, V37, P17590, DOI 10.1021/bi981888v; HUALA E, 1991, J BACTERIOL, V173, P382, DOI 10.1128/jb.173.1.382-390.1991; HUNTER GA, 1995, ANAL BIOCHEM, V226, P221, DOI 10.1006/abio.1995.1217; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; JOHN RA, 1995, BBA-PROTEIN STRUCT M, V1248, P81, DOI 10.1016/0167-4838(95)00025-P; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI JM, 1989, J BACTERIOL, V171, P2547, DOI 10.1128/jb.171.5.2547-2552.1989; MUNAKATA H, 1993, J BIOCHEM, V114, P103, DOI 10.1093/oxfordjournals.jbchem.a124123; Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282; Nakamura T, 1999, J BIOL CHEM, V274, P19041, DOI 10.1074/jbc.274.27.19041; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; ROTE KV, 1989, J BIOL CHEM, V264, P1156; Sadlon TJ, 1999, INT J BIOCHEM CELL B, V31, P1153, DOI 10.1016/S1357-2725(99)00073-4; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STERNBERG MJE, 1977, J MOL BIOL, V110, P269, DOI 10.1016/S0022-2836(77)80072-7; Tan DW, 1996, BIOCHEMISTRY-US, V35, P8934, DOI 10.1021/bi952918m; Tan DW, 1998, PROTEIN SCI, V7, P1208, DOI 10.1002/pro.5560070516; Tan DW, 1998, BIOCHEMISTRY-US, V37, P1478, DOI 10.1021/bi971928f; Uversky VN, 1996, PROTEIN SCI, V5, P1844, DOI 10.1002/pro.5560050910; VIGUERA AR, 1995, J MOL BIOL, V247, P670, DOI 10.1016/S0022-2836(05)80146-9; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Zhang PH, 1996, PROTEIN SCI, V5, P1290, DOI 10.1002/pro.5560050708; ZHANG T, 1993, BIOCHEMISTRY-US, V32, P12311, DOI 10.1021/bi00097a006	52	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19141	19149		10.1074/jbc.M100329200	http://dx.doi.org/10.1074/jbc.M100329200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279050	hybrid, Green Accepted			2022-12-27	WOS:000169091000069
J	Prevo, R; Banerji, S; Ferguson, DJP; Clasper, S; Jackson, DG				Prevo, R; Banerji, S; Ferguson, DJP; Clasper, S; Jackson, DG			Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEINS; TNF-ALPHA; MEDIATED ENDOCYTOSIS; TRANSMEMBRANE DOMAIN; PRIMARY ADHESION; MONOCYTE CD44; IDENTIFICATION; PROTEOGLYCAN; TISSUE; CELLS	glycosaminoglycan hyaluronan is a key substrate for cell migration in tissues during inflammation, wound healing, and neoplasia. Unlike other matrix components, hyaluronan (HA) is turned over rapidly, yet most degradation occurs not locally but within distant lymph nodes, through mechanisms that are not yet understood. While it is not clear which receptors are involved in binding and uptake of hyaluronan within the lymphatics, one likely candidate is the lymphatic endothelial hyaluronan receptor LYVE-1 recently described in our laboratory (Banerji, S., Ni, J., Wang, S., Clasper, S., Su, J., Tammi, R., Jones, M., and Jackson, D.G. (1999) J. Cell Biol. 144, 789-891.). Here we present evidence that LYVE-1 is involved in the uptake of hyaluronan by lymphatic endothelial cells using a new murine LYVE-1 orthologue identified from the EST data base. We show that mouse LYVE-1 both binds and internalizes hyaluronan in transfected 293T fibroblasts in vitro and demonstrate using immunoelectron microscopy that it is distributed equally among the luminal and abluminal surfaces of lymphatic vessels in vivo. In addition, we show by means of specific antisera that expression of mouse LYVE-1 remains restricted to the lymphatics in homozygous knockout mice lacking a functional gene for CD44, the closest homologue of LYVE-1 and the only other Link superfamily HA receptor known to date. Together these results suggest a role for LYVE-1 in the transport of HA from tissue to lymph and imply that further novel hyaluronan receptors must exist that can compensate for the loss of CD44 function.	John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England; John Radcliffe Hosp, Nuffield Dept Pathol, Oxford OX3 9DS, England	University of Oxford; University of Oxford	Jackson, DG (corresponding author), John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England.	djackson@enterprise.molbiol.ox.ac.uk		, david/0000-0002-4133-9364; Ferguson, David/0000-0001-5045-819X				Aguiar DJ, 1999, EXP CELL RES, V252, P292, DOI 10.1006/excr.1999.4641; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bajorath J, 1998, J BIOL CHEM, V273, P338, DOI 10.1074/jbc.273.1.338; Bajorath J, 2000, PROTEINS, V39, P103, DOI 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.3.CO;2-7; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Brissett NC, 1996, FEBS LETT, V388, P211, DOI 10.1016/0014-5793(96)00576-5; Brown TJ, 1999, J INVEST DERMATOL, V113, P740, DOI 10.1046/j.1523-1747.1999.00745.x; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; Day AJ, 1999, BIOCHEM SOC T, V27, P115, DOI 10.1042/bst0270115; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; FRASER JRE, 1989, CIBA F SYMP, V143, P41; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; HUA Q, 1993, J CELL SCI, V106, P365; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; JACKSON DG, 2001, ANTICANCER RES, V7, P1; JACKSON DG, 2000, IN PRESS HYALURONAN; JONES WR, 1986, LYMPHOLOGY, V19, P5; Kincade PW, 1997, CURR OPIN CELL BIOL, V9, P635, DOI 10.1016/S0955-0674(97)80116-0; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Lesley J, 2000, J BIOL CHEM, V275, P26967; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Levesque MC, 1997, J IMMUNOL, V159, P6184; Levesque MC, 1999, CELL IMMUNOL, V193, P209, DOI 10.1006/cimm.1999.1456; Liu D, 1996, J EXP MED, V183, P1987, DOI 10.1084/jem.183.5.1987; Liu DC, 1997, J IMMUNOL, V159, P2702; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Mancardi S, 1999, EXP CELL RES, V246, P368, DOI 10.1006/excr.1998.4270; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MIKECZ K, 1995, NAT MED, V1, P558, DOI 10.1038/nm0695-558; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; NEAME PJ, 1993, EXPERIENTIA, V49, P393, DOI 10.1007/BF01923584; O'Morchoe C C, 1988, Contrib Nephrol, V68, P230; OMORCHOE CCC, 1984, J CELL BIOL, V98, P629, DOI 10.1083/jcb.98.2.629; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; Predescu D, 1998, P NATL ACAD SCI USA, V95, P6175, DOI 10.1073/pnas.95.11.6175; Protin U, 1999, J IMMUNOL, V163, P4917; RAUCH U, 1992, J BIOL CHEM, V267, P19536; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SCHAERER E, 1990, J CELL BIOL, V110, P987, DOI 10.1083/jcb.110.4.987; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; SCREATON GR, 1993, J BIOL CHEM, V268, P12235; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; TZAICOS C, 1989, BIOCHEM J, V264, P823, DOI 10.1042/bj2640823; Weiss JM, 1997, J CELL BIOL, V137, P1137, DOI 10.1083/jcb.137.5.1137; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; YAMADA H, 1994, J BIOL CHEM, V269, P10119; YANNARIELLOBROWN J, 1992, J CELL BIOCHEM, V48, P73, DOI 10.1002/jcb.240480111; YANNARIELLOBROWN J, 1992, J BIOL CHEM, V267, P20451; YU Q, 1995, BIOTECHNIQUES, V19, P122; ZHENG Z, 1995, J CELL BIOL, V130, P485, DOI 10.1083/jcb.130.2.485; Zhou B, 1999, J BIOL CHEM, V274, P33831, DOI 10.1074/jbc.274.48.33831; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	70	372	397	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19420	19430		10.1074/jbc.M011004200	http://dx.doi.org/10.1074/jbc.M011004200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278811	hybrid			2022-12-27	WOS:000169091000104
J	Yamaguchi, Y; Katoh, H; Yasui, H; Mori, K; Negishi, M				Yamaguchi, Y; Katoh, H; Yasui, H; Mori, K; Negishi, M			RhoA inhibits the nerve growth factor-induced Rac1 activation through Rho-associated kinase-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PC12 CELLS; NEURITE OUTGROWTH; FAMILY GTPASES; SIGNALING PATHWAYS; AXONAL OUTGROWTH; MAP KINASE; RAS; PROTEIN; DIFFERENTIATION; BINDING	The Rho family of small GTPases has been shown to be involved in the regulation of neuronal morphology, and Rac and Rho exert antagonistic actions in neurite formation. In this study, we have examined the cross-talk between Rac and Rho in relation to the nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. NGF induced a rapid activation of Pac 1 and suppression of RhoA activity. Constitutively active RhoA, RhoA(V14) or constitutively active G alpha (12)-induced endogenous RhoA activation inhibited the NGF-induced Rad activation without any effect on the NGF-induced extracellular signal-regulated kinase activation. Moreover, Y-27632, an inhibitor of Rho-associated kinase, completely abolished the RhoA-induced down-regulation of the NGF-induced Rad activation. We also revealed that NGF induced a rapid recruitment of Rad to the cell surface protrusion sites and formed filamentous actin-rich protrusions. Activation of RhoA and Rho-associated kinase formed a thick ringlike structure of cortical actin filaments at the cell periphery and then inhibited the NGF-induced recruitment of Rad to protrusions. These results indicate that RhoA down-regulates the NGF-induced Rad activation through Rho-associated kinase, inhibiting the neurite formation.	Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Negishi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan.	mnegishi@pharm.kyoto-u.ac.jp	Yamaguchi, Yoshiaki/K-9418-2013	Yamaguchi, Yoshiaki/0000-0003-4126-542X				Albertinazzi C, 1998, J CELL BIOL, V142, P815, DOI 10.1083/jcb.142.3.815; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Burridge K, 1999, SCIENCE, V283, P2028, DOI 10.1126/science.283.5410.2028; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Katoh H, 1998, J BIOL CHEM, V273, P2489, DOI 10.1074/jbc.273.5.2489; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Lamoureux P, 1997, J CELL SCI, V110, P635; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Moorman JP, 1999, ONCOGENE, V18, P47, DOI 10.1038/sj.onc.1202262; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; Ory S, 2000, J CELL SCI, V113, P1177; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sarner S, 2000, MOL CELL BIOL, V20, P158, DOI 10.1128/MCB.20.1.158-172.2000; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Sebok A, 1999, J NEUROCHEM, V73, P949, DOI 10.1046/j.1471-4159.1999.0730949.x; SPERO DA, 1985, DEV BRAIN RES, V23, P155, DOI 10.1016/0165-3806(85)90016-1; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; van Leeuwen FN, 1999, NAT CELL BIOL, V1, P242, DOI 10.1038/12068; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Yamaguchi Y, 2000, J NEUROCHEM, V75, P708, DOI 10.1046/j.1471-4159.2000.0750708.x; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	50	156	160	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18977	18983		10.1074/jbc.M100254200	http://dx.doi.org/10.1074/jbc.M100254200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279039	hybrid			2022-12-27	WOS:000169091000045
J	Brufatto, N; Nesheim, ME				Brufatto, N; Nesheim, ME			The use of prothrombin(S525C) labeled with fluorescein to directly study the inhibition of prothrombinase by antithrombin during prothrombin activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-XA REACTION; BOVINE FACTOR-V; PROTEIN-C; HEPARIN; THROMBIN; BINDING; COMPLEX; MEIZOTHROMBIN; INACTIVATION; ENHANCEMENT	Serine 525 of human prothrombin was mutated to cysteine and covalently labeled with fluorescein to make II(S525C)-fluorescein. Kinetics of cleavage of this derivative by prothrombinase are identical to those of wild-type prothrombin, Cleavage is coincident with a 50% increase in fluorescence intensity and the product is catalytically inactive. Thus, it allows convenient monitoring of prothrombin activation without generating active thrombin, The kinetics of inhibition of factor Xa (FXa) by antithrombin (AT) and AT-heparin were measured by monitoring activation of II(S525C)-fluorescein and the hydrolysis of the chromogenic substrate S2222 in the presence of AT. With S2222 as the substrate the rate constant for inhibition of FXa, Ca2+, and unilamellar vesicles of phosphatidylcholine and phosphatidylserine (75:25) (PCPS) vesicles by AT was 3.51 x 10(3) M-1 s(-1); when factor Va (FVa) was included the rate constant was 1.55 x 10(3) M-1 s(-1). In the absence of FVa, II(S525C)-fluorescein had no effect on inhibition. When II(S525C)-fluorescein was the substrate, however, FVa at saturating concentrations profoundly protected FXa from inhibition by AT, increasing the half-life from 3 min with FXa, Ca2+, PCPS, and II(S525C)-fluorescein, to greater than 69 min when FVa was included. Thus, both FVa and prothrombin are necessary for this level of protection. In the absence of prothrombin, FVa decreased the second order rate constant for inhibition by the AT-heparin complex from 1.58 x 10(7) M-1 s(-1), for FXa, Ca2+, and PCPS, to 7.72 x 10(6) M-1 s(-1). II(S525C)-fluorescein and factor Va together reduced the rate constant to less than 1% of that for FXa, Ca2+, and PCPS, At a heparin concentration of 0.2 unit/ml, this corresponds to a half-life increase from 1 s to 136 s.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Nesheim, ME (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 46703] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAJZAR L, 1990, J BIOL CHEM, V265, P16948; BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P4419, DOI 10.1021/bi00587a023; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COTE HCF, 1994, J BIOL CHEM, V269, P11374; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; EISENBERG PR, 1993, J CLIN INVEST, V91, P1877, DOI 10.1172/JCI116404; ELLIS V, 1984, BIOCHEMISTRY-US, V23, P5882, DOI 10.1021/bi00319a030; GRIFFITH MJ, 1982, J BIOL CHEM, V257, P7360; Herault JP, 1997, J PHARMACOL EXP THER, V283, P16; JORDAN R, 1979, J BIOL CHEM, V254, P2902; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; LEBONNIEC BF, 1991, J BIOL CHEM, V266, P13796; LINDHOUT T, 1986, BIOCHEMISTRY-US, V25, P5962, DOI 10.1021/bi00368a019; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1987, TRENDS BIOCHEM SCI, V12, P229, DOI 10.1016/0968-0004(87)90115-0; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; NESHEIM ME, 1983, J BIOL CHEM, V258, P4708; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OWEN BA, 1990, BIOCHEMISTRY-US, V29, P9412, DOI 10.1021/bi00492a015; POMERANTZ MW, 1978, BIOCHIM BIOPHYS ACTA, V535, P66, DOI 10.1016/0005-2795(78)90033-8; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; SCHOEN P, 1989, J BIOL CHEM, V264, P10002; SCHOEN P, 1991, BLOOD, V78, P118; SPEIJER H, 1995, THROMB HAEMOSTASIS, V73, P648; TRACY PB, 1981, J BIOL CHEM, V256, P743; TRACY PB, 1985, J BIOL CHEM, V260, P2119; WALKER FJ, 1979, BIOCHEM BIOPH RES CO, V90, P641, DOI 10.1016/0006-291X(79)91283-X; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; YAN SCB, 1990, BIO-TECHNOL, V8, P655, DOI 10.1038/nbt0790-655	31	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17663	17671		10.1074/jbc.M011586200	http://dx.doi.org/10.1074/jbc.M011586200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278943	hybrid			2022-12-27	WOS:000168866500007
J	Calderini, O; Glab, N; Bergounioux, C; Heberle-Bors, E; Wilson, C				Calderini, O; Glab, N; Bergounioux, C; Heberle-Bors, E; Wilson, C			A novel tobacco mitogen-activated protein (MAP) kinase kinase, NtMEK1, activates the cell cycle-regulated p43(Ntf6) MAP kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; FUNCTIONAL COMPLEMENTATION; YEAST; EXPRESSION; HOMOLOG; PLANT; GROWTH; GENE; CYTOKININ; CASCADE	Two-hybrid screening of a tobacco BY-2 cell suspension cDNA library using the p43(Ntf6) mitogen-activated protein (MAP) kinase as bait resulted in the isolation of a cDNA encoding a protein with features characteristic of a MAP kinase kinase (MEK), which has been called NtMEK1. Two-hybrid interaction analysis and pull-down experiments showed a physical interaction between NtMEK1 and the tobacco MAP kinases p43(Ntf6) and p45(Ntf4), but not p43(Ntf3). I, kinase assays NtMEK1 preferentially phosphorylated p43(Ntf6). Functional studies in yeast showed that p43(Ntf6) could complement the yeast MAP kinase mutant mpk1 when co-expressed with NtMEK1, and that this complementation depended on the kinase activity of p43(Ntf6), Expression analysis showed that the NtMEK1 and ntf6 genes are co-expressed both in plant tissues and following the induction of cell division in leaf pieces. These data suggest that NtMEK1 is an MEK for the p43(Ntf6) MAP kinase.	Univ Vienna, Inst Microbiol & Genet, A-1030 Vienna, Austria; CNR, Ist Ric Miglioramento Genet Piante Foraggere, I-06128 Perugia, Italy; Univ Paris 11, Inst Biotechnol Plantes, CNRS, ERS 569, F-91405 Orsay, France	University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Heberle-Bors, E (corresponding author), Univ Vienna, Inst Microbiol & Genet, Dr Bohrgasse 9, A-1030 Vienna, Austria.	erwin@gem.univie.ac.at	Calderini, Ornella/H-7772-2016	Calderini, Ornella/0000-0001-9516-8997; Wilson, Cathal/0000-0002-0637-8608				ANNWEILER A, 1991, NUCLEIC ACIDS RES, V19, P3750, DOI 10.1093/nar/19.13.3750; Bogre L, 1999, PLANT CELL, V11, P101, DOI 10.1105/tpc.11.1.101; BRUNET A, 1994, FEBS LETT, V346, P299, DOI 10.1016/0014-5793(94)00475-7; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Calderini O, 1998, J CELL SCI, V111, P3091; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; HACKETT RM, 1998, PLANT PHYSIOL, V117, P1526; Hamal A, 1999, PLANT SCI, V140, P41, DOI 10.1016/S0168-9452(98)00203-9; Hardin SC, 1998, PLANTA, V206, P577, DOI 10.1007/s004250050435; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Huang YF, 2000, PLANT PHYSIOL, V122, P1301, DOI 10.1104/pp.122.4.1301; Ichimura K, 1998, BIOCHEM BIOPH RES CO, V253, P532, DOI 10.1006/bbrc.1998.9796; JONAK C, 1995, MOL GEN GENET, V248, P686, DOI 10.1007/BF02191708; Kieran MW, 1999, ONCOGENE, V18, P6647, DOI 10.1038/sj.onc.1203057; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; Ligterink W, 2000, RES PRO CEL, V27, P11; Liu YH, 2000, MOL PLANT MICROBE IN, V13, P118, DOI 10.1094/MPMI.2000.13.1.118; MAZZONI C, 1993, J CELL BIOL, V123, P1821, DOI 10.1083/jcb.123.6.1821; MEMELINK J, 1987, EMBO J, V6, P3579, DOI 10.1002/j.1460-2075.1987.tb02688.x; Meskiene I, 2000, PLANT MOL BIOL, V42, P791, DOI 10.1023/A:1006405929082; Mizoguchi T, 1998, FEBS LETT, V437, P56, DOI 10.1016/S0014-5793(98)01197-1; Morris PC, 1997, PLANT MOL BIOL, V35, P1057, DOI 10.1023/A:1005963222768; Nakashima M, 1998, PLANT CELL PHYSIOL, V39, P690, DOI 10.1093/oxfordjournals.pcp.a029423; Pan ZQ, 1999, FEBS LETT, V459, P405, DOI 10.1016/S0014-5793(99)01306-X; Planchais S, 1997, PLANT J, V12, P191, DOI 10.1046/j.1365-313X.1997.12010191.x; Reszka AA, 1997, MOL BIOL CELL, V8, P1219, DOI 10.1091/mbc.8.7.1219; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Trehin C, 1998, PLANTA, V206, P215, DOI 10.1007/s004250050393; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; VORONIN V, 2001, IN PRESS PLANT MOL B; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wilsbacher JL, 1999, J BIOL CHEM, V274, P16988, DOI 10.1074/jbc.274.24.16988; WILSON C, 1995, EUR J BIOCHEM, V233, P249, DOI 10.1111/j.1432-1033.1995.249_1.x; ZHENG CF, 1993, J BIOL CHEM, V268, P23933	39	42	48	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18139	18145		10.1074/jbc.M010621200	http://dx.doi.org/10.1074/jbc.M010621200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278711	hybrid			2022-12-27	WOS:000168866500071
J	Espinosa, E; Belmant, C; Pont, F; Luciani, B; Poupot, R; Romagne, F; Brailly, H; Bonneville, M; Fournie, JJ				Espinosa, E; Belmant, C; Pont, F; Luciani, B; Poupot, R; Romagne, F; Brailly, H; Bonneville, M; Fournie, JJ			Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPEPTIDE ANTIGENS; RECOGNITION; LIGANDS; RECEPTORS; IMMUNITY; DAUDI	Small phosphorylated metabolites from mycobacteria stimulate human gamma delta T lymphocytes. Although such phosphoantigens could prove useful in the composition of vaccines involving gamma delta T cell-mediated immunity, their very low abundance in natural sources limits such applications. Here, we describe the chemical production, purification, and bioactivity of a phosphorylated bromohydrin (BrHPP) analogue that mimics the biological properties of natural phosphoantigens, This compound can be obtained in gram amounts, is easy to detect, and is of high stability in aqueous solutions. Whereas unspecific binding of BrHPP to a wide panel of cell surface receptors is not detected even at micromolar concentrations, nanomolar concentrations specifically trigger effector responses of human gamma delta T lymphocytes, Thus, BrHPP is a novel molecule enabling potent immunostimulation of human gamma delta T lymphocytes.	CHU Purpan, INSERM, U395, F-31024 Toulouse, France; Inst Biol, INSERM, U463, F-44035 Nantes, France; Immeuble Grand Pre, Innate Pharma, F-13006 Marseille, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Fournie, JJ (corresponding author), CHU Purpan, INSERM, U395, BP3028, F-31024 Toulouse, France.		PONT, Frédéric/G-6289-2011; Fournie, Jean-Jacques/J-7805-2013; espinosa, eric/E-4872-2013	PONT, Frédéric/0000-0002-5493-527X; Fournie, Jean-Jacques/0000-0001-6542-6908; espinosa, eric/0000-0002-3512-0921				Belman C, 1999, J BIOL CHEM, V274, P32079, DOI 10.1074/jbc.274.45.32079; Belmant C, 2000, FASEB J, V14, P1669, DOI 10.1096/fj.99-0909fje; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Bukowski JF, 1998, J IMMUNOL, V161, P286; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; DAVISSON VJ, 1986, J ORG CHEM, V51, P4768, DOI 10.1021/jo00375a005; DAVODEAU F, 1993, J IMMUNOL, V151, P1214; Fisch P, 2000, IMMUNOL TODAY, V21, P187, DOI 10.1016/S0167-5699(99)01576-5; Fournie JJ, 1996, RES IMMUNOL, V147, P338, DOI 10.1016/0923-2494(96)89648-9; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; NAG B, 1992, J IMMUNOL, V148, P2040; Poccia F, 1998, IMMUNOL TODAY, V19, P253, DOI 10.1016/S0167-5699(98)01266-3; Poquet Y, 1996, EUR J IMMUNOL, V26, P2344, DOI 10.1002/eji.1830261011; Poquet Y, 1996, ANAL BIOCHEM, V243, P119, DOI 10.1006/abio.1996.0489; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; Sicard H, 2000, INFECT IMMUN, V68, P4375, DOI 10.1128/IAI.68.8.4375-4377.2000; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175	20	134	137	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18337	18344		10.1074/jbc.M100495200	http://dx.doi.org/10.1074/jbc.M100495200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279081	hybrid			2022-12-27	WOS:000168866500097
J	Friedman, DB; Kern, JW; Huneycutt, BJ; Vinh, DBN; Crawford, DK; Steiner, E; Scheiltz, D; Yates, J; Resing, KA; Ahn, NG; Winey, M; Davis, TN				Friedman, DB; Kern, JW; Huneycutt, BJ; Vinh, DBN; Crawford, DK; Steiner, E; Scheiltz, D; Yates, J; Resing, KA; Ahn, NG; Winey, M; Davis, TN			Yeast Mps1p phosphorylates the spindle pole component Spc110p in the N-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-TUBULIN COMPLEX; DUPLICATION GENE MPS1; SACCHAROMYCES-CEREVISIAE; BODY DUPLICATION; SPACER PROTEIN; CALMODULIN; KINASE; SPC98P; LOCALIZATION; MICROTUBULES	The yeast spindle pole body (SPB) component Spc110p (Nuf1p) undergoes specific serine/threonine phosphorylation as the mitotic spindle apparatus forms, and this phosphorylation persists until cells enter anaphase. We demonstrate that the dual-specificity kinase Mps1p is essential for the mitosis-specific phosphorylation of Spc110p in vivo and that Mps1p phosphorylates Spc110p in vitro. Phosphopeptides generated by proteolytic cleavage were identified and sequenced by mass spectrometry, Ser(60), Thr(64), and Thr(68) are the major sites in Spc110p phosphorylated by Mps1p in vitro, and alanine substitution at these sites abolishes the mitosis-specific isoform in vivo, This is the first time that phosphorylation sites of an SPB component have been determined, and these are the first sites of Mps1p phosphorylation identified. Alanine substitution for any one of these phosphorylated residues, in conjunction with an alanine substitution at residue Ser(36), is lethal in combination with alleles of SPC97, which encodes a component of the Tub4p complex. Consistent with a specific dysfunction for the alanine substitution mutations, simultaneous mutation of all four serine/threonine residues to aspartate does not confer any defect. Sites of Mps1p phosphorylation and Ser36 are located within the N-terminal globular domain of Spc110p, which resides at the inner plaque of the SPB and binds the Tub4p complex.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Davis, TN (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	tdavis@u.washington.edu	Davis, Trisha/F-8584-2010	Davis, Trisha/0000-0003-4797-3152	NCI NIH HHS [T32-CA09437] Funding Source: Medline; NCRR NIH HHS [P41RR11823, P41 RR011823] Funding Source: Medline; NIAMS NIH HHS [AR39730] Funding Source: Medline; NIGMS NIH HHS [R01 GM051312, GM-07135, R01 GM040506, GM-51312, F32-GM17946, GM-40506] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009437] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR039730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007135, R01GM040506, R01GM051312, F32GM017946] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams IR, 1999, J CELL BIOL, V145, P809, DOI 10.1083/jcb.145.4.809; BAUM P, 1986, P NATL ACAD SCI USA, V83, P5512, DOI 10.1073/pnas.83.15.5512; BLACK S, 1995, YEAST, V11, P747, DOI 10.1002/yea.320110806; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; CENTONZE VE, 1990, J CELL SCI, V95, P405; DAVIS TN, 1992, J CELL BIOL, V118, P607, DOI 10.1083/jcb.118.3.607; Elliott S, 1999, P NATL ACAD SCI USA, V96, P6205, DOI 10.1073/pnas.96.11.6205; ENGLE DB, 1988, CELL MOTIL CYTOSKEL, V10, P432, DOI 10.1002/cm.970100310; Friedman DB, 1996, J CELL BIOL, V132, P903, DOI 10.1083/jcb.132.5.903; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GEISER JR, 1993, MOL CELL BIOL, V13, P7913, DOI 10.1128/MCB.13.12.7913; Geiser JR, 1997, MOL BIOL CELL, V8, P1035, DOI 10.1091/mbc.8.6.1035; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; HISAMOTO N, 1994, MOL CELL BIOL, V14, P3158, DOI 10.1128/MCB.14.5.3158; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jones MH, 1999, MOL BIOL CELL, V10, P2377, DOI 10.1091/mbc.10.7.2377; Kilmartin JV, 1996, EMBO J, V15, P4592, DOI 10.1002/j.1460-2075.1996.tb00837.x; KILMARTIN JV, 1993, J CELL BIOL, V123, P1175, DOI 10.1083/jcb.123.5.1175; Knop M, 1998, EMBO J, V17, P3952, DOI 10.1093/emboj/17.14.3952; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGAN TA, 1989, MOL CELL BIOL, V9, P3860, DOI 10.1128/MCB.9.9.3860; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; MACKELVIE SH, 1995, MOL CELL BIOL, V15, P3777; MASUDA H, 1992, J CELL BIOL, V117, P1055, DOI 10.1083/jcb.117.5.1055; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Nguyen T, 1998, MOL BIOL CELL, V9, P2201, DOI 10.1091/mbc.9.8.2201; Pereira G, 1998, MOL BIOL CELL, V9, P775, DOI 10.1091/mbc.9.4.775; Schutz AR, 1998, MOL BIOL CELL, V9, P759, DOI 10.1091/mbc.9.4.759; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; Spang A, 1996, J CELL SCI, V109, P2229; Stirling DA, 1996, BIOCHEM BIOPH RES CO, V222, P236, DOI 10.1006/bbrc.1996.0728; Sundberg HA, 1996, J CELL BIOL, V133, P111, DOI 10.1083/jcb.133.1.111; Sundberg HA, 1997, MOL BIOL CELL, V8, P2575, DOI 10.1091/mbc.8.12.2575; VANDRE DD, 1989, J CELL SCI, V94, P245; VANDRE DD, 1992, J CELL SCI, V101, P79; WATTS JD, 1994, J BIOL CHEM, V269, P29520; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745	44	22	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17958	17967		10.1074/jbc.M010461200	http://dx.doi.org/10.1074/jbc.M010461200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278681	hybrid, Green Accepted			2022-12-27	WOS:000168866500047
J	Geerlings, A; Nunez, E; Lopez-Corcuera, B; Aragon, C				Geerlings, A; Nunez, E; Lopez-Corcuera, B; Aragon, C			Calcium- and syntaxin 1-mediated trafficking of the neuronal glycine transporter GLYT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPETITIVE ACTION-POTENTIALS; HUMAN DOPAMINE TRANSPORTER; SYNAPTIC VESICLES; NEUROTRANSMITTER RELEASE; NERVE-TERMINALS; PROLINE TRANSPORTER; MOLECULAR-BIOLOGY; PHORBOL ESTERS; PROTEIN; BRAIN	Previously we demonstrated the existence of a physical and functional interaction between the glycine transporters and the SNARE protein syntaxin 1, In the present report the physiological role of the syntaxin l-glycine transporter 2 (GLYT2) interaction has been investigated by using a brain-derived preparation. Previous studies, focused on syntaxin 1-transporter interactions using overexpression systems, led to the postulation that syntaxin is somehow implicated in protein trafficking. Since syntaxin 1 is involved in exocytosis of neurotransmitter and also interacts with GLYT2, we stimulated exocytosis in synaptosomes and examined its effect on surface-expression and transport activity of GLYT2, We found that, under conditions that stimulate vesicular glycine release, GLYT2 is rapidly trafficked first toward the plasma membrane and then internalized. When the same experiments were performed with synaptosomes inactivated for syntaxin 1 by a pretreatment with the neurotoxin Bont/C, GLYT2 was unable to reach the plasma membrane but still was able to leave it. These results indicate the existence of a SNARE-mediated regulatory mechanism that controls the surface-expression of GLYT2. Syntaxin 1 is involved in the arrival to the plasma membrane but not in the retrieval. Furthermore, by using immunogold labeling on purified preparations from synaptosomes, we demonstrate that GLYT2 is present in small synaptic-like vesicles. GLYT2-containing vesicles may represent neurotransmitter transporter that is being trafficked. The results of our work suggest a close correlation between exocytosis of neurotransmitter and its reuptake by transporters.	Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Aragon, C (corresponding author), Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.		Corcuera, Beatriz López/D-5188-2009; Aragon, Carmen/K-9783-2014	Corcuera, Beatriz López/0000-0002-0383-4241; Aragon, Carmen/0000-0001-8287-9386				Beckman ML, 1998, J NEUROSCI, V18, P6103; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Blakely RD, 2000, CURR OPIN NEUROBIOL, V10, P328, DOI 10.1016/S0959-4388(00)00088-X; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BOROWSKY B, 1993, NEURON, V10, P851, DOI 10.1016/0896-6273(93)90201-2; Boudier JA, 1999, EUR J NEUROSCI, V11, P3449, DOI 10.1046/j.1460-9568.1999.00778.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckley KM, 2000, J PHYSIOL-LONDON, V525, P11, DOI 10.1111/j.1469-7793.2000.t01-2-00011.x; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; COREY JL, 1994, J BIOL CHEM, V269, P14759; Cousin MA, 1997, J NEUROCHEM, V69, P1927; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; DIEBLER MF, 1985, J NEUROCHEM, V44, P1633, DOI 10.1111/j.1471-4159.1985.tb08806.x; Geerlings A, 2000, FEBS LETT, V470, P51, DOI 10.1016/S0014-5793(00)01297-7; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GOMEZA J, 1995, BBA-BIOMEMBRANES, V1233, P41, DOI 10.1016/0005-2736(94)00249-O; GUASTELLA J, 1992, P NATL ACAD SCI USA, V89, P7189, DOI 10.1073/pnas.89.15.7189; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jayanthi LD, 2000, BRIT J PHARMACOL, V129, P465, DOI 10.1038/sj.bjp.0703071; JAYANTHI LD, 1994, J BIOL CHEM, V269, P14424; Kippenberger AG, 1999, J NEUROCHEM, V73, P1024, DOI 10.1046/j.1471-4159.1999.0731024.x; LIU QR, 1993, J BIOL CHEM, V268, P22802; LIU QR, 1992, FEBS LETT, V305, P110, DOI 10.1016/0014-5793(92)80875-H; Lopez-Corcuera B, 1998, J NEUROCHEM, V71, P2211; Melikian HE, 1999, J NEUROSCI, V19, P7699; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; NICHOLS RA, 1994, J BIOL CHEM, V269, P23817; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; Qi JJ, 1999, J BIOL CHEM, V274, P30345, DOI 10.1074/jbc.274.43.30345; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; Renick SE, 1999, J NEUROSCI, V19, P21, DOI 10.1523/JNEUROSCI.19-01-00021.1999; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; Tibbs GR, 1996, J NEUROCHEM, V67, P389; TIBBS GR, 1989, J NEUROCHEM, V53, P1693, DOI 10.1111/j.1471-4159.1989.tb09232.x; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; Zafra F, 1997, MOL NEUROBIOL, V14, P117, DOI 10.1007/BF02740653; ZAFRA F, 1995, J NEUROSCI, V15, P3952	46	84	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17584	17590		10.1074/jbc.M010602200	http://dx.doi.org/10.1074/jbc.M010602200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278707	hybrid			2022-12-27	WOS:000168730400131
J	Handa, P; Roy, S; Varshney, U				Handa, P; Roy, S; Varshney, U			The role of leucine 191 of Escherichia coli uracil DNA glycosylase in the formation of a highly stable complex with the substrate mimic, Ugi, and in uracil excision from the synthetic substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; INHIBITOR PROTEIN; BINDING-PROTEIN; REPAIR; CATALYSIS; MECHANISM; GLYCOSIDASE; OLIGOMERS; SEQUENCE	Uracil DNA glycosylase (UDG), a highly conserved DNA repair enzyme, initiates the uracil excision repair pathway. Ugi, a bacteriophage-encoded peptide, potently inhibits UDGs by serving as a remarkable substrate mimic. Structure determination of UDGs has identified regions important for the exquisite specificity in the detection and removal of uracils from DNA and in their interaction with Ugi, In this study, we carried out mutational analysis of the Escherichia coli UDG at Leu(191) within the (HPSPLS192)-H-187 moth (DNA intercalation loop). We show that with the decrease in side chain length at position 191, the stability of the UDG-Ugi complexes regresses. Further, while the L191V and L191F mutants were as ef)efficient as the wild type protein, the L191A and L191G mutants retained only 10 and 1% of the enzymatic activity, respectively. Importantly, however, substitution of Leu(191) with smaller side chains had no effect on the relative efficiencies of uracil excision from the single-stranded and a corresponding double-stranded substrate. Our results suggest that leucine within the HPSPLS motif is crucial for the uracil excision activity of UDG, and it contributes to the formation of a physiologically irreversible complex with Ugi. We also envisage a role for Leu(191) in stabilizing the productive enzyme-substrate complex.	Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Varshney, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.		Varshney, Umesh/A-8062-2009; Varshney, Umesh/Q-6914-2019					Aravind L., 2000, GENOME BIOL; BENNETT SE, 1992, J BIOL CHEM, V267, P22512; Chaconas G, 1980, Methods Enzymol, V65, P75; DOWD JE, 1965, J BIOL CHEM, V240, P863; Friedberg E. C., 1995, DNA REPAIR MUTAGENES, P1; Ghosh M, 2000, NUCLEIC ACIDS RES, V28, P1906, DOI 10.1093/nar/28.9.1906; Handa P, 1998, INDIAN J BIOCHEM BIO, V35, P63; Handa P, 2000, NUCLEIC ACIDS RES, V28, P3823, DOI 10.1093/nar/28.19.3823; Krokan HE, 1997, BIOCHEM J, V325, P1; KUMAR NV, 1994, NUCLEIC ACIDS RES, V22, P3737, DOI 10.1093/nar/22.18.3737; Kumar NV, 1997, NUCLEIC ACIDS RES, V25, P2336, DOI 10.1093/nar/25.12.2336; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lundquist AJ, 1997, J BIOL CHEM, V272, P21408, DOI 10.1074/jbc.272.34.21408; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; Nagelhus TA, 1997, J BIOL CHEM, V272, P6561, DOI 10.1074/jbc.272.10.6561; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Purnapatre K, 1999, NUCLEIC ACIDS RES, V27, P3487, DOI 10.1093/nar/27.17.3487; Putnam CD, 1999, J MOL BIOL, V287, P331, DOI 10.1006/jmbi.1999.2605; Rao JVK, 2000, EUR J BIOCHEM, V267, P5967, DOI 10.1046/j.1432-1327.2000.01667.x; Ravishankar R, 1998, NUCLEIC ACIDS RES, V26, P4880, DOI 10.1093/nar/26.21.4880; Roy S, 1998, PROTEIN EXPRES PURIF, V13, P155, DOI 10.1006/prep.1998.0878; Sambrook J., 2002, MOL CLONING LAB MANU; SAVVA R, 1995, NAT STRUCT BIOL, V2, P752, DOI 10.1038/nsb0995-752; SAVVA R, 1995, NATURE, V373, P483; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; Shroyer MJN, 1999, BIOCHEMISTRY-US, V38, P4834, DOI 10.1021/bi982986j; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; TYE BK, 1977, P NATL ACAD SCI USA, V74, P154, DOI 10.1073/pnas.74.1.154; VARSHNEY U, 1988, J BIOL CHEM, V263, P7776; VARSHNEY U, 1991, BIOCHEMISTRY-US, V30, P4055, DOI 10.1021/bi00230a033; WANG Z, 1989, J BIOL CHEM, V264, P1163; Werner RM, 2000, BIOCHEMISTRY-US, V39, P12585, DOI 10.1021/bi001532v; Xiao GY, 1999, PROTEINS, V35, P13	41	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17324	17331		10.1074/jbc.M011166200	http://dx.doi.org/10.1074/jbc.M011166200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278852	hybrid			2022-12-27	WOS:000168730400097
J	Kamimura, K; Fujise, M; Villa, F; Izumi, S; Habuchi, H; Kimata, K; Nakato, H				Kamimura, K; Fujise, M; Villa, F; Izumi, S; Habuchi, H; Kimata, K; Nakato, H			Drosophila heparan sulfate 6-O-sulfotransferase (dHS6ST) gene - Structure, expression, and function in the formation of the tracheal system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; FGF RECEPTOR HOMOLOG; HAMSTER OVARY CELLS; TOUT-VELU; CRYSTAL-STRUCTURE; ANGIOGENESIS; MIGRATION; SULFOTRANSFERASE; ACTIVATION; PATTERN	Heparan sulfate, one of the most abundant components of the cell surface and the extracellular matrix, is involved in a variety of biological processes such as growth factor signaling, cell adhesion, and enzymatic catalysis. The heparan sulfate chains have markedly heterogeneous structures in which distinct sequences of sulfate groups determine specific binding properties. Sulfation at each different position of heparan sulfate is catalyzed by distinct enzymes, sulfotransferases, In this study, we identified and characterized Drosophila heparan sulfate 6-O-sulfotransferase (dHS6ST), The deduced primary structure of dHS6ST exhibited several common features found in those of mammalian HS6STs. We confirmed that, when the protein encoded by the cDNA was expressed in COS-7 cells, it showed HS6ST activity. Whole mount in situ hybridization revealed highly specific expression of dHS6ST mRNA in embryonic tracheal cells. The spatial and temporal pattern of dHS6ST expression in these cells clearly resembles that of the Drosophila fibroblast growth factor (FGF) receptor, breathless (btl). RNA interference experiments demonstrated that reduced dHS6ST activity caused embryonic lethality and disruption of the primary branching of the tracheal system. These phenotypes were reminiscent of the defects observed in mutants of FGF signaling components. We also show that FGF-dependent mitogen-activated protein kinase activation is significantly reduced in dHS6ST double-stranded RNA-injected embryos. These findings indicate that dHS6ST is required for tracheal development in Drosophila and suggest the evolutionally conserved roles of 6-O-sulfated heparan sulfate in FGF signaling.	Tokyo Metropolitan Univ, Dept Biol, Hachioji, Tokyo 1920397, Japan; Univ Arizona, Div Neurobiol, Tucson, AZ 85721 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan	Tokyo Metropolitan University; University of Arizona; University of Arizona; Aichi Medical University	Nakato, H (corresponding author), Tokyo Metropolitan Univ, Dept Biol, Hachioji, Tokyo 1920397, Japan.							ARKHIPOVA IR, 1995, GENETICS, V139, P1359; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; DELFERT DM, 1985, ANAL BIOCHEM, V148, P303, DOI 10.1016/0003-2697(85)90233-7; EMORI Y, 1993, FEBS LETT, V332, P111, DOI 10.1016/0014-5793(93)80494-F; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Gabay L, 1997, DEVELOPMENT, V124, P3535; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; HABUCHI H, 1995, J BIOL CHEM, V270, P4172, DOI 10.1074/jbc.270.8.4172; HABUCHI O, 1980, BIOCHIM BIOPHYS ACTA, V616, P208, DOI 10.1016/0005-2744(80)90139-4; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; HULTMARK D, 1986, CELL, V44, P429, DOI 10.1016/0092-8674(86)90464-2; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lin XH, 1999, DEVELOPMENT, V126, P3715; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; MANNING G, 1993, DEV DROSOPHILA MELAN, V1, P2609; PERRIMON N, 1991, DEV GENET, V12, P238, DOI 10.1002/dvg.1020120309; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Sambrook J., 2002, MOL CLONING LAB MANU; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	56	95	97	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17014	17021		10.1074/jbc.M011354200	http://dx.doi.org/10.1074/jbc.M011354200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278892	hybrid			2022-12-27	WOS:000168730400055
J	Klatt, AR; Nitsche, DP; Kobbe, B; Macht, M; Paulsson, M; Wagener, R				Klatt, AR; Nitsche, DP; Kobbe, B; Macht, M; Paulsson, M; Wagener, R			Molecular structure, processing, and tissue distribution of matrilin-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARTILAGE MATRIX PROTEIN; HELICAL COILED-COIL; C-TERMINAL DOMAIN; SKELETAL DEVELOPMENT; FILAMENTOUS NETWORK; FORMS; ORGANIZATION; PURIFICATION; EXPRESSION; ASSEMBLES	Matrilin-4 is the most recently identified member of the matrilin family of von Willebrand factor A-like domain containing extracellular matrix adapter proteins. Full-length matrilin-4 was expressed in 293-EBNA cells, purified using affinity tags, and subjected to biochemical characterization. The largest oligomeric form of recombinantly expressed full-length matrilin-1 is a trimer as shown by electron microscopy, SDS-polyacrylamide gel electrophoresis, and mass spectrometry, Proteolytically processed matrilin-4 species were also detected, The cleavage occurs in the short linker region between the second von Willebrand factor A-like domain and the coiled-coil domain leading to the release of large fragments and the formation of dimers and monomers of intact subunits still containing a trimeric coiled-coil. In immunoblots of calvaria extracts similar degradation products could be detected, indicating that a related proteolytic processing occurs in vivo. Matrilin-4 was first observed at day 7.5 post-coitum in mouse embryos. Affinity-purified antibodies detect a broad expression in dense and loose connective tissue, bone, cartilage, central and peripheral nervous systems and in association with basement membranes. In the matrix formed by cultured primary embryonic fibroblasts, matrilin-4 is found in a filamentous network connecting individual cells.	Univ Cologne, Fac Med, Inst Biochem 2, D-50931 Cologne, Germany; Univ Cologne, Fac Med, Cologne Serv Lab, Ctr Mol Med, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Wagener, R (corresponding author), Univ Cologne, Fac Med, Inst Biochem 2, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.							Aszodi A, 1999, MOL CELL BIOL, V19, P7841; Beck K, 1996, J MOL BIOL, V256, P909, DOI 10.1006/jmbi.1996.0137; CHEN Q, 1995, MOL BIOL CELL, V6, P1743, DOI 10.1091/mbc.6.12.1743; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; DEBLOCK M, 1993, ANAL BIOCHEM, V215, P86, DOI 10.1006/abio.1993.1558; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; Gibson TJ, 2000, BIOCHEM SOC T, V28, P259, DOI 10.1042/bst0280259; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HAUSER N, 1994, J BIOL CHEM, V269, P25747; Huang XM, 1999, DEV DYNAM, V216, P434, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<434::AID-DVDY11>3.3.CO;2-O; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Pan OH, 1998, J BIOL CHEM, V273, P14205, DOI 10.1074/jbc.273.23.14205; PAULSSON M, 1981, BIOCHEM J, V197, P367, DOI 10.1042/bj1970367; Piecha D, 1999, J BIOL CHEM, V274, P13353, DOI 10.1074/jbc.274.19.13353; Segat D, 2000, MATRIX BIOL, V19, P649, DOI 10.1016/S0945-053X(00)00112-8; Smyth N, 2000, METH MOL B, V139, P49; Wagener R, 1998, FEBS LETT, V438, P165, DOI 10.1016/S0014-5793(98)01293-9; Wagener R, 1998, FEBS LETT, V436, P123, DOI 10.1016/S0014-5793(98)01111-9; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307; Wu JJ, 1998, J BIOL CHEM, V273, P17433, DOI 10.1074/jbc.273.28.17433; WUTTKE M, 2001, THESIS U COLOGNE GER; Zatterstrom UK, 2000, CELL STRUCT FUNCT, V25, P97; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200	26	64	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17267	17275		10.1074/jbc.M100587200	http://dx.doi.org/10.1074/jbc.M100587200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279097	hybrid			2022-12-27	WOS:000168730400089
J	Mitsuzawa, H; Seino, H; Yamao, F; Ishihama, A				Mitsuzawa, H; Seino, H; Yamao, F; Ishihama, A			Two WD repeat-containing TATA-binding protein-associated factors in fission yeast that suppress defects in the anaphase-promoting complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION IN-VIVO; TBP-ASSOCIATED FACTORS; HISTONE-LIKE TAFS; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; NUCLEOSOME ACETYLATION; MOLECULAR-CLONING; SAGA COMPLEXES; TFIID COMPLEX	The general transcription factor IID consists of the TATA-binding protein (TBP) and multiple TBP-associated factors (TAFs). Here we report the isolation of two related TAF genes from the fission yeast Schizosaccha romyces pombe as multicopy suppressors of a temperature-sensitive mutation in the ubiquitin-conjugating enzyme gene ubcP4(+). The ubcP4(ts) mutation causes cell cycle arrest in mitosis, probably due to defects in ubiquitination mediated by the anaphase-promoting complex/cyclosome. One multicopy suppressor is the previously reported gene taf72(+), whereas the other is a previously unidentified gene named taf73(+). We show that the taf73(+) gene, like taf72(+), is essential for cell viability. The taf72(+) and taf73(+) genes encode proteins homologous to WD repeat-containing TAFs such as human TAF100, Drosophila TAF80/85, and Saccharomyces cerevisiae TAF90, We demonstrate that TAF72 and TAF73 proteins are present in the same complex with TBP and other TAFs and that TAF72, but not TAF73, is associated with the putative histone acetylase Gcn5, We also show that overexpression of TAF72 or TAF73 suppresses the cell cycle arrest in mitosis caused by a mutation in the anaphase-promoting complex/cyclosome subunit gene cut9(+), These results suggest that TAF72 and TAF73 may regulate the expression of genes involved in ubiquitin-dependent proteolysis during mitosis. Our study thus provides evidence for a possible role of WD repeat-containing TAFs in the expression of genes involved in progression through the M phase of the cell cycle.	Natl Inst Genet, Dept Mol Genet, Div Mol Genet, Mishima, Shizuoka 4118540, Japan; Natl Inst Genet, Dept Mol Genet, Div Mutagenesis, Mishima, Shizuoka 4118540, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Mitsuzawa, H (corresponding author), Natl Inst Genet, Dept Mol Genet, Div Mol Genet, Mishima, Shizuoka 4118540, Japan.	hmitsuza@lab.nig.ac.jp						Alfa C., 1993, EXPT FISSION YEAST; Apone LM, 1996, GENE DEV, V10, P2368, DOI 10.1101/gad.10.18.2368; Apone LM, 1998, MOL CELL, V2, P653, DOI 10.1016/S1097-2765(00)80163-X; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bell B, 1999, EXP CELL RES, V246, P11, DOI 10.1006/excr.1998.4294; Brand M, 1999, J BIOL CHEM, V274, P18285, DOI 10.1074/jbc.274.26.18285; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Candau R, 1997, EMBO J, V16, P555, DOI 10.1093/emboj/16.3.555; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; DYNLACHT BD, 1993, NATURE, V363, P176, DOI 10.1038/363176a0; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KOKUBO T, 1993, MOL CELL BIOL, V13, P7859, DOI 10.1128/MCB.13.12.7859; Komarnitsky PB, 1999, GENE DEV, V13, P2484, DOI 10.1101/gad.13.19.2484; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Michel B, 1998, MOL CELL, V2, P663, DOI 10.1016/S1097-2765(00)80164-1; Moqtaderi Z, 1998, MOL CELL, V2, P675, DOI 10.1016/S1097-2765(00)80165-3; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Natarajan K, 1998, MOL CELL, V2, P683, DOI 10.1016/S1097-2765(00)80166-5; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Osaka F, 1997, MOL CELL BIOL, V17, P3388, DOI 10.1128/MCB.17.6.3388; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; REESE JC, 1994, NATURE, V371, P523, DOI 10.1038/371523a0; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SAMEJIMA I, 1994, J CELL BIOL, V127, P1655, DOI 10.1083/jcb.127.6.1655; Sanders SL, 1999, J BIOL CHEM, V274, P18847, DOI 10.1074/jbc.274.27.18847; Shibuya T, 1999, GENETICS, V152, P869; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Struhl K, 1998, CELL, V94, P1, DOI 10.1016/S0092-8674(00)81213-1; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Tao Y, 1997, J BIOL CHEM, V272, P6714, DOI 10.1074/jbc.272.10.6714; Walker SS, 1996, NATURE, V383, P185, DOI 10.1038/383185a0; Walker SS, 1997, CELL, V90, P607, DOI 10.1016/S0092-8674(00)80522-X; WINSTON F, 1983, METHOD ENZYMOL, V101, P211; Yamada H, 1997, J CELL SCI, V110, P1793; Yamamoto T, 1997, GENES CELLS, V2, P245, DOI 10.1046/j.1365-2443.1997.1180316.x; Yamashita YM, 1996, NATURE, V384, P276, DOI 10.1038/384276a0; Yanagida M, 1998, TRENDS CELL BIOL, V8, P144, DOI 10.1016/S0962-8924(98)01236-7; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; ZHANG MQ, 1994, NUCLEIC ACIDS RES, V22, P1750, DOI 10.1093/nar/22.9.1750	50	30	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17117	17124		10.1074/jbc.M100248200	http://dx.doi.org/10.1074/jbc.M100248200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279037	hybrid			2022-12-27	WOS:000168730400070
J	Bour, S; Perrin, C; Akari, H; Strebel, K				Bour, S; Perrin, C; Akari, H; Strebel, K			The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of I kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PROGRAMMED CELL-DEATH; RAPID DEGRADATION; PARTICLE RELEASE; ENVELOPE PROTEIN; PLASMA-MEMBRANE; GENE-EXPRESSION; MYELOID CELLS; HIV-1 VPU; TNF-ALPHA	The human immunodeficiency virus type 1 (HIV-1) Vpu protein binds to the CD4 receptor and induces its degradation by cytosolic proteasomes. This process involves the recruitment of human beta TrCP (TrCP), a key member of the SkpI-Cdc53-F-box E3 ubiquitin ligase complex that specifically interacts with phosphorylated Vpu molecules. Interestingly, Vpu itself, unlike other TrCP-interacting proteins, is not targeted for degradation by proteasomes. We now report that, by virtue of its affinity for TrCP and resistance to degradation, Vpu, but not a phosphorylation mutant unable to interact with TrCP, has a dominant negative effect on TrCP function. As a consequence, expression of Vpu in HIV-infected T cells or in HeLa cells inhibited TNF-alpha -induced degradation of I kappaB-alpha. Vpu did not inhibit TNF-alpha -mediated activation of the I kappaB kinase but instead interfered with the subsequent TrCP-dependent degradation of phosphorylated I kappaB-alpha. This resulted in a pronounced reduction of NF-kappaB activity. We also observed that in cells producing Vpu-defective virus, NF-kappaB activity was significantly increased even in the absence of cytokine stimulation. However, in the presence of Vpu, this HIV-mediated NF-kappaB activation was markedly reduced. These results suggest that Vpu modulates both virus- and cytokine-induced activation of NF-kappaB in HIV-1-infected cells.	NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Strebel, K (corresponding author), NIAID, Mol Microbiol Lab, NIH, 4-312,4 Ctr Dr,MSC 0460, Bethesda, MD 20892 USA.	kstrebel@nih.gov	AKARI, Hirofumi/AGR-4616-2022	Bour, Stephan/0000-0002-0211-0110; Akari, Hirofumi/0000-0003-2166-6015	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000669, Z01AI000669] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Asin S, 1999, J VIROL, V73, P3893, DOI 10.1128/JVI.73.5.3893-3903.1999; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Beauparlant P, 1996, J VIROL, V70, P5777, DOI 10.1128/JVI.70.9.5777-5785.1996; Bendall HH, 1999, MOL IMMUNOL, V36, P187, DOI 10.1016/S0161-5890(99)00031-0; Blazquez MV, 1999, AIDS RES HUM RETROV, V15, P1209, DOI 10.1089/088922299310304; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; Bour S, 1999, J BIOL CHEM, V274, P33800, DOI 10.1074/jbc.274.47.33800; Bour S, 1996, J VIROL, V70, P8285, DOI 10.1128/JVI.70.12.8285-8300.1996; Bour S, 2000, Adv Pharmacol, V48, P75; BOUR S, 1991, J VIROL, V65, P6387, DOI 10.1128/JVI.65.12.6387-6396.1991; BRADY HJM, 1995, J VIROL, V69, P7622, DOI 10.1128/JVI.69.12.7622-7629.1995; Briant L, 1998, J VIROL, V72, P6207, DOI 10.1128/JVI.72.7.6207-6214.1998; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Casella CR, 1999, J VIROL, V73, P92, DOI 10.1128/JVI.73.1.92-100.1999; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; CLOUSE KA, 1991, J IMMUNOL, V147, P2892; Cohen OJ, 1997, IMMUNOL REV, V159, P31, DOI 10.1111/j.1600-065X.1997.tb01005.x; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; DeLuca C, 1999, CYTOKINE GROWTH F R, V10, P235, DOI 10.1016/S1359-6101(99)00015-5; DeLuca C, 1999, J BIOL CHEM, V274, P13010, DOI 10.1074/jbc.274.19.13010; DeLuca C, 1998, VIROLOGY, V244, P27, DOI 10.1006/viro.1998.9085; DeLuca C, 1996, J VIROL, V70, P5183, DOI 10.1128/JVI.70.8.5183-5193.1996; Demarchi F, 1999, J VIROL, V73, P7080, DOI 10.1128/JVI.73.8.7080-7086.1999; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dudley E, 1999, EUR J IMMUNOL, V29, P878, DOI 10.1002/(SICI)1521-4141(199903)29:03<878::AID-IMMU878>3.0.CO;2-9; ESTAQUIER J, 1994, P NATL ACAD SCI USA, V91, P9431, DOI 10.1073/pnas.91.20.9431; Felzien LK, 1998, P NATL ACAD SCI USA, V95, P5281, DOI 10.1073/pnas.95.9.5281; Fujita K, 1997, J GEN VIROL, V78, P619, DOI 10.1099/0022-1317-78-3-619; Gougeon ML, 1996, J IMMUNOL, V156, P3509; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; HOBER D, 1989, CLIN EXP IMMUNOL, V78, P329; HOFMAN FM, 1993, BLOOD, V82, P2774; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; KORBER B, 1988, HUMAN RETROVIRUSES A, pA43; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Margottin F, 1996, VIROLOGY, V223, P381, DOI 10.1006/viro.1996.0491; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; MATSUMOTO T, 1993, CLIN EXP IMMUNOL, V93, P149; MOLINA JM, 1989, J CLIN INVEST, V84, P733, DOI 10.1172/JCI114230; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Paul M, 1998, J VIROL, V72, P1270, DOI 10.1128/JVI.72.2.1270-1279.1998; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Raja NU, 1996, VIROLOGY, V220, P141, DOI 10.1006/viro.1996.0294; Renard P, 2000, J BIOL CHEM, V275, P15193, DOI 10.1074/jbc.275.20.15193; Roux P, 2000, J VIROL, V74, P4658, DOI 10.1128/JVI.74.10.4658-4665.2000; ROUXLOMBARD P, 1989, CLIN IMMUNOL IMMUNOP, V50, P374, DOI 10.1016/0090-1229(89)90144-X; SCHUBERT U, 1994, J MOL BIOL, V236, P16, DOI 10.1006/jmbi.1994.1114; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; SCHULICK RD, 1993, EUR J IMMUNOL, V23, P412, DOI 10.1002/eji.1830230217; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; STREBEL K, 1989, J VIROL, V63, P3784, DOI 10.1128/JVI.63.9.3784-3791.1989; Strebel K, 1999, AIDS, V13, pS13; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; VOTH R, 1990, J IMMUNOL, V144, P970; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	64	150	154	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15920	15928		10.1074/jbc.M010533200	http://dx.doi.org/10.1074/jbc.M010533200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278695	hybrid			2022-12-27	WOS:000168623100049
J	Kain, KH; Klemke, RL				Kain, KH; Klemke, RL			Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; GROWTH-FACTOR RECEPTOR; C-ABL; PHILADELPHIA-CHROMOSOME; DNA-DAMAGE; PROTEIN; BINDING; ACTIN; PHOSPHORYLATION; ACTIVATION	c-Abl and the Abl-related gene product (Arg) are nonreceptor tyrosine kinases that regulate the actin cytoskeleton of cells by direct association with F-actin and localization to focal contacts. However, the biological significance of this interaction is not known. We show here that transfection of COS-7 cells with a kinase-inactive form of c-Abl (Abl) promotes c-Crk II/p130(CAS) (Crk-CAS) coupling, enhancing cell migration. Moreover, embryonic fibroblast cells isolated from mice devoid of endogenous Abl and Arg (abl-/- arg-/-) demonstrate increased Crk-CAS coupling and motility. Conversely, expression of a kinase-active form of Abl or reconstitution of abl-/- arg-/- cells with wild-type Abl prevents Crk-CAS coupling and inhibits cell migration. Thus, Abl and Arg kinases play a critical role in preventing cell migration through regulation of Crk and CAS adaptor protein complexes, which are necessary for cell movement.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Klemke, RL (corresponding author), Scripps Res Inst, Dept Immunol, CAL-9,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Agami R, 1999, NATURE, V399, P809; Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Bhatia R, 1998, BLOOD, V91, P3414, DOI 10.1182/blood.V91.9.3414.3414_3414_3422; BIRGE RB, 1992, J BIOL CHEM, V267, P10588; Buchdunger E, 1996, CANCER RES, V56, P100; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Cho SY, 2000, J CELL BIOL, V149, P223, DOI 10.1083/jcb.149.1.223; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Escalante M, 2000, J BIOL CHEM, V275, P24787, DOI 10.1074/jbc.M000711200; FAJARDO JE, 1993, MOL CELL BIOL, V13, P7295, DOI 10.1128/MCB.13.12.7295; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; GERTLER FB, 1993, GENE DEV, V7, P441, DOI 10.1101/gad.7.3.441; Hashimoto Y, 1998, J BIOL CHEM, V273, P17186, DOI 10.1074/jbc.273.27.17186; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Kadlec L, 1997, P NATL ACAD SCI USA, V94, P12390, DOI 10.1073/pnas.94.23.12390; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KRUH GD, 1990, P NATL ACAD SCI USA, V87, P5802, DOI 10.1073/pnas.87.15.5802; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101; Lewis JM, 1998, J BIOL CHEM, V273, P14225, DOI 10.1074/jbc.273.23.14225; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; MANDANAS RA, 1992, LEUKEMIA, V6, P796; MATSUDA M, 1993, J BIOL CHEM, V268, P4441; Matsuda M, 1996, J BIOL CHEM, V271, P14468, DOI 10.1074/jbc.271.24.14468; MATSUDA M, 1994, MOL CELL BIOL, V14, P5495, DOI 10.1128/MCB.14.8.5495; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; MCWHIRTER JR, 1993, EMBO J, V12, P1533, DOI 10.1002/j.1460-2075.1993.tb05797.x; Nakashima N, 1999, J BIOL CHEM, V274, P3001, DOI 10.1074/jbc.274.5.3001; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Renshaw MW, 2000, ONCOGENE, V19, P3216, DOI 10.1038/sj.onc.1203667; Salgia R, 1999, BLOOD, V94, P4233; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; SIRARD C, 1994, BLOOD, V83, P1575; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Wang BL, 1996, ONCOGENE, V13, P193; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542; Wang BL, 1996, ONCOGENE, V13, P1379; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Yano H, 2000, J NEUROSCI RES, V59, P356, DOI 10.1002/(SICI)1097-4547(20000201)59:3<356::AID-JNR9>3.0.CO;2-G; Yuan ZM, 1997, P NATL ACAD SCI USA, V94, P1437, DOI 10.1073/pnas.94.4.1437	54	121	122	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16185	16192		10.1074/jbc.M100095200	http://dx.doi.org/10.1074/jbc.M100095200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279004	hybrid			2022-12-27	WOS:000168623100083
J	Wakasugi, M; Shimizu, M; Morioka, H; Linn, S; Nikaido, O; Matsunaga, T				Wakasugi, M; Shimizu, M; Morioka, H; Linn, S; Nikaido, O; Matsunaga, T			Damaged DNA-binding protein DDB stimulates the excision of cyclobutane pyrimidine dimers in vitro in concert with XPA and replication protein A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENTATION GROUP-E; IN-VITRO; 6-4 PHOTOPRODUCTS; MAMMALIAN-CELLS; REPAIR; NUCLEASE; COMPLEX; TRANSCRIPTION; RECOGNITION; GENES	Human cells contain a protein that binds to UV-irradiated DNA with high affinity. This protein, damaged DNA-binding protein (DDB), is a heterodimer of two polypeptides, p127 and p48, Recent in vivo studies suggested that DDB is involved in global genome repair of cyclobutane pyrimidine dimers (CPDs), but the mechanism remains unclear. Here, we show that in vitro DDB directly stimulates the excision of CPDs but not (6-4)photoproducts, The excision activity of cell-free extracts from Chinese hamster AA8 cell line that lacks DDB activity was increased 3-4-fold by recombinant DDB heterodimer but not p127 subunit alone. Moreover, the addition of XPA or XPA + replication protein A (RPA), which themselves enhanced excision, also enhanced the excision in the presence of DDB, DDB was found to elevate the binding of XPA to damaged DNA and to make a complex with damaged DNA and XPA or XPA + RPA as judged by both electrophoretic mobility shift assays and DNase I protection assays. These results suggest that DDB assists in the recognition of CPDs by core NER factors, possibly through the efficient recruitment of XPA or XPA.RPA, and thus stimulates the excision reaction of CPDs.	Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9200934, Japan; Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; Univ Calif Berkeley, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	Kanazawa University; Hokkaido University; University of California System; University of California Berkeley	Matsunaga, T (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, 13-1 Takara Machi, Kanazawa, Ishikawa 9200934, Japan.		Wakasugi, Mitsuo/D-8417-2015	Wakasugi, Mitsuo/0000-0001-9593-0566				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Araujo SJ, 2000, GENE DEV, V14, P349; ASAHINA H, 1994, MUTAT RES-DNA REPAIR, V315, P229, DOI 10.1016/0921-8777(94)90034-5; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Burns JL, 1996, J BIOL CHEM, V271, P11607, DOI 10.1074/jbc.271.20.11607; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; CLUGSTON CK, 1992, CANCER RES, V52, P6375; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P191; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Guzder SN, 1998, J BIOL CHEM, V273, P6292, DOI 10.1074/jbc.273.11.6292; GUZDER SN, 1995, J BIOL CHEM, V270, P12973, DOI 10.1074/jbc.270.22.12973; Guzder SN, 1997, J BIOL CHEM, V272, P21665, DOI 10.1074/jbc.272.35.21665; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Itoh T, 1999, J INVEST DERMATOL, V113, P251, DOI 10.1046/j.1523-1747.1999.00652.x; JONES CJ, 1993, BIOCHEMISTRY-US, V32, P12006; KATAOKA H, 1991, BIOCHEM BIOPH RES CO, V175, P1139, DOI 10.1016/0006-291X(91)91684-5; Kazantsev A, 1996, P NATL ACAD SCI USA, V93, P5014, DOI 10.1073/pnas.93.10.5014; KEENEY S, 1993, J BIOL CHEM, V268, P21293; KEENEY S, 1992, MUTAT RES, V273, P49, DOI 10.1016/0921-8777(92)90049-9; Lauder S, 1996, MOL CELL BIOL, V16, P6783; Lombaerts M, 1997, NUCLEIC ACIDS RES, V25, P3974, DOI 10.1093/nar/25.20.3974; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; Mu D, 1997, J BIOL CHEM, V272, P28971, DOI 10.1074/jbc.272.46.28971; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Nichols AF, 2000, J BIOL CHEM, V275, P21422, DOI 10.1074/jbc.M000960200; Nichols AF, 1996, J BIOL CHEM, V271, P24317, DOI 10.1074/jbc.271.40.24317; Otrin VR, 1997, J CELL SCI, V110, P1159; Otrin VR, 1998, MOL CELL BIOL, V18, P3182, DOI 10.1128/MCB.18.6.3182; Patrick SM, 1998, BIOCHEMISTRY-US, V37, P8808, DOI 10.1021/bi9730590; Reardon JT, 1996, J BIOL CHEM, V271, P19451, DOI 10.1074/jbc.271.32.19451; REARDON JT, 1993, J BIOL CHEM, V268, P21301; Reed SH, 1998, J BIOL CHEM, V273, P29481, DOI 10.1074/jbc.273.45.29481; Reed SH, 1999, GENE DEV, V13, P3052, DOI 10.1101/gad.13.23.3052; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; VENEMA J, 1990, NUCLEIC ACIDS RES, V18, P443, DOI 10.1093/nar/18.3.443; VENEMA J, 1991, MOL CELL BIOL, V11, P4128, DOI 10.1128/MCB.11.8.4128; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Zhao XD, 1997, J BIOL CHEM, V272, P32580, DOI 10.1074/jbc.272.51.32580	51	79	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15434	15440		10.1074/jbc.M011177200	http://dx.doi.org/10.1074/jbc.M011177200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278856	hybrid			2022-12-27	WOS:000168528800119
J	Sousa, MM; Saraiva, MJ				Sousa, MM; Saraiva, MJ			Internalization of transthyretin - Evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL AMYLOIDOTIC POLYNEUROPATHY; DENSITY-LIPOPROTEIN RECEPTOR; APOLIPOPROTEIN-A-I; PLASMA TRANSTHYRETIN; LIGAND INTERACTIONS; SCAVENGER RECEPTOR; SR-BI; BINDING; IDENTIFICATION; DEGRADATION	Transthyretin (TTR) is a plasma carrier of thyroxine and retinol-binding protein (REP), Though the liver is the major site of TTR degradation, its cellular uptake is poorly understood. We explored TTR uptake using hepatomas and primary hepatocytes and showed internalization by a specific receptor. REP complexed with TTR led to a 70% decrease of TTR internalization, whereas TTR bound to thyroxine led to a 20% increase. Different TTR mutants showed differences in uptake, suggesting receptor recognition dependent on the structure of TTR. Cross-linking studies using hepatomas and I-125-TTR revealed a similar to 90-kDa complex corresponding to I-125-TTR bound to its receptor. Given previous evidence that; a fraction of TTR is associated with high-density lipoproteins (HDL) and that in the kidney, megalin, a member of the low-density lipoprotein receptor family (LDLr) internalizes TTR, we hypothesized that TTR and lipoproteins could share related degradation pathways. Using lipid-deficient serum in uptake assays, no significant changes were observed showing that TTR uptake is not lipoprotein-dependent or due to TTR-lipoprotein complexes. However, competition studies showed that lipoproteins inhibit TTR internalization. The scavenger receptor SR-BI, a HDL receptor, and known LDLr family hepatic receptors did not mediate TTR uptake as assessed using different cellular systems. Interestingly, the receptor-associated protein (RAP), a ligand for all members of the LDLr, was able to inhibit TTR internalization. Moreover, the similar to 90-kDa TTR-receptor complex obtained by cross-linking was sensitive to the presence of RAP, To confirm that RAP sensitivity observed in hepatomas did not represent a mechanism absent in normal cells, primary hepatocytes were tested, and similar results were obtained. The RAP-sensitive TTR internalization together with displacement of TTR uptake by lipoproteins, further suggests that a common pathway might exist between TTR and lipoprotein metabolism and that an as yet unidentified RAP-sensitive receptor mediates TTR uptake.	Univ Porto, Inst Biol Mol & Celular, Amyloid Unit, P-4150 Oporto, Portugal; Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4150 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Saraiva, MJ (corresponding author), Univ Porto, Inst Biol Mol & Celular, Amyloid Unit, R Campo Alegre 823, P-4150 Oporto, Portugal.	mjsaraiv@ibmc.up.pt	Sousa, Monica/K-4367-2013; Saraiva, Maria João/K-3907-2013	Sousa, Monica/0000-0002-4524-2260; Saraiva, Maria João/0000-0002-3360-6899				Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Almeida MR, 1997, ENDOCRINE, V6, P309, DOI 10.1007/BF02820508; Alves IL, 1997, EUR J BIOCHEM, V249, P662, DOI 10.1111/j.1432-1033.1997.00662.x; BAVIK CO, 1991, J BIOL CHEM, V266, P1478; BLANER WS, 1991, FEBS LETT, V287, P193, DOI 10.1016/0014-5793(91)80049-9; DIVINO CM, 1990, J BIOL CHEM, V265, P1425; DIVINO CM, 1990, J CLIN ENDOCR METAB, V71, P1265, DOI 10.1210/jcem-71-5-1265; Goodman DS, 1984, RETINOIDS, P41, DOI DOI 10.1016/B978-0-12-658102-7.50008-7; HERZ J, 1991, J BIOL CHEM, V266, P21232; JI ZS, 1994, ARTERIOSCLER THROMB, V14, P2025, DOI 10.1161/01.ATV.14.12.2025; Kozyraki R, 1999, NAT MED, V5, P656, DOI 10.1038/9504; Kuchler-Bopp S, 2000, BRAIN RES, V870, P185, DOI 10.1016/S0006-8993(00)02413-6; Lundgren S, 1997, J HISTOCHEM CYTOCHEM, V45, P383, DOI 10.1177/002215549704500306; MAKOVER A, 1988, J BIOL CHEM, V263, P8598; Medh JD, 1996, J BIOL CHEM, V271, P17073, DOI 10.1074/jbc.271.29.17073; MITA S, 1986, J BIOCHEM-TOKYO, V100, P1215, DOI 10.1093/oxfordjournals.jbchem.a121826; Obunike JC, 1996, J LIPID RES, V37, P2439; Orlando RA, 1997, P NATL ACAD SCI USA, V94, P2368, DOI 10.1073/pnas.94.6.2368; PALHA JA, 1994, J BIOL CHEM, V269, P33135; Palha JA, 1997, AM J PHYSIOL-ENDOC M, V272, pE485, DOI 10.1152/ajpendo.1997.272.3.E485; RAZ A, 1970, J BIOL CHEM, V245, P1903; REID DG, 1989, J BIOL CHEM, V264, P2013; SARAIVA MJM, 1983, J LAB CLIN MED, V102, P590; SARAIVA MJM, 1996, NATURE ORIGIN AMYLOI, P47; Sarti M, 2000, EXP CELL RES, V260, P199, DOI 10.1006/excr.2000.4993; SIVAPRASADARAO A, 1994, BIOCHEM J, V302, P245, DOI 10.1042/bj3020245; SOPRANO DR, 1985, J BIOL CHEM, V260, P1793; Sousa MM, 2000, J BIOL CHEM, V275, P38176, DOI 10.1074/jbc.M002886200; Sousa MM, 2000, J LIPID RES, V41, P58; van Vlijmen BJM, 1999, J BIOL CHEM, V274, P35219, DOI 10.1074/jbc.274.49.35219; VIEIRA AV, 1995, J BIOL CHEM, V270, P2952, DOI 10.1074/jbc.270.7.2952; Vieira OV, 1996, J LIPID RES, V37, P2715; Xu SZ, 1997, J LIPID RES, V38, P1289	33	54	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14420	14425		10.1074/jbc.M010869200	http://dx.doi.org/10.1074/jbc.M010869200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278770	hybrid			2022-12-27	WOS:000168356600120
J	Ihara, H; Denhardt, DT; Furuya, K; Yamashita, T; Muguruma, Y; Tsuji, K; Hruska, KA; Higashio, K; Enomoto, S; Nifuji, A; Rittling, SR; Noda, M				Ihara, H; Denhardt, DT; Furuya, K; Yamashita, T; Muguruma, Y; Tsuji, K; Hruska, KA; Higashio, K; Enomoto, S; Nifuji, A; Rittling, SR; Noda, M			Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOPROTEGERIN LIGAND; MICE LACKING; IN-VITRO; OSTEOCLAST DIFFERENTIATION; TRANSCRIPTIONAL REGULATION; ALPHA(V)BETA(3) INTEGRIN; T-CELLS; SIALOPROTEIN; BIOLOGY; MATRIX	Osteopontin is an RGDS-containing protein that acts as a ligand for the alpha (nu)beta (3) integrin, which is abundantly expressed in osteoclasts, cells responsible for bone resorption in osteopenic diseases such as osteoporosis and hyperparathyroidism. However, the role of osteopontin in the process of bone resorption has not yet been fully understood. Therefore, we investigated the direct function of osteopontin in bone resorption using an organ culture system. The amount of Ca-45 released from the osteopontin-deficient bones was not significantly different from the basal release from wild type bones. However, in contrast to the parathyroid hormone (PTH) enhancement of the Ca-45 release from wild type bones, PTH had no effect on Ca-45 release from organ cultures of osteopontin-deficient bones. Because PTH is located upstream of receptor activator of NF-kappaB ligand (RANKL), that directly promotes bone resorption, we also examined the effect of RANKL, Soluble RANKL with macrophage-colony stimulating factor enhanced Ca-45 release from the bones of wild type fetal mice but not from the bones of osteopontin-deficient mice. To obtain insight into the cellular mechanism underlying the phenomena observed in osteopontin-deficient bone, we investigated the number of tartrate-resistant acid phosphatase (TRAP)-positive cells in the bones subjected to PTH treatment in cultures. The number of TRAP-positive cells was increased significantly by PTH in wild type bone; however, no such PTH-induced increase in TRAP-positive cells was observed in osteopontin-deficient bones. These results indicate that the absence of osteopontin suppressed PTH-induced increase in bone resorption via preventing the increase in the number of osteoclasts in the local milieu of bone.	Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Chiyoda Ku, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, Dept Oral Surg, Tokyo 1010062, Japan; Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; Washington Univ, Dept Internal Med, St Louis, MO 63110 USA; Snow Brand Milk Prod Co Ltd, Ishibashi, Tochigi 32905, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Rutgers State University New Brunswick; Washington University (WUSTL); Snow Brand Milk Products Co., Ltd.	Noda, M (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Chiyoda Ku, 3-10 Kanda Surugadai 2 Chome, Tokyo 1010062, Japan.	noda.mph@mri.tmd.ac.jp	Nifuji, Akira/AAX-7907-2021	Nifuji, Akira/0000-0002-8182-4380	NCI NIH HHS [CA72740] Funding Source: Medline; NIAMS NIH HHS [AR44434] Funding Source: Medline; NIEHS NIH HHS [ES06897] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES006897] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Bautista DS, 1996, CLIN BIOCHEM, V29, P231, DOI 10.1016/0009-9120(96)84728-A; Butler William T., 1996, P167; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853; Engelman VW, 1997, J CLIN INVEST, V99, P2284, DOI 10.1172/JCI119404; Faccio R, 1998, BIOCHEM BIOPH RES CO, V249, P522, DOI 10.1006/bbrc.1998.9180; FITZPATRICK LA, 1996, PRINCIPLES BONE BIOL, V3, P339; FLORES ME, 1992, EXP CELL RES, V201, P526, DOI 10.1016/0014-4827(92)90305-R; Furuya K, 2000, EXP CELL RES, V261, P329, DOI 10.1006/excr.2000.5051; GIACHELLI CM, 1995, TRENDS CARDIOVAS MED, V5, P88, DOI 10.1016/1050-1738(95)00005-T; GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408; Hofbauer LC, 1999, EUR J ENDOCRINOL, V141, P195, DOI 10.1530/eje.0.1410195; HORTON MA, 1995, ANN NY ACAD SCI, V760, P190, DOI 10.1111/j.1749-6632.1995.tb44630.x; HORTON MA, 1996, PRINCIPLES BONE BIOL, V3, P217; HRUSKA KA, 1995, ENDOCRINOLOGY, V136, P2984, DOI 10.1210/en.136.7.2984; HWANG S, 1994, J BIOL CHEM, V269, P711; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LEE MY, 1992, BLOOD, V80, P1710; Liaw L, 1998, J CLIN INVEST, V101, P1468; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; McKee MD, 1996, ANAT RECORD, V245, P293, DOI 10.1002/(SICI)1097-0185(199606)245:2<293::AID-AR13>3.0.CO;2-K; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; Nakamura I, 1999, J CELL SCI, V112, P3985; NODA M, 1989, J CELL BIOL, V108, P713, DOI 10.1083/jcb.108.2.713; Reinholt FP, 1999, EXP CELL RES, V251, P477, DOI 10.1006/excr.1999.4585; Rittling SR, 1999, EXP NEPHROL, V7, P103; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454; Rodan SB, 1997, J ENDOCRINOL, V154, pS47; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; ROSS FP, 1993, J BIOL CHEM, V268, P9901; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Weber Georg F., 1996, Cytokine and Growth Factor Reviews, V7, P241, DOI 10.1016/S1359-6101(96)00030-5; Witty JP, 1996, J BONE MINER RES, V11, P72; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156	42	101	107	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13065	13071		10.1074/jbc.M010938200	http://dx.doi.org/10.1074/jbc.M010938200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278791	hybrid			2022-12-27	WOS:000168198600085
J	Uranishi, H; Tetsuka, T; Yamashita, M; Asamitsu, K; Shimizu, M; Itoh, M; Okamoto, T				Uranishi, H; Tetsuka, T; Yamashita, M; Asamitsu, K; Shimizu, M; Itoh, M; Okamoto, T			Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; THYROID-HORMONE RECEPTORS; HUMAN MYELOID-LEUKEMIA; TUMOR-NECROSIS-FACTOR; RAT MESANGIAL CELLS; DNA-BINDING; CHROMOSOMAL TRANSLOCATION; ACTIVATION DOMAIN; MAMMALIAN-CELLS	In this study, we have demonstrated that translocated in liposarcoma (TLS), also termed FUS, is an interacting molecule of the p65 (Re1A) subunit of the transcription factor nuclear factor kappaB (NF-kappaB) using a yeast two-hybrid screen. We confirmed the interaction between TLS and p65 by the pull-down assay in vitro and by a coimmunoprecipitation experiment followed by Western blot of the cultured cell in vivo, TLS was originally identified as part of a fusion protein with CHOP arising from chromosomal translocation in human myxoid liposarcomas. TLS has been shown to be involved in TFIID complex formation and associated with RNA polymerase II. However, the role of TLS in transcriptional regulation has not yet been clearly elucidated. We found that TLS en hanced the NF-kappaB-mediated transactivation induced by physiological stimuli such as tumor necrosis factor alpha, interleukin-1 beta, and overexpression of NF-kappaB-inducing kinase, TLS augmented NF-kappaB-dependent promoter activity of the intercellular adhesion molecule-1 gene and interferon-beta gene. These results suggest that TLS acts as a coactivator of NF-kappaB and plays a pivotal role in the NP-kappaB-mediated transactivation.	Nagoya City Univ, Sch Med, Dept Mol Genet, Mizuho Ku, Aichi 4678601, Japan; Nagoya City Univ, Sch Med, Dept Internal Med 1, Mizuho Ku, Aichi 4678601, Japan	Nagoya City University; Nagoya City University	Okamoto, T (corresponding author), Nagoya City Univ, Sch Med, Dept Mol Genet, Mizuho Ku, 1 Kawasumi, Aichi 4678601, Japan.	tokamoto@med.nagoya-cu.ac.jp		Asamitsu, Kaori/0000-0001-5333-8011				Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bertolotti A, 1999, ONCOGENE, V18, P8000, DOI 10.1038/sj.onc.1203207; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; BLAIR WS, 1994, MOL CELL BIOL, V14, P7226, DOI 10.1128/MCB.14.11.7226; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; CALVIO C, 1995, RNA, V1, P724; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guermah M, 1998, MOL CELL BIOL, V18, P3234, DOI 10.1128/MCB.18.6.3234; HAYASHI T, 1993, J BIOL CHEM, V268, P11380; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; ICHIKAWA H, 1994, CANCER RES, V54, P2865; Ichikawa H, 1999, MOL CELL BIOL, V19, P7639; IMMANUEL D, 1995, MOL CELL BIOL, V15, P4562; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Kajino S, 2000, ONCOGENE, V19, P2233, DOI 10.1038/sj.onc.1203560; KERR LD, 1993, NATURE, V365, P412, DOI 10.1038/365412a0; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Madge LA, 2000, J BIOL CHEM, V275, P15458, DOI 10.1074/jbc.M001237200; Mengus G, 1997, GENE DEV, V11, P1381, DOI 10.1101/gad.11.11.1381; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; MOORE PA, 1993, MOL CELL BIOL, V13, P1666, DOI 10.1128/MCB.13.3.1666; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Okamoto T, 1997, CURR TOP CELL REGUL, V35, P149, DOI 10.1016/S0070-2137(97)80006-4; Parkhurst SM, 1998, TRENDS GENET, V14, P130, DOI 10.1016/S0168-9525(98)01407-3; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; POON D, 1993, J BIOL CHEM, V268, P15325; PRASAD DDK, 1994, ONCOGENE, V9, P3717; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; REESE JC, 1994, NATURE, V371, P523, DOI 10.1038/371523a0; Sato T, 1998, AIDS RES HUM RETROV, V14, P293, DOI 10.1089/aid.1998.14.293; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; SCHMITZ ML, 1995, J BIOL CHEM, V270, P15576, DOI 10.1074/jbc.270.26.15576; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; Tetsuka T, 1996, J CLIN INVEST, V97, P2051, DOI 10.1172/JCI118641; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; Tetsuka T, 1996, J BIOL CHEM, V271, P11689, DOI 10.1074/jbc.271.20.11689; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; XU X, 1993, MOL CELL BIOL, V13, P6733, DOI 10.1128/MCB.13.11.6733; Yamit-Hezi A, 1998, EMBO J, V17, P5161, DOI 10.1093/emboj/17.17.5161; Yamit-Hezi E, 2000, J BIOL CHEM, V275, P18180, DOI 10.1074/jbc.275.24.18180; Yang JP, 1999, ONCOGENE, V18, P5177, DOI 10.1038/sj.onc.1202904; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; Yang L, 2000, MOL CELL BIOL, V20, P3345, DOI 10.1128/MCB.20.10.3345-3354.2000; Yoza BK, 1996, J BIOL CHEM, V271, P18306, DOI 10.1074/jbc.271.31.18306; Zandi E, 1999, MOL CELL BIOL, V19, P4547; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513; Zinszner H, 1997, ONCOGENE, V14, P451, DOI 10.1038/sj.onc.1200854	61	123	128	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13395	13401		10.1074/jbc.M011176200	http://dx.doi.org/10.1074/jbc.M011176200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278855	hybrid			2022-12-27	WOS:000168198600127
J	Yerushalmi, H; Mordoch, SS; Schuldiner, S				Yerushalmi, H; Mordoch, SS; Schuldiner, S			A single carboxyl mutant of the multidrug transporter EmrE is fully functional	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MEMBRANE-PROTEIN; ANTIPORTER; EFFLUX; RESISTANCE; BINDING; MUTATIONS; PATHWAY; HELICES; RESIDUE	EmrE, a multidrug transporter from Escherichia coli removes toxic compounds from the cell in exchange with protons. Glu-14 is the only charged residue in the putative membrane domains and is fully conserved in more than 50 homologues of the protein. This residue was shown to be an essential part of the binding site, common to protons and substrate. EmrE bearing a single carboxylic residue, Glu-14, shows uptake and binding properties similar to those of the wild type. This suggests that a small protein bearing only 110 amino acids with a single carboxyl in position 14 is the most basic structure that shows ion-coupled transport activity. The role of Glu-14 in substrate binding was examined by using dicyclohexylcarbodiimide, a hydrophobic carbodiimide that is known to react with carboxyls, Tetraphenylphosphonium binding to both wild type and the single carboxyl mutant is inhibited by dicyclohexylcarbodiimide in a dose-dependent manner. Ethidium and other substrates of EmrE prevent this inhibition with an order of potency in accord with their apparent affinities. This suggests that dicyclohexylcarbodiimide binding is sterically prevented by the substrate, supporting the contention that Glu-14, the reactive residue, is part of the substrate-binding site.	Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.		Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708, R56NS016708] Funding Source: NIH RePORTER; NINDS NIH HHS [NS16708] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arkin IT, 1996, BIOCHEMISTRY-US, V35, P7233, DOI 10.1021/bi960094i; Barker EL, 1999, J NEUROSCI, V19, P4705; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GRINIUS LL, 1994, J BIOL CHEM, V269, P29998; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; KONINGS WN, 1996, TRANSPORT PROCESSES, V2; MCMURRY LM, 1992, J BACTERIOL, V174, P6294, DOI 10.1128/JB.174.19.6294-6297.1992; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Paulsen IT, 1996, MOL MICROBIOL, V19, P1167, DOI 10.1111/j.1365-2958.1996.tb02462.x; Schuldiner S, 1997, J EXP BIOL, V200, P335; Schwaiger M, 1998, EUR J BIOCHEM, V254, P610, DOI 10.1046/j.1432-1327.1998.2540610.x; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; Tate CG, 2001, EMBO J, V20, P77, DOI 10.1093/emboj/20.1.77; YAMAGUCHI A, 1992, J BIOL CHEM, V267, P7490; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; Yerushalmi H, 2000, FEBS LETT, V476, P93, DOI 10.1016/S0014-5793(00)01677-X; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044	28	53	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12744	12748		10.1074/jbc.M010979200	http://dx.doi.org/10.1074/jbc.M010979200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278804	hybrid			2022-12-27	WOS:000168198600039
J	Adamkewicz, JI; Hansen, KE; Prud'homme, WA; Davis, JL; Thorner, J				Adamkewicz, JI; Hansen, KE; Prud'homme, WA; Davis, JL; Thorner, J			High affinity interaction of yeast transcriptional regulator, Mot1, with TATA box-binding protein (TBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTION; RNA-POLYMERASE; IN-VIVO; CRYSTAL-STRUCTURE; GENE-EXPRESSION; NUCLEAR IMPORT; MAP KINASE; TFIIA; DNA; PROMOTER	Yeast Mot1 an essential ATP-dependent regulator of basal transcription, removes TATA box binding protein (TBP) from TATA sites in vitro. Complexes of Mot1 and Spt15 (yeast TBP), radiolabeled in vitro, were immunoprecipitated with anti-TBP (or anti-Mot1) antibodies in the absence of DNA, showing Mot1 binds TBP in solution. Mot1 N-terminal deletions (residues 25-801) abolished TBP binding, whereas C-terminal ATPase domain deletions (residues 802-1867) did not. Complex formation was prevented above 200 mM salt, consistent with electrostatic interaction. Correspondingly, TBP variants lacking solvent exposed positive charge did not bind Mot1, whereas a mutant lacking positive charge within the DNA-binding groove bound Mot1. ATPase-defective mutant, Mot1(D1408N), which inhibits growth when overexpressed (but is suppressed by co-overexpression of TBP), bound TBP normally in vitro, suggesting it forms nonrecyclable complexes. N-terminal deletions of Mot1(D1408N) were not growth-inhibitory. C-terminal deletions were toxic when overexpressed, and toxicity was ameliorated by TBP co-overproduction. Residues 1-800 of Mot1 are therefore necessary and sufficient for TBP binding. The N terminus of 89B, a tissue-specific Drosophila Mot1 homolog, bound the TBP-like factor, dTRF1. Native Mot1 and derivatives deleterious to growth localized in the nucleus, whereas nontoxic derivatives localized to the cytosol, suggesting TBP binding and nuclear transport of Mot1 are coupled.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Thorner, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Rm 401,Barker Hall, Berkeley, CA 94720 USA.	jeremy@socrates.berkeley.edu	THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021841, R01GM021841] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamkewicz JI, 2000, J BIOL CHEM, V275, P21158, DOI 10.1074/jbc.M002639200; ADAMKEWICZ JI, 1999, THESIS U CALIFORNIA; Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; ARNDT KM, 1992, MOL CELL BIOL, V12, P2372, DOI 10.1128/MCB.12.5.2372; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Bagby S, 2000, FEBS LETT, V468, P149, DOI 10.1016/S0014-5793(00)01213-8; BARDWELL L, 1994, P NATL ACAD SCI USA, V91, P3926, DOI 10.1073/pnas.91.9.3926; BARDWELL L, 1992, MOL CELL BIOL, V12, P3041, DOI 10.1128/MCB.12.7.3041; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; BENTON BM, 1990, MOL CELL BIOL, V10, P353, DOI 10.1128/MCB.10.1.353; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURATOWSKI S, 1992, SCIENCE, V255, P1130, DOI 10.1126/science.1546314; Cang Y, 1999, EMBO J, V18, P6662, DOI 10.1093/emboj/18.23.6662; CHATTERJEE S, 1995, NATURE, V374, P820, DOI 10.1038/374820a0; Chicca JJ, 1998, MOL CELL BIOL, V18, P1701, DOI 10.1128/MCB.18.3.1701; Collart MA, 1996, MOL CELL BIOL, V16, P6668; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; DAVIS JL, 1992, MOL CELL BIOL, V12, P1879, DOI 10.1128/MCB.12.4.1879; DAWES IW, 1974, MOL GEN GENET, V131, P281, DOI 10.1007/BF00264859; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GoldmanLevi R, 1996, NUCLEIC ACIDS RES, V24, P3121, DOI 10.1093/nar/24.16.3121; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; HANSEN K, 1996, THESIS U CALIFORNIA; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Holmes MC, 2000, SCIENCE, V288, P867, DOI 10.1126/science.288.5467.867; INOSTROZA JA, 1992, CELL, V70, P477; KIM TK, 1995, J BIOL CHEM, V270, P10976, DOI 10.1074/jbc.270.18.10976; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; KLAGES N, 1995, NATURE, V374, P822, DOI 10.1038/374822a0; KLEIN C, 1994, SCIENCE, V266, P280, DOI 10.1126/science.7939664; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Liu Q, 1999, MOL CELL BIOL, V19, P8673; MA D, 1995, MOL BIOL CELL, V6, P889, DOI 10.1091/mbc.6.7.889; Madison JM, 1997, MOL CELL BIOL, V17, P287, DOI 10.1128/MCB.17.1.287; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Maldonado E, 1999, J BIOL CHEM, V274, P12963, DOI 10.1074/jbc.274.19.12963; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; Morehouse H, 1999, P NATL ACAD SCI USA, V96, P12542, DOI 10.1073/pnas.96.22.12542; Myer VE, 1998, J BIOL CHEM, V273, P27757, DOI 10.1074/jbc.273.43.27757; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; Parvin JD, 1998, CURR OPIN GENET DEV, V8, P565, DOI 10.1016/S0959-437X(98)80012-9; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Pemberton LF, 1999, J CELL BIOL, V145, P1407, DOI 10.1083/jcb.145.7.1407; PIATTI S, 1992, CHROMOSOMA, V102, pS107, DOI 10.1007/BF02451793; POON D, 1993, J BIOL CHEM, V268, P15325; POON D, 1994, J BIOL CHEM, V269, P23135; PRELICH G, 1993, GENETICS, V135, P665; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Ramboarina S, 1998, PROTEIN ENG, V11, P729, DOI 10.1093/protein/11.9.729; RANISH JA, 1991, J BIOL CHEM, V266, P19320; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; STARGELL LA, 1995, SCIENCE, V269, P75, DOI 10.1126/science.7604282; Stargell LA, 1996, TRENDS GENET, V12, P311, DOI 10.1016/0168-9525(96)10028-7; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tanford C., 1961, PHYS CHEM MACROMOLEC; Teichmann M, 1999, P NATL ACAD SCI USA, V96, P13720, DOI 10.1073/pnas.96.24.13720; Travers A, 1996, CURR BIOL, V6, P401, DOI 10.1016/S0960-9822(02)00507-9; vanderKnaap JA, 1997, P NATL ACAD SCI USA, V94, P11827, DOI 10.1073/pnas.94.22.11827; Wade PA, 1996, MOL CELL BIOL, V16, P1641; Weideman CA, 1997, J MOL BIOL, V271, P61, DOI 10.1006/jmbi.1997.1152; XIAO H, 1995, MOL CELL BIOL, V15, P5757; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895	85	28	30	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11883	11894		10.1074/jbc.M010665200	http://dx.doi.org/10.1074/jbc.M010665200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278722	hybrid			2022-12-27	WOS:000168081800062
J	Hofmann, WE; Liu, XT; Bearden, CM; Harper, ME; Kozak, LP				Hofmann, WE; Liu, XT; Bearden, CM; Harper, ME; Kozak, LP			Effects of genetic background on thermoregulation and fatty acid-induced uncoupling of mitochondria in UCP1-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; INDUCED THERMOGENESIS; NONSHIVERING THERMOGENESIS; MESSENGER-RNA; BLOOD-FLOW; PROTEIN; RAT; PROBE; UCP1; NORADRENALINE	An interaction between free fatty acids and UCP1 (uncoupling protein-1) leading to de-energization of mitochondria was assumed to be a key event for triggering heat production in brown fat. Recently, Matthias ef al;, finding indistinguishable de-energization of isolated brown fat mitochondria by fatty acids in UCP1-deficient mice and control mice, challenged this assumption (Matthias, A., Jacobsson, A., Cannon, B,, and Nedergaard, J, (1999) J, Biol. Chem, 274, 28150-28160). Since their results were obtained using UCP1-deficient and control mice on an undefined genetic background, we wanted to determine unambiguously the phenotype of UCP1 deficiency with the targeted Ucp1 allele on congenic C57BL/6J and 129/SvImJ backgrounds. UCP1-deficient congenic mice have a very pronounced cold-sensitive phenotype; however, deficient mice on the F1 hybrid background were resistant to cold. We propose that heterosis provides a mechanism to compensate for UCP1 deficiency. contrary to the results of Matthias st al,, we found a significant loss of fatty acid-induced de-energization, as reflected by membrane potential and oxygen consumption, in brown fat mitochondria from UCP1-deficient mice. Unlike cold sensitivity, fatty acid-induced uncoupling of mitochondria was independent of the genetic background of UCP1-deficient mice. We propose that intracellular free fatty acids directly regulate uncoupling activity of UCP1 in a manner consistent with models described in the literature.	Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; Univ Ottawa, Fac Med, Dept Biochem, Ottawa, ON K1H 8M5, Canada	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Ottawa	Kozak, LP (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	KozakLP@pbrc.edu		Harper, Mary-Ellen/0000-0003-3864-5886				BARBATO GF, 1992, BEHAV GENET, V22, P381, DOI 10.1007/BF01066669; Cannon B, 1979, Methods Enzymol, V55, P65; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; CHEN C, 1994, SCIENCE, V266, P291, DOI 10.1126/science.7939668; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Comings DE, 2000, MOL GENET METAB, V71, P19, DOI 10.1006/mgme.2000.3015; DAVIS TRA, 1954, AM J PHYSIOL, V177, P222; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; FOSTER DO, 1979, CAN J PHYSIOL PHARM, V57, P257, DOI 10.1139/y79-039; FOSTER DO, 1978, CAN J PHYSIOL PHARM, V56, P110, DOI 10.1139/y78-015; GARDNER RS, 1974, ANAL BIOCHEM, V59, P272, DOI 10.1016/0003-2697(74)90033-5; GonzalezBarroso MM, 1996, EUR J BIOCHEM, V239, P445, DOI 10.1111/j.1432-1033.1996.0445u.x; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; JEZEK P, 1990, J LIPID MEDIATOR, V2, P85; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Matthias A, 1999, J BIOL CHEM, V274, P28150, DOI 10.1074/jbc.274.40.28150; Monemdjou S, 1999, AM J PHYSIOL-ENDOC M, V276, pE1073, DOI 10.1152/ajpendo.1999.276.6.E1073; NEDERGAARD J, 1983, EUR J BIOCHEM, V133, P185, DOI 10.1111/j.1432-1033.1983.tb07446.x; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; PRUSINER SB, 1968, EUR J BIOCHEM, V7, P51, DOI 10.1111/j.1432-1033.1968.tb19572.x; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; RICQUIER D, 1984, FEBS LETT, V178, P240, DOI 10.1016/0014-5793(84)80608-0; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; SMITH RE, 1969, PHYSIOL REV, V49, P330, DOI 10.1152/physrev.1969.49.2.330; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; TRAYHURN P, 1977, NATURE, V266, P60, DOI 10.1038/266060a0; WINKLER E, 1994, J BIOL CHEM, V269, P2508; WOITCZAK L, 1993, BIOCHIM BIOPHYS ACTA, V1183, P41, DOI 10.1016/0005-2728(93)90004-Y; Zhao J, 1998, AM J PHYSIOL-REG I, V275, pR2002, DOI 10.1152/ajpregu.1998.275.6.R2002	35	97	98	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12460	12465		10.1074/jbc.M100466200	http://dx.doi.org/10.1074/jbc.M100466200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11279075	hybrid			2022-12-27	WOS:000168081800136
J	Chong, SS; Hu, P; Hernandez, N				Chong, SS; Hu, P; Hernandez, N			Reconstitution of transcription from the human U6 small nuclear RNA promoter with eight recombinant polypeptides and a partially purified RNA polymerase III complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL SEQUENCE ELEMENT; SACCHAROMYCES-CEREVISIAE ENCODES; 2 FUNCTIONAL COMPONENTS; TERMINATION FACTOR LA; BINDING PROTEIN LA; HUMAN SNRNA GENES; C III; INVITRO TRANSCRIPTION; SUBUNIT COMMON; HUMAN HOMOLOG	The human U6 small nuclear (sn) RNA core promoter consists of a proximal sequence element, which recruits the multisubunit factor SNAP(c), and a TATA box, which recruits the TATA box-binding protein, TBP, In addition to SNAP(c) and TBP, transcription from the human U6 promoter requires two well defined factors. The first is hB", a human homologue of the B" subunit of yeast TFIIIB generally required for transcription of RNA polymerase III genes, and the second is hBRFU, one of two human homologues of the yeast TFIIIB subunit BRF specifically required for transcription of U6-type RNA polymerase III promoters. Here, we have partially puri fled and characterized a RNA polymerase III complex that can direct transcription from the human U6 promoter when combined with recombinant SNAP(c), recombinant TBP, recombinant hB", and recombinant hBRFU, These results open the way to reconstitution of U6 transcription from entirely defined components.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Microbiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hernandez, N (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.			Hernandez, Nouria/0000-0003-1465-4585	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038810] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38810] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; ARCHAMBAULT J, 1990, MOL CELL BIOL, V10, P6123, DOI 10.1128/MCB.10.12.6123; BROW DA, 1990, GENE DEV, V4, P1345, DOI 10.1101/gad.4.8.1345; BURATOWSKI S, 1992, CELL, V71, P221, DOI 10.1016/0092-8674(92)90351-C; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; CHEONG JH, 1995, EMBO J, V14, P143, DOI 10.1002/j.1460-2075.1995.tb06984.x; CHIANNILKULCHAI N, 1992, MOL CELL BIOL, V12, P4433, DOI 10.1128/MCB.12.10.4433; Chicca JJ, 1998, MOL CELL BIOL, V18, P1701, DOI 10.1128/MCB.18.3.1701; COLBERT T, 1992, GENE DEV, V6, P1940, DOI 10.1101/gad.6.10.1940; Dammann R, 1998, BBA-GENE STRUCT EXPR, V1396, P153, DOI 10.1016/S0167-4781(97)00206-6; DEAN N, 1987, NUCLEIC ACIDS RES, V15, P9895, DOI 10.1093/nar/15.23.9895; DEAN N, 1988, MOL CELL BIOL, V8, P3017, DOI 10.1128/MCB.8.8.3017; DEQUARDCHABLAT M, 1991, J BIOL CHEM, V266, P15300; DUJON B, 1994, NATURE, V369, P371, DOI 10.1038/369371a0; ESCHENLAUER JB, 1993, MOL CELL BIOL, V13, P3015, DOI 10.1128/MCB.13.5.3015; Fan H, 1997, CELL, V88, P707, DOI 10.1016/S0092-8674(00)81913-3; Ferri ML, 2000, MOL CELL BIOL, V20, P488, DOI 10.1128/MCB.20.2.488-495.2000; GERLACH VL, 1995, MOL CELL BIOL, V15, P1455; Goodier JL, 1998, J BIOL CHEM, V273, P26110, DOI 10.1074/jbc.273.40.26110; Goodier JL, 1997, MOL CELL BIOL, V17, P5823, DOI 10.1128/MCB.17.10.5823; GOTTLIEB E, 1989, EMBO J, V8, P851, DOI 10.1002/j.1460-2075.1989.tb03446.x; GOTTLIEB EL, 1989, EMBO J, V8, P841, DOI 10.1002/j.1460-2075.1989.tb03445.x; Harlow E., 1988, ANTIBODIES LAB MANUA; Henry RW, 1998, COLD SPRING HARB SYM, V63, P111, DOI 10.1101/sqb.1998.63.111; HENRY RW, 1995, NATURE, V374, P653, DOI 10.1038/374653a0; Henry RW, 1998, GENE DEV, V12, P2664, DOI 10.1101/gad.12.17.2664; Hsieh YJ, 1999, MOL CELL BIOL, V19, P4944; Hsieh YJ, 1999, MOL CELL BIOL, V19, P7697; ITTMANN M, 1987, MOL CELL BIOL, V7, P3386, DOI 10.1128/MCB.7.10.3386; ITTMANN M, 1993, CELL GROWTH DIFFER, V4, P503; JAMES P, 1991, J BIOL CHEM, V266, P5616; KASSAVETIS GA, 1992, CELL, V71, P1055, DOI 10.1016/0092-8674(92)90399-W; KASSAVETIS GA, 1995, P NATL ACAD SCI USA, V92, P9786, DOI 10.1073/pnas.92.21.9786; KOVELMAN R, 1992, J BIOL CHEM, V267, P24446; Kuhlman TC, 1999, MOL CELL BIOL, V19, P2130; LAGNA G, 1994, MOL CELL BIOL, V14, P3053, DOI 10.1128/MCB.14.5.3053; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; LETOILE ND, 1994, P NATL ACAD SCI USA, V91, P1652, DOI 10.1073/pnas.91.5.1652; LOBO SM, 1992, CELL, V71, P1029, DOI 10.1016/0092-8674(92)90397-U; LOBO SM, 1991, GENE DEV, V5, P1477, DOI 10.1101/gad.5.8.1477; LOPEZDELEON A, 1992, CELL, V71, P211, DOI 10.1016/0092-8674(92)90350-L; MANN C, 1987, CELL, V48, P627, DOI 10.1016/0092-8674(87)90241-8; MANN C, 1992, MOL CELL BIOL, V12, P4314, DOI 10.1128/MCB.12.10.4314; MARAIA RJ, 1994, MOL CELL BIOL, V14, P2147, DOI 10.1128/MCB.14.3.2147; Maraia RJ, 1996, P NATL ACAD SCI USA, V93, P3383, DOI 10.1073/pnas.93.8.3383; MARGOTTIN F, 1991, SCIENCE, V251, P424, DOI 10.1126/science.1989075; MARONEY PA, 1990, P NATL ACAD SCI USA, V87, P709, DOI 10.1073/pnas.87.2.709; McCulloch V, 2000, EMBO J, V19, P4134, DOI 10.1093/emboj/19.15.4134; MCKUNE K, 1994, MOL CELL BIOL, V14, P4155, DOI 10.1128/MCB.14.6.4155; MCKUNE K, 1995, MOL CELL BIOL, V15, P6895; MEISSNER W, 1993, NUCLEIC ACIDS RES, V21, P1013; Mital R, 1996, MOL CELL BIOL, V16, P7031; Mittal V, 1997, SCIENCE, V275, P1136, DOI 10.1126/science.275.5303.1136; MOENNE A, 1990, EMBO J, V9, P271, DOI 10.1002/j.1460-2075.1990.tb08105.x; MOSRIN C, 1990, MOL CELL BIOL, V10, P4737, DOI 10.1128/MCB.10.9.4737; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; Myers LC, 1997, METHODS, V12, P212, DOI 10.1006/meth.1997.0473; Oettel S, 1997, NUCLEIC ACIDS RES, V25, P2440, DOI 10.1093/nar/25.12.2440; Oettel S, 1998, NUCLEIC ACIDS RES, V26, P4324, DOI 10.1093/nar/26.19.4324; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Roberts S, 1996, J BIOL CHEM, V271, P14903, DOI 10.1074/jbc.271.25.14903; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Ruth J, 1996, EMBO J, V15, P1941, DOI 10.1002/j.1460-2075.1996.tb00545.x; SADHALE PP, 1994, MOL CELL BIOL, V14, P6164, DOI 10.1128/MCB.14.9.6164; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; Sepehri S, 1997, GENOME RES, V7, P1006, DOI 10.1101/gr.7.10.1006; SHPAKOVSKI GV, 1995, MOL CELL BIOL, V15, P4702; SIMMEN KA, 1991, EMBO J, V10, P1853, DOI 10.1002/j.1460-2075.1991.tb07711.x; SINN E, 1995, GENE DEV, V9, P675, DOI 10.1101/gad.9.6.675; STETTLER S, 1992, J BIOL CHEM, V267, P21390; Teichmann M, 2000, P NATL ACAD SCI USA, V97, P14200, DOI 10.1073/pnas.97.26.14200; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Treich Isabelle, 1992, Gene Expression, V2, P31; WALDSCHMIDT R, 1992, J BIOL CHEM, V267, P16359; Wang Y, 1998, MOL CELL BIOL, V18, P1570, DOI 10.1128/MCB.18.3.1570; Wang ZX, 1996, MOL CELL BIOL, V16, P6841; Wang ZX, 1997, GENE DEV, V11, P2371, DOI 10.1101/gad.11.18.2371; Wang ZX, 1997, GENE DEV, V11, P1315, DOI 10.1101/gad.11.10.1315; Wang ZX, 2000, EMBO J, V19, P6823, DOI 10.1093/emboj/19.24.6823; WOYCHIK NA, 1990, J BIOL CHEM, V265, P17816; WOYCHIK NA, 1990, GENE DEV, V4, P313, DOI 10.1101/gad.4.3.313; YOON JB, 1995, MOL CELL BIOL, V15, P2019; YOSHINAGA SK, 1987, P NATL ACAD SCI USA, V84, P3585, DOI 10.1073/pnas.84.11.3585	84	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20727	20734		10.1074/jbc.M100088200	http://dx.doi.org/10.1074/jbc.M100088200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279001	hybrid			2022-12-27	WOS:000169135100140
J	Saliba, KJ; Kirk, K				Saliba, KJ; Kirk, K			H+-coupled pantothenate transport in the intracellular malaria parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM; FUNCTIONAL EXPRESSION; ACID; ERYTHROCYTES; MEMBRANE; CLONING; CELLS	Pantothenate, the precursor of coenzyme A, is an essential nutrient for the intraerythrocytic stage of the malaria parasite Plasmodium falciparum. Pantothenate enters the malaria-infected erythrocyte via new permeation pathways induced by the parasite in the host cell membrane (Saliba, K, J,, Horner, H, A, and Kirk, K, (1998) J, Biol, Chem, 273, 10190-10195). We show here that pantothenate is taken up by the intracellular parasite via a novel H+-coupled transporter, quite different from the Na+-coupled transporters that mediate pantothenate uptake into mammalian cells. The plasmodial H+:pantothenate transporter has a low affinity for pantothenate (K-m similar to 23 mM) and a stoichiometry of 1 H+:1 pantothenate, It is inhibited by low concentrations of the bioflavonoid phloretin and the thiol-modifying agent p-chloromercuribenzene sulfonate. On entering the parasite, pantothenate is phosphorylated land thereby trapped) by an unusually high affinity pantothenate kinase (K-m similar to 300 nM), The combination of H+-coupled transporter and kinase provides the parasite with an efficient, high affinity pantothenate uptake system, which is distinct from that of the host and is therefore an attractive target for antimalarial chemotherapy.	Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia	Australian National University	Kirk, K (corresponding author), Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia.	kiaran.kirk@anu.edu.au	Kirk, Kiaran/C-8299-2009; Saliba, Kevin J/C-9166-2009	Kirk, Kiaran/0000-0002-5613-2622; Saliba, Kevin J/0000-0003-3345-8440				Ansorge I, 1997, MOL BIOCHEM PARASIT, V84, P259, DOI 10.1016/S0166-6851(96)02806-X; BIGGS BA, 1991, P NATL ACAD SCI USA, V88, P9171, DOI 10.1073/pnas.88.20.9171; BOSIA A, 1993, J CELL PHYSIOL, V154, P527, DOI 10.1002/jcp.1041540311; BOYER MJ, 1994, METHOD CELL BIOL, V41, P135; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; DESAI SA, 1993, NATURE, V362, P643, DOI 10.1038/362643a0; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; Ellory J C, 1987, Symp Soc Exp Biol, V41, P53; GERMINARIO RJ, 1977, CAN J MICROBIOL, V23, P922, DOI 10.1139/m77-136; Hayashi M, 2000, J BIOL CHEM, V275, P34353, DOI 10.1074/jbc.M003323200; Jackson VN, 1996, J BIOL CHEM, V271, P861, DOI 10.1074/jbc.271.2.861; KHOMICH T I, 1990, Biokhimiya, V55, P1468; Kirk K, 1996, MOL BIOCHEM PARASIT, V82, P195, DOI 10.1016/0166-6851(96)02734-X; Prasad PD, 2000, BIOCHEM BIOPH RES CO, V270, P836, DOI 10.1006/bbrc.2000.2498; Prasad PD, 1999, ARCH BIOCHEM BIOPHYS, V366, P95, DOI 10.1006/abbi.1999.1213; Prasad PD, 1998, J BIOL CHEM, V273, P7501, DOI 10.1074/jbc.273.13.7501; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Stein WD., 1986, TRANSPORT DIFFUSION, P1; Stolz J, 1999, J BIOL CHEM, V274, P18747, DOI 10.1074/jbc.274.26.18747; TAHILIANI AG, 1991, VITAM HORM, V46, P165; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VALLARI DS, 1985, J BACTERIOL, V162, P1156, DOI 10.1128/JB.162.3.1156-1161.1985; Wang HP, 1999, J BIOL CHEM, V274, P14875, DOI 10.1074/jbc.274.21.14875; WITTWER CT, 1989, AM J CLIN NUTR, V50, P1072, DOI 10.1093/ajcn/50.5.1072; Wunsch S, 1998, J CELL BIOL, V140, P335, DOI 10.1083/jcb.140.2.335	26	61	63	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18115	18121		10.1074/jbc.M010942200	http://dx.doi.org/10.1074/jbc.M010942200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278793	hybrid			2022-12-27	WOS:000168866500068
J	Zyryanov, AB; Pohjanjoki, P; Kasho, VN; Shestakov, AS; Goldman, A; Lahti, R; Baykov, AA				Zyryanov, AB; Pohjanjoki, P; Kasho, VN; Shestakov, AS; Goldman, A; Lahti, R; Baykov, AA			The electrophilic and leaving group phosphates in the catalytic mechanism of yeast pyrophosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI INORGANIC PYROPHOSPHATASE; DIVALENT METAL-ION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ACTIVE-SITE; REACTION PATHWAY; OXYGEN-EXCHANGE; MAGNESIUM-ION; 2 PATHWAYS; BINDING	Binding of pyrophosphate or two phosphate molecules to the pyrophosphatase (PPase) active site occurs at two subsites, P1 and P2. Mutations at P2 subsite residues (Y93F and K56R) caused a much greater decrease in phosphate binding affinity of yeast PPase in the presence of Mn2+ or Co2+ than mutations at P1 subsite residues (R78K and K193R). Phosphate binding was estimated in these experiments from the inhibition of ATP hydrolysis at a sub-K-m concentration of ATP. Tight phosphate binding required four Mn2+ ions/active site. These data identify P2 as the high affinity subsite and pi as the low affinity subsite, the difference in the affinities being at least 250-fold. The time course of five "isotopomers" of phosphate that have from zero to four O-18 during [O-18]P-i-[O-16]H2O oxygen exchange indicated that the phosphate containing added water is released after the leaving group phosphate during pyrophosphate hydrolysis, These findings provide support for the structure-based mechanism in which pyrophosphate hydrolysis involves water attack on the phosphorus atom located at the P2 subsite of PPase.	Univ Turku, Dept Biochem, FIN-20500 Turku, Finland; Moscow MV Lomonosov State Univ, Sch Chem, Moscow 119899, Russia; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia; Univ Calif Los Angeles, Dept Med, Ctr Ulcer Res & Educ, Los Angeles, CA 90073 USA; Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	Finland National Institute for Health & Welfare; University of Turku; Lomonosov Moscow State University; Lomonosov Moscow State University; University of California System; University of California Los Angeles; University of Helsinki	Lahti, R (corresponding author), Univ Turku, Dept Biochem, FIN-20500 Turku, Finland.		Baykov, Alexander A/C-7981-2012; Shestakov, Alexander/A-3216-2019; Baykov, Alexander/AAH-5301-2021	Sestakov, Aleksandr/0000-0002-0426-4789; Baykov, Alexander/0000-0002-2495-8200				Avaeva S, 1997, FEBS LETT, V410, P502, DOI 10.1016/S0014-5793(97)00650-9; Baykov A A, 1999, Prog Mol Subcell Biol, V23, P127; BAYKOV AA, 1992, EUR J BIOCHEM, V206, P463, DOI 10.1111/j.1432-1033.1992.tb16947.x; Baykov AA, 2000, BIOCHEMISTRY-US, V39, P11939, DOI 10.1021/bi000627u; Baykov AA, 1996, BIOCHEMISTRY-US, V35, P4655, DOI 10.1021/bi952635u; BAYKOV AA, 1989, BIOKHIMIYA, V54, P796; Belogurov GA, 2000, BIOCHEMISTRY-US, V39, P13931, DOI 10.1021/bi000895s; BERGER L, 1956, BIOCHIM BIOPHYS ACTA, V20, P23, DOI 10.1016/0006-3002(56)90257-8; CHUKHLANTSEV VG, 1961, IZV VYSSH UCHCBN ZAV, V5, P707; COHEN SA, 1978, J BIOL CHEM, V253, P889; COHN M, 1958, J BIOL CHEM, V230, P369; COOPERMAN BS, 1992, TRENDS BIOCHEM SCI, V17, P262, DOI 10.1016/0968-0004(92)90406-Y; COOPERMAN BS, 1981, BIOCHEMISTRY-US, V20, P6051, DOI 10.1021/bi00524a021; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; DIXON M, 1979, ENZYMES, P144; Fabrichniy IP, 1997, BIOCHEMISTRY-US, V36, P7746, DOI 10.1021/bi9629844; GOLOSHCHAPOV MV, 1966, INORG CHEM, V11, P935; GONZALEZ MA, 1984, BIOCHEMISTRY-US, V23, P797, DOI 10.1021/bi00300a002; Hackney D D, 1980, Methods Enzymol, V64, P60; HACKNEY DD, 1980, J BIOL CHEM, V255, P5320; Harutyunyan EH, 1997, BIOCHEMISTRY-US, V36, P7754, DOI 10.1021/bi962637u; Harutyunyan EH, 1996, EUR J BIOCHEM, V239, P220, DOI 10.1111/j.1432-1033.1996.0220u.x; Heikinheimo P, 1996, STRUCTURE, V4, P1491, DOI 10.1016/S0969-2126(96)00155-4; Heikinheimo P, 1996, EUR J BIOCHEM, V239, P138, DOI 10.1111/j.1432-1033.1996.0138u.x; Heikinheimo P, 2001, P NATL ACAD SCI USA, V98, P3121, DOI 10.1073/pnas.061612498; JANSON CA, 1979, J BIOL CHEM, V254, P3743; KASHO VN, 1989, BIOCHEM BIOPH RES CO, V161, P475, DOI 10.1016/0006-291X(89)92623-5; KNIGHT WB, 1984, J BIOL CHEM, V259, P2886; Kornberg A., 1962, HORIZONS BIOCH, P251; KUNITZ M, 1952, J GEN PHYSIOL, V35, P423, DOI 10.1085/jgp.35.3.423; ROWATT E, 1989, BIOCHEM J, V259, P295, DOI 10.1042/bj2590295; SCHLESINGER MJ, 1960, BIOCHIM BIOPHYS ACTA, V41, P30, DOI 10.1016/0006-3002(60)90365-6; SMIRNOVA IN, 1989, EUR J BIOCHEM, V182, P451, DOI 10.1111/j.1432-1033.1989.tb14852.x; SPRINGS B, 1981, BIOCHEMISTRY-US, V20, P6384, DOI 10.1021/bi00525a016; TEPLYAKOV A, 1994, PROTEIN SCI, V3, P1098, DOI 10.1002/pro.5560030713; Tuominen V, 1998, J MOL BIOL, V284, P1565, DOI 10.1006/jmbi.1998.2266; VANNI A, 1986, ANN CHIM-ROME, V76, P375; WELSH KM, 1983, BIOCHEMISTRY-US, V22, P2243, DOI 10.1021/bi00278a029	38	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17629	17634		10.1074/jbc.M100343200	http://dx.doi.org/10.1074/jbc.M100343200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279052	hybrid			2022-12-27	WOS:000168866500003
J	Sirakova, TD; Thirumala, AK; Dubey, VS; Sprecher, H; Kolattukudy, PE				Sirakova, TD; Thirumala, AK; Dubey, VS; Sprecher, H; Kolattukudy, PE			The Mycobacterium tuberculosis pks2 gene encodes the synthase for the hepta- and octamethyl-branched fatty acids required for sulfolipid synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGOSOME-LYSOSOME FUSION; BOVIS BCG; PATHOGENIC MYCOBACTERIA; CULTURED MACROPHAGES; SULFATIDE; IDENTIFICATION; BIOSYNTHESIS; INHIBITION; SMEGMATIS; CLUSTER	Multidrug-resistant tuberculosis is a major global health emergency. Cell wall lipids of Mycobacterium. tuberculosis can play crucial roles in the pathogenesis, The enzymes involved in their synthesis can be ideal new drug targets against tuberculosis, because many such lipids are unique to this pathogen, A variety of multiple methyl-branched fatty acids are among such unique lipids. We have identified seven genes highly homologous to the mas gene, which is known to be involved in the production of one class of such multiple methyl-branched fatty acids. One of these mas-like genes, pks2, was disrupted using a phage-mediated delivery of the disruption construct. Gene disruption by homologous recombination was confirmed by polymerase chain reaction analysis of the flanking regions of the introduced disrupted gene and by Southern analysis. Thin-layer and radio gas-chromatographic analyses of lipids derived from [1-C-14]propionic acid and gas chromatography/mass spectrometry analysis of the fatty acids and hydroxy fatty acids showed that the pks2 mutant was incapable of producing hepta- and octamethyl phthioceranic acids and hydroxyphthioceranic acids that are the major acyl constituents of sulfolipids. Consequently, pks2 mutant does not produce sulfolipids. Sulfolipid deficiency in pks2 mutant was confirmed by two-dimensional thin-layer chromatographic analysis of lipids derived from [1-C-14]propionic acid and (SO4-2)-S-35 With this sulfolipid-deficient mutant, it should be possible to test for the postulated important roles for sulfolipids in the pathogenesis of M. tuberculosis.	Ohio State Univ, Neurobiotechnol Ctr, Columbus, OH 43210 USA; Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kolattukudy, PE (corresponding author), Ohio State Univ, Neurobiotechnol Ctr, Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.		kolattukudy, pappachan e/A-1350-2012		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035272, R01AI046582] Funding Source: NIH RePORTER; NIAID NIH HHS [AI35272, AI46582] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALGUPALLI S, 1995, J BACTERIOL, V177, P4566; Anderson RM, 1999, NAT MED, V5, P147, DOI 10.1038/5507; Azad AK, 1997, J BIOL CHEM, V272, P16741, DOI 10.1074/jbc.272.27.16741; Azad AK, 1996, P NATL ACAD SCI USA, V93, P4787, DOI 10.1073/pnas.93.10.4787; Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; BROZNA JP, 1991, INFECT IMMUN, V59, P2542, DOI 10.1128/IAI.59.8.2542-2548.1991; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Derbyshire KM, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P93; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Faldt J, 1999, CLIN EXP IMMUNOL, V118, P253, DOI 10.1046/j.1365-2249.1999.01040.x; Fernandes ND, 1997, J BACTERIOL, V179, P7538, DOI 10.1128/jb.179.23.7538-7543.1997; Fitzmaurice AM, 1998, J BIOL CHEM, V273, P8033, DOI 10.1074/jbc.273.14.8033; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; GOREN MB, 1976, P NATL ACAD SCI USA, V73, P2510, DOI 10.1073/pnas.73.7.2510; GOREN MB, 1976, BIOCHEMISTRY-US, V15, P2728, DOI 10.1021/bi00658a003; GOREN MB, 1987, J LEUKOCYTE BIOL, V41, P111, DOI 10.1002/jlb.41.2.111; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; HATFULL GF, 2000, MOL GENETICS MYCOBAC, P316; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Liu J, 1999, MYCOBACTERIA MOL BIO, P220; LYDIATE DJ, 1989, J GEN MICROBIOL, V135, P941; MATHUR M, 1992, J BIOL CHEM, V267, P19388; PABST MJ, 1988, J IMMUNOL, V140, P634; Rhoades ER, 2000, IMMUNOL CELL BIOL, V78, P301, DOI 10.1046/j.1440-1711.2000.00938.x; Sambrook J., 2002, MOL CLONING LAB MANU; Schorey JS, 1997, SCIENCE, V277, P1091, DOI 10.1126/science.277.5329.1091; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Soto CY, 2000, FEMS MICROBIOL LETT, V187, P103, DOI 10.1016/S0378-1097(00)00183-X; TAKAYAMA K, 1984, MYCOBACTERIA SOURC A, P315; Vergne I, 1998, FRONT BIOSCI, V3, pd865; ZHANG L, 1988, INFECT IMMUN, V56, P2876, DOI 10.1128/IAI.56.11.2876-2883.1988	39	141	151	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16833	16839		10.1074/jbc.M011468200	http://dx.doi.org/10.1074/jbc.M011468200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278910	hybrid			2022-12-27	WOS:000168730400033
J	Das, M; Bouchey, DM; Moore, MJ; Hopkins, DC; Nemenoff, RA; Stenmark, KR				Das, M; Bouchey, DM; Moore, MJ; Hopkins, DC; Nemenoff, RA; Stenmark, KR			Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on G protein-mediated activation of mitogen-activated protein kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC GROWTH-FACTORS; RAT CARDIAC MYOCYTES; SIGNALING PATHWAYS; MAP KINASES; PULMONARY-HYPERTENSION; PC12 CELLS; STRESS; ERK; TRANSDUCTION; STIMULATION	Hypoxia has been shown to act as a proliferative stimulus for adventitial fibroblasts of the pulmonary artery. The signaling pathways involved in this growth response, however, remain unclear. We tested the hypothesis that hypoxia-induced proliferation of fibroblasts would be dependent on distinct (compared with serum) activation and utilization patterns of mitogen-activated protein (MAP) kinases initiated by G alpha (i/o) proteins. We found that hypoxia stimulated increases in DNA synthesis and growth of quiescent fibroblasts in the absence of exogenous mitogens and also markedly augmented serum-stimulated growth responses. Hypoxia caused a transient activation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), the time course and pattern of which was somewhat similar to that induced by serum but which was of lesser magnitude. On the other hand, hypoxia-induced activation of p38 MAP kinase was biphasic, whereas serum-stimulated activation of p38 MAP kinase was transient, and the magnitude of activation was greater for hypoxia compared with that of serum stimulation. ERK1/2, JNK1, and p38 MAP kinase but not JNK2 were necessary for hypoxia-induced proliferation because PD98059, SB202190, and JNK1 antisense oligonucleotides nearly ablated the growth response. JNK2; appeared to act as a negative modulator of hypoxia-induced growth because JNK2 antisense oligonucleotides led to an increase in DNA synthesis, In serum-stimulated cells, antisense JNK1 oligonucleotides and PD98059 had inhibitory effects on proliferation, whereas SB202190 led to an increase in DNA synthesis. Pertussis toxin, which blocks G alpha (i/o)-mediated signaling, markedly attenuated hypoxia-induced DNA synthesis and activation of ERK and JNK but not p38 MAP kinase, We conclude that hypoxia itself can act as a growth promoting stimulus for subsets of bovine neonatal adventitial fibroblasts largely through G alpha (i/o)-mediated activation of a complex network of MAP kinases whose specific contributions to hypoxia-induced proliferation differ from traditional serum-induced growth signals.	Univ Colorado, Hlth Sci Ctr, Cardiovasc Pulm Res Lab, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dev Lung Biol Res Lab, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Renal Med, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Das, M (corresponding author), Univ Colorado, Hlth Sci Ctr, Cardiovasc Pulm Res Lab, Campus Box B-131,4200 E 9th Ave, Denver, CO 80262 USA.		stenmark, kurt/AFI-6776-2022; stenmark, kurt/AAH-3124-2022		NHLBI NIH HHS [HL 14985, HL 62924, HL 07171, HL 56481] Funding Source: Medline; NIDDK NIH HHS [DK 39902, DK 19928] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007171, R43HL062924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039902, P01DK019928] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bost F, 1997, J BIOL CHEM, V272, P33422, DOI 10.1074/jbc.272.52.33422; Butterfield L, 1997, J BIOL CHEM, V272, P10110; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Cheng Y, 2000, J BIOL CHEM, V275, P23326, DOI 10.1074/jbc.M001837200; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; Cook SJ, 2000, BIOCHEM SOC T, V28, P233, DOI 10.1042/bst0280233; DAS M, 1995, AM J PHYSIOL-LUNG C, V269, pL660, DOI 10.1152/ajplung.1995.269.5.L660; Das M, 2000, AM J RESP CELL MOL, V22, P15, DOI 10.1165/ajrcmb.22.1.3536; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Dhanasekaran N, 1998, BIOL SIGNAL RECEPT, V7, P109; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Feldkamp MM, 1999, INT J CANCER, V81, P118, DOI 10.1002/(SICI)1097-0215(19990331)81:1<118::AID-IJC20>3.3.CO;2-X; Foltz IN, 1997, BLOOD, V89, P3092, DOI 10.1182/blood.V89.9.3092; Foltz IN, 1997, J BIOL CHEM, V272, P3296, DOI 10.1074/jbc.272.6.3296; Frid MG, 1999, ARTERIOSCL THROM VAS, V19, P2884, DOI 10.1161/01.ATV.19.12.2884; Gonda K, 1999, BIOCHEM J, V337, P67, DOI 10.1042/0264-6021:3370067; Gudi SRP, 1996, CIRC RES, V79, P834, DOI 10.1161/01.RES.79.4.834; HAWORTH SG, 1993, EUR RESPIR J, V6, P1037; Jin NJ, 2000, AM J RESP CELL MOL, V23, P593, DOI 10.1165/ajrcmb.23.5.3921; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; Kobayashi S, 1999, PFLUG ARCH EUR J PHY, V438, P750, DOI 10.1007/s004240051102; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Laderoute KR, 1999, J BIOL CHEM, V274, P12890, DOI 10.1074/jbc.274.18.12890; Lee DJ, 2000, EXP CELL RES, V257, P190, DOI 10.1006/excr.2000.4866; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Liu RY, 2000, J BIOL CHEM, V275, P21086, DOI 10.1074/jbc.M001281200; Manthey CL, 1998, J LEUKOCYTE BIOL, V64, P409, DOI 10.1002/jlb.64.3.409; Matsuda N, 1998, BIOCHEM BIOPH RES CO, V249, P350, DOI 10.1006/bbrc.1998.9151; Minden A., 1997, BIOCHIM BIOPHYS ACTA, V1333, P85, DOI DOI 10.1016/S0304-419X(97)00018-8; Mironov SL, 2000, BRAIN RES, V853, P60, DOI 10.1016/S0006-8993(99)02234-9; MORIN FC, 1995, AM J RESP CRIT CARE, V151, P2010, DOI 10.1164/ajrccm.151.6.7767553; Nagata Y, 1998, BLOOD, V92, P1859, DOI 10.1182/blood.V92.6.1859.418k37_1859_1869; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Pestell RG, 1996, MOL ENDOCRINOL, V10, P1084, DOI 10.1210/me.10.9.1084; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Sarbassov DD, 1997, MOL ENDOCRINOL, V11, P2038, DOI 10.1210/me.11.13.2038; Scott PH, 1998, AM J RESP CRIT CARE, V158, P958, DOI 10.1164/ajrccm.158.3.9712130; Seko Y, 1996, CIRC RES, V78, P82, DOI 10.1161/01.RES.78.1.82; Seko Y, 1997, BIOCHEM BIOPH RES CO, V239, P840, DOI 10.1006/bbrc.1997.7570; Sodhi CP, 2000, KIDNEY INT, V58, P691, DOI 10.1046/j.1523-1755.2000.00215.x; STENMARK KR, 1987, J APPL PHYSIOL, V62, P821, DOI 10.1152/jappl.1987.62.2.821; Stenmark KR, 1997, ANNU REV PHYSIOL, V59, P89, DOI 10.1146/annurev.physiol.59.1.89; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Welsh DJ, 1998, AM J RESP CRIT CARE, V158, P1757, DOI 10.1164/ajrccm.158.6.9706054; Wenzlaff H, 1998, N-S ARCH PHARMACOL, V358, P360, DOI 10.1007/PL00005265; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zechner D, 1998, J BIOL CHEM, V273, P8232, DOI 10.1074/jbc.273.14.8232; Zundel W, 2000, GENE DEV, V14, P391	52	94	98	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15631	15640		10.1074/jbc.M010690200	http://dx.doi.org/10.1074/jbc.M010690200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278727	hybrid			2022-12-27	WOS:000168623100011
J	Kawar, Z; Karaveg, K; Moremen, KW; Jarvis, DL				Kawar, Z; Karaveg, K; Moremen, KW; Jarvis, DL			Insect cells encode a class II alpha-mannosidase with unique properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; BROAD-SPECIFICITY ALPHA-1->2; RAT-LIVER; EXPRESSION; CDNA; PURIFICATION; ALPHA-1,2-MANNOSIDASE; BIOSYNTHESIS; PROTEINS; PATHWAY	Previously, we cloned and characterized an insect (Sf9) cell cDNA encoding a class II alpha -mannosidase with amino acid sequence and biochemical similarities to mammalian Golgi alpha -mannosidase II. Since then, it has been demonstrated that other mammalian class II alpha -mannosidases can participate in N-glycan processing. Thus, the present study was performed to evaluate the catalytic properties of the Sf9 class II alpha -mannosidase and to more clearly determine its relationship to mammalian Golgi alpha -mannosidase II. The results showed that the Sf9 enzyme is cobalt-dependent and can hydrolyze Man(5)GlcNAc(2) to Man(3)GlcNAc(2), but it cannot hydrolyze GlcNAcMan(5)GlcNAc(2). These data establish that the Sf9 enzyme is distinct from Golgi alpha -mannosidase II. This enzyme is not a lysosomal alpha -mannosidase because it is not active at acidic pH and it is localized in the Golgi apparatus. In fact, its sensitivity to swainsonine distinguishes the Sf9 enzyme from all other known mammalian class II alpha -mannosidases that can hydrolyze Man(5)GlcNAc(2). Based on these properties, we designated this enzyme Sf9 alpha -mannosidase III and concluded that it probably provides an alternate N-glycan processing pathway in Sf9 cells.	Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of Wyoming; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Jarvis, DL (corresponding author), Univ Wyoming, Dept Mol Biol, POB 3944, Laramie, WY 82071 USA.		Moremen, Kelley/AAD-4661-2019	Jarvis, Donald/0000-0002-8104-7155	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049734, R01GM047533] Funding Source: NIH RePORTER; NCRR NIH HHS [RR05351, P41 RR005351] Funding Source: Medline; NIGMS NIH HHS [R01 GM049734, GM47533, GM49734, R01 GM047533] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMANN F, 1993, GLYCOBIOLOGY, V3, P619, DOI 10.1093/glycob/3.6.619; BISCHOFF J, 1990, J BIOL CHEM, V265, P17110; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BONAY P, 1991, EUR J BIOCHEM, V197, P229, DOI 10.1111/j.1432-1033.1991.tb15903.x; BONAY P, 1992, EUR J BIOCHEM, V205, P399, DOI 10.1111/j.1432-1033.1992.tb16793.x; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; DANIEL PF, 1994, GLYCOBIOLOGY, V4, P551, DOI 10.1093/glycob/4.5.551; FODDY L, 1986, BIOCHEM J, V233, P697, DOI 10.1042/bj2330697; Gonzalez DS, 1999, J BIOL CHEM, V274, P21375, DOI 10.1074/jbc.274.30.21375; GRACE TDC, 1962, NATURE, V195, P788, DOI 10.1038/195788a0; Grard T, 1996, BIOCHEM J, V316, P787, DOI 10.1042/bj3160787; HUGHES RC, 1986, EUR J BIOCHEM, V158, P227, DOI 10.1111/j.1432-1033.1986.tb09742.x; Jarvis DL, 1996, PROTEIN EXPRES PURIF, V8, P191, DOI 10.1006/prep.1996.0092; Jarvis DL, 1998, CURR OPIN BIOTECH, V9, P528, DOI 10.1016/S0958-1669(98)80041-4; Jarvis DL, 1997, GLYCOBIOLOGY, V7, P113, DOI 10.1093/glycob/7.1.113; Kawar Z, 2000, GLYCOBIOLOGY, V10, P347, DOI 10.1093/glycob/10.4.347; Kawar Z, 1997, GLYCOBIOLOGY, V7, P433, DOI 10.1093/glycob/7.3.433; Kawar Z, 2001, INSECT BIOCHEM MOLEC, V31, P289, DOI 10.1016/S0965-1748(00)00121-1; KITTS PA, 1993, BIOTECHNIQUES, V14, P810; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARZ L, 1995, GLYCOPROTEINS A, V29, P543; MISAGO M, 1995, P NATL ACAD SCI USA, V92, P11766, DOI 10.1073/pnas.92.25.11766; MONIS E, 1987, EUR J BIOCHEM, V168, P287, DOI 10.1111/j.1432-1033.1987.tb13419.x; Moremen K., 2000, OLIGOSACCHARIDES CHE, VII, P81; MOREMEN KW, 1994, GLYCOBIOLOGY, V4, P113, DOI 10.1093/glycob/4.2.113; MURHAMMER DW, 1988, BIO-TECHNOL, V6, P1411, DOI 10.1038/nbt1288-1411; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Ren JX, 1997, BIOCHEM J, V324, P951, DOI 10.1042/bj3240951; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; SUMMERS MD, 1987, TEX AGR EXP STN B, V1555; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Weng SA, 1996, ARCH BIOCHEM BIOPHYS, V325, P113, DOI 10.1006/abbi.1996.0014; Yamashiro K, 1997, J BIOCHEM-TOKYO, V122, P1174, DOI 10.1093/oxfordjournals.jbchem.a021878	35	38	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16335	16340		10.1074/jbc.M100119200	http://dx.doi.org/10.1074/jbc.M100119200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279010	Green Accepted, hybrid			2022-12-27	WOS:000168623100102
J	Lewis, JL; Dong, M; Earles, CA; Chapman, ER				Lewis, JL; Dong, M; Earles, CA; Chapman, ER			The transmembrane domain of syntaxin 1A is critical for cytoplasmic domain protein-protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT MEMBRANE-FUSION; SNARE COMPLEX; NEUROTRANSMITTER RELEASE; VESICLE FUSION; T-SNARE; SYNAPTIC EXOCYTOSIS; SYNAPTOTAGMIN-I; C2B DOMAIN; ALPHA-SNAP; BINDING	Assembly of the plasma membrane proteins syntaxin 1A and SNAP-25 with the vesicle protein synaptobrevin is a critical step in neuronal exocytosis. Syntaxin is anchored to the inner face of presynaptic plasma membrane via a single C-terminal membrane-spanning domain. Here we report that this transmembrane domain plays a critical role in a wide range of syntaxin protein-protein interactions. Truncations or deletions of the membrane-spanning domain reduce synaptotagmin, alpha/beta -SNAP, and synaptobrevin binding. In contrast, deletion of the transmembrane domain potentiates SNAP-25 and rbSec1A/nsec-1/munc18 binding. Normal partner protein binding activity of the isolated cytoplasmic domain could be "rescued" by fusion to the transmembrane segments of synaptobrevin and to a lesser extent, synaptotagmin. However, efficient rescue was not achieved by replacing deleted transmembrane segments with corresponding lengths of other hydrophobic amino acids. Mutations reported to diminish the dimerization of the transmembrane domain of syntaxin did not impair the interaction of full-length syntaxin with other proteins. Finally, we observed that membrane insertion and wild-type interactions with interacting proteins are not correlated. We conclude that the transmembrane domain, via a length-dependent and sequence-specific mechanism, affects the ability of the cytoplasmic domain to engage other proteins.	Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Dept Physiol, SMI 129,1300 Univ Ave, Madison, WI 53706 USA.	chapman@physiology.wisc.edu		Chapman, Edwin/0000-0001-9787-8140	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056827] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56827-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Betz A, 1997, J BIOL CHEM, V272, P2520; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Damer CK, 1996, J NEUROCHEM, V67, P1661; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; INOUE A, 1992, J BIOL CHEM, V267, P10613; Jagadish MN, 1997, BIOCHEM J, V321, P151, DOI 10.1042/bj3210151; Kee Y, 1996, J NEUROSCI, V16, P1975; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Leyman B, 1999, SCIENCE, V283, P537, DOI 10.1126/science.283.5401.537; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Margittai M, 1999, FEBS LETT, V446, P40, DOI 10.1016/S0014-5793(99)00028-9; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Quinones B, 1999, J CELL SCI, V112, P4291; Rothman JE, 1996, PROTEIN SCI, V5, P185; SCHIAVO G, 1995, J BIOL CHEM, V270, P10566, DOI 10.1074/jbc.270.18.10566; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Steel GJ, 1997, BIOCHEM J, V325, P511, DOI 10.1042/bj3250511; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; von Poser C, 2000, J BIOL CHEM, V275, P30916, DOI 10.1074/jbc.M005559200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	60	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15458	15465		10.1074/jbc.M011687200	http://dx.doi.org/10.1074/jbc.M011687200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278966	Green Published, hybrid			2022-12-27	WOS:000168528800123
J	Perrais, M; Pigny, P; Buisine, MP; Porchet, N; Aubert, JP; Van Seuningen-Lempire, I				Perrais, M; Pigny, P; Buisine, MP; Porchet, N; Aubert, JP; Van Seuningen-Lempire, I			Aberrant expression of human mucin gene MUC5B in gastric carcinoma and cancer cells - Identification and regulation of a distal promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-SITU HYBRIDIZATION; LARGE CENTRAL EXON; GENOMIC ORGANIZATION; DNA HYPERMETHYLATION; 5'-FLANKING REGION; DISTINCT PATTERNS; COLORECTAL-CANCER; CPG ISLAND; METHYLATION; TISSUES	In gastric cancer, altered expression of MUC1, MUC2, MUC5AC, and MUC6 mucin genes has already been described. We show in this report by the means of in situ hybridization, reverse transcriptase-polymerase chain reaction, and transfection assays that MUC5B is also abnormally expressed in gastric carcinomatous tissues and cell lines. We thus undertook to elucidate the molecular mechanisms that regulate the transcription of MUC5B in gastric cancer cells. To this end, high expressing (KATO-III) and low expressing (AGS) gastric cancer cell lines were chosen to study human mucin gene MUC5B expression and promoter activity, Sequencing of the promoter region revealed a distal TATA box located 1 kilobase upstream of the proximal TATA box. Functional activity of the promoter was addressed by using deletion mutants covering 2044 nucleotides upstream of the MUC5B transcription start site, We identified a distal promoter 10 times more active than the proximal promoter in KATO-III cells, In AGS cells, both promoters, much less active, showed the same range of activity. Binding assays allowed us to show that the transcription factor ATF-1 binds to a cis-element present in the distal promoter. Sp1, which binds to both promoters specifically transactivates the proximal promoter. Treatment of transfected cells with PMA, cholera toxin A subunit, and calcium ionophore A23187 showed that only PMA led to a substantial activation of the distal promoter, MUC5B 5'-flanking region having a high GC content, influence of methylation on the MUC5B expression was assessed, Our results indicate that repression of MUC5B expression visualized in AGS cells is due in part to the presence of numerous methylated cytosine residues throughout the 5'-flanking region, Altogether these results demonstrate that MUC5B expression in gastric cancer cells is governed by a highly active distal promoter that is up-regulated by protein kinase C and that repression is under the influence of methylation.	INSERM, U377, F-59045 Lille, France; Univ Lille 2, Fac Med, F-59045 Lille, France; Ctr Hosp Reg & Univ Lille, Hop C Huriez, Lab Biochim & Biol Mol, F-59037 Lille, France; Ctr Hosp Reg & Univ Lille, Hop C Huriez, Lab Endocrinol, F-59037 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Van Seuningen-Lempire, I (corresponding author), INSERM, U377, Pl Verdun, F-59045 Lille, France.		VAN SEUNINGEN, Isabelle/N-6176-2016	VAN SEUNINGEN, Isabelle/0000-0002-3131-2694				Agrawal B, 1998, MOL MED TODAY, V4, P397, DOI 10.1016/S1357-4310(98)01322-7; AUBERT JP, 1991, AM J RESP CELL MOL, V5, P178, DOI 10.1165/ajrcmb/5.2.178; AUDIE JP, 1993, J HISTOCHEM CYTOCHEM, V41, P1479, DOI 10.1177/41.10.8245407; BALAGUE C, 1995, GASTROENTEROLOGY, V109, P953, DOI 10.1016/0016-5085(95)90406-9; BARRANCO SC, 1983, CANCER RES, V43, P1703; Bartman AE, 1998, J PATHOL, V186, P398; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Buisine MP, 1999, INFLAMM BOWEL DIS, V5, P24, DOI 10.1097/00054725-199902000-00004; Buisine MP, 1998, BIOCHEM J, V332, P729, DOI 10.1042/bj3320729; Buisine MP, 1998, GUT, V43, P519, DOI 10.1136/gut.43.4.519; Buisine MP, 1996, GASTROENTEROLOGY, V110, P84, DOI 10.1053/gast.1996.v110.pm8536891; Buisine MP, 2000, J HISTOCHEM CYTOCHEM, V48, P1657, DOI 10.1177/002215540004801209; Choudhury A, 2000, J BIOL CHEM, V275, P33929, DOI 10.1074/jbc.M005115200; Desseyn JL, 1998, J BIOL CHEM, V273, P30157, DOI 10.1074/jbc.273.46.30157; Desseyn JL, 1997, J BIOL CHEM, V272, P16873, DOI 10.1074/jbc.272.27.16873; Desseyn JL, 1997, J BIOL CHEM, V272, P3168, DOI 10.1074/jbc.272.6.3168; DUFOSSE J, 1993, BIOCHEM J, V293, P329, DOI 10.1042/bj2930329; Filipe MI, 1996, EUR J CANCER PREV, V5, P287, DOI 10.1097/00008469-199608000-00009; FORSTNER G, 1995, ANNU REV PHYSIOL, V57, P585, DOI 10.1146/annurev.ph.57.030195.003101; Gum JR, 1999, AM J PHYSIOL-GASTR L, V276, pG666, DOI 10.1152/ajpgi.1999.276.3.G666; Gum JR, 1997, BIOCHEM J, V325, P259, DOI 10.1042/bj3250259; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hanski C, 1997, LAB INVEST, V77, P685; Hiltunen MO, 1997, BRIT J CANCER, V76, P1124, DOI 10.1038/bjc.1997.522; HO JJL, 1995, INT J ONCOL, V7, P913; HO SB, 1995, GASTROENTEROLOGY, V109, P735, DOI 10.1016/0016-5085(95)90380-1; HO SB, 1993, CANCER RES, V53, P641; HO SB, 1995, CANCER RES, V55, P2681; Hong DH, 1999, AM J PHYSIOL-GASTR L, V277, pG1041, DOI 10.1152/ajpgi.1999.277.5.G1041; Jirtle Randy L., 2000, Environmental Health Perspectives, V108, P271, DOI 10.2307/3454445; Kim YJ, 1999, AM J PATHOL, V155, P461, DOI 10.1016/S0002-9440(10)65142-5; LENCER WI, 1990, AM J PHYSIOL, V258, pG96, DOI 10.1152/ajpgi.1990.258.1.G96; LESUFFLEUR T, 1995, J BIOL CHEM, V270, P13665, DOI 10.1074/jbc.270.23.13665; LESUFFLEUR T, 1994, CRIT REV ONCOL HEMAT, V17, P153, DOI 10.1016/1040-8428(94)90053-1; Machado JC, 2000, J PATHOL, V190, P437; Pigny P, 1996, BIOCHEM BIOPH RES CO, V220, P186, DOI 10.1006/bbrc.1996.0378; Pigny P, 1996, GENOMICS, V38, P340, DOI 10.1006/geno.1996.0637; Porchet Nicole, 1999, Journal de la Societe de Biologie, V193, P85; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Reis CA, 2000, J HISTOCHEM CYTOCHEM, V48, P377, DOI 10.1177/002215540004800307; Reis CA, 1999, CANCER RES, V59, P1003; Reis CA, 1997, INT J CANCER, V74, P112, DOI 10.1002/(SICI)1097-0215(19970220)74:1<112::AID-IJC19>3.3.CO;2-Q; Schwienbacher C, 2000, P NATL ACAD SCI USA, V97, P5445, DOI 10.1073/pnas.090087497; SEKIGUCHI M, 1978, JPN J EXP MED, V48, P61; Toyota M, 2000, ELECTROPHORESIS, V21, P329, DOI 10.1002/(SICI)1522-2683(20000101)21:2<329::AID-ELPS329>3.0.CO;2-9; Toyota M, 1999, CANCER RES, V59, P5438; Tycko B, 2000, J CLIN INVEST, V105, P401, DOI 10.1172/JCI9462; van Klinken BJW, 1998, AM J PHYSIOL-GASTR L, V274, pG871, DOI 10.1152/ajpgi.1998.274.5.G871; Van Seuningen I, 2000, BIOCHEM J, V348, P675; Vandenhaute B, 1997, J HEPATOL, V27, P1057, DOI 10.1016/S0168-8278(97)80150-X; VanKlinken BJW, 1996, GLYCOCONJUGATE J, V13, P757, DOI 10.1007/BF00702340; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Velcich A, 1997, J BIOL CHEM, V272, P7968, DOI 10.1074/jbc.272.12.7968; Williams SJ, 1999, CANCER RES, V59, P4083; Yamamura H, 1997, J BIOCHEM, V122, P157; Zaretsky JZ, 1999, FEBS LETT, V461, P189, DOI 10.1016/S0014-5793(99)01452-0	57	67	71	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15386	15396		10.1074/jbc.M010534200	http://dx.doi.org/10.1074/jbc.M010534200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278696	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000168528800114
J	Stevenson, AS; Gomez, MF; Hill-Eubanks, DC; Nelson, MT				Stevenson, AS; Gomez, MF; Hill-Eubanks, DC; Nelson, MT			NFAT4 movement in native smooth muscle - A role for differential Ca2+ signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TRANSCRIPTIONAL PATHWAY; T-CELLS; GROWTH-FACTOR; RYANODINE RECEPTORS; CALCIUM CHANNELS; GENE-EXPRESSION; NUCLEAR IMPORT; CALCINEURIN; ACTIVATION; FAMILY	The transcription factor NFAT (nuclear factor of activated T-cells) plays a central role in mediating Ca2+-dependent gene transcription in a variety of cell types. Sustained increases in intracellular calcium concentration ([Ca2+](i)) are presumed to be required for NFAT dephosphorylation by the Ca2+/calmodulin-dependent protein calcineurin and its subsequent nuclear translocation. Here, we provide the first identification and characterization of NFAT in native smooth muscle, showing that NFAT4 is the predominant isoform detected by reverse transcriptase-polymerase chain reaction and Western blot analysis. PDGF induces NFAT4 translocation in smooth muscle, leading to an increase in NFAT transcriptional activity. NFAT4 activation by PDGF depends on Ca2+ entry through voltage-dependent Ca2+ channels, because its nuclear accumulation is prevented by the Ca2+ channel blocker nisoldipine and the K+ channel opener pinacidil. Interestingly, elevation of [Ca2+](i) by membrane depolarization or ionomycin treatment are not effective stimuli for NFAT4 nuclear accumulation, indicating that Ca2+ influx is necessary but not sufficient for NFAT4 activation. In contrast, membrane depolarization readily activates the Ca2+-dependent transcription factor CREB (cAMP-responsive element-binding protein). The calcineurin blockers CsA and FK506 also prevented the PDGF-induced NFAT4 nuclear localization. These results indicate that both the nature of the calcium signal and PDGF-induced modulation of nuclear import-export of NFAT are critical for NFAT4 activation in this tissue.	Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA	University of Vermont	Nelson, MT (corresponding author), Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA.		Gomez, Maria F/D-3696-2014	Gomez, Maria F/0000-0001-6210-3142; Nelson, Mark/0000-0002-6608-8784	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063722, R01HL044455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053832, R01DK053832] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07647-12, HL63722, HL44455] Funding Source: Medline; NIDDK NIH HHS [DK53832] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beck PL, 1999, INFLAMM BOWEL DIS, V5, P44, DOI 10.1097/00054725-199902000-00007; Boss V, 1998, J BIOL CHEM, V273, P19664, DOI 10.1074/jbc.273.31.19664; Brady MJ, 1998, J BIOL CHEM, V273, P14063, DOI 10.1074/jbc.273.23.14063; Cartin L, 2000, CIRC RES, V86, P760, DOI 10.1161/01.RES.86.7.760; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chow CW, 2000, MOL CELL BIOL, V20, P5227, DOI 10.1128/MCB.20.14.5227-5234.2000; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Gomez M, 1997, AM J PHYSIOL-CELL PH, V273, pC1714, DOI 10.1152/ajpcell.1997.273.5.C1714; Gomez M, 2000, BIOPHYS J, V78, p103A; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Hill-Eubanks DC, 2000, FASEB J, V14, pA576; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; HSU S, 1995, J CELL PHYSIOL, V165, P239, DOI 10.1002/jcp.1041650204; Imamura R, 1998, J IMMUNOL, V161, P3455; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V279, pC1528, DOI 10.1152/ajpcell.2000.279.5.C1528; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; LUCKHOFF A, 1994, BIOPHYS J, V67, P177, DOI 10.1016/S0006-3495(94)80467-9; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Nie L, 1996, MOL PHARMACOL, V50, P763; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Owens GK, 1998, ACTA PHYSIOL SCAND, V164, P623, DOI 10.1111/j.1365-201X.1998.tb10706.x; Piazuelo E, 2000, EUR SURG RES, V32, P191, DOI 10.1159/000008762; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RIDEFELT P, 1995, GROWTH FACTORS, V12, P191, DOI 10.3109/08977199509036879; Rincon M, 1996, MOL CELL BIOL, V16, P1074; SANDERS KM, 1992, ANNU REV PHYSIOL, V54, P439; STEVENSON AS, 2000, FASEB J; SWARD K, 1994, AM J PHYSIOL, V266, pC1754, DOI 10.1152/ajpcell.1994.266.6.C1754; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	42	101	102	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15018	15024		10.1074/jbc.M011684200	http://dx.doi.org/10.1074/jbc.M011684200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278965	hybrid			2022-12-27	WOS:000168528800067
J	Andersen, MD; Shaffer, J; Jennings, PA; Adams, JA				Andersen, MD; Shaffer, J; Jennings, PA; Adams, JA			Structural characterization of protein kinase A as a function of nucleotide binding - Hydrogen-deuterium exchange studies using matrix-assisted laser desorption ionization-time of flight mass spectrometry detection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; FOLDING INTERMEDIATE; ESCHERICHIA-COLI; TYROSINE KINASE; MOLECULAR-BASIS; MOLTEN GLOBULE; MECHANISM; ACTIVATION	Transient state kinetic studies indicate that substrate phosphorylation in protein kinase A is partially rate-limited by conformational changes, some of which may be associated with nucleotide binding (Shaffer, J,, and Adams, J. A. (1999) Biochemistry 38, 12072-12079). To assess whether specific structural changes are associated with the binding of nucleotides, hydrogen-deuterium exchange experiments were performed on the enzyme in the absence and presence of ADP, Four regions of the protein are protected from exchange in the presence of ADP. Two regions encompass the catalytic and glycine-rich loops and are integral parts of the active site. Conversely, protection of probes in the C terminus is consistent with nucleotide-induced domain closure. One protected probe encompasses a portion of helix C, a secondary structural element that does not make any direct contacts with the nucleotide but has been reported to undergo segmental motion upon the activation of some protein kinases. The combined data suggest that binding of the nucleotide has distal structural effects that may include stabilizing the closed state of the enzyme and altering the position of a critical helix outside the active site. The latter represents the first evidence that the nucleotide alone can induce changes in helix C in solution.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Adams, JA (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	joeadams@ucsd.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054038, R01GM054038, R29GM054846] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54038, GM 54846] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; ALHANATY E, 1981, P NATL ACAD SCI-BIOL, V78, P3492, DOI 10.1073/pnas.78.6.3492; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Batkin M, 2000, BIOCHEMISTRY-US, V39, P5366, DOI 10.1021/bi000153z; BEASTY AM, 1985, BIOCHEMISTRY-US, V24, P3547, DOI 10.1021/bi00335a024; Burlacu-Miron S, 1999, EUR J BIOCHEM, V264, P765, DOI 10.1046/j.1432-1327.1999.00633.x; BYCROFT M, 1990, NATURE, V346, P488, DOI 10.1038/346488a0; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Chamberlain AK, 1996, NAT STRUCT BIOL, V3, P782, DOI 10.1038/nsb0996-782; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Cheng XD, 1998, BIOCHEMISTRY-US, V37, P14005, DOI 10.1021/bi981057p; CHENG XD, 1991, J MOL BIOL, V220, P381, DOI 10.1016/0022-2836(91)90020-7; CLAUSER E, 1992, HORM RES, V38, P5, DOI 10.1159/000182470; Cohen P, 1999, CURR OPIN CHEM BIOL, V3, P459, DOI 10.1016/S1367-5931(99)80067-2; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Englander JJ, 1998, J MOL BIOL, V284, P1707, DOI 10.1006/jmbi.1998.2279; Englander JJ, 1998, J MOL BIOL, V284, P1695, DOI 10.1006/jmbi.1998.2278; ENGLANDER SW, 1992, SCIENCE, V256, P1684, DOI 10.1126/science.256.5064.1684; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; FINUCANE MD, 1995, J MOL BIOL, V253, P576, DOI 10.1006/jmbi.1995.0574; Gangal M, 1998, BIOCHEMISTRY-US, V37, P13728, DOI 10.1021/bi980560z; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; HERBERG FW, 1993, PROTEIN ENG, V6, P771, DOI 10.1093/protein/6.7.771; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kossiakoff A A, 1984, Basic Life Sci, V27, P281; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Lew J, 1997, BIOCHEMISTRY-US, V36, P6717, DOI 10.1021/bi963164u; LIAN LY, 1994, METHOD ENZYMOL, V239, P657; Linderstrom-Lang K., 1957, S PROT STRUCT, V9, P23; LU JR, 1992, BIOCHEMISTRY-US, V31, P4749, DOI 10.1021/bi00135a002; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Mandell JG, 1998, ANAL CHEM, V70, P3987, DOI 10.1021/ac980553g; McCallum SA, 2000, BIOCHEMISTRY-US, V39, P7343, DOI 10.1021/bi992767d; MEIERING EM, 1993, BIOCHEMISTRY-US, V32, P10975, DOI 10.1021/bi00092a006; Narayana N, 1997, BIOCHEMISTRY-US, V36, P4438, DOI 10.1021/bi961947+; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Ni DQ, 2000, PROTEIN SCI, V9, P1818, DOI 10.1110/ps.9.9.1818; Nolen B, 2001, NAT STRUCT BIOL, V8, P176, DOI 10.1038/84178; OLAH GA, 1993, BIOCHEMISTRY-US, V32, P3649, DOI 10.1021/bi00065a018; PETROS AM, 1994, METHOD ENZYMOL, V239, P717; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; Raschke TM, 1997, NAT STRUCT BIOL, V4, P298, DOI 10.1038/nsb0497-298; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Resing KA, 1998, BIOCHEMISTRY-US, V37, P463, DOI 10.1021/bi971750x; Robertson SC, 2000, TRENDS GENET, V16, P265, DOI 10.1016/S0168-9525(00)02021-7; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; RODER H, 1988, NATURE, V335, P700, DOI 10.1038/335700a0; ROSA JJ, 1979, J MOL BIOL, V133, P399, DOI 10.1016/0022-2836(79)90400-5; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Saylor P, 1998, BIOCHEMISTRY-US, V37, P17875, DOI 10.1021/bi981775b; Shaffer J, 1999, BIOCHEMISTRY-US, V38, P5572, DOI 10.1021/bi982768q; Shaffer J, 1999, BIOCHEMISTRY-US, V38, P12072, DOI 10.1021/bi991109q; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; UDGAONKAR JB, 1988, NATURE, V335, P694, DOI 10.1038/335694a0; Wang F, 2000, PROTEIN SCI, V9, P1660, DOI 10.1110/ps.9.9.1660; Wang F, 1997, BIOCHEMISTRY-US, V36, P3755, DOI 10.1021/bi963065g; YOON MY, 1987, BIOCHEMISTRY-US, V26, P4118, DOI 10.1021/bi00387a056; Zhang M, 2000, J PEPT RES, V55, P398, DOI 10.1034/j.1399-3011.2000.00698.x; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhang ZQ, 1996, BIOCHEMISTRY-US, V35, P779, DOI 10.1021/bi952227q; ZHENG JH, 1991, METHOD ENZYMOL, V200, P508; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; Zhou J, 1997, BIOCHEMISTRY-US, V36, P2977, DOI 10.1021/bi9619132	77	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14204	14211		10.1074/jbc.M011543200	http://dx.doi.org/10.1074/jbc.M011543200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278927	hybrid			2022-12-27	WOS:000168356600093
J	Audinot, V; Beauverger, P; Lahaye, C; Suply, T; Rodriguez, M; Ouvry, C; Lamamy, V; Imbert, J; Rique, H; Nahon, JL; Galizzi, JP; Canet, E; Levens, N; Fauchere, JL; Boutin, JA				Audinot, V; Beauverger, P; Lahaye, C; Suply, T; Rodriguez, M; Ouvry, C; Lamamy, V; Imbert, J; Rique, H; Nahon, JL; Galizzi, JP; Canet, E; Levens, N; Fauchere, JL; Boutin, JA			Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide ligands at SLC-1, the human MCH receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; GAMMA-S BINDING; MOLECULAR CHARACTERIZATION; COMBINATORIAL LIBRARIES; RAT HYPOTHALAMUS; AGONIST ACTIVITY; CYCLIC STRUCTURE; NEUROPEPTIDE-Y; BODY-WEIGHT; AMINO-ACIDS	Melanin-concentrating hormone (MCH) is a cyclic nonadecapeptide involved in the regulation of feeding behavior, which acts through a G protein coupled receptor (SLC-1) inhibiting adenylcyclase activity. In this study, 57 analogues of MCH were investigated on the recently cloned human MCH receptor stably expressed in HEK293 cells, on both the inhibition of forskolin-stimulated cAMP production and guanosine-5'-O-(3-[S-35]thiotriphosphate ([S-35]GTP gammaS) binding. The dodecapeptide MCH-(6-17) (MCH ring between Cys(7) and Cys(16), with a single extra amino acid at the N terminus (Arg(6)) and at the C terminus (Trp(17))) was found to be the minimal sequence required for a full and potent agonistic response on cAMP formation and [S-35]GTP gammaS binding. We Ala-scanned this dodecapeptide and found that only 3 of 8 amino acids of the ring, namely Met(8), Arg(11), and Tyr(13), were essential to elicit full and potent responses in both tests. Deletions inside the ring led either to inactivity or to poor antagonists with potencies in the micromolar range. Cys(7), and Cys(16) were substituted by Asp and Lys or one of their analogues, in an attempt to replace the disulfide bridge by an amide bond. However, those modifications were deleterious for agonistic activity. In [S-35]GTP gammaS binding, these compounds behaved as weak antagonists (K-B 1-4 muM). Finally, substitution in MCH-(6-17) of 6 out of 12 amino acids by non-natural residues and concomitant replacement of the disulfide bond by an amide bond led to three compounds with potent antagonistic properties (K-B = 0.1-0.2 muM). Exploitation of these structure-activity relationships should open the way to the design of short and stable MCH peptide antagonists.	Inst Rech Servier, Div Pharmacol Mol & Cellulaire, F-78290 Croissy sur Seine, France; Inst Pharmacol Mol & Cellulaire, CNRS, UMR 6097, F-06100 Sophia Antipolis, France; Inst Rech Servier, Div Metab, F-92150 Suresnes, France; Inst Rech Servier, Div Peptides & Chim Combinatoire, F-92150 Suresnes, France	Servier; Institut de Recherches Internationales Servier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Servier; Institut de Recherches Internationales Servier; Servier; Institut de Recherches Internationales Servier	Boutin, JA (corresponding author), Inst Rech Servier, Div Pharmacol Mol & Cellulaire, 125 Chemin Ronde, F-78290 Croissy sur Seine, France.	jean.boutin@fr.netgrs.com	NAHON, Jean-Louis/O-7977-2016; Boutin, Jean Albert/W-9103-2019	NAHON, Jean-Louis/0000-0001-9572-7779; Boutin, Jean Albert/0000-0003-0068-7204				ADHAM N, 1993, MOL PHARMACOL, V43, P427; Atherton E., 1989, SOLID PHASE PEPTIDE, P1; Audinot V, 2001, NEUROPHARMACOLOGY, V40, P57, DOI 10.1016/S0028-3908(00)00104-0; Bachner D, 1999, FEBS LETT, V457, P522, DOI 10.1016/S0014-5793(99)01092-3; BECKSICKINGER AG, 1994, EUR J BIOCHEM, V225, P947, DOI 10.1111/j.1432-1033.1994.0947b.x; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Boutin JA, 1996, ANAL BIOCHEM, V234, P126, DOI 10.1006/abio.1996.0064; Boutin JA, 1999, J CHROMATOGR B, V725, P17, DOI 10.1016/S0378-4347(98)00569-6; Boutin JA, 2000, J RECEPT SIGNAL TR R, V20, P105, DOI 10.3109/10799890009150040; Bradley RL, 2000, DIABETES, V49, P1073, DOI 10.2337/diabetes.49.7.1073; Burgaud JL, 1997, BIOCHEM BIOPH RES CO, V241, P622, DOI 10.1006/bbrc.1997.7849; Cabrele C, 2000, J BIOL CHEM, V275, P36043, DOI 10.1074/jbc.M000626200; CARPINO LA, 1993, TETRAHEDRON LETT, V34, P7829, DOI 10.1016/S0040-4039(00)61487-9; CASTRUCCI AMD, 1992, COMP BIOCHEM PHYS B, V103, P317; Chambers J, 1999, NATURE, V400, P261, DOI 10.1038/22313; Cohen FR, 1996, BRIT J PHARMACOL, V117, P1521, DOI 10.1111/j.1476-5381.1996.tb15316.x; COSTE J, 1991, TETRAHEDRON LETT, V32, P1967, DOI 10.1016/0040-4039(91)85015-W; Doods HN, 1996, REGUL PEPTIDES, V65, P71, DOI 10.1016/0167-0115(96)00074-2; DROZDZ R, 1995, FEBS LETT, V359, P199, DOI 10.1016/0014-5793(95)00043-9; DROZDZ R, 1995, J RECEPT SIGNAL TR R, V15, P487, DOI 10.3109/10799899509045235; Drozdz R, 1995, J Pept Sci, V1, P58, DOI 10.1002/psc.310010108; Drozdz R, 1998, ANN NY ACAD SCI, V839, P210, DOI 10.1111/j.1749-6632.1998.tb10761.x; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fauchere JL, 1998, CHEMOMETR INTELL LAB, V43, P43, DOI 10.1016/S0169-7439(98)00082-3; FAUCHERE JL, 1995, E SCHERING RES FDN W, V15, P129; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Hervieu GJ, 2000, EUR J NEUROSCI, V12, P1194, DOI 10.1046/j.1460-9568.2000.00008.x; HILF G, 1989, EUR J BIOCHEM, V186, P725, DOI 10.1111/j.1432-1033.1989.tb15266.x; Hintermann E, 1999, J RECEPT SIGNAL TR R, V19, P411, DOI 10.3109/10799899909036661; KAWAUCHI H, 1983, NATURE, V305, P321, DOI 10.1038/305321a0; KAWAZOE I, 1987, INT J PEPT PROT RES, V29, P714; Keire DA, 2000, AM J PHYSIOL-GASTR L, V279, pG126, DOI 10.1152/ajpgi.2000.279.1.G126; Kokkotou E, 2000, NEUROPEPTIDES, V34, P240, DOI 10.1054/npep.2000.0821; Kolakowski LF, 1996, FEBS LETT, V398, P253, DOI 10.1016/S0014-5793(96)01160-X; Lakaye B, 1998, BBA-MOL CELL RES, V1401, P216, DOI 10.1016/S0167-4889(97)00135-3; LAZARENO S, 1993, LIFE SCI, V52, P449, DOI 10.1016/0024-3205(93)90301-I; LEBL M, 1988, J MED CHEM, V31, P949, DOI 10.1021/jm00400a010; LEBL M, 1989, LIFE SCI, V44, P451; Lembo PMC, 1999, NAT CELL BIOL, V1, P267, DOI 10.1038/12978; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macdonald D, 2000, MOL PHARMACOL, V58, P217, DOI 10.1124/mol.58.1.217; MATSUNAGA TO, 1989, PEPTIDES, V10, P773, DOI 10.1016/0196-9781(89)90112-5; MATSUNAGA TO, 1992, LIFE SCI, V51, P679; NAHON JL, 1994, CRIT REV NEUROBIOL, V8, P221; NewmanTancredi A, 1997, NEUROPHARMACOLOGY, V36, P451, DOI 10.1016/S0028-3908(97)00022-1; Presse F, 1996, NEUROSCIENCE, V71, P735, DOI 10.1016/0306-4522(95)00481-5; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Rossi M, 1997, ENDOCRINOLOGY, V138, P351, DOI 10.1210/en.138.1.351; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shimomura Y, 1999, BIOCHEM BIOPH RES CO, V261, P622, DOI 10.1006/bbrc.1999.1104; Stanton JA, 1997, EUR J PHARMACOL, V320, P267, DOI 10.1016/S0014-2999(96)00914-4; Tritos NA, 1999, NEUROPEPTIDES, V33, P339, DOI 10.1054/npep.1999.0055; Tritos NA, 1998, DIABETES, V47, P1687, DOI 10.2337/diabetes.47.11.1687; VAUGHAN JM, 1989, ENDOCRINOLOGY, V125, P1660, DOI 10.1210/endo-125-3-1660; Viale A, 1997, MOL BRAIN RES, V46, P243, DOI 10.1016/S0169-328X(97)00018-1; [No title captured]	57	60	70	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13554	13562		10.1074/jbc.M010727200	http://dx.doi.org/10.1074/jbc.M010727200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278733	hybrid			2022-12-27	WOS:000168356600009
J	Belletti, B; Prisco, M; Morrione, A; Valentinis, B; Navarro, M; Baserga, R				Belletti, B; Prisco, M; Morrione, A; Valentinis, B; Navarro, M; Baserga, R			Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by phosphatidylinositol 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; AKT/PROTEIN KINASE-B; CELL-CYCLE ARREST; C-MYC EXPRESSION; HEMATOPOIETIC-CELLS; INSULIN-LIKE-GROWTH-FACTOR-1 RECEPTOR; GRANULOCYTIC DIFFERENTIATION; PHOSPHOINOSITIDE 3-KINASE; RETINOBLASTOMA PROTEIN; PROSTATE-CANCER	The Id proteins play an important role in proliferation, differentiation, and tumor development. We report here that Id gene expression can be regulated by the insulin-like growth factor I receptor (IGF-IR), a receptor that also participates in the regulation of cellular proliferation and differentiation. Specifically, we found that the IGF-IR activated by its ligand was a strong inducer of Id2 gene expression in 32D murine hemopoietic cells. This activation was not simply the result of cellular proliferation, as Id2 gene expression was higher in 32D cells stimulated by IGF-I than in cells exponentially growing in interleukin 3. The up-regulation of Id2 gene expression was largely dependent on the presence of insulin receptor substrate-1, a major substrate of the IGF-IR and a potent activator of the phosphatidylinositol 3-kinase (PI3K) pathway. The role of PI3K activity in the up-regulation of Id2 gene expression by the IGF-IR was confirmed by different methods and in different cell types. In 32D cells, the up regulation of Id2 gene expression by the PI3K pathway correlated with interleukin-3 independence and inhibition of differentiation.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University	Baserga, R (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, 233 S 10th St,264 BLSB, Philadelphia, PA 19107 USA.	r_baserga@lac.jci.tju.edu	Belletti, Barbara/J-2028-2018	Belletti, Barbara/0000-0003-2249-0285	NATIONAL CANCER INSTITUTE [P01CA056309, P01CA078890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK002896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016291] Funding Source: NIH RePORTER; NCI NIH HHS [CA 56309, CA 78890] Funding Source: Medline; NIA NIH HHS [AG 16291] Funding Source: Medline; NIDDK NIH HHS [K01 DK 02896-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aoki M, 2000, J BIOL CHEM, V275, P6267, DOI 10.1074/jbc.275.9.6267; ASKEW DS, 1991, ONCOGENE, V6, P1915; BARONE MV, 1994, P NATL ACAD SCI USA, V91, P4985, DOI 10.1073/pnas.91.11.4985; Baserga R, 1999, J CELL BIOCHEM, P68; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Brown G, 1999, EXP CELL RES, V253, P511, DOI 10.1006/excr.1999.4660; CAMPISI J, 1984, MOL CELL BIOL, V4, P1807, DOI 10.1128/MCB.4.9.1807; Carson JP, 1999, CANCER RES, V59, P1449; Chambery D, 1999, CANCER RES, V59, P2898; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; Conover CA, 1998, EXP CELL RES, V238, P122, DOI 10.1006/excr.1997.3815; Cooper CL, 1998, J CELL BIOCHEM, V71, P277, DOI 10.1002/(SICI)1097-4644(19981101)71:2<277::AID-JCB12>3.0.CO;2-I; Davies MA, 1999, CANCER RES, V59, P2551; Desprez PY, 1998, MOL CELL BIOL, V18, P4577, DOI 10.1128/MCB.18.8.4577; DESPREZ PY, 1995, MOL CELL BIOL, V15, P3398; Dews M, 2000, ENDOCRINOLOGY, V141, P1289, DOI 10.1210/en.141.4.1289; Didichenko SA, 1996, CURR BIOL, V6, P1271, DOI 10.1016/S0960-9822(02)70713-6; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; EINARSON MB, 1995, MOL CELL BIOL, V15, P4175; Florio M, 1998, MOL CELL BIOL, V18, P5435, DOI 10.1128/MCB.18.9.5435; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Furnari FB, 1998, CANCER RES, V58, P5002; HARA E, 1994, J BIOL CHEM, V269, P2139; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Ishiguro A, 1996, BLOOD, V87, P5225, DOI 10.1182/blood.V87.12.5225.bloodjournal87125225; Jen Y, 1996, DEV DYNAM, V207, P235; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li J, 1998, CANCER RES, V58, P5667; Lin CQ, 2000, CANCER RES, V60, P1332; LISTER J, 1995, J BIOL CHEM, V270, P17939, DOI 10.1074/jbc.270.30.17939; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Mendez R, 1997, MOL CELL BIOL, V17, P5184, DOI 10.1128/MCB.17.9.5184; MYERS MG, 1994, J BIOL CHEM, V269, P28783; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; PIETRZKOWSKI Z, 1993, CANCER RES, V53, P1102; Reiss K, 1999, J CELL PHYSIOL, V181, P124, DOI 10.1002/(SICI)1097-4652(199910)181:1<124::AID-JCP13>3.0.CO;2-0; Reiss K, 2000, ONCOGENE, V19, P2687, DOI 10.1038/sj.onc.1203587; Reiss K, 1998, EXP CELL RES, V242, P361, DOI 10.1006/excr.1998.4113; Romano G, 1999, J CELL BIOCHEM, V72, P294, DOI 10.1002/(SICI)1097-4644(19990201)72:2<294::AID-JCB14>3.0.CO;2-0; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Valentinis B, 1999, J BIOL CHEM, V274, P12423, DOI 10.1074/jbc.274.18.12423; Valentinis B, 2000, J BIOL CHEM, V275, P25451, DOI 10.1074/jbc.M002271200; VALTIERI M, 1987, J IMMUNOL, V138, P3829; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; Ward AC, 1999, J BIOL CHEM, V274, P14956, DOI 10.1074/jbc.274.21.14956; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Yenush L, 1998, MOL CELL BIOL, V18, P6784, DOI 10.1128/MCB.18.11.6784	60	40	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13867	13874		10.1074/jbc.M010509200	http://dx.doi.org/10.1074/jbc.M010509200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278691	Green Published, hybrid			2022-12-27	WOS:000168356600052
J	Zheng, XL; Matsubara, S; Diao, C; Hollenberg, MD; Wong, NCW				Zheng, XL; Matsubara, S; Diao, C; Hollenberg, MD; Wong, NCW			Epidermal growth factor induction of apolipoprotein A-I is mediated by the Ras-MAP kinase cascade and Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; LINE HEP G2; GENE-EXPRESSION; CELL-LINE; EGF RECEPTOR; TRANSCRIPTIONAL REGULATION; PHOSPHORYLATION SITES; DNA-SYNTHESIS	Insulin induces apolipoprotein A-I, apoA-I gene transcription via a membrane receptor with intrinsic tyrosine kinase activity. This finding prompted us to ask whether the gene is stimulated by epidermal growth factor (EGF), EGF a peptide hormone that binds to another member of the receptor superfamily with tyrosine kinase activity. Our data showed that like insulin, EGF increased abundance of apoA-I protein and transcription of the gene in human hepatoma, Hep G2 cells. The effects of both hormones appeared direct because their induction of apoA-I gene transcription was not affected by the protein synthesis inhibitor, cycloheximide. Although both insulin and EGF stimulate apoA-I expression, each hormone binds to a distinct membrane receptor thus suggesting differential intracellular signaling. Therefore, we used a panel of inhibitors to define the pathway(s) that mediate the actions of these hormones. Whereas, the actions of EGF required only the Ras-mitogen-activated protein, MAP kinase, those of insulin were mediated by equal participation of both the Ras-MAP kinase and protein kinase:C, PKC cascades, Despite differences in signaling pathways triggered by each hormone receptor, the activation of apoA-I transcription required the participation of a single transcription factor, Sp1, Furthermore, EGF induction of transcription was attenuated by mutating the MAP kinase site at amino acid, Thr(266) rendering Sp1 phosphorylation deficient, In summary, EGF stimulation of apoA-I expression is mediated solely by the Ras-MAP kinase cascade and enhanced activity of this pathway requires Sp1 with an intact phosphorylation site at Thr(266). However, insulin induction of this gene is different and requires both Ras-MAP kinase and PKC pathways but their actions are also mediated by Sp1.	Univ Calgary, Hlth Sci Ctr, Fac Med, Dept Med,Endocrine Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Endocrine Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Endocrine Res Grp, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary; University of Calgary	Wong, NCW (corresponding author), Univ Calgary, Hlth Sci Ctr, Fac Med, Dept Med,Endocrine Res Grp, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	newwong@ucalgary.ca	Hollenberg, Morley/AFV-6966-2022	Zheng, Xi-Long/0000-0002-0889-1827				Ahlgren R, 1999, J BIOL CHEM, V274, P19422, DOI 10.1074/jbc.274.27.19422; Andersson LO, 1997, CURR OPIN LIPIDOL, V8, P225, DOI 10.1097/00041433-199708000-00006; Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Band CJ, 1997, J BIOL CHEM, V272, P138; Barter PJ, 1996, ATHEROSCLEROSIS, V121, P1, DOI 10.1016/0021-9150(95)05675-0; Barter PJ, 1996, CURR OPIN LIPIDOL, V7, P82, DOI 10.1097/00041433-199604000-00006; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BROUILLETTE CG, 1995, BBA-LIPID LIPID MET, V1256, P103, DOI 10.1016/0005-2760(95)00018-8; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Chupreta S, 2000, AM J PHYSIOL-CELL PH, V278, pC697, DOI 10.1152/ajpcell.2000.278.4.C697; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; de Backer G, 1998, ATHEROSCLEROSIS, V137, pS1, DOI 10.1016/S0021-9150(97)00310-9; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Eisenberg Daniel A., 1998, American Journal of Medicine, V104, p2S, DOI 10.1016/S0002-9343(98)00038-2; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Hargrove GM, 1999, J MOL ENDOCRINOL, V22, P103, DOI 10.1677/jme.0.0220103; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; LAWN RM, 1992, NATURE, V360, P670, DOI 10.1038/360670a0; LI Y, 2000, J BIOL CHEM; Luoma PV, 1997, PHARMACOL TOXICOL, V81, P57, DOI 10.1111/j.1600-0773.1997.tb00032.x; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Marino M, 1996, CELL SIGNAL, V8, P555, DOI 10.1016/S0898-6568(96)00111-8; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; MILLER NE, 1985, NATURE, V314, P109, DOI 10.1038/314109a0; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Murao K, 1998, J BIOL CHEM, V273, P18959, DOI 10.1074/jbc.273.30.18959; Nagase T, 1996, INT J CANCER, V65, P620, DOI 10.1002/(SICI)1097-0215(19960301)65:5<620::AID-IJC11>3.0.CO;2-B; Nanjee MN, 1996, ARTERIOSCL THROM VAS, V16, P1203, DOI 10.1161/01.ATV.16.9.1203; Nelson M, 1993, EXS, V64, P186; Ness GC, 1998, BIOCHEM PHARMACOL, V56, P121, DOI 10.1016/S0006-2952(98)00119-1; Pal S, 1998, J BIOL CHEM, V273, P26277, DOI 10.1074/jbc.273.41.26277; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; RICHARDS CA, 1990, CANCER RES, V50, P1521; ROMNEY JS, 1992, MOL ENDOCRINOL, V6, P943, DOI 10.1210/me.6.6.943; Sakai T, 2000, ATHEROSCLEROSIS, V149, P43, DOI 10.1016/S0021-9150(99)00292-0; Saltiel AR, 1996, AM J PHYSIOL-ENDOC M, V270, pE375, DOI 10.1152/ajpendo.1996.270.3.E375; Sergeant N, 2000, J BIOL CHEM, V275, P17094, DOI 10.1074/jbc.M000237200; Taylor A H, 1997, Proc West Pharmacol Soc, V40, P127; Taylor AH, 1996, BIOCHEMISTRY-US, V35, P8281, DOI 10.1021/bi960269o; Thoresen GH, 1998, J CELL PHYSIOL, V175, P10, DOI 10.1002/(SICI)1097-4652(199804)175:1<10::AID-JCP2>3.3.CO;2-6; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; VANDEYAR MA, 1988, GENE, V65, P129, DOI 10.1016/0378-1119(88)90425-8; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wu JYJ, 1999, AM J PHYSIOL-CELL PH, V277, pC537, DOI 10.1152/ajpcell.1999.277.3.C537; Zheng XL, 2000, J BIOL CHEM, V275, P31747, DOI 10.1074/jbc.M000621200; Zheng XL, 1999, J PHARMACOL EXP THER, V289, P632; Zhong ZD, 2000, J BIOL CHEM, V275, P18602, DOI 10.1074/jbc.M001389200; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	58	56	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13822	13829		10.1074/jbc.M011031200	http://dx.doi.org/10.1074/jbc.M011031200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278817	hybrid			2022-12-27	WOS:000168356600046
J	Bertenshaw, GP; Turk, BE; Hubbard, SJ; Matters, GL; Bylander, JE; Crisman, JM; Cantley, LC; Bond, JS				Bertenshaw, GP; Turk, BE; Hubbard, SJ; Matters, GL; Bylander, JE; Crisman, JM; Cantley, LC; Bond, JS			Marked differences between metalloproteases meprin A and B in substrate and peptide bond specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE KIDNEY; METALLOENDOPEPTIDASE MEPRIN; ALPHA-SUBUNIT; BETA-SUBUNIT; EXPRESSION; PROTEINASE; ASTACIN; SECRETION; INTESTINE; PROTEASES	Meprin A and B are highly regulated, secreted, and cell-surface metalloendopeptidases that are abundantly expressed in the kidney and intestine. Meprin oligomers consist of evolutionarily related alpha and/or beta subunits. The work herein was carried out to identify bioactive peptides and proteins that are susceptible to hydrolysis by mouse meprins and kinetically characterize the hydrolysis. Gastrin-releasing peptide fragment 14-27 and gastrin 17, regulatory molecules of the gastrointestinal tract, were found to be the best peptide substrates for meprin A and B, respectively. Peptide libraries and a variety of naturally occurring peptides revealed that the meprin p subunit has a clear preference for acidic amino acids in the P1 and P1 ' sites of substrates. The meprin alpha subunit selected for small (e,g, serine, alanine) or hydrophobic (e.g, phenylalanine) residues in the P1 and P1 ' sites, and proline was the most preferred amino acid at the P2 ' position. Thus, although the meprin alpha and beta subunits share 55% amino acid identity within the protease domain and are normally localized at the same tissue cell surfaces, they have very different substrate and peptide bond specificities indicating different functions. Homology models of the mouse meprin alpha and beta protease domains, based on the astacin crystal structure, revealed active site differences that can account for the marked differences in substrate specificity of the two subunits.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, Manchester M60 1QD, Lancs, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Manchester	Bond, JS (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, H171, Hershey, PA 17033 USA.	jbond@psu.edu	Hubbard, Simon J/B-9006-2009; Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Hubbard, Simon/0000-0002-8601-9524; Matters, Gail/0000-0001-8613-8649; Bertenshaw, Greg/0000-0003-4903-3412; , Jacqueline/0000-0002-0803-4729	NIDDK NIH HHS [DK19691, DK54625] Funding Source: Medline; NIGMS NIH HHS [R01 GM056203] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019691, R01DK054625, R56DK019691, R37DK019691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bankus JM, 1996, ARCH BIOCHEM BIOPHYS, V331, P87, DOI 10.1006/abbi.1996.0286; Beynon RJ, 1996, BIOCHEM J, V315, P461, DOI 10.1042/bj3150461; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; Bond J, 1997, BIOM HLTH R, V15, P58; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; BRADY CE, 1988, AM J GASTROENTEROL, V83, P130; BUTLER PE, 1988, J BIOL CHEM, V263, P13419; BUTLER PE, 1987, BIOCHEM J, V241, P229, DOI 10.1042/bj2410229; Chestukhin A, 1997, J BIOL CHEM, V272, P3153, DOI 10.1074/jbc.272.6.3153; CRAIG SS, 1987, AM J PHYSIOL, V253, P535; CUBER JC, 1989, REGUL PEPTIDES, V26, P203, DOI 10.1016/0167-0115(89)90188-2; DIAMOND JR, 1995, AM J PATHOL, V146, P1455; FERSHT A, 1985, ENZYME STRUCTURE MEC, P98; GORBEA CM, 1993, J BIOL CHEM, V268, P21035; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; HEGBRANT J, 1991, SCAND J GASTROENTERO, V26, P599, DOI 10.3109/00365529109043633; Jiang WP, 2000, ARCH BIOCHEM BIOPHYS, V379, P183, DOI 10.1006/abbi.2000.1873; JOHNSON GD, 1992, J BIOL CHEM, V267, P13505; Kadowaki T, 2000, J BIOL CHEM, V275, P25577, DOI 10.1074/jbc.M003521200; KOUNNAS MZ, 1991, J BIOL CHEM, V266, P17350; Kumar JM, 2001, BBA-GENE STRUCT EXPR, V1518, P106, DOI 10.1016/S0167-4781(01)00188-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Marchand P, 1996, J BIOL CHEM, V271, P24236, DOI 10.1074/jbc.271.39.24236; MARCHAND P, 1994, J BIOL CHEM, V269, P15388; Matters GL, 1999, MOL CARCINOGEN, V25, P169, DOI 10.1002/(SICI)1098-2744(199907)25:3<169::AID-MC3>3.0.CO;2-Y; MORLEY JS, 1965, NATURE, V207, P1356, DOI 10.1038/2071356a0; PETITHORY JR, 1991, P NATL ACAD SCI USA, V88, P11510, DOI 10.1073/pnas.88.24.11510; RAY WJ, 1964, J BIOL CHEM, V239, P1228; Ricardo SD, 1996, AM J PHYSIOL-RENAL, V270, pF669, DOI 10.1152/ajprenal.1996.270.4.F669; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; Sterchi E.E., 1998, HDB PROTEOLYTIC ENZY, P1229; Tsukuba T, 1998, J BIOL CHEM, V273, P35260, DOI 10.1074/jbc.273.52.35260; Walker PD, 1998, KIDNEY INT, V53, P1673, DOI 10.1046/j.1523-1755.1998.00949.x; WOLZ RL, 1994, ARCH BIOCHEM BIOPHYS, V310, P144, DOI 10.1006/abbi.1994.1150; WOLZ RL, 1990, ANAL BIOCHEM, V191, P314	38	97	101	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13248	13255		10.1074/jbc.M011414200	http://dx.doi.org/10.1074/jbc.M011414200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278902	hybrid			2022-12-27	WOS:000168198600108
J	Bouma, P; Cabral, WA; Cole, WG; Marini, JC				Bouma, P; Cabral, WA; Cole, WG; Marini, JC			COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of alpha 1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN GENE COL5A1; V COLLAGEN; CHAIN; ORGANIZATION; PROCOLLAGEN; FIBRILLOGENESIS; EXPRESSION; DIGESTION; NOSOLOGY; SITE	We studied four affected individuals from a family of three generations with Ehlers-Danlos Syndrome II. Type V collagen transcripts of affected individuals were screened by reverse transcriptase-polymerase chain reaction. Amplification of the exon 9-28 region of alpha1(V) yielded normal and larger products from the proband, Sequencing of cDNA revealed a 100-base pair insertion from the 3'-end of intron 13 between exons 13 and 14 in one allele. The genomic defect was identified as an A(-2)-->G substitution at the exon 14 splice acceptor site. A cryptic acceptor site -100 nucleotide within intron 13 is used instead of the mutant splice site. The insertion shifts the reading frame +1 and results in a stop codon within exon 17. The mutant transcript was much less abundant than normal allele product in untreated cultured fibroblasts but was approximately equimolar in cycloheximide treated cells, suggesting that the mutation causes nonsense-mediated decay of mRNA. By RNase protection experiments, the level of mutant transcript was determined to be 8% that of the normal transcript in untreated proband fibroblasts, Relative to type I collagen, proband fibroblasts secreted only 65% of the amount of type V collagen secreted by normal controls. Selective salt precipitation of proband secreted collagen provided supportive evidence that the alpha chain composition of type V collagen remains alpha1(V)(2)alpha2(V) even in the context of alpha1(V) haploinsufficiency. Type V collagen incorporates into type I collagen fibrils in the extracellular matrix and is thought to regulate fibril diameter. Transmission electron micrographs of type I collagen fibrils in a proband dermal biopsy showed greater heterogeneity in fibril diameter than in a matched control. The proband had a greater proportion of both larger and smaller fibrils and occasional fibrils with a cauliflower configuration. Unlike the genotype/phenotype relationship seen for type I collagen defects and osteogenesis imperfecta, the null allele in this family appears to cause clinical features similar to those seen in cases with structural alterations in type V collagen.	NICHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; Hosp Sick Children, Div Orthopaed, Toronto, ON M5G 1X8, Canada	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Marini, JC (corresponding author), NICHD, Heritable Disorders Branch, NIH, Bldg 10,Rm 9S241,9000 Rockville Pike, Bethesda, MD 20892 USA.	oidoc@helix.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000408] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000408] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDRIKOPOULOS K, 1995, NAT GENET, V9, P31, DOI 10.1038/ng0195-31; Bateman JF, 1999, HUM MUTAT, V13, P311, DOI 10.1002/(SICI)1098-1004(1999)13:4<311::AID-HUMU8>3.3.CO;2-G; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BEIGHTON P, 1992, MCKUSICKS HERITABLE, P189; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1990, J CELL SCI, V95, P649; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BROWN RA, 1978, BIOCHEM BIOPH RES CO, V80, P866, DOI 10.1016/0006-291X(78)91324-4; BURGESON RE, 1976, P NATL ACAD SCI USA, V257, P7852; Burridge SM, 1999, AM J HUM GENET, V65, pA286; Burrows NP, 1998, AM J HUM GENET, V63, P390, DOI 10.1086/301948; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DePaepe A, 1997, AM J HUM GENET, V60, P547; FESSLER LI, 1985, J BIOL CHEM, V260, P3286; GRANGE DK, 1990, NUCLEIC ACIDS RES, V18, P4227, DOI 10.1093/nar/18.14.4227; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; Imamura Y, 2000, J BIOL CHEM, V275, P8749, DOI 10.1074/jbc.275.12.8749; JIMENEZ SA, 1978, BIOCHEM BIOPH RES CO, V81, P1298, DOI 10.1016/0006-291X(78)91277-9; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; Michalickova K, 1998, HUM MOL GENET, V7, P249, DOI 10.1093/hmg/7.2.249; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Nicholls AC, 1996, J MED GENET, V33, P940, DOI 10.1136/jmg.33.11.940; NIYIBIZI C, 1989, CONNECT TISSUE RES, V20, P247, DOI 10.3109/03008208909023894; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; RHODES RK, 1978, BIOCHEMISTRY-US, V17, P3442, DOI 10.1021/bi00610a003; Richards AJ, 1998, J MED GENET, V35, P846, DOI 10.1136/jmg.35.10.846; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOFIELD JD, 1974, BIOCHEMISTRY-US, V13, P1801, DOI 10.1021/bi00706a004; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; SOBEL ME, 1978, P NATL ACAD SCI USA, V75, P5846, DOI 10.1073/pnas.75.12.5846; Steinmann Beat, 1993, P351; TAKAHARA K, 1995, GENOMICS, V29, P588, DOI 10.1006/geno.1995.9961; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930	38	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13356	13364		10.1074/jbc.M011742200	http://dx.doi.org/10.1074/jbc.M011742200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278977	hybrid			2022-12-27	WOS:000168198600122
J	Cerutti, ML; Centeno, JM; Goldbaum, FA; de Prat-Gay, G				Cerutti, ML; Centeno, JM; Goldbaum, FA; de Prat-Gay, G			Generation of sequence-specific, high affinity anti-DNA antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIABLE GENES; BINDING DOMAIN; MOUSE; RECOGNITION; PROTEINS	By taking advantage of the extreme stability of a protein-DNA complex, we have obtained two highly specific monoclonal antibodies against a predetermined palindromic DNA sequence corresponding to the binding site of the E2 transcriptional regulator of the human papillomavirus (HPV-16), The purified univalent antibody fragments bind to a double-stranded DNA oligonucleotide corresponding to the E2 binding site in solution with dissociation constants in the low and subnanomolar range. This affinity matches that of the natural DNA binding domain and is severalfold higher than the affinity of a homologous bovine E2 C-terminal domain (BPV-1) for the same DNA. These antibodies discriminate effectively among a number of double- and single-stranded synthetic DNAs with factors ranging from 125- to 20,000-fold the dissociation constant of the specific DNA sequence used in the immunogenic protein-DNA complex. Moreover, they are capable of fine specificity tuning, since they both bind less tightly to another HPV-16 E2 binding site, differing in only 1 base pair in a noncontact flexible region. Beyond the relevance of obtaining a specific anti-DNA response, these results provide a first glance at how DNA as an antigen is recognized specifically by an antibody. The accuracy of the spectroscopic method used for the binding analysis suggests that a detailed mechanistic analysis is attainable.	Fdn Campomar, Inst Invest Bioquim, RA-1405 Buenos Aires, DF, Argentina; Univ Buenos Aires, Fac Ciencias Exactas & Nat, RA-1405 Buenos Aires, DF, Argentina	Leloir Institute; University of Buenos Aires	de Prat-Gay, G (corresponding author), Fdn Campomar, Inst Invest Bioquim, Av Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.			Prat Gay, Gonzalo/0000-0001-5748-6863; Goldbaum, Fernando/0000-0001-6235-3002				BARBAS SM, 1994, J AM CHEM SOC, V116, P2161, DOI 10.1021/ja00084a073; Blackburn G.M, 1996, NUCL ACIDS CHEM BIOL; BRANDEN C, 1999, INTRO PROTEIN STRUCT, P299; Dattamajumdar AK, 1996, IMMUNOGENETICS, V43, P141, DOI 10.1007/BF00176675; DEPRATGAY G, 1994, BIOCHEMISTRY-US, V33, P1957; DESJARLAIS JR, 1993, P NATL ACAD SCI USA, V90, P2256, DOI 10.1073/pnas.90.6.2256; Ferreiro DU, 2000, BIOCHEMISTRY-US, V39, P14692, DOI 10.1021/bi001694r; FRIGUET B, 1997, PROTEIN STRUCTURE; Galfre G, 1981, Methods Enzymol, V73, P3; Goldbaum FA, 1999, J IMMUNOL, V162, P6040; GREISMAN HA, 1997, SCIENCE, V275, P357; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; HEINRICH G, 1984, J EXP MED, V159, P417, DOI 10.1084/jem.159.2.417; Krishnan MR, 1996, J IMMUNOL, V157, P2430; LeBlanc JF, 1998, BIOCHEMISTRY-US, V37, P6015, DOI 10.1021/bi9730792; Mauricio L, 1997, J BIOL CHEM, V272, P19295, DOI 10.1074/jbc.272.31.19295; MCBRIDE AA, 1991, J BIOL CHEM, V266, P18411; Mok YK, 1996, NAT STRUCT BIOL, V3, P711, DOI 10.1038/nsb0896-711; Oehler S, 1999, ANAL BIOCHEM, V268, P330, DOI 10.1006/abio.1998.3056; Payelle-Brogard B, 1998, HYBRIDOMA, V17, P289, DOI 10.1089/hyb.1998.17.289; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Rondon IJ, 1997, ANNU REV MICROBIOL, V51, P257, DOI 10.1146/annurev.micro.51.1.257; STOLLAR BD, 1986, CRC CR REV BIOCH MOL, V20, P1, DOI 10.3109/10409238609115899; STOLLAR BD, 1994, FASEB J, V8, P337, DOI 10.1096/fasebj.8.3.7511550; Thiebe R, 1999, EUR J IMMUNOL, V29, P2072, DOI 10.1002/(SICI)1521-4141(199907)29:07&lt;2072::AID-IMMU2072&gt;3.0.CO;2-E; TRAVERS A, 1993, DNA PROTEIN INTERACT, P375	26	23	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12769	12773		10.1074/jbc.M100260200	http://dx.doi.org/10.1074/jbc.M100260200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11279040	Green Published, hybrid			2022-12-27	WOS:000168198600043
J	Will, E; Gallwitz, D				Will, E; Gallwitz, D			Biochemical characterization of Gyp6p, a Ypt/Rab-specific GTPase-activating protein from yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT; FAMILY; GAP; IDENTIFICATION; EXPRESSION; MEMBER; DOMAIN; SITE	Gyp6p from yeast belongs to the GYP family of Ypt/ Rab-specific GTPase-activating proteins, and Ypt6p is its preferred substrate (Strom, M., Vollmer, P., Tan, T. J., and Gallwitz, D. (1993) Nature 361, 736-739). We have investigated the kinetic parameters of Gyp6p/Ypt6p interactions and find that Gyp6p accelerates the intrinsic GTPase activity of Ypt6p (0.0002 min(-1)) by a factor of 5 x 10(6) and that they have a very low affinity for its preferred substrate (K-m = 592 muM). Substitution with alanine of several arginines, which Gyp6p shares with other GYP family members, resulted in significant inhibition of GAP activity. Replacement of arginine-155 with either alanine or lysine abolished its GAP activity, indicating a direct involvement of this strictly conserved arginine in catalysis, Physical interaction of the catalytically inactive Gyp6(R155A) mutant GAP with Ypt6 wild-type and Ypt6 mutant proteins could be demonstrated with the two-hybrid system. Short N-terminal and C-terminal truncations of Gyp6p resulted in a complete loss of GAP activity and Ypt6p binding, showing that in contrast to two other Gyp proteins studied previously, most of the 458 amino acid-long Gyp6p sequence is required to form a three-dimensional structure that allows substrate binding and catalysis.	Max Planck Inst Biophys Chem, Dept Mol Genet, D-37070 Gottingen, Germany	Max Planck Society	Gallwitz, D (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Genet, D-37070 Gottingen, Germany.							Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Albert S, 1999, J BIOL CHEM, V274, P33186, DOI 10.1074/jbc.274.47.33186; Albert S, 2000, BIOL CHEM, V381, P453, DOI 10.1515/BC.2000.059; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Du LL, 1998, J BIOL CHEM, V273, P3253, DOI 10.1074/jbc.273.6.3253; DUGGLEBY RG, 1991, BIOCHIM BIOPHYS ACTA, V1080, P231, DOI 10.1016/0167-4838(91)90007-M; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; HARPER JW, 1993, CELL, V75, P805; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Miller J. H, 1972, EXPT MOL GENETICS; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P243, DOI 10.1016/S0968-0004(97)01073-6; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Sambrook J., 2002, MOL CLONING LAB MANU; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Tsukada M, 1999, MOL BIOL CELL, V10, P63, DOI 10.1091/mbc.10.1.63; VOLLMER P, 1995, METHOD ENZYMOL, V257, P118; Vollmer P, 1999, EUR J BIOCHEM, V260, P284, DOI 10.1046/j.1432-1327.1999.00192.x; WAGNER P, 1992, METHOD ENZYMOL, V219, P369; Will E, 2001, METHOD ENZYMOL, V329, P50	23	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12135	12139		10.1074/jbc.M011451200	http://dx.doi.org/10.1074/jbc.M011451200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278907	Green Published, hybrid			2022-12-27	WOS:000168081800094
J	Caloca, MJ; Wang, HB; Delemos, A; Wang, SM; Kazanietz, MG				Caloca, MJ; Wang, HB; Delemos, A; Wang, SM; Kazanietz, MG			Phorbol esters and related analogs regulate the subcellular localization of beta 2-chimaerin, a non-protein kinase C phorbol ester receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; SITE-DIRECTED MUTAGENESIS; CYSTEINE-RICH REGION; MOLECULAR-DYNAMICS; TUMOR PROMOTERS; INDUCED TRANSLOCATION; LIGAND-BINDING; N-CHIMAERIN; DELTA; DIACYLGLYCEROL	The novel phorbol ester receptor beta2-chimaerin is a Rac-GAP protein possessing a single copy of the C1 domain, a 50-amino acid motif initially identified in protein kinase C (PKC) isozymes that is involved in phorbol ester and diacylglycerol binding. We have previously shown that, like PKCs, beta2-chimaerin binds phorbol esters with high affinity in a phospholipid-dependent manner (Caloca, M. J., Fernandez, M. N,, Lewin, N. E., Ching, D., Modali, R., Blumberg, P. M., and Kazanietz, M. G. (1997) J. Biol. Chem. 272, 26488-26496). In this paper we report that like PKC isozymes, beta2-chimaerin is translocated by phorbol esters from the cytosolic to particulate fraction. Phorbol esters also induce translocation of alpha1 (n)- and beta1-chimaerins, suggesting common regulatory mechanisms for all chimaerin isoforms. The subcellular redistribution of beta2-chimaerin by phorbol esters is entirely dependent on the C1 domain, as revealed by deletional analysis and site-directed mutagenesis. Interestingly, beta2-chimaerin translocates to the Golgi apparatus after phorbol ester treatment, as revealed by co-staining with the Golgi marker BODIPY-TR-ceramide. Structure relationship analysis of translocation using a series of PKC ligands revealed substantial differences between translocation of beta2-chimaerin and PKC alpha. Strikingly, the mezerein analog thymeleatoxin is not able to translocate beta2-chimaerin, although it very efficiently translocates PKC alpha. Phorbol esters also promote the association of beta2-chimaerin with Rac in cells. These data suggest that chimaerins can be positionally regulated by phorbol esters and that each phorbol ester receptor class has distinct pharmacological properties and targeting mechanisms. The identification of selective ligands for each phorbol ester receptor class represents an important step in dissecting their specific cellular functions.	Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Georgetown Univ, Med Ctr, Georgetown Inst Cognit & Computat Sci, Washington, DC 20007 USA	University of Pennsylvania; University of Pennsylvania; Georgetown University	Kazanietz, MG (corresponding author), Univ Penn, Sch Med, Ctr Expt Therapeut, 816 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelo@spirit.gcrc.upenn.edu	Caloca, María-José/K-9357-2014; wang, hongbin/E-5541-2011	Wang, Shaomeng/0000-0002-8782-6950; Caloca, Maria-Jose/0000-0002-1003-2685	NATIONAL CANCER INSTITUTE [R01CA074197] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA74197-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHMED S, 1993, J BIOL CHEM, V268, P10709; Alonso M, 1998, EUR J CELL BIOL, V76, P93, DOI 10.1016/S0171-9335(98)80021-6; ARECES LB, 1994, J BIOL CHEM, V269, P19553; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BLUMBERG PM, 1991, MOL CARCINOGEN, V4, P339, DOI 10.1002/mc.2940040502; Bogi K, 1999, FEBS LETT, V456, P27, DOI 10.1016/S0014-5793(99)00927-8; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Feng X, 1998, J BIOL CHEM, V273, P10755, DOI 10.1074/jbc.273.17.10755; GARRETT MD, 1989, J BIOL CHEM, V264, P10; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; Gordon AS, 1997, MOL PHARMACOL, V52, P554, DOI 10.1124/mol.52.4.554; HALL C, 1993, MOL CELL BIOL, V13, P4986, DOI 10.1128/MCB.13.8.4986; Hurley JH, 1997, PROTEIN SCI, V6, P477; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; Kazanietz MG, 2000, BIOCHEM PHARMACOL, V60, P1417, DOI 10.1016/S0006-2952(00)00470-6; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P10777, DOI 10.1074/jbc.270.18.10777; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; LEHEL C, 1995, P NATL ACAD SCI USA, V92, P1406, DOI 10.1073/pnas.92.5.1406; LEUNG T, 1994, J BIOL CHEM, V269, P12888; LEUNG T, 1993, J BIOL CHEM, V268, P3813; Li LW, 1999, MOL CELL BIOL, V19, P8547; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mochly-Rosen D, 1998, FASEB J, V12, P35; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ohmori S, 1998, MOL CELL BIOL, V18, P5263, DOI 10.1128/MCB.18.9.5263; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; Pak YS, 2000, J PHYS CHEM B, V104, P354, DOI 10.1021/jp993073h; QUEST AFG, 1994, J BIOL CHEM, V269, P2961; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Simon JP, 1996, J CELL BIOL, V135, P355, DOI 10.1083/jcb.135.2.355; Slater SJ, 1998, J BIOL CHEM, V273, P23160, DOI 10.1074/jbc.273.36.23160; Song Y, 1999, MOL BIOL CELL, V10, P1609, DOI 10.1091/mbc.10.5.1609; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; Takahashi M, 2000, J BIOL CHEM, V275, P34592, DOI 10.1074/jbc.M005285200; Wan QJ, 2000, J BIOL CHEM, V275, P12136, DOI 10.1074/jbc.275.16.12136; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Wang SM, 1999, J MED CHEM, V42, P3436, DOI 10.1021/jm990129n; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	52	65	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18303	18312		10.1074/jbc.M011368200	http://dx.doi.org/10.1074/jbc.M011368200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278894	hybrid			2022-12-27	WOS:000168866500093
J	Heron-Milhavet, L; Karas, M; Goldsmith, CM; Baum, BJ; LeRoith, D				Heron-Milhavet, L; Karas, M; Goldsmith, CM; Baum, BJ; LeRoith, D			Insulin-like growth factor-I (IGF-I) receptor activation rescues UV-damaged cells through a p38 signaling pathway - Potential role of the IGF-I receptor in DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PATHWAYS; 4-NITROQUINOLINE 1-OXIDE; INHIBITS APOPTOSIS; PROLIFERATION; TYROSINE; SURVIVAL; STRESS; GENE; PHOSPHORYLATION; TRANSDUCTION	The activated insulin-like growth factor-I receptor (IGF-IR) is implicated in mitogenesis, transformation, and anti-apoptosis. To investigate the role of the IGF-IR in protection from UV-mimetic-induced DNA damage, 4-nitroquinoline N-oxide (4-NQO) was used. In this study we show that the activation of the IGF-IR is capable of rescuing NWTb3 cells overexpressing normal IGF-IRs from 4-NQO-induced DNA damage as demonstrated by cellular proliferation assays, This action was specific for the IGF-IR since cells expressing dominant negative IGF-IRs were not rescued from 4-NQO UV-mimetic treatment. DNA damage induced by 4-NQO in NWTb3 cells was significantly decreased after IGF-IR activation as measured by comet assay, IGF-I was also able to overcome the cell cycle arrest, observed after 4-NQO treatment, thereby enhancing the ability of NWTb3 cells to enter S phase. Interestingly, the p38 mitogen-activated protein kinase pathway was shown to represent the main signaling pathway involved in the TGF-IR-mediated rescue of UV-like damaged cells. The ability of the IGF-IR to induce DNA repair was also demonstrated by infecting NWTb3 cells with W-irradiated adenovirus, Activation of the IGF-IR resulted in enhanced P-galactosidase reporter gene activity demonstrating repair of the damaged DNA, This study indicates a direct role of the IGF system in the rescue of damaged cells via DNA repair.	NIDDK, Sect Cellular & Mol Physiol, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA; NIDCR, Gene Therapy & Therapeut Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	LeRoith, D (corresponding author), NIDDK, Sect Cellular & Mol Physiol, Clin Endocrinol Branch, NIH, Rm 8D12,Bldg 10, Bethesda, MD 20892 USA.	Derek@helix.nih.gov	Heron-Milhavet, Lisa/O-4339-2017	Heron-Milhavet, Lisa/0000-0002-7099-0850	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000336, ZIADE000336] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Addison CL, 1997, J GEN VIROL, V78, P1653, DOI 10.1099/0022-1317-78-7-1653; BECK KD, 1994, PROG NEUROBIOL, V44, P497, DOI 10.1016/0301-0082(94)90009-4; BENNETT CB, 1988, MUTAGENESIS, V3, P157, DOI 10.1093/mutage/3.2.157; BLAKESLEY VA, 1995, J BIOL CHEM, V270, P2764, DOI 10.1074/jbc.270.6.2764; Blakesley VA, 1998, J BIOL CHEM, V273, P18411, DOI 10.1074/jbc.273.29.18411; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; Delporte C, 1998, BIOCHEM BIOPH RES CO, V246, P584, DOI 10.1006/bbrc.1998.8668; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Heck S, 1999, J BIOL CHEM, V274, P9828, DOI 10.1074/jbc.274.14.9828; KATO H, 1993, J BIOL CHEM, V268, P2655; KIYOHARA C, 1991, MUTAT RES, V249, P111, DOI 10.1016/0027-5107(91)90137-D; Kuhn C, 1999, INT J CANCER, V80, P431, DOI 10.1002/(SICI)1097-0215(19990129)80:3<431::AID-IJC16>3.3.CO;2-X; Kulik G, 1998, MOL CELL BIOL, V18, P6711, DOI 10.1128/MCB.18.11.6711; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; McKay BC, 1997, PHOTOCHEM PHOTOBIOL, V66, P659, DOI 10.1111/j.1751-1097.1997.tb03203.x; McKay BC, 1996, MUTAT RES-DNA REPAIR, V363, P125, DOI 10.1016/0921-8777(96)00013-4; MIRZAYANS R, 1989, CANCER RES, V49, P5523; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Okajima Y, 1998, J BIOL CHEM, V273, P22877, DOI 10.1074/jbc.273.36.22877; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Parrizas M, 1997, J BIOL CHEM, V272, P154; Pugazhenthi S, 1999, J BIOL CHEM, V274, P2829, DOI 10.1074/jbc.274.5.2829; Qu BH, 1999, J BIOL CHEM, V274, P31179, DOI 10.1074/jbc.274.44.31179; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rausch O, 1999, J BIOL CHEM, V274, P4096, DOI 10.1074/jbc.274.7.4096; RODRIGUEZTARDUCHY G, 1992, J IMMUNOL, V149, P535; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Scrimgeour AG, 1997, ENDOCRINOLOGY, V138, P2552, DOI 10.1210/en.138.6.2552; SELL C, 1995, CANCER RES, V55, P303; SNYDERWINE EG, 1992, CANCER RES, V52, P4183; TADA M, 1975, NATURE, V255, P510, DOI 10.1038/255510a0; Valentinis, 1997, BIOCHIM BIOPHYS ACTA, V1332, P105; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	37	75	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18185	18192		10.1074/jbc.M011490200	http://dx.doi.org/10.1074/jbc.M011490200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278917	hybrid			2022-12-27	WOS:000168866500077
J	Xie, RL; van Wijnen, AJ; van der Meijden, C; Luong, MX; Stein, JL; Stein, GS				Xie, RL; van Wijnen, AJ; van der Meijden, C; Luong, MX; Stein, JL; Stein, GS			The cell cycle control element of histone H4 gene transcription is maximally responsive to interferon regulatory factor pairs IRF-1/IRF-3 and IRF-1/IRF-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE BINDING-PROTEIN; VIRUS-INFECTION; FACTOR IRF-2; FACTOR-II; IN-VIVO; HINF-D; POSITIVE FEEDBACK; DNA INTERACTIONS; INDUCIBLE GENES; G1/S PHASE	Interferon regulatory factors (IRFs) are transcriptional mediators of interferon-responsive signaling pathways that are involved in antiviral defense, immune response, and hell growth regulation. To investigate the role of IRF proteins in the regulation of histone H4 gene transcription, we compared the transcriptional contributions of IRF-1, IRF-2, IRF-3, and IRF-7 using transient transfection assays with H4 promoter/luciferase (Luc) reporter genes. These IRF proteins up-regulate reporter gene expression but IRF-1, IRF-3, and IRF-7 are more potent activators of the H4 promoter than IRF-2. Forced expression of different IRF combinations reveals that IRF-2 reduces IRF-1 or IRF-3 dependent activation, but does not affect IRF-7 function. Thus, IRF-2 may have a dual function in histone H4 gene transcription by acting as a weak activator at low dosage and a competitive inhibitor of other strongly activating IRFs at high levels. IRF-1/IRF-3 and IRF-1/IRF-7 pairs each mediate the highest levels of site II-dependent promoter activity and can up-regulate transcription by 120-150-fold. We also find that interferon gamma up-regulates IRF-1 and site II-dependent promoter activity. This upregulation is not observed when the IRF site is mutated or if cells are preloaded with IRF-1. Our results indicate that IRF-1, IRF-2, IRF-3, and IRF-7 can all regulate histone H4 gene expression. The pairwise utilization of distinct IRF factors provides a flexible transcriptional mechanism for integration of diverse growth-related signaling pathways.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Stein, GS (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 55 Lake Ave N, Worcester, MA 01655 USA.		van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946	NIDDK NIH HHS [DK50222] Funding Source: Medline; NIGMS NIH HHS [GM32010] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK050222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032010] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Aziz F, 1998, J CELL PHYSIOL, V177, P453, DOI 10.1002/(SICI)1097-4652(199812)177:3<453::AID-JCP8>3.0.CO;2-F; Aziz F, 1998, MOL BIOL REP, V25, P1, DOI 10.1023/A:1006888731301; BALKWILL F, 1978, NATURE, V274, P798, DOI 10.1038/274798a0; Behre G, 1999, BIOTECHNIQUES, V26, P24, DOI 10.2144/99261bm03; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Coccia EM, 1999, ONCOGENE, V18, P2129, DOI 10.1038/sj.onc.1202536; Coughlin CM, 1998, IMMUNITY, V9, P25, DOI 10.1016/S1074-7613(00)80585-3; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HISCOTT J, 1995, SEMIN VIROL, V6, P161, DOI 10.1006/smvy.1995.0021; Jesse TL, 1998, J CELL BIOL, V140, P1265, DOI 10.1083/jcb.140.5.1265; Kano A, 1999, BIOCHEM BIOPH RES CO, V257, P672, DOI 10.1006/bbrc.1999.0276; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kirchhoff S, 1998, BIOCHIMIE, V80, P659, DOI 10.1016/S0300-9084(99)80019-4; KROEGER P, 1987, P NATL ACAD SCI USA, V84, P3982, DOI 10.1073/pnas.84.12.3982; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Manzella L, 2000, EXP CELL RES, V256, P248, DOI 10.1006/excr.1999.4794; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Masumi A, 1999, MOL CELL BIOL, V19, P1810; Meraro D, 1999, J IMMUNOL, V163, P6468; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Navarro L, 1998, MOL CELL BIOL, V18, P3796, DOI 10.1128/MCB.18.7.3796; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Nonkwelo C, 1997, J VIROL, V71, P6887, DOI 10.1128/JVI.71.9.6887-6897.1997; NOVELLI F, 1994, J IMMUNOL, V152, P496; PALOMBELLA VJ, 1992, MOL CELL BIOL, V12, P3325, DOI 10.1128/MCB.12.8.3325; PAULI U, 1987, SCIENCE, V236, P1308, DOI 10.1126/science.3035717; PINE R, 1992, J VIROL, V66, P4470, DOI 10.1128/JVI.66.7.4470-4478.1992; RAMSEYEWING A, 1994, P NATL ACAD SCI USA, V91, P4475, DOI 10.1073/pnas.91.10.4475; Salkowski CA, 1999, J IMMUNOL, V163, P1529; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schaefer BC, 1997, MOL CELL BIOL, V17, P873, DOI 10.1128/MCB.17.2.873; Sharf R, 1997, J BIOL CHEM, V272, P9785; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shiffman D, 1996, J BIOL CHEM, V271, P12199, DOI 10.1074/jbc.271.21.12199; SIERRA F, 1983, NUCLEIC ACIDS RES, V11, P7069, DOI 10.1093/nar/11.20.7069; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stein GS, 1996, CELL BIOL INT, V20, P41, DOI 10.1006/cbir.1996.0007; Stein GS, 1984, HISTONE GENES; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; TANAKA H, 1994, P NATL ACAD SCI USA, V91, P7995, DOI 10.1073/pnas.91.17.7995; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; TANIGUCHI T, 1995, J CANCER RES CLIN, V121, P516, DOI 10.1007/BF01197763; Taniguchi T, 1997, BBA-REV CANCER, V1333, pM9, DOI 10.1016/S0304-419X(97)00014-0; van der Meijden CMJ, 1998, BBA-GENE STRUCT EXPR, V1442, P82, DOI 10.1016/S0167-4781(98)00147-X; VANWIJNEN AJ, 1992, MOL CELL BIOL, V12, P3273, DOI 10.1128/MCB.12.7.3273; VANWIJNEN AJ, 1991, J CELL BIOCHEM, V46, P174, DOI 10.1002/jcb.240460211; VAUGHAN PS, 1995, NATURE, V377, P362, DOI 10.1038/377362a0; Vaughan PS, 1997, J MOL MED-JMM, V75, P348, DOI 10.1007/s001090050120; Vaughan PS, 1998, J BIOL CHEM, V273, P194, DOI 10.1074/jbc.273.1.194; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Xi HK, 1999, ONCOGENE, V18, P5889, DOI 10.1038/sj.onc.1202969; YAMAMOTO H, 1994, ONCOGENE, V9, P1423; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang LW, 1999, MOL CELL BIOL, V19, P3216	68	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18624	18632		10.1074/jbc.M010391200	http://dx.doi.org/10.1074/jbc.M010391200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278666	hybrid			2022-12-27	WOS:000168866500133
J	Chang, PS; Li, L; McAnally, J; Olson, EN				Chang, PS; Li, L; McAnally, J; Olson, EN			Muscle specificity encoded by specific serum response factor-binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ACTIN GENE; SMOOTH-MUSCLE; C-FOS; PROMOTER ELEMENTS; TRANSCRIPTIONAL ACTIVATION; HOMEODOMAIN PROTEINS; TRANSGENIC MICE; XENOPUS EMBRYOS; FACTOR P62TCF; IN-VIVO	Serum response factor (SRF) is a MADS box transcription factor that regulates muscle-specific and growth factor-inducible genes by binding the consensus sequence CC(A/T)(6)GG, known as a CArG box. Because SRF expression is not restricted solely to muscle, its expression alone cannot account for the muscle specificity of some of its target genes. To understand further the role of SRF in muscle-specific transcription, we created transgenic mice harboring lacZ transgenes linked to tandem copies of different CArG boxes with flanking sequences. CArG boxes from the SM22 and skeletal cy-actin promoters directed highly restricted expression in developing smooth, cardiac, and skeletal muscle cells during early embryogenesis, In contrast, the CArG boar and flanking sequences from the c-fos promoter directed expression throughout the embryo, with no preference for muscle cells. Systematic swapping of the core and flanking sequences of the SM22 and c-fos CArG boxes revealed that cell type specificity was dictated in large part by sequences immediately flanking the CArG box core. Sequences that directed widespread embryonic expression bound SRF more strongly than those that directed muscle-restricted expression. We conclude that sequence variations among CArG boxes influence cell type specificity of expression and account, at least in part, for the ability of SRF to distinguish between growth factor-inducible and muscle-specific genes in vivo.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Wayne State Univ, Detroit, MI 48201 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Wayne State University	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	eolson@hamon.swmed.edu						Belaguli NS, 1999, MOL CELL BIOL, V19, P4582; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; BERGSMA DJ, 1986, MOL CELL BIOL, V6, P2462, DOI 10.1128/MCB.6.7.2462; BLANK RS, 1992, J BIOL CHEM, V267, P984; BOXER LM, 1989, MOL CELL BIOL, V9, P515, DOI 10.1128/MCB.9.2.515; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; Camoretti-Mercado B, 2000, J BIOL CHEM, V275, P30387, DOI 10.1074/jbc.M000840200; Chen CY, 1996, MOL CELL BIOL, V16, P6372; CHENG TC, 1992, J CELL BIOL, V119, P1649, DOI 10.1083/jcb.119.6.1649; CHOW KL, 1990, MOL CELL BIOL, V10, P528, DOI 10.1128/MCB.10.2.528; Croissant JD, 1996, DEV BIOL, V177, P250, DOI 10.1006/dbio.1996.0160; CSERJESI P, 1992, DEVELOPMENT, V115, P1087; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GRICHNIK JM, 1988, MOL CELL BIOL, V8, P4587, DOI 10.1128/MCB.8.11.4587; GRICHNIK JM, 1987, TRANSCRIPTIONAL CONT, P57; Groisman R, 1996, J BIOL CHEM, V271, P5258; GRUENEBERG DA, 1995, MOL CELL BIOL, V15, P3318; GRUENEBERG DA, 1992, SCIENCE, V257, P1089, DOI 10.1126/science.257.5073.1089; Hautmann MB, 1998, J BIOL CHEM, V273, P8398, DOI 10.1074/jbc.273.14.8398; Hautmann MB, 1997, CIRC RES, V81, P600, DOI 10.1161/01.RES.81.4.600; Herring BP, 1997, AM J PHYSIOL-CELL PH, V272, pC1394, DOI 10.1152/ajpcell.1997.272.4.C1394; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; KATOH Y, 1994, J BIOL CHEM, V269, P30538; Kemp PR, 2000, BIOCHEM J, V345, P445, DOI 10.1042/0264-6021:3450445; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; KOTHARY R, 1989, DEVELOPMENT, V105, P707; LEE TC, 1991, MOL CELL BIOL, V11, P5090, DOI 10.1128/MCB.11.10.5090; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; LYONS GE, 1991, DEVELOPMENT, V111, P451; Mack CP, 1999, CIRC RES, V84, P852; MANAK JR, 1991, MOL CELL BIOL, V11, P3652, DOI 10.1128/MCB.11.7.3652; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; MIWA T, 1987, MOL CELL BIOL, V7, P2803, DOI 10.1128/MCB.7.8.2803; MOHUN TJ, 1989, EMBO J, V8, P1153, DOI 10.1002/j.1460-2075.1989.tb03486.x; MOLLER W, 1994, BIOTECH HISTOCHEM, V69, P289, DOI 10.3109/10520299409106304; MORRIS CHT, 1988, NUCLEIC ACIDS RES, V16, P8835, DOI 10.1093/nar/16.18.8835; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Obata H, 1997, J BIOL CHEM, V272, P26643, DOI 10.1074/jbc.272.42.26643; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; RUZICKA DL, 1988, J CELL BIOL, V107, P2575, DOI 10.1083/jcb.107.6.2575; SANTORO IM, 1991, MOL CELL BIOL, V11, P6296, DOI 10.1128/MCB.11.12.6296; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Spencer JA, 1999, J BIOL CHEM, V274, P15686, DOI 10.1074/jbc.274.22.15686; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; TAKAHASHI K, 1991, J BIOL CHEM, V266, P13284; TAYLOR M, 1989, DEVELOPMENT, V106, P67; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; TUIL D, 1990, J MOL BIOL, V213, P677, DOI 10.1016/S0022-2836(05)80255-4; Vogel AM, 1999, MECH DEVELOP, V81, P217, DOI 10.1016/S0925-4773(98)00245-7; WALSH K, 1989, MOL CELL BIOL, V9, P2191, DOI 10.1128/MCB.9.5.2191; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963	56	64	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17206	17212		10.1074/jbc.M010983200	http://dx.doi.org/10.1074/jbc.M010983200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278806	hybrid			2022-12-27	WOS:000168730400081
J	Hishikawa, K; Oemar, BS; Nakaki, T				Hishikawa, K; Oemar, BS; Nakaki, T			Static pressure regulates connective tissue growth factor expression in human mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; VASCULAR ENDOTHELIAL-CELLS; STIMULATES SUPEROXIDE PRODUCTION; FACTOR INDUCES APOPTOSIS; RENAL FIBROSIS; FACTOR GENE; KAPPA-B; GLOMERULOSCLEROSIS; OVEREXPRESSION; PROLIFERATION	Connective tissue growth factor (CTGF) is overexpressed in a variety of fibrotic disorders such as renal fibrosis and atherosclerosis. Fibrosis is a common final pathway of renal diseases of diverse etiology, including inflammation, hemodynamics, and metabolic injury, Mechanical strains such as stretch, shear stress,and static pressure are possible regulatory elements in CTGF expression. In this study, we examined the ability of static pressure to modulate CTGF gene expression in cultured human mesangial cells. Low static pressure (40-80 mm Hg) stimulated cell proliferation via a protein kinase C-dependent pathway. In contrast, high static pressure (100-180 mm Hg) induced apoptosis in human mesangial cells. This effect was reversed by treatment with CTGF antisense oligonucleotide but not with transforming growth factor pi-neutralizing antibody or protein kinase C inhibitor. High static pressure not only up-regulated the expression of CTGF, but also the expression of extracellular matrix proteins (collagen I and TV, laminin), This up-regulation of extracellular matrix proteins was also reversed by treatment with CTGF antisense oligonucleotide. As judged by mRNA expression of a total of 1100 genes, including apoptoisis-associated genes using DNA microarray techniques, recombinant CTGF protein induced apoptosis by down-regulation of a number of anti-apoptotic genes. Overexpression of CTGF in mesangial cells by transient transfection had similar effects. Taken together, these results suggest that high blood pressure up-regulates CTG;F expression in mesangial cells. High levels of CTGF in turn enhance extracellular matrix production and induce apoptosis in mesangial cells, and may contribute to remodeling of mesangium and ultimately glomerulosclerosis.	Teikyo Univ, Sch Med, Dept Pharmacol, Itabashi Ku, Tokyo 1738605, Japan; Centocor Inc, Malvern, PA 19355 USA	Teikyo University; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Hishikawa, K (corresponding author), Teikyo Univ, Sch Med, Dept Pharmacol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	hisikawa@med.teikyo-u.ac.jp	Hishikawa, Keiichi/A-8661-2011; Nakaki, Toshio/C-4832-2009	Oemar, Barry/0000-0003-1996-5817				Amemiya T, 1999, KIDNEY INT, V56, P2055, DOI 10.1046/j.1523-1755.1999.00796.x; ANDO J, 1991, BIOCHEM BIOPH RES CO, V179, P1192, DOI 10.1016/0006-291X(91)91698-C; AWOLESI MA, 1995, J CLIN INVEST, V96, P1449, DOI 10.1172/JCI118181; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; DAVIS MJ, 1992, AM J PHYSIOL, V263, pH1292, DOI 10.1152/ajpheart.1992.263.4.H1292; Fan WH, 2000, BIOCHEM BIOPH RES CO, V275, P312, DOI 10.1006/bbrc.2000.3314; Fogo AB, 2000, KIDNEY INT, V57, pS15, DOI 10.1046/j.1523-1755.2000.07505.x; Frazier KS, 2000, VET PATHOL, V37, P328, DOI 10.1354/vp.37-4-328; Goldschmeding R, 2000, NEPHROL DIAL TRANSPL, V15, P296, DOI 10.1093/ndt/15.3.296; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Gupta S, 2000, KIDNEY INT, V58, P1389, DOI 10.1046/j.1523-1755.2000.00301.x; Hahn A, 2000, J BIOL CHEM, V275, P37429, DOI 10.1074/jbc.M000976200; Hirahashi J, 2000, KIDNEY INT, V57, P959, DOI 10.1046/j.1523-1755.2000.00924.x; Hishikawa K, 1999, CIRCULATION, V100, P2108, DOI 10.1161/01.CIR.100.20.2108; HISHIKAWA K, 1992, EUR J PHARMACOL, V215, P329, DOI 10.1016/0014-2999(92)90051-5; HISHIKAWA K, 1994, J CLIN INVEST, V93, P1975, DOI 10.1172/JCI117189; Hishikawa K, 2000, EUR J PHARMACOL, V392, P19, DOI 10.1016/S0014-2999(00)00115-1; HISHIKAWA K, 1995, HYPERTENSION, V25, P449, DOI 10.1161/01.HYP.25.3.449; Hishikawa K, 1997, CIRC RES, V81, P797; Hishikawa K, 1999, J BIOL CHEM, V274, P37461, DOI 10.1074/jbc.274.52.37461; Hishikawa K, 1997, CIRCULATION, V96, P3610; HISHIKAWA K, 1992, J CARDIOVASC PHARM, V20, pS66, DOI 10.1097/00005344-199204002-00020; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Kawata Y, 1998, BBA-MOL CELL RES, V1401, P195, DOI 10.1016/S0167-4889(97)00112-2; Kubota S, 2000, FEBS LETT, V474, P58, DOI 10.1016/S0014-5793(00)01573-8; KULIK TJ, 1991, BIOCHEM BIOPH RES CO, V180, P982, DOI 10.1016/S0006-291X(05)81162-3; Marcantoni C, 2000, KIDNEY INT, V57, pS44, DOI 10.1046/j.1523-1755.2000.07508.x; Murphy M, 1999, J BIOL CHEM, V274, P5830, DOI 10.1074/jbc.274.9.5830; Oemar BS, 1997, ARTERIOSCL THROM VAS, V17, P1483, DOI 10.1161/01.ATV.17.8.1483; Oemar BS, 1997, CIRCULATION, V95, P831; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Shakunaga T, 2000, CANCER, V89, P1466, DOI 10.1002/1097-0142(20001001)89:7<1466::AID-CNCR8>3.0.CO;2-G; Shimo T, 1998, J BIOCHEM-TOKYO, V124, P130, DOI 10.1093/oxfordjournals.jbchem.a022071; SUMPIO BE, 1994, J CELL PHYSIOL, V158, P133, DOI 10.1002/jcp.1041580117; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200	35	94	125	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16797	16803		10.1074/jbc.M010722200	http://dx.doi.org/10.1074/jbc.M010722200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278731	hybrid			2022-12-27	WOS:000168730400028
J	Slack, DN; Seternes, OM; Gabrielsen, M; Keyse, SM				Slack, DN; Seternes, OM; Gabrielsen, M; Keyse, SM			Distinct binding determinants for ERK2/p38 alpha and JNK MAP kinases mediate catalytic activation and substrate selectivity of MAP kinase phosphatase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; DUAL-SPECIFICITY PHOSPHATASE; C-TERMINAL DOMAIN; IN-VIVO; CONDITIONAL EXPRESSION; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; SAP KINASES; HEAT-SHOCK; STRESS	Mitogen-activated protein (MAP) kinase phosphatase 1 (MKP-1/CL100) is an inducible nuclear dual specificity protein phosphatase that can dephosphorylate and inactivate both mitogen- and stress-activated protein kinases in vitro and in vivo, However, the molecular mechanism responsible for the substrate selectivity of MKP-1 is unknown, In addition, it has been suggested that the signal transducers and activators of transcription 1 (STAT1) transcription factor is a physiological non-MAP kinase substrate for MKP-1, We have used the yeast two-hybrid assay to demonstrate that MKP-1 is able to interact selectively with the extracellular signal-regulated kinase 1/2 (ERK1/2), p38 alpha, and c-Jun NH2-terminal kinase (JNK) MAP kinase isoforms, Furthermore, this binding is accompanied by catalytic activation of recombinant MKP-1 protein in vitro, and these end points show an absolute correlation with MKP-1 substrate selectivity in vivo. In contrast, MKP-1 does not interact with STAT1, Recombinant STAT1 does not cause catalytic activation of MKP-1; nor does MKP-1 block tyrosine phosphorylation of STAT1 in vivo. Both binding and catalytic activation of MKP-1 are abrogated by mutation of a conserved docking site in ERK2, p38 alpha, and JNK1 MAP kinases, Within MKP-1, MAP kinase binding is mediated by the amino-terminal noncatalytic domain of the protein. However, mutation of a conserved cluster of positively charged residues within this domain abolishes the binding and activation of MKP-1 by ERK2 and p38 alpha but not JNK1, indicating that there are distinct binding determinants for these MAP kinase isoforms, We conclude that the substrate selectivity of MKP-1 is determined by specific protein-protein interactions coupled with catalytic activation of the phosphatase and that these interactions are restricted to members of the MAP kinase family of enzymes.	Ninewells Hosp, Imperial Canc Res Fund, Mol Pharmacol Unit, Ctr Biomed Res, Dundee DD1 9SY, Scotland	University of Dundee	Keyse, SM (corresponding author), Ninewells Hosp, Imperial Canc Res Fund, Mol Pharmacol Unit, Ctr Biomed Res, Level 5, Dundee DD1 9SY, Scotland.		Keyse, Stephen M./B-9575-2009; Seternes, Ole Morten/M-9520-2019	Keyse, Stephen M./0000-0002-5150-8221; Seternes, Ole Morten/0000-0001-8537-3612; Gabrielsen, Mads/0000-0002-9848-2276				Abe MK, 1999, MOL CELL BIOL, V19, P1301; ALESSI DR, 1993, ONCOGENE, V8, P2015; BOTT CM, 1994, FEBS LETT, V352, P201, DOI 10.1016/0014-5793(94)00958-9; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Dowd S, 1998, J CELL SCI, V111, P3389; Ducret C, 2000, ONCOGENE, V19, P5063, DOI 10.1038/sj.onc.1203892; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; GUAN KL, 1995, J BIOL CHEM, V270, P7179; Hutter D, 2000, BIOCHEM J, V352, P155, DOI 10.1042/0264-6021:3520155; ISHIBASHI T, 1994, J BIOL CHEM, V269, P29897; Johnson TR, 2000, J BIOL CHEM, V275, P31755, DOI 10.1074/jbc.M004182200; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; KEYSE SM, 1993, TRENDS BIOCHEM SCI, V18, P377, DOI 10.1016/0968-0004(93)90092-2; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; King AG, 1995, ONCOGENE, V11, P2553; KWAK SP, 1994, J BIOL CHEM, V269, P3596; KWAK SP, 1995, J BIOL CHEM, V270, P1156, DOI 10.1074/jbc.270.3.1156; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; MARTELL KJ, 1995, J NEUROCHEM, V65, P1823; Mertens S, 1996, FEBS LETT, V383, P273, DOI 10.1016/0014-5793(96)00255-4; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; Muda M, 1997, J BIOL CHEM, V272, P5141, DOI 10.1074/jbc.272.8.5141; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Shin DY, 1997, ONCOGENE, V14, P2633, DOI 10.1038/sj.onc.1201106; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Theodosiou AM, 1996, HUM MOL GENET, V5, P675, DOI 10.1093/hmg/5.5.675; Venema RC, 1998, J BIOL CHEM, V273, P30795, DOI 10.1074/jbc.273.46.30795; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Zhan XL, 1999, GENE DEV, V13, P2811, DOI 10.1101/gad.13.21.2811; ZHENG CF, 1993, J BIOL CHEM, V268, P16116; Zhou B, 2001, J BIOL CHEM, V276, P6506, DOI 10.1074/jbc.M009753200; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	51	224	233	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16491	16500		10.1074/jbc.M010966200	http://dx.doi.org/10.1074/jbc.M010966200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278799	hybrid			2022-12-27	WOS:000168623100123
J	Goda, T; Funakoshi, M; Suhara, H; Nishimoto, T; Kobayashi, H				Goda, T; Funakoshi, M; Suhara, H; Nishimoto, T; Kobayashi, H			The N-terminal helix of Xenopus cyclins A and B contributes to binding specificity of the cyclin-CDK complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; RETINOBLASTOMA PROTEIN; KINASE ACTIVATION; DEPENDENT KINASES; CRYSTAL-STRUCTURE; A-TYPE; PHOSPHORYLATION; IDENTIFICATION; LOCALIZATION; DESTRUCTION	Mitotic cyclins A and B contain a conserved N-terminal helix upstream of the cyclin box fold that contributes to a significant interface between cyclin and cyclin-dependent kinase (CDK). To address its contribution on cyclin-CDK interaction, we have constructed mutants in conserved residues of the N-terminal helix of Xenopus cyclins B2 and A1. The mutants showed altered binding affinities to Cdc2 and/or Cdk2, We also screened for mutations in the C-terminal lobe of CDK that exhibited different binding affinities for the cyclin-CDK complex. These mutations were at residues that interact with the cyclin N-terminal helix motif. The cyclin N-terminal helix mutations have a significant effect on the interaction between the cyclin-CDK complex and specific substrates, Xenopus Cdc6 and Cdc25C, These results suggest that the N-terminal helix of mitotic cyclins is required for specific interactions with CDKs and that to interact with CDK, specific substrates Cdc6 and Cdc25C require the CDK to be associated with a cyclin, The interaction between the cyclin N-terminal helix and the CDK C-terminal lobe may contribute to binding specificity of the cyclin-CDK complex.	Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan	Kyushu University	Kobayashi, H (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan.							Andersen G, 1997, EMBO J, V16, P958, DOI 10.1093/emboj/16.5.958; BROWN NR, 1995, STRUCTURE, V3, P1235, DOI 10.1016/S0969-2126(01)00259-3; CLARKE PR, 1992, EMBO J, V11, P1751, DOI 10.1002/j.1460-2075.1992.tb05227.x; Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; DYNLACHT BD, 1994, GENE DEV, V8, P1772, DOI 10.1101/gad.8.15.1772; Endicott JA, 1999, CURR OPIN STRUC BIOL, V9, P738, DOI 10.1016/S0959-440X(99)00038-X; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Fan JS, 1998, BIOCHEM BIOPH RES CO, V253, P621, DOI 10.1006/bbrc.1998.9828; Funakoshi M, 1999, EMBO J, V18, P5009, DOI 10.1093/emboj/18.18.5009; Funakoshi M, 1997, GENES CELLS, V2, P329, DOI 10.1046/j.1365-2443.1997.1230320.x; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Holland PM, 1999, CURR BIOL, V9, pR329, DOI 10.1016/S0960-9822(99)80205-X; Horton MR, 1991, DIRECTED MUTAGENESIS, P217; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kelly BL, 1998, P NATL ACAD SCI USA, V95, P2535, DOI 10.1073/pnas.95.5.2535; Kim KK, 1996, NAT STRUCT BIOL, V3, P849, DOI 10.1038/nsb1096-849; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; KOBAYASHI H, 1992, MOL BIOL CELL, V3, P1279, DOI 10.1091/mbc.3.11.1279; KOBAYASHI H, 1991, J CELL BIOL, V114, P755, DOI 10.1083/jcb.114.4.755; KOBAYASHI H, 1994, J BIOL CHEM, V269, P29153; Kong M, 2000, EMBO J, V19, P1378, DOI 10.1093/emboj/19.6.1378; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEES EM, 1993, MOL CELL BIOL, V13, P1194, DOI 10.1128/MCB.13.2.1194; Liu F, 1999, MOL CELL BIOL, V19, P5113; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; Roberts JM, 1999, CELL, V98, P129, DOI 10.1016/S0092-8674(00)81007-7; Romanowski P, 2000, J BIOL CHEM, V275, P4239, DOI 10.1074/jbc.275.6.4239; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Sikder H, 1997, CELL STRUCT FUNCT, V22, P465, DOI 10.1247/csf.22.465; STEWART E, 1994, EMBO J, V13, P584, DOI 10.1002/j.1460-2075.1994.tb06296.x	39	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15415	15422		10.1074/jbc.M011101200	http://dx.doi.org/10.1074/jbc.M011101200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278837	hybrid			2022-12-27	WOS:000168528800117
J	Jiang, LH; Rassendren, F; Spelta, V; Surprenant, A; North, RA				Jiang, LH; Rassendren, F; Spelta, V; Surprenant, A; North, RA			Amino acid residues involved in gating identified in the first membrane-spanning domain of the rat P2X(2) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; STRUCTURAL MOTIF; SUBUNITS; TOPOLOGY; BINDING; SITE	The first hydrophobic segment of the rat P2X(2) receptor extends from residue Leu(29) to Val(51), In the rat P2X(2) receptor, we mutated amino acids in this segment and adjoining flanking regions (Asp(15) through Thr(60)) individually to cysteine and expressed the constructs in human embryonic kidney cells. Whole-cell recordings were used to measure membrane currents evoked by brief (2-s) applications of ATP (0.3-100 muM). Currents were normal except for Y16C, R34C, Y43C, Y55C, and Q56C (no currents but normal membrane expression by immunohistochemistry), Q37C (small currents), and F44C (normal current but increased sensitivity to ATP, as well as cup-methylene-ATP), We used methanethiosulfonates of positive, negative, or no charge to test the accessibility of the substituted cysteines. D15C, P19C, V23C, V24C, G30C, Q37C, F44C, and V48C were strongly inhibited by neutral, membrane-permeant methanethiosulfonates. Only V48C was also inhibited by positively and negatively charged methanethiosulfonates, consistent with an extracellular position; however, accessibility of V48C was increased by channel opening. V48C could disulfide with I328C, as shown by the large increase in ATP-evoked current caused by reducing agents. The results suggest that Val(48) at the outer end of the first hydrophobic segment takes part in the gating movement of channel opening.	Univ Sheffield, Inst Mol Physiol, Sheffield S10 2TN, S Yorkshire, England; Inst Genet Humaine, CNRS, UPR 1142, F-34396 Montpellier, France	University of Sheffield; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	North, RA (corresponding author), Univ Sheffield, Inst Mol Physiol, Alfred Denny Bldg,Western Bank, Sheffield S10 2TN, S Yorkshire, England.		Jiang, Lin-Hua/D-2030-2010; Jiang, Lin-Hua/AAU-1078-2020; Rassendren, Francois/AAA-6190-2021; North, Richard/GQA-6156-2022	Jiang, Lin-Hua/0000-0001-6398-0411; Jiang, Lin-Hua/0000-0001-6398-0411; Rassendren, Francois/0000-0003-3320-2461				Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Egan TM, 1998, J NEUROSCI, V18, P2350; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; KHAKH BS, 1995, J PHYSIOL-LONDON, V484, P385, DOI 10.1113/jphysiol.1995.sp020672; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Nicke A, 1999, PROG BRAIN RES, V120, P61; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 1996, CURR OPIN CELL BIOL, V8, P474, DOI 10.1016/S0955-0674(96)80023-8; North RA, 1996, CIBA F SYMP, V198, P91; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Rettinger J, 2000, J BIOL CHEM, V275, P33542, DOI 10.1074/jbc.M002918200; Stoop R, 1999, MOL PHARMACOL, V56, P973, DOI 10.1124/mol.56.5.973; Torres GE, 1998, FEBS LETT, V425, P19, DOI 10.1016/S0014-5793(98)00179-3	22	100	101	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14902	14908		10.1074/jbc.M011327200	http://dx.doi.org/10.1074/jbc.M011327200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278888	hybrid			2022-12-27	WOS:000168528800052
J	Nyfeler, S; Senn, K; Kempf, C				Nyfeler, S; Senn, K; Kempf, C			Expression of Semliki Forest virus E1 protein in Escherichia coli - Low pH-induced pore formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIKE PROTEIN; MEMBRANE-PERMEABILITY; GLUCOSE-TRANSPORTER; LOCALIZATION SITES; ENVELOPED VIRUSES; CELL-FUSION; ANIMAL-CELL; ALPHAVIRUSES; PENETRATION; CHANNELS	Exposure of Semliki Forest virus 1 to mildly acidic conditions results in conformational changes of the viral spike proteins, which in turn leads to a pore formation across its membrane. The ability to form a pore has been ascribed to the ectodomain of the Semliki Forest virus (SFV) E1 spike protein. To elucidate whether the E1 protein per se is sufficient for low pH-dependent pore formation, we expressed E1 in Escherichia coli in an inducible manner using the pET11c expression system. The data obtained clearly showed that the E1 protein was expressed in the bacterial cell membrane and that exposure of E. coli expressing the SFV E1 protein to low pH (< 6.2) resulted in a permeability change of the membrane. Thus, we conclude that the E1 protein of SFV per se is sufficient to promote pore formation under mildly acidic conditions.	Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; ZLB Bioplasma AG, CH-3000 Bern 22, Switzerland	University of Bern	Kempf, C (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.							Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2; BUHR A, 1994, J BIOL CHEM, V269, P23437; Dick M, 1996, VIROLOGY, V220, P204, DOI 10.1006/viro.1996.0301; GAROFF H, 1982, CURR TOP MICROBIOL, V99, P1; JUSTMAN J, 1993, J VIROL, V67, P7597, DOI 10.1128/JVI.67.12.7597-7607.1993; Kasermann F, 1996, J GEN VIROL, V77, P3025, DOI 10.1099/0022-1317-77-12-3025; KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7; Lama J, 1996, J GEN VIROL, V77, P2109, DOI 10.1099/0022-1317-77-9-2109; Lanz R, 1998, J BIOL CHEM, V273, P12239, DOI 10.1074/jbc.273.20.12239; LANZREIN M, 1994, BIOCHEM J, V302, P313, DOI 10.1042/bj3020313; LANZREIN M, 1992, BIOSCIENCE REP, V12, P221, DOI 10.1007/BF01121792; LANZREIN M, 1993, VIROLOGY, V193, P296, DOI 10.1006/viro.1993.1125; LEVYMINTZ P, 1991, J VIROL, V65, P4292, DOI 10.1128/JVI.65.8.4292-4300.1991; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; LOEWY A, 1995, J VIROL, V69, P469, DOI 10.1128/JVI.69.1.469-475.1995; MARSH M, 1983, CELL, V32, P931, DOI 10.1016/0092-8674(83)90078-8; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nguyen NY, 1996, J INTERF CYTOK RES, V16, P835, DOI 10.1089/jir.1996.16.835; OMAR A, 1988, VIROLOGY, V166, P17, DOI 10.1016/0042-6822(88)90141-9; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Sambrook J., 2002, MOL CLONING LAB MANU; SANZ MA, 1994, J BIOL CHEM, V269, P12106; SCHLEGEL A, 1991, BIOSCIENCE REP, V11, P243, DOI 10.1007/BF01127500; SCHLEGEL A, 1992, NATO ASI SER H, V63, P375; SIMONS K, 1984, ADV PROTEIN CHEM, V36, P79, DOI 10.1016/S0065-3233(08)60296-X; SPYR CA, 1995, FEBS LETT, V375, P134, DOI 10.1016/0014-5793(95)01197-M; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; VAANANEN P, 1980, J GEN VIROL, V46, P467, DOI 10.1099/0022-1317-46-2-467; WAHLBERG JM, 1992, J CELL BIOL, V116, P339, DOI 10.1083/jcb.116.2.339; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273	32	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15453	15457		10.1074/jbc.M011061200	http://dx.doi.org/10.1074/jbc.M011061200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278826	hybrid			2022-12-27	WOS:000168528800122
J	Sun, Y; Wong, MD; Rosen, BP				Sun, Y; Wong, MD; Rosen, BP			Role of cysteinyl residues in sensing Pb(II), Cd(II), and Zn(II) by the plasmid pI258 CadC repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADMIUM RESISTANCE; GENE; SMTB; BINDING; PROTEIN; IDENTIFICATION; POLYMERASE; EXPRESSION; LOCUS	The cadCA operon of Staphylococcus aureus plasmid pI258 confers resistance to salts of the soft metals lead, cadmium, and zinc. The operon is regulated by CadC, a member of the ArsR family of metal-responsive transcriptional repressors. In this study the role of the five cysteine residues of CadC in soft metal ion sensing was investigated, Cys-7, Cys-11, Cys-52, Cys-58, and Cys-60 were changed individually to glycine or serine residues. The effect of the cadC mutations was examined in Escherichia coli using a green fluorescent protein reporter system. None of the mutations affected the ability of CadC to repress gfp expression. Neither Cys-11 nor Cys-52 was required for in vivo response to Pb(II), Zn(II), or Cd(II), Cys-7, Cys-58, or Cys-60 mutations each reduced or eliminated soft metal sensing. Wild-type and mutant CadC proteins were purified, and the effect of the substitutions on DNA binding was determined using a restriction enzyme protection assay. Binding of wild-type CadC protected end operator DNA from digestion at the single SspI site, and the addition of Pb(II), Zn(II), or Cd(II) resulted in deprotection, Chemical modification of the cysteine residues in CadC had no effect on protection but eliminated deprotection, C11G and C52G proteins exhibited wild-type properties in vitro, C7G, C58S, and C60G proteins were able to be protected from SspI digestion but had reduced responses to soft metal ions. The results indicate that Cys-7, Cys-58, and Cys-60 are involved in sensing those soft metals and suggest that they are ligands to Pb(II), Zn(II), and Cd(II).	Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University	Rosen, BP (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield Ave, Detroit, MI 48201 USA.	brosen@med.wayne.edu	Sun, Yan/A-7461-2008	Rosen, Barry P./0000-0002-5230-4271	NIAID NIH HHS [AI45428] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; CORBISIER P, 1993, FEMS MICROBIOL LETT, V110, P231, DOI 10.1111/j.1574-6968.1993.tb06325.x; DELAGRAVE S, 1995, BIO-TECHNOL, V13, P151, DOI 10.1038/nbt0295-151; Gatti D, 2000, J BIOL CHEM, V275, P34009, DOI 10.1074/jbc.R000012200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GUPTA A, 1992, P ROY SOC B-BIOL SCI, V248, P273, DOI 10.1098/rspb.1992.0072; JOACHIMIAK A, 1983, P NATL ACAD SCI-BIOL, V80, P668, DOI 10.1073/pnas.80.3.668; Kar SR, 1997, BIOCHEMISTRY-US, V36, P15343, DOI 10.1021/bi971690v; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewis JC, 1999, ANAL CHEM, V71, P4321, DOI 10.1021/ac990404d; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; POOLE RK, 1989, J GEN MICROBIOL, V135, P1865; Rasmussen B, 2000, NATURE, V405, P676, DOI 10.1038/35015063; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Rensing C, 1998, J BIOL CHEM, V273, P32614, DOI 10.1074/jbc.273.49.32614; Rensing C, 1999, J BACTERIOL, V181, P5891, DOI 10.1128/JB.181.19.5891-5897.1999; Rosen BP, 1999, BBA-BIOMEMBRANES, V1461, P207, DOI 10.1016/S0005-2736(99)00159-5; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHI WP, 1994, J BIOL CHEM, V269, P19826; SMITH DJ, 1975, BIOCHEMISTRY-US, V14, P766, DOI 10.1021/bi00675a019; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tauriainen S, 1998, BIOSENS BIOELECTRON, V13, P931, DOI 10.1016/S0956-5663(98)00027-X; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner JS, 1996, NUCLEIC ACIDS RES, V24, P3714, DOI 10.1093/nar/24.19.3714; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; WU JH, 1993, J BIOL CHEM, V268, P52; Xu C, 1998, J BIOCHEM-TOKYO, V123, P16; Xu C, 1999, METALS AND GENETICS, P5; Xu C, 1997, J BIOL CHEM, V272, P15734, DOI 10.1074/jbc.272.25.15734; YOON KP, 1991, J BACTERIOL, V173, P7636, DOI 10.1128/jb.173.23.7636-7642.1991	34	53	56	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14955	14960		10.1074/jbc.M010595200	http://dx.doi.org/10.1074/jbc.M010595200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278706	hybrid			2022-12-27	WOS:000168528800059
J	Yamamoto, M; Lin, XH; Kominato, Y; Hata, Y; Noda, R; Saitou, N; Yamamoto, F				Yamamoto, M; Lin, XH; Kominato, Y; Hata, Y; Noda, R; Saitou, N; Yamamoto, F			Murine equivalent of the human histo-blood group ABO gene is a cis-AB gene and encodes a glycosyltransferase with both A and B transferase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP SYSTEM; NUCLEOTIDE INSERTION; EXPRESSION CLONING; GROUP ANTIGENS; HUMAN SERUM; CDNA CLONE; O-ALLELE; SEQUENCE; DNA; EVOLUTION	We have cloned murine genomic and complementary DNA that is equivalent to the human ABO gene. The murine gene consists of at least six coding exons and spans at least 11 kilobase pairs. Exon-intron boundaries are similar to those of the human gene. Unlike human A and B genes that encode two distinct glycosyltransferases with different donor nucleotide-sugar specificities, the murine gene is a cis-AB gene that encodes an enzyme with both A and B transferase activities, and this cis-AB gene prevails in the mouse population. Cloning of the murine AB gene may be helpful in establishing a mouse model system to assess the functionality of the ABO genes in the future.	Burnham Inst, La Jolla Canc Res Ctr, La Jolla, CA 92037 USA; Toyama Med & Pharmaceut Univ, Fac Med, Dept Legal Med, Toyama 93001, Japan; Natl Inst Genet, Lab Evolutionary Genet, Mishima, Shizuoka 411, Japan	Sanford Burnham Prebys Medical Discovery Institute; University of Toyama; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Yamamoto, F (corresponding author), Burnham Inst, La Jolla Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	fyamamoto@burnham.org	Yamamoto, Fumiichiro/F-1478-2016; Yamamoto, Miyako/F-1722-2016	Yamamoto, Fumiichiro/0000-0001-9690-7034; Yamamoto, Miyako/0000-0001-9516-1402				ARENDRUP M, 1991, AIDS, V5, P441, DOI 10.1097/00002030-199104000-00014; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; CHANG DW, 1993, GENE, V127, P95, DOI 10.1016/0378-1119(93)90621-9; CLAUSEN H, 1990, J BIOL CHEM, V265, P1139; Costa C, 1999, FASEB J, V13, P1762, DOI 10.1096/fasebj.13.13.1762; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GALILI U, 1985, J EXP MED, V162, P573, DOI 10.1084/jem.162.2.573; Haslam DB, 1996, P NATL ACAD SCI USA, V93, P10697, DOI 10.1073/pnas.93.20.10697; HEIN J, 1990, METHOD ENZYMOL, V183, P626; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; JOZIASSE DH, 1989, J BIOL CHEM, V264, P14290; Kabat EA, 1956, BLOOD GROUP SUBSTANC; Kimura M., 1983, NEUTRAL THEORY MOL E; KOMINATO Y, 1992, BIOCHEM BIOPH RES CO, V189, P154, DOI 10.1016/0006-291X(92)91538-2; LARSEN RD, 1990, J BIOL CHEM, V265, P7055; LARSEN RD, 1989, P NATL ACAD SCI USA, V86, P8227, DOI 10.1073/pnas.86.21.8227; Maniatis T., 1982, MOL CLONING; MARTINKO JM, 1993, IMMUNOGENETICS, V37, P274; Ogasawara K, 1996, BLOOD, V88, P2732, DOI 10.1182/blood.V88.7.2732.bloodjournal8872732; Ogasawara K, 1996, HUM GENET, V97, P777; OhUigin C, 1997, HUM GENET, V101, P141, DOI 10.1007/s004390050603; Olsson ML, 1996, TRANSFUSION, V36, P309, DOI 10.1046/j.1537-2995.1996.36496226142.x; Olsson ML, 1998, TRANSFUSION MED, V8, P231; Olsson ML, 1996, VOX SANG, V71, P113, DOI 10.1046/j.1423-0410.1996.7120113.x; OLSSON ML, 1995, BIOCHEM BIOPH RES CO, V216, P642, DOI 10.1006/bbrc.1995.2670; ORIOL R, 1986, VOX SANG, V51, P161, DOI 10.1111/j.1423-0410.1986.tb01946.x; ORIOL R, 1992, APMIS S, V27, P28; PITTIGLIO DH, 1986, GENETICS BIOCH A B H, P1; Saitou N, 1997, MOL BIOL EVOL, V14, P399, DOI 10.1093/oxfordjournals.molbev.a025776; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanger F, 1992, Biotechnology, V24, P104; STRAHAN KM, 1995, IMMUNOGENETICS, V41, P101, DOI 10.1007/BF00182319; STRAHAN KM, 1995, TRANSPLANT P, V27, P245; Takeuchi Y, 1996, NATURE, V379, P85, DOI 10.1038/379085a0; Tearle RG, 1996, TRANSPLANTATION, V61, P13, DOI 10.1097/00007890-199601150-00004; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; Yamamoto F, 1996, J BIOL CHEM, V271, P10515, DOI 10.1074/jbc.271.18.10515; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; YAMAMOTO F, 1993, VOX SANG, V64, P171, DOI 10.1111/j.1423-0410.1993.tb05157.x; YAMAMOTO F, 1990, J BIOL CHEM, V265, P1146; YAMAMOTO F, 1992, BIOCHEM BIOPH RES CO, V187, P366, DOI 10.1016/S0006-291X(05)81502-5; YAMAMOTO F, 1993, VOX SANG, V64, P175, DOI 10.1111/j.1423-0410.1993.tb05158.x; Yamamoto F, 2000, VOX SANG, V78, P91; YAMAMOTO FI, 1993, VOX SANG, V64, P120, DOI 10.1111/j.1423-0410.1993.tb02529.x; YAMAMOTO FI, 1993, VOX SANG, V64, P116, DOI 10.1111/j.1423-0410.1993.tb02528.x	46	56	59	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13701	13708		10.1074/jbc.M010805200	http://dx.doi.org/10.1074/jbc.M010805200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278752	hybrid			2022-12-27	WOS:000168356600029
J	Yang, CH; Murti, A; Pfeffer, SR; Kim, JG; Donner, DB; Pfeffer, LM				Yang, CH; Murti, A; Pfeffer, SR; Kim, JG; Donner, DB; Pfeffer, LM			Interferon alpha/beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION; CYTOKINE RECEPTORS; INDUCED APOPTOSIS; DOWN-REGULATION; BETA RECEPTOR; GROWTH-FACTOR; DAUDI CELLS; STAT3; EXPRESSION	Interferons (IFNs) play critical roles in host defense by modulating gene expression via activation of signal transducer and activator of transcription (STAT) factors. IFN-alpha/beta also activates another transcription factor, nuclear factor kappaB (NF-kappaB), which protects cells against apoptotic stimuli. NF-kappaB activation requires the IFN-dependent association of STAT3 with the IFNAR1 chain of the IFN receptor. IFN-dependent NF-kappaB activation involves the sequential activation of a serine kinase cascade involving phosphatidylinositol 3-kinase (PI-3K) and Akt. Whereas constitutively active PI-3K and Akt induce NF-kappaB activation, Ly294002 (a PI-3K inhibitor), dominant-negative PI-3K, and kinase-dead Akt block IFN-dependent NF-kappaB activation. Moreover, dominant-negative PI-3K blocks IFN-promoted degradation of kappa Box alpha. Ly294002, a dominant-negative PI-3K construct, and kinase-dead Akt block IFN-promoted cell survival, enhancing apoptotic cell death. Therefore, STAT3, PI-3K, and Akt are components of an IFN signaling pathway that promotes cell survival through NF-kappaB activation.	Univ Tennessee, Ctr Hlth Sci, Dept Pathol, Memphis, TN 38163 USA; Indiana Univ, Sch Med, Walther Oncol Ctr, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	University of Tennessee System; University of Tennessee Health Science Center; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute	Pfeffer, LM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pathol, Memphis, TN 38163 USA.				NCI NIH HHS [CA67891, CA73023, CA73753] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073753, R55CA067891, R01CA067891, R01CA073023] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKAI H, 1989, J BIOL CHEM, V264, P3252; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Blanco FL, 1998, BIOTECHNIQUES, V24, P354, DOI 10.2144/98243bm04; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chen RH, 1999, J BIOL CHEM, V274, P23013, DOI 10.1074/jbc.274.33.23013; COLAMONICI OR, 1994, J BIOL CHEM, V269, P9598; CONSTANTINESCU SN, 1994, P NATL ACAD SCI USA, V91, P9602, DOI 10.1073/pnas.91.20.9602; Cremer I, 1999, VIROLOGY, V253, P241, DOI 10.1006/viro.1998.9470; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DOMANSKI P, 1995, J BIOL CHEM, V270, P21606, DOI 10.1074/jbc.270.37.21606; Einhorn S, 1996, J INTERF CYTOK RES, V16, P275, DOI 10.1089/jir.1996.16.275; FALTYNEK CR, 1989, J BIOL CHEM, V264, P14305; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; FRIEDMAN RL, 1985, NATURE, V314, P637, DOI 10.1038/314637a0; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; IMPROTA T, 1992, J INTERFERON RES, V12, P87, DOI 10.1089/jir.1992.12.87; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; LAMER AC, 1993, SCIENCE, V261, P1730; LARNER AC, 1986, J BIOL CHEM, V261, P453; LUTFALLA G, 1995, EMBO J, V14, P5100, DOI 10.1002/j.1460-2075.1995.tb00192.x; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; MULLERSMAN JE, 1994, TRENDS BIOCHEM SCI, V20, P55; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; OLIVEIRA IC, 1994, MOL CELL BIOL, V14, P5300, DOI 10.1128/MCB.14.8.5300; Ozes ON, 1999, NATURE, V401, P82; PFEFFER LM, 1991, P NATL ACAD SCI USA, V88, P7988, DOI 10.1073/pnas.88.18.7988; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Rani MRS, 1999, J BIOL CHEM, V274, P32507, DOI 10.1074/jbc.274.45.32507; REICH NC, 1990, P NATL ACAD SCI USA, V87, P8761, DOI 10.1073/pnas.87.22.8761; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Sano S, 2000, P NATL ACAD SCI USA, V97, P13824, DOI 10.1073/pnas.240303097; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Takeda K, 1998, J IMMUNOL, V161, P4652; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; VAN AD, 1996, SCIENCE, V274, P787; VANDENBROECKE C, 1988, J INTERFERON RES, V8, P803; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057; Yang CH, 2000, P NATL ACAD SCI USA, V97, P13631, DOI 10.1073/pnas.250477397; Zushi SI, 1998, INT J CANCER, V78, P326, DOI 10.1002/(SICI)1097-0215(19981029)78:3<326::AID-IJC12>3.0.CO;2-4	54	79	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13756	13761		10.1074/jbc.M011006200	http://dx.doi.org/10.1074/jbc.M011006200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278812	hybrid			2022-12-27	WOS:000168356600036
J	Baudry, K; Swain, E; Rahier, A; Germann, M; Batta, A; Rondet, S; Mandala, S; Henry, K; Tint, GS; Edlind, T; Kurtz, M; Nickels, JT				Baudry, K; Swain, E; Rahier, A; Germann, M; Batta, A; Rondet, S; Mandala, S; Henry, K; Tint, GS; Edlind, T; Kurtz, M; Nickels, JT			The effect of the erg26-1 mutation on the regulation of lipid metabolism in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT STEROL BIOSYNTHESIS; PHOSPHOLIPID BIOSYNTHESIS; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDYLINOSITOL SYNTHASE; PARTIAL-PURIFICATION; YEAST; GENE; REDUCTASE; ACID; IDENTIFICATION	A temperature-sensitive Saccharomyces cerevisiae mutant harboring a lesion in the ERG26 gene has been isolated. ERG26 encodes 4 alpha -carboxysterol-C3 dehydrogenase, one of three enzymatic activities required for the conversion of 4,4-dimethylzymosterol to zymosterol. Gas chromatography/mass spectrometry analyses of sterols in this mutant, designated erg26-1, revealed the aberrant accumulation of a 4-methyl-4-carboxy zymosterol intermediate, as well as a novel 4-carboxysterol. Neutral lipid radiolabeling studies showed that erg26-1 cells also harbored defects in the rate of biosynthesis and steady-state levels of mono-, di-, and triglycerides. Phospholipid radiolabeling studies showed defects in the rate of biosynthesis of both phosphatidic acid and phosphatidylinositol. Biochemical studies revealed that microsomes isolated from erg26-1 cells contained greatly reduced 4 alpha -carboxysterol-C3 dehydrogenase activity when compared with microsomes from wild type cells. Previous studies have shown that loss of function mutations in either of the fatty acid elongase genes SUR4/EL03 or FEN1/GNS1/ELO2 can "by-pass" the essentiality of certain ERG genes (Ladeveze, V., Marcireau, C., Delourme, D., and Karat, F. (1993) Lipids 28, 907-912; Silve, S., Leplatois, P., Josse, A., Dupuy, P. H., Lanau, C., Kaghad, M., Dhers, C., Picard, C., Rahier, A, Taton, M., Le Fur, G., Caput, D., Ferrara, P., and Loison, G. (1996) Mol Cell. Biol. 16, 2719-2727). Studies presented here have shown that this sphingolipid-dependent "bypass" mechanism did not suppress the essential requirement for zymosterol biosynthesis. However, studies aimed at understanding the underlying physiology behind the temperature-sensitive growth defect of erg26-1 cells showed that the addition of several antifungal compounds to the growth media of erg26-1 cells could suppress the temperature-sensitive growth defect. Fluorescence microscopic analysis showed that GFP-Erg26p and GFP-Erg27p fusion proteins were localized to the endoplasmic reticulum. Two-hybrid analysis indicated that Erg25p, Erg26p, and Erg27p, which are required for the biosynthesis of zymosterol, form a complex within the cell.	Med Coll Penn & Hahnemann Univ, Dept Biochem, Philadelphia, PA 19129 USA; Med Coll Penn & Hahnemann Univ, Dept Immunol & Microbiol, Philadelphia, PA 19129 USA; Inst Bot, Dept Enzymol Cellulaire & Mol, Strasbourg, France; Univ Med & Dent New Jersey, Dept Vet Affairs, E Orange, NJ 07018 USA; Merck Res Labs, Dept Biochem, Rahway, NJ 07065 USA	Drexel University; Drexel University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Merck & Company	Nickels, JT (corresponding author), 245 N 15th St, Philadelphia, PA 19102 USA.	Joseph.Nickels@drexel.edu						AOYAMA Y, 1987, J BIOL CHEM, V262, P1239; ASHMAN WH, 1991, LIPIDS, V26, P628, DOI 10.1007/BF02536427; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; Bammert GF, 2000, ANTIMICROB AGENTS CH, V44, P1255, DOI 10.1128/AAC.44.5.1255-1265.2000; Bard M, 1996, P NATL ACAD SCI USA, V93, P186, DOI 10.1073/pnas.93.1.186; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; BAUDRY K, UNPUB; BERRY DJ, 1982, BIOCHEMISTRY-US, V21, P573, DOI 10.1021/bi00532a025; BILLHEIMER JT, 1981, ARCH BIOCHEM BIOPHYS, V211, P430, DOI 10.1016/0003-9861(81)90474-4; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BOTTEMA CK, 1978, BIOCHIM BIOPHYS ACTA, V531, P301, DOI 10.1016/0005-2760(78)90212-6; BOUROT S, 1995, GENE, V165, P97, DOI 10.1016/0378-1119(95)00478-O; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; CARMAN GM, 1992, METHOD ENZYMOL, V209, P305; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; Farese RV, 1998, TRENDS GENET, V14, P115, DOI 10.1016/S0168-9525(97)01377-2; FAUST JR, 1988, BIOL CHOLESTEROL, P19; FINE JB, 1982, J LIPID RES, V23, P660; FISCHL AS, 1986, J BIOL CHEM, V261, P3178; FOREMAN PK, 1994, GENE, V144, P63, DOI 10.1016/0378-1119(94)90204-6; FUKUSHIMA H, 1981, J BIOL CHEM, V256, P4822; Gachotte D, 1999, P NATL ACAD SCI USA, V96, P12655, DOI 10.1073/pnas.96.22.12655; Gachotte D, 1998, P NATL ACAD SCI USA, V95, P13794, DOI 10.1073/pnas.95.23.13794; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Illingworth R, 2000, MED CLIN N AM, V84, P23, DOI 10.1016/S0025-7125(05)70205-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Kelly SL, 1997, J BIOL CHEM, V272, P9986, DOI 10.1074/jbc.272.15.9986; KINNEY AJ, 1990, J BACTERIOL, V172, P1133, DOI 10.1128/jb.172.2.1133-1136.1990; LADEVEZE V, 1993, LIPIDS, V28, P907, DOI 10.1007/BF02537499; LAI K, 1995, J BIOL CHEM, V270, P2525, DOI 10.1074/jbc.270.6.2525; Lees N., 1997, BIOCH FUNCTION STERO, P85; LEIDICH SD, 1995, METHOD ENZYMOL, V250, P560; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; LIN YP, 1989, J BIOL CHEM, V264, P8641; LORENZ RT, 1986, J BACTERIOL, V167, P981, DOI 10.1128/jb.167.3.981-985.1986; MANDALA S, COMMUNICATION; MOLZAHN SW, 1972, J GEN MICROBIOL, V72, P339, DOI 10.1099/00221287-72-2-339; MORLOCK KR, 1991, J BIOL CHEM, V266, P3586; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; OSUMI T, 1979, J BIOCHEM-TOKYO, V85, P819; PARKS LW, 1995, LIPIDS, V30, P227, DOI 10.1007/BF02537825; PASCAL S, 1993, J BIOL CHEM, V268, P11639; PASCAL S, 1994, ARCH BIOCHEM BIOPHYS, V312, P260, DOI 10.1006/abbi.1994.1308; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; PLEMENITAS A, 1990, J BIOL CHEM, V265, P17012; RAHIMTULA AD, 1972, J BIOL CHEM, V247, P9; Rondet S, 1999, ARCH BIOCHEM BIOPHYS, V366, P249, DOI 10.1006/abbi.1999.1218; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SHERMAN F, 1982, METHODS YEAST GENETI, P170; SIKORSKI RS, 1989, GENETICS, V122, P19; Silve S, 1996, MOL CELL BIOL, V16, P2719; Szkopinska A, 2000, BIOCHEM BIOPH RES CO, V267, P473, DOI 10.1006/bbrc.1999.1981; WELIHINDA AA, 1994, BBA-BIOMEMBRANES, V1193, P107, DOI 10.1016/0005-2736(94)90339-5; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171; WU WI, 1993, J BIOL CHEM, V268, P13830; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353	63	48	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12702	12711		10.1074/jbc.M100274200	http://dx.doi.org/10.1074/jbc.M100274200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11279045	hybrid			2022-12-27	WOS:000168198600033
J	Mohanty, BK; Bussiere, DE; Sahoo, T; Pai, KS; Meijer, WJJ; Bron, S; Bastia, D				Mohanty, BK; Bussiere, DE; Sahoo, T; Pai, KS; Meijer, WJJ; Bron, S; Bastia, D			Structural and functional analysis of a bipolar replication terminus - Implications for the origin of polarity of fork arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-SPECIFIC TERMINATION; BACILLUS-SUBTILIS CHROMOSOME; DNA-BINDING DOMAIN; ESCHERICHIA-COLI; PROTEIN COMPLEX; EDTA-IRON; CONTRAHELICASE; IDENTIFICATION; HELICASE; TRANSLOCATION	We have delineated the amino acid to nucleotide contacts made by two interacting dimers of the replication terminator protein (RTP) of Bacillus subtilis with a novel naturally occurring bipolar replication terminus by converting RTP to a site-directed chemical nuclease and mapping its cleavage sites on the terminus. The data show a relatively symmetrical arrangement of the amino acid to base contacts, and a comparison of the bipolar contacts with that of a normal unipolar terminus suggests that the DNA-protein contacts play an important determinative role in generating polarity from structurally symmetrical RTP dimers, The amino acid to nucleotide contacts provided distance constraints that enabled us to build a three-dimensional model of the protein-DNA complex. The model is consistent with features of the bipolar Ter RTP complex derived from mutational and cross-linking data. The bipolar terminus arrested Escherichia coli DNA replication and DnaB helicase and T7 RNA polymerase in vitro in both orientations. RTP arrested the unwinding of duplex DNA on the bipolar Ter DNA substrate regardless of the length of the duplex DNA The latter result suggested further that the terminus arrested authentic DNA unwinding by the helicase rather than just translocation of helicase on DNA.	Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA; Chiron Corp, Struct Biol Grp, Dept Biol Chem, Emeryville, CA 94608 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Groningen Biomol Sci & Biotechnol Inst, Dept Genet, Haren, Netherlands	Duke University; Novartis; Baylor College of Medicine; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Groningen	Bastia, D (corresponding author), Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA.	basti002@mc.duke.edu		Meijer, Wilfried/0000-0003-1842-0049				Bastia D, 1996, STRUCTURE, V4, P661, DOI 10.1016/S0969-2126(96)00072-X; Bastia D., 1996, DNA REPLICATION EUKA, P177; BUSSIERE DE, 1995, CELL, V80, P651; Bussiere DE, 1999, MOL MICROBIOL, V31, P1611, DOI 10.1046/j.1365-2958.1999.01287.x; CARRIGAN CM, 1991, J MOL BIOL, V222, P197, DOI 10.1016/0022-2836(91)90206-L; EBRIGHT YW, 1992, BIOCHEMISTRY-US, V31, P10664, DOI 10.1021/bi00159a004; GAUTAM A, 2001, IN PRESS J BIOL CHEM; HIASA H, 1992, J BIOL CHEM, V267, P11379; Kamada K, 1996, NATURE, V383, P598, DOI 10.1038/383598a0; KAUL S, 1994, P NATL ACAD SCI USA, V91, P11143, DOI 10.1073/pnas.91.23.11143; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; Kralicek AV, 1997, NUCLEIC ACIDS RES, V25, P590, DOI 10.1093/nar/25.3.590; LANGLEY DB, 1993, MOL MICROBIOL, V10, P771, DOI 10.1111/j.1365-2958.1993.tb00947.x; LEWIS PJ, 1990, J MOL BIOL, V214, P73, DOI 10.1016/0022-2836(90)90147-E; Manna AC, 1996, CELL, V87, P881, DOI 10.1016/S0092-8674(00)81995-9; MAZZARELLI JM, 1993, BIOCHEMISTRY-US, V32, P2979, DOI 10.1021/bi00063a008; Meijer WJJ, 1996, MOL MICROBIOL, V19, P1295, DOI 10.1111/j.1365-2958.1996.tb02474.x; Mohanty BK, 1998, J BIOL CHEM, V273, P3051, DOI 10.1074/jbc.273.5.3051; Mohanty BK, 1996, EMBO J, V15, P2530, DOI 10.1002/j.1460-2075.1996.tb00610.x; OAKLEY MG, 1990, SCIENCE, V248, P847, DOI 10.1126/science.2111578; Pai KS, 1996, EMBO J, V15, P3164, DOI 10.1002/j.1460-2075.1996.tb00679.x; Pai KS, 1996, P NATL ACAD SCI USA, V93, P10647, DOI 10.1073/pnas.93.20.10647; SAHOO T, 1995, J BIOL CHEM, V270, P29138, DOI 10.1074/jbc.270.49.29138; SAHOO T, 1995, EMBO J, V14, P619, DOI 10.1002/j.1460-2075.1995.tb07038.x; WAHLE E, 1989, J BIOL CHEM, V264, P2469; Wake RG, 1997, STRUCTURE, V5, P1, DOI 10.1016/S0969-2126(97)00160-3; White S.R., COMMUNICATION	27	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13160	13168		10.1074/jbc.M010940200	http://dx.doi.org/10.1074/jbc.M010940200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278792	hybrid			2022-12-27	WOS:000168198600097
J	Miyata, Y; Ikawa, Y; Shibuya, M; Nishida, E				Miyata, Y; Ikawa, Y; Shibuya, M; Nishida, E			Specific association of a set of molecular chaperones including HSP90 and Cdc37 with MOK, a member of the mitogen-activated protein kinase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; 90-KDA STRESS PROTEIN; ROUS-SARCOMA VIRUS; MAP KINASE; SIGNAL-TRANSDUCTION; CELL-CYCLE; BIOCHEMICAL-PROPERTIES; TARGETING SUBUNIT; MAMMALIAN CDC37; CLONING	We have recently identified and cloned a novel member of mitogen-activated protein kinase superfamily protein, MOK (Miyata, Y,, Akashi, M,, and Nishida, E, (1999) Genes Cells 4, 299-309), To address its regulatory mechanisms, we searched for cellular proteins that specifically associate with MOK by co-immunoprecipitation experiments. Several cellular proteins including a major 90-kDa molecular chaperone HSP90 were found associated with MOK, Treatment of cells with geldanamycin, an HSP90-specific inhibitor, rapidly decreased the protein level of MOK, and the decrease was attributed to enhanced degradation of MOK through proteasome-dependent pathways. Our data suggest that the association with HSP90 may regulate intracellular protein stability and solubility of MOK, Experiments with a series of deletion mutants of MOK indicated that the region encompassing the protein kinase catalytic subdomains I-IV is required for HSP90 binding. Closely related protein kinases (male germ cell-associated kinase and male germ cell-associated kinase-related kinase) were also found to associate with HSP90, whereas conventional mitogen-activated protein kinases (extracellular signal-regulated kinase, p38, and c-Jun N-terminal kinase/ stress-activated protein kinase) were not associated with HSP90. In addition, we found that other molecular chaperones including Cdc37, HSC70, HSP70, and HSP60 but not GRP94, FKBP52, or Hop were detected specifically in the MOK-HSP90 immunocomplexes. These results taken together suggest a role of at specific set of molecular chaperones in the stability of signal-transducing protein kinases.	Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; Tokyo Med & Dent Univ, Dept Retroviral Regulat, Bunkyo Ku, Tokyo 1138519, Japan; Univ Tokyo, Inst Med Sci, Dept Genet, Minato Ku, Tokyo 1088639, Japan	Kyoto University; Tokyo Medical & Dental University (TMDU); University of Tokyo	Miyata, Y (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.		Miyata, Y/X-7111-2019					Abe MK, 1999, MOL CELL BIOL, V19, P1301; Abe S, 1995, ONCOGENE, V11, P2187; Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; BRUGGE JS, 1981, CELL, V25, P363, DOI 10.1016/0092-8674(81)90055-6; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Caplan AJ, 1999, TRENDS CELL BIOL, V9, P262, DOI 10.1016/S0962-8924(99)01580-9; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; CSERMELY P, 1995, J BIOL CHEM, V270, P6381, DOI 10.1074/jbc.270.11.6381; Dai K, 1996, J BIOL CHEM, V271, P22030, DOI 10.1074/jbc.271.36.22030; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; Fisher RP, 1997, CURR OPIN GENET DEV, V7, P32, DOI 10.1016/S0959-437X(97)80106-2; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Hartson SD, 2000, BIOCHEMISTRY-US, V39, P7631, DOI 10.1021/bi000315r; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; JOVE R, 1986, J VIROL, V60, P849, DOI 10.1128/JVI.60.3.849-857.1986; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 2000, IMMUNOL RES, V21, P233, DOI 10.1385/IR:21:2-3:233; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; KOYASU S, 1986, P NATL ACAD SCI USA, V83, P8054, DOI 10.1073/pnas.83.21.8054; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Lamphere L, 1997, ONCOGENE, V14, P1999, DOI 10.1038/sj.onc.1201036; Lavoie J N, 1996, Prog Cell Cycle Res, V2, P49; LEBEAU MC, 1992, J BIOL CHEM, V267, P4281; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Matsuda S, 1999, J BIOL CHEM, V274, P34515, DOI 10.1074/jbc.274.49.34515; MATSUSHIME H, 1990, MOL CELL BIOL, V10, P2261, DOI 10.1128/MCB.10.5.2261; Minami Y, 2000, J BIOL CHEM, V275, P9055, DOI 10.1074/jbc.275.12.9055; Miyata Y, 1997, P NATL ACAD SCI USA, V94, P14500, DOI 10.1073/pnas.94.26.14500; Miyata Y, 2000, ONCOGENE, V19, P1477, DOI 10.1038/sj.onc.1203475; MIYATA Y, 1995, BIOCHEMISTRY-US, V34, P8123, DOI 10.1021/bi00025a019; Miyata Y, 1999, GENES CELLS, V4, P299, DOI 10.1046/j.1365-2443.1999.00261.x; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Ozaki T, 1995, DNA CELL BIOL, V14, P1017, DOI 10.1089/dna.1995.14.1017; Perdew GH, 1997, BIOCHEMISTRY-US, V36, P3600, DOI 10.1021/bi9612529; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Stepanova L, 1997, METHOD ENZYMOL, V283, P220; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; Toft DO, 1998, TRENDS ENDOCRIN MET, V9, P238, DOI 10.1016/S1043-2760(98)00060-5; UEHARA Y, 1986, MOL CELL BIOL, V6, P2198, DOI 10.1128/MCB.6.6.2198; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Yahara I, 1998, ANN NY ACAD SCI, V851, P54, DOI 10.1111/j.1749-6632.1998.tb08976.x; YAMAZAKI M, 1989, NUCLEIC ACIDS RES, V17, P7108, DOI 10.1093/nar/17.17.7108; Zanke BW, 1996, J BIOL CHEM, V271, P29876, DOI 10.1074/jbc.271.47.29876; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	61	58	61	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21841	21848		10.1074/jbc.M010944200	http://dx.doi.org/10.1074/jbc.M010944200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11278794	hybrid			2022-12-27	WOS:000169297900135
J	Simon, M; Jonca, N; Guerrin, M; Haftek, M; Bernard, D; Caubet, C; Egelrud, T; Schmidt, R; Serre, G				Simon, M; Jonca, N; Guerrin, M; Haftek, M; Bernard, D; Caubet, C; Egelrud, T; Schmidt, R; Serre, G			Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRATUM-CORNEUM; S GENE; IN-VITRO; EXPRESSION; HLA; DESMOSOMES; IDENTIFICATION; CLONING; PURIFICATION; ASSOCIATION	Corneodesmosin is a putative adhesion glycoprotein located in the extracellular part of the desmosomes in the upper layers of the epidermis. Synthesized by granular keratinocytes as a 52-56-kDa protein, corneodesmosin is progressively proteolysed during corneocyte maturation. This processing is a prerequisite for desquamation. Two glycine- and serine-rich domains of the protein might take on the conformation of adhesive secondary structures similar to glycine loops. Corneodesmosin proteolysis was further characterized. Deglycosylation experiments and reactivity with lectins demonstrated that the corneodesmosin carbohydrate moiety does not prevent the proteolysis. Immunoblotting, immunohistochemistry, and immunoelectron microscopy experiments using affinity-purified antipeptide antibodies raised to four of the five structural domains of corneodesmosin and a monoclonal antibody against its fifth central domain showed that the first step in corneodesmosin processing is the cleavage of its extremities and probably occurs before its incorporation into desmosomes. Then the glycine loop-related domains are cleaved, first the N-terminal and then part of the C-terminal domain. At the epidermis surface, the multistep proteolytic cleavage leaves intact only the central domain, which was detected on exfoliated corneocytes and probably lacks adhesive properties. Importantly, corneodesmosin was demonstrated to be a preferred substrate of two serine proteases involved in desquamation, the stratum corneum tryptic and chymotryptic enzymes.	Univ Toulouse 3, Sch Med, Dept Biol & Pathol Cell, INSERM,Contrat Jeune Format 9602, Toulouse, France; LOreal, Life Sci Res, Ctr Charles Zviak, F-92583 Clichy, France; Univ Umea Hosp, Dept Dermatol, S-90185 Umea, Sweden; CNRS, INSERM, U346, F-69437 Lyon, France; Univ Toulouse 3, Sch Med, Dept Biol & Patholl Cell, INSERM,Contrat Jeune Format 9602, F-31059 Toulouse, France; Univ Toulouse 3, Ctr Hosp, Inst Fed Rech 30, INSERM,CNRS, F-31073 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; L'Oreal Group; Umea University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Serre, G (corresponding author), Univ Toulouse 3, Sch Med, Dept Biol & Patholl Cell, INSERM,Contrat Jeune Format 9602, Pl Dr Baylac, F-31059 Toulouse, France.	serre.g@chu-toulouse.fr	Jonca, Nathalie/AAX-3870-2020; Simon, Michel/B-7308-2011	Jonca, Nathalie/0000-0003-3602-0102; Simon, Michel/0000-0003-3655-6329				Ahnini RT, 1999, HUM MOL GENET, V8, P1135, DOI 10.1093/hmg/8.6.1135; Allen MH, 1999, LANCET, V353, P1589, DOI 10.1016/S0140-6736(99)01618-9; ALLEN TD, 1975, J ULTRA MOL STRUCT R, V51, P94, DOI 10.1016/S0022-5320(75)80011-6; ARNEMANN J, 1993, J CELL SCI, V104, P741; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; CHAPMAN SJ, 1990, ARCH DERMATOL RES, V282, P304, DOI 10.1007/BF00375724; Diamandis EP, 2000, TRENDS ENDOCRIN MET, V11, P54, DOI 10.1016/S1043-2760(99)00225-8; Egelrud T, 2000, CRC DERMAT, P109; Ekholm IE, 2000, J INVEST DERMATOL, V114, P56, DOI 10.1046/j.1523-1747.2000.00820.x; Enerback C, 2000, J INVEST DERMATOL, V114, P1158, DOI 10.1046/j.1523-1747.2000.00002.x; GHADIALLY R, 1992, J INVEST DERMATOL, V99, P755, DOI 10.1111/1523-1747.ep12614489; Guerrin M, 1998, J BIOL CHEM, V273, P22640, DOI 10.1074/jbc.273.35.22640; Guerrin M, 2001, TISSUE ANTIGENS, V57, P32, DOI 10.1034/j.1399-0039.2001.057001032.x; HAFTEK M, 1994, J INVEST DERMATOL, V103, P656, DOI 10.1111/1523-1747.ep12398417; HAFTEK M, 1991, J HISTOCHEM CYTOCHEM, V39, P1531, DOI 10.1177/39.11.1717544; Haftek M, 1997, BRIT J DERMATOL, V137, P864, DOI 10.1046/j.1365-2133.1997.19792087.x; HANSSON L, 1994, J BIOL CHEM, V269, P19420; HOLBROOK K, 1994, KERATINOCYTE HDB, P275; Jenisch S, 1999, TISSUE ANTIGENS, V54, P439, DOI 10.1034/j.1399-0039.1999.540501.x; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; Long S, 1996, J INVEST DERMATOL, V106, P397; LUNDSTROM A, 1994, ARCH DERMATOL RES, V286, P369, DOI 10.1007/BF00371795; LUNDSTROM A, 1990, J INVEST DERMATOL, V94, P216, DOI 10.1111/1523-1747.ep12874531; MENTON DN, 1971, J ULTRA MOL STRUCT R, V35, P247, DOI 10.1016/S0022-5320(71)80155-7; MOMMAAS AM, 1992, HUM IMMUNOL, V34, P99, DOI 10.1016/0198-8859(92)90035-L; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; SERRE G, 1991, J INVEST DERMATOL, V97, P1061, DOI 10.1111/1523-1747.ep12492589; Simon M, 2001, J INVEST DERMATOL, V116, P23, DOI 10.1046/j.1523-1747.2001.00208.x; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; SKERROW CJ, 1989, J CELL SCI, V92, P667; SKYTT A, 1995, BIOCHEM BIOPH RES CO, V211, P586, DOI 10.1006/bbrc.1995.1853; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; SUZUKI Y, 1994, ARCH DERMATOL RES, V286, P249, DOI 10.1007/BF00387596; Vicanova J, 1996, CELL TISSUE RES, V286, P115, DOI 10.1007/s004410050680; ZHOU YQ, 1993, P NATL ACAD SCI USA, V90, P9470, DOI 10.1073/pnas.90.20.9470	35	135	141	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20292	20299		10.1074/jbc.M100201200	http://dx.doi.org/10.1074/jbc.M100201200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279026	hybrid			2022-12-27	WOS:000169135100085
J	Vinson, M; Strijbos, PJLM; Rowles, A; Facci, L; Moore, SE; Simmons, DL; Walsh, FS				Vinson, M; Strijbos, PJLM; Rowles, A; Facci, L; Moore, SE; Simmons, DL; Walsh, FS			Myelin-associated glycoprotein interacts with ganglioside GT1b - A mechanism for neurite outgrowth inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING LECTIN; MONOCLONAL-ANTIBODY; CELL-ADHESION; HUMAN-MELANOMA; RAT-BRAIN; ONE SET; SIALOADHESIN; PROTEIN; SITE; SPECIFICITY	Myelin-associated glycoprotein (MAG) is expressed on myelinating glia and inhibits neurite outgrowth from post-natal neurons. MAG has a sialic acid binding site in its N-terminal domain and binds to specific sialylated glycans and gangliosides present on the surface of neurons, but the significance of these interactions in the effect of MAG on neurite outgrowth is unclear. Here we present evidence to suggest that recognition of sialylated glycans is essential for inhibition of neurite outgrowth by MAG. Arginine 118 on MAG is known to make a key contact with sialic acid. me show that mutation of this residue reduces the potency of MAG inhibitory activity hut that residual activity is also a result of carbohydrate recognition. me then go on to investigate gangliosides GT1b and GD1a as candidate MAG receptors. me show that MAG specifically binds both gangliosides and that both are expressed on the surface of MAG-responsive neurons. Furthermore, antibody cross-linking of cell surface GT1b, but not GD1a, mimics the effect of MAG, in that neurite outgrowth is inhibited through activation of Rho kinase, These data strongly suggest that interaction with GT1b on the neuronal cell surface is a potential mechanism for inhibition of neurite outgrowth by MAG.	GlaxoSmithKline, Neurol Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England	GlaxoSmithKline	Vinson, M (corresponding author), GlaxoSmithKline, Neurol Ctr Excellence Drug Discovery, New Frontiers Sci Pk N,3rd Ave, Harlow CM19 5AW, Essex, England.	Mary_Vinson-1@sbphrd.com						Angata T, 2000, GLYCOBIOLOGY, V10, P431, DOI 10.1093/glycob/10.4.431; Barnes YC, 1999, BLOOD, V93, P1245, DOI 10.1182/blood.V93.4.1245.404k09_1245_1252; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8625, DOI 10.1074/jbc.275.12.8625; Buffo A, 2000, J NEUROSCI, V20, P2275; BURNS GF, 1988, J CELL BIOL, V107, P1225, DOI 10.1083/jcb.107.3.1225; CHAKRABORTY M, 1993, BRAIN RES, V625, P197, DOI 10.1016/0006-8993(93)91059-2; CHERESH DA, 1984, P NATL ACAD SCI-BIOL, V81, P5767, DOI 10.1073/pnas.81.18.5767; CHERESH DA, 1986, J CELL BIOL, V102, P688, DOI 10.1083/jcb.102.3.688; Collins BE, 1999, J BIOL CHEM, V274, P37637, DOI 10.1074/jbc.274.53.37637; Collins BE, 1997, J BIOL CHEM, V272, P1248, DOI 10.1074/jbc.272.2.1248; CONFORTI G, 1990, J BIOL CHEM, V265, P4011; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; Crocker PR, 1999, BIOCHEM J, V341, P355, DOI 10.1042/0264-6021:3410355; De Bellard M, 1999, J NEUROSCI RES, V56, P213, DOI 10.1002/(SICI)1097-4547(19990415)56:2<213::AID-JNR11>3.3.CO;2-L; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; DOHI T, 1988, CANCER RES, V48, P5680; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; FERRARI G, 1995, J BIOL CHEM, V270, P3074, DOI 10.1074/jbc.270.7.3074; Floyd H, 2000, J BIOL CHEM, V275, P861, DOI 10.1074/jbc.275.2.861; FREDMAN P, 1984, ARCH BIOCHEM BIOPHYS, V233, P661, DOI 10.1016/0003-9861(84)90492-2; FREEMAN SD, 1995, BLOOD, V85, P2005, DOI 10.1182/blood.V85.8.2005.bloodjournal8582005; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; JOHNSON AR, 1993, BIOESSAYS, V15, P807, DOI 10.1002/bies.950151206; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kasahara K, 2000, J BIOL CHEM, V275, P34701, DOI 10.1074/jbc.M003163200; Kelm S, 1998, EUR J BIOCHEM, V255, P663, DOI 10.1046/j.1432-1327.1998.2550663.x; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; KOTANI M, 1992, BIOCHIM BIOPHYS ACTA, V1117, P97, DOI 10.1016/0304-4165(92)90168-T; Kotani M, 2000, J BIOCHEM-TOKYO, V127, P13, DOI 10.1093/oxfordjournals.jbchem.a022574; Lassmann H, 1997, GLIA, V19, P104, DOI 10.1002/(SICI)1098-1136(199702)19:2<104::AID-GLIA2>3.3.CO;2-R; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Li C, 1998, J NEUROSCI RES, V51, P210, DOI 10.1002/(SICI)1097-4547(19980115)51:2<210::AID-JNR9>3.0.CO;2-G; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Lunn MPT, 2000, J NEUROCHEM, V75, P404, DOI 10.1046/j.1471-4159.2000.0750404.x; Masserini M, 1999, J NEUROCHEM, V73, P1, DOI 10.1046/j.1471-4159.1999.0730001.x; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; MUTOH T, 1995, P NATL ACAD SCI USA, V92, P5087, DOI 10.1073/pnas.92.11.5087; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; OZAWA H, 1992, BIOCHIM BIOPHYS ACTA, V1123, P184, DOI 10.1016/0005-2760(92)90110-H; Palestini P, 1999, BIOSCIENCE REP, V19, P385, DOI 10.1023/A:1020208121454; Patel N, 1999, J BIOL CHEM, V274, P22729, DOI 10.1074/jbc.274.32.22729; Pitto M, 1998, FEBS LETT, V439, P93, DOI 10.1016/S0014-5793(98)01344-1; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; Prinetti A, 1999, J BIOL CHEM, V274, P20916, DOI 10.1074/jbc.274.30.20916; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Probstmeier R, 1999, EUR J NEUROSCI, V11, P2474, DOI 10.1046/j.1460-9568.1999.00670.x; Probstmeier R, 1999, GLYCOBIOLOGY, V9, P101, DOI 10.1093/glycob/9.2.101; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; SBASCHNIGAGLER M, 1988, J NEUROCHEM, V51, P212, DOI 10.1111/j.1471-4159.1988.tb04858.x; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SKAPER SD, 1990, METHODS NEUROSCIENCE, V2, P17; Strenge K, 1999, FEBS LETT, V444, P59, DOI 10.1016/S0014-5793(99)00029-0; Strenge K, 1998, EUR J BIOCHEM, V258, P677, DOI 10.1046/j.1432-1327.1998.2580677.x; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Taylor VC, 1999, J BIOL CHEM, V274, P11505, DOI 10.1074/jbc.274.17.11505; TETTAMANTI G, 1993, ADV LIPID RES, V25, P235; vanderMerwe PA, 1996, J BIOL CHEM, V271, P9273, DOI 10.1074/jbc.271.16.9273; Vinson M, 1996, J BIOL CHEM, V271, P9267, DOI 10.1074/jbc.271.16.9267; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814	69	152	153	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20280	20285		10.1074/jbc.M100345200	http://dx.doi.org/10.1074/jbc.M100345200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279053	hybrid			2022-12-27	WOS:000169135100083
J	Shih, WM; Spudich, JA				Shih, WM; Spudich, JA			The myosin relay helix to converter interface remains intact throughout the actomyosin ATPase cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN GENE; DICTYOSTELIUM-DISCOIDEUM; MOTOR DOMAIN; MOLECULAR MOTOR; SUBFRAGMENT-1; HYDROLYSIS; COMPLEXES; RECEPTOR; ACTIN; STATE	Crystal structures of the myosin motor domain in the presence of different nucleotides show the lever arm domain in two basic angular states, postulated to represent prestroke and poststroke states, respectively (Rayment, I. (1996) J, Biol Chem. 271, 15850-15853; Dominguez, R, Freyzon, Y,, Trybus, K.M., and Cohen, C, (1998) Cell 94, 559-571). Contact is maintained between two domains, the relay and the converter, in both of these angular states, Therefore it has been proposed by Dominguez et al. (cited above) that this contact is critical for mechanically driving the angular change of the lever arm domain. However, structural information is lacking on whether this contact is maintained throughout the actin-activated myosin ATPase cycle. To test the functional importance of this interdomain contact, we introduced cysteines into the sequence of a "cysteine-light" myosin motor at position 499 on the lower cleft and position 738 on the converter domain (Shih, W, Ri,, Gryczynski, Z,, Lakowicz, J,L,, and Spudich, J, A (2000) Cell 102, 683-694), Disulfide cross-linking could be induced. The cross-link had minimal effects on actin binding, ATP-induced actin release, and actin-activated ATPase, These results demonstrate that the relay/converter interface remains intact in the actin strongly bound state of myosin and throughout the entire actin-activated myosin ATPase cycle.	Stanford Univ, Sch Med, Dept Biochem, Beckman Ctr B400, Stanford, CA 94305 USA	Stanford University	Spudich, JA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Beckman Ctr B400, Stanford, CA 94305 USA.	jspudich@cmgm.stanford.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR42895] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; EGELHOFF TT, 1991, METHOD ENZYMOL, V196, P319; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Giese KC, 1997, BIOCHEMISTRY-US, V36, P8465, DOI 10.1021/bi963141f; Goldman YE, 1998, CELL, V93, P1, DOI 10.1016/S0092-8674(00)81137-X; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; LYMN RW, 1970, BIOCHEMISTRY-US, V9, P2975, DOI 10.1021/bi00817a007; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MURAI N, 1996, J BIOL CHEM, V271, P28829; Murphy CT, 1998, BIOCHEMISTRY-US, V37, P6738, DOI 10.1021/bi972903j; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rayment I, 1996, J BIOL CHEM, V271, P15850, DOI 10.1074/jbc.271.27.15850; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shih WM, 2000, CELL, V102, P683, DOI 10.1016/S0092-8674(00)00090-8; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; WERBER MM, 1992, BIOCHEMISTRY-US, V31, P7190, DOI 10.1021/bi00146a023; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017	23	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19491	19494		10.1074/jbc.M010887200	http://dx.doi.org/10.1074/jbc.M010887200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278776	hybrid			2022-12-27	WOS:000169091000111
J	Willats, WGT; Orfila, C; Limberg, G; Buchholt, HC; van Alebeek, GJWM; Voragen, AGJ; Marcus, SE; Christensen, TMIE; Mikkelsen, JD; Murray, BS; Knox, JP				Willats, WGT; Orfila, C; Limberg, G; Buchholt, HC; van Alebeek, GJWM; Voragen, AGJ; Marcus, SE; Christensen, TMIE; Mikkelsen, JD; Murray, BS; Knox, JP			Modulation of the degree and pattern of methyl-esterification of pectic homogalacturonan in plant cell walls - Implications for pectin methyl esterase action, matrix properties, and cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTURONIC ACID; ASPERGILLUS-NIGER; APPLE PECTIN; PECTINMETHYLESTERASE ISOFORMS; RHAMNOGALACTURONAN-II; ARABIDOPSIS-THALIANA; PART 2; ENDOPOLYGALACTURONASE; METHYLESTERASE; SEPARATION	Homogalacturonan (HG) is a multifunctional pectic polysaccharide of the primary cell wall matrix of all land plants. HG is thought to be deposited in cell walls in a highly methyl-esterified form but can be subsequently de-esterified by wall-based pectin methyl esterases (PMEs) that have the capacity to remove methyl ester groups from HG. Plant PMEs typically occur in multigene families/isoforms, but the precise details of the functions of PMEs are far from clear. Most are thought to act in a processive or blockwise fashion resulting in domains of contiguous de-esterified galacturonic acid residues. Such de-esterified blocks of HG can be crosslinked by calcium resulting in gel formation and can contribute to intercellular adhesion. We demonstrate that, in addition to blockwise de-esterification, HG with a non-blockwise distribution of methyl esters is also an abundant feature of HG in primary plant cell walls. A partially methyl-esterified epitope of HG that is generated in greatest abundance by non-blockwise de-esterification is spatially regulated within the cell wall matrix and occurs at points of cell separation at intercellular spaces in parenchymatous tissues of pea and other angiosperms. Analysis of the properties of calcium-mediated gels formed from pectins containing HG domains with differing degrees and patterns of methyl-esterification indicated that HG with a non-blockwise pattern of methyl ester group distribution is likely to contribute distinct mechanical and porosity properties to the cell wall matrix. These findings have important implications for our understanding of both the action of pectin methyl esterases on matrix properties and mechanisms of intercellular adhesion and its loss in plants.	Univ Leeds, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England; Danisco Biotechnol, DK-1001 Copenhagen K, Denmark; Danisco Cultor, DK-8220 Brabrand, Denmark; Univ Wageningen & Res Ctr, Food Chem Lab, Dept Agrotechnol & Food Sci, NL-6703 HD Wageningen, Netherlands; Univ Leeds, Procter Dept Food Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; Wageningen University & Research; University of Leeds	Knox, JP (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England.	j.p.knox@leeds.ac.uk	Knox, Paul/H-4577-2012	Knox, Paul/0000-0002-9231-6891; Orfila, Caroline/0000-0003-2564-8068; Willats, William/0000-0003-2064-4025				Bordenave M, 1996, PLANT MOL BIOL, V31, P1039, DOI 10.1007/BF00040722; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Catoire L, 1998, J BIOL CHEM, V273, P33150, DOI 10.1074/jbc.273.50.33150; Daas PJH, 2000, CARBOHYD RES, V326, P120, DOI 10.1016/S0008-6215(00)00037-9; Denes JM, 2000, CARBOHYD RES, V327, P385, DOI 10.1016/S0008-6215(00)00070-7; Dumville JC, 2000, PLANT PHYSIOL BIOCH, V38, P125, DOI 10.1016/S0981-9428(00)00163-7; EBERHARD S, 1989, PLANT CELL, V1, P747, DOI 10.1105/tpc.1.8.747; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; JARVIS MC, 1984, PLANT CELL ENVIRON, V7, P153, DOI 10.1111/1365-3040.ep11614586; Jarvis MC, 1998, PLANT CELL ENVIRON, V21, P1307, DOI 10.1046/j.1365-3040.1998.00363.x; KNOX JP, 1992, PLANT J, V2, P137, DOI 10.1111/j.1365-313X.1992.00137.x; KNOX JP, 1990, PLANTA, V181, P512, DOI 10.1007/BF00193004; KOLLOFFEL C, 1984, PROTOPLASMA, V120, P12, DOI 10.1007/BF01287613; Liberman M, 1999, ANN BOT-LONDON, V84, P225, DOI 10.1006/anbo.1999.0914; Limberg G, 2000, CARBOHYD RES, V327, P321, DOI 10.1016/S0008-6215(00)00068-9; Limberg G, 2000, CARBOHYD RES, V327, P293, DOI 10.1016/S0008-6215(00)00067-7; MacDougall AJ, 1996, CARBOHYD RES, V293, P235, DOI 10.1016/0008-6215(96)00197-8; Massiot P, 1997, FOOD SCI TECHNOL-LEB, V30, P697; Micheli F, 1998, GENE, V220, P13, DOI 10.1016/S0378-1119(98)00431-4; Moerschbacher BM, 1999, J EXP BOT, V50, P605, DOI 10.1093/jexbot/50.334.605; Mohnen D, 1999, COMPREHENSIVE NATURA, V3, P497; MORT AJ, 1993, CARBOHYD RES, V247, P21, DOI 10.1016/0008-6215(93)84238-2; MOUSTACAS AM, 1986, BIOCHEM J, V279, P351; NARI J, 1986, EUR J BIOCHEM, V155, P199, DOI 10.1111/j.1432-1033.1986.tb09477.x; ONeill M., 1990, METHODS PLANT BIOCH, V2, P415, DOI [DOI 10.1016/B978-0-12-461012-5.50018-5, 10.1016/b978-0-12-461012-5.50018-5]; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; PILNIK W, 1990, GUMS STABILISERS FOO, P209; Roberts JA, 2000, ANN BOT-LONDON, V86, P223, DOI 10.1006/anbo.2000.1203; Schols HA, 1995, CARBOHYD RES, V279, P265, DOI 10.1016/0008-6215(95)00287-1; Torki M, 2000, GENE, V242, P427, DOI 10.1016/S0378-1119(99)00497-7; Vidal S, 2000, CARBOHYD RES, V326, P277, DOI 10.1016/S0008-6215(00)00036-7; Wen FS, 1999, PLANT CELL, V11, P1129, DOI 10.1105/tpc.11.6.1129; Willats WGT, 2000, CARBOHYD RES, V327, P309, DOI 10.1016/S0008-6215(00)00039-2; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Willats WGT, 1999, PLANT J, V18, P57, DOI 10.1046/j.1365-313X.1999.00427.x; ZHANG GF, 1992, PLANT PHYSIOL, V99, P1070, DOI 10.1104/pp.99.3.1070	36	445	460	6	102	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19404	19413		10.1074/jbc.M011242200	http://dx.doi.org/10.1074/jbc.M011242200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278866	hybrid			2022-12-27	WOS:000169091000102
J	Kawasaki-Nishi, S; Nishi, T; Forgac, M				Kawasaki-Nishi, S; Nishi, T; Forgac, M			Yeast V-ATPase complexes containing different isoforms of the 100-kDa a-subunit differ in coupling efficiency and in vivo dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; LIVING CELLS; GENE ENCODES; CDNA SEQUENCE; PROTON PUMP; F-TYPE; POLYPEPTIDE; TRANSPORT; PH; EXPRESSION	The 100 kDa a-subunit of the yeast vacuolar (H+)ATPase (V-ATPase) is encoded by two genes, VPH1 and STV1, These genes encode unique isoforms of the a-subunit that have previously been shown to reside in different intracellular compartments in yeast. Vph1p localizes to the central vacuole, whereas Stv1p is present in some other compartment, possibly the Golgi or endosomes, To compare the properties of V-ATPases containing Vph1p or Stv1p, Stv1p was expressed at higher than normal levels in a strain disrupted in both genes, under which conditions V-ATPase complexes containing Stv1p appear in the vacuole, Complexes containing Stv1p showed lower assembly with the peripheral V-1 domain than did complexes containing Vph1p, When corrected for this lower degree of assembly, however, V-ATPase complexes containing Vph1p and Stv1p had similar kinetic properties. Both exhibited a K-m for ATP of about 250 muM, and both showed resistance to sodium azide and vanadate and sensitivity to nanomolar concentrations of concanamycin A. Stv1p-containing complexes, however, showed a 4-5-fold lower ratio of proton transport to ATP hydrolysis than Vph1p-containing complexes. We also compared the ability of V-ATPase complexes containing Vph1p or Stv1p to undergo in vivo dissociation in response to glucose depletion. Vph1p-containing complexes present in the vacuole showed dissociation in response to glucose depletion, whereas Stv1p-containing complexes present in their normal intracellular location (Golgi/endosomes) did not. Upon overexpression of Stv1p, Stv1p-containing complexes present in the vacuole showed glucose-dependent dissociation. Blocking delivery of Vph1p-containing complexes to the vacuole in vps21 Delta and vps27 Delta strains caused partial inhibition of glucose-dependent dissociation. These results suggest that dissociation of the V-ATPase complex in vivo is controlled both by the cellular environment and by the 100-kDa a-subunit isoform present in the complex.	Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM034478, R37 GM034478, GM34478] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANRAKU Y, 1992, J BIOENERG BIOMEMBR, V24, P395, DOI 10.1007/BF00762532; ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; BOWMAN BJ, 1988, J BIOL CHEM, V263, P14002; Capaldi RA, 2000, J EXP BIOL, V203, P29; CHATTERJEE D, 1992, P NATL ACAD SCI USA, V89, P6257, DOI 10.1073/pnas.89.14.6257; Cross RL, 1996, J BIOENERG BIOMEMBR, V28, P403, DOI 10.1007/BF02113981; FENG Y, 1992, J BIOL CHEM, V267, P5817; Fillingame RH, 2000, J EXP BIOL, V203, P9; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Futai M, 1996, J BIOENERG BIOMEMBR, V28, P409, DOI 10.1007/BF02113982; Gerrard SR, 2000, MOL BIOL CELL, V11, P613, DOI 10.1091/mbc.11.2.613; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GLUCK SL, 1992, J BIOENERG BIOMEMBR, V24, P351, DOI 10.1007/BF00762528; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Hunt IE, 1997, J BIOENERG BIOMEMBR, V29, P533, DOI 10.1023/A:1022474816665; Kane PM, 1999, J BIOENERG BIOMEMBR, V31, P49, DOI 10.1023/A:1005444513542; KANE PM, 1989, J BIOL CHEM, V264, P19236; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 1992, J BIOL CHEM, V267, P447; Kim JH, 1996, J CELL BIOL, V134, P1387, DOI 10.1083/jcb.134.6.1387; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Margolles-Clark E, 1999, J BIOENERG BIOMEMBR, V31, P29, DOI 10.1023/A:1005440412633; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Moriyama Y, 1996, BIOL CHEM H-S, V377, P155; MYERS M, 1993, J CELL PHYSIOL, V156, P35, DOI 10.1002/jcp.1041560106; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; NELSON N, 1992, J BIOENERG BIOMEMBR, V24, P407, DOI 10.1007/BF00762533; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pedersen PL, 1996, J BIOENERG BIOMEMBR, V28, P389, DOI 10.1007/BF02113979; PERIN MS, 1991, J BIOL CHEM, V266, P3877; SEKSEK O, 1995, J BIOL CHEM, V270, P4967, DOI 10.1074/jbc.270.10.4967; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; SZE H, 1992, J BIOENERG BIOMEMBR, V24, P371, DOI 10.1007/BF00762530; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; WIECZOREK H, 1991, J BIOL CHEM, V266, P15340; ZIMNIAK L, 1988, J BIOL CHEM, V263, P9102	50	46	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17941	17948		10.1074/jbc.M010790200	http://dx.doi.org/10.1074/jbc.M010790200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278748	hybrid			2022-12-27	WOS:000168866500045
J	Maranda, B; Brown, D; Bourgoin, S; Casanova, JE; Vinay, P; Ausiello, DA; Marshansky, V				Maranda, B; Brown, D; Bourgoin, S; Casanova, JE; Vinay, P; Ausiello, DA; Marshansky, V			Intra-endosomal pH-sensitive recruitment of the Arf-nucleotide exchange factor ARNO and Arf6 from cytoplasm to proximal tubule endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; GTP-BINDING PROTEIN; RECEPTOR-MEDIATED ENDOCYTOSIS; COP-COATED VESICLES; PLASMA-MEMBRANE; GUANINE-NUCLEOTIDE; GOLGI MEMBRANES; PHOSPHOLIPASE-D; INTRACELLULAR-TRANSPORT; REGULATED EXOCYTOSIS	Kidney proximal tubule epithelial cells have an extensive apical endocytotic apparatus that is critical for the reabsorption and degradation of proteins that traverse the glomerular filtration barrier and that is also involved in the extensive recycling of functionally important apical plasma membrane transporters. We show here that an Arf-nucleotide exchange factor, ARNO (ADP-ribosylation factor nucleotide site opener) as well as Arf6 and Arf1 small GTPases are located in the kidney proximal tubule receptor-mediated endocytosis pathway, and that ARNO and Arf6 recruitment from cytosol to endosomes is pH-dependent. In proximal tubules in situ, ARNO and Arf6 partially co-localized with the V-ATPase in apical endosomes in proximal tubules, Arf1 was localized both at the apical pole of proximal tubule epithelial cells, but also in the Golgi, By Western blot analysis ARNO, Arf6, and Arf1 were detected both in purified endosomes and in proximal tubule cytosol, A translocation assay showed that ATP-driven endosomal acidification triggered the recruitment of ARNO and Arf6 from proximal tubule cytosol to endosomal membranes. The translocation of both ARNO and Arf6 was reversed by V-type ATPase inhibitors and by uncouplers of endosomal intralumenal pH, and was correlated with the magnitude of intra-endosomal acidification. Our data suggest that V-type ATPase-dependent acidification stimulates the selective recruitment of ARNO and Arf6 to proximal tubule early endosomes, This mechanism may play an important role in the pa-dependent regulation of receptor-mediated endocytosis in proximal tubules in situ.	Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02129 USA; Massachusetts Gen Hosp, Renal Unit, Boston, MA 02129 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02129 USA; Univ Montreal, GRTM, Montreal, PQ H2L 4M1, Canada; Univ Montreal, CHUM, LC Simard Res Ctr, Lab Renal Biochem, Montreal, PQ H2L 4M1, Canada; Univ Laval, CHUL, Ctr Rech, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1V 4G2, Canada; Univ Virginia, Hlth Sci Ctr, Dept Cell Biol, Charlottesville, VA 22908 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Universite de Montreal; Universite de Montreal; Laval University; University of Virginia	Marshansky, V (corresponding author), Harvard Univ, Massachusetts Gen Hosp E, Sch Med, Program Membrane Biol, 149 13th St, Boston, MA 02129 USA.		Marshansky, Vladimir/AAZ-7890-2020	Bourgoin, Sylvain/0000-0001-9779-0368	NIDDK NIH HHS [DK38452, DK42956] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038452, R01DK042956, R37DK042956] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Aniento F, 1995, COLD SPRING HARB SYM, V60, P205, DOI 10.1101/SQB.1995.060.01.023; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Aoe T, 1998, P NATL ACAD SCI USA, V95, P1624, DOI 10.1073/pnas.95.4.1624; Breton S, 2000, AM J PHYSIOL-RENAL, V278, pF717, DOI 10.1152/ajprenal.2000.278.5.F717; Brown D, 1996, PHYSIOL REV, V76, P245, DOI 10.1152/physrev.1996.76.1.245; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Caumont AS, 1998, J BIOL CHEM, V273, P1373, DOI 10.1074/jbc.273.3.1373; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONALDSON JG, 1994, CURR OPIN CELL BIOL, V6, P527, DOI 10.1016/0955-0674(94)90072-8; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Gaschet J, 1999, J BIOL CHEM, V274, P20040, DOI 10.1074/jbc.274.28.20040; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; Hanakam F, 1996, EMBO J, V15, P2935, DOI 10.1002/j.1460-2075.1996.tb00656.x; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Hemmings BA, 1997, SCIENCE, V275, P1899, DOI 10.1126/science.275.5308.1899; Herak-Kramberger CM, 1998, KIDNEY INT, V53, P1713, DOI 10.1046/j.1523-1755.1998.00914.x; HILL HD, 1988, ANAL BIOCHEM, V170, P203, DOI 10.1016/0003-2697(88)90109-1; Jung FF, 1998, KIDNEY INT, V53, P358, DOI 10.1046/j.1523-1755.1998.00766.x; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENCER WI, 1990, AM J PHYSIOL, V258, pC309, DOI 10.1152/ajpcell.1990.258.2.C309; Lippincott-Schwartz J, 1998, HISTOCHEM CELL BIOL, V109, P449, DOI 10.1007/s004180050247; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Londono I, 1999, KIDNEY INT, V55, P1407, DOI 10.1046/j.1523-1755.1999.00365.x; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Marshansky V, 1997, ELECTROPHORESIS, V18, P538, DOI 10.1002/elps.1150180334; Marshansky V, 1996, BBA-BIOMEMBRANES, V1284, P171, DOI 10.1016/S0005-2736(96)00123-X; Marshansky V, 1997, ELECTROPHORESIS, V18, P2661, DOI 10.1002/elps.1150181423; Marshansky V, 1996, J MEMBRANE BIOL, V153, P59, DOI 10.1007/s002329900110; Meacci E, 1997, P NATL ACAD SCI USA, V94, P1745, DOI 10.1073/pnas.94.5.1745; MELLMAN I, 1992, J EXP BIOL, V172, P39; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Price SR, 1996, MOL CELL BIOCHEM, V159, P15; SEKSEK O, 1995, J BIOL CHEM, V270, P4967, DOI 10.1074/jbc.270.10.4967; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SHI LB, 1991, BIOPHYS J, V59, P1208, DOI 10.1016/S0006-3495(91)82336-0; Shome K, 1997, CURR BIOL, V7, P387, DOI 10.1016/S0960-9822(06)00186-2; SLUSAREWICZ P, 1994, CELL BIOL LAB HDB, P509; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stoeckelhuber M, 1996, J CELL SCI, V109, P1825; Stroffekova K, 1998, AM J PHYSIOL-CELL PH, V275, pC1113, DOI 10.1152/ajpcell.1998.275.4.C1113; Sullivan BM, 2000, MOL BIOL CELL, V11, P3155, DOI 10.1091/mbc.11.9.3155; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; VINAY P, 1981, AM J PHYSIOL, V241, P403; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P5583; ZEUZEM S, 1992, P NATL ACAD SCI USA, V89, P6619, DOI 10.1073/pnas.89.14.6619; ZEUZEM S, 1992, J MEMBRANE BIOL, V125, P231; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418	67	114	114	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18540	18550		10.1074/jbc.M011577200	http://dx.doi.org/10.1074/jbc.M011577200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278939	hybrid			2022-12-27	WOS:000168866500123
J	Wolters, PJ; Pham, CTN; Muilenburg, DJ; Ley, TJ; Caughey, GH				Wolters, PJ; Pham, CTN; Muilenburg, DJ; Ley, TJ; Caughey, GH			Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAPILLON-LEFEVRE-SYNDROME; CATHEPSIN-C GENE; NEUTROPHIL ELASTASE; SECRETORY GRANULES; SERINE PROTEASES; GRANZYME-A; MOUSE; EXPRESSION; HEPARIN; IDENTIFICATION	Dipeptidyl peptidase I (DPPI) is the sole activator in vivo of several granule-associated serine proteases of cytotoxic lymphocytes. In vitro, DPPI also activates mast cell chymases and tryptases, To determine whether DPPI is essential for their activation in vivo, we used enzyme histochemical and immunohistochemical approaches and solution-based activity assays to study these enzymes in tissues and bone marrow-derived mast cells (BMMCs) from DPPI +/+ and DPPI -/- mice. We find that DPPI -/- mast cells contain normal amounts of immunoreactive chymases but no chymase activity, indicating that DPPI is essential for chymase activation and suggesting that DPPI -/- mice are functional chymase knockouts. The absence of DPPI and chymase activity does not affect the growth, granularity, or staining characteristics of BMMCs and, despite prior predictions, does not alter IgE-mediated exocytosis of histamine. In contrast, the level of active tryptase (mMCP-6) in DPPI -/- BMMCs is 25% that of DPPI +/- BMMCs. These findings indicate that DPPI is not essential for mMCP-6 activation but does influence the total amount of active mMCP-6 in mast cells and therefore may be an important, but not exclusive mechanism for tryptase activation.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wolters, PJ (corresponding author), Univ Calif San Francisco, Dept Med, Box 0911, San Francisco, CA 94143 USA.		Wolters, Paul/A-7181-2009		NHLBI NIH HHS [HL-04055, HL-24136, HL-03774, K08 HL004055] Funding Source: Medline; NIDDK NIH HHS [DK-49786] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004055, P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049786] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; CAUGHEY GH, 1994, AM J RESP CRIT CARE, V150, P138; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; DIKOV MM, 1994, J BIOL CHEM, V269, P25897; Fang KC, 1996, J CLIN INVEST, V97, P1589, DOI 10.1172/JCI118583; HANEKE E, 1979, HUM GENET, V51, P1, DOI 10.1007/BF00278288; Hart TC, 1999, J MED GENET, V36, P881; He SH, 1999, J PHARMACOL EXP THER, V291, P517; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; Hunt JE, 1997, J BIOL CHEM, V272, P29158, DOI 10.1074/jbc.272.46.29158; Khiav BE, 1998, BRIT J PHARMACOL, V123, P1267; KIDO H, 1985, BIOCHEM INT, V10, P863; Kummer JA, 1996, J BIOL CHEM, V271, P9281, DOI 10.1074/jbc.271.16.9281; LEDER L-D, 1979, American Journal of Dermatopathology, V1, P39; McEuen AR, 1998, EUR J BIOCHEM, V253, P300, DOI 10.1046/j.1432-1327.1998.2530300.x; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; MCGUIRE MJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P280, DOI 10.1016/0003-9861(92)90519-3; MCNEIL HP, 1992, J IMMUNOL, V149, P2466; McQueney MS, 1997, J BIOL CHEM, V272, P13955, DOI 10.1074/jbc.272.21.13955; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; MURAKAMI M, 1995, J BIOL CHEM, V270, P2218, DOI 10.1074/jbc.270.5.2218; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; RAZIN E, 1984, J IMMUNOL, V132, P1479; Sakai K, 1996, J CLIN INVEST, V97, P988, DOI 10.1172/JCI118523; SCHICK B, 1984, J IMMUNOL, V132, P2571; SCHWARTZ LB, 1981, J IMMUNOL, V126, P1290; Scudamore CL, 1997, AM J PATHOL, V150, P1661; SERAFIN WE, 1991, P NATL ACAD SCI USA, V88, P5984, DOI 10.1073/pnas.88.14.5984; SMYTH MJ, 1995, J IMMUNOL, V154, P6299; Springman E. B, 1995, MAST CELL PROTEASES, P169; STEVENS RL, 1994, P NATL ACAD SCI USA, V91, P128, DOI 10.1073/pnas.91.1.128; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Valchanov KP, 1999, J HISTOCHEM CYTOCHEM, V47, P617, DOI 10.1177/002215549904700504; Wolters PJ, 1998, J BIOL CHEM, V273, P15514, DOI 10.1074/jbc.273.25.15514; Wong UW, 1999, J BIOL CHEM, V274, P30784, DOI 10.1074/jbc.274.43.30784	39	153	160	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18551	18556		10.1074/jbc.M100223200	http://dx.doi.org/10.1074/jbc.M100223200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279033	hybrid			2022-12-27	WOS:000168866500124
J	Arlt, W; Auchus, RJ; Miller, WL				Arlt, W; Auchus, RJ; Miller, WL			Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3 beta-hydroxysteroid dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC-OVARY-SYNDROME; ACTIVATED RECEPTOR-GAMMA; DEPENDENT DIABETES-MELLITUS; INSULIN-RESISTANCE; 17,20-LYASE ACTIVITY; RESPIRATORY-CHAIN; CYTOCHROME B(5); OBESE WOMEN; 17-ALPHA-HYDROXYLASE; TROGLITAZONE	Androgen biosynthesis requires 3 beta -hydroxysteroid dehydrogenase type II (3 beta HSDII) and the 17 alpha -hydroxylase and 17,20-lyase activities of cytochrome P450c17. Thiazolidinedione and biguanide drugs, which are used to increase insulin sensitivity in type 2 diabetes, lower serum androgen concentrations in women with polycystic ovary syndrome. However, it is unclear whether this is secondary to increased insulin sensitivity or to direct effects on steroidogenesis, To investigate potential actions of these drugs on P450c17 and 3 beta HSDII, we used "humanized yeast" that express these steroidogenic enzymes in microsomal environments. The biguanide metformin had no effect on either enzyme, whereas the thiazolidinedione troglitazone inhibited 3 beta HSDII (K-I = 25.4 +/- 5.1 muM) and both activities of P450c17 (K-I for 17 alpha -hydroxylase, 8.4 +/- 0.6 muM; K-I for 17,20-lyase, 5.3 +/- 0.7 mum) The action of troglitazone on P450c17 was competitive, but it was mainly a noncompetitive inhibitor of 3 beta HSDII, The thiazolidinediones rosiglitazone and pioglitazone exerted direct but weaker inhibitory effects on both P450c17 and 3 beta HSDII, These differential effects of the thiazolidinediones do not correlate with their effects on insulin sensitivity, suggesting that distinct regions of the thiazolidinedione molecule mediate these two actions. Thus, thiazolidinediones inhibit two key enzymes in human androgen synthesis contributing to their androgen-lowering effects, whereas metformin affects androgen synthesis indirectly, probably by lowering circulating insulin concentrations.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA; Univ Texas, SW Med Ctr, Dept Med, Dallas, TX 75390 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Miller, WL (corresponding author), Univ Calif San Francisco, Dept Pediat, Bldg MR-4,Rm 209, San Francisco, CA 94143 USA.	wlmlab@itsa.ucsf.edu	Arlt, Wiebke/B-6310-2009; Miller, Walter L/J-3696-2012	Arlt, Wiebke/0000-0001-5106-9719; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD034449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002387, R01DK037922] Funding Source: NIH RePORTER; NICHD NIH HHS [U54-HD 34449] Funding Source: Medline; NIDDK NIH HHS [R01-DK 37922, K08-DK 02387] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Berger J, 1996, ENDOCRINOLOGY, V137, P4189, DOI 10.1210/en.137.10.4189; Camp HS, 2000, DIABETES, V49, P539, DOI 10.2337/diabetes.49.4.539; CHUNG BC, 1987, P NATL ACAD SCI USA, V84, P407, DOI 10.1073/pnas.84.2.407; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Cox PJ, 2000, DRUG METAB DISPOS, V28, P772; CRAVE JC, 1995, J CLIN ENDOCR METAB, V80, P2057, DOI 10.1210/jc.80.7.2057; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Dixon M., 1979, ENZYMES, Vthird; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Dunaif A, 1996, J CLIN ENDOCR METAB, V81, P3299, DOI 10.1210/jc.81.9.3299; EHRMANN DA, 1995, ENDOCR REV, V16, P322, DOI 10.1210/er.16.3.322; Ehrmann DA, 1997, J CLIN ENDOCR METAB, V82, P2108, DOI 10.1210/jc.82.7.2108; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HADFIELD C, 1986, GENE, V45, P149, DOI 10.1016/0378-1119(86)90249-0; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; KIDDY DS, 1992, CLIN ENDOCRINOL, V36, P105, DOI 10.1111/j.1365-2265.1992.tb02909.x; la Marca A, 2000, HUM REPROD, V15, P21, DOI 10.1093/humrep/15.1.21; Lee TC, 1999, J CLIN ENDOCR METAB, V84, P2104, DOI 10.1210/jc.84.6.2104; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; LIN D, 1991, J BIOL CHEM, V266, P15992; LIN D, 1993, ENDOCRINOLOGY, V132, P2498, DOI 10.1210/en.132.6.2498; Loi CM, 1999, J CLIN PHARMACOL, V39, P920, DOI 10.1177/00912709922008533; Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Nestler JE, 1996, NEW ENGL J MED, V335, P617, DOI 10.1056/NEJM199608293350902; Nestler JE, 1997, J CLIN ENDOCR METAB, V82, P4075, DOI 10.1210/jc.82.12.4075; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Penning TM, 1997, ENDOCR REV, V18, P281, DOI 10.1210/er.18.3.281; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; RHEAUME E, 1991, MOL ENDOCRINOL, V5, P1147, DOI 10.1210/mend-5-8-1147; Sambol NC, 1996, J CLIN PHARMACOL, V36, P1012, DOI 10.1177/009127009603601105; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; THOMAS JL, 1989, J STEROID BIOCHEM, V33, P209, DOI 10.1016/0022-4731(89)90296-3; VELAZQUEZ EM, 1994, METABOLISM, V43, P647, DOI 10.1016/0026-0495(94)90209-7; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; ZUBER MX, 1986, SCIENCE, V234, P1258, DOI 10.1126/science.3535074	41	126	137	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16767	16771		10.1074/jbc.M100040200	http://dx.doi.org/10.1074/jbc.M100040200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278997	hybrid			2022-12-27	WOS:000168730400024
J	Mukhin, YV; Vlasova, T; Jaffa, AA; Collinsworth, G; Bell, JL; Tholanikunnel, BG; Pettus, T; Fizgibbon, W; Ploth, DW; Raymond, JR; Garnovskaya, MN				Mukhin, YV; Vlasova, T; Jaffa, AA; Collinsworth, G; Bell, JL; Tholanikunnel, BG; Pettus, T; Fizgibbon, W; Ploth, DW; Raymond, JR; Garnovskaya, MN			Bradykinin B-2 receptors activate Na+/H+ exchange in mIMCD-3 cells via Janus kinase 2 aHld Ca2+/calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-STIMULATED PHOSPHORYLATION; EPIDERMAL-GROWTH-FACTOR; COLLECTING DUCT CELLS; PROTEIN-KINASE; TYROSINE RESIDUES; 5-HT1A RECEPTOR; ISOFORM-1 NHE1; CALMODULIN; SITES; IDENTIFICATION	We used a cultured murine cell model of the inner medullary collecting duct (mIMCD-3 cells) to examine the regulation of the ubiquitous sodium-proton exchanger, Na+/H+ exchanger isoform 1 (NHE-1), by a prototypical G protein-coupled receptor, the bradykinin B, receptor. Bradykinin rapidly activates NHE-1 in a concentration-dependent manner as assessed by proton microphysiometry of quiescent cells and by 2'-7'-bis[2-carboxymethyl]-5(6)-carboxyfluorescein fluorescence measuring the accelerated rate of pH, recovery from an imposed acid load. The activation of NHE-1 is blocked by inhibitors of the bradykinin B, receptor, phospholipase C, Ca2+/calmodulin (CaM), and Janus kinase 2 (Jak2), but not by pertussis toxin or by inhibitors of protein kinase C and phosphatidylinositol 3'-kinase, Immunoprecipitation studies showed that bradykinin stimulates the assembly of a signal transduction complex that includes CaM, Jak2, and NHE-1, CaM appears to be a direct substrate for phosphorylation by Jak2 as measured by an in vitro kinase assay. We propose that Jak2 is a new indirect regulator of NHE-1 activity, which modulates the activity of NHE-1 by increasing the tyrosine phosphorylation of Ca2+ and most likely by increasing the binding of CaM to NHE-1.	Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; Med Univ S Carolina, Div Endocrinol, Dept Med, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA; Med Univ S Carolina, Ralph H Johnson Vet Affairs Med Ctr, Med Serv, Charleston, SC 29425 USA; Med Univ S Carolina, Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Garnovskaya, MN (corresponding author), Med Univ S Carolina, Dept Med, Div Nephrol, Rm 829 CSB,171 Ashley Ave, Charleston, SC 29425 USA.			Garnovskaya, Maria/0000-0002-6216-038X	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK002694, R56DK052448, R01DK052448] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR13005] Funding Source: Medline; NIDDK NIH HHS [DK52448, K01-DK02694] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aharonovitz O, 1996, J BIOL CHEM, V271, P16494, DOI 10.1074/jbc.271.28.16494; BARBER DL, 1991, CELL SIGNAL, V3, P387, DOI 10.1016/0898-6568(91)90069-7; Benaim G, 1998, COMP BIOCHEM PHYS C, V120, P57, DOI 10.1016/S0742-8413(98)00006-1; BENGURIA A, 1994, EUR J BIOCHEM, V224, P909, DOI 10.1111/j.1432-1033.1994.00909.x; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Bianchini L, 1997, J BIOL CHEM, V272, P271; BORON WF, 1977, AM J PHYSIOL, V233, pC61, DOI 10.1152/ajpcell.1977.233.3.C61; Bouaboula M, 1999, FEBS LETT, V449, P61, DOI 10.1016/S0014-5793(99)00395-6; Briand SI, 1996, J CELL BIOCHEM, V63, P292, DOI 10.1002/(SICI)1097-4644(19961201)63:3<292::AID-JCB4>3.0.CO;2-S; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P166; Corti C, 1999, EUR J BIOCHEM, V262, P790, DOI 10.1046/j.1432-1327.1999.00441.x; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DHANASEKARAN N, 1994, J BIOL CHEM, V269, P11802; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; FUKAMI Y, 1986, P NATL ACAD SCI USA, V83, P4190, DOI 10.1073/pnas.83.12.4190; Garnovskaya MN, 1998, BIOCHEM J, V330, P489; Garnovskaya MN, 1997, J BIOL CHEM, V272, P7770, DOI 10.1074/jbc.272.12.7770; Gupta A, 1996, BONE, V18, P87, DOI 10.1016/8756-3282(95)00455-6; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; HOCK FJ, 1991, BRIT J PHARMACOL, V102, P769, DOI 10.1111/j.1476-5381.1991.tb12248.x; Joyal JL, 1996, BIOCHEMISTRY-US, V35, P6267, DOI 10.1021/bi9600198; KITAMURA K, 1995, AM J PHYSIOL, V268, P101; Kusuhara M, 1998, CIRC RES, V83, P824, DOI 10.1161/01.RES.83.8.824; Marrero MB, 1997, J BIOL CHEM, V272, P24684, DOI 10.1074/jbc.272.39.24684; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; Mukai H, 1996, AM J PHYSIOL-REG I, V271, pR352, DOI 10.1152/ajpregu.1996.271.2.R352; Naidu PS, 1999, AM J PHYSIOL-HEART C, V277, pH1061, DOI 10.1152/ajpheart.1999.277.3.H1061; NOEL J, 1995, AM J PHYSIOL-CELL PH, V268, pC283, DOI 10.1152/ajpcell.1995.268.2.C283; Paillard M, 1997, EXP NEPHROL, V5, P277; Prpic V, 1998, AM J PHYSIOL-GASTR L, V275, pG689, DOI 10.1152/ajpgi.1998.275.4.G689; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Reshkin SJ, 2000, J BIOL CHEM, V275, P5361, DOI 10.1074/jbc.275.8.5361; Ruhfus B, 1998, IN VITRO CELL DEV-AN, V34, P227; SACKS DB, 1989, BIOCHEM J, V263, P803, DOI 10.1042/bj2630803; SACKS DB, 1995, BIOCHEM J, V312, P197, DOI 10.1042/bj3120197; SACKS DB, 1992, BIOCHEM J, V286, P211, DOI 10.1042/bj2860211; Sacks DB, 1996, EUR J BIOCHEM, V239, P98, DOI 10.1111/j.1432-1033.1996.0098u.x; SARDET C, 1991, J BIOL CHEM, V266, P19166; Sauvage M, 2000, EUR J BIOCHEM, V267, P955, DOI 10.1046/j.1432-1327.2000.01084.x; SAVILLE MK, 1994, BIOCHEM J, V299, P863, DOI 10.1042/bj2990863; Schroeder K.S., 1996, J BIOMOL SCREEN, V1, P75, DOI DOI 10.1177/108705719600100205; SHRODE LD, 1995, AM J PHYSIOL-CELL PH, V269, pC257, DOI 10.1152/ajpcell.1995.269.1.C257; SLOTKI IN, 1990, AM J PHYSIOL, V259, pF666, DOI 10.1152/ajprenal.1990.259.4.F666; Snabaitis AK, 2000, CIRC RES, V86, P214, DOI 10.1161/01.RES.86.2.214; SOLEIMANI M, 1994, J BIOL CHEM, V269, P27973; Sun AM, 1998, J MEMBRANE BIOL, V164, P293, DOI 10.1007/s002329900414; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P5583	51	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17339	17346		10.1074/jbc.M010834200	http://dx.doi.org/10.1074/jbc.M010834200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278760	hybrid			2022-12-27	WOS:000168730400099
J	de Beer, MC; Durbin, DM; Cai, L; Mirocha, N; Jonas, A; Webb, NR; de Beer, FC; van der Westhuyzen, R				de Beer, MC; Durbin, DM; Cai, L; Mirocha, N; Jonas, A; Webb, NR; de Beer, FC; van der Westhuyzen, R			Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B TYPE-I; ESTER TRANSFER PROTEIN; CELLULAR CHOLESTEROL EFFLUX; SR-BI; HDL RECEPTOR; LPA-I; TARGETED MUTATION; TRANSGENIC MICE; PARTICLES; AII	High density lipoprotein (HDL) represents a mixture of particles containing either apoA-I and apoA-II (LpA-I/A-II) or apoA-I without apoA-II (LpA-I). Differences in the function and metabolism of LpA-I and LpA-I/A-II have been reported, and studies in transgenic mice have suggested that apoA-II is pro-atherogenic in contrast to anti-atherogenic apoA-I. The molecular basis for these observations is unclear. The scavenger receptor BI (SR-BI) is an HDL receptor that plays a key role in HDL metabolism. In this study we investigated the abilities of apoA-I and apoA-II to mediate SR-BI-specific binding and selective uptake of cholesterol ester using reconstituted HDLs (rHDLs) that were homogeneous in size and apolipoprotein content. Particles were labeled in the protein (with I-125) and in the lipid (with [H-3]cholesterol ether) components and SR-BI-specific events were analyzed in SR-BI-transfected Chinese hamster ovary cells. At 1 mug/ml apolipoprotein, SR-BI-mediated cell association of palmitoyloleoylphosphatidylcholine-containing AI-rHDL was significantly greater (3-fold) than that of AI/AII-rHDL, with a lower K-d and a higher B-max for AI-rHDL as compared with AI/AII-rHDL. Unexpectedly, selective cholesterol ester uptake from AI/AII-rHDL was not compromised compared with AI-rHDL, despite decreased binding. The efficiency of selective cholesterol ester uptake in terms of SR-BI-associated rHDL was 4-5-fold greater for AI/AII-rHDL than AI-rHDL. These results are consistent with a two-step mechanism in which SR-BI binds ligand and then mediates selective cholesterol ester uptake with an efficiency dependent on the composition of the ligand, ApoA-II decreases binding but increases selective uptake. These findings show that apoA-II can exert a significant influence on selective cholesterol ester uptake by SR-BI and may consequently influence the metabolism and function of HDL, as well as the pathway of reverse cholesterol transport.	Univ Kentucky, Med Ctr, Dept Internal Med, Lexington, KY 40536 USA; Dept Vet Affair Med Ctr, Lexington, KY 40511 USA; Univ Illinois, Coll Med, Dept Biochem, Urbana, IL 61801 USA	University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Illinois System; University of Illinois Urbana-Champaign	van der Westhuyzen, R (corresponding author), Univ Kentucky, Med Ctr, Dept Internal Med, MN520,800 Rose St, Lexington, KY 40536 USA.	dvwest1@pop.uky.edu	Webb, Nancy/AAL-7030-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059376, R01HL016059, R01HL063763] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-16059, HL-59376, HL-63763] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Arai T, 1999, P NATL ACAD SCI USA, V96, P12050, DOI 10.1073/pnas.96.21.12050; BARBARAS R, 1987, BIOCHEM BIOPH RES CO, V142, P63, DOI 10.1016/0006-291X(87)90451-7; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BLANCHE PJ, 1988, BIOCHIM BIOPHYS ACTA, V958, P143, DOI 10.1016/0005-2760(88)90171-3; BU XD, 1994, HUM GENET, V93, P639, DOI 10.1007/BF00201563; Calvo D, 1998, J LIPID RES, V39, P777; CHEUNG MC, 1984, J BIOL CHEM, V259, P2201; de Beer FC, 2000, J LIPID RES, V41, P1849; de Beer MC, 2001, J LIPID RES, V42, P309; Durbin DM, 1997, J BIOL CHEM, V272, P31333, DOI 10.1074/jbc.272.50.31333; FIELDING CJ, 1995, J LIPID RES, V36, P211; FRANCONE OL, 1995, J CLIN INVEST, V96, P1440, DOI 10.1172/JCI118180; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Greene DJ, 2001, J BIOL CHEM, V276, P4804, DOI 10.1074/jbc.M008725200; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; LAGROST L, 1994, J BIOL CHEM, V269, P3189; LAGROST L, 1995, J BIOL CHEM, V270, P13004, DOI 10.1074/jbc.270.22.13004; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; MAHLBERG FH, 1992, J BIOL CHEM, V267, P4541; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MEHRABIAN M, 1993, ARTERIOSCLER THROMB, V13, P1, DOI 10.1161/01.ATV.13.1.1; OIKAWA S, 1993, BIOCHIM BIOPHYS ACTA, V1165, P327, DOI 10.1016/0005-2760(93)90144-X; PIETERS MN, 1993, BIOCHEM J, V292, P819, DOI 10.1042/bj2920819; PIETERS MN, 1994, BBA-MOL BASIS DIS, V1225, P125, DOI 10.1016/0925-4439(94)90069-8; Pilon A, 2000, ARTERIOSCL THROM VAS, V20, P1074, DOI 10.1161/01.ATV.20.4.1074; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; POWNALL HJ, 1986, METHOD ENZYMOL, V128, P515; RADER DJ, 1991, J LIPID RES, V32, P1849; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rinninger F, 1998, BBA-LIPID LIPID MET, V1393, P277, DOI 10.1016/S0005-2760(98)00082-4; SCHULTZ JR, 1993, NATURE, V365, P762, DOI 10.1038/365762a0; STEIN O, 1995, BBA-LIPID LIPID MET, V1257, P174, DOI 10.1016/0005-2760(95)00069-O; Tailleux A, 2000, ARTERIOSCL THROM VAS, V20, P2453, DOI 10.1161/01.ATV.20.11.2453; Tall AR, 1998, EUR HEART J, V19, pA31; Urban S, 2000, J BIOL CHEM, V275, P33409, DOI 10.1074/jbc.M004031200; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; WARDEN CH, 1993, SCIENCE, V261, P469, DOI 10.1126/science.8332912; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; Weigel P H, 1993, Subcell Biochem, V19, P125; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; Williams DL, 2000, J BIOL CHEM, V275, P18897, DOI 10.1074/jbc.M002411200; Xu SZ, 1997, J LIPID RES, V38, P1289; ZHONG SB, 1994, J CLIN INVEST, V94, P2457, DOI 10.1172/JCI117614	50	58	58	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15832	15839		10.1074/jbc.M100228200	http://dx.doi.org/10.1074/jbc.M100228200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279034	hybrid			2022-12-27	WOS:000168623100036
J	Inagaki, Y; Nemoto, T; Nakao, A; ten Dijke, P; Kobayashi, K; Takehara, K; Greenwel, P				Inagaki, Y; Nemoto, T; Nakao, A; ten Dijke, P; Kobayashi, K; Takehara, K; Greenwel, P			Interaction between GC box binding factors and smad proteins modulates cell lineage-specific alpha 2(I) collagen gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; HUMAN SKIN FIBROBLASTS; NECROSIS-FACTOR-ALPHA; FAT-STORING CELLS; TGF-BETA; FUNCTIONAL-ANALYSIS; ENDOTHELIAL-CELLS; SP1; PROMOTER; EXPRESSION	Type I collagen is produced predominantly in mesenchymal cells, but molecular mechanisms responsible for cell type-specific expression are virtually unknown. During fibrogenic process in the liver, activated hepatic stellate cells (HSC) are the main producers of type I collagen, whereas parenchymal hepatocytes produce little, if any, of this protein. We have previously reported that Sp1 and an interacting unknown factor(s) bind to the -313 to -255 sequence of the alpha2(I) collagen gene (COL1A2) and play essential roles for basal and TGF-beta -stimulated transcription in skin fibroblasts and HSC. Recently, Smad3 has been shown to bind to this region, and its interaction with Sp1 has been implicated in TGF-beta -elicited COL1A2 stimulation. The present study demonstrates predominant binding of Sp3 rather than Sp1 to this regulatory element in parenchymal hepatocytes. In these cells, this region did not exhibit strong enhancer activity or mediate the effect of TGF-beta, Transfection of HSC with an Sp3 expression plasmid abolished the COL1A2 response to TGF-beta, whereas overexpression of Spl in hepatocytes increased basal COL1A2 transcription and conferred TGF-beta responsiveness. Functional and physical interactions between Sp1 and Smad3, but not between Sp3 and Smad3, were demonstrated using the bacterial GAL4 system and immunoprecipitation-Western blot analyses. These results indicate that cell lineage-specific interactions between GC box binding factors and Smad protein(s) may account, at least in part, for differential COL1A2 transcription and TGF-beta responsiveness in HSC and parenchymal hepatocytes.	Natl Kanazawa Hosp, Dept Internal Med, Kanazawa, Ishikawa 9208650, Japan; Kanazawa Univ, Sch Med, Dept Dermatol, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Sch Med, Dept Internal Med 1, Kanazawa, Ishikawa 9208640, Japan; Juntendo Univ, Sch Med, Allergy Res Ctr, Tokyo 1138421, Japan; Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands; Mt Sinai Sch Med, Dept Biochem & Mol Biol, Brookdale Ctr, New York, NY 10029 USA	Kanazawa University; Kanazawa University; Juntendo University; Netherlands Cancer Institute; Icahn School of Medicine at Mount Sinai	Inagaki, Y (corresponding author), Natl Kanazawa Hosp, Dept Internal Med, 1-1 Shimoishibiki Machi, Kanazawa, Ishikawa 9208650, Japan.		Dijke, Peter ten/AAG-4660-2021	Dijke, Peter ten/0000-0002-7234-342X	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012196] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA12196] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BOAST S, 1990, J BIOL CHEM, V265, P13351; Chen SJ, 1998, GENE, V215, P101, DOI 10.1016/S0378-1119(98)00268-6; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; ELDER GA, 1992, NUCLEIC ACIDS RES, V20, P6281, DOI 10.1093/nar/20.23.6281; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; FRIEDMAN SL, 1990, SEMIN LIVER DIS, V10, P20, DOI 10.1055/s-2008-1040454; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Greenwel P, 1997, J BIOL CHEM, V272, P19738, DOI 10.1074/jbc.272.32.19738; Greenwel P, 2000, MOL CELL BIOL, V20, P912, DOI 10.1128/MCB.20.3.912-918.2000; GREENWEL P, 1991, LAB INVEST, V65, P644; GREENWEL P, 1993, LAB INVEST, V69, P210; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hasegawa T, 1996, NUCLEIC ACIDS RES, V24, P3253, DOI 10.1093/nar/24.16.3253; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HOUGLUM K, 1995, J CLIN INVEST, V96, P2269, DOI 10.1172/JCI118282; Ihn H, 1996, J BIOL CHEM, V271, P26717, DOI 10.1074/jbc.271.43.26717; Ihn H, 1997, NUCLEIC ACIDS RES, V25, P3712, DOI 10.1093/nar/25.18.3712; INAGAKI Y, 1995, J BIOL CHEM, V270, P3353, DOI 10.1074/jbc.270.7.3353; INAGAKI Y, 1995, HEPATOLOGY, V22, P573, DOI 10.1016/0270-9139(95)90582-0; Inagaki Y, 1998, BIOCHEM BIOPH RES CO, V250, P606, DOI 10.1006/bbrc.1998.9345; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; Inagaki Y, 2001, J CELL PHYSIOL, V187, P117, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1059>3.0.CO;2-S; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MAHER JJ, 1988, J CLIN INVEST, V82, P450, DOI 10.1172/JCI113618; MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; MILANI S, 1989, HEPATOLOGY, V10, P84, DOI 10.1002/hep.1840100117; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; MURATA Y, 1994, J BIOL CHEM, V269, P20674; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; RAMIREZ F, 1990, FASEB J, V4, P1616, DOI 10.1096/fasebj.4.6.2180769; Sowa Y, 1999, CANCER RES, V59, P4266; SUMMERFIELD JA, 1982, J CLIN INVEST, V69, P1337, DOI 10.1172/JCI110573; TAKAHARA T, 1988, LAB INVEST, V59, P509; TRUTER S, 1992, J BIOL CHEM, V267, P25389; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200	45	59	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16573	16579		10.1074/jbc.M010485200	http://dx.doi.org/10.1074/jbc.M010485200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278686	hybrid			2022-12-27	WOS:000168623100134
J	Zheng, J; Gilbert, HF				Zheng, J; Gilbert, HF			Discrimination between native and non-native disulfides by protein-disulfide isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; ACTIVE-SITE CYSTEINE; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONES; RIBONUCLEASE-A; CATALYSIS; BONDS; ISOMERIZATION; RESIDUES; MUTANTS	The folding assistant and chaperone protein-disulfide isomerase (PDI) catalyzes disulfide formation, reduction, and isomerization of misfolded proteins. PDI substrates are not restricted to misfolded proteins; PDI catalyzes the dithiothreitol (DTT)-dependent reduction of native ribonuclease A, microbial ribonuclease, and pancreatic trypsin inhibitor, suggesting that an ongoing surveillance by PDI can test even native disulfides for their ability to rearrange. The mechanism of reduction is consistent with an equilibrium unfolding of the substrate, attack by the nucleophilic cysteine of PDI followed by direct attack of DTT on a covalent intermediate between PDI and the substrate. For native proteins, the rate constants for PDI-catalyzed reduction correlate very well with the rate constants for uncatalyzed reduction by DTT. However, the rate is weakly correlated with disulfide stability, surface exposure, or local disorder in the crystal. Compared with native proteins, scrambled ribonuclease is a much better substrate for PDI than predicted from its reactivity with DTT; however, partially reduced bovine pancreatic trypsin inhibitor (des(14-38)) is not. An extensively unfolded polypeptide may be required by PDI to distinguish native from non-native disulfides.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA	Baylor College of Medicine	Gilbert, HF (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA.				NIGMS NIH HHS [GM40379] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040379] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buchner J, 1996, FASEB J, V10, P10, DOI 10.1096/fasebj.10.1.8566529; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; CREIGHTON TE, 1984, J MOL BIOL, V179, P497, DOI 10.1016/0022-2836(84)90077-9; CREIGHTON TE, 1980, NATURE, V284, P487, DOI 10.1038/284487a0; CREIGHTON TE, 1974, J MOL BIOL, V87, P563, DOI 10.1016/0022-2836(74)90104-1; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; GASPERIK J, 1982, BIOLOGIA, V37, P377; Gilbert H F, 1991, Protein Expr Purif, V2, P194, DOI 10.1016/1046-5928(91)90071-P; Gilbert HF, 1994, MECH PROTEIN FOLDING, P104; GOLDENBERG DP, 1988, BIOCHEMISTRY-US, V27, P2481, DOI 10.1021/bi00407a034; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; HURLE MR, 1990, BIOCHEMISTRY-US, V29, P4410, DOI 10.1021/bi00470a021; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Iwaoka M, 1999, BIOCHEMISTRY-US, V38, P2805, DOI 10.1021/bi982593k; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; LI YJ, 1995, NAT STRUCT BIOL, V2, P489, DOI 10.1038/nsb0695-489; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Martin J, 1997, CURR OPIN STRUC BIOL, V7, P41, DOI 10.1016/S0959-440X(97)80006-1; MENDOZA JA, 1994, BIOCHEMISTRY-US, V33, P1143, DOI 10.1021/bi00171a013; NOIVA R, 1992, J BIOL CHEM, V267, P3553; Pace CN, 1998, J MOL BIOL, V279, P271, DOI 10.1006/jmbi.1998.1760; REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; SHAFFER SW, 1975, J BIOL CHEM, V250, P8483; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; WALKER KW, 1995, BIOCHEMISTRY-US, V34, P13642, DOI 10.1021/bi00041a045; WUNDERLICH M, 1995, J MOL BIOL, V247, P28, DOI 10.1006/jmbi.1995.0119; Zahn R, 1996, SCIENCE, V271, P642, DOI 10.1126/science.271.5249.642; ZAPUN A, 1994, BIOCHEMISTRY-US, V33, P1907, DOI 10.1021/bi00173a038	32	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15747	15752		10.1074/jbc.M011444200	http://dx.doi.org/10.1074/jbc.M011444200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278905	hybrid			2022-12-27	WOS:000168623100025
J	Horiuchi, M; Baron, GS; Xiong, LW; Caughey, B				Horiuchi, M; Baron, GS; Xiong, LW; Caughey, B			Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE CONVERSION; IN-VITRO FORMATION; SECONDARY STRUCTURE; RESISTANT PRP; SCRAPIE; MICE; TRANSMISSION; REPLICATION; DISEASE; BARRIER	The formation of protease-resistant prion protein (PrP-res or PrPSc) involves selective interactions between PrP-res and its normal protease-sensitive counterpart, PrP-sen or PrPC. Previous studies have shown that synthetic peptide fragments of the PrP sequence corresponding to residues 119-136 of hamster PrP (Ha119-136) can selectively block PrP-res formation in cell-free systems and scrapie-infected tissue culture cells. Here we show that two other peptides corresponding to residues 166-179 (Ha166-179) and 200-223 (Ha200-223) also potently inhibit the PrP-res induced cell-free conversion of PrP-sen to the protease-resistant state. In contrast, Ha121-141, Ha180-199, and Ha218-232 were much less effective as inhibitors. Mechanistic analyses indicated that Ha166-179, Ha200-223, and peptides containing residues 119-136 inhibit primarily by binding to PrP-sen and blocking its binding to PrP-res, Circular dichroism analyses indicated that Ha117-141 and Ha200-223, but not non-inhibitory peptides, readily formed high beta -sheet structures when placed under the conditions of the conversion reaction, We conclude that these inhibitory peptides may mimic contact surfaces between PrP-res and PrP-sen and thereby serve as models of potential therapeutic agents for transmissible spongiform encephalopathies.	NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; Obihiro Univ Agr & Vet Med, Dept Vet Publ Hlth, Obihiro, Hokkaido 0808555, Japan; Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Obihiro University of Agriculture & Veterinary Medicine; Obihiro University of Agriculture & Veterinary Medicine	Caughey, B (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, 903 S 4th St, Hamilton, MT 59840 USA.	bcaughey@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000580, ZIAAI000580] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bossers A, 1996, J GEN VIROL, V77, P2669, DOI 10.1099/0022-1317-77-10-2669; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caughey B, 1999, MOL BIOTECHNOL, V13, P45, DOI 10.1385/MB:13:1:45; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Chabry J, 1998, J BIOL CHEM, V273, P13203, DOI 10.1074/jbc.273.21.13203; Chabry J, 1999, J VIROL, V73, P6245, DOI 10.1128/JVI.73.8.6245-6250.1999; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Demaimay R, 2000, ARCH VIROL, P277; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; GIACCONE G, 1992, P NATL ACAD SCI USA, V89, P9349, DOI 10.1073/pnas.89.19.9349; GOLDFARB LG, 1993, P NATL ACAD SCI USA, V90, P4451, DOI 10.1073/pnas.90.10.4451; Holscher C, 1998, J VIROL, V72, P1153; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Kaneko K, 1997, J MOL BIOL, V270, P574, DOI 10.1006/jmbi.1997.1135; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; KANEKO K, 1995, P NATL ACAD SCI USA, V92, P11160, DOI 10.1073/pnas.92.24.11160; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P525, DOI 10.1006/bbrc.1993.1447; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; MURAMOTO T, 1993, J VIROL, V67, P6808, DOI 10.1128/JVI.67.11.6808-6810.1993; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Perrier V, 2000, P NATL ACAD SCI USA, V97, P6073, DOI 10.1073/pnas.97.11.6073; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Soto C, 2000, LANCET, V355, P192, DOI 10.1016/S0140-6736(99)11419-3; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; ZHANG H, 1995, J MOL BIOL, V250, P514, DOI 10.1006/jmbi.1995.0395	42	63	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15489	15497		10.1074/jbc.M100288200	http://dx.doi.org/10.1074/jbc.M100288200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279046	hybrid			2022-12-27	WOS:000168528800127
J	Mizuguchi, G; Vassilev, A; Tsukiyama, T; Nakatani, Y; Wu, C				Mizuguchi, G; Vassilev, A; Tsukiyama, T; Nakatani, Y; Wu, C			ATP-dependent nucleosome remodeling and histone hyperacetylation synergistically facilitate transcription of chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RNA-POLYMERASE-II; SOLUBLE NUCLEAR FRACTION; SWI-SNF COMPLEX; ACETYLTRANSFERASE COMPLEXES; IN-VITRO; YEAST GCN5P; FACTOR NURF; ACETYLATION; ACTIVATION; ISWI	Drosophila nucleosome remodeling factor (NURF) is an ISWI-containing protein complex that facilitates nucleosome mobility and transcriptional activation in an ATP-dependent manner. Numerous studies have implicated histone acetylation in transcriptional activation. We investigated the relative contributions of these two chromatin modifications to transcription in vitro of a chromatinized adenovirus E4 minimal promoter that contains binding sites for the GAL4-VP16 activator. We found that NURF could remodel chromatin and stimulate transcription irrespective of the acetylation status of histones, In contrast, hyperacetylation of histones in the absence of NURF was unable to stimulate transcription, suggesting that NURF-dependent chromatin remodeling is an obligatory step in E4 promoter activation. When chromatin templates were first hyperacetylated and then incubated with NURF, significantly greater transcription stimulation was observed. The results suggest that changes in chromatin induced by acetylation of histones and the mobilization of nucleosomes by NURF combine synergistically to facilitate transcription. Experiments using single and multiple rounds of transcription indicate that these chromatin modifications stimulate transcription preinitiation as well as reinitiation.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; NICHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kyoto University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Fred Hutchinson Cancer Center; Harvard University; Dana-Farber Cancer Institute	Wu, C (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	carlwu@helix.nih.gov						Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Armstrong JA, 1998, CURR OPIN GENET DEV, V8, P165, DOI 10.1016/S0959-437X(98)80137-8; Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Austin RJ, 1996, P NATL ACAD SCI USA, V93, P5788, DOI 10.1073/pnas.93.12.5788; BAKER CC, 1981, J MOL BIOL, V149, P189, DOI 10.1016/0022-2836(81)90298-9; BECKER PB, 1991, P NATL ACAD SCI USA, V88, P4109, DOI 10.1073/pnas.88.10.4109; BECKER PB, 1992, MOL CELL BIOL, V12, P2241, DOI 10.1128/MCB.12.5.2241; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Bustin M, 1999, MOL CELL BIOL, V19, P5237; CHASMAN DI, 1989, MOL CELL BIOL, V9, P4746, DOI 10.1128/MCB.9.11.4746; CONAWAY RC, 1990, J BIOL CHEM, V265, P7559; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Cote J, 1998, P NATL ACAD SCI USA, V95, P4947, DOI 10.1073/pnas.95.9.4947; Davie JR, 1998, CURR OPIN GENET DEV, V8, P173, DOI 10.1016/S0959-437X(98)80138-X; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; EVANS RM, 1977, CELL, V12, P733, DOI 10.1016/0092-8674(77)90273-2; Fletcher TM, 1996, CRIT REV EUKAR GENE, V6, P149, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.40; Gdula DA, 1998, GENE DEV, V12, P3206, DOI 10.1101/gad.12.20.3206; Georgel PT, 1997, EMBO J, V16, P4717, DOI 10.1093/emboj/16.15.4717; GRUNSTEIN M, 1990, ANNU REV CELL BIOL, V6, P643, DOI 10.1146/annurev.cellbio.6.1.643; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; GUO HL, 1993, J BIOL CHEM, V268, P18762; Guschin D, 1999, CURR BIOL, V9, pR742, DOI 10.1016/S0960-9822(99)80473-4; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; HANSEN SK, 1995, CELL, V82, P565, DOI 10.1016/0092-8674(95)90029-2; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Howe L, 1999, CRIT REV EUKAR GENE, V9, P231, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.80; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Ito T, 2000, GENE DEV, V14, P1899; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kal AJ, 2000, GENE DEV, V14, P1058; KAMAKAKA RT, 1993, GENE DEV, V7, P1779, DOI 10.1101/gad.7.9.1779; KAMAKAKA RT, 1991, P NATL ACAD SCI USA, V88, P1024, DOI 10.1073/pnas.88.3.1024; KAMAKAKA RT, 1994, METHOD CELL BIOL, V44, P225, DOI 10.1016/S0091-679X(08)60916-4; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cellbio.8.1.563; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Krajewski WA, 1998, P NATL ACAD SCI USA, V95, P1540, DOI 10.1073/pnas.95.4.1540; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Mizuguchi G, 1999, METH MOL B, V119, P333; Mizzen CA, 1998, CELL MOL LIFE SCI, V54, P6, DOI 10.1007/s000180050121; Nightingale KP, 1998, EMBO J, V17, P2865, DOI 10.1093/emboj/17.10.2865; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Okada M, 1998, MOL CELL BIOL, V18, P2455, DOI 10.1128/MCB.18.5.2455; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; Peterson CL, 1996, CURR OPIN GENET DEV, V6, P171, DOI 10.1016/S0959-437X(96)80047-5; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Ramakrishnan V, 1997, ANNU REV BIOPH BIOM, V26, P83, DOI 10.1146/annurev.biophys.26.1.83; Reines D, 1997, METHODS, V12, P192, DOI 10.1006/meth.1997.0471; Roberts SM, 1997, GENETICS, V147, P451; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; Steger DJ, 1998, P NATL ACAD SCI USA, V95, P12924, DOI 10.1073/pnas.95.22.12924; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Tyler JK, 1999, CELL, V99, P443, DOI 10.1016/S0092-8674(00)81530-5; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; VANHOLDE K, 1995, CHROMATIN STRUCTURE, P1; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Wade PA, 1997, CURR BIOL, V7, pR82, DOI 10.1016/S0960-9822(06)00042-X; Wallberg AE, 1999, MOL CELL BIOL, V19, P5952; WEINZIERL ROJ, 1993, NATURE, V362, P511, DOI 10.1038/362511a0; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Wu C, 1997, J BIOL CHEM, V272, P28171, DOI 10.1074/jbc.272.45.28171; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; ZHENG XM, 1987, CELL, V50, P361, DOI 10.1016/0092-8674(87)90490-9	104	51	51	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14773	14783		10.1074/jbc.M100125200	http://dx.doi.org/10.1074/jbc.M100125200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279013	hybrid			2022-12-27	WOS:000168528800034
J	Pequignot, MO; Desguerre, I; Dey, R; Tartari, M; Zeviani, M; Agostino, A; Benelli, C; Fouque, F; Prip-Buus, C; Marchant, D; Abitbol, M; Marsac, C				Pequignot, MO; Desguerre, I; Dey, R; Tartari, M; Zeviani, M; Agostino, A; Benelli, C; Fouque, F; Prip-Buus, C; Marchant, D; Abitbol, M; Marsac, C			New splicing-site mutations in the SURF1 gene in Leigh syndrome patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; DEFICIENCY	The gene SURF1 encodes a factor involved in the biogenesis of cytochrome c oxidase, the last complex in the respiratory chain. Mutations of the SURF1 gene result in Leigh syndrome and severe cytochrome c oxidase deficiency. Analysis of seven unrelated patients with cytochrome c oxidase deficiency and typical Leigh syndrome revealed different SURF1 mutations in four of them. Only these four cases had associated demyelinating neuropathy. Three mutations were novel splicing-site mutations that lead to the excision of exon 6. Two different novel heterozygous mutations were found at the same guanine residue at the donor splice site of intron 6; one was a deletion, whereas the other was a transition [588+1.G>A]. The third novel splicing-site mutation was a homozygous [516-2_516-1delAG] in intron 5. One patient only had a homozygous polymorphism in the middle of the intron 8 [835+25C>T]. Western blot analysis showed that Surf1 protein was absent in all four patients harboring mutations. Our studies confirm that the SURF1 gene is an important nuclear gene involved in the cytochrome c oxidase deficiency. We also show that Surf1 protein is not implicated in the assembly of other respiratory chain complexes or the pyruvate dehydrogenase complex.	Fac Med Necker, Lab CERTO, F-75015 Paris, France; Hop St Vincent de Paul, Serv Neuropediat, F-75014 Paris, France; CNRS, UPR 1524, F-92190 Meudon, France; Inst Nazl Neurol Carlo Besta, I-20133 Milan, Italy; Hop Necker, INSERM, U30, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); IRCCS Istituto Neurologico Besta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Marsac, C (corresponding author), Fac Med Necker, Lab CERTO, 156 Rue Vaugirard, F-75015 Paris, France.		Zeviani, Massimo/K-2891-2014; Pequignot, Marie O/P-1994-2017; PRIP-BUUS, Carina/P-9084-2017; Zeviani, Massimo/AAU-2632-2021	Zeviani, Massimo/0000-0002-9067-5508; Marchant, Dominique/0000-0003-4841-7254; Pequignot, Marie/0000-0002-8866-3778; Prip-Buus, Carina/0000-0002-2153-7857				BONNE G, 1983, PEDIATR RES, V33, P284; DEGOUL F, 1991, J NEUROL SCI, V101, P168, DOI 10.1016/0022-510X(91)90042-6; Geoffroy V, 1996, PEDIATRICS, V97, P267; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; LEWIN B, 1997, GENE, V6, P889; PEQUIGNOT MO, 2001, IN PRESS HUM MUTAT; Poyau A, 2000, HUM GENET, V106, P194, DOI 10.1007/s004390051028; Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4; Teraoka M, 1999, HUM GENET, V105, P560, DOI 10.1007/s004390051145; Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	13	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15326	15329		10.1074/jbc.M100388200	http://dx.doi.org/10.1074/jbc.M100388200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279059	hybrid			2022-12-27	WOS:000168528800106
J	Zhang, ZS; Lewis, D; Sumbilla, C; Inesi, G; Toyoshima, C				Zhang, ZS; Lewis, D; Sumbilla, C; Inesi, G; Toyoshima, C			The role of the M6-M7 loop (L67) in stabilization of the phosphorylation and Ca2+ binding domains of the sarcoplasmic reticulum Ca2+-ATPase (SERCA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SEGMENT-6; CYTOPLASMIC LOOP; ATPASE; ACTIVATION; CELLS; PUMP; RECOMBINATION; CA-2+-ATPASE	The amino acid sequence (L67) intervening between the M6 and M7 transmembrane segments of the Ca2+ transport ATPase was subjected to mutational analysis. Mutation of Pro(820) to Ala interferes with protein expression even though transcription occurs at normal levels. Single mutations of Lys(819) or Arg(822) to Ala, Phe, or Glu allow good expression, but produce strong inhibition of ATPase activity. The main defect produced by these mutations is strong interference with enzyme phosphorylation by ATP in the presence of Ca2+, and also by P-i in the absence of Ca2+. The Lys(819) and Arg(822) mutants undergo slight and moderate reduction of Ca2+ binding affinity, respectively. Reduction of overall steady state ATPase velocity is then due to inhibition of phosphorylated intermediate formation. On the other hand, a cluster of conservative mutations of Asp(813), Asp(815), and Asp(818) to Asn interferes strongly with enzyme activation by Ca2+ binding and formation of phosphorylated enzyme intermediate by utilization of ATP, Enzyme phosphorylation by P-i in the absence of Ca2+ undergoes slight or no inhibition by the triple aspartate mutation. Therefore, the triple mutation interferes mainly with the calcium-dependent activation of the ATPase, The effect of the triple mutation can be to a large extent reproduced by single mutation of Asp(813) (but not of Asp(815) or Asp(818)) to Asn, Functional and structural analysis of the experimental data demonstrates that the L67 loop plays an important role in protein folding and function. This role is sustained by linking the cytosolic catalytic domain and the transmembrane Ca2+ binding domain through a network of hydrogen bonds.	Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 113, Japan	University System of Maryland; University of Maryland Baltimore; University of Tokyo	Inesi, G (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	ginesi@umaryland.edu	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL027867] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL27867] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; FABIATO A, 1978, J PHYSIOL-LONDON, V276, P233, DOI 10.1113/jphysiol.1978.sp012231; Falson P, 1997, J BIOL CHEM, V272, P17258, DOI 10.1074/jbc.272.28.17258; GRAHAM FL, 1992, VACCINES NEW APPROAC, P363; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; HASSELBACH W, 1963, BIOCHEM Z, V339, P94; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; INESI G, 1988, METHOD ENZYMOL, V157, P154; INESI G, 1980, J BIOL CHEM, V255, P3025; INESI G, 1992, ADV ENZYMOLOGY, P185; KARIN NJ, 1989, MOL CELL BIOL, V9, P1978, DOI 10.1128/MCB.9.5.1978; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; Menguy T, 1998, J BIOL CHEM, V273, P20134, DOI 10.1074/jbc.273.32.20134; Sorensen TLM, 2000, J BIOL CHEM, V275, P28954, DOI 10.1074/jbc.M004072200; SUMBILLA C, 1993, J BIOL CHEM, V268, P21185; TAYLOR KA, 1986, J MOL BIOL, V187, P417, DOI 10.1016/0022-2836(86)90442-0; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; ZHANG Z, 1995, J BIOL CHEM, V270, P16283; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	24	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15232	15239		10.1074/jbc.M010813200	http://dx.doi.org/10.1074/jbc.M010813200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278755	hybrid			2022-12-27	WOS:000168528800094
J	Fan, GF; Shumay, E; Malbon, CC; Wang, HY				Fan, GF; Shumay, E; Malbon, CC; Wang, HY			c-Src tyrosine kinase binds the beta 2-adrenergic receptor via phospho-Tyr-350, phosphorylates G-protein-linked receptor kinase 2, and mediates agonist-induced receptor desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; COUPLED RECEPTORS; INSULIN; COMPLEXES; EXPRESSION; SUBSTRATE; GRAVIN; ROLES	The nonreceptor tyrosine kinase Src has been implicated in the switching of signaling of beta2-adrenergic receptors from adenylylcyclase coupling to the mitogen-activated protein kinase pathway, In the current work, we demonstrate that Src plays an active role in the agonist-induced desensitization of beta2-adrenergic receptors, Both the expression of dominant-negative Src and treatment with the 4-amine-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) inhibitor of Src kinase activity blocks agonist-induced desensitization. Agonist triggers tyrosine phosphorylation of the beta2-adrenergic receptor and recruitment and activation of Src. Because phosphorylation of the Tyr-350 residue of the beta2-adrenergic receptor creates a conditional, canonical SH2-binding site on the receptor, we examined the effect of the Y350F mutation on Src phosphorylation, Src recruitment, and desensitization, Mutant beta2-adrenergic receptors with a Tyr-to-Phe substitution at Tyr-350 do not display agonist-induced desensitization, Src recruitment, or Src activation, Downstream of binding to the receptor, Src phosphorylates and activates G-protein-linked receptor kinase 2 (GRK2), a response obligate for agonist-induced desensitization. Constitutively active Src increases GRK phosphorylation, whereas either expression of dominant-negative Src or treatment with the PP2 inhibitor abolishes tyrosine phosphorylation of GRK and desensitization. Thus, in addition to its role in signal switching to the mitogen-activated protein kinase pathway, Src recruitment to the pa-adrenergic receptor and activation are obligate for normal agonist-induced desensitization.	SUNY Stony Brook, Dept Mol Pharmacol, Med Ctr, Diabet & Metabol Dis Res Program, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Physiol, Med Ctr, Stony Brook, NY 11794 USA; SUNY Stony Brook, Biophys Diabet & Metabol Dis Res Program, Med Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Malbon, CC (corresponding author), SUNY Stony Brook, Pharmacol HSC, Stony Brook, NY 11794 USA.		malbon, craig/ABF-3604-2020					Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Baltensperger K, 1996, J BIOL CHEM, V271, P1061, DOI 10.1074/jbc.271.2.1061; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Karoor V, 1998, Adv Pharmacol, V42, P425; Karoor V, 1996, PROG NEUROBIOL, V48, P555, DOI 10.1016/0301-0082(96)00004-4; KAROOR V, 1995, J BIOL CHEM, V270, P25305, DOI 10.1074/jbc.270.43.25305; Karoor V, 1998, J BIOL CHEM, V273, P33035, DOI 10.1074/jbc.273.49.33035; KASHLES O, 1987, BIOCHEM PHARMACOL, V36, P1531, DOI 10.1016/0006-2952(87)90122-5; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Lin FB, 2000, J BIOL CHEM, V275, P19025, DOI 10.1074/jbc.275.25.19025; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MALBON CC, 1980, J BIOL CHEM, V255, P8692; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; PITCHER JA, 1995, P NATL ACAD SCI USA, V92, P8343, DOI 10.1073/pnas.92.18.8343; Sarnago S, 1999, J BIOL CHEM, V274, P34411, DOI 10.1074/jbc.274.48.34411; Shih ML, 1998, CELL SIGNAL, V10, P575, DOI 10.1016/S0898-6568(97)00195-2; Shih ML, 1996, J BIOL CHEM, V271, P21478, DOI 10.1074/jbc.271.35.21478; SHIH ML, 1994, P NATL ACAD SCI USA, V91, P12193, DOI 10.1073/pnas.91.25.12193; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Wang HY, 2000, J BIOL CHEM, V275, P36086, DOI 10.1074/jbc.M004404200; WANG HY, 1991, INT J BIOCHEM, V23, P7	26	86	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13240	13247		10.1074/jbc.M011578200	http://dx.doi.org/10.1074/jbc.M011578200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278940	hybrid			2022-12-27	WOS:000168198600107
J	Ingham, RJ; Santos, L; Dang-Lawson, M; Holgado-Madruga, M; Dudek, P; Maroun, CR; Wong, AJ; Matsuuchi, L; Gold, MR				Ingham, RJ; Santos, L; Dang-Lawson, M; Holgado-Madruga, M; Dudek, P; Maroun, CR; Wong, AJ; Matsuuchi, L; Gold, MR			The Gab1 docking protein links the B cell antigen receptor to the phosphatidylinositol 3-kinase/Akt signaling pathway and to the SHP2 tyrosine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; GROWTH-FACTOR RECEPTORS; PHOSPHOTYROSINE PHOSPHATASE; GRB2-ASSOCIATED BINDER-1; ADAPTER PROTEIN; PH DOMAIN; GUANOSINE TRIPHOSPHATASES; IN-VIVO; C-MET; KINASE	B cell antigen receptor (BCR) signaling causes tyrosine phosphorylation of the Gab1 docking protein. This allows phosphatidylinositol 3-kinase (PI3K) and the SHP2 tyrosine phosphatase to bind to Gab1. In this report, we tested the hypothesis that Gab1 acts as an amplifier of PI3K- and SHP2-dependent signaling in B lymphocytes, By overexpressing Gab1 in the WEHI-231 B cell line, me found that Gab1 can potentiate BCR-induced phosphorylation of Akt, a PI3K-dependent response. Gab1 expression also increased BCR-induced tyrosine phosphorylation of SHP2 as well as the binding of Grb2 to SHP2. We show that the pleckstrin homology (PH) domain of Gab1 is required for BCR-induced phosphorylation of Gab1 and for Gab1 participation in BCR signaling. Moreover, using confocal microscopy, we show that BCR ligation can induce the translocation of Gab1 from the cytosol to the plasma membrane and that this requires the Gab1 PH domain as well as PI3K activity. These findings are consistent with a model in which the binding of the Gab1 PH domain to PI3K-derived lipids brings Gab1 to the plasma membrane, where it can be tyrosine-phosphorylated and then act as an amplifier of BCR signaling.	Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z3, Canada; Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA; McGill Univ, Ctr Hosp, Dept Med, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada	University of British Columbia; University of British Columbia; Jefferson University; McGill University	Gold, MR (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 6174 Univ Blvd, Vancouver, BC V6T 1Z3, Canada.	mgold@interchange.ubc.ca	Gold, Michael/AAF-2081-2021	Gold, Michael/0000-0003-1222-3191				Astoul E, 1999, J CELL BIOL, V145, P1511, DOI 10.1083/jcb.145.7.1511; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; Coffer PJ, 1998, BIOCHEM J, V335, P1; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Frearson JA, 1998, J EXP MED, V187, P1417, DOI 10.1084/jem.187.9.1417; Garcia-Guzman M, 1999, ONCOGENE, V18, P7775, DOI 10.1038/sj.onc.1203198; GOLD MR, 1994, J IMMUNOL, V152, P42; Gold MR, 1999, J IMMUNOL, V163, P1894; Gold MR, 2000, CURR TOP MICROBIOL, V245, P77; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Herbst R, 1996, CELL, V85, P899, DOI 10.1016/S0092-8674(00)81273-8; Hibi M, 2000, LEUKEMIA LYMPHOMA, V37, P299, DOI 10.3109/10428190009089430; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Ingham RJ, 1998, J BIOL CHEM, V273, P30630, DOI 10.1074/jbc.273.46.30630; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Justement LB, 2000, CURR TOP MICROBIOL, V245, P1; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kelly ME, 2000, CURR OPIN IMMUNOL, V12, P267, DOI 10.1016/S0952-7915(00)00086-8; KIM TJ, 1995, J BIOL CHEM, V270, P27504, DOI 10.1074/jbc.270.46.27504; Krebs Danielle L., 1999, Methods in Cell Science, V21, P57, DOI 10.1023/A:1009843325770; KUHNE MR, 1994, J BIOL CHEM, V269, P15833; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Lecoq-Lafon C, 1999, BLOOD, V93, P2578, DOI 10.1182/blood.V93.8.2578.408k24_2578_2585; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Maroun CR, 1999, J BIOL CHEM, V274, P31719, DOI 10.1074/jbc.274.44.31719; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; MATSUUCHI L, 1991, J CELL BIOL, V112, P843, DOI 10.1083/jcb.112.5.843; MATSUUCHI L, 1992, P NATL ACAD SCI USA, V89, P3404, DOI 10.1073/pnas.89.8.3404; Myers MG, 1998, J BIOL CHEM, V273, P26908, DOI 10.1074/jbc.273.41.26908; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Onishi M, 1996, EXP HEMATOL, V24, P324; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pogue SL, 2000, J IMMUNOL, V165, P1300, DOI 10.4049/jimmunol.165.3.1300; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Richards JD, 1996, J BIOL CHEM, V271, P6458, DOI 10.1074/jbc.271.11.6458; Rocchi S, 1998, MOL ENDOCRINOL, V12, P914, DOI 10.1210/me.12.7.914; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Sakkab D, 2000, J BIOL CHEM, V275, P10772, DOI 10.1074/jbc.275.15.10772; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Wickrema A, 1999, J BIOL CHEM, V274, P24469, DOI 10.1074/jbc.274.35.24469; Yenush L, 1997, BIOESSAYS, V19, P491, DOI 10.1002/bies.950190608; Zhao CM, 1999, J BIOL CHEM, V274, P19649, DOI 10.1074/jbc.274.28.19649; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	67	47	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12257	12265		10.1074/jbc.M010590200	http://dx.doi.org/10.1074/jbc.M010590200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278704	hybrid			2022-12-27	WOS:000168081800110
J	Chughtai, ZS; Rassadi, R; Matusiewicz, N; Stochaj, U				Chughtai, ZS; Rassadi, R; Matusiewicz, N; Stochaj, U			Starvation promotes nuclear accumulation of the hsp70 Ssa4p in yeast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; LOCALIZATION; EXPORT; TRANSPORT; PROTEIN; SEQUENCES; ENVELOPE; IMPORT	Nuclear import of proteins that are too large to passively enter the nucleus requires soluble factors, energy, and a nuclear localization signal (NLS). Nuclear protein transport can be regulated, and different forms of stress affect nucleocytoplasmic trafficking. As such, import of proteins containing a classical NLS is inhibited in starving yeast cells. In contrast, the hsp70 Ssa4p concentrates in nuclei upon starvation. Nuclear concentration of Ssa4p in starving cells is reversible, and transfer of stationary phase cells to fresh medium induces Ssa4p nuclear export. This export reaction represents an active process that is sensitive to oxidative stress. In starving cells, the N-terminal domain of Ssa4p mediates Ssa4p nuclear accumulation, and a short hydrophobic sequence, termed Star (for starvation), is sufficient to localize the reporter proteins green fluorescent protein or beta -galactosidase to nuclei. To determine whether nuclear accumulation of Star-beta -galactosidase depends on a specific nuclear carrier, we have analyzed its distribution in mutant yeast strains that carry a deletion of a single beta -importin gene. With this assay we have identified Nmd5p as a beta -importin required to concentrate Star-beta -galactosidase in nuclei when cells enter stationary phase.	McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University	Stochaj, U (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	stochaj@med.mcgill.ca	stochaj, ursula/AAC-1865-2021					Albertini M, 1998, J CELL BIOL, V143, P1447, DOI 10.1083/jcb.143.6.1447; Barth W, 1999, BIOCHEM CELL BIOL, V77, P355, DOI 10.1139/bcb-77-4-355; Barth W, 1996, BIOCHEM CELL BIOL, V74, P363, DOI 10.1139/o96-039; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Griffioen G, 2000, J BIOL CHEM, V275, P1449, DOI 10.1074/jbc.275.2.1449; Hood JK, 1999, CURR OPIN CELL BIOL, V11, P241, DOI 10.1016/S0955-0674(99)80032-5; Kudo N, 1999, J BIOL CHEM, V274, P15151, DOI 10.1074/jbc.274.21.15151; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; MANDELL RB, 1990, J CELL BIOL, V111, P1775, DOI 10.1083/jcb.111.5.1775; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Ohno M, 1998, CELL, V92, P327, DOI 10.1016/S0092-8674(00)80926-5; Shiota C, 1999, J BIOL CHEM, V274, P37125, DOI 10.1074/jbc.274.52.37125; Shulga N, 1999, J BIOL CHEM, V274, P16501, DOI 10.1074/jbc.274.23.16501; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; Stochaj U, 1999, BIOESSAYS, V21, P579, DOI 10.1002/(SICI)1521-1878(199907)21:7<579::AID-BIES6>3.0.CO;2-E; STOCHAJ U, 2000, FASEB J         0908; Wozniak RW, 1998, TRENDS CELL BIOL, V8, P184, DOI 10.1016/S0962-8924(98)01248-3; [No title captured]	21	34	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20261	20266		10.1074/jbc.M100364200	http://dx.doi.org/10.1074/jbc.M100364200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279056	hybrid			2022-12-27	WOS:000169135100081
J	Kayser, EB; Morgan, PG; Hoppel, CL; Sedensky, MM				Kayser, EB; Morgan, PG; Hoppel, CL; Sedensky, MM			Mitochondrial expression and function of GAS-1 in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDOREDUCTASE COMPLEX-I; VOLATILE ANESTHETICS; ELECTRON-TRANSPORT; C-ELEGANS; GENE; NEMATODE; PROTEIN; NADH; RESPIRATION; SENSITIVITY	A mutation in the gene gas-1 alters sensitivity to volatile anesthetics, fecundity, and life span in the nematode Caenorhabditis elegans. gas-1 encodes a close homologue of the 49-kDa iron protein subunit of Complex I of the mitochondrial electron transport chain from bovine heart. gas-1 is widely expressed in the nematode neuromuscular system and in a subcellular pattern consistent with that of a mitochondrial protein. Pharmacological studies indicate that gas-1 functions partially via presynaptic effects. In addition, a mutation in the gas-1 gene profoundly decreases Complex I-dependent metabolism in mitochondria as measured by rates of both oxidative phosphorylation and electron transport. An increase in Complex II-dependent metabolism also is seen in mitochondria from gas-1 animals. There is no apparent alteration in physical structure in mitochondria from gas-1 nematodes compared with those from wild type. These data indicate that gas-1 is the major 49-kDa protein of complex I and that the GAS-1 protein is critical to mitochondrial function in C. elegans. They also reveal the importance of mitochondrial function in determining not only aging and life span, but also anesthetic sensitivity, in this model organism.	Univ Hosp Cleveland, Dept Anesthesiol, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Vet Affairs Med Ctr, Dept Pharmacol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Vet Affairs Med Ctr, Dept Med, Cleveland, OH 44106 USA	University Hospitals of Cleveland; University Hospitals of Cleveland; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Sedensky, MM (corresponding author), Univ Hosp Cleveland, Dept Anesthesiol, 2400 Bolwell Bldg,11100 Euclid Ave, Cleveland, OH 44106 USA.	margaret.sedensky@uhhs.com			NIA NIH HHS [P01 AG15885] Funding Source: Medline; NIGMS NIH HHS [GM58881, GM45402] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058881, R01GM045402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015885] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON GR, 1995, PARASITE, V2, P49, DOI 10.1051/parasite/1995021049; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHANCE B, 1955, J BIOL CHEM, V217, P409; COHEN PJ, 1973, ANESTHESIOLOGY, V39, P153, DOI 10.1097/00000542-197308000-00007; Dernburg AF, 2000, GENE DEV, V14, P1578; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; HARRIS RA, 1971, ARCH BIOCHEM BIOPHYS, V142, P435, DOI 10.1016/0003-9861(71)90507-8; HARTMAN PS, 2000, IN PRESS MECH AGEING; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; HERMAN RK, 1988, GENETICS C ELEGANS N, P22; Hoppel CL, 1998, J BIOL CHEM, V273, P23495, DOI 10.1074/jbc.273.36.23495; HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066; HORVITZ HR, 1979, MOL GEN GENET, V175, P129, DOI 10.1007/BF00425528; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Kayser EB, 1999, ANESTHESIOLOGY, V90, P545, DOI 10.1097/00000542-199902000-00031; KOBLIN DD, 1990, ANESTHESIA, P51; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MELLO C, 1995, CAENORHABDITIS ELEGA, P452; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; MORGAN PG, 1994, ANESTHESIOLOGY, V81, P888, DOI 10.1097/00000542-199410000-00016; MORGAN PG, 1990, P NATL ACAD SCI USA, V87, P2965, DOI 10.1073/pnas.87.8.2965; MURFITT RR, 1976, COMP BIOCHEM PHYS B, V53, P423, DOI 10.1016/0305-0491(76)90191-7; NGUYEN M, 1995, GENETICS, V140, P527; PREIS D, 1990, CURR GENET, V18, P59, DOI 10.1007/BF00321116; SCHULTE U, 1994, BBA-BIOENERGETICS, V1187, P121, DOI 10.1016/0005-2728(94)90096-5; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; XU XM, 1992, BIOCHEMISTRY-US, V31, P6925, DOI 10.1021/bi00145a009; Yen MY, 1996, BRIT J OPHTHALMOL, V80, P78, DOI 10.1136/bjo.80.1.78	37	124	132	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20551	20558		10.1074/jbc.M011066200	http://dx.doi.org/10.1074/jbc.M011066200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278828	hybrid			2022-12-27	WOS:000169135100118
J	Parks, WT; Frank, DB; Huff, C; Haft, CR; Martino, J; Meng, XW; de Caestecker, MP; McNally, JG; Reddi, A; Taylor, SI; Roberts, AB; Wang, TW; Lechleider, RJ				Parks, WT; Frank, DB; Huff, C; Haft, CR; Martino, J; Meng, XW; de Caestecker, MP; McNally, JG; Reddi, A; Taylor, SI; Roberts, AB; Wang, TW; Lechleider, RJ			Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I RECEPTORS; SMAD PROTEINS; ACTIVIN; COMPLEX; ACTIVATION; MEMBRANE; CLONING; IDENTIFICATION; BIOSYNTHESIS; RESPONSES	Sorting nexins (SNX) comprise a family of proteins with homology to several yeast proteins, including Vps5p and Mvp1p, that are required for the sorting of proteins to the yeast vacuole. Human SNX1, -2, and -4 have been proposed to play a role in receptor trafficking and have been shown to bind to several receptor tyrosine kinases, including receptors for epidermal growth factor, platelet-derived growth factor, and insulin as well as the long form of the leptin receptor, a glycoprotein 130-associated receptor. We now describe a novel member of this family, SNX6, which interacts with mem bers of the transforming growth factor-p family of receptor serine-threonine kinases. These receptors belong to two classes: type II receptors that bind ligand, and type I receptors that are subsequently recruited to transduce the signal. Of the type II receptors, SNX6 was found to interact strongly with ActRIIB and more moderately with wild type and kinase-defective mutants of T beta RII. Of the type I receptors, SNX6 was found to interact only with inactivated T beta RI. SNXs 1-4 also interacted with the transforming growth factor-p receptor family, showing different receptor preferences. Conversely, SNX6 behaved similarly to the other SNX proteins in its interactions with receptor tyrosine kinases. Strong heteromeric interactions were also seen among SNX1, -2, -4, and -6, suggesting the formation in vivo of oligomeric complexes. These findings are the first evidence for the association of the SNX family of molecules with receptor serine-threonine kinases.	NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA; NIDDK, Diabet Branch, NIH, Bethesda, MD 20892 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Genet,Dept Surg, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Harvard Medical School; Massachusetts General Hospital	Roberts, AB (corresponding author), NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA.			Parks, W. Tony/0000-0001-7341-3277				Attisano L, 1996, MOL CELL BIOL, V16, P1066; Attisano L, 1998, CURR OPIN CELL BIOL, V10, P188, DOI 10.1016/S0955-0674(98)80141-5; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Christian JL, 1999, BIOESSAYS, V21, P382, DOI 10.1002/(SICI)1521-1878(199905)21:5<382::AID-BIES5>3.0.CO;2-V; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; EKENA K, 1995, MOL CELL BIOL, V15, P1671; FROLIK CA, 1984, J BIOL CHEM, V259, P995; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; Kim RH, 2000, GENE DEV, V14, P1605; Koli KM, 1997, J BIOL CHEM, V272, P6423, DOI 10.1074/jbc.272.10.6423; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; MASSAGUE J, 1985, J CELL BIOL, V100, P1508, DOI 10.1083/jcb.100.5.1508; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Otsuki T, 1999, BIOCHEM BIOPH RES CO, V265, P630, DOI 10.1006/bbrc.1999.1731; Padgett Richard W., 1997, Cytokine and Growth Factor Reviews, V8, P1, DOI 10.1016/S1359-6101(96)00050-0; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Padgett RW, 1998, BIOESSAYS, V20, P382, DOI 10.1002/(SICI)1521-1878(199805)20:5&lt;382::AID-BIES5&gt;3.0.CO;2-Q; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TSUCHIDA K, 1993, P NATL ACAD SCI USA, V90, P11242, DOI 10.1073/pnas.90.23.11242; WAKEFIELD LM, 1987, J CELL BIOL, V105, P965, DOI 10.1083/jcb.105.2.965; Wells RG, 1997, J BIOL CHEM, V272, P11444; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; ZHAO J, 1995, CANCER RES, V55, P6181	36	108	115	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19332	19339		10.1074/jbc.M100606200	http://dx.doi.org/10.1074/jbc.M100606200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11279102	hybrid			2022-12-27	WOS:000169091000093
J	Shinkai, A; Patel, PH; Loeb, LA				Shinkai, A; Patel, PH; Loeb, LA			The conserved active site motif a of Escherichia coli DNA polymerase I is highly mutable	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; REVERSE-TRANSCRIPTASE; ANGSTROM RESOLUTION; TERNARY COMPLEXES; KLENOW FRAGMENT; REPLICATION; BETA; RESISTANCE; FIDELITY	Escherichia coli DNA polymerase I participates in DNA replication, DNA repair, and genetic recombination; it is the most extensively studied of all DNA polymerases, Motif A in the polymerase active site has a required role in catalysis and is highly conserved. To assess the tolerance of motif A for amino acid substitutions, we determined the mutability of the 13 constituent amino acids Val(700)-Arg(712) by using random mutagenesis and genetic selection. We observed that every residue except the catalytically essential Asp(705) can be mutated while allowing bacterial growth and preserving wild-type DNA polymerase activity. Hence, the primary structure of motif A is plastic. We present evidence that mutability of motif A has been conserved during evolution, supporting the premise that the tolerance for mutation is adaptive. In addition, our work allows identification of refinements in catalytic function that may contribute to preservation of the wildtype motif A sequence. As an example, we established that the naturally occurring Ile(709) has a previously undocumented role in supporting sugar discrimination.	Univ Washington, Dept Pathol, Joseph Gottstein Mem Canc Res Lab, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Loeb, LA (corresponding author), Univ Washington, Dept Pathol, Joseph Gottstein Mem Canc Res Lab, Box 357705, Seattle, WA 98195 USA.		Shinkai, Akeo/E-8354-2013	Shinkai, Akeo/0000-0002-9867-0832	NATIONAL CANCER INSTITUTE [R01CA078885, R35CA039903, P01CA074184] Funding Source: NIH RePORTER; NCI NIH HHS [CA74184, CA78885, CA39903] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; BATTULA N, 1974, J BIOL CHEM, V249, P4086; BLANCO L, 1991, GENE, V100, P27, DOI 10.1016/0378-1119(91)90346-D; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397; GIBBONS RJ, 1967, J BACTERIOL, V93, P510, DOI 10.1128/JB.93.1.510-512.1967; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JOYCE CM, 1982, J BIOL CHEM, V257, P1958; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kornberg A., 1992, DNA REPLICATION; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kunkel TA, 1998, NAT STRUCT BIOL, V5, P95, DOI 10.1038/nsb0298-95; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Mao EF, 1997, J BACTERIOL, V179, P417, DOI 10.1128/jb.179.2.417-422.1997; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Patel PH, 2000, P NATL ACAD SCI USA, V97, P5095, DOI 10.1073/pnas.97.10.5095; Patel PH, 2000, J BIOL CHEM, V275, P40266, DOI 10.1074/jbc.M005757200; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; POLESKY AH, 1992, J BIOL CHEM, V267, P8417; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; SPANOS A, 1981, NUCLEIC ACIDS RES, V9, P1825, DOI 10.1093/nar/9.8.1825; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; SWEASY JB, 1992, J BIOL CHEM, V267, P1407; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; WITKIN EM, 1992, J BACTERIOL, V174, P4166, DOI 10.1128/jb.174.12.4166-4168.1992	35	42	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18836	18842		10.1074/jbc.M011472200	http://dx.doi.org/10.1074/jbc.M011472200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278911	hybrid			2022-12-27	WOS:000169091000026
J	Bartels, F; Fernandez, S; Holtel, A; Timmiss, KN; de Lorenzo, V				Bartels, F; Fernandez, S; Holtel, A; Timmiss, KN; de Lorenzo, V			The essential HupB and HupN proteins of Pseudomonas putida provide redundant and nonspecific DNA-bending functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; GRAM-NEGATIVE BACTERIA; HISTONE-LIKE PROTEINS; ESCHERICHIA-COLI HU; BINDING PROTEIN; TOL PLASMID; NUCLEOTIDE-SEQUENCE; GENETIC-CHARACTERIZATION; CHROMOSOMAL INSERTION; MOLECULAR-CLONING	A protein mixture containing two major components able to catalyze a beta -recombination reaction requiring nonspecific DNA bending was obtained by fractionation of a Pseudomonas putida extract. N-terminal sequence analysis and genomic data base searches identified the major component as an analogue of HupB of Pseudomonas aeruginosa and Escherichia coli, encoding one HU protein variant. The minor component of the fraction, termed HupN, was divergent enough from HupB to predict a separate DNA-bending competence. The determinants of the two proteins were cloned and hyperexpressed, and the gene products were purified. Their activities were examined in vitro in beta -recombination assays and in vivo by complementation of the Hbsu function of Bacillus subtilis. HupB and HupN were equally efficient in all tests, suggesting that they are independent and functionally redundant DNA bending proteins. This was reflected in the maintenance of in vivo activity of the sigma (54) Ps promoter of the toluene degradation plasmid, TOL, which requires facilitated DNA bending, in Delta hupB or Delta hupN strains. However, hupB/hupN double mutants were not viable. It is suggested that the requirement for protein-facilitated DNA bending is met in P. putida by two independent proteins that ensure an adequate supply of an essential cellular activity.	CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Madrid 28049, Spain; GBF, Div Microbiol, D-38124 Braunschweig, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Helmholtz Association; Helmholtz-Center for Infection Research	de Lorenzo, V (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Campus Cantoblanc, Madrid 28049, Spain.	vdlorenzo@cnb.uam.es		de Lorenzo, Victor/0000-0002-6041-2731				ABRIL MA, 1989, J BACTERIOL, V171, P6782, DOI 10.1128/jb.171.12.6782-6790.1989; ALONSO JC, 1995, J BIOL CHEM, V270, P2938, DOI 10.1074/jbc.270.7.2938; ASSINDER SJ, 1990, ADV MICROB PHYSIOL, V31, P1; Ausubel FM, 1988, MOL REPROD DEV; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; BOUBRIK F, 1995, P NATL ACAD SCI USA, V92, P3958, DOI 10.1073/pnas.92.9.3958; Cases I, 2001, EMBO J, V20, P1, DOI 10.1093/emboj/20.1.1; CHAUDHRY GR, 1991, MICROBIOL REV, V55, P59, DOI 10.1128/MMBR.55.1.59-79.1991; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; CRAIG NL, 1984, CELL, V39, P707, DOI 10.1016/0092-8674(84)90478-1; de Lorenzo V, 1998, FEMS MICROBIOL ECOL, V27, P211, DOI 10.1016/S0168-6496(98)00064-6; DELICATTREE I, 1995, GENE, V154, P61, DOI 10.1016/0378-1119(94)00875-S; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FERNANDEZ S, 1995, MOL MICROBIOL, V16, P205, DOI 10.1111/j.1365-2958.1995.tb02293.x; Fernandez S, 1997, MOL MICROBIOL, V23, P1169, DOI 10.1046/j.1365-2958.1997.3061670.x; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; GILADI H, 1992, NUCLEIC ACIDS RES, V20, P4092, DOI 10.1093/nar/20.15.4092; GOODRICH JA, 1990, NUCLEIC ACIDS RES, V18, P4993, DOI 10.1093/nar/18.17.4993; Grasser KD, 1997, EUR J BIOCHEM, V249, P70; HAIMA P, 1987, MOL GEN GENET, V209, P335, DOI 10.1007/BF00329663; HAWKINS AR, 1981, FEBS LETT, V130, P275, DOI 10.1016/0014-5793(81)81138-6; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HOLTEL A, 1994, J BACTERIOL, V176, P1773, DOI 10.1128/jb.176.6.1773-1776.1994; HUISMAN O, 1989, J BACTERIOL, V171, P3704, DOI 10.1128/jb.171.7.3704-3712.1989; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KANO Y, 1988, GENE, V69, P331; KANO Y, 1986, GENE, V45, P37; KANO Y, 1985, MOL GEN GENET, V201, P360, DOI 10.1007/BF00425687; KANO Y, 1987, MOL GEN GENET, V209, P408, DOI 10.1007/BF00329674; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Li SS, 1998, J BACTERIOL, V180, P3750, DOI 10.1128/JB.180.15.3750-3756.1998; Maiorino M, 1996, EUR J BIOCHEM, V238, P838, DOI 10.1111/j.1432-1033.1996.0838w.x; MENDELSON I, 1991, J BACTERIOL, V173, P1670, DOI 10.1128/jb.173.5.1670-1676.1991; MICKA B, 1992, BIOCHIMIE, V74, P641, DOI 10.1016/0300-9084(92)90136-3; MICKA B, 1991, J BACTERIOL, V173, P3191, DOI 10.1128/JB.173.10.3191-3198.1991; MURRAY K, 1974, J BACTERIOL, V117, P1153, DOI 10.1128/JB.117.3.1153-1157.1974; NASH HA, 1981, J BIOL CHEM, V256, P9246; NASH HA, 1987, J BACTERIOL, V169, P4124, DOI 10.1128/jb.169.9.4124-4127.1987; Oberto J, 1996, J BACTERIOL, V178, P293, DOI 10.1128/jb.178.1.293-297.1996; PADAS PM, 1992, GENE, V117, P39, DOI 10.1016/0378-1119(92)90487-A; PEREZMARTIN J, 1994, MICROBIOL REV, V58, P268; PEREZMARTIN J, 1995, J BACTERIOL, V177, P3758, DOI 10.1128/jb.177.13.3758-3763.1995; PerezMartin J, 1997, ANNU REV MICROBIOL, V51, P593, DOI 10.1146/annurev.micro.51.1.593; Pettijohn D.E., 1996, ESCHERICHIA COLI SAL, P158; PETTIJOHN DE, 1988, J BIOL CHEM, V263, P12793; Pinson V, 1999, J MOL BIOL, V287, P485, DOI 10.1006/jmbi.1999.2631; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; ROJO F, 1994, J MOL BIOL, V238, P159, DOI 10.1006/jmbi.1994.1278; ROUVIEREYANIV J, 1979, FEBS LETT, V106, P297, DOI 10.1016/0014-5793(79)80518-9; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanchez-Romero JM, 1998, APPL ENVIRON MICROB, V64, P4040; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMID MB, 1988, TRENDS BIOCHEM SCI, V13, P131, DOI 10.1016/0968-0004(88)90069-2; SHINGLER V, 1993, J BACTERIOL, V175, P1596, DOI 10.1128/JB.175.6.1596-1604.1993; STEIN DC, 1992, GENE, V117, P157, DOI 10.1016/0378-1119(92)90506-K; SU W, 1990, P NATL ACAD SCI USA, V87, P5504, DOI 10.1073/pnas.87.14.5504; TOUSSAINT B, 1993, BIOCHEM BIOPH RES CO, V196, P416, DOI 10.1006/bbrc.1993.2265; WADA M, 1988, J MOL BIOL, V204, P581, DOI 10.1016/0022-2836(88)90357-9; Williams Peter A., 1994, Biodegradation, V5, P195, DOI 10.1007/BF00696460	64	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16641	16648		10.1074/jbc.M011295200	http://dx.doi.org/10.1074/jbc.M011295200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278879	hybrid			2022-12-27	WOS:000168730400008
J	Hahn-Dantona, E; Ruiz, JF; Bornstein, P; Strickland, DK				Hahn-Dantona, E; Ruiz, JF; Bornstein, P; Strickland, DK			The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FIBROBLAST COLLAGENASE; ACTIVATOR INHIBITOR TYPE-1; ALPHA-2-MACROGLOBULIN RECEPTOR; PLASMINOGEN-ACTIVATOR; UROKINASE RECEPTOR; ALPHA(2)-MACROGLOBULIN RECEPTOR; DECREASED EXPRESSION; MOLECULAR CHAPERONE; DEGRADATION; CELLS	Members of the matrix metalloproteinase (MMP) family of enzymes participate in matrix remodeling and share a number of structural and functional features. The activity of this family of proteinases is carefully regulated at the level of zymogen activation and by a family of specific inhibitors termed tissue inhibitors of metalloproteinases (TIMP). It is now becoming clear that levels of certain MMPs are modulated by their association with cellular receptors that mediate their rapid internalization and degradation. In the current investigation we report that the amount of MMP-9 in conditioned cell culture medium is significantly increased when mouse embryonic fibroblasts are grown in the presence of the 39-kDa receptor-associated protein (RAP), an antagonist of ligand binding to low density lipoprotein receptor-related protein (LRP). In vitro assays reveal that the MMP-9-TIMP-1 complex binds to LRP with high affinity and that the binding determinant for LRP appears to reside on MMP-9. Cell lines expressing LRP mediate the internalization of I-125-labeled MMP-9.TIMP-1 complexes, whereas cell lines genetically deficient in LRP show a diminished capacity to mediate the cellular catabolism of MMP-9.TIMP-1 complexes. The results demonstrate that LRP is a functional receptor for MMP-9 and suggest a major role for LRP in modulating remodeling of the extracellular matrix by regulating extracellular proteinase activity.	Amer Red Cross, Holland Lab, Dept Vasc Biol, Rockville, MD 20855 USA; George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; George Washington Univ, Med Ctr, Inst Biomed Sci, Washington, DC 20037 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA	American Red Cross; George Washington University; George Washington University; University of Washington; University of Washington Seattle	Strickland, DK (corresponding author), Amer Red Cross, Holland Lab, Dept Vasc Biol, 15601 Crabbs Branch Way, Rockville, MD 20855 USA.				NHLBI NIH HHS [HL50784, HL54710] Funding Source: Medline; NIAMS NIH HHS [AR 45418] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050784, P01HL054710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045418] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALEXANDER CM, 1992, J CELL BIOL, V118, P727, DOI 10.1083/jcb.118.3.727; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; Barmina OY, 1999, J BIOL CHEM, V274, P30087, DOI 10.1074/jbc.274.42.30087; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; BERNHARD EJ, 1995, INT J CANCER, V60, P718, DOI 10.1002/ijc.2910600525; BU GJ, 1992, P NATL ACAD SCI USA, V89, P7427, DOI 10.1073/pnas.89.16.7427; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; CHEN JM, 1991, J BIOL CHEM, V266, P5113; CHEN K, 1996, P NATL ACAD SCI USA, V271, P15993; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; deVries TJ, 1996, CANCER RES, V56, P1432; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Hahn-Dantona EA, 2000, J BIOL CHEM, V275, P40827, DOI 10.1074/jbc.M006234200; HEMBROUGH TA, 2001, IN PRESS J BIOL CHEM; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; KANCHA RK, 1994, ONCOL RES, V6, P365; KHOKHA R, 1989, SCIENCE, V243, P947, DOI 10.1126/science.2465572; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P21862; Liu Z, 1998, J EXP MED, V188, P475, DOI 10.1084/jem.188.3.475; MIKHAILENKO I, 1995, J BIOL CHEM, V270, P9543, DOI 10.1074/jbc.270.16.9543; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Okada SS, 1996, ARTERIOSCL THROM VAS, V16, P1269, DOI 10.1161/01.ATV.16.10.1269; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5678; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Weaver AM, 1997, J BIOL CHEM, V272, P14372, DOI 10.1074/jbc.272.22.14372; Wijnberg MJ, 1997, THROMB HAEMOSTASIS, V78, P880; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1994, J CELL SCI, V107, P719; WINDSOR LJ, 1991, BIOCHEMISTRY-US, V30, P641, DOI 10.1021/bi00217a008; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Yang ZT, 2000, MOL BIOL CELL, V11, P3353, DOI 10.1091/mbc.11.10.3353; Yu Q, 2000, GENE DEV, V14, P163; Zhang JC, 1998, J BIOL CHEM, V273, P32273, DOI 10.1074/jbc.273.48.32273	44	182	189	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15498	15503		10.1074/jbc.M100121200	http://dx.doi.org/10.1074/jbc.M100121200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11279011	hybrid			2022-12-27	WOS:000168528800128
J	Lopez, MM; Yutani, K; Makhatadze, GI				Lopez, MM; Yutani, K; Makhatadze, GI			Interactions of the cold shock protein CspB from Bacillus subtilis with single-stranded DNA - Importance of the T base content and position within the template	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-COOPERATIVE BINDING; ESCHERICHIA-COLI; TRANSCRIPTION TERMINATION; LOW-TEMPERATURES; RNA CHAPERONES; LARGE LIGANDS; FAMILY; THERMODYNAMICS; SEQUENCES; PARAMETERS	The cold shock protein CspB from Bacillus subtilis binds T-based single-stranded DNA (ssDNA) with high affinity (Lopez, M. M,, Yutani, K,, and Makhatadze, G, I. (1999) J, Biol, Chem 274, 33601-33608). In this paper we report the results of CspB interactions with non-homogeneous ssDNA templates containing continuous and non-continuous stretches of T bases. The analysis of CspB-ssDNA interactions was performed using fluorescence spectroscopy, analytical centrifugation and isothermal titration calorimetry. We show that (i) there is a strong correlation between the CspB affinity and stoichiometry and the T content in the oligonucleotide that is independent of which other bases are incorporated into the sequence of ssDNA; (ii) the binding properties of CspB to ssDNA templates with continuous or non-continuous stretches of T bases with similar T content is very similar, and (iii) the mechanism of interaction between CspB and the T based non-homogeneous ssDNA is mainly through the bases (a stretch of three T bases located in the middle of the ssDNA templates makes the binding independent of the ionic strength). The biological relevance of these results to the role of CspB as an RNA chaperone is discussed.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; Osaka Univ, Inst Prot Res, Osaka 5650871, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Osaka University	Makhatadze, GI (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.							ADHYA S, 1978, ANNU REV BIOCHEM, V47, P967, DOI 10.1146/annurev.bi.47.070178.004535; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; EPSTEIN IR, 1978, BIOPHYS CHEM, V8, P327, DOI 10.1016/0301-4622(78)80015-5; FERRARI ME, 1994, J MOL BIOL, V236, P106, DOI 10.1006/jmbi.1994.1122; GRAUMANN P, 1994, FEBS LETT, V338, P157, DOI 10.1016/0014-5793(94)80355-2; Graumann P, 1997, MOL MICROBIOL, V25, P741, DOI 10.1046/j.1365-2958.1997.5121878.x; Graumann Peter L., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P203; Hayman ML, 1999, J BIOL CHEM, V274, P12067, DOI 10.1074/jbc.274.17.12067; Henkin TM, 1996, ANNU REV GENET, V30, P35, DOI 10.1146/annurev.genet.30.1.35; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Inouye Masayori, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P191; Jiang WN, 1997, J BIOL CHEM, V272, P196; Jiang WN, 1996, J BACTERIOL, V178, P4919, DOI 10.1128/jb.178.16.4919-4925.1996; KOWALCZYKOWSKI SC, 1986, BIOCHEMISTRY-US, V25, P1226, DOI 10.1021/bi00354a006; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P400; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P424; LOHMAN TM, 1991, METHOD ENZYMOL, V208, P258; Lopez MM, 2000, BBA-PROTEIN STRUCT M, V1479, P196, DOI 10.1016/S0167-4838(00)00048-0; Lopez MM, 1999, J BIOL CHEM, V274, P33601, DOI 10.1074/jbc.274.47.33601; MAKHATADZE GI, 1994, PROTEIN SCI, V3, P2144, DOI 10.1002/pro.5560031127; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Pelletier M, 2000, NUCLEIC ACIDS RES, V28, P1266, DOI 10.1093/nar/28.5.1266; Phadtare S, 1999, MOL MICROBIOL, V33, P1004, DOI 10.1046/j.1365-2958.1999.01541.x; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; RICHARDSON JP, 1993, CRIT REV BIOCHEM MOL, V28, P1, DOI 10.3109/10409239309082571; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SCHINDELIN H, 1993, NATURE, V364, P164, DOI 10.1038/364164a0; SCHNUCHEL A, 1993, NATURE, V364, P169, DOI 10.1038/364169a0; SCHRODER K, 1995, MOL MICROBIOL, V16, P699, DOI 10.1111/j.1365-2958.1995.tb02431.x; WALLACE RB, 1987, METHOD ENZYMOL, V152, P432; WILLIMSKY G, 1992, J BACTERIOL, V174, P6326, DOI 10.1128/JB.174.20.6326-6335.1992; Yamanaka Kunitoshi, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P193; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	34	44	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15511	15518		10.1074/jbc.M010474200	http://dx.doi.org/10.1074/jbc.M010474200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278683	hybrid			2022-12-27	WOS:000168528800130
J	Nieto, C; Puyet, A; Espinosa, M				Nieto, C; Puyet, A; Espinosa, M			MalR-mediated regulation of the Streptococcus pneumoniae malMP operon at promoter P-M - Influence of a proximal divergent promoter region and competition between MalR and RNA polymerase proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; CATABOLITE REPRESSION; BACILLUS-SUBTILIS; OPEN-COMPLEX; TRANSCRIPTION; DNA; EXPRESSION; SITE; INHIBITION	The Streptococcus pneumoniae mal regulon contains two operons, malXCD and malMP involved in the uptake and utilization of maltosaccharides. Both operons are transcribed from two divergent promoters, P-X and P-M, and are negatively regulated by the MalR transcriptional repressor. Purified MalR protein binds to two DNA regions that encompasses both promoters, thus occupying its two operators, O-M and O-X. However, the levels of occupation and repression were different, being higher when MalR was bound to O-M than when it was anchored to O-X. Competition experiments between MalR and the Escherichia coli RNA polymerase on promoters P-M and P-X showed that the affinity of either protein for the promoter/operator DNA sequences was important to determine the frequency of transcription initiation. In addition to the control exerted by MalR, expression from promoter P-M was affected by upstream sequences located within or close to P-X promoter.	CSIC, Ctr Invest Biol, E-28006 Madrid, Spain; Univ Complutense Madrid, Fac Vet, Dept Bioquim & Biol Mol 4, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Complutense University of Madrid	Espinosa, M (corresponding author), CSIC, Ctr Invest Biol, Velazquez 144, E-28006 Madrid, Spain.		Nieto, Concha/ABG-2127-2020; Puyet, Antonio/I-4720-2014; Espinosa, Manuel/M-5282-2019	Nieto, Concha/0000-0003-0790-3440; Puyet, Antonio/0000-0002-2026-7955; 				CHEN JD, 1988, GENE, V64, P155, DOI 10.1016/0378-1119(88)90489-1; CHOY HE, 1992, P NATL ACAD SCI USA, V89, P11264, DOI 10.1073/pnas.89.23.11264; COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; de Palencia PF, 2000, FEMS MICROBIOL LETT, V183, P229, DOI 10.1111/j.1574-6968.2000.tb08963.x; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Gralla JD, 1996, ESCHERICHIA COLI SAL, P1232; HINDLE Z, 1994, MOL MICROBIOL, V12, P737, DOI 10.1111/j.1365-2958.1994.tb01061.x; Kim JH, 1997, NUCLEIC ACIDS RES, V25, P3490, DOI 10.1093/nar/25.17.3490; LACKS SA, 1986, J MOL BIOL, V192, P753, DOI 10.1016/0022-2836(86)90026-4; Li M, 1997, P NATL ACAD SCI USA, V94, P3691, DOI 10.1073/pnas.94.8.3691; Mota LJ, 1999, MOL MICROBIOL, V33, P476, DOI 10.1046/j.1365-2958.1999.01484.x; Nieto C, 1997, J BIOL CHEM, V272, P30860, DOI 10.1074/jbc.272.49.30860; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; OSKOUIAN B, 1990, J BACTERIOL, V172, P3804, DOI 10.1128/jb.172.7.3804-3812.1990; OZOLINE ON, 1995, NUCLEIC ACIDS RES, V23, P4533, DOI 10.1093/nar/23.22.4533; PUYET A, 1993, J BIOL CHEM, V268, P25402; PUYET A, 1993, J MOL BIOL, V230, P800, DOI 10.1006/jmbi.1993.1202; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; SABELNIKOV AG, 1995, J MOL BIOL, V250, P144, DOI 10.1006/jmbi.1995.0366; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLAX PJ, 1995, J MOL BIOL, V245, P331, DOI 10.1006/jmbi.1994.0028; Singh VK, 1999, MOL MICROBIOL, V33, P200, DOI 10.1046/j.1365-2958.1999.01466.x; Smith TL, 1996, P NATL ACAD SCI USA, V93, P8868, DOI 10.1073/pnas.93.17.8868; STASSI DL, 1981, P NATL ACAD SCI-BIOL, V78, P7028, DOI 10.1073/pnas.78.11.7028; STASSI DL, 1982, GENE, V20, P359, DOI 10.1016/0378-1119(82)90204-9; Strainic MG, 2000, J BACTERIOL, V182, P216, DOI 10.1128/JB.182.1.216-220.2000; VONHIPPEL PH, 1995, NUCL ACIDS S SER, V33, P1; WILLIAMS DR, 1993, NUCLEIC ACIDS RES, V21, P1141, DOI 10.1093/nar/21.5.1141; Xiong AM, 2000, MICROBIOL-UK, V146, P659, DOI 10.1099/00221287-146-3-659; Zhang X, 1996, J MOL BIOL, V258, P14, DOI 10.1006/jmbi.1996.0230	33	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14946	14954		10.1074/jbc.M010911200	http://dx.doi.org/10.1074/jbc.M010911200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278784	Green Published, hybrid			2022-12-27	WOS:000168528800058
J	Charrin, S; Le Naour, F; Oualid, M; Billard, M; Faure, G; Hanash, SM; Boucheix, C; Rubinstein, E				Charrin, S; Le Naour, F; Oualid, M; Billard, M; Faure, G; Hanash, SM; Boucheix, C; Rubinstein, E			The major CD9 and CD81 molecular partner - Identification and characterization of the complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRASPANIN SUPERFAMILY; CD9-DEFICIENT MICE; INTEGRIN COMPLEXES; PROTEIN MRP-1/CD9; PLASMA-MEMBRANE; EXPRESSION; MOTILITY; ASSOCIATION; CANCER; CD151	By associating with specific partner molecules and with each other, the tetraspanins are thought to assemble multimolecular complexes that may be especially relevant with respect to metastasis. We have previously identified a 135-kDa molecule (CD9P-1) as a major molecular partner of CD9 in cancer cell lines. This molecule was identified, after immunoaffinity purification and mass spectrometry analysis, as the protein encoded by the KIAA1436 gene and the human ortholog of a rat protein known as FPRP. Cross-linking experiments detected a complex of the size of CD9 plus CD9P-1, showing that these glycoproteins directly associate with each other, probably in the absence of any other molecule. The use of chimeric CD9/CD82 molecules revealed the role of the second half of CD9, comprising the large extracellular loop and the fourth transmembrane domain. CD9P-1 was also shown to form separate complexes with CD81 and with an unidentified 175-kDa molecule. It also associated with other tetraspanins under conditions maintaining tetraspanin/tetraspanin interactions. The identification of a protein strongly linked to the tetraspanin web and the production of a specific monoclonal antibody will help to further characterize the role of this "web" under physiological and pathological conditions.	Hop Paul Brousse, INSERM, U268, F-94807 Villejuif, France; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Fac Med Vandoeuvre Nancy, Immunol Lab, F-54500 Vandoeuvre Nancy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Michigan System; University of Michigan; Universite de Lorraine	Rubinstein, E (corresponding author), Hop Paul Brousse, INSERM, U268, F-94807 Villejuif, France.		Rubinstein, Eric/B-4650-2019; CHARRIN, Stephanie/B-2892-2019	Rubinstein, Eric/0000-0001-7623-9665; Boucheix, Claude/0000-0003-4184-7008; Charrin, Stephanie/0000-0002-4942-3990				Adachi M, 1998, J CLIN ONCOL, V16, P1397, DOI 10.1200/JCO.1998.16.4.1397; ANGELISOVA P, 1994, IMMUNOGENETICS, V39, P249; Azorsa DO, 1999, J IMMUNOL METHODS, V229, P35, DOI 10.1016/S0022-1759(99)00102-7; Berditchevski F, 1996, MOL BIOL CELL, V7, P193, DOI 10.1091/mbc.7.2.193; Cajot JF, 1997, CANCER RES, V57, P2593; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Hemler ME, 1996, BBA-REV CANCER, V1287, P67, DOI 10.1016/0304-419X(96)00007-8; IKEYAMA S, 1993, J EXP MED, V177, P1231, DOI 10.1084/jem.177.5.1231; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; Lagaudriere-Gesbert C, 1997, CELL IMMUNOL, V182, P105, DOI 10.1006/cimm.1997.1223; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Lozahic S, 2000, EUR J IMMUNOL, V30, P900, DOI 10.1002/1521-4141(200003)30:3<900::AID-IMMU900>3.0.CO;2-X; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; MIYAKE M, 1995, CANCER RES, V55, P4127; Mori M, 1998, CLIN CANCER RES, V4, P1507; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Orlicky DJ, 1996, PROSTAG LEUKOTR ESS, V54, P247, DOI 10.1016/S0952-3278(96)90055-1; ORLICKY DJ, 1990, PROSTAG LEUKOTR ESS, V41, P51, DOI 10.1016/0952-3278(90)90131-4; Orlicky DJ, 1996, PROSTAG LEUKOTR ESS, V55, P261, DOI 10.1016/S0952-3278(96)90007-1; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; RUBINSTEIN E, 1994, EUR J IMMUNOL, V24, P3005, DOI 10.1002/eji.1830241213; Rubinstein E, 1997, EUR J IMMUNOL, V27, P1919, DOI 10.1002/eji.1830270815; Rubinstein E, 1996, EUR J IMMUNOL, V26, P2657, DOI 10.1002/eji.1830261117; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; SI ZY, 1993, INT J CANCER, V54, P37, DOI 10.1002/ijc.2910540107; Sincock PM, 1999, J CELL SCI, V112, P833; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; THIERY JP, 1999, GUIDEBOOK EXTRACELLU, P125; Uchida S, 1999, BRIT J CANCER, V79, P1168, DOI 10.1038/sj.bjc.6690186; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829	35	181	193	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14329	14337		10.1074/jbc.M011297200	http://dx.doi.org/10.1074/jbc.M011297200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278880	hybrid			2022-12-27	WOS:000168356600108
J	Matsumoto, M; Ogawa, M; Hino, Y; Furukawa, K; Ono, Y; Takahashi, M; Ohba, M; Kuroki, T; Kasuga, M				Matsumoto, M; Ogawa, M; Hino, Y; Furukawa, K; Ono, Y; Takahashi, M; Ohba, M; Kuroki, T; Kasuga, M			Inhibition of insulin-induced activation of Akt by a kinase-deficient mutant of the epsilon isozyme of protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GLUCOSE-UPTAKE; PHOSPHOINOSITIDE 3-KINASE; GLYCOGEN-SYNTHASE; PHOSPHORYLATION; PDK1; REQUIREMENT; EXPRESSION; HOMOLOGY; TARGET	Akt, also known as protein kinase B, is a protein-serine/threonine kinase that is activated by growth factors in a phosphoinositide (PI) 3-kinase-dependent manner. Although Akt mediates a variety of biological activities, the mechanisms by which its activity is regulated remain unclear. The potential role of the a isozyme of protein kinase C (PKC) in the activation of Akt induced by insulin has now been examined. Expression of a kinase-deficient mutant of PKC epsilon (epsilon KD), but not that of wild-type PKC epsilon or of kinase-deficient mutants of PKC alpha or PKC lambda, with the use of adenovirus-mediated gene transfer inhibited the phosphorylation and activation of Akt induced by insulin in Chinese hamster ovary cells or L6 myotubes, Whereas the epsilon KD mutant did not affect insulin stimulation of PI 3-kinase activity, the phosphorylation and activation of Akt induced by a constitutively active mutant of PI 3-kinase were inhibited by epsilon KD, suggesting that epsilon KD affects insulin signaling downstream of PI 3-kinase. PDK1 (3'-phosphoinositide-dependent kinase 1) is thought to participate in Akt activation. Overexpression of PDK1 with the use of an adenovirus vector induced the phosphorylation and activation of Akt; epsilon KD inhibited, whereas wild-type PKC epsilon had no effect on, these actions of PDK1. These results suggest that epsilon KD inhibits the insulin-induced phosphorylation and activation of Akt by interfering with the ability of PDK1 to phosphorylate Akt.	Kobe Univ, Sch Med, Dept Internal Med 2, Chuo Ku, Kobe, Hyogo 6500017, Japan; Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan; Showa Univ, Sch Med, Inst Mol Oncol, Shinagawa Ku, Tokyo 1428666, Japan	Kobe University; Kobe University; Kobe University; Showa University	Ogawa, M (corresponding author), Kobe Univ, Sch Med, Dept Internal Med 2, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ogawa@med.kobe-u.ac.jp	Kuroki, Toshio/A-9500-2011	Kuroki, Toshio/0000-0001-6369-4351				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andersen CB, 1998, J BIOL CHEM, V273, P18705, DOI 10.1074/jbc.273.30.18705; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Balendran A, 1999, J BIOL CHEM, V274, P37400, DOI 10.1074/jbc.274.52.37400; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DEPESO L, 1997, SCIENCE, V278, P687; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Doornbos RP, 1999, J BIOL CHEM, V274, P8589, DOI 10.1074/jbc.274.13.8589; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GENOT EM, 1995, J BIOL CHEM, V270, P9833, DOI 10.1074/jbc.270.17.9833; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Kotani K, 1999, J BIOL CHEM, V274, P21305, DOI 10.1074/jbc.274.30.21305; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mitsumoto Y, 1993, ENDOCR J, V1, P307; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; MORAG S, 1998, BIOCHEM J, V336, P241; Moriya S, 1996, P NATL ACAD SCI USA, V93, P151, DOI 10.1073/pnas.93.1.151; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; OHNO S, 1990, J BIOL CHEM, V265, P6296; ONO Y, 1988, J BIOL CHEM, V263, P6927; Ozes ON, 1999, NATURE, V401, P82; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sakaue H, 1997, MOL ENDOCRINOL, V11, P1552, DOI 10.1210/me.11.10.1552; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Takahashi M, 2000, J BIOL CHEM, V275, P34592, DOI 10.1074/jbc.M005285200; Takata M, 1999, J BIOL CHEM, V274, P20611, DOI 10.1074/jbc.274.29.20611	49	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14400	14406		10.1074/jbc.M011093200	http://dx.doi.org/10.1074/jbc.M011093200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278835	hybrid			2022-12-27	WOS:000168356600117
J	Navab, R; Chevet, E; Authier, F; Di Guglielmo, GM; Bergeron, JJM; Brodt, P				Navab, R; Chevet, E; Authier, F; Di Guglielmo, GM; Bergeron, JJM; Brodt, P			Inhibition of endosomal insulin-like growth factor-I processing by cysteine proteinase inhibitors blocks receptor-mediated functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATHEPSIN-B; SIGNAL-TRANSDUCTION; RAT-LIVER; CELLS; SHC; ENDOCYTOSIS; INTERNALIZATION; PROTEOLYSIS; SUBSTRATE-1; ACTIVATION	The receptor for the type 1 insulin-like growth factor (IGF-D has been implicated in cellular transformation and the acquisition of an invasive/metastatic phenotype in various tumors. Following ligand binding, the IGF-I receptor is internalized, and the receptor ligand complex dissociates as the ligand is degraded by endosomal proteinases, In the present study we show that the inhibition of endosomal IGF-I-degrading enzymes in human breast and murine lung carcinoma cells by the cysteine proteinase inhibitors, E-64 and CA074-methyl ester, profoundly altered receptor trafficking and signaling. In treated cells, intracellular ligand degradation was blocked, and although the receptor and two substrates, Shc and Insulin receptor substrate, mere hyperphosphorylated on tyrosine, IGF-I-induced DNA synthesis, anchorage-independent growth, and matrix metalloproteinase synthesis were inhibited. The results suggest that ligand processing by endosomal proteinases is a key step in receptor signaling and function and a potential target for therapy.	McGill Univ, Royal Victoria Hosp, Ctr Hlth, Dept Surg, Montreal, PQ H3A 1A4, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; Fac Pharm Paris 11, INSERM, U510, F-92296 Chatenay Malabry, France	McGill University; Royal Victoria Hospital; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Brodt, P (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, Dept Surg, Rm H625, Montreal, PQ H3A 1A4, Canada.		Bergeron, John/AAW-1893-2021; chevet, eric/E-4992-2016; Navab, Roya/AGD-7380-2022	chevet, eric/0000-0001-5855-4522; 				AUTHIER F, 1994, J BIOL CHEM, V269, P3010; Authier F, 1998, BIOCHEM J, V332, P421, DOI 10.1042/bj3320421; AUTHIER F, 1995, J BIOL CHEM, V270, P15798, DOI 10.1074/jbc.270.26.15798; Authier F, 1999, J BIOL CHEM, V274, P33723, DOI 10.1074/jbc.274.47.33723; Authier F, 1999, FEBS LETT, V461, P25, DOI 10.1016/S0014-5793(99)01413-1; Baserga R, 1997, ENDOCRINE, V7, P99, DOI 10.1007/BF02778073; BRIOZZO P, 1988, CANCER RES, V48, P3688; BRODT P, 1992, BIOCHIM BIOPHYS ACTA, V1139, P77, DOI 10.1016/0925-4439(92)90085-2; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; CRAPARO A, 1995, J BIOL CHEM, V270, P15639, DOI 10.1074/jbc.270.26.15639; Dey BR, 1996, MOL ENDOCRINOL, V10, P631, DOI 10.1210/me.10.6.631; Di Guglielmo GM, 1998, MOL CELL BIOCHEM, V182, P59, DOI 10.1023/A:1006883311233; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Drake PG, 1996, ENDOCRINOLOGY, V137, P4960, DOI 10.1210/en.137.11.4960; Haugh JM, 1999, J BIOL CHEM, V274, P34350, DOI 10.1074/jbc.274.48.34350; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Long L, 1998, CANCER RES, V58, P3243; LONG L, 1994, CANCER RES, V54, P3732; Long L, 1998, EXP CELL RES, V238, P116, DOI 10.1006/excr.1997.3814; MCPHERSON GA, 1983, J PHARMACOL METHOD, V10, P231, DOI 10.1016/0160-5402(83)90017-7; MCPHERSON GA, 1983, COMPUT PROG BIOMED, V17, P107, DOI 10.1016/0010-468X(83)90031-4; Navab R, 1997, CLIN EXP METASTAS, V15, P121, DOI 10.1023/A:1018496625936; NIP J, 1995, J CLIN INVEST, V95, P2096, DOI 10.1172/JCI117897; SAIGA T, 1987, IN VITRO CELL DEV B, V23, P850; Werner H, 1998, MOL CELL ENDOCRINOL, V141, P1, DOI 10.1016/S0303-7207(98)00099-9; WERNER H, 1989, P NATL ACAD SCI USA, V86, P7451, DOI 10.1073/pnas.86.19.7451; Xing RY, 1998, CANCER RES, V58, P904	32	41	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13644	13649		10.1074/jbc.M100019200	http://dx.doi.org/10.1074/jbc.M100019200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11278993	hybrid			2022-12-27	WOS:000168356600021
J	Sugiyama, Y; Tomoda, K; Tanaka, T; Arata, Y; Yoneda-Kato, N; Kato, J				Sugiyama, Y; Tomoda, K; Tanaka, T; Arata, Y; Yoneda-Kato, N; Kato, J			Direct binding of the signal-transducing adaptor Grb2 facilitates down-regulation of the cyclin-dependent kinase inhibitor p27(Kip1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; COP9 SIGNALOSOME; S-PHASE; SUBCELLULAR-LOCALIZATION; BREAST-CANCER; MESSENGER-RNA; DEGRADATION; P27; GROWTH; ACCUMULATION	Ectopic expression of Jab1/CSN5 induces specific down-regulation of the cyclin-dependent kinase (Cdk) inhibitor p27 (p27(Kip1)) in a manner dependent upon transportation from the nucleus to the cytoplasm. Here we show that Grb2 and Grb3-3, the molecules functioning as an adaptor in the signal transduction pathway, specifically and directly bind to p27 in the cytoplasm and participate in the regulation of p27. The interaction requires the C-terminal SH3-domain of Grb2/3-3 and the proline-rich sequence contained in p27 immediately downstream of the Cdk binding domain. In living cells, enforcement of the cytoplasmic localization of p27, either by artificial manipulation of the nuclear/cytoplasmic transport signal sequence or by coexpression of ectopic Jab1/CSN5, markedly enhances the stable interaction between p27 and Grb2. Overexpression of Grb2 accelerates Jab1/CSN5-mediated degradation of p27, while Grb3-3 expression suppresses if. A p27 mutant unable to bind to Grb2 is transported into the cytoplasm in cells ectopically expressing Jab1/CSN5 but is refractory to the subsequent degradation. These findings indicate that Grb2 participates in a negative regulation of p27 and may directly link the signal transduction pathway with the cell cycle regulatory machinery.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Nara Institute of Science & Technology	Kato, J (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300101, Japan.		Arata, Yukinobu/AAE-3467-2019; Tanaka, Toshiaki/C-5567-2013	Tanaka, Toshiaki/0000-0002-9448-1452				Akamatsu E, 1998, J BIOL CHEM, V273, P16494, DOI 10.1074/jbc.273.26.16494; Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Birge RB, 1996, GENES CELLS, V1, P595, DOI 10.1046/j.1365-2443.1996.00258.x; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Deng XW, 2000, TRENDS GENET, V16, P202, DOI 10.1016/S0168-9525(00)01982-X; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; FATH I, 1994, SCIENCE, V264, P971, DOI 10.1126/science.8178156; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; KATO J, 1993, GENE DEV, V7, P331; Kawada M, 1997, ONCOGENE, V15, P629, DOI 10.1038/sj.onc.1201228; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Millard SS, 2000, MOL CELL BIOL, V20, P5947, DOI 10.1128/MCB.20.16.5947-5959.2000; Millard SS, 1997, J BIOL CHEM, V272, P7093, DOI 10.1074/jbc.272.11.7093; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; NISHI K, 1994, J BIOL CHEM, V269, P6320; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; SHCLESSINGER J, 2000, CELL, V103, P211; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Takuwa N, 1997, MOL CELL BIOL, V17, P5348, DOI 10.1128/MCB.17.9.5348; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6	36	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12084	12090		10.1074/jbc.M010811200	http://dx.doi.org/10.1074/jbc.M010811200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11278754	hybrid			2022-12-27	WOS:000168081800088
J	Bain, DL; Berton, N; Ortega, M; Baran, J; Yang, Q; Catalano, CE				Bain, DL; Berton, N; Ortega, M; Baran, J; Yang, Q; Catalano, CE			Biophysical characterization of the DNA binding domain of gpNu1, a viral DNA packaging protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-LAMBDA TERMINASE; GENE-PRODUCT-A; PHAGE-LAMBDA; KINETIC CHARACTERIZATION; LARGE SUBUNIT; ENDONUCLEASE ACTIVITY; DEFINED SYSTEM; ENZYME; PURIFICATION; HOLOENZYME	Terminase enzymes are common to double-stranded DNA viruses. These enzymes "package" the viral genome into a pre-formed capsid, Terminase from bacteriophage lambda is composed of gpA (72.4 kDa) and gpNu1 (20.4 kDa) subunits. We have described the expression and biochemical characterization of gpNu1 Delta K100, a construct comprising the N-terminal 100 amino acids of gpNu1 (Yang, Q., de Beer, T., Woods, L., Meyer, J., Manning, M., Overduin, M., and Catalano, C. E. (1999) Biochemistry 38, 465-477), Here we present a biophysical characterization of this construct. Thermally induced loss of secondary and tertiary structures is fully reversible. Surprisingly, although loss of tertiary structure is cooperative, loss of secondary structure is non-cooperative. NMR and limited proteolysis data suggest that approximate to 30 amino acids of gpNu1 Delta K100 are solvent-exposed and highly flexible. We therefore constructed gpNu1 Delta E68, a protein consisting of the N-terminal 68 residues of gpNu1. gpNu1 Delta E68 is a dimer with no evidence of dissociation or further aggregation, Thermally induced unfolding of gpNu1 Delta E68 is reversible, with concomitant loss of both secondary and tertiary structure, The melting temperature increases with increasing protein concentration, suggesting that dimerization and folding are, at least in part, coupled. The data suggest that gpNu1 Delta E68 represents the minimal DNA binding domain of gpNu1. We further suggest that the C-terminal approximate to 30 residues in gpNu1 Delta K100 adopt a pseudo-stable alpha -helix that extends from the folded core of the protein. A model describing the role of this helix in the assembly of the packaging apparatus is discussed.	Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Program Mol Biol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Catalano, CE (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, 4200 E 9th Ave,Campus Box C238, Denver, CO 80262 USA.	carlos.catalano@uchsc.edu		Catalano, Carlos E./0000-0003-2349-5758				BECKER A, 1990, J BACTERIOL, V172, P2819, DOI 10.1128/jb.172.6.2819-2824.1990; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Cai ZH, 1997, J BACTERIOL, V179, P2479, DOI 10.1128/jb.179.8.2479-2485.1997; Catalano CE, 2000, CELL MOL LIFE SCI, V57, P128, DOI 10.1007/s000180050503; CATALANO CE, 1995, MOL MICROBIOL, V16, P1075, DOI 10.1111/j.1365-2958.1995.tb02333.x; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cohn E. J., 1943, PROTEINS AMINO ACIDS; CUE D, 1992, J MOL BIOL, V228, P72, DOI 10.1016/0022-2836(92)90492-3; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Droge A, 2000, J MOL BIOL, V296, P103, DOI 10.1006/jmbi.1999.3449; FEISS M, 1986, TRENDS GENET, V2, P100, DOI 10.1016/0168-9525(86)90193-9; FEISS M, 1982, GENE, V17, P123, DOI 10.1016/0378-1119(82)90064-6; Fujisawa H, 1997, GENES CELLS, V2, P537, DOI 10.1046/j.1365-2443.1997.1450343.x; Fujita N, 2000, BIOCHEMISTRY-US, V39, P6243, DOI 10.1021/bi000020d; Furth M., 1983, LAMBDA 2, P145; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GILL SC, 1990, ANAL BIOCHEM, V189, P283; GOLD M, 1983, J BIOL CHEM, V258, P4619; GUO PX, 1986, P NATL ACAD SCI USA, V83, P3505, DOI 10.1073/pnas.83.10.3505; Hanagan A, 1998, INT J BIOL MACROMOL, V23, P37, DOI 10.1016/S0141-8130(98)00010-5; Hang Q, 1999, J BIOL CHEM, V274, P15305, DOI 10.1074/jbc.274.22.15305; Hwang Y, 1996, BIOCHEMISTRY-US, V35, P2796, DOI 10.1021/bi952322z; HWANG Y, 1995, VIROLOGY, V211, P367, DOI 10.1006/viro.1995.1419; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301; KYPR J, 1986, J MOL BIOL, V191, P139, DOI 10.1016/0022-2836(86)90430-4; Meyer JD, 1998, INT J BIOL MACROMOL, V23, P27, DOI 10.1016/S0141-8130(98)00009-9; MURIALDO H, 1991, ANNU REV BIOCHEM, V60, P125; PARRIS W, 1988, J BIOL CHEM, V263, P8413; PARRIS W, 1994, J BIOL CHEM, V269, P13564; RAO VB, 1988, J MOL BIOL, V200, P475, DOI 10.1016/0022-2836(88)90537-2; ROIZMAN B, 1996, FIELDS VIROLOGY, V2, P2231; RUBINCHIK S, 1994, J BIOL CHEM, V269, P13586; RUBINCHIK S, 1995, J BIOL CHEM, V270, P20059, DOI 10.1074/jbc.270.34.20059; RUBINCHIK S, 1994, J BIOL CHEM, V269, P13575; SKALKA AM, 1977, CURR TOP MICROBIOL, P201; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; TOMKA MA, 1993, BIOCHEMISTRY-US, V32, P11992, DOI 10.1021/bi00096a008; TOMKA MA, 1993, J BIOL CHEM, V268, P3056; Woods L, 1997, BIOCHEMISTRY-US, V36, P5777, DOI 10.1021/bi963044m; Woods L, 1999, BIOCHEMISTRY-US, V38, P14624, DOI 10.1021/bi990866l; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; Yang Q, 1997, BIOCHEMISTRY-US, V36, P10638, DOI 10.1021/bi970689t; Yang Q, 1999, BIOCHEMISTRY-US, V38, P465, DOI 10.1021/bi981271d; Yang Q, 1999, BIOCHEMISTRY-US, V38, P14238, DOI 10.1021/bi991408f; Yang Q, 1997, BIOCHEMISTRY-US, V36, P2744, DOI 10.1021/bi9622682; [No title captured]	47	13	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20175	20181		10.1074/jbc.M100517200	http://dx.doi.org/10.1074/jbc.M100517200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279084	hybrid			2022-12-27	WOS:000169135100068
J	Hartmann, H; Lohkamp, B; Hellmann, N; Decker, H				Hartmann, H; Lohkamp, B; Hellmann, N; Decker, H			The allosteric effector L-lactate induces a conformational change of 2x6-meric lobster hemocyanin in the oxy state as revealed by small angle x-ray scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARANTULA EURYPELMA-CALIFORNICUM; ASPARTATE-TRANSCARBAMYLASE; CARBON-MONOXIDE; NESTED ALLOSTERY; HOMARUS-VULGARIS; BINDING; HIERARCHIES; TRANSITION; MODULATION; CRYSTAL	Hemocyanins are multisubunit respiratory proteins found in many invertebrates. They bind oxygen highly cooperatively. However, not much is known about the structural basis of this behavior. We studied the influence of the physiological allosteric effector L-lactate on the oxygenated quaternary structure of the 2x6-meric hemocyanin from the lobster Homarus americanus employing small angle x-ray scattering (SAXS), The presence of 20 mM L-lactate resulted in different scattering curves compared with those obtained in the absence of L-lactate. The distance distribution functions p(r) indicated a more compact molecule in presence of L-lactate, which is also reflected in a reduction of the radius of gyration by about 0.2 nm (3%), Thus, we show for the first time on a structural basis that a hemocyanin in the oxy state can adopt two different conformations. This is as predicted from the analysis of oxygen binding curves according to the "nesting" model. A comparison of the distance distribution functions p(r) obtained from SAXS with those deduced hom electron microscopy revealed large differences. The distance between the two hexamers as deduced from electron microscopy has to be shortened by up to 1.1 nm to agree well with the small angle x-ray curves.	Univ Mainz, Inst Mol Biophys, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz	Decker, H (corresponding author), Univ Mainz, Inst Mol Biophys, Welder Weg 26, D-55128 Mainz, Germany.			Lohkamp, Bernhard/0000-0002-5646-2090				BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BROUWER M, 1989, BIOCHEMISTRY-US, V28, P8819, DOI 10.1021/bi00448a021; CONNELLY PR, 1989, J MOL BIOL, V207, P829, DOI 10.1016/0022-2836(89)90248-9; CONRAD H, 1969, J MOL BIOL, V41, P225, DOI 10.1016/0022-2836(69)90387-8; Dainese E, 1998, EUR J BIOCHEM, V256, P350, DOI 10.1046/j.1432-1327.1998.2560350.x; DECKER H, 1990, J MOL BIOL, V211, P281, DOI 10.1016/0022-2836(90)90027-J; Decker H, 1996, FEBS LETT, V393, P226, DOI 10.1016/0014-5793(96)00887-3; DECKER H, 1990, BIOPHYS CHEM, V37, P257, DOI 10.1016/0301-4622(90)88025-N; DECKER H, 1990, NATURWISSENSCHAFTEN, V77, P561, DOI 10.1007/BF01133724; DECKER H, 1988, BIOCHEMISTRY-US, V27, P6901, DOI 10.1021/bi00418a036; DEHAAS F, 1991, J STRUCT BIOL, V107, P86; DURCHSCHSLAG H, 1971, EUR J BIOCHEM, V19, P9, DOI 10.1111/j.1432-1033.1971.tb01282.x; ELLERTON HD, 1983, PROG BIOPHYS MOL BIO, V41, P143, DOI 10.1016/0079-6107(83)90028-7; HAUBOLD HG, 1989, REV SCI INSTRUM, V60, P1943, DOI 10.1063/1.1140895; HERVE G, 1985, J MOL BIOL, V185, P189, DOI 10.1016/0022-2836(85)90190-1; KIHARA H, 1987, J MOL BIOL, V198, P745, DOI 10.1016/0022-2836(87)90215-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEIDESCHER T, 1990, EUR J BIOCHEM, V187, P617, DOI 10.1111/j.1432-1033.1990.tb15345.x; MAKINO N, 1993, BIOCHIM BIOPHYS ACTA, V1162, P237, DOI 10.1016/0167-4838(93)90287-2; MANGUM CP, 1993, BIOL BULL, V184, P105, DOI 10.2307/1542384; Markl J., 1992, Advances in Comparative and Environmental Physiology, V13, P325; Menze MA, 2000, BIOCHEMISTRY-US, V39, P10806, DOI 10.1021/bi000008l; Menze MA, 2001, J EXP BIOL, V204, P1033; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MOODY MF, 1979, J MOL BIOL, V133, P517, DOI 10.1016/0022-2836(79)90405-4; MORIMOTO K, 1971, ARCH BIOCHEM BIOPHYS, V142, P247, DOI 10.1016/0003-9861(71)90281-5; Morris S., 1986, P353; MULLER K, 1972, H-S Z PHYSIOL CHEM, V353, P803, DOI 10.1515/bchm2.1972.353.1.803; PARADIES HH, 1978, ARCH BIOCHEM BIOPHYS, V191, P169, DOI 10.1016/0003-9861(78)90079-6; PERKINS SJ, 1988, MODERN PHYSICAL METH, P143; RICHEY B, 1985, BIOCHEMISTRY-US, V24, P109, DOI 10.1021/bi00322a016; ROBERT CH, 1987, P NATL ACAD SCI USA, V84, P1891, DOI 10.1073/pnas.84.7.1891; Snyder G.K., 1982, Progress in Clinical and Biological Research, V81, P173; SVERGUN DI, 1988, ACTA CRYSTALLOGR A, V44, P244, DOI 10.1107/S0108767387011255; Svergun DI, 1997, PROTEINS, V27, P110; SVERGUN DI, 1994, J APPL CRYSTALLOGR, V27, P241, DOI 10.1107/S0021889893008337; TAUC P, 1990, J MOL BIOL, V214, P327, DOI 10.1016/0022-2836(90)90164-H; Truchot J.P., 1992, Advances in Comparative and Environmental Physiology, V13, P377; TRUCHOT JP, 1992, NEWS PHYSIOL SCI, V7, P49; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; VOLBEDA A, 1989, J MOL BIOL, V209, P249, DOI 10.1016/0022-2836(89)90276-3; ZEIS B, 1992, J EXP BIOL, V168, P93	43	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19954	19958		10.1074/jbc.M010435200	http://dx.doi.org/10.1074/jbc.M010435200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11278676	hybrid			2022-12-27	WOS:000169135100037
J	Berkowitz, JKM; Catz, SD; Johnson, JL; Ruedi, JM; Thon, V; Babior, BM				Berkowitz, JKM; Catz, SD; Johnson, JL; Ruedi, JM; Thon, V; Babior, BM			JFC1, a novel tandem C2 domain-containing protein associated with the leukocyte NADPH oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; DINUCLEOTIDE PHOSPHATE OXIDASE; INOSITOL 1,3,4,5-TETRAKISPHOSPHATE BINDING; CHRONIC GRANULOMATOUS-DISEASE; PLASMA-MEMBRANE; KINASE-C; PHOSPHATIDYLINOSITOL 3-KINASE; HUMAN-NEUTROPHILS; PHOSPHOINOSITIDE 3-KINASE; COMPONENT P47(PHOX)	We have employed a yeast two-hybrid system to screen a B lymphoblast-derived cDNA library, searching for regulatory components of the NADPH oxidase. Using as bait the C-terminal half of p67(phox), which contains both Src homology 3 domains, we have cloned JFC1, a novel human 62-kDa protein. JFC1 possesses two C2 domains in tandem. The C2A domain shows homology with the C2B domain of synaptotagmins. JFC1 mRNA was abundantly expressed in bone marrow and leukocytes, The expression of JFC1 in neutrophils was restricted to the plasma membrane/secretory vesicle fraction. We confirmed JFC1-p67(phox) association by affinity chromatography, JFC1-containing beads pulled down both p67(phox) and p47(phox) subunits from neutrophil cytosol, but when the recombinant proteins were used, only p67(phox) bound to JFC1, indicating that JFC1 binds to the cytosolic complex via p67(phox) without affecting the interaction Between p67(phox) and p47(phox), In contrast to synaptotagmins, JFC1 was unable to bind to inositol 1,3,4,5-tetrakisphosphate but did bind to phosphatidylinositol 3,4,S-trisphosphate and to a lesser extent to phosphatidylinositol 3,4-diphosphate, From the data presented here, it is proposed that JFC1 is acting as an adaptor protein between phosphatidylinositol 3-kinase products and the oxidase cytosolic complex.	Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA	Scripps Research Institute	Babior, BM (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA.	babior@scripps.edu		McAdara, Jeanne/0000-0002-6364-0123; Catz, Sergio/0000-0002-1873-0277	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044434, R01AI024227, R37AI024227] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-44434, AI-24227] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; Arcaro A, 1998, J BIOL CHEM, V273, P33082, DOI 10.1074/jbc.273.49.33082; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BABIOR BM, 1992, ADV ENZYMOL RAMB, V65, P49; BABIOR BM, 1990, SEMIN HEMATOL, V27, P247; BOKOCH GM, 1991, SCIENCE, V254, P1794, DOI 10.1126/science.1763330; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Cullen PJ, 1998, BBA-MOL CELL BIOL L, V1436, P35, DOI 10.1016/S0005-2760(98)00149-0; Dang PMC, 1999, BIOCHEMISTRY-US, V38, P5746, DOI 10.1021/bi982750f; Dang PMC, 2000, BIOCHEMISTRY-US, V39, P3069, DOI 10.1021/bi9919807; DEMENDEZ I, 1994, J BIOL CHEM, V269, P16326; deMendez I, 1997, MOL CELL BIOL, V17, P2177, DOI 10.1128/MCB.17.4.2177; deMendez I, 1996, EMBO J, V15, P1211, DOI 10.1002/j.1460-2075.1996.tb00462.x; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Edwards AS, 1997, BIOCHEMISTRY-US, V36, P15615, DOI 10.1021/bi9718752; ElBenna J, 1995, BLOOD CELL MOL DIS, V21, P201, DOI 10.1006/bcmd.1995.0023; ElBenna J, 1996, J BIOL CHEM, V271, P6374; ELBENNA J, 1994, J BIOL CHEM, V269, P6729; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; ElBenna J, 1997, J BIOL CHEM, V272, P17204, DOI 10.1074/jbc.272.27.17204; Freeman JL, 1996, J BIOL CHEM, V271, P22578, DOI 10.1074/jbc.271.37.22578; Fukuda M, 1996, J BIOL CHEM, V271, P18838, DOI 10.1074/jbc.271.31.18838; Fukuda M, 1996, J BIOL CHEM, V271, P8430, DOI 10.1074/jbc.271.14.8430; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HARPER JW, 1993, CELL, V75, P805; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Ibata K, 1998, J BIOL CHEM, V273, P12267, DOI 10.1074/jbc.273.20.12267; Johnson JL, 1998, J BIOL CHEM, V273, P35147, DOI 10.1074/jbc.273.52.35147; Karlsson A, 2000, J LEUKOCYTE BIOL, V67, P396, DOI 10.1002/jlb.67.3.396; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Kodama T, 1999, BIOCHEM J, V337, P201, DOI 10.1042/0264-6021:3370201; Koppler P, 1996, BIOCHEMISTRY-US, V35, P5481, DOI 10.1021/bi9522918; Koshkin V, 1996, J BIOL CHEM, V271, P30326, DOI 10.1074/jbc.271.48.30326; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Lockyer PJ, 1997, CURR BIOL, V7, P1007, DOI 10.1016/S0960-9822(06)00423-4; MARKERT M, 1984, METHOD ENZYMOL, V105, P358; Mizutani A, 1997, BIOCHEM BIOPH RES CO, V240, P128, DOI 10.1006/bbrc.1997.7578; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Oishi H, 1996, BIOCHEM BIOPH RES CO, V229, P498, DOI 10.1006/bbrc.1996.1833; Paclet MH, 2000, BIOCHEMISTRY-US, V39, P9302, DOI 10.1021/bi000483j; PARK JW, 1992, J BIOL CHEM, V267, P19901; PARK JW, 1994, BIOCHEMISTRY-US, V33, P2907, DOI 10.1021/bi00176a021; PARK JW, 1992, J BIOL CHEM, V267, P17327; QUINN MT, 1989, NATURE, V342, P198, DOI 10.1038/342198a0; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SUE AQA, 1997, J CELL PHYSL, V172, P94; TRAYNORKAPLAN AE, 1988, NATURE, V334, P353, DOI 10.1038/334353a0; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; Yamamori T, 2000, FEBS LETT, V467, P253, DOI 10.1016/S0014-5793(00)01167-4; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993	63	41	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18855	18862		10.1074/jbc.M011167200	http://dx.doi.org/10.1074/jbc.M011167200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11278853	hybrid			2022-12-27	WOS:000169091000029
J	Cal, S; Arguelles, JM; Fernandez, PL; Lopez-Otin, C				Cal, S; Arguelles, JM; Fernandez, PL; Lopez-Otin, C			Identification, characterization, and intracellular processing of ADAM-TS12, a novel human disintegrin with a complex structural organization involving multiple thrombospondin-1 repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOPROTEASE-DISINTEGRIN; ADAMTS FAMILY; MATRIX METALLOPROTEINASE; HUMAN FIBROBLASTS; CELL-ADHESION; GROWTH-FACTOR; EXPRESSION; CLONING; GENE; PROTEINS	We have identified and cloned a human fetal lung cDNA encoding a new protein of the ADAM-TS family (a disintegrin and metalloproteinase domain, with thrombospondin type-1 modules) that has been called ADAM-TS12, This protein exhibits a domain organization similar to the remaining family members including a propeptide and metalloproteinase-like, disintegrin-like, and cysteine-rich domains. However, the number and organization of the TS repeats is unique with respect to other human ADAM-TSs. A total of eight TS-l repeats arranged in three groups are present in this novel ADAM-TS. Analysis of intracellular processing of ADAM-TS12 revealed that it is synthesized as a precursor molecule that is first activated by cleavage of the prodomain in a furin-mediated process and subsequently processed into two fragments of different size: a 120-kDa N-terminal proteolytically active fragment containing the metalloproteinase and disintegrin domains, and a 83-kDa C-terminal fragment containing most of the TS-1 repeats. Somatic cell hybrid and radiation hybrid mapping experiments showed that the human ADAM-TS12 gene maps to 5q35, a location that differs from all ADAM genes mapped to date. Northern blot analysis of RNAs from human adult and fetal tissues demonstrated that ADAM-TS12 transcripts are only detected at significant levels in fetal lung but not in any other analyzed tissues. In addition, ADAM-TS12 transcripts were detected in gastric carcinomas and in tumor cell lines from diverse sources, being induced by transforming growth factor-beta in KMST human fibroblasts, These data suggest that ADAM-TS12 may play roles in pulmonary cells during fetal development or in tumor processes through its proteolytic activity or as a molecule potentially involved in regulation of cell adhesion.	Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, Inst Univ Oncol, E-33006 Oviedo, Spain; Hosp Clin Barcelona, IDIBAPS, Serv Anat Patol, E-08036 Barcelona, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Lopez-Otin, C (corresponding author), Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, Inst Univ Oncol, E-33006 Oviedo, Spain.		Fernandez, Pedro L/H-2594-2017	Fernandez, Pedro Luis/0000-0002-8618-4597				Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; BLACK RA, 1997, NATURE, V38, P5729; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; Cal S, 2000, MOL BIOL CELL, V11, P1457, DOI 10.1091/mbc.11.4.1457; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; DING SF, 1991, BRIT J CANCER, V64, P1083, DOI 10.1038/bjc.1991.468; EMI M, 1993, NAT GENET, V5, P151, DOI 10.1038/ng1093-151; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Inoue D, 1998, J BIOL CHEM, V273, P4180, DOI 10.1074/jbc.273.7.4180; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Jaju RJ, 1999, BLOOD, V94, P773; Johansson B, 1997, CANCER GENET CYTOGEN, V99, P97, DOI 10.1016/S0165-4608(97)00198-2; KRATSCHMAR J, 1995, J BIOL CHEM, V271, P4593; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 1999, J BIOL CHEM, V274, P18821, DOI 10.1074/jbc.274.26.18821; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; MELODY EC, 2000, GENOMICS, V67, P343; MUELLER CG, 1997, J EXP MED, V189, P655; NAGEL S, 1995, CANCER RES, V55, P2866; NOMURA H, 1995, CANCER RES, V55, P3263; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WOLFSBERG TG, 1995, J CELL BIOL, V131, P275, DOI 10.1083/jcb.131.2.275; Wolfsberg TG, 1996, DEV BIOL, V180, P389, DOI 10.1006/dbio.1996.0313; Wu E, 1997, BIOCHEM BIOPH RES CO, V235, P437, DOI 10.1006/bbrc.1997.6714; Yavari R, 1998, HUM MOL GENET, V7, P1161, DOI 10.1093/hmg/7.7.1161	35	74	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17932	17940		10.1074/jbc.M100534200	http://dx.doi.org/10.1074/jbc.M100534200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11279086	hybrid			2022-12-27	WOS:000168866500044
J	Addinall, SG; Mayr, PS; Doyle, S; Sheehan, JK; Woodman, PG; Allan, VJ				Addinall, SG; Mayr, PS; Doyle, S; Sheehan, JK; Woodman, PG; Allan, VJ			Phosphorylation by cdc2-cyclinB1 kinase releases cytoplasmic dynein from membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-INTERMEDIATE CHAIN; KINESIN-LIKE PROTEIN; CELL-CYCLE REGULATION; HEAVY-CHAIN; GOLGI-APPARATUS; XENOPUS-LAEVIS; ASSOCIATION; TRANSPORT; LOCALIZATION; MOTILITY	Movement of various cargoes toward microtubule minus ends is driven by the microtubule motor cytoplasmic dynein (CD). Many cargoes are motile only during certain cell cycle phases, suggesting that CD function may be under cell cycle control. Phosphorylation of the CD light intermediate chain (DLIC) has been suggested to play a crucial role in modulating CD function during the Xenopus embryonic cell cycle, where CD-driven organelle movement is active in interphase but greatly reduced in metaphase. This down-regulation correlates with hyperphosphorylation of DLIC and release of CD from the membrane. Here we investigate the role of the key mitotic kinase, cdc2-cyclinB1, in this process. We show that DLIC within the native Xenopus CD complex is an excellent substrate for purified Xenopus cdc2-glutathione S-transferase (GST) cyclinB1 (cdcB-GSTcyclinB1) kinase, Mass spectrometry of native DLIC revealed that a conserved cdc2 site (Ser-197) previously implicated in the metaphase modulation of CD remains phosphorylated in interphase and so is unlikely to be the key regulatory site. We also demonstrate that incubating interphase membranes with cdc2-GSTcyclinB1 kinase results in substantial release of CD from the membrane. These data suggest that phosphorylation of DLIC by cdc2 kinase leads directly to the loss of membrane-associated CD and an inhibition of organelle movement.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Allan, VJ (corresponding author), Univ Manchester, Sch Biol Sci, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	viki.allan@man.ac.uk		Allan, Victoria/0000-0003-4583-0836				ALLAN V, 1995, J CELL BIOL, V128, P879, DOI 10.1083/jcb.128.5.879; Allan V, 1996, CURR BIOL, V6, P630, DOI 10.1016/S0960-9822(09)00434-5; Allan VJ, 1998, METHOD ENZYMOL, V298, P339, DOI 10.1016/S0076-6879(98)98030-2; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Borgne A, 1999, J BIOL CHEM, V274, P11977, DOI 10.1074/jbc.274.17.11977; Bowman AB, 1999, J CELL BIOL, V146, P165; Dell KR, 2000, TRAFFIC, V1, P38, DOI 10.1034/j.1600-0854.2000.010107.x; DILLMAN JF, 1994, J CELL BIOL, V127, P1671, DOI 10.1083/jcb.127.6.1671; FERRELL JE, 1991, MOL CELL BIOL, V11, P1965, DOI 10.1128/MCB.11.4.1965; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; GILL SR, 1994, MOL BIOL CELL, V5, P645, DOI 10.1091/mbc.5.6.645; Habura A, 1999, J BIOL CHEM, V274, P15447, DOI 10.1074/jbc.274.22.15447; Harrison A, 1998, J CELL BIOL, V140, P1137, DOI 10.1083/jcb.140.5.1137; Heald R, 2000, CELL, V102, P399, DOI 10.1016/S0092-8674(00)00044-1; HIROKAWA N, 1990, J CELL BIOL, V111, P1027, DOI 10.1083/jcb.111.3.1027; Huang CYF, 1999, J BIOL CHEM, V274, P14262, DOI 10.1074/jbc.274.20.14262; HUGHES SM, 1995, J CELL SCI, V108, P17; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; Lane J, 1998, BBA-REV BIOMEMBRANES, V1376, P27, DOI 10.1016/S0304-4157(97)00010-5; Lane JD, 1999, MOL BIOL CELL, V10, P1909, DOI 10.1091/mbc.10.6.1909; LEE KS, 1995, MOL CELL BIOL, V15, P7143; LIN SXH, 1994, J CELL BIOL, V127, P1009, DOI 10.1083/jcb.127.4.1009; Liu B, 1996, PLANT CELL, V8, P119, DOI 10.1105/tpc.8.1.119; Maeda S, 1998, CELL STRUCT FUNCT, V23, P169, DOI 10.1247/csf.23.169; Maeda S, 1998, CELL STRUCT FUNCT, V23, P9, DOI 10.1247/csf.23.9; Mayr PSM, 1999, EUR J CELL BIOL, V78, P224, DOI 10.1016/S0171-9335(99)80055-7; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Niclas J, 1996, J CELL BIOL, V133, P585, DOI 10.1083/jcb.133.3.585; Nicolas FJ, 1997, J CELL SCI, V110, P3019; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Pearson RB, 1998, SEL METH EN, P65; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Reese EL, 2000, J CELL BIOL, V151, P155, DOI 10.1083/jcb.151.1.155; Robertson A M, 1997, Prog Cell Cycle Res, V3, P59; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; Roghi C, 1999, J CELL SCI, V112, P4673; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith RF, 1996, GENOME RES, V6, P454, DOI 10.1101/gr.6.5.454; Suelmann R, 2000, RES MICROBIOL, V151, P247, DOI 10.1016/S0923-2508(00)00151-0; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tai AW, 1998, J BIOL CHEM, V273, P19639, DOI 10.1074/jbc.273.31.19639; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047	51	41	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15939	15944		10.1074/jbc.M011628200	http://dx.doi.org/10.1074/jbc.M011628200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278950	hybrid			2022-12-27	WOS:000168623100051
J	Jezewska, MJ; Rajendran, S; Bujalowski, W				Jezewska, MJ; Rajendran, S; Bujalowski, W			Energetics and specificity of rat DNA polymerase beta interactions with template-primer and gapped DNA substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; DIMENSIONAL HOMOGENEOUS LATTICE; NON-COOPERATIVE BINDING; SINGLE-STRANDED-DNA; ABASIC SITE REPAIR; LARGE LIGANDS; NUCLEIC-ACID; OLIGONUCLEOTIDE INTERACTIONS; BOVINE TESTIS; PROTEIN	Interactions between rat polymerase beta (pol beta) and the template-primer, as well as gapped DNAs, were studied using the quantitative fluorescence titration technique. Stoichiometries of rat pol beta complexes with DNA substrates are much higher than stoichiometries predicted by the structures of co-crystals. The data can be understood in the context of the two single-stranded (ss)DNA-binding modes of the enzyme, the (pol beta)(16) and (pol beta)(5) binding modes, which differ by the number of nucleotides occluded by the protein. The 8-kDa domain of the enzyme engages the double-stranded (ds) DNA downstream from the primer, while the 31-kDa domain has similar affinity for the ss-ds DNA junction and the dsDNA. The affinity of rat pol beta for the gapped DNA is not affected by the size of the gap. The results indicate a plausible model for recognition of the gapped DNA by rat pol beta. The enzyme binds the ss-ds DNA junction of the gap using the 31-kDa domain. This binding induces an allosteric transition, resulting in the association of the 8-kDa domain with the dsDNA, leading to an amplification of the affinity for the gap. The 5' terminal phosphate, downstream from the primer, has little effect on the affinity, but affects the ssDNA conformation of the gap.	Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Bujalowski, W (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, 301 Univ Blvd, Galveston, TX 77555 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058565] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-58565] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER BM, 1978, BIOPOLYMERS, V17, P1361, DOI 10.1002/bip.1978.360170519; BERRY RS, 1980, PHYSICAL CHEM, P738; Budd ME, 1997, MUTAT RES-DNA REPAIR, V384, P157, DOI 10.1016/S0921-8777(97)00024-4; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; BUJALOWSKI W, 1989, BIOPOLYMERS, V28, P1637, DOI 10.1002/bip.360280912; Bujalowski W., 2000, SPECTROPHOTOMETRY SP, P141; CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909; CASASFINET JR, 1991, J BIOL CHEM, V266, P19618; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; EPSTEIN IR, 1978, BIOPHYS CHEM, V8, P327, DOI 10.1016/0301-4622(78)80015-5; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HAMMOND RA, 1990, BIOCHEMISTRY-US, V29, P286, DOI 10.1021/bi00453a039; Hill T. L., 1985, COOPERATIVITY THEORY; HOFFMANN JS, 1995, P NATL ACAD SCI USA, V92, P5356, DOI 10.1073/pnas.92.12.5356; Hubscher U, 2000, TRENDS BIOCHEM SCI, V25, P143, DOI 10.1016/S0968-0004(99)01523-6; JENCKS WP, 1981, P NATL ACAD SCI USA, V78, P4096; Jezewska MJ, 1997, BIOPHYS CHEM, V64, P253, DOI 10.1016/S0301-4622(96)02221-1; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 1997, BIOCHEMISTRY-US, V36, P10320, DOI 10.1021/bi970712a; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; Jezewska MJ, 1998, J MOL BIOL, V284, P1113, DOI 10.1006/jmbi.1998.2252; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kornberg A., 1992, DNA REPLICATION; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P7156, DOI 10.1021/bi00483a002; LEDNEVA RK, 1977, NUCLEIC ACIDS RES, V5, P4226; Liu DJ, 1996, BIOCHEMISTRY-US, V35, P6188, DOI 10.1021/bi952656o; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; MATSUMOTO Y, 1989, MOL CELL BIOL, V9, P3750, DOI 10.1128/MCB.9.9.3750; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Mullen GP, 1997, BIOCHEMISTRY-US, V36, P4713, DOI 10.1021/bi962363a; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; PRASAD R, 1994, J BIOL CHEM, V269, P18096; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Rajendran S, 1998, J BIOL CHEM, V273, P31021, DOI 10.1074/jbc.273.47.31021; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; TOLMAN GL, 1974, BIOCHEMISTRY-US, V13, P4869, DOI 10.1021/bi00721a001; WANG TSF, 1982, BIOCHEMISTRY-US, V21, P1597, DOI 10.1021/bi00536a021; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; ZMUDZKA BZ, 1986, P NATL ACAD SCI USA, V83, P5106, DOI 10.1073/pnas.83.14.5106	45	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16123	16136		10.1074/jbc.M010434200	http://dx.doi.org/10.1074/jbc.M010434200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278675	hybrid			2022-12-27	WOS:000168623100076
J	Node, K; Ruan, XL; Dai, JW; Yang, SX; Graham, L; Zeldin, DC; Liao, JK				Node, K; Ruan, XL; Dai, JW; Yang, SX; Graham, L; Zeldin, DC; Liao, JK			Activation of G alpha(s) mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTERIAL SMOOTH-MUSCLE; ARACHIDONIC-ACID; ENDOTHELIAL-CELLS; RELAXING FACTOR; CYCLIC-AMP; 11,12-EPOXYEICOSATRIENOIC ACID; HYPERPOLARIZING FACTORS; CORONARY-ARTERIES; MOLECULAR-CLONING; ADP-RIBOSYLATION	The epoxyeicosatrienoic acids (EETs) are products of cytochrome P450 (CYP) epoxygenases that have vasodilatory and anti-inflammatory properties. Here we report that EETs have additional fibrinolytic properties. In vascular endothelial cells, physiological concentrations of EETs, particularly 11,12-EET, or overexpression of the endothelial epoxygenase, CYP2J2, increased tissue plasminogen activator (t-PA) expression by 2.5-fold without affecting plasminogen activator inhibitor-1 expression. This increase in t-PA expression correlated with a 4-fold induction in t-PA gene transcription and a 3-fold increase in t-PA fibrinolytic activity and was blocked by the CYP inhibitor, SKF525A, but not by the calcium-activated potassium channel blocker, charybdotoxin, indicating a mechanism that does not involve endothelial cell hyperpolarization. The t-PA promoter is cAMP-responsive, and induction of t-PA gene transcription by EETs correlated with increases in intracellular cAMP levels and, functionally, with cAMP-driven promoter activity. To determine whether increases in intracellular cAMP levels were due to modulation of guanine nucleotide-binding proteins, we assessed the effects of EETs on G alpha (s) and G alpha (i2). Treatment with EETs increased G alpha (s), but not G alpha (i2), GTP-binding activity by 3.5-fold. These findings indicate that EETs possess fibrinolytic properties through the induction of t-PA and suggest that endothelial CYP2J2 may play an important role in regulating vascular hemostasis.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Osaka 5650871, Japan; NIEHS, Pulm Pathobiol Lab, NIH, Res Triangle Pk, NC 27709 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Osaka University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Liao, JK (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 221 Longwood Ave,LMRC-322, Boston, MA 02115 USA.	jliao@rics.bwh.harvard.edu	Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, R01HL052233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050106, Z01ES025044, Z01ES025043, Z01ES025041, Z01ES025034] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-52233, HL-48743] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Campbell WB, 1999, CIRC RES, V84, P484, DOI 10.1161/01.RES.84.4.484; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; DEGEN SJF, 1986, J BIOL CHEM, V261, P6972; FALCK JR, 1990, METHOD ENZYMOL, V187, P357; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Imig JD, 1999, HYPERTENSION, V33, P408, DOI 10.1161/01.HYP.33.1.408; KARARA A, 1992, BIOCHEM BIOPH RES CO, V182, P1320, DOI 10.1016/0006-291X(92)91877-S; Leffler CW, 1997, AM J PHYSIOL-HEART C, V273, pH333, DOI 10.1152/ajpheart.1997.273.1.H333; Li PL, 1999, CIRC RES, V85, P349, DOI 10.1161/01.RES.85.4.349; LIAO JK, 1992, CIRC RES, V70, P1018, DOI 10.1161/01.RES.70.5.1018; LIAO JK, 1993, J CLIN INVEST, V92, P2168, DOI 10.1172/JCI116818; LIAO JK, 1993, J BIOL CHEM, V268, P19528; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Miyamoto A, 1999, J BIOL CHEM, V274, P12055, DOI 10.1074/jbc.274.17.12055; NAGAMINE Y, 1985, P NATL ACAD SCI USA, V82, P4606, DOI 10.1073/pnas.82.14.4606; NAGY LE, 1992, BIOCHEM J, V286, P681, DOI 10.1042/bj2860681; NAKAGAWA J, 1988, J BIOL CHEM, V263, P2460; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Oltman CL, 1998, CIRC RES, V83, P932; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; RIDKER PM, 1993, LANCET, V341, P1165, DOI 10.1016/0140-6736(93)90998-V; ROSOLOWSKY M, 1990, CIRC RES, V66, P608, DOI 10.1161/01.RES.66.3.608; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SANTELL L, 1988, J BIOL CHEM, V263, P16802; SEKI K, 1992, BIOCHEM J, V281, P185, DOI 10.1042/bj2810185; Soeda S, 1997, BIOL PHARM BULL, V20, P15; Sumpio BE, 1997, AM J PHYSIOL-CELL PH, V273, pC1441, DOI 10.1152/ajpcell.1997.273.5.C1441; Uno S, 1998, J BIOCHEM, V123, P806; VONDERLEYEN HE, 1995, P NATL ACAD SCI USA, V92, P1137, DOI 10.1073/pnas.92.4.1137; Wong PYK, 1997, J LIPID MEDIAT CELL, V16, P155, DOI 10.1016/S0929-7855(97)00005-9; Wu S, 1996, J BIOL CHEM, V271, P3460; Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551	35	199	216	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15983	15989		10.1074/jbc.M100439200	http://dx.doi.org/10.1074/jbc.M100439200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11279071	hybrid			2022-12-27	WOS:000168623100057
J	Kypreos, KE; van Dijk, KW; van der Zee, A; Havekes, LM; Zannis, VI				Kypreos, KE; van Dijk, KW; van der Zee, A; Havekes, LM; Zannis, VI			Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo - Carboxyl-terminal region 203-299 promotes hepatic very low density lipoprotein-triglyceride secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING DOMAIN; E-DEFICIENT MICE; TRANSGENIC MICE; APO-E; ATHEROSCLEROSIS; DIET; HYPERLIPOPROTEINEMIA; HYPERCHOLESTEROLEMIA; EXPRESSION; VARIANT	Apolipoprotein (apo)E has been implicated in cholesterol. and triglyceride homeostasis in humans. At physiological concentration apoE promotes efficient clearance of apoE-containing lipoprotein remnants. However, high apoE plasma levels correlate with high plasma triglyceride levels. We have used adenovirus-mediated gene transfer in apoE-deficient mice (E-/-) to define the domains of apoE required for cholesterol and triglyceride homeostasis in, vivo. A dose of 2 x 10(9) plaque-forming units of apoE4-expressing adenovirus reduced slightly the cholesterol levels of E-/- mice and resulted in severe hypertriglyceridemia, due to accumulation of cholesterol and triglyceride-rich very low density Lipoprotein particles in plasma, In contrast, the truncated form apoE4-202 resulted in a 90% reduction in the plasma cholesterol levels but did not alter plasma triglyceride levels in the E-/- mice. ApoE secretion by cell cultures, as well as the steady-state hepatic mRNA levels in individual mice expressing apoE4 or apoE4-202, were similar. In contrast, very low density lipoprotein-triglyceride secretion in mice expressing apoE4, but not, apoE4-202, was increased 10-fold, as compared with mice infected with a control adenovirus, The findings suggest that the amino-terminal 1-202 region of apoE4 contains the domains required for the in vivo clearance of Lipoprotein remnants. Furthermore, the carboxyl-terminal 203-299 residues of apoE promote hepatic very low density lipoprotein-triglyceride secretion and contribute to apoE-induced hypertriglyceridemia.	Boston Univ, Sch Med, Dept Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; Leiden Univ, Med Ctr, Dept Human & Clin Genet, NL-2333 AL Leiden, Netherlands; TNO PG Prevent & Hlth, Gaubius Lab, NL-2333 CK Leiden, Netherlands; Univ Crete, Dept Biochem, Iraklion 71110, Crete, Greece; Univ Crete, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece	Boston University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; University of Crete; University of Crete	Zannis, VI (corresponding author), Boston Univ, Sch Med, Dept Med, Whitaker Cardiovasc Inst, 715 Albany St,W509, Boston, MA 02118 USA.	vzannis@bu.edu	van Dijk, Ko Willems/A-1798-2008; Kypreos, Kyriakos/AAG-1745-2020; van Dijk, Ko Willems/AAT-4681-2021; KYPREOS, KYRIAKOS/AAN-4485-2020	van Dijk, Ko Willems/0000-0002-2172-7394; Kypreos, Kyriakos/0000-0001-6784-2710; van Dijk, Ko Willems/0000-0002-2172-7394; 	NATIONAL INSTITUTE ON AGING [R01AG012717] Funding Source: NIH RePORTER; NIA NIH HHS [AG12717] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Aleshkov S, 1997, BIOCHEMISTRY-US, V36, P10571, DOI 10.1021/bi9626362; CARDIN AD, 1986, BIOCHEM BIOPH RES CO, V134, P783, DOI 10.1016/S0006-291X(86)80489-2; CHAIT A, 1978, METABOLISM, V27, P1055, DOI 10.1016/0026-0495(78)90151-8; CLADARAS C, 1987, J BIOL CHEM, V262, P2310; Cohn JS, 1996, ARTERIOSCL THROM VAS, V16, P149, DOI 10.1161/01.ATV.16.1.149; Cullen P, 1998, J CLIN INVEST, V101, P1670, DOI 10.1172/JCI119887; Dong LM, 1996, NAT STRUCT BIOL, V3, P718, DOI 10.1038/nsb0896-718; DONG LM, 1994, J BIOL CHEM, V269, P22358; EHNHOLM C, 1984, P NATL ACAD SCI-BIOL, V81, P5566, DOI 10.1073/pnas.81.17.5566; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Fan JL, 1998, J CLIN INVEST, V101, P2151, DOI 10.1172/JCI1599; FAZIO S, 1994, ARTERIOSCLER THROMB, V14, P1873, DOI 10.1161/01.ATV.14.11.1873; FAZIO S, 1994, J LIPID RES, V35, P408; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; FAZIO S, 1993, J CLIN INVEST, V92, P1497, DOI 10.1172/JCI116728; GHISELLI G, 1981, SCIENCE, V214, P1239, DOI 10.1126/science.6795720; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huang YD, 1999, ARTERIOSCL THROM VAS, V19, P2952, DOI 10.1161/01.ATV.19.12.2952; Huang YD, 1998, J BIOL CHEM, V273, P17483, DOI 10.1074/jbc.273.28.17483; Huang YD, 1997, ARTERIOSCL THROM VAS, V17, P2010, DOI 10.1161/01.ATV.17.10.2010; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; HUANG YD, 1994, P NATL ACAD SCI USA, V91, P1834, DOI 10.1073/pnas.91.5.1834; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; INNERARITY TL, 1983, J BIOL CHEM, V258, P2341; JI SS, 1994, J BIOL CHEM, V289, P2784; JI ZS, 1994, J BIOL CHEM, V269, P13421; JI ZS, 1993, J BIOL CHEM, V268, P10160; JI ZS, 1995, J LIPID RES, V36, P583; Jong MC, 1997, BIOCHEM J, V328, P745; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; KULPERS F, 1997, J CLIN INVEST, V100, P2915; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; MANN WA, 1989, BIOCHIM BIOPHYS ACTA, V1005, P239, DOI 10.1016/0005-2760(89)90043-X; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; RALL SC, 1989, J CLIN INVEST, V83, P1095, DOI 10.1172/JCI113988; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rensen PCN, 1996, J BIOL CHEM, V271, P14791, DOI 10.1074/jbc.271.25.14791; Salah D, 1997, J LIPID RES, V38, P904; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; SHIMANO H, 1995, J CLIN INVEST, V95, P469, DOI 10.1172/JCI117687; SMIT M, 1990, J LIPID RES, V31, P45; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; VANDENMAAGDENBERG AMJM, 1989, BIOCHEM BIOPH RES CO, V165, P851, DOI 10.1016/S0006-291X(89)80044-0; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; VANREE JH, 1994, ATHEROSCLEROSIS, V111, P25, DOI 10.1016/0021-9150(94)90188-0; vanVlijmen BJM, 1996, J BIOL CHEM, V271, P30595, DOI 10.1074/jbc.271.48.30595; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; WARDELL MR, 1987, J CLIN INVEST, V80, P483, DOI 10.1172/JCI113096; WARDELL MR, 1989, J BIOL CHEM, V264, P21205; WEISGRABER KH, 1986, J BIOL CHEM, V261, P2068; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2348; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; WILSON C, 1994, STRUCTURE, V2, P713, DOI 10.1016/S0969-2126(00)00072-1; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; WOLF BB, 1992, AM J PATHOL, V141, P37; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhu YH, 1998, P NATL ACAD SCI USA, V95, P7585, DOI 10.1073/pnas.95.13.7585	61	57	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19778	19786		10.1074/jbc.M100418200	http://dx.doi.org/10.1074/jbc.M100418200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279066	hybrid			2022-12-27	WOS:000169135100015
J	Roeffen, WFG; Raats, JMH; Teelen, K; Hoet, RMA; Eling, WM; van Venrooij, WJ; Sauerwein, RW				Roeffen, WFG; Raats, JMH; Teelen, K; Hoet, RMA; Eling, WM; van Venrooij, WJ; Sauerwein, RW			Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSION-BLOCKING IMMUNITY; TARGET ANTIGENS; LIBRARIES; REACTIVITY; PHAGE; ASSAY	We report the first construction of two combinatorial human phage display libraries derived from malaria-immune patients. Specific single-chain Fv fragments (scFv) against Pfs48/45, a gamete surface protein of the sexual stages of Plasmodium falciparum, were selected and analyzed extensively. The selected scFv reacted with the surface of extracellular sexual forms of the parasite and showed Pfs48/45 reactivity on immunoblot. The scFv inhibit binding of human malaria sera to native Pfs48/45 from gametocytes. Moreover, the scFv bind to target epitopes of Pfs48/45 exposed in natural infections. Sequence analysis of eight scFv clones specific for epitope III of Pfs48/45 revealed that these clones could be divided into one V-H family-derived germ-line gene (V(H)1) and two V-L family segments (V(L)2 and VKI).	Univ Med Ctr St Radboud, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; Dyax BV, NL-6202 AZ Maastricht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Roeffen, WFG (corresponding author), Univ Med Ctr St Radboud, Dept Med Microbiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Roeffen, W.F.G./L-4607-2015; Sauerwein, Robert/C-8519-2013					BURTON DR, 1994, ADV IMMUNOL, V57, P191, DOI 10.1016/S0065-2776(08)60674-4; CARTER R, 1990, PARASITE IMMUNOL, V12, P587, DOI 10.1111/j.1365-3024.1990.tb00990.x; Hoet RMA, 1998, MOL IMMUNOL, V35, P1045, DOI 10.1016/S0161-5890(98)00093-5; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; KUMAR N, 1984, MOL BIOCHEM PARASIT, V13, P333, DOI 10.1016/0166-6851(84)90124-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MEULEMANS EV, 1994, J MOL BIOL, V244, P353, DOI 10.1006/jmbi.1994.1735; Nakane M. B., 1978, IMMUNOFLUORESCENCE R, P215; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; RENER J, 1983, J EXP MED, V158, P976, DOI 10.1084/jem.158.3.976; Roeffen W, 1996, PARASITE IMMUNOL, V18, P103, DOI 10.1046/j.1365-3024.1996.d01-54.x; ROEFFEN W, 1995, AM J TROP MED HYG, V52, P60, DOI 10.4269/ajtmh.1995.52.60; ROEFFEN W, 1995, EXP PARASITOL, V80, P15, DOI 10.1006/expr.1995.1003; Roeffen W, 2001, EXP PARASITOL, V97, P45, DOI 10.1006/expr.2000.4586; TARGETT GAT, 1990, IMMUNOL LETT, V25, P77, DOI 10.1016/0165-2478(90)90095-8; Tomlinson I, 1996, 5 BASE SEQUENCE DIRE; VERMEULEN AN, 1985, J EXP MED, V162, P1460, DOI 10.1084/jem.162.5.1460	18	28	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19807	19811		10.1074/jbc.M100562200	http://dx.doi.org/10.1074/jbc.M100562200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11279092	Green Published, hybrid			2022-12-27	WOS:000169135100019
J	Moreira, EF; Jaworski, C; Li, A; Rodriguez, IR				Moreira, EF; Jaworski, C; Li, A; Rodriguez, IR			Molecular and biochemical characterization of a novel oxysterol-binding protein (OSBP2) highly expressed in retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL OXIDES; GOLGI LOCALIZATION; CDNA CLONING; GENE; PHOSPHORYLATION; METABOLISM; DOMAIN	We are interested in understanding the possible function(s) of the oxysterol-binding proteins in mediating oxysterol cytotoxicity in the retina. In this study we describe the cloning, localization, and biological activity of a novel oxysterol-binding protein (OSBP2), and complete the molecular characterization of the previously known OSBP1. Both OSBP genes contain 14 exons and have similar exon sizes and splice sites suggesting they may have arisen from a gene duplication event. OSBP1 is located in chromosome 11q12.1, and OSBP2 is located in 22q12. At the protein level they share 63% overall similarity and although they have unique N termini, both have similar pleckstrin homology domains within the N terminus region. Northern blot analyses indicate that OSBP1 is broadly expressed in human and monkey tissues. OSBP2 is detected mainly in retina, testis, and fetal liver. Western blot analysis using peptide antibodies specific to OSBP1 and OSBP2 detected the proteins in different subcellular fractions in the retinal monkey tissue. OSBP1 is detected mainly in the soluble or cytosolic fraction and nuclei whereas OSBP2 is detected exclusively in the detergent soluble fraction suggesting association with membranes. Immunohistochemical localization of OSBP1 and OSBP2 in the monkey retina placed these two proteins in similar but distinct areas of the inner retina. OSBP2 was found to bind 7-ketocholesterol but to have very little affinity for cholesterol or 25-hydroxycholesterol.	NEI, NIH, Retinal Cell & Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Rodriguez, IR (corresponding author), NEI, NIH, Retinal Cell & Mol Biol Lab, 6 Ctr Dr,MSC 2740,Bldg 6,Rom 304, Bethesda, MD 20892 USA.				NATIONAL EYE INSTITUTE [Z01EY000307, ZIAEY000307] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BOISSONNEAULT GA, 1991, P SOC EXP BIOL MED, V196, P338; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Chang JY, 1998, CURR EYE RES, V17, P95, DOI 10.1076/ceyr.17.1.95.5252; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; Fournier MV, 1999, CANCER RES, V59, P3748; Girao H, 1998, EXP EYE RES, V66, P645, DOI 10.1006/exer.1998.0465; KANDUTSCH AA, 1980, J BIOL CHEM, V255, P813; Laitinen S, 1999, J LIPID RES, V40, P2204; LEVANON D, 1990, GENOMICS, V7, P65, DOI 10.1016/0888-7543(90)90519-Z; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Noske UM, 1998, OPHTHALMOLOGE, V95, P814, DOI 10.1007/s003470050358; PENG SK, 1991, J CLIN LAB ANAL, V5, P144, DOI 10.1002/jcla.1860050212; PENG SK, 1985, ATHEROSCLEROSIS, V54, P121, DOI 10.1016/0021-9150(85)90172-8; Putilina T, 1999, MOL CELL BIOCHEM, V195, P219, DOI 10.1023/A:1006932522197; Ridgway ND, 1998, J BIOL CHEM, V273, P31621, DOI 10.1074/jbc.273.47.31621; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Ridgway ND, 1998, BBA-LIPID LIPID MET, V1390, P37, DOI 10.1016/S0005-2760(97)00167-7; RODRIGUEZ IR, 1994, J BIOL CHEM, V269, P31969; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; SMITH LL, 1989, FREE RADICAL BIO MED, V7, P285, DOI 10.1016/0891-5849(89)90136-6; Spiess AN, 1999, BIOTECHNIQUES, V26, P46, DOI 10.2144/99261bm06; Storey MK, 1998, BIOCHEM J, V336, P247, DOI 10.1042/bj3360247; TAYLOR FR, 1985, CHEM PHYS LIPIDS, V38, P187, DOI 10.1016/0009-3084(85)90066-0; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; Thompson EB, 1999, CRIT REV BIOCHEM MOL, V34, P25, DOI 10.1080/10409239991209174	27	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18570	18578		10.1074/jbc.M011259200	http://dx.doi.org/10.1074/jbc.M011259200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278871	hybrid			2022-12-27	WOS:000168866500127
J	Sakai, D; Horiuchi, T; Komano, T				Sakai, D; Horiuchi, T; Komano, T			ATPase activity and multimer formation of PilQ protein are required for thin pilus biogenesis in plasmid R64	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL SECRETORY PATHWAY; ERWINIA-CHRYSANTHEMI; ESCHERICHIA-COLI; MEMBRANE; DNA; POLYMERASE; ENZYMOLOGY; MUTATIONS; SEQUENCES; COMPONENT	Plasmid R64 pilQ gene is essential for the formation of thin pilus, a type IV pilus. The pilQ product contains NTP binding motifs and belongs to the PulE-VirB11 family of NTPases, The pilQ gene was overexpressed with an N-terminal His tag, and PilQ protein was purified. Purified His tag PilQ protein displayed ATPase activity with a V-max of 0.71 nmol/min/mg of protein and a K-m of 0.26 mM at pH 6.5. By gel filtration chromatography, PilQ protein was eluted at the position corresponding to 460 kDa, suggesting that PilQ protein forms a homooctamer, To analyze the relationship between structure and function of PilQ protein, amino acid substitutions were introduced within several conserved motifs, Among 11 missense mutants, 7 mutants exhibited various levels of reduced DNA transfer frequencies in liquid matings, Four mutant genes (T234I, K238Q, D263N, and H328A) were overexpressed with a His tag, The purified mutant PilQ proteins contained various levels of reduced ATPase activity. Three mutant PilQ proteins formed stable multimers similar to wild-type PilQ, whereas the PilQ D263N multimer was unstable. PilQ D263N monomer exhibited low ATPase activity, while PilQ D263N multimer did not. These results indicate that ATPase activity of the PilQ multimer is essential for R64 thin pilus biogenesis.	Tokyo Metropolitan Univ, Dept Biol, Tokyo 1920397, Japan	Tokyo Metropolitan University	Komano, T (corresponding author), Tokyo Metropolitan Univ, Dept Biol, Tokyo 1920397, Japan.	komano-teruya@c.metro-u.ac.jp						BOEKE JD, 1982, P NATL ACAD SCI-BIOL, V79, P5200, DOI 10.1073/pnas.79.17.5200; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; CHRISTIE PJ, 1989, P NATL ACAD SCI USA, V86, P9677, DOI 10.1073/pnas.86.24.9677; CONDEMINE G, 1992, MOL MICROBIOL, V6, P3199, DOI 10.1111/j.1365-2958.1992.tb01775.x; DENFERT C, 1989, J BIOL CHEM, V264, P17462; DUMS F, 1991, MOL GEN GENET, V229, P357, DOI 10.1007/BF00267456; Furuya N, 1996, J BACTERIOL, V178, P1491, DOI 10.1128/jb.178.6.1491-1497.1996; HOBBS M, 1993, NATURE, V346, P362; ITO W, 1991, GENE, V102, P67, DOI 10.1016/0378-1119(91)90539-N; Kim SR, 1997, J BACTERIOL, V179, P3594, DOI 10.1128/jb.179.11.3594-3603.1997; Komano T, 1999, ANNU REV GENET, V33, P171, DOI 10.1146/annurev.genet.33.1.171; KOMANO T, 1990, J BACTERIOL, V172, P2230, DOI 10.1128/jb.172.5.2230-2235.1990; KOMANO T, 1994, J MOL BIOL, V243, P6, DOI 10.1006/jmbi.1994.1625; Krause S, 2000, P NATL ACAD SCI USA, V97, P3067, DOI 10.1073/pnas.050578697; Krause S, 2000, J BACTERIOL, V182, P2761, DOI 10.1128/JB.182.10.2761-2770.2000; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Lai EM, 2000, TRENDS MICROBIOL, V8, P361, DOI 10.1016/S0966-842X(00)01802-3; NUNN D, 1990, J BACTERIOL, V172, P2911, DOI 10.1128/jb.172.6.2911-2919.1990; Pansegrau W, 1996, PROG NUCLEIC ACID RE, V54, P197, DOI 10.1016/S0079-6603(08)60364-5; POSSOT O, 1994, MOL MICROBIOL, V12, P287, DOI 10.1111/j.1365-2958.1994.tb01017.x; Possot OM, 1997, GENE, V192, P45, DOI 10.1016/S0378-1119(97)00009-7; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Py B, 1999, J MOL BIOL, V289, P659, DOI 10.1006/jmbi.1999.2803; Ramer SW, 1996, J BACTERIOL, V178, P6555, DOI 10.1128/jb.178.22.6555-6563.1996; Rivas S, 1997, J BIOL CHEM, V272, P25583, DOI 10.1074/jbc.272.41.25583; Sakai D, 2000, PLASMID, V43, P149, DOI 10.1006/plas.1999.1434; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; STEPHENS KM, 1995, J BACTERIOL, V177, P27, DOI 10.1002/path.1711770106; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TURNER LR, 1993, J BACTERIOL, V175, P4962, DOI 10.1128/JB.175.16.4962-4969.1993; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P8829; WHITCHURCH CB, 1991, GENE, V101, P33, DOI 10.1016/0378-1119(91)90221-V; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yoshida T, 1998, J BACTERIOL, V180, P2842, DOI 10.1128/JB.180.11.2842-2848.1998; Yoshida T, 1999, J BACTERIOL, V181, P2038, DOI 10.1128/JB.181.7.2038-2043.1999	40	45	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					17968	17975		10.1074/jbc.M010652200	http://dx.doi.org/10.1074/jbc.M010652200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11278718	hybrid			2022-12-27	WOS:000168866500048
J	Corsico, B; Toledo, JD; Garda, HA				Corsico, B; Toledo, JD; Garda, HA			Evidence for a central apolipoprotein A-I domain loosely bound to lipids in discoidal lipoproteins that is capable of penetrating the bilayer of phospholipid vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; CELLULAR CHOLESTEROL; GEL-ELECTROPHORESIS; AMPHIPATHIC HELIX; PLASMA-MEMBRANE; BELT MODEL; ANT VENOM; APOA-I; EFFLUX	Previous evidence indicated that discoidal reconstituted high density lipoproteins (rHDL) of apolipoprotein A-I (apoA-I) can interact with lipid membranes (Tricerri, M. A., Corsico, B,, Toledo, J. D,, Garda, H, A., and Brenner, R, R, (1998) Biochim. Biophys. Acta 1391, 67-78), With the aim of studying this interaction, photoactivable reagents and protein cleavage with CNBr and hydroxylamine were used. The generic hydrophobic reagent 3-(trifluoromethyl)-3-(m-[I-125]iodophenyl)diazirine gave information on the apoA-I regions in contact with the lipid phase in the rHDL discs, Two protein regions loosely bound to lipids were detected: a C-terminal domain and a central one located between residues 87 and 112, They consist of class Y amphipathic alpha -helices that have a different distribution of the charged residues in their polar faces by comparison with class A helices, which predominate in the rest of the apoA-I molecule. The phospholipid analog 1-O-hexadecanoyl-2-O-[9-[[[2-[I-125]iodo-4-(trifluoro-methyl-3-H-diazirin-3-yl)benzyl]ox]nonanoyl]-sn-glycero-3-phosphocholine, which does not undergo significant exchange between membranes and lipoproteins, was used to identify the apoA-I domain directly involved in the interaction of rHDL discs with membranes, By incubating either rHDL or lipid-free apoA-I with lipid vesicles containing I-125-TID-PC, only the 87-112 apoA-I segment becomes labeled after photoactivation. These results indicate that the central domain formed by two type Y helices swings away from lipid contact in the discoidal lipoproteins and is able to insert into membrane bilayers, a process that may be of great importance for the mechanism of cholesterol exchange between high density lipoproteins and cell membranes.	Univ Nacl La Plata, Fac Ciencias Med, INIBIOLP, Consejo Nacl Invest Cient & Tecn, RA-1900 La Plata, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Garda, HA (corresponding author), Univ Nacl La Plata, Fac Ciencias Med, INIBIOLP, Consejo Nacl Invest Cient & Tecn, Calles 60 & 120, RA-1900 La Plata, Argentina.	hgarda@atlas.med.unlp.edu.ar						ARSENIEV AS, 1994, FEBS LETT, V347, P112, DOI 10.1016/0014-5793(94)00518-4; BERGERON J, 1995, J BIOL CHEM, V270, P27429, DOI 10.1074/jbc.270.46.27429; BHAMBENOIT O, 2001, J BIOL CHEM, V276, P9955; BISSON R, 1985, TECHNIQUES ANAL MEMB, P153; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; BOTTUM K, 1995, BIOCHEMISTRY-US, V34, P7264, DOI 10.1021/bi00021a043; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1043, P245, DOI 10.1016/0005-2760(90)90023-Q; BREWER HB, 1978, BIOCHEM BIOPH RES CO, V80, P623, DOI 10.1016/0006-291X(78)91614-5; BROUILLETTE CG, 1984, BIOCHEMISTRY-US, V23, P359, DOI 10.1021/bi00297a027; BROUILLETTE CG, 1995, BBA-LIPID LIPID MET, V1256, P103, DOI 10.1016/0005-2760(95)00018-8; CALABRESI L, 1993, BIOCHEMISTRY-US, V32, P6477, DOI 10.1021/bi00076a023; DALTON MB, 1993, J BIOL CHEM, V268, P19274; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; EISENBERG S, 1984, J LIPID RES, V25, P1017; FIELDING CJ, 1995, J LIPID RES, V36, P211; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; FRANCONE OL, 1990, EUR HEART J, V11, P218, DOI 10.1093/eurheartj/11.suppl_E.218; Frank PG, 1997, BIOCHEMISTRY-US, V36, P1798, DOI 10.1021/bi962118r; Garner J, 1998, J BIOL CHEM, V273, P5167, DOI 10.1074/jbc.273.9.5167; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; HARA H, 1992, BIOCHEMISTRY-US, V31, P2040, DOI 10.1021/bi00122a021; HARA H, 1991, J BIOL CHEM, V266, P3080; HUIHUA L, 2000, J BIOL CHEM, V275, P37048; JI Y, 1995, J BIOL CHEM, V270, P11290, DOI 10.1074/jbc.270.19.11290; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; JONAS A, 1990, J BIOL CHEM, V265, P22123; JONAS A, 1989, J BIOL CHEM, V264, P4818; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Koppaka V, 1999, J BIOL CHEM, V274, P14541, DOI 10.1074/jbc.274.21.14541; LEROY A, 1993, J BIOL CHEM, V268, P4798; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maiorano JN, 2000, J BIOL CHEM, V275, P17374, DOI 10.1074/jbc.M000044200; MCLACHLAN AD, 1977, NATURE, V267, P465, DOI 10.1038/267465a0; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; NOLDE DE, 1995, J BIOMOL NMR, V5, P1, DOI 10.1007/BF00227465; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 1996, J LIPID RES, V37, P2473; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Phillips JC, 1997, BIOPHYS J, V73, P2337, DOI 10.1016/S0006-3495(97)78264-X; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; Pluzhnikov K, 1999, EUR J BIOCHEM, V262, P501, DOI 10.1046/j.1432-1327.1999.00426.x; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; Rothblat GH, 1999, J LIPID RES, V40, P781; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SEGREST JP, 1992, J LIPID RES, V33, P141; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; Toledo JD, 2000, ARCH BIOCHEM BIOPHYS, V380, P63, DOI 10.1006/abbi.2000.1901; Tricerri A, 1998, BBA-LIPID LIPID MET, V1391, P67, DOI 10.1016/S0005-2760(97)00187-2; TRICERRI MA, 1994, INT J BIOCHROMATOGR, V1, P159; TRICERRI MA, 1998, THESIS U NACL LA PLA; VERGERES G, 1995, J BIOL CHEM, V270, P19879, DOI 10.1074/jbc.270.34.19879; WALD JH, 1990, J BIOL CHEM, V265, P20037; WALD JH, 1990, J BIOL CHEM, V265, P20044; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; WEBER T, 1994, J BIOL CHEM, V269, P18353; WEBER T, 1995, J AM CHEM SOC, V117, P3084, DOI 10.1021/ja00116a013; WONG L, 1992, J CLIN INVEST, V90, P2370, DOI 10.1172/JCI116127; YANCEY PG, 1995, BIOCHEMISTRY-US, V34, P7955, DOI 10.1021/bi00024a021	69	41	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16978	16985		10.1074/jbc.M011533200	http://dx.doi.org/10.1074/jbc.M011533200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278925	Green Published, hybrid			2022-12-27	WOS:000168730400050
J	Cottin, V; Van Linden, AA; Riches, DWH				Cottin, V; Van Linden, AA; Riches, DWH			Phosphorylation of the tumor necrosis factor receptor CD120a (p55) recruits Bcl-2 and protects against apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAS-INDUCED APOPTOSIS; NF-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAYS; BREAST-CARCINOMA CELLS; MEDIATED APOPTOSIS; TNF-ALPHA; ENDOPLASMIC-RETICULUM; SUBCELLULAR LOCATION; MOUSE MACROPHAGES; CYTOCHROME-C	Ligation of the tumor necrosis factor cu receptor CD120a initiates responses as diverse as apoptosis and the expression of NF-KB-dependent pro-survival genes. How these opposing responses are controlled remains poorly understood. Here we demonstrate that phosphorylation by p42(mapk/erk2) inhibits the apoptotic activity of CD120a while preserving its ability to activate NF-KB. Phosphorylated CD120a is re-localized from the Golgi complex to tubular structures of the endoplasmic reticulum wherein it recruits Bcl-2. Antisense-mediated down-regulation of Bel-2 antagonized the localization of CD120a to tubular structures and reversed the protection from apoptosis conferred by receptor phosphorylation. We propose that phosphorylation of CD120a represents a novel, Bcl-2-dependent mechanism by which the apoptotic activity of the receptor may be regulated. Thus, oncogenic activation of p42(mapk/erk2) may serve to inhibit the apoptotic activity of this death receptor while preserving NF-KB-dependent responses and may thus indirectly contribute to a failure to eliminate cells bearing oncogenes of the Ras-Raf-MEK-p42(mapk/erk2) pathway.	Natl Jewish Med & Res Ctr, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm & Crit Care Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Riches, DWH (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, Cell Biol Program, Neustadt Rm D405,1400 Jackson St, Denver, CO 80206 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056556, R01HL055549] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL55549, HL 56556] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; BRADLEY JR, 1995, AM J PATHOL, V146, P27; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; Chan ED, 1997, P NATL ACAD SCI USA, V94, P13169, DOI 10.1073/pnas.94.24.13169; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cottin V, 1999, J BIOL CHEM, V274, P32975, DOI 10.1074/jbc.274.46.32975; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; GOTTSCHALK AR, 1994, P NATL ACAD SCI USA, V91, P7350, DOI 10.1073/pnas.91.15.7350; Grullich C, 2000, J BIOL CHEM, V275, P8650, DOI 10.1074/jbc.275.12.8650; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Hausmann G, 2000, J CELL BIOL, V149, P623, DOI 10.1083/jcb.149.3.623; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; JAATTELA M, 1995, ONCOGENE, V10, P2297; Jones SJ, 1999, J IMMUNOL, V162, P1042; Kawahara A, 1998, ONCOGENE, V17, P2549, DOI 10.1038/sj.onc.1202192; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; Perez D, 2000, MOL CELL, V6, P53, DOI 10.1016/S1097-2765(00)00007-1; Perez D, 1998, J CELL BIOL, V141, P1255, DOI 10.1083/jcb.141.5.1255; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Srinivasan A, 1998, J BIOL CHEM, V273, P4523, DOI 10.1074/jbc.273.8.4523; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Van Linden AA, 2000, J BIOL CHEM, V275, P6996, DOI 10.1074/jbc.275.10.6996; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Winston BW, 1997, J IMMUNOL, V159, P4491; WINSTON BW, 1995, J IMMUNOL, V155, P1525; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yasuhara N, 1997, ONCOGENE, V15, P1921, DOI 10.1038/sj.onc.1201370; Yeh JH, 1998, J EXP MED, V188, P1795, DOI 10.1084/jem.188.10.1795; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; Zamzami N, 1998, ONCOGENE, V16, P2265, DOI 10.1038/sj.onc.1201989; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x; Ziegler A, 1997, JNCI-J NATL CANCER I, V89, P1027, DOI 10.1093/jnci/89.14.1027	59	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17252	17260		10.1074/jbc.M010681200	http://dx.doi.org/10.1074/jbc.M010681200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278725	hybrid			2022-12-27	WOS:000168730400087
J	Lee, YI; Kang-Park, S; Do, SI; Lee, YI				Lee, YI; Kang-Park, S; Do, SI; Lee, YI			The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; CELL-CYCLE REGULATION; NERVE GROWTH-FACTOR; T-ANTIGEN; KINASE-B; PHOSPHOINOSITIDE 3-KINASE; GUANOSINE TRIPHOSPHATASES; AKT PHOSPHORYLATION; 3T3-L1 ADIPOCYTES; TRANSACTIVATOR-X	The hepatitis B virus-X (HBx) protein is known as a multifunctional protein that not only coactivates l;tanscription of viral and cellular genes but coordinates the balance between proliferation and programmed cell death, by inducing or blocking apoptosis, In this study the role of the HBx protein in activation of phosphatidylinositol 3-kinase (PI3K) was investigated as a possible cause of anti-apoptosis in liver cells. HBx relieved serum deprivation-induced and pro-apoptic stimuli-induced apoptosis in Chang liver (CHL) cells. Treatment with 1-D-3-deoxy-3-fluoro-myo-inositol, an antagonist to PI3K, which blocks the formation of 3'-phosphorylated phosphatidyl inositol in CHL cells transformed by HBx (CHL-X) but not normal Chang liver (CHL) cells, showed a marked loss of viability with evidence of apoptosis, Similarly, treatment with wortmannin, an inhibitor of PI3K, stimulated apoptosis in HBx-transformed CHL cells but not in normal cells, confirming that HBx blocks apoptosis through the PI3K pathway. The serine 47 threonine kinase, Akt, one of the downstream effecters of PI3K-dependent survival signaling was 2-fold higher in HBx-transformed CHL (CHL-X) cells than CHL cells, Phosphorylation of Akt at serine 473 and Bad at serine 136 were induced by HBx, which were specifically blocked by wortmannin and dominant negative mutants of Akt and Bad, respectively. We also demonstrated that HBx inhibits caspase 3 activity and HBx down-regulation of caspase 3 activity was blocked by the PI3K inhibitor. Regions required for PI3K phosphorylation on the HBx protein overlap with the known transactivation domains. HBx blocks apoptosis induced by serum withdrawal in CHL cells in a p53-independent manner. The results indicate that, unlike other DNA tumor viruses that block apoptosis by inactivating p53, the hepatitis B virus achieves protection from apoptotic death through a HBx-PI3K-Akt-Bad pathway and by inactivating caspase 3 activity that is at least partially p53-independent in liver cells. Moreover, these data suggest that modulation of the PI3K activity may represent a potential therapeutic strategy to counteract the occurrence of apoptosis in human hepatocellular carcinoma.	Korea Res Inst Biosci & Biotechnol, Liver Cell Signal Transduct Res Unit, Taejon 305600, South Korea; Korea Res Inst Biosci & Biotechnol, Biosci Res Div, Anim Cell & Med Glycobiol Res Unit, Taejon 305600, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, YI (corresponding author), Korea Res Inst Biosci & Biotechnol, Liver Cell Signal Transduct Res Unit, POB 115, Taejon 305600, South Korea.	yilee@mail.kribb.re.kr						Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bialik S, 1999, CIRC RES, V85, P403, DOI 10.1161/01.RES.85.5.403; BUERKE M, 1995, P NATL ACAD SCI USA, V92, P8031, DOI 10.1073/pnas.92.17.8031; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Colussi PA, 1999, IMMUNOL CELL BIOL, V77, P58, DOI 10.1046/j.1440-1711.1999.00788.x; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Dahl J, 1998, J VIROL, V72, P3221, DOI 10.1128/JVI.72.4.3221-3226.1998; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Didichenko SA, 1996, CURR BIOL, V6, P1271, DOI 10.1016/S0960-9822(02)70713-6; Doherty J, 1997, ONCOGENE, V14, P1923, DOI 10.1038/sj.onc.1201025; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; FREUND R, 1992, AM J PATHOL, V141, P1409; Frevert EU, 1997, MOL CELL BIOL, V17, P190, DOI 10.1128/MCB.17.1.190; FROMM L, 1994, MOL CELL BIOL, V14, P6743, DOI 10.1128/MCB.14.10.6743; Fujita E, 1999, BIOCHEM BIOPH RES CO, V264, P550, DOI 10.1006/bbrc.1999.1387; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; Hermann M., 1994, NUCLEIC ACIDS RES, V22, P5506; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; JACKOWSKI S, 1988, J BIOL CHEM, V263, P16830; JOHNSON SC, 1993, J MED CHEM, V36, P3628, DOI 10.1021/jm00075a018; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kim H, 1998, J BIOL CHEM, V273, P381, DOI 10.1074/jbc.273.1.381; KIM YH, 1993, BIOCHEM BIOPH RES CO, V197, P894, DOI 10.1006/bbrc.1993.2563; KIM YS, 1984, KOREAN BIOCH J, V17, P7076; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Klippel A, 1996, MOL CELL BIOL, V16, P4117; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; Lau JYN, 1998, SEMIN LIVER DIS, V18, P169, DOI 10.1055/s-2007-1007152; Lee YI, 1998, ONCOGENE, V16, P2367, DOI 10.1038/sj.onc.1201760; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; LI GP, 1995, P NATL ACAD SCI USA, V92, P10207, DOI 10.1073/pnas.92.22.10207; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Martin SS, 1996, ENDOCRINOLOGY, V137, P5045, DOI 10.1210/en.137.11.5045; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; Matsuzaki H, 1999, J NEUROCHEM, V73, P2037; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MCCARTHY SA, 1994, P NATL ACAD SCI USA, V91, P3979, DOI 10.1073/pnas.91.9.3979; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURAKAMI S, 1994, J BIOL CHEM, V269, P15118; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; OFFER J, 1993, BIOCHEM J, V291, P553, DOI 10.1042/bj2910553; POWIS G, 1991, CANCER CHEMOTH PHARM, V29, P95, DOI 10.1007/BF00687317; POWIS G, 1994, CANCER RES, V54, P2419; RAZVI ES, 1995, ADV VIRUS RES, V45, P1, DOI 10.1016/S0065-3527(08)60057-3; Ryu BR, 1999, J NEUROBIOL, V39, P536, DOI 10.1002/(SICI)1097-4695(19990615)39:4<536::AID-NEU7>3.0.CO;2-J; SHEN V, 1995, CURR OPIN GENE DEV, V5, P105; SHIRAKATA Y, 1989, JPN J CANCER RES, V50, P517; Su F, 1997, P NATL ACAD SCI USA, V94, P8744, DOI 10.1073/pnas.94.16.8744; Swart R, 2000, J VIROL, V74, P10838, DOI 10.1128/JVI.74.22.10838-10845.2000; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; WANG XW, 1995, CANCER RES, V55, P6012; WANG Y, 1995, ONCOGENE, V12, P2731; Wu WH, 2000, J BIOL CHEM, V275, P40113, DOI 10.1074/jbc.M004108200; YAMADA T, 1994, J VIROL, V68, P3374, DOI 10.1128/JVI.68.5.3374-3379.1994; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995	75	158	176	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16969	16977		10.1074/jbc.M011263200	http://dx.doi.org/10.1074/jbc.M011263200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278872	hybrid			2022-12-27	WOS:000168730400049
J	Smith, AJ; Surviladze, Z; Gaudet, EA; Backer, JM; Mitchell, CA; Wilson, BS				Smith, AJ; Surviladze, Z; Gaudet, EA; Backer, JM; Mitchell, CA; Wilson, BS			P110 beta and p110 delta phosphatidylinositol 3-kinases up-regulate Fc epsilon RI-activated Ca2+ influx by enhancing inositol 1,4,5-trisphosphate production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASOPHILIC LEUKEMIA-CELLS; RBL-2H3 MAST-CELLS; PHOSPHOLIPASE C-GAMMA-1; PHOSPHOINOSITIDE 3-KINASE; TYROSINE PHOSPHORYLATION; NEGATIVE REGULATION; PHOSPHATASE SHIP; CALCIUM-RELEASE; RECEPTOR; WORTMANNIN	Fc is an element of RI-induced Ca2+ signaling in mast cells is initiated by activation of cytosolic tyrosine kinases, Here, in vitro phospholipase assays establish that the phosphatidylinositol S-kinase (PI 3-kinase) lipid product, phosphatidylinositol 3,4,5-triphosphate, further stimulates phospholipase Cy2 that has been activated by conformational changes associated with tyrosine phosphorylation or low pH, A microinjection approach is used to directly assess the consequences of inhibiting class IA PI 3-kinases on Ca2+ responses after Fc is an element of RI cross-linking in RBL-2H3 cells. Injection of antibodies to the p110 beta or p110 delta catalytic isoforms of PI 3-kinase, but not antibodies to p110 alpha, lengthens the lag time to release of Ca2+ stores and blunts the sustained phase of the calcium response. Ca2+ responses are also inhibited in cells microinjected with recombinant inositol polyphosphate B-phosphatase I, which degrades inositol 1,4,5-trisphosphate (Ins(1,4,5)P-3), or heparin, a competitive inhibitor of the Ins(1,4,5)P-3 receptor. This indicates a requirement for Ins(1,4,5)P-3 to initiate and sustain Ca2+ responses even when PI 3-kinase is fully active. Antigen-induced cell ruffling, a calcium-independent event, is blocked by injection of p110 beta and p110 delta antibodies, but not by injection of B-phosphatase I, heparin, or anti-p110 alpha antibodies. These results suggest that the p110 beta and p110 delta isoforms of PI 3-kinase support Fc is an element of RI-induced calcium signaling by modulating Ins(1,4,5)P-3 production, not by directly regulating the Ca2+ influx channel.	Univ New Mexico, Sch Med, Cancc Res & Treatment Ctr, Albuquerque, NM 87107 USA; Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87107 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia	University of New Mexico; University of New Mexico; Yeshiva University; Albert Einstein College of Medicine; Monash University	Wilson, BS (corresponding author), Univ New Mexico, Canc Res Facil, Rm 205, Albuquerque, NM 87131 USA.			Smith, Alex/0000-0002-3034-9137; Mitchell, Christina A/0000-0001-9372-3192				Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Barker SA, 1999, J LEUKOCYTE BIOL, V65, P321, DOI 10.1002/jlb.65.3.321; BARKER SA, 1995, MOL BIOL CELL, V6, P1145, DOI 10.1091/mbc.6.9.1145; Barker SA, 1998, MOL BIOL CELL, V9, P483, DOI 10.1091/mbc.9.2.483; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Choi OH, 1996, NATURE, V380, P634; DeSmedt F, 1997, J BIOL CHEM, V272, P17367, DOI 10.1074/jbc.272.28.17367; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; FASOLATO C, 1993, J BIOL CHEM, V268, P20737; Fierro L, 2000, J PHYSIOL-LONDON, V522, P247, DOI 10.1111/j.1469-7793.2000.t01-1-00247.x; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Garcia RL, 1997, BIOCHEM BIOPH RES CO, V239, P279, DOI 10.1006/bbrc.1997.7458; Glitsch MD, 2000, J PHYSIOL-LONDON, V523, P283, DOI 10.1111/j.1469-7793.2000.t01-2-00283.x; Hill K, 2000, J BIOL CHEM, V275, P3741, DOI 10.1074/jbc.275.6.3741; HILL TD, 1987, BIOCHEM BIOPH RES CO, V149, P897, DOI 10.1016/0006-291X(87)90492-X; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Hooshmand-Rad R, 2000, J CELL SCI, V113, P207; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hsu AL, 2000, J BIOL CHEM, V275, P16242, DOI 10.1074/jbc.M002077200; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Johanson SO, 1999, EXP CELL RES, V248, P223, DOI 10.1006/excr.1999.4405; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; LEE RJ, 1995, MOL BIOL CELL, V6, P825, DOI 10.1091/mbc.6.7.825; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; LI W, 1992, MOL CELL BIOL, V12, P3176, DOI 10.1128/MCB.12.7.3176; Lu-Kuo JM, 2000, J BIOL CHEM, V275, P6022, DOI 10.1074/jbc.275.8.6022; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Majerus PW, 1996, GENE DEV, V10, P1051, DOI 10.1101/gad.10.9.1051; Malbec O, 1998, J IMMUNOL, V160, P1647; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Parekh AB, 1997, CELL, V89, P973, DOI 10.1016/S0092-8674(00)80282-2; PARK DJ, 1991, J BIOL CHEM, V266, P24237; Pasquet JM, 2000, EMBO J, V19, P2793, DOI 10.1093/emboj/19.12.2793; PFEIFFER JR, 1985, J CELL BIOL, V101, P2145, DOI 10.1083/jcb.101.6.2145; Rosado JA, 2000, BIOCHEM J, V350, P631, DOI 10.1042/0264-6021:3500631; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; SIRAGANIAN RP, 1975, J IMMUNOL, V115, P1599; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; WAHL MI, 1992, J BIOL CHEM, V267, P10447; Wilson BS, 1998, MOL BIOL CELL, V9, P1465, DOI 10.1091/mbc.9.6.1465; YANO H, 1993, J BIOL CHEM, V268, P25846; ZHANG L, 1995, J PHYSIOL-LONDON, V483, P59, DOI 10.1113/jphysiol.1995.sp020567; Zhou C, 1999, J BIOL CHEM, V274, P2786, DOI 10.1074/jbc.274.5.2786	45	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					17213	17220		10.1074/jbc.M100417200	http://dx.doi.org/10.1074/jbc.M100417200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11279065	hybrid			2022-12-27	WOS:000168730400082
J	Stoica, GE; Kuo, A; Aigner, A; Sunitha, I; Souttou, B; Malerczyk, C; Caughey, DJ; Wen, DZ; Karavanov, A; Riegel, AT; Wellstein, A				Stoica, GE; Kuo, A; Aigner, A; Sunitha, I; Souttou, B; Malerczyk, C; Caughey, DJ; Wen, DZ; Karavanov, A; Riegel, AT; Wellstein, A			Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE TYROSINE KINASE; NON-HODGKINS-LYMPHOMA; NIH 3T3 CELLS; SIGNAL-TRANSDUCTION; HEMATOPOIETIC-CELLS; NERVOUS-SYSTEM; UP-REGULATION; EGF RECEPTOR; IN-VIVO; PROTEIN	Pleiotrophin (PTN) is a secreted growth factor that induces neurite outgrowth and is mitogenic for fibroblasts, epithelial, and endothelial cells. During tumor growth PTN can serve as an angiogenic factor and drive tumor invasion and metastasis, To identify a receptor for PTN, we penned a phage display human cDNA library against immobilized PTN protein as a bait. From this we isolated a phage insert that was homologous to an amino acid sequence stretch in the extracellular domain (ECD) of the orphan receptor tyrosine kinase anaplastic lymphoma kinase (ALK), In parallel with PTN, ALK is highly expressed during perinatal development of the nervous system and down-modulated in the adult. Here we show in cell-free assays as well as in radioligand receptor binding studies in intact cells that PTN binds to the ALK ECD with an apparent K-d of 32 +/- 9 pM, This receptor binding is inhibited by an excess of PTN, by the ALK ECD, and by anti-PTN and anti-ECD antibodies. PTN added to ALK-expressing cells induces phosphorylation of both ALK and of the downstream effector molecules IRS-1, She, phospholipase C-gamma, and phosphatidylinositol 3-kinase, Furthermore, the growth stimulatory effect of PTN on different cell lines in culture coincides with the endogenous expression of ALK mRNA, and the effect of PTN is enhanced by ALK overexpression. From this we conclude that ALK is a receptor that transduces PTN-mediated signals and propose that the PTN-ALK axis can play a significant role during development and during disease processes.	Georgetown Univ, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA; AMGEN, Thousand Oaks, CA 91320 USA; Ciphergen Biosyst, Palo Alto, CA 94306 USA	Georgetown University; Amgen	Wellstein, A (corresponding author), Georgetown Univ, Vincent T Lombardi Canc Res Ctr, Res Bldg E311,3970 Reservoir Rd NW, Washington, DC 20007 USA.		Aigner, Achim/R-4429-2017	Aigner, Achim/0000-0002-2778-6256; Wellstein, Anton/0000-0002-0570-4950	NCI NIH HHS [CA58185] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058185] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; CHAUHAN AK, 1993, P NATL ACAD SCI USA, V90, P679, DOI 10.1073/pnas.90.2.679; Choudhuri R, 1997, CANCER RES, V57, P1814; COURTY J, 1991, BIOCHEM BIOPH RES CO, V180, P145, DOI 10.1016/S0006-291X(05)81267-7; CZUBAYKO F, 1994, J BIOL CHEM, V269, P21358; Czubayko F, 1996, P NATL ACAD SCI USA, V93, P14753, DOI 10.1073/pnas.93.25.14753; DIFIORE PP, 1990, SCIENCE, V248, P79, DOI 10.1126/science.2181668; Dove AQ, 1999, NAT BIOTECHNOL, V17, P233, DOI 10.1038/6972; FANG WJ, 1992, J BIOL CHEM, V267, P25889; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Hernandez L, 1999, BLOOD, V94, P3265; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; Ishiguro T, 1996, CANCER RES, V56, P875; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Kojima T, 1996, J BIOL CHEM, V271, P5914, DOI 10.1074/jbc.271.10.5914; KOZUTSUMI H, 1994, ONCOGENE, V9, P2991; KROLEWSKI JJ, 1991, EMBO J, V10, P2911, DOI 10.1002/j.1460-2075.1991.tb07841.x; Kuefer MU, 1997, BLOOD, V90, P2901, DOI 10.1182/blood.V90.8.2901; KUO MD, 1992, BIOCHEM BIOPH RES CO, V182, P188, DOI 10.1016/S0006-291X(05)80129-9; Lamant L, 1999, BLOOD, V93, P3088; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; LI YS, 1993, BIOCHEM BIOPH RES CO, V195, P1089, DOI 10.1006/bbrc.1993.2156; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Nakanishi T, 1997, J BIOCHEM-TOKYO, V121, P197; PIERCE JH, 1988, SCIENCE, V239, P628, DOI 10.1126/science.3257584; Pulford K, 1997, BLOOD, V89, P1394, DOI 10.1182/blood.V89.4.1394; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schulte AM, 1997, TUMOUR ANGIOGENESIS, P273; Schulte AM, 1996, P NATL ACAD SCI USA, V93, P14759, DOI 10.1073/pnas.93.25.14759; Souttou B, 1997, J BIOL CHEM, V272, P19588, DOI 10.1074/jbc.272.31.19588; Souttou B, 1998, J NATL CANCER I, V90, P1468, DOI 10.1093/jnci/90.19.1468; SPORN MB, 1985, NATURE, V313, P745, DOI 10.1038/313745a0; UENO H, 1995, J BIOL CHEM, V270, P20135, DOI 10.1074/jbc.270.34.20135; Ueno H, 1997, ONCOGENE, V14, P3067, DOI 10.1038/sj.onc.1201153; Ueno H, 1996, J BIOL CHEM, V271, P27707, DOI 10.1074/jbc.271.44.27707; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; Weber D, 2000, CANCER RES, V60, P5284; Wellmann A, 1997, FASEB J, V11, P965, DOI 10.1096/fasebj.11.12.9337149; WELLSTEIN A, 1992, J BIOL CHEM, V267, P2582; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; Yamakawa T, 1999, CANCER LETT, V135, P91; Yeh HJ, 1998, J NEUROSCI, V18, P3699; Zhang N, 1997, J BIOL CHEM, V272, P16733, DOI 10.1074/jbc.272.27.16733	49	307	341	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16772	16779		10.1074/jbc.M010660200	http://dx.doi.org/10.1074/jbc.M010660200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11278720	hybrid			2022-12-27	WOS:000168730400025
J	Peltier, JB; Ytterberg, J; Liberles, DA; Roepstorff, P; van Wijk, KJ				Peltier, JB; Ytterberg, J; Liberles, DA; Roepstorff, P; van Wijk, KJ			Identification of a 350-kDa ClpP protease complex with 10 different Clp isoforms in chloroplasts of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; ESCHERICHIA-COLI; POLYACRYLAMIDE GELS; MASS-SPECTROMETRY; GENE-EXPRESSION; PROTEINS; DEGRADATION; PROTEOMICS; COMPONENT; HOMOLOG	A 350-kDa ClpP protease complex with 10 different subunits was identified in chloroplast of Arabidopsis thaliana, using Blue-Native gel electrophoresis, followed by matrix-assisted laser desorption ionization time-of-flight and nano-electrospray tandem mass spectrometry. The complex was copurified with the thylakoid membranes, and all identified Clp subunits show chloroplast targeting signals, supporting that this complex is indeed localized in the chloroplast. The complex contains chloroplast-encoded pClpP and six nuclear-encoded proteins nCpP1-6, as well as two unassigned Clp homologues (nClpP7, nClpP8). An additional Clp protein was identified in this complex; it does not belong to any of the known Clp genes families and is here assigned ClpS1. Expression and accumulation of several of these Clp proteins have never been shown earlier. Sequence and phylogenetic tree analysis suggests that nClpP5, nClpP2, and nClpP8 are not catalytically active and form a new group of Clp higher plant proteins, orthologous to the cyanobacterial ClpR protein, and are renamed ClpR1, -2, and -3, respectively. We speculate that ClpR1, -2, and -3 are part of the heptameric rings, whereas ClpS1 is a regulatory subunit positioned at the axial opening of the ClpP/R core. Several truncations and errors in intron and exon prediction of the annotated Clp genes were corrected using mass spectrometry data and by matching genomic sequences with cDNA sequences. This strategy will be widely applicable for the much needed verification of protein prediction from genomic sequence. The extreme complexity of the chloroplast Clp complex is discussed.	Univ Stockholm, Arrhenius Labs, Dept Biochem, S-10691 Stockholm, Sweden; Univ Stockholm, Stockholm Bioinformat Ctr, S-10691 Stockholm, Sweden; Odense Univ, Dept Mol Biol, DK-5230 Odense M, Denmark	Stockholm University; Stockholm University; University of Southern Denmark	van Wijk, KJ (corresponding author), Cornell Univ, Dept Plant Biol, Emerson Bldg,3rd Fl,Tower Rd, Ithaca, NY 14853 USA.	kv35@cornell.edu	Ytterberg, Anders/E-1773-2016	Ytterberg, Anders/0000-0002-1485-2314; Peltier, Jean-Benoit/0000-0001-6656-6072				Abdallah F, 2000, TRENDS PLANT SCI, V5, P141, DOI 10.1016/S1360-1385(00)01574-0; Adam Z, 2000, BIOCHIMIE, V82, P647, DOI 10.1016/S0300-9084(00)00612-X; Adam Z, 2001, PLANT PHYSIOL, V125, P1912, DOI 10.1104/pp.125.4.1912; Benner SA, 2000, RES MICROBIOL, V151, P97, DOI 10.1016/S0923-2508(00)00123-6; Burlingame AL, 1998, ANAL CHEM, V70, p647R; Clarke AK, 1999, ANN BOT-LONDON, V83, P593, DOI 10.1006/anbo.1999.0878; Clarke AK, 1998, PLANT MOL BIOL, V37, P791, DOI 10.1023/A:1006016302074; DAMERAU K, 1993, J BACTERIOL, V175, P53, DOI 10.1128/JB.175.1.53-63.1993; Desimone M, 1997, BOT ACTA, V110, P234, DOI 10.1111/j.1438-8677.1997.tb00634.x; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Halperin T, 1996, PLANT MOL BIOL, V30, P925, DOI 10.1007/BF00020804; HUANG CZ, 1994, MOL GEN GENET, V244, P151, DOI 10.1007/BF00283516; Jensen ON, 1998, PROTEINS, P74; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; LIU XQ, 1984, FEBS LETT, V166, P248; Majeran W, 2000, PLANT CELL, V12, P137; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; MAURIZI MR, 1990, J BIOL CHEM, V265, P12536; Miller JD, 1999, PLANT PHYSIOL, V120, P1015, DOI 10.1104/pp.120.4.1015; Missiakas D, 1996, EMBO J, V15, P6899, DOI 10.1002/j.1460-2075.1996.tb01082.x; MOORE T, 1993, PLANT MOL BIOL, V21, P525, DOI 10.1007/BF00028809; Nakabayashi K, 1999, PLANT CELL PHYSIOL, V40, P504, DOI 10.1093/oxfordjournals.pcp.a029571; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Peltier JB, 2000, PLANT CELL, V12, P319, DOI 10.1105/tpc.12.3.319; RABILLOUD T, 1994, CELL MOL BIOL, V40, P57; Santagata S, 1999, J BIOL CHEM, V274, P16311, DOI 10.1074/jbc.274.23.16311; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; SHANKLIN J, 1995, PLANT CELL, V7, P1713, DOI 10.1105/tpc.7.10.1713; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sokolenko A, 1998, PLANTA, V207, P286, DOI 10.1007/s004250050485; van Dyck L, 1998, FEBS LETT, V438, P250, DOI 10.1016/S0014-5793(98)01310-6; van Wijk KJ, 2000, TRENDS PLANT SCI, V5, P420, DOI 10.1016/S1360-1385(00)01737-4; VANWIJK KJ, 2001, REGULATORY ASPECTS P, V8; Weaver LM, 1999, PLANT PHYSIOL, V119, P1209, DOI 10.1104/pp.119.4.1209; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Yona G, 1999, PROTEINS, V37, P360, DOI 10.1002/(SICI)1097-0134(19991115)37:3<360::AID-PROT5>3.0.CO;2-Z	45	90	107	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16318	16327		10.1074/jbc.M010503200	http://dx.doi.org/10.1074/jbc.M010503200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11278690	hybrid			2022-12-27	WOS:000168623100100
J	Fang, X; Kaduce, TL; Weintraub, NL; Harmon, S; Teesch, LM; Morisseau, C; Thompson, DA; Hammock, BD; Spector, AA				Fang, X; Kaduce, TL; Weintraub, NL; Harmon, S; Teesch, LM; Morisseau, C; Thompson, DA; Hammock, BD; Spector, AA			Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells - Implications for the vascular effects of soluble epoxide hydrolase inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKIN FIBROBLASTS; ARTERIAL SMOOTH-MUSCLE; ARACHIDONIC-ACID; 11,12-EPOXYEICOSATRIENOIC ACID; PEROXISOMAL OXIDATION; FATTY-ACIDS; CYTOCHROME-P450 METABOLITES; BETA-OXIDATION; CONVERSION; MONOOXYGENASE	Epoxyeicosatrienoic acids (EETs) are products of cytochrome P-450 epoxygenase that possess important vasodilating and anti-inflammatory properties. EETs are converted to the corresponding dihydroxyeicosatrienoic acid (DHET) by soluble epoxide hydrolase (sEH) in mammalian tissues, and inhibition of sEH has been proposed as a novel approach for the treatment of hypertension, We observed that sEH is present in porcine coronary endothelial cells (PCEC), and we found that low concentrations of N,N'-dicyclohexylurea (DCU), a selective sEH inhibitor, have profound effects on EET metabolism in PCEC cultures. Treatment with 3 muM DCU reduced cellular conversion of 14,15-EET to 14,15-DHET by 3-fold after 4 h of incubation, with a concomitant increase in the formation of the novel beta -oxidation products 10,11-epoxy-16:2 and 8,9-epoxy-14:1, DCU also markedly enhanced the incorporation of 14,18-EET and its metabolites into PCEC lipids. The most abundant product in DCU treated cells was 16,17-epoxy-22:3, the elongation product of 14,15-EET, Another novel metabolite, 14,15-epoxy-20:2, was present in DCU-treated cells. DCU also caused a 4-fold increase in release of 14,15-EET when the cells were stimulated with a calcium ionophore, Furthermore, DCU decreased the conversion of [H-3]11,12-EET to 11,12-DHET, increased 11,12-EET retention in PCEC lipids, and produced an accumulation of the partial S-oxidation product 7,8-epoxy-16:2 in the medium. These findings suggest that in addition to being metabolized by sEH, EETs are substrates for beta -oxidation and chain elongation in endothelial cells and that there is considerable interaction among the three pathways. The modulation of EET metabolism by DCU provides novel insight into the mechanisms by which pharmacological or molecular inhibition of sEH effectively treats hypertension.	Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Mol Anal Facil, Iowa City, IA 52242 USA; Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Canc Res, Davis, CA 95616 USA	University of Iowa; University of Iowa; University of Iowa; University of California System; University of California Davis; University of California System; University of California Davis	Spector, AA (corresponding author), Univ Iowa, Coll Med, Dept Biochem, 4-403 BSB, Iowa City, IA 52242 USA.	arthur-spector@uiowa.edu	Spector, Arthur/AAG-9860-2020	Weintraub, Neal/0000-0002-5138-3705	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062984, P01HL049264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R01ES002710, P30ES005707] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL49264, HL07013, HL62984] Funding Source: Medline; NIEHS NIH HHS [P30 ES05707, P42 ES04699, R01 ES02710] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADAMS J, 1988, ORG MASS SPECTROM, V23, P307, DOI 10.1002/oms.1210230505; BERNSTROM K, 1991, ANAL BIOCHEM, V198, P203, DOI 10.1016/0003-2697(91)90530-7; BORHAN B, 1995, ANAL BIOCHEM, V231, P188, DOI 10.1006/abio.1995.1520; Bylund J, 1998, ANAL BIOCHEM, V265, P55, DOI 10.1006/abio.1998.2897; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Capdevila JH, 2000, J LIPID RES, V41, P163; CARROLL MA, 1987, EUR J PHARMACOL, V138, P281, DOI 10.1016/0014-2999(87)90445-6; CHACOS N, 1983, ARCH BIOCHEM BIOPHYS, V223, P639, DOI 10.1016/0003-9861(83)90628-8; FALCK JR, 1990, METHOD ENZYMOL, V187, P357; FANG X, 1995, J LIPID RES, V36, P1236; Fang X, 1999, J LIPID RES, V40, P699; Fang X, 2000, J LIPID RES, V41, P66; Fang X, 1996, CIRC RES, V79, P784, DOI 10.1161/01.RES.79.4.784; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; GORDON JA, 1994, J BIOL CHEM, V269, P4103; GUENTHNER TM, 1986, BIOCHEM PHARMACOL, V35, P839, DOI 10.1016/0006-2952(86)90253-4; GUENTHNER TM, 1986, DRUG METAB DISPOS, V14, P208; HARDER DR, 1995, J VASC RES, V32, P79, DOI 10.1159/000159080; Hoebel BG, 1998, EUR J PHARMACOL, V346, P115, DOI 10.1016/S0014-2999(98)00118-6; HU SL, 1993, EUR J PHARMACOL, V230, P215, DOI 10.1016/0014-2999(93)90805-R; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; MEIJER J, 1988, CHEM-BIOL INTERACT, V64, P207, DOI 10.1016/0009-2797(88)90100-7; Mombouli JV, 1999, J CARDIOVASC PHARM, V33, P779, DOI 10.1097/00005344-199905000-00015; Morisseau C, 1999, P NATL ACAD SCI USA, V96, P8849, DOI 10.1073/pnas.96.16.8849; MULLIN CA, 1982, ARCH BIOCHEM BIOPHYS, V216, P423, DOI 10.1016/0003-9861(82)90231-4; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Oltman CL, 1998, CIRC RES, V83, P932; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; PFISTER SL, 1991, AM J PHYSIOL, V261, pH843, DOI 10.1152/ajpheart.1991.261.3.H843; PROCTOR KG, 1987, CIRC RES, V60, P50, DOI 10.1161/01.RES.60.1.50; Quilley J, 2000, TRENDS PHARMACOL SCI, V21, P121, DOI 10.1016/S0165-6147(00)01445-0; Rosolowsky M, 1996, BBA-LIPID LIPID MET, V1299, P267, DOI 10.1016/0005-2760(95)00216-2; SHEN XY, 1988, BIOCHEMISTRY-US, V27, P996, DOI 10.1021/bi00403a024; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; SPECTOR AA, 1988, PROG LIPID RES, V27, P271, DOI 10.1016/0163-7827(88)90009-4; Spector AA, 1999, PROSTAG LEUKOTR ESS, V60, P377, DOI 10.1016/S0952-3278(99)80016-7; Spector AA, 1997, PROSTAG LEUKOTR ESS, V57, P101, DOI 10.1016/S0952-3278(97)90499-3; VanRollins M, 1996, J BIOL CHEM, V271, P14001, DOI 10.1074/jbc.271.24.14001; VANROLLINS M, 1993, J LIPID RES, V34, P1931; Weintraub NL, 1999, AM J PHYSIOL-HEART C, V277, pH2098, DOI 10.1152/ajpheart.1999.277.5.H2098; Weintraub NL, 1997, CIRC RES, V81, P258, DOI 10.1161/01.RES.81.2.258; Williard DE, 1998, J LIPID RES, V39, P978; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402	44	174	180	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14867	14874		10.1074/jbc.M011761200	http://dx.doi.org/10.1074/jbc.M011761200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278979	hybrid			2022-12-27	WOS:000168528800047
J	Graves, JD; Draves, KE; Gotoh, Y; Krebs, EG; Clark, EA				Graves, JD; Draves, KE; Gotoh, Y; Krebs, EG; Clark, EA			Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; ACTIVATION; FAMILY; INDUCTION; MST/KRS; DOMAIN; PAK	The serine/threonine kinase Mst1, a mammalian homolog of the budding yeast Ste20 kinase, is cleaved by caspase-mediated proteolysis in response to apoptotic stimuli such as ligation of CD95/Fas or treatment with staurosporine. Furthermore, overexpression of Mst1 induces morphological changes characteristic of apoptosis in human B lymphoma cells. Mst1 may therefore represent an important target for caspases during cell death which serves to amplify the apoptotic response. Here we report that Mst1 has two caspase cleavage sites, and we present evidence indicating that cleavage may occur in an ordered fashion and be mediated by distinct caspases, We also show that caspase-mediated cleavage alone is insufficient to activate Mst1, suggesting that full activation of Mst1 during apoptosis requires both phosphorylation and proteolysis, Another role of phosphorylation may be to influence the susceptibility of Mst1 to proteolysis. Autophosphorylation of Mst1 on a serine residue close to one of the caspase sites inhibited caspase-mediated cleavage in vitro, Finally, Mst1 appears to function upstream of the protein kinase MEKK1 in the SAPK pathway. In conclusion, Mst1 activity is regulated by both phosphorylation and proteolysis, suggesting that protein kinase and caspase pathways work in concert to regulate cell death.	Univ Washington, Med Ctr, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Pharmacol, Seattle, WA 98195 USA; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1138654, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Tokyo	Graves, JD (corresponding author), Univ Washington, Med Ctr, Dept Immunol, Hlth Sci Bldg,Box 357330, Seattle, WA 98195 USA.		Clark, Edward/K-3462-2012	Clark, Edward A/0000-0001-8061-5475	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058487] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI44250] Funding Source: Medline; NIGMS NIH HHS [R01GM58487] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arch RH, 1999, ANNU REV CELL DEV BI, V15, P113, DOI 10.1146/annurev.cellbio.15.1.113; Barkett M, 1997, J BIOL CHEM, V272, P29419, DOI 10.1074/jbc.272.47.29419; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Daum G, 1997, CIRC RES, V81, P17, DOI 10.1161/01.RES.81.1.17; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; Kakeya H, 1999, ANN NY ACAD SCI, V886, P273, DOI 10.1111/j.1749-6632.1999.tb09434.x; Krebs EG, 2000, ADV ENZYME REGUL, V40, P441, DOI 10.1016/S0065-2571(99)00030-8; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; LIOU J, 2000, J BIOL CHEM, V275, P25850; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sabourin LA, 2000, MOL CELL BIOL, V20, P684, DOI 10.1128/MCB.20.2.684-696.2000; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; SIDORENKO SP, 1992, NEOPLASMA, V39, P3; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Walter BN, 1998, J BIOL CHEM, V273, P28733, DOI 10.1074/jbc.273.44.28733	30	122	131	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14909	14915		10.1074/jbc.M010905200	http://dx.doi.org/10.1074/jbc.M010905200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11278782	hybrid			2022-12-27	WOS:000168528800053
J	Albsoul-Younes, AM; Sternweis, PM; Zhao, P; Nakata, H; Nakajima, S; Nakajima, Y; Kozasa, T				Albsoul-Younes, AM; Sternweis, PM; Zhao, P; Nakata, H; Nakajima, S; Nakajima, Y; Kozasa, T			Interaction sites of the G protein beta subunit with brain G protein-coupled inward rectifier K+ channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNITS; POTASSIUM CHANNEL; ACTIVATION; BINDING; INHIBITION; EXPRESSION; MEMBRANE; NEURONS; CELLS	G protein-coupled inward rectifier K+ channels (GIRK channels) are activated directly by the G protein Py subunit, The crystal structure of the G protein py subunits reveals that the beta subunit consists of an N-terminal a helix followed by a symmetrical seven-bladed propeller structure. Each blade is made up of four antiparallel P strands. The top surface of the propeller structure interacts with the G alpha subunit, The outer surface of the py torus is largely made from outer beta strands of the propeller. We analyzed the interaction between the beta subunit and brain GIRK channels by mutating the outer surface of the py torus, Mutants of the outer surface of the beta, subunit were generated by replacing the sequences at the outer p strands of each blade with corresponding sequences of the yeast P subunit, STE4, The mutant beta (1)gamma (2) subunits were expressed in and purified from Sf9 cells. They were applied to inside-out patches of cultured locus coeruleus neurons, The wild type Ply, induced robust GIRK channel activity with an EC50 of about 4 nM, Among the eight outer surface mutants tested, blade 1 and blade 2 mutants (D1 and CD2) were far less active than the wild type in stimulating GIRK channels. However, the ability of I)1 and CD2 to regulate type I and type II adenylyl cyclases was not very different from that of the wild type beta (1)gamma (2), As to the activities to stimulate phospholipase C beta (2) D1 was more potent and CD2 was less potent than the wild type beta (1)gamma (2),. Additionally we tested four beta (1) mutants in which mutated residues are located in the top G alpha/beta interacting surface, Among them, mutant W332A showed far less ability than the wild type to activate GIRK channels. These results suggest that the outer surface of blade 1 and blade 2 of the beta subunit might specifically interact with GIRK and that the beta subunit interacts with GIRK both over the outer surface and over the top G alpha interacting surface.	Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Kozasa, T (corresponding author), 835 S Wolcott Ave, Chicago, IL 60612 USA.	tkozas@uic.edu	Albsoul, Abla/AAU-9751-2020	Albsoul, Abla/0000-0002-4749-4066	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006093] Funding Source: NIH RePORTER; NIA NIH HHS [AG06093] Funding Source: Medline; NIGMS NIH HHS [GM61454] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Grigg JJ, 1996, J NEUROPHYSIOL, V75, P318, DOI 10.1152/jn.1996.75.1.318; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LEBERER E, 1992, EMBO J, V11, P4805, DOI 10.1002/j.1460-2075.1992.tb05586.x; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; LOGOTHETIS DE, 1988, P NATL ACAD SCI USA, V85, P5814, DOI 10.1073/pnas.85.16.5814; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MASUKO S, 1986, J NEUROSCI, V6, P3229; Nakajima Y, 1996, NEUROSCI RES, V26, P195, DOI 10.1016/S0168-0102(96)01101-7; Nakajima Y, 1996, FEBS LETT, V390, P217, DOI 10.1016/0014-5793(96)00661-8; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; Peng LY, 2000, BIOPHYS J, V78, p465A; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; Summers MD, 1987, TEXAS AGR EXPT STATI; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0	25	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12712	12717		10.1074/jbc.M011231200	http://dx.doi.org/10.1074/jbc.M011231200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278861	hybrid			2022-12-27	WOS:000168198600034
J	Govaerts, C; Blanpain, C; Deupi, X; Ballet, S; Ballesteros, JA; Wodak, SJ; Vassart, G; Pardo, L; Parmentier, M				Govaerts, C; Blanpain, C; Deupi, X; Ballet, S; Ballesteros, JA; Wodak, SJ; Vassart, G; Pardo, L; Parmentier, M			The TXP motif in the second transmembrane helix of CCR5 - A structural determinant of chemokine-induced activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; MEMBRANE-SPANNING SEGMENT; BINDING-SITE CREVICE; MONOCYTE CHEMOTACTIC PROTEIN-1; BETA(2) ADRENERGIC-RECEPTOR; SMALL-MOLECULE INHIBITOR; DOPAMINE D2 RECEPTOR; ALPHA-HELICES; CONFORMATIONAL-CHANGES; HIV-1 ENTRY	CCR5 is a G-protein-coupled receptor activated by the chemokines RANTES (regulated on activation normal T cell expressed and secreted), macrophage inflammatory protein Icu and Ip, and monocyte chemotactic protein 2 and is the main co-receptor for the macrophage-tropic human immunodeficiency virus strains. We have identified a sequence motif (TXP) in the second transmembrane helix of chemokine receptors and investigated its role by theoretical and experimental approaches. Molecular dynamics simulations of model cy-helices in a nonpolar environment were used to show that a TXP motif strongly bends these helices, due to the coordinated action of the proline, which kinks the helix, and of the threonine, which further accentuates this structural deformation. Site-directed mutagenesis of the corresponding Pro and Thr residues in CCR5 allowed us to probe the consequences of these structural findings in the context of the whole receptor. The P84A mutation leads to a decreased binding affinity for chemokines and nearly abolishes the functional response of the receptor. In contrast, mutation of Thr-82(2.56) into Val, Ala, Cys, or Ser does not affect chemokine binding. However, the functional response was found to depend strongly on the nature of the substituted side chain. The rank order of impairment of receptor activation is P84A > T82V > T82A > T82C > T82S. This ranking of impairment parallels the bending of the alpha -helix observed in the molecular simulation study.	Free Univ Brussels, Inst Rech Interdisciplinary Biol Humaine & Nucl, B-1070 Brussels, Belgium; Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Spain; Free Univ Brussels, Serv Conformat Macromol Biol, B-1050 Brussels, Belgium; Novasite Pharmaceut Inc, San Diego, CA 92121 USA	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Autonomous University of Barcelona; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Parmentier, M (corresponding author), Free Univ Brussels, Inst Rech Interdisciplinary Biol Humaine & Nucl, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.		Deupi, Xavier/B-2424-2009; Blanpain, Cedric/ABD-8392-2021	Deupi, Xavier/0000-0003-4572-9316; wodak, shoshana/0000-0002-0701-6545; Parmentier, Marc/0000-0001-8081-4685; Pardo, Leonardo/0000-0003-1778-7420				Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Blanpain C, 1999, BLOOD, V94, P1899; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Blanpain C, 1999, J BIOL CHEM, V274, P34719, DOI 10.1074/jbc.274.49.34719; BLUNDELL T, 1983, NATURE, V306, P281, DOI 10.1038/306281a0; CASE DA, 1997, AMBER5; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; ELLING CE, 1995, NATURE, V374, P74, DOI 10.1038/374074a0; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; Han KH, 1999, J BIOL CHEM, V274, P32055, DOI 10.1074/jbc.274.45.32055; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Hesselgesser J, 1998, J BIOL CHEM, V273, P15687, DOI 10.1074/jbc.273.25.15687; HOM F, 1998, NUCLEIC ACIDS RES, V26, P275; Hong SH, 1997, J BIOL CHEM, V272, P4166, DOI 10.1074/jbc.272.7.4166; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; Javitch JA, 1995, BIOCHEMISTRY-US, V34, P16433, DOI 10.1021/bi00050a026; Javitch JA, 1998, BIOCHEMISTRY-US, V37, P998, DOI 10.1021/bi972241y; Javitch JA, 1999, BIOCHEMISTRY-US, V38, P7961, DOI 10.1021/bi9905314; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; KOLAKOWSKI LF, 1995, J BIOL CHEM, V270, P18077, DOI 10.1074/jbc.270.30.18077; LAROSA GJ, 1992, J BIOL CHEM, V267, P25402; Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4; MCGREGOR MJ, 1987, J MOL BIOL, V198, P295, DOI 10.1016/0022-2836(87)90314-7; Mirzadegan T, 2000, J BIOL CHEM, V275, P25562, DOI 10.1074/jbc.M000692200; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Ri Y, 1999, BIOPHYS J, V76, P2887, DOI 10.1016/S0006-3495(99)77444-8; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934; Sheikh SP, 1999, J BIOL CHEM, V274, P17033, DOI 10.1074/jbc.274.24.17033; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Stables J, 1997, ANAL BIOCHEM, V252, P115, DOI 10.1006/abio.1997.2308; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; Tonacchera M, 1998, J CLIN ENDOCR METAB, V83, P492, DOI 10.1210/jc.83.2.492; Unger VM, 1997, NATURE, V389, P203, DOI 10.1038/38316; Vichi P, 1999, J BIOL CHEM, V274, P10331, DOI 10.1074/jbc.274.15.10331; WESS J, 1993, EMBO J, V12, P331, DOI 10.1002/j.1460-2075.1993.tb05661.x; Wintjens RT, 1996, J MOL BIOL, V255, P235, DOI 10.1006/jmbi.1996.0020; WOOLFSON DN, 1990, FEBS LETT, V277, P185, DOI 10.1016/0014-5793(90)80839-B; YUN RH, 1991, PROTEINS, V10, P219, DOI 10.1002/prot.340100306	59	117	120	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13217	13225		10.1074/jbc.M011670200	http://dx.doi.org/10.1074/jbc.M011670200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278962	hybrid			2022-12-27	WOS:000168198600104
J	Johnson, KE; Rajagopalan, KV				Johnson, KE; Rajagopalan, KV			An active site tyrosine influences the ability of the dimethyl sulfoxide reductase family of molybdopterin enzymes to reduce S-oxides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-ABSORPTION SPECTROSCOPY; IRON-SULFUR MOLYBDOENZYME; F-SP DENITRIFICANS; ESCHERICHIA-COLI; DIMETHYLSULFOXIDE REDUCTASE; RHODOBACTER-SPHAEROIDES; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; DMSO REDUCTASE; ANGSTROM RESOLUTION	Dimethyl sulfoxide reductase (DMSOR), trimethylamine-N-oxide reductase (TMAOR), and biotin sulfoxide reductase (BSOR) are members of a class of bacterial oxotransferases that contain the bis(molybdopterin guanine dinucleotide)molybdenum cofactor. The presence of a Tyr residue in the active site of DMSOR and BSOR that is missing in TMAOR has been implicated in the inability of TMAOR, unlike DMSOR and BSOR, to utilize S-oxides. To test this hypothesis, Escherichia coli TMAOR was cloned and expressed at high levels, and site-directed mutagenesis was utilized to generate the Tyr-114 --> Ala and Phe variants of Rhodobacter sphaeroides DMSOR and insert a Tyr residue into the equivalent position in TMAOR. Although all of the mutants turn over in a manner similar to their respective wildtype enzymes, mutation of Tyr-114 in DMSOR results in a decreased specificity for S-oxides and an increased specificity for trimethylamine-N-oxide (Me3NO), with a greater change observed for DMSOR-Y114A. Insertion of a Tyr into TMAOR results in a decreased preference for Me3NO relative to dimethyl sulfoxide. Kinetic analysis and UV-visible absorption spectra indicate that the ability of DMSOR to be reduced by dimethyl sulfide is lost upon mutation of Tyr-114 and that TMAOR does not exhibit this activity even in the Tyr insertion mutant.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Rajagopalan, KV (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.				NIGMS NIH HHS [GM00091] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams B, 1999, BIOCHEMISTRY-US, V38, P8501, DOI 10.1021/bi9902034; Bastian NR, 1995, BIOFACTORS, V5, P5; BASTIAN NR, 1991, J BIOL CHEM, V266, P45; Baugh PE, 1997, J BIOL INORG CHEM, V2, P634, DOI 10.1007/s007750050178; BENNETT B, 1994, EUR J BIOCHEM, V225, P321, DOI 10.1111/j.1432-1033.1994.00321.x; Buc J, 1999, MOL MICROBIOL, V32, P159, DOI 10.1046/j.1365-2958.1999.01340.x; Czjzek M, 1998, J MOL BIOL, V284, P435, DOI 10.1006/jmbi.1998.2156; Dos Santos JP, 1998, J MOL BIOL, V284, P421, DOI 10.1006/jmbi.1998.2155; Garton SD, 1997, J AM CHEM SOC, V119, P12906, DOI 10.1021/ja972109l; Garton SD, 2000, J BIOL CHEM, V275, P6798, DOI 10.1074/jbc.275.10.6798; George GN, 1996, J AM CHEM SOC, V118, P1113, DOI 10.1021/ja953317l; George GN, 1999, J AM CHEM SOC, V121, P1256, DOI 10.1021/ja982843k; Hilton JC, 1999, J BIOL CHEM, V274, P8428, DOI 10.1074/jbc.274.13.8428; Hilton JC, 1996, BBA-PROTEIN STRUCT M, V1294, P111, DOI 10.1016/0167-4838(96)00015-5; Hilton JC, 1996, ARCH BIOCHEM BIOPHYS, V325, P139, DOI 10.1006/abbi.1996.0017; HUNGKEI L, 2000, J AM CHEM SOC, V122, P7673; IobbiNivol C, 1996, BBA-PROTEIN STRUCT M, V1294, P77, DOI 10.1016/0167-4838(95)00271-5; McAlpine AS, 1997, J BIOL INORG CHEM, V2, P690, DOI 10.1007/s007750050185; McAlpine AS, 1998, J MOL BIOL, V275, P613, DOI 10.1006/jmbi.1997.1513; MEJEAN V, 1994, MOL MICROBIOL, V11, P1169, DOI 10.1111/j.1365-2958.1994.tb00393.x; PIERSON DE, 1990, J BACTERIOL, V172, P2194, DOI 10.1128/jb.172.4.2194-2198.1990; Pollock VV, 2000, J BIOL CHEM, V275, P35086, DOI 10.1074/jbc.M006872200; Pollock VV, 1997, J BIOL CHEM, V272, P3355, DOI 10.1074/jbc.272.6.3355; SATOH T, 1987, J BIOCHEM-TOKYO, V102, P191, DOI 10.1093/oxfordjournals.jbchem.a122032; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schneider F, 1996, J MOL BIOL, V263, P53, DOI 10.1006/jmbi.1996.0555; SHIMOKAWA O, 1979, J BIOCHEM, V86, P1709, DOI 10.1093/oxfordjournals.jbchem.a132691; SILVESTRO A, 1988, BIOCHIM BIOPHYS ACTA, V954, P1, DOI 10.1016/0167-4838(88)90049-0; SILVESTRO A, 1989, BIOCHIM BIOPHYS ACTA, V999, P208, DOI 10.1016/0167-4838(89)90220-3; Simala-Grant JL, 1998, EUR J BIOCHEM, V251, P510, DOI 10.1046/j.1432-1327.1998.2510510.x; Stewart LJ, 2000, J MOL BIOL, V299, P593, DOI 10.1006/jmbi.2000.3702; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; Temple CA, 2000, BIOCHEMISTRY-US, V39, P4046, DOI 10.1021/bi9921541; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Temple CA, 2000, J BIOL CHEM, V275, P40202, DOI 10.1074/jbc.M007407200; WEINER JH, 1992, BIOCHIM BIOPHYS ACTA, V1102, P1, DOI 10.1016/0167-4838(92)90493-W; WEINER JH, 1988, J BACTERIOL, V170, P1505, DOI 10.1128/jb.170.4.1505-1510.1988; YAMAMOTO I, 1986, J BIOCHEM, V99, P1773, DOI 10.1093/oxfordjournals.jbchem.a135655	38	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13178	13185		10.1074/jbc.M010965200	http://dx.doi.org/10.1074/jbc.M010965200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11278798	hybrid			2022-12-27	WOS:000168198600099
J	Sugimoto, H; Bakovic, M; Yamashita, S; Vance, DE				Sugimoto, H; Bakovic, M; Yamashita, S; Vance, DE			Identification of transcriptional enhancer factor-4 as a transcriptional modulator of CTP : phosphocholine cytidylyltransferase alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CTP; DNA-BINDING; CTPPHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PHOSPHORYLCHOLINE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHORYLATION SITES; MOLECULAR-CLONING; FACTOR-I; PROTEIN; GENE	CTP:phosphocholine cytidylyltransferase (CCT) is the rate-limiting and regulated enzyme of mammalian phosphatidylcholine biosynthesis. There are three isoforms, CCT alpha, CCT beta1, and CCT beta2. The mouse CCT alpha gene promoter is regulated by an enhancer element (Eb) located between -103 and -82 base pairs (5'-GTTTTCAGGAAT-GCGGAGGTGG-3') upstream from the transcriptional start site (Bakovic, M., Waite, K., Tang, W., Tabas, I., and Vance, D. E. (1999) Biochim. Biophys. Acta 1436, 147-165). To identify the Eb-binding protein(s), we screened a mouse embryo cDNA library by the yeast one-hybrid system and obtained 19 positive clones. Ten cDNA clones were identified as transcriptional enhancer factor-4 (TEF-4). The TEF-binding consensus sequence, 5'-(A/T)(A/G)(A/G) (APT)ATG(CIT) (G/A)-3', was identified within the Eb binding region. Gel-shift analysis using radiolabeled Eb fragment as a probe showed that cell extracts from yeast expressing hemagglutinin-tagged TEF-4 caused a marked band retardation that could be prevented with an anti-hemagglutinin antibody. When COS-7 cells were transfected with TEF-4, CCT alpha promoter-luciferase reporter activity and CCT alpha mRNA levels increased. A TEF-4 deletion mutant containing a DNA-binding domain, mTEA(+), stimulated the CCT alpha promoter activity, whereas protein lacking the DNA binding domain, mTEA(-), did not. Unexpectedly, when the ATG core of the TEF-4 binding consensus within the Eb region was mutated, promoter activity was enhanced rather than decreased. Thus, TEF-4 might act as a dual transcriptional modulator as follows: as a suppressor via its direct binding to the Eb element and as an activator via its interactions with the basal transcriptional machinery. These results provide the first evidence that TEF-4 is an important regulator of CCT alpha gene expression.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; Univ Alberta, CIHR Grp Mol & Cell Biol Lipids, Heritage Med Res Ctr 328, Edmonton, AB T6G 2S2, Canada; Univ Guelph, Dept Human Biol & Nutr Sci, Guelph, ON N1G 2W1, Canada; Gunma Univ, Sch Med, Dept Biochem, Maebashi, Gumma 3718511, Japan	University of Alberta; University of Alberta; University of Guelph; Gunma University	Vance, DE (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca						ADAMS MD, 1992, NATURE, V357, P367, DOI 10.1038/357367b0; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ARNDT KT, 1987, SCIENCE, V237, P874, DOI 10.1126/science.3303332; Arnold RS, 1997, BIOCHEMISTRY-US, V36, P6149, DOI 10.1021/bi970023z; Bakovic M, 1999, BBA-MOL CELL BIOL L, V1438, P147, DOI 10.1016/S1388-1981(99)00042-6; Bakovic M, 2000, J LIPID RES, V41, P583; Belandia B, 2000, J BIOL CHEM, V275, P30801, DOI 10.1074/jbc.C000484200; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; FELDMAN DA, 1987, J BIOL CHEM, V262, P9075; FUJITA Y, 1994, BIOCHEM BIOPH RES CO, V199, P706, DOI 10.1006/bbrc.1994.1286; Gupta MP, 1997, MOL CELL BIOL, V17, P3924, DOI 10.1128/MCB.17.7.3924; GUPTA MP, 1994, J BIOL CHEM, V269, P29677; Hogan M, 1996, BIOCHEM J, V314, P799, DOI 10.1042/bj3140799; HOUWELING M, 1994, J BIOL CHEM, V269, P7544; Houweling M, 1997, BBA-LIPID LIPID MET, V1346, P1, DOI 10.1016/S0005-2760(97)00011-8; HOUWELING M, 1993, EUR J BIOCHEM, V214, P927, DOI 10.1111/j.1432-1033.1993.tb17996.x; HWANG JJ, 1993, EMBO J, V12, P2337, DOI 10.1002/j.1460-2075.1993.tb05888.x; ISHIJI T, 1992, EMBO J, V11, P2271, DOI 10.1002/j.1460-2075.1992.tb05286.x; Jacquemin P, 1996, J BIOL CHEM, V271, P21775, DOI 10.1074/jbc.271.36.21775; Jacquemin P, 1997, J BIOL CHEM, V272, P12928, DOI 10.1074/jbc.272.20.12928; Jiang SW, 1996, J BIOL CHEM, V271, P9510, DOI 10.1074/jbc.271.16.9510; Jiang SW, 2000, BIOCHEMISTRY-US, V39, P3505, DOI 10.1021/bi991048w; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KALMAR GB, 1990, P NATL ACAD SCI USA, V87, P6029, DOI 10.1073/pnas.87.16.6029; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; Lykidis A, 1999, J BIOL CHEM, V274, P26992, DOI 10.1074/jbc.274.38.26992; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MARTINA H, 1994, AM J PHYSIOL, V267, pL25; PELECH SL, 1982, J BIOL CHEM, V257, P4198; Sesca E, 1996, BIOCHEM BIOPH RES CO, V229, P158, DOI 10.1006/bbrc.1996.1773; SHIMIZU N, 1993, NUCLEIC ACIDS RES, V21, P4103, DOI 10.1093/nar/21.17.4103; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; SONG CZ, 1994, J BIOL CHEM, V269, P26976; Tang W, 1997, J BIOL CHEM, V272, P13146, DOI 10.1074/jbc.272.20.13146; TESSNER TG, 1991, J BIOL CHEM, V266, P16261; VANCE DE, 1996, BIOCH LIPIDS LIPOPRO, P153; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; WANG YL, 1995, J BIOL CHEM, V270, P17843, DOI 10.1074/jbc.270.30.17843; WEINHOLD PA, 1986, J BIOL CHEM, V261, P5104; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; YANG W, 1995, J BIOL CHEM, V270, P16503, DOI 10.1074/jbc.270.28.16503; YASUNAMI M, 1995, J BIOL CHEM, V270, P18649, DOI 10.1074/jbc.270.31.18649; ZINN AR, 1991, GENOMICS, V11, P1097, DOI 10.1016/0888-7543(91)90037-F	53	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12338	12344		10.1074/jbc.M100090200	http://dx.doi.org/10.1074/jbc.M100090200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11279002	hybrid			2022-12-27	WOS:000168081800120
